Citrus Sinensis ID: 039419

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030-----
Protein Sequence
SSSIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYPQSNNTSFSASSLLYSSASKTTFK
Secondary Structure (PSIPRED)
ccccccccccccccccccccccEEEEcccccEEEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEccccccccccccccEEcccccccccccHHccccccccEEEccccEEEEEccccccccccccEEEccccccEEEccHHHHccccccEEEccccEEEEcccHHccccccccEEEccccccccccccccEEEEcccccccccccccEEEcccccccccccHHHHcccccccEEccccEEEEEccccHHccccccHHccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHHccccccEEccccccccccccHHHHcccccccccccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHcccccccEEccccccEEEEEEEccccEEEEEEEccccccccccccccccccccccHHHHHHHHHHccccccccccEEEEEEcccccEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHHHHcccccccccccEEEccccccccccccccEEEccccHHHcccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHcHHHHHHHHccccccccccccccccccccccccccccccccccccccccccEEEcccccccc
Secondary Structure Prediction (SSPRO)
ccccccHccccccccccccccEEEEEcccccEEEEEEccccccccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccEEEccccHHHHHcccccEEEccccccccccccHHHccccccEEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHccccccEEEEEcccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEEcccccccccHHHccccccEEEEHHHHccccccEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHccHccEEEccccccccccccHccccccEEEEEEccccccccccccHHccccHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccEcccHccccccHHHHHHHccHccEEEccccEEEEEEEcccccEEEEEEccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEEEccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEcccccHHEEccccccEEEccccccccccHEEcccccEccccEEEEEEcccccHEHHHHHHHHHHcccccccccccccccHHHHHHcccccHHHccHHHccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccEccccEcccc
Coil and Loop (DISEMBL)
sssipsalsnwnpsdsnpckwshitcspqnfvteINIQSielelpfpsnlssLSFLQKLIIsgsnltgpispdlgdctqlttidvssnslvggvpssigklinlqdlilnsnqltgeIPKELGACIKLKnlllfdnylsgnlpvelgKLVNLEVIraggnkdiagkipyeigdcQSLLVVGLAdtkvagslpaslgklsklqSLSVYTTmlsgeippqigncseLVDLFLYendlsgslprelGKLQKLEKMLLWQnnfdgaipeeignckslktiDLSLnffsgslpqsfgnLSSLEELMLsnnnisgsippvlSNATSLLQLQLDTNQISVFFAWQnklegsipstlancrsleavdlshnaltgslhpglfqlQNLTKLLLIsngisglippeigncSSLIRLRLMSFGNCTQLQMLNlsnntlggtlpsslASLTRLQVLDISVNQFVGLIPESFGQLASLNRLIlsknsfsgaipsslgrceslqsldlssnklsgkipvelfeiegldislnlswnalsgaippqisaLNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYnnftgylpdsklFRQLSATEmagnqglcsrghescflsnattvgmgngggfrksEKLKIAIALLVTFTIALAIFGAFAVVRAGkmvgddvdsemggnslpwqltpfqklNFTVEQVLKCLVEdsvvgkgcSGIVYRaemengeviavkklwpttmaaeydcqndkigiggvrDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLmydympngslgslLHERRDSCLEWELRYRIILGAAQGLaylhhdcvppivhrdikanniligpefepyiadfGLAKLVvegdfarssntvagsygyiapeygymmkiteksdvYSYGVVVLEVltgkqpidptipeglhiVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLcvnptpddrptMKDVAAMIKEIKQEREEcmkvdmlpsegsangqrennnssstammpnlypqsnntsfsASSLLYSsaskttfk
Flexible Loop (DISEMBL)
sssipsalsnwnpsdsnpCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSlpaslgklskLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIvyraemengeVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTlgsirhknivRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDfarssntvagsygyiAPEYGYMMKITEKSDVYSYGVVVLEVLTgkqpidptipeglhivdwVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVnptpddrptMKDVAAMIKEIKQEREECMKvdmlpsegsangqRENNNSSSTAMMPNLYPQSNNtsfsassllyssaskttfk
Low Complexity Region (SEG)
SSSIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIelelpfpsnlsslsflQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPAslgklsklqslsVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGnlssleelmlsnnnisGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGlfqlqnltklllisngisgliPPEIGNCSSLIRLRLMSFGNCTQLQMlnlsnntlggtlPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKlggdllalsgldnlvslNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYPQSNNTsfsassllyssasKTTFK
Disordered region (IsUnstruct)
******************CKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAI*******************LSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVN*********************************************************************************
Disordered Region (DISOPRED)
***IPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHE***********************LKIAIALLVTFTIALAIFGAFAVVR*********************LTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEY**********GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE***************************************************************
Disordered Region (DISEMBL)
***************SNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYPQSNNTSFSASSLL**********
Disordered Region (DISPRO)
***************SNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHE*****************FRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKM*************LPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWP********************DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK*************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHiiiiiiiiHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
SSSIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYPQSNNTSFSASSLLYSSASKTTFK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1035	2.2.26 [Sep-21-2011]
C0LGV1	1135	LRR receptor-like serine/	yes	no	0.957	0.873	0.673	0.0
Q9LHP4	1141	Receptor-like protein kin	no	no	0.938	0.851	0.638	0.0
C0LGR3	1091	Probable LRR receptor-lik	no	no	0.911	0.864	0.447	0.0
C0LGF5	1072	Probable LRR receptor-lik	no	no	0.929	0.897	0.445	0.0
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.906	0.851	0.393	0.0
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.914	0.858	0.382	0.0
O49318	1124	Probable leucine-rich rep	no	no	0.885	0.814	0.384	1e-172
O49545	1003	Leucine-rich repeat recep	no	no	0.876	0.904	0.376	1e-168
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.883	0.912	0.363	1e-168
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.882	0.901	0.374	1e-165

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score = 1409 bits (3646), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 709/1052 (67%), Positives = 832/1052 (79%), Gaps = 61/1052 (5%)

Query: 5    PSALSNWNPSDSNPCKWSHITCSPQN--FVTEINIQSIELELPFPSNLSSLSFLQKLIIS 62
            PS  S WNPSDS+PC+W +ITCS  +   VTEIN+ S++L LPFP N+SS + LQKL+IS
Sbjct: 55   PSVFSGWNPSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVIS 114

Query: 63   GSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKEL 122
             +NLTG IS ++GDC++L  ID+SSNSLVG +PSS+GKL NLQ+L LNSN LTG+IP EL
Sbjct: 115  NTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPEL 174

Query: 123  GACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGL 182
            G C+ LKNL +FDNYLS NLP+ELGK+  LE IRAGGN +++GKIP EIG+C++L V+GL
Sbjct: 175  GDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGL 234

Query: 183  ADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRE 242
            A TK++GSLP SLG+LSKLQSLSVY+TMLSGEIP ++GNCSEL++LFLY+NDLSG+LP+E
Sbjct: 235  AATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKE 294

Query: 243  LGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELML 302
            LGKLQ LEKMLLWQNN  G IPEEIG  KSL  IDLS+N+FSG++P+SFGNLS+L+ELML
Sbjct: 295  LGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELML 354

Query: 303  SNNNISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPST 348
            S+NNI+GSIP +LSN T L+Q Q+D NQIS              +F  WQNKLEG+IP  
Sbjct: 355  SSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDE 414

Query: 349  LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
            LA C++L+A+DLS N LTGSL  GLFQL+NLTKLLLISN ISG+IP EIGNC+SL+RLRL
Sbjct: 415  LAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRL 474

Query: 409  ----------------------------------MSFGNCTQLQMLNLSNNTLGGTLPSS 434
                                              +   NC QLQMLNLSNNTL G LP S
Sbjct: 475  VNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLS 534

Query: 435  LASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL 494
            L+SLT+LQVLD+S N   G IP+S G L SLNRLILSKNSF+G IPSSLG C +LQ LDL
Sbjct: 535  LSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDL 594

Query: 495  SSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLA 554
            SSN +SG IP ELF+I+ LDI+LNLSWN+L G IP +ISALN+LS+LD+SHN L GDL A
Sbjct: 595  SSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSA 654

Query: 555  LSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMG 614
            LSGL+NLVSLN+S+N F+GYLPDSK+FRQL   EM GN GLCS+G  SCF+SN++ +   
Sbjct: 655  LSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQ 714

Query: 615  NGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPF 674
             G     S +L+IAI LL++ T  LA+ G  AV+RA +M+ DD DSE G N   WQ TPF
Sbjct: 715  RG---VHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPF 771

Query: 675  QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKI 734
            QKLNFTVE VLKCLVE +V+GKGCSGIVY+AEM N EVIAVKKLWP T+       N+K 
Sbjct: 772  QKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPN----LNEKT 827

Query: 735  GIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC 794
               GVRDSFSAE+KTLGSIRHKNIVRFLGCCWN+NTRLLMYDYM NGSLGSLLHER   C
Sbjct: 828  KSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVC 887

Query: 795  -LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
             L WE+RY+IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP+FEPYI DFGLAKLV +
Sbjct: 888  SLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDD 947

Query: 854  GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI 913
            GDFARSSNT+AGSYGYIAPEYGY MKITEKSDVYSYGVVVLEVLTGKQPIDPTIP+GLHI
Sbjct: 948  GDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHI 1007

Query: 914  VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            VDWV++ R  I+V+D+ L+ARPE E+EEM+QTLGVALLC+NP P+DRPTMKDVAAM+ EI
Sbjct: 1008 VDWVKKIRD-IQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEI 1066

Query: 974  KQEREECMKVDMLPSEGSANGQRENNNSSSTA 1005
             QEREE MKVD     GS N  RE     ST+
Sbjct: 1067 CQEREESMKVD--GCSGSCNNGRERGKDDSTS 1096

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score = 1306 bits (3380), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 655/1026 (63%), Positives = 805/1026 (78%), Gaps = 55/1026 (5%)

Query: 10   NWNPSDSNPCK-WSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTG 68
            NWN  D+ PC  W+ ITCS Q F+T+I+I+S+ L+L  P NL +   LQKL ISG+NLTG
Sbjct: 60   NWNSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTG 119

Query: 69   PISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKL 128
             +   LGDC  L  +D+SSN LVG +P S+ KL NL+ LILNSNQLTG+IP ++  C KL
Sbjct: 120  TLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKL 179

Query: 129  KNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVA 188
            K+L+LFDN L+G++P ELGKL  LEVIR GGNK+I+G+IP EIGDC +L V+GLA+T V+
Sbjct: 180  KSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVS 239

Query: 189  GSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQK 248
            G+LP+SLGKL KL++LS+YTTM+SGEIP  +GNCSELVDLFLYEN LSGS+PRE+G+L K
Sbjct: 240  GNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTK 299

Query: 249  LEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS 308
            LE++ LWQN+  G IPEEIGNC +LK IDLSLN  SGS+P S G LS LEE M+S+N  S
Sbjct: 300  LEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFS 359

Query: 309  GSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPSTLANCRS 354
            GSIP  +SN +SL+QLQLD NQIS              +FFAW N+LEGSIP  LA+C  
Sbjct: 360  GSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTD 419

Query: 355  LEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL------ 408
            L+A+DLS N+LTG++  GLF L+NLTKLLLISN +SG IP EIGNCSSL+RLRL      
Sbjct: 420  LQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRIT 479

Query: 409  ---------------MSF-------------GNCTQLQMLNLSNNTLGGTLPSSLASLTR 440
                           + F             G+C++LQM++LSNN+L G+LP+ ++SL+ 
Sbjct: 480  GEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSG 539

Query: 441  LQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS 500
            LQVLD+S NQF G IP S G+L SLN+LILSKN FSG+IP+SLG C  LQ LDL SN+LS
Sbjct: 540  LQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELS 599

Query: 501  GKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDN 560
            G+IP EL +IE L+I+LNLS N L+G IP +I++LNKLSILDLSHN L GDL  L+ ++N
Sbjct: 600  GEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIEN 659

Query: 561  LVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFR 620
            LVSLN+SYN+F+GYLPD+KLFRQLS  ++ GN+ LCS   +SCFL+     G+G+ G   
Sbjct: 660  LVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDAS 719

Query: 621  KSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFT 680
            ++ KL++ +ALL+T T+ L I GA AV+RA + + ++ DSE+G  +  WQ TPFQKLNF+
Sbjct: 720  RTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELG-ETYKWQFTPFQKLNFS 778

Query: 681  VEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
            V+Q+++CLVE +V+GKGCSG+VYRA+++NGEVIAVKKLWP  +   +D +        VR
Sbjct: 779  VDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKN-----VR 833

Query: 741  DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
            DSFSAE+KTLG+IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR S L+W+LR
Sbjct: 834  DSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLR 893

Query: 801  YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
            YRI+LGAAQGLAYLHHDC+PPIVHRDIKANNILIG +FEPYIADFGLAKLV EGD  R S
Sbjct: 894  YRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCS 953

Query: 861  NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
            NTVAGSYGYIAPEYGY MKITEKSDVYSYGVVVLEVLTGKQPIDPT+PEG+H+VDWVRQ 
Sbjct: 954  NTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQN 1013

Query: 921  RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREEC 980
            RG++EVLD +LR+R E E +EM+Q LG ALLCVN +PD+RPTMKDVAAM+KEIKQEREE 
Sbjct: 1014 RGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQEREEY 1073

Query: 981  MKVDML 986
             KVD+L
Sbjct: 1074 AKVDLL 1079

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1

 Score =  835 bits (2158), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 467/1044 (44%), Positives = 669/1044 (64%), Gaps = 101/1044 (9%)

Query: 7    ALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFP-SNLSSLSFLQKLIISGSN 65
            A S+W+ +D++PC W  + C+ +  V+EI ++ ++L+   P ++L SL  L  L +S  N
Sbjct: 45   AFSSWHVADTSPCNWVGVKCNRRGEVSEIQLKGMDLQGSLPVTSLRSLKSLTSLTLSSLN 104

Query: 66   LTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGAC 125
            LTG I  ++GD T+L  +D+S NSL G +P  I +L  L+ L LN+N L G IP E+G  
Sbjct: 105  LTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLKKLKTLSLNTNNLEGHIPMEIGNL 164

Query: 126  IKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADT 185
              L  L+LFDN LSG +P  +G+L NL+V+RAGGNK++ G++P+EIG+C++L+++GLA+T
Sbjct: 165  SGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGGNKNLRGELPWEIGNCENLVMLGLAET 224

Query: 186  KVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGK 245
             ++G LPAS+G L ++Q++++YT++LSG IP +IG C+EL +L+LY+N +SGS+P  +G 
Sbjct: 225  SLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYCTELQNLYLYQNSISGSIPTTIGG 284

Query: 246  LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN 305
            L+KL+ +LLWQNN  G IP E+GNC  L  ID S N  +G++P+SFG L +L+EL LS N
Sbjct: 285  LKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENLLTGTIPRSFGKLENLQELQLSVN 344

Query: 306  NISGSIPPVLSNATSLLQLQLDTNQI--------------SVFFAWQNKLEGSIPSTLAN 351
             ISG+IP  L+N T L  L++D N I              ++FFAWQNKL G+IP +L+ 
Sbjct: 345  QISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNLRSLTMFFAWQNKLTGNIPQSLSQ 404

Query: 352  CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL--- 408
            CR L+A+DLS+N+L+GS+   +F L+NLTKLLL+SN +SG IPP+IGNC++L RLRL   
Sbjct: 405  CRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSNDLSGFIPPDIGNCTNLYRLRLNGN 464

Query: 409  -------MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG-------- 453
                      GN   L  +++S N L G++P +++    L+ LD+  N   G        
Sbjct: 465  RLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGCESLEFLDLHTNSLSGSLLGTTLP 524

Query: 454  ---------------LIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK 498
                            +P   G L  L +L L+KN  SG IP  +  C SLQ L+L  N 
Sbjct: 525  KSLKFIDFSDNALSSTLPPGIGLLTELTKLNLAKNRLSGEIPREISTCRSLQLLNLGEND 584

Query: 499  LSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGL 558
             SG+IP EL +I  L ISLNLS N   G IP + S L  L +LD+SHN+L G+L  L+ L
Sbjct: 585  FSGEIPDELGQIPSLAISLNLSCNRFVGEIPSRFSDLKNLGVLDVSHNQLTGNLNVLTDL 644

Query: 559  DNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGG 618
             NLVSLN+SYN+F+G LP++  FR+L  +++A N+GL        ++SNA  +       
Sbjct: 645  QNLVSLNISYNDFSGDLPNTPFFRRLPLSDLASNRGL--------YISNA--ISTRPDPT 694

Query: 619  FRKSEKLKIAIALLVTFTIALAIFGAFAVVRA----GKMVGDDVDSEMGGNSLPWQLTPF 674
             R S  +++ I +LV  T  L +   + +VRA     +++G+++DS        W++T +
Sbjct: 695  TRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAAGKQLLGEEIDS--------WEVTLY 746

Query: 675  QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKI 734
            QKL+F+++ ++K L   +V+G G SG+VYR  + +GE +AVKK+W    +          
Sbjct: 747  QKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAVKKMWSKEESG--------- 797

Query: 735  GIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH-ERRDS 793
                   +F++EIKTLGSIRH+NIVR LG C NRN +LL YDY+PNGSL S LH   +  
Sbjct: 798  -------AFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSSRLHGAGKGG 850

Query: 794  CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-- 851
            C++WE RY ++LG A  LAYLHHDC+P I+H D+KA N+L+GP FEPY+ADFGLA+ +  
Sbjct: 851  CVDWEARYDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLADFGLARTISG 910

Query: 852  ---VEGDFARSSNT--VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 906
                  D A+ +N   +AGSYGY+APE+  M +ITEKSDVYSYGVV+LEVLTGK P+DP 
Sbjct: 911  YPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVLTGKHPLDPD 970

Query: 907  IPEGLHIVDWVR----QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
            +P G H+V WVR    +K+    +LD  L  R +  + EMLQTL VA LCV+   ++RP 
Sbjct: 971  LPGGAHLVKWVRDHLAEKKDPSRLLDPRLDGRTDSIMHEMLQTLAVAFLCVSNKANERPL 1030

Query: 963  MKDVAAMIKEIKQ---EREECMKV 983
            MKDV AM+ EI+     R E  K+
Sbjct: 1031 MKDVVAMLTEIRHIDVGRSETEKI 1054

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2

 Score =  797 bits (2059), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 462/1038 (44%), Positives = 647/1038 (62%), Gaps = 76/1038 (7%)

Query: 5    PSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGS 64
            PS  S+W+P D  PC W  ITCS  N V  ++I    L L    +LSSLS LQ L +S +
Sbjct: 42   PSLFSSWDPQDQTPCSWYGITCSADNRVISVSIPDTFLNLSSIPDLSSLSSLQFLNLSST 101

Query: 65   NLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGA 124
            NL+GPI P  G  T L  +D+SSNSL G +PS +G+L  LQ LILN+N+L+G IP ++  
Sbjct: 102  NLSGPIPPSFGKLTHLRLLDLSSNSLSGPIPSELGRLSTLQFLILNANKLSGSIPSQISN 161

Query: 125  CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLAD 184
               L+ L L DN L+G++P   G LV+L+  R GGN ++ G IP ++G  ++L  +G A 
Sbjct: 162  LFALQVLCLQDNLLNGSIPSSFGSLVSLQQFRLGGNTNLGGPIPAQLGFLKNLTTLGFAA 221

Query: 185  TKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELG 244
            + ++GS+P++ G L  LQ+L++Y T +SG IPPQ+G CSEL +L+L+ N L+GS+P+ELG
Sbjct: 222  SGLSGSIPSTFGNLVNLQTLALYDTEISGTIPPQLGLCSELRNLYLHMNKLTGSIPKELG 281

Query: 245  KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSN 304
            KLQK+  +LLW N+  G IP EI NC SL   D+S N  +G +P   G L  LE+L LS+
Sbjct: 282  KLQKITSLLLWGNSLSGVIPPEISNCSSLVVFDVSANDLTGDIPGDLGKLVWLEQLQLSD 341

Query: 305  NNISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPSTLA 350
            N  +G IP  LSN +SL+ LQLD N++S               FF W+N + G+IPS+  
Sbjct: 342  NMFTGQIPWELSNCSSLIALQLDKNKLSGSIPSQIGNLKSLQSFFLWENSISGTIPSSFG 401

Query: 351  NCRSLEAVDLSHNALTGSLHPGLF------------------------QLQNLTKLLLIS 386
            NC  L A+DLS N LTG +   LF                        + Q+L +L +  
Sbjct: 402  NCTDLVALDLSRNKLTGRIPEELFSLKRLSKLLLLGNSLSGGLPKSVAKCQSLVRLRVGE 461

Query: 387  NGISGLIPPEIGNCSSLIRLRL----------MSFGNCTQLQMLNLSNNTLGGTLPSSLA 436
            N +SG IP EIG   +L+ L L              N T L++L++ NN + G +P+ L 
Sbjct: 462  NQLSGQIPKEIGELQNLVFLDLYMNHFSGGLPYEISNITVLELLDVHNNYITGDIPAQLG 521

Query: 437  SLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSS 496
            +L  L+ LD+S N F G IP SFG L+ LN+LIL+ N  +G IP S+   + L  LDLS 
Sbjct: 522  NLVNLEQLDLSRNSFTGNIPLSFGNLSYLNKLILNNNLLTGQIPKSIKNLQKLTLLDLSY 581

Query: 497  NKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALS 556
            N LSG+IP EL ++  L I+L+LS+N  +G IP   S L +L  LDLS N L GD+  L 
Sbjct: 582  NSLSGEIPQELGQVTSLTINLDLSYNTFTGNIPETFSDLTQLQSLDLSSNSLHGDIKVLG 641

Query: 557  GLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNG 616
             L +L SLN+S NNF+G +P +  F+ +S T    N  LC   H    ++ ++  G  NG
Sbjct: 642  SLTSLASLNISCNNFSGPIPSTPFFKTISTTSYLQNTNLC---HSLDGITCSSHTGQNNG 698

Query: 617  GGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGN------SLPWQ 670
                KS K+ +A+  ++  +I +AI  A+ ++     +     +           S PW 
Sbjct: 699  ---VKSPKI-VALTAVILASITIAILAAWLLILRNNHLYKTSQNSSSSPSTAEDFSYPWT 754

Query: 671  LTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQ 730
              PFQKL  TV  ++  L +++V+GKGCSGIVY+AE+ NG+++AVKKLW T         
Sbjct: 755  FIPFQKLGITVNNIVTSLTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKTK-------D 807

Query: 731  NDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER 790
            N++ G   + DSF+AEI+ LG+IRH+NIV+ LG C N++ +LL+Y+Y PNG+L  LL   
Sbjct: 808  NNEEGESTI-DSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQGN 866

Query: 791  RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
            R+  L+WE RY+I +GAAQGLAYLHHDCVP I+HRD+K NNIL+  ++E  +ADFGLAKL
Sbjct: 867  RN--LDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILADFGLAKL 924

Query: 851  VVEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE 909
            ++   ++  + + VAGSYGYIAPEYGY M ITEKSDVYSYGVV+LE+L+G+  ++P I +
Sbjct: 925  MMNSPNYHNAMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSAVEPQIGD 984

Query: 910  GLHIVDWVRQKRGAIE----VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKD 965
            GLHIV+WV++K G  E    VLD  L+  P+  ++EMLQTLG+A+ CVNP+P +RPTMK+
Sbjct: 985  GLHIVEWVKKKMGTFEPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSPVERPTMKE 1044

Query: 966  VAAMIKEIKQEREECMKV 983
            V  ++ E+K   EE  K 
Sbjct: 1045 VVTLLMEVKCSPEEWGKT 1062

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  662 bits (1707), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 418/1061 (39%), Positives = 578/1061 (54%), Gaps = 123/1061 (11%)

Query: 8    LSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLT 67
            L++WN  DSNPC W+ I C+    VT +++  + L       +  L  L+KL +S + ++
Sbjct: 45   LASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFIS 104

Query: 68   GPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIK 127
            GPI  DL  C  L  +D+ +N   G +P  +  +I L+ L L  N L G IP+++G    
Sbjct: 105  GPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSS 164

Query: 128  LKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKV 187
            L+ L+++ N L+G +P  + KL  L +IRAG N   +G IP EI  C+SL V+GLA+  +
Sbjct: 165  LQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRN-GFSGVIPSEISGCESLKVLGLAENLL 223

Query: 188  AGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQ 247
             GSLP  L KL  L  L ++   LSGEIPP +GN S L  L L+EN  +GS+PRE+GKL 
Sbjct: 224  EGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLT 283

Query: 248  KLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGN-------------- 293
            K++++ L+ N   G IP EIGN      ID S N  +G +P+ FG+              
Sbjct: 284  KMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENIL 343

Query: 294  ----------LSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI------------ 331
                      L+ LE+L LS N ++G+IP  L     L+ LQL  NQ+            
Sbjct: 344  LGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYS 403

Query: 332  -----------------SVFFAWQ---------NKLEGSIPSTLANCRSLEAVDLSHNAL 365
                             + F  +Q         NKL G+IP  L  C+SL  + L  N L
Sbjct: 404  NFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQL 463

Query: 366  TGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS----------FGNCT 415
            TGSL   LF LQNLT L L  N +SG I  ++G   +L RLRL +           GN T
Sbjct: 464  TGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLT 523

Query: 416  QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF 475
            ++   N+S+N L G +P  L S   +Q LD+S N+F G I +  GQL  L  L LS N  
Sbjct: 524  KIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRL 583

Query: 476  SGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISAL 535
            +G IP S G    L  L L  N LS  IPVEL ++  L ISLN+S N LSG IP  +  L
Sbjct: 584  TGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNL 643

Query: 536  NKLSILDLSHNKLGGDLLALSGLDNLVSL---NVSYNNFTGYLPDSKLFRQLSATEMAGN 592
              L IL L+ NKL G++ A  G  NL+SL   N+S NN  G +PD+ +F+++ ++  AGN
Sbjct: 644  QMLEILYLNDNKLSGEIPASIG--NLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGN 701

Query: 593  QGLCSRGHESCF----LSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVV 648
             GLC+     C      S++    + NG     S++ KI        TI   + G+  ++
Sbjct: 702  HGLCNSQRSHCQPLVPHSDSKLNWLING-----SQRQKI-------LTITCIVIGSVFLI 749

Query: 649  RAGKMVGDDVDSEMGGNSLPWQLTP-------FQKLNFTVEQVL---KCLVEDSVVGKGC 698
                +       E    +L  Q  P       F K  FT + ++   +   ED V+G+G 
Sbjct: 750  TFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGA 809

Query: 699  SGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI 758
             G VY+AEM  GEVIAVKKL      A  D            +SF AEI TLG IRH+NI
Sbjct: 810  CGTVYKAEMSGGEVIAVKKLNSRGEGASSD------------NSFRAEISTLGKIRHRNI 857

Query: 759  VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIILGAAQGLAYLHHD 817
            V+  G C+++N+ LL+Y+YM  GSLG  L     +C L+W  RYRI LGAA+GL YLHHD
Sbjct: 858  VKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHD 917

Query: 818  CVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM 877
            C P IVHRDIK+NNIL+   F+ ++ DFGLAKL ++  +++S + VAGSYGYIAPEY Y 
Sbjct: 918  CRPQIVHRDIKSNNILLDERFQAHVGDFGLAKL-IDLSYSKSMSAVAGSYGYIAPEYAYT 976

Query: 878  MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG----AIEVLDKSLRA 933
            MK+TEK D+YS+GVV+LE++TGK P+ P + +G  +V+WVR+        IE+ D  L  
Sbjct: 977  MKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRSIRNMIPTIEMFDARLDT 1035

Query: 934  RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK 974
              +  + EM   L +AL C + +P  RPTM++V AMI E +
Sbjct: 1036 NDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  640 bits (1650), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/1064 (38%), Positives = 589/1064 (55%), Gaps = 118/1064 (11%)

Query: 8    LSNWNPSDSNPCKWSHITCS-----PQNFVTEINIQSIELELPFPSNLSSLSFLQKLIIS 62
            L NWN +DS PC W+ + CS     P+  V  +N+ S+ L      ++  L  L++L +S
Sbjct: 48   LRNWNSNDSVPCGWTGVMCSNYSSDPE--VLSLNLSSMVLSGKLSPSIGGLVHLKQLDLS 105

Query: 63   GSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKEL 122
             + L+G I  ++G+C+ L  + +++N   G +P  IGKL++L++LI+ +N+++G +P E+
Sbjct: 106  YNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEI 165

Query: 123  GACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGL 182
            G  + L  L+ + N +SG LP  +G L  L   RAG N  I+G +P EIG C+SL+++GL
Sbjct: 166  GNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNM-ISGSLPSEIGGCESLVMLGL 224

Query: 183  ADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRE 242
            A  +++G LP  +G L KL  + ++    SG IP +I NC+ L  L LY+N L G +P+E
Sbjct: 225  AQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKE 284

Query: 243  LGKLQKLEKMLLWQNNFDGAIPEEIGNC-------------------------------- 270
            LG LQ LE + L++N  +G IP EIGN                                 
Sbjct: 285  LGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYL 344

Query: 271  ----------------KSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPV 314
                            K+L  +DLS+N  +G +P  F  L  L  L L  N++SG+IPP 
Sbjct: 345  FENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPK 404

Query: 315  LSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPSTLANCRSLEAVDL 360
            L   + L  L +  N +S              +     N L G+IP+ +  C++L  + L
Sbjct: 405  LGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRL 464

Query: 361  SHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLM----------S 410
            + N L G     L +  N+T + L  N   G IP E+GNCS+L RL+L            
Sbjct: 465  ARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPRE 524

Query: 411  FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLIL 470
             G  +QL  LN+S+N L G +PS + +   LQ LD+  N F G +P   G L  L  L L
Sbjct: 525  IGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKL 584

Query: 471  SKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPP 530
            S N+ SG IP +LG    L  L +  N  +G IP EL  + GL I+LNLS+N L+G IPP
Sbjct: 585  SNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPP 644

Query: 531  QISALNKLSILDLSHNKLGGDL-LALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEM 589
            ++S L  L  L L++N L G++  + + L +L+  N SYN+ TG +P   L R +S +  
Sbjct: 645  ELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSF 701

Query: 590  AGNQGLCSRGHESCFLSN--ATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAV 647
             GN+GLC      C  +   A +   G  GG R S+ + I  A++   ++ L     + +
Sbjct: 702  IGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLM 761

Query: 648  VRAGKMVG----DDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKC---LVEDSVVGKGCSG 700
             R  + V     D   SEM   SL     P  K  FT + ++       E  VVG+G  G
Sbjct: 762  RRPVRTVASSAQDGQPSEM---SLDIYFPP--KEGFTFQDLVAATDNFDESFVVGRGACG 816

Query: 701  IVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR 760
             VY+A +  G  +AVKKL     A+ ++  N+      V +SF AEI TLG+IRH+NIV+
Sbjct: 817  TVYKAVLPAGYTLAVKKL-----ASNHEGGNNN----NVDNSFRAEILTLGNIRHRNIVK 867

Query: 761  FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIILGAAQGLAYLHHDCV 819
              G C ++ + LL+Y+YMP GSLG +LH+   SC L+W  R++I LGAAQGLAYLHHDC 
Sbjct: 868  LHGFCNHQGSNLLLYEYMPKGSLGEILHD--PSCNLDWSKRFKIALGAAQGLAYLHHDCK 925

Query: 820  PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK 879
            P I HRDIK+NNIL+  +FE ++ DFGLAK V++   ++S + +AGSYGYIAPEY Y MK
Sbjct: 926  PRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPHSKSMSAIAGSYGYIAPEYAYTMK 984

Query: 880  ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ--KRGAIE--VLDKSLRARP 935
            +TEKSD+YSYGVV+LE+LTGK P+ P I +G  +V+WVR   +R A+   VLD  L    
Sbjct: 985  VTEKSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIRRDALSSGVLDARLTLED 1043

Query: 936  EVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE 979
            E  +  ML  L +ALLC + +P  RP+M+ V  M+  I+ ER E
Sbjct: 1044 ERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML--IESERSE 1085

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  606 bits (1563), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 370/962 (38%), Positives = 541/962 (56%), Gaps = 46/962 (4%)

Query: 35   INIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGV 94
             NI + +L  P P  +  L  L++L+   +NLTGP+   LG+  +LTT     N   G +
Sbjct: 162  FNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNI 221

Query: 95   PSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEV 154
            P+ IGK +NL+ L L  N ++GE+PKE+G  +KL+ ++L+ N  SG +P ++G L +LE 
Sbjct: 222  PTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLET 281

Query: 155  IRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGE 214
            +   GN  + G IP EIG+ +SL  + L   ++ G++P  LGKLSK+  +     +LSGE
Sbjct: 282  LALYGN-SLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGE 340

Query: 215  IPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLK 274
            IP ++   SEL  L+L++N L+G +P EL KL+ L K+ L  N+  G IP    N  S++
Sbjct: 341  IPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMR 400

Query: 275  TIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVF 334
             + L  N  SG +PQ  G  S L  +  S N +SG IPP +   ++L+ L L +N+I   
Sbjct: 401  QLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIF-- 458

Query: 335  FAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIP 394
                    G+IP  +  C+SL  + +  N LTG     L +L NL+ + L  N  SG +P
Sbjct: 459  --------GNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLP 510

Query: 395  PEIGNCSSLIRLRLMS----------FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVL 444
            PEIG C  L RL L +              + L   N+S+N+L G +PS +A+   LQ L
Sbjct: 511  PEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRL 570

Query: 445  DISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIP 504
            D+S N F+G +P   G L  L  L LS+N FSG IP ++G    L  L +  N  SG IP
Sbjct: 571  DLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIP 630

Query: 505  VELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LALSGLDNLVS 563
             +L  +  L I++NLS+N  SG IPP+I  L+ L  L L++N L G++      L +L+ 
Sbjct: 631  PQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLG 690

Query: 564  LNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNAT---TVGMGNGGGFR 620
             N SYNN TG LP +++F+ ++ T   GN+GLC     SC  S+++      +  G   R
Sbjct: 691  CNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARR 750

Query: 621  KSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFT 680
                + ++  +     + +AI   F             D E           P ++  FT
Sbjct: 751  GRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKER--FT 808

Query: 681  VEQVL---KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG 737
            V+ +L   K   +  +VG+G  G VY+A M +G+ IAVKKL       E + + +     
Sbjct: 809  VKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKL-------ESNREGNNNNSN 861

Query: 738  GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCL 795
               +SF AEI TLG IRH+NIVR    C+++  N+ LL+Y+YM  GSLG LLH  +   +
Sbjct: 862  NTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSM 921

Query: 796  EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
            +W  R+ I LGAA+GLAYLHHDC P I+HRDIK+NNILI   FE ++ DFGLAK V++  
Sbjct: 922  DWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAK-VIDMP 980

Query: 856  FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
             ++S + VAGSYGYIAPEY Y MK+TEK D+YS+GVV+LE+LTGK P+ P + +G  +  
Sbjct: 981  LSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGDLAT 1039

Query: 916  W----VRQKRGAIEVLDKSL-RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
            W    +R      E+LD  L +   +V +  M+    +A+LC   +P DRPTM++V  M+
Sbjct: 1040 WTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099

Query: 971  KE 972
             E
Sbjct: 1100 IE 1101

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  593 bits (1528), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 372/989 (37%), Positives = 537/989 (54%), Gaps = 82/989 (8%)

Query: 6   SALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSN 65
           S LS+W  S S  C W  +TC     V+  ++ S++L                   SG N
Sbjct: 45  SPLSSWKVSTSF-CTWIGVTCD----VSRRHVTSLDL-------------------SGLN 80

Query: 66  LTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGA- 124
           L+G +SPD+     L  + ++ N + G +P  I  L  L+ L L++N   G  P E+ + 
Sbjct: 81  LSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSG 140

Query: 125 CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLAD 184
            + L+ L +++N L+G+LPV +  L  L  +  GGN   AGKIP   G    +  + ++ 
Sbjct: 141 LVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNY-FAGKIPPSYGSWPVIEYLAVSG 199

Query: 185 TKVAGSLPASLGKLSKLQSLSV-YTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPREL 243
            ++ G +P  +G L+ L+ L + Y       +PP+IGN SELV        L+G +P E+
Sbjct: 200 NELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEI 259

Query: 244 GKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLS 303
           GKLQKL+ + L  N F G +  E+G   SLK++DLS N F+G +P SF  L +L  L L 
Sbjct: 260 GKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLF 319

Query: 304 NNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHN 363
            N + G IP  + +   L  LQL          W+N   GSIP  L     L  VDLS N
Sbjct: 320 RNKLHGEIPEFIGDLPELEVLQL----------WENNFTGSIPQKLGENGKLNLVDLSSN 369

Query: 364 ALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS-----------FG 412
            LTG+L P +     L  L+ + N + G IP  +G C SL R+R+             FG
Sbjct: 370 KLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFG 429

Query: 413 NCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSK 472
              +L  + L +N L G LP +      L  + +S NQ  G +P + G    + +L+L  
Sbjct: 430 -LPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDG 488

Query: 473 NSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQI 532
           N F G IPS +G+ + L  +D S N  SG+I  E+   + L   ++LS N LSG IP +I
Sbjct: 489 NKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTF-VDLSRNELSGEIPNEI 547

Query: 533 SALNKLSILDLSHNKLGGDLL-ALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAG 591
           +A+  L+ L+LS N L G +  ++S + +L SL+ SYNN +G +P +  F   + T   G
Sbjct: 548 TAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLG 607

Query: 592 NQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAG 651
           N  LC      C        G+  GG    S+    A   L+     L    AFAVV   
Sbjct: 608 NPDLCGPYLGPC------KDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAII 661

Query: 652 KMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGE 711
           K       SE    S  W+LT FQ+L+FT + VL  L ED+++GKG +GIVY+  M NG+
Sbjct: 662 KARSLKKASE----SRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGVMPNGD 717

Query: 712 VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR 771
           ++AVK+L   +  + +D              F+AEI+TLG IRH++IVR LG C N  T 
Sbjct: 718 LVAVKRLAAMSRGSSHD------------HGFNAEIQTLGRIRHRHIVRLLGFCSNHETN 765

Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANN 831
           LL+Y+YMPNGSLG +LH ++   L W+ RY+I L AA+GL YLHHDC P IVHRD+K+NN
Sbjct: 766 LLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNN 825

Query: 832 ILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGV 891
           IL+   FE ++ADFGLAK + +   +   + +AGSYGYIAPEY Y +K+ EKSDVYS+GV
Sbjct: 826 ILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGV 885

Query: 892 VVLEVLTGKQPIDPTIPEGLHIVDWVRQ-----KRGAIEVLDKSLRARPEVEIEEMLQTL 946
           V+LE++TG++P+     +G+ IV WVR+     K   ++VLD  L + P   I E+    
Sbjct: 886 VLLELVTGRKPVG-EFGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIP---IHEVTHVF 941

Query: 947 GVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
            VA+LCV     +RPTM++V  ++ EI +
Sbjct: 942 YVAMLCVEEQAVERPTMREVVQILTEIPK 970

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  592 bits (1527), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 366/1006 (36%), Positives = 542/1006 (53%), Gaps = 92/1006 (9%)

Query: 8   LSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLT 67
           L++WN S +  C W+ +TC                         SL  +  L +SG NL+
Sbjct: 47  LTSWNLS-TTFCSWTGVTCD-----------------------VSLRHVTSLDLSGLNLS 82

Query: 68  GPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGA-CI 126
           G +S D+     L  + +++N + G +P  I  L  L+ L L++N   G  P EL +  +
Sbjct: 83  GTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDELSSGLV 142

Query: 127 KLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTK 186
            L+ L L++N L+G+LPV L  L  L  +  GGN   +GKIP   G    L  + ++  +
Sbjct: 143 NLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNY-FSGKIPATYGTWPVLEYLAVSGNE 201

Query: 187 VAGSLPASLGKLSKLQSLSV-YTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGK 245
           + G +P  +G L+ L+ L + Y       +PP+IGN SELV        L+G +P E+GK
Sbjct: 202 LTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIPPEIGK 261

Query: 246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN 305
           LQKL+ + L  N F G I +E+G   SLK++DLS N F+G +P SF  L +L  L L  N
Sbjct: 262 LQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRN 321

Query: 306 NISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNAL 365
            + G+IP  +     L  LQL          W+N   GSIP  L     L  +DLS N L
Sbjct: 322 KLYGAIPEFIGEMPELEVLQL----------WENNFTGSIPQKLGENGRLVILDLSSNKL 371

Query: 366 TGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL-MSFGNCT--------- 415
           TG+L P +     L  L+ + N + G IP  +G C SL R+R+  +F N +         
Sbjct: 372 TGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLP 431

Query: 416 QLQMLNLSNNTLGGTLPSSLASLT-RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS 474
           +L  + L +N L G LP S   ++  L  + +S NQ  G +P + G L+ + +L+L  N 
Sbjct: 432 KLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNK 491

Query: 475 FSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISA 534
           FSG+IP  +GR + L  LD S N  SG+I  E+   + L   ++LS N LSG IP +++ 
Sbjct: 492 FSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTF-VDLSRNELSGDIPNELTG 550

Query: 535 LNKLSILDLSHNKLGGDL-LALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQ 593
           +  L+ L+LS N L G + + ++ + +L S++ SYNN +G +P +  F   + T   GN 
Sbjct: 551 MKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNS 610

Query: 594 GLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKM 653
            LC      C        G G      K       + L++       +F   A+++A  +
Sbjct: 611 HLCGPYLGPC--------GKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSL 662

Query: 654 VGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVI 713
                       +  W+LT FQ+L+FT + VL  L ED+++GKG +GIVY+  M  G+++
Sbjct: 663 -------RNASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLV 715

Query: 714 AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLL 773
           AVK+L   +  + +D              F+AEI+TLG IRH++IVR LG C N  T LL
Sbjct: 716 AVKRLATMSHGSSHD------------HGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 763

Query: 774 MYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL 833
           +Y+YMPNGSLG +LH ++   L W  RY+I L AA+GL YLHHDC P IVHRD+K+NNIL
Sbjct: 764 VYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNIL 823

Query: 834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVV 893
           +   FE ++ADFGLAK + +   +   + +AGSYGYIAPEY Y +K+ EKSDVYS+GVV+
Sbjct: 824 LDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVL 883

Query: 894 LEVLTGKQPIDPTIPEGLHIVDWVR-----QKRGAIEVLDKSLRARPEVEIEEMLQTLGV 948
           LE++TGK+P+     +G+ IV WVR      K   ++V+D  L + P   + E+     V
Sbjct: 884 LELITGKKPVG-EFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVP---VHEVTHVFYV 939

Query: 949 ALLCVNPTPDDRPTMKDVAAMIKEI------KQEREECMKVDMLPS 988
           ALLCV     +RPTM++V  ++ EI      KQ+  E    +  P+
Sbjct: 940 ALLCVEEQAVERPTMREVVQILTEIPKIPLSKQQAAESDVTEKAPA 985

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  584 bits (1506), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 373/995 (37%), Positives = 535/995 (53%), Gaps = 82/995 (8%)

Query: 8   LSNWNPSD-SNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNL 66
           L +W  SD S+ C W+ + C+    V                        +KL ++G NL
Sbjct: 48  LKDWKLSDTSDHCNWTGVRCNSNGNV------------------------EKLDLAGMNL 83

Query: 67  TGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACI 126
           TG IS  +   + L + ++S N     +P SI  L   + + ++ N  +G +       +
Sbjct: 84  TGKISDSISQLSSLVSFNISCNGFESLLPKSIPPL---KSIDISQNSFSGSLFLFSNESL 140

Query: 127 KLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTK 186
            L +L    N LSGNL  +LG LV+LEV+   GN    G +P    + Q L  +GL+   
Sbjct: 141 GLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNF-FQGSLPSSFKNLQKLRFLGLSGNN 199

Query: 187 VAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKL 246
           + G LP+ LG+L  L++  +      G IPP+ GN + L  L L    LSG +P ELGKL
Sbjct: 200 LTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKL 259

Query: 247 QKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNN 306
           + LE +LL++NNF G IP EIG+  +LK +D S N  +G +P     L +L+ L L  N 
Sbjct: 260 KSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNK 319

Query: 307 ISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALT 366
           +SGSIPP +S   SL QLQ       V   W N L G +PS L     L+ +D+S N+ +
Sbjct: 320 LSGSIPPAIS---SLAQLQ-------VLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFS 369

Query: 367 GSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL----------MSFGNCTQ 416
           G +   L    NLTKL+L +N  +G IP  +  C SL+R+R+          + FG   +
Sbjct: 370 GEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEK 429

Query: 417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS 476
           LQ L L+ N L G +P  ++    L  +D S NQ    +P +   + +L   +++ N  S
Sbjct: 430 LQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFIS 489

Query: 477 GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALN 536
           G +P     C SL +LDLSSN L+G IP  +   E L +SLNL  N L+G IP QI+ ++
Sbjct: 490 GEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKL-VSLNLRNNNLTGEIPRQITTMS 548

Query: 537 KLSILDLSHNKLGGDLLALSGLD-NLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGL 595
            L++LDLS+N L G L    G    L  LNVSYN  TG +P +   + ++  ++ GN GL
Sbjct: 549 ALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGL 608

Query: 596 CSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTI-ALAIFGAFAVVRAGKMV 654
           C      C      T    +  G R      I IA ++   I  +     +    +    
Sbjct: 609 CGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFC 668

Query: 655 GDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEM-ENGEVI 713
           GD+  S+      PW+L  F +L FT   +L C+ E +++G G +GIVY+AEM  +  V+
Sbjct: 669 GDETASK---GEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYKAEMSRSSTVL 725

Query: 714 AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLL 773
           AVKKLW +    E           G    F  E+  LG +RH+NIVR LG  +N    ++
Sbjct: 726 AVKKLWRSAADIE----------DGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMI 775

Query: 774 MYDYMPNGSLGSLLHERRDS---CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN 830
           +Y++M NG+LG  +H +  +    ++W  RY I LG A GLAYLHHDC PP++HRDIK+N
Sbjct: 776 VYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSN 835

Query: 831 NILIGPEFEPYIADFGLAKLVVEGDFARSSNT---VAGSYGYIAPEYGYMMKITEKSDVY 887
           NIL+    +  IADFGLA+++     AR   T   VAGSYGYIAPEYGY +K+ EK D+Y
Sbjct: 836 NILLDANLDARIADFGLARMM-----ARKKETVSMVAGSYGYIAPEYGYTLKVDEKIDIY 890

Query: 888 SYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK-RGAI---EVLDKSLRARPEVEIEEML 943
           SYGVV+LE+LTG++P++P   E + IV+WVR+K R  I   E LD ++     V+ EEML
Sbjct: 891 SYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRYVQ-EEML 949

Query: 944 QTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
             L +ALLC    P DRP+M+DV +M+ E K  R+
Sbjct: 950 LVLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRK 984

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1035
255560235	1126	Receptor protein kinase CLAVATA1 precurs	0.963	0.885	0.762	0.0
356566445	1122	PREDICTED: LRR receptor-like serine/thre	0.971	0.896	0.720	0.0
359480096	1142	PREDICTED: LRR receptor-like serine/thre	0.974	0.883	0.725	0.0
356527419	1127	PREDICTED: LRR receptor-like serine/thre	0.971	0.892	0.715	0.0
255554216	1145	Leucine-rich repeat receptor protein kin	0.968	0.875	0.690	0.0
42568408	1135	LRR receptor-like serine/threonine-prote	0.957	0.873	0.673	0.0
297792091	1133	hypothetical protein ARALYDRAFT_917829 [	0.959	0.876	0.672	0.0
29119651	1135	LRR receptor-like kinase 1 [Arabidopsis	0.957	0.873	0.673	0.0
147766422	1182	hypothetical protein VITISV_031044 [Viti	0.972	0.851	0.682	0.0
224075593	1146	predicted protein [Populus trichocarpa]	0.966	0.872	0.684	0.0

>gi|255560235|ref|XP_002521135.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223539704|gb|EEF41286.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis]

 Score = 1597 bits (4135), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 804/1054 (76%), Positives = 893/1054 (84%), Gaps = 57/1054 (5%)

Query: 7    ALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNL 66
            A SNWN  DSNPCKWSHITCS  NFV EI+ QS+++ LPFPSNLSSL +L+KLI+SG NL
Sbjct: 57   AFSNWNHLDSNPCKWSHITCSSSNFVIEIDFQSVDIALPFPSNLSSLIYLEKLILSGVNL 116

Query: 67   TGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACI 126
            TG I PD+GDCT+LT +DVSSNSLVG +P SIG L NLQDLILNSNQ+TGEIP E+G C 
Sbjct: 117  TGTIPPDIGDCTKLTLLDVSSNSLVGTIPPSIGNLKNLQDLILNSNQITGEIPVEIGNCT 176

Query: 127  KLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTK 186
             LKNL+++DNYLSG LP+ELG+L +LEV+RAGGNK+I GKIP E+GDC++L V+GLADTK
Sbjct: 177  NLKNLIIYDNYLSGKLPIELGRLSDLEVVRAGGNKNIEGKIPDELGDCKNLQVLGLADTK 236

Query: 187  VAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKL 246
            ++GS+PASLG L+ LQ+LSVYTTMLSG IPPQ+GNCSELVDLFLYENDLSGSLP ELGKL
Sbjct: 237  ISGSIPASLGNLNNLQTLSVYTTMLSGVIPPQLGNCSELVDLFLYENDLSGSLPPELGKL 296

Query: 247  QKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNN 306
            QKLEKMLLWQNNFDG IPEEIGNCKSLK IDLSLN FSG +P SFGNLS+LEELMLSNNN
Sbjct: 297  QKLEKMLLWQNNFDGTIPEEIGNCKSLKIIDLSLNLFSGIIPPSFGNLSTLEELMLSNNN 356

Query: 307  ISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPSTLANC 352
            ISGSIPPVLSNAT+LLQLQLDTNQIS              VFFAWQNKLEGSIP+ LA C
Sbjct: 357  ISGSIPPVLSNATNLLQLQLDTNQISGSIPAELGKLTQLTVFFAWQNKLEGSIPAQLAGC 416

Query: 353  RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS-- 410
            RSLEA+DLSHN LTGSL PGLFQLQNLTKLLLISN ISG IP EIGNCSSL+RLRL++  
Sbjct: 417  RSLEALDLSHNVLTGSLPPGLFQLQNLTKLLLISNDISGSIPHEIGNCSSLVRLRLINNK 476

Query: 411  --------------------------------FGNCTQLQMLNLSNNTLGGTLPSSLASL 438
                                             GNC +LQMLNLSNNTL GTLPSSL+SL
Sbjct: 477  ISGNIPKEIGFLKDLSFLDLSDNHLSGMVPAEIGNCNELQMLNLSNNTLQGTLPSSLSSL 536

Query: 439  TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK 498
            TRL+VLD+S+N+FVG IP  FG+L SLNRLILSKNS SGAIPSSLG C SLQ LDLSSN+
Sbjct: 537  TRLEVLDLSLNRFVGEIPFDFGKLISLNRLILSKNSLSGAIPSSLGHCSSLQLLDLSSNE 596

Query: 499  LSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGL 558
            LSG IPVE+F+IEGLDI+LNLSWNALSG IP QISALNKLSILDLSHNKLGGDLLAL+ L
Sbjct: 597  LSGIIPVEMFDIEGLDIALNLSWNALSGMIPLQISALNKLSILDLSHNKLGGDLLALAEL 656

Query: 559  DNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGG 618
            +N+VSLN+SYNNFTGYLPDSKLFRQLSA E+AGNQGLCSRG ESCFLSN T     N   
Sbjct: 657  ENIVSLNISYNNFTGYLPDSKLFRQLSAAELAGNQGLCSRGRESCFLSNGTMTSKSNNN- 715

Query: 619  FRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLN 678
            F++S++  +AIA LVT TIA+AIFGA AV+RA K+  DD +SEMGG+S PW+ TPFQKLN
Sbjct: 716  FKRSKRFNLAIASLVTLTIAMAIFGAIAVLRARKLTRDDCESEMGGDSWPWKFTPFQKLN 775

Query: 679  FTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGG 738
            F+VEQVLKCLVE +V+GKGCSGIVYRAE+ENGEVIAVKKLWP  +AA  DCQND+IG+GG
Sbjct: 776  FSVEQVLKCLVEANVIGKGCSGIVYRAELENGEVIAVKKLWPAAIAAGNDCQNDRIGVGG 835

Query: 739  VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
            VRDSFSAE+KTLGSIRHKNIVRFLGCCWNR+TRLLMYDYMPNGSLGSLLHER   CLEWE
Sbjct: 836  VRDSFSAEVKTLGSIRHKNIVRFLGCCWNRHTRLLMYDYMPNGSLGSLLHERSGGCLEWE 895

Query: 799  LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
            +RY+I+L AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV +GDFAR
Sbjct: 896  VRYKIVLEAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVDDGDFAR 955

Query: 859  SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR 918
            SS TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP+GLHIVDW+R
Sbjct: 956  SSATVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWIR 1015

Query: 919  QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
            QKRG  EVLD  LRARPE EI EMLQT+GVALLCVNP PDDRPTMKDV+AM+KEI+QERE
Sbjct: 1016 QKRGRNEVLDPCLRARPESEIAEMLQTIGVALLCVNPCPDDRPTMKDVSAMLKEIRQERE 1075

Query: 979  ECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYP 1012
            EC+KVDML +  SAN        +   MM + YP
Sbjct: 1076 ECLKVDMLLNGSSAN--------NPAVMMQHSYP 1101

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356566445|ref|XP_003551442.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RCH1-like [Glycine max]

 Score = 1540 bits (3987), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 760/1055 (72%), Positives = 873/1055 (82%), Gaps = 49/1055 (4%)

Query: 1    SSSIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLI 60
            S+++P A S+WNP DSNPC WS+I CS  +FVTEI IQ++EL LPFPS +SS  FLQKL+
Sbjct: 45   SNTVPLAFSSWNPLDSNPCNWSYIKCSSASFVTEITIQNVELALPFPSKISSFPFLQKLV 104

Query: 61   ISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPK 120
            ISG+NLTG IS D+G+C +L  +D+SSNSLVGG+PSSIG+L NLQ+L LNSN LTG+IP 
Sbjct: 105  ISGANLTGVISIDIGNCLELVVLDLSSNSLVGGIPSSIGRLRNLQNLSLNSNHLTGQIPS 164

Query: 121  ELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVV 180
            E+G C+ LK L +FDN L+G+LPVELGKL NLEVIRAGGN  IAG IP E+GDC++L V+
Sbjct: 165  EIGDCVNLKTLDIFDNNLNGDLPVELGKLSNLEVIRAGGNSGIAGNIPDELGDCKNLSVL 224

Query: 181  GLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLP 240
            GLADTK++GSLPASLGKLS LQ+LS+Y+TMLSGEIPP+IGNCSELV+LFLYEN LSGSLP
Sbjct: 225  GLADTKISGSLPASLGKLSMLQTLSIYSTMLSGEIPPEIGNCSELVNLFLYENGLSGSLP 284

Query: 241  RELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEEL 300
            RE+GKLQKLEKMLLWQN+F G IPEEIGNC+SLK +D+SLN FSG +PQS G LS+LEEL
Sbjct: 285  REIGKLQKLEKMLLWQNSFVGGIPEEIGNCRSLKILDVSLNSFSGGIPQSLGKLSNLEEL 344

Query: 301  MLSNNNISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIP 346
            MLSNNNISGSIP  LSN T+L+QLQLDTNQ+S              +FFAWQNKLEG IP
Sbjct: 345  MLSNNNISGSIPKALSNLTNLIQLQLDTNQLSGSIPPELGSLTKLTMFFAWQNKLEGGIP 404

Query: 347  STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
            STL  CRSLEA+DLS+NALT SL PGLF+LQNLTKLLLISN ISG IPPEIG CSSLIRL
Sbjct: 405  STLEGCRSLEALDLSYNALTDSLPPGLFKLQNLTKLLLISNDISGPIPPEIGKCSSLIRL 464

Query: 407  RL----------------------------------MSFGNCTQLQMLNLSNNTLGGTLP 432
            RL                                  +  GNC +LQMLNLSNN+L G LP
Sbjct: 465  RLVDNRISGEIPKEIGFLNSLNFLDLSENHLTGSVPLEIGNCKELQMLNLSNNSLSGALP 524

Query: 433  SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSL 492
            S L+SLTRL VLD+S+N F G +P S GQL SL R+ILSKNSFSG IPSSLG+C  LQ L
Sbjct: 525  SYLSSLTRLDVLDLSMNNFSGEVPMSIGQLTSLLRVILSKNSFSGPIPSSLGQCSGLQLL 584

Query: 493  DLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL 552
            DLSSNK SG IP EL +IE LDISLN S NALSG +PP+IS+LNKLS+LDLSHN L GDL
Sbjct: 585  DLSSNKFSGTIPPELLQIEALDISLNFSHNALSGVVPPEISSLNKLSVLDLSHNNLEGDL 644

Query: 553  LALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVG 612
            +A SGL+NLVSLN+S+N FTGYLPDSKLF QLSAT++AGNQGLC  GH+SCF+SNA    
Sbjct: 645  MAFSGLENLVSLNISFNKFTGYLPDSKLFHQLSATDLAGNQGLCPNGHDSCFVSNAAMTK 704

Query: 613  MGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLT 672
            M NG   ++SE +K+AI LL    +A+AIFGA  V RA KM+  D DSE+GG+S PWQ T
Sbjct: 705  MINGTNSKRSEIIKLAIGLLSALVVAMAIFGAVKVFRARKMIQADNDSEVGGDSWPWQFT 764

Query: 673  PFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQND 732
            PFQK+NF+VEQV KCLVE +V+GKGCSGIVYRAEMENG++IAVK+LWPTT AA YD Q+D
Sbjct: 765  PFQKVNFSVEQVFKCLVESNVIGKGCSGIVYRAEMENGDIIAVKRLWPTTSAARYDSQSD 824

Query: 733  KIGI-GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR 791
            K+ + GGVRDSFSAE+KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE+ 
Sbjct: 825  KLAVNGGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHEQS 884

Query: 792  DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
             +CLEW++R+RIILGAAQG+AYLHHDC PPIVHRDIKANNILIGPEFEPYIADFGLAKLV
Sbjct: 885  GNCLEWDIRFRIILGAAQGVAYLHHDCAPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 944

Query: 852  VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL 911
             +GDFARSS+T+AGSYGYIAPEYGYMMKITEKSDVYSYG+VVLEVLTGKQPIDPTIP+GL
Sbjct: 945  DDGDFARSSSTLAGSYGYIAPEYGYMMKITEKSDVYSYGIVVLEVLTGKQPIDPTIPDGL 1004

Query: 912  HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK 971
            HIVDWVR KRG +EVLD+SLRARPE EIEEMLQTLGVALL VN +PDDRPTMKDV AM+K
Sbjct: 1005 HIVDWVRHKRGGVEVLDESLRARPESEIEEMLQTLGVALLSVNSSPDDRPTMKDVVAMMK 1064

Query: 972  EIKQEREECMKVDMLPSEGSANGQRENNNSSSTAM 1006
            EI+QEREEC+KVDML +  SAN Q+E N+ +   M
Sbjct: 1065 EIRQEREECVKVDMLLNASSANEQQERNHLTEEPM 1099

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359480096|ref|XP_003632398.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RCH1-like [Vitis vinifera]

 Score = 1536 bits (3976), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 773/1066 (72%), Positives = 887/1066 (83%), Gaps = 57/1066 (5%)

Query: 1    SSSIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLI 60
            S S P   S+WNP   +PC WS+ITCS +NFVTEIN+QS+ L LPFPSNLSSL FL+K  
Sbjct: 65   SPSPPLGFSDWNPLAPHPCNWSYITCSSENFVTEINVQSLHLALPFPSNLSSLVFLKKFT 124

Query: 61   ISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPK 120
            +S +NLTG I  D+GDCT+LT +DV SNSLVG +PSSIGKL  L+DLILNSNQ+TG+IP 
Sbjct: 125  VSDANLTGTIPADIGDCTELTVLDVGSNSLVGSIPSSIGKLHYLEDLILNSNQITGKIPA 184

Query: 121  ELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVV 180
            ELG C  LK+LLL+DN LSG++PVELGKL++LEVIRAGGN+DI+G IP E+G+CQ+L V+
Sbjct: 185  ELGDCTGLKSLLLYDNQLSGDIPVELGKLLSLEVIRAGGNRDISGIIPDELGNCQNLKVL 244

Query: 181  GLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLP 240
            GLA TK++GS+P SLGKLSKLQ+LSVYTTMLSGEIP ++GNCSELVDLFLYEN LSGSLP
Sbjct: 245  GLAYTKISGSIPVSLGKLSKLQTLSVYTTMLSGEIPQELGNCSELVDLFLYENSLSGSLP 304

Query: 241  RELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEEL 300
             +LGKLQKLEKMLLWQNN DG IPEEIGNC SL+T+DLSLN FSGS+P SFG L+ LEEL
Sbjct: 305  LQLGKLQKLEKMLLWQNNLDGTIPEEIGNCGSLRTLDLSLNSFSGSIPLSFGTLTMLEEL 364

Query: 301  MLSNNNISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIP 346
            MLSNNN+SGSIP  LSNAT+LLQLQ+DTNQIS              VFF W NK EGSIP
Sbjct: 365  MLSNNNLSGSIPSGLSNATNLLQLQVDTNQISGPIPQELGMLRDLTVFFGWDNKFEGSIP 424

Query: 347  STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
            S LA CRSL+A+DLSHN+LTGSL PGLFQLQNLTKLLLISN ISG IP EIGNCSSL+RL
Sbjct: 425  SALAGCRSLQALDLSHNSLTGSLPPGLFQLQNLTKLLLISNDISGSIPVEIGNCSSLVRL 484

Query: 407  RL------------------MSF----------------GNCTQLQMLNLSNNTLGGTLP 432
            RL                  +SF                GNCT LQM++LSNN+  GTLP
Sbjct: 485  RLQDNKITGEIPKEVGFLTNLSFLDLSQNRLSGRVPDEIGNCTDLQMVDLSNNSFVGTLP 544

Query: 433  SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSL 492
             SL+SLTRLQVLD+S+NQF G IP SFGQL +LNRL+L +NS SG+IPSSLG+C SLQ L
Sbjct: 545  GSLSSLTRLQVLDVSMNQFEGEIPGSFGQLTALNRLVLRRNSLSGSIPSSLGQCSSLQLL 604

Query: 493  DLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL 552
            DLSSN LSG IP ELF IE LDI+LNLSWNAL+G I PQISAL++LSILDLSHNK+GGDL
Sbjct: 605  DLSSNALSGGIPKELFGIEALDIALNLSWNALTGVISPQISALSRLSILDLSHNKIGGDL 664

Query: 553  LALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVG 612
            +ALSGL+NLVSLN+SYNNF+GYLPD+KLFRQLSAT++AGN+GLCS   +SCF+ N   VG
Sbjct: 665  MALSGLENLVSLNISYNNFSGYLPDNKLFRQLSATDLAGNKGLCSSNRDSCFVRNPADVG 724

Query: 613  MGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLT 672
            + N   FR+S++LK+AIALLV  T+A+AI G  AV RA KMVGDD DSE+GG+S PWQ T
Sbjct: 725  LPNSSRFRRSQRLKLAIALLVALTVAMAILGMLAVFRARKMVGDDNDSELGGDSWPWQFT 784

Query: 673  PFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQND 732
            PFQKLNF+VEQVL+CLVE +V+GKGCSG+VYRAEMENGEVIAVKKLWPTT+AA Y+CQ+D
Sbjct: 785  PFQKLNFSVEQVLRCLVEANVIGKGCSGVVYRAEMENGEVIAVKKLWPTTLAAGYNCQDD 844

Query: 733  KIGIG-GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR 791
            ++G+  GVRDSFS E+KTLGSIRHKNIVRFLGCCWN++TRLLMYD+MPNGSLGSLLHER 
Sbjct: 845  RLGVNKGVRDSFSTEVKTLGSIRHKNIVRFLGCCWNQSTRLLMYDFMPNGSLGSLLHERS 904

Query: 792  DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
              CLEW+LRYRI+LG+AQGL+YLHHDCVPPIVHRDIKANNILIG +FEPYIADFGLAKLV
Sbjct: 905  RCCLEWDLRYRIVLGSAQGLSYLHHDCVPPIVHRDIKANNILIGFDFEPYIADFGLAKLV 964

Query: 852  VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL 911
             + D+ARSSNT+AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP+GL
Sbjct: 965  DDRDYARSSNTIAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGL 1024

Query: 912  HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK 971
            HIVDWVRQ++G IEVLD SL +RPE E+EEM+QTLGVALLCVNPTPDDRP+MKDVAAM+K
Sbjct: 1025 HIVDWVRQRKGQIEVLDPSLHSRPESELEEMMQTLGVALLCVNPTPDDRPSMKDVAAMLK 1084

Query: 972  EIKQEREECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYPQSNNT 1017
            EI+ EREE MKVDML      NG  E        MM   YPQSNNT
Sbjct: 1085 EIRHEREESMKVDMLLKGSPENGPSE--------MMQCSYPQSNNT 1122

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356527419|ref|XP_003532308.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RCH1-like [Glycine max]

 Score = 1523 bits (3943), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 756/1056 (71%), Positives = 868/1056 (82%), Gaps = 50/1056 (4%)

Query: 1    SSSIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLI 60
            S+++PSA S+WNP DSNPC WS+I CS  + VTEI IQ++EL L FPS +SS  FLQ+L+
Sbjct: 49   SNTVPSAFSSWNPLDSNPCNWSYIKCSSASLVTEIAIQNVELALHFPSKISSFPFLQRLV 108

Query: 61   ISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPK 120
            ISG+NLTG ISPD+G+C +L  +D+SSNSLVGG+PSSIG+L  LQ+L LNSN LTG IP 
Sbjct: 109  ISGANLTGAISPDIGNCPELIVLDLSSNSLVGGIPSSIGRLKYLQNLSLNSNHLTGPIPS 168

Query: 121  ELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVV 180
            E+G C+ LK L +FDN LSG LPVELGKL NLEVIRAGGN  I GKIP E+GDC++L V+
Sbjct: 169  EIGDCVNLKTLDIFDNNLSGGLPVELGKLTNLEVIRAGGNSGIVGKIPDELGDCRNLSVL 228

Query: 181  GLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLP 240
            GLADTK++GSLPASLGKLS LQ+LS+Y+TMLSGEIPP+IGNCSELV+LFLYEN LSG LP
Sbjct: 229  GLADTKISGSLPASLGKLSMLQTLSIYSTMLSGEIPPEIGNCSELVNLFLYENGLSGFLP 288

Query: 241  RELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEEL 300
            RE+GKLQKLEKMLLWQN+F G IPEEIGNC+SLK +D+SLN  SG +PQS G LS+LEEL
Sbjct: 289  REIGKLQKLEKMLLWQNSFGGGIPEEIGNCRSLKILDVSLNSLSGGIPQSLGQLSNLEEL 348

Query: 301  MLSNNNISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIP 346
            MLSNNNISGSIP  LSN T+L+QLQLDTNQ+S              VFFAWQNKLEG IP
Sbjct: 349  MLSNNNISGSIPKALSNLTNLIQLQLDTNQLSGSIPPELGSLTKLTVFFAWQNKLEGGIP 408

Query: 347  STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
            STL  C+ LEA+DLS+NALT SL PGLF+LQNLTKLLLISN ISG IPPEIGNCSSLIRL
Sbjct: 409  STLGGCKCLEALDLSYNALTDSLPPGLFKLQNLTKLLLISNDISGPIPPEIGNCSSLIRL 468

Query: 407  RL----------------------------------MSFGNCTQLQMLNLSNNTLGGTLP 432
            RL                                  +  GNC +LQMLNLSNN+L G LP
Sbjct: 469  RLVDNRISGEIPKEIGFLNSLNFLDLSENHLTGSVPLEIGNCKELQMLNLSNNSLSGALP 528

Query: 433  SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSL 492
            S L+SLTRL+VLD+S+N+F G +P S GQL SL R+ILSKNSFSG IPSSLG+C  LQ L
Sbjct: 529  SYLSSLTRLEVLDVSMNKFSGEVPMSIGQLISLLRVILSKNSFSGPIPSSLGQCSGLQLL 588

Query: 493  DLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL 552
            DLSSN  SG IP EL +I  LDISLNLS NALSG +PP+IS+LNKLS+LDLSHN L GDL
Sbjct: 589  DLSSNNFSGSIPPELLQIGALDISLNLSHNALSGVVPPEISSLNKLSVLDLSHNNLEGDL 648

Query: 553  LALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVG 612
            +A SGL+NLVSLN+SYN FTGYLPDSKLF QLSAT++AGNQGLC  GH+SCF+SNA    
Sbjct: 649  MAFSGLENLVSLNISYNKFTGYLPDSKLFHQLSATDLAGNQGLCPDGHDSCFVSNAAMTK 708

Query: 613  MGNG-GGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQL 671
            M NG    ++SE +K+AI LL    +A+AIFG   V RA KM+  D DSE+GG+S PWQ 
Sbjct: 709  MLNGTNNSKRSEIIKLAIGLLSALVVAMAIFGVVTVFRARKMIQADNDSEVGGDSWPWQF 768

Query: 672  TPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQN 731
            TPFQK++F+VEQVLKCLV+ +V+GKGCSGIVYRAEMENG+VIAVK+LWPTT+AA YD ++
Sbjct: 769  TPFQKVSFSVEQVLKCLVDSNVIGKGCSGIVYRAEMENGDVIAVKRLWPTTLAARYDSKS 828

Query: 732  DKIGI-GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER 790
            DK+ + GGVRDSFSAE+KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLG LLHER
Sbjct: 829  DKLAVNGGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGGLLHER 888

Query: 791  RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
              +CLEW++R+RIILGAAQG+AYLHHDC PPIVHRDIKANNILIG EFEPYIADFGLAKL
Sbjct: 889  SGNCLEWDIRFRIILGAAQGVAYLHHDCAPPIVHRDIKANNILIGTEFEPYIADFGLAKL 948

Query: 851  VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG 910
            V + DFARSS+T+AGSYGYIAPEYGYMMKITEKSDVYSYG+VVLEVLTGKQPIDPTIP+G
Sbjct: 949  VDDRDFARSSSTLAGSYGYIAPEYGYMMKITEKSDVYSYGIVVLEVLTGKQPIDPTIPDG 1008

Query: 911  LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
            LHIVDWVRQKRG +EVLD+SLRARPE EIEEMLQTLGVALLCVN +PDDRPTMKDV AM+
Sbjct: 1009 LHIVDWVRQKRGGVEVLDESLRARPESEIEEMLQTLGVALLCVNSSPDDRPTMKDVVAMM 1068

Query: 971  KEIKQEREECMKVDMLPSEGSANGQRENNNSSSTAM 1006
            KEI+QEREEC+KVDML    SAN Q+E N+S    M
Sbjct: 1069 KEIRQEREECVKVDMLLDASSANDQQERNHSIEEPM 1104

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255554216|ref|XP_002518148.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] gi|223542744|gb|EEF44281.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis]

 Score = 1410 bits (3650), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 737/1067 (69%), Positives = 853/1067 (79%), Gaps = 65/1067 (6%)

Query: 8    LSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLT 67
            LSNWN  DS PCKW+ ITCS Q FVTEINIQS+ L+LP P NLSS   L KL+IS +NLT
Sbjct: 59   LSNWNNLDSTPCKWTSITCSLQGFVTEINIQSVPLQLPVPLNLSSFRSLSKLVISDANLT 118

Query: 68   GPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIK 127
            G I  D+G+   LT +D+SSNSLVG +P SIG+L NL+DLILNSNQLTG+IP EL  C  
Sbjct: 119  GTIPIDIGNSVSLTVLDLSSNSLVGTIPESIGQLQNLEDLILNSNQLTGKIPTELSNCTS 178

Query: 128  LKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKV 187
            LKNLLLFDN LSG +P ELGKL +LEV+RAGGNKDI GKIP E+GDC +L V+GLADT+V
Sbjct: 179  LKNLLLFDNRLSGYIPTELGKLSSLEVLRAGGNKDIVGKIPDELGDCSNLTVLGLADTRV 238

Query: 188  AGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQ 247
            +GSLP S GKLSKLQ+LS+YTTMLSGEIP  IGNCSELV+LFLYEN LSGS+P E+GKL+
Sbjct: 239  SGSLPVSFGKLSKLQTLSIYTTMLSGEIPADIGNCSELVNLFLYENSLSGSIPPEIGKLK 298

Query: 248  KLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNI 307
            KLE++LLWQN+  G IPEEIGNC SLK IDLSLN  SG++P S G+L  LEE M+SNNN+
Sbjct: 299  KLEQLLLWQNSLVGVIPEEIGNCTSLKMIDLSLNSLSGTIPSSIGSLVELEEFMISNNNV 358

Query: 308  SGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPSTLANCR 353
            SGSIP  LSNAT+LLQLQLDTNQIS              VFFAWQN+LEGSIP +LA C 
Sbjct: 359  SGSIPSDLSNATNLLQLQLDTNQISGLIPPELGMLSKLNVFFAWQNQLEGSIPFSLARCS 418

Query: 354  SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL----- 408
            +L+A+DLSHN+LTGS+ PGLFQLQNLTKLLLISN ISG IPPEIGNCSSL+RLRL     
Sbjct: 419  NLQALDLSHNSLTGSIPPGLFQLQNLTKLLLISNDISGSIPPEIGNCSSLVRLRLGNNRI 478

Query: 409  -------------MSF----------------GNCTQLQMLNLSNNTLGGTLPSSLASLT 439
                         ++F                G+CT+LQM++LSNNT+ G+LP+SL+SL+
Sbjct: 479  AGGIPKEIGHLRNLNFLDLSSNRLSGSVPDEIGSCTELQMIDLSNNTVEGSLPNSLSSLS 538

Query: 440  RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKL 499
             LQVLDIS+NQF G +P SFG+L SLN+LILS+NSFSGAIP S+  C SLQ LDL+SN+L
Sbjct: 539  GLQVLDISINQFSGQVPASFGRLLSLNKLILSRNSFSGAIPPSISLCSSLQLLDLASNEL 598

Query: 500  SGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLD 559
            SG IP+EL  +E L+I+LNLS+N L+G IPP ISAL KLSILDLSHNKL GDL  LSGLD
Sbjct: 599  SGSIPMELGRLEALEIALNLSYNGLTGPIPPPISALTKLSILDLSHNKLEGDLSHLSGLD 658

Query: 560  NLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMG-NGGG 618
            NLVSLNVSYNNFTGYLPD+KLFRQLS  ++AGNQGLCS   +SCFLS+    G+  NG  
Sbjct: 659  NLVSLNVSYNNFTGYLPDNKLFRQLSPADLAGNQGLCSSLKDSCFLSDIGRTGLQRNGND 718

Query: 619  FRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLN 678
             R+S KLK+AIALL+T T+A+ I G FA++RA + + DD D  + G+S PWQ TPFQKLN
Sbjct: 719  IRQSRKLKLAIALLITLTVAMVIMGTFAIIRARRTIRDD-DESVLGDSWPWQFTPFQKLN 777

Query: 679  FTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGG 738
            F+V+Q+L+ LV+ +V+GKGCSGIVYRA+MENG+VIAVKKLWP TMA    C ++K    G
Sbjct: 778  FSVDQILRSLVDTNVIGKGCSGIVYRADMENGDVIAVKKLWPNTMATTNGCNDEK---SG 834

Query: 739  VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
            VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER  + LEW+
Sbjct: 835  VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERTGNALEWD 894

Query: 799  LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
            LRY+I+LGAA+GLAYLHHDCVPPIVHRDIKANNILIG EFEPYIADFGLAKLV +GDFAR
Sbjct: 895  LRYQILLGAAEGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFAR 954

Query: 859  SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR 918
            SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH+ DWVR
Sbjct: 955  SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHVADWVR 1014

Query: 919  QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
            QK+G IEVLD SL +RP  EI+EM+Q LG+ALLCVN +PD+RPTMKDVAAM+KEIK ERE
Sbjct: 1015 QKKGGIEVLDPSLLSRPGPEIDEMMQALGIALLCVNSSPDERPTMKDVAAMLKEIKHERE 1074

Query: 979  ECMKVDM-LPSEGSANGQRENNNSSS-----------TAMMPNLYPQ 1013
            E  KVDM L +  +A    EN NS +              M NLYP+
Sbjct: 1075 EYAKVDMLLKASPAAAADTENKNSRNGVPATTSSSKPQQTMANLYPK 1121

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42568408|ref|NP_199705.2| LRR receptor-like serine/threonine-protein kinase RCH1 [Arabidopsis thaliana] gi|263505419|sp|C0LGV1.1|RCH1_ARATH RecName: Full=LRR receptor-like serine/threonine-protein kinase RCH1; AltName: Full=Protein ROOT CLAVATA-HOMOLOG1 1; Flags: Precursor gi|224589709|gb|ACN59386.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332008362|gb|AED95745.1| LRR receptor-like serine/threonine-protein kinase RCH1 [Arabidopsis thaliana]

 Score = 1409 bits (3646), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 709/1052 (67%), Positives = 832/1052 (79%), Gaps = 61/1052 (5%)

Query: 5    PSALSNWNPSDSNPCKWSHITCSPQN--FVTEINIQSIELELPFPSNLSSLSFLQKLIIS 62
            PS  S WNPSDS+PC+W +ITCS  +   VTEIN+ S++L LPFP N+SS + LQKL+IS
Sbjct: 55   PSVFSGWNPSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVIS 114

Query: 63   GSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKEL 122
             +NLTG IS ++GDC++L  ID+SSNSLVG +PSS+GKL NLQ+L LNSN LTG+IP EL
Sbjct: 115  NTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPEL 174

Query: 123  GACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGL 182
            G C+ LKNL +FDNYLS NLP+ELGK+  LE IRAGGN +++GKIP EIG+C++L V+GL
Sbjct: 175  GDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGL 234

Query: 183  ADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRE 242
            A TK++GSLP SLG+LSKLQSLSVY+TMLSGEIP ++GNCSEL++LFLY+NDLSG+LP+E
Sbjct: 235  AATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKE 294

Query: 243  LGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELML 302
            LGKLQ LEKMLLWQNN  G IPEEIG  KSL  IDLS+N+FSG++P+SFGNLS+L+ELML
Sbjct: 295  LGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELML 354

Query: 303  SNNNISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPST 348
            S+NNI+GSIP +LSN T L+Q Q+D NQIS              +F  WQNKLEG+IP  
Sbjct: 355  SSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDE 414

Query: 349  LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
            LA C++L+A+DLS N LTGSL  GLFQL+NLTKLLLISN ISG+IP EIGNC+SL+RLRL
Sbjct: 415  LAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRL 474

Query: 409  ----------------------------------MSFGNCTQLQMLNLSNNTLGGTLPSS 434
                                              +   NC QLQMLNLSNNTL G LP S
Sbjct: 475  VNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLS 534

Query: 435  LASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL 494
            L+SLT+LQVLD+S N   G IP+S G L SLNRLILSKNSF+G IPSSLG C +LQ LDL
Sbjct: 535  LSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDL 594

Query: 495  SSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLA 554
            SSN +SG IP ELF+I+ LDI+LNLSWN+L G IP +ISALN+LS+LD+SHN L GDL A
Sbjct: 595  SSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSA 654

Query: 555  LSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMG 614
            LSGL+NLVSLN+S+N F+GYLPDSK+FRQL   EM GN GLCS+G  SCF+SN++ +   
Sbjct: 655  LSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQ 714

Query: 615  NGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPF 674
             G     S +L+IAI LL++ T  LA+ G  AV+RA +M+ DD DSE G N   WQ TPF
Sbjct: 715  RG---VHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPF 771

Query: 675  QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKI 734
            QKLNFTVE VLKCLVE +V+GKGCSGIVY+AEM N EVIAVKKLWP T+       N+K 
Sbjct: 772  QKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPN----LNEKT 827

Query: 735  GIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC 794
               GVRDSFSAE+KTLGSIRHKNIVRFLGCCWN+NTRLLMYDYM NGSLGSLLHER   C
Sbjct: 828  KSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVC 887

Query: 795  -LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
             L WE+RY+IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP+FEPYI DFGLAKLV +
Sbjct: 888  SLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDD 947

Query: 854  GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI 913
            GDFARSSNT+AGSYGYIAPEYGY MKITEKSDVYSYGVVVLEVLTGKQPIDPTIP+GLHI
Sbjct: 948  GDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHI 1007

Query: 914  VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            VDWV++ R  I+V+D+ L+ARPE E+EEM+QTLGVALLC+NP P+DRPTMKDVAAM+ EI
Sbjct: 1008 VDWVKKIRD-IQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEI 1066

Query: 974  KQEREECMKVDMLPSEGSANGQRENNNSSSTA 1005
             QEREE MKVD     GS N  RE     ST+
Sbjct: 1067 CQEREESMKVD--GCSGSCNNGRERGKDDSTS 1096

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297792091|ref|XP_002863930.1| hypothetical protein ARALYDRAFT_917829 [Arabidopsis lyrata subsp. lyrata] gi|297309765|gb|EFH40189.1| hypothetical protein ARALYDRAFT_917829 [Arabidopsis lyrata subsp. lyrata]

 Score = 1407 bits (3641), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 707/1052 (67%), Positives = 831/1052 (78%), Gaps = 59/1052 (5%)

Query: 5    PSALSNWNPSDSNPCKWSHITCSPQN--FVTEINIQSIELELPFPSNLSSLSFLQKLIIS 62
            PS  S WNPSDS+PC+W +ITCS  +   VTEIN+ S++L LPFP N+SS + L+KL+IS
Sbjct: 50   PSVFSGWNPSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLEKLVIS 109

Query: 63   GSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKEL 122
             +NLTG IS ++GDC++L  ID+SSNSLVG +PSS+GKL NLQ+L LNSN LTG+IP EL
Sbjct: 110  NTNLTGSISSEIGDCSELRVIDLSSNSLVGEIPSSLGKLKNLQELSLNSNGLTGKIPPEL 169

Query: 123  GACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGL 182
            G C+ LKNL +FDNYLSGNLP+ELGK+  LE IRAGGN +++GKIP EIG+C +L V+GL
Sbjct: 170  GDCVALKNLEIFDNYLSGNLPLELGKIPTLESIRAGGNSELSGKIPEEIGNCGNLKVLGL 229

Query: 183  ADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRE 242
            A TK++GSLP SLGKLSKLQSLSVY+TMLSGEIP ++GNCSEL++LFLY+NDLSG+LP+E
Sbjct: 230  AATKISGSLPVSLGKLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKE 289

Query: 243  LGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELML 302
            LGKLQ LEKMLLWQNN  G IPEEIG  KSL  IDLS+N+FSG++P+SFGNLS+L+ELML
Sbjct: 290  LGKLQNLEKMLLWQNNLHGLIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELML 349

Query: 303  SNNNISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPST 348
            S+NNI+GSIP VLSN T L+Q Q+D NQIS              +F  WQNKLEG+IP  
Sbjct: 350  SSNNITGSIPSVLSNCTRLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPVE 409

Query: 349  LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
            LA C++L+A+DLS N LTG+L  GLF L+NLTKLLLISN ISG+IPPEIGNC+SL+RLRL
Sbjct: 410  LAGCQNLQALDLSQNYLTGALPAGLFHLRNLTKLLLISNAISGVIPPEIGNCTSLVRLRL 469

Query: 409  ----------------------------------MSFGNCTQLQMLNLSNNTLGGTLPSS 434
                                              +   NC QLQMLNLSNNTL G LP  
Sbjct: 470  VNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLP 529

Query: 435  LASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL 494
            L+SLT+LQVLD+S N   G IP+S G L  LNRL+LSKNSF+G IPSSLG C +LQ LDL
Sbjct: 530  LSSLTKLQVLDVSSNDLTGKIPDSLGHLILLNRLVLSKNSFNGEIPSSLGHCTNLQLLDL 589

Query: 495  SSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLA 554
            SSN +SG IP ELF+I+ LDI+LNLSWN+L G+IP +ISALN+LS+LD+SHN L GDL  
Sbjct: 590  SSNNISGTIPEELFDIQDLDIALNLSWNSLDGSIPARISALNRLSVLDISHNMLSGDLFV 649

Query: 555  LSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMG 614
            LSGL+NLVSLN+S+N F+GYLPDSK+FRQL   EM GN GLCS+G  SCF+SN+T +   
Sbjct: 650  LSGLENLVSLNISHNRFSGYLPDSKVFRQLIRAEMEGNNGLCSKGFRSCFVSNSTQLSTQ 709

Query: 615  NGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPF 674
             G     S++LKIAI LL++ T  LA+ G  AV+RA +M+ D  DSE G N   WQ TPF
Sbjct: 710  RG---VHSQRLKIAIGLLISVTAVLAVLGVLAVLRAKQMIRDGNDSETGENLWTWQFTPF 766

Query: 675  QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKI 734
            QKLNFTVE VLKCLVE +V+GKGCSGIVY+AEM N EVIAVKKLWP T+       N+K 
Sbjct: 767  QKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNQEVIAVKKLWPVTVTLPN--LNEKT 824

Query: 735  GIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC 794
               GVRDSFSAE+KTLGSIRHKNIVRFLGCCWN+NTRLLMYDYM NGSLGSLLHER   C
Sbjct: 825  KSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVC 884

Query: 795  -LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
             L WE+RY+IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP+FEPYI DFGLAKLV +
Sbjct: 885  SLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDD 944

Query: 854  GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI 913
            GDFARSSNT+AGSYGYIAPEYGY MKITEKSDVYSYGVVVLEVLTGKQPIDPTIP+GLHI
Sbjct: 945  GDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHI 1004

Query: 914  VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            VDWV++ R  I+V+D++L+ARPE E+EEM+QTLGVALLC+NP P+DRPTMKDVAAM+ EI
Sbjct: 1005 VDWVKKVRD-IQVIDQTLQARPESEVEEMMQTLGVALLCINPLPEDRPTMKDVAAMLSEI 1063

Query: 974  KQEREECMKVDMLPSEGSANGQRENNNSSSTA 1005
            +QEREE MKVD     GS N  RE     ST 
Sbjct: 1064 RQEREESMKVD--GCSGSCNNGRERRKDDSTT 1093

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|29119651|emb|CAD79349.1| LRR receptor-like kinase 1 [Arabidopsis thaliana]

 Score = 1402 bits (3630), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 708/1052 (67%), Positives = 831/1052 (78%), Gaps = 61/1052 (5%)

Query: 5    PSALSNWNPSDSNPCKWSHITCS-PQN-FVTEINIQSIELELPFPSNLSSLSFLQKLIIS 62
            PS  S WNPSDS+PC+W +ITCS P N  VTEIN+ S++L LPFP N+SS + LQKL+IS
Sbjct: 55   PSVFSGWNPSDSDPCQWPYITCSSPDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVIS 114

Query: 63   GSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKEL 122
             +NLTG IS ++GDC++L  ID+SSNSLVG +PSS+GKL NLQ+L LNSN LTG+IP EL
Sbjct: 115  NTNLTGAISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPEL 174

Query: 123  GACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGL 182
            G C+ LKNL +FDNYLS NLP+ELGK+  LE IRAGGN +++GKIP EIG+C++L V+GL
Sbjct: 175  GDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGL 234

Query: 183  ADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRE 242
            A TK++GSLP SLG+LSKLQSL VY+TMLSGEIP ++GNCSEL++LFLY+NDLSG+LP+E
Sbjct: 235  AATKISGSLPVSLGQLSKLQSLFVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKE 294

Query: 243  LGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELML 302
            LGKLQ LEKMLLWQNN  G IPEEIG  KSL  IDLS+N+FSG++P+SFGNLS+L+ELML
Sbjct: 295  LGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELML 354

Query: 303  SNNNISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPST 348
            S+NNI+GSIP +LS+ T L+Q Q+D NQIS              +F  WQNKLEG+IP  
Sbjct: 355  SSNNITGSIPSILSDCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDE 414

Query: 349  LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
            LA C++L+A+DLS N LTGSL  GLFQL+NLTKLLLISN ISG+IP E GNC+SL+RLRL
Sbjct: 415  LAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLETGNCTSLVRLRL 474

Query: 409  ----------------------------------MSFGNCTQLQMLNLSNNTLGGTLPSS 434
                                              +   NC QLQMLNLSNNTL G LP S
Sbjct: 475  VNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLS 534

Query: 435  LASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL 494
            L+SLT+LQVLD+S N   G IP+S G L SLNRLILSKNSF+G IPSSLG C +LQ LDL
Sbjct: 535  LSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDL 594

Query: 495  SSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLA 554
            SSN +SG IP ELF+I+ LDI+LNLSWN+L G IP +ISALN+LS+LD+SHN L GDL A
Sbjct: 595  SSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSA 654

Query: 555  LSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMG 614
            LSGL+NLVSLN+S+N F+GYLPDSK+FRQL   EM GN GLCS+G  SCF+SN++ +   
Sbjct: 655  LSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQ 714

Query: 615  NGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPF 674
             G     S +L+IAI LL++ T  LA+ G  AV+RA +M+ DD DSE G N   WQ TPF
Sbjct: 715  RG---VHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPF 771

Query: 675  QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKI 734
            QKLNFTVE VLKCLVE +V+GKGCSGIVY+AEM N EVIAVKKLWP T+       N+K 
Sbjct: 772  QKLNFTVEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPN----LNEKT 827

Query: 735  GIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC 794
               GVRDSFSAE+KTLGSIRHKNIVRFLGCCWN+NTRLLMYDYM NGSLGSLLHER   C
Sbjct: 828  KSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVC 887

Query: 795  -LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
             L WE+RY+IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP+FEPYI DFGLAKLV +
Sbjct: 888  SLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDD 947

Query: 854  GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI 913
            GDFARSSNT+AGSYGYIAPEYGY MKITEKSDVYSYGVVVLEVLTGKQPIDPTIP+GLHI
Sbjct: 948  GDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHI 1007

Query: 914  VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            VDWV++ R  I+V+D+ L+ARPE E+EEM+QTLGVALLC+NP P+DRPTMKDVAAM+ EI
Sbjct: 1008 VDWVKKIRD-IQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEI 1066

Query: 974  KQEREECMKVDMLPSEGSANGQRENNNSSSTA 1005
             QEREE MKVD     GS N  RE     ST+
Sbjct: 1067 CQEREESMKVD--GCSGSCNNGRERGKDDSTS 1096

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147766422|emb|CAN73805.1| hypothetical protein VITISV_031044 [Vitis vinifera]

 Score = 1399 bits (3621), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 728/1067 (68%), Positives = 860/1067 (80%), Gaps = 60/1067 (5%)

Query: 6    SALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSN 65
            S+L +WN +D+ PC W+ I CSP+ FVTEINIQS+ LELP PSNLSS  FLQKL+IS +N
Sbjct: 101  SSLPDWNINDATPCNWTSIVCSPRGFVTEINIQSVHLELPIPSNLSSFQFLQKLVISDAN 160

Query: 66   LTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGAC 125
            +TG I P++G CT L  ID+SSNSLVG +P+S+GKL  L+DL+LNSNQLTG+IP EL  C
Sbjct: 161  ITGTIPPEIGGCTALRIIDLSSNSLVGTIPASLGKLQKLEDLVLNSNQLTGKIPVELSNC 220

Query: 126  IKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADT 185
            + L+NLLLFDN L GN+P +LGKL NLEVIRAGGNK+I GKIP E+G+C +L V+GLADT
Sbjct: 221  LNLRNLLLFDNRLGGNIPPDLGKLSNLEVIRAGGNKEITGKIPAELGECSNLTVLGLADT 280

Query: 186  KVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGK 245
            +V+GSLPASLGKLS+LQ+LS+YTTMLSGEIPP IGNCSELV+L+LYEN LSGS+P ELGK
Sbjct: 281  QVSGSLPASLGKLSRLQTLSIYTTMLSGEIPPDIGNCSELVNLYLYENSLSGSVPPELGK 340

Query: 246  LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN 305
            LQKL+ + LWQN   G IPEEIGNC SL+ IDLSLN  SG++P S G+LS L+E M+SNN
Sbjct: 341  LQKLQTLFLWQNTLVGVIPEEIGNCSSLQMIDLSLNSLSGTIPPSLGDLSELQEFMISNN 400

Query: 306  NISGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPSTLAN 351
            N+SGSIP VLSNA +L+QLQLDTNQIS              VFFAW N+LEGSIPSTLAN
Sbjct: 401  NVSGSIPSVLSNARNLMQLQLDTNQISGLIPPDLGKLSKLGVFFAWDNQLEGSIPSTLAN 460

Query: 352  CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL--- 408
            CR+L+ +DLSHN+LTG++  GLFQLQNLTKLLLISN ISG IPPEIGNCSSL+R+RL   
Sbjct: 461  CRNLQVLDLSHNSLTGTIPSGLFQLQNLTKLLLISNDISGTIPPEIGNCSSLVRMRLGNN 520

Query: 409  ---------------MSF----------------GNCTQLQMLNLSNNTLGGTLPSSLAS 437
                           ++F                 +CT+LQM++LSNN L G LP+SL+S
Sbjct: 521  RITGGIPRQIGGLKNLNFLDLSRNRLSGSVPDEIESCTELQMVDLSNNILEGPLPNSLSS 580

Query: 438  LTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN 497
            L+ LQVLD+SVN+  G IP SFG+L SLN+LILS+NS SG+IP SLG C SLQ LDLSSN
Sbjct: 581  LSGLQVLDVSVNRLTGQIPASFGRLVSLNKLILSRNSLSGSIPPSLGLCSSLQLLDLSSN 640

Query: 498  KLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSG 557
            +L G IP+EL +IE L+I+LNLS N L+G IP QISALNKLSILDLSHNKL G+L+ L+ 
Sbjct: 641  ELFGSIPMELSQIEALEIALNLSCNGLTGPIPTQISALNKLSILDLSHNKLEGNLIPLAK 700

Query: 558  LDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGG 617
            LDNLVSLN+SYNNFTGYLPD+KLFRQL A ++AGNQGLCS G +SCFL++ T +   N  
Sbjct: 701  LDNLVSLNISYNNFTGYLPDNKLFRQLPAIDLAGNQGLCSWGRDSCFLNDVTGL-TRNKD 759

Query: 618  GFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKL 677
              R+S KLK+AIALL+T T+AL I G  AV+RA   +  D DSE+GG+S PWQ TPFQKL
Sbjct: 760  NVRQSRKLKLAIALLITMTVALVIMGTIAVIRARTTIRGDDDSELGGDSWPWQFTPFQKL 819

Query: 678  NFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG 737
            NF+VEQ+L+CLV+ +V+GKGCSG+VYRA+M+NGEVIAVKKLWPT M A  +  NDK    
Sbjct: 820  NFSVEQILRCLVDSNVIGKGCSGVVYRADMDNGEVIAVKKLWPTAMGAA-NGDNDK---S 875

Query: 738  GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            GVRDSFSAE+KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE+  + LEW
Sbjct: 876  GVRDSFSAEVKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHEKAGNSLEW 935

Query: 798  ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
             LRY+I++GAAQGLAYLHHDCVPPIVHRDIKANNILIG EFEPYIADFGLAKLV + DFA
Sbjct: 936  GLRYQILMGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVNDADFA 995

Query: 858  RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV 917
            RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYG+VVLEVLTGKQPIDPTIP+GLH+VDWV
Sbjct: 996  RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGIVVLEVLTGKQPIDPTIPDGLHVVDWV 1055

Query: 918  RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER 977
            RQK+G +EVLD SL  RPE E++EM+Q LG+ALLCVN +PD+RPTMKDVAAM+KEIK ER
Sbjct: 1056 RQKKGGVEVLDPSLLCRPESEVDEMMQALGIALLCVNSSPDERPTMKDVAAMLKEIKHER 1115

Query: 978  EECMKVDMLPSEGSANGQRENNNSS-------STAMMPNLYPQSNNT 1017
            E+  KVD+L     A   ++N +SS       ST    +LYP+SNNT
Sbjct: 1116 EDYAKVDVLLKGFPATDIQDNKSSSGAPATSSSTPTTQSLYPKSNNT 1162

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224075593|ref|XP_002304699.1| predicted protein [Populus trichocarpa] gi|222842131|gb|EEE79678.1| predicted protein [Populus trichocarpa]

 Score = 1384 bits (3581), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 726/1061 (68%), Positives = 848/1061 (79%), Gaps = 61/1061 (5%)

Query: 10   NWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGP 69
            NWN  DS PCKW+ ITCSPQ FVTEINIQS+ L++PF  NLSS  FL KL+IS +N+TG 
Sbjct: 66   NWNNLDSTPCKWTSITCSPQGFVTEINIQSVPLQIPFSLNLSSFHFLSKLVISDANITGT 125

Query: 70   ISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLK 129
            I  D+GDC  L  ID+SSNSLVG +P+SIGKL NL++LILNSNQLTG+IP EL +C +LK
Sbjct: 126  IPVDIGDCLSLKFIDLSSNSLVGTIPASIGKLQNLENLILNSNQLTGKIPVELCSCFRLK 185

Query: 130  NLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG 189
            NLLLFDN L+G +P ELGKL +L+V+RAGGNKDI GK+P E+ DC  L V+GLADT+++G
Sbjct: 186  NLLLFDNRLAGYIPPELGKLSSLQVLRAGGNKDIIGKVPDELADCSKLTVLGLADTRISG 245

Query: 190  SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKL 249
            SLP SLGKLSKLQ+LS+YTTMLSGEIPP +GNCSELV+LFLYEN LSGS+P E+GKL KL
Sbjct: 246  SLPVSLGKLSKLQTLSIYTTMLSGEIPPDLGNCSELVNLFLYENSLSGSIPPEIGKLHKL 305

Query: 250  EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
            E++LLWQN+  GAIPEEIGNC SLK IDLSLN  SG++P S G L  LEE M+S+NN+SG
Sbjct: 306  EQLLLWQNSLIGAIPEEIGNCTSLKMIDLSLNSLSGTIPISIGGLFQLEEFMISDNNVSG 365

Query: 310  SIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPSTLANCRSL 355
            SIP  LSNAT+LLQLQLDTNQIS              VFFAWQN+LEGSIPS+LA+C SL
Sbjct: 366  SIPSDLSNATNLLQLQLDTNQISGLIPPELGMLSKLTVFFAWQNQLEGSIPSSLASCSSL 425

Query: 356  EAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL------- 408
            +A+DLSHN+LTGS+ PGLFQLQNLTKLL+ISN ISG +PPEIGNCSSL+RLRL       
Sbjct: 426  QALDLSHNSLTGSIPPGLFQLQNLTKLLMISNDISGALPPEIGNCSSLVRLRLGNNRIAG 485

Query: 409  -----------MSF----------------GNCTQLQMLNLSNNTLGGTLPSSLASLTRL 441
                       ++F                G+CT+LQM++LSNN L G LP+SL+SLT L
Sbjct: 486  TIPKEIGGLGILNFLDLSSNRLSGPVPDEIGSCTELQMIDLSNNILQGPLPNSLSSLTGL 545

Query: 442  QVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSG 501
            QVLD+S NQF G IP SFG+L SLN+L+LS+NSFSG+IP SLG   SLQ LDLSSN L+G
Sbjct: 546  QVLDVSANQFTGQIPASFGRLTSLNKLMLSRNSFSGSIPLSLGLSSSLQLLDLSSNGLTG 605

Query: 502  KIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNL 561
             IP+EL +IE L+I+LNLS N L+G IPPQIS+L  LSILDLSHNKL G L  L+ LDNL
Sbjct: 606  SIPMELGQIETLEIALNLSCNRLTGPIPPQISSLTMLSILDLSHNKLEGHLSPLAELDNL 665

Query: 562  VSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGM-GNGGGFR 620
            VSLN+SYN F GYLPD+KLFRQLS T++ GNQGLCS   +SCFL +A   G+  N    R
Sbjct: 666  VSLNISYNAFIGYLPDNKLFRQLSPTDLVGNQGLCSSIRDSCFLKDADRTGLPRNENDTR 725

Query: 621  KSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFT 680
            +S KLK+A+ALL+T T+A+ I GA A++RA + + DD DSE+ G+S PWQ TPFQKLNF+
Sbjct: 726  QSRKLKLALALLITLTVAMVIMGAIAIMRARRTIRDDDDSEL-GDSWPWQFTPFQKLNFS 784

Query: 681  VEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
            V+QVL+CLV+ +V+GKGCSG+VYRA+M+NGEVIAVKKLWP TMAA   C ++K     VR
Sbjct: 785  VDQVLRCLVDTNVIGKGCSGVVYRADMDNGEVIAVKKLWPNTMAASNGCNDEKC---SVR 841

Query: 741  DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
            DSFS E+KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE+  + LEWELR
Sbjct: 842  DSFSTEVKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHEKTGNALEWELR 901

Query: 801  YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
            Y+I+LGAAQGLAYLHHDCVPPIVHRDIKANNILIG EFEPYIADFGLAKLV +GDFARSS
Sbjct: 902  YQILLGAAQGLAYLHHDCVPPIVHRDIKANNILIGLEFEPYIADFGLAKLVDDGDFARSS 961

Query: 861  NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
            NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP+GLH+VDWVRQK
Sbjct: 962  NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHVVDWVRQK 1021

Query: 921  RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREEC 980
            RG IEVLD SL  RP  EIEEM+Q LG+ALLCVN +PD+RP MKDVAAM+KEIK EREE 
Sbjct: 1022 RGGIEVLDPSLLPRPASEIEEMMQALGIALLCVNSSPDERPNMKDVAAMLKEIKHEREEY 1081

Query: 981  MKVDMLPSEGSANGQRENN--------NSSSTAMMPNLYPQ 1013
             KVD+L     A   +EN          SSS  +  +LYP+
Sbjct: 1082 AKVDVLLKGSPATDNQENKKSSGVVPATSSSKPVTQSLYPK 1122

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1035
TAIR|locus:2154344	1135	AT5G48940 [Arabidopsis thalian	0.923	0.842	0.519	1.1e-252
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.903	0.819	0.517	1.3e-251
TAIR|locus:2161825	1090	AT5G56040 [Arabidopsis thalian	0.928	0.881	0.395	2.4e-186
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.862	0.794	0.362	1.4e-144
TAIR|locus:2131518	1091	AT4G26540 [Arabidopsis thalian	0.916	0.869	0.341	2.2e-144
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.860	0.808	0.364	1.3e-141
TAIR|locus:2161158	1041	PXY "PHLOEM INTERCALATED WITH	0.863	0.858	0.361	3.9e-140
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.860	0.879	0.351	4.9e-140
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.856	0.804	0.364	5.2e-136
TAIR|locus:2120412	992	BAM3 "BARELY ANY MERISTEM 3" [	0.845	0.882	0.352	9.1e-132

TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)]

 Score = 2433 (861.5 bits), Expect = 1.1e-252, P = 1.1e-252
 Identities = 515/992 (51%), Positives = 638/992 (64%)

Query:    57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSN-QLT 115
             Q+L ++ + LTG I P+LGDC  L  +++  N L   +P  +GK+  L+ +    N +L+
Sbjct:   157 QELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRAGGNSELS 216

Query:   116 GEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQ 175
             G+IP+E+G C  LK L L    +SG+LPV LG+L  L+ +       ++G+IP E+G+C 
Sbjct:   217 GKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTM-LSGEIPKELGNCS 275

Query:   176 SLLVVGLADTKVAGSLPAXXXXXXXXXXXXVYTTMLSGEIPPQIGNCSELVDLFLYENDL 235
              L+ + L D  ++G+LP             ++   L G IP +IG    L  + L  N  
Sbjct:   276 ELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYF 335

Query:   236 SGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGXXX 295
             SG++P+  G L  L++++L  NN  G+IP  + NC  L    +  N  SG +P   G   
Sbjct:   336 SGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLK 395

Query:   296 XXXXXXXXXXXXXGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSL 355
                          G+IP  L+   +L  L L           QN L GS+P+ L   R+L
Sbjct:   396 ELNIFLGWQNKLEGNIPDELAGCQNLQALDLS----------QNYLTGSLPAGLFQLRNL 445

Query:   356 EAVDLSHNALTGSLHPGXXXXXXXXXXXXXXXXXXXXXPPEIGNCSSLIRLRL------- 408
               + L  NA++G +                        P  IG   +L  L L       
Sbjct:   446 TKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSG 505

Query:   409 ---MSFGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASL 465
                +   NC QLQM            P SL+SLT+LQVLD+S N   G IP+S G L SL
Sbjct:   506 PVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISL 565

Query:   466 NRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALS 525
             NRLILSKNSF+G IPSSLG C +LQ LDLSSN +SG IP ELF+I+ LDI+LNLSWN+L 
Sbjct:   566 NRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLD 625

Query:   526 GAIPPQISALNKLSILDLSHNKXXXXXXXXXXXXXXXXXNVSYNNFTGYLPDSKLFRQLS 585
             G IP +ISALN+LS+LD+SHN                  N+S+N F+GYLPDSK+FRQL 
Sbjct:   626 GFIPERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLI 685

Query:   586 ATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAF 645
               EM GN GLCS+G  SCF+SN++ +    G     S +L+IAI LL++ T  LA+ G  
Sbjct:   686 GAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGV---HSHRLRIAIGLLISVTAVLAVLGVL 742

Query:   646 AVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA 705
             AV+RA +M+ DD DSE G N   WQ TPFQKLNFTVE VLKCLVE +V+GKGCSGIVY+A
Sbjct:   743 AVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGIVYKA 802

Query:   706 EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC 765
             EM N EVIAVKKLWP T+       N+K    GVRDSFSAE+KTLGSIRHKNIVRFLGCC
Sbjct:   803 EMPNREVIAVKKLWPVTVPN----LNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCC 858

Query:   766 WNRNTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIILGAAQGLAYLHHDCVPPIVH 824
             WN+NTRLLMYDYM NGSLGSLLHER   C L WE+RY+IILGAAQGLAYLHHDCVPPIVH
Sbjct:   859 WNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVH 918

Query:   825 RDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 884
             RDIKANNILIGP+FEPYI DFGLAKLV +GDFARSSNT+AGSYGYIAPEYGY MKITEKS
Sbjct:   919 RDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITEKS 978

Query:   885 DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQ 944
             DVYSYGVVVLEVLTGKQPIDPTIP+GLHIVDWV++ R  I+V+D+ L+ARPE E+EEM+Q
Sbjct:   979 DVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKKIRD-IQVIDQGLQARPESEVEEMMQ 1037

Query:   945 TLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDMLPSEGSANGQREN--NNSS 1002
             TLGVALLC+NP P+DRPTMKDVAAM+ EI QEREE MKVD     GS N  RE   ++S+
Sbjct:  1038 TLGVALLCINPIPEDRPTMKDVAAMLSEICQEREESMKVD--GCSGSCNNGRERGKDDST 1095

Query:  1003 STAMMPNL-YPQSNNTXXXXXXXXXXXXXKTT 1033
             S+ M     Y +S++T               T
Sbjct:  1096 SSVMQQTAKYLRSSSTSFSASSLLYSSSSSAT 1127

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 2423 (858.0 bits), Expect = 1.3e-251, P = 1.3e-251
 Identities = 499/965 (51%), Positives = 641/965 (66%)

Query:    57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSN-QLT 115
             + LI++ + LTG I PD+  C++L ++ +  N L G +P+ +GKL  L+ + +  N +++
Sbjct:   156 ETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEIS 215

Query:   116 GEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQ 175
             G+IP E+G C  L  L L +  +SGNLP  LGKL  LE +       I+G+IP ++G+C 
Sbjct:   216 GQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTM-ISGEIPSDLGNCS 274

Query:   176 SLLVVGLADTKVAGSLPAXXXXXXXXXXXXVYTTMLSGEIPPQIGNCSELVDLFLYENDL 235
              L+ + L +  ++GS+P             ++   L G IP +IGNCS L  + L  N L
Sbjct:   275 ELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLL 334

Query:   236 SGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGXXX 295
             SGS+P  +G+L  LE+ ++  N F G+IP  I NC SL  + L  N  SG +P   G   
Sbjct:   335 SGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLT 394

Query:   296 XXXXXXXXXXXXXGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSL 355
                          GSIPP L++ T L  L L           +N L G+IPS L   R+L
Sbjct:   395 KLTLFFAWSNQLEGSIPPGLADCTDLQALDLS----------RNSLTGTIPSGLFMLRNL 444

Query:   356 EAVDLSHNALTGSLHPGXXXXXXXXXXXXXXXXXXXXXPPEIGNCSSLIRLRLMS----- 410
               + L  N+L+G +                        P  IG+   +  L   S     
Sbjct:   445 TKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHG 504

Query:   411 -----FGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASL 465
                   G+C++LQM            P+ ++SL+ LQVLD+S NQF G IP S G+L SL
Sbjct:   505 KVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSL 564

Query:   466 NRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALS 525
             N+LILSKN FSG+IP+SLG C  LQ LDL SN+LSG+IP EL +IE L+I+LNLS N L+
Sbjct:   565 NKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLT 624

Query:   526 GAIPPQISALNKLSILDLSHNKXXXXXXXXXXXXXXXXXNVSYNNFTGYLPDSKLFRQLS 585
             G IP +I++LNKLSILDLSHN                  N+SYN+F+GYLPD+KLFRQLS
Sbjct:   625 GKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLS 684

Query:   586 ATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAF 645
               ++ GN+ LCS   +SCFL+     G+G+ G   ++ KL++ +ALL+T T+ L I GA 
Sbjct:   685 PQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAV 744

Query:   646 AVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA 705
             AV+RA + + ++ DSE+G  +  WQ TPFQKLNF+V+Q+++CLVE +V+GKGCSG+VYRA
Sbjct:   745 AVIRARRNIDNERDSELG-ETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRA 803

Query:   706 EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC 765
             +++NGEVIAVKKLWP  +   +D +  K     VRDSFSAE+KTLG+IRHKNIVRFLGCC
Sbjct:   804 DVDNGEVIAVKKLWPAMVNGGHD-EKTK----NVRDSFSAEVKTLGTIRHKNIVRFLGCC 858

Query:   766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR 825
             WNRNTRLLMYDYMPNGSLGSLLHERR S L+W+LRYRI+LGAAQGLAYLHHDC+PPIVHR
Sbjct:   859 WNRNTRLLMYDYMPNGSLGSLLHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHR 918

Query:   826 DIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSD 885
             DIKANNILIG +FEPYIADFGLAKLV EGD  R SNTVAGSYGYIAPEYGY MKITEKSD
Sbjct:   919 DIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSD 978

Query:   886 VYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQT 945
             VYSYGVVVLEVLTGKQPIDPT+PEG+H+VDWVRQ RG++EVLD +LR+R E E +EM+Q 
Sbjct:   979 VYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMMQV 1038

Query:   946 LGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDML--PSEGSANGQRENNNSSS 1003
             LG ALLCVN +PD+RPTMKDVAAM+KEIKQEREE  KVD+L   S       +E    + 
Sbjct:  1039 LGTALLCVNSSPDERPTMKDVAAMLKEIKQEREEYAKVDLLLKKSPPPTTTMQEECRKNE 1098

Query:  1004 TAMMP 1008
               M+P
Sbjct:  1099 MMMIP 1103

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)]

 Score = 1807 (641.2 bits), Expect = 2.4e-186, P = 2.4e-186
 Identities = 405/1025 (39%), Positives = 584/1025 (56%)

Query:     7 ALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIXXXXXXXXXXXXXXXXQKLI-ISGSN 65
             ALS+W  S+SNPC+W  I C+ +  V+EI +Q +                  L+ ++  N
Sbjct:    48 ALSSWKASESNPCQWVGIKCNERGQVSEIQLQVMDFQGPLPATNLRQIKSLTLLSLTSVN 107

Query:    66 LTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGAC 125
             LTG I  +LGD ++L  +D++ NSL G +P  I KL  L+ L LN+N L G IP ELG  
Sbjct:   108 LTGSIPKELGDLSELEVLDLADNSLSGEIPVDIFKLKKLKILSLNTNNLEGVIPSELGNL 167

Query:   126 IKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADT 185
             + L  L LFDN L+G +P  +G+L NLE+ RAGGNK++ G++P+EIG+C+SL+ +GLA+T
Sbjct:   168 VNLIELTLFDNKLAGEIPRTIGELKNLEIFRAGGNKNLRGELPWEIGNCESLVTLGLAET 227

Query:   186 KVAGSLPAXXXXXXXXXXXXVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGK 245
              ++G LPA            +YT++LSG IP +IGNC+EL +L+LY+N +SGS+P  +G+
Sbjct:   228 SLSGRLPASIGNLKKVQTIALYTSLLSGPIPDEIGNCTELQNLYLYQNSISGSIPVSMGR 287

Query:   246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGXXXXXXXXXXXXX 305
             L+KL+ +LLWQNN  G IP E+G C  L  +DLS N  +G++P+SFG             
Sbjct:   288 LKKLQSLLLWQNNLVGKIPTELGTCPELFLVDLSENLLTGNIPRSFGNLPNLQELQLSVN 347

Query:   306 XXXGSIPPVLSNATSLLQLQLDTNQIS--------------VFFAWQNKLEGSIPSTLAN 351
                G+IP  L+N T L  L++D NQIS              +FFAWQN+L G IP +L+ 
Sbjct:   348 QLSGTIPEELANCTKLTHLEIDNNQISGEIPPLIGKLTSLTMFFAWQNQLTGIIPESLSQ 407

Query:   352 CRSLEAVDLSHNALTGSLHPGXXXXXXXXXXXXXXXXXXXXXPPEIGNCSSLIRLRL--- 408
             C+ L+A+DLS+N L+GS+  G                     PP+IGNC++L RLRL   
Sbjct:   408 CQELQAIDLSYNNLSGSIPNGIFEIRNLTKLLLLSNYLSGFIPPDIGNCTNLYRLRLNGN 467

Query:   409 -------MSFGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQ 461
                       GN   L              P  ++  T L+ +D+  N   G +P +  +
Sbjct:   468 RLAGNIPAEIGNLKNLNFIDISENRLIGNIPPEISGCTSLEFVDLHSNGLTGGLPGTLPK 527

Query:   462 LASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSW 521
               SL  + LS NS +G++P+ +G    L  L+L+ N+ SG+IP E+     L + LNL  
Sbjct:   528 --SLQFIDLSDNSLTGSLPTGIGSLTELTKLNLAKNRFSGEIPREISSCRSLQL-LNLGD 584

Query:   522 NALSGAIPPQISALNKLSI-LDLSHNKXXXXX-XXXXXXXXXXXXNVSYNNFTGYLPDSK 579
             N  +G IP ++  +  L+I L+LS N                   +VS+N   G L    
Sbjct:   585 NGFTGEIPNELGRIPSLAISLNLSCNHFTGEIPSRFSSLTNLGTLDVSHNKLAGNLNVLA 644

Query:   580 LFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSE-----KLKIAIALLVT 634
               + L +  ++ N+      +   F     +V   N G F  +      + +   A+ VT
Sbjct:   645 DLQNLVSLNISFNEFSGELPNTLFFRKLPLSVLESNKGLFISTRPENGIQTRHRSAVKVT 704

Query:   635 FTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVV 694
              +I +A      ++    +V     +        W++T +QKL+F+++ ++K L   +V+
Sbjct:   705 MSILVAASVVLVLMAVYTLVKAQRITGKQEELDSWEVTLYQKLDFSIDDIVKNLTSANVI 764

Query:   695 GKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR 754
             G G SG+VYR  + +GE +AVKK+W    + E   +N          +F++EI TLGSIR
Sbjct:   765 GTGSSGVVYRVTIPSGETLAVKKMW----SKE---ENR---------AFNSEINTLGSIR 808

Query:   755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE--RRDSCLEWELRYRIILGAAQGLA 812
             H+NI+R LG C NRN +LL YDY+PNGSL SLLH   +     +WE RY ++LG A  LA
Sbjct:   809 HRNIIRLLGWCSNRNLKLLFYDYLPNGSLSSLLHGAGKGSGGADWEARYDVVLGVAHALA 868

Query:   813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-----VEGDFARSSNT--VAG 865
             YLHHDC+PPI+H D+KA N+L+G  FE Y+ADFGLAK+V      +GD ++ SN   +AG
Sbjct:   869 YLHHDCLPPILHGDVKAMNVLLGSRFESYLADFGLAKIVSGEGVTDGDSSKLSNRPPLAG 928

Query:   866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ----KR 921
             SYGY+APE+  M  ITEKSDVYSYGVV+LEVLTGK P+DP +P G H+V WVR     K+
Sbjct:   929 SYGYMAPEHASMQHITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVQWVRDHLAGKK 988

Query:   922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECM 981
                E+LD  LR R +  + EMLQTL V+ LCV+    DRP MKD+ AM+KEI+Q   +  
Sbjct:   989 DPREILDPRLRGRADPIMHEMLQTLAVSFLCVSNKASDRPMMKDIVAMLKEIRQFDMDRS 1048

Query:   982 KVDML 986
             + DM+
Sbjct:  1049 ESDMI 1053

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 1413 (502.5 bits), Expect = 1.4e-144, P = 1.4e-144
 Identities = 341/941 (36%), Positives = 496/941 (52%)

Query:    57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTG 116
             ++L+   +NLTGP+   LG+  +LTT     N   G +P+ IGK +NL+ L L  N ++G
Sbjct:   184 EELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISG 243

Query:   117 EIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS 176
             E+PKE+G  +KL+ ++L+ N  SG +P ++G L +LE +   GN  + G IP EIG+ +S
Sbjct:   244 ELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNS-LVGPIPSEIGNMKS 302

Query:   177 LLVVGLADTKVAGSLPAXXXXXXXXXXXXVYTTMLSGEIPPQIGNCSELVDLFLYENDLS 236
             L  + L   ++ G++P                 +LSGEIP ++   SEL  L+L++N L+
Sbjct:   303 LKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLT 362

Query:   237 GSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGXXXX 296
             G +P EL KL+ L K+ L  N+  G IP    N  S++ + L  N  SG +PQ  G    
Sbjct:   363 GIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSP 422

Query:   297 XXXXXXXXXXXXGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLE 356
                         G IPP +   ++L+ L L +N+I  F        G+IP  +  C+SL 
Sbjct:   423 LWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRI--F--------GNIPPGVLRCKSLL 472

Query:   357 AVDLSHNALTGSLHPGXXXXXXXXXXXXXXXXXXXXXPPEIGNCSSLIRLRLMS--FGN- 413
              + +  N LTG                          PPEIG C  L RL L +  F + 
Sbjct:   473 QLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSN 532

Query:   414 -------CTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
                     + L              PS +A+   LQ LD+S N F+G +P   G L  L 
Sbjct:   533 LPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLE 592

Query:   467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSG 526
              L LS+N FSG IP ++G    L  L +  N  SG IP +L  +  L I++NLS+N  SG
Sbjct:   593 ILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSG 652

Query:   527 AIPPQISALNKLSILDLSHNKXXXXXXXXXXXXXXXXX-NVSYNNFTGYLPDSKLFRQLS 585
              IPP+I  L+ L  L L++N                   N SYNN TG LP +++F+ ++
Sbjct:   653 EIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMT 712

Query:   586 ATEMAGNQGLCSRGH-ESCFLSNATTVGMGN--GGGFRKSEKLKIAIALLVTFTIALAIF 642
              T   GN+GLC  GH  SC  S+++   + +   G  R+   + I  +++   ++ L   
Sbjct:   713 LTSFLGNKGLCG-GHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAI 771

Query:   643 GAFAVVRAGKMVGDDV-DSEMGGNSLPWQLTPFQKLNFTVEQVLKCL--VEDS-VVGKGC 698
                 +    +     V D E           P  K  FTV+ +L+      DS +VG+G 
Sbjct:   772 VVHFLRNPVEPTAPYVHDKEPFFQESDIYFVP--KERFTVKDILEATKGFHDSYIVGRGA 829

Query:   699 SGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI 758
              G VY+A M +G+ IAVKKL       E + + +        +SF AEI TLG IRH+NI
Sbjct:   830 CGTVYKAVMPSGKTIAVKKL-------ESNREGNNNNSNNTDNSFRAEILTLGKIRHRNI 882

Query:   759 VRFLGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH 816
             VR    C+++  N+ LL+Y+YM  GSLG LLH  +   ++W  R+ I LGAA+GLAYLHH
Sbjct:   883 VRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYLHH 942

Query:   817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY 876
             DC P I+HRDIK+NNILI   FE ++ DFGLAK V++   ++S + VAGSYGYIAPEY Y
Sbjct:   943 DCKPRIIHRDIKSNNILIDENFEAHVGDFGLAK-VIDMPLSKSVSAVAGSYGYIAPEYAY 1001

Query:   877 MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW----VRQKRGAIEVLDKSL- 931
              MK+TEK D+YS+GVV+LE+LTGK P+ P + +G  +  W    +R      E+LD  L 
Sbjct:  1002 TMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGDLATWTRNHIRDHSLTSEILDPYLT 1060

Query:   932 RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
             +   +V +  M+    +A+LC   +P DRPTM++V  M+ E
Sbjct:  1061 KVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1411 (501.8 bits), Expect = 2.2e-144, P = 2.2e-144
 Identities = 349/1022 (34%), Positives = 534/1022 (52%)

Query:    32 VTEINIQSIXXXXXXXXXXXXXXXXQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLV 91
             +T + + S+                + L +S ++L+G I  ++    +L T+ +++N+L 
Sbjct:    95 LTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLKKLKTLSLNTNNLE 154

Query:    92 GGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLF----DNYLSGNLPVELG 147
             G +P  IG L  L +L+L  N+L+GEIP+ +G   +LKNL +     +  L G LP E+G
Sbjct:   155 GHIPMEIGNLSGLVELMLFDNKLSGEIPRSIG---ELKNLQVLRAGGNKNLRGELPWEIG 211

Query:   148 KLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPAXXXXXXXXXXXXVY 207
                NL V+       ++GK+P  IG+ + +  + +  + ++G +P             +Y
Sbjct:   212 NCENL-VMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYCTELQNLYLY 270

Query:   208 TTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEI 267
                +SG IP  IG   +L  L L++N+L G +P ELG   +L  +   +N   G IP   
Sbjct:   271 QNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENLLTGTIPRSF 330

Query:   268 GNCKSLKTIDLSLNFFSGSLPQSFGXXXXXXXXXXXXXXXXGSIPPVLSNATSLLQLQLD 327
             G  ++L+ + LS+N  SG++P+                   G IP ++SN  SL      
Sbjct:   331 GKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNLRSL------ 384

Query:   328 TNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGXXXXXXXXXXXXXXX 387
                 ++FFAWQNKL G+IP +L+ CR L+A+DLS+N+L+GS+                  
Sbjct:   385 ----TMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSN 440

Query:   388 XXXXXXPPEIGNCSSLIRLRL----------MSFGNCTQLQMXXXXXXXXXXXXPSSLAS 437
                   PP+IGNC++L RLRL             GN   L              P +++ 
Sbjct:   441 DLSGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISG 500

Query:   438 LTRLQVLDISVNQFVG-LIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSS 496
                L+ LD+  N   G L+  +  +  SL  +  S N+ S  +P  +G    L  L+L+ 
Sbjct:   501 CESLEFLDLHTNSLSGSLLGTTLPK--SLKFIDFSDNALSSTLPPGIGLLTELTKLNLAK 558

Query:   497 NKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSI-LDLSHNKXXXXX-XX 554
             N+LSG+IP E+     L + LNL  N  SG IP ++  +  L+I L+LS N+        
Sbjct:   559 NRLSGEIPREISTCRSLQL-LNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIPSR 617

Query:   555 XXXXXXXXXXNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCF----LSN-AT 609
                       +VS+N  TG L      + L +  ++ N       +   F    LS+ A+
Sbjct:   618 FSDLKNLGVLDVSHNQLTGNLNVLTDLQNLVSLNISYNDFSGDLPNTPFFRRLPLSDLAS 677

Query:   610 TVGM--GNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMV-GDDVDSEMGGNS 666
               G+   N    R     + +  + +T  I + +     ++    +V       ++ G  
Sbjct:   678 NRGLYISNAISTRPDPTTRNSSVVRLTILILVVVTAVLVLMAVYTLVRARAAGKQLLGEE 737

Query:   667 LP-WQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAA 725
             +  W++T +QKL+F+++ ++K L   +V+G G SG+VYR  + +GE +AVKK+W      
Sbjct:   738 IDSWEVTLYQKLDFSIDDIVKNLTSANVIGTGSSGVVYRITIPSGESLAVKKMW------ 791

Query:   726 EYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGS 785
                   ++ G      +F++EIKTLGSIRH+NIVR LG C NRN +LL YDY+PNGSL S
Sbjct:   792 ----SKEESG------AFNSEIKTLGSIRHRNIVRLLGWCSNRNLKLLFYDYLPNGSLSS 841

Query:   786 LLHER-RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
              LH   +  C++WE RY ++LG A  LAYLHHDC+P I+H D+KA N+L+GP FEPY+AD
Sbjct:   842 RLHGAGKGGCVDWEARYDVVLGVAHALAYLHHDCLPTIIHGDVKAMNVLLGPHFEPYLAD 901

Query:   845 FGLAKLVV----EG-DFARSSNT--VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 897
             FGLA+ +      G D A+ +N   +AGSYGY+APE+  M +ITEKSDVYSYGVV+LEVL
Sbjct:   902 FGLARTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQRITEKSDVYSYGVVLLEVL 961

Query:   898 TGKQPIDPTIPEGLHIVDWVR----QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCV 953
             TGK P+DP +P G H+V WVR    +K+    +LD  L  R +  + EMLQTL VA LCV
Sbjct:   962 TGKHPLDPDLPGGAHLVKWVRDHLAEKKDPSRLLDPRLDGRTDSIMHEMLQTLAVAFLCV 1021

Query:   954 NPTPDDRPTMKDVAAMIKEIKQEREECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYPQ 1013
             +   ++RP MKDV AM+ EI+       + + + + G   G +E     S   + N +  
Sbjct:  1022 SNKANERPLMKDVVAMLTEIRHIDVGRSETEKIKAGGC--GSKEPQQFMSNEKIINSHGS 1079

Query:  1014 SN 1015
             SN
Sbjct:  1080 SN 1081

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1385 (492.6 bits), Expect = 1.3e-141, P = 1.3e-141
 Identities = 344/944 (36%), Positives = 492/944 (52%)

Query:    58 KLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGE 117
             +L+   +N++G +   +G+  +LT+     N + G +PS IG   +L  L L  NQL+GE
Sbjct:   173 QLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGE 232

Query:   118 IPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSL 177
             +PKE+G   KL  ++L++N  SG +P E+    +LE +    N+ + G IP E+GD QSL
Sbjct:   233 LPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQ-LVGPIPKELGDLQSL 291

Query:   178 LVVGLADTKVAGSLPAXXXXXXXXXXXXVYTTMLSGEIPPQIGNCSELVDLFLYENDLSG 237
               + L    + G++P                  L+GEIP ++GN   L  L+L+EN L+G
Sbjct:   292 EFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTG 351

Query:   238 SLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGXXXXX 297
             ++P EL  L+ L K+ L  N   G IP      + L  + L  N  SG++P   G     
Sbjct:   352 TIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDL 411

Query:   298 XXXXXXXXXXXGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA 357
                        G IP  L   ++++ L L TN +S          G+IP+ +  C++L  
Sbjct:   412 WVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLS----------GNIPTGITTCKTLVQ 461

Query:   358 VDLSHNALTGSLHPGXXXXXXXXXXXXXXXXXXXXXPPEIGNCSSLIRLRLMS------- 410
             + L+ N L G                          P E+GNCS+L RL+L         
Sbjct:   462 LRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGEL 521

Query:   411 ---FGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNR 467
                 G  +QL              PS + +   LQ LD+  N F G +P   G L  L  
Sbjct:   522 PREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLEL 581

Query:   468 LILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGA 527
             L LS N+ SG IP +LG    L  L +  N  +G IP EL  + GL I+LNLS+N L+G 
Sbjct:   582 LKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGE 641

Query:   528 IPPQISALNKLSILDLSHNKXXXXX-XXXXXXXXXXXXNVSYNNFTGYLPDSKLFRQLSA 586
             IPP++S L  L  L L++N                   N SYN+ TG +P   L R +S 
Sbjct:   642 IPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISM 698

Query:   587 TEMAGNQGLCSRGHESCFLSN--ATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGA 644
             +   GN+GLC      C  +   A +   G  GG R S+ + I  A++   ++ L     
Sbjct:   699 SSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIV 758

Query:   645 FAVVRAGKMVGDDV-DSEMGGNSLPWQLTPFQKLNFTVEQVLKC---LVEDSVVGKGCSG 700
             + + R  + V     D +    SL     P  K  FT + ++       E  VVG+G  G
Sbjct:   759 YLMRRPVRTVASSAQDGQPSEMSLDIYFPP--KEGFTFQDLVAATDNFDESFVVGRGACG 816

Query:   701 IVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR 760
              VY+A +  G  +AVKKL     A+ ++  N+      V +SF AEI TLG+IRH+NIV+
Sbjct:   817 TVYKAVLPAGYTLAVKKL-----ASNHEGGNNN----NVDNSFRAEILTLGNIRHRNIVK 867

Query:   761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIILGAAQGLAYLHHDCV 819
               G C ++ + LL+Y+YMP GSLG +LH+   SC L+W  R++I LGAAQGLAYLHHDC 
Sbjct:   868 LHGFCNHQGSNLLLYEYMPKGSLGEILHD--PSCNLDWSKRFKIALGAAQGLAYLHHDCK 925

Query:   820 PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK 879
             P I HRDIK+NNIL+  +FE ++ DFGLAK V++   ++S + +AGSYGYIAPEY Y MK
Sbjct:   926 PRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPHSKSMSAIAGSYGYIAPEYAYTMK 984

Query:   880 ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ--KRGAIE--VLDKSLRARP 935
             +TEKSD+YSYGVV+LE+LTGK P+ P I +G  +V+WVR   +R A+   VLD  L    
Sbjct:   985 VTEKSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIRRDALSSGVLDARLTLED 1043

Query:   936 EVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE 979
             E  +  ML  L +ALLC + +P  RP+M+ V  M+  I+ ER E
Sbjct:  1044 ERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML--IESERSE 1085

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)]

 Score = 1371 (487.7 bits), Expect = 3.9e-140, P = 3.9e-140
 Identities = 342/946 (36%), Positives = 480/946 (50%)

Query:    59 LIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEI 118
             L +S  NL+G I   +   + L  +++S NSL G  P+SI  L  L  L ++ N      
Sbjct:    86 LDLSHRNLSGRIPIQIRYLSSLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSF 145

Query:   119 PKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLL 178
             P  +     LK    F N   G LP ++ +L  LE +  GG+    G+IP   G  Q L 
Sbjct:   146 PPGISKLKFLKVFNAFSNNFEGLLPSDVSRLRFLEELNFGGSY-FEGEIPAAYGGLQRLK 204

Query:   179 VVGLADTKVAGSLPAXXXXXXXXXXXXVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGS 238
              + LA   + G LP             +     +G IP +    S L    +    LSGS
Sbjct:   205 FIHLAGNVLGGKLPPRLGLLTELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGS 264

Query:   239 LPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGXXXXXX 298
             LP+ELG L  LE + L+QN F G IPE   N KSLK +D S N  SGS+P  F       
Sbjct:   265 LPQELGNLSNLETLFLFQNGFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLT 324

Query:   299 XXXXXXXXXXGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAV 358
                       G +P  +     L  L          F W N   G +P  L +   LE +
Sbjct:   325 WLSLISNNLSGEVPEGIGELPELTTL----------FLWNNNFTGVLPHKLGSNGKLETM 374

Query:   359 DLSHNALTGSLHPGXXXXXXXXXXXXXXXXXXXXXPPEIGNCSSLIRLRLMS-------- 410
             D+S+N+ TG++                        P  +  C SL R R  +        
Sbjct:   375 DVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEGELPKSLTRCESLWRFRSQNNRLNGTIP 434

Query:   411 --FGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRL 468
               FG+   L              P+  A+   LQ L++S N F   +PE+  +  +L   
Sbjct:   435 IGFGSLRNLTFVDLSNNRFTDQIPADFATAPVLQYLNLSTNFFHRKLPENIWKAPNLQIF 494

Query:   469 ILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAI 528
               S ++  G IP+ +G C+S   ++L  N L+G IP ++   E L + LNLS N L+G I
Sbjct:   495 SASFSNLIGEIPNYVG-CKSFYRIELQGNSLNGTIPWDIGHCEKL-LCLNLSQNHLNGII 552

Query:   529 PPQISALNKLSILDLSHNKXXXXX-XXXXXXXXXXXXNVSYNNFTGYLPDSKLFRQLSAT 587
             P +IS L  ++ +DLSHN                   NVSYN   G +P    F  L+ +
Sbjct:   553 PWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTITTFNVSYNQLIGPIPSGS-FAHLNPS 611

Query:   588 EMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAI-FGAFA 646
               + N+GLC         S+    G  +  G  K E+ K     +V + +A AI  G F 
Sbjct:   612 FFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHKEERPKKTAGAIV-WILAAAIGVGFFV 670

Query:   647 VVRAG----KMVGDDVDS--EMGGNSLPWQLTPFQKLNFTVEQVLKCLVE-DSVVGKGCS 699
             +V A     K  G+ VD     GG+  PW+LT FQ+LNFT + V++CL + D+++G G +
Sbjct:   671 LVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTAFQRLNFTADDVVECLSKTDNILGMGST 730

Query:   700 GIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV 759
             G VY+AEM NGE+IAVKKLW          +N KI     +    AE+  LG++RH+NIV
Sbjct:   731 GTVYKAEMPNGEIIAVKKLWGKNK------ENGKIRRR--KSGVLAEVDVLGNVRHRNIV 782

Query:   760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLH---ERRDSCLEWELRYRIILGAAQGLAYLHH 816
             R LGCC NR+  +L+Y+YMPNGSL  LLH   +   +  EW   Y+I +G AQG+ YLHH
Sbjct:   783 RLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAIGVAQGICYLHH 842

Query:   817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY 876
             DC P IVHRD+K +NIL+  +FE  +ADFG+AKL+ + D   S + VAGSYGYIAPEY Y
Sbjct:   843 DCDPVIVHRDLKPSNILLDADFEARVADFGVAKLI-QTD--ESMSVVAGSYGYIAPEYAY 899

Query:   877 MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK----RGAIEVLDKSLR 932
              +++ +KSD+YSYGV++LE++TGK+ ++P   EG  IVDWVR K        EVLDKS+ 
Sbjct:   900 TLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVDWVRSKLKTKEDVEEVLDKSMG 959

Query:   933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
                 +  EEM Q L +ALLC + +P DRP M+DV  +++E K +R+
Sbjct:   960 RSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQEAKPKRK 1005

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010089 "xylem development" evidence=IMP

GO:0010223 "secondary shoot formation" evidence=IMP

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009887 "organ morphogenesis" evidence=RCA

GO:0009944 "polarity specification of adaxial/abaxial axis" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010051 "xylem and phloem pattern formation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048439 "flower morphogenesis" evidence=RCA

GO:0048519 "negative regulation of biological process" evidence=RCA

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 1370 (487.3 bits), Expect = 4.9e-140, P = 4.9e-140
 Identities = 331/942 (35%), Positives = 480/942 (50%)

Query:    57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTG 116
             +KL ++G NLTG IS  +   + L + ++S N     +P SI  L ++    ++ N  +G
Sbjct:    74 EKLDLAGMNLTGKISDSISQLSSLVSFNISCNGFESLLPKSIPPLKSID---ISQNSFSG 130

Query:   117 EIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS 176
              +       + L +L    N LSGNL  +LG LV+LEV+   GN    G +P    + Q 
Sbjct:   131 SLFLFSNESLGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNF-FQGSLPSSFKNLQK 189

Query:   177 LLVVGLADTKVAGSLPAXXXXXXXXXXXXVYTTMLSGEIPPQIGNCSELVDLFLYENDLS 236
             L  +GL+   + G LP+            +      G IPP+ GN + L  L L    LS
Sbjct:   190 LRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLS 249

Query:   237 GSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGXXXX 296
             G +P ELGKL+ LE +LL++NNF G IP EIG+  +LK +D S N  +G +P        
Sbjct:   250 GEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKN 309

Query:   297 XXXXXXXXXXXXGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLE 356
                         GSIPP +S   SL QLQ       V   W N L G +PS L     L+
Sbjct:   310 LQLLNLMRNKLSGSIPPAIS---SLAQLQ-------VLELWNNTLSGELPSDLGKNSPLQ 359

Query:   357 AVDLSHNALTGSLHPGXXXXXXXXXXXXXXXXXXXXXPPEIGNCSSLIRLRLMS------ 410
              +D+S N+ +G +                        P  +  C SL+R+R+ +      
Sbjct:   360 WLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGS 419

Query:   411 ----FGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
                 FG   +LQ             P  ++    L  +D S NQ    +P +   + +L 
Sbjct:   420 IPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQ 479

Query:   467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSG 526
               +++ N  SG +P     C SL +LDLSSN L+G IP  +   E L +SLNL  N L+G
Sbjct:   480 AFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKL-VSLNLRNNNLTG 538

Query:   527 AIPPQISALNKLSILDLSHNKXXXXXXXXXXXX-XXXXXNVSYNNFTGYLPDSKLFRQLS 585
              IP QI+ ++ L++LDLS+N                   NVSYN  TG +P +   + ++
Sbjct:   539 EIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTIN 598

Query:   586 ATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGA- 644
               ++ GN GLC      C      T    +  G R      I IA ++   I   +    
Sbjct:   599 PDDLRGNSGLCGGVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTL 658

Query:   645 FAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYR 704
             +    +    GD+  S+      PW+L  F +L FT   +L C+ E +++G G +GIVY+
Sbjct:   659 YKKWYSNGFCGDETASK---GEWPWRLMAFHRLGFTASDILACIKESNMIGMGATGIVYK 715

Query:   705 AEMENGE-VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG 763
             AEM     V+AVKKLW +  AA+ +         G    F  E+  LG +RH+NIVR LG
Sbjct:   716 AEMSRSSTVLAVKKLWRS--AADIE--------DGTTGDFVGEVNLLGKLRHRNIVRLLG 765

Query:   764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDS---CLEWELRYRIILGAAQGLAYLHHDCVP 820
               +N    +++Y++M NG+LG  +H +  +    ++W  RY I LG A GLAYLHHDC P
Sbjct:   766 FLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHP 825

Query:   821 PIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI 880
             P++HRDIK+NNIL+    +  IADFGLA+++       + + VAGSYGYIAPEYGY +K+
Sbjct:   826 PVIHRDIKSNNILLDANLDARIADFGLARMMARKK--ETVSMVAGSYGYIAPEYGYTLKV 883

Query:   881 TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK-RGAI---EVLDKSLRARPE 936
              EK D+YSYGVV+LE+LTG++P++P   E + IV+WVR+K R  I   E LD ++     
Sbjct:   884 DEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIRDNISLEEALDPNVGNCRY 943

Query:   937 VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
             V+ EEML  L +ALLC    P DRP+M+DV +M+ E K  R+
Sbjct:   944 VQ-EEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRK 984

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 1332 (473.9 bits), Expect = 5.2e-136, P = 5.2e-136
 Identities = 344/943 (36%), Positives = 478/943 (50%)

Query:    57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTG 116
             Q+L+I  +NLTG I P +    QL  I    N   G +PS I    +L+ L L  N L G
Sbjct:   166 QELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEG 225

Query:   117 EIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS 176
              +PK+L     L +L+L+ N LSG +P  +G +  LEV+    N    G IP EIG    
Sbjct:   226 SLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENY-FTGSIPREIGKLTK 284

Query:   177 LLVVGLADTKVAGSLPAXXXXXXXXXXXXVYTTMLSGEIPPQIGNCSELVDLFLYENDLS 236
             +  + L   ++ G +P                  L+G IP + G+   L  L L+EN L 
Sbjct:   285 MKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILL 344

Query:   237 GSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGXXXX 296
             G +PRELG+L  LEK+ L  N  +G IP+E+     L  + L  N   G +P   G    
Sbjct:   345 GPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSN 404

Query:   297 XXXXXXXXXXXXGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLE 356
                         G IP       +L+ L L +N          KL G+IP  L  C+SL 
Sbjct:   405 FSVLDMSANSLSGPIPAHFCRFQTLILLSLGSN----------KLSGNIPRDLKTCKSLT 454

Query:   357 AVDLSHNALTGSLHPGXXXXXXXXXXXXXXXXXXXXXPPEIGNCSSLIRLRLMS------ 410
              + L  N LTGSL                          ++G   +L RLRL +      
Sbjct:   455 KLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGE 514

Query:   411 ----FGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
                  GN T++              P  L S   +Q LD+S N+F G I +  GQL  L 
Sbjct:   515 IPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLE 574

Query:   467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSG 526
              L LS N  +G IP S G    L  L L  N LS  IPVEL ++  L ISLN+S N LSG
Sbjct:   575 ILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSG 634

Query:   527 AIPPQISALNKLSILDLSHNKXXXXXXXXXXXXXXXXX-NVSYNNFTGYLPDSKLFRQLS 585
              IP  +  L  L IL L+ NK                  N+S NN  G +PD+ +F+++ 
Sbjct:   635 TIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMD 694

Query:   586 ATEMAGNQGLCS--RGHESCFL--SNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAI 641
             ++  AGN GLC+  R H    +  S++    + NG    + +K+ + I  +V  ++ L  
Sbjct:   695 SSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGS---QRQKI-LTITCIVIGSVFLIT 750

Query:   642 F-GAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKC---LVEDSVVGKG 697
             F G    ++  +     ++ +   + +     P  K  FT + ++       ED V+G+G
Sbjct:   751 FLGLCWTIKRREPAFVALEDQTKPDVMDSYYFP--KKGFTYQGLVDATRNFSEDVVLGRG 808

Query:   698 CSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD-SFSAEIKTLGSIRHK 756
               G VY+AEM  GEVIAVKKL            N + G G   D SF AEI TLG IRH+
Sbjct:   809 ACGTVYKAEMSGGEVIAVKKL------------NSR-GEGASSDNSFRAEISTLGKIRHR 855

Query:   757 NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL-EWELRYRIILGAAQGLAYLH 815
             NIV+  G C+++N+ LL+Y+YM  GSLG  L     +CL +W  RYRI LGAA+GL YLH
Sbjct:   856 NIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLH 915

Query:   816 HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             HDC P IVHRDIK+NNIL+   F+ ++ DFGLAKL+ +  +++S + VAGSYGYIAPEY 
Sbjct:   916 HDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLI-DLSYSKSMSAVAGSYGYIAPEYA 974

Query:   876 YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK-RG---AIEVLDKSL 931
             Y MK+TEK D+YS+GVV+LE++TGK P+ P + +G  +V+WVR+  R     IE+ D  L
Sbjct:   975 YTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRSIRNMIPTIEMFDARL 1033

Query:   932 RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK 974
                 +  + EM   L +AL C + +P  RPTM++V AMI E +
Sbjct:  1034 DTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1292 (459.9 bits), Expect = 9.1e-132, P = 9.1e-132
 Identities = 336/952 (35%), Positives = 481/952 (50%)

Query:    58 KLIISGSNLTGPISPDLGDCT-QLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTG 116
             +L +S  N++G ISP++   +  L  +D+SSNS  G +P  I +L  L+ L ++SN   G
Sbjct:    80 RLDLSNLNISGTISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEG 139

Query:   117 EIP-KELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQ 175
             E+  +      +L  L  +DN  +G+LP+ L  L  LE +  GGN    G+IP   G   
Sbjct:   140 ELETRGFSQMTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNY-FDGEIPRSYGSFL 198

Query:   176 SLLVVGLADTKVAGSLPAXXXXXXXXXXXXV-YTTMLSGEIPPQIGNCSELVDLFLYEND 234
             SL  + L+   + G +P             + Y     G IP   G    LV L L    
Sbjct:   199 SLKFLSLSGNDLRGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCS 258

Query:   235 LSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGXX 294
             L GS+P ELG L+ LE + L  N   G++P E+GN  SLKT+DLS NF  G +P      
Sbjct:   259 LKGSIPAELGNLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGL 318

Query:   295 XXXXXXXXXXXXXXGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRS 354
                           G IP  +S    L  L+L          W N   G IPS L +  +
Sbjct:   319 QKLQLFNLFFNRLHGEIPEFVSELPDLQILKL----------WHNNFTGKIPSKLGSNGN 368

Query:   355 LEAVDLSHNALTGSLHPGXXXXXXXXXXXXXXXXXXXXXPPEIGNCSSLIRLRLMSFGNC 414
             L  +DLS N LTG +                        P ++G C  L R RL   G  
Sbjct:   369 LIEIDLSTNKLTGLIPESLCFGRRLKILILFNNFLFGPLPEDLGQCEPLWRFRL---GQ- 424

Query:   415 TQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFG---QLASLNRLILS 471
                              P  L  L  L +L++  N   G IPE      Q +SL ++ LS
Sbjct:   425 ----------NFLTSKLPKGLIYLPNLSLLELQNNFLTGEIPEEEAGNAQFSSLTQINLS 474

Query:   472 KNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQ 531
              N  SG IP S+    SLQ L L +N+LSG+IP E+  ++ L + +++S N  SG  PP+
Sbjct:   475 NNRLSGPIPGSIRNLRSLQILLLGANRLSGQIPGEIGSLKSL-LKIDMSRNNFSGKFPPE 533

Query:   532 ISALNKLSILDLSHNKXXXXX-XXXXXXXXXXXXNVSYNNFTGYLPDSKLF-RQLSATEM 589
                   L+ LDLSHN+                  NVS+N+F   LP+   + + L++ + 
Sbjct:   534 FGDCMSLTYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPNELGYMKSLTSADF 593

Query:   590 AGNQ--------GLCSRGHESCFLSNATTVGMG----NGGGFRKSEKL--------KIAI 629
             + N         G  S  + + FL N    G      NG   +   +L        +  I
Sbjct:   594 SHNNFSGSVPTSGQFSYFNNTSFLGNPFLCGFSSNPCNGSQNQSQSQLLNQNNARSRGEI 653

Query:   630 ALLVTFTIALAIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLV 689
             +        L + G F V     +V +    +   N   W+L  FQKL F  E +L+C+ 
Sbjct:   654 SAKFKLFFGLGLLGFFLVFVVLAVVKNRRMRKNNPNL--WKLIGFQKLGFRSEHILECVK 711

Query:   690 EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
             E+ V+GKG  GIVY+  M NGE +AVKKL   T  + +D            +  +AEI+T
Sbjct:   712 ENHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHD------------NGLAAEIQT 759

Query:   750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             LG IRH+NIVR L  C N++  LL+Y+YMPNGSLG +LH +    L+WE R +I L AA+
Sbjct:   760 LGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAK 819

Query:   810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS-NTVAGSYG 868
             GL YLHHDC P I+HRD+K+NNIL+GPEFE ++ADFGLAK +++ + A    +++AGSYG
Sbjct:   820 GLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYG 879

Query:   869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR-----QKRGA 923
             YIAPEY Y ++I EKSDVYS+GVV+LE++TG++P+D    EG+ IV W +      ++G 
Sbjct:   880 YIAPEYAYTLRIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGV 939

Query:   924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
             ++++D+ L   P   + E ++   VA+LCV     +RPTM++V  MI + KQ
Sbjct:   940 VKIIDQRLSNIP---LAEAMELFFVAMLCVQEHSVERPTMREVVQMISQAKQ 988

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048437 "floral organ development" evidence=IGI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
C0LGV1	RCH1_ARATH	2, ., 7, ., 1, 1, ., 1	0.6739	0.9574	0.8731	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1035
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-150
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-41
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-31
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-27
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-25
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-25
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-23
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-21
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-20
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-19
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-16
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-11
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-09
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	8e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-06
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-06
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	5e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-05
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-05
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-04
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	0.002
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.003
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  472 bits (1217), Expect = e-150
 Identities = 329/994 (33%), Positives = 497/994 (50%), Gaps = 104/994 (10%)

Query: 8   LSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLT 67
           LSNWN S ++ C W  ITC+  + V      SI+L                   SG N++
Sbjct: 48  LSNWNSS-ADVCLWQGITCNNSSRVV-----SIDL-------------------SGKNIS 82

Query: 68  GPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLI-NLQDLILNSNQLTGEIPKELGACI 126
           G IS  +     + TI++S+N L G +P  I     +L+ L L++N  TG IP+  G+  
Sbjct: 83  GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIP 140

Query: 127 KLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTK 186
            L+ L L +N LSG +P ++G   +L+V+  GGN  + GKIP  + +  SL  + LA  +
Sbjct: 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV-LVGKIPNSLTNLTSLEFLTLASNQ 199

Query: 187 VAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKL 246
           + G +P  LG++  L+ + +    LSGEIP +IG  + L  L L  N+L+G +P  LG L
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259

Query: 247 QKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNN 306
           + L+ + L+QN   G IP  I + + L ++DLS N  SG +P+    L +LE L L +NN
Sbjct: 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNN 319

Query: 307 ISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALT 366
            +G IP  L++   L  LQL          W NK  G IP  L    +L  +DLS N LT
Sbjct: 320 FTGKIPVALTSLPRLQVLQL----------WSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369

Query: 367 GSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFG-------NCTQLQM 419
           G +  GL    NL KL+L SN + G IP  +G C SL R+RL             T+L +
Sbjct: 370 GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429

Query: 420 ---LNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS 476
              L++SNN L G + S    +  LQ+L ++ N+F G +P+SFG    L  L LS+N FS
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFS 488

Query: 477 GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALN 536
           GA+P  LG    L  L LS NKLSG+IP EL   + L +SL+LS N LSG IP   S + 
Sbjct: 489 GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL-VSLDLSHNQLSGQIPASFSEMP 547

Query: 537 KLSILDLSHNKLGGDLLA-LSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGL 595
            LS LDLS N+L G++   L  +++LV +N+S+N+  G LP +  F  ++A+ +AGN  L
Sbjct: 548 VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDL 607

Query: 596 CSRGHESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAFAVVRAGKMVG 655
           C            TT G+      RK+      I   +   + LA+     V   G+   
Sbjct: 608 C---------GGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNL 658

Query: 656 D--DVDSEMGGNSLPWQLTPFQK---LNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENG 710
           +   V++E G     W+L  F      + T+  +L  L E++V+ +G  G  Y+ +    
Sbjct: 659 ELKRVENEDG----TWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKN 714

Query: 711 EV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 769
            +   VK++            ND   I       S+EI  +G ++H NIV+ +G C +  
Sbjct: 715 GMQFVVKEI------------NDVNSIP------SSEIADMGKLQHPNIVKLIGLCRSEK 756

Query: 770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKA 829
              L+++Y+   +L  +L       L WE R +I +G A+ L +LH  C P +V  ++  
Sbjct: 757 GAYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811

Query: 830 NNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSY 889
             I+I  + EP++    L  L+       +      S  Y+APE      ITEKSD+Y +
Sbjct: 812 EKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGF 864

Query: 890 GVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV---LDKSLRARPEVEIEEMLQTL 946
           G++++E+LTGK P D        IV+W R       +   +D S+R    V   E+++ +
Sbjct: 865 GLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924

Query: 947 GVALLCVNPTPDDRPTMKDVAAMIKEIKQEREEC 980
            +AL C    P  RP   DV   ++   +    C
Sbjct: 925 NLALHCTATDPTARPCANDVLKTLESASRSSSSC 958

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  159 bits (404), Expect = 3e-44
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 22/205 (10%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G VY A   + G+ +A+K +              K     + +    EI+ L  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII-------------KKEDSSSLLEELLREIEILKK 47

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+  G   + N   L+ +Y   GSL  LL E     L  +   RI+L   +GL 
Sbjct: 48  LNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLE 106

Query: 813 YLHHDCVPPIVHRDIKANNILIG-PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           YLH +    I+HRD+K  NIL+     +  +ADFGL+KL+          T+ G+  Y+A
Sbjct: 107 YLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--SLLKTIVGTPAYMA 161

Query: 872 PE-YGYMMKITEKSDVYSYGVVVLE 895
           PE        +EKSD++S GV++ E
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  160 bits (407), Expect = 4e-44
 Identities = 76/292 (26%), Positives = 123/292 (42%), Gaps = 51/292 (17%)

Query: 688 LVEDSVVGKGCSGIVYRAE-----MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
           L     +G+G  G VY+             +AVK L       +              + 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ-------------IEE 47

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
           F  E + +  + H NIV+ LG C      +++ +YMP G L   L + R   L       
Sbjct: 48  FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLS 107

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
             L  A+G+ YL        +HRD+ A N L+G      I+DFGL++ + + D+ +    
Sbjct: 108 FALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG 164

Query: 863 ---VAGSYGYIAPE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVD 915
              +     ++APE    G   K T KSDV+S+GV++ E+ T G++P       G+   +
Sbjct: 165 KLPIR----WMAPESLKEG---KFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAE 212

Query: 916 WVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                   +E L K  R  +P     E+ +   + L C    P+DRPT  ++
Sbjct: 213 -------VLEYLKKGYRLPKPPNCPPELYK---LMLQCWAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  157 bits (399), Expect = 4e-43
 Identities = 76/292 (26%), Positives = 123/292 (42%), Gaps = 52/292 (17%)

Query: 688 LVEDSVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
           L     +G+G  G VY+ +++         +AVK L       +              + 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ-------------IEE 47

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
           F  E + +  + H N+V+ LG C       ++ +YM  G L S L + R   L       
Sbjct: 48  FLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-LSLSDLLS 106

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
             L  A+G+ YL        +HRD+ A N L+G      I+DFGL++ + + D+ R    
Sbjct: 107 FALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG 163

Query: 863 ---VAGSYGYIAPE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVD 915
              +     ++APE    G   K T KSDV+S+GV++ E+ T G+QP       G+   +
Sbjct: 164 KLPIR----WMAPESLKEG---KFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEE 211

Query: 916 WVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                   +E L    R  +P     E+     + L C    P+DRPT  ++
Sbjct: 212 -------VLEYLKNGYRLPQPPNCPPELYD---LMLQCWAEDPEDRPTFSEL 253

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  154 bits (392), Expect = 4e-42
 Identities = 70/218 (32%), Positives = 115/218 (52%), Gaps = 30/218 (13%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G  G VY A + + GE++AVK +       E    +++       ++   EI+ L 
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSV-------ELSGDSEE-----ELEALEREIRILS 54

Query: 752 SIRHKNIVRFLGCCWNRNT---RLLMYDYMPNGSLGSLLHERRDSCLEWEL--RY-RIIL 805
           S++H NIVR+ G   +       + + +Y+  GSL SLL  ++   L   +  +Y R IL
Sbjct: 55  SLQHPNIVRYYGSERDEEKNTLNIFL-EYVSGGSLSSLL--KKFGKLPEPVIRKYTRQIL 111

Query: 806 GAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
              +GLAYLH +     IVHRDIK  NIL+  +    +ADFG AK + + +    + +V 
Sbjct: 112 ---EGLAYLHSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR 164

Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           G+  ++APE     +    +D++S G  V+E+ TGK P
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  152 bits (386), Expect = 2e-41
 Identities = 82/287 (28%), Positives = 127/287 (44%), Gaps = 51/287 (17%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G VY+A     G+++AVK L           + D+            EI+ L 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKR----SEKSKKDQTAR--------REIRILR 53

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            + H NIVR +    +++   L+ +Y   G L   L       L  +   +I L   +GL
Sbjct: 54  RLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGL 111

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH +    I+HRD+K  NIL+       IADFGLAK +++     S  T  G+  Y+A
Sbjct: 112 EYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS--SSLTTFVGTPWYMA 166

Query: 872 PE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
           PE      GY      K DV+S GV++ E+LTGK P       G +I+D        +++
Sbjct: 167 PEVLLGGNGY----GPKVDVWSLGVILYELLTGKPP-----FSGENILD-------QLQL 210

Query: 927 LDKSLRARPEVEI-------EEMLQTLGVALLCVNPTPDDRPTMKDV 966
           + + L    E +        EE    +    L  +P+   RPT +++
Sbjct: 211 IRRILGPPLEFDEPKWSSGSEEAKDLIKK-CLNKDPS--KRPTAEEI 254

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  149 bits (379), Expect = 2e-40
 Identities = 81/297 (27%), Positives = 126/297 (42%), Gaps = 53/297 (17%)

Query: 688 LVEDSVVGKGCSGIVYRAEM-----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
           L     +G+G  G VY+  +          +AVK L       E             R+ 
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEE-------------REE 47

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
           F  E   +  + H NIVR LG C       ++ +YMP G L   L +  +  L  +   +
Sbjct: 48  FLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQ 106

Query: 803 IILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
           + L  A+G+ YL   +     VHRD+ A N L+       I+DFGL++ + E D+ R   
Sbjct: 107 MALQIAKGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG 162

Query: 862 TVAGSYGYIAPE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV 917
                  ++APE    G   K T KSDV+S+GV++ E+ T G+QP      E   +++ +
Sbjct: 163 GGKLPIKWMAPESLKDG---KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--EVLELL 217

Query: 918 RQKRGAIEVLDKSLR-ARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
                         R  RPE    E+ E++      L C    P+DRPT  ++   +
Sbjct: 218 EDGY----------RLPRPENCPDELYELM------LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  149 bits (378), Expect = 4e-40
 Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 46/293 (15%)

Query: 693 VVGKGCSGIVYRAEMENG-----EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            +G+G  G VY+ +++       EV AVK L       E             R  F  E 
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEV-AVKTLKEDASEEE-------------RKDFLKEA 47

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-------DSCLEWELR 800
           + +  + H N+VR LG C       L+ +YM  G L   L + R        S L  +  
Sbjct: 48  RVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107

Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
               +  A+G+ YL        VHRD+ A N L+G +    I+DFGL++ V + D+ R  
Sbjct: 108 LSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164

Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ 919
                   ++APE       T KSDV+S+GV++ E+ T G  P  P +     +++++R 
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY-PGLS-NEEVLEYLR- 221

Query: 920 KRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK 971
            +G    L K      E+ E+  ML        C    P+DRPT  ++   ++
Sbjct: 222 -KG--YRLPKPEYCPDELYEL--MLS-------CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  146 bits (370), Expect = 3e-39
 Identities = 80/282 (28%), Positives = 123/282 (43%), Gaps = 47/282 (16%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  G VY A   + G+++A+K +              K  I   R+    EIK L 
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVI-------------KKKKIKKDRERILREIKILK 52

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL-EWELRYRIILGAAQG 810
            ++H NIVR      + +   L+ +Y   G L  LL +R    L E E R+  +      
Sbjct: 53  KLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG--RLSEDEARF-YLRQILSA 109

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L YLH      IVHRD+K  NIL+  +    +ADFGLA+ +  G+      T  G+  Y+
Sbjct: 110 LEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYM 163

Query: 871 APE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           APE      YG         D++S GV++ E+LTGK P     P    +++  ++     
Sbjct: 164 APEVLLGKGYGK------AVDIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPK 213

Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                     PE +I    + L   LL  +  P+ R T ++ 
Sbjct: 214 PPFP-----PPEWDISPEAKDLIRKLLVKD--PEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (310), Expect = 3e-31
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 40/221 (18%)

Query: 692 SVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
             +GKG  G VY+A     G+ +A+K +   +   +    N              EI+ L
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN--------------EIQIL 51

Query: 751 GSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
              +H NIV++ G  + +   L ++ ++   GSL  LL     +  E ++ Y +     +
Sbjct: 52  KKCKHPNIVKYYGS-YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-VCKELLK 109

Query: 810 GLAYLH--HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
           GL YLH        I+HRDIKA NIL+  + E  + DFGL+  + +    ++ NT+ G+ 
Sbjct: 110 GLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT---KARNTMVGTP 161

Query: 868 GYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            ++APE      Y Y      K+D++S G+  +E+  GK P
Sbjct: 162 YWMAPEVINGKPYDY------KADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 4e-31
 Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 22/212 (10%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G  G+VY+   +E G+ +A+K++    +  E               S   EI  L 
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEE------------ALKSIMQEIDLLK 54

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           +++H NIV+++G     ++  ++ +Y  NGSL  ++   +       L    +    QGL
Sbjct: 55  NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQGL 112

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA-KLVVEGDFARSSNTVAGSYGYI 870
           AYLH      ++HRDIKA NIL   +    +ADFG+A KL    D ++   +V G+  ++
Sbjct: 113 AYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKL---NDVSKDDASVVGTPYWM 166

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           APE   M   +  SD++S G  V+E+LTG  P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  120 bits (303), Expect = 4e-30
 Identities = 86/292 (29%), Positives = 143/292 (48%), Gaps = 43/292 (14%)

Query: 689 VEDSVVGKGCSGIVYRA-EMENGEVIAVKKL-WPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           V+  ++GKG  G VY A  +  GE++AVK++  P T+A              +  +  +E
Sbjct: 4   VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIA-----GRHDSRQKDMVKALRSE 58

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
           I+TL  + H NIV++LG         +  +Y+P GS+GS L  R     E +L       
Sbjct: 59  IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQ 116

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
             +GLAYLH      I+HRD+KA+N+L+  +    I+DFG++K   +      + ++ GS
Sbjct: 117 VLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 867 YGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
             ++APE       GY  K+    D++S G VVLE+  G++P             W  ++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKV----DIWSLGCVVLEMFAGRRP-------------WSDEE 216

Query: 921 RGAIEVLDK--SLRARPEV--EIEEMLQTLGVALL--CVNPTPDDRPTMKDV 966
             AI  + K  + R+ P +  ++   L  + +  L  C    PD+RPT +++
Sbjct: 217 --AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (282), Expect = 3e-27
 Identities = 85/304 (27%), Positives = 133/304 (43%), Gaps = 51/304 (16%)

Query: 694 VGKGCSGIVYRAEMEN-----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +G+G  G V     +      GE +AVK L  +             G    R  F  EI+
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-------------GEEQHRSDFEREIE 58

Query: 749 TLGSIRHKNIVRFLGCCW---NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
            L ++ H+NIV++ G C     R+ RL+M +Y+P+GSL   L   RD         R++L
Sbjct: 59  ILRTLDHENIVKYKGVCEKPGGRSLRLIM-EYLPSGSLRDYLQRHRDQ----INLKRLLL 113

Query: 806 GA---AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSN 861
            +    +G+ YL        +HRD+ A NIL+  E    I+DFGLAK++ E  D+     
Sbjct: 114 FSSQICKGMDYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE 170

Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT----GKQPIDPTIPEGLHIVDWV 917
                  + APE     K +  SDV+S+GV + E+ T     + P        + I    
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP-AEFLRMIGIAQGQ 229

Query: 918 RQKRGAIEVLDKSLR-ARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                 +E+L +  R  RP     E+ ++++      LC    P DRP+  D   +I  +
Sbjct: 230 MIVTRLLELLKEGERLPRPPSCPDEVYDLMK------LCWEAEPQDRPSFAD---LILIV 280

Query: 974 KQER 977
            + R
Sbjct: 281 DRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  110 bits (276), Expect = 1e-26
 Identities = 93/303 (30%), Positives = 146/303 (48%), Gaps = 48/303 (15%)

Query: 692 SVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
             +GKG  G V    Y    +N GEV+AVKKL  +T  AE+           +RD F  E
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEH-----------LRD-FERE 55

Query: 747 IKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
           I+ L S++H NIV++ G C++   RN RL+M +Y+P GSL   L + R+     + R ++
Sbjct: 56  IEILKSLQHDNIVKYKGVCYSAGRRNLRLVM-EYLPYGSLRDYLQKHRERL---DHR-KL 110

Query: 804 ILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARS 859
           +L A+Q   G+ YL        VHRD+   NIL+  E    I DFGL K++  + ++ + 
Sbjct: 111 LLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167

Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
                    + APE     K +  SDV+S+GVV+ E+ T          E + ++   +Q
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ 227

Query: 920 KRGA----IEVLDKSLR-ARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK 971
            +      IE+L  + R   P     EI  ++        C N  P  RP+  ++A  ++
Sbjct: 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIM------KECWNNDPSQRPSFSELALQVE 281

Query: 972 EIK 974
            I+
Sbjct: 282 AIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  107 bits (268), Expect = 2e-25
 Identities = 82/311 (26%), Positives = 128/311 (41%), Gaps = 57/311 (18%)

Query: 685 LKCLVEDSVVGKGCSGIVYRAEMENG------EVIAVKKLWPTTMAAEYDCQNDKIGIGG 738
              +V    +G+G  G V+  E  +       E++AVK L  T                 
Sbjct: 4   RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND------------- 50

Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL--HERRDSCL- 795
            R  F  E + L + +H+NIV+F G C   +  +++++YM +G L   L  H    + L 
Sbjct: 51  ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLK 110

Query: 796 -----EWELR----YRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                  EL      +I +  A G+ YL   H      VHRD+   N L+G +    I D
Sbjct: 111 SPDSPMGELTLSQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGD 165

Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
           FG+++ V   D+ R          ++ PE     K T +SDV+S+GVV+ E+ T GKQP 
Sbjct: 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP- 224

Query: 904 DPTIPEGLHIVDWVR-QKRGAIEVLDKS-LRARPEVEIEEMLQTLGVALLCVNPTPDDRP 961
                       W        IE + +  L  RP     E+     + L C    P  R 
Sbjct: 225 ------------WYGLSNEEVIECITQGRLLQRPRTCPSEVYD---IMLGCWKRDPQQRI 269

Query: 962 TMKDVAAMIKE 972
            +KD+   +++
Sbjct: 270 NIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (264), Expect = 5e-25
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 56/285 (19%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGG---VRDSFSAEI 747
            V+G+G SG+VY+      G++ A+KK                I + G    R     E+
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKK----------------IHVDGDEEFRKQLLREL 50

Query: 748 KTLGSIRHKNIVRFLGC-CWNRNTRLLMYDYMPNGSLGSLLHERRDSCL-EWELRY--RI 803
           KTL S     +V+  G         +++ +YM  GSL  LL  ++   + E  L Y  R 
Sbjct: 51  KTLRSCESPYVVKCYGAFYKEGEISIVL-EYMDGGSLADLL--KKVGKIPEPVLAYIARQ 107

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           IL   +GL YLH      I+HRDIK +N+LI  + E  IADFG++K++         NT 
Sbjct: 108 IL---KGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTF 160

Query: 864 AGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV 917
            G+  Y++PE      Y Y       +D++S G+ +LE   GK P  P  P      + +
Sbjct: 161 VGTVTYMSPERIQGESYSY------AADIWSLGLTLLECALGKFPFLP--PGQPSFFELM 212

Query: 918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
           +       + D    + P  E     +   ++  C+   P  RP+
Sbjct: 213 QA------ICDGPPPSLPAEEFSPEFRDF-IS-ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  108 bits (269), Expect = 5e-25
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 28/284 (9%)

Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
             +G+G  G VY A   + +++A+K L                      + F  EI+ L 
Sbjct: 6   RKLGEGSFGEVYLAR--DRKLVALKVL-----------AKKLESKSKEVERFLREIQILA 52

Query: 752 SIRH-KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQ 809
           S+ H  NIV+      +  +  L+ +Y+  GSL  LL +      L       I+     
Sbjct: 53  SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKLVVEGDFARS----SNTVA 864
            L YLH      I+HRDIK  NIL+  +     + DFGLAKL+ +     S     +T  
Sbjct: 113 ALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 865 GSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
           G+ GY+APE    +     +  SD++S G+ + E+LTG  P +                 
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKD 965
                L   L       I +    L   LL  +  P +R +   
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKD--PKNRLSSSS 271

Length = 384

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  104 bits (262), Expect = 8e-25
 Identities = 73/217 (33%), Positives = 111/217 (51%), Gaps = 21/217 (9%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           V+GKG  G VY      G++IAVK++   T        ++ +      +    E+  L S
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDT--------SNVLAAEKEYEKLQEEVDLLKS 58

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR--YRIILGAAQG 810
           ++H NIV++LG C + NT  +  +++P GS+ S+L  R     E       + IL    G
Sbjct: 59  LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQIL---DG 114

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA-KLVVEGDFARSSNTVAGSYG- 868
           +AYLH++CV   VHRDIK NN+++ P     + DFG A +L   G     SN +   +G 
Sbjct: 115 VAYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171

Query: 869 --YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
             ++APE         KSD++S G  V E+ TGK P+
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 3e-24
 Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 46/293 (15%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
             +  + V+G G  G V R  +    +    +A+K L   +   +             R 
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ-------------RL 50

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
            F  E   +G   H NI+R  G        +++ +YM NGSL   L E            
Sbjct: 51  DFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK-FTVGQLV 109

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
            ++ G A G+ YL        VHRD+ A NIL+       ++DFGL++ + + +   ++ 
Sbjct: 110 GMLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE---ATY 163

Query: 862 TVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVD 915
           T  G  G I     APE     K T  SDV+S+G+V+ EV++ G++P            D
Sbjct: 164 TTKG--GKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW----------D 211

Query: 916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA 968
              Q    I+ ++   R  P ++    L  L   L C     ++RPT   + +
Sbjct: 212 MSNQD--VIKAVEDGYRLPPPMDCPSALYQL--MLDCWQKDRNERPTFSQIVS 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  101 bits (254), Expect = 7e-24
 Identities = 77/219 (35%), Positives = 110/219 (50%), Gaps = 35/219 (15%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +++G+  AVK++   ++A      + + G   V+     EI  L  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEV---SLA-----DDGQTGQEAVKQ-LEQEIALLSK 58

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR-Y-RIILGAAQG 810
           ++H NIV++LG     +   +  + +P GSL  LL ++  S  E  +R Y R IL    G
Sbjct: 59  LQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQIL---LG 114

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L YLH       VHRDIK  NIL+       +ADFG+AK VVE  FA+S     GS  ++
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS---FKGSPYWM 168

Query: 871 APE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           APE       YG        +D++S G  VLE+ TGK P
Sbjct: 169 APEVIAQQGGYGL------AADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 99.1 bits (247), Expect = 6e-23
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G+V++     +  V A+K++  + M                R+    E + L  
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR------------EREEAIDEARVLAK 55

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +    I+R+     ++    ++ +Y  NG L  LL  +R   L  +  +R  +    GLA
Sbjct: 56  LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH      I+HRDIK+ N+ +       I D G+AKL+   D    +NT+ G+  Y++P
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSP 170

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EKSDV++ GVV+ E  TGK P D
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 99.5 bits (248), Expect = 6e-23
 Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 15/216 (6%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +++G G  G VY      +GE++AVK++   +++A    +   +      D+ + EI  L
Sbjct: 6   ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSM-----LDALAREIALL 60

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
             ++H+NIV++LG   + +   +  +Y+P GS+ +LL+       E  L    +    +G
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKG 118

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT----VAGS 866
           L YLH+     I+HRDIK  NIL+  +    I+DFG++K +     +  +N     + GS
Sbjct: 119 LNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
             ++APE       T K+D++S G +V+E+LTGK P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 99.4 bits (248), Expect = 6e-23
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 37/223 (16%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKL----WPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           V+G G + +VY A  + N E +A+K++      T++                 D    E+
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-----------------DELRKEV 50

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRDSCLEWELRYRIILG 806
           + +    H N+V++       +   L+  Y+  GSL  ++        L+  +   ++  
Sbjct: 51  QAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKE 110

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG--DFARSSNTVA 864
             +GL YLH +     +HRDIKA NIL+G +    IADFG++  + +G     +   T  
Sbjct: 111 VLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167

Query: 865 GSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           G+  ++APE     +GY      K+D++S+G+  +E+ TG  P
Sbjct: 168 GTPCWMAPEVMEQVHGY----DFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 77/277 (27%), Positives = 123/277 (44%), Gaps = 50/277 (18%)

Query: 695 GKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR 754
           G G  G V+         +AVK L P TM+ E               +F  E + +  +R
Sbjct: 15  GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---------------AFLQEAQIMKKLR 59

Query: 755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ---GL 811
           H  +V+    C       ++ +YM  GSL   L       L      +++  AAQ   G+
Sbjct: 60  HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP---QLVDMAAQIAEGM 116

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYI 870
           AYL        +HRD+ A NIL+G      IADFGLA+L+ + ++ AR          + 
Sbjct: 117 AYLESRNY---IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWT 171

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK 929
           APE     + T KSDV+S+G+++ E++T G+ P       G+         R  +E +++
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY-----PGMT-------NREVLEQVER 219

Query: 930 SLR-ARPE---VEIEEMLQTLGVALLCVNPTPDDRPT 962
             R  RP     E+ +++      L C +  P++RPT
Sbjct: 220 GYRMPRPPNCPEELYDLM------LQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 78/295 (26%), Positives = 132/295 (44%), Gaps = 54/295 (18%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G  G VYR   +  G V+A+K +         D  +D      V D    E+  L 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKII-------NLDTPDDD-----VSD-IQREVALLS 54

Query: 752 SIRH---KNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
            +R     NI ++ G  + +  RL ++ +Y   GS+ +L+   +   +  +    II   
Sbjct: 55  QLRQSQPPNITKYYGS-YLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISVIIREV 110

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
              L Y+H      ++HRDIKA NIL+       + DFG+A L+ +    RS  T  G+ 
Sbjct: 111 LVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS--TFVGTP 165

Query: 868 GYIAPEYGYMMKITE------KSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
            ++APE      ITE      K+D++S G+ + E+ TG  P           VD  R   
Sbjct: 166 YWMAPEV-----ITEGKYYDTKADIWSLGITIYEMATGNPP--------YSDVDAFR--- 209

Query: 922 GAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
            A+ ++ KS   R  +    ++L+    A  C++  P +R + +++    K IK 
Sbjct: 210 -AMMLIPKSKPPRLEDNGYSKLLREFVAA--CLDEEPKERLSAEELLKS-KWIKA 260

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 57/283 (20%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G+V+  +      +A+K +    M+                D F  E K +  +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------------EDDFIEEAKVMMKL 56

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ---- 809
            H N+V+  G C  +    ++ +YM NG L + L ER+      +L    +L        
Sbjct: 57  SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCE 111

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT---VAGS 866
            + YL  +     +HRD+ A N L+G +    ++DFGLA+ V++  +  S  T   V  +
Sbjct: 112 AMEYLESNGF---IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIE 925
                PE     + + KSDV+S+GV++ EV + GK P +               +    E
Sbjct: 169 ----PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE---------------RFSNSE 209

Query: 926 VLDKSLRA----RPEVEIEEMLQTLGVALLCVNPTPDDRPTMK 964
           V++         RP++   E+   +     C +  P+DRP  K
Sbjct: 210 VVESVSAGYRLYRPKLAPTEVYTIMY---SCWHEKPEDRPAFK 249

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 97.7 bits (244), Expect = 3e-22
 Identities = 64/220 (29%), Positives = 107/220 (48%), Gaps = 38/220 (17%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
             +G+G SG VY+A +   G+ +A+KK+           QN ++ I         EI  +
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKM-------RLRKQNKELIIN--------EILIM 69

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY--RIILGAA 808
              +H NIV +       +   ++ +YM  GSL  ++ +      E ++ Y  R +L   
Sbjct: 70  KDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL--- 126

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
           QGL YLH      ++HRDIK++NIL+  +    +ADFG A  + +    R  N+V G+  
Sbjct: 127 QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPY 181

Query: 869 YIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++APE      YG       K D++S G++ +E+  G+ P
Sbjct: 182 WMAPEVIKRKDYG------PKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 29/218 (13%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY A  ++ GE++AVK+     +  +    ND   I  + D    E+K L  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKE-----IRIQ---DNDPKTIKEIAD----EMKVLEL 55

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H N+V++ G   +R    +  +Y   G+L  LL   R         Y + L   +GLA
Sbjct: 56  LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLA 113

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD--FARSSNTVAGSYGYI 870
           YLH      IVHRDIK  NI +       + DFG A  +            ++AG+  Y+
Sbjct: 114 YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 871 APEYGYMMKITEKS------DVYSYGVVVLEVLTGKQP 902
           APE   ++   +        D++S G VVLE+ TGK+P
Sbjct: 171 APE---VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  G VY+A   E G+V+A+K                 + +         EI  L 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKV----------------VPVEEDLQEIIKEISILK 53

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV++ G  +      ++ +Y   GS+  ++     +  E E+   I+    +GL
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-ILYQTLKGL 112

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA-KLVVEGDFARSSNTVAGSYGYI 870
            YLH +     +HRDIKA NIL+  E +  +ADFG++ +L    D     NTV G+  ++
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT---DTMAKRNTVIGTPFWM 166

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           APE    +    K+D++S G+  +E+  GK P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 30/220 (13%)

Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           + +GKG  G V   +    +V AVK L           ++D         +F AE   + 
Sbjct: 12  ATIGKGEFGDVMLGDYRGQKV-AVKCL-----------KDD----STAAQAFLAEASVMT 55

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           ++RH N+V+ LG     N   ++ +YM  GSL   L  R  + +    +    L   +G+
Sbjct: 56  TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGM 115

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY--GY 869
            YL        VHRD+ A N+L+  +    ++DFGLAK         S    +G     +
Sbjct: 116 EYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKW 165

Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
            APE     K + KSDV+S+G+++ E+ + G+ P  P IP
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 40/273 (14%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+     N   +AVK L P TM  +                F AE + +  +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---------------DFLAEAQIMKKL 58

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH  +++    C       ++ + M  GSL   L       L+      +    A G+AY
Sbjct: 59  RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118

Query: 814 L--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYI 870
           L   +      +HRD+ A N+L+G      +ADFGLA+++ E  + AR          + 
Sbjct: 119 LEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWT 171

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK 929
           APE     + + KSDV+S+G+++ E++T G+ P  P +                ++ +D+
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY-PGMT-----------NAEVLQQVDQ 219

Query: 930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
             R        + L    + L C    PDDRPT
Sbjct: 220 GYRMPCPPGCPKELYD--IMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 63/296 (21%), Positives = 124/296 (41%), Gaps = 64/296 (21%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +GKG  G VY      +G++  +K++  + M+     + ++       D+ + E+K L 
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-----EKER------EDALN-EVKILK 54

Query: 752 SIRHKNIVRFLGCCWNRNTRLL--MYDYMPNGSLGSLLHERRDSCLE------WELRYRI 803
            + H NI+++    +    +L   M +Y   G L   + +++            +   ++
Sbjct: 55  KLNHPNIIKYYES-FEEKGKLCIVM-EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112

Query: 804 ILGAAQGLAYLH--HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSS 860
            L     L YLH        I+HRDIK  NI +       + DFG++K++    D A   
Sbjct: 113 CLA----LKYLHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA--- 160

Query: 861 NTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV 914
            TV G+  Y++PE      Y Y      KSD++S G V+ E+ T K P +      L  +
Sbjct: 161 KTVVGTPYYLSPELCQNKPYNY------KSDIWSLGCVLYELCTLKHPFEGENLLEL-AL 213

Query: 915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
             ++ +          + ++   E+  ++ +       +   P++RP++  +    
Sbjct: 214 KILKGQY-------PPIPSQYSSELRNLVSS------LLQKDPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 70/281 (24%), Positives = 122/281 (43%), Gaps = 46/281 (16%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +GKG  G VY+  ++    +AVK              + K         F  E + L   
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKT------CRSTLPPDLKR-------KFLQEAEILKQY 49

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG----AAQ 809
            H NIV+ +G C  +    ++ + +P GSL + L ++++      L  + +L     AA 
Sbjct: 50  DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAA 104

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ YL        +HRD+ A N L+G      I+DFG+++    G +  S         +
Sbjct: 105 GMEYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161

Query: 870 IAPE---YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            APE   YG   + T +SDV+SYG+++ E  +      P +          +Q R   E 
Sbjct: 162 TAPEALNYG---RYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTR---ER 207

Query: 927 LDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           ++   R   P++  EE+ + +   L C    P++RP+  ++
Sbjct: 208 IESGYRMPAPQLCPEEIYRLM---LQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 41/232 (17%)

Query: 694 VGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G VY+ E        +   +A+K L              +     V+  F  E 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTL-------------KENAEPKVQQEFRQEA 59

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL--------------HERRDS 793
           + +  ++H NIV  LG C       ++++Y+ +G L   L               E   S
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 794 CLEWELRYRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            L+      I +  A G+ YL  HH      VHRD+ A N L+G      I+DFGL++ +
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDI 174

Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
              D+ R  +       ++ PE     K T +SD++S+GVV+ E+ + G QP
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 20/210 (9%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+    +N   +A+K L            +D +     +  F  E++ L  +
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKIL----------KSDDLL----KQQDFQKEVQALKRL 59

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RHK+++     C       ++ + M  GSL + L       L       +    A+G+AY
Sbjct: 60  RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           L        +HRD+ A NIL+G +    +ADFGLA+L+ E D   SS+     Y + APE
Sbjct: 120 LEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKI-PYKWTAPE 174

Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
                  + KSDV+S+G+++ E+ T G+ P
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 90.7 bits (225), Expect = 5e-20
 Identities = 80/295 (27%), Positives = 124/295 (42%), Gaps = 68/295 (23%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS--FSAEIKT 749
           V+GKG  GIVY A ++     IA+K+                I     R       EI  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKE----------------IPERDSRYVQPLHEEIAL 58

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE--LRY--RIIL 805
              ++H+NIV++LG         +  + +P GSL +LL  +     + E  + +  + IL
Sbjct: 59  HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-----IADFGLAKLVVEGDFARSS 860
              +GL YLH +    IVHRDIK +N+L+      Y     I+DFG +K +        +
Sbjct: 119 ---EGLKYLHDN---QIVHRDIKGDNVLV----NTYSGVVKISDFGTSKRL--AGINPCT 166

Query: 861 NTVAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPEGL 911
            T  G+  Y+APE        YG        +D++S G  ++E+ TGK P I+   P+  
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYG------APADIWSLGCTIVEMATGKPPFIELGEPQAA 220

Query: 912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                   K G  ++        PE+      +     L C  P PD R +  D+
Sbjct: 221 MF------KVGMFKI-------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDL 262

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.5 bits (225), Expect = 7e-20
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 21/215 (9%)

Query: 692 SVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
             +G G SG+V +      G+++AVK     T+  E    N+ I     +     E+  L
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVK-----TIRLE---INEAI-----QKQILRELDIL 53

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
                  IV F G  +N     +  +YM  GSL  +L E +    E  L  +I +   +G
Sbjct: 54  HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-KIAVAVLKG 112

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L YLH      I+HRD+K +NIL+    +  + DFG++  +V    A    T  G+  Y+
Sbjct: 113 LTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-SLA---KTFVGTSSYM 166

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           APE       + KSD++S G+ ++E+ TG+ P  P
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 90.7 bits (225), Expect = 7e-20
 Identities = 84/299 (28%), Positives = 137/299 (45%), Gaps = 46/299 (15%)

Query: 693 VVGKGCSG--IVYRAEMEN---GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           V+G+G  G   +Y  +  N   GE++AVK     T+  E   QN           +  EI
Sbjct: 11  VLGEGHFGKVSLYCYDPANDGTGEMVAVK-----TLKRECGQQN--------TSGWKKEI 57

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTR--LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
             L ++ H+NIV++ GCC  +  +   L+ +Y+P GSL   L + + +  +      ++L
Sbjct: 58  NILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ------LLL 111

Query: 806 GAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSN 861
            A Q   G+AYLH       +HRD+ A N+L+  +    I DFGLAK V EG ++ R   
Sbjct: 112 FAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168

Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT---GKQPIDPTIPEGLHIVDWVR 918
                  + A E     K +  SDV+S+GV + E+LT    KQ       E +       
Sbjct: 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM 228

Query: 919 QKRGAIEVLDKSLR-ARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                IE+L++ +R   P+    E+  +++       C       RPT + +  ++KE+
Sbjct: 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKN------CWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.8 bits (226), Expect = 8e-20
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 28/212 (13%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  GIV++A + E GE +A+KK+    +          I    +R     EIK L +
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRL-------EGGIPNQALR-----EIKALQA 55

Query: 753 IRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELR--YRIILGAAQ 809
            +H  +V+ L   +   +   L+ +YMP   L  +L +      E +++   R++L    
Sbjct: 56  CQHPYVVKLLDV-FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK--- 110

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+AY+H +    I+HRD+K  N+LI  +    IADFGLA+L  E +    S+ VA +  Y
Sbjct: 111 GVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWY 166

Query: 870 IAPE--YGYMMKITEKSDVYSYGVVVLEVLTG 899
            APE  YG   K     D+++ G +  E+L G
Sbjct: 167 RAPELLYG-ARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 21/212 (9%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G+V+         +A+K +    M+ E                F  E + +  +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---------------DFIEEAQVMMKL 56

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H  +V+  G C  R+   L++++M +G L   L  +R      E    + L   +G+AY
Sbjct: 57  SHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAY 115

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           L    V   +HRD+ A N L+G      ++DFG+ + V++  +  S+ T      + +PE
Sbjct: 116 LESSNV---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT-KFPVKWSSPE 171

Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
                K + KSDV+S+GV++ EV + GK P +
Sbjct: 172 VFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 78/304 (25%), Positives = 120/304 (39%), Gaps = 65/304 (21%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            VVG+G  G+V +      GE++A+KK          D   D+     V+ +   E+K L
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKK-----FKESED---DED----VKKTALREVKVL 54

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH--ERRDSCLEWELRYRIILGAA 808
             +RH+NIV        +    L+++Y+      +LL   E     L  +     I    
Sbjct: 55  RQLRHENIVNLKEAFRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLL 110

Query: 809 QGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
           Q +AY H H+    I+HRDIK  NIL+       + DFG A+ +     +  ++ VA  +
Sbjct: 111 QAIAYCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW 166

Query: 868 GYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQP-------ID--------- 904
            Y APE       YG      +  DV++ G ++ E+L G +P       ID         
Sbjct: 167 -YRAPELLVGDTNYG------KPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCL 218

Query: 905 -PTIPEGLHIVDWVRQKRGA----IEVLDK-SLRARPEVEIEEMLQTLGVALLCVNPTPD 958
            P  P   H   +    R A     E     SL  R   ++      L     C+   P 
Sbjct: 219 GPLPPS--HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPA--LDFLKACLRMDPK 274

Query: 959 DRPT 962
           +R T
Sbjct: 275 ERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 66/243 (27%), Positives = 102/243 (41%), Gaps = 39/243 (16%)

Query: 688 LVEDSVVGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           L     +G+G  G V +AE            +AVK L     A E D          + D
Sbjct: 14  LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--KDDATEKD----------LSD 61

Query: 742 SFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
             S E++ +  I +HKNI+  LG C       ++ +Y  +G+L   L  RR         
Sbjct: 62  LVS-EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPD 120

Query: 801 YRIILG--------------AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
                                A+G+ +L        +HRD+ A N+L+  +    IADFG
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFG 177

Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP 905
           LA+ +   D+ R +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-P 236

Query: 906 TIP 908
            IP
Sbjct: 237 GIP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 5e-19
 Identities = 82/316 (25%), Positives = 130/316 (41%), Gaps = 59/316 (18%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           + +VE S +G+G  G V +  ++N  +I   K   T    +   Q        +R     
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQI-------LR----- 48

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNT---RLLMYDYMPNGSLGSLLHERRDS---CLEWEL 799
           E++   S +   IV++ G   + ++    + M +Y   GSL S+  + +       E  L
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVL 107

Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
             +I     +GL+YLH      I+HRDIK +NIL+  + +  + DFG     V G+   S
Sbjct: 108 G-KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG-----VSGELVNS 158

Query: 860 -SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR 918
            + T  G+  Y+APE       +  SDV+S G+ +LEV   + P     PEG        
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF---PPEG-------E 208

Query: 919 QKRGAIEVLDKSLRAR-------PEVEI---EEMLQTLGVALLCVNPTPDDRPTMKD--- 965
              G IE+L   +          P   I   EE    +     C+   P  RPT  D   
Sbjct: 209 PPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWDMLE 265

Query: 966 ----VAAMIKEIKQER 977
                A M K++   +
Sbjct: 266 HPWIKAQMKKKVNMAK 281

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.5 bits (219), Expect = 5e-19
 Identities = 80/301 (26%), Positives = 135/301 (44%), Gaps = 58/301 (19%)

Query: 694 VGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G V+ AE  N        ++AVK L   T+AA              R  F  E 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--------------RKDFQREA 58

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH------------ERRDSCL 795
           + L +++H++IV+F G C + +  +++++YM +G L   L             + R +  
Sbjct: 59  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118

Query: 796 EWELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
           E  L   + + +  A G+ YL        VHRD+   N L+G      I DFG+++ V  
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175

Query: 854 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP---IDPTIPE 909
            D+ R          ++ PE     K T +SDV+S+GV++ E+ T GKQP   +  T   
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-- 233

Query: 910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
              +++ + Q R    VL+     RP V  +E+     + L C    P  R  +K++  +
Sbjct: 234 ---VIECITQGR----VLE-----RPRVCPKEVYD---IMLGCWQREPQQRLNIKEIYKI 278

Query: 970 I 970
           +
Sbjct: 279 L 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 87.4 bits (216), Expect = 7e-19
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 58

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 59  RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 117

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 118 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 173

Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 221

Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 222 MPCPPECPESLHDL--MCQCWRKEPEERPTFEYLQAFLED 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.3 bits (216), Expect = 8e-19
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 27/224 (12%)

Query: 687 CLVEDSVVGKGCSGIVYRAEME---NGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            + +  V+G G  G V+R  ++     EV +A+K L P     +             R  
Sbjct: 6   HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-------------RQD 52

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
           F +E   +G   H NI+R  G        +++ +YM NG+L   L +       ++L   
Sbjct: 53  FLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VG 111

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
           ++ G A G+ YL        VHRD+ A NIL+    E  ++DFGL++ V+E D    + T
Sbjct: 112 MLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSR-VLE-DDPEGTYT 166

Query: 863 VAGS---YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            +G      + APE     K T  SDV+S+G+V+ EV++ G++P
Sbjct: 167 TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.0 bits (214), Expect = 2e-18
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 29/215 (13%)

Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G V     ++ G++ A+K L    +      +  ++      +    E   L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-----IKRKEV------EHTLTERNILSR 49

Query: 753 IRHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ-- 809
           I H  IV+ L   +    +L +  +Y P G L S L +      E    Y     AA+  
Sbjct: 50  INHPFIVK-LHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY-----AAEIV 103

Query: 810 -GLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
             L YLH       I++RD+K  NIL+  +    + DFGLAK +        +NT  G+ 
Sbjct: 104 LALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTP 157

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            Y+APE        +  D +S GV++ E+LTGK P
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 80/285 (28%), Positives = 125/285 (43%), Gaps = 57/285 (20%)

Query: 702 VYRAEMENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV 759
           VY   M++G+ +  AVK L    +AA              +  F  E   +  + H  IV
Sbjct: 15  VYL--MKSGKEVEVAVKTLKQEHIAAG-------------KKEFLREASVMAQLDHPCIV 59

Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD----SCLEWELRYRIILGAAQGLAYLH 815
           R +G C      L+M +  P G L   L +RR+       E   +       A G+AYL 
Sbjct: 60  RLIGVCKGEPLMLVM-ELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLE 112

Query: 816 HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGSY--GYIAP 872
                  VHRD+ A N+L+    +  I+DFG+++ +  G D+ R+  T AG +   + AP
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA--TTAGRWPLKWYAP 167

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA--IEVLDK 929
           E     K + KSDV+SYGV + E  + G +P                + +GA  I +L+ 
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKP--------------YGEMKGAEVIAMLES 213

Query: 930 SLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             R  RPE   +E+     + L C    P+DRPT  ++ +  +  
Sbjct: 214 GERLPRPEECPQEIYS---IMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 75/295 (25%), Positives = 117/295 (39%), Gaps = 47/295 (15%)

Query: 694 VGKGCSGIVYR---AEMENGEV---IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G+VY      +  GE    +A+K +       E             R  F  E 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-------------RIEFLNEA 60

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL-----RYR 802
             +      ++VR LG        L++ + M  G L S L  RR               +
Sbjct: 61  SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120

Query: 803 IILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
            I  AA+   G+AYL        VHRD+ A N ++  +    I DFG+ + + E D+ R 
Sbjct: 121 FIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVR 918
                    ++APE       T KSDV+S+GVV+ E+ T  +QP      +GL       
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-----QGL------- 225

Query: 919 QKRGAIE-VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                ++ V+D      PE    + L  L    +C    P  RPT  ++ + +K+
Sbjct: 226 SNEEVLKFVIDGGHLDLPE-NCPDKLLEL--MRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 85.7 bits (213), Expect = 4e-18
 Identities = 69/222 (31%), Positives = 110/222 (49%), Gaps = 39/222 (17%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIG--IGGVRDSFSAEIKTL 750
           +G+G  G VY+A   + GE++A+KK+           +N+K G  I  +R     EIK L
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIR-----EIKLL 52

Query: 751 GSIRHKNIVRFLGCCWN--RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA 808
             +RH NIVR      +  + +  ++++YM +  L  LL        E +++   +    
Sbjct: 53  QKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC-YMKQLL 110

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
           +GL YLH +    I+HRDIK +NILI  +    +ADFGLA+   + + A  +N V   + 
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW- 166

Query: 869 YIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           Y  PE       YG       + D++S G ++ E+  GK PI
Sbjct: 167 YRPPELLLGATRYGP------EVDMWSVGCILAELFLGK-PI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 65/278 (23%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G VY   +++ G  +AVK++ P          +       V ++   EI+ L +
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQV-PF-------DPDSPETKKEV-NALECEIQLLKN 60

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL--RY-RIILGAAQ 809
           ++H+ IV++ GC  +  T  +  +YMP GS+   L  +    L   +  +Y R IL   +
Sbjct: 61  LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL---E 115

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK----LVVEGDFARSSNTVAG 865
           G+ YLH +    IVHRDIK  NIL        + DFG +K    +   G   +S   V G
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS---VTG 169

Query: 866 SYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGK-----------------QP 902
           +  +++PE      YG       K+DV+S G  V+E+LT K                 QP
Sbjct: 170 TPYWMSPEVISGEGYG------RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 223

Query: 903 IDPTIPEGL--HIVDWVRQKRGAIEVLDKSLRARPEVE 938
            +P +P  +     +++R+         ++ + RP  E
Sbjct: 224 TNPQLPSHVSPDARNFLRR------TFVENAKKRPSAE 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 85.4 bits (211), Expect = 4e-18
 Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 43/232 (18%)

Query: 694 VGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G V+ AE  N        ++AVK L   + +A  D Q +            AE+
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE------------AEL 60

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL----------GSLLHERRD-SCLE 796
            T+  ++H++IVRF G C      L++++YM +G L            +L    D +  +
Sbjct: 61  LTV--LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQ 118

Query: 797 WELRYRIILGA--AQGLAYL---HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
             L   + + +  A G+ YL   H       VHRD+   N L+G      I DFG+++ +
Sbjct: 119 LTLGQMLAIASQIASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172

Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
              D+ R          ++ PE     K T +SD++S+GVV+ E+ T GKQP
Sbjct: 173 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 85.0 bits (210), Expect = 4e-18
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 22/237 (9%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F +E   +G   H NI+   G        +++ +YM NGSL + L  + D       
Sbjct: 49  RRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQ 107

Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              ++ G A G+ YL        VHRD+ A NIL+       ++DFGL++ V+E D   +
Sbjct: 108 LVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAA 163

Query: 860 SNTVAGSYG--YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDW 916
             T  G     + APE     K T  SDV+SYG+V+ EV++ G++P             W
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------W 211

Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
               +  I+ +++  R    ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 212 EMSNQDVIKAIEEGYRLPAPMDCPAALHQL--MLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 72/288 (25%), Positives = 127/288 (44%), Gaps = 45/288 (15%)

Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           D  +G+GC G V+         +A+K L P TM  E               +F  E + +
Sbjct: 11  DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---------------AFLQEAQIM 55

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
             +RH  +V       +     ++ ++M  GSL   L E     L+      +    A G
Sbjct: 56  KKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADG 114

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           +AY+        +HRD++A NIL+G      IADFGLA+L+ + ++  +         + 
Sbjct: 115 MAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWT 170

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK 929
           APE     + T KSDV+S+G+++ E++T G+ P    +             R  +E +++
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV------------NREVLEQVER 218

Query: 930 SLRAR-----PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
             R       PE  + E+++      LC    PD+RPT + + + +++
Sbjct: 219 GYRMPCPQGCPE-SLHELMK------LCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 46/226 (20%)

Query: 692 SVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
             +G G  G VY+A     GE++A+K +              K+  G   +    EI  L
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVI--------------KLEPGDDFEIIQQEISML 54

Query: 751 GSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
              RH NIV + G  + R  +L ++ +Y   GSL  +    R    E ++ Y +     +
Sbjct: 55  KECRHPNIVAYFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY-VCRETLK 112

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA----- 864
           GLAYLH       +HRDIK  NIL+  + +  +ADFG++        A+ + T+A     
Sbjct: 113 GLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVS--------AQLTATIAKRKSF 161

Query: 865 -GSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            G+  ++APE        GY      K D+++ G+  +E+   + P
Sbjct: 162 IGTPYWMAPEVAAVERKGGY----DGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 77/293 (26%), Positives = 116/293 (39%), Gaps = 52/293 (17%)

Query: 694 VGKGCSGIVYRAEMEN--GEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           +G G  G+V R E     G+VI  AVK L    ++              + D F  E   
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------------DIMDDFLKEAAI 49

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           + S+ H+N++R  G        L+M   +    LGSLL   R   L   L   +   A Q
Sbjct: 50  MHSLDHENLIRLYGVV--LTHPLMMVTEL--APLGSLLDRLRKDALGHFLISTLCDYAVQ 105

Query: 810 ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTVAG 865
              G+ YL        +HRD+ A NIL+  + +  I DFGL + L    D       +  
Sbjct: 106 IANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
            + + APE       +  SDV+ +GV + E+ T G++P             W        
Sbjct: 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP-------------WA--GLSGS 207

Query: 925 EVLDKSLRA-----RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
           ++L K  +      RPE   +++     V L C    P DRPT   +   + E
Sbjct: 208 QILKKIDKEGERLERPEACPQDIYN---VMLQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.1 bits (210), Expect = 7e-18
 Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 34/288 (11%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G G  G VY+   +  GE + +    P  +    +    K  +      F  E   + 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKI----PVAIKILNETTGPKANV-----EFMDEALIMA 64

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           S+ H ++VR LG C +   +L+    MP+G L   +HE +D+ +  +L     +  A+G+
Sbjct: 65  SMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGM 122

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY--GY 869
            YL       +VHRD+ A N+L+       I DFGLA+L +EGD  +  N   G     +
Sbjct: 123 MYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGD-EKEYNADGGKMPIKW 177

Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           +A E  +  K T +SDV+SYGV + E++T G +P D  IP            R   ++L+
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIP-----------TREIPDLLE 225

Query: 929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  P+  I   +    V + C     D RP  K++AA    + ++
Sbjct: 226 KGERL-PQPPI-CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 85.2 bits (211), Expect = 7e-18
 Identities = 69/214 (32%), Positives = 102/214 (47%), Gaps = 26/214 (12%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY A ++   EV+A+KK+  +   +    Q D I           E++ L  
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DII----------KEVRFLQQ 71

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH N + + GC    +T  L+ +Y   GS   +L   +    E E+   I  GA QGLA
Sbjct: 72  LRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA-AICHGALQGLA 129

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH       +HRDIKA NIL+       +ADFG A LV        +N+  G+  ++AP
Sbjct: 130 YLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLV------SPANSFVGTPYWMAP 180

Query: 873 EYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI 903
           E    M   +   K DV+S G+  +E+   K P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 84.6 bits (209), Expect = 8e-18
 Identities = 53/167 (31%), Positives = 84/167 (50%), Gaps = 9/167 (5%)

Query: 740 RDSFSA---EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
           R +F      +  +GS+ H  IVR LG C   + +L+     P GSL   + + RDS L+
Sbjct: 50  RQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQHRDS-LD 107

Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
            +      +  A+G+ YL       +VHR++ A NIL+  +    IADFG+A L+   D 
Sbjct: 108 PQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164

Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
               +       ++A E     + T +SDV+SYGV V E+++ G +P
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 72/262 (27%), Positives = 107/262 (40%), Gaps = 59/262 (22%)

Query: 673 PFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGE-----------------VIAV 715
           P Q LNF VE++          G+G  G V+  E +  +                 ++AV
Sbjct: 3   PRQPLNF-VEKL----------GEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAV 51

Query: 716 KKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMY 775
           K L P                   R+ F  E+K L  +   NI R LG C       ++ 
Sbjct: 52  KVLRPD-------------ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIM 98

Query: 776 DYMPNGSLGSLL--HERRDSCLEWE--------LRYRIILGAAQGLAYL-HHDCVPPIVH 824
           +YM NG L   L  H    S L           L Y +    A G+ YL   +     VH
Sbjct: 99  EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLY-MATQIASGMRYLESLN----FVH 153

Query: 825 RDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKS 884
           RD+   N L+G  +   IADFG+++ +   D+ R          ++A E   + K T KS
Sbjct: 154 RDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKS 213

Query: 885 DVYSYGVVVLEVLT--GKQPID 904
           DV+++GV + E+LT   +QP +
Sbjct: 214 DVWAFGVTLWEILTLCREQPYE 235

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 87.6 bits (217), Expect = 1e-17
 Identities = 47/103 (45%), Positives = 62/103 (60%), Gaps = 14/103 (13%)

Query: 382 LLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRL 441
           L L + G+ G IP +I       +LR         LQ +NLS N++ G +P SL S+T L
Sbjct: 423 LGLDNQGLRGFIPNDIS------KLR--------HLQSINLSGNSIRGNIPPSLGSITSL 468

Query: 442 QVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLG 484
           +VLD+S N F G IPES GQL SL  L L+ NS SG +P++LG
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 2e-17
 Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 43/286 (15%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G     Y+A +++ G ++AVK++           +N       V ++   EI+ + 
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQV--------TYVRNTSSEQEEVVEALRKEIRLMA 58

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            + H +I+R LG     +   L  ++M  GS+  LL +      +  +         +GL
Sbjct: 59  RLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGL 116

Query: 812 AYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLA-----KLVVEGDFARSSNTV 863
           +YLH +    I+HRD+K  N+LI   G      IADFG A     K    G+F      +
Sbjct: 117 SYLHEN---QIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEF---QGQL 168

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK-RG 922
            G+  ++APE     +     DV+S G V++E+ T K P             W  +K   
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP-------------WNAEKHSN 215

Query: 923 AIEVLDKSLRARPEVEIEEMLQ--TLGVALLCVNPTPDDRPTMKDV 966
            + ++ K   A     I E L      V L C+   P+DRP  +++
Sbjct: 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 83.6 bits (207), Expect = 2e-17
 Identities = 64/230 (27%), Positives = 95/230 (41%), Gaps = 48/230 (20%)

Query: 693 VVGKGCSGIVYRA----EMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           V+G G  G VY+     E E  ++ +A+K L   T                       E 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-------------EILDEA 60

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEWELRYR 802
             + S+ H ++VR LG C +     L+   MP G L   +   +D       L W ++  
Sbjct: 61  YVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ-- 117

Query: 803 IILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
                A+G++YL         +VHRD+ A N+L+       I DFGLAKL+         
Sbjct: 118 ----IAKGMSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLL-----DVDE 163

Query: 861 NTVAGSYG-----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
                  G     ++A E       T KSDV+SYGV V E++T G +P +
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.9 bits (207), Expect = 2e-17
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 28/215 (13%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY A ++ N EV+A+KK     M+      N+K            E++ L  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKK-----MSYSGKQSNEKW------QDIIKEVRFLQK 71

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH N +++ GC    +T  L+ +Y   GS   LL   +    E E+   +  GA QGLA
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQGLA 129

Query: 813 YLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           YLH H+    ++HRD+KA NIL+       + DFG A ++        +N   G+  ++A
Sbjct: 130 YLHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANXFVGTPYWMA 179

Query: 872 PEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI 903
           PE    M   +   K DV+S G+  +E+   K P+
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 83.3 bits (206), Expect = 2e-17
 Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 63/303 (20%)

Query: 694 VGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G V++A        E   ++AVK L      A  D Q D          F  E 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQAD----------FQREA 59

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-----------RDSCLE 796
             +    H NIV+ LG C       L+++YM  G L   L  R             S  +
Sbjct: 60  ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119

Query: 797 WELRY---------RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL 847
             L            I    A G+AYL        VHRD+   N L+G      IADFGL
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 176

Query: 848 AKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT 906
           ++ +   D+ ++S   A    ++ PE  +  + T +SDV++YGVV+ E+ + G QP    
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236

Query: 907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPE---VEIEEMLQTLGVALLCVNPTPDDRPTM 963
             E   ++ +VR         D ++ + P+   +E+  +++      LC +  P DRP+ 
Sbjct: 237 AHE--EVIYYVR---------DGNVLSCPDNCPLELYNLMR------LCWSKLPSDRPSF 279

Query: 964 KDV 966
             +
Sbjct: 280 ASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 73/240 (30%), Positives = 115/240 (47%), Gaps = 40/240 (16%)

Query: 671 LTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDC 729
           +T F+KLN               +G+G  GIVYRA +  +GE++A+KK+         D 
Sbjct: 6   VTEFEKLN--------------RIGEGTYGIVYRARDTTSGEIVALKKV-------RMDN 44

Query: 730 QNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR--NTRLLMYDYMPNGSLGSLL 787
           + D I I  +R     EI  L ++RH NIV        +  ++  L+ +Y     L SLL
Sbjct: 45  ERDGIPISSLR-----EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL 98

Query: 788 HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL 847
                   E +++  ++L   +GL YLH +    I+HRD+K +N+L+  +    IADFGL
Sbjct: 99  DNMPTPFSESQVKC-LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGL 154

Query: 848 AKLVVEGDFARSSNTVAGSYGYIAPE--YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           A+    G  A+       +  Y APE   G     T   D+++ G ++ E+L  K P+ P
Sbjct: 155 ARTY--GLPAKPMTPKVVTLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHK-PLLP 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 47/276 (17%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+         +A+K L   +M+ E               +F AE   +  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---------------AFLAEANLMKQL 58

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA--AQGL 811
           +H  +VR L     +    ++ +YM NGSL   L  +    ++  +   I + A  A+G+
Sbjct: 59  QHPRLVR-LYAVVTQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGM 115

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYI 870
           A++        +HRD++A NIL+       IADFGLA+L+ + ++ AR          + 
Sbjct: 116 AFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWT 170

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP--TIPEGLHIVDWVRQKRGAIEVL 927
           APE       T KSDV+S+G+++ E++T G+ P  P  T PE              I+ L
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY-PGMTNPE-------------VIQNL 216

Query: 928 DKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
           ++  R  RP+   EE+ +   +  LC    P++RPT
Sbjct: 217 ERGYRMPRPDNCPEELYE---LMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 70/276 (25%), Positives = 114/276 (41%), Gaps = 37/276 (13%)

Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +     +AVK L   TM  E                F  E   +  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 58

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           I+H N+V+ LG C       ++ ++M  G+L   L E     +   +   +    +  + 
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YL        +HRD+ A N L+G      +ADFGL++L + GD   +         + AP
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAP 174

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           E     K + KSDV+++GV++ E+ T G  P       G+ +           E+L+K  
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQ-------VYELLEKGY 222

Query: 932 RA-RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           R  RPE    ++ + +     C    P DRP+  ++
Sbjct: 223 RMERPEGCPPKVYELM---RACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 83.6 bits (206), Expect = 3e-17
 Identities = 87/323 (26%), Positives = 147/323 (45%), Gaps = 44/323 (13%)

Query: 694  VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +G G  G VY A ++   EV+A+KK+  +   +    Q+              E+K L  
Sbjct: 33   IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-----------IIKEVKFLQR 81

Query: 753  IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            I+H N + + GC    +T  L+ +Y   GS   LL   +    E E+   I  GA QGLA
Sbjct: 82   IKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGLA 139

Query: 813  YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
            YLH      ++HRDIKA NIL+    +  +ADFG A +      A  +N+  G+  ++AP
Sbjct: 140  YLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAP 190

Query: 873  EYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI-DPTIPEGLHIVDWVRQKRGAIEVLD 928
            E    M   +   K DV+S G+  +E+   K P+ +      L+ +   + +   ++  +
Sbjct: 191  EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPTLQSNE 248

Query: 929  KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDMLPS 988
             S   R  V+             C+   P DRPT +++   +  ++ ER E + +D++  
Sbjct: 249  WSDYFRNFVDS------------CLQKIPQDRPTSEELLKHMFVLR-ERPETVLIDLI-- 293

Query: 989  EGSANGQRENNNSSSTAMMPNLY 1011
            + + +  RE +N     M   L+
Sbjct: 294  QRTKDAVRELDNLQYRKMKKLLF 316

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 83.2 bits (205), Expect = 4e-17
 Identities = 69/214 (32%), Positives = 100/214 (46%), Gaps = 26/214 (12%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY A      EV+AVKK     M+      N+K            E+K L  
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKK-----MSYSGKQTNEKW------QDIIKEVKFLQQ 77

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H N + + GC    +T  L+ +Y   GS   LL   +    E E+   I  GA QGLA
Sbjct: 78  LKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AITHGALQGLA 135

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH      ++HRDIKA NIL+    +  +ADFG A        +  +N+  G+  ++AP
Sbjct: 136 YLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAP 186

Query: 873 EYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI 903
           E    M   +   K DV+S G+  +E+   K P+
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 81.7 bits (201), Expect = 8e-17
 Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 23/221 (10%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G V+ AE  N        L P         +  K      R  F  E + L ++
Sbjct: 13  LGEGAFGKVFLAECYN--------LCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCL------EWELRYRIILG 806
           +H++IV+F G C   +  +++++YM +G L   L     D+ L        EL    +L 
Sbjct: 65  QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 807 AAQ----GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
            AQ    G+ YL        VHRD+   N L+G      I DFG+++ V   D+ R    
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
                 ++ PE     K T +SDV+S GVV+ E+ T GKQP
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 8e-17
 Identities = 68/256 (26%), Positives = 116/256 (45%), Gaps = 30/256 (11%)

Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           VR     E++ +   R   IV F G   N N   +  ++M  GSL  +   ++   +  E
Sbjct: 46  VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY--KKGGPIPVE 103

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           +  +I +   +GL YL++  V  I+HRDIK +NIL+    +  + DFG     V G+   
Sbjct: 104 ILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFG-----VSGELIN 156

Query: 859 S-SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV 917
           S ++T  G+  Y++PE     K T KSDV+S G+ ++E+  GK P            D  
Sbjct: 157 SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA--FSNIDD--DGQ 212

Query: 918 RQKRGAIEVLDKSLRARP--------EVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
               G +++L + ++  P          ++ + +        C+   P +RPT + + AM
Sbjct: 213 DDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVD------ACLLKDPTERPTPQQLCAM 266

Query: 970 IKEIKQEREECMKVDM 985
              I+  R     VD+
Sbjct: 267 PPFIQALRAS--NVDL 280

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 84.1 bits (208), Expect = 1e-16
 Identities = 50/127 (39%), Positives = 69/127 (54%), Gaps = 6/127 (4%)

Query: 420 LNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAI 479
           L L N  L G +P+ ++ L  LQ +++S N   G IP S G + SL  L LS NSF+G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 480 PSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIP------PQIS 533
           P SLG+  SL+ L+L+ N LSG++P  L        S N + NA    IP      P +S
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542

Query: 534 ALNKLSI 540
              K+ I
Sbjct: 543 VGAKIGI 549

Length = 623

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 72/281 (25%), Positives = 125/281 (44%), Gaps = 37/281 (13%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+         +AVK L P TM+ E               SF  E + +  +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---------------SFLEEAQIMKKL 58

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH  +V+      +     ++ +YM  GSL   L +     L+      +    A G+AY
Sbjct: 59  RHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAP 872
           +        +HRD+++ NIL+G      IADFGLA+L+ + ++ AR          + AP
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAP 172

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           E     + T KSDV+S+G+++ E++T G+ P       G++        R  +E +++  
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPY-----PGMN-------NREVLEQVERGY 220

Query: 932 RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
           R     +    L  L   L C    P++RPT + + + +++
Sbjct: 221 RMPCPQDCPISLHEL--MLQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 77/302 (25%), Positives = 118/302 (39%), Gaps = 47/302 (15%)

Query: 686 KCLVEDSVVGKGCSGIVYRAE---MENGEV---IAVKKLWPTTMAAEYDCQNDKIGIGGV 739
             +     +G G  G VY       +   V   +AVK L      +E D ++D       
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQD-ESD------- 55

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SC 794
              F  E   +    H+NIVR +G  + R  R ++ + M  G L S L E R      S 
Sbjct: 56  ---FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS 112

Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLV 851
           L  +         A+G  YL  +     +HRDI A N L+   GP     IADFG+A+ +
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169

Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLT-GKQPIDPTIPE 909
               + R          ++ PE  ++  I T K+DV+S+GV++ E+ + G  P  P    
Sbjct: 170 YRASYYRKGGRAMLPIKWMPPE-AFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-PG--- 224

Query: 910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
                   R  +  +E +    R  P            +   C   TP+DRP    +   
Sbjct: 225 --------RTNQEVMEFVTGGGRLDPPKGCPG--PVYRIMTDCWQHTPEDRPNFATILER 274

Query: 970 IK 971
           I+
Sbjct: 275 IQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 86/311 (27%), Positives = 127/311 (40%), Gaps = 63/311 (20%)

Query: 688 LVEDSVVGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           LV    +G+G  G V +A             +AVK L     ++E             RD
Sbjct: 2   LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL------------RD 49

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR---------- 791
             S E   L  + H ++++  G C      LL+ +Y   GSL S L E R          
Sbjct: 50  LLS-EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSD 108

Query: 792 --------DSCLEWELRYRIILGAA----QGLAYLHHDCVPPIVHRDIKANNILIGPEFE 839
                   D+  E  L    ++  A    +G+ YL       +VHRD+ A N+L+    +
Sbjct: 109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRK 165

Query: 840 PYIADFGLAKLVVEGD--FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 897
             I+DFGL++ V E D    RS   +     ++A E  +    T +SDV+S+GV++ E++
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Query: 898 T-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPT 956
           T G  P     PE L    +   K G           RPE   EEM     + L C    
Sbjct: 224 TLGGNPYPGIAPERL----FNLLKTG-------YRMERPENCSEEMYN---LMLTCWKQE 269

Query: 957 PDDRPTMKDVA 967
           PD RPT  D++
Sbjct: 270 PDKRPTFADIS 280

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 42/289 (14%)

Query: 683 QVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           +VLK L      GKG  G VY+ + + + +  A+K++   +M+     Q ++       D
Sbjct: 3   KVLKKL------GKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-----QKER------ED 45

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--SCLEWEL 799
           + + EI+ L S+ H NI+ +     + N   ++ +Y P G L   + +R+     +  + 
Sbjct: 46  AVN-EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQE 104

Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
            +RI +   +GL  LH      I+HRD+K+ NIL+       I D G++K V++ + A+ 
Sbjct: 105 IWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISK-VLKKNMAK- 159

Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
             T  G+  Y+APE       + KSD++S G ++ E+ T   P +    + L      + 
Sbjct: 160 --TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR----YKV 213

Query: 920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA 968
           +RG    +        +  I  MLQ            P  RP    + A
Sbjct: 214 QRGKYPPIPPIYSQDLQNFIRSMLQ----------VKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 30/218 (13%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A +   GE++A+KK+     +              +R     EIK L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-------LR-----EIKLLKE 54

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL---EWELRYRIILGAAQ 809
           + H NI++ L    ++    L++++M       L    +D      E  ++   +    Q
Sbjct: 55  LNHPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKS-YLYQLLQ 109

Query: 810 GLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
           GLA+ H H     I+HRD+K  N+LI  E    +ADFGLA+          ++ V   + 
Sbjct: 110 GLAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLAR-SFGSPVRPYTHYVVTRW- 163

Query: 869 YIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDP 905
           Y APE     K  +   D++S G +  E+L+  +P+ P
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RPLFP 200

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS 744
           L+ L    ++G+G  G V + E   G+ +AVK +     A                 +F 
Sbjct: 5   LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA----------------QAFL 47

Query: 745 AEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII 804
            E   +  + HKN+VR LG   +    ++M + M  G+L + L  R  + +      +  
Sbjct: 48  EETAVMTKLHHKNLVRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFS 106

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           L  A+G+ YL       +VHRD+ A NIL+  +    ++DFGLA++      +   +   
Sbjct: 107 LDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVG-----SMGVDNSK 158

Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
               + APE     K + KSDV+SYGV++ EV + G+ P
Sbjct: 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 73/298 (24%), Positives = 125/298 (41%), Gaps = 45/298 (15%)

Query: 687 CLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
           C+  + V+G G  G V R  ++        +A+K     T+ + Y  +         R  
Sbjct: 5   CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIK-----TLKSGYTEKQ--------RRD 51

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
           F +E   +G   H NI+   G        +++ ++M NG+L S L +        +L   
Sbjct: 52  FLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-VG 110

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
           ++ G A G+ YL        VHRD+ A NIL+       ++DFGL++ + +     S  T
Sbjct: 111 MLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD---TSDPT 164

Query: 863 VAGSYG------YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVD 915
              S G      + APE     K T  SDV+SYG+V+ EV++ G++P             
Sbjct: 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------ 212

Query: 916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           W    +  I  +++  R  P ++    L  L   L C     + RP    + + + ++
Sbjct: 213 WDMSNQDVINAIEQDYRLPPPMDCPTALHQL--MLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 51/286 (17%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G+V+  +      +A+K +    M+                + F  E K +  +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---------------EEDFIEEAKVMMKL 56

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ---- 809
            H  +V+  G C  +    ++ ++M NG L + L +R+      +L   ++L   Q    
Sbjct: 57  SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCE 111

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ YL  +     +HRD+ A N L+       ++DFG+ + V++ ++  SS+       +
Sbjct: 112 GMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKW 167

Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
             PE     K + KSDV+S+GV++ EV T GK P                +K+   EV++
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF---------------EKKSNYEVVE 212

Query: 929 KSLRA----RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
              R     RP++    + +   V   C +  P+ RPT  ++   I
Sbjct: 213 MISRGFRLYRPKLASMTVYE---VMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 26/234 (11%)

Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D F  E K +  + H+ +V+  G C  +    ++ +YM NG L + L E        +L 
Sbjct: 44  DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL- 102

Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
             +     +G+AYL        +HRD+ A N L+  +    ++DFGL++ V++ ++  S 
Sbjct: 103 LEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159

Query: 861 NT---VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDW 916
            +   V  S     PE     K + KSDV+++GV++ EV + GK P +         V+ 
Sbjct: 160 GSKFPVRWS----PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF--NNSETVEK 213

Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
           V Q              RP +  E++     +   C +   ++RPT + + + I
Sbjct: 214 VSQGLRLY---------RPHLASEKVYA---IMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 79.8 bits (197), Expect = 5e-16
 Identities = 79/271 (29%), Positives = 127/271 (46%), Gaps = 49/271 (18%)

Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTR 771
           +AVK L PT  ++E             R++  +E+K +  +  H+NIV  LG C      
Sbjct: 68  VAVKMLKPTAHSSE-------------REALMSELKIMSHLGNHENIVNLLGACTIGGPI 114

Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYL-HHDCVPPIVHRDIKAN 830
           L++ +Y   G L + L  +R+S L  E         A+G+A+L   +C    +HRD+ A 
Sbjct: 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC----IHRDLAAR 170

Query: 831 NILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA-GS----YGYIAPEYGYMMKITEKSD 885
           N+L+       I DFGLA+     D    SN V  G+      ++APE  +    T +SD
Sbjct: 171 NVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 225

Query: 886 VYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV---EIEE 941
           V+SYG+++ E+ + G  P  P +P     VD    K     + +    A+PE    EI +
Sbjct: 226 VWSYGILLWEIFSLGSNPY-PGMP-----VDSKFYKL----IKEGYRMAQPEHAPAEIYD 275

Query: 942 MLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
           +++T      C +  P  RPT K +  +I +
Sbjct: 276 IMKT------CWDADPLKRPTFKQIVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 75/293 (25%), Positives = 117/293 (39%), Gaps = 42/293 (14%)

Query: 691 DSVVGKGCSGIVYRA--EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
              +G+G  G VY+        E IAV         A   C+N       VR+ F  E  
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAV---------AVKTCKNC--TSPSVREKFLQEAY 59

Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA 808
            +    H +IV+ +G        ++M +  P G L S L   + S    +L   +IL + 
Sbjct: 60  IMRQFDHPHIVKLIGVITENPVWIVM-ELAPLGELRSYLQVNKYSL---DLA-SLILYSY 114

Query: 809 Q---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
           Q    LAYL        VHRDI A N+L+       + DFGL++ + +  + ++S     
Sbjct: 115 QLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS-KGKL 170

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              ++APE     + T  SDV+ +GV + E+L  G +P              V+     I
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF-----------QGVKNND-VI 218

Query: 925 EVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
             ++   R   P       L +L     C    P  RP   ++ A + +I QE
Sbjct: 219 GRIENGERLPMPP-NCPPTLYSL--MTKCWAYDPSKRPRFTELKAQLSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 20/207 (9%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           ++GKG  G V++  +++   +AVK            C+ D      ++  F +E + L  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKT-----------CKEDLPQELKIK--FLSEARILKQ 48

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
             H NIV+ +G C  R    ++ + +P G   S L +++D  L+ +   +  L AA G+A
Sbjct: 49  YDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDE-LKTKQLVKFALDAAAGMA 107

Query: 813 YLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           YL   +C    +HRD+ A N L+G      I+DFG+++   +G ++ SS        + A
Sbjct: 108 YLESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTA 162

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLT 898
           PE     + + +SDV+SYG+++ E  +
Sbjct: 163 PEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.5 bits (193), Expect = 6e-16
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 28/218 (12%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +GKG  G V   +   G  +AVK +           +ND         +F AE   +  
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVKCI-----------KNDATA-----QAFLAEASVMTQ 55

Query: 753 IRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           +RH N+V+ LG        L ++ +YM  GSL   L  R  S L  +   +  L   + +
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL  +     VHRD+ A N+L+  +    ++DFGL K     + + + +T      + A
Sbjct: 116 EYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTA 167

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
           PE     K + KSDV+S+G+++ E+ + G+ P  P IP
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.4 bits (193), Expect = 8e-16
 Identities = 68/279 (24%), Positives = 118/279 (42%), Gaps = 36/279 (12%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           VVG+G  GIV+    +  + + + K  P     + +           R +   E + L  
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-----------RLAAQNECQVLKL 55

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NI+ +          +++ +Y P G+L   + +R +S L+ +    I+    Q L 
Sbjct: 56  LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED---TILHFFVQILL 112

Query: 813 YLHHDCVPPIVHRDIKANNILIGP-EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            LHH     I+HRD+K  NIL+   +    I DFG++K++     A    TV G+  YI+
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYIS 169

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE        +KSD+++ G V+ E+ + K+  +      L ++  +      I     S 
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-VLKIMSGTFAPI-----SD 223

Query: 932 RARPEVE--IEEMLQTLGVALLCVNPTPDDRPTMKDVAA 968
           R  P++   I  ML             P  RP +  + A
Sbjct: 224 RYSPDLRQLILSMLNL----------DPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 79.2 bits (195), Expect = 9e-16
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 20/175 (11%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER--------- 790
           R+ F  E+K L  ++  NI+R LG C + +   ++ +YM NG L   L            
Sbjct: 63  RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122

Query: 791 -----RDSCL---EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI 842
                   CL    +     + L  A G+ YL        VHRD+   N L+G      I
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKI 179

Query: 843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 897
           ADFG+++ +  GD+ R          ++A E   M K T  SDV+++GV + E+L
Sbjct: 180 ADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 9e-16
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 40/220 (18%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +GKG  G VY+A +    +V+A+K +       + +   D+I      +    EI+ L 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVI-------DLEEAEDEI------EDIQQEIQFLS 54

Query: 752 SIRHKNIVRFLGCCWNRNTRL--LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             R   I ++ G  + + ++L  +M +Y   GS   LL   +    E  + + I+     
Sbjct: 55  QCRSPYITKYYGS-FLKGSKLWIIM-EYCGGGSCLDLLKPGKLD--ETYIAF-ILREVLL 109

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS---NTVAGS 866
           GL YLH +     +HRDIKA NIL+  E +  +ADFG     V G    +    NT  G+
Sbjct: 110 GLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFG-----VSGQLTSTMSKRNTFVGT 161

Query: 867 YGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQP 902
             ++APE     GY     EK+D++S G+  +E+  G+ P
Sbjct: 162 PFWMAPEVIKQSGY----DEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 78.9 bits (194), Expect = 1e-15
 Identities = 84/313 (26%), Positives = 138/313 (44%), Gaps = 60/313 (19%)

Query: 688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWP---TTMAAEY--DCQNDKIGIGGVRDS 742
           LV    +G+GC G V RAE        + K  P    T+A +   D   DK     + D 
Sbjct: 14  LVLGKPLGEGCFGQVVRAE-----AYGIDKSRPDQTVTVAVKMLKDNATDK----DLADL 64

Query: 743 FSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW---- 797
            S E++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR    ++    
Sbjct: 65  IS-EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123

Query: 798 ------ELRYRIILG----AAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
                 +L ++ ++      A+G+ YL    C+    HRD+ A N+L+  +    IADFG
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI----HRDLAARNVLVTEDNVMKIADFG 179

Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP 905
           LA+ V + D+ + ++       ++APE  +    T +SDV+S+G+++ E+ T G  P  P
Sbjct: 180 LARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY-P 238

Query: 906 TIPEGLHIVDWVRQKRGAIEVLDKSLRA-----RPEVEIEEMLQTLGVALLCVNPTPDDR 960
            IP               +E L K LR      +P     E+     +   C +  P  R
Sbjct: 239 GIP---------------VEELFKLLREGHRMDKPSNCTHEL---YMLMRECWHAVPTQR 280

Query: 961 PTMKDVAAMIKEI 973
           PT K +   + ++
Sbjct: 281 PTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 67/274 (24%), Positives = 111/274 (40%), Gaps = 42/274 (15%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+     N   +AVK L P TM+ +               +F  E   + ++
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ---------------AFLEEANLMKTL 58

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           +H  +VR            ++ +YM  GSL   L       +            A+G+AY
Sbjct: 59  QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 118

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        +HRD++A N+L+       IADFGLA+ V+E +   +         + APE
Sbjct: 119 IERK---NYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPE 174

Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                  T KSDV+S+G+++ E++T GK P                     +  L +  R
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG------------MSNSDVMSALQRGYR 222

Query: 933 -ARPE---VEIEEMLQTLGVALLCVNPTPDDRPT 962
             R E    E+ ++++T      C     ++RPT
Sbjct: 223 MPRMENCPDELYDIMKT------CWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 42/224 (18%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+V++    E G+++A+KK     + +E D    KI +         EI+ L  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIAL--------REIRMLKQ 56

Query: 753 IRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHE--RRDSCLEWELRYRIILGAAQ 809
           ++H N+V  +   + R  +L L+++Y  +    ++L+E  +    +   L  +II    Q
Sbjct: 57  LKHPNLVNLIEV-FRRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQ 111

Query: 810 GLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
            + + H H+C+    HRD+K  NILI  + +  + DFG A+++        ++ VA  + 
Sbjct: 112 AVNFCHKHNCI----HRDVKPENILITKQGQIKLCDFGFARILTGPGDDY-TDYVATRW- 165

Query: 869 YIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           Y APE       YG         DV++ G V  E+LTG QP+ P
Sbjct: 166 YRAPELLVGDTQYG------PPVDVWAIGCVFAELLTG-QPLWP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 80.2 bits (198), Expect = 2e-15
 Identities = 44/134 (32%), Positives = 68/134 (50%), Gaps = 14/134 (10%)

Query: 1   SSSIPSALSNWNPSDSNPC-----KWSHITCSPQN-----FVTEINIQSIELELPFPSNL 50
           S  +P     WN    +PC      WS   C   +     F+  + + +  L    P+++
Sbjct: 383 SLGLPLRFG-WN---GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDI 438

Query: 51  SSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILN 110
           S L  LQ + +SG+++ G I P LG  T L  +D+S NS  G +P S+G+L +L+ L LN
Sbjct: 439 SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498

Query: 111 SNQLTGEIPKELGA 124
            N L+G +P  LG 
Sbjct: 499 GNSLSGRVPAALGG 512

Length = 623

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 695 GKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR 754
           G G  G VY+A+ +   + A  K+       E +              F  EI  L   +
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-------------DFMVEIDILSECK 60

Query: 755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYL 814
           H NIV      +  N   ++ ++   G+L S++ E      E ++RY +     + L +L
Sbjct: 61  HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFL 119

Query: 815 HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE- 873
           H      ++HRD+KA NIL+  + +  +ADFG++         R   T  G+  ++APE 
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--TFIGTPYWMAPEV 174

Query: 874 ----------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                     Y Y      K+D++S G+ ++E+   + P
Sbjct: 175 VACETFKDNPYDY------KADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 71/244 (29%), Positives = 111/244 (45%), Gaps = 43/244 (17%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G  G VY   + + G  +AVK++       + D Q     +    ++   EI+ L 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQV-----PFDPDSQETSKEV----NALECEIQLLK 59

Query: 752 SIRHKNIVRFLGCCWNRNTRLL--MYDYMPNGSLGSLLHERRDSCLEWELRY-RIILGAA 808
           ++RH  IV++ GC  +   + L    +YMP GS+   L            RY R IL   
Sbjct: 60  NLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL--- 116

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK----LVVEGDFARSSNTVA 864
           QG++YLH +    IVHRDIK  NIL        + DFG +K    + + G   +S   V 
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS---VT 170

Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-----------------QPIDPTI 907
           G+  +++PE         K+DV+S    V+E+LT K                 QP  P +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML 230

Query: 908 PEGL 911
           P+G+
Sbjct: 231 PDGV 234

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 42/283 (14%)

Query: 693 VVGKGCSG--IVYRAEMENGEV----IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           V+GKG  G   +YR   ++  V    + + +L         D  N              E
Sbjct: 7   VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALN--------------E 49

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
           I  L  ++H NI+ +     + NT L+  +Y   G+L   +  ++    E E+    +  
Sbjct: 50  IVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ 109

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
               ++Y+H      I+HRDIK  NI +       + DFG++K++  G     + TV G+
Sbjct: 110 IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGT 164

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
             Y++PE    +K   KSD+++ G V+ E+LT K+  D T P  L++V  + Q       
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVKIVQGNYTPV- 221

Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
                     V   E++    +    +   P+ RPT  +V   
Sbjct: 222 --------VSVYSSELIS---LVHSLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 14/189 (7%)

Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR------LLMYDYMPNGSLGS-LLHERRDS 793
           + F +E   +    H N++R +G C            +++  +M +G L S LL+ R   
Sbjct: 45  EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104

Query: 794 C---LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
           C   L  ++  + +   A G+ YL        +HRD+ A N ++       +ADFGL+K 
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKK 161

Query: 851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG 910
           +  GD+ R          +IA E       T KSDV+S+GV + E+ T  Q   P + E 
Sbjct: 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-EN 220

Query: 911 LHIVDWVRQ 919
             I D++RQ
Sbjct: 221 SEIYDYLRQ 229

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 4e-15
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 24/160 (15%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A + + GE++A+KK+         D + + I    +R     EI  L  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALR-----EISLLKE 54

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR---YRIILGAAQ 809
           ++H NIV+ L          L+++Y     L   L +R        ++   Y+++    +
Sbjct: 55  LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL----R 109

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           GLAY H      I+HRD+K  NILI  +    +ADFGLA+
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.4 bits (190), Expect = 4e-15
 Identities = 72/234 (30%), Positives = 113/234 (48%), Gaps = 31/234 (13%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEY--DCQNDKIGIGGVRDSFSAEIKTLG 751
           +G+GC G V  AE    +     K  P T+A +   D   DK     + D  S E++ + 
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNK--PVTVAVKMLKDDATDK----DLSDLVS-EMEMMK 72

Query: 752 SI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------DSCL--EWELR 800
            I +HKNI+  LG C       ++ +Y   G+L   L  RR        D+C   E +L 
Sbjct: 73  MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132

Query: 801 YRIILG----AAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
           ++ ++      A+G+ YL    C+    HRD+ A N+L+  +    IADFGLA+ V   D
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCI----HRDLAARNVLVTEDNVMKIADFGLARDVHNID 188

Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
           + + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIP 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 76.3 bits (187), Expect = 5e-15
 Identities = 69/221 (31%), Positives = 101/221 (45%), Gaps = 38/221 (17%)

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLL--MYDYMPNGSLGSLLHERRDSCLEWEL 799
           +   EI+ L +++H+ IV++ GC  +R  + L    +YMP GS+   L            
Sbjct: 50  ALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR 109

Query: 800 RY-RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK----LVVEG 854
           +Y R IL   +G++YLH +    IVHRDIK  NIL        + DFG +K    + + G
Sbjct: 110 KYTRQIL---EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163

Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-------------- 900
              RS   V G+  +++PE         K+DV+S G  V+E+LT K              
Sbjct: 164 TGIRS---VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK 220

Query: 901 ---QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVE 938
              QP +P +P   HI +  R   G I V     R RP  E
Sbjct: 221 IATQPTNPQLPS--HISEHARDFLGCIFV---EARHRPSAE 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 45/288 (15%)

Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +  +G G  G V+ A       +AVK + P +M+ E               +F AE   +
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---------------AFLAEANVM 55

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA--A 808
            +++H  +V+ L     +    ++ ++M  GSL   L  + D   +  L   I   A  A
Sbjct: 56  KTLQHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIA 112

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF-ARSSNTVAGSY 867
           +G+A++        +HRD++A NIL+       IADFGLA+++ + ++ AR         
Sbjct: 113 EGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PI 167

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP-TIPEGLHIVDWVRQKRGAIE 925
            + APE       T KSDV+S+G++++E++T G+ P    + PE              I 
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------------VIR 214

Query: 926 VLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            L++  R  RPE   EE+     + + C    P++RPT + + +++ +
Sbjct: 215 ALERGYRMPRPENCPEELYN---IMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 76.2 bits (187), Expect = 8e-15
 Identities = 67/240 (27%), Positives = 109/240 (45%), Gaps = 43/240 (17%)

Query: 694 VGKGCSGIVYRAEM--------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +G+GC G V  AE         +    +AVK L     A E D  +             +
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML--KDDATEKDLSD-----------LVS 69

Query: 746 EIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW------- 797
           E++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+       
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 798 ---ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
              ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLAR 185

Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
            V   D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 76.1 bits (187), Expect = 9e-15
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 12/168 (7%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL--HERRDSCLEW 797
           R+ F  EIK +  ++  NI+R L  C   +   ++ +YM NG L   L  HE +++  + 
Sbjct: 63  RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122

Query: 798 ELRY----RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
           ++       +I  A Q   G+ YL        VHRD+   N L+G  +   IADFG+++ 
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179

Query: 851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
           +  GD+ R          +++ E   + K T  SDV+++GV + E+LT
Sbjct: 180 LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 41/290 (14%)

Query: 693 VVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           V+GKG  G VY   +   +G+ I  AVK L   T   E +              F  E  
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-------------QFLKEGI 48

Query: 749 TLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG- 806
            +    H N++  LG C  +  + L++  YM +G L    +  R       ++  I  G 
Sbjct: 49  IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDLIGFGL 105

Query: 807 -AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL        VHRD+ A N ++   F   +ADFGLA+ + + ++    N    
Sbjct: 106 QVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162

Query: 866 SY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA 923
                ++A E     K T KSDV+S+GV++ E++T   P  P + +   I  ++ Q R  
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYLLQGRRL 221

Query: 924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                     +PE   + + +   V L C +P P+ RPT  ++ + I++I
Sbjct: 222 ---------LQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.5 bits (191), Expect = 2e-14
 Identities = 34/81 (41%), Positives = 53/81 (65%)

Query: 235 LSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNL 294
           L G +P ++ KL+ L+ + L  N+  G IP  +G+  SL+ +DLS N F+GS+P+S G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 295 SSLEELMLSNNNISGSIPPVL 315
           +SL  L L+ N++SG +P  L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 79/300 (26%), Positives = 141/300 (47%), Gaps = 61/300 (20%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           +VG+G  G+V + +  E G+++A+KK          + ++DK+    V+     EI+ L 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF--------LESEDDKM----VKKIAMREIRMLK 55

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            +RH+N+V  +     +    L+++++ +  L  L  E+  + L+     + +    +G+
Sbjct: 56  QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL--EKYPNGLDESRVRKYLFQILRGI 113

Query: 812 AYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
            + H H+    I+HRDIK  NIL+       + DFG A+ +        ++ VA  + Y 
Sbjct: 114 EFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YTDYVATRW-YR 167

Query: 871 APE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQ--PIDPTIPEGLHIVDWVRQKR 921
           APE       YG  +      D+++ G +V E+LTG+   P D  I +  HI+    +  
Sbjct: 168 APELLVGDTKYGRAV------DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII----KCL 217

Query: 922 GAI-----EVLDKS-----LRARPEV-EIEEMLQ--------TLGVALLCVNPTPDDRPT 962
           G +     E+  K+     +R  PEV EIE + +         L +A  C+   PDDRP+
Sbjct: 218 GNLIPRHQEIFQKNPLFAGMRL-PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 80/288 (27%), Positives = 123/288 (42%), Gaps = 57/288 (19%)

Query: 688 LVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           LVE  V+G+G  G VY+A   + G+++A+K +         D   D+       +    E
Sbjct: 10  LVE--VIGEGTYGKVYKARHKKTGQLVAIKIM---------DIIEDEE------EEIKEE 52

Query: 747 IKTLGSI-RHKNIVRFLGCCWNRNTR-------LLMYDYMPNGSLGSL---LHERRDSCL 795
              L     H NI  F G    +N         L+M +    GS+  L   L ++     
Sbjct: 53  YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM-ELCGGGSVTDLVKGLRKKGKRLK 111

Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
           E  + Y I+    +GLAYLH + V   +HRDIK  NIL+    E  + DFG++  +    
Sbjct: 112 EEWIAY-ILRETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167

Query: 856 FARSSNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDPT- 906
             R  NT  G+  ++APE              +SDV+S G+  +E+  GK P   + P  
Sbjct: 168 GRR--NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225

Query: 907 ----IPEG-----LHIVDWVRQKRGAI-EVLDKSLRARPEVEIEEMLQ 944
               IP           +W ++    I E L K+   RP +  EE+L+
Sbjct: 226 ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFM--EELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 74.9 bits (185), Expect = 2e-14
 Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 41/170 (24%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKTL 750
           +G+G   +VY+A   E G ++A+KK+              K GI     +F+A  EIK L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERK------EAKDGI-----NFTALREIKLL 56

Query: 751 GSIRHKNIVRFLGC-CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA- 808
             ++H NI+  L       N  L+  ++M    L  ++ ++            I+L  A 
Sbjct: 57  QELKHPNIIGLLDVFGHKSNINLVF-EFME-TDLEKVIKDKS-----------IVLTPAD 103

Query: 809 ---------QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
                    +GL YLH +    I+HRD+K NN+LI  +    +ADFGLA+
Sbjct: 104 IKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 21/217 (9%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +GKG  G V +     +G+++  K++       +Y    +K      +    +E+  L 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEI-------DYGNMTEK-----EKQQLVSEVNILR 54

Query: 752 SIRHKNIVRFLGCCWNR-NTRLLMY-DYMPNGSLGSLL-HERRD-SCLEWELRYRIILGA 807
            ++H NIVR+     +R N  L +  +Y   G L  L+   +++   +E E  +RI+   
Sbjct: 55  ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQL 114

Query: 808 AQGLAYLHHDCVPP--IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              L   H+   P   ++HRD+K  NI +       + DFGLAK++        + T  G
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVG 172

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +  Y++PE    M   EKSD++S G ++ E+     P
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 37/287 (12%)

Query: 694 VGKGCSGIVYRAEMENG--EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           +G G  G VY+   +N    ++A+K++     A   D +     IG       +E+  + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG----DIVSEVTIIK 63

Query: 752 -SIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSL---LHERRDSCLE---WELRYRI 803
             +RH NIVR+    +  N RL ++ D +    LG     L E++    E   W +  ++
Sbjct: 64  EQLRHPNIVRYYKT-FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           +L     L YLH +    IVHRD+  NNI++G + +  I DFGLAK         S   V
Sbjct: 123 VLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS---V 173

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA 923
            G+  Y  PE        EK+DV+++G ++ ++ T + P   T    L           A
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-----------A 222

Query: 924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
            ++++      PE    E +    V   C+ P  + RP +  V+AMI
Sbjct: 223 TKIVEAVYEPLPEGMYSEDVT--DVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 74.2 bits (182), Expect = 3e-14
 Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 15/175 (8%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS------ 793
           R+ F  EIK +  +++ NI+R LG C + +   ++ +YM NG L   L +R         
Sbjct: 61  RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHA 120

Query: 794 ----CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
                +       + +  A G+ YL        VHRD+   N L+G  +   IADFG+++
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177

Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV--LTGKQP 902
            +  GD+ R          ++A E   + K T  SDV+++GV + E+  L  +QP
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 73.6 bits (180), Expect = 4e-14
 Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 33/222 (14%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           V+G+G  G V +A ++      ++         EY  ++D       RD F+ E++ L  
Sbjct: 2   VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDH------RD-FAGELEVLCK 51

Query: 753 I-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSCLEW 797
           +  H NI+  LG C +R    L  +Y P+G+L   L + R               S L  
Sbjct: 52  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 111

Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
           +         A+G+ YL        +HRD+ A NIL+G  +   IADFGL++    G   
Sbjct: 112 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEV 164

Query: 858 RSSNTVAG-SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
               T+      ++A E       T  SDV+SYGV++ E+++
Sbjct: 165 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 73.1 bits (179), Expect = 6e-14
 Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 32/228 (14%)

Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +   GK   G +Y   M++ +++A+K L       ++               F  E   +
Sbjct: 15  ECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG-------------EFQQEASLM 61

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-----------RDSCLEWEL 799
             + H NIV  LG         ++++Y+  G L   L  R            D  ++  L
Sbjct: 62  AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121

Query: 800 RY----RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
            +     I +  A G+ YL        VH+D+ A NILIG +    I+D GL++ +   D
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           + R          ++ PE     K +  SD++S+GVV+ E+ + G QP
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.0 bits (179), Expect = 6e-14
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 29/215 (13%)

Query: 694 VGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +G+G  G V    Y  E +N GE +AVK L P +              G        EI+
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-------------GNHIADLKKEIE 58

Query: 749 TLGSIRHKNIVRFLGCC---WNRNTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRII 804
            L ++ H+NIV++ G C        +L+M +++P+GSL   L   ++   L+ +L+Y + 
Sbjct: 59  ILRNLYHENIVKYKGICTEDGGNGIKLIM-EFLPSGSLKEYLPRNKNKINLKQQLKYAVQ 117

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTV 863
           +   +G+ YL        VHRD+ A N+L+  E +  I DFGL K +  + ++    + +
Sbjct: 118 I--CKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
                + APE     K    SDV+S+GV + E+LT
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.1 bits (179), Expect = 8e-14
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 33/224 (14%)

Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           + V+G+G  G V RA ++      +K      M  E+  +ND       RD F+ E++ L
Sbjct: 7   EDVIGEGNFGQVIRAMIKKD---GLKMNAAIKMLKEFASENDH------RD-FAGELEVL 56

Query: 751 GSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSCL 795
             +  H NI+  LG C NR    +  +Y P G+L   L + R               S L
Sbjct: 57  CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
             +   +     A G+ YL        +HRD+ A N+L+G      IADFGL++    G+
Sbjct: 117 TSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR----GE 169

Query: 856 FARSSNTVAG-SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
                 T+      ++A E       T KSDV+S+GV++ E+++
Sbjct: 170 EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.5 bits (180), Expect = 9e-14
 Identities = 53/214 (24%), Positives = 102/214 (47%), Gaps = 20/214 (9%)

Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V + + +   +I  +KL    +               +R+    E++ L 
Sbjct: 11  SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP------------AIRNQIIRELQVLH 58

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L E +   +  E+  ++ +   +GL
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGL 116

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           AYL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 117 AYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 170

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.1 bits (179), Expect = 9e-14
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 26/222 (11%)

Query: 690 EDSVVGKGCSGIVYRA----EMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS 744
           +  V+G G  G VY+     E E  ++ +A+K+L   T                      
Sbjct: 11  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-------------ANKEIL 57

Query: 745 AEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS-CLEWELRYRI 803
            E   + S+ + ++ R LG C     +L+    MP G L   + E +D+   ++ L + +
Sbjct: 58  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 116

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
            +  A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +   
Sbjct: 117 QI--AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
                ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.7 bits (178), Expect = 1e-13
 Identities = 78/316 (24%), Positives = 133/316 (42%), Gaps = 74/316 (23%)

Query: 693 VVGKGCSGIVYRAEMENGEV---IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V +A ++   +    A+K++       EY  ++D       RD F+ E++ 
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRM------KEYASKDDH------RD-FAGELEV 60

Query: 750 LGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSC 794
           L  +  H NI+  LG C +R    L  +Y P+G+L   L + R               S 
Sbjct: 61  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK---LV 851
           L  +         A+G+ YL        +HRD+ A NIL+G  +   IADFGL++   + 
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177

Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP-------- 902
           V+    R          ++A E       T  SDV+SYGV++ E+++ G  P        
Sbjct: 178 VKKTMGRL------PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231

Query: 903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
           +   +P+G                L+K L    EV   ++++       C    P +RP+
Sbjct: 232 LYEKLPQGYR--------------LEKPLNCDDEV--YDLMRQ------CWREKPYERPS 269

Query: 963 MKDVAAMIKEIKQERE 978
              +   +  + +ER+
Sbjct: 270 FAQILVSLNRMLEERK 285

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 71.6 bits (175), Expect = 3e-13
 Identities = 76/273 (27%), Positives = 116/273 (42%), Gaps = 50/273 (18%)

Query: 694 VGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY+    ++G + AVK L P               I  V +   AE   L S
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDP---------------ISDVDEEIEAEYNILQS 74

Query: 753 I-RHKNIVRFLGCCWNRNTRL-----LMYDYMPNGSLGSLLHE--RRDSCLEWELRYRII 804
           +  H N+V+F G  +  +  +     L+ +    GS+  L+         L+  +   I+
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
            GA  GL +LH++    I+HRD+K NNIL+  E    + DFG++  +      R  NT  
Sbjct: 135 YGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSV 189

Query: 865 GSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPI--------------DP 905
           G+  ++APE       Y      + DV+S G+  +E+  G  P+              +P
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249

Query: 906 TIPEGLHIVDWVRQKRGAI-EVLDKSLRARPEV 937
             P  LH   W R     I + L K   ARP V
Sbjct: 250 P-PTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 75/292 (25%), Positives = 118/292 (40%), Gaps = 46/292 (15%)

Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           + KG  G V+ A+ ++ G++ A+K +    M  +              D    E   L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRK-----------NQVDQVLTERDILSQ 49

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +   +V+       +    L+ +Y+P G L SLL       L+ ++    I      L 
Sbjct: 50  AQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALE 107

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG------DFARSSNTVAGS 866
           YLH +    I+HRD+K +NILI       + DFGL+K+ +        D  +    + G+
Sbjct: 108 YLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL--HIVDWVRQKRGAI 924
             YIAPE       ++  D +S G ++ E L G  P     PE +  +I+       G I
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL------NGKI 218

Query: 925 EVLDKSLRARPE-VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
           E         PE VE+ +    L   LL  +P    R   K     I+EIK 
Sbjct: 219 E--------WPEDVEVSDEAIDLISKLLVPDPE--KRLGAKS----IEEIKN 256

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.7 bits (174), Expect = 5e-13
 Identities = 53/166 (31%), Positives = 76/166 (45%), Gaps = 26/166 (15%)

Query: 745 AEIKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
            E + L SIRH  +V   G    + N  L+M +Y+P G L S L +           Y  
Sbjct: 50  NEKRILQSIRHPFLVNLYGSFQDDSNLYLVM-EYVPGGELFSHLRKSGRFPEPVARFY-- 106

Query: 804 ILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
              AAQ    L YLH      IV+RD+K  N+L+  +    I DFG AK V    +    
Sbjct: 107 ---AAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY---- 156

Query: 861 NTVAGSYGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            T+ G+  Y+APE     GY     +  D ++ G+++ E+L G  P
Sbjct: 157 -TLCGTPEYLAPEIILSKGY----GKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 14/171 (8%)

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL--- 799
           F  E   + +  H NIV+ LG C     + ++ + M  G L S L + R       L   
Sbjct: 46  FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105

Query: 800 --RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP-----YIADFGLAKLVV 852
                I L  A+G  YL        +HRD+ A N L+  +         I DFGLA+ + 
Sbjct: 106 KELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162

Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           + D+ R          ++APE     K T +SDV+S+GV++ E+LT G+QP
Sbjct: 163 KSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.8 bits (173), Expect = 6e-13
 Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 23/178 (12%)

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+         
Sbjct: 77  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPE 134

Query: 798 -ELRYRIILG----AAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            +L ++ ++      A+G+ YL    C+    HRD+ A N+L+  +    IADFGLA+ +
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDI 190

Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 22/210 (10%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY+  +    EV+A+K +       + +   D+I      +    EI  L  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKII-------DLEEAEDEI------EDIQQEITVLSQ 58

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
                I R+ G         ++ +Y+  GS   LL   +   LE      I+    +GL 
Sbjct: 59  CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLD 115

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH +     +HRDIKA N+L+  + +  +ADFG+A  + +    R  NT  G+  ++AP
Sbjct: 116 YLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP 170

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K+D++S G+  +E+  G+ P
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 73/305 (23%), Positives = 120/305 (39%), Gaps = 56/305 (18%)

Query: 688 LVEDSVVGKGCSGIVYRAEM-----ENGE-VIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           L E + +G+G  G V+ A+      E GE ++ VK L  T    + + Q++         
Sbjct: 7   LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSE--------- 54

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC------- 794
            F  E+     + HKN+VR LG C       ++ +Y   G L   L   +          
Sbjct: 55  -FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 795 LEWELRYRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
           L  + +  +    A G+ +L          VHRD+ A N L+  + E  ++   L+K V 
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168

Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL 911
             ++ +  N +     ++APE       + KSDV+S+GV++ EV T G+ P      E  
Sbjct: 169 NSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-- 225

Query: 912 HIVDWVRQKRGAIEVLD----KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
                        EVL+      L           L  L     C    P DRP+  ++ 
Sbjct: 226 -------------EVLNRLQAGKLELPVPEGCPSRLYKL--MTRCWAVNPKDRPSFSELV 270

Query: 968 AMIKE 972
           + + E
Sbjct: 271 SALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 69.2 bits (170), Expect = 9e-13
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 20/163 (12%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E + L    H  IV+      ++    ++ +Y   G L ++L +R     E+  R+  I 
Sbjct: 43  EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARF-YIA 100

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
                  YLH+     I++RD+K  N+L+       + DFG AK +  G   + + T  G
Sbjct: 101 CVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCG 154

Query: 866 SYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +  Y+APE      Y +        D +S G+++ E+LTG+ P
Sbjct: 155 TPEYVAPEIILNKGYDFS------VDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 9e-13
 Identities = 69/271 (25%), Positives = 107/271 (39%), Gaps = 47/271 (17%)

Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           + KG  G VY A+    G+  A+K L  + M A       K  +  V+    AE   +  
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-------KNQVTNVK----AERAIMMI 52

Query: 753 IRHK-NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 + +      +++   L+ +Y+  G   SL+        +W  +Y  I     G+
Sbjct: 53  QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLGV 110

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
             LH      I+HRDIK  N+LI       + DFGL++  +E      +    G+  Y+A
Sbjct: 111 EDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLA 161

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE    +   + SD +S G V+ E L G  P     P+                V D  L
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---------------AVFDNIL 206

Query: 932 RAR---PEVEIEEMLQTLGV----ALLCVNP 955
             R   PE E++E      V     LLC++P
Sbjct: 207 SRRINWPE-EVKEFCSPEAVDLINRLLCMDP 236

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 68.8 bits (168), Expect = 2e-12
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG VY A ++  G+ +A+K++           Q  K      ++    EI  +  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQ--------QQPK------KELIINEILVMRE 72

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H NIV +L      +   ++ +Y+  GSL  ++ E   +C++      +     Q L 
Sbjct: 73  NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 129

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH + V   +HRDIK++NIL+G +    + DFG    +      RS  T+ G+  ++AP
Sbjct: 130 FLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAP 184

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K D++S G++ +E++ G+ P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.6 bits (167), Expect = 2e-12
 Identities = 52/210 (24%), Positives = 103/210 (49%), Gaps = 23/210 (10%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG V+ A ++  G+ +A+K++         + Q         ++    EI  +  
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQI---------NLQKQP-----KKELIINEILVMKE 72

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +++ NIV FL      +   ++ +Y+  GSL  ++ E   +C++      +     Q L 
Sbjct: 73  LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALE 129

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH +    ++HRDIK++N+L+G +    + DFG    +      RS  T+ G+  ++AP
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAP 184

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K D++S G++ +E++ G+ P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 14/179 (7%)

Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           +R+    E+K L       IV F G  ++     +  ++M  GSL  +L  ++   +   
Sbjct: 42  IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEN 99

Query: 799 LRYRIILGAAQGLAYLH--HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           +  +I +   +GL YL   H     I+HRD+K +NIL+    E  + DFG     V G  
Sbjct: 100 ILGKISIAVLRGLTYLREKHK----IMHRDVKPSNILVNSRGEIKLCDFG-----VSGQL 150

Query: 857 ARS-SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV 914
             S +N+  G+  Y++PE       T +SD++S G+ ++E+  G+ PI P   + L  +
Sbjct: 151 IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 74/273 (27%), Positives = 124/273 (45%), Gaps = 52/273 (19%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G  G VY   + + G  +AVK++       ++D ++ +       ++   EI+ L 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQV-------QFDPESPETS--KEVNALECEIQLLK 59

Query: 752 SIRHKNIVRFLGCCWNRNTRLL--MYDYMPNGSLGSLLHERRDSCLEWELRY-RIILGAA 808
           ++ H+ IV++ GC  +   R L    ++MP GS+   L            +Y R IL   
Sbjct: 60  NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL--- 116

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK----LVVEGDFARSSNTVA 864
           +G++YLH +    IVHRDIK  NIL        + DFG +K    + + G   +S   V 
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS---VT 170

Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-----------------QPIDPTI 907
           G+  +++PE         K+D++S G  V+E+LT K                 QP +P +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVL 230

Query: 908 PEGLHIVDWVRQ--KRGAIEVLDKSLRARPEVE 938
           P   H+ D  R   KR  +E      + RP  +
Sbjct: 231 PP--HVSDHCRDFLKRIFVEA-----KLRPSAD 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.6 bits (173), Expect = 3e-12
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 39/225 (17%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWE 798
           R  F  E      + H NIV  L         L  +++Y+P  +L  +L    D  L   
Sbjct: 22  RARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAA--DGALPAG 79

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKL---VV 852
              R++L     LA  H+     IVHRD+K  NI++   G      + DFG+  L   V 
Sbjct: 80  ETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136

Query: 853 EGDFARSSNT--VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ--------- 901
           + D A  + T  V G+  Y APE      +T  SD+Y++G++ LE LTG++         
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAE 196

Query: 902 -------PIDPTIP---EGLHIVDWVRQKRGAIEVLDKSLRARPE 936
                  P+D ++P    G  +   +R      + L+K  R R  
Sbjct: 197 ILYQQLSPVDVSLPPWIAGHPLGQVLR------KALNKDPRQRAA 235

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 20/209 (9%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A     GEV+A+KK+         D + +     GV  +   EI  L  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETE-----GVPSTAIREISLLKE 55

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     S +   L    +    QGLA
Sbjct: 56  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 115 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 169

Query: 873 EYGYMMKI-TEKSDVYSYGVVVLEVLTGK 900
           E     K  +   D++S G +  E++T +
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 81/265 (30%), Positives = 119/265 (44%), Gaps = 48/265 (18%)

Query: 692 SVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE---I 747
           +V+G+G  G V  AE  + GE+ A+K L             D++      +S   E    
Sbjct: 5   AVLGRGHFGKVLLAEYKKTGELYAIKAL-----KKGDIIARDEV------ESLMCEKRIF 53

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
           +T  S RH  +V    C    +    + +Y   G L  ++H   D   E     R +  A
Sbjct: 54  ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSE----PRAVFYA 107

Query: 808 AQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTV 863
           A    GL YLH +    IV+RD+K +N+L+  E    IADFGL K   EG  F   ++T 
Sbjct: 108 ACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTF 161

Query: 864 AGSYGYIAPEYGYMMKITEKS-----DVYSYGVVVLEVLTGKQPIDPTIPEGLH--IV-D 915
            G+  ++APE      +TE S     D +  GV++ E+L G+ P      E +   IV D
Sbjct: 162 CGTPEFLAPEV-----LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216

Query: 916 WVRQKR----GAIEVLDKSLRARPE 936
            VR  R     AI ++ + LR  PE
Sbjct: 217 EVRYPRFLSREAISIMRRLLRRNPE 241

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 24/214 (11%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+A+ +    +A  K+  T    E +              +  EI+ L + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-------------DYMVEIEILATC 66

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H  IV+ LG  +      +M ++ P G++ +++ E      E +++  I     + L Y
Sbjct: 67  NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQY 125

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           LH      I+HRD+KA N+L+  + +  +ADFG++   V+    R S    G+  ++APE
Sbjct: 126 LHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPE 180

Query: 874 YGY--MMKITE---KSDVYSYGVVVLEVLTGKQP 902
                 MK T    K+D++S G+ ++E+   + P
Sbjct: 181 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 26/242 (10%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC----- 794
           R  F  E   +      ++VR LG        L++ + M +G L S L   R        
Sbjct: 53  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112

Query: 795 -LEWELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                L+  I + A  A G+AYL+       VHRD+ A N ++  +F   I DFG+ + +
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 169

Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEG 910
            E D+ R          ++APE       T  SD++S+GVV+ E+ +  +QP      +G
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY-----QG 224

Query: 911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
           L        ++    V+D     +P+    E +  L    +C    P  RPT  ++  ++
Sbjct: 225 L------SNEQVLKFVMDGGYLDQPD-NCPERVTDL--MRMCWQFNPKMRPTFLEIVNLL 275

Query: 971 KE 972
           K+
Sbjct: 276 KD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 67.7 bits (166), Expect = 5e-12
 Identities = 54/163 (33%), Positives = 79/163 (48%), Gaps = 24/163 (14%)

Query: 695 GKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G+G  G VY+A +++ G V+A+KK+    M  E     D   I  +R     EIK L  +
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKI---LMHNE----KDGFPITALR-----EIKILKKL 64

Query: 754 RHKNIVRFLGCCWNR-----NTRLLMYDYMP--NGSLGSLLHERRDSCLEWELRYRIILG 806
           +H N+V  +     R       R  +Y   P  +  L  LL        E +++   +L 
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC-YMLQ 123

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
             +G+ YLH +    I+HRDIKA NILI  +    IADFGLA+
Sbjct: 124 LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 36/219 (16%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V   +  +  ++ A+K          Y  +   +  G VR+  + E + L 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMK----------YMNKQKCVEKGSVRNVLN-ERRILQ 55

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLG-SLLHERRDSCLEWELRYRIILGA-AQ 809
            + H  +V       +     L+ D +  G L   L  + + S    E + +  +     
Sbjct: 56  ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS----EEQVKFWICEIVL 111

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRDIK +NIL+  +   +I DF +A  V        + + +G+ GY
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGY 165

Query: 870 IAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +APE      Y          D +S GV   E L GK+P
Sbjct: 166 MAPEVLCRQGYSV------AVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 67.3 bits (164), Expect = 7e-12
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 24/214 (11%)

Query: 693 VVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  AE++  GE  AVK L           + D + I    +    E + L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKAL-----------KKDVVLIDDDVECTMVEKRVLA 50

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ-- 809
                  +  L C +     L       NG  G L+   +D    ++L YR    AA+  
Sbjct: 51  LAWENPFLTHLYCTFQTKEHLFFVMEFLNG--GDLMFHIQDKG-RFDL-YRATFYAAEIV 106

Query: 810 -GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
            GL +LH      I++RD+K +N+++  +    IADFG+ K  V GD    ++T  G+  
Sbjct: 107 CGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPD 161

Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           YIAPE    +K T   D +S+GV++ E+L G+ P
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 24/214 (11%)

Query: 693 VVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  AE++   E  A+K L           + D +      +    E + L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKAL-----------KKDVVLEDDDVECTMVERRVLA 50

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ-- 809
                  +  L C +     L       NG  G L+   + S   ++   R    AA+  
Sbjct: 51  LAWEHPFLTHLFCTFQTKEHLFFVMEYLNG--GDLMFHIQ-SSGRFDE-ARARFYAAEII 106

Query: 810 -GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
            GL +LH      I++RD+K +N+L+  +    IADFG+ K  + G+    ++T  G+  
Sbjct: 107 CGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPD 161

Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           YIAPE     K  E  D +S+GV++ E+L G+ P
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 41/226 (18%)

Query: 700 GIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G VY+  +      E  + +A+K L             DK   G +R+ F  E      +
Sbjct: 19  GKVYKGHLFGTAPGEQTQAVAIKTL------------KDKAE-GPLREEFKHEAMMRSRL 65

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSCLEWEL 799
           +H NIV  LG         +++ Y  +  L   L  R                S LE   
Sbjct: 66  QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125

Query: 800 RYRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
              I+   A G+ +L  HH     +VH+D+   N+L+  +    I+D GL + V   D+ 
Sbjct: 126 FVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180

Query: 858 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           +          +++PE     K +  SD++SYGVV+ EV + G QP
Sbjct: 181 KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 59/243 (24%), Positives = 107/243 (44%), Gaps = 34/243 (13%)

Query: 693 VVGKGCSGIVYRAEMENGEV----IAVKKLWPTTMAAEYDCQNDKIGIGGVRD--SFSAE 746
           ++G+G  G V   ++   +     +AVK +              K+ I    +   F +E
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTM--------------KLDIHTYSEIEEFLSE 51

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTR------LLMYDYMPNGSLGSLLHERRDSCLEWELR 800
              +    H N+++ +G C+  ++       +++  +M +G L S L   R   L  +L 
Sbjct: 52  AACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP 111

Query: 801 ----YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
                + ++  A G+ YL +      +HRD+ A N ++  +    +ADFGL+K +  GD+
Sbjct: 112 LQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168

Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
            R          +IA E       T KSDV+++GV + E+ T  Q   P + E   I D+
Sbjct: 169 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDY 227

Query: 917 VRQ 919
           +R 
Sbjct: 228 LRH 230

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.3 bits (161), Expect = 1e-11
 Identities = 53/210 (25%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG VY A ++  G+ +A+K++         + Q         ++    EI  +  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQM---------NLQQQP-----KKELIINEILVMRE 72

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            ++ NIV +L      +   ++ +Y+  GSL  ++ E   +C++      +     Q L 
Sbjct: 73  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALD 129

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH +    ++HRDIK++NIL+G +    + DFG    +      RS  T+ G+  ++AP
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAP 184

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K D++S G++ +E++ G+ P
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 67.3 bits (164), Expect = 1e-11
 Identities = 80/245 (32%), Positives = 122/245 (49%), Gaps = 22/245 (8%)

Query: 344 SIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSL 403
                L N   L ++DL+ N L  ++   L +L NLT L L +N I+  IPP IG   S 
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITD-IPPLIGLLKS- 140

Query: 404 IRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLA 463
                        L+ L+LS+N +  +LPS L +L  L+ LD+S N  +  +P+    L+
Sbjct: 141 ------------NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND-LSDLPKLLSNLS 186

Query: 464 SLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNA 523
           +LN L LS N  S  +P  +    +L+ LDLS+N +  ++   L  ++ L   L LS N 
Sbjct: 187 NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL-SGLELSNNK 243

Query: 524 LSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQ 583
           L   +P  I  L+ L  LDLS+N++   + +L  L NL  L++S N+ +  LP   L   
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPLIALLLL 301

Query: 584 LSATE 588
           L    
Sbjct: 302 LLELL 306

Length = 394

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 15/170 (8%)

Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE-- 796
           VRD    E + +  + +  IVR +G C      L+M +    G L   L  ++D      
Sbjct: 38  VRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVM-EMASGGPLNKFLSGKKDEITVSN 96

Query: 797 -WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
             EL +++    + G+ YL        VHRD+ A N+L+  +    I+DFGL+K +   D
Sbjct: 97  VVELMHQV----SMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Query: 856 FARSSNTVAGSY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
               + + AG +   + APE     K + +SDV+SYG+ + E  + G++P
Sbjct: 150 SYYKARS-AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)

Query: 693 VVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++GKG  G V+ AE++   +  A+K L    +  + D +   +           E + L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMV-----------EKRVLS 50

Query: 752 SIRHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ- 809
                  +  L C +     L  + +Y+  G L  + H +  SC +++L  R    AA+ 
Sbjct: 51  LAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQ--SCHKFDLP-RATFYAAEI 105

Query: 810 --GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
             GL +LH      IV+RD+K +NIL+  +    IADFG+ K  + GD A++  T  G+ 
Sbjct: 106 ICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT-CTFCGTP 160

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            YIAPE     K     D +S+GV++ E+L G+ P
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 64.9 bits (159), Expect = 3e-11
 Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 35/174 (20%)

Query: 683 QVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEY----DCQNDKIGIG 737
           +V+K L      G G  G VY A   E GE++A+KK     M  ++    +C N      
Sbjct: 2   KVIKQL------GDGTFGSVYLARNKETGELVAIKK-----MKKKFYSWEECMN------ 44

Query: 738 GVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
            +R     E+K+L  +  H NIV+        +    +++YM  G+L  L+ +R+     
Sbjct: 45  -LR-----EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS 97

Query: 797 WELRYR-IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
            E   R II    QGLA++H        HRD+K  N+L+       IADFGLA+
Sbjct: 98  -ESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.4 bits (162), Expect = 4e-11
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 33/181 (18%)

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL---VVEGDFARSSNTVAG 865
           Q L  +HH     ++HRDIK+ NIL+       + DFG +K+    V  D  R   T  G
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR---TFCG 207

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE 925
           +  Y+APE       ++K+D++S GV++ E+LT K+P D    E +             E
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD---GENME------------E 252

Query: 926 VLDKSLRAR----PEVEIEEMLQTLGVALLCVNP-------TPDDRPTMKDVAAMIKEIK 974
           V+ K+L  R    P   I   +Q +  ALL  +P          + P  K   + + EI 
Sbjct: 253 VMHKTLAGRYDPLPP-SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIV 311

Query: 975 Q 975
           Q
Sbjct: 312 Q 312

Length = 496

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 64.5 bits (158), Expect = 4e-11
 Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 62/243 (25%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR----DSFSAEI 747
           ++G+G    V  A E E  +  A+K L             DK  +  ++         E 
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKIL-------------DKRQL--IKEKKVKYVKIEK 52

Query: 748 KTLGSI-RHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCL-EWELRYRII 804
           + L  +  H  I++ L   +     L  + +Y PNG L   + +     L E   R+   
Sbjct: 53  EVLTRLNGHPGIIK-LYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFY-- 107

Query: 805 LGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV---------- 851
             AA+    L YLH      I+HRD+K  NIL+  +    I DFG AK++          
Sbjct: 108 --AAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Query: 852 ---------VEGDFARSSNTVAGSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTG 899
                    +E +  R ++ V G+  Y++PE   ++      + SD+++ G ++ ++LTG
Sbjct: 163 GDATNIDSQIEKNRRRFASFV-GTAEYVSPE---LLNEKPAGKSSDLWALGCIIYQMLTG 218

Query: 900 KQP 902
           K P
Sbjct: 219 KPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 56/221 (25%), Positives = 104/221 (47%), Gaps = 38/221 (17%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+A+ +   V+A  K+  T    E +              +  EI  L S 
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE-------------DYMVEIDILASC 59

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H NIV+ L   +  N   ++ ++   G++ +++ E      E ++R  +     + L Y
Sbjct: 60  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNY 118

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA------GSY 867
           LH +    I+HRD+KA NIL   + +  +ADFG++        A+++ T+       G+ 
Sbjct: 119 LHEN---KIIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTP 167

Query: 868 GYIAPEYGYMMKITE------KSDVYSYGVVVLEVLTGKQP 902
            ++APE   M + ++      K+DV+S G+ ++E+   + P
Sbjct: 168 YWMAPEV-VMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 56/289 (19%)

Query: 693 VVGKGCSGIVYRA----EMENGEV-IAVKKLWP-TTMAAEYDCQNDKIGIGGVRDSFSAE 746
           V+G G  G VY+     + EN ++ +A+K L   T+  A  +  ++   + GV   +   
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY--- 70

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEWELRY 801
                      + R LG C     +L+    MP G L   + E +D       L W ++ 
Sbjct: 71  -----------VCRLLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNWCVQ- 117

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL--VVEGDFARS 859
                 A+G++YL       +VHRD+ A N+L+       I DFGLA+L  + E ++   
Sbjct: 118 -----IAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD 169

Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVR 918
              V     ++A E     + T +SDV+SYGV V E++T G +P D              
Sbjct: 170 GGKV--PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI------------ 215

Query: 919 QKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
             R   ++L+K  R  +P +   ++     + + C     + RP  +++
Sbjct: 216 PAREIPDLLEKGERLPQPPICTIDVYM---IMVKCWMIDSECRPRFREL 261

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 63/242 (26%), Positives = 105/242 (43%), Gaps = 26/242 (10%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSC 794
           R  F  E   +      ++VR LG        L++ + M  G L S L   R     +  
Sbjct: 53  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 112

Query: 795 LEWELRYRIILGA---AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                  ++I  A   A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + +
Sbjct: 113 QAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 169

Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEG 910
            E D+ R          +++PE       T  SDV+S+GVV+ E+ T  +QP      +G
Sbjct: 170 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QG 224

Query: 911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
           +     +R       V++  L  +P+    +ML    +  +C    P  RP+  ++ + I
Sbjct: 225 MSNEQVLRF------VMEGGLLDKPD-NCPDML--FELMRMCWQYNPKMRPSFLEIISSI 275

Query: 971 KE 972
           KE
Sbjct: 276 KE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.6 bits (158), Expect = 5e-11
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 39/217 (17%)

Query: 697 GCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH 755
           G  G+VYRA + + GE++A+KKL       + + + +   I  +R     EI  L  ++H
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITSLR-----EINILLKLQH 63

Query: 756 KNIVRF----LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            NIV      +G   N +   ++ +Y+ +  L SL+   +   L+ E++  ++L    G+
Sbjct: 64  PNIVTVKEVVVGS--NLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC-LMLQLLSGV 119

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           A+LH +    I+HRD+K +N+L+       I DFGLA+         +   V  +  Y A
Sbjct: 120 AHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRA 174

Query: 872 PE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQ 901
           PE       Y      +   D++S G +  E+LT K 
Sbjct: 175 PELLLGAKEY------STAIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 6e-11
 Identities = 30/89 (33%), Positives = 49/89 (55%)

Query: 180 VGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSL 239
           +GL +  + G +P  + KL  LQS+++    + G IPP +G+ + L  L L  N  +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 240 PRELGKLQKLEKMLLWQNNFDGAIPEEIG 268
           P  LG+L  L  + L  N+  G +P  +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.1 bits (158), Expect = 6e-11
 Identities = 50/214 (23%), Positives = 101/214 (47%), Gaps = 20/214 (9%)

Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   +I  +KL    +               +R+    E++ L 
Sbjct: 11  SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP------------AIRNQIIRELQVLH 58

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 59  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 116

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 117 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 170

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 64.4 bits (157), Expect = 6e-11
 Identities = 67/232 (28%), Positives = 107/232 (46%), Gaps = 47/232 (20%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIG--IGGVRDSFSAEIK 748
             +G+G  G VY+A + + GE++A+KK+            N+K G  I  +R     EIK
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKV---------RLDNEKEGFPITAIR-----EIK 58

Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL----------LMYDYMPNGSLGSLLHERRDSCLEWE 798
            L  + H+NIV       ++   L          L+++YM +  +G LL        E  
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG-LLESGLVHFSEDH 117

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           ++   +    +GL Y H       +HRDIK +NIL+  + +  +ADFGLA+L    +   
Sbjct: 118 IK-SFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Query: 859 SSNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            +N V   + Y  PE       YG  +      DV+S G ++ E+ T K+PI
Sbjct: 174 YTNKVITLW-YRPPELLLGEERYGPAI------DVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 4/160 (2%)

Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           ++  F  E + L    H NIVR +G C  +    ++ + +  G   + L          E
Sbjct: 36  LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           L  +++  AA G+ YL        +HRD+ A N L+  +    I+DFG+++   +G +A 
Sbjct: 96  L-IQMVENAAAGMEYLESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS 151

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
           +         + APE     + + +SDV+S+G+++ E  +
Sbjct: 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 26/184 (14%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E + L  + H  I+R      ++    ++ +Y+P G L S L           L Y   +
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A  L YLH      IV+RD+K  NIL+  E    + DFG AK + +  +     T+ G
Sbjct: 111 VCA--LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-----TLCG 160

Query: 866 SYGYIAPEYGYMMKITEKS-----DVYSYGVVVLEVLTGKQPIDPTIPEGL------HIV 914
           +  Y+APE      I  K      D ++ G+++ E+L G  P     P G+        +
Sbjct: 161 TPEYLAPEV-----IQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL 215

Query: 915 DWVR 918
           ++ R
Sbjct: 216 EFPR 219

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 64.3 bits (157), Expect = 8e-11
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 30/219 (13%)

Query: 693 VVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  AE++   E+ AVK L       +   Q+D +      +    E + L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVL-----KKDVILQDDDV------ECTMTEKRVLA 50

Query: 752 SIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ- 809
                  +  L  C+    RL  + +Y+  G L  + H +R    +     R    AA+ 
Sbjct: 51  LAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEP---RARFYAAEI 105

Query: 810 --GLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL-VVEGDFARSSNTVAG 865
             GL +LH       I++RD+K +N+L+  E    IADFG+ K  ++ G    +++T  G
Sbjct: 106 VLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTFCG 158

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           +  YIAPE           D ++ GV++ E+L G+ P +
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.5 bits (157), Expect = 8e-11
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 48/224 (21%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY+      G + A+K +        Y    D      VR     EI+ L  
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVI--------YGNHED-----TVRRQICREIEILRD 128

Query: 753 IRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSL--GSLLHERRDSCLEWELRYRIILGAAQ 809
           + H N+V+     ++ N  + ++ ++M  GSL    +  E+  + +      R IL    
Sbjct: 129 VNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQIL---S 179

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+AYLH      IVHRDIK +N+LI       IADFG+++++ +       N+  G+  Y
Sbjct: 180 GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAY 234

Query: 870 IAPEY-----------GYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++PE            GY        D++S GV +LE   G+ P
Sbjct: 235 MSPERINTDLNHGAYDGY------AGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 64.0 bits (155), Expect = 8e-11
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG VY A ++  G+ +A++++         + Q         ++    EI  +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM---------NLQQQP-----KKELIINEILVMRE 73

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            ++ NIV +L      +   ++ +Y+  GSL  ++ E   +C++      +     Q L 
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH +    ++HRDIK++NIL+G +    + DFG    +      RS+  + G+  ++AP
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 185

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K D++S G++ +E++ G+ P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 63.4 bits (154), Expect = 1e-10
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 26/231 (11%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F AE  TLG   H NIVR  G     NT +++ +YM NG+L S L +     +  +L
Sbjct: 50  RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL 109

Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG-LAKLVVEGDFAR 858
              ++ G A G+ YL        VH+ + A+ +L+  +    I+ F  L +   E  +  
Sbjct: 110 -MGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT- 164

Query: 859 SSNTVAGSYG--YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVD 915
              T++G     + APE       +  SDV+S+G+V+ EV++ G++P             
Sbjct: 165 ---TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY------------ 209

Query: 916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           W    +  I+ ++   R         +L  L   L C      +RP    +
Sbjct: 210 WDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL--MLDCWQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 24/224 (10%)

Query: 683 QVLKCLVEDSVVGKGCSGIVYRA-EMENG-EVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           Q  +C+ E   +G+G  G V++A +++NG   +A+K++   T         + + +  +R
Sbjct: 1   QQYECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTIR 50

Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCW----NRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
           +   A ++ L +  H N+VR    C     +R T+L +     +  L + L +  +  + 
Sbjct: 51  EV--AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVP 108

Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
            E    ++    +GL +LH   V   VHRD+K  NIL+    +  +ADFGLA++     F
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY---SF 162

Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
             +  +V  +  Y APE           D++S G +  E+   K
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 76/312 (24%), Positives = 128/312 (41%), Gaps = 65/312 (20%)

Query: 678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           NF +E           +GKG   +VY+A  + +G V+A+KK+    M             
Sbjct: 3   NFKIE---------KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---------- 43

Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRDSCL 795
              R     EI  L  + H N++++L      N   ++ +    G L  ++ H ++   L
Sbjct: 44  -KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL 102

Query: 796 -----EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
                 W+   ++       L ++H      I+HRDIK  N+ I       + D GL + 
Sbjct: 103 IPERTIWKYFVQL----CSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF 155

Query: 851 VVEGDFARSSNTVA-----GSYGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQ 901
                   SS T A     G+  Y++PE     GY      KSD++S G ++ E+   + 
Sbjct: 156 F-------SSKTTAAHSLVGTPYYMSPERIHENGYNF----KSDIWSLGCLLYEMAALQS 204

Query: 902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP 961
           P      + +++   + +K   IE  D      P     E L+ L V+  C+NP P+ RP
Sbjct: 205 PFY---GDKMNLYS-LCKK---IEKCDYP--PLPADHYSEELRDL-VS-RCINPDPEKRP 253

Query: 962 TMKDVAAMIKEI 973
            +  V  + KE+
Sbjct: 254 DISYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 35/219 (15%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVK--KLWPTTMAAEYDCQNDKIGIGGVRDSFS---AEI 747
           VG G  G VY+A  +  GE+ AVK  KL P                    D FS    EI
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPG-------------------DDFSLIQQEI 57

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
             +   +H NIV + G   +R    +  +Y   GSL  + H       E ++ Y +    
Sbjct: 58  FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAY-VCRET 115

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            QGLAYLH       +HRDIK  NIL+    +  +ADFG+A  +      R S    G+ 
Sbjct: 116 LQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTP 170

Query: 868 GYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPI 903
            ++APE   + K     +  D+++ G+  +E+   + P+
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 2e-10
 Identities = 32/72 (44%), Positives = 46/72 (63%)

Query: 261 GAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATS 320
           G IP +I   + L++I+LS N   G++P S G+++SLE L LS N+ +GSIP  L   TS
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 321 LLQLQLDTNQIS 332
           L  L L+ N +S
Sbjct: 492 LRILNLNGNSLS 503

Length = 623

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.0 bits (153), Expect = 3e-10
 Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 32/234 (13%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIV-YRAEMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q++N T+ +V     +   VG G  G V    +   G  +A+KKL+          Q++ 
Sbjct: 4   QEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-------QSEL 56

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDY---MP--NGSLGSLL- 787
                 R     E++ L  ++H+N++  L       +    +D+   MP     LG L+ 
Sbjct: 57  FAKRAYR-----ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK 111

Query: 788 HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL 847
           HE+        L Y+++    +GL Y+H      I+HRD+K  N+ +  + E  I DFGL
Sbjct: 112 HEKLSEDRIQFLVYQML----KGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 164

Query: 848 AKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           A+   + D   +   V  +  Y APE     M  T+  D++S G ++ E+LTGK
Sbjct: 165 AR---QTDSEMTGYVV--TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 53/210 (25%), Positives = 95/210 (45%), Gaps = 22/210 (10%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G V++  +    +V+A+K +       + +   D+I      +    EI  L  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKII-------DLEEAEDEI------EDIQQEITVLSQ 58

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
                + ++ G         ++ +Y+  GS   LL        +     + IL   +GL 
Sbjct: 59  CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLD 115

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH +     +HRDIKA N+L+  + +  +ADFG+A  + +    R  NT  G+  ++AP
Sbjct: 116 YLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP 170

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K+D++S G+  +E+  G+ P
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 4e-10
 Identities = 57/190 (30%), Positives = 91/190 (47%), Gaps = 30/190 (15%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKL-WPTTMAAEYDCQNDKIGIGGVRDSFSAEI---K 748
           +G+G  G VY+A ++  G  +A+KK+  P +         + I +  +R     EI   K
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLS--------EEGIPLSTLR-----EIALLK 53

Query: 749 TLGSIRHKNIVRFLGCCWN-RNTR----LLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
            L S  H NIVR L  C   R  R     L+++++ +  L + L +     L  E    +
Sbjct: 54  QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDL 112

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           +    +G+ +LH      IVHRD+K  NIL+  + +  IADFGLA++     F  +  +V
Sbjct: 113 MRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSV 166

Query: 864 AGSYGYIAPE 873
             +  Y APE
Sbjct: 167 VVTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 26/217 (11%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           VVG+G  G+V +    E  E++A+KK              D      V+++   E+K L 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKF------------KDSEENEEVKETTLRELKMLR 55

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR---YRIILGAA 808
           +++ +NIV        R    L+++Y+    L  LL E  +     ++R   Y++I    
Sbjct: 56  TLKQENIVELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLI---- 110

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
           + + + H +    IVHRDIK  N+LI       + DFG A+ + EG  A  +  VA  + 
Sbjct: 111 KAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW- 166

Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           Y +PE        +  D++S G ++ E+  G QP+ P
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCILGELSDG-QPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.0 bits (151), Expect = 5e-10
 Identities = 49/234 (20%), Positives = 91/234 (38%), Gaps = 49/234 (20%)

Query: 691 DSVVGKGCSGI----VYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS-- 744
            +++GK    +    + + +     ++AVKK          +  +        ++     
Sbjct: 3   LTLIGKCFEDLMIVHLAKHK-PTNTLVAVKK---------INLDSC------SKEDLKLL 46

Query: 745 -AEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
             EI T   ++H NI+ ++      +   ++   M  GS   LL       L  EL    
Sbjct: 47  QQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAF 105

Query: 804 IL-GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-------- 854
           IL      L Y+H       +HR +KA++IL+  + +  ++    +  +++         
Sbjct: 106 ILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162

Query: 855 DFARSSNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           DF +SS        +++PE       GY     EKSD+YS G+   E+  G  P
Sbjct: 163 DFPKSSVKN---LPWLSPEVLQQNLQGY----NEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 61.2 bits (148), Expect = 6e-10
 Identities = 67/275 (24%), Positives = 123/275 (44%), Gaps = 38/275 (13%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G V++  +    +V+A+K +       + +   D+I      +    EI  L  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKII-------DLEEAEDEI------EDIQQEITVLSQ 58

Query: 753 IRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                + ++ G  + ++T+L ++ +Y+  GS   LL        +     R IL   +GL
Sbjct: 59  CDSPYVTKYYGS-YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGL 114

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH +     +HRDIKA N+L+    E  +ADFG+A  + +    R  NT  G+  ++A
Sbjct: 115 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMA 169

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE         K+D++S G+  +E+  G+ P     P  + ++  + +          +L
Sbjct: 170 PEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--MKVLFLIPKNN------PPTL 221

Query: 932 RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                  ++E ++       C+N  P  RPT K++
Sbjct: 222 EGNYSKPLKEFVEA------CLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 60.7 bits (147), Expect = 6e-10
 Identities = 64/290 (22%), Positives = 119/290 (41%), Gaps = 46/290 (15%)

Query: 694 VGKGCSGIVYRAEMENGEVIA---VKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  G V   E   G   A   VK+L  +    E             +  F  E++  
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE-------------QLLFLQEVQPY 49

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-----HERRDSCLEWELRYRIIL 805
             + H N+++ LG C      LL+ ++ P G L + L        + +  + ++  R+  
Sbjct: 50  RELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA--QKDVLQRMAC 107

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A GL +LH       +H D+   N  +  +    I D+GLA      D+  + +  A 
Sbjct: 108 EVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164

Query: 866 SYGYIAPEYG-------YMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV 917
              ++APE              T+KS+++S GV + E+ T   QP  P + +   ++  V
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSD-EQVLKQV 222

Query: 918 RQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                   V ++ ++  +P+++++   +   V   C    P+ RPT ++V
Sbjct: 223 --------VREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 7e-10
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 52/235 (22%)

Query: 694 VGKGCSGIVYRAEMEN---GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G+G  G VY+A+ +N   G+  A+KK              DK    G+  S   EI  L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKG-----------DKEQYTGISQSACREIALL 56

Query: 751 GSIRHKNIVRFLGCCWNRNTRL--LMYDYMPNGSLGSLLHERRDSCLEW-------ELRY 801
             ++H+N+V  +        +   L++DY  +  L  ++   R +            L +
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVE--GD 855
           +I+     G+ YLH +    ++HRD+K  NIL+  E        I D GLA+L       
Sbjct: 116 QIL----NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 856 FARSSNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            A   + V  +  Y APE       Y      T+  D+++ G +  E+LT + PI
Sbjct: 169 LA-DLDPVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLE-PI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G V++A   E  E++A+K++         D  ++     GV  S   EI  L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDE-----GVPSSALREICLLKE 55

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC---LEWELRYRIILGAAQ 809
           ++HKNIVR      +     L+++Y         L +  DSC   ++ E+    +    +
Sbjct: 56  LKHKNIVRLYDVLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLK 110

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           GLA+ H   V   +HRD+K  N+LI    E  +ADFGLA+    G   R  +    +  Y
Sbjct: 111 GLAFCHSHNV---LHRDLKPQNLLINKNGELKLADFGLARAF--GIPVRCYSAEVVTLWY 165

Query: 870 IAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDP 905
             P+  +  K+   S D++S G +  E+    +P+ P
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 9e-10
 Identities = 51/162 (31%), Positives = 78/162 (48%), Gaps = 27/162 (16%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A +   GE++A+KK+    +  E +         GV  +   EI  L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDE---------GVPSTAIREISLLKE 54

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG----AA 808
           + H NIVR L    + N   L++++     L   L +  DS     L   +I        
Sbjct: 55  LNHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109

Query: 809 QGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           QG+AY H H     ++HRD+K  N+LI  E    +ADFGLA+
Sbjct: 110 QGIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 45/168 (26%), Positives = 82/168 (48%), Gaps = 12/168 (7%)

Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE-- 796
           ++D    E   +  + +  IVR +G C   +  L+M +    G L   L + +    +  
Sbjct: 39  LKDELLREANVMQQLDNPYIVRMIGICEAESWMLVM-ELAELGPLNKFLQKNKHVTEKNI 97

Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGD 855
            EL +++    + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  + +
Sbjct: 98  TELVHQV----SMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150

Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           + ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 48/231 (20%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIG--IGGVRDSFSAEIKTL 750
           +G+G  G V++A   +  +++A+KK+    M      +N+K G  I  +R     EIK L
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKV---LM------ENEKEGFPITALR-----EIKIL 65

Query: 751 GSIRHKNIVRFLGCCWN--------RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
             ++H+N+V  +  C          + +  L++++  +  L  LL  +       E++ +
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIK-K 123

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV---EGDFARS 859
           ++     GL Y+H +    I+HRD+KA NILI  +    +ADFGLA+           R 
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 860 SNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +N V   + Y  PE       YG         D++  G ++ E+ T + PI
Sbjct: 181 TNRVVTLW-YRPPELLLGERDYG------PPIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 66/297 (22%), Positives = 124/297 (41%), Gaps = 46/297 (15%)

Query: 693 VVGKGCSGIVYRA--EMENG--EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           ++GKG  G V  A  + E+G  + +AVK L      A+    +D        + F  E  
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKML-----KADIFSSSDI-------EEFLREAA 53

Query: 749 TLGSIRHKNIVRFLGCCWNRNTR------LLMYDYMPNGSLGSLLHERRDS----CLEWE 798
            +    H N+++ +G       +      +++  +M +G L + L   R       L  +
Sbjct: 54  CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQ 113

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
              R ++  A G+ YL        +HRD+ A N ++       +ADFGL+K +  GD+ R
Sbjct: 114 TLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR 918
                     ++A E       T  SDV+++GV + E++T  Q     + E   I +++ 
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-ENSEIYNYL- 228

Query: 919 QKRGAIEVLDKSLRARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  +    L+  P+   ++ E++        C +P P  RP+ + +   ++ I
Sbjct: 229 -------IKGNRLKQPPDCLEDVYELMCQ------CWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.4 bits (149), Expect = 2e-09
 Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 18/158 (11%)

Query: 492 LDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGD 551
           L L +  L G IP ++ ++  L  S+NLS N++ G IPP + ++  L +LDLS+N   G 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 552 LLA-LSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEM--AGNQGLCS-RGHESCFLSN 607
           +   L  L +L  LN++ N+ +G +P +   R L         N GLC   G  +C    
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC---- 537

Query: 608 ATTVGMGNGGGFRKSEKLKIAIALLVTFTIALAIFGAF 645
                   G       K+ IA  + V F + L I    
Sbjct: 538 --------GPHLSVGAKIGIAFGVSVAF-LFLVICAMC 566

Length = 623

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 60.4 bits (147), Expect = 2e-09
 Identities = 70/288 (24%), Positives = 96/288 (33%), Gaps = 71/288 (24%)

Query: 241 RELGKLQKLEKMLLWQNNFDG----AIPEEIGNCKSLKTIDLSLNF------FSGSLPQS 290
             L KL  L+ + L  N        A+   +    SLK + LSLN          SL Q 
Sbjct: 17  ELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQG 76

Query: 291 FGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQ-LDTNQISVFFAWQNKLEGSIPSTL 349
                 L+EL LS+N +      VL +      LQ L  N         N L       L
Sbjct: 77  LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLN--------NNGLGDRGLRLL 128

Query: 350 A-----NCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI 404
           A        +LE + L  N L          L       L +N                 
Sbjct: 129 AKGLKDLPPALEKLVLGRNRLE---GASCEALAK----ALRANR---------------- 165

Query: 405 RLRLMSFGNCTQLQMLNLSNNTLGG----TLPSSLASLTRLQVLDISVNQF----VGLIP 456
                       L+ LNL+NN +G      L   L +   L+VLD++ N         + 
Sbjct: 166 -----------DLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALA 214

Query: 457 ESFGQLASLNRLILSKNSFSGAI-----PSSLGRCESLQSLDLSSNKL 499
           E+   L SL  L L  N+ + A       + L    SL +L LS N +
Sbjct: 215 ETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 33/97 (34%), Positives = 55/97 (56%), Gaps = 5/97 (5%)

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
           A GL +LH      I++RD+K +N+++  E    IADFG+ K  + G   +++ T  G+ 
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTP 165

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
            YIAPE        +  D +++GV++ E+L G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.2 bits (148), Expect = 2e-09
 Identities = 65/262 (24%), Positives = 115/262 (43%), Gaps = 46/262 (17%)

Query: 745 AEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL---EWE--- 798
           +E+  L +  H  IV+      + +  LL+ +Y   G L   + +R    L   E+E   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           L Y+I+L     L  +H      ++HRD+K+ NI + P     + DFG +K   +     
Sbjct: 174 LFYQIVLA----LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID-PTIPEGLHIVDWV 917
            +++  G+  Y+APE     + ++K+D++S GV++ E+LT  +P   P+           
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----------- 275

Query: 918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT---------MKDVAA 968
            Q+    +VL       P   +   ++ L   LL  NP    RPT         +K VA 
Sbjct: 276 -QREIMQQVLYGKYDPFP-CPVSSGMKALLDPLLSKNPA--LRPTTQQLLHTEFLKYVAN 331

Query: 969 MIKEI--------KQEREECMK 982
           + ++I          +REE ++
Sbjct: 332 LFQDIVRHSETISPHDREEILR 353

Length = 478

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.2 bits (147), Expect = 2e-09
 Identities = 60/237 (25%), Positives = 95/237 (40%), Gaps = 66/237 (27%)

Query: 692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA----- 745
             +G G  G+V  A  +  G  +A+KK+                      D   A     
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-----------------DDLIDAKRILR 48

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLL----------MY---DYMPNGSLGSLLHERRD 792
           EIK L  +RH+NI+  L         +L          +Y   + M    L  ++   + 
Sbjct: 49  EIKLLRHLRHENIIGLL--------DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP 99

Query: 793 SCLEWE----LRYRIILGAAQGLAYLH--HDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             L  +      Y+I+ G    L YLH  +     ++HRD+K +NIL+    +  I DFG
Sbjct: 100 --LTDDHIQYFLYQILRG----LKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFG 148

Query: 847 LAKLVVEGDFARSSNT--VAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGK 900
           LA+ V   +  +   T  V   + Y APE      + T+  D++S G +  E+LT K
Sbjct: 149 LARGVDPDEDEKGFLTEYVVTRW-YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A E   G+ +AVKK+         D +  +      R+    E+  +  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 75

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
             H+N+V         +   ++ +++  G+L  ++   R   +  E    + L   + L+
Sbjct: 76  YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALS 132

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH+  V   +HRDIK+++IL+  +    ++DFG    V +    R S  + G+  ++AP
Sbjct: 133 YLHNQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAP 187

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +    + D++S G++V+E++ G+ P
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 34/224 (15%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G V++    +NG   AVK L P               I  + +   AE   L +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDP---------------IHDIDEEIEAEYNILKA 70

Query: 753 IR-HKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGSLLHE--RRDSCLEWELRYRII 804
           +  H N+V+F G  + ++ +      L+ +    GS+  L+    +R   +E  +   I+
Sbjct: 71  LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
             A  GL +LH +     +HRD+K NNIL+  E    + DFG++  +      R  NT  
Sbjct: 131 HEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR--NTSV 185

Query: 865 GSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           G+  ++APE              + DV+S G+  +E+  G  P+
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 53/200 (26%)

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
           +I +   + L YLH      ++HRD+K +N+LI    +  + DFG++  +V+   A++ +
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-SVAKTID 163

Query: 862 TVAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQPID--------- 904
             AG   Y+APE         GY +    KSDV+S G+ ++E+ TG+ P D         
Sbjct: 164 --AGCKPYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYDSWKTPFQQL 217

Query: 905 --------PTIPEG---LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCV 953
                   P +P         D+V +       L K+ + RP     E+LQ     L   
Sbjct: 218 KQVVEEPSPQLPAEKFSPEFQDFVNK------CLKKNYKERP--NYPELLQHPFFEL--- 266

Query: 954 NPTPDDRPTMKDVAAMIKEI 973
                      DVA+ +  I
Sbjct: 267 -----HLSKNTDVASFVSLI 281

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 53/238 (22%)

Query: 688 LVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           LVE  VVG G  G VY+   ++ G++ A+K +         D   D+       +    E
Sbjct: 20  LVE--VVGNGTYGQVYKGRHVKTGQLAAIKVM---------DVTEDE------EEEIKLE 62

Query: 747 IKTLGSI-RHKNIVRFLGC------CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           I  L     H+NI  + G         + +   L+ ++   GS+  L+   + + L+ + 
Sbjct: 63  INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122

Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              I     +GLA+LH      ++HRDIK  N+L+    E  + DFG     V     R+
Sbjct: 123 IAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFG-----VSAQLDRT 174

Query: 860 ---SNTVAGSYGYIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               NT  G+  ++APE           Y Y      +SD++S G+  +E+  G  P+
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDY------RSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 51/210 (24%), Positives = 98/210 (46%), Gaps = 23/210 (10%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A E  +G  +AVK +         D +  +      R+    E+  +  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM---------DLRKQQ-----RRELLFNEVVIMRD 74

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H+N+V             ++ +++  G+L  ++ + R   L  E    +     Q L 
Sbjct: 75  YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQALC 131

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH   V   +HRDIK+++IL+  +    ++DFG    + + D  +  + V   Y ++AP
Sbjct: 132 YLHSQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRKSLVGTPY-WMAP 186

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         + D++S G++V+E++ G+ P
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 18/166 (10%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR------DSCLEWEL 799
           E+  L  ++H NIV F           ++ +Y   G L   ++ +R      D  L W  
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW-- 106

Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKLVVEGDFAR 858
                +  + GL ++H      I+HRDIK+ NI +        + DFG+A+ +   D   
Sbjct: 107 ----FVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSME 157

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
            + T  G+  Y++PE         K+D++S G V+ E+ T K P +
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 59.6 bits (144), Expect = 3e-09
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 28/219 (12%)

Query: 692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+GKG  G V  AE +   E+ A+K L    +  + D +   +           E + L
Sbjct: 6   MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV-----------EKRVL 54

Query: 751 GSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
                   +  L  C+    RL  + +Y+  G L  + H ++    +     + +  AA+
Sbjct: 55  ALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFK---EPQAVFYAAE 109

Query: 810 ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTVAG 865
              GL +LH      I++RD+K +N+++  E    IADFG+ K  +V+G   R   T  G
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR---TFCG 163

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           +  YIAPE        +  D ++YGV++ E+L G+ P D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 25/172 (14%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR------DS 793
           R+    E+  L +++H NIV++           ++ DY   G L   ++ +R      D 
Sbjct: 43  REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ 102

Query: 794 CLEWELRYRIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV- 851
            L+W ++          LA  H HD    I+HRDIK+ NI +  +    + DFG+A+++ 
Sbjct: 103 ILDWFVQI--------CLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152

Query: 852 --VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ 901
             VE   AR   T  G+  Y++PE         KSD+++ G V+ E+ T K 
Sbjct: 153 STVE--LAR---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 26/217 (11%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  A + E+G + AVK L    +      Q+D +      +    E + L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-----LQDDDV------ECTMTEKRILS 50

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ-- 809
             R+   +  L CC+    RL       NG  G L+   + S    E R R    AA+  
Sbjct: 51  LARNHPFLTQLYCCFQTPDRLFFVMEFVNG--GDLMFHIQKSRRFDEARARFY--AAEIT 106

Query: 810 -GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF-ARSSNTVAGSY 867
             L +LH      I++RD+K +N+L+  E    +ADFG+ K   EG F  ++++T  G+ 
Sbjct: 107 SALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTP 160

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
            YIAPE    M      D ++ GV++ E+L G  P +
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.0 bits (143), Expect = 4e-09
 Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 30/224 (13%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+GKG  G+V  A +   GE +A+KK+        ++  +D   I  +R     EIK L
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-----FEHVSDATRI--LR-----EIKLL 53

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE--RRDSCLEWELRYRIILGAA 808
             +RH +IV         + R     Y+    + S LH+  + +  L  E     +    
Sbjct: 54  RLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL 113

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV----- 863
           + L Y+H   V    HRD+K  NIL   + +  I DFGLA++     F  +   +     
Sbjct: 114 RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVA----FNDTPTAIFWTDY 166

Query: 864 AGSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
             +  Y APE    +  K T   D++S G +  EVLTGK P+ P
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP 209

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 58.4 bits (141), Expect = 5e-09
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY+A +  +G  +A+K +   T         D + +  VR+   A +K L +
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQT-------NEDGLPLSTVREV--ALLKRLEA 58

Query: 753 IRHKNIVRFLGCC----WNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
             H NIVR +  C     +R T++ L+++++ +  L + L +     L  E    ++   
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF 117

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            +GL +LH +C   IVHRD+K  NIL+    +  +ADFGLA++        +   V  + 
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTL 171

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            Y APE           D++S G +  E+   K
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 50/210 (23%), Positives = 104/210 (49%), Gaps = 23/210 (10%)

Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A +++ G+++AVKK+         D +  +      R+    E+  +  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 73

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H+N+V         +   ++ +++  G+L  ++   R   +  E    + L   + L+
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLKALS 130

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
            LH   V   +HRDIK+++IL+  +    ++DFG    V + +  R  + V   Y ++AP
Sbjct: 131 VLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPY-WMAP 185

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +    + D++S G++V+E++ G+ P
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 58.2 bits (140), Expect = 5e-09
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 41/232 (17%)

Query: 688 LVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           LVE  +VG G  G VY+   ++ G++ A+K +         D   D+       +    E
Sbjct: 10  LVE--LVGNGTYGQVYKGRHVKTGQLAAIKVM---------DVTGDE------EEEIKQE 52

Query: 747 IKTLGSI-RHKNIVRFLGCCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           I  L     H+NI  + G    +N         L+ ++   GS+  L+   + + L+ E 
Sbjct: 53  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 112

Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              I     +GL++LH      ++HRDIK  N+L+    E  + DFG++  +      R 
Sbjct: 113 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR- 168

Query: 860 SNTVAGSYGYIAPEYGYMMKITE--------KSDVYSYGVVVLEVLTGKQPI 903
            NT  G+  ++APE   ++   E        KSD++S G+  +E+  G  P+
Sbjct: 169 -NTFIGTPYWMAPE---VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 59.2 bits (143), Expect = 6e-09
 Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 14/199 (7%)

Query: 383 LLISNGISGLIPPEIGNCSSLIRLR---------LMSFGNCTQLQMLNLSNNTLGGTLPS 433
           L +S+    L+P  +    SL  L            +  N   L  L+L+ N L     S
Sbjct: 52  LNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRS-NIS 110

Query: 434 SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLD 493
            L  LT L  LD+  N    + P      ++L  L LS N    ++PS L    +L++LD
Sbjct: 111 ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169

Query: 494 LSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL 553
           LS N LS  +P  L  +  L+ +L+LS N +S  +PP+I  L+ L  LDLS+N +   L 
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLN-NLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLS 226

Query: 554 ALSGLDNLVSLNVSYNNFT 572
           +LS L NL  L +S N   
Sbjct: 227 SLSNLKNLSGLELSNNKLE 245

Length = 394

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.7 bits (142), Expect = 6e-09
 Identities = 39/129 (30%), Positives = 59/129 (45%), Gaps = 10/129 (7%)

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL-VVEGDFARSSNTVAGSY 867
           +GL YLH      I+HRD+K  NI I    +  I D G A+  VV   F      +AG+ 
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLAGTV 220

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVL 927
              APE     K   K+D++S G+V+ E+L     I    P      ++V+     +  +
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE--EYVKSCHSHLLKI 278

Query: 928 DKSLRARPE 936
             +L+  PE
Sbjct: 279 ISTLKVHPE 287

Length = 357

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 58.3 bits (141), Expect = 7e-09
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 39/227 (17%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKL---WPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           VG G  G+V  A +   G+ +A+KK+   + T + A              + ++  E+K 
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLA--------------KRTYR-ELKL 62

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           L  +RH+NI+       +    +     +    L  LL  R    LE +     +    +
Sbjct: 63  LKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP---LEKQFIQYFLYQILR 119

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           GL Y+H   V   VHRD+K +NILI    +  I DFGLA++       + +  V+  Y Y
Sbjct: 120 GLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRY-Y 171

Query: 870 IAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI 913
            APE   M+   K   + D++S G +  E+L GK    P  P   H+
Sbjct: 172 RAPE--IMLTWQKYDVEVDIWSAGCIFAEMLEGK----PLFPGKDHV 212

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 7e-09
 Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 18/157 (11%)

Query: 823 VHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT 881
           +HRD+ A NIL+       I DFGLA+ +  + D+ R  +       ++APE  +    T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPESIFDKVYT 253

Query: 882 EKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEI 939
            +SDV+S+GV++ E+ + G  P       G+ I +   ++      L +  R R PE   
Sbjct: 254 TQSDVWSFGVLLWEIFSLGASPY-----PGVQIDEEFCRR------LKEGTRMRAPEYAT 302

Query: 940 EEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
            E+   +   L C +  P+DRPT  ++  ++ ++ QE
Sbjct: 303 PEIYSIM---LDCWHNNPEDRPTFSELVEILGDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.4 bits (138), Expect = 8e-09
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 25/214 (11%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY+A  +  GE+ A+K +              K+  G        EI  +  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVI--------------KLEPGEDFAVVQQEIIMMKD 62

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H NIV + G    R+   +  ++   GSL  + H       E ++ Y +     QGL 
Sbjct: 63  CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAY-VSRETLQGLY 120

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH       +HRDIK  NIL+       +ADFG++   +    A+  + +   Y ++AP
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQ-ITATIAKRKSFIGTPY-WMAP 175

Query: 873 EYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPI 903
           E   + +     +  D+++ G+  +E+   + P+
Sbjct: 176 EVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.6 bits (139), Expect = 9e-09
 Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 45/229 (19%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY+      G  +A+K++       E D              F+  I  L  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI-----RLELD-----------ESKFNQIIMEL-D 51

Query: 753 IRHK----NIVRFLGCCWNRNTRLLMYDYMPNGSL-----GSLLHERRDSCLEWELRYRI 803
           I HK     IV F G  +      +  +YM  GSL     G +  E     +   + Y +
Sbjct: 52  ILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS-SNT 862
           +    +GL +L  +    I+HRD+K  N+L+    +  + DFG     V G+   S + T
Sbjct: 112 V----KGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFG-----VSGNLVASLAKT 160

Query: 863 VAGSYGYIAPEY---GYMMKI---TEKSDVYSYGVVVLEVLTGKQPIDP 905
             G   Y+APE    G   +    T +SDV+S G+ +LE+  G+ P  P
Sbjct: 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 58.7 bits (142), Expect = 1e-08
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 10/99 (10%)

Query: 300 LMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVD 359
           L L N  + G IP  +S    L  + L  N I           G+IP +L +  SLE +D
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSI----------RGNIPPSLGSITSLEVLD 472

Query: 360 LSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIG 398
           LS+N+  GS+   L QL +L  L L  N +SG +P  +G
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 58.1 bits (140), Expect = 1e-08
 Identities = 90/269 (33%), Positives = 130/269 (48%), Gaps = 27/269 (10%)

Query: 191 LPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLE 250
           LP+SL +L  L  LS  + + S +    + N   L  L L  N L  ++  EL +L  L 
Sbjct: 62  LPSSLSRLLSLDLLSP-SGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLT 119

Query: 251 KMLLWQNNFDGAIPEEIGN-CKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
            + L  NN    IP  IG    +LK +DLS N    SLP    NL +L+ L LS N++S 
Sbjct: 120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176

Query: 310 SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSL 369
            +P +LSN ++L  L L  N+IS            +P  +    +LE +DLS+N++   L
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-----------DLPPEIELLSALEELDLSNNSII-EL 224

Query: 370 HPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLM--------SFGNCTQLQMLN 421
              L  L+NL+ L L +N +  L    IGN S+L  L L         S G+ T L+ L+
Sbjct: 225 LSSLSNLKNLSGLELSNNKLEDLPES-IGNLSNLETLDLSNNQISSISSLGSLTNLRELD 283

Query: 422 LSNNTLGGTLPSSLASLTRLQVLDISVNQ 450
           LS N+L   LP     L  L++L   +  
Sbjct: 284 LSGNSLSNALPLIALLLLLLELLLNLLLT 312

Length = 394

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 24/216 (11%)

Query: 693 VVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  AE++   EV A+K L       +   Q+D +      D    E + L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVL-----KKDVILQDDDV------DCTMTEKRILA 50

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ-- 809
                  +  L CC+    RL       NG  G L+ + + S    E R R    AA+  
Sbjct: 51  LAAKHPFLTALHCCFQTKDRLFFVMEYVNG--GDLMFQIQRSRKFDEPRSRFY--AAEVT 106

Query: 810 -GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             L +LH   V   ++RD+K +NIL+  E    +ADFG+ K  +      ++ T  G+  
Sbjct: 107 LALMFLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPD 161

Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           YIAPE    ++     D ++ GV++ E++ G+ P +
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 11/177 (6%)

Query: 732 DKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL----LMYDYMPNGSLGSLL 787
              G   + D    EIK L  I   NI++  G   +    L    L+ +Y   G L  +L
Sbjct: 54  FHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL 113

Query: 788 HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL 847
            + +D  L ++ +  + +   +GL  L+     P  ++++ + + L+   ++  I   GL
Sbjct: 114 DKEKD--LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGL 169

Query: 848 AKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
            K++    F   +  V  SY  +   +    + T K D+YS GVV+ E+ TGK P +
Sbjct: 170 EKILSSPPFKNVNFMVYFSYKMLNDIFS---EYTIKDDIYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 24/161 (14%)

Query: 802 RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           R +  AA+   GL  LH +    IV+RD+K  NIL+       I+D GLA  + EG+  R
Sbjct: 103 RAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR 918
                 G+ GY+APE     + T   D +  G ++ E++ GK P               R
Sbjct: 160 GR---VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ------------R 204

Query: 919 QKRGAIEVLDKSLRARPEVEIE---EMLQTLGVALLCVNPT 956
           +++   E +++ ++   E   E   E  +++   LL  +P 
Sbjct: 205 KEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPG 245

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.0 bits (137), Expect = 2e-08
 Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 30/220 (13%)

Query: 693 VVGKGCSGIVYRAEMENGE-VIAVKKL--WPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V   +++N + V A+K L  W     AE  C             F  E   
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-------------FREERDV 54

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI--ILGA 807
           L +  ++ I        + N   L+ DY   G L +LL +  D   E   R+ +  ++ A
Sbjct: 55  LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA 114

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
              +  LH+      VHRDIK +NIL+       +ADFG    ++E    +SS  V G+ 
Sbjct: 115 IDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTP 167

Query: 868 GYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQP 902
            YI+PE    M     K   + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 2e-08
 Identities = 54/222 (24%), Positives = 95/222 (42%), Gaps = 32/222 (14%)

Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           VG+G  G V+ A+ ++ GE++A+K++  + +      + +++           E   L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEV------RHVLTERDILTT 57

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII-----LGA 807
            + + +V+ L    +     L  +Y+P G   +LL+       E   R+ +      + A
Sbjct: 58  TKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDA 116

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
              L Y         +HRD+K  N LI       + DFGL+K +V       +N+V GS 
Sbjct: 117 LHELGY---------IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSP 162

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE 909
            Y+APE           D +S G ++ E L G  P   + P 
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 25/173 (14%)

Query: 808 AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAG 865
           A+G+ +L    C+    HRD+ A NIL+       I DFGLA+ + +  D+ R  +    
Sbjct: 189 AKGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV--RQKRG 922
              ++APE  +    T +SDV+S+GV++ E+ + G  P       G+ I +    R K G
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEG 298

Query: 923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
                   +RA P+    EM QT+   L C +  P  RPT  ++   +  + Q
Sbjct: 299 T------RMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 341

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 3e-08
 Identities = 83/324 (25%), Positives = 126/324 (38%), Gaps = 86/324 (26%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G+G  G V+   + + G+V A+K L  + M       +             AE   L
Sbjct: 7   KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-----------VRAERDIL 55

Query: 751 GSIRHKNIVRFLGCCW--NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI--ILG 806
                  IV+ L   +    +  L+M +YMP G L +LL  R+D   E   R+ I  ++ 
Sbjct: 56  ADADSPWIVK-LYYSFQDEEHLYLVM-EYMPGGDLMNLL-IRKDVFPEETARFYIAELVL 112

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK---------LVVEGDFA 857
           A   +  L        +HRDIK +NILI  +    +ADFGL K           +     
Sbjct: 113 ALDSVHKLGF------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 858 RS------------------SNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVV 893
                               +N+  G+  YIAPE      YG       + D +S GV++
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL------ECDWWSLGVIL 220

Query: 894 LEVLTGKQPI-DPTIPEGLH-IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL 951
            E+L G  P    T+ E  + I++W            +SLR  P+  +      L   LL
Sbjct: 221 YEMLYGFPPFYSDTLQETYNKIINW-----------KESLRFPPDPPVSPEAIDLICRLL 269

Query: 952 CVNPTPDDRPTMKDVAAMIKEIKQ 975
           C    P+DR  +       +EIK 
Sbjct: 270 C---DPEDR--LGSF----EEIKS 284

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 56.0 bits (135), Expect = 4e-08
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 26/162 (16%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A +    E IA+KK+           Q D+    GV  +   EI  L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLE--------QEDE----GVPSTAIREISLLKE 57

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII----LGAA 808
           ++H NIVR      +     L+++Y     L   L +  DS  ++    R+I        
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAK 849
           +G+AY H      ++HRD+K  N+LI        +ADFGLA+
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 9/104 (8%)

Query: 802 RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           R +  AA+   GL  LH +     V+RD+K  NIL+       I+D GLA  + EG+  R
Sbjct: 103 RALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                 G+ GY+APE     + T   D +  G ++ E++ G+ P
Sbjct: 160 GR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 18/157 (11%)

Query: 802 RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           R +  AA+   GL  LH +    IV+RD+K  NIL+       I+D GLA  V EG   +
Sbjct: 103 RAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR 918
                 G+ GY+APE     + T   D ++ G ++ E++ G+ P               +
Sbjct: 160 GR---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK---------K 207

Query: 919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNP 955
            KR  +E L K ++     +     ++L   LLC +P
Sbjct: 208 IKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDP 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 27/211 (12%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G G  G VY+A  +    ++AVK + P  +  E            ++    +E++ L 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVI-PLDITVE------------LQKQIMSELEILY 54

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 I+ F G  +  N   +  ++M  GSL   ++ +    +   +  RI +   +GL
Sbjct: 55  KCDSPYIIGFYGAFFVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGL 108

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +N+L+    +  + DFG++  +V       + T  G+  Y+A
Sbjct: 109 TYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMA 161

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           PE     +    SDV+S G+  +E+  G+ P
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 5e-08
 Identities = 30/90 (33%), Positives = 53/90 (58%), Gaps = 1/90 (1%)

Query: 83  IDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNL 142
           + + +  L G +P+ I KL +LQ + L+ N + G IP  LG+   L+ L L  N  +G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 143 PVELGKLVNLEVIRAGGNKDIAGKIPYEIG 172
           P  LG+L +L ++   GN  ++G++P  +G
Sbjct: 483 PESLGQLTSLRILNLNGNS-LSGRVPAALG 511

Length = 623

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 5/95 (5%)

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
           A  L +LH      I++RD+K  NIL+  E    + DFGL+K  ++ +  + + +  G+ 
Sbjct: 108 ALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTV 162

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            Y+APE       T+ +D +S+GV++ E+LTG  P
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.9 bits (133), Expect = 5e-08
 Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 24/155 (15%)

Query: 755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYL 814
           + N ++           +L+ DY+ +G L  LL   ++  L      +II    + L  L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVEALNDL 125

Query: 815 H-HDCVPPIVHRDIKANNILI-GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           H H+    I+H DIK  N+L    +   Y+ D+GL K  + G    + +   G+  Y +P
Sbjct: 126 HKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG----TPSCYDGTLDYFSP 175

Query: 873 EYGYMMKITEKS-----DVYSYGVVVLEVLTGKQP 902
           E     KI   +     D ++ GV+  E+LTGK P
Sbjct: 176 E-----KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.4 bits (133), Expect = 7e-08
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 48/229 (20%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKL---WPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V   +M++ E I   K+   W     AE  C             F  E   
Sbjct: 8   VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC-------------FREE--- 51

Query: 750 LGSIRHKNIVRFLGCCW---------NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
                 +N++    C W         + N   L+ DY   G L +LL +  D   E   R
Sbjct: 52  ------RNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105

Query: 801 YRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           + I  ++ A   +  LH+      VHRDIK +N+L+       +ADFG + L +  D   
Sbjct: 106 FYIAEMVLAIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTV 158

Query: 859 SSNTVAGSYGYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQP 902
            S+   G+  YI+PE    M     K   + D +S GV + E+L G+ P
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.1 bits (133), Expect = 7e-08
 Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 37/228 (16%)

Query: 688 LVEDSVVGKGCSGIVYRAEM---ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS 744
           L +   +G+G  G V +  M    +G ++AVK++             D+     +     
Sbjct: 6   LKDLGEIGRGAFGTVNK--MLHKPSGTIMAVKRI---------RSTVDEKEQKRLLMDLD 54

Query: 745 AEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSL---LHERRDSCLEWELRY 801
             ++   S     IV+F G  +      +  + M + SL      ++E   S +  E+  
Sbjct: 55  VVMR---SSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG 110

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
           +I +   + L YL  +    I+HRD+K +NIL+       + DFG++  +V+   A++ +
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-SIAKTRD 167

Query: 862 TVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEVLTGKQP 902
             AG   Y+APE        GY ++    SDV+S G+ + EV TGK P
Sbjct: 168 --AGCRPYMAPERIDPSARDGYDVR----SDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.4 bits (133), Expect = 7e-08
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 20/212 (9%)

Query: 693 VVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  A+ + +G   AVK L   T+  + +  +    I   R+        L 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNH----IMAERNVL------LK 51

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG-AAQG 810
           +++H  +V              + DY+  G L    H +R+ C   E R R      A  
Sbjct: 52  NLKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFL-EPRARFYAAEVASA 108

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           + YLH      I++RD+K  NIL+  +    + DFGL K  VE +   +++T  G+  Y+
Sbjct: 109 IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYL 163

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           APE           D +  G V+ E+L G  P
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 60/283 (21%), Positives = 121/283 (42%), Gaps = 30/283 (10%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G    VYRA  + +G  +A+KK+        +D  + K      R     EI  L  
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKV------QIFDLMDAK-----ARADCIKEIDLLKQ 58

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH--ERRDSCLEWELRYRIILGAAQG 810
           + H N++++       N   ++ +    G L  ++   +++   +  +  ++  +     
Sbjct: 59  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L ++H      ++HRDIK  N+ I       + D GL +       A  ++++ G+  Y+
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYM 173

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS 930
           +PE  +      KSD++S G ++ E+   + P      + +++    ++    IE  D  
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLYSLCKK----IEQCDYP 226

Query: 931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
               P     E L+ L    +C+NP P+ RP +  V  + K +
Sbjct: 227 --PLPSDHYSEELRQL--VNMCINPDPEKRPDITYVYDVAKRM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 8e-08
 Identities = 51/175 (29%), Positives = 82/175 (46%), Gaps = 35/175 (20%)

Query: 808 AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
           AQG+ +L   +C+    HRD+ A N+L+       I DFGLA+     D    SN V   
Sbjct: 222 AQGMDFLASKNCI----HRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272

Query: 867 YG-----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVD---WV 917
                  ++APE  +    T +SDV+SYG+++ E+ + GK P  P I     +V+   + 
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY-PGI-----LVNSKFYK 326

Query: 918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
             KRG          +RP+    E+   +    +C N  P +RPT   ++ +I+ 
Sbjct: 327 MVKRG-------YQMSRPDFAPPEIYSIMK---MCWNLEPTERPTFSQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.0 bits (132), Expect = 9e-08
 Identities = 47/139 (33%), Positives = 72/139 (51%), Gaps = 23/139 (16%)

Query: 773 LMYDYMPNGSLGSLLHERRDSCLEWELRY---RIILGAAQGLAYLHHDCVPPIVHRDIKA 829
           L+ DY+  G + + L++R D+  E E+R+    IIL     L +LH      IV+RDIK 
Sbjct: 82  LILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILA----LEHLHK---LGIVYRDIKL 133

Query: 830 NNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKS----- 884
            NIL+  E    + DFGL+K  +  +  R+  +  G+  Y+APE      I  K      
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLSEEKERTY-SFCGTIEYMAPEI-----IRGKGGHGKA 187

Query: 885 -DVYSYGVVVLEVLTGKQP 902
            D +S G+++ E+LTG  P
Sbjct: 188 VDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 54.4 bits (131), Expect = 9e-08
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 35/216 (16%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A +   G  +AVKK+         D +  +      R+    E+  +  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 72

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H NIV         +   ++ +++  G+L  ++   R   +  E    + L   + L+
Sbjct: 73  YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALS 129

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH   V   +HRDIK+++IL+  +    ++DFG    V + +  R  + V   Y ++AP
Sbjct: 130 FLHAQGV---IHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPY-WMAP 184

Query: 873 E------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E      YG     TE  D++S G++V+E++ G+ P
Sbjct: 185 EVISRLPYG-----TE-VDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 33/234 (14%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           +++N TV ++ +       VG G  G V  A +   GE +A+KKL           Q++ 
Sbjct: 4   EEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEI 56

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDY---MP--NGSLGSLL- 787
                 R     E+  L  ++H+N++  L    +  +     D+   MP     L  ++ 
Sbjct: 57  FAKRAYR-----ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG 111

Query: 788 HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL 847
           H   +  +++ L Y+++     GL Y+H      I+HRD+K  N+ +  + E  I DFGL
Sbjct: 112 HPLSEDKVQY-LVYQML----CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL 163

Query: 848 AKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           A+     D A  +  V   + Y APE     M   +  D++S G ++ E+LTGK
Sbjct: 164 AR---HAD-AEMTGYVVTRW-YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 54.5 bits (132), Expect = 1e-07
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 59/231 (25%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA-----EI 747
           +GKG  GIV++A +    EV+A+KK+        +D           R++  A     EI
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKI--------FD---------AFRNATDAQRTFREI 57

Query: 748 KTLGSIR-HKNIVRFLGCCWNRNTR--LLMYDYMPNGSLGSLLHE--RRDSCLEWELRYR 802
             L  +  H NIV+ L      N +   L+++YM      + LH   R +   +   RY 
Sbjct: 58  MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-----TDLHAVIRANILEDVHKRYI 112

Query: 803 I--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
           +  +L A   L Y+H   V   +HRD+K +NIL+  +    +ADFGLA+ + E +    +
Sbjct: 113 MYQLLKA---LKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166

Query: 861 NT----VAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGK 900
                 VA  + Y APE       Y      T+  D++S G ++ E+L GK
Sbjct: 167 PVLTDYVATRW-YRAPEILLGSTRY------TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 23/174 (13%)

Query: 808 AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTVAG 865
           A+G+ +L    C+    HRD+ A NIL+       I DFGLA+ +  + D+ R  +    
Sbjct: 184 ARGMEFLASRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              ++APE  +    T +SDV+S+GV++ E+ + G  P       G+ I +   Q+    
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-----PGVQINEEFCQR---- 289

Query: 925 EVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER 977
             L    R R PE    E+     + L C    P +RPT   +  ++ ++ QE 
Sbjct: 290 --LKDGTRMRAPENATPEI---YRIMLACWQGDPKERPTFSALVEILGDLLQEN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 45/137 (32%), Positives = 68/137 (49%), Gaps = 20/137 (14%)

Query: 773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRI-ILGAAQGLAYLH-HDCVPPIVHRDIKAN 830
           L+ DYM  G L    H +++     E R +  I      L +LH +D    IV+RD+K  
Sbjct: 73  LVTDYMSGGEL--FWHLQKEGRFS-EDRAKFYIAELVLALEHLHKYD----IVYRDLKPE 125

Query: 831 NILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-----GYMMKITEKSD 885
           NIL+       + DFGL+K  +  +  +++NT  G+  Y+APE      GY    T+  D
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGY----TKHVD 179

Query: 886 VYSYGVVVLEVLTGKQP 902
            +S GV+V E+  G  P
Sbjct: 180 FWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.4 bits (131), Expect = 2e-07
 Identities = 28/85 (32%), Positives = 45/85 (52%)

Query: 160 NKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQI 219
           N+ + G IP +I   + L  + L+   + G++P SLG ++ L+ L +     +G IP  +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 220 GNCSELVDLFLYENDLSGSLPRELG 244
           G  + L  L L  N LSG +P  LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 54.6 bits (131), Expect = 2e-07
 Identities = 97/366 (26%), Positives = 158/366 (43%), Gaps = 37/366 (10%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQD 106
            SNL S++  +  +   SN    +   L     L  +  S  S + G  + +  L+ L  
Sbjct: 39  DSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLN-LLPLPS 97

Query: 107 LILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLV-NLEVIRAGGNKDIAG 165
           L LN N+L   I  EL     L +L L +N ++ ++P  +G L  NL+ +    NK    
Sbjct: 98  LDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK---- 151

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSEL 225
                                   SLP+ L  L  L++L +    LS ++P  + N S L
Sbjct: 152 ----------------------IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNL 188

Query: 226 VDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSG 285
            +L L  N +S  LP E+  L  LE++ L  NN    +   + N K+L  ++LS N    
Sbjct: 189 NNLDLSGNKIS-DLPPEIELLSALEELDL-SNNSIIELLSSLSNLKNLSGLELSNNKLE- 245

Query: 286 SLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSI 345
            LP+S GNLS+LE L LSNN I  S    L + T+L +L L  N +S        L   +
Sbjct: 246 DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLL 303

Query: 346 PSTLANCRSLEAVDLS-HNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI 404
              L    +L+A++L  ++ L  +      +  +   L ++ +  +        + S+L 
Sbjct: 304 ELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLN 363

Query: 405 RLRLMS 410
           R  + +
Sbjct: 364 RYIVKN 369

Length = 394

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 33/183 (18%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E+  L +++H NIV             L+++Y     L S L +  D+C      + + +
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKI 107

Query: 806 GAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS--- 859
              Q   GL+Y H      I+HRD+K  N+LI  + E  +ADFGLA+       A+S   
Sbjct: 108 FMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR-------AKSVPT 157

Query: 860 ---SNTVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDP--TIPEGL 911
              SN V   + Y  P+   ++  TE S   D++  G ++ E+ TG+ P+ P  T+ E L
Sbjct: 158 KTYSNEVVTLW-YRPPD--VLLGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEEL 213

Query: 912 HIV 914
           H++
Sbjct: 214 HLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 64/291 (21%), Positives = 119/291 (40%), Gaps = 44/291 (15%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTM---AAEYDCQNDKIGIGGVRDSFSAEIKT 749
           +G+G    VYRA  + + + +A+KK+    M    A  DC                EI  
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVK--------------EIDL 55

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH--ERRDSCLEWELRYRIILGA 807
           L  + H N++++L      N   ++ +    G L  ++   +++   +     ++  +  
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA--- 864
              + ++H      ++HRDIK  N+ I       + D GL      G F  S  T A   
Sbjct: 116 CSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSL 166

Query: 865 -GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA 923
            G+  Y++PE  +      KSD++S G ++ E+   + P      + +++    ++    
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---YGDKMNLFSLCQK---- 219

Query: 924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK 974
           IE  D      P     E L+ L    +C+ P PD RP +  V  + K++ 
Sbjct: 220 IEQCDYP--PLPTEHYSEKLREL--VSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 43/134 (32%), Positives = 69/134 (51%), Gaps = 13/134 (9%)

Query: 780 NGSLGSLLHE-RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF 838
           NG  G L H  +R+   +     R     A+ L  L +     +++RD+K  NIL+  ++
Sbjct: 76  NG--GELFHHLQREGRFD---LSRARFYTAELLCALENLHKFNVIYRDLKPENILL--DY 128

Query: 839 EPYIA--DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
           + +IA  DFGL KL ++ D    +NT  G+  Y+APE       T+  D ++ GV++ E+
Sbjct: 129 QGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186

Query: 897 LTGKQPI-DPTIPE 909
           LTG  P  D  + E
Sbjct: 187 LTGLPPFYDENVNE 200

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 30/225 (13%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G    VY+     NG+++A+K +   +M  E     + +    +R     E   L  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVI---SMKTE-----EGVPFTAIR-----EASLLKG 59

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H NIV        + T   +++YM +  L   + +       + +R   +    +GLA
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLA 117

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y+H      I+HRD+K  N+LI    E  +ADFGLA+         SS  V  +  Y  P
Sbjct: 118 YIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPP 172

Query: 873 EYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDP---TIPEGL 911
           +   ++  T+ S   D++  G + +E+L G QP  P    + E L
Sbjct: 173 D--VLLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQL 214

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 42/128 (32%), Positives = 61/128 (47%), Gaps = 9/128 (7%)

Query: 776 DYMPNGSLGSLLHERRDSCLEWELRYRIILGA-AQGLAYLHHDCVPPIVHRDIKANNILI 834
           DY+  G L    H +R+ C   E R R      A  L YLH      IV+RD+K  NIL+
Sbjct: 76  DYINGGEL--FYHLQRERCF-LEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILL 129

Query: 835 GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVL 894
             +    + DFGL K  +E +   +++T  G+  Y+APE  +        D +  G V+ 
Sbjct: 130 DSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLY 187

Query: 895 EVLTGKQP 902
           E+L G  P
Sbjct: 188 EMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.7 bits (129), Expect = 3e-07
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 31/173 (17%)

Query: 808 AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
           A+G+++L   +C+    HRD+ A NIL+       I DFGLA+     D    SN V   
Sbjct: 224 AKGMSFLASKNCI----HRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274

Query: 867 YG-----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQK 920
                  ++APE  +    T +SDV+SYG+++ E+ + G  P  P +P     VD    K
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PGMP-----VDSKFYK 328

Query: 921 RGAIEVLDKSLRA-RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                ++ +  R   PE    EM   +     C +  P  RPT K +  +I++
Sbjct: 329 -----MIKEGYRMLSPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLIEQ 373

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.9 bits (115), Expect = 3e-07
 Identities = 22/60 (36%), Positives = 32/60 (53%)

Query: 440 RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKL 499
            L+ LD+S N+   +   +F  L +L  L LS N+ +   P +     SL+SLDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 41/137 (29%), Positives = 65/137 (47%), Gaps = 18/137 (13%)

Query: 773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA-AQGLAYLHHDCVPPIVHRDIKANN 831
           L+ DY+  G L + L++R           R+ +      L +LH      I++RDIK  N
Sbjct: 82  LILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLALDHLHQ---LGIIYRDIKLEN 135

Query: 832 ILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEY------GYMMKITEKSD 885
           IL+  E    + DFGL+K  +  +  R + +  G+  Y+APE       G+     +  D
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGH----DKAVD 190

Query: 886 VYSYGVVVLEVLTGKQP 902
            +S GV+  E+LTG  P
Sbjct: 191 WWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 57/236 (24%), Positives = 109/236 (46%), Gaps = 26/236 (11%)

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELR- 800
           F  E +   S++H N+++ LG C      LL+ ++ P G L G L   R+   +  +   
Sbjct: 42  FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT 101

Query: 801 -YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
             R+    A GL +LH +     +H D+   N L+  +    I D+GL+    + D+  +
Sbjct: 102 LQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158

Query: 860 SNTVAGSYGYIAPE-----YGYMMKI--TEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL 911
            + +     +IAPE     +G ++ +  T++S+V+S GV + E+   G QP         
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR------- 211

Query: 912 HIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           H+ D   ++     V ++ L+  +P +++    +   V   C    P+ RP+ ++V
Sbjct: 212 HLSD---EQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR------DSCLEWELRYRI 803
           L  ++H NIV F           ++ +Y   G L   +  +R      D+ L+W ++  +
Sbjct: 52  LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSNT 862
                 G+ ++H   V   +HRDIK+ NI +    +  + DFG A+L+   G +A    T
Sbjct: 112 ------GVQHIHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA---CT 159

Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
             G+  Y+ PE    M    KSD++S G ++ E+ T K P
Sbjct: 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.1 bits (127), Expect = 4e-07
 Identities = 71/268 (26%), Positives = 109/268 (40%), Gaps = 43/268 (16%)

Query: 684 VLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
           VLK   +   +G G  GIV  A +   G  +AVKKL           QN        R  
Sbjct: 19  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL-------SRPFQNQTHAKRAYR-- 69

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNT-----RLLMYDYMPNGSLGSLLHERRDSCLEW 797
              E+  L  + HKNI+  L     + +      + +   + + +L  ++H   D     
Sbjct: 70  ---ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS 126

Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
            L Y+++ G    + +LH      I+HRD+K +NI++  +    I DFGLA+     +F 
Sbjct: 127 YLLYQMLCG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TACTNFM 178

Query: 858 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-HIVDW 916
            +   V   Y   APE    M   E  D++S G ++ E++ G       I +G  HI  W
Sbjct: 179 MTPYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGELVKGS-----VIFQGTDHIDQW 231

Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQ 944
            +     IE L       P  E    LQ
Sbjct: 232 NK----VIEQL-----GTPSAEFMNRLQ 250

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 52.5 bits (126), Expect = 5e-07
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 30/155 (19%)

Query: 762 LGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCL-EWELRY---RIILGAAQGLAYLHH 816
           L  C+   +RL  + +++  G L  + H +R   L E   R+    I L     L +LH 
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLA----LNFLHE 114

Query: 817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL-VVEGDFARSSNTVAGSYGYIAPE-- 873
                I++RD+K +N+L+  E    + D+G+ K  +  GD   +++T  G+  YIAPE  
Sbjct: 115 R---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEIL 168

Query: 874 ----YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
               YG+ +      D ++ GV++ E++ G+ P D
Sbjct: 169 RGEDYGFSV------DWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 64/234 (27%)

Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY+   +  G V+AVK++  T    E    N +I    + D    ++  L S
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE----NKRI----LMD---LDV-VLKS 70

Query: 753 IRHKNIVRFLGC-CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI-------I 804
                IV+  G    + +  + M              E   +CL+ +L  RI       I
Sbjct: 71  HDCPYIVKCYGYFITDSDVFICM--------------ELMSTCLD-KLLKRIQGPIPEDI 115

Query: 805 LG-----AAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
           LG       + L YL   H     ++HRD+K +NIL+       + DFG++  +V+   A
Sbjct: 116 LGKMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKA 170

Query: 858 RSSNTVAGSYGYIAPEYGYMMKITEK---------SDVYSYGVVVLEVLTGKQP 902
           ++ +  AG   Y+APE     +I            +DV+S G+ ++E+ TG+ P
Sbjct: 171 KTRS--AGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 52.3 bits (126), Expect = 6e-07
 Identities = 57/243 (23%), Positives = 100/243 (41%), Gaps = 71/243 (29%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA------ 745
            +G G  G+V  A +  +G+ +A+KK                     +  +F        
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKK---------------------IPHAFDVPTLAKR 50

Query: 746 ---EIKTLGSIRHKNIVRF---------LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS 793
              E+K L   +H NI+                 ++  ++M D M +  L  ++H  +  
Sbjct: 51  TLRELKILRHFKHDNIIAIRDILRPPGADF----KDVYVVM-DLMES-DLHHIIHSDQPL 104

Query: 794 CLEWELRYRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
             E  +RY +  +L   +GL Y+H   V   +HRD+K +N+L+  + E  I DFG+A+  
Sbjct: 105 TEE-HIRYFLYQLL---RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARG- 156

Query: 852 VEGDFARSSNTVAGSY--------GYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQP 902
                  SS T    +         Y APE    + + T   D++S G +  E+L G++ 
Sbjct: 157 -----LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210

Query: 903 IDP 905
           + P
Sbjct: 211 LFP 213

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.3 bits (125), Expect = 7e-07
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 7/98 (7%)

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL-VVEGDFARSSNTVAGS 866
           A GL +LH      I++RD+K +N+++  E    IADFG+ K  + +G    ++ T  G+
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGT 164

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
             YIAPE        +  D +++GV++ E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.9 bits (124), Expect = 7e-07
 Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 11/161 (6%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHER-RDSCLEWELRYRI 803
           E + L  IR    +  L   +  +T+L L+ DY+  G L + L +R R    E ++    
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           I+ A   L +LH      I++RDIK  NIL+       + DFGL+K   E +  R+ +  
Sbjct: 114 IVLA---LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-F 166

Query: 864 AGSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            G+  Y+AP+   G      +  D +S GV++ E+LTG  P
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.1 bits (125), Expect = 7e-07
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 36/229 (15%)

Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G V +A     G+++A+KK+    ++ +       +G+ G+  +   E+K +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSL------LHERRDSCLEWELRYRIILG 806
           I+H+NI+  +      +   L+ D M    L  +      L E +  C+  +     IL 
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQ-----IL- 129

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK----LVVEGDFARSSNT 862
              GL  LH       +HRD+   NI I  +    IADFGLA+           ++    
Sbjct: 130 --NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 863 VAG--------SYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGK 900
                      +  Y APE   +M   K     D++S G +  E+LTGK
Sbjct: 185 QRREEMTSKVVTLWYRAPE--LLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 51.9 bits (125), Expect = 8e-07
 Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 56/246 (22%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN TV +V       S VG G  G V  A   + G  +A+KKL               
Sbjct: 4   QELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL--------------- 48

Query: 734 IGIGGVRDSFSA--------EIKTLGSIRHKNIVRFLGCCWNRNTRLL----MYDYMP-- 779
                 R   SA        E++ L  + H+N++  L   +   + L     +Y      
Sbjct: 49  -----SRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV-FTPASSLEDFQDVYLVTHLM 102

Query: 780 NGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE 837
              L +++  ++  D  +++ L Y+I+    +GL Y+H      I+HRD+K +NI +  +
Sbjct: 103 GADLNNIVKCQKLSDDHIQF-LVYQIL----RGLKYIHS---AGIIHRDLKPSNIAVNED 154

Query: 838 FEPYIADFGLAKLVVEGDFARSSNT--VAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVL 894
            E  I DFGLA+            T  VA  + Y APE     M   +  D++S G ++ 
Sbjct: 155 CELKILDFGLARH------TDDEMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMA 207

Query: 895 EVLTGK 900
           E+LTGK
Sbjct: 208 ELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.4 bits (111), Expect = 9e-07
 Identities = 24/60 (40%), Positives = 32/60 (53%)

Query: 416 QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF 475
            L+ L+LSNN L      +   L  L+VLD+S N    + PE+F  L SL  L LS N+ 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 51.6 bits (123), Expect = 9e-07
 Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 22/151 (14%)

Query: 762 LGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVP 820
           L  C+   +RL L+ +Y+  G L  + H +R   L  E            L +LH     
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFLHER--- 115

Query: 821 PIVHRDIKANNILIGPEFEPYIADFGLAKL-VVEGDFARSSNTVAGSYGYIAPE------ 873
            I++RD+K +N+L+  +    + D+G+ K  +  GD   +++T  G+  YIAPE      
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTFCGTPNYIAPEILRGEE 172

Query: 874 YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           YG+ +      D ++ GV++ E++ G+ P D
Sbjct: 173 YGFSV------DWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 36/104 (34%), Positives = 52/104 (50%), Gaps = 9/104 (8%)

Query: 802 RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           R I  AA+   GL  L  +    IV+RD+K  NIL+       I+D GLA  + EG+  R
Sbjct: 103 RAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                 G+ GY+APE     K T   D +  G ++ E++ G+ P
Sbjct: 160 GR---VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.5 bits (126), Expect = 1e-06
 Identities = 45/194 (23%), Positives = 77/194 (39%), Gaps = 41/194 (21%)

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-----VEGDF 856
            I       + Y+H      ++HRD+K +NIL+G   E  I D+G A           D 
Sbjct: 117 SIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI 173

Query: 857 -------ARSSNT----VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
                    SS T    + G+  Y+APE    +  +E +D+Y+ GV++ ++LT   P   
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-- 231

Query: 906 TIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV----EIEEMLQTLGVALLCVNPTPDDRP 961
                       R+K+G        + +  EV    EI   L  + +  L V+P      
Sbjct: 232 ------------RRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDP----AE 275

Query: 962 TMKDVAAMIKEIKQ 975
               V  + ++++ 
Sbjct: 276 RYSSVQELKQDLEP 289

Length = 932

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 22/151 (14%)

Query: 762 LGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVP 820
           L  C+   +RL  + +Y+  G L  + H +R   L  E         +  L YLH     
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHER--- 115

Query: 821 PIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSNTVAGSYGYIAPE------ 873
            I++RD+K +N+L+  E    + D+G+ K  +  GD   +++T  G+  YIAPE      
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGED 172

Query: 874 YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           YG+ +      D ++ GV++ E++ G+ P D
Sbjct: 173 YGFSV------DWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 41/225 (18%)

Query: 692 SVVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMA-AEYDCQNDKIGIGGVRDSFSAE 746
            V+GKG  G V++       + G++ A+K L   T+   + D  + K           AE
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK-----------AE 50

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY---RI 803
              L +++H  IV  +          L+ +Y+  G L   L ER    +E    +    I
Sbjct: 51  RNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLSEI 109

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
            L     L +LH      I++RD+K  NIL+  +    + DFGL K  +       ++T 
Sbjct: 110 SLA----LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTF 160

Query: 864 AGSYGYIAPEYGYMMKITEKS------DVYSYGVVVLEVLTGKQP 902
            G+  Y+APE      I  +S      D +S G ++ ++LTG  P
Sbjct: 161 CGTIEYMAPE------ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 28/213 (13%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G    VY+      GE++A+K++    + AE    +  I           EI  +  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEI---HLDAEEGTPSTAI----------REISLMKE 54

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIILGAAQGL 811
           ++H+NIVR        N  +L+++YM +  L   +        L+            +G+
Sbjct: 55  LKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG---SYG 868
           A+ H +    ++HRD+K  N+LI    E  +ADFGLA+      F    NT +    +  
Sbjct: 114 AFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR-----AFGIPVNTFSNEVVTLW 165

Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           Y AP+     +    S D++S G ++ E++TG+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 58/240 (24%), Positives = 98/240 (40%), Gaps = 44/240 (18%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLL--MYDYMPNGSL--------GSLLHE 789
           R +   E + L  ++H NIV +    W     LL  +  +   G L        G LL E
Sbjct: 43  RKAAEQEAQLLSQLKHPNIVAYRES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE 101

Query: 790 RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
            +   +EW       +  A  L YLH      I+HRD+K  N+ +       + D G+A+
Sbjct: 102 NQ--VVEW------FVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR 150

Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE 909
            V+E     +S  +   Y Y++PE         KSDV++ G  V E+ T K   +     
Sbjct: 151 -VLENQCDMASTLIGTPY-YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN 208

Query: 910 GLHIVDWVRQKRGAIEVLDKSLRARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
            L              +++  L   P+    E+ E++ T+      ++  P+ RP++K +
Sbjct: 209 SL-----------VYRIIEGKLPPMPKDYSPELGELIATM------LSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 45/143 (31%), Positives = 64/143 (44%), Gaps = 14/143 (9%)

Query: 767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRD 826
             N  L+M +Y P G L SLL+   D   E   ++ +    A+ +  +H       VHRD
Sbjct: 73  KDNLYLVM-EYQPGGDLLSLLNRYEDQFDEDMAQFYL----AELVLAIHSVHQMGYVHRD 127

Query: 827 IKANNILIGPEFEPYIADFG-LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKS- 884
           IK  N+LI       +ADFG  A+L        +S    G+  YIAPE    M    K  
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGT 185

Query: 885 -----DVYSYGVVVLEVLTGKQP 902
                D +S GV+  E++ G+ P
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 49/290 (16%)

Query: 353 RSLEAVDLSHNALTGSLHPGLF---QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLM 409
             L+ + L  N L       L    + Q   K L +S   +G IP  + +        L 
Sbjct: 23  LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSL-------LQ 75

Query: 410 SFGNCTQLQMLNLSNNTLGGTLPSSLASLTR---LQVLDISVN----QFVGLIPESFGQL 462
                  LQ L+LS+N LG      L SL R   LQ L ++ N    + + L+ +    L
Sbjct: 76  GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL 135

Query: 463 A-SLNRLILSKNSFSG----AIPSSLGRCESLQSLDLSSNKLSG----KIPVELFEIEGL 513
             +L +L+L +N   G    A+  +L     L+ L+L++N +       +   L     L
Sbjct: 136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNL 195

Query: 514 DISLNLSWNAL----SGAIPPQISALNKLSILDLSHNKLGGDLLA------LSGLDNLVS 563
           ++ L+L+ N L    + A+   +++L  L +L+L  N L     A      LS   +L++
Sbjct: 196 EV-LDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLT 254

Query: 564 LNVSYNNFT--------GYLPDSKLFRQLSATEM----AGNQGLCSRGHE 601
           L++S N+ T          L + +   +L          G Q L     E
Sbjct: 255 LSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLE 304

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 36/114 (31%), Positives = 53/114 (46%), Gaps = 16/114 (14%)

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL--------VVEGDFARSS-- 860
           L YLH+     IVHRD+K +N+LI       + DFGL+K+        + EG   + +  
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 861 ---NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL 911
                V G+  YIAPE        +  D ++ G+++ E L G  P     PE L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 224

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 52/183 (28%), Positives = 82/183 (44%), Gaps = 33/183 (18%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E+  L  ++H NIV          +  L+++Y     L   L +  D C      + + L
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKL 108

Query: 806 GAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS--- 859
              Q   GL Y H      ++HRD+K  N+LI    E  +ADFGLA+       A+S   
Sbjct: 109 FLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-------AKSIPT 158

Query: 860 ---SNTVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDP--TIPEGL 911
              SN V   + Y  P+   ++  T+ S   D++  G +  E+ TG+ P+ P  T+ E L
Sbjct: 159 KTYSNEVVTLW-YRPPD--ILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQL 214

Query: 912 HIV 914
           H +
Sbjct: 215 HFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 49.8 bits (119), Expect = 4e-06
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 65/238 (27%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G +G+V+ A + +  + +AVKK+  T      D Q+ K  +         EIK +  
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLT------DPQSVKHAL--------REIKIIRR 58

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR----DSCLEWELR-------- 800
           + H NIV+         + L          +GSL            +E +L         
Sbjct: 59  LDHDNIVKVYEVLGPSGSDL-------TEDVGSLTELNSVYIVQEYMETDLANVLEQGPL 111

Query: 801 ---------YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKL 850
                    Y+++    +GL Y+H   V   +HRD+K  N+ I  E     I DFGLA+ 
Sbjct: 112 SEEHARLFMYQLL----RGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLAR- 163

Query: 851 VVEGDFARS---SNTVAGSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGK 900
           +V+  ++     S  +   + Y +P        Y    T+  D+++ G +  E+LTGK
Sbjct: 164 IVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNY----TKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.7 bits (119), Expect = 5e-06
 Identities = 70/252 (27%), Positives = 111/252 (44%), Gaps = 57/252 (22%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  GIV  A   E  E +A+KK+     A  +D + D      +R     EIK L  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKI-----ANAFDNRIDAKRT--LR-----EIKLLRH 60

Query: 753 IRHKNIVRFLGCCW-----NRNTRLLMYDYMPNGSLGSLLHE--RRDSCLEWE----LRY 801
           + H+N++              N   ++Y+ M        LH+  R    L  +      Y
Sbjct: 61  LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLY 115

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSS 860
           +++    +GL Y+H      ++HRD+K +N+L+    +  I DFGLA+   E GDF   +
Sbjct: 116 QLL----RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM--T 166

Query: 861 NTVAGSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
             V   + Y APE       Y   I    DV+S G +  E+L G++P+ P         D
Sbjct: 167 EYVVTRW-YRAPELLLNCSEYTTAI----DVWSVGCIFAELL-GRKPLFPG-------KD 213

Query: 916 WVRQKRGAIEVL 927
           +V Q +   E+L
Sbjct: 214 YVHQLKLITELL 225

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 34/104 (32%), Positives = 50/104 (48%), Gaps = 9/104 (8%)

Query: 802 RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           R I  AAQ   GL +LH      IV+RD+K  N+L+       I+D GLA  +  G   +
Sbjct: 96  RAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK 152

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                AG+ GY+APE           D ++ G  + E++ G+ P
Sbjct: 153 GR---AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.8 bits (119), Expect = 5e-06
 Identities = 39/142 (27%), Positives = 61/142 (42%), Gaps = 27/142 (19%)

Query: 773 LMYDYMPNGSLGSLLHERRDSCLEWELRY--RIILGAAQGLAYLHHDCVPPIVHRDIKAN 830
           ++ +YMP G L +L+    D   +W   Y   ++L     L  +H       +HRD+K +
Sbjct: 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLA----LDAIHS---MGFIHRDVKPD 171

Query: 831 NILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE----------YGYMMKI 880
           N+L+       +ADFG    +      R    V G+  YI+PE          YG     
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYG----- 225

Query: 881 TEKSDVYSYGVVVLEVLTGKQP 902
             + D +S GV + E+L G  P
Sbjct: 226 -RECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 43.9 bits (104), Expect = 5e-06
 Identities = 13/23 (56%), Positives = 17/23 (73%)

Query: 5  PSALSNWNPSDSNPCKWSHITCS 27
            ALS+WNPS S+PC W+ +TC 
Sbjct: 20 SGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 5e-06
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 51/233 (21%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWP---TTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           S +G+G  G+V  A     G  +A+KK+ P    T      CQ        +R     EI
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTF-----CQRT------LR-----EI 54

Query: 748 KTLGSIRHKNIVRFL-----GCCWNRNTRLLMYDYMPNGSLGSLLHERR---DSCLEWEL 799
           K L   +H+NI+  L         + N   ++ + M    L  L+  +    D    +  
Sbjct: 55  KILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYF-- 111

Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
            Y+I+    +GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++         
Sbjct: 112 LYQIL----RGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPE----H 160

Query: 860 SNT------VAGSYGYIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDP 905
            +T      VA  + Y APE     K   K+ D++S G ++ E+L+ + P+ P
Sbjct: 161 DHTGFLTEYVATRW-YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 5e-06
 Identities = 63/220 (28%), Positives = 95/220 (43%), Gaps = 30/220 (13%)

Query: 693 VVGKGCSGIVYRAEMEN-GEVIAVKKL--WPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V   +M+N G+V A+K L  W     AE  C             F  E   
Sbjct: 8   VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC-------------FREERDV 54

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI--ILGA 807
           L +   + I        + N   L+ DY   G L +LL +  D   E   R+ +  ++ A
Sbjct: 55  LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLA 114

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
              +  L +      VHRDIK +N+L+       +ADFG + L +  D    SN   G+ 
Sbjct: 115 IDSVHQLGY------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTP 167

Query: 868 GYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQP 902
            YI+PE    M     +   + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.6 bits (118), Expect = 6e-06
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 22/207 (10%)

Query: 704 RAEMENGEVIAVKKLWPTTMAAEYDCQNDK-----IGIGGVRDSFSAEIKTLGSIRHKNI 758
           RA +E      ++   P      + C ++K     +   G R   + E   L +I H +I
Sbjct: 86  RAGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSI 145

Query: 759 VRFLGC-CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY-RIILGAAQGLAYLHH 816
           ++  G   +N+ T L++  Y  +  L   L  +R+  +   L   R +L A Q   YLH 
Sbjct: 146 IQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDILAIERSVLRAIQ---YLHE 200

Query: 817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA---PE 873
           +    I+HRDIKA NI I    +  + DFG A   V+     ++N   G  G IA   PE
Sbjct: 201 N---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD----INANKYYGWAGTIATNAPE 253

Query: 874 YGYMMKITEKSDVYSYGVVVLEVLTGK 900
                      D++S G+V+ E+ T  
Sbjct: 254 LLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 19/99 (19%)

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGSYGY 869
           L YLH      +V+RD+K  N+++  +    I DFGL K   EG     +  T  G+  Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161

Query: 870 IAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +APE      YG  +      D +  GVV+ E++ G+ P
Sbjct: 162 LAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.2 bits (117), Expect = 6e-06
 Identities = 42/121 (34%), Positives = 62/121 (51%), Gaps = 21/121 (17%)

Query: 799 LRYRIILG----AAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
           L Y  ++G     A G+ +L   +CV    HRD+ A N+LI       I DFGLA+    
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLAR---- 287

Query: 854 GDFARSSNTVA-GS----YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 907
            D  R SN ++ GS      ++APE  +    T  SDV+S+G+++ E+ T G  P  P +
Sbjct: 288 -DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY-PEL 345

Query: 908 P 908
           P
Sbjct: 346 P 346

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 7e-06
 Identities = 63/239 (26%), Positives = 114/239 (47%), Gaps = 42/239 (17%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKL---WPTTMAAEYDCQ 730
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL   + + + A+   +
Sbjct: 6   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR 65

Query: 731 NDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD--YMPNGSLGSLLH 788
                          E++ L  ++H+N++  L   +     L  ++  Y+    +G+ L+
Sbjct: 66  ---------------ELRLLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLN 109

Query: 789 ------ERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI 842
                 +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I
Sbjct: 110 NIVKCQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI 161

Query: 843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
            DFGLA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 162 LDFGLARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.3 bits (117), Expect = 7e-06
 Identities = 70/298 (23%), Positives = 121/298 (40%), Gaps = 67/298 (22%)

Query: 693 VVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G  G V   + ++ G V A+K L    M        +K  +G +R    AE   L 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-------EKEQVGHIR----AERDILV 56

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 +V+      ++    L+ +++P G + +LL  ++D+  E E ++ I   A   L
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM-KKDTLTEEETQFYI---AETVL 112

Query: 812 AYLHHDCVPPI--VHRDIKANNILIGPEFEPYIADFGLA---KLVVEGDFARSSN----- 861
           A    D +  +  +HRDIK +N+L+  +    ++DFGL    K     +F R+ N     
Sbjct: 113 AI---DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 862 -------------------------TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
                                    +  G+  YIAPE        +  D +S GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 897 LTGKQPIDPTIPEGLH--IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLC 952
           L G  P     P+  +  +++W            ++L   PEV I E  + L +   C
Sbjct: 230 LIGYPPFCSETPQETYKKVMNW-----------KETLIFPPEVPISEKAKDLILRFCC 276

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 48.5 bits (115), Expect = 1e-05
 Identities = 63/249 (25%), Positives = 100/249 (40%), Gaps = 73/249 (29%)

Query: 690 EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           E   VG+G  G VY+A+ ++G+              + D    +I   G+  S   EI  
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGK-------------DDRDYALKQIEGTGISMSACREIAL 51

Query: 750 LGSIRHKNIVRFLGCCWNRNTR--LLMYDY-----------------------MPNGSLG 784
           L  ++H N++       +   R   L++DY                       +P G + 
Sbjct: 52  LRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 111

Query: 785 SLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEF-EP 840
           SLL++  D                 G+ YLH + V   +HRD+K  NIL+   GPE    
Sbjct: 112 SLLYQILD-----------------GIHYLHANWV---LHRDLKPANILVMGEGPERGRV 151

Query: 841 YIADFGLAKLVVE-----GDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVL 894
            IAD G A+L         D     + V  ++ Y APE     +  T+  D+++ G +  
Sbjct: 152 KIADMGFARLFNSPLKPLADL----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207

Query: 895 EVLTGKQPI 903
           E+LT  +PI
Sbjct: 208 ELLT-SEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.4 bits (115), Expect = 1e-05
 Identities = 46/140 (32%), Positives = 68/140 (48%), Gaps = 24/140 (17%)

Query: 777 YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP 836
           +M  GS  SLL       +   L   I+ GA +GL YLH +     +HR+IKA++ILI  
Sbjct: 80  FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISG 136

Query: 837 EFEPYIADFG-LAKLVVEG-------DFARSSNTVAGSYGYIAPE------YGYMMKITE 882
           +    ++    L  LV  G       DF + S +V     +++PE      YGY +K   
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV---LPWLSPELLRQDLYGYNVK--- 190

Query: 883 KSDVYSYGVVVLEVLTGKQP 902
            SD+YS G+   E+ TG+ P
Sbjct: 191 -SDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 49/188 (26%), Positives = 75/188 (39%), Gaps = 56/188 (29%)

Query: 776 DYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG 835
           DY+P G + SLL   R    E +L    I      +  +H       +HRDIK +NILI 
Sbjct: 81  DYIPGGDMMSLL--IRLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILID 135

Query: 836 PEFEPYIADFGL---------AKLVVEGDFAR---------------------------- 858
            +    + DFGL         +K   +GD  R                            
Sbjct: 136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195

Query: 859 ----SSNTVAGSYGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPE 909
                ++++ G+  YIAPE     GY    T+  D +S GV++ E+L G+ P +  T  E
Sbjct: 196 HQRCLAHSLVGTPNYIAPEVLLRTGY----TQLCDWWSVGVILYEMLVGQPPFLADTPAE 251

Query: 910 GLH-IVDW 916
               +++W
Sbjct: 252 TQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 47.8 bits (114), Expect = 2e-05
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 15/104 (14%)

Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS- 859
           Y+I+    +GL YLH      I+HRDIK  N+L+       I DFGLA+ V E D ++  
Sbjct: 110 YQIL----RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHM 161

Query: 860 SNTVAGSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGK 900
           +  V   Y Y APE   +M     T   D++S G +  E+L  +
Sbjct: 162 TQEVVTQY-YRAPE--ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 47.5 bits (113), Expect = 2e-05
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 20/212 (9%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  A+   +G+  AVK L    +      + ++  I   R+        L 
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK----KKEQKHIMAERNVL------LK 51

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA-AQG 810
           +++H  +V         +    + DY+  G L    H +R+     E R R      A  
Sbjct: 52  NVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFP-EPRARFYAAEIASA 108

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L YLH      I++RD+K  NIL+  +    + DFGL K  +E    ++++T  G+  Y+
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYL 163

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           APE           D +  G V+ E+L G  P
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 63/237 (26%), Positives = 103/237 (43%), Gaps = 49/237 (20%)

Query: 690 EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           E   VG+G  G VY+A+ ++G+              E +    +I   G+  S   EI  
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGK-------------DEKEYALKQIEGTGISMSACREIAL 51

Query: 750 LGSIRHKNIVRFLGCCWNRNTR--LLMYDYMPNGSLGSLLHERRDS-----------CLE 796
           L  ++H N++       + + R   L++DY  +  L  ++   R S            + 
Sbjct: 52  LRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMV 110

Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEF-EPYIADFGLAKLVV 852
             L Y+I+     G+ YLH + V   +HRD+K  NIL+   GPE     IAD G A+L  
Sbjct: 111 KSLLYQIL----DGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 853 E-----GDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPI 903
                  D     + V  ++ Y APE     +  T+  D+++ G +  E+LT  +PI
Sbjct: 164 SPLKPLADL----DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 9/104 (8%)

Query: 802 RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           R+I  +AQ   G+ +LH      IV+RD+K  N+L+  +    ++D GLA  + +G   +
Sbjct: 96  RVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---K 149

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +    AG+ GY+APE       +   D ++ G  + E++ G+ P
Sbjct: 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 40/127 (31%), Positives = 64/127 (50%), Gaps = 21/127 (16%)

Query: 796 EWELRY---RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
           E E+R+    IILG    L ++H+  V   V+RD+K  NIL+       I+D GLA    
Sbjct: 96  EKEMRFYATEIILG----LEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA---- 144

Query: 853 EGDFARSS-NTVAGSYGYIAPEYGYMMKIT---EKSDVYSYGVVVLEVLTGKQPIDPTIP 908
             DF++   +   G++GY+APE   + K T     +D +S G ++ ++L G  P      
Sbjct: 145 -CDFSKKKPHASVGTHGYMAPE--VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201

Query: 909 EGLHIVD 915
           +  H +D
Sbjct: 202 KDKHEID 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.3 bits (112), Expect = 3e-05
 Identities = 50/219 (22%), Positives = 82/219 (37%), Gaps = 52/219 (23%)

Query: 745 AEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII 804
           AE   L    ++ +VR      +++    + DY+P G + SLL   R      +L    I
Sbjct: 50  AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDLARFYI 107

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL---------AKLVVEGD 855
                 +  +H       +HRDIK +NILI  +    + DFGL         +K    GD
Sbjct: 108 AELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGD 164

Query: 856 FARS------------------------------------SNTVAGSYGYIAPEYGYMMK 879
             R                                     ++++ G+  YIAPE      
Sbjct: 165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG 224

Query: 880 ITEKSDVYSYGVVVLEVLTGKQPIDPTIP--EGLHIVDW 916
            T+  D +S GV++ E+L G+ P     P    + +++W
Sbjct: 225 YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 16/157 (10%)

Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+   +  G+++A+KK+    + +E +         GV  +   EI  L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEE---------GVPSTAIREISLLKE 55

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H NIV         +   L+++++       L    +   ++ EL    +    QG+ 
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           + H   V   +HRD+K  N+LI  +    +ADFGLA+
Sbjct: 116 FCHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.0 bits (111), Expect = 4e-05
 Identities = 62/236 (26%), Positives = 111/236 (47%), Gaps = 36/236 (15%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN TV +V +     + VG G  G V  A +    + +AVKKL     +  +      
Sbjct: 4   QELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH------ 57

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFL------GCCWNRNTRLLMYDYMPNGSLGSLL 787
                 R ++  E++ L  ++H+N++  L          N N   L+ + M    L +++
Sbjct: 58  -----ARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIV 110

Query: 788 HERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
             ++  D  +++ L Y+++    +GL Y+H      I+HRD+K +N+ +  + E  I DF
Sbjct: 111 KCQKLSDEHVQF-LIYQLL----RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDF 162

Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           GLA+   +      +  VA  + Y APE     M   +  D++S G ++ E+L GK
Sbjct: 163 GLARQADD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.8 bits (99), Expect = 5e-05
 Identities = 19/60 (31%), Positives = 27/60 (45%)

Query: 248 KLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNI 307
            L+ + L  N              +LK +DLS N  +   P++F  L SL  L LS NN+
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.2 bits (109), Expect = 5e-05
 Identities = 33/96 (34%), Positives = 46/96 (47%), Gaps = 7/96 (7%)

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGS 866
           A  L YLH      IV+RD+K  NIL+  +    + DFGL K   EG   + ++ T  G+
Sbjct: 106 ASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGT 159

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
             Y+APE           D +  G V+ E+L G  P
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.6 bits (110), Expect = 5e-05
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 26/153 (16%)

Query: 762 LGCCWNRNTRLLM-YDYMPNGSLGSLLHERRDSCLEWELRYR----IILGAAQGLAYLHH 816
           L C +  +  L M  +YMP G L +L+    D   +W   Y     + L A   +     
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMG---- 162

Query: 817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-- 874
                ++HRD+K +N+L+       +ADFG    + E    R  +T  G+  YI+PE   
Sbjct: 163 -----LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR-CDTAVGTPDYISPEVLK 216

Query: 875 -----GYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                GY  +   + D +S GV + E+L G  P
Sbjct: 217 SQGGDGYYGR---ECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 46.0 bits (109), Expect = 6e-05
 Identities = 30/104 (28%), Positives = 51/104 (49%), Gaps = 8/104 (7%)

Query: 802 RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           R     AQ   GL +LH      I++RD+K  N+L+  +    I+D GLA  + +G    
Sbjct: 98  RACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--S 152

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            +   AG+ G++APE     +     D ++ GV + E++  + P
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 46.1 bits (109), Expect = 6e-05
 Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 33/183 (18%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E+  L  ++H NIV          +  L+++Y+        L +  D C      + + +
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKD-----LKQYMDDCGNIMSMHNVKI 108

Query: 806 GAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS--- 859
              Q   GLAY H      ++HRD+K  N+LI    E  +ADFGLA+       A+S   
Sbjct: 109 FLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-------AKSVPT 158

Query: 860 ---SNTVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDP--TIPEGL 911
              SN V   + Y  P+   ++  +E S   D++  G +  E+ +G+ P+ P  T+ + L
Sbjct: 159 KTYSNEVVTLW-YRPPD--VLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDEL 214

Query: 912 HIV 914
           H++
Sbjct: 215 HLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 46.1 bits (109), Expect = 6e-05
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 29/214 (13%)

Query: 694 VGKGCSGIVYRAEMENGEV--IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           +G G  G V  A  +N +   +A+K+            +  KI      D   +E K L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRF-----------EKSKIIKQKQVDHVFSERKILN 86

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG---AA 808
            I H   V   G   + +   L+ +++  G   + L  RR+       R+   +G   AA
Sbjct: 87  YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNK------RFPNDVGCFYAA 138

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
           Q +    +     IV+RD+K  N+L+  +    + DFG AK+V        + T+ G+  
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPE 193

Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           YIAPE    +   + +D ++ G+ + E+L G  P
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 46.0 bits (109), Expect = 6e-05
 Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 8/90 (8%)

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH      I++RD+K  N+L+  +    + DFG AK V +  F     T+ G+  Y+AP
Sbjct: 133 YLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-----TLCGTPEYLAP 184

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E        +  D ++ GV++ E + G  P
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.2 bits (109), Expect = 7e-05
 Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 18/161 (11%)

Query: 746 EIKTLGSIRHKNIVRFLGCC-WNRNTRLL-------MYDYMPNGSLGSLLHERRDSCLEW 797
           EI  LG + H+NI++         NT ++       +Y +M + +      + +D  L  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----DWKDRPLLK 267

Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
           + R  I+      + Y+H      ++HRDIK  NI +  + +  + DFG A    +   A
Sbjct: 268 QTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323

Query: 858 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
                V G+    +PE        E +D++S G+++L++L+
Sbjct: 324 FDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 45.5 bits (108), Expect = 7e-05
 Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 14/168 (8%)

Query: 749 TLGSIRHKNIVRFLGCCWNRNTR-LLMYDYMPNGSLGSLLHERRDSCLEWE--LRYR--- 802
            L  + H+NI+  L  C        ++Y YM  G+L   L + R         L  +   
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 803 -IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
            + +  A G++YLH      ++H+DI A N +I  E +  I D  L++ +   D+    +
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177

Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP---IDP 905
                  ++A E     + +  SDV+S+GV++ E++T G+ P   IDP
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 11/159 (6%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E + L + RH  +         ++    + +Y+  G L    H  R+     E R R   
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFS-EDRTRF-Y 100

Query: 806 GA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           GA     L YLH      IV+RD+K  N+++  +    I DFGL K  +    A +  T 
Sbjct: 101 GAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTF 155

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            G+  Y+APE           D +  GVV+ E++ G+ P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 7e-05
 Identities = 49/185 (26%), Positives = 76/185 (41%), Gaps = 40/185 (21%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNG------SLGSLLHERRDSCLEWEL 799
           E   L  ++H NIV        + T  L+++Y+           G  L         ++L
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQL 112

Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
                    +GLAY H      ++HRD+K  N+LI    E  +ADFGLA+       A+S
Sbjct: 113 --------LRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-------AKS 154

Query: 860 ------SNTVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDPTIPEG 910
                 SN V   + Y  P+   ++  TE S   D++  G +  E+ TG+    P  P  
Sbjct: 155 VPSKTYSNEVVTLW-YRPPD--VLLGSTEYSTSLDMWGVGCIFYEMATGR----PLFPGS 207

Query: 911 LHIVD 915
             + D
Sbjct: 208 TDVED 212

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.9 bits (109), Expect = 8e-05
 Identities = 67/247 (27%), Positives = 100/247 (40%), Gaps = 46/247 (18%)

Query: 683 QVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
            VLK       +G G  GIV  A +   G+ +A+KKL           QN        R 
Sbjct: 13  TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL-------SRPFQNVTHAKRAYR- 64

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL-------LMYDYMPNGSLGS-----LLHE 789
               E+  +  + HKNI+  L   +     L       L+ + M + +L       L HE
Sbjct: 65  ----ELVLMKLVNHKNIIGLLNV-FTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE 118

Query: 790 RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           R    L     Y+++ G    + +LH      I+HRD+K +NI++  +    I DFGLA+
Sbjct: 119 RMSYLL-----YQMLCG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166

Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE 909
               G     +  V   Y Y APE    M   E  D++S G ++ E++ G        P 
Sbjct: 167 --TAGTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV----LFPG 219

Query: 910 GLHIVDW 916
             HI  W
Sbjct: 220 TDHIDQW 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 9e-05
 Identities = 21/60 (35%), Positives = 31/60 (51%)

Query: 272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
           +LK++DLS N  +     +F  L +L+ L LS NN++   P   S   SL  L L  N +
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 1e-04
 Identities = 24/85 (28%), Positives = 31/85 (36%), Gaps = 25/85 (29%)

Query: 464 SLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNA 523
           +L  L LS N  +     +     +L+ LDLS N L+                  +S  A
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-----------------ISPEA 43

Query: 524 LSGAIPPQISALNKLSILDLSHNKL 548
            SG        L  L  LDLS N L
Sbjct: 44  FSG--------LPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 50/219 (22%), Positives = 88/219 (40%), Gaps = 62/219 (28%)

Query: 768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI-----ILGAAQGLAYLHHDCVPPI 822
           RN  L+M +++P G + +LL  ++D+  E   ++ I      + A   L +         
Sbjct: 74  RNLYLIM-EFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLGF--------- 122

Query: 823 VHRDIKANNILIGPEFEPYIADFGLA---KLVVEGDFARS-------------------- 859
           +HRDIK +N+L+  +    ++DFGL    K     +F R+                    
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 860 ----------SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE 909
                     + +  G+  YIAPE        +  D +S GV++ E+L G  P     P+
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 910 GLH--IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTL 946
             +  +++W            ++L   PEV I E  + L
Sbjct: 243 ETYRKVMNW-----------KETLVFPPEVPISEKAKDL 270

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 23/170 (13%)

Query: 808 AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
           A+G+ +L   +CV    HRD+ A N+L+       I DFGLA+ ++      S  +    
Sbjct: 247 ARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD---WVRQKRGA 923
             ++APE  +    T  SDV+SYG+++ E+ +    +  T   G+ IVD   + + K G 
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS----LGGTPYPGM-IVDSTFYNKIKSG- 356

Query: 924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                    A+P+   +E+   +   + C N  P+ RP+   ++ +++ +
Sbjct: 357 ------YRMAKPDHATQEVYDIM---VKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 56/221 (25%)

Query: 745 AEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII 804
           AE   L    ++ +V+      +++    + DY+P G + SLL  R +   E   R+ I 
Sbjct: 50  AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-IRMEVFPEVLARFYI- 107

Query: 805 LGAAQGLAY--LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL---------AKLVVE 853
             A   LA   +H       +HRDIK +NILI  +    + DFGL         +K   +
Sbjct: 108 --AELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQK 162

Query: 854 GDFARS------------------------------------SNTVAGSYGYIAPEYGYM 877
           G   R                                     ++++ G+  YIAPE    
Sbjct: 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222

Query: 878 MKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPEG-LHIVDW 916
              T+  D +S GV++ E+L G+ P + PT  E  L +++W
Sbjct: 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 12/97 (12%)

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS---SNTVAGS 866
           GL Y+H   V   +HRD+K  N+L+  + E  I DFGLA+   E     +   +  VA  
Sbjct: 117 GLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 867 YGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGK 900
           + Y APE   M+     +   DV+S G ++ E+L  K
Sbjct: 174 W-YRAPE--IMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.8 bits (106), Expect = 2e-04
 Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 8/171 (4%)

Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD 792
           K   GG   +   EI  L +I H+ I+  +     ++T  ++   MP        +  R 
Sbjct: 125 KAVTGG--KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRS 179

Query: 793 SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
             L  E    I     + LAYLH      I+HRD+K  NI +       + DFG A  + 
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236

Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
                      +G+    +PE   +     K+D++S G+V+ E+      +
Sbjct: 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 25/141 (17%)

Query: 773 LMYDYMPNGSLGSLLHERRDSCLEWELRYR----IILGAAQGLAYLHHDCVPPIVHRDIK 828
           ++ +YMP G L +L+    D   +W   Y     + L A   + +         +HRD+K
Sbjct: 120 MVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVK 169

Query: 829 ANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-------GYMMKIT 881
            +N+L+       +ADFG    + +    R  +T  G+  YI+PE        GY  +  
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGR-- 226

Query: 882 EKSDVYSYGVVVLEVLTGKQP 902
            + D +S GV + E+L G  P
Sbjct: 227 -ECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 36/112 (32%), Positives = 58/112 (51%), Gaps = 17/112 (15%)

Query: 796 EWELRY---RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
           E E+R+    IILG    L ++H+  V   V+RD+K  NIL+       I+D GLA    
Sbjct: 96  EAEMRFYAAEIILG----LEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA---- 144

Query: 853 EGDFARSS-NTVAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
             DF++   +   G++GY+APE     +     +D +S G ++ ++L G  P
Sbjct: 145 -CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 46/237 (19%), Positives = 89/237 (37%), Gaps = 41/237 (17%)

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-LEWELR 800
           +F      +  + HK++V+  G C      ++  +Y+  G L   LH  +++  L W+L 
Sbjct: 47  AFFETASLMSQLSHKHLVKLYGVCVRDENIMVE-EYVKFGPLDVFLHREKNNVSLHWKL- 104

Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPY----IADFGLAKLVVE 853
             +    A  L YL       +VH ++   NIL+   G          ++D G+   V+ 
Sbjct: 105 -DVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160

Query: 854 GDFARSSNTVAGSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLT-GKQPI-DPTIPE 909
            +             +IAPE        +T  +D +S+G  +LE+ + G++P+   +  E
Sbjct: 161 REERVERIP------WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214

Query: 910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                     +              P  +  E+   +     C    P  RP+ + +
Sbjct: 215 KER-----FYQDQHR---------LPMPDCAELANLI---NQCWTYDPTKRPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 43.4 bits (103), Expect = 4e-04
 Identities = 64/250 (25%), Positives = 98/250 (39%), Gaps = 66/250 (26%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++GKG  G V+   +   G++ A+K L    M      + +K+     R     EI  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKV----KRVLTEQEI--LA 56

Query: 752 SIRHKNIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCL-EWELRYRI--I 804
           ++ H  +        +        L+M DY P G L  LL  +   CL E   R+    +
Sbjct: 57  TLDHPFLPTLY---ASFQTETYLCLVM-DYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK--------------- 849
           L A   L YLH   +  IV+RD+K  NIL+       ++DF L+K               
Sbjct: 113 LLA---LEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166

Query: 850 -------------LVVEGDFARSSNTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVV 892
                           E    R SN+  G+  YIAPE     G+        D ++ G++
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFR-SNSFVGTEEYIAPEVISGDGH----GSAVDWWTLGIL 221

Query: 893 VLEVLTGKQP 902
           + E+L G  P
Sbjct: 222 LYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.5 bits (102), Expect = 4e-04
 Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 10/129 (7%)

Query: 776 DYMPNGSLGSLLHERRDSCLEWELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNIL 833
           +Y   G L    H  R+     E R R   GA     L YLH +    +V+RD+K  N++
Sbjct: 75  EYANGGEL--FFHLSRERVFS-EDRARF-YGAEIVSALDYLHSE--KNVVYRDLKLENLM 128

Query: 834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVV 893
           +  +    I DFGL K  ++     +  T  G+  Y+APE           D +  GVV+
Sbjct: 129 LDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 186

Query: 894 LEVLTGKQP 902
            E++ G+ P
Sbjct: 187 YEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 51/234 (21%)

Query: 692 SVVGKGCSGIV------YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +V+G+G   ++      Y+     GE + V+++    + A   C N+ +           
Sbjct: 4   TVIGRGFEDLMTVNLARYKP---TGEYVTVRRI---NLEA---CTNEMVTF------LQG 48

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRII 804
           E+       H NIV +       N   ++  +M  GS   L+     D   E  + Y I+
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-IL 107

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL----------AKLVVEG 854
            G  + L Y+HH      VHR +KA++ILI  + + Y++  GL           +L V  
Sbjct: 108 QGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVH 162

Query: 855 DFARSSNTVAGSYGYIAPEY------GYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           DF + S  V     +++PE       GY      KSD+YS G+   E+  G  P
Sbjct: 163 DFPKYSVKV---LPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.0 bits (103), Expect = 5e-04
 Identities = 73/336 (21%), Positives = 129/336 (38%), Gaps = 62/336 (18%)

Query: 746  EIKTLGSIRHKNIVRFLGCCWNR-NTRL-LMYDYMPNGSLGSLLHE--RRDSCLEWELRY 801
            E+  +  ++HKNIVR++    N+ N +L ++ ++   G L   + +  +    +E     
Sbjct: 62   EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 802  RIILGAAQGLAYLHHDCVPP----IVHRDIKANNILIGPEFE-----------------P 840
             I       LAY H+    P    ++HRD+K  NI +                       
Sbjct: 122  DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 841  YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT----EKSDVYSYGVVVLEV 896
             I DFGL+K +     A S     G+  Y +PE   ++  T    +KSD+++ G ++ E+
Sbjct: 182  KIGDFGLSKNIGIESMAHS---CVGTPYYWSPEL--LLHETKSYDDKSDMWALGCIIYEL 236

Query: 897  LTGKQPID---------------PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEE 941
             +GK P                 P +P        ++ K   + +L K+L      E   
Sbjct: 237  CSGKTPFHKANNFSQLISELKRGPDLP--------IKGKSKELNILIKNLLNLSAKERPS 288

Query: 942  MLQTLGVALL-CVNPTPDDRPTMKDVAAMIKEIKQER---EECMKVDMLPSEGSANGQRE 997
             LQ LG  ++  V P          VAA    +   R   +E   + +   E + + +  
Sbjct: 289  ALQCLGYQIIKNVGPPVGAAGGGAGVAAAPGAVVARRNPSKEHPGLQLAAMEKAKHAEAA 348

Query: 998  NNNSSSTAMMPNLYPQSNNTSFSASSLLYSSASKTT 1033
            N   S   ++ N   +  +   S+S     SA+  T
Sbjct: 349  NYGISPNTLI-NQRNEEQHGRRSSSCASRQSANNVT 383

Length = 1021

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.5 bits (102), Expect = 5e-04
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191

Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 5e-04
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 5/78 (6%)

Query: 773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNI 832
           L+ +Y+  G + SLLH       E  ++Y  I   A  L YLH      I+HRD+K +N+
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMAVKY--ISEVALALDYLHRH---GIIHRDLKPDNM 135

Query: 833 LIGPEFEPYIADFGLAKL 850
           LI  E    + DFGL+K+
Sbjct: 136 LISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.7 bits (103), Expect = 5e-04
 Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 20/101 (19%)

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILI-GPEFEPYIADFGLAKLVVEGDFARSS 860
           R +L A   + Y+H +    I+HRDIK  N+L+ GPE +  + DFG A       FAR S
Sbjct: 267 RQLLSA---IDYIHGE---GIIHRDIKTENVLVNGPE-DICLGDFGAAC------FARGS 313

Query: 861 NT------VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLE 895
            +      +AG+    APE       T   D++S G+V+ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 5e-04
 Identities = 78/332 (23%), Positives = 127/332 (38%), Gaps = 93/332 (28%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G  G V   +  + G + A+KKL  + M        +K  +  VR    AE   L 
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-------EKEQVAHVR----AERDILA 56

Query: 752 SIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRI---ILG- 806
              +  +V+ L   +     L L+ +Y+P G + +LL  ++D+  E E R+ I   IL  
Sbjct: 57  EADNPWVVK-LYYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFYIAETILAI 114

Query: 807 -AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV---VEGDFARSSN- 861
            +   L Y         +HRDIK +N+L+  +    ++DFGL   +      +F R  + 
Sbjct: 115 DSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165

Query: 862 --------------------------------TVAGSYGYIAPE----YGYMMKITEKSD 885
                                           +  G+  YIAPE     GY     ++ D
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY----NKECD 221

Query: 886 VYSYGVVVLEVLTGKQPI--DPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEML 943
            +S GV++ E+L G  P   D        I++W            ++L+   EV +    
Sbjct: 222 WWSLGVIMYEMLVGYPPFCSDNPQETYRKIINW-----------KETLQFPDEVPLSPEA 270

Query: 944 QTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
           + L   L C     + R     V     EIK 
Sbjct: 271 KDLIKRLCC---EAERRLGNNGV----NEIKS 295

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 42.6 bits (101), Expect = 5e-04
 Identities = 50/190 (26%), Positives = 71/190 (37%), Gaps = 75/190 (39%)

Query: 744 SAEIKTLGSIR-HKNIVRFLGCCWNRNT-RL-----LM----YDYMPNGSLGSLLHERRD 792
             EI+ L  +  H NI+R +   ++R T RL     LM    Y+ +            R 
Sbjct: 45  LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKG----------RK 94

Query: 793 SCLEWELR-----YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL 847
             L  E R     Y+++      L ++H +    I HRDIK  NILI            +
Sbjct: 95  RPLP-EKRVKSYMYQLLKS----LDHMHRN---GIFHRDIKPENILI---------KDDI 137

Query: 848 AKLVVEGDFARSSNTVAGSYG------YI------APE-------YGYMMKITEKSDVYS 888
            KL    DF     +  G Y       YI      APE       YG  M      D+++
Sbjct: 138 LKL---ADFG----SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKM------DIWA 184

Query: 889 YGVVVLEVLT 898
            G V  E+L+
Sbjct: 185 VGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.2 bits (101), Expect = 5e-04
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 32/215 (14%)

Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 70

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDY-----MPNGSLGSLLHERRDSCLEWELRYRIIL 805
             + HKNI+  L     + +     D      + + +L  ++    D      L Y+++ 
Sbjct: 71  KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
           G    + +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V  
Sbjct: 131 G----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVT 181

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            Y Y APE    M   E  D++S G ++ E++  K
Sbjct: 182 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 6e-04
 Identities = 21/74 (28%), Positives = 32/74 (43%), Gaps = 14/74 (18%)

Query: 378 NLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLAS 437
           NL  L L +N ++  IP               +F     L++L+LS N L    P + + 
Sbjct: 1   NLKSLDLSNNRLTV-IPDG-------------AFKGLPNLKVLDLSGNNLTSISPEAFSG 46

Query: 438 LTRLQVLDISVNQF 451
           L  L+ LD+S N  
Sbjct: 47  LPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 43.1 bits (101), Expect = 6e-04
 Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 9/94 (9%)

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG--DFARSSNTVAGSYG 868
           L YLH   V   V+RDIK  N+++  +    I DFGL K   EG  D A +  T  G+  
Sbjct: 108 LEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGA-TMKTFCGTPE 160

Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           Y+APE           D +  GVV+ E++ G+ P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.8 bits (100), Expect = 7e-04
 Identities = 51/210 (24%), Positives = 94/210 (44%), Gaps = 26/210 (12%)

Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G    VY+ + + NG+++A+K +           Q ++    G   +   E   L  
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVI---------RLQEEE----GTPFTAIREASLLKG 59

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H NIV        + T  L+++Y+       +  ++    L  E     +    +GL+
Sbjct: 60  LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQLLRGLS 117

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y+H      I+HRD+K  N+LI    E  +ADFGLA+         S+  V  +  Y  P
Sbjct: 118 YIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPP 172

Query: 873 EYGYMMKITEKS---DVYSYGVVVLEVLTG 899
           +   ++  TE S   D++  G + +E++ G
Sbjct: 173 D--VLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 42.2 bits (99), Expect = 8e-04
 Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 22/160 (13%)

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------DSCLEW 797
           E + L  + H  IV+F      R+   ++ +Y     L   L E +        +   EW
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DF 856
            ++  +      G+ Y+H      I+HRD+KA NI +       I DFG+++L++   D 
Sbjct: 112 FIQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDL 161

Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
           A    T  G+  Y++PE         KSD++S G ++ E+
Sbjct: 162 A---TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.3 bits (90), Expect = 9e-04
 Identities = 17/54 (31%), Positives = 24/54 (44%), Gaps = 2/54 (3%)

Query: 337 WQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGI 389
             N+L            +L+ +DLS N LT S+ P  F  L +L  L L  N +
Sbjct: 8   SNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 22/152 (14%)

Query: 783 LGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI 842
           +   L+   +    W     + L A      LH +    IV RD+  NNIL+       +
Sbjct: 76  ISKFLNIPEECVKRWAAEMVVALDA------LHRE---GIVCRDLNPNNILLDDRGHIQL 126

Query: 843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
             F         +   S +  A    Y APE G + + TE  D +S G ++ E+LTGK  
Sbjct: 127 TYFSRWS-----EVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTL 181

Query: 903 IDPTIPEG------LHIVDWV-RQKRGAIEVL 927
           ++   P G      L+I +WV  + R  ++ L
Sbjct: 182 VE-CHPSGINTHTTLNIPEWVSEEARSLLQQL 212

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 18/60 (30%), Positives = 28/60 (46%), Gaps = 2/60 (3%)

Query: 56  LQKLIISGSNLTGPISPD-LGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQL 114
           L+ L +S + LT  I          L  +D+S N+L    P +   L +L+ L L+ N L
Sbjct: 2   LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 53/233 (22%), Positives = 102/233 (43%), Gaps = 41/233 (17%)

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE----RRDSCLEWELRYRIILGAA 808
           ++H NI++ LG C      LL+++Y   G L S L +    RR+S  +  L  R+    A
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNS--QLLLLQRMACEIA 109

Query: 809 QGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            G+ ++H H+     +H D+   N  +  +    + D+G+     + D+  + +      
Sbjct: 110 AGVTHMHKHN----FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL 165

Query: 868 GYIAPE-----YGYMMKI--TEKSDVYSYGVVVLEVL-TGKQPIDPTIPEGLHIVDWVRQ 919
            ++APE     +G ++    T+ S+V++ GV + E+     QP         H+ D    
Sbjct: 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS-------HLSD---- 214

Query: 920 KRGAIEVLDKSLRAR------PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                EVL+  ++ +      P++E+    +   V   C    P+ R T ++V
Sbjct: 215 ----REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 41.2 bits (96), Expect = 0.003
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 40/222 (18%)

Query: 692 SVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +++G G  G+VY A  ++  E +A+KK+       +Y                + E+  +
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKV---LQDPQYK---------------NRELLIM 113

Query: 751 GSIRHKNIV----RFLGCCWNRNTRLL----MYDYMPNGSLGSLLH-ERRDSCLEWELRY 801
            ++ H NI+     +   C+ +N + +    + +++P      + H  R +  L   L  
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVK 173

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
                  + LAY+H      I HRD+K  N+LI P      + DFG AK ++ G   RS 
Sbjct: 174 LYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSV 228

Query: 861 NTVAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTG 899
           + +   + Y APE   M+  T  +   D++S G ++ E++ G
Sbjct: 229 SYICSRF-YRAPE--LMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 48/217 (22%), Positives = 83/217 (38%), Gaps = 20/217 (9%)

Query: 691 DSVVGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS 744
           D ++G G  G VY  +      + N  V  ++ L   T+  E    N+   I  +     
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKI----- 71

Query: 745 AEIKTLGSIRHKNIVRFLGC-CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
           A  K + +I H  I ++ GC  + R      +  +      +    +R  C   +L   I
Sbjct: 72  ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNI 131

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGD----FAR 858
           +      L Y+H      I H DIK  NI++      YI D+G+A   ++ G        
Sbjct: 132 MKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLE 895
             +   G+  Y   +      +T + D+ S G  +L+
Sbjct: 189 QKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.004
 Identities = 28/85 (32%), Positives = 38/85 (44%), Gaps = 26/85 (30%)

Query: 488 SLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNK 547
           +L+SLDLS+N+L+                  +   A  G        L  L +LDLS N 
Sbjct: 1   NLKSLDLSNNRLT-----------------VIPDGAFKG--------LPNLKVLDLSGNN 35

Query: 548 LGG-DLLALSGLDNLVSLNVSYNNF 571
           L      A SGL +L SL++S NN 
Sbjct: 36  LTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1035
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.98
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.82
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.75
PRK10345	210	hypothetical protein; Provisional	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.73
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.71
smart00090	237	RIO RIO-like kinase.	99.71
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.65
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.58
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.57
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
PLN03150	623	hypothetical protein; Provisional	99.43
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.42
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.39
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.37
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.33
PLN03150	623	hypothetical protein; Provisional	99.32
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.31
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.25
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.25
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.22
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.18
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.18
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.17
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.17
KOG3087	229	consensus Serine/threonine protein kinase [General	99.16
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.11
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.1
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.09
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
KOG1243	690	consensus Protein kinase [General function predict	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.06
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.03
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	99.03
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.03
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.03
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.91
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.87
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.85
COG4248	637	Uncharacterized protein with protein kinase and he	98.83
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.77
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.72
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.68
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.65
PRK09902	216	hypothetical protein; Provisional	98.59
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.58
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.53
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.51
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.48
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.44
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.37
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.37

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.4e-110  Score=1071.35  Aligned_cols=900  Identities=33%  Similarity=0.542  Sum_probs=761.7

Q ss_pred             cccCCCCCCCCCCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCC-CCCCCceee
Q 039419            6 SALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLG-DCTQLTTID   84 (1035)
Q Consensus         6 ~~l~~w~~~~~~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~-~l~~L~~L~   84 (1035)
                      ..+++|+.. .+||.|.||+|+..+.|+.|+++++++.+.++..+..+++|+.|+|++|.+++.+|..+. .+++|++|+
T Consensus        46 ~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~  124 (968)
T PLN00113         46 KYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN  124 (968)
T ss_pred             ccCCCCCCC-CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEE
Confidence            357899765 489999999999878999999999999999999999999999999999999999998866 899999999


Q ss_pred             CCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccC
Q 039419           85 VSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIA  164 (1035)
Q Consensus        85 ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~  164 (1035)
                      |++|++++.+|.  +.+++|++|+|++|.+++.+|..++.+++|++|+|++|.+.+.+|..++++++|++|++++|. +.
T Consensus       125 Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~-l~  201 (968)
T PLN00113        125 LSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ-LV  201 (968)
T ss_pred             CcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCC-Cc
Confidence            999999988885  578999999999999999999999999999999999999999999999999999999999996 67


Q ss_pred             CCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhh
Q 039419          165 GKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELG  244 (1035)
Q Consensus       165 ~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~  244 (1035)
                      +.+|..++++++|+.|++++|++.+.+|..++++++|++|++++|.+.+.+|..++++++|+.|+|++|.+++.+|..+.
T Consensus       202 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~  281 (968)
T PLN00113        202 GQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF  281 (968)
T ss_pred             CcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHh
Confidence            78899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCcccee
Q 039419          245 KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQL  324 (1035)
Q Consensus       245 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  324 (1035)
                      ++++|++|++++|++.+.+|..+.++++|+.|++++|.+++..|..+..+++|+.|++++|.+.+..|..+..+++|+.|
T Consensus       282 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L  361 (968)
T PLN00113        282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL  361 (968)
T ss_pred             hccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcce
Q 039419          325 QLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI  404 (1035)
Q Consensus       325 ~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  404 (1035)
                      ++++|+++          +.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|++++|++++..|..+..     
T Consensus       362 ~Ls~n~l~----------~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~-----  426 (968)
T PLN00113        362 DLSTNNLT----------GEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK-----  426 (968)
T ss_pred             ECCCCeeE----------eeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhc-----
Confidence            99998775          467888999999999999999999999999999999999999999999888776544     


Q ss_pred             eEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccC
Q 039419          405 RLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLG  484 (1035)
Q Consensus       405 ~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  484 (1035)
                               ++.|+.|+|++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++++..|..|.
T Consensus       427 ---------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~  496 (968)
T PLN00113        427 ---------LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLG  496 (968)
T ss_pred             ---------CCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhh
Confidence                     5669999999999999999999999999999999999998888776 458999999999999999999999


Q ss_pred             CCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccC-ccccccccCCCcE
Q 039419          485 RCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVS  563 (1035)
Q Consensus       485 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~  563 (1035)
                      .+++|++|+|++|++++.+|..+..+..+. .|+|++|.+++.+|..|..+++|+.|||++|++.+ .|..+..+++|+.
T Consensus       497 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  575 (968)
T PLN00113        497 SLSELMQLKLSENKLSGEIPDELSSCKKLV-SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ  575 (968)
T ss_pred             hhhccCEEECcCCcceeeCChHHcCccCCC-EEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCE
Confidence            999999999999999999999988877655 79999999999999999999999999999999997 5567899999999


Q ss_pred             EeccCCcCcccCCChhhhhccccccccccccCCCCCC----CCCcCCCCcccCCCCCCCCCCcchhhhHHHHHHHHHHHH
Q 039419          564 LNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGH----ESCFLSNATTVGMGNGGGFRKSEKLKIAIALLVTFTIAL  639 (1035)
Q Consensus       564 L~ls~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~~----~~c~~~~~~~~~~~~~~~~~~~~~~~i~i~~~~~~~v~~  639 (1035)
                      |++++|++++.+|....|..+....+.||+.+|+.+.    .+|...           ..+..+.+.+++++++++++++
T Consensus       576 l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~-----------~~~~~~~~~~~~~~~~~~~~~~  644 (968)
T PLN00113        576 VNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV-----------RKTPSWWFYITCTLGAFLVLAL  644 (968)
T ss_pred             EeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc-----------cccceeeeehhHHHHHHHHHHH
Confidence            9999999999999998999999999999999998653    233210           0111222222222222222222


Q ss_pred             HHHHhhHhhhccCccCCCccccCCCCCCCCccCcccccCccHHHHHhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEe
Q 039419          640 AIFGAFAVVRAGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKL  718 (1035)
Q Consensus       640 ~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~  718 (1035)
                      ++++++.++|+++......+...+. .............++++++.+.|...++||+|+||.||+|++ .+++.||||++
T Consensus       645 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~  723 (968)
T PLN00113        645 VAFGFVFIRGRNNLELKRVENEDGT-WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI  723 (968)
T ss_pred             HHHHHHHHHhhhccccccccccccc-ccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEc
Confidence            2222222222221111111111110 000000111112356778888899999999999999999977 46899999988


Q ss_pred             cCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHH
Q 039419          719 WPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE  798 (1035)
Q Consensus       719 ~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~  798 (1035)
                      .....                  ....|++++++++|||||++++++.+++..|+||||+++|+|.++++.     ++|.
T Consensus       724 ~~~~~------------------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~  780 (968)
T PLN00113        724 NDVNS------------------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWE  780 (968)
T ss_pred             cCCcc------------------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHH
Confidence            53211                  123568899999999999999999999999999999999999999963     7899


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccC
Q 039419          799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM  878 (1035)
Q Consensus       799 ~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  878 (1035)
                      .+.+++.|+|+|++|||..+.++|+||||||+||+++.++.+++. ||.+.....      .....||+.|+|||+..+.
T Consensus       781 ~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~  853 (968)
T PLN00113        781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETK  853 (968)
T ss_pred             HHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCC
Confidence            999999999999999996655699999999999999999888875 665543211      1234688999999999999


Q ss_pred             CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc---hhhhcccccCCCcccHHHHHHHHHHHHhccCC
Q 039419          879 KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA---IEVLDKSLRARPEVEIEEMLQTLGVALLCVNP  955 (1035)
Q Consensus       879 ~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~  955 (1035)
                      .++.++|||||||++|||++|+.||+...........|++.....   ...+++.+.........+..+..+++.+||+.
T Consensus       854 ~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~  933 (968)
T PLN00113        854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT  933 (968)
T ss_pred             CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcC
Confidence            999999999999999999999999976555555667776643221   22334444433344456667778899999999


Q ss_pred             CCCCCCCHHHHHHHHHHHHHhH
Q 039419          956 TPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       956 dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ||++||+|+|+++.|+++.+..
T Consensus       934 ~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        934 DPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             CchhCcCHHHHHHHHHHhhccc
Confidence            9999999999999998875433

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.9e-58  Score=592.78  Aligned_cols=518  Identities=37%  Similarity=0.570  Sum_probs=483.0

Q ss_pred             cccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhh-ccccccceEecccCCCCCCchhhhhhcccccee
Q 039419           54 SFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIG-KLINLQDLILNSNQLTGEIPKELGACIKLKNLL  132 (1035)
Q Consensus        54 ~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  132 (1035)
                      .+++.|+|++|.+++.++..+..+++|++|+|++|++.+.+|..+. .+++|++|+|++|.+++.+|.  +.+++|++|+
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~  146 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD  146 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence            4689999999999999999999999999999999999999998876 999999999999999988885  5689999999


Q ss_pred             ccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccc
Q 039419          133 LFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLS  212 (1035)
Q Consensus       133 l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~  212 (1035)
                      |++|.+.+.+|..++++++|++|++++|. +.+.+|..++++++|++|++++|.+.+.+|..++++++|++|++++|.+.
T Consensus       147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  225 (968)
T PLN00113        147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNV-LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS  225 (968)
T ss_pred             CcCCcccccCChHHhcCCCCCEEECccCc-ccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence            99999999999999999999999999996 66788999999999999999999999999999999999999999999999


Q ss_pred             cCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCcccc
Q 039419          213 GEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFG  292 (1035)
Q Consensus       213 ~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~  292 (1035)
                      +.+|..++++++|+.|+|++|.+++.+|..|+++++|++|++++|++.+.+|..+.++++|+.|+|++|.+.+.+|..+.
T Consensus       226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~  305 (968)
T PLN00113        226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI  305 (968)
T ss_pred             CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCC
Q 039419          293 NLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPG  372 (1035)
Q Consensus       293 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~  372 (1035)
                      ++++|+.|++++|.+.+..|..+..+++|+.|++++|++.          +.+|..+..+++|+.|++++|++++..|..
T Consensus       306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~----------~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~  375 (968)
T PLN00113        306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFS----------GEIPKNLGKHNNLTVLDLSTNNLTGEIPEG  375 (968)
T ss_pred             CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCc----------CcCChHHhCCCCCcEEECCCCeeEeeCChh
Confidence            9999999999999999999999999999999999988764          567889999999999999999999999999


Q ss_pred             cccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccC
Q 039419          373 LFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFV  452 (1035)
Q Consensus       373 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~  452 (1035)
                      +..+++|+.|++++|.+.+..|..+..              +++|+.|+|++|++++..|..|..++.|+.|++++|+++
T Consensus       376 ~~~~~~L~~L~l~~n~l~~~~p~~~~~--------------~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  441 (968)
T PLN00113        376 LCSSGNLFKLILFSNSLEGEIPKSLGA--------------CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ  441 (968)
T ss_pred             HhCcCCCCEEECcCCEecccCCHHHhC--------------CCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCccc
Confidence            999999999999999999888876654              466999999999999999999999999999999999999


Q ss_pred             CCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccc
Q 039419          453 GLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQI  532 (1035)
Q Consensus       453 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~  532 (1035)
                      +.++..+..+++|+.|+|++|++.+.+|..+ ..++|+.|+|++|++++.+|..+..+..+. .|+|++|++.+.+|+.+
T Consensus       442 ~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~  519 (968)
T PLN00113        442 GRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELM-QLKLSENKLSGEIPDEL  519 (968)
T ss_pred             CccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccC-EEECcCCcceeeCChHH
Confidence            9999999999999999999999998888766 468999999999999999998888776664 79999999999999999


Q ss_pred             cCCccccEEeccCCcccCc-cccccccCCCcEEeccCCcCcccCCCh-hhhhccccccccccccCCCCCC
Q 039419          533 SALNKLSILDLSHNKLGGD-LLALSGLDNLVSLNVSYNNFTGYLPDS-KLFRQLSATEMAGNQGLCSRGH  600 (1035)
Q Consensus       533 ~~l~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~l~~~~~~~N~~~c~~~~  600 (1035)
                      ..+++|++|+|++|++++. +..+..+++|+.|+|++|++++.+|.. ..+..+..+++.+|+..+..|.
T Consensus       520 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~  589 (968)
T PLN00113        520 SSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS  589 (968)
T ss_pred             cCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence            9999999999999999985 467999999999999999999988864 3466788889999998876664

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=413.28  Aligned_cols=278  Identities=42%  Similarity=0.789  Sum_probs=230.6

Q ss_pred             HHHHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          681 VEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       681 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      +...+++|...++||+|+||.||+|...+|+.||||++.......              ..+|.+|+.++.+++|||+|+
T Consensus        70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--------------~~eF~~Ei~~ls~l~H~Nlv~  135 (361)
T KOG1187|consen   70 LRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--------------EREFLNEVEILSRLRHPNLVK  135 (361)
T ss_pred             HHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--------------hhHHHHHHHHHhcCCCcCccc
Confidence            455568999999999999999999999999999999875532210              245999999999999999999


Q ss_pred             EEeEEEcCC-cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          761 FLGCCWNRN-TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       761 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++|||.+.+ +.++|||||++|+|.++++......++|..|++||.++|+||+|||+.+.+.|+||||||+|||+|++++
T Consensus       136 LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  136 LLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             EEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence            999999998 5999999999999999998765436899999999999999999999998888999999999999999999


Q ss_pred             eEEeeccCccccccCCcccccccc-CCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC-CchhHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTV-AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP-EGLHIVDWV  917 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~-~~~~~~~~~  917 (1035)
                      +||+|||+|+......  ...... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+...+ .......|+
T Consensus       216 aKlsDFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~  293 (361)
T KOG1187|consen  216 AKLSDFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA  293 (361)
T ss_pred             EEccCccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence            9999999996543311  111122 899999999999999999999999999999999999999886543 334477776


Q ss_pred             HHhc---cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          918 RQKR---GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       918 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      ....   ...+++|+.+.........++.+...++.+|++++|++||+|.||++.|+.+.
T Consensus       294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            4422   33567777766322211256777888999999999999999999999885543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-46  Score=386.55  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=206.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .+++..+.||+|..|+||+++++ +++.+|+|++......             ..++++.+|++++++.+||+||.+||.
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~-------------~~~~Qi~rEl~il~~~~spyIV~~yga  145 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP-------------ALQKQILRELEILRSCQSPYIVGFYGA  145 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH-------------HHHHHHHHHHHHHhhCCCCCeeeEeEE
Confidence            34556789999999999999887 5889999999443221             246789999999999999999999999


Q ss_pred             EEcCC-cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceEE
Q 039419          765 CWNRN-TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       765 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      |..++ ..+++||||++|||+++++..+.  +++....+|+.+|++||.|||+ +   +||||||||+|||++..|+|||
T Consensus       146 F~~~~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKi  220 (364)
T KOG0581|consen  146 FYSNGEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKI  220 (364)
T ss_pred             EEeCCceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEe
Confidence            99998 49999999999999999987654  8999999999999999999996 5   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      ||||.++...+.    .....+||..|||||.+.+..|+.++||||||++++|+.+|++||.+..+........+..   
T Consensus       221 cDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~---  293 (364)
T KOG0581|consen  221 CDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA---  293 (364)
T ss_pred             ccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH---
Confidence            999999987664    4457899999999999999999999999999999999999999998753322222222111   


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         .++......|..  ....++..++-.|+++||.+||+++|++++
T Consensus       294 ---Iv~~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  294 ---IVDEPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ---HhcCCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               111111111111  112223446777999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-45  Score=381.37  Aligned_cols=204  Identities=30%  Similarity=0.510  Sum_probs=182.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+.......            ...+-+..|+++++.++|||||++++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~------------k~~e~L~~Ei~iLkel~H~nIV~l~d   76 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK------------KLVELLLSEIKILKELKHPNIVRLLD   76 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH------------HHHHHHHHHHHHHHhcCCcceeeEEE
Confidence            456888888999999999999876 48999999997654322            23567889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC------
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE------  837 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~------  837 (1035)
                      +++.++..|+|||||+||+|.+|++.++.  +++..+..++.|+|.|+++||++   +||||||||+|||++..      
T Consensus        77 ~~~~~~~i~lVMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~  151 (429)
T KOG0595|consen   77 CIEDDDFIYLVMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTS  151 (429)
T ss_pred             EEecCCeEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCC
Confidence            99999999999999999999999998765  99999999999999999999999   99999999999999865      


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      -.+||+|||+|+...++..   ..+.+|++.|||||++...+|+.|+|+||+|+++|||++|+.||+...+
T Consensus       152 ~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  152 PVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             ceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            4589999999999876543   3478999999999999999999999999999999999999999986543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-44  Score=396.65  Aligned_cols=260  Identities=35%  Similarity=0.564  Sum_probs=209.8

Q ss_pred             ccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcC
Q 039419          689 VEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR  768 (1035)
Q Consensus       689 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  768 (1035)
                      ...+.||+|+||+||+|.|.....||||++........            ..+.|.+|+.+|.+++|||||+++|++.++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~------------~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDE------------SRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChH------------HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            34456999999999999999555599999976543332            156899999999999999999999999988


Q ss_pred             C-cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCC-eeccCCCcccEEEcCCC-ceEEeec
Q 039419          769 N-TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPP-IVHRDIKANNILIGPEF-EPYIADF  845 (1035)
Q Consensus       769 ~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivHrDikp~NIll~~~~-~~kl~DF  845 (1035)
                      . ..++||||+++|+|.++++......+++..+++++.+||+||.|||++   + ||||||||+|||++.++ ++||+||
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCC
Confidence            7 789999999999999999885445699999999999999999999999   7 99999999999999998 9999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGY--MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |+++......  .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||....+  .+....+-.    
T Consensus       189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~----  260 (362)
T KOG0192|consen  189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVV----  260 (362)
T ss_pred             ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh----
Confidence            9998765432  2334478999999999999  56899999999999999999999999987654  222222111    


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                           ...+...+..  ....+..++.+||+.||++||++.+++..|+.+.....
T Consensus       261 -----~~~Rp~~p~~--~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  261 -----GGLRPPIPKE--CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             -----cCCCCCCCcc--CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                 1111111111  11223346677999999999999999999998876544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-45  Score=380.47  Aligned_cols=262  Identities=24%  Similarity=0.345  Sum_probs=209.6

Q ss_pred             HHHhccccCCeeeeeCCcEEEEE-EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ...+.|...+.+|+|+||.|-+| +.++|+.||||++........... .      .-...+.+|+++|++|+||+||++
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~-~------~~~~~v~~EieILkkL~HP~IV~~  241 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA-I------AKTRDVQNEIEILKKLSHPNIVRI  241 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc-c------cchhhhHHHHHHHHhcCCCCEEEE
Confidence            35577889999999999999999 455799999999987655442210 0      012346799999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC---C
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE---F  838 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~---~  838 (1035)
                      +++|..++..||||||++||+|.+.+-..+.  +.+.....++.|++.|+.|||++   ||+||||||+|||+..+   .
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~  316 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDC  316 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcce
Confidence            9999999999999999999999999876654  77788889999999999999999   99999999999999766   6


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCC--C-ccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI--T-EKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~-~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                      .+||+|||+|+....+   ..+.+.+||+.|.|||++.+..+  . .++|+||+||++|-+++|.+||....... ...+
T Consensus       317 llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-sl~e  392 (475)
T KOG0615|consen  317 LLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-SLKE  392 (475)
T ss_pred             EEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-cHHH
Confidence            7999999999987654   34568899999999999875543  3 47899999999999999999998643221 0111


Q ss_pred             HHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                               ..........+..+..-..+.+.++.+|+..||++||++.|++++
T Consensus       393 ---------QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  393 ---------QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ---------HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                     112222333334444555567789999999999999999999985

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-44  Score=395.08  Aligned_cols=251  Identities=27%  Similarity=0.399  Sum_probs=211.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|||+.||.++. ..|+.||+|++.+......           ..++.+.+|+++.+.|+|||||+++++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-----------~~reKv~~EIeIHr~L~HpnIV~f~~~   86 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-----------KQREKVLNEIEIHRSLKHPNIVQFYHF   86 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-----------chHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence            5689999999999999999987 6799999999976544433           457889999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |++.+.+|+|.|+|..++|..+++.++  .+++.+++.+++||+.||.|||+.   +|+|||||..|+|++++.++||+|
T Consensus        87 FEDs~nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgD  161 (592)
T KOG0575|consen   87 FEDSNNVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGD  161 (592)
T ss_pred             eecCCceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecc
Confidence            999999999999999999999998544  499999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|......+.  ...+.+|||.|.|||++.....+..+||||+|||+|-|+.|++||+...-         +.....+
T Consensus       162 FGLAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---------kety~~I  230 (592)
T KOG0575|consen  162 FGLATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---------KETYNKI  230 (592)
T ss_pred             cceeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH---------HHHHHHH
Confidence            999998875532  23578999999999999999999999999999999999999999985411         1111111


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..-+...+.      .-...+.++|..+|++||.+|||+++|+.+
T Consensus       231 k~~~Y~~P~------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  231 KLNEYSMPS------HLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HhcCccccc------ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            111112222      122233457778999999999999999985

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=368.26  Aligned_cols=252  Identities=24%  Similarity=0.324  Sum_probs=204.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|+..++||+|+||.||+++.++ ++.||+|++++......           ...+...+|..++.+++||+||+++.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----------~e~~~~~~Er~IL~~v~hPFiv~l~y   92 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----------KEVRHTKAERNILSKIKHPFIVKLIY   92 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----------hhHHHHHHHHHHHHhCCCCcEeeeEE
Confidence            3678999999999999999997664 89999999976544333           34678899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .|++.+..|+|+||+.||.|...++..+.  +++..+.-++.+|+.||.|||+.   ||||||+||+|||+|.+|+++|+
T Consensus        93 sFQt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen   93 SFQTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             ecccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEe
Confidence            99999999999999999999999987665  99999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+|+......  ..+.+++||+.|||||++.+..|+.++|.||+|+++|||++|.+||....     ...+.+..   
T Consensus       168 DFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~~~~~~~I---  237 (357)
T KOG0598|consen  168 DFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----VKKMYDKI---  237 (357)
T ss_pred             ccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----HHHHHHHH---
Confidence            999999654433  23346899999999999999999999999999999999999999997542     12222211   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC----CHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP----TMKDVAA  968 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP----s~~el~~  968 (1035)
                         ....+...+.....   ...+++.+.+..||++|-    ++.+|.+
T Consensus       238 ---~~~k~~~~p~~ls~---~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  238 ---LKGKLPLPPGYLSE---EARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             ---hcCcCCCCCccCCH---HHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence               11111111111111   223466778999999995    5666554

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=384.42  Aligned_cols=255  Identities=27%  Similarity=0.454  Sum_probs=212.7

Q ss_pred             cccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      +...+.||+|-||.||.|.+.....||+|.++.....               .+.|.+|+++|++|+|++||+++++|..
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---------------~~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---------------PEAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---------------hhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            4456789999999999999998889999999765332               3579999999999999999999999999


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                      ++.+|||||||+.|+|.++++...+..+...+.+.++.|||+|++||+++   ++|||||..+||||+++..+||+|||+
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGL  349 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGL  349 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccc
Confidence            99999999999999999999986667799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          848 AKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       848 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      |+...+ +.+.......-+..|.|||.+...+++.|||||||||+||||+| |+.||....     ..+.+       +.
T Consensus       350 Ar~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev~-------~~  416 (468)
T KOG0197|consen  350 ARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEVL-------EL  416 (468)
T ss_pred             ccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHHH-------HH
Confidence            995444 33444445556788999999999999999999999999999999 899987542     22222       23


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      +.+..+...+..+++  .+.+++..||+.+|++|||++.+...++++..
T Consensus       417 le~GyRlp~P~~CP~--~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  417 LERGYRLPRPEGCPD--EVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HhccCcCCCCCCCCH--HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            333333333332222  23458888999999999999999998888754

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.7e-46  Score=387.51  Aligned_cols=484  Identities=29%  Similarity=0.409  Sum_probs=398.3

Q ss_pred             CcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhcccccee
Q 039419           53 LSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLL  132 (1035)
Q Consensus        53 l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  132 (1035)
                      -..|+.|+|+.|.++ .+-+.+.+|..|++|++.+|++. .+|.+|+.+..++.|+.++|+++ .+|++++.+.+|++|+
T Consensus        44 qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~  120 (565)
T KOG0472|consen   44 QVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD  120 (565)
T ss_pred             hcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence            345788999999998 67777899999999999999999 89999999999999999999998 8999999999999999


Q ss_pred             ccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccc
Q 039419          133 LFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLS  212 (1035)
Q Consensus       133 l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~  212 (1035)
                      .++|.+. ++|++++.+..|+.|+..+|+  ....|..+..+.+|..+++.+|+++...|+.+. |+.|+.|+...|.++
T Consensus       121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~--i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~  196 (565)
T KOG0472|consen  121 CSSNELK-ELPDSIGRLLDLEDLDATNNQ--ISSLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE  196 (565)
T ss_pred             cccccee-ecCchHHHHhhhhhhhccccc--cccCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh
Confidence            9999998 899999999999999999887  667899999999999999999999965555555 999999999999998


Q ss_pred             cCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCcccc-CCCCCcEEEccCccCCCCCCccc
Q 039419          213 GEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIG-NCKSLKTIDLSLNFFSGSLPQSF  291 (1035)
Q Consensus       213 ~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~  291 (1035)
                       .+|+.++.+.+|..|+|.+|+|. .+| +|..+..|.+|+++.|++. .+|.+.. ++++|.+|||..|+++ ..|+.+
T Consensus       197 -tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~  271 (565)
T KOG0472|consen  197 -TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEI  271 (565)
T ss_pred             -cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHH
Confidence             89999999999999999999999 677 8999999999999999999 6776665 9999999999999999 789999


Q ss_pred             cCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcE----EeccCcCCC-
Q 039419          292 GNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA----VDLSHNALT-  366 (1035)
Q Consensus       292 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~----L~Ls~N~l~-  366 (1035)
                      +-+++|++||+|+|.|+ ..|..++++ .|+.|.+.+|.++.+...  -+.+.-...   ++.|+.    =-++.-.=. 
T Consensus       272 clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~--ii~~gT~~v---LKyLrs~~~~dglS~se~~~  344 (565)
T KOG0472|consen  272 CLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRRE--IISKGTQEV---LKYLRSKIKDDGLSQSEGGT  344 (565)
T ss_pred             HHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHH--HHcccHHHH---HHHHHHhhccCCCCCCcccc
Confidence            99999999999999999 667789999 999999999999866420  000000000   111111    001110000 


Q ss_pred             -------CCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCC
Q 039419          367 -------GSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLT  439 (1035)
Q Consensus       367 -------~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~  439 (1035)
                             ....+....+.+.+.|+++.-+++..+.+.|....+            .-+...+++.|++. .+|..+..++
T Consensus       345 e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~------------~~Vt~VnfskNqL~-elPk~L~~lk  411 (565)
T KOG0472|consen  345 ETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKS------------EIVTSVNFSKNQLC-ELPKRLVELK  411 (565)
T ss_pred             cccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhh------------cceEEEecccchHh-hhhhhhHHHH
Confidence                   011122234567888888888888543333322111            22678999999999 6788888777


Q ss_pred             Ccc-EEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceee
Q 039419          440 RLQ-VLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLN  518 (1035)
Q Consensus       440 ~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~  518 (1035)
                      .+. .+++++|.++ .+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|+|++. .+|..+..+..+. .+-
T Consensus       412 elvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE-tll  487 (565)
T KOG0472|consen  412 ELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE-TLL  487 (565)
T ss_pred             HHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH-HHH
Confidence            654 4677777776 77889999999999999999998 78999999999999999999998 8998877776665 355


Q ss_pred             ccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCc
Q 039419          519 LSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT  572 (1035)
Q Consensus       519 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~  572 (1035)
                      .++|++..+.|..+.+|.+|.+|||.+|.|...|+.++++.+|++|++++|+|+
T Consensus       488 as~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  488 ASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            677999988888899999999999999999999999999999999999999999

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-44  Score=355.86  Aligned_cols=255  Identities=21%  Similarity=0.328  Sum_probs=201.4

Q ss_pred             HhccccCCeeeeeCCcEEEEE-EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +..|++.++||+|+||+||++ ...+|..+|.|.++-...+..            .+++...|+.+|++|+|||||++++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k------------~rq~~v~Ei~lLkQL~HpNIVqYy~   85 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAK------------ARQDCVKEISLLKQLNHPNIVQYYA   85 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHH------------HHHHHHHHHHHHHhcCCchHHHHHH
Confidence            456888889999999999999 556799999999975443332            4678999999999999999999999


Q ss_pred             -EEEcCCc-ceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeccCCCcccEEEcCC
Q 039419          764 -CCWNRNT-RLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPP--IVHRDIKANNILIGPE  837 (1035)
Q Consensus       764 -~~~~~~~-~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivHrDikp~NIll~~~  837 (1035)
                       .+.++.. .++|||||.+|+|.+.++..  ....+++..+++++.|+++||.++|.+.. .  |+||||||.||+++.+
T Consensus        86 ~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~  164 (375)
T KOG0591|consen   86 HSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTAN  164 (375)
T ss_pred             HhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCC
Confidence             4544444 79999999999999988643  34569999999999999999999999432 4  9999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      |.||++|||+++++.....  .....+|||.||+||.+.+..|+.|+||||+||++|||+.-+.||.+.  .-......+
T Consensus       165 gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI  240 (375)
T KOG0591|consen  165 GVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKI  240 (375)
T ss_pred             CceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHH
Confidence            9999999999998866432  234689999999999999999999999999999999999999999754  111111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA  967 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~  967 (1035)
                      .+.         ..+..|.  .-..-++..++..|+.+||+.||+...++
T Consensus       241 ~qg---------d~~~~p~--~~YS~~l~~li~~ci~vd~~~RP~t~~~v  279 (375)
T KOG0591|consen  241 EQG---------DYPPLPD--EHYSTDLRELINMCIAVDPEQRPDTVPYV  279 (375)
T ss_pred             HcC---------CCCCCcH--HHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence            111         1111111  12223344577889999999999843333

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=376.54  Aligned_cols=254  Identities=23%  Similarity=0.320  Sum_probs=209.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  763 (1035)
                      ++|..++.||+|+|++||+|+.+ .++.||||++.++....+..           .+.+.+|-.+|.+| .||.|+++|.
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K-----------vkYV~~Ek~~l~~L~~hPgivkLy~  141 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK-----------VKYVTREKEALTQLSGHPGIVKLYF  141 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc-----------cchhhHHHHHHHHhhCCCCeEEEEE
Confidence            57889999999999999999665 58999999997665544322           35678899999999 8999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .|+++...|+|+||+++|+|.++|++.+.  +++..+..++.+|+.||+|||++   |||||||||+|||+|.+|+++|+
T Consensus       142 TFQD~~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikIT  216 (604)
T KOG0592|consen  142 TFQDEESLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKIT  216 (604)
T ss_pred             EeecccceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEe
Confidence            99999999999999999999999998765  99999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCcc---------ccc--cccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          844 DFGLAKLVVEGDFA---------RSS--NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       844 DFG~a~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      |||.|+.+.+....         ...  ..++||..|++||++.....++.+|+|+|||++|+|+.|++||....+.  .
T Consensus       217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--l  294 (604)
T KOG0592|consen  217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--L  294 (604)
T ss_pred             eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--H
Confidence            99999987643211         111  4589999999999999999999999999999999999999999865321  1


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      +.+.+       ..++..+....+.      .+.+++.+.+..||.+|++.+||.++.
T Consensus       295 iFqkI-------~~l~y~fp~~fp~------~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  295 IFQKI-------QALDYEFPEGFPE------DARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HHHHH-------HHhcccCCCCCCH------HHHHHHHHHHccCccccccHHHHhhCc
Confidence            11111       1122223333222      234466778999999999999998864

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.2e-41  Score=340.14  Aligned_cols=262  Identities=23%  Similarity=0.335  Sum_probs=202.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+...++|+|+||+||++++++ |+.||||++.....+            ..+++-..||++++++++|||+|.++++
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd------------~~VkKIAlREIrmLKqLkH~NLVnLiEV   69 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD------------PVVKKIALREIRMLKQLKHENLVNLIEV   69 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc------------HHHHHHHHHHHHHHHhcccchHHHHHHH
Confidence            568888899999999999998875 999999999543221            1356778999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |......++|+|||+- ++-+.+.... ..++...+.+++.|+++|+.|+|++   +++||||||+|||++.+|.+||||
T Consensus        70 FrrkrklhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCD  144 (396)
T KOG0593|consen   70 FRRKRKLHLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCD  144 (396)
T ss_pred             HHhcceeEEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEecc
Confidence            9999999999999965 4444454433 3388899999999999999999999   999999999999999999999999


Q ss_pred             ccCccccc-cCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          845 FGLAKLVV-EGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       845 FG~a~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      ||+|+... +++.   .+.++.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|.+..+  .+....++...+
T Consensus       145 FGFAR~L~~pgd~---YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG  219 (396)
T KOG0593|consen  145 FGFARTLSAPGDN---YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLG  219 (396)
T ss_pred             chhhHhhcCCcch---hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHc
Confidence            99999886 4333   346788999999998876 7899999999999999999999988875432  222222222111


Q ss_pred             c-----hhhhcc--c-----ccCC--Ccc----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 A-----IEVLDK--S-----LRAR--PEV----EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~-----~~~~~~--~-----~~~~--~~~----~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .     ...+..  .     ++..  ++.    .....--.++++..|++.||++|++.+|++.+
T Consensus       220 ~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  220 NLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            1     111110  0     0000  000    00111235678899999999999999999863

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.8e-45  Score=377.48  Aligned_cols=483  Identities=28%  Similarity=0.412  Sum_probs=359.0

Q ss_pred             EEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecc
Q 039419           32 VTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNS  111 (1035)
Q Consensus        32 v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~  111 (1035)
                      ...+.+++|.+. .+-+++.+|..|.+|++++|.+. +.|++++.+.+++.|+.++|+++ ++|+.++.+.+|..|++++
T Consensus        47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~  123 (565)
T KOG0472|consen   47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS  123 (565)
T ss_pred             hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence            345677788777 45667889999999999999998 78999999999999999999999 9999999999999999999


Q ss_pred             cCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccC
Q 039419          112 NQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSL  191 (1035)
Q Consensus       112 n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~  191 (1035)
                      |.+. ++|++++.+-.|..|+..+|++. .+|+.++++.+|..|++.+|+  ....|...-.|+.|++++...|-+. .+
T Consensus       124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~--l~~l~~~~i~m~~L~~ld~~~N~L~-tl  198 (565)
T KOG0472|consen  124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNK--LKALPENHIAMKRLKHLDCNSNLLE-TL  198 (565)
T ss_pred             ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccc--hhhCCHHHHHHHHHHhcccchhhhh-cC
Confidence            9998 88899999999999999999998 899999999999999999997  4456655555999999999888775 88


Q ss_pred             cccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhh-cccchhHhhcccccccccCCccccCC
Q 039419          192 PASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELG-KLQKLEKMLLWQNNFDGAIPEEIGNC  270 (1035)
Q Consensus       192 p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~l~~n~l~~~~p~~~~~l  270 (1035)
                      |..++.|.+|+.|++++|++. .+| +|..++.|++|+++.|+|. .+|.+.+ ++++|..|||.+|++. ..|+.++-+
T Consensus       199 P~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clL  274 (565)
T KOG0472|consen  199 PPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLL  274 (565)
T ss_pred             ChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHh
Confidence            999999999999999999998 777 8999999999999999999 6777665 8999999999999999 789999999


Q ss_pred             CCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCC--ccceecc--ccchhhhhhhhccccCCC--
Q 039419          271 KSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNAT--SLLQLQL--DTNQISVFFAWQNKLEGS--  344 (1035)
Q Consensus       271 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L--~~N~i~~l~~~~n~l~~~--  344 (1035)
                      .+|.+||+++|.|+ ..|..++++ .|+.|.+.+|.+..+-.+.+..-+  -|++|.=  ..-.++.-. ...--.+.  
T Consensus       275 rsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se-~~~e~~~t~~  351 (565)
T KOG0472|consen  275 RSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSE-GGTETAMTLP  351 (565)
T ss_pred             hhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCc-ccccccCCCC
Confidence            99999999999999 578889999 899999999998643333222211  1333321  000110000 00000001  


Q ss_pred             --CCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcc---cceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccce
Q 039419          345 --IPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQN---LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQM  419 (1035)
Q Consensus       345 --~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~  419 (1035)
                        .......+.+.+.|++++-+++ .+|...+....   .+..+++.|++.. .|..+..+..+             +..
T Consensus       352 ~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~e-lPk~L~~lkel-------------vT~  416 (565)
T KOG0472|consen  352 SESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLCE-LPKRLVELKEL-------------VTD  416 (565)
T ss_pred             CCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHhh-hhhhhHHHHHH-------------HHH
Confidence              1112234556778888888887 44444443333   7778888888874 35444333221             334


Q ss_pred             eecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcC
Q 039419          420 LNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKL  499 (1035)
Q Consensus       420 L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  499 (1035)
                      +.+++|.++ .+|..++.+++|..|+|++|-+.. +|..++.+..|+.|++++|++. .+|..+..+..|+.+-.++|++
T Consensus       417 l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~-LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi  493 (565)
T KOG0472|consen  417 LVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLND-LPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQI  493 (565)
T ss_pred             HHhhcCccc-cchHHHHhhhcceeeecccchhhh-cchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccc
Confidence            556666665 566667777777777777776663 4556666666777777777776 6666666666666666666777


Q ss_pred             cCccchh-hhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccC
Q 039419          500 SGKIPVE-LFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG  550 (1035)
Q Consensus       500 ~~~~p~~-~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  550 (1035)
                      . .++.+ +.....+ +.|||.+|.+. .+|+.+++|++|++|+|++|.+..
T Consensus       494 ~-~vd~~~l~nm~nL-~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~  542 (565)
T KOG0472|consen  494 G-SVDPSGLKNMRNL-TTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ  542 (565)
T ss_pred             c-ccChHHhhhhhhc-ceeccCCCchh-hCChhhccccceeEEEecCCccCC
Confidence            5 44443 4444444 35777777776 678889999999999999999984

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=331.59  Aligned_cols=203  Identities=25%  Similarity=0.336  Sum_probs=183.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +++|+..+.+|.|+||+|.+++.+ +|..||+|++.....-.           ....++...|..+++.+.||+++++++
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-----------lKQveH~~nEk~vL~~v~~PFlv~l~~  111 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-----------LKQVEHTHNEKRVLKAVSHPFLVKLYG  111 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-----------HHHHHHHhhHHHHHhhccCceeEEEEE
Confidence            457888899999999999999876 48899999996543322           234678889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .+.+.+..|+||||++||.|.+++++.++  +++..++.++.||+.|++|||+.   +|++||+||+|||+|.+|.+||+
T Consensus       112 t~~d~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKit  186 (355)
T KOG0616|consen  112 TFKDNSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKIT  186 (355)
T ss_pred             eeccCCeEEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEE
Confidence            99999999999999999999999998766  99999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      |||+|+.....     +.+.+|||.|+|||++....+..++|.|||||++|||+.|.+||....+
T Consensus       187 DFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  187 DFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             eccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            99999976442     3478999999999999999999999999999999999999999976543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=352.17  Aligned_cols=266  Identities=22%  Similarity=0.254  Sum_probs=208.4

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCcee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIV  759 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv  759 (1035)
                      ....++|...+.||.|.||.||+|+. .+|+.||||+++.+...-+             .-.=.||+..+++++ |||||
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-------------e~~nLREvksL~kln~hpnii   72 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-------------ECMNLREVKSLRKLNPHPNII   72 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-------------HHHHHHHHHHHHhcCCCCcch
Confidence            45678899999999999999999955 4699999999976543211             112368999999998 99999


Q ss_pred             eEEeEEEcCC-cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          760 RFLGCCWNRN-TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       760 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      ++.+++.+.+ ..|+||||| ..+|+++++.+ ...|++..+..|+.||++||+|+|.+   |+.|||+||+|||+....
T Consensus        73 kL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~  147 (538)
T KOG0661|consen   73 KLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGND  147 (538)
T ss_pred             hhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccc
Confidence            9999999988 899999999 57999999988 56799999999999999999999999   999999999999999888


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG-YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      .+||+|||+|+.+.....   .+.++.|.+|.|||++ +.+.|+.+.||||+|||++|+.+-++-|.+... -.++...-
T Consensus       148 ~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc  223 (538)
T KOG0661|consen  148 VIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKIC  223 (538)
T ss_pred             eeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHH
Confidence            999999999998766543   3478899999999985 567799999999999999999999988865432 11121111


Q ss_pred             HHhc-cc----------hhhhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKR-GA----------IEVLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~-~~----------~~~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .... +.          ...+.-.+...+...++     ...+...++.+|+.+||++||||+|++++
T Consensus       224 ~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  224 EVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1100 00          01111112222222222     22356678889999999999999999986

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-40  Score=344.28  Aligned_cols=264  Identities=24%  Similarity=0.346  Sum_probs=207.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|+..+.||.|..++||+|+. +.++.||||++..+....+             .+.+.+|+..|+.++||||++++.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-------------ld~l~kE~~~msl~~HPNIv~~~~   91 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-------------LDALRKEVQTMSLIDHPNIVTYHC   91 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-------------HHHHHHHHHHhhhcCCCCcceEEE
Confidence            36788999999999999999954 5689999999976543332             468999999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .|..+...|+||.||.+||+.+.++..-...+++..+..|++++++||.|||++   |.||||||+.|||++.+|.|||+
T Consensus        92 sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen   92 SFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             EEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEc
Confidence            999999999999999999999999988777799999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCc-cccc-cccCCcccccCCcccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          844 DFGLAKLVVEGDF-ARSS-NTVAGSYGYIAPEYGY--MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       844 DFG~a~~~~~~~~-~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      |||.+..+.+... .... ...+||+.|||||+..  ...|+.|+||||||++..|+.+|..||....|-..-. ..+..
T Consensus       169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-~tLqn  247 (516)
T KOG0582|consen  169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-LTLQN  247 (516)
T ss_pred             CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-HHhcC
Confidence            9998876655432 1112 5678999999999943  3469999999999999999999999998654422111 01110


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....+  ..  ....+...........++..|+++||++|||+++++++
T Consensus       248 ~pp~~~--t~--~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  248 DPPTLL--TS--GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCCCcc--cc--cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            000000  00  00000001111133456677999999999999999873

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=350.51  Aligned_cols=257  Identities=31%  Similarity=0.439  Sum_probs=199.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++...+.||+|+||+||++...+ |+.+|||.+......              ..+.+.+|+.+|++++|||||+++|..
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--------------~~~~l~~Ei~iL~~l~~p~IV~~~G~~   83 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--------------TSESLEREIRILSRLNHPNIVQYYGSS   83 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--------------hHHHHHHHHHHHHhCCCCCEEeeCCcc
Confidence            46667899999999999997664 899999998653110              145689999999999999999999985


Q ss_pred             EcCC--cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-CCceEE
Q 039419          766 WNRN--TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-EFEPYI  842 (1035)
Q Consensus       766 ~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl  842 (1035)
                      ...+  .++++|||+++|+|.+++...+. .+++..+..+..||++||+|||++   ||+||||||+|||++. ++.+||
T Consensus        84 ~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kl  159 (313)
T KOG0198|consen   84 SSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKL  159 (313)
T ss_pred             ccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEe
Confidence            5544  58999999999999999998775 599999999999999999999999   9999999999999999 799999


Q ss_pred             eeccCcccccc-CCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          843 ADFGLAKLVVE-GDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       843 ~DFG~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      +|||.++.... ...........||+.|||||+... ....+++||||+||++.||+||+.||....    ....++-..
T Consensus       160 aDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~----~~~~~~~~i  235 (313)
T KOG0198|consen  160 ADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF----EEAEALLLI  235 (313)
T ss_pred             ccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc----chHHHHHHH
Confidence            99999987653 111223346789999999999884 344569999999999999999999997530    111111111


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      .     .....+.. +..+.+  ...+++.+|+..||++||||++++++....
T Consensus       236 g-----~~~~~P~i-p~~ls~--~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  236 G-----REDSLPEI-PDSLSD--EAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             h-----ccCCCCCC-CcccCH--HHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence            0     01111111 111111  234577789999999999999999975443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=364.76  Aligned_cols=369  Identities=25%  Similarity=0.234  Sum_probs=310.7

Q ss_pred             ceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcc
Q 039419          176 SLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLW  255 (1035)
Q Consensus       176 ~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~  255 (1035)
                      .-+.|++++|++....++.|.++++|+++++.+|.++ .+|...+...+|+.|+|.+|.|+.+-.+.+..++.|+.|||+
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            3467899999999999999999999999999999999 899888888889999999999998888899999999999999


Q ss_pred             cccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhh
Q 039419          256 QNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFF  335 (1035)
Q Consensus       256 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~  335 (1035)
                      .|.|+...-..|..-.++++|+|++|+|+....+.|.++.+|..|.|+.|+|+...+..|.++++|+.|+|..|+|+...
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive  237 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE  237 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence            99999766667877789999999999999999999999999999999999999999999999999999999999998542


Q ss_pred             hhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCC
Q 039419          336 AWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCT  415 (1035)
Q Consensus       336 ~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~  415 (1035)
                      .          .+|.++++|+.|.|..|.|.......|..+.++++|+|+.|+++....+++              .+++
T Consensus       238 ~----------ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~l--------------fgLt  293 (873)
T KOG4194|consen  238 G----------LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWL--------------FGLT  293 (873)
T ss_pred             h----------hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccc--------------cccc
Confidence            2          589999999999999999998888999999999999999999986655554              4567


Q ss_pred             ccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcC
Q 039419          416 QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLS  495 (1035)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  495 (1035)
                      .|+.|+||+|.|..+.++...-.++|++|+|++|+|+...+..|..+.+|++|+|++|+|+.+...+|..+.+|+.|||+
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr  373 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR  373 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence            79999999999999999999989999999999999999999999999999999999999998888899999999999999


Q ss_pred             CCcCcCccchh--hhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCc-cccccccCCCcEEeccCCc
Q 039419          496 SNKLSGKIPVE--LFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGD-LLALSGLDNLVSLNVSYNN  570 (1035)
Q Consensus       496 ~N~l~~~~p~~--~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~ls~N~  570 (1035)
                      +|.|+..|.+.  .|.....+..|.|.+|+|..+.-.+|..++.|+.|||.+|.|... +.+|..+ .|++|-++.-.
T Consensus       374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss  450 (873)
T KOG4194|consen  374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS  450 (873)
T ss_pred             CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence            99999666542  222222233455555555555555555555555555555555442 2344444 45555444333

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=361.00  Aligned_cols=254  Identities=24%  Similarity=0.337  Sum_probs=204.1

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRF  761 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  761 (1035)
                      ..+.|...+.||+|+||.|+.|.+. +++.||+|++.........         ....+.+.+|+.++++++ ||||+++
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---------~~~~~~i~rEi~~~~~~~~HpnI~~l   85 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---------QKLDELIKREISILRRLRSHPNIIRL   85 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---------cccchhhHHHHHHHHHhccCCCEeEE
Confidence            3468999999999999999999665 5899999977654222111         123456779999999999 9999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC-Cce
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-FEP  840 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~  840 (1035)
                      ++++......|+||||+.||+|.+++...+.  +.+..+.+++.|++.|++|||++   ||+||||||+||+++.+ +.+
T Consensus        86 ~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~--l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~  160 (370)
T KOG0583|consen   86 LEVFATPTKIYIVMEYCSGGDLFDYIVNKGR--LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNL  160 (370)
T ss_pred             EEEEecCCeEEEEEEecCCccHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCE
Confidence            9999999999999999999999999988443  88899999999999999999999   99999999999999999 999


Q ss_pred             EEeeccCccccc-cCCccccccccCCcccccCCcccccCC-CC-ccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          841 YIADFGLAKLVV-EGDFARSSNTVAGSYGYIAPEYGYMMK-IT-EKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       841 kl~DFG~a~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      ||+|||++.... .+   ......+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+....     ....
T Consensus       161 Kl~DFG~s~~~~~~~---~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~  232 (370)
T KOG0583|consen  161 KLSDFGLSAISPGED---GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLY  232 (370)
T ss_pred             EEeccccccccCCCC---CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHH
Confidence            999999999773 22   3345789999999999998877 76 789999999999999999999986321     1111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      +.....      ...  .+..+. ......++.+|+.+||.+|+++.++++
T Consensus       233 ~ki~~~------~~~--~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  233 RKIRKG------EFK--IPSYLL-SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             HHHhcC------Ccc--CCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            111100      010  111111 334456788899999999999999995

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=365.18  Aligned_cols=404  Identities=27%  Similarity=0.276  Sum_probs=242.2

Q ss_pred             CCcCCCCCcccceEeecCcccCCCCCC-CCC-CC-CCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhh
Q 039419           46 FPSNLSSLSFLQKLIISGSNLTGPISP-DLG-DC-TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKEL  122 (1035)
Q Consensus        46 ~~~~~~~l~~L~~L~L~~~~l~~~~~~-~~~-~l-~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l  122 (1035)
                      .|+...+..  +.||.+++.|.. +.. .+. .+ +.-+.||+++|++...-+..|.++++|++++|.+|.++ .+|...
T Consensus        46 cpa~c~c~~--~lldcs~~~lea-~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~  121 (873)
T KOG4194|consen   46 CPATCPCNT--RLLDCSDRELEA-IDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFG  121 (873)
T ss_pred             CCCcCCCCc--eeeecCcccccc-ccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccc
Confidence            344444433  456666666652 211 111 11 23344555555555555555555555555555555555 455444


Q ss_pred             hhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCccccccccccc
Q 039419          123 GACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQ  202 (1035)
Q Consensus       123 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~  202 (1035)
                      ....+|+.|+|.+|.|.                                                 ..-.+.+.-++.|+
T Consensus       122 ~~sghl~~L~L~~N~I~-------------------------------------------------sv~se~L~~l~alr  152 (873)
T KOG4194|consen  122 HESGHLEKLDLRHNLIS-------------------------------------------------SVTSEELSALPALR  152 (873)
T ss_pred             ccccceeEEeeeccccc-------------------------------------------------cccHHHHHhHhhhh
Confidence            44444444444444443                                                 33345666777888


Q ss_pred             ceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCcc
Q 039419          203 SLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNF  282 (1035)
Q Consensus       203 ~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~  282 (1035)
                      .|||+.|.|+..--..|..-.++++|+|++|.|+..-...|..+.+|..|.|++|.++...+..|.+|++|+.|+|..|+
T Consensus       153 slDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~  232 (873)
T KOG4194|consen  153 SLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNR  232 (873)
T ss_pred             hhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccc
Confidence            88888888884444556666778888888888887767777777777777777777776666667777777777777777


Q ss_pred             CCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccC
Q 039419          283 FSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH  362 (1035)
Q Consensus       283 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~  362 (1035)
                      |.-..--.|.+|++|+.|.|..|.|.....++|..+.++++|+|..|+++.+..          .++.++++|+.|+||+
T Consensus       233 irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~----------g~lfgLt~L~~L~lS~  302 (873)
T KOG4194|consen  233 IRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNE----------GWLFGLTSLEQLDLSY  302 (873)
T ss_pred             eeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhc----------ccccccchhhhhccch
Confidence            764334566777777777777777776666666666666666666666665432          4566666666666666


Q ss_pred             cCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCcc
Q 039419          363 NALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQ  442 (1035)
Q Consensus       363 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~  442 (1035)
                      |.|..+.+..+...++|++|+|++|+|+...+.              +|..+.+|++|+|++|+|+.+...+|..+++|+
T Consensus       303 NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~--------------sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~  368 (873)
T KOG4194|consen  303 NAIQRIHIDSWSFTQKLKELDLSSNRITRLDEG--------------SFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLH  368 (873)
T ss_pred             hhhheeecchhhhcccceeEeccccccccCChh--------------HHHHHHHhhhhcccccchHHHHhhHHHHhhhhh
Confidence            666655566666566666666666665533332              233344455555555555554445555555555


Q ss_pred             EEEcCCCccCCCCc---hhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeec
Q 039419          443 VLDISVNQFVGLIP---ESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNL  519 (1035)
Q Consensus       443 ~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~L  519 (1035)
                      +|||++|.|+..+.   ..|.+|++|+.|+|.+|+|..+...+|.+++.|++|||.+|.|                    
T Consensus       369 ~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Nai--------------------  428 (873)
T KOG4194|consen  369 KLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAI--------------------  428 (873)
T ss_pred             hhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcc--------------------
Confidence            55555555554332   2344555555555555555544445555555555555555554                    


Q ss_pred             cCccCCCCCCccccCCccccEEeccCCcccCcc
Q 039419          520 SWNALSGAIPPQISALNKLSILDLSHNKLGGDL  552 (1035)
Q Consensus       520 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  552 (1035)
                           .++-|.+|..+ +|++|.+..-.+-++.
T Consensus       429 -----aSIq~nAFe~m-~Lk~Lv~nSssflCDC  455 (873)
T KOG4194|consen  429 -----ASIQPNAFEPM-ELKELVMNSSSFLCDC  455 (873)
T ss_pred             -----eeecccccccc-hhhhhhhcccceEEec
Confidence                 45677788888 8888888777666554

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.4e-40  Score=355.28  Aligned_cols=249  Identities=23%  Similarity=0.322  Sum_probs=203.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|+.+ +.+.||+|.+.+....++            ..+.+.+|++++++++|||||.++++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k------------~l~~l~~ev~i~r~lkHpniv~m~es   69 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK------------ELKNLRQEVRILRSLKHPNIVEMLES   69 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH------------HHHHHHHHHHHHHhcCCcchhhHHHh
Confidence            46777889999999999999655 588999999865433221            24678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |+...+.|+|+||+.| +|..++...+.  ++++.+..++.+++.||.|||+.   +|.|||+||+|||++.+|++|+||
T Consensus        70 fEt~~~~~vVte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~Klcd  143 (808)
T KOG0597|consen   70 FETSAHLWVVTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCD  143 (808)
T ss_pred             hcccceEEEEehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeech
Confidence            9999999999999976 99999987655  99999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|+.+....  .....+.|||.|||||+..++.|+..+|+||+||++||+++|++||-..     .+...++.     
T Consensus       144 Fg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~-----  211 (808)
T KOG0597|consen  144 FGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKS-----  211 (808)
T ss_pred             hhhhhhcccCc--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHH-----
Confidence            99999775532  3455788999999999999999999999999999999999999999532     22222211     


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           .....+............++...+.+||.+|.+..+++.+
T Consensus       212 -----I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  212 -----ILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -----HhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                 1111111111222233345556789999999999999875

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-40  Score=339.49  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=213.5

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEE-ECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ..+..+|++.+.+|+|.||.|-+|. +..|+.||||.+.++.+.++.+           .-++.+|+++|+.|+||||++
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqD-----------lvhIRREIeIMSsLNHPhII~  117 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQD-----------LVHIRREIEIMSSLNHPHIIQ  117 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHH-----------HHHHHHHHHHHhhcCCCceee
Confidence            3456788889999999999999994 5779999999998877766533           457889999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +|++|...+.+.+||||..+|.|++|+.+++.  +++.++..+++||..|+.|+|..   +++|||+|.+|||+|.++.+
T Consensus       118 IyEVFENkdKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~Ni  192 (668)
T KOG0611|consen  118 IYEVFENKDKIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNI  192 (668)
T ss_pred             hhhhhcCCceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCe
Confidence            99999999999999999999999999988766  99999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||++..+.++.+   ..+++|++.|.+||+..+.+|. +.+|-||+||++|-++.|..||++.     +.-..+++
T Consensus       193 KIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQ  264 (668)
T KOG0611|consen  193 KIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQ  264 (668)
T ss_pred             eeeccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHH
Confidence            9999999998876544   3478999999999999988876 7899999999999999999999853     22233333


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      ...      ...+.....     .+.-.+|.+|+..+|++|.|+.+|..+.
T Consensus       265 Is~------GaYrEP~~P-----SdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  265 ISR------GAYREPETP-----SDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             hhc------ccccCCCCC-----chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            211      111111111     1223477889999999999999998864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-40  Score=356.05  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=204.8

Q ss_pred             HHhccccCCeeeeeCCcEEEEEE-ECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ....|..-+.||+|+.|.||.|. ..+++.||||++.......              ++-+..|+.+|+..+|+|||+++
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--------------keLilnEi~Vm~~~~H~NiVnfl  336 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--------------KELLLNEILVMRDLHHPNIVNFL  336 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--------------hhhhHHHHHHHHhccchHHHHHH
Confidence            34567777899999999999994 4568999999996543222              45688999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +.|...+..|+||||++||+|.+.+....   +++.++..|+.++++||+|||.+   ||+|||||.+|||++.+|.+||
T Consensus       337 ~Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKl  410 (550)
T KOG0578|consen  337 DSYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKL  410 (550)
T ss_pred             HHhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEE
Confidence            99999999999999999999999987654   89999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+|..+.....  .....+||+.|||||+.....|++|.||||||++++||+.|++||-...|-..   -|.-...+
T Consensus       411 tDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA---lyLIa~ng  485 (550)
T KOG0578|consen  411 TDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIATNG  485 (550)
T ss_pred             eeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH---HHHHhhcC
Confidence            99999998876543  33577899999999999999999999999999999999999999975333211   11111111


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+.   ..+......+      .++..+||..||++||++.|++++
T Consensus       486 ~P~l---k~~~klS~~~------kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  486 TPKL---KNPEKLSPEL------KDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCCc---CCccccCHHH------HHHHHHHhhcchhcCCCHHHHhcC
Confidence            1000   0111122223      345666999999999999999985

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.5e-39  Score=349.30  Aligned_cols=254  Identities=25%  Similarity=0.373  Sum_probs=204.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+..++||+|+||.||+|+.+ +|+.+|+|++++......           ...+.+..|-.+|...++|.||++|-.
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~-----------~Qv~hV~aERdiL~~~ds~~vVKLyYs  209 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKK-----------NQVEHVRAERDILAEVDSPWVVKLYYS  209 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhh-----------hhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence            67999999999999999999666 499999999987554433           336788999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |++.+..|+||||++||++..+|...+.  +++..+..++.+++-|++.+|+.   |||||||||+|+|||..|++||+|
T Consensus       210 FQD~~~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  210 FQDKEYLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             ecCCCeeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence            9999999999999999999999977655  89999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccc----------------------CCcc-----cc------------------ccccCCcccccCCcccccCC
Q 039419          845 FGLAKLVVE----------------------GDFA-----RS------------------SNTVAGSYGYIAPEYGYMMK  879 (1035)
Q Consensus       845 FG~a~~~~~----------------------~~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~  879 (1035)
                      ||++.-...                      .+..     ..                  ....+|||.|||||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            999853321                      0001     00                  11346999999999999999


Q ss_pred             CCccccchhHHHHHHHHHhCCCCCCCCCCCc--hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCC
Q 039419          880 ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG--LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTP  957 (1035)
Q Consensus       880 ~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP  957 (1035)
                      |+..+|.||+|||+|||+.|.+||....+..  ..+..|...           +..+...  ....++.++|.+|+. ||
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-----------l~fP~~~--~~s~eA~DLI~rll~-d~  430 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-----------LKFPEEV--DLSDEAKDLITRLLC-DP  430 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-----------ccCCCcC--cccHHHHHHHHHHhc-CH
Confidence            9999999999999999999999998765532  233334322           1111111  111344567777777 99


Q ss_pred             CCCC---CHHHHHHH
Q 039419          958 DDRP---TMKDVAAM  969 (1035)
Q Consensus       958 ~~RP---s~~el~~~  969 (1035)
                      ++|-   .++||.++
T Consensus       431 ~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  431 ENRLGSKGAEEIKKH  445 (550)
T ss_pred             HHhcCcccHHHHhcC
Confidence            9996   57777664

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-40  Score=363.60  Aligned_cols=263  Identities=25%  Similarity=0.432  Sum_probs=217.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+..+.++||.|.||+||+|+.+.    ...||||.++....+..             +.+|..|+.||.+++||||+++
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekq-------------rrdFL~EAsIMGQFdHPNIIrL  695 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQ-------------RRDFLSEASIMGQFDHPNIIRL  695 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHH-------------HhhhhhhhhhcccCCCCcEEEE
Confidence            455677899999999999997763    45799999987554433             6789999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      .|+.......++|+|||++|+|+.+|+..... +++.+...++++||.|++||.++   ++|||||..+|||++.+-.+|
T Consensus       696 EGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCK  771 (996)
T KOG0196|consen  696 EGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCK  771 (996)
T ss_pred             EEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEE
Confidence            99999999999999999999999999988754 99999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ++|||+++...++.. ........-..+|.|||.+...+++.++||||||||+||.++ |..||=....  .+.      
T Consensus       772 VsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--QdV------  843 (996)
T KOG0196|consen  772 VSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDV------  843 (996)
T ss_pred             eccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--HHH------
Confidence            999999997766542 222223344679999999999999999999999999999887 9999743311  111      


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                          +..+....+..++.+++.  .+.++++.||++|-.+||.+.||+..|.++.+....
T Consensus       844 ----IkaIe~gyRLPpPmDCP~--aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  844 ----IKAIEQGYRLPPPMDCPA--ALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             ----HHHHHhccCCCCCCCCcH--HHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence                223444455555554444  445689999999999999999999999998766554

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=348.67  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=204.8

Q ss_pred             ccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|...+.||+|+||.||+|.+ +.++.||+|++..+...++             .+.+++|+.++..++++||.++|+.+
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-------------Iediqqei~~Ls~~~~~~it~yygsy   80 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-------------IEDIQQEISVLSQCDSPNITEYYGSY   80 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchh-------------hHHHHHHHHHHHhcCcchHHhhhhhe
Confidence            355668999999999999955 4689999999987665543             56889999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ..+...+++||||.||++.+.++....  +++....-+++++..|+.|+|.+   +.+|||||+.||++..+|.+|++||
T Consensus        81 l~g~~LwiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~Df  155 (467)
T KOG0201|consen   81 LKGTKLWIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADF  155 (467)
T ss_pred             eecccHHHHHHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEec
Confidence            999999999999999999999976543  47777788899999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |.+.........+  ..++||+.|||||++.+..|+.|+||||||++.|||.+|.+||...+|...-        .-...
T Consensus       156 gVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl--------flIpk  225 (467)
T KOG0201|consen  156 GVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL--------FLIPK  225 (467)
T ss_pred             ceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE--------EeccC
Confidence            9998876654332  6789999999999999889999999999999999999999999876552110        00001


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...+.+.......+.      +++..|+++||+.||+|.+++++
T Consensus       226 ~~PP~L~~~~S~~~k------EFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  226 SAPPRLDGDFSPPFK------EFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCCCccccccCHHHH------HHHHHHhhcCcccCcCHHHHhhh
Confidence            111222222223333      35566999999999999999874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=355.89  Aligned_cols=262  Identities=27%  Similarity=0.409  Sum_probs=203.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +.+...+.||+|.||+||+|+|-  ..||||++......++            ..+.|+.|+.++++-+|.||+-+.|+|
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~------------qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE------------QLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             HHhhccceeccccccceeecccc--cceEEEEEecCCCCHH------------HHHHHHHHHHHHhhcchhhheeeehhh
Confidence            45567889999999999999986  3599999976654443            367899999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ..+.. .+|+.||+|.+|+.+++..+. .|+..+.+.|+.|||+|+.|||.+   +|||||+|..||++.+++.|||+||
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence            98887 999999999999999998764 489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |++..-..-........-.|...|||||++..   .+|++.+||||||+|+|||++|..||.....+.  +...+-+...
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--IifmVGrG~l  610 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--IIFMVGRGYL  610 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--eEEEeccccc
Confidence            99875432211122223458889999999764   358899999999999999999999998432221  1111111100


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      ..+..  ......+   +++   .+++..||..++++||.+.+|+..|+++.+.
T Consensus       611 ~pd~s--~~~s~~p---k~m---k~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  611 MPDLS--KIRSNCP---KAM---KRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             Cccch--hhhccCH---HHH---HHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            00000  0111111   222   3356679999999999999999998887653

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-39  Score=370.45  Aligned_cols=261  Identities=29%  Similarity=0.491  Sum_probs=215.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      .+....+.||+|+||+||+|+..      +...||||.++.+....             .+++|+||++.+..++|||||
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~-------------~~~dF~REaeLla~l~H~nIV  552 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ-------------ARQDFRREAELLAELQHPNIV  552 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH-------------HHHHHHHHHHHHHhccCCCeE
Confidence            44556678999999999999653      35679999997654332             367999999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCC
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI  827 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDi  827 (1035)
                      +++|.|.+++..++|+|||..|||.++|+.+..            ..++..+.+.||.|||.|++||-++   .+|||||
T Consensus       553 rLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDL  629 (774)
T KOG1026|consen  553 RLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDL  629 (774)
T ss_pred             EEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccch
Confidence            999999999999999999999999999976532            2278899999999999999999999   9999999


Q ss_pred             CcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 039419          828 KANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT  906 (1035)
Q Consensus       828 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~  906 (1035)
                      ..+|+||.++..|||+|||+++..-..+.++....-.-..+|||||.+..++++.++|||||||++||+++ |+.||.+.
T Consensus       630 ATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl  709 (774)
T KOG1026|consen  630 ATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL  709 (774)
T ss_pred             hhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc
Confidence            99999999999999999999998877777766555556789999999999999999999999999999999 99999765


Q ss_pred             CCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      ..+  +..+.+++.         .+...|+....   .+..++..||+..|++||+++||-..|+.....
T Consensus       710 Sn~--EVIe~i~~g---------~lL~~Pe~CP~---~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  710 SNQ--EVIECIRAG---------QLLSCPENCPT---EVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             chH--HHHHHHHcC---------CcccCCCCCCH---HHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            332  233333221         22233333223   345688899999999999999999999887644

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.8e-39  Score=360.68  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=201.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEE------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCce
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNI  758 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  758 (1035)
                      ++|.+.+.||+|+||.||+|.+      .+++.||||++.......             ..+.+.+|+.+++++ +||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~h~ni   73 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS-------------EHKALMSELKILIHIGNHLNV   73 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH-------------HHHHHHHHHHHHHHhccCcce
Confidence            5788899999999999999964      235689999986432211             245789999999999 89999


Q ss_pred             eeEEeEEEcCC-cceEEEEeCCCCChhhhhhhcCC---------------------------------------------
Q 039419          759 VRFLGCCWNRN-TRLLMYDYMPNGSLGSLLHERRD---------------------------------------------  792 (1035)
Q Consensus       759 v~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------  792 (1035)
                      +++++++...+ ..++||||+++|+|.+++.....                                             
T Consensus        74 v~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (338)
T cd05102          74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPST  153 (338)
T ss_pred             eeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccccccc
Confidence            99999887654 57899999999999999875321                                             


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCcc
Q 039419          793 ---------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA  857 (1035)
Q Consensus       793 ---------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~  857 (1035)
                                     ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       154 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~  230 (338)
T cd05102         154 SGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY  230 (338)
T ss_pred             CcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcch
Confidence                           2377888899999999999999998   9999999999999999999999999999865433222


Q ss_pred             ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCc
Q 039419          858 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPE  936 (1035)
Q Consensus       858 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (1035)
                      .......++..|+|||+..+..++.++|||||||++|||++ |..||...... ..+...+...         . ....+
T Consensus       231 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~---------~-~~~~~  299 (338)
T cd05102         231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLKDG---------T-RMRAP  299 (338)
T ss_pred             hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHhcC---------C-CCCCC
Confidence            22233456788999999988899999999999999999997 99999754321 1111111110         0 00001


Q ss_pred             ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          937 VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       937 ~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ..  ....+..++.+||+.||++||++.|+++.|+++..
T Consensus       300 ~~--~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         300 EN--ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CC--CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            11  11234568888999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=349.79  Aligned_cols=243  Identities=28%  Similarity=0.449  Sum_probs=202.0

Q ss_pred             cccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      ....+-+|+|+.|.||+|+.+ ++.||||++.                     +.=..++.-|++|+||||+.|.|+|..
T Consensus       126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~---------------------elkETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVR---------------------ELKETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             hhhhhhhccCcccceeeeecc-CceehhHHHh---------------------hhhhhhHHHHHhccCcceeeEeeeecC
Confidence            345678999999999999998 7889999883                     223468889999999999999999999


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                      ...++||||||..|-|+..++..+.  +.......+..+||.|+.|||..   .|||||||.-|||+..+..|||+|||.
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~~--itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGT  258 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGRP--ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGT  258 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccCc--cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccc
Confidence            9999999999999999999987665  78888899999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhh
Q 039419          848 AKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVL  927 (1035)
Q Consensus       848 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1035)
                      ++...+.   .....++||..|||||++...+.+.|+||||||||||||+||..||.......     .      ..-+-
T Consensus       259 S~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----I------IwGVG  324 (904)
T KOG4721|consen  259 SKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----I------IWGVG  324 (904)
T ss_pred             hHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----e------EEecc
Confidence            9977654   23457899999999999999999999999999999999999999997432110     0      00111


Q ss_pred             cccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       928 ~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ...+....+..+.+-+++  ++.+||+-.|..||++.+++.+|+-.
T Consensus       325 sNsL~LpvPstcP~Gfkl--L~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKL--LLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             CCcccccCcccCchHHHH--HHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            222333334444454444  67789999999999999999988543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-39  Score=340.55  Aligned_cols=272  Identities=22%  Similarity=0.290  Sum_probs=205.1

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ...++.|.+.+.||+|.||.|-+|+.. +++.||||++.+........+.+.........++..+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            445688999999999999999999665 6899999999876555444333333222233578999999999999999999


Q ss_pred             EEeEEEcC--CcceEEEEeCCCCChhhhhhhcCCCC-CCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          761 FLGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       761 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++++..+.  +..|||+|||..|.+...   ..... +...++++++.++..||+|||.+   ||+||||||+|+|++.+
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence            99998764  578999999988876432   22233 88999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCc---cccccccCCcccccCCcccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 039419          838 FEPYIADFGLAKLVVEGDF---ARSSNTVAGSYGYIAPEYGYMMK----ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG  910 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~  910 (1035)
                      |+|||+|||.+.....+..   .......+|||.|+|||...++.    .+.+.||||+||+||+|+.|+.||-+...  
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--  324 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--  324 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence            9999999999986632211   11223468999999999876532    45789999999999999999999974311  


Q ss_pred             hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                         .+..+      ..+...+......++.+  ..-+++.+++.+||++|.+..+|..+..-
T Consensus       325 ---~~l~~------KIvn~pL~fP~~pe~~e--~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  325 ---LELFD------KIVNDPLEFPENPEINE--DLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             ---HHHHH------HHhcCcccCCCcccccH--HHHHHHHHHhhcChhheeehhhheeccee
Confidence               11111      11222222211112233  33458888999999999999999887533

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-38  Score=340.98  Aligned_cols=270  Identities=24%  Similarity=0.298  Sum_probs=206.5

Q ss_pred             ccHHHHHhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc
Q 039419          679 FTVEQVLKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN  757 (1035)
Q Consensus       679 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  757 (1035)
                      ..+..-.+.|+..++||+|.||.||+|++ .+|+.||+|++..+.....            ...-..|||.+|++|+|||
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~------------~~~t~~REI~ILr~l~HpN  177 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG------------FPITAIREIKILRRLDHPN  177 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc------------chHHHHHHHHHHHhcCCCc
Confidence            44555567788889999999999999954 5699999999976543332            3456789999999999999


Q ss_pred             eeeEEeEEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          758 IVRFLGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       758 iv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      |+++.+...+.  ..+|+|+|||+ -+|..++...+ ..|+..++..++.|++.||+|||.+   ||+|||||.+|||||
T Consensus       178 IikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLid  252 (560)
T KOG0600|consen  178 IIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILID  252 (560)
T ss_pred             ccceeeEEEecCCceEEEEEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEc
Confidence            99999999877  68899999995 58988886533 3489999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCC-CchhH
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIP-EGLHI  913 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~-~~~~~  913 (1035)
                      .+|.+||+|||+|+++...... ..+..+.|.+|.|||++.|. .|+.+.|+||.|||+.||++|++.|.+... ++.+.
T Consensus       253 n~G~LKiaDFGLAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k  331 (560)
T KOG0600|consen  253 NNGVLKIADFGLARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK  331 (560)
T ss_pred             CCCCEEeccccceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH
Confidence            9999999999999988765533 34567889999999987654 699999999999999999999999875432 11110


Q ss_pred             ----------HHHHHHhccchhhhcccccCCCcccHHHHH-----HHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          914 ----------VDWVRQKRGAIEVLDKSLRARPEVEIEEML-----QTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       914 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                                ..|-..+......+.+.  ..+...+.+..     ..+.++..+|..||++|.|+.+++.
T Consensus       332 IfklcGSP~e~~W~~~kLP~~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  332 IFKLCGSPTEDYWPVSKLPHATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HHHHhCCCChhccccccCCcccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                      11221111110111100  01111222221     3456777788899999999999986

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-39  Score=351.72  Aligned_cols=251  Identities=27%  Similarity=0.359  Sum_probs=205.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +-|+.++.||+|+-|.|-.|++. +|+.+|||++.......+           .....+.+|+-+|+-+.||||+++|++
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~-----------s~~~~IerEIviMkLi~HpnVl~LydV   80 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSS-----------SQPAGIEREIVIMKLIEHPNVLRLYDV   80 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeecccccccc-----------ccccchhhhhHHHHHhcCCCeeeeeee
Confidence            34667789999999999999664 699999999976532222           234568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+..+.|+|.||++||.|.+++..++.  +++.++.+++.||+.|+.|+|..   +|+|||+||+|+|+|..+.+||+|
T Consensus        81 we~~~~lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIAD  155 (786)
T KOG0588|consen   81 WENKQHLYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIAD  155 (786)
T ss_pred             eccCceEEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeec
Confidence            9999999999999999999999987765  88999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+|....++.   ...+.||++.|.|||+..|.+|+ .++||||.|||||.+++|+.||++.  .-..+...|  +++.
T Consensus       156 FGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--Nir~LLlKV--~~G~  228 (786)
T KOG0588|consen  156 FGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--NIRVLLLKV--QRGV  228 (786)
T ss_pred             cceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--cHHHHHHHH--HcCc
Confidence            99998765543   33467999999999999998876 7899999999999999999999843  111111111  2222


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      .++.     ...+.      ++.+++.+|++.||+.|.|++||.++.
T Consensus       229 f~MP-----s~Is~------eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  229 FEMP-----SNISS------EAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ccCC-----CcCCH------HHHHHHHHHhccCccccccHHHHhhCc
Confidence            2211     22222      234466779999999999999999863

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-39  Score=354.66  Aligned_cols=245  Identities=24%  Similarity=0.336  Sum_probs=201.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .++|...++||+|+||.|++|..+. ++.||||++++..+-...           ..+..+.|.+|+... +||.++.++
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d-----------~Ve~~~~EkrI~~la~~HPFL~~L~  435 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD-----------EVESLMCEKRIFELANRHPFLVNLF  435 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc-----------cHHHHHHHHHHHHHhccCCeEeecc
Confidence            4678899999999999999998774 889999999876554432           256788888888877 599999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      .+|+.+++.|+||||+.||++..+.+.   ..+++.++..++..|+-||+|||++   ||||||||.+|||+|.+|++||
T Consensus       436 ~~fQT~~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~ki  509 (694)
T KOG0694|consen  436 SCFQTKEHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKI  509 (694)
T ss_pred             cccccCCeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEe
Confidence            999999999999999999995554443   3499999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+++.-...+  ..+.+++||+.|||||++.+..|+.++|.|||||++|||+.|+.||.+...+             
T Consensus       510 ADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------  574 (694)
T KOG0694|consen  510 ADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------  574 (694)
T ss_pred             cccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------
Confidence            9999998654222  3456899999999999999999999999999999999999999999854322             


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM  963 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~  963 (1035)
                        +.++..+...+....--..+...++.+.+.++|++|--+
T Consensus       575 --e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  575 --EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              233333333332222233345567888999999999754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.2e-38  Score=311.93  Aligned_cols=264  Identities=23%  Similarity=0.310  Sum_probs=201.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .+|...+++|+|.||.||+|++ ++|+.||||+++.....+            ++.....||+..++.++||||+.++++
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd------------Gi~~talREIK~Lqel~h~nIi~LiD~   69 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD------------GINRTALREIKLLQELKHPNIIELIDV   69 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc------------CccHHHHHHHHHHHHccCcchhhhhhh
Confidence            3577788999999999999954 569999999998754332            334567899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |...+..-+|+||++ .+|+..++... ..+....+..++.++++|++|||++   .|+||||||.|+|++.+|.+||+|
T Consensus        70 F~~~~~l~lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiAD  144 (318)
T KOG0659|consen   70 FPHKSNLSLVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIAD  144 (318)
T ss_pred             ccCCCceEEEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeec
Confidence            999999999999995 59999998764 4588899999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+|+.+......  ....+.|..|.|||.+.| ..|+...||||.|||+.||+-|.+-|.+..+ -.++....+.....
T Consensus       145 FGLAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP  221 (318)
T KOG0659|consen  145 FGLARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTP  221 (318)
T ss_pred             ccchhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCC
Confidence            9999988765432  233478999999998765 4599999999999999999998866654321 11111111110000


Q ss_pred             h--------hhhcc-cccCCCc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 I--------EVLDK-SLRARPE-----VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~--------~~~~~-~~~~~~~-----~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .        ...+. .++..|.     ......-+.++++..++..||.+|+++.|++++
T Consensus       222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  222 TPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0        00000 0000000     011222344778889999999999999999885

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-39  Score=312.52  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=209.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|++++.+|+|.||.||.|+.+ ++-.||+|++.+.....           .+...++.+|+++-+.|+||||+++|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-----------~~v~~qlrREiEIqs~L~hpnilrlY~   89 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-----------TQVEHQLRREIEIQSHLRHPNILRLYG   89 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-----------hcchhhhhheeEeecccCCccHHhhhh
Confidence            357899999999999999999665 57899999996644322           245678999999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      +|.++...|+++||..+|+++..++.++...+++.....++.|+|.|+.|+|..   +++||||||+|+|++..+..|++
T Consensus        90 ~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   90 YFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             heeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence            999999999999999999999999988777899999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||.+-....    ......+||..|.+||...+...+..+|+|++|++.||++.|..||+... .+..+.. +      
T Consensus       167 dfGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkr-I------  234 (281)
T KOG0580|consen  167 DFGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKR-I------  234 (281)
T ss_pred             CCCceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHH-H------
Confidence            9999865321    22346899999999999999999999999999999999999999998653 1111111 1      


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                       ..++-..+...+.      .+.+++.+|+.++|.+|.+..|++++-
T Consensus       235 -~k~~~~~p~~is~------~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  235 -RKVDLKFPSTISG------GAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             -HHccccCCcccCh------hHHHHHHHHhccCccccccHHHHhhhH
Confidence             1111111222222      234577789999999999999998863

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-38  Score=343.93  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=211.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +++|...+++|+|+||.++.++++ +++.|++|++........            .++...+|+.++++++|||||.+++
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~------------~r~~A~~E~~lis~~~hP~iv~y~d   70 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP------------ERRSAIQEMDLLSKLLHPNIVEYKD   70 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch------------hhHHHHHHHHHHHhccCCCeeeecc
Confidence            467888999999999999999766 478999999976544332            2456789999999999999999999


Q ss_pred             EEEcCCc-ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          764 CCWNRNT-RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       764 ~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      .|.+++. .++||+||+||++.+.+.+++...++++++..++.|++.|++|||+.   .|+|||||+.||++++++.|+|
T Consensus        71 s~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkL  147 (426)
T KOG0589|consen   71 SFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKL  147 (426)
T ss_pred             chhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceee
Confidence            9999998 89999999999999999998888899999999999999999999988   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+|+......  .....+.||+.||.||.+.+.+|+.|+||||+||++|||++-+.+|......     ..+...  
T Consensus       148 gDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~Li~ki--  218 (426)
T KOG0589|consen  148 GDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----ELILKI--  218 (426)
T ss_pred             cchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----HHHHHH--
Confidence            9999999887754  2334689999999999999999999999999999999999999999754321     111110  


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ........+.   .....+..++..|+..+|..||++.+++..
T Consensus       219 ----~~~~~~Plp~---~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  219 ----NRGLYSPLPS---MYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----hhccCCCCCc---cccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                0001111111   222233446777999999999999999986

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=371.50  Aligned_cols=262  Identities=29%  Similarity=0.442  Sum_probs=213.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC--Cc----EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN--GE----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      +.....+.||+|+||.||.|...+  |.    .||||.+.......             ...+|.+|..+|+.++|||||
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~-------------~~~~Fl~Ea~~m~~f~HpNiv  758 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQ-------------EVSDFLKEALLMSKFDHPNIV  758 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHH-------------HHHHHHHHHHHHhcCCCccee
Confidence            345566899999999999996653  43    48999886543332             267899999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll  834 (1035)
                      +++|.+.+.+..++++|||+||+|..++++.+     ...+...+.+.++.+||+|+.||+++   ++|||||..+|+||
T Consensus       759 ~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL  835 (1025)
T KOG1095|consen  759 SLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLL  835 (1025)
T ss_pred             eEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheee
Confidence            99999999999999999999999999998763     24588999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhH
Q 039419          835 GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHI  913 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~  913 (1035)
                      +....|||+|||+|+.+.+.+.++......-...|||||.+..+.++.|+|||||||++||++| |..||.....  .++
T Consensus       836 ~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--~~v  913 (1025)
T KOG1095|consen  836 DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--FEV  913 (1025)
T ss_pred             cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--HHH
Confidence            9999999999999996666666655544445578999999999999999999999999999999 9999975422  122


Q ss_pred             HH-HHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          914 VD-WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       914 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      .. +..+          . +..++..+.+.  +.+++..||+.+|++||++..+++.+..+.....
T Consensus       914 ~~~~~~g----------g-RL~~P~~CP~~--ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  914 LLDVLEG----------G-RLDPPSYCPEK--LYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             HHHHHhC----------C-ccCCCCCCChH--HHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            22 2211          1 22233333333  3468999999999999999999998877765544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.8e-38  Score=352.16  Aligned_cols=248  Identities=21%  Similarity=0.255  Sum_probs=199.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|+++ +++.||+|++........           ...+.+.+|+.++++++||||++++++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~~   86 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM-----------KQVQHVAQEKSILMELSHPFIVNMMCS   86 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-----------hhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            56888999999999999999776 589999999864321111           224678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        87 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~D  161 (329)
T PTZ00263         87 FQDENRVYFLLEFVVGGELFTHLRKAGR--FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTD  161 (329)
T ss_pred             EEcCCEEEEEEcCCCCChHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999999976543  78889999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.  .....+..     
T Consensus       162 fg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~-----  229 (329)
T PTZ00263        162 FGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYEKILA-----  229 (329)
T ss_pred             ccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHHHHhc-----
Confidence            99998653322     2457999999999999888999999999999999999999999653221  11111111     


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                          .....  +....  ....+++.+||++||++||+     +++++++
T Consensus       230 ----~~~~~--p~~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        230 ----GRLKF--PNWFD--GRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ----CCcCC--CCCCC--HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                00000  01111  12345788899999999986     6777765

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.4e-38  Score=350.04  Aligned_cols=245  Identities=21%  Similarity=0.262  Sum_probs=194.4

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCc
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNT  770 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  770 (1035)
                      +.||+|+||.||+|+.+ +|+.||+|++........           .....+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   69 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAK-----------DEVAHTLTESRVLQNTRHPFLTALKYSFQTHDR   69 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------HHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCE
Confidence            46899999999999765 589999999865322111           124567899999999999999999999999999


Q ss_pred             ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          771 RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       771 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      .|+||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+++.
T Consensus        70 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~  144 (323)
T cd05571          70 LCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence            999999999999999987654  389999999999999999999999   999999999999999999999999999875


Q ss_pred             cccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccc
Q 039419          851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS  930 (1035)
Q Consensus       851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (1035)
                      .....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+...       ...
T Consensus       145 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~~~-------~~~  213 (323)
T cd05571         145 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME-------EIR  213 (323)
T ss_pred             cccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHHcC-------CCC
Confidence            43221  1223467999999999999889999999999999999999999999653211  111111110       001


Q ss_pred             ccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       931 ~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      +.....      ..+.+++.+||++||++||     ++.+++++
T Consensus       214 ~p~~~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         214 FPRTLS------PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCC------HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            111111      2234577889999999999     79998874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=347.93  Aligned_cols=259  Identities=25%  Similarity=0.397  Sum_probs=203.6

Q ss_pred             cCCeeeeeCCcEEEEEEECC--C--cE-EEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          690 EDSVVGKGCSGIVYRAEMEN--G--EV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       690 ~~~~iG~G~~g~V~~~~~~~--~--~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..++||+|+||.||+|+.+.  +  .. ||||..+.......           ....+|.+|+++|+.++|||||++||+
T Consensus       161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~-----------~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTK-----------EQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccH-----------HHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            44799999999999996653  2  23 89999875221111           236789999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +..+..+|+|||+|+||+|.+++++.+. .++..++..++.++|+||+|||++   +++||||..+|+|++.++.+||+|
T Consensus       230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  230 AVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             EcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence            9999999999999999999999988764 489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++.-..  .........-...|+|||.+....++.++|||||||++||+++ |..||.+....  ....++.     
T Consensus       306 FGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~-----  376 (474)
T KOG0194|consen  306 FGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV-----  376 (474)
T ss_pred             cccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH-----
Confidence            999875431  1111112246689999999999999999999999999999999 88899765322  2222221     


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                          ....+...+...+...  ..++.+||..||++||+|.++.+.++.+....+
T Consensus       377 ----~~~~r~~~~~~~p~~~--~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  377 ----KNGYRMPIPSKTPKEL--AKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ----hcCccCCCCCCCHHHH--HHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                1112222222222222  235668999999999999999999999876554

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.2e-37  Score=344.15  Aligned_cols=263  Identities=27%  Similarity=0.430  Sum_probs=200.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-----------------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHH
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-----------------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK  748 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  748 (1035)
                      ++|...+.||+|+||.||+|.+.+                 +..||+|.+......             ....+|.+|+.
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~   71 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK-------------NARNDFLKEVK   71 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH-------------HHHHHHHHHHH
Confidence            568888999999999999997532                 346999998653221             12467999999


Q ss_pred             HHhcCCCCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC-----------------CCCCHHHHHHHHHHHHHHH
Q 039419          749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----------------SCLEWELRYRIILGAAQGL  811 (1035)
Q Consensus       749 ~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~l~~~~~~~i~~~ia~~L  811 (1035)
                      ++++++||||+++++++.+.+..++||||+++|+|.+++.....                 ..+++..+.+++.||+.||
T Consensus        72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al  151 (304)
T cd05096          72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM  151 (304)
T ss_pred             HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999999999865321                 2367888999999999999


Q ss_pred             HHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHH
Q 039419          812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGV  891 (1035)
Q Consensus       812 ~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv  891 (1035)
                      +|||+.   +|+||||||+||+++.++.+||+|||+++...............++..|+|||+..+..++.++||||||+
T Consensus       152 ~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  228 (304)
T cd05096         152 KYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV  228 (304)
T ss_pred             HHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence            999999   99999999999999999999999999998765444333333455688999999988888999999999999


Q ss_pred             HHHHHHh--CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          892 VVLEVLT--GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       892 vl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ++|||++  +..||......  ....++.......  ........++..   ...+.+++.+||+.||++||++.+|.+.
T Consensus       229 ~l~el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RPs~~~i~~~  301 (304)
T cd05096         229 TLWEILMLCKEQPYGELTDE--QVIENAGEFFRDQ--GRQVYLFRPPPC---PQGLYELMLQCWSRDCRERPSFSDIHAF  301 (304)
T ss_pred             HHHHHHHccCCCCCCcCCHH--HHHHHHHHHhhhc--cccccccCCCCC---CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999987  55677643221  2222221110000  000000111111   1234567889999999999999999988


Q ss_pred             HH
Q 039419          970 IK  971 (1035)
Q Consensus       970 L~  971 (1035)
                      |+
T Consensus       302 l~  303 (304)
T cd05096         302 LT  303 (304)
T ss_pred             Hh
Confidence            75

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.8e-37  Score=341.27  Aligned_cols=254  Identities=21%  Similarity=0.262  Sum_probs=199.0

Q ss_pred             cccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |...+.||+|+||+||+|.. .+++.||+|++........           .....+.+|+.++++++|++|+++++++.
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~~~~iv~~~~~~~   70 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----------KGEAMALNEKRILEKVNSRFVVSLAYAYE   70 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh-----------hhHHHHHHHHHHHHhcCCCcEEEEEEEEc
Confidence            66778999999999999976 4689999999865432211           12346789999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +.+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg  147 (285)
T cd05631          71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLG  147 (285)
T ss_pred             cCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999999999999999888765545589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      ++........   .....||..|+|||++.+..++.++|||||||++|||++|+.||......... ..........   
T Consensus       148 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~~---  220 (285)
T cd05631         148 LAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDRRVKED---  220 (285)
T ss_pred             CcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHHHhhcc---
Confidence            9986543321   23457899999999999999999999999999999999999999754322110 0000000000   


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                       ........    .  .....++.+||+.||++||+     +++++++
T Consensus       221 -~~~~~~~~----s--~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 -QEEYSEKF----S--EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -cccCCccC----C--HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             00011111    1  23345788899999999997     7888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.7e-37  Score=351.31  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=202.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      .++|...+.||+|+||.||+|.+      .++..||||++.......             ..+.+.+|+.+++.+ +|||
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~-------------~~~~~~~Ei~il~~l~~Hpn  100 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT-------------EREALMSELKVLSYLGNHIN  100 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH-------------HHHHHHHHHHHHHHhcCCcc
Confidence            45688899999999999999964      235689999986432211             245788999999999 8999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC---------------------------------------------
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD---------------------------------------------  792 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------  792 (1035)
                      |+++++++.+.+..++||||+++|+|.++++....                                             
T Consensus       101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  180 (375)
T cd05104         101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP  180 (375)
T ss_pred             eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence            99999999999999999999999999999865321                                             


Q ss_pred             ----------------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          793 ----------------------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       793 ----------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                                                  ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D  257 (375)
T cd05104         181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICD  257 (375)
T ss_pred             cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEec
Confidence                                        2478888999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||...... .....++..... 
T Consensus       258 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~-  335 (375)
T cd05104         258 FGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYR-  335 (375)
T ss_pred             CccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCcc-
Confidence            999986644332222223445678999999998899999999999999999998 88898654221 122222221110 


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                           ..   .+...   ..++.+++.+||++||++||++.|+++.|+.
T Consensus       336 -----~~---~~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 -----ML---SPECA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -----CC---CCCCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                 00   01111   1234567888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=336.03  Aligned_cols=265  Identities=29%  Similarity=0.414  Sum_probs=216.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ....+.++||+|-||.|..+....+.+||||++++.....             .+.+|.+|+++|.+++|||||+++|+|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~-------------~r~~F~kEIkiLsqLkhPNIveLvGVC  604 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKN-------------ARNDFLKEIKILSRLKHPNIVELLGVC  604 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchh-------------HHHHHHHHHHHHhccCCCCeeEEEeee
Confidence            5677889999999999999999888999999998765433             267899999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ..++.+++||||+++|+|.+++..............+|+.|||.|++||.+.   ++||||+.++|+|++.++++||+||
T Consensus       605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadf  681 (807)
T KOG1094|consen  605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADF  681 (807)
T ss_pred             ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCc
Confidence            9999999999999999999999887554445566778999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh--CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT--GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |+++-...++.++.....+-..+|||||.+.-++++.++|||+||+++||+++  ...||.....++  ..+..-..-  
T Consensus       682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~--  757 (807)
T KOG1094|consen  682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFF--  757 (807)
T ss_pred             ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhc--
Confidence            99998777777777777777899999999999999999999999999999877  677987543321  111111100  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      .+.-.+.....|......   ++++++.||..|-++||+++++...|.+.
T Consensus       758 ~~~~~~~~l~~P~~cp~~---lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  758 RDQGRQVVLSRPPACPQG---LYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCCCcceeccCCCcCcHH---HHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            011111122233333333   45689999999999999999999988764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5e-37  Score=336.71  Aligned_cols=250  Identities=19%  Similarity=0.289  Sum_probs=196.6

Q ss_pred             CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc----
Q 039419          692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN----  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----  767 (1035)
                      ..||+|++|.||+|.+ +|+.||||++........           ...+.|.+|+.++++++||||+++++++.+    
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~   93 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHK-----------VLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD   93 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccH-----------HHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence            5899999999999988 489999999865322111           224678899999999999999999999877    


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                      ....++||||+++|+|.++++..+  .+++.....++.+++.|++|+|+..  +++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988         94 LPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccch
Confidence            346789999999999999997754  3889999999999999999999742  788999999999999999999999999


Q ss_pred             ccccccCCccccccccCCcccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          848 AKLVVEGDFARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       848 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      ++......     ....|+..|+|||+..+  ..++.++|||||||++|||++|+.||......  .....+...     
T Consensus       170 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~~-----  237 (283)
T PHA02988        170 EKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIINK-----  237 (283)
T ss_pred             Hhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhc-----
Confidence            98654322     23468899999999865  67999999999999999999999999754221  111111110     


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                          ..+...+....  ..+.+++.+||+.||++||+++++++.|+....
T Consensus       238 ----~~~~~~~~~~~--~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        238 ----NNSLKLPLDCP--LEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ----CCCCCCCCcCc--HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                00111111111  123457888999999999999999999988753

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=355.23  Aligned_cols=259  Identities=24%  Similarity=0.372  Sum_probs=203.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCC-cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENG-EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      .++++.++|.+|||+.||.|+...+ ..||+|++....   +           ...+.+.+|+++|+.|+ |||||.++|
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d---e-----------~~L~~v~~EI~~MK~L~gh~nIV~yid  102 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND---E-----------EALNAVKREIDIMKLLSGHKNIVSYID  102 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC---H-----------HHHHHHHHHHHHHHHhcCCCceeeEec
Confidence            4577888999999999999987765 999999986542   1           23567899999999997 999999999


Q ss_pred             -EEEcC------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          764 -CCWNR------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       764 -~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                       .....      -.+++.||||.||.|-+++..+....|++.++++|+.++++|+++||.. .++|||||||-+||||+.
T Consensus       103 ss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~  181 (738)
T KOG1989|consen  103 SSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSA  181 (738)
T ss_pred             cccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcC
Confidence             33221      2468999999999999999987776799999999999999999999996 458999999999999999


Q ss_pred             CCceEEeeccCccccccCCcccc-------ccccCCcccccCCcc---cccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          837 EFEPYIADFGLAKLVVEGDFARS-------SNTVAGSYGYIAPEY---GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~---~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      +|..||||||.|.-.........       .-...-|+.|+|||.   ..+..+++|+|||||||+||-++....||+..
T Consensus       182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            99999999999874432221000       012346899999996   45778999999999999999999999999854


Q ss_pred             CCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      ...               .+++......+.....+  .+-.+|..||++||++||++-||++.+.++...
T Consensus       262 g~l---------------aIlng~Y~~P~~p~ys~--~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  262 GKL---------------AILNGNYSFPPFPNYSD--RLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             cce---------------eEEeccccCCCCccHHH--HHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence            221               22232222222222233  334478889999999999999999998887643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=344.19  Aligned_cols=247  Identities=22%  Similarity=0.251  Sum_probs=198.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|..+ +++.||+|++........           ...+.+.+|+.++++++||||+++++++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~   70 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL-----------KQEQHVHNEKRVLKEVSHPFIIRLFWTE   70 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhh-----------HHHHHHHHHHHHHHhCCCCcHhhhHhhh
Confidence            5788899999999999999776 589999999864322111           1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||+++|+|.+++...+.  +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Df  145 (291)
T cd05612          71 HDQRFLYMLMEYVPGGELFSYLRNSGR--FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDF  145 (291)
T ss_pred             ccCCeEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEec
Confidence            999999999999999999999976543  88999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....    
T Consensus       146 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~----  214 (291)
T cd05612         146 GFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--GIYEKILAGK----  214 (291)
T ss_pred             CcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC----
Confidence            999865332     12457999999999998888999999999999999999999999754221  1111111100    


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                         .......      .....+++.+||+.||.+||+     +++++++
T Consensus       215 ---~~~~~~~------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 ---LEFPRHL------DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---cCCCccC------CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               0011111      123356788899999999995     8888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.7e-37  Score=350.86  Aligned_cols=261  Identities=26%  Similarity=0.399  Sum_probs=202.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      .++|+..+.||+|+||.||+|.+.      ++..||+|++.......             ..+.+.+|+.+++.+ +|||
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~il~~l~~h~n  103 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD-------------EREALMSELKILSHLGQHKN  103 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHH-------------HHHHHHHHHHHHHhhccCCc
Confidence            357889999999999999999642      24579999996543221             245788999999999 8999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcC----------------------------------------------
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR----------------------------------------------  791 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------  791 (1035)
                      ||++++++...+..|+||||+++|+|.++++...                                              
T Consensus       104 Iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (374)
T cd05106         104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE  183 (374)
T ss_pred             eeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence            9999999999999999999999999999986432                                              


Q ss_pred             ----------------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          792 ----------------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       792 ----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                                            ...+++..+.+++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+++
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~  260 (374)
T cd05106         184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR  260 (374)
T ss_pred             cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeee
Confidence                                  12367888999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhhc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLD  928 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (1035)
                      ...............++..|+|||+..+..++.++|||||||++|||++ |+.||....... .....+...      ..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~------~~  333 (374)
T cd05106         261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRG------YQ  333 (374)
T ss_pred             eccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcc------cC
Confidence            6544322222223345678999999988899999999999999999997 999997543221 111111110      00


Q ss_pred             ccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       929 ~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      .......+      ..+..++.+||+.||++||++.++++.|+++.
T Consensus       334 ~~~~~~~~------~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         334 MSRPDFAP------PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ccCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            00011111      23455778899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=321.30  Aligned_cols=266  Identities=29%  Similarity=0.427  Sum_probs=200.0

Q ss_pred             cccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhc--CCCCceeeEEeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS--IRHKNIVRFLGCC  765 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~  765 (1035)
                      ....++||+|.||.||+|+.. ++.||||++...                 .++.|+.|-++.+-  ++|+||++++++-
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~-----------------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e  273 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ-----------------EKQSFQNEKNIYSLPGMKHENILQFIGAE  273 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHH-----------------HHHHHHhHHHHHhccCccchhHHHhhchh
Confidence            445568899999999999887 599999999642                 35678888888875  5899999999987


Q ss_pred             EcCC----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhcc------CCCCeeccCCCcccEEEc
Q 039419          766 WNRN----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHD------CVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       766 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~ivHrDikp~NIll~  835 (1035)
                      ...+    .+++|+||.+.|+|.+|++..-   .+|....+|+..+++||+|||+.      ..|+|+|||||.+|||+.
T Consensus       274 kr~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK  350 (534)
T KOG3653|consen  274 KRGTADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK  350 (534)
T ss_pred             ccCCccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc
Confidence            6655    7899999999999999998754   89999999999999999999975      336899999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCC------CCccccchhHHHHHHHHHhCCCCCCC-CCC
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK------ITEKSDVYSYGVVVLEVLTGKQPIDP-TIP  908 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvvl~elltg~~P~~~-~~~  908 (1035)
                      .++++.|+|||+|..+..+.........+||.+|||||++.+..      .-.+.||||+|.|+|||++....+++ ..+
T Consensus       351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            99999999999999988776666666689999999999876532      22478999999999999997665532 111


Q ss_pred             C-chhHHHHHHHhccchh----hhcccccCCCc---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          909 E-GLHIVDWVRQKRGAIE----VLDKSLRARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       909 ~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      + ...+..-+.......+    ++.+..+...+   .....+..+.+.+..||+.||+.|-|+.=+.+.+.++.
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            1 1111111111111111    11111111111   11233334455777899999999999999988887764

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-37  Score=343.03  Aligned_cols=246  Identities=23%  Similarity=0.326  Sum_probs=193.0

Q ss_pred             CeeeeeCCcEEEEEEE----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          692 SVVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      +.||+|+||.||+|+.    ..++.||+|++........          ......+.+|+.++++++||||+++++++..
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~   71 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN----------QKDTAHTKAERNILEAVKHPFIVDLIYAFQT   71 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh----------hhhHHHHHHHHHHHHhCCCCchhceeeEEec
Confidence            5799999999999965    3578999999864322111          0124567899999999999999999999999


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                      ++..|+||||+++|+|.+++...+.  +.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  146 (323)
T cd05584          72 GGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGL  146 (323)
T ss_pred             CCeEEEEEeCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcC
Confidence            9999999999999999999976543  78888889999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhh
Q 039419          848 AKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVL  927 (1035)
Q Consensus       848 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1035)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ......      .
T Consensus       147 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~------~  213 (323)
T cd05584         147 CKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKI------L  213 (323)
T ss_pred             CeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHH------H
Confidence            87543322  1223467999999999998888999999999999999999999999754221     111110      0


Q ss_pred             cccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       928 ~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      ..... .++ .+  .....+++.+||++||++||     ++++++++
T Consensus       214 ~~~~~-~~~-~~--~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         214 KGKLN-LPP-YL--TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             cCCCC-CCC-CC--CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            00000 011 11  11234678889999999999     78888774

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.4e-37  Score=342.76  Aligned_cols=245  Identities=22%  Similarity=0.269  Sum_probs=193.5

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCc
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNT  770 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  770 (1035)
                      +.||+|+||.||+|+.. +|+.||+|++........           .....+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~   69 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----------DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR   69 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----------HHHHHHHHHHHHHHhCCCCCCcceeeEEecCCE
Confidence            46899999999999765 589999999865322111           124567889999999999999999999999999


Q ss_pred             ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          771 RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       771 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      .|+||||+++|+|..++...+  .+++..+..++.||+.||+|||+.   ||+||||||+|||++.++.+||+|||+++.
T Consensus        70 ~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~  144 (323)
T cd05595          70 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE  144 (323)
T ss_pred             EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence            999999999999999887654  389999999999999999999999   999999999999999999999999999875


Q ss_pred             cccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccc
Q 039419          851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS  930 (1035)
Q Consensus       851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (1035)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+..  .     ...
T Consensus       145 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--~~~~~~~~--~-----~~~  213 (323)
T cd05595         145 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFELILM--E-----EIR  213 (323)
T ss_pred             ccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHhc--C-----CCC
Confidence            43222  1123467999999999998889999999999999999999999999754221  11111100  0     000


Q ss_pred             ccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       931 ~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      .....+      ....+++.+||++||++||     ++.+++++
T Consensus       214 ~p~~~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 FPRTLS------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCC------HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            111111      1234577789999999998     88888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-37  Score=343.48  Aligned_cols=243  Identities=21%  Similarity=0.257  Sum_probs=190.7

Q ss_pred             eeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcce
Q 039419          694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL  772 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  772 (1035)
                      ||+|+||.||+|++. +++.||+|++........           ...+.+.+|+.++++++||||+++++++.+.+..|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   69 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSR-----------SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLY   69 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEE
Confidence            699999999999776 488999999864321111           12457889999999999999999999999999999


Q ss_pred             EEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccc
Q 039419          773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV  852 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~  852 (1035)
                      +||||+++|+|.+++...+.  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        70 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~  144 (312)
T cd05585          70 LVLAFINGGELFHHLQREGR--FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNM  144 (312)
T ss_pred             EEEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence            99999999999999976543  89999999999999999999999   99999999999999999999999999998543


Q ss_pred             cCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccccc
Q 039419          853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR  932 (1035)
Q Consensus       853 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (1035)
                      ...  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ..........    .....
T Consensus       145 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~----~~~~~  213 (312)
T cd05585         145 KDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQE----PLRFP  213 (312)
T ss_pred             cCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcC----CCCCC
Confidence            322  122356799999999999988999999999999999999999999975321     1111111000    00011


Q ss_pred             CCCcccHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 039419          933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPT---MKDVAAM  969 (1035)
Q Consensus       933 ~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs---~~el~~~  969 (1035)
                      ...+      ....+++.+||++||++||+   +.+++.+
T Consensus       214 ~~~~------~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         214 DGFD------RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CcCC------HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            1111      22345778899999999985   5555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.9e-37  Score=311.33  Aligned_cols=268  Identities=22%  Similarity=0.238  Sum_probs=202.0

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      +.-.++|+..+.|++|+||.||+|+++ +++.||+|+++.+....            +..-.-.||+.++.+.+|||||.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~------------GFPItsLREIniLl~~~H~NIV~  139 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE------------GFPITSLREINILLKARHPNIVE  139 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC------------CCcchhHHHHHHHHhcCCCCeee
Confidence            334567888999999999999999766 58999999997654222            23345689999999999999999


Q ss_pred             EEeEEEc--CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          761 FLGCCWN--RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       761 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +-.+...  -+.+|+|||||+ .+|.++++..+ ..+...++..+..|+++|++|||..   .|+|||+||+|+|+...|
T Consensus       140 vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G  214 (419)
T KOG0663|consen  140 VKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKG  214 (419)
T ss_pred             eEEEEeccccceeeeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCC
Confidence            9988764  357899999995 59999998765 4588899999999999999999999   899999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      .+||+|||+|+.+....  ...+..+.|..|.|||.+.+. .|+.+.|+||+|||+.||+++++-|.+...- .++-..+
T Consensus       215 ~lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If  291 (419)
T KOG0663|consen  215 ILKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIF  291 (419)
T ss_pred             cEEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHH
Confidence            99999999999886653  334567889999999987654 5999999999999999999999888654321 1111111


Q ss_pred             HHhccch----------hhhc-ccccCCCcccH----HH---HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAI----------EVLD-KSLRARPEVEI----EE---MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~----------~~~~-~~~~~~~~~~~----~~---~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +......          ..+. -.+...+...+    ..   .-..+++....+..||.+|.|++|.+++
T Consensus       292 ~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  292 KLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             HHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            1111110          0010 00011111100    10   1233456777889999999999999875

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.4e-37  Score=342.37  Aligned_cols=245  Identities=22%  Similarity=0.250  Sum_probs=194.2

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCc
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNT  770 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  770 (1035)
                      +.||+|+||.||+|+.. +++.||+|++........           .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   69 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK-----------DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR   69 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCE
Confidence            46899999999999765 589999999865322211           124578899999999999999999999999999


Q ss_pred             ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          771 RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       771 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      .|+||||+++|+|..++...+  .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        70 ~~lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~  144 (328)
T cd05593          70 LCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE  144 (328)
T ss_pred             EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence            999999999999999887654  389999999999999999999999   999999999999999999999999999875


Q ss_pred             cccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccc
Q 039419          851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS  930 (1035)
Q Consensus       851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (1035)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     .........    ...
T Consensus       145 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~----~~~  213 (328)
T cd05593         145 GITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILME----DIK  213 (328)
T ss_pred             CCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccC----Ccc
Confidence            43221  1223467999999999998889999999999999999999999999653211     111110000    001


Q ss_pred             ccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       931 ~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      +.....      .....++.+||++||++||     ++.|++++
T Consensus       214 ~p~~~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         214 FPRTLS------ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCC------HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            111111      1234577889999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-37  Score=344.06  Aligned_cols=255  Identities=22%  Similarity=0.305  Sum_probs=201.2

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|.+.+.||+|+||.||+|++. +++.||||++........           ...+.+.+|+.+++.++||||+++++++
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~h~~iv~~~~~~   70 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKL-----------NEVRHVLTERDILTTTKSEWLVKLLYAF   70 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-----------hHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            5888899999999999999876 489999999865322111           1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||++||+|.+++.....  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Df  145 (333)
T cd05600          71 QDDEYLYLAMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDF  145 (333)
T ss_pred             EcCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeC
Confidence            999999999999999999999976543  88999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |+++....     ......||+.|+|||++.+..++.++|||||||++|||++|..||....+.  .....+....   .
T Consensus       146 g~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~---~  215 (333)
T cd05600         146 GLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENLKYWK---E  215 (333)
T ss_pred             cCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHHHhcc---c
Confidence            99976533     223567999999999999889999999999999999999999999754321  1111111100   0


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .........+.  ........+++.+|+..+|++||++++++++
T Consensus       216 ~~~~~~~~~~~--~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         216 TLQRPVYDDPR--FNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCCCCCccc--cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            01100000000  0112234557788999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.2e-37  Score=320.07  Aligned_cols=257  Identities=20%  Similarity=0.247  Sum_probs=208.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|+..+.||+|.-|+||+++.++ +..+|+|++.+.......           -..+.+.|.+||+.++||.++.+|+.
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rk-----------Kl~Ra~tE~eIL~~lDHPFlPTLYa~  145 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRK-----------KLKRAQTEREILSLLDHPFLPTLYAS  145 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhh-----------HHHHHHHHHHHHHhcCCCccchhhhe
Confidence            456667789999999999998875 589999999876655431           24678889999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |+.++..|+|||||+||+|..+.+++....+++..+..++.+++-||+|||-.   |||+|||||+||||.++|++.|+|
T Consensus       146 fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  146 FETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             eeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeee
Confidence            99999999999999999999999999999999999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccccc---------------------------------CCc---------------------cccccccCCccccc
Q 039419          845 FGLAKLVVE---------------------------------GDF---------------------ARSSNTVAGSYGYI  870 (1035)
Q Consensus       845 FG~a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~  870 (1035)
                      |.++.....                                 ...                     ...+..++||-+|+
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            998743210                                 000                     01123467999999


Q ss_pred             CCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHH
Q 039419          871 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVAL  950 (1035)
Q Consensus       871 aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~  950 (1035)
                      |||++.+...+.++|.|+|||.+|||+.|..||.+..... .+..          ++.+.+......  .....+.++|.
T Consensus       303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-Tl~N----------Iv~~~l~Fp~~~--~vs~~akDLIr  369 (459)
T KOG0610|consen  303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-TLRN----------IVGQPLKFPEEP--EVSSAAKDLIR  369 (459)
T ss_pred             cceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-hHHH----------HhcCCCcCCCCC--cchhHHHHHHH
Confidence            9999999999999999999999999999999998654321 1111          222222221111  33445567888


Q ss_pred             hccCCCCCCCCC----HHHHHHH
Q 039419          951 LCVNPTPDDRPT----MKDVAAM  969 (1035)
Q Consensus       951 ~cl~~dP~~RPs----~~el~~~  969 (1035)
                      +.+.+||.+|-.    ++||.++
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHhccChhhhhccccchHHhhcC
Confidence            899999999987    7777664

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-37  Score=345.91  Aligned_cols=249  Identities=21%  Similarity=0.256  Sum_probs=198.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC--CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN--GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      .++|...+.||+|+||.||+|.++.  +..||+|++........           ...+.+.+|+.+++.++||||++++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~Iv~~~   97 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ-----------KQVDHVFSERKILNYINHPFCVNLY   97 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhh-----------hhHHHHHHHHHHHHhCCCCCCcceE
Confidence            4568889999999999999997543  36899999854321111           2245788999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+++..|+||||+++|+|.+++.....  +++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        98 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL  172 (340)
T PTZ00426         98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKR--FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKM  172 (340)
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999976543  88999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.  .....+.    
T Consensus       173 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~i~----  241 (340)
T PTZ00426        173 TDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--LIYQKIL----  241 (340)
T ss_pred             ecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--HHHHHHh----
Confidence            999999865322     23467999999999998888999999999999999999999999754221  1111111    


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                           ..... .+. ...  ....+++.+|++.||++|+     ++++++++
T Consensus       242 -----~~~~~-~p~-~~~--~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        242 -----EGIIY-FPK-FLD--NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -----cCCCC-CCC-CCC--HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                 00000 011 111  1234578889999999995     88888875

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-36  Score=345.19  Aligned_cols=261  Identities=25%  Similarity=0.391  Sum_probs=203.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn  757 (1035)
                      .++|.+.+.||+|+||.||+|.+..      +..||||++......             ...+.+.+|+++++++. |||
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-------------~~~~~~~~Ei~~l~~l~~Hpn  102 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS-------------SEKQALMSELKIMTHLGPHLN  102 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh-------------HHHHHHHHHHHHHHhcCCCCC
Confidence            4678889999999999999997532      347999998653221             12467999999999996 999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcC----------------------------------------------
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR----------------------------------------------  791 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------  791 (1035)
                      |+++++++.+.+..|+||||+++|+|.++++...                                              
T Consensus       103 Iv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (400)
T cd05105         103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ  182 (400)
T ss_pred             eeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence            9999999999999999999999999999886532                                              


Q ss_pred             ------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCee
Q 039419          792 ------------------------------------------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIV  823 (1035)
Q Consensus       792 ------------------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv  823 (1035)
                                                                      ...+++..+..++.|+++||+|||+.   +|+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iv  259 (400)
T cd05105         183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCV  259 (400)
T ss_pred             ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence                                                            12377888899999999999999998   999


Q ss_pred             ccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 039419          824 HRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP  902 (1035)
Q Consensus       824 HrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P  902 (1035)
                      ||||||+||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus       260 H~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P  339 (400)
T cd05105         260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP  339 (400)
T ss_pred             CCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999999999999999999999986644332222234457788999999988889999999999999999997 9999


Q ss_pred             CCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      |....... .....+...          .....+..  ....+.+++.+||+.||++||++.++.+.|+.+.
T Consensus       340 ~~~~~~~~-~~~~~~~~~----------~~~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         340 YPGMIVDS-TFYNKIKSG----------YRMAKPDH--ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             CcccchhH-HHHHHHhcC----------CCCCCCcc--CCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            87542211 111111110          00000111  1123456888999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=302.92  Aligned_cols=262  Identities=21%  Similarity=0.302  Sum_probs=202.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.+|+|||+-||.++. .+++.||+|++......              ..+...+|++..++++|||+++++++
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~--------------~~e~~~rEid~~rkf~s~~vl~l~dh   86 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE--------------DIEEALREIDNHRKFNSPNVLRLVDH   86 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH--------------HHHHHHHHHHHHHhhCCcchHHHHHH
Confidence            6799999999999999999964 46889999999654321              25678999999999999999999998


Q ss_pred             EEcCC-----cceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          765 CWNRN-----TRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       765 ~~~~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ...+.     ..|++++|...|+|.+.+....  ...+++.+.+.|+.+|++||++||+.. ++++||||||.||++.+.
T Consensus        87 ~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~  165 (302)
T KOG2345|consen   87 QLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDS  165 (302)
T ss_pred             HHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCC
Confidence            75443     4899999999999999987543  346899999999999999999999983 369999999999999999


Q ss_pred             CceEEeeccCccccccCCcc-------ccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 039419          838 FEPYIADFGLAKLVVEGDFA-------RSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTI  907 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~  907 (1035)
                      +.+++.|||.+....-.-..       .....-..|..|.|||.+.   +...+.++|||||||++|+|+.|..||+...
T Consensus       166 ~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~  245 (302)
T KOG2345|consen  166 GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY  245 (302)
T ss_pred             CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence            99999999998765322110       1112334789999999865   5568899999999999999999999998543


Q ss_pred             CCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ..+..+.         ..+........-...  ....+.+++.+|++.||.+||++.+++..+.++
T Consensus       246 ~~GgSla---------LAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  246 QQGGSLA---------LAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             hcCCeEE---------EeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            2211110         111111111111111  222345688899999999999999999988765

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-36  Score=341.20  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=191.4

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHH---hcCCCCceeeEEe
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL---GSIRHKNIVRFLG  763 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpniv~l~~  763 (1035)
                      |.+.+.||+|+||.||+|.+. +++.||||++........           ...+.+.+|+.++   ++++||||+++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~l~~e~~~~~~~~~l~hp~i~~~~~   69 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR-----------DEVESLMCEKRIFETANSERHPFLVNLFA   69 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhccccCCCChhceee
Confidence            566789999999999999765 589999999865322111           1234566776655   5678999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||++||+|..+++..   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        70 ~~~~~~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~  143 (324)
T cd05589          70 CFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIA  143 (324)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeC
Confidence            999999999999999999999888643   389999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+++......  .......|++.|+|||+..+..++.++|||||||++|||++|+.||......  .....+....  
T Consensus       144 Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~~--  217 (324)
T cd05589         144 DFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDE--  217 (324)
T ss_pred             cccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC--
Confidence            999987543221  2233567999999999998889999999999999999999999999754221  1111111100  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                           .......+      ....+++.+||+.||++||     ++.+++++
T Consensus       218 -----~~~p~~~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 -----VRYPRFLS------REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             -----CCCCCCCC------HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                 00111111      2234578889999999999     56666653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-36  Score=329.19  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=200.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|++.+.||+|+||.||+|.++    .+..||+|++.......             ..+.|.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~iv~~   71 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDK-------------QRRGFLAEALTLGQFDHSNIVRL   71 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHH-------------HHHHHHHHHHHHhcCCCCCcCeE
Confidence            46888899999999999999653    36789999986542211             24578999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++...+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~  147 (266)
T cd05064          72 EGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCK  147 (266)
T ss_pred             EEEEecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEE
Confidence            999999999999999999999999997643 3488999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      ++|||.+......... ......++..|+|||+..+..++.++|||||||++||+++ |..||......  .....+...
T Consensus       148 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~  224 (266)
T cd05064         148 ISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAVEDG  224 (266)
T ss_pred             ECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCC
Confidence            9999987654322211 1123345678999999988899999999999999999775 99999754221  122222110


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                                .....+....  ....+++..||+++|++||+++++.+.|..+
T Consensus       225 ----------~~~~~~~~~~--~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ----------FRLPAPRNCP--NLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----------CCCCCCCCCC--HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                      0000111111  1234577889999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-36  Score=341.64  Aligned_cols=256  Identities=21%  Similarity=0.241  Sum_probs=196.1

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRF  761 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  761 (1035)
                      +|.+.+.||+|+||.||+|+..    +++.||+|++........          ....+.+.+|+.+++++ +||+|+++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~~i~~~   70 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK----------AKTVEHTRTERNVLEHVRQSPFLVTL   70 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhh----------hhHHHHHHHHHHHHHhccCCCCcccE
Confidence            3777899999999999999653    578999999864321111          12246788999999999 59999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+++..|+||||+++|+|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        71 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~k  145 (332)
T cd05614          71 HYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVV  145 (332)
T ss_pred             EEEEecCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEE
Confidence            9999999999999999999999999976543  88999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |+|||+++.+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ........
T Consensus       146 l~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~  223 (332)
T cd05614         146 LTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRI  223 (332)
T ss_pred             EeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHH
Confidence            9999999865443221 22346799999999998765 478899999999999999999999974322111 01111110


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      .    ..+.......+      ....+++.+||+.||++||     ++++++++
T Consensus       224 ~----~~~~~~~~~~~------~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         224 L----KCDPPFPSFIG------PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             h----cCCCCCCCCCC------HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            0    01111111111      1234577889999999999     77788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-36  Score=341.86  Aligned_cols=200  Identities=27%  Similarity=0.468  Sum_probs=174.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+..+.||+|+||.||+|+++ ++..||+|++......             ...+++.+|++++++++||||++++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~   71 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGFYGA   71 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH-------------HHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence            56888899999999999999776 5888999998643211             125679999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..++||||+++|+|.+++.....  +++..+..++.|++.||.|||+.+  +|+||||||+||+++.++.+||+|
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~D  147 (331)
T cd06649          72 FYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCD  147 (331)
T ss_pred             EEECCEEEEEeecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEcc
Confidence            9999999999999999999999976543  889999999999999999999862  699999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ||+++.....    ......|++.|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus       148 fg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         148 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             Cccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9998765332    123457999999999999889999999999999999999999999643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-36  Score=340.78  Aligned_cols=240  Identities=25%  Similarity=0.333  Sum_probs=186.1

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHH-HHhcCCCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK-TLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||+||+|.+. +|+.||+|++........           ...+++.+|.. +++.++||||+++++++.+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~   69 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-----------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD   69 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-----------hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC
Confidence            46899999999999775 589999999864322111           11234555555 567899999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|..++....  .+++..+..++.||++||+|||+.   ||+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~  144 (323)
T cd05575          70 KLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCc
Confidence            9999999999999999987654  388999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....+..      ...
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i------~~~  211 (323)
T cd05575         145 EGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNI------LNK  211 (323)
T ss_pred             ccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHH------HcC
Confidence            543222  223356799999999999988999999999999999999999999975321     1111111      111


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK  964 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~  964 (1035)
                      .....+..    .....+++.+|++.||++||++.
T Consensus       212 ~~~~~~~~----~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         212 PLRLKPNI----SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCCC----CHHHHHHHHHHhhcCHHhCCCCC
Confidence            11111111    12234577889999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.6e-37  Score=341.51  Aligned_cols=240  Identities=26%  Similarity=0.338  Sum_probs=185.5

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHH-HHhcCCCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK-TLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      ++||+|+||.||+|++. +++.||+|++........           .....+.+|.. +++.++||||+++++++.+.+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~   69 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK-----------KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE   69 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-----------hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            47999999999999775 588999999865322111           11344555554 578899999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|..++....  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  144 (321)
T cd05603          70 KLYFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK  144 (321)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCc
Confidence            9999999999999998886543  378888999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+.         ..
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~---------~~  211 (321)
T cd05603         145 EGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--QMYDNIL---------HK  211 (321)
T ss_pred             cCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--HHHHHHh---------cC
Confidence            542222  2233567999999999998888999999999999999999999999754211  1111111         11


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK  964 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~  964 (1035)
                      .... +.   .......+++.+|+++||.+||++.
T Consensus       212 ~~~~-~~---~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 PLQL-PG---GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCC-CC---CCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1111 11   1112345578889999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.7e-36  Score=345.68  Aligned_cols=256  Identities=23%  Similarity=0.288  Sum_probs=193.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|...+.||+|+||+||+|++. +++.||||++........           ...+.+.+|+.++++++||||+++++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~h~~iv~l~~~~   70 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR-----------NQVAHVKAERDILAEADNEWVVKLYYSF   70 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----------HHHHHHHHHHHHHHhcCCCCeeeeEEEE
Confidence            4778889999999999999665 588999999865322111           1245789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++++||+||
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DF  145 (381)
T cd05626          71 QDKDNLYFVMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDF  145 (381)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeC
Confidence            999999999999999999999976543  88899999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCc---------------------------------------------cccccccCCcccccCCcccccCCC
Q 039419          846 GLAKLVVEGDF---------------------------------------------ARSSNTVAGSYGYIAPEYGYMMKI  880 (1035)
Q Consensus       846 G~a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~  880 (1035)
                      |+++.......                                             ........||+.|+|||++.+..+
T Consensus       146 Gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  225 (381)
T cd05626         146 GLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY  225 (381)
T ss_pred             cCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC
Confidence            99764311000                                             000123579999999999988889


Q ss_pred             CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHh--ccCCCCC
Q 039419          881 TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPD  958 (1035)
Q Consensus       881 ~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~--cl~~dP~  958 (1035)
                      +.++|||||||++|||++|+.||....+...  ...+...       ...........+  .....+++.+  |+.++|.
T Consensus       226 ~~~~DiwSlG~il~elltG~~Pf~~~~~~~~--~~~i~~~-------~~~~~~~~~~~~--s~~~~dli~~ll~~~~~~~  294 (381)
T cd05626         226 TQLCDWWSVGVILFEMLVGQPPFLAPTPTET--QLKVINW-------ENTLHIPPQVKL--SPEAVDLITKLCCSAEERL  294 (381)
T ss_pred             CCccceeehhhHHHHHHhCCCCCcCCCHHHH--HHHHHcc-------ccccCCCCCCCC--CHHHHHHHHHHccCccccc
Confidence            9999999999999999999999975432211  0000000       000000000000  1112233433  6677888


Q ss_pred             CCCCHHHHHHH
Q 039419          959 DRPTMKDVAAM  969 (1035)
Q Consensus       959 ~RPs~~el~~~  969 (1035)
                      .||++++++++
T Consensus       295 ~R~~~~~~l~h  305 (381)
T cd05626         295 GRNGADDIKAH  305 (381)
T ss_pred             CCCCHHHHhcC
Confidence            89999999885

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.9e-36  Score=334.88  Aligned_cols=264  Identities=18%  Similarity=0.247  Sum_probs=195.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|+.. +++.||||++.......             ....+.+|+.++++++||||++++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~~~~~   71 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-------------TPFTAIREASLLKGLKHANIVLLHDI   71 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-------------cchhHHHHHHHHhhCCCCCcCeEEEE
Confidence            56888999999999999999776 58999999986432111             13457789999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        72 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  146 (303)
T cd07869          72 IHTKETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLAD  146 (303)
T ss_pred             EecCCeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECC
Confidence            999999999999995 68888876543 3478889999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc-
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG-  922 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-  922 (1035)
                      ||+++......  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+.............. 
T Consensus       147 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  224 (303)
T cd07869         147 FGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP  224 (303)
T ss_pred             CCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCC
Confidence            99987543221  12234568999999998764 457889999999999999999999997543211111111100000 


Q ss_pred             chhh---------hcc-cccCCCcccHHH-------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEV---------LDK-SLRARPEVEIEE-------MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~---------~~~-~~~~~~~~~~~~-------~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....         ..+ ......+.....       .....+++.+|++.||++|||+.|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         225 NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0000         000 000000000000       1234567888999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.5e-36  Score=332.65  Aligned_cols=263  Identities=19%  Similarity=0.259  Sum_probs=196.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|..+ +++.||+|++......             .....+.+|+.++++++||||++++++
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~~   71 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------------GAPCTAIREVSLLKNLKHANIVTLHDI   71 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-------------CcchhHHHHHHHHHhCCCCCEeeEEEE
Confidence            56888999999999999999765 5899999998643211             113467899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus        72 ~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~D  146 (288)
T cd07871          72 IHTERCLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLAD  146 (288)
T ss_pred             EcCCCeEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECc
Confidence            999999999999997 49999886543 3478899999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc-c
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR-G  922 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~  922 (1035)
                      ||+++......  .......|++.|+|||+..+ ..++.++||||+||++|||++|+.||........ ......... .
T Consensus       147 fG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~  223 (288)
T cd07871         147 FGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTP  223 (288)
T ss_pred             CcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence            99987543322  12234568999999998765 5688999999999999999999999975432111 111100000 0


Q ss_pred             chhh-------------hcccccCCCccc--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEV-------------LDKSLRARPEVE--IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~-------------~~~~~~~~~~~~--~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+.             ..+.....+...  ........+++.+|+++||.+|||++|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         224 TEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000             000000000000  0011234578889999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.7e-36  Score=332.00  Aligned_cols=257  Identities=27%  Similarity=0.497  Sum_probs=203.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|+..+.||+|+||.||+|....      ...||+|.+......             ...+.|.+|+.++++++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~-------------~~~~~~~~ei~~l~~l~h~~i~   71 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-------------KVQQEFRQEAELMSDLQHPNIV   71 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH-------------HHHHHHHHHHHHHHhcCCcccc
Confidence            467888999999999999997643      257999988643211             1256789999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeecc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR  825 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHr  825 (1035)
                      ++++++.+.+..+++|||+++|+|.+++.....              ..+++..+..++.|++.||+|||+.   +++||
T Consensus        72 ~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~  148 (283)
T cd05048          72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHR  148 (283)
T ss_pred             eEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceecc
Confidence            999999998999999999999999999976422              3478889999999999999999999   99999


Q ss_pred             CCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 039419          826 DIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID  904 (1035)
Q Consensus       826 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~  904 (1035)
                      ||||+||+++.++.++|+|||+++...............+++.|+|||+..+..++.++|||||||++|||++ |..||.
T Consensus       149 dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~  228 (283)
T cd05048         149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY  228 (283)
T ss_pred             ccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999986544433333334567889999999888889999999999999999998 999997


Q ss_pred             CCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                      .....  .....+...         .....+.   .....+..++.+||+.||++||++.||+++|+.
T Consensus       229 ~~~~~--~~~~~i~~~---------~~~~~~~---~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         229 GFSNQ--EVIEMIRSR---------QLLPCPE---DCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCHH--HHHHHHHcC---------CcCCCcc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            54321  222222211         0011111   111234567888999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-37  Score=315.38  Aligned_cols=265  Identities=24%  Similarity=0.321  Sum_probs=202.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      -..|...+.||+|+||.|+.|.++ +|+.||||++.......            ...++..||+..++.++|+||+.+++
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~------------~~akRtlRElklLr~~~HeNIi~l~d   88 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ------------IDAKRTLRELKLLRHLRHENIIGLLD   88 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch------------HHHHHHHHHHHHHHHhcCCCcceEEe
Confidence            345666789999999999999665 68999999996322111            23567889999999999999999999


Q ss_pred             EEEc-----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          764 CCWN-----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       764 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      .+..     -...|+|+|+| +.+|.+.++....  ++...+..++.|+++||.|+|+.   +|+|||+||+|++++.+.
T Consensus        89 i~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c  162 (359)
T KOG0660|consen   89 IFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADC  162 (359)
T ss_pred             ecccccccccceeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCC
Confidence            9865     24579999999 7799999987655  88999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCccc-ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG-YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      ..||+|||+|+...........+..+.|..|.|||+. ....|+.+.||||.|||+.||++|+.-|.+...-  +....+
T Consensus       163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI  240 (359)
T KOG0660|consen  163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLI  240 (359)
T ss_pred             CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHH
Confidence            9999999999987554333445678899999999985 4667999999999999999999999988754211  111111


Q ss_pred             HHhccc-------------hhhhcccccCCCcccHHHH-----HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGA-------------IEVLDKSLRARPEVEIEEM-----LQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~-------------~~~~~~~~~~~~~~~~~~~-----~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....+.             ....-+.+...+...+...     ...+++..+|+..||.+|+|++|.+++
T Consensus       241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000000             0001111222222222222     245678888999999999999999985

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.2e-36  Score=342.89  Aligned_cols=205  Identities=24%  Similarity=0.333  Sum_probs=175.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+..+.||+|+||+||+|+.. +++.||+|++........           .....+.+|+.++.+++||||+++++.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~il~~~~~~~iv~~~~~   69 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-----------EQVGHIRAERDILVEADSLWVVKMFYS   69 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-----------hHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            36788899999999999999765 589999999864321111           124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+....|+||||++||+|.+++...+.  +++..+..++.|++.||+|||+.   ||+||||||+|||++.++.+||+|
T Consensus        70 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~D  144 (363)
T cd05628          70 FQDKLNLYLIMEFLPGGDMMTLLMKKDT--LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSD  144 (363)
T ss_pred             EecCCeEEEEEcCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEee
Confidence            9999999999999999999999976543  89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCcc---------------------------------ccccccCCcccccCCcccccCCCCccccchhHHH
Q 039419          845 FGLAKLVVEGDFA---------------------------------RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGV  891 (1035)
Q Consensus       845 FG~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv  891 (1035)
                      ||+++........                                 ......+||+.|+|||++.+..++.++|||||||
T Consensus       145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGv  224 (363)
T cd05628         145 FGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV  224 (363)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHH
Confidence            9998754321100                                 0012357999999999998889999999999999


Q ss_pred             HHHHHHhCCCCCCCC
Q 039419          892 VVLEVLTGKQPIDPT  906 (1035)
Q Consensus       892 vl~elltg~~P~~~~  906 (1035)
                      ++|||++|+.||...
T Consensus       225 il~ell~G~~Pf~~~  239 (363)
T cd05628         225 IMYEMLIGYPPFCSE  239 (363)
T ss_pred             HHHHHHhCCCCCCCC
Confidence            999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.2e-36  Score=341.34  Aligned_cols=245  Identities=21%  Similarity=0.264  Sum_probs=193.2

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCc
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNT  770 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  770 (1035)
                      +.||+|+||.||+|... +++.||+|++........           .....+.+|+++++.++||||+++++++.+.+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~   69 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-----------DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR   69 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCE
Confidence            46899999999999764 689999999865322211           124567889999999999999999999999999


Q ss_pred             ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          771 RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       771 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      .|+||||+++|+|..++...+  .+++..+..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~  144 (325)
T cd05594          70 LCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK  144 (325)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCe
Confidence            999999999999999887654  38999999999999999999997 6   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+...       ..
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i~~~-------~~  213 (325)
T cd05594         145 EGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME-------EI  213 (325)
T ss_pred             ecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHHhcC-------CC
Confidence            543221  1223457999999999998889999999999999999999999999654221  111111100       00


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      .+.....      ....+++.+||+.||++|+     ++.+++++
T Consensus       214 ~~p~~~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 RFPRTLS------PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCC------HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            0111111      1234577889999999996     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=365.95  Aligned_cols=499  Identities=26%  Similarity=0.302  Sum_probs=391.2

Q ss_pred             CccceeEEeC--CCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCC
Q 039419           18 PCKWSHITCS--PQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP   95 (1035)
Q Consensus        18 ~c~w~gi~c~--~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p   95 (1035)
                      ||+-+-|.-.  +.-.++.++++.|-+..-.-+.+..--+|+.|+|++|.+. ..|..+..+.+|+.|+++.|.|. .+|
T Consensus         7 ~~~l~~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp   84 (1081)
T KOG0618|consen    7 DEQLELIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVP   84 (1081)
T ss_pred             cccCcccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCc
Confidence            4555555431  1112777888887664322233444445999999999998 79999999999999999999999 999


Q ss_pred             hhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCcc
Q 039419           96 SSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQ  175 (1035)
Q Consensus        96 ~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~  175 (1035)
                      .+++++.+|++|.|.+|++. .+|..+..+.+|+.|+++.|++. .+|..+..++.++.+..++|. .....+    ...
T Consensus        85 ~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~-~~~~lg----~~~  157 (1081)
T KOG0618|consen   85 SSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNE-KIQRLG----QTS  157 (1081)
T ss_pred             hhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcch-hhhhhc----ccc
Confidence            99999999999999999998 89999999999999999999997 999999999999999999993 222222    222


Q ss_pred             ceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcc
Q 039419          176 SLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLW  255 (1035)
Q Consensus       176 ~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~  255 (1035)
                       ++.+++..+.+.+.++..+..++.  .|+|++|.+.   --.+.++.+|+.|....|+++...    -..++|+.|+.+
T Consensus       158 -ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~  227 (1081)
T KOG0618|consen  158 -IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYAD  227 (1081)
T ss_pred             -chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeec
Confidence             788888999998888888888887  8999999876   345677888999999999887321    234788899999


Q ss_pred             cccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhh
Q 039419          256 QNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFF  335 (1035)
Q Consensus       256 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~  335 (1035)
                      +|.+....+..  .-.+|+++++++|+++ .+|.+++.+.+|+.|+..+|++. ..|..+..+++|+.|...+|+++.  
T Consensus       228 ~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~y--  301 (1081)
T KOG0618|consen  228 HNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEY--  301 (1081)
T ss_pred             cCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhh--
Confidence            99988433322  2358999999999999 56689999999999999999996 778888889999999999999984  


Q ss_pred             hhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcc-cCc-ccceEeccccccccCCCCCCCCCCcceeEeeeccCC
Q 039419          336 AWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLF-QLQ-NLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGN  413 (1035)
Q Consensus       336 ~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~  413 (1035)
                               +|.....+++|++|+|..|+|. ..|..+. .+. .|..|..+.|++....  .++            =..
T Consensus       302 ---------ip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp--~~~------------e~~  357 (1081)
T KOG0618|consen  302 ---------IPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLP--SYE------------ENN  357 (1081)
T ss_pred             ---------CCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccc--ccc------------chh
Confidence                     5677888999999999999998 4444433 333 3788888888887443  111            123


Q ss_pred             CCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEE
Q 039419          414 CTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLD  493 (1035)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  493 (1035)
                      +..|+.|+|.+|.++...-..|.+.+.|++|+|++|+|...+...+.++..|++|+||+|+++ .+|..+..++.|++|.
T Consensus       358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~  436 (1081)
T KOG0618|consen  358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR  436 (1081)
T ss_pred             hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence            466999999999999877778889999999999999999887788899999999999999998 7788999999999999


Q ss_pred             cCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCc-ccCccccccccCCCcEEeccCC
Q 039419          494 LSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNK-LGGDLLALSGLDNLVSLNVSYN  569 (1035)
Q Consensus       494 Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~l~~L~~L~ls~N  569 (1035)
                      ..+|+|. .+| ++..+..+. .+|+|.|+|+...-+.....++|++|||++|. +..+-..|..+.++...+++-|
T Consensus       437 ahsN~l~-~fP-e~~~l~qL~-~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  437 AHSNQLL-SFP-ELAQLPQLK-VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             hcCCcee-ech-hhhhcCcce-EEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            9999998 777 555555554 67788887775533333333778888888886 3334455666666666666666

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.6e-36  Score=326.75  Aligned_cols=254  Identities=23%  Similarity=0.383  Sum_probs=204.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|+..+.||+|+||.||+|...+++.||+|.+.....               ..+.+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------------SVQAFLEEANLMKTLQHDKLVRLYAVV   70 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---------------hHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            56888999999999999999988888999998754221               245789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||+++++|.++++......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df  147 (261)
T cd05072          71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADF  147 (261)
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCC
Confidence            9999999999999999999999876555688999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++....... .......++..|+|||+..+..++.++|||||||++|+|++ |..||......  ....++....   
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~---  221 (261)
T cd05072         148 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGY---  221 (261)
T ss_pred             ccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC---
Confidence            99987644321 11223446778999999888889999999999999999998 99999643221  1122221110   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                         .......      ......+++.+|++++|++||+++++.+.|++
T Consensus       222 ---~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 ---RMPRMEN------CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCCCCC------CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               0000001      11234568889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3e-36  Score=338.01  Aligned_cols=251  Identities=22%  Similarity=0.332  Sum_probs=192.2

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||.||+|+.. +++.||+|++........           ...+.+.+|+.++.++ +||||+++++++.+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~   69 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-----------EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   69 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch-----------hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC
Confidence            46899999999999765 578999999965432221           1245678899998877 7999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|..++...+  .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~  144 (329)
T cd05618          70 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  144 (329)
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccc
Confidence            9999999999999999887654  389999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC---chhHHHHHHHhccchhh
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE---GLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~  926 (1035)
                      ......  .......||+.|+|||+..+..++.++|||||||++|||++|+.||......   ......++....     
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-----  217 (329)
T cd05618         145 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-----  217 (329)
T ss_pred             cccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-----
Confidence            543221  1223567999999999999999999999999999999999999999632111   111111211110     


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT------MKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs------~~el~~~  969 (1035)
                      ...... .+. .  .......++.+||+.||++||+      +.+++++
T Consensus       218 ~~~~~~-~p~-~--~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         218 LEKQIR-IPR-S--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             hcCCCC-CCC-C--CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            011111 011 1  1123346788899999999998      4566553

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.4e-36  Score=338.40  Aligned_cols=261  Identities=26%  Similarity=0.402  Sum_probs=202.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCce
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNI  758 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  758 (1035)
                      ++|++.+.||+|+||.||+|...      .++.||+|++.......             ..+.+.+|+.++.++ +||||
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~-------------~~~~~~~E~~~~~~l~~h~ni   73 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS-------------EYKALMTELKILIHIGHHLNV   73 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH-------------HHHHHHHHHHHHHhhccCcch
Confidence            46888999999999999999542      24789999986432211             135678899999999 79999


Q ss_pred             eeEEeEEEcC-CcceEEEEeCCCCChhhhhhhcCC---------------------------------------------
Q 039419          759 VRFLGCCWNR-NTRLLMYDYMPNGSLGSLLHERRD---------------------------------------------  792 (1035)
Q Consensus       759 v~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------  792 (1035)
                      +++++++... ...+++|||+++++|.+++.....                                             
T Consensus        74 v~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (337)
T cd05054          74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSL  153 (337)
T ss_pred             hheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcch
Confidence            9999988754 467899999999999999864321                                             


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccc
Q 039419          793 --------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR  858 (1035)
Q Consensus       793 --------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  858 (1035)
                                    ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||+++.+.......
T Consensus       154 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~  230 (337)
T cd05054         154 SDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV  230 (337)
T ss_pred             hhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh
Confidence                          2578999999999999999999999   99999999999999999999999999998764433222


Q ss_pred             cccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcc
Q 039419          859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV  937 (1035)
Q Consensus       859 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  937 (1035)
                      ......++..|+|||+..+..++.++|||||||++|||++ |..||....... .....+....      .   ...+. 
T Consensus       231 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~------~---~~~~~-  299 (337)
T cd05054         231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT------R---MRAPE-  299 (337)
T ss_pred             hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC------C---CCCCc-
Confidence            2334456788999999999999999999999999999998 999997543221 1111111100      0   00011 


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          938 EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       938 ~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                        .....+.+++.+||+.+|++||++.|++++|+++.+
T Consensus       300 --~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         300 --YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             --cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              111234567888999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.5e-36  Score=332.95  Aligned_cols=264  Identities=21%  Similarity=0.250  Sum_probs=198.1

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|.+.+.||+|+||+||+|+++ +++.||+|++.......            ...+.+.+|+.++++++||||+++++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   69 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE------------EVKETTLRELKMLRTLKQENIVELKEAF   69 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc------------cchhhHHHHHHHHHhCCCccccchhhhE
Confidence            5888899999999999999876 57899999986532211            2346788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ...+..|+||||++++.+..+....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        70 ~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Df  144 (287)
T cd07848          70 RRRGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDF  144 (287)
T ss_pred             ecCCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence            9999999999999988776554332  3488999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc--
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA--  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--  923 (1035)
                      |+++....... .......|++.|+|||+..+..++.++||||+||++|||++|+.||....... ............  
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  222 (287)
T cd07848         145 GFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGPLPA  222 (287)
T ss_pred             cCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCCCCH
Confidence            99987643321 12234578999999999988889999999999999999999999997542211 110000000000  


Q ss_pred             -----------hhhhcccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 -----------IEVLDKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 -----------~~~~~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                                 ................     .....+.+++.+||++||++|||++|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                       0000000000000000     011235678899999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=343.41  Aligned_cols=255  Identities=22%  Similarity=0.306  Sum_probs=195.7

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||+||+|++. +++.||||++........           .....+.+|+.+++.++||||+++++++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~h~~iv~~~~~~   70 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK-----------EQVAHVRAERDILAEADNPWVVKLYYSF   70 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            5788899999999999999776 589999999964321111           1245688999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..|+||||++||+|.+++...+.  +++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+||
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  145 (364)
T cd05599          71 QDENYLYLIMEYLPGGDMMTLLMKKDT--FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDF  145 (364)
T ss_pred             EcCCeEEEEECCCCCcHHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeec
Confidence            999999999999999999999976543  89999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccc------------------------------------cccccCCcccccCCcccccCCCCccccchhH
Q 039419          846 GLAKLVVEGDFAR------------------------------------SSNTVAGSYGYIAPEYGYMMKITEKSDVYSY  889 (1035)
Q Consensus       846 G~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl  889 (1035)
                      |+++.........                                    ......||+.|+|||++....++.++|||||
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  225 (364)
T cd05599         146 GLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL  225 (364)
T ss_pred             ccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecc
Confidence            9987543211000                                    0112469999999999988899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC---HHHH
Q 039419          890 GVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT---MKDV  966 (1035)
Q Consensus       890 Gvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs---~~el  966 (1035)
                      ||++|||++|..||....+.  .....+....       ..+.......+  .....+++.+|+. +|.+|++   +.|+
T Consensus       226 G~il~el~~G~~Pf~~~~~~--~~~~~i~~~~-------~~~~~~~~~~~--s~~~~~li~~ll~-~p~~R~~~~~~~~l  293 (364)
T cd05599         226 GVIMYEMLVGYPPFCSDNPQ--ETYRKIINWK-------ETLQFPDEVPL--SPEAKDLIKRLCC-EAERRLGNNGVNEI  293 (364)
T ss_pred             hhHHHHhhcCCCCCCCCCHH--HHHHHHHcCC-------CccCCCCCCCC--CHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence            99999999999999754321  1111111000       00000000001  1123345666775 8999997   8888


Q ss_pred             HHH
Q 039419          967 AAM  969 (1035)
Q Consensus       967 ~~~  969 (1035)
                      +++
T Consensus       294 l~h  296 (364)
T cd05599         294 KSH  296 (364)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.7e-36  Score=335.44  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=188.8

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||.||+|+.. +++.||+|++........           ...+.+..|..++... +||||+++++++...+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~   69 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED-----------DDVECTMVERRVLALAWEHPFLTHLFCTFQTKE   69 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hhHHHHHHHHHHHHhccCCCCccceeeEEEcCC
Confidence            46899999999999775 478999999865332111           1234556677777654 8999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||++||+|..++.....  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~gg~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~  144 (316)
T cd05592          70 HLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCe
Confidence            99999999999999999876543  88999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+..   .    ..
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~---~----~~  213 (316)
T cd05592         145 ENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFDSILN---D----RP  213 (316)
T ss_pred             ECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHc---C----CC
Confidence            643322  2233567999999999998888999999999999999999999999754221  11111110   0    00


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK-DVAA  968 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~-el~~  968 (1035)
                      ......+      ....+++.+||+.||++||++. ++++
T Consensus       214 ~~~~~~~------~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         214 HFPRWIS------KEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCC------HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            1111111      1234577789999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.8e-37  Score=316.68  Aligned_cols=257  Identities=26%  Similarity=0.336  Sum_probs=193.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|...+++|+|+||.||+|... .++.||||+..++..-.                  .+|+++|++++|||||++.-+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------------------nrEl~im~~l~HpNIV~L~~~f   86 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------------------NRELQIMRKLDHPNIVRLLYFF   86 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------------------cHHHHHHHhcCCcCeeeEEEEE
Confidence            4677789999999999999655 47999999997654322                  3799999999999999999888


Q ss_pred             EcCC-----cceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC-
Q 039419          766 WNRN-----TRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-  837 (1035)
Q Consensus       766 ~~~~-----~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~-  837 (1035)
                      ....     ...+||||++ .+|+++++..  ....++...+.-+..||.+||+|||+.   +|+||||||+|+|+|.+ 
T Consensus        87 ~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~t  162 (364)
T KOG0658|consen   87 SSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDT  162 (364)
T ss_pred             EecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCC
Confidence            6432     3358999996 4999998742  123377777888999999999999998   99999999999999977 


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      |.+||||||.|+....++..   ..+..|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+... ..+....
T Consensus       163 g~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eI  238 (364)
T KOG0658|consen  163 GVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEI  238 (364)
T ss_pred             CeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHH
Confidence            89999999999998776543   356789999999987654 699999999999999999999998876432 1222222


Q ss_pred             HHHhccc-hh---hh--------cccccCCCc---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRGA-IE---VL--------DKSLRARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~~-~~---~~--------~~~~~~~~~---~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ++-.... .+   ..        .+.+...+.   ..-....+.++++.+++..+|.+|.++.|++++
T Consensus       239 ik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  239 IKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            2211111 01   00        011111111   011122355678888999999999999999874

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.5e-36  Score=323.22  Aligned_cols=251  Identities=25%  Similarity=0.449  Sum_probs=200.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|+++++..+|+|.+.....               ..+.|.+|+.++++++||||+++++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---------------SEEDFIEEAKVMMKLSHPKLVQLYGVC   68 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---------------cHHHHHHHHHHHHHCCCCCceeEEEEE
Confidence            45777889999999999999998888999998753321               135788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||+++|+|.++++.... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        69 ~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~  144 (256)
T cd05114          69 TQQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF  144 (256)
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCC
Confidence            999999999999999999999875432 488999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++........ ......++..|+|||+..+..++.++||||||+++|||++ |+.||.....  ......+.....  
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i~~~~~--  219 (256)
T cd05114         145 GMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMISRGFR--  219 (256)
T ss_pred             CCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCC--
Confidence            998865433221 1223345678999999988889999999999999999999 8999965421  122222211100  


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                             ...+..   .......++.+||+++|++||+++++++.|
T Consensus       220 -------~~~~~~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 -------LYRPKL---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             -------CCCCCC---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                   001111   112346688899999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5.3e-36  Score=334.87  Aligned_cols=260  Identities=26%  Similarity=0.403  Sum_probs=201.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-Cc----EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GE----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .+|...+.||+|+||.||+|.+.. ++    .||+|++......             ...+++.+|+.+++.++||||++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~   73 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-------------KANKEILDEAYVMASVDNPHVCR   73 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCCCCe
Confidence            458888999999999999997643 33    4899998543211             12467889999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++... ..++|+||+++|+|.++++... ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+
T Consensus        74 ~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~  148 (316)
T cd05108          74 LLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHV  148 (316)
T ss_pred             EEEEEcCC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcE
Confidence            99998764 5689999999999999998654 2378899999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||......  .+..+...
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~  226 (316)
T cd05108         149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK  226 (316)
T ss_pred             EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhC
Confidence            9999999987654332222223345678999999988899999999999999999998 99999753211  11111111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      .        ..... ++.   .......++.+||..||++||++.+++..+..+.+..
T Consensus       227 ~--------~~~~~-~~~---~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         227 G--------ERLPQ-PPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             C--------CCCCC-CCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            0        00010 111   1123456888999999999999999999988775433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.5e-36  Score=336.44  Aligned_cols=244  Identities=22%  Similarity=0.307  Sum_probs=191.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC-CceeeEEeE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH-KNIVRFLGC  764 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~  764 (1035)
                      +|...+.||+|+||.||+|+.+ +++.||||++........           ...+.+..|.+++..++| ++|++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~   69 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD-----------DDVECTMVEKRVLALPGKPPFLTQLHSC   69 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhcCCCCceeeeEEE
Confidence            4778899999999999999776 478999999865322111           124578899999999976 568899999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++|+|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        70 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~D  144 (324)
T cd05587          70 FQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIAD  144 (324)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEee
Confidence            9999999999999999999999876543  88999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+++......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+....   
T Consensus       145 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~~---  217 (324)
T cd05587         145 FGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIMEHN---  217 (324)
T ss_pred             cCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCC---
Confidence            99987532221  1223467999999999999889999999999999999999999999754221  1111111100   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM  963 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~  963 (1035)
                          ........      ....+++.+|+++||++|++.
T Consensus       218 ----~~~~~~~~------~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 ----VSYPKSLS------KEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ----CCCCCCCC------HHHHHHHHHHhhcCHHHcCCC
Confidence                00111111      133457788999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-37  Score=333.25  Aligned_cols=244  Identities=30%  Similarity=0.439  Sum_probs=195.1

Q ss_pred             eeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcc
Q 039419          693 VVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR  771 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  771 (1035)
                      ++|+|.||+||-|++.+ ...+|||-+..+...              ..+-+..|+...++++|.|||+++|.+.+.++.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr--------------~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~  647 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR--------------EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFF  647 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccch--------------hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeE
Confidence            89999999999998775 567899988543221              235688999999999999999999999999999


Q ss_pred             eEEEEeCCCCChhhhhhhcCCCCC--CHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc-CCCceEEeeccCc
Q 039419          772 LLMYDYMPNGSLGSLLHERRDSCL--EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG-PEFEPYIADFGLA  848 (1035)
Q Consensus       772 ~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~~kl~DFG~a  848 (1035)
                      -+.||.++||||.++++..=+ ++  .+.+.-.+.+||++||.|||+.   .|||||||-+|||++ -.|.+||+|||.+
T Consensus       648 kIFMEqVPGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTs  723 (1226)
T KOG4279|consen  648 KIFMEQVPGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTS  723 (1226)
T ss_pred             EEEeecCCCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccc
Confidence            999999999999999975422 23  6677778899999999999999   999999999999996 4689999999999


Q ss_pred             cccccCCccccccccCCcccccCCcccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          849 KLVVEGDFARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      +....  ....+.++.||..|||||++..+  .|++++|||||||++.||.||++||.........   +.+.       
T Consensus       724 KRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---MFkV-------  791 (1226)
T KOG4279|consen  724 KRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---MFKV-------  791 (1226)
T ss_pred             hhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---hhhh-------
Confidence            87643  33456678999999999997644  4889999999999999999999999754332211   1111       


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                        ......|+...+-..+...++++|+.+||.+||++.++++
T Consensus       792 --GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  792 --GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             --cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence              1112233333333445566899999999999999999987

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.4e-36  Score=335.97  Aligned_cols=200  Identities=25%  Similarity=0.462  Sum_probs=174.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+..+.||+|+||.||+|.++ +++.+|+|++......             ...+.+.+|++++++++||||++++++
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~   71 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGFYGA   71 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH-------------HHHHHHHHHHHHHHHCCCCcccceeEE
Confidence            57888999999999999999776 5888999988653211             124678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++|+|.+++...+.  +++..+..++.+++.|++|||+.+  +|+||||||+||+++.++.+||+|
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~D  147 (333)
T cd06650          72 FYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCD  147 (333)
T ss_pred             EEECCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEee
Confidence            9999999999999999999999976543  788999999999999999999752  699999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ||++......    ......|+..|+|||+..+..++.++|||||||++|||++|+.||...
T Consensus       148 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         148 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             CCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            9998765332    123457899999999998888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-35  Score=324.20  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=203.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+.||+|+||.||+|.++.    ...||||++......             ...+.|.+|+.++++++||||+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~   70 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD-------------KQRLDFLTEASIMGQFDHPNIIRL   70 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh-------------HHHHHHHHHHHHHHhCCCCCcceE
Confidence            468889999999999999997753    457999988643221             235678999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+.+..++||||+++++|.+++..... .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++
T Consensus        71 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~  146 (266)
T cd05033          71 EGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (266)
T ss_pred             eEEEecCCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEE
Confidence            9999999999999999999999999976543 489999999999999999999998   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||......  .....+...
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~  224 (266)
T cd05033         147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDG  224 (266)
T ss_pred             ECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcC
Confidence            999999987752222112223345678999999988889999999999999999998 99998643211  122222110


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      .          ....+.  .......+++.+||+.+|++||++.+++++|+++
T Consensus       225 ~----------~~~~~~--~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 Y----------RLPPPM--DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C----------CCCCCC--CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0          000001  1112345688899999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-36  Score=328.22  Aligned_cols=251  Identities=29%  Similarity=0.498  Sum_probs=192.4

Q ss_pred             cCCeeeeeCCcEEEEEEEC-----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          690 EDSVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       690 ~~~~iG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..+.||.|.||.||+|.+.     .+..|+||.+.......             ..+.|.+|++.+++++||||++++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~ni~~~~g~   69 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE-------------EEEEFLNEIQILRKLRHPNIVKLYGF   69 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH-------------HHHHHHHHHHHHHTHSBTTBE-EEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc-------------cceeeeeccccccccccccccccccc
Confidence            3568999999999999776     26789999995532221             25689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +...+..++||||+++|+|.++++......+++..+..|+.||++||+|||+.   +++|+||+++||+++.++.+||+|
T Consensus        70 ~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~  146 (259)
T PF07714_consen   70 CIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSD  146 (259)
T ss_dssp             EESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEES
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            99888899999999999999999987455689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++...............+...|+|||......++.++||||||+++||+++ |+.||....  ...+...+..... 
T Consensus       147 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~~~~~~~~~~~-  223 (259)
T PF07714_consen  147 FGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEEIIEKLKQGQR-  223 (259)
T ss_dssp             TTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHHHHHHHHTTEE-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccc-
Confidence            999987643333333344567889999999988889999999999999999999 788986542  1222222211110 


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                           .......+      .....++..||+.||++||++.++++.|
T Consensus       224 -----~~~~~~~~------~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 -----LPIPDNCP------KDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----TTSBTTSB------HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ceeccchh------HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 00111111      1234578889999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=305.23  Aligned_cols=253  Identities=23%  Similarity=0.311  Sum_probs=201.4

Q ss_pred             hccccCCeeeeeCCcEEEEE-EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|.+-+.||+|.|+.||++ ..++|+.+|+|++..+.....            ..+.+.+|+.+-+.|+|||||++.+.
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------------~~e~l~rEarIC~~LqHP~IvrL~~t   78 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------------DFQKLEREARICRKLQHPNIVRLHDS   78 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------------cHHHHHHHHHHHHhcCCCcEeehhhh
Confidence            45666778999999999998 445699999999976554432            35789999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc---CCCceE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG---PEFEPY  841 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~---~~~~~k  841 (1035)
                      +.+.+..|+|+|+|+|++|..-+-.+.  .+++..+-.++.||+++|.|+|.+   +|||||+||+|+++.   ...-+|
T Consensus        79 i~~~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vK  153 (355)
T KOG0033|consen   79 IQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVK  153 (355)
T ss_pred             hcccceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCcee
Confidence            999999999999999999987765553  377888889999999999999999   999999999999995   345689


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ++|||+|....++.   .....+|||+|||||+....+|+..+|||+-||++|-++.|++||-+...  ..+.+.+.+  
T Consensus       154 L~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rlye~I~~--  226 (355)
T KOG0033|consen  154 LADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYEQIKA--  226 (355)
T ss_pred             ecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHHHHHhc--
Confidence            99999999887432   34578899999999999999999999999999999999999999975321  122222211  


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +.     .....+.+..+.+  ...+++.+|+..||.+|.|+.|.+.+
T Consensus       227 g~-----yd~~~~~w~~is~--~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  227 GA-----YDYPSPEWDTVTP--EAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             cc-----cCCCCcccCcCCH--HHHHHHHHHhccChhhhccHHHHhCC
Confidence            11     1111212222222  23457888999999999999998764

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.4e-36  Score=338.17  Aligned_cols=245  Identities=21%  Similarity=0.335  Sum_probs=192.6

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  769 (1035)
                      ++||+|+||.||+|+.. +++.||+|++........           ...+.+..|.+++..+ +||||+++++++.+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~   69 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-----------DDVDCTMTEKRILALAAKHPFLTALHCCFQTKD   69 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh-----------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCC
Confidence            36899999999999776 478999999865322111           1245677899999876 7999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|..++...+.  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~E~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~  144 (321)
T cd05591          70 RLFFVMEYVNGGDLMFQIQRSRK--FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK  144 (321)
T ss_pred             eEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccce
Confidence            99999999999999999876543  88999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+....       .
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--~~~~~i~~~~-------~  213 (321)
T cd05591         145 EGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFESILHDD-------V  213 (321)
T ss_pred             ecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--HHHHHHHcCC-------C
Confidence            543322  1223457999999999998889999999999999999999999999754321  1111111100       0


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-------TMKDVAAM  969 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-------s~~el~~~  969 (1035)
                      ......+      ....+++.+||++||++||       ++++++++
T Consensus       214 ~~p~~~~------~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         214 LYPVWLS------KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCC------HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            0000111      2334577889999999999       78888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-36  Score=339.41  Aligned_cols=240  Identities=24%  Similarity=0.327  Sum_probs=189.7

Q ss_pred             CeeeeeCCcEEEEEEE----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          692 SVVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      +.||+|+||.||+++.    .+|+.||+|++.......            .....+.+|++++++++||||+++++++.+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   69 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV------------RDRVRTKMERDILAEVNHPFIVKLHYAFQT   69 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh------------hhHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence            5799999999999965    358899999986432211            123467889999999999999999999999


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                      ++..|+||||+++|+|.+++....  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        70 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~  144 (318)
T cd05582          70 EGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL  144 (318)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccC
Confidence            999999999999999999997654  389999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhh
Q 039419          848 AKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVL  927 (1035)
Q Consensus       848 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1035)
                      ++......  .......||+.|+|||+..+..++.++|||||||++|||++|+.||......  .....+..        
T Consensus       145 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~i~~--------  212 (318)
T cd05582         145 SKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTMILK--------  212 (318)
T ss_pred             CcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHHHHc--------
Confidence            88654332  1223467999999999998888999999999999999999999999754211  11111110        


Q ss_pred             cccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 039419          928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKD  965 (1035)
Q Consensus       928 ~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~e  965 (1035)
                       .... .+ ..+.  .....++.+||++||++||++.+
T Consensus       213 -~~~~-~p-~~~~--~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         213 -AKLG-MP-QFLS--PEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCC-CC-CCCC--HHHHHHHHHHhhcCHhHcCCCCC
Confidence             0000 01 1111  12345778899999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.3e-36  Score=337.82  Aligned_cols=239  Identities=21%  Similarity=0.326  Sum_probs=188.4

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||+||+|+.+ +++.||||++........           ...+.+..|..++..+ +||||+++++++.+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   69 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-----------DDVECTMTEKRILSLARNHPFLTQLYCCFQTPD   69 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc-----------cHHHHHHHHHHHHHhccCCCchhceeeEEEcCC
Confidence            46899999999999776 588999999865322111           1245677888888876 6999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|.+++...+.  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~iv~Ey~~~g~L~~~i~~~~~--l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~  144 (320)
T cd05590          70 RLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK  144 (320)
T ss_pred             EEEEEEcCCCCchHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCe
Confidence            99999999999999999876543  88999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....       .
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~~~~-------~  213 (320)
T cd05590         145 EGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAILNDE-------V  213 (320)
T ss_pred             ecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcCC-------C
Confidence            543221  1223467999999999999889999999999999999999999999754221  1111111100       0


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM  963 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~  963 (1035)
                      ......+      ....+++.+|++.||++||++
T Consensus       214 ~~~~~~~------~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         214 VYPTWLS------QDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCC------HHHHHHHHHHcccCHHHCCCC
Confidence            0011111      123457788999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-39  Score=363.85  Aligned_cols=485  Identities=25%  Similarity=0.279  Sum_probs=395.9

Q ss_pred             EEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCC
Q 039419           35 INIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQL  114 (1035)
Q Consensus        35 l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l  114 (1035)
                      +++++..++ .+|+.+..-..+..|+++.|.+-.-..+.+...-+|+.|||++|.+. ..|..|..+.+|+.|+++.|.+
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i   80 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI   80 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence            455555555 57887777777999999999887433445556666999999999998 8999999999999999999999


Q ss_pred             CCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCccc
Q 039419          115 TGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPAS  194 (1035)
Q Consensus       115 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~  194 (1035)
                      . ..|.++.++.+|++|.|.+|.+. .+|..+..+++|+.|++++|.  .+.+|..+..+..+.++..++|...    ..
T Consensus        81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~--f~~~Pl~i~~lt~~~~~~~s~N~~~----~~  152 (1081)
T KOG0618|consen   81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNH--FGPIPLVIEVLTAEEELAASNNEKI----QR  152 (1081)
T ss_pred             h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhc--cCCCchhHHhhhHHHHHhhhcchhh----hh
Confidence            8 88999999999999999999998 899999999999999999997  7788999999999999999988222    22


Q ss_pred             ccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCc
Q 039419          195 LGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLK  274 (1035)
Q Consensus       195 l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  274 (1035)
                      ++... .+.+++..|.+.+.++..+.++..  .|+|++|.+. .  -.+..+.+|+.|.+..|++....    -..++|+
T Consensus       153 lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~  222 (1081)
T KOG0618|consen  153 LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLT  222 (1081)
T ss_pred             hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcchh
Confidence            33333 889999999999999999888877  8999999987 2  34778899999999999987432    2457899


Q ss_pred             EEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCC
Q 039419          275 TIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRS  354 (1035)
Q Consensus       275 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~  354 (1035)
                      .|+.++|.++...+. + --.+|+++++++|+++. .|+.+..+.+|+.++..+|++..           +|..+....+
T Consensus       223 ~L~a~~n~l~~~~~~-p-~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~~-----------lp~ri~~~~~  288 (1081)
T KOG0618|consen  223 ALYADHNPLTTLDVH-P-VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLVA-----------LPLRISRITS  288 (1081)
T ss_pred             eeeeccCcceeeccc-c-ccccceeeecchhhhhc-chHHHHhcccceEecccchhHHh-----------hHHHHhhhhh
Confidence            999999999843332 2 23689999999999995 55999999999999999999974           4667888899


Q ss_pred             CcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCC-CccceeecCCCccCCCCcc
Q 039419          355 LEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNC-TQLQMLNLSNNTLGGTLPS  433 (1035)
Q Consensus       355 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l-~~L~~L~L~~N~l~~~~~~  433 (1035)
                      |+.|.+.+|.++ -+|+...+++.|++|+|..|+|....+..+              .-+ ..|..|+.+.|++....--
T Consensus       289 L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l--------------~v~~~~l~~ln~s~n~l~~lp~~  353 (1081)
T KOG0618|consen  289 LVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFL--------------AVLNASLNTLNVSSNKLSTLPSY  353 (1081)
T ss_pred             HHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHH--------------hhhhHHHHHHhhhhccccccccc
Confidence            999999999998 778888889999999999999985544222              112 2377888888888843322


Q ss_pred             cccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccC
Q 039419          434 SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGL  513 (1035)
Q Consensus       434 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l  513 (1035)
                      .=...+.|+.|++.+|+++...-..+.++.+|+.|+|++|+|.......+.++..|++|+||+|+|+ .+|..+..+..+
T Consensus       354 ~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L  432 (1081)
T KOG0618|consen  354 EENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRL  432 (1081)
T ss_pred             cchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhh
Confidence            2224568999999999999877778889999999999999998666667889999999999999998 899888887776


Q ss_pred             cceeeccCccCCCCCCccccCCccccEEeccCCcccCcc-ccccccCCCcEEeccCCcCc
Q 039419          514 DISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LALSGLDNLVSLNVSYNNFT  572 (1035)
Q Consensus       514 ~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~ls~N~l~  572 (1035)
                      . +|...+|+|. ..| .+..+++|+.+|||.|+|+... +.....++|++|||+||...
T Consensus       433 ~-tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  433 H-TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             H-HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            5 6889999998 445 8999999999999999998744 22222389999999999853

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-36  Score=323.48  Aligned_cols=254  Identities=26%  Similarity=0.408  Sum_probs=203.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|.+.+++.||+|.+.....               ..+.+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---------------DPKDFLAEAQIMKKLRHPKLIQLYAVC   70 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---------------cHHHHHHHHHHHHHCCCCCccceeEEE
Confidence            56888899999999999999887788999999864321               135688999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ...+..|+||||+++++|.+++.......+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df  147 (261)
T cd05068          71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADF  147 (261)
T ss_pred             ecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCc
Confidence            9999999999999999999999776545589999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |+++....... .......++..|+|||+..+..++.++||||||+++|||++ |+.||......  .....+...    
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~----  220 (261)
T cd05068         148 GLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQG----  220 (261)
T ss_pred             ceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcC----
Confidence            99987653221 11122234568999999988899999999999999999999 99999653211  111111110    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                            .....+.  .......+++.+|++.+|++||++.++.+.|++
T Consensus       221 ------~~~~~~~--~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         221 ------YRMPCPP--GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             ------CCCCCCC--cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                  0000011  111234568889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-36  Score=329.93  Aligned_cols=254  Identities=22%  Similarity=0.258  Sum_probs=199.0

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |+..+.||+|+||+||+|... +++.||+|++........           .....+.+|+.++++++||||+++++++.
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   70 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----------KGEAMALNEKQILEKVNSRFVVSLAYAYE   70 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh-----------hhHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            677889999999999999765 589999999865332211           12346788999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +++..++||||+++|+|.+++.......+++..+..++.|++.|++|||+.   +|+||||||+||++++++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05605          71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             CCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCC
Confidence            999999999999999999988765545689999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      +++.......   .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... . ...+..      .
T Consensus       148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~-~~~~~~------~  216 (285)
T cd05605         148 LAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-K-REEVER------R  216 (285)
T ss_pred             CceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-H-HHHHHH------H
Confidence            9986543221   124578999999999988889999999999999999999999997543211 0 011110      0


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      +.... ...+....  ....+++.+||+.||++||     ++++++++
T Consensus       217 ~~~~~-~~~~~~~~--~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         217 VKEDQ-EEYSEKFS--EAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hhhcc-cccCcccC--HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            00000 01111111  2234578889999999999     78888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-36  Score=351.97  Aligned_cols=251  Identities=20%  Similarity=0.251  Sum_probs=197.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-C-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-N-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .|...+.||+|+||.||+|... + ++.||+|++.....              .....+.+|+.+++.++|||||+++++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~--------------~~~~~~~~E~~~l~~l~Hpniv~~~~~  133 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE--------------RQAAYARSELHCLAACDHFGIVKHFDD  133 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH--------------HHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            4888999999999999999654 3 57788887643211              123467889999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +..++..|+||||++||+|.++++..  ....+++..+..++.||+.||+|+|+.   +|+||||||+||+++.++.+||
T Consensus       134 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL  210 (478)
T PTZ00267        134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKL  210 (478)
T ss_pred             EEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEE
Confidence            99999999999999999999988643  234588899999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+++.+............+||+.|+|||+..+..++.++|||||||++|||++|+.||.....  ......+..   
T Consensus       211 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--~~~~~~~~~---  285 (478)
T PTZ00267        211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--REIMQQVLY---  285 (478)
T ss_pred             EeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh---
Confidence            999999876543322233456799999999999888999999999999999999999999964321  111111111   


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                            ......+. .  .......++.+||++||++||++++++.
T Consensus       286 ------~~~~~~~~-~--~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        286 ------GKYDPFPC-P--VSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ------CCCCCCCc-c--CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                  00000011 1  1123455788899999999999999975

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5e-36  Score=335.85  Aligned_cols=244  Identities=21%  Similarity=0.285  Sum_probs=191.7

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGC  764 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  764 (1035)
                      +|...+.||+|+||.||+|+.. +++.||||++........           ...+.+..|..++..+ +||+|++++++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~   69 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----------DDVECTMVEKRVLALSGKPPFLTQLHSC   69 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhccCCCeEeeEEEE
Confidence            3677889999999999999776 478999999865332111           1234577788888877 58999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++|+|.+++.....  +++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        70 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~D  144 (323)
T cd05616          70 FQTMDRLYFVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD  144 (323)
T ss_pred             EecCCEEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEcc
Confidence            9999999999999999999999876543  88999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....   
T Consensus       145 fG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~~~---  217 (323)
T cd05616         145 FGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEHN---  217 (323)
T ss_pred             CCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC---
Confidence            99987543222  1223567999999999999999999999999999999999999999754321  1111111110   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM  963 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~  963 (1035)
                          .......      ......++.+|++.||++|++.
T Consensus       218 ----~~~p~~~------s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 ----VAYPKSM------SKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ----CCCCCcC------CHHHHHHHHHHcccCHHhcCCC
Confidence                0011111      1233557888999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.1e-36  Score=334.35  Aligned_cols=244  Identities=23%  Similarity=0.337  Sum_probs=189.7

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||.||+|+++ +|+.||+|++........           ...+.+..|..++... +||||+++++++.+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   69 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-----------DDVECTMVEKRVLALAWENPFLTHLYCTFQTKE   69 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-----------chHHHHHHHHHHHHhccCCCCccCeeEEEEeCC
Confidence            46999999999999776 588999999965322111           1234567788888754 8999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|..++.....  +++..+..++.|+++||+|||+.   ||+||||||+||+++.++.++|+|||+++
T Consensus        70 ~~~lv~E~~~~g~L~~~i~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05620          70 HLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEEECCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCe
Confidence            99999999999999999876543  88999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+...       ..
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~-------~~  213 (316)
T cd05620         145 ENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVD-------TP  213 (316)
T ss_pred             ecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-------CC
Confidence            532221  1223567999999999999889999999999999999999999999754221  111111110       01


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK-DVAA  968 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~-el~~  968 (1035)
                      .......      .+..+++.+||+.||++||++. ++.+
T Consensus       214 ~~~~~~~------~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         214 HYPRWIT------KESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCCCC------HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            1111111      1234577889999999999984 5654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.6e-36  Score=341.47  Aligned_cols=193  Identities=23%  Similarity=0.276  Sum_probs=168.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..|...+.||+|+||.||+|.+. .++.||+|+..                    .+.+.+|++++++++||||++++++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------------------~~~~~~E~~il~~l~HpnIv~~~~~  151 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------------------RGGTATEAHILRAINHPSIIQLKGT  151 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------------------hhhhHHHHHHHHhCCCCCCCCEeEE
Confidence            56999999999999999999665 58899999652                    2346789999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +......++|||++ +++|..++.....  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       152 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~D  225 (391)
T PHA03212        152 FTYNKFTCLILPRY-KTDLYCYLAAKRN--IAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGD  225 (391)
T ss_pred             EEECCeeEEEEecC-CCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEe
Confidence            99999999999999 5789888876543  88999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      ||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||-.
T Consensus       226 FG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        226 FGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             CCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            999975433221 122346799999999999888999999999999999999999988643

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.6e-36  Score=337.95  Aligned_cols=262  Identities=27%  Similarity=0.336  Sum_probs=193.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|... +++.||||++.......            ....++.+|+.++++++||||+++++++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~~~~   68 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV------------SDATRILREIKLLRLLRHPDIVEIKHIM   68 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc------------hhHHHHHHHHHHHHhCCCCCEeeecceE
Confidence            4778899999999999999765 58999999986422111            1235688999999999999999999988


Q ss_pred             EcCC-----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          766 WNRN-----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       766 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ....     ..|+||||+ +++|.+++.....  +++..+..++.||++||+|||+.   +|+||||||+||+++.++.+
T Consensus        69 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  142 (338)
T cd07859          69 LPPSRREFKDIYVVFELM-ESDLHQVIKANDD--LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKL  142 (338)
T ss_pred             eccCCCCCceEEEEEecC-CCCHHHHHHhccc--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcE
Confidence            6432     479999999 5789998876543  89999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCc-cccccccCCcccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          841 YIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      ||+|||+++....... ........||+.|+|||+..+  ..++.++|||||||++|||++|+.||......  .....+
T Consensus       143 kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~  220 (338)
T cd07859         143 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLI  220 (338)
T ss_pred             EEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHH
Confidence            9999999986533221 111234579999999998765  67899999999999999999999999653211  111111


Q ss_pred             HHhccc--------------hhhhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGA--------------IEVLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~--------------~~~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....+.              ...+.. .....+....     ......+++.+||+.||++||+++|++++
T Consensus       221 ~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         221 TDLLGTPSPETISRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhCCCCHHHHHHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000000              000000 0000000000     01234568889999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.2e-36  Score=335.69  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=193.5

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  769 (1035)
                      ++||+|+||.||+|++. +++.||+|++........           ...+.+.+|..++.++ +||||+++++++.+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~-----------~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~   69 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD-----------EDIDWVQTEKHVFETASNHPFLVGLHSCFQTES   69 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC
Confidence            47899999999999775 588999999965432221           1245688999999998 7999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||++||+|.+++...+  .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~  144 (329)
T cd05588          70 RLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK  144 (329)
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccc
Confidence            9999999999999999887654  389999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC---chhHHHHHHHhccchhh
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE---GLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~  926 (1035)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....   ......+....     .
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----~  217 (329)
T cd05588         145 EGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV-----I  217 (329)
T ss_pred             ccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH-----H
Confidence            532211  1223567999999999999989999999999999999999999999742211   11111121111     0


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT------MKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs------~~el~~~  969 (1035)
                      ....... + ..+  .....+++.+|++.||.+||+      +++++++
T Consensus       218 ~~~~~~~-p-~~~--~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         218 LEKQIRI-P-RSL--SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             HcCCCCC-C-CCC--CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            1111111 1 111  123355788899999999997      5677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-35  Score=326.40  Aligned_cols=263  Identities=22%  Similarity=0.296  Sum_probs=194.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC--CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC---CCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME--NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI---RHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~  760 (1035)
                      ++|...+.||+|+||+||+|++.  +++.||+|++........            ....+.+|+.+++.+   +||||++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~hpniv~   68 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------------MPLSTIREVAVLRHLETFEHPNVVR   68 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC------------chHHHHHHHHHHHhhcccCCCCcce
Confidence            36888899999999999999763  468899999865432221            234566777777766   6999999


Q ss_pred             EEeEEEc-----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          761 FLGCCWN-----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       761 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      +++++..     ....++||||+. ++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        69 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~  144 (290)
T cd07862          69 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVT  144 (290)
T ss_pred             EEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEc
Confidence            9999852     346799999995 6999999876555689999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                      .++.+||+|||+++.....   .......||+.|+|||+..+..++.++|||||||++|||++|+.||......  ....
T Consensus       145 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~~~~  219 (290)
T cd07862         145 SSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLG  219 (290)
T ss_pred             CCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--HHHH
Confidence            9999999999999865433   2233567899999999998888999999999999999999999999754321  1111


Q ss_pred             HHHHhccc--hhhh-------cccccCCCcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGA--IEVL-------DKSLRARPEVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~--~~~~-------~~~~~~~~~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+......  .+..       .......+......     .....+++.+|++.||++||++.|++++
T Consensus       220 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         220 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             HHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            11110000  0000       00000011111111     1123468889999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-35  Score=326.52  Aligned_cols=257  Identities=25%  Similarity=0.428  Sum_probs=200.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      +.|+..+.||+|+||+||+|.+     ..+..||+|.+......             ...+.+.+|+.++++++||||++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~   71 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-------------QQWGEFQQEASLMAELHHPNIVC   71 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH-------------HHHHHHHHHHHHHhhCCCCCeee
Confidence            4577888999999999999974     24678999998643211             12357889999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeecc
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERR---------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR  825 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHr  825 (1035)
                      +++++...+..|+||||+++++|.+++....               ...+++..+..++.|++.||+|||+.   +++||
T Consensus        72 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~  148 (283)
T cd05090          72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHK  148 (283)
T ss_pred             EEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehh
Confidence            9999999999999999999999999986432               12378888999999999999999999   99999


Q ss_pred             CCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 039419          826 DIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID  904 (1035)
Q Consensus       826 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~  904 (1035)
                      ||||+||+++.++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.
T Consensus       149 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~  228 (283)
T cd05090         149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY  228 (283)
T ss_pred             ccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999987654433233334556788999999988889999999999999999998 998986


Q ss_pred             CCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                      ...+  ......+.....    .  ......+      .....++.+||++||++||++.++.+.|+.
T Consensus       229 ~~~~--~~~~~~~~~~~~----~--~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         229 GFSN--QEVIEMVRKRQL----L--PCSEDCP------PRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCCH--HHHHHHHHcCCc----C--CCCCCCC------HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            4321  122222221110    0  0011111      233457788999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.6e-36  Score=327.49  Aligned_cols=256  Identities=30%  Similarity=0.500  Sum_probs=201.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|.+.+.||+|+||.||+|...+      ++.||||++......             ...+.+.+|++++++++||||+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~   71 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-------------DARKDFEREAELLTNFQHENIV   71 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH-------------HHHHHHHHHHHHHHhcCCCCch
Confidence            457778899999999999997643      478999998643221             1246899999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCC
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI  827 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDi  827 (1035)
                      ++++++...+..++||||+++++|.++++..+            ...+++..+..++.|++.|++|+|+.   +++||||
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dl  148 (280)
T cd05049          72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDL  148 (280)
T ss_pred             heeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Ceecccc
Confidence            99999999999999999999999999997543            23478889999999999999999999   9999999


Q ss_pred             CcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 039419          828 KANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT  906 (1035)
Q Consensus       828 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~  906 (1035)
                      ||+||+++.++.++|+|||.++...............+++.|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus       149 kp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         149 ATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             ccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999976543332222234456789999999999999999999999999999998 99998654


Q ss_pred             CCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      ...  .....+...         .....+.   .......+++.+||++||++||++.|+++.|+
T Consensus       229 ~~~--~~~~~~~~~---------~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         229 SNE--EVIECITQG---------RLLQRPR---TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CHH--HHHHHHHcC---------CcCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            221  122222110         0111111   11123456888899999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-35  Score=325.90  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=200.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .++|+..+.||+|+||.||+|.+.      .++.||+|++......             ....++.+|+.+++.++||||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i   71 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM-------------RERIEFLNEASVMKEFNCHHV   71 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCCe
Confidence            467889999999999999999653      2567999987542211             124568899999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN  830 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~  830 (1035)
                      +++++++.+.+..++||||+++|+|.++++....        ..+++..+..++.|++.|++|||+.   +++||||||+
T Consensus        72 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~  148 (277)
T cd05062          72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAAR  148 (277)
T ss_pred             eeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchh
Confidence            9999999999999999999999999999875332        2357888999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 039419          831 NILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPE  909 (1035)
Q Consensus       831 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~  909 (1035)
                      ||+++.++.++|+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus       149 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~  228 (277)
T cd05062         149 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE  228 (277)
T ss_pred             eEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999876544333222223456788999999988889999999999999999999 78888654221


Q ss_pred             chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                        .....+...         .....+.. ..  ..+.+++.+||+.||++||++.|+++.++
T Consensus       229 --~~~~~~~~~---------~~~~~~~~-~~--~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         229 --QVLRFVMEG---------GLLDKPDN-CP--DMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             --HHHHHHHcC---------CcCCCCCC-CC--HHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence              112211110         00011111 11  13456888999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-36  Score=330.90  Aligned_cols=257  Identities=23%  Similarity=0.314  Sum_probs=210.2

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCcee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIV  759 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv  759 (1035)
                      ....+.|...+.||+|.||.||+++.+. |+.+|+|++.........           ..+.+.+|+.+|+++. |||||
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----------~~~~v~~Ev~il~~l~~hpniv   99 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----------DREDVRREVAILQQLSGHPNIV   99 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----------cHHHHHHHHHHHHhccCCCCEE
Confidence            4455678888999999999999997775 999999999765543321           2568899999999998 99999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC--
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE--  837 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~--  837 (1035)
                      ++++.|.+....++|||++.||.|.+.+...   .+++..+..++.|++.+++|||+.   ||+|||+||+|+|+...  
T Consensus       100 ~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~  173 (382)
T KOG0032|consen  100 QLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDE  173 (382)
T ss_pred             EEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccC
Confidence            9999999999999999999999999999876   289999999999999999999998   99999999999999643  


Q ss_pred             --CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          838 --FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       838 --~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                        +.+|++|||++.....+   ......+||+.|+|||+.....|+..+||||+||++|.|++|..||......... . 
T Consensus       174 ~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-~-  248 (382)
T KOG0032|consen  174 GSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-L-  248 (382)
T ss_pred             CCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-H-
Confidence              47999999999987662   3445789999999999999999999999999999999999999999765332111 1 


Q ss_pred             HHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+.  .     .+..+...+...+.+  .+-+++..++..||.+|+++.+++++
T Consensus       249 ~i~--~-----~~~~f~~~~w~~is~--~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 AIL--R-----GDFDFTSEPWDDISE--SAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHH--c-----CCCCCCCCCccccCH--HHHHHHHHhcccCcccCCCHHHHhcC
Confidence            110  0     111222223332322  33457888999999999999999995

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=311.37  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=202.7

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |.+.+++|+|+||.||+|.++ .|..+|||++..+.                ..+++.+|+.+|++++.|++|++||.+.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----------------DLQEIIKEISIMQQC~S~yVVKYYGSYF   98 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----------------DLQEIIKEISIMQQCKSKYVVKYYGSYF   98 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----------------hHHHHHHHHHHHHHcCCchhhhhhhhhc
Confidence            455678999999999999554 59999999986532                2567889999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      .....|+|||||--|++.+.++.++ +.+.+.++..++...++||+|||..   .-+|||||..|||++.+|.+|++|||
T Consensus        99 K~sDLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFG  174 (502)
T KOG0574|consen   99 KHSDLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFG  174 (502)
T ss_pred             cCCceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhcc
Confidence            9999999999999999999998765 4589999999999999999999998   88999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      .|....+.-  ...+.+.||+.|||||++..-.|+.++||||+|++..||..|++||.+.+|-..            ..+
T Consensus       175 VAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA------------IFM  240 (502)
T KOG0574|consen  175 VAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA------------IFM  240 (502)
T ss_pred             ccchhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce------------eEe
Confidence            998765543  234578999999999999999999999999999999999999999986544211            011


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +.............-.-..-+++..|+-+.|++|.|+.++.++
T Consensus       241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            1111111111111112234568889999999999999999875

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-35  Score=322.61  Aligned_cols=255  Identities=23%  Similarity=0.371  Sum_probs=202.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .+|...+.||+|+||.||+|.++ .++.||+|++.....               ..+.+.+|++++++++||||++++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQLLGV   70 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch---------------HHHHHHHHHHHHHhCCCCChhheEEE
Confidence            45778889999999999999765 488999999854211               13578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +..++..++||||+++++|.+++.......+++..+..++.|+++||+|||+.   +++||||||+||++++++.+||+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d  147 (263)
T cd05052          71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD  147 (263)
T ss_pred             EcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCC
Confidence            99999999999999999999999776555689999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.+......... ......++..|+|||+..+..++.++|||||||++|||++ |..||......  .....+..   .
T Consensus       148 f~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~---~  221 (263)
T cd05052         148 FGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK---G  221 (263)
T ss_pred             Cccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC---C
Confidence            9999876543221 1122345678999999988899999999999999999998 99998653221  11111111   0


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                         .........      .....+++.+||+.||++||++.++++.|+.+
T Consensus       222 ---~~~~~~~~~------~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 ---YRMERPEGC------PPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---CCCCCCCCC------CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               000111111      12345578889999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-35  Score=321.40  Aligned_cols=262  Identities=20%  Similarity=0.323  Sum_probs=206.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|+.. +++.||||.+........           .....+.+|++++++++||||++++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA-----------KARQDCVKEIDLLKQLNHPNVIKYLDS   70 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCH-----------HHHHHHHHHHHHHHhCCCcceeeeeee
Confidence            46888999999999999999765 689999998754322111           234678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +.+.+..++||||+++|+|.+++....  ...++...+..++.|+++||+|||+.   +++||||||+||+++.++.++|
T Consensus        71 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l  147 (267)
T cd08228          71 FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             EEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEE
Confidence            999999999999999999999886422  23478899999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||.+........  ......|++.|+|||...+..++.++|+||+|+++|||++|+.||.............+...  
T Consensus       148 ~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--  223 (267)
T cd08228         148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC--  223 (267)
T ss_pred             CccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC--
Confidence            99999887644321  12245688999999998888899999999999999999999999965432222222211110  


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                             .....+..  .......+++.+||+.+|++||++.++++.++.++
T Consensus       224 -------~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 -------DYPPLPTE--HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -------CCCCCChh--hcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                   00111111  11223456788899999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.4e-35  Score=323.42  Aligned_cols=258  Identities=26%  Similarity=0.393  Sum_probs=199.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCc----EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGE----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|...+.||+|+||+||+|.+. +++    .+++|++......             ....++..|+.++++++||||++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~~~~~l~~l~h~~iv~   73 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR-------------QTFQEITDHMLAMGSLDHAYIVR   73 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch-------------HHHHHHHHHHHHHhcCCCCCcce
Confidence            46778899999999999999774 344    4677776422111             12357888999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++. ....+++|||+++|+|.+++.... ..+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+
T Consensus        74 ~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~  148 (279)
T cd05111          74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV  148 (279)
T ss_pred             EEEEEC-CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcE
Confidence            999875 455789999999999999997643 3489999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||.++...............++..|+|||+..+..++.++||||||+++||+++ |..||....+.  ...+++..
T Consensus       149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~  226 (279)
T cd05111         149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLEK  226 (279)
T ss_pred             EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC
Confidence            9999999987654432222334567789999999988889999999999999999998 99999754321  12222211


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ....         ..+..   .......++.+||+.||++||++.|+++.+..+.+
T Consensus       227 ~~~~---------~~~~~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         227 GERL---------AQPQI---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCcC---------CCCCC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            1000         00111   11233557888999999999999999998888753

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.3e-36  Score=337.04  Aligned_cols=256  Identities=22%  Similarity=0.272  Sum_probs=197.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+|... +++.||+|++........           ...+.+.+|+.+++.++||||++++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~i~~~~~~~~i~~~~~~   69 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ-----------ETVSFFEEERDILSISNSPWIPQLQYA   69 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhCCCCCCcceeeE
Confidence            35788899999999999999765 589999999965322111           234678899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        70 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~D  145 (330)
T cd05601          70 FQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLAD  145 (330)
T ss_pred             EecCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEecc
Confidence            999999999999999999999997653 2489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      ||+++........ ......||+.|+|||++.      ...++.++|||||||++|||++|+.||......     ....
T Consensus       146 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~  219 (330)
T cd05601         146 FGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYN  219 (330)
T ss_pred             CCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHH
Confidence            9999876443221 222357899999999875      456788999999999999999999999754221     1111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..........  ....+    .......+++..|+. +|++||++++++++
T Consensus       220 ~i~~~~~~~~--~~~~~----~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         220 NIMNFQRFLK--FPEDP----KVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HHHcCCCccC--CCCCC----CCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            1000000000  00101    011123446667887 99999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.4e-36  Score=338.30  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=191.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||||++......             ...+.+.+|++++++++|+||+++++
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~  139 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED-------------TVRRQICREIEILRDVNHPNVVKCHD  139 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH-------------HHHHHHHHHHHHHHhCCCCCcceeee
Confidence            456677889999999999999765 5899999998543211             23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||+++|+|.+..      ...+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       140 ~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~  210 (353)
T PLN00034        140 MFDHNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIA  210 (353)
T ss_pred             EeccCCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEc
Confidence            999999999999999999986532      245677889999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      |||+++......  .......||..|+|||++..     ...+.++|||||||++|||++|+.||........  .....
T Consensus       211 DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~  286 (353)
T PLN00034        211 DFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--ASLMC  286 (353)
T ss_pred             ccccceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHH
Confidence            999998654322  11234579999999998642     2345689999999999999999999973322111  11110


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...      .......+.   .....+.+++.+||+.||++||++.|++++
T Consensus       287 ~~~------~~~~~~~~~---~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        287 AIC------MSQPPEAPA---TASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHh------ccCCCCCCC---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000      000000001   111234567888999999999999999885

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=9.1e-36  Score=326.78  Aligned_cols=249  Identities=20%  Similarity=0.271  Sum_probs=192.0

Q ss_pred             eeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcce
Q 039419          694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL  772 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  772 (1035)
                      ||+|+||+||+|.++ +++.||+|++........           ...+.+..|++++++++||||+++++++..++..|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~   69 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR-----------KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLC   69 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhh-----------HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEE
Confidence            699999999999765 588999999865332211           12356788999999999999999999999999999


Q ss_pred             EEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          773 LMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      +||||+++|+|..++...  ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||.+..
T Consensus        70 lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  146 (280)
T cd05608          70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVE  146 (280)
T ss_pred             EEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcccee
Confidence            999999999999887532  224589999999999999999999999   999999999999999999999999999976


Q ss_pred             cccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccc
Q 039419          851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS  930 (1035)
Q Consensus       851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (1035)
                      ......  ......||+.|+|||+..+..++.++|||||||++|||++|+.||........ .......      .....
T Consensus       147 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~------~~~~~  217 (280)
T cd05608         147 LKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQR------ILNDS  217 (280)
T ss_pred             cCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHh------hcccC
Confidence            544322  22345789999999999999999999999999999999999999975422110 0011100      00010


Q ss_pred             ccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       931 ~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      ... ++   .......+++.+||+.||++||     ++++++++
T Consensus       218 ~~~-~~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         218 VTY-PD---KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCC-cc---cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            000 00   1112234577889999999999     67777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.5e-35  Score=326.63  Aligned_cols=260  Identities=28%  Similarity=0.477  Sum_probs=204.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|.+.+.||+|+||.||++...      ++..+|+|.+.....              ...+.+.+|++++++++||||+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~   70 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--------------NARKDFHREAELLTNLQHEHIV   70 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH--------------HHHHHHHHHHHHHHhCCCCCcc
Confidence            56888899999999999999642      345689998853211              1245789999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC-----------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCC
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIK  828 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDik  828 (1035)
                      ++++++...+..++||||+++++|.+++...+.           ..+++..+..++.|++.||+|||+.   |++|||||
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlk  147 (288)
T cd05093          71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLA  147 (288)
T ss_pred             eEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccC
Confidence            999999999999999999999999999875431           2489999999999999999999998   99999999


Q ss_pred             cccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 039419          829 ANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI  907 (1035)
Q Consensus       829 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~  907 (1035)
                      |+||+++.++.++|+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus       148 p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~  227 (288)
T cd05093         148 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  227 (288)
T ss_pred             cceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986544332222233456788999999988889999999999999999998 899986543


Q ss_pred             CCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      ..  .....+....         ....+..   ....+.+++.+||++||.+||++.++.+.|+++.+.
T Consensus       228 ~~--~~~~~i~~~~---------~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         228 NN--EVIECITQGR---------VLQRPRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HH--HHHHHHHcCC---------cCCCCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            21  1111111110         0001111   112346688899999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=339.53  Aligned_cols=205  Identities=23%  Similarity=0.319  Sum_probs=173.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||+||+|... +++.||||++........           ...+.+.+|++++++++||||++++++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~hp~iv~~~~~   69 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKK-----------DQLAHVKAERDVLAESDSPWVVSLYYS   69 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHh-----------HHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            35788899999999999999665 689999999854321111           124678899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||++||+|.+++...+  .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus        70 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~D  144 (377)
T cd05629          70 FQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSD  144 (377)
T ss_pred             EEcCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEee
Confidence            999999999999999999999997654  388899999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCcc------------c---------------------------------cccccCCcccccCCcccccCC
Q 039419          845 FGLAKLVVEGDFA------------R---------------------------------SSNTVAGSYGYIAPEYGYMMK  879 (1035)
Q Consensus       845 FG~a~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~  879 (1035)
                      ||+++.+......            .                                 ......||+.|+|||++.+..
T Consensus       145 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  224 (377)
T cd05629         145 FGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG  224 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC
Confidence            9998643211000            0                                 001246999999999998889


Q ss_pred             CCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          880 ITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       880 ~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ++.++|||||||++|||++|..||...
T Consensus       225 ~~~~~DiwSlGvil~elltG~~Pf~~~  251 (377)
T cd05629         225 YGQECDWWSLGAIMFECLIGWPPFCSE  251 (377)
T ss_pred             CCCceeeEecchhhhhhhcCCCCCCCC
Confidence            999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-35  Score=354.67  Aligned_cols=264  Identities=22%  Similarity=0.277  Sum_probs=200.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|++........           ...++|.+|++++++++||||++++++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e-----------~~~~rflrEi~ILs~L~HPNIVkl~~v   70 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP-----------LLKKRFLREAKIAADLIHPGIVPVYSI   70 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCH-----------HHHHHHHHHHHHHHhCCCcCcCeEEEE
Confidence            56888999999999999999776 489999999865332211           235689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERR---------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      +.+.+..|+||||++||+|.+++....         ....++..+..++.||++||+|||+.   ||+||||||+||+++
T Consensus        71 ~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd  147 (932)
T PRK13184         71 CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLG  147 (932)
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEc
Confidence            999999999999999999999986421         12356677889999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCc----------------cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 039419          836 PEFEPYIADFGLAKLVVEGDF----------------ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG  899 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg  899 (1035)
                      .++.++|+|||+++.......                ........||+.|+|||+..+..++.++|||||||++|||++|
T Consensus       148 ~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG  227 (932)
T PRK13184        148 LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL  227 (932)
T ss_pred             CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHC
Confidence            999999999999986621110                0011235699999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHHHH
Q 039419          900 KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-TMKDVAAMIKEIKQ  975 (1035)
Q Consensus       900 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-s~~el~~~L~~~~~  975 (1035)
                      +.||...........   ..       ........+.....  ..+..++.+|+++||++|| +++++.+.|+....
T Consensus       228 ~~PF~~~~~~ki~~~---~~-------i~~P~~~~p~~~iP--~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        228 SFPYRRKKGRKISYR---DV-------ILSPIEVAPYREIP--PFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             CCCCCCcchhhhhhh---hh-------ccChhhccccccCC--HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            999975322111000   00       00000000001111  1234578889999999995 66777777776643

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-36  Score=338.37  Aligned_cols=255  Identities=25%  Similarity=0.316  Sum_probs=200.2

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|.+.+.||+|+||+||+|+.. +++.||||++........           .....+.+|+.++..++||||+++++++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~   70 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR-----------NQIAHVRAERDILADADSPWIVKLYYSF   70 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhc-----------cHHHHHHHHHHHHHhcCCCCccchhhhe
Confidence            5788899999999999999776 689999999864322111           2346788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..|+||||+++++|.+++....  .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Df  145 (350)
T cd05573          71 QDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADF  145 (350)
T ss_pred             ecCCeEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecC
Confidence            99999999999999999999997763  489999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCC---------------------------ccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh
Q 039419          846 GLAKLVVEGD---------------------------FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT  898 (1035)
Q Consensus       846 G~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt  898 (1035)
                      |+++......                           .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~  225 (350)
T cd05573         146 GLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLY  225 (350)
T ss_pred             CCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhcc
Confidence            9998654432                           0012234579999999999999899999999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 039419          899 GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-MKDVAAM  969 (1035)
Q Consensus       899 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-~~el~~~  969 (1035)
                      |+.||......     ..........    ..........  .......++.+|+. ||++||+ +++++++
T Consensus       226 g~~Pf~~~~~~-----~~~~~i~~~~----~~~~~p~~~~--~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         226 GFPPFYSDTLQ-----ETYNKIINWK----ESLRFPPDPP--VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCCCCHH-----HHHHHHhccC----CcccCCCCCC--CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            99999754321     1111100000    0011000000  11223456777897 9999999 9999885

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=318.32  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=205.3

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +..-|...+.||+|.|+.|-+|++- .|+.||||++.+...+.-            ...++.+|++.|+-++|||||++|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~------------st~hlfqEVRCMKLVQHpNiVRLY   83 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL------------STGHLFQEVRCMKLVQHPNIVRLY   83 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh------------hhhHHHHHHHHHHHhcCcCeeeee
Confidence            3445777889999999999999664 699999999987655442            356889999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE-cCCCceE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI-GPEFEPY  841 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll-~~~~~~k  841 (1035)
                      ++...+...|+|.|.-++|+|++|+-++.. .+.+..+.+++.||..|+.|+|+.   .+||||+||+||.+ .+-|-||
T Consensus        84 EViDTQTKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVK  159 (864)
T KOG4717|consen   84 EVIDTQTKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVK  159 (864)
T ss_pred             ehhcccceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceE
Confidence            999999999999999999999999977654 388999999999999999999998   89999999999977 5678999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      ++|||++..+.++..   ....+|+..|.|||++.+..|+ +++||||+|||+|-+++|+.||+...+.+.         
T Consensus       160 LTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------  227 (864)
T KOG4717|consen  160 LTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------  227 (864)
T ss_pred             eeeccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------
Confidence            999999988877643   3467999999999999999988 578999999999999999999986543211         


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                         ..++..   -.+...-.-.-+..++|..|+..||++|.+.++|+.
T Consensus       228 ---LTmImD---CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  228 ---LTMIMD---CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             ---hhhhhc---ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence               111111   111111122223455777899999999999999875

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.1e-36  Score=333.01  Aligned_cols=244  Identities=24%  Similarity=0.353  Sum_probs=189.9

Q ss_pred             CeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||+||+|++.+ ++.||||++........           ...+.+..|..++... +||||+++++++.+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~   69 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-----------DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE   69 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-----------chHHHHHHHHHHHHhccCCCcCcceEEEEEeCC
Confidence            468999999999997764 78999999865422111           1234567788888764 8999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|.+++.....  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  144 (316)
T cd05619          70 NLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK  144 (316)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcce
Confidence            99999999999999999976543  88899999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+...       ..
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~-------~~  213 (316)
T cd05619         145 ENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD-------NP  213 (316)
T ss_pred             ECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-------CC
Confidence            532221  1223467999999999998889999999999999999999999999754221  111111110       01


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK-DVAA  968 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~-el~~  968 (1035)
                      ......    .  ....+++.+||+.||++||++. ++.+
T Consensus       214 ~~~~~~----~--~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         214 CYPRWL----T--REAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCccC----C--HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111111    1  1234578889999999999997 5654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-35  Score=321.38  Aligned_cols=251  Identities=26%  Similarity=0.415  Sum_probs=200.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||+||+|++.++..+|+|.+.....               ..+.|.+|+.++++++||||+++++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---------------SEDEFIEEAKVMMKLSHEKLVQLYGVC   68 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---------------cHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            45778889999999999999888777899998854321               135689999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||+.+|+|.+++..... .+++..++.++.||+.|++|||+.   +++|+||||+||+++.++.+||+||
T Consensus        69 ~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~  144 (256)
T cd05113          69 TKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDF  144 (256)
T ss_pred             ccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCC
Confidence            998899999999999999999976443 489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++........ ......++..|+|||+..+..++.++||||||+++|||++ |..||......  .....+.....  
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--  219 (256)
T cd05113         145 GLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--ETVEKVSQGLR--  219 (256)
T ss_pred             ccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHhcCCC--
Confidence            998865443221 1122346678999999988889999999999999999998 99999643221  11111111100  


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                             ...+..   ......+++.+||++||++||++.++++.+
T Consensus       220 -------~~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         220 -------LYRPHL---ASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             -------CCCCCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence                   000111   123345688889999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.7e-35  Score=319.66  Aligned_cols=253  Identities=26%  Similarity=0.443  Sum_probs=201.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|++.+.||+|+||.||+|..+++..+|+|.+.....               ..+.+.+|+.++++++||+++++++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---------------~~~~~~~E~~~l~~l~~~~i~~~~~~~   70 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---------------SPESFLEEAQIMKKLRHDKLVQLYAVV   70 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---------------CHHHHHHHHHHHHhcCCCceEEEEeEE
Confidence            56888899999999999999888888999999865322               135689999999999999999999987


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      . .+..|++|||+++++|.++++......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+||
T Consensus        71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~df  146 (260)
T cd05070          71 S-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADF  146 (260)
T ss_pred             C-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCc
Confidence            5 45689999999999999999876555689999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.+........ .......++..|+|||+..+..++.++||||||+++|||++ |..||.....  ......+...    
T Consensus       147 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~----  219 (260)
T cd05070         147 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVERG----  219 (260)
T ss_pred             eeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcC----
Confidence            99986544321 11123345678999999888889999999999999999999 8889864321  1111221110    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                            .....+.  .....+.+++.+|++++|++|||+.++.+.|++
T Consensus       220 ------~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 ------YRMPCPQ--DCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ------CCCCCCC--cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  0000011  112335568889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.4e-36  Score=323.89  Aligned_cols=255  Identities=26%  Similarity=0.434  Sum_probs=206.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..+|...+.||.|+||.||+|.+.+++.+|+|++.....              ...+.+.+|+.+++.++||||++++++
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--------------LKQQDFQKEVQALKRLRHKHLISLFAV   70 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--------------hhHHHHHHHHHHHhcCCCcchhheeee
Confidence            356888899999999999999988899999999865322              124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..++||||+++++|.++++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d  147 (261)
T cd05148          71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVAD  147 (261)
T ss_pred             EecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEcc
Confidence            99999999999999999999999876666689999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.+.........  .....++..|+|||+..+..++.++||||||+++|+|++ |+.||......  .....+..    
T Consensus       148 ~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~----  219 (261)
T cd05148         148 FGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITA----  219 (261)
T ss_pred             ccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHh----
Confidence            9999876443211  123456778999999888889999999999999999998 89999654321  11122111    


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                            ......+.  .....+.+++.+||+.||++||++.++++.|+.
T Consensus       220 ------~~~~~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         220 ------GYRMPCPA--KCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ------CCcCCCCC--CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                  00000011  111234568889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-35  Score=332.20  Aligned_cols=245  Identities=22%  Similarity=0.335  Sum_probs=192.8

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||+||+|.+. +++.||||++........           ...+.+.+|..+++.+ +||||+++++++.+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~   69 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-----------DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD   69 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-----------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCC
Confidence            46899999999999776 478999999865322111           1245677899999888 6999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||++||+|..++...+.  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  144 (318)
T cd05570          70 RLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK  144 (318)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCe
Confidence            99999999999999998876543  89999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+....       .
T Consensus       145 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--~~~~~~i~~~~-------~  213 (318)
T cd05570         145 EGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--DELFQSILEDE-------V  213 (318)
T ss_pred             ecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--HHHHHHHHcCC-------C
Confidence            532222  122345689999999999999999999999999999999999999975421  11111111100       0


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM-----KDVAAM  969 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~-----~el~~~  969 (1035)
                      ......+      ....+++.+||+.||++||++     .+++++
T Consensus       214 ~~~~~~~------~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         214 RYPRWLS------KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCcCC------HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            0111111      233567888999999999999     777764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.5e-36  Score=333.94  Aligned_cols=243  Identities=25%  Similarity=0.291  Sum_probs=185.9

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHH-HHHhcCCCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI-KTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||+||+|++. +++.||+|++........           .....+.+|. .+++.++||||+++++++.+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~   69 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-----------KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD   69 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-----------hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC
Confidence            46899999999999776 478899999864322111           1123344444 4567889999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|.+++.....  +.+..+..++.||++||+|||+.   ||+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~  144 (325)
T cd05602          70 KLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK  144 (325)
T ss_pred             eEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCc
Confidence            99999999999999999976543  78888889999999999999999   99999999999999999999999999997


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||+..+..++.++||||+||++|||++|+.||......  .....+..         .
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~---------~  211 (325)
T cd05602         145 ENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNILN---------K  211 (325)
T ss_pred             ccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHHh---------C
Confidence            543322  2233567999999999999989999999999999999999999999743221  11111111         1


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA  967 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~  967 (1035)
                      .....+.  ..  ....+++.+|+++||.+||++.+.+
T Consensus       212 ~~~~~~~--~~--~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         212 PLQLKPN--IT--NSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CcCCCCC--CC--HHHHHHHHHHcccCHHHCCCCCCCH
Confidence            1111111  11  1234577789999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.3e-36  Score=339.99  Aligned_cols=256  Identities=20%  Similarity=0.233  Sum_probs=197.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|+.+ +++.||+|++........           ...+.+.+|+.+++.++||||+++++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~il~~~~h~~iv~~~~  110 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR-----------SDSAFFWEERDIMAHANSEWIVQLHY  110 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            357888999999999999999775 588999999854221111           12356789999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+||||++||+|.+++....   ++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~~---l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~  184 (370)
T cd05596         111 AFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA  184 (370)
T ss_pred             EEecCCEEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEE
Confidence            9999999999999999999999986542   78888889999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccC----CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM----KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      |||++........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||......  .....+..
T Consensus       185 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~~  261 (370)
T cd05596         185 DFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMD  261 (370)
T ss_pred             eccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--HHHHHHHc
Confidence            9999986543321 122356799999999987543    4788999999999999999999999754321  11111110


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDD--RPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~--RPs~~el~~~  969 (1035)
                      ...       ....  +..........+++.+|+..+|++  ||++++++++
T Consensus       262 ~~~-------~~~~--~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         262 HKN-------SLTF--PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCC-------cCCC--CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            000       0000  000011123345777899989988  9999999886

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.2e-35  Score=325.87  Aligned_cols=259  Identities=27%  Similarity=0.405  Sum_probs=201.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      +|+..+.||+|+||.||+|...      ....+|+|.+.......             ..+++.+|+.++++++||||++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~   67 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS-------------ELRDLLSEFNLLKQVNHPHVIK   67 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH-------------HHHHHHHHHHHHhhCCCCCEee
Confidence            3677889999999999999653      23578888886433211             1357889999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhccC
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERR----------------------DSCLEWELRYRIILGAAQGLAYLHHDC  818 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~  818 (1035)
                      +++.+...+..++||||+.+|+|.+++....                      ...+++..+..++.|++.||+|||+. 
T Consensus        68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-  146 (290)
T cd05045          68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-  146 (290)
T ss_pred             EEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-
Confidence            9999999999999999999999999986432                      12478899999999999999999998 


Q ss_pred             CCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh
Q 039419          819 VPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT  898 (1035)
Q Consensus       819 ~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt  898 (1035)
                        +|+||||||+||+++.++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++
T Consensus       147 --~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t  224 (290)
T cd05045         147 --KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  224 (290)
T ss_pred             --CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHh
Confidence              999999999999999999999999999986544332222233456778999999888889999999999999999998


Q ss_pred             -CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          899 -GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       899 -g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                       |..||....+.  .+..++...          .....+..  .......++.+||+++|++||+++++++.|+++..
T Consensus       225 ~g~~p~~~~~~~--~~~~~~~~~----------~~~~~~~~--~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         225 LGGNPYPGIAPE--RLFNLLKTG----------YRMERPEN--CSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             cCCCCCCCCCHH--HHHHHHhCC----------CCCCCCCC--CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             99999654322  222222110          01111111  11234567888999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.2e-35  Score=318.71  Aligned_cols=249  Identities=22%  Similarity=0.373  Sum_probs=193.6

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCc
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNT  770 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  770 (1035)
                      +.||+|+||.||+|.+. +++.||+|.+......             .....+.+|++++++++||||+++++++...+.
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   67 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP-------------DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP   67 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCH-------------HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC
Confidence            46899999999999765 6899999987532211             124678999999999999999999999999999


Q ss_pred             ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          771 RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       771 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      .|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        68 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  143 (252)
T cd05084          68 IYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE  143 (252)
T ss_pred             eEEEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcc
Confidence            999999999999999997543 3478999999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |..||......  .....+..          
T Consensus       144 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~----------  211 (252)
T cd05084         144 EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQ----------  211 (252)
T ss_pred             cccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHc----------
Confidence            543221111112234567999999988889999999999999999998 88888643221  11111110          


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      ......+.  .......+++.+|++++|++||++.++.+.|+
T Consensus       212 ~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         212 GVRLPCPE--LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCCCCcc--cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            00000111  11123456888999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-36  Score=323.42  Aligned_cols=251  Identities=21%  Similarity=0.329  Sum_probs=200.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~  764 (1035)
                      +.|++.+.||+||.+.||++...+.+.||+|++.....+.            ...+-|..|+..|.+|+ |.+||++|+|
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~------------qtl~gy~nEI~lL~KLkg~~~IIqL~DY  428 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADN------------QTLDGYRNEIALLNKLKGHDKIIQLYDY  428 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCH------------HHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence            5688889999999999999998888999999886543332            24678999999999995 9999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      -..++..||||||- ..+|..+++++......| .++.++.|++.|+.++|+.   ||||.||||.|+|+-+ |.+||+|
T Consensus       429 Ev~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLID  502 (677)
T KOG0596|consen  429 EVTDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLID  502 (677)
T ss_pred             eccCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeee
Confidence            99999999999986 579999998876654445 7788999999999999999   9999999999999965 5899999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccC-----------CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-----------KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI  913 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~  913 (1035)
                      ||+|..+..+...-.....+||+.||+||.+...           ++++++||||+|||+|+|+.|+.||....      
T Consensus       503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------  576 (677)
T KOG0596|consen  503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------  576 (677)
T ss_pred             echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------
Confidence            9999988776655556678999999999975432           36789999999999999999999996321      


Q ss_pred             HHHHHHhccchhhhcc----cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          914 VDWVRQKRGAIEVLDK----SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      -.|.+-.    ...++    .+...++.     ..+..++..|+..||++||++.+++++
T Consensus       577 n~~aKl~----aI~~P~~~Iefp~~~~~-----~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  577 NQIAKLH----AITDPNHEIEFPDIPEN-----DELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHHHHHH----hhcCCCccccccCCCCc-----hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            1222211    11122    11122211     115667888999999999999999985

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.6e-36  Score=343.05  Aligned_cols=204  Identities=25%  Similarity=0.322  Sum_probs=172.6

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|...+.||+|+||+||+|+.. +++.||+|++........           ...+.+.+|+.++++++||||+++++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~-----------~~~~~~~~E~~il~~~~h~~iv~~~~~~   70 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLR-----------NQVAHVKAERDILAEADNEWVVRLYYSF   70 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhH-----------HHHHHHHHHHHHHHhCCCCcCCeEEEEE
Confidence            4778899999999999999765 588999999864321111           2246788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DF  145 (382)
T cd05625          71 QDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (382)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeEC
Confidence            99999999999999999999997654  378889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCC---------------------------------------------ccccccccCCcccccCCcccccCCC
Q 039419          846 GLAKLVVEGD---------------------------------------------FARSSNTVAGSYGYIAPEYGYMMKI  880 (1035)
Q Consensus       846 G~a~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~  880 (1035)
                      |+++.+....                                             .........||+.|+|||++.+..+
T Consensus       146 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  225 (382)
T cd05625         146 GLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY  225 (382)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC
Confidence            9975321100                                             0000123569999999999998899


Q ss_pred             CccccchhHHHHHHHHHhCCCCCCCC
Q 039419          881 TEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       881 ~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      +.++||||+||++|||++|+.||...
T Consensus       226 ~~~~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         226 TQLCDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             CCeeeEEechHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.4e-35  Score=320.20  Aligned_cols=254  Identities=27%  Similarity=0.459  Sum_probs=201.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +.|.+.+.||+|+||.||+|.+.++..||+|++.....               ..+.|.+|++++++++||||+++++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---------------~~~~~~~E~~~l~~l~~~~i~~~~~~~   70 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------------SPEAFLQEAQVMKKLRHEKLVQLYAVV   70 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---------------CHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            46888999999999999999888777899999864221               135789999999999999999999987


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      . ++..|+||||+++|+|.+++.......+++..+..++.|++.||+|+|+.   +++||||||+||+++.++.++|+||
T Consensus        71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~df  146 (262)
T cd05071          71 S-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  146 (262)
T ss_pred             C-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccC
Confidence            4 45689999999999999999865445578999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++........ ......++..|+|||+..+..++.++||||||+++|||++ |..||....+.  ........     
T Consensus       147 g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~~~~~~~-----  218 (262)
T cd05071         147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVER-----  218 (262)
T ss_pred             Cceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HHHHHHhc-----
Confidence            999866443321 1223456778999999888889999999999999999999 88888644221  11111000     


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                           .......  ......+.+++.+|+++||++||+++++++.|++.
T Consensus       219 -----~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         219 -----GYRMPCP--PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -----CCCCCCc--cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                 0000000  11222345789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-35  Score=340.31  Aligned_cols=205  Identities=25%  Similarity=0.328  Sum_probs=173.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|++.+.||+|+||+||+|+.. +++.||||++........           ...+.+.+|++++++++||||+++++.+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~h~~iv~~~~~~   70 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-----------NQAAHVKAERDILAEADNEWVVKLYYSF   70 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhh-----------hhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            5888899999999999999765 589999999854321111           1246788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..|+||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        71 ~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DF  145 (376)
T cd05598          71 QDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDF  145 (376)
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999999997654  378888899999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCC-----------------------------------------ccccccccCCcccccCCcccccCCCCccc
Q 039419          846 GLAKLVVEGD-----------------------------------------FARSSNTVAGSYGYIAPEYGYMMKITEKS  884 (1035)
Q Consensus       846 G~a~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  884 (1035)
                      |+|..+....                                         .........||+.|+|||++.+..++.++
T Consensus       146 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  225 (376)
T cd05598         146 GLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC  225 (376)
T ss_pred             CCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcce
Confidence            9975331000                                         00011235799999999999988999999


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCC
Q 039419          885 DVYSYGVVVLEVLTGKQPIDPTI  907 (1035)
Q Consensus       885 Dv~SlGvvl~elltg~~P~~~~~  907 (1035)
                      |||||||++|||++|+.||....
T Consensus       226 DiwSlGvilyell~G~~Pf~~~~  248 (376)
T cd05598         226 DWWSVGVILYEMLVGQPPFLADT  248 (376)
T ss_pred             eeeeccceeeehhhCCCCCCCCC
Confidence            99999999999999999997653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-35  Score=326.88  Aligned_cols=260  Identities=26%  Similarity=0.415  Sum_probs=203.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      .++|...+.||+|+||.||+|.+.+      ...+|+|.+.......             ...++.+|+.+++++ +|||
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~-------------~~~~~~~E~~~l~~l~~h~~   77 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-------------DLSDLVSEMEMMKMIGKHKN   77 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH-------------HHHHHHHHHHHHHhhcCCCC
Confidence            3568888999999999999997642      3679999886532211             235688999999999 7999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCee
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIV  823 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv  823 (1035)
                      |+++++++...+..+++|||+++|+|.++++...              ...+++..++.++.|++.|++|||+.   +|+
T Consensus        78 i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~iv  154 (293)
T cd05053          78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCI  154 (293)
T ss_pred             eeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            9999999999999999999999999999996532              24588999999999999999999998   999


Q ss_pred             ccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCC
Q 039419          824 HRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP  902 (1035)
Q Consensus       824 HrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P  902 (1035)
                      ||||||+||+++.++.+||+|||.++...............++..|+|||+..+..++.++|||||||++||+++ |..|
T Consensus       155 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  234 (293)
T cd05053         155 HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP  234 (293)
T ss_pred             ccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence            999999999999999999999999987654432222223345678999999888889999999999999999997 9999


Q ss_pred             CCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      |......  ..........         ....+.   .....+.+++.+||+.||++|||+.++++.|+++.
T Consensus       235 ~~~~~~~--~~~~~~~~~~---------~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         235 YPGIPVE--ELFKLLKEGY---------RMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCCCHH--HHHHHHHcCC---------cCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            8643221  1111111100         000111   11223456888999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-35  Score=323.09  Aligned_cols=249  Identities=22%  Similarity=0.281  Sum_probs=193.0

Q ss_pred             eeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcce
Q 039419          694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL  772 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  772 (1035)
                      ||+|+||.||+|+.+ +|+.||+|++........           ...+.+..|++++++++||||+++++++.++...|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----------~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~   69 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-----------SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLC   69 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-----------hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEE
Confidence            699999999999765 589999999864322111           11345667999999999999999999999999999


Q ss_pred             EEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccc
Q 039419          773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV  852 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~  852 (1035)
                      +||||++|++|.+++.......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++....
T Consensus        70 lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~  146 (277)
T cd05607          70 LVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK  146 (277)
T ss_pred             EEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecC
Confidence            999999999999998766655689999999999999999999998   99999999999999999999999999988664


Q ss_pred             cCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccccc
Q 039419          853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR  932 (1035)
Q Consensus       853 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (1035)
                      ...   ......|+..|+|||+..+..++.++||||+||++|||++|+.||....... .........      ......
T Consensus       147 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~------~~~~~~  216 (277)
T cd05607         147 DGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRT------LEDEVK  216 (277)
T ss_pred             CCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHh------hccccc
Confidence            432   1224568999999999988889999999999999999999999997532211 111111110      000110


Q ss_pred             CCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       933 ~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .... .  ......+++.+||++||++||+++|+++.
T Consensus       217 ~~~~-~--~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         217 FEHQ-N--FTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             cccc-c--CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            0000 0  11124567888999999999999776643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-35  Score=338.15  Aligned_cols=203  Identities=23%  Similarity=0.294  Sum_probs=173.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|++. +++.||+|++........           ...+.+.+|+.+++.++||||++++++
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR-----------SDSAFFWEERDIMAFANSPWVVQLFCA  111 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            57888899999999999999876 478999999854221111           124568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.+++....   +++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~~---~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~D  185 (370)
T cd05621         112 FQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLAD  185 (370)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999996542   78889999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccC----CCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM----KITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ||+|+....... .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||...
T Consensus       186 FG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         186 FGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             cccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            999987643321 122356799999999987653    3778999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-35  Score=347.91  Aligned_cols=256  Identities=23%  Similarity=0.296  Sum_probs=200.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||+||+|+.. +++.||||++........            ....+.+|+.++..++|+||+++++
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~------------~~~~~~~Ei~~l~~~~h~~iv~~~~   98 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEA------------DKNRAQAEVCCLLNCDFFSIVKCHE   98 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHH------------HHHHHHHHHHHHhcCCCCcEEEeec
Confidence            468999999999999999999654 689999999865432211            2457889999999999999999988


Q ss_pred             EEEcCC--------cceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          764 CCWNRN--------TRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       764 ~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      .+...+        ..++||||+++|+|.++++.+.  ...+++..+..++.|++.||+|+|+.   +|+||||||+||+
T Consensus        99 ~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NIL  175 (496)
T PTZ00283         99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANIL  175 (496)
T ss_pred             ceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEE
Confidence            775432        3579999999999999987543  24588999999999999999999999   9999999999999


Q ss_pred             EcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhH
Q 039419          834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI  913 (1035)
Q Consensus       834 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~  913 (1035)
                      ++.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.....     
T Consensus       176 l~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----  250 (496)
T PTZ00283        176 LCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----  250 (496)
T ss_pred             EeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----
Confidence            999999999999999876543322333456799999999999998999999999999999999999999975321     


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...+.....      ......++. .  ......++.+||+.||++||++.+++++
T Consensus       251 ~~~~~~~~~------~~~~~~~~~-~--~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        251 EEVMHKTLA------GRYDPLPPS-I--SPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHHhc------CCCCCCCCC-C--CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111111100      000011111 1  1223457888999999999999999864

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.3e-35  Score=324.48  Aligned_cols=259  Identities=28%  Similarity=0.492  Sum_probs=204.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|...+.||+|+||.||+|++.      ++..+++|.+.....              ...+.+.+|++++++++||||+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~   70 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--------------AARKDFQREAELLTNLQHEHIV   70 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--------------HHHHHHHHHHHHHhcCCCCCcc
Confidence            45778889999999999999653      345688888754221              1235789999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeecc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR  825 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHr  825 (1035)
                      ++++++.+.+..++||||+++++|.+++....              ...+++..++.++.||+.|++|||++   +|+||
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~  147 (291)
T cd05094          71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHR  147 (291)
T ss_pred             eEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            99999999999999999999999999997543              13478999999999999999999999   99999


Q ss_pred             CCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 039419          826 DIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID  904 (1035)
Q Consensus       826 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~  904 (1035)
                      ||||+||+++.++.++|+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |+.||.
T Consensus       148 dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  227 (291)
T cd05094         148 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             ccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999976544332222334567889999999988899999999999999999999 999986


Q ss_pred             CCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .....  .....+...         .....+..   ....+.+++.+||++||++||++.++++.|+++.+
T Consensus       228 ~~~~~--~~~~~~~~~---------~~~~~~~~---~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         228 QLSNT--EVIECITQG---------RVLERPRV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             CCCHH--HHHHHHhCC---------CCCCCCcc---CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            54321  111111110         00001111   11234568888999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=306.99  Aligned_cols=269  Identities=25%  Similarity=0.356  Sum_probs=207.8

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC--CCCceee
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI--RHKNIVR  760 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~  760 (1035)
                      .+.+.....+.||+|.||.||+|+|. |+.||||++....                 .+.+.+|.++++..  +|+||..
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-----------------E~SWfrEtEIYqTvmLRHENILg  269 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-----------------ERSWFRETEIYQTVMLRHENILG  269 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecccc-----------------hhhhhhHHHHHHHHHhccchhhh
Confidence            34477888899999999999999998 8999999996422                 34678888888864  9999999


Q ss_pred             EEeEEEcCC----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-----cCCCCeeccCCCccc
Q 039419          761 FLGCCWNRN----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-----DCVPPIVHRDIKANN  831 (1035)
Q Consensus       761 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-----~~~~~ivHrDikp~N  831 (1035)
                      +++.-..++    +.|+|++|.+.|||++|+...   .++.+..++++..+|.||+|||-     ++.|.|+|||||..|
T Consensus       270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN  346 (513)
T KOG2052|consen  270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN  346 (513)
T ss_pred             hhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence            999875443    569999999999999999873   38999999999999999999995     466899999999999


Q ss_pred             EEEcCCCceEEeeccCccccccC--CccccccccCCcccccCCcccccCC------CCccccchhHHHHHHHHHhC----
Q 039419          832 ILIGPEFEPYIADFGLAKLVVEG--DFARSSNTVAGSYGYIAPEYGYMMK------ITEKSDVYSYGVVVLEVLTG----  899 (1035)
Q Consensus       832 Ill~~~~~~kl~DFG~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvvl~elltg----  899 (1035)
                      ||+.+++.+.|+|+|+|-.....  ......+..+||.+|||||++...-      .-..+||||||.|+||+...    
T Consensus       347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g  426 (513)
T KOG2052|consen  347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG  426 (513)
T ss_pred             EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence            99999999999999999776544  1223345678999999999865321      22469999999999998862    


Q ss_pred             ------CCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          900 ------KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       900 ------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                            +.||.+..+.+..+.++.+.  ...+.+.+.++. .+...+.+....+++..||..+|..|-|+--+.+.|.++
T Consensus       427 gi~eey~~Pyyd~Vp~DPs~eeMrkV--VCv~~~RP~ipn-rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  427 GIVEEYQLPYYDVVPSDPSFEEMRKV--VCVQKLRPNIPN-RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CEehhhcCCcccCCCCCCCHHHHhcc--eeecccCCCCCc-ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence                  45777665555444333211  111111121111 123456677777899999999999999999998888777


Q ss_pred             HH
Q 039419          974 KQ  975 (1035)
Q Consensus       974 ~~  975 (1035)
                      ..
T Consensus       504 ~~  505 (513)
T KOG2052|consen  504 SN  505 (513)
T ss_pred             hc
Confidence            54

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.6e-35  Score=325.58  Aligned_cols=260  Identities=26%  Similarity=0.394  Sum_probs=203.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      .++|...+.||+|+||.||+|.+.      .+..||+|++......             ...+.+.+|+.+++++ +|||
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~~  100 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS-------------SEREALMSELKIMSHLGNHEN  100 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh-------------HHHHHHHHHHHHHHhccCCCC
Confidence            357889999999999999999642      2557999988643211             1246789999999999 7999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      |+++++++...+..|+||||+.+|+|.++++......+++.++..++.|++.|++|||+.   +|+|+||||+||+++.+
T Consensus       101 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~  177 (302)
T cd05055         101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHG  177 (302)
T ss_pred             cceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCC
Confidence            999999999999999999999999999999865555589999999999999999999998   99999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~  916 (1035)
                      +.++++|||.++...............++..|+|||...+..++.++||||+||++|||++ |..||...... ......
T Consensus       178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~  256 (302)
T cd05055         178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKL  256 (302)
T ss_pred             CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHH
Confidence            9999999999986544322111223456788999999988889999999999999999998 99998754221 111111


Q ss_pred             HHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      +...          .....+..  ......+++.+|++++|++||++.|+++.|+++
T Consensus       257 ~~~~----------~~~~~~~~--~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         257 IKEG----------YRMAQPEH--APAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHcC----------CcCCCCCC--CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1110          00000000  112345688889999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.8e-35  Score=327.65  Aligned_cols=262  Identities=26%  Similarity=0.395  Sum_probs=203.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC--------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CC
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME--------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RH  755 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1035)
                      .++|.+.+.||+|+||.||+|++.        ++..+|+|.+.......             ..+.+.+|+.+++++ +|
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~-------------~~~~~~~e~~~l~~l~~h   83 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-------------DLSDLISEMEMMKMIGKH   83 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH-------------HHHHHHHHHHHHHHhcCC
Confidence            367899999999999999999753        23579999986542111             245688899999999 79


Q ss_pred             CceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 039419          756 KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPP  821 (1035)
Q Consensus       756 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  821 (1035)
                      |||+++++++...+..|+||||+++|+|.+++...+.              ..+++..+..++.|++.||+|||+.   |
T Consensus        84 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---g  160 (307)
T cd05098          84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---K  160 (307)
T ss_pred             CCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            9999999999999999999999999999999976432              2478899999999999999999998   9


Q ss_pred             eeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 039419          822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK  900 (1035)
Q Consensus       822 ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~  900 (1035)
                      ++||||||+||+++.++.+||+|||.++...............++..|+|||+..+..++.++|||||||++|||++ |.
T Consensus       161 i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~  240 (307)
T cd05098         161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  240 (307)
T ss_pred             cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999876543322222222335578999999888889999999999999999998 88


Q ss_pred             CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       901 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      .||.....  ......+....         ....+..   ......+++.+||+.+|++||++.++++.|+++...
T Consensus       241 ~p~~~~~~--~~~~~~~~~~~---------~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         241 SPYPGVPV--EELFKLLKEGH---------RMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             CCCCcCCH--HHHHHHHHcCC---------CCCCCCc---CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            88864321  11111111100         0011111   112344578889999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.6e-35  Score=335.10  Aligned_cols=261  Identities=24%  Similarity=0.359  Sum_probs=201.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn  757 (1035)
                      .++|.+.+.||+|+||.||+|++.      .++.||+|++.......             ..+.+.+|+.++.++. |||
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~-------------~~~~~~~E~~~l~~l~~H~n  102 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS-------------EKQALMSELKIMSHLGPHLN  102 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh-------------HHHHHHHHHHHHHhcCCCCC
Confidence            356888899999999999999764      24689999996432211             2357889999999997 999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC---------------------------------------------
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD---------------------------------------------  792 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------  792 (1035)
                      ||++++++..++..++||||+++|+|.++++..+.                                             
T Consensus       103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (401)
T cd05107         103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS  182 (401)
T ss_pred             eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence            99999999999999999999999999999975321                                             


Q ss_pred             ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 039419          793 ---------------------------------------------------SCLEWELRYRIILGAAQGLAYLHHDCVPP  821 (1035)
Q Consensus       793 ---------------------------------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  821 (1035)
                                                                         ..+++..+..++.|++.||+|||+.   +
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~  259 (401)
T cd05107         183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---N  259 (401)
T ss_pred             CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---C
Confidence                                                               2367778889999999999999998   9


Q ss_pred             eeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 039419          822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK  900 (1035)
Q Consensus       822 ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~  900 (1035)
                      ++||||||+||+++.++.+||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |.
T Consensus       260 ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~  339 (401)
T cd05107         260 CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG  339 (401)
T ss_pred             cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCC
Confidence            99999999999999999999999999986543322122223457889999999988889999999999999999998 88


Q ss_pred             CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       901 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      .||....... .....+.          ...+...+..  ....+.+++.+||+++|++||+++++++.|+.+.
T Consensus       340 ~P~~~~~~~~-~~~~~~~----------~~~~~~~p~~--~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         340 TPYPELPMNE-QFYNAIK----------RGYRMAKPAH--ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCCCCCchH-HHHHHHH----------cCCCCCCCCC--CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            9986432111 1111111          1111111111  1123455788899999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.2e-35  Score=323.42  Aligned_cols=266  Identities=28%  Similarity=0.382  Sum_probs=198.6

Q ss_pred             cccCCeeeeeCCcEEEEEEE-----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEM-----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      |...+.||+|+||+||++..     .+++.||+|.+......             ...+.|.+|++++++++||||++++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~   72 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ-------------QNTSGWKKEINILKTLYHENIVKYK   72 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh-------------HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            37788999999999988643     35788999998653221             1245788999999999999999999


Q ss_pred             eEEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          763 GCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       763 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++...  ...++||||+++++|.+++....   +++..+..++.|+++|++|||+.   +|+||||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~  146 (283)
T cd05080          73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLV  146 (283)
T ss_pred             EEEecCCCceEEEEecCCCCCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcE
Confidence            988654  35789999999999999997643   89999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +|+|||+++....+... .......++..|+|||...+..++.++||||||+++|||++|..||............+...
T Consensus       147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  226 (283)
T cd05080         147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG  226 (283)
T ss_pred             EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence            99999999876543221 11123345678999999888889999999999999999999999986432211111110000


Q ss_pred             hccc---hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          920 KRGA---IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       920 ~~~~---~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      ....   .+..........+.  .......+++..||++||++||+++++++.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         227 QMTVVRLIELLERGMRLPCPK--NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             ccchhhhhhhhhcCCCCCCCC--CCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0000   00111111111011  11124456888899999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-35  Score=319.29  Aligned_cols=251  Identities=27%  Similarity=0.450  Sum_probs=198.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .+|.+.+.||+|+||.||+|.+++++.+|+|++.....               ..+.+.+|+.++++++||||+++++++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---------------SEDDFIEEAKVMMKLSHPNLVQLYGVC   68 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---------------CHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            35778889999999999999888788899999854221               134688999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||+++++|.+++..... .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~df  144 (256)
T cd05059          69 TKQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDF  144 (256)
T ss_pred             cCCCceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCc
Confidence            999999999999999999999976443 489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++...+.... ......++..|+|||...+..++.++||||||+++||+++ |+.||....+.  .....+...    
T Consensus       145 g~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~----  217 (256)
T cd05059         145 GLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAG----  217 (256)
T ss_pred             ccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcC----
Confidence            999865433211 1112234567999999988899999999999999999999 89999754221  111111110    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                        ...   ..+.   .......+++.+||..+|++||++.++++.|
T Consensus       218 --~~~---~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 --YRL---YRPK---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CcC---CCCC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              000   0011   1122455688899999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.1e-35  Score=333.50  Aligned_cols=241  Identities=25%  Similarity=0.306  Sum_probs=186.7

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHH-HHhcCCCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK-TLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||+||+|+.. +|+.||+|++........           ...+.+.+|.. +++.++||||+++++++...+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~   69 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-----------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE   69 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC
Confidence            46899999999999765 589999999865322111           12345556655 467789999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|..++....  .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~  144 (325)
T cd05604          70 KLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK  144 (325)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcc
Confidence            9999999999999999887654  389999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ...+..      ...
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~------~~~  211 (325)
T cd05604         145 EGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNI------LHK  211 (325)
T ss_pred             cCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHH------HcC
Confidence            532221  1223567999999999999989999999999999999999999999754211     111111      111


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKD  965 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~e  965 (1035)
                      .....+.    ......+++.+|++.||.+||++.+
T Consensus       212 ~~~~~~~----~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         212 PLVLRPG----ASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CccCCCC----CCHHHHHHHHHHhccCHHhcCCCCC
Confidence            1111111    1123345788899999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3e-36  Score=296.43  Aligned_cols=262  Identities=25%  Similarity=0.339  Sum_probs=206.1

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceee
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVR  760 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  760 (1035)
                      +-..+|...+.+|.|..++|.++.+ ++|+.+|+|++.........+.      .....+.-.+|+.+++++ .||+|++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~------~~~~~EaT~~Ev~ILRqv~GHP~II~   87 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET------PYEMREATRQEISILRQVMGHPYIID   87 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc------HHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence            3456788888999999999999854 4689999999965433222110      123467778999999998 5999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +.++++.+...++|+|.|+.|.|.+++...-.  ++++...+|+.|+.+|++|+|.+   .|||||+||+|||++++.++
T Consensus        88 l~D~yes~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i  162 (411)
T KOG0599|consen   88 LQDVYESDAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNI  162 (411)
T ss_pred             eeeeccCcchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccce
Confidence            99999999999999999999999999987544  89999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                      ||+|||+|+...+++.-   ...+|||+|.|||.+.      ...|+...|+||.||++|-++.|.+||-          
T Consensus       163 ~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw----------  229 (411)
T KOG0599|consen  163 KISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW----------  229 (411)
T ss_pred             EEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh----------
Confidence            99999999988776543   3689999999999753      3458889999999999999999999983          


Q ss_pred             HHHHHhccchhhh-cccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          915 DWVRQKRGAIEVL-DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       915 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                        -+.+.-...++ ........+...+.....-+++.+|++.||.+|.|++|++++-
T Consensus       230 --HRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  230 --HRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             --HHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence              21111111111 1111111122222233345678889999999999999999863

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-35  Score=324.90  Aligned_cols=263  Identities=25%  Similarity=0.399  Sum_probs=199.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC---------------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHH
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN---------------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL  750 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l  750 (1035)
                      ++|++.+.||+|+||.||+|+...               ...||+|++......             ...+.|.+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~ei~~l   71 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK-------------TARNDFLKEIKIM   71 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH-------------HHHHHHHHHHHHH
Confidence            468888999999999999996542               235899998653221             1245799999999


Q ss_pred             hcCCCCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC----------CCCCHHHHHHHHHHHHHHHHHhhccCCC
Q 039419          751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD----------SCLEWELRYRIILGAAQGLAYLHHDCVP  820 (1035)
Q Consensus       751 ~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~  820 (1035)
                      ++++||||+++++++...+..++||||+++++|.+++.....          ..+++..+..++.|++.|++|||+.   
T Consensus        72 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---  148 (295)
T cd05097          72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---  148 (295)
T ss_pred             HhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---
Confidence            999999999999999999999999999999999999865321          2368889999999999999999999   


Q ss_pred             CeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh--
Q 039419          821 PIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT--  898 (1035)
Q Consensus       821 ~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt--  898 (1035)
                      +++||||||+||+++.++.+||+|||++................++..|+|||+..+..++.++|||||||++|||++  
T Consensus       149 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~  228 (295)
T cd05097         149 NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC  228 (295)
T ss_pred             CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcC
Confidence            999999999999999999999999999986544332222333456789999999888889999999999999999998  


Q ss_pred             CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          899 GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       899 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      |..||......  .....+.......  ........++.   ....+.+++.+||+.||++||++.+|++.|+
T Consensus       229 ~~~p~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         229 KEQPYSLLSDE--QVIENTGEFFRNQ--GRQIYLSQTPL---CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             CCCCCcccChH--HHHHHHHHhhhhc--cccccCCCCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            66677643221  1111111100000  00000001111   1124566889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=319.40  Aligned_cols=255  Identities=24%  Similarity=0.422  Sum_probs=204.6

Q ss_pred             cccCCeeeeeCCcEEEEEEEC---CCc--EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME---NGE--VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ....+.||.|-||.||+|...   .|+  .||||.-+.+...+.             .+.|..|+.+|+.++|||||+++
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-------------tekflqEa~iMrnfdHphIikLI  457 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-------------TEKFLQEASIMRNFDHPHIIKLI  457 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-------------HHHHHHHHHHHHhCCCcchhhee
Confidence            345578999999999999543   344  477887765443332             67899999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      |.|.+. ..|+|||.++-|.|..|++..+. .++......++.||+.||+|||+.   .+|||||..+|||+.....||+
T Consensus       458 Gv~~e~-P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL  532 (974)
T KOG4257|consen  458 GVCVEQ-PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL  532 (974)
T ss_pred             eeeecc-ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence            999764 57999999999999999987654 488899999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      +|||+++.+.++..+..+ ...-..-|||||-+.-.+++.++|||.|||.+||++. |..||.+-...+.          
T Consensus       533 aDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------  601 (974)
T KOG4257|consen  533 ADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------  601 (974)
T ss_pred             cccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------
Confidence            999999998887766543 4556778999999999999999999999999999988 9999985432211          


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                        +-.+...-+...+.  .....+..++.+||+.||.+||.+.++.+.|.++..
T Consensus       602 --I~~iEnGeRlP~P~--nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 --IGHIENGERLPCPP--NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             --EEEecCCCCCCCCC--CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence              01111111111111  122234567889999999999999999999988755

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.9e-35  Score=327.50  Aligned_cols=196  Identities=27%  Similarity=0.348  Sum_probs=172.5

Q ss_pred             ccccCCeeeeeCCcEEEEEE-ECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CC-----cee
Q 039419          687 CLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HK-----NIV  759 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv  759 (1035)
                      +|.+.++||+|+||.|.+|. .++++.||||+++.+..               ...+-..|+.+|..|+ |.     |+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---------------f~~Q~~~Ei~iL~~ln~~d~~~~~n~V  251 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---------------FLRQAQIEIRILELLNKHDPDDKYNIV  251 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---------------HHHHHHHHHHHHHHHhccCCCCCeeEE
Confidence            78999999999999999994 45699999999976432               2345677999999996 43     899


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC--
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE--  837 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~--  837 (1035)
                      +++++|...++.|+|+|.+ ..+|+++++......++...+..|+.||+.||.+||+.   +|||+||||+||||...  
T Consensus       252 rm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r  327 (586)
T KOG0667|consen  252 RMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKR  327 (586)
T ss_pred             Eeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCc
Confidence            9999999999999999999 67999999998888899999999999999999999998   99999999999999654  


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ..+||+|||.|++......     .+.-+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+.
T Consensus       328 ~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  328 SRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             CceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            4699999999997644322     567889999999999999999999999999999999997767543

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-35  Score=331.40  Aligned_cols=245  Identities=22%  Similarity=0.336  Sum_probs=189.3

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||.||+|... +++.||+|++........           ...+.+.+|+.++.++ +||+|+++++++.+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   69 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD-----------EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS   69 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC
Confidence            46999999999999765 478999999975432221           1245688999999988 6999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|..++...+.  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        70 ~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~  144 (327)
T cd05617          70 RLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK  144 (327)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccce
Confidence            99999999999999998876543  89999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-chhHHHHHHHhccchhhhc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE-GLHIVDWVRQKRGAIEVLD  928 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~  928 (1035)
                      ......  .......||+.|+|||+..+..++.++|||||||++|||++|+.||...... ......++.+..     ..
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----~~  217 (327)
T cd05617         145 EGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-----LE  217 (327)
T ss_pred             eccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-----Hh
Confidence            532211  1223567999999999999999999999999999999999999999643221 111111111110     01


Q ss_pred             ccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 039419          929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM  963 (1035)
Q Consensus       929 ~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~  963 (1035)
                      .... .+. ...  .....++.+|++.||++|+++
T Consensus       218 ~~~~-~p~-~~~--~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         218 KPIR-IPR-FLS--VKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCC-CCC-CCC--HHHHHHHHHHhccCHHHcCCC
Confidence            1111 011 111  223457888999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-35  Score=318.60  Aligned_cols=257  Identities=25%  Similarity=0.451  Sum_probs=199.5

Q ss_pred             cccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          688 LVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      |.+.+.||+|+||.||+|....    +..||+|++.......            ...+.+.+|+..++.++||||+++++
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~   68 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY------------SEIEEFLSEAACMKDFDHPNVMKLIG   68 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH------------HHHHHHHHHHHHHHhCCCCCeeeEEe
Confidence            4567899999999999997642    4779999986432211            12457899999999999999999999


Q ss_pred             EEEcCCc------ceEEEEeCCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          764 CCWNRNT------RLLMYDYMPNGSLGSLLHERR----DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       764 ~~~~~~~------~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      ++...+.      .++||||+++|+|.+++....    ...+++..+..++.|++.||+|||+.   +++||||||+||+
T Consensus        69 ~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil  145 (273)
T cd05035          69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCM  145 (273)
T ss_pred             eeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEE
Confidence            8876554      799999999999999985432    23588999999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchh
Q 039419          834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLH  912 (1035)
Q Consensus       834 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~  912 (1035)
                      +++++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..||.....  ..
T Consensus       146 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~  223 (273)
T cd05035         146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HE  223 (273)
T ss_pred             ECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HH
Confidence            99999999999999987655443322233445778999999888889999999999999999999 8889865322  12


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ...++....         ....+.   .......+++.+||+.||++||++.|+++.|+++
T Consensus       224 ~~~~~~~~~---------~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         224 IYDYLRHGN---------RLKQPE---DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHHHcCC---------CCCCCc---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            222221110         001111   1122445678889999999999999999998765

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6e-35  Score=320.69  Aligned_cols=261  Identities=21%  Similarity=0.340  Sum_probs=205.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      .++|...+.||+|+||.||+|.+..     +..||+|++......             ...+.+.+|+.++++++||||+
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni~   71 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASE-------------IQVTLLLQESCLLYGLSHQNIL   71 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCH-------------HHHHHHHHHHHHHHhCCCCCCC
Confidence            3578888999999999999998765     688999987543211             1256788999999999999999


Q ss_pred             eEEeEEEc-CCcceEEEEeCCCCChhhhhhhcCC------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccE
Q 039419          760 RFLGCCWN-RNTRLLMYDYMPNGSLGSLLHERRD------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNI  832 (1035)
Q Consensus       760 ~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NI  832 (1035)
                      ++++++.. ....++++||+++|+|.+++.....      ..+++..+..++.|++.||+|||+.   +++||||||+||
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~ni  148 (280)
T cd05043          72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNC  148 (280)
T ss_pred             eEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhE
Confidence            99998776 4678999999999999999876432      3488999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCch
Q 039419          833 LIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL  911 (1035)
Q Consensus       833 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~  911 (1035)
                      +++.++.+||+|||+++.+.............++..|+|||+..+..++.++||||||+++||+++ |+.||....+  .
T Consensus       149 l~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~  226 (280)
T cd05043         149 VIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--F  226 (280)
T ss_pred             EEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--H
Confidence            999999999999999986654432222233456778999999988889999999999999999999 9999975422  1


Q ss_pred             hHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .+..++.....    .  ......+      ..+.+++.+||..||++||++.++++.|+++..
T Consensus       227 ~~~~~~~~~~~----~--~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         227 EMAAYLKDGYR----L--AQPINCP------DELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHHHHHcCCC----C--CCCCcCC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            22222221100    0  0001111      134568888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.3e-35  Score=321.19  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=198.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|...+.||+|+||.||+|.+..      +..||+|.+.......             ....|.+|+.++++++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i~   72 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-------------DESDFLMEALIMSKFNHQNIV   72 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH-------------HHHHHHHHHHHHHhCCCCCEe
Confidence            568888999999999999997753      5678889875432111             235689999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll  834 (1035)
                      ++++++.+.+..++||||++|++|.+++...+.     ..+++..+.+++.||+.|++|||+.   +++||||||+||++
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~  149 (277)
T cd05036          73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLL  149 (277)
T ss_pred             eEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEE
Confidence            999999999999999999999999999976542     2488999999999999999999999   99999999999999


Q ss_pred             cCCC---ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 039419          835 GPEF---EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEG  910 (1035)
Q Consensus       835 ~~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~  910 (1035)
                      +.++   .+||+|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||...... 
T Consensus       150 ~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-  228 (277)
T cd05036         150 TCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-  228 (277)
T ss_pred             eccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            8754   589999999987643322222223334578999999988889999999999999999997 99999754321 


Q ss_pred             hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                       .....+...          .....+...  .....+++.+|++.+|++||++.+|+++|.
T Consensus       229 -~~~~~~~~~----------~~~~~~~~~--~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 -EVMEFVTGG----------GRLDPPKGC--PGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HHHHHHHcC----------CcCCCCCCC--CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             111111110          000111111  123456788899999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.4e-35  Score=317.27  Aligned_cols=253  Identities=24%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +.|+..++||+|+||.||+|..++++.||+|.+.....               ..+++.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~~~   70 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---------------SPEAFLAEANLMKQLQHPRLVRLYAVV   70 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---------------cHHHHHHHHHHHHhcCCcCeeeEEEEE
Confidence            56888899999999999999988899999999864321               135789999999999999999999986


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      . .+..+++|||+.+++|.+++.......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        71 ~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~df  146 (260)
T cd05067          71 T-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADF  146 (260)
T ss_pred             c-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccC
Confidence            4 46789999999999999998766555689999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.+........ .......++..|+|||+..+..++.++||||||+++||+++ |+.||.....  ...........   
T Consensus       147 g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~---  220 (260)
T cd05067         147 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLERGY---  220 (260)
T ss_pred             cceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHcCC---
Confidence            99976653221 11223446778999999988889999999999999999999 9999974422  11222211110   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                         ........      .....+++.+|++.+|++||+++++.+.|+.
T Consensus       221 ---~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         221 ---RMPRPDNC------PEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCCCC------CHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               00011111      1234567888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.4e-35  Score=325.24  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=201.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCc--EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGE--VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  761 (1035)
                      ++|.+.+.||+|+||.||+|.+. ++.  .+|+|.+......             ...+.+.+|+.++.++ +||||+++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~Ei~~l~~l~~h~~iv~~   73 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-------------DDHRDFAGELEVLCKLGHHPNIINL   73 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH-------------HHHHHHHHHHHHHHHhcCCCCcceE
Confidence            56788899999999999999765 344  4577776432111             1245788999999999 89999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCC
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI  827 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDi  827 (1035)
                      ++++.+.+..|+||||+++|+|.++++..+.              ..+++..+..++.|+++|++|||+.   ||+||||
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl  150 (303)
T cd05088          74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDL  150 (303)
T ss_pred             EEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Ccccccc
Confidence            9999999999999999999999999975431              2478999999999999999999998   9999999


Q ss_pred             CcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 039419          828 KANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT  906 (1035)
Q Consensus       828 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~  906 (1035)
                      ||+||+++.++.+||+|||+++.....   .......++..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus       151 kp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  227 (303)
T cd05088         151 AARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  227 (303)
T ss_pred             chheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence            999999999999999999998642111   11112234678999999888889999999999999999998 99999643


Q ss_pred             CCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHHh
Q 039419          907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREEC  980 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~  980 (1035)
                      ...  .....+.          .......+..  ......+++.+||+.+|++||+++++++.++.+.......
T Consensus       228 ~~~--~~~~~~~----------~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~  287 (303)
T cd05088         228 TCA--ELYEKLP----------QGYRLEKPLN--CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  287 (303)
T ss_pred             ChH--HHHHHHh----------cCCcCCCCCC--CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence            221  1111111          0000000011  1123456888999999999999999999999886665543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.2e-35  Score=324.55  Aligned_cols=261  Identities=26%  Similarity=0.394  Sum_probs=203.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC--------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CC
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME--------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RH  755 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1035)
                      .++|.+.+.||+|+||.||+|++.        ++..||+|.+.......             ..+.+.+|+.+++.+ +|
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~h   80 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-------------DLSDLVSEMEMMKMIGKH   80 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchH-------------HHHHHHHHHHHHHhhccC
Confidence            467888899999999999999642        24579999886432111             245788999999999 89


Q ss_pred             CceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 039419          756 KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPP  821 (1035)
Q Consensus       756 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  821 (1035)
                      |||+++++++...+..|+||||+++|+|.+++.....              ..+++..+..++.||++||+|||+.   |
T Consensus        81 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---g  157 (304)
T cd05101          81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---K  157 (304)
T ss_pred             CCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence            9999999999999999999999999999999976432              2478888999999999999999999   9


Q ss_pred             eeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 039419          822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK  900 (1035)
Q Consensus       822 ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~  900 (1035)
                      ++||||||+||+++.++.+||+|||.++...............++..|+|||+..+..++.++||||||+++||+++ |.
T Consensus       158 ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~  237 (304)
T cd05101         158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  237 (304)
T ss_pred             eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999987654333222334456788999999988889999999999999999998 78


Q ss_pred             CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       901 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .||.....     ..+.........      ...+.   ........++.+||+++|++||++.++++.|+.+..
T Consensus       238 ~p~~~~~~-----~~~~~~~~~~~~------~~~~~---~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         238 SPYPGIPV-----EELFKLLKEGHR------MDKPA---NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             CCcccCCH-----HHHHHHHHcCCc------CCCCC---CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            88854321     112111111000      00011   111234457888999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.1e-35  Score=316.31  Aligned_cols=253  Identities=27%  Similarity=0.470  Sum_probs=200.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|.+..+..+|+|++.....               ..+.+.+|++++++++|||++++++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~~~   70 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------------MPEAFLQEAQIMKKLRHDKLVPLYAVV   70 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------------cHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            45788889999999999999888777899998754321               245788999999999999999999987


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      . .+..++||||+++++|.++++......+++..+..++.|++.||+|||+.   +++||||||+||++++++.++|+||
T Consensus        71 ~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~df  146 (260)
T cd05069          71 S-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF  146 (260)
T ss_pred             c-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCC
Confidence            5 45689999999999999999876555689999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++....... .......++..|+|||+..+..++.++||||||+++|||++ |..||....+.  ....++...    
T Consensus       147 g~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~----  219 (260)
T cd05069         147 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERG----  219 (260)
T ss_pred             ccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC----
Confidence            99986543321 11123346778999999888889999999999999999999 89999754221  111121110    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                            .....+.  .....+.+++.+||++||++||+++++.+.|++
T Consensus       220 ------~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 ------YRMPCPQ--GCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ------CCCCCCc--ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                  0000011  111234557888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.7e-35  Score=324.04  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=198.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .|...+.||+|+||.||+|.+.      +++.||+|++......             ...+.+.+|+.+++.++||||++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~~iv~   72 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG-------------PLREEFKHEAMMRSRLQHPNIVC   72 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH-------------HHHHHHHHHHHHHhcCCCCCcCe
Confidence            4666788999999999999764      2578999998643211             12467899999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccC
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRD  826 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrD  826 (1035)
                      +++++.+.+..++++||+.+++|.+++....              ...+++..+..++.|++.||+|+|+.   +|+|||
T Consensus        73 ~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~d  149 (283)
T cd05091          73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKD  149 (283)
T ss_pred             EEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence            9999999999999999999999999985321              12478888999999999999999999   999999


Q ss_pred             CCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 039419          827 IKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP  905 (1035)
Q Consensus       827 ikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~  905 (1035)
                      |||+||++++++.+||+|||+++...............+++.|+|||+..+..++.++||||||+++|||++ |..||..
T Consensus       150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  229 (283)
T cd05091         150 LATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG  229 (283)
T ss_pred             cchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999999886644332222234456789999999888889999999999999999998 8888865


Q ss_pred             CCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          906 TIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      ...  ......+....         ....+ .....  .+..++..||+.+|++||++.++++.|+
T Consensus       230 ~~~--~~~~~~i~~~~---------~~~~~-~~~~~--~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         230 YSN--QDVIEMIRNRQ---------VLPCP-DDCPA--WVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             CCH--HHHHHHHHcCC---------cCCCC-CCCCH--HHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            322  12222221111         00001 11111  2345788899999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-35  Score=307.81  Aligned_cols=266  Identities=22%  Similarity=0.289  Sum_probs=201.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc-eeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN-IVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~  762 (1035)
                      ...|...++||+|+||+||+|+.+ +|+.||+|++......            ++......+|+.++++++|+| ||+++
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------------EG~P~taiREisllk~L~~~~~iv~L~   77 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------------EGVPSTAIREISLLKRLSHANHIVRLH   77 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------------cCCCchhhHHHHHHHHhCCCcceEEEE
Confidence            455667778999999999999665 5899999999654322            124556789999999999999 99999


Q ss_pred             eEEEcCC------cceEEEEeCCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE
Q 039419          763 GCCWNRN------TRLLMYDYMPNGSLGSLLHERRD--SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       763 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll  834 (1035)
                      +++...+      ..++|+||+ .-+|..++.....  ..++...+..++.||++||+|||++   +|+||||||+||++
T Consensus        78 dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi  153 (323)
T KOG0594|consen   78 DVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLI  153 (323)
T ss_pred             eeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEE
Confidence            9998877      778999999 5699999987664  3577788999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhH
Q 039419          835 GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI  913 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~  913 (1035)
                      ++.|.+||+|||+|+.+.-..  ......++|..|.|||++.+. .|+...||||+||+++||++++.-|.+.... .+.
T Consensus       154 ~~~G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql  230 (323)
T KOG0594|consen  154 SSSGVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQL  230 (323)
T ss_pred             CCCCcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHH
Confidence            999999999999999664222  223456789999999998776 6999999999999999999998888754331 111


Q ss_pred             HHHHHHhccc--------hh--hhcccccCCC-cccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          914 VDWVRQKRGA--------IE--VLDKSLRARP-EVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       914 ~~~~~~~~~~--------~~--~~~~~~~~~~-~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....+.....        ..  ..+....... +.....     .....+++.+|++.+|.+|.|++.++++
T Consensus       231 ~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  231 FRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1111110000        00  0000011110 001111     1245678888999999999999999886

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-35  Score=330.01  Aligned_cols=261  Identities=24%  Similarity=0.372  Sum_probs=199.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEE------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCce
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNI  758 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  758 (1035)
                      ++|++.+.||+|+||+||+|.+      .+++.||||++.......             ..+.+.+|+.++.++ +||||
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~h~ni   73 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------------EHRALMSELKILIHIGHHLNV   73 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH-------------HHHHHHHHHHHHHhccCCccH
Confidence            5788999999999999999964      347889999986532211             135688999999999 68999


Q ss_pred             eeEEeEEEcCC-cceEEEEeCCCCChhhhhhhcCC---------------------------------------------
Q 039419          759 VRFLGCCWNRN-TRLLMYDYMPNGSLGSLLHERRD---------------------------------------------  792 (1035)
Q Consensus       759 v~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------  792 (1035)
                      +++++++...+ ..++||||+++|+|.++++....                                             
T Consensus        74 v~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (343)
T cd05103          74 VNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFV  153 (343)
T ss_pred             hhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccccccc
Confidence            99999886654 57899999999999999865321                                             


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccc
Q 039419          793 --------------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV  852 (1035)
Q Consensus       793 --------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~  852 (1035)
                                          ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~  230 (343)
T cd05103         154 EEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIY  230 (343)
T ss_pred             CCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccc
Confidence                                2367888899999999999999999   99999999999999999999999999998654


Q ss_pred             cCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhhcccc
Q 039419          853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL  931 (1035)
Q Consensus       853 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (1035)
                      ............++..|+|||+..+..++.++||||||+++|||++ |..||...... ......+...  .       .
T Consensus       231 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~--~-------~  300 (343)
T cd05103         231 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEG--T-------R  300 (343)
T ss_pred             cCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHHHHhcc--C-------C
Confidence            3322222223446678999999888889999999999999999997 99998653221 1111111100  0       0


Q ss_pred             cCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          932 RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       932 ~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ...+...   .....+++..||++||++||++.+++++|+.+.+
T Consensus       301 ~~~~~~~---~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         301 MRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            0001111   1234567888999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.8e-35  Score=320.61  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=201.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCc----EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGE----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|...+.||+|+||+||+|++. +++    .||+|++......             ...+.+.+|+.+++.++||||++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~   73 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-------------KANKEILDEAYVMAGVGSPYVCR   73 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH-------------HHHHHHHHHHHHHHhcCCCCCce
Confidence            46778899999999999999754 344    4899998643221             12457889999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++.. ...+++|||+++|+|.++++... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+
T Consensus        74 ~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~  148 (279)
T cd05109          74 LLGICLT-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHV  148 (279)
T ss_pred             EEEEEcC-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcE
Confidence            9999875 45789999999999999987643 3489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||.....  .....++..
T Consensus       149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~  226 (279)
T cd05109         149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEK  226 (279)
T ss_pred             EECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHC
Confidence            9999999987644322212223345678999999988889999999999999999998 9999864322  122223222


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ...          ...+.  ........++.+||+.||++||++.++++.++.+.+..
T Consensus       227 ~~~----------~~~~~--~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         227 GER----------LPQPP--ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CCc----------CCCCc--cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            110          00000  11123456788899999999999999999887775443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.4e-34  Score=315.38  Aligned_cols=262  Identities=21%  Similarity=0.343  Sum_probs=206.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|... +|+.||+|.++.....+.           ...+.+.+|++++++++|+||++++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~~ei~~l~~~~~~~i~~~~~~   70 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA-----------KARQDCLKEIDLLKQLDHPNVIKYLAS   70 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccch-----------hhHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            46888899999999999999776 789999999864332221           125678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +.+.+..++||||+++|+|.+++...  ....+++..+..++.++++|++|||+.   ||+||||||+||+++.++.++|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l  147 (267)
T cd08224          71 FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             eecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEE
Confidence            99999999999999999999998643  224478999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||.++.......  ......|+..|+|||...+..++.++|||||||++|+|++|+.||......   ..........
T Consensus       148 ~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~  222 (267)
T cd08224         148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIEK  222 (267)
T ss_pred             eccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc---HHHHHhhhhc
Confidence            99999876543221  122356889999999988888999999999999999999999999644321   1111111100


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                            ......+..  .......+++.+||+++|++||++.++++.++++.
T Consensus       223 ------~~~~~~~~~--~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 ------CDYPPLPAD--HYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------CCCCCCChh--hcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  001111110  11123456788899999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.3e-35  Score=318.62  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=195.1

Q ss_pred             ccCCeeeeeCCcEEEEEEECC-Cc--EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          689 VEDSVVGKGCSGIVYRAEMEN-GE--VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       689 ~~~~~iG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .+.+.||+|+||.||+|.+.. ++  .||+|.+.......            ...+.+.+|+.++++++||||+++++++
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   69 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR------------SEMEDFLSEAVCMKEFDHPNVMRLIGVC   69 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH------------HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            456889999999999997764 32  68999886532211            1246789999999999999999999987


Q ss_pred             EcC------CcceEEEEeCCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          766 WNR------NTRLLMYDYMPNGSLGSLLHERR----DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       766 ~~~------~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ...      ...++||||+++|+|.+++...+    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        70 ~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~  146 (272)
T cd05075          70 LQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLN  146 (272)
T ss_pred             ccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEc
Confidence            532      24689999999999999874321    23478999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHH
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~  914 (1035)
                      .++.+||+|||+++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||.....  ....
T Consensus       147 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~  224 (272)
T cd05075         147 ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIY  224 (272)
T ss_pred             CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence            999999999999987654332222233456778999999988889999999999999999999 8889865322  1221


Q ss_pred             HHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ..+....    .    . ..++ ...  ....+++.+||++||++||++.++++.|+++
T Consensus       225 ~~~~~~~----~----~-~~~~-~~~--~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         225 DYLRQGN----R----L-KQPP-DCL--DGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHcCC----C----C-CCCC-CCC--HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            2111100    0    0 0111 111  1245688899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-35  Score=321.62  Aligned_cols=257  Identities=26%  Similarity=0.380  Sum_probs=202.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .++|...+.||+|+||.||+|..++      +..||+|.+......             .....+.+|+.+++.++||||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i   71 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-------------RERIEFLNEASVMKEFNCHHV   71 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH-------------HHHHHHHHHHHHHHhCCCCce
Confidence            3578888999999999999997642      468999998543211             124578899999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN  830 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~  830 (1035)
                      +++++++......|+||||+++|+|.+++.....        ..+++..+..++.|++.|+.|||+.   +|+||||||+
T Consensus        72 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~  148 (277)
T cd05032          72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAAR  148 (277)
T ss_pred             eEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChh
Confidence            9999999999999999999999999999865322        2368889999999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 039419          831 NILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPE  909 (1035)
Q Consensus       831 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~  909 (1035)
                      ||+++.++.+||+|||+++...............++..|+|||...+..++.++|||||||++||+++ |..||......
T Consensus       149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  228 (277)
T cd05032         149 NCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE  228 (277)
T ss_pred             eEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH
Confidence            99999999999999999986655433233334557889999999888889999999999999999998 99998643221


Q ss_pred             chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                        ....++...         .....+...   ...+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 --~~~~~~~~~---------~~~~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         229 --EVLKFVIDG---------GHLDLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --HHHHHHhcC---------CCCCCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence              222222110         000111111   223456888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6e-35  Score=316.21  Aligned_cols=252  Identities=26%  Similarity=0.357  Sum_probs=202.0

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|..+ +++.|++|.+.......            ...+.+.+|++++++++||||+++++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR------------REREEAIDEARVLAKLDSSYIIRYYESF   68 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH------------HHHHHHHHHHHHHHhcCCCCeehheeee
Confidence            3667789999999999999765 58999999986432221            1356789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||+++++|.++++......+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+||
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df  145 (256)
T cd08529          69 LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDL  145 (256)
T ss_pred             ccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEccc
Confidence            9999999999999999999999876555689999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |+++.......  ......|++.|+|||+..+..++.++|+||||+++|||++|+.||.....  ......+..      
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~------  215 (256)
T cd08529         146 GVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GALILKIIR------  215 (256)
T ss_pred             ccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc------
Confidence            99886654322  12345688999999999888899999999999999999999999975431  111111110      


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ..... .+.  .......+++.+||+.+|++||++.+++++
T Consensus       216 ---~~~~~-~~~--~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         216 ---GVFPP-VSQ--MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---CCCCC-Ccc--ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               00000 010  112234568888999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-34  Score=321.20  Aligned_cols=263  Identities=25%  Similarity=0.414  Sum_probs=198.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-----------------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHH
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-----------------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK  748 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  748 (1035)
                      ++|++.+.||+|+||.||+|++.+                 +..||+|++......             ...++|.+|+.
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~-------------~~~~~~~~E~~   71 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK-------------NARNDFLKEIK   71 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH-------------HHHHHHHHHHH
Confidence            468888999999999999985432                 346888888543211             12467999999


Q ss_pred             HHhcCCCCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhccCC
Q 039419          749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD---------SCLEWELRYRIILGAAQGLAYLHHDCV  819 (1035)
Q Consensus       749 ~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~  819 (1035)
                      ++++++||||+++++++...+..++||||+++|+|.+++.....         ..+++..+..++.|++.|++|||+.  
T Consensus        72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~--  149 (296)
T cd05095          72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL--  149 (296)
T ss_pred             HHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC--
Confidence            99999999999999999999999999999999999999876432         2367788999999999999999999  


Q ss_pred             CCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-
Q 039419          820 PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-  898 (1035)
Q Consensus       820 ~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-  898 (1035)
                       +++||||||+||+++.++.++|+|||+++.+.............++..|+|||...+..++.++|||||||++|||++ 
T Consensus       150 -~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~  228 (296)
T cd05095         150 -NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL  228 (296)
T ss_pred             -CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence             999999999999999999999999999986544332222223345678999998888889999999999999999998 


Q ss_pred             -CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          899 -GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       899 -g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                       |..||......  ..........  ...........+.. ..  ....+++.+||+.||++||++.+|.+.|+
T Consensus       229 ~~~~p~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~-~~--~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         229 CKEQPYSQLSDE--QVIENTGEFF--RDQGRQVYLPKPAL-CP--DSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             CCCCCccccChH--HHHHHHHHHH--hhccccccCCCCCC-CC--HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             77888643221  1111110000  00000000011111 11  23456888999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=8e-35  Score=331.28  Aligned_cols=201  Identities=28%  Similarity=0.335  Sum_probs=169.4

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.++|...+.||+|+||.||+|... +|+.||+|++.......            ...+.+.+|+.+++.++||||+++
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~   85 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ------------THAKRAYRELVLLKCVNHKNIISL   85 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch------------hHHHHHHHHHHHHHhCCCCCEeee
Confidence            45688999999999999999999765 58999999986532211            124578899999999999999999


Q ss_pred             EeEEEcCC------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          762 LGCCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       762 ~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++...+      ..|+||||+++ ++.+.++.    .+++..+..++.|++.||+|||+.   ||+||||||+||+++
T Consensus        86 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~  157 (359)
T cd07876          86 LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK  157 (359)
T ss_pred             eeeeccCCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEC
Confidence            99986543      46999999965 66666643    278888999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      .++.+||+|||+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       158 ~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         158 SDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             CCCCEEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999754332   1223457899999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.8e-35  Score=321.87  Aligned_cols=263  Identities=27%  Similarity=0.410  Sum_probs=201.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-----------------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHH
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-----------------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK  748 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  748 (1035)
                      ++|...+.||+|+||.||+|...+                 +..||+|++......             ...+.+.+|++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~e~~   71 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-------------NAREDFLKEVK   71 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-------------HHHHHHHHHHH
Confidence            568889999999999999996643                 245899988654322             12567899999


Q ss_pred             HHhcCCCCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhccCC
Q 039419          749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD---------SCLEWELRYRIILGAAQGLAYLHHDCV  819 (1035)
Q Consensus       749 ~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~  819 (1035)
                      ++++++||||+++++++..++..++||||+++++|.+++.....         ..+++..+..++.|++.||+|||+.  
T Consensus        72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~--  149 (296)
T cd05051          72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL--  149 (296)
T ss_pred             HHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--
Confidence            99999999999999999999999999999999999999876541         2488999999999999999999998  


Q ss_pred             CCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-
Q 039419          820 PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-  898 (1035)
Q Consensus       820 ~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-  898 (1035)
                       +|+||||||+||+++.++.++|+|||+++...............++..|+|||+..+..++.++|||||||++|||++ 
T Consensus       150 -~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  228 (296)
T cd05051         150 -NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL  228 (296)
T ss_pred             -CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence             999999999999999999999999999986544433333334567789999999888889999999999999999998 


Q ss_pred             -CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          899 -GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       899 -g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                       |..||.....  ......+.......  -.......+..   ....+.+++.+|++.||++||++.|+++.|+
T Consensus       229 ~~~~p~~~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         229 CREQPYEHLTD--QQVIENAGHFFRDD--GRQIYLPRPPN---CPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             CCCCCCCCcCh--HHHHHHHHhccccc--cccccCCCccC---CCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence             6778754321  12222211110000  00000001111   1124566889999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.5e-35  Score=329.83  Aligned_cols=243  Identities=22%  Similarity=0.300  Sum_probs=190.3

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLGCC  765 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  765 (1035)
                      |...+.||+|+||+||+|... +++.||+|++........           ...+.+..|..+++.+. |++|+++++++
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~   70 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----------DDVECTMVEKRVLALQDKPPFLTQLHSCF   70 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhccCCCchhheeeEE
Confidence            667789999999999999765 589999999864322111           12456788999998885 57888999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||++||+|.+++.....  +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Df  145 (323)
T cd05615          71 QTVDRLYFVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADF  145 (323)
T ss_pred             ecCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecc
Confidence            999999999999999999999876543  89999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |+++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+....    
T Consensus       146 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~~~~----  217 (323)
T cd05615         146 GMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIMEHN----  217 (323)
T ss_pred             ccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC----
Confidence            99875432221  123456999999999998888999999999999999999999999754221  1111111100    


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM  963 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~  963 (1035)
                         .......      .....+++.+|+++||++|++.
T Consensus       218 ---~~~p~~~------~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ---VSYPKSL------SKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCCccC------CHHHHHHHHHHcccCHhhCCCC
Confidence               0001111      1233557888999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-34  Score=316.14  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=188.8

Q ss_pred             CeeeeeCCcEEEEEEECC---CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcC
Q 039419          692 SVVGKGCSGIVYRAEMEN---GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR  768 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  768 (1035)
                      +.||+|+||.||+|.+.+   +..+|+|.+......             .....+.+|+.++++++||||+++++++.+.
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   67 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-------------QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV   67 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-------------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            358999999999997653   467999987543221             1235788999999999999999999999999


Q ss_pred             CcceEEEEeCCCCChhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          769 NTRLLMYDYMPNGSLGSLLHERRD---SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       769 ~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ...++||||+++|+|.++++....   ...++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~df  144 (269)
T cd05087          68 TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDY  144 (269)
T ss_pred             CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCc
Confidence            999999999999999999975432   2456778889999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccC-------CCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHH
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-------KITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~  917 (1035)
                      |.++...............|+..|+|||+..+.       .++.++||||||+++|||++ |+.||....+...  ....
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~  222 (269)
T cd05087         145 GLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT  222 (269)
T ss_pred             cccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH
Confidence            999765443332223345678899999986532       35789999999999999996 9999975432211  1111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      . .........+......+   +   ....++.+|| .+|++||++++|++.|+
T Consensus       223 ~-~~~~~~~~~~~~~~~~~---~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         223 V-REQQLKLPKPRLKLPLS---D---RWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             h-hcccCCCCCCccCCCCC---h---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            0 00001111111111111   1   1234667798 58999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.4e-35  Score=321.21  Aligned_cols=259  Identities=24%  Similarity=0.382  Sum_probs=200.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .++|.+.+.||+|+||.||+|..+      .+..||+|.+......             .....+.+|+.++++++||||
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i   71 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-------------RERIEFLNEASVMKGFTCHHV   71 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-------------HHHHHHHHHHHHHHhCCCCCe
Confidence            467889999999999999999653      2457999987533211             123468899999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN  830 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~  830 (1035)
                      +++++++.+.+..|+||||+++|+|.++++....        ..+++..+..++.|++.||+|||+.   +|+||||||+
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~  148 (288)
T cd05061          72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAAR  148 (288)
T ss_pred             eeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChh
Confidence            9999999999999999999999999999975331        2356778889999999999999998   9999999999


Q ss_pred             cEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 039419          831 NILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPE  909 (1035)
Q Consensus       831 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~  909 (1035)
                      ||+++.++.++|+|||+++...............++..|+|||...+..++.++|||||||++|||++ |..||.....+
T Consensus       149 nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~  228 (288)
T cd05061         149 NCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE  228 (288)
T ss_pred             eEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986544333222233446778999999988889999999999999999999 78898653221


Q ss_pred             chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                        .....+..         ......+..   ....+.+++.+|++.||++||++.++++.+++.
T Consensus       229 --~~~~~~~~---------~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         229 --QVLKFVMD---------GGYLDQPDN---CPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             --HHHHHHHc---------CCCCCCCCC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence              11111111         000011111   112345688889999999999999999988765

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-35  Score=353.69  Aligned_cols=258  Identities=20%  Similarity=0.283  Sum_probs=195.6

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ...+.|.+.+.||+|+||+||+|.+.. ++.||+|++.......            ...+.|..|+.++++++|||||++
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e------------~~~~~~~~EI~IL~~L~HPNIVrl   77 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE------------REKSQLVIEVNVMRELKHKNIVRY   77 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH------------HHHHHHHHHHHHHHHcCCCCcCeE
Confidence            345789999999999999999997764 7789999886543222            124678999999999999999999


Q ss_pred             EeEEEcC--CcceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCC----CCeeccCCCcccEE
Q 039419          762 LGCCWNR--NTRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCV----PPIVHRDIKANNIL  833 (1035)
Q Consensus       762 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~ivHrDikp~NIl  833 (1035)
                      +++|.+.  ...|+||||+++|+|.+++....  ...+++..++.|+.||+.||+|||+.+.    .+|+||||||+|||
T Consensus        78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL  157 (1021)
T PTZ00266         78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF  157 (1021)
T ss_pred             EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence            9998654  46899999999999999987532  2358999999999999999999998521    25999999999999


Q ss_pred             EcC-----------------CCceEEeeccCccccccCCccccccccCCcccccCCccccc--CCCCccccchhHHHHHH
Q 039419          834 IGP-----------------EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVL  894 (1035)
Q Consensus       834 l~~-----------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~  894 (1035)
                      ++.                 .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++|||||||++|
T Consensus       158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY  234 (1021)
T PTZ00266        158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY  234 (1021)
T ss_pred             eecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence            964                 2348999999998654322   2234579999999998753  45889999999999999


Q ss_pred             HHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          895 EVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       895 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ||++|+.||.....    ....+......     +.+.   ..  .....+..++..||+.+|++||++.|++.+
T Consensus       235 ELLTGk~PF~~~~~----~~qli~~lk~~-----p~lp---i~--~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        235 ELCSGKTPFHKANN----FSQLISELKRG-----PDLP---IK--GKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHHHCCCCCCcCCc----HHHHHHHHhcC-----CCCC---cC--CCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            99999999974321    11111111000     0000   00  011234557888999999999999999853

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.4e-35  Score=317.63  Aligned_cols=261  Identities=20%  Similarity=0.320  Sum_probs=204.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|.. .+++.||||.+........           ...+++.+|+.+++.++||||++++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~h~~i~~~~~~   70 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA-----------KARADCIKEIDLLKQLNHPNVIKYYAS   70 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhH-----------HHHHHHHHHHHHHHHccCCchhhhhhe
Confidence            4577788999999999999975 4689999998854322111           124678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +.+++..+++|||+++++|.+++...  ....+++..+..++.|+++|++|||+.   +++|+||||+||+++.++.+++
T Consensus        71 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l  147 (267)
T cd08229          71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL  147 (267)
T ss_pred             eEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEE
Confidence            99999999999999999999988642  224588999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||.+........  ......|+..|+|||+..+..++.++||||||+++|+|++|..||.............+..   
T Consensus       148 ~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---  222 (267)
T cd08229         148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---  222 (267)
T ss_pred             CcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc---
Confidence            99999886644321  1224568899999999988889999999999999999999999996443221111111110   


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                            ......+...  ....+..++.+||+.||++|||+.+|++.++++
T Consensus       223 ------~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         223 ------CDYPPLPSDH--YSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ------CCCCCCCccc--ccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                  0001111111  112344578889999999999999999998775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=326.39  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=205.0

Q ss_pred             cCCeeeeeCCcEEEEEEECC--C--cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          690 EDSVVGKGCSGIVYRAEMEN--G--EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       690 ~~~~iG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ..+.||+|+||.|++|.|..  |  -.||||.+.......             ..++|.+|+.+|.+|+|||++++||..
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-------------~mddflrEas~M~~L~H~hliRLyGvV  180 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-------------IMDDFLREASHMLKLQHPHLIRLYGVV  180 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------------hHHHHHHHHHHHHhccCcceeEEeeee
Confidence            44689999999999998863  4  359999997654332             367899999999999999999999998


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+ ....||||.++.|||.+.+++.....|.......++.|||.|++||..+   ++||||+..+|+++.....|||+||
T Consensus       181 l~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DF  256 (1039)
T KOG0199|consen  181 LD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDF  256 (1039)
T ss_pred             cc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecc
Confidence            87 6678999999999999999986566788899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCC-ccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          846 GLAKLVVEGD-FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       846 G~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |+++.....+ .+.+.....-...|+|||.+...+++.++|||+|||++|||++ |..||.+-.  +.++...++     
T Consensus       257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g~qIL~~iD-----  329 (1039)
T KOG0199|consen  257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--GIQILKNID-----  329 (1039)
T ss_pred             cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--HHHHHHhcc-----
Confidence            9999876543 3444445567789999999999999999999999999999999 888997542  223333222     


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                          +...-.++..+-   .++.+++..||..+|++||++..|.+.+-.
T Consensus       330 ----~~erLpRPk~cs---edIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  330 ----AGERLPRPKYCS---EDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             ----ccccCCCCCCCh---HHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence                111222333332   344668899999999999999999865433

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-34  Score=324.05  Aligned_cols=205  Identities=27%  Similarity=0.310  Sum_probs=172.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+++.+. ++.||+|++........           ...+.+.+|+.++..++|++|++++++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~~   69 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR-----------AETACFREERDVLVNGDNQWITTLHYA   69 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHh-----------hHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            367888999999999999997764 78899999854221111           124568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||+++|+|.+++..... .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~D  145 (332)
T cd05623          70 FQDENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  145 (332)
T ss_pred             EecCCEEEEEEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999999976432 388899999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ||++........ .......||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       146 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         146 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             cchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence            999876543221 1223457999999999875     346788999999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=325.01  Aligned_cols=205  Identities=26%  Similarity=0.310  Sum_probs=172.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++........           ...+.+.+|+.++..++||||++++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~~   69 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKR-----------AETACFREERDVLVNGDRRWITNLHYA   69 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-----------hhHHHHHHHHHHHHhCCCCCCCceEEE
Confidence            36888899999999999999766 489999999854211111           124568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.+++.... ..+++..+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus        70 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  145 (331)
T cd05597          70 FQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLAD  145 (331)
T ss_pred             EecCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEE
Confidence            999999999999999999999997543 3388899999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ||++........ .......||+.|+|||++..     ..++.++||||+||++|||++|+.||...
T Consensus       146 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         146 FGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             CCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence            999876544322 11223569999999998753     45788999999999999999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-34  Score=322.75  Aligned_cols=261  Identities=27%  Similarity=0.432  Sum_probs=201.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC--------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCC
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME--------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHK  756 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  756 (1035)
                      ++|.+.+.||+|+||.||+|+..        ....+|+|.+......             ...+.+.+|+.+++++ +||
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~   78 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-------------KDLADLISEMELMKLIGKHK   78 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh-------------HHHHHHHHHHHHHHhccCCC
Confidence            57888999999999999999652        2457899987643211             1245688999999999 699


Q ss_pred             ceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 039419          757 NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPPI  822 (1035)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  822 (1035)
                      ||+++++++.+.+..|+||||+++|+|.+++.....              ..+++..+..++.|++.||+|||+.   |+
T Consensus        79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi  155 (314)
T cd05099          79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RC  155 (314)
T ss_pred             CeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            999999999999999999999999999999976431              3478899999999999999999998   99


Q ss_pred             eccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 039419          823 VHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ  901 (1035)
Q Consensus       823 vHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~  901 (1035)
                      +||||||+||+++.++.+||+|||.++...............++..|+|||+..+..++.++||||||+++|||++ |..
T Consensus       156 ~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~  235 (314)
T cd05099         156 IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS  235 (314)
T ss_pred             eeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999986644322222222335568999999888889999999999999999999 888


Q ss_pred             CCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       902 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      ||......  .....+...         .....+.. .  ..+..+++.+||+.||++||++.++++.|+.+...
T Consensus       236 p~~~~~~~--~~~~~~~~~---------~~~~~~~~-~--~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         236 PYPGIPVE--ELFKLLREG---------HRMDKPSN-C--THELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             CCCCCCHH--HHHHHHHcC---------CCCCCCCC-C--CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            98643221  111111110         00001111 1  11334578889999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-35  Score=336.04  Aligned_cols=205  Identities=23%  Similarity=0.338  Sum_probs=174.8

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|...+.||+|+||+||+|..+ +++.||+|++........           ...+.+.+|+.++..++||+|+++++.+
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~iv~~~~~~   70 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-----------EQVAHIRAERDILVEADGAWVVKMFYSF   70 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhh-----------hhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            5778899999999999999765 589999999864321111           2346788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||++||+|.+++...+.  +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~Df  145 (360)
T cd05627          71 QDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDF  145 (360)
T ss_pred             EcCCEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeec
Confidence            999999999999999999999976543  88999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCc---------------------------------cccccccCCcccccCCcccccCCCCccccchhHHHH
Q 039419          846 GLAKLVVEGDF---------------------------------ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVV  892 (1035)
Q Consensus       846 G~a~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvv  892 (1035)
                      |+++.......                                 .......+||+.|+|||++.+..++.++|||||||+
T Consensus       146 G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi  225 (360)
T cd05627         146 GLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI  225 (360)
T ss_pred             cCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccce
Confidence            99875432110                                 000123579999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCC
Q 039419          893 VLEVLTGKQPIDPTI  907 (1035)
Q Consensus       893 l~elltg~~P~~~~~  907 (1035)
                      +|||++|+.||....
T Consensus       226 lyel~tG~~Pf~~~~  240 (360)
T cd05627         226 MYEMLIGYPPFCSET  240 (360)
T ss_pred             eeecccCCCCCCCCC
Confidence            999999999997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.4e-35  Score=324.18  Aligned_cols=263  Identities=16%  Similarity=0.242  Sum_probs=195.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|+.+ +++.||+|.+.......             ....+.+|++++++++||||++++++
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~~~~~   72 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------------APCTAIREVSLLKDLKHANIVTLHDI   72 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-------------cchhHHHHHHHHHhCCCCCcceEEEE
Confidence            56888899999999999999766 57889999986432211             13457789999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +..++..++||||+++ +|.+++...+ ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        73 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~D  147 (309)
T cd07872          73 VHTDKSLTLVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLAD  147 (309)
T ss_pred             EeeCCeEEEEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence            9999999999999964 8888886553 3478899999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc--
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR--  921 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--  921 (1035)
                      ||+++......  .......+++.|+|||+..+ ..++.++||||+||++|||++|+.||........ .....+...  
T Consensus       148 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~  224 (309)
T cd07872         148 FGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTP  224 (309)
T ss_pred             cccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Confidence            99987643322  11224567899999998754 4688999999999999999999999975432111 000000000  


Q ss_pred             ---------cchhhhcccccCCCccc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 ---------GAIEVLDKSLRARPEVE-----IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ---------~~~~~~~~~~~~~~~~~-----~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                               ......+.......+..     ........+++.+|++.||++|||++|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         225 TEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             CHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence                     00000000000000000     0011234568889999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=314.87  Aligned_cols=257  Identities=24%  Similarity=0.320  Sum_probs=199.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|... +++.||+|.+.........         ....+.+.+|++++++++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~   72 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET---------KKEVNALECEIQLLKNLQHERIVQYYGC   72 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh---------HHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence            35788899999999999999764 5899999998643221110         0124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..++||||+++++|.+++.....  +++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|
T Consensus        73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          73 LRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             EccCCeEEEEEEECCCCcHHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            9999999999999999999999976543  78899999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccc-cccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFAR-SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.++......... ......|+..|+|||+..+..++.++||||+|+++|||++|+.||......  ..........  
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~--  223 (263)
T cd06625         148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--AAIFKIATQP--  223 (263)
T ss_pred             cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--HHHHHHhccC--
Confidence            99987654322111 112356888999999998888999999999999999999999999643211  1111111000  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         .........+      .....++.+||..+|++||++.+++++
T Consensus       224 ---~~~~~~~~~~------~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 ---TNPQLPSHVS------PDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---CCCCCCccCC------HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence               0011111111      123457788999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-34  Score=324.50  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=201.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC--------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCC
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN--------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHK  756 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  756 (1035)
                      .+|.+.+.||+|+||.||+|++..        +..||+|.+......             ...+++.+|+.+++++ +||
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~   78 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD-------------KDLSDLVSEMEMMKMIGKHK   78 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH-------------HHHHHHHHHHHHHHhhcCCC
Confidence            468889999999999999996531        236899987643211             1246789999999999 799


Q ss_pred             ceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 039419          757 NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPI  822 (1035)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  822 (1035)
                      ||+++++++...+..|++|||+++|+|.+++....              ...+++..+..++.|++.||+|||+.   ||
T Consensus        79 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi  155 (334)
T cd05100          79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KC  155 (334)
T ss_pred             CeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence            99999999999999999999999999999987542              13478889999999999999999998   99


Q ss_pred             eccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 039419          823 VHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ  901 (1035)
Q Consensus       823 vHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~  901 (1035)
                      +||||||+||+++.++.+||+|||+++...............++..|+|||+..+..++.++||||||+++|||++ |..
T Consensus       156 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~  235 (334)
T cd05100         156 IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS  235 (334)
T ss_pred             eccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999986644332222223345678999999988889999999999999999998 888


Q ss_pred             CCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       902 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ||......  .....+...         .....+..   ....+..++.+||+.+|++||++.|+++.|+.+..
T Consensus       236 p~~~~~~~--~~~~~~~~~---------~~~~~~~~---~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         236 PYPGIPVE--ELFKLLKEG---------HRMDKPAN---CTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             CCCCCCHH--HHHHHHHcC---------CCCCCCCC---CCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            88643211  111111110         00001111   11234467888999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.6e-34  Score=317.59  Aligned_cols=254  Identities=21%  Similarity=0.273  Sum_probs=198.5

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |+..+.||+|+||+||+|.+. +++.||+|.+........           ...+.+.+|+.++++++|++|+++++.+.
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~~~~i~~~~~~~~   70 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----------KGESMALNEKQILEKVNSRFVVSLAYAYE   70 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch-----------HHHHHHHHHHHHHHhCCCCCeeeeeEEEe
Confidence            566789999999999999765 588999999865432211           12346788999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +.+..++||||++|++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg  147 (285)
T cd05630          71 TKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLG  147 (285)
T ss_pred             cCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999998765555689999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      ++........   .....|+..|+|||+..+..++.++||||+|+++|||++|+.||......... ... ...   ...
T Consensus       148 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~-~~~---~~~  219 (285)
T cd05630         148 LAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEV-ERL---VKE  219 (285)
T ss_pred             ceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH-HHH-Hhh---hhh
Confidence            9876533221   12357899999999998889999999999999999999999999754321100 000 000   000


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                      ..........      ....+++.+||+.||++||+     ++|++++
T Consensus       220 ~~~~~~~~~~------~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 VQEEYSEKFS------PDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hhhhcCccCC------HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            0111111111      12345778899999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9e-35  Score=334.00  Aligned_cols=260  Identities=19%  Similarity=0.194  Sum_probs=197.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ..+|.+.+.||+|+||.||+|...   .++.||+|.+...                   +.+.+|++++++++||||+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------------~~~~~E~~il~~l~h~~iv~~  151 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------------KTPGREIDILKTISHRAIINL  151 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------------ccHHHHHHHHHhcCCCCccce
Confidence            357999999999999999999654   3578999987431                   235689999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++......|+|||++. ++|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++
T Consensus       152 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~  225 (392)
T PHA03207        152 IHAYRWKSTVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAV  225 (392)
T ss_pred             eeeEeeCCEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEE
Confidence            999999999999999994 6898888543  3489999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc--hhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG--LHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~  919 (1035)
                      |+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+...++.
T Consensus       226 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~  305 (392)
T PHA03207        226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC  305 (392)
T ss_pred             EccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence            999999987655433333345679999999999998899999999999999999999999997543221  111111111


Q ss_pred             hccch-h--------------hhcccccCCC--cccH---HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAI-E--------------VLDKSLRARP--EVEI---EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~-~--------------~~~~~~~~~~--~~~~---~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..... +              ......+...  +..+   ........++.+|+..||++||++.|++.+
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000 0              0000000000  0000   011234457888999999999999999986

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-34  Score=314.75  Aligned_cols=255  Identities=27%  Similarity=0.461  Sum_probs=204.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++|.+.+.||+|+||.||+|..++++.||||.+.....               ..+++.+|+.++++++||||++++++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~~   69 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---------------SPEAFLQEAQIMKKLRHDKLVQLYAV   69 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---------------CHHHHHHHHHHHhhCCCCCEeeeeee
Confidence            467888999999999999999888888999999864321               13578999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +......++||||+++++|.+++.......+++..+..++.+++.|++|||+.   +++||||||+||+++.++.++++|
T Consensus        70 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d  146 (261)
T cd05034          70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIAD  146 (261)
T ss_pred             eecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECc
Confidence            99888999999999999999999876555689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.++....... .......++..|+|||...+..++.++||||+|+++||+++ |+.||.....  ......+...   
T Consensus       147 ~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~---  220 (261)
T cd05034         147 FGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVERG---  220 (261)
T ss_pred             cccceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC---
Confidence            999886643221 11122335678999999988889999999999999999998 9999964321  1111111110   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                             .....+...  .....+++.+|+..+|++||+++++.+.|+.
T Consensus       221 -------~~~~~~~~~--~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 -------YRMPRPPNC--PEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -------CCCCCCCCC--CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                   000000011  1234568888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.6e-35  Score=330.67  Aligned_cols=203  Identities=22%  Similarity=0.282  Sum_probs=173.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|+++ +++.||+|++........           ...+.+.+|+.+++.++||||++++++
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~-----------~~~~~~~~e~~i~~~~~hp~iv~~~~~  111 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-----------SDSAFFWEERDIMAFANSPWVVQLFYA  111 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhh-----------HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            78999999999999999999776 478999999854221111           124567899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.++++...   ++...+..++.||+.||+|||++   +|+||||||+||+++.++.+||+|
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~D  185 (371)
T cd05622         112 FQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  185 (371)
T ss_pred             EEcCCEEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999987543   78888899999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccC----CCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM----KITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ||+++....... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...
T Consensus       186 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         186 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             CCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            999986643221 122356799999999987643    3788999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.6e-34  Score=317.85  Aligned_cols=254  Identities=22%  Similarity=0.267  Sum_probs=197.4

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |...+.||+|+||+||+|.+. +++.||+|++........           ...+.+.+|++++++++|++|+++++++.
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~~~~i~~~~~~~~   70 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR-----------KGESMALNEKQILEKVNSQFVVNLAYAYE   70 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh-----------hHHHHHHHHHHHHHHcCCcCceeEEEEEe
Confidence            566788999999999999765 589999999865432211           12346788999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +++..++||||+++++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg  147 (285)
T cd05632          71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG  147 (285)
T ss_pred             cCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCC
Confidence            999999999999999999988765555689999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      ++.......   ......|+..|+|||+..+..++.++|+||||+++|||++|..||....... ....+.......   
T Consensus       148 ~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~~~~~~~~~---  220 (285)
T cd05632         148 LAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREEVDRRVLET---  220 (285)
T ss_pred             cceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhhcc---
Confidence            987643322   1224578999999999988889999999999999999999999997542211 011111100000   


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                       ........+      ....+++..|+++||++||+     +.+++++
T Consensus       221 -~~~~~~~~~------~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 -EEVYSAKFS------EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -ccccCccCC------HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence             001111111      12345778899999999999     6677663

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-34  Score=313.70  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=192.6

Q ss_pred             eeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCC
Q 039419          693 VVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      .||+|+||.||+|.++   +++.+|+|++.......            ...+.+.+|+.++++++||||+++++++. .+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~   68 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP------------ALKDELLREANVMQQLDNPYIVRMIGICE-AE   68 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcH------------HHHHHHHHHHHHHHhCCCCCcceEEEEEc-CC
Confidence            5899999999999653   57889999986432211            13567899999999999999999999875 45


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..++||||+++|+|.+++....  .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||.++
T Consensus        69 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~  143 (257)
T cd05116          69 SWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSK  143 (257)
T ss_pred             CcEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcccc
Confidence            6789999999999999997654  388999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhh
Q 039419          850 LVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVL  927 (1035)
Q Consensus       850 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1035)
                      ........ .......++..|+|||......++.++|||||||++|||++ |..||.....  ......+....    . 
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~~~----~-  216 (257)
T cd05116         144 ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESGE----R-  216 (257)
T ss_pred             ccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHCCC----C-
Confidence            66443221 11123345678999999888889999999999999999998 9999975422  12222222110    0 


Q ss_pred             cccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       928 ~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                       .......+      ..+.+++.+||++||++||++.+|++.|+.
T Consensus       217 -~~~~~~~~------~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 -MECPQRCP------PEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             -CCCCCCCC------HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence             00111111      223458888999999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-34  Score=334.75  Aligned_cols=259  Identities=19%  Similarity=0.237  Sum_probs=195.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..|.+.+.||+|+||.||+|.+.. ++.||||...                    ...+.+|++++++++|||||+++++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------------------~~~~~~E~~iL~~L~HpnIv~l~~~  228 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------------------YASSVHEARLLRRLSHPAVLALLDV  228 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------------------ccCHHHHHHHHHHCCCCCCCcEEEE
Confidence            358888999999999999997764 7889999642                    1236689999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +...+..++|||++ .++|.+++.... ..+++..+..++.||++||+|||+.   ||+||||||+|||++.++.+||+|
T Consensus       229 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~D  303 (461)
T PHA03211        229 RVVGGLTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGD  303 (461)
T ss_pred             EEECCEEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcc
Confidence            99999999999999 578988886543 2489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC------CCchhHHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI------PEGLHIVDWVR  918 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~------~~~~~~~~~~~  918 (1035)
                      ||+++...............||..|+|||++.+..++.++|||||||++|||++|..|+-...      +....+...+.
T Consensus       304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~  383 (461)
T PHA03211        304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR  383 (461)
T ss_pred             cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence            999986644322222234679999999999999999999999999999999999887653221      11122222322


Q ss_pred             Hhccchhhhccc--------------ccCCCccc-------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKS--------------LRARPEVE-------IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~--------------~~~~~~~~-------~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ........+...              ....+...       ........+++.+||+.||.+|||+.|++++
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            211100000000              00000000       0111234568889999999999999999885

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.3e-34  Score=313.44  Aligned_cols=248  Identities=26%  Similarity=0.375  Sum_probs=197.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|... |+.||+|.+....                ..+.+.+|+.++++++|||++++++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----------------~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQLLGVI   68 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----------------hHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            56888899999999999999776 7889999874321                245788999999999999999999976


Q ss_pred             E-cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          766 W-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       766 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      . +.+..|+||||+++++|.++++......+++..+..++.|++.||+|||+.   |++||||||+||+++.++.+|++|
T Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d  145 (256)
T cd05082          69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSD  145 (256)
T ss_pred             EcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecC
Confidence            5 456789999999999999999876665689999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++......     ....++..|+|||+..+..++.++||||||+++|||++ |+.||.....  .....++....  
T Consensus       146 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~--  216 (256)
T cd05082         146 FGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY--  216 (256)
T ss_pred             CccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC--
Confidence            99987543321     23345678999999988889999999999999999998 9999864321  11222221110  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                          ........      .....+++.+|++.+|++||++.++++.|++
T Consensus       217 ----~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         217 ----KMDAPDGC------PPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ----CCCCCCCC------CHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                00011111      1234557888999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.6e-35  Score=318.90  Aligned_cols=255  Identities=28%  Similarity=0.474  Sum_probs=198.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|...+.||+|+||.||+|...      ++..+|+|.+.....              ...+.+.+|++++++++||||+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~   70 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--------------SARQDFQREAELLTVLQHQHIV   70 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH--------------HHHHHHHHHHHHHhcCCCCCCc
Confidence            45677889999999999999642      356789998753221              1246799999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccC
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRD  826 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrD  826 (1035)
                      ++++++.+.+..+++|||+++++|.+++...+.             ..+++..+..++.|++.|++|||+.   +++|||
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~d  147 (280)
T cd05092          71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRD  147 (280)
T ss_pred             eEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence            999999999999999999999999999876432             2478899999999999999999998   999999


Q ss_pred             CCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 039419          827 IKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP  905 (1035)
Q Consensus       827 ikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~  905 (1035)
                      |||+||++++++.+||+|||+++...............+++.|+|||+..+..++.++|||||||++|||++ |..||..
T Consensus       148 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  227 (280)
T cd05092         148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ  227 (280)
T ss_pred             ccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence            999999999999999999999976544332222233446788999999988889999999999999999998 8999864


Q ss_pred             CCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          906 TIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      ....  ..........      .   ...+. ..  .....+++.+||+.||++||++.++++.|+
T Consensus       228 ~~~~--~~~~~~~~~~------~---~~~~~-~~--~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         228 LSNT--EAIECITQGR------E---LERPR-TC--PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             CCHH--HHHHHHHcCc------c---CCCCC-CC--CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            3221  1111111100      0   00011 11  112346788899999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.7e-35  Score=314.34  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=199.8

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|+..+.||+|+||.||++.+. +++.||+|.+......             ...+.+.+|+.++++++||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   67 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-------------SAVEDSRKEAVLLAKMKHPNIVAFKESF   67 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-------------HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            3677889999999999999766 5899999998543211             1246788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..|+||||+++|+|.+++.......++...+..++.|++.|+.|||+.   +|+|+||||+||+++.++.++++||
T Consensus        68 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~df  144 (255)
T cd08219          68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDF  144 (255)
T ss_pred             EECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEccc
Confidence            9999999999999999999998765555688999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |.+........  ......|++.|+|||+..+..++.++|+||||+++|+|++|..||......  .....+..  ..  
T Consensus       145 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~--~~--  216 (255)
T cd08219         145 GSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--NLILKVCQ--GS--  216 (255)
T ss_pred             Ccceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--HHHHHHhc--CC--
Confidence            99876543221  223457899999999998888999999999999999999999999753211  11111100  00  


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           ....+. ..  .....+++.+||+.||++||++.+++..
T Consensus       217 -----~~~~~~-~~--~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -----YKPLPS-HY--SYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -----CCCCCc-cc--CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                 000011 11  1234467888999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.2e-35  Score=326.50  Aligned_cols=205  Identities=25%  Similarity=0.279  Sum_probs=173.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||+||+|+.+ +++.||+|++........           ...+.+.+|+.++..++|++|++++++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~l~~~   69 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKR-----------AETACFREERNVLVNGDCQWITTLHYA   69 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhh-----------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            36888899999999999999776 578899999854211111           124568889999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.+++.... ..+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|
T Consensus        70 ~~~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~D  145 (331)
T cd05624          70 FQDENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLAD  145 (331)
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEe
Confidence            999999999999999999999997643 2378899999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ||+++....... .......||+.|+|||++.+     ..++.++|||||||++|||++|+.||...
T Consensus       146 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         146 FGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence            999986644322 12234579999999998765     46788999999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.8e-34  Score=319.61  Aligned_cols=259  Identities=25%  Similarity=0.383  Sum_probs=198.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-Cc--EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GE--VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  761 (1035)
                      ++|.+.+.||+|+||.||+|..++ +.  .+++|.++.....             ...+.+.+|+.+++++ +||||+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~E~~~l~~l~~hp~iv~~   68 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-------------NDHRDFAGELEVLCKLGHHPNIINL   68 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH-------------HHHHHHHHHHHHHHhhcCCCchhhe
Confidence            468888999999999999997654 33  4688877532111             1245789999999999 79999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCC
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI  827 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDi  827 (1035)
                      ++++.+.+..|+||||+++++|.++++....              ..+++..+..++.|++.|++|||+.   +|+||||
T Consensus        69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dl  145 (297)
T cd05089          69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDL  145 (297)
T ss_pred             EEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcC
Confidence            9999999999999999999999999975431              2478899999999999999999998   9999999


Q ss_pred             CcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 039419          828 KANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT  906 (1035)
Q Consensus       828 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~  906 (1035)
                      ||+||+++.++.+||+|||++......   ........+..|+|||+..+..++.++|||||||++|||++ |..||...
T Consensus       146 kp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~  222 (297)
T cd05089         146 AARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM  222 (297)
T ss_pred             CcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999999998643211   11112233567999999888889999999999999999997 99999754


Q ss_pred             CCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ...  .   .....       ........+...  .....+++.+||+.+|.+||+++++++.|+.+....
T Consensus       223 ~~~--~---~~~~~-------~~~~~~~~~~~~--~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         223 TCA--E---LYEKL-------PQGYRMEKPRNC--DDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CHH--H---HHHHH-------hcCCCCCCCCCC--CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            321  1   11111       000110011111  123456888899999999999999999998886544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-34  Score=315.77  Aligned_cols=255  Identities=24%  Similarity=0.283  Sum_probs=197.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....              ...+.+.+|+.++++++||||+++++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~ii~~~~   73 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--------------DDFSLIQQEIFMVKECKHCNIVAYFG   73 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--------------chHHHHHHHHHHHHhcCCCCeeeeeE
Confidence            356888999999999999999764 588999999854321              11346789999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++..++..|+||||+++++|.++++...  .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+
T Consensus        74 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~  148 (267)
T cd06646          74 SYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLA  148 (267)
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEC
Confidence            9999999999999999999999987654  378999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |||+++......  .......|+..|+|||...   ...++.++||||+||++|||++|+.||....+.... ..+.   
T Consensus       149 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~---  222 (267)
T cd06646         149 DFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMS---  222 (267)
T ss_pred             cCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeee---
Confidence            999998664322  1123456889999999864   445778999999999999999999998643221100 0000   


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      .  .....+.....    ......+.+++.+||+.||++||+++++++++
T Consensus       223 ~--~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         223 K--SNFQPPKLKDK----TKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             c--CCCCCCCCccc----cccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0  00000000000    01112345678889999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.7e-34  Score=315.21  Aligned_cols=257  Identities=25%  Similarity=0.436  Sum_probs=199.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-C---cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-G---EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+|...+.||+|+||.||+|.++. +   ..||||++......             ...++|..|+.++++++||||+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni~~~   70 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE-------------KQRRDFLSEASIMGQFDHPNIIHL   70 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH-------------HHHHHHHHHHHHHHhCCCcCcceE
Confidence            457788999999999999997653 3   36999998643211             125689999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+++..++||||+++++|.++++... ..+++..+..++.|++.|++|||+.   |++||||||+||+++.++.++
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~k  146 (269)
T cd05065          71 EGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (269)
T ss_pred             EEEECCCCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEE
Confidence            999999999999999999999999987643 3488999999999999999999998   999999999999999999999


Q ss_pred             EeeccCccccccCCcccccc-cc--CCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHH
Q 039419          842 IADFGLAKLVVEGDFARSSN-TV--AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~-~~--~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~  917 (1035)
                      ++|||+++............ ..  .++..|+|||+..+..++.++|||||||++||+++ |..||.....  .....++
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i  224 (269)
T cd05065         147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAI  224 (269)
T ss_pred             ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHH
Confidence            99999988664432211111 11  12457999999988899999999999999999886 9999965422  1222232


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ...          .....+...  .....+++.+||.++|++||++.++++.|+.+
T Consensus       225 ~~~----------~~~~~~~~~--~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 EQD----------YRLPPPMDC--PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HcC----------CcCCCcccC--CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111          000001111  12234578889999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.2e-34  Score=310.59  Aligned_cols=248  Identities=25%  Similarity=0.421  Sum_probs=195.6

Q ss_pred             CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcc
Q 039419          692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR  771 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  771 (1035)
                      ++||+|+||.||+|...+++.||+|.+......             .....+.+|++++++++||||+++++++...+..
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   67 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-------------ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPI   67 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCH-------------HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCcc
Confidence            368999999999998888899999998643211             1245788999999999999999999999999999


Q ss_pred             eEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcccc
Q 039419          772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV  851 (1035)
Q Consensus       772 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~  851 (1035)
                      ++||||+++++|.+++.... ..+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||++...
T Consensus        68 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  143 (250)
T cd05085          68 YIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQE  143 (250)
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceec
Confidence            99999999999999987543 3478999999999999999999998   9999999999999999999999999998754


Q ss_pred             ccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhhccc
Q 039419          852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS  930 (1035)
Q Consensus       852 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (1035)
                      ..... .......++..|+|||+..+..++.++||||||+++||+++ |..||......  .....+..          .
T Consensus       144 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~----------~  210 (250)
T cd05085         144 DDGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEK----------G  210 (250)
T ss_pred             ccccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHc----------C
Confidence            33221 11122345678999999988889999999999999999998 99999654221  11111111          0


Q ss_pred             ccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       931 ~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      .....+..  ......+++.+|+..+|++||++.++++.|.
T Consensus       211 ~~~~~~~~--~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         211 YRMSCPQK--CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCC--CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            00000111  1123456888999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=3.7e-37  Score=332.89  Aligned_cols=369  Identities=26%  Similarity=0.358  Sum_probs=257.8

Q ss_pred             eEEEEecccccc-ccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcc
Q 039419          177 LLVVGLADTKVA-GSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLW  255 (1035)
Q Consensus       177 L~~L~l~~~~~~-~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~  255 (1035)
                      .+-+++++|.++ +..|..+..|++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+...++.|+.|+.+.+.
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R   86 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR   86 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence            344445555554 445666666666666666666665 56666666666666666666666 555666677777777777


Q ss_pred             cccccc-cCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhh
Q 039419          256 QNNFDG-AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVF  334 (1035)
Q Consensus       256 ~n~l~~-~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l  334 (1035)
                      +|++.. -+|..+..+..|+.||||+|+++ ..|..+..-+++-.|+||+|+|..++...|.+++.|-.|+|++|++.  
T Consensus        87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe--  163 (1255)
T KOG0444|consen   87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE--  163 (1255)
T ss_pred             ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh--
Confidence            777642 35666677777777777777777 56777777777777777777777666666677777777777777776  


Q ss_pred             hhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccc-cCCCCCCCCCCcceeEeeeccCC
Q 039419          335 FAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGIS-GLIPPEIGNCSSLIRLRLMSFGN  413 (1035)
Q Consensus       335 ~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~~~~~~~  413 (1035)
                               .+|..+..+..|++|+|++|.+....-..+-.+++|+.|.+++.+-+ .-+|..+              .+
T Consensus       164 ---------~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl--------------d~  220 (1255)
T KOG0444|consen  164 ---------MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL--------------DD  220 (1255)
T ss_pred             ---------hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCch--------------hh
Confidence                     34666777777777777777776333333444556666667665433 2234333              33


Q ss_pred             CCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEE
Q 039419          414 CTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLD  493 (1035)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  493 (1035)
                      +.+|..+|||.|.+. .+|+.+..+++|+.|+||+|+|+.+ ........+|++|+||.|+++ .+|+.+.++++|+.|+
T Consensus       221 l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL-~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy  297 (1255)
T KOG0444|consen  221 LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL-NMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLY  297 (1255)
T ss_pred             hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee-eccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHH
Confidence            455777788888887 7778888888888888888888754 334455567788888888887 7778888888888888


Q ss_pred             cCCCcCc-CccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCc
Q 039419          494 LSSNKLS-GKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT  572 (1035)
Q Consensus       494 Ls~N~l~-~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~  572 (1035)
                      +.+|+++ .-||..++.+..+. .+..++|.+. ..|+.+..+.+|+.|.|++|+|-..|.++.-++.|+.|||..|+=-
T Consensus       298 ~n~NkL~FeGiPSGIGKL~~Le-vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  298 ANNNKLTFEGIPSGIGKLIQLE-VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             hccCcccccCCccchhhhhhhH-HHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCc
Confidence            8888776 34677777666554 4667777776 7888888899999999999999888988888899999999999866


Q ss_pred             ccCCCh
Q 039419          573 GYLPDS  578 (1035)
Q Consensus       573 ~~~p~~  578 (1035)
                      ..+|.+
T Consensus       376 VMPPKP  381 (1255)
T KOG0444|consen  376 VMPPKP  381 (1255)
T ss_pred             cCCCCc
Confidence            666654

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.3e-34  Score=312.36  Aligned_cols=254  Identities=24%  Similarity=0.431  Sum_probs=202.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++|...+.||+|+||.||+|.+.++..+|+|.+.....               ..+.+.+|++++++++|+||++++++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~~~   69 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------------SVEAFLAEANVMKTLQHDKLVKLHAV   69 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh---------------HHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            467888999999999999999888888899998864211               14578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+ ...+++|||+++++|.+++.......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|
T Consensus        70 ~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d  145 (260)
T cd05073          70 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD  145 (260)
T ss_pred             EcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECC
Confidence            887 7789999999999999999876555688999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.+........ .......++..|+|||+.....++.++|+|||||++|++++ |..||.....  .....++..... 
T Consensus       146 ~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~~-  221 (260)
T cd05073         146 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR-  221 (260)
T ss_pred             CcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCC-
Confidence            999976543321 11223346678999999988889999999999999999999 9999964322  122222211100 


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                             .. .+.   .......+++.+|++++|++||++.++.+.|+.
T Consensus       222 -------~~-~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 -------MP-RPE---NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -------CC-Ccc---cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                   00 001   111234567888999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.2e-35  Score=338.38  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=189.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|... .++.||||++...                  .....+|+.+++.++|||||+++++
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------------------~~~~~~Ei~il~~l~h~niv~l~~~  127 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------------------PQYKNRELLIMKNLNHINIIFLKDY  127 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------------------cchHHHHHHHHHhcCCCCCcceeee
Confidence            57899999999999999999775 5889999988432                  1234579999999999999999998


Q ss_pred             EEcC--------CcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE
Q 039419          765 CWNR--------NTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       765 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll  834 (1035)
                      +...        ...++||||++ +++.+++...  ....+++..+..++.||+.||+|||+.   +|+||||||+||++
T Consensus       128 ~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl  203 (440)
T PTZ00036        128 YYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLI  203 (440)
T ss_pred             EeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEE
Confidence            7532        13568999996 5787776532  234589999999999999999999999   99999999999999


Q ss_pred             cCCC-ceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          835 GPEF-EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       835 ~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      +.++ .+||+|||+|+......   ......||+.|+|||++.+ ..++.++|||||||++|||++|..||...... ..
T Consensus       204 ~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~  279 (440)
T PTZ00036        204 DPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQ  279 (440)
T ss_pred             cCCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HH
Confidence            9665 69999999998764432   1234578999999998765 46899999999999999999999999754321 11


Q ss_pred             HHHHHHHhcc-chhhh---ccc-----ccCCCcccHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          913 IVDWVRQKRG-AIEVL---DKS-----LRARPEVEIE------EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       913 ~~~~~~~~~~-~~~~~---~~~-----~~~~~~~~~~------~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +...+..... ..+..   .+.     ..........      ....+.+++.+||..||.+|||+.|++++
T Consensus       280 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            1111111000 00000   000     0000000000      11245678889999999999999999975

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-34  Score=320.64  Aligned_cols=255  Identities=22%  Similarity=0.361  Sum_probs=200.9

Q ss_pred             HHHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          681 VEQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       681 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      +.+..++|...+.||+|+||.||+|... +++.||+|.+......              ..+.+.+|+.+++.++||||+
T Consensus        15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~v~   80 (296)
T cd06654          15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------------KKELIINEILVMRENKNPNIV   80 (296)
T ss_pred             cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--------------hHHHHHHHHHHHHhCCCCCEe
Confidence            3344567888899999999999999764 5899999998643221              235788999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++++++......|+||||+++++|.+++...   .+++.++..++.|++.||+|||+.   ||+||||||+||+++.++.
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~  154 (296)
T cd06654          81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGS  154 (296)
T ss_pred             eEEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            9999999999999999999999999998653   378899999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ++|+|||.+.......  .......|++.|+|||...+..++.++|||||||++|+|++|+.||....+... ...+.. 
T Consensus       155 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~-  230 (296)
T cd06654         155 VKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIAT-  230 (296)
T ss_pred             EEECccccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhc-
Confidence            9999999987654322  112245688999999998888899999999999999999999999975433211 111110 


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        ..    .+....  +....  ..+.+++.+||.+||++||++.+++++
T Consensus       231 --~~----~~~~~~--~~~~~--~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         231 --NG----TPELQN--PEKLS--AIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             --CC----CCCCCC--ccccC--HHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence              00    000000  11111  223457888999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.4e-34  Score=313.48  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=201.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+|++.+.||+|+||.||+|.+.    .+..+|+|.+......             ...+.+.+|+.++++++||||+++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~   70 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE-------------KQRRDFLSEASIMGQFDHPNIIHL   70 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH-------------HHHHHHHHHHHHHHhCCCCCcceE
Confidence            46788899999999999999764    2347999988643221             124678999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+++..|+||||+++++|.+++.... ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++
T Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~  146 (267)
T cd05066          71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCK  146 (267)
T ss_pred             EEEEecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEE
Confidence            999999999999999999999999997654 3478999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccc-cccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDFAR-SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ++|||.++......... ......++..|+|||+..+..++.++||||||+++||+++ |..||......  .....+..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~  224 (267)
T cd05066         147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEE  224 (267)
T ss_pred             eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhC
Confidence            99999998765432111 1112234568999999988889999999999999999886 99999654321  12222211


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ..      ..  . .+ .  .......+++.+|++++|++||++.++++.|+++
T Consensus       225 ~~------~~--~-~~-~--~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 GY------RL--P-AP-M--DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CC------cC--C-CC-C--CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            10      00  0 00 0  1112335678889999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-34  Score=317.62  Aligned_cols=263  Identities=22%  Similarity=0.241  Sum_probs=193.1

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC---CCCceeeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI---RHKNIVRFL  762 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~  762 (1035)
                      +|+..+.||+|+||+||+|.++ +++.||+|.+........            ....+.+|+++++++   +||||++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~h~ni~~~~   68 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG------------LPLSTVREVALLKRLEAFDHPNIVRLM   68 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC------------CchHHHHHHHHHHHhhhcCCCCeeeee
Confidence            4778889999999999999776 588999999865322211            123466788777766   699999999


Q ss_pred             eEEEcC-----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          763 GCCWNR-----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       763 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      +++...     ...++||||+. ++|.+++.......+++..+..++.|++.||+|||+.   ||+||||||+||+++.+
T Consensus        69 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~  144 (288)
T cd07863          69 DVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSG  144 (288)
T ss_pred             eeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence            988642     35789999996 5899998776555689999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||+++......   ......||..|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus       145 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~  220 (288)
T cd07863         145 GQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIF  220 (288)
T ss_pred             CCEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHH
Confidence            999999999998664322   123456899999999998888999999999999999999999999654221 1111111


Q ss_pred             HHhcc-chhhh-------cccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRG-AIEVL-------DKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~-~~~~~-------~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..... .....       .............     ......+++.+|+++||++||++.|++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            10000 00000       0000000000000     11223568889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.6e-35  Score=315.36  Aligned_cols=255  Identities=30%  Similarity=0.428  Sum_probs=198.9

Q ss_pred             cccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |+..+.||+|+||+||+|+... ++.||+|++........            ......+|+.++++++||||+++++++.
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~   68 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE------------EREENIREIKILRRLRHPNIVQILDVFQ   68 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH------------HHHHHHHHHHHHHHHTBTTBCHEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc------------ccchhhhhhhcccccccccccccccccc
Confidence            5677899999999999998775 67899999976543332            1233456999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +....++||||+++++|.+++.....  +++..+..++.|+++||++||+.   +|+||||||+||+++.++.++|+|||
T Consensus        69 ~~~~~~~v~~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg  143 (260)
T PF00069_consen   69 DDNYLYIVMEYCPGGSLQDYLQKNKP--LSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFG  143 (260)
T ss_dssp             ESSEEEEEEEEETTEBHHHHHHHHSS--BBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGT
T ss_pred             cccccccccccccccccccccccccc--ccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            99999999999999999999984433  89999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      .+......  ........++..|+|||+.. +..++.++||||+|+++|+|++|..||.....  .............  
T Consensus       144 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~--  217 (260)
T PF00069_consen  144 SSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKR--  217 (260)
T ss_dssp             TTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHT--
T ss_pred             cccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcccc--
Confidence            98764111  22334567899999999988 88899999999999999999999999985411  1111111111100  


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ........  .  ......+.+++.+||+.||++||++.+++++
T Consensus       218 ~~~~~~~~--~--~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  218 PLPSSSQQ--S--REKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHHTTS--H--TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccccccc--c--chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000000  0  0001345668888999999999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.9e-34  Score=310.71  Aligned_cols=249  Identities=23%  Similarity=0.376  Sum_probs=192.1

Q ss_pred             eeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCC
Q 039419          693 VVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      .||+|+||.||+|.+.   ++..||+|++......             ...+.+.+|+.++++++||||+++++++. .+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~   67 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK-------------SVRDEMMREAEIMHQLDNPYIVRMIGVCE-AE   67 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh-------------HHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CC
Confidence            3899999999999664   3567999988653211             13467999999999999999999999875 45


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..++||||+++++|.+++.... ..+++..+.+++.|++.|++|||++   +++||||||+||+++.++.+||+|||+++
T Consensus        68 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          68 ALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             CeEEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence            7899999999999999987543 3489999999999999999999998   99999999999999999999999999998


Q ss_pred             ccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhh
Q 039419          850 LVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVL  927 (1035)
Q Consensus       850 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1035)
                      ........ .......++..|+|||+..+..++.++||||||+++||+++ |..||....+.  .....+....      
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~------  215 (257)
T cd05115         144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQGK------  215 (257)
T ss_pred             cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHCCC------
Confidence            65443221 11122334678999999888889999999999999999996 99999754221  1222221110      


Q ss_pred             cccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       928 ~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                          ....+.  .....+.+++.+||..||++||++.+|.+.|+.+
T Consensus       216 ----~~~~~~--~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 ----RLDCPA--ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ----CCCCCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                000111  1112334578889999999999999999988764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-35  Score=329.78  Aligned_cols=244  Identities=25%  Similarity=0.288  Sum_probs=185.0

Q ss_pred             eeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC---CCCceeeEEeEEEcCC
Q 039419          694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI---RHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~  769 (1035)
                      ||+|+||+||+|+.. +++.||||++........           .....+..|..++.+.   +||||+++++++.+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~   69 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-----------KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS   69 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh-----------hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC
Confidence            699999999999765 589999999854322111           1133455677777665   6999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|.+++...+.  +++..+..++.||++||+|||+.   +|+||||||+|||++.++.++|+|||+++
T Consensus        70 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~  144 (330)
T cd05586          70 DLYLVTDYMSGGELFWHLQKEGR--FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK  144 (330)
T ss_pred             eEEEEEcCCCCChHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCc
Confidence            99999999999999999876543  89999999999999999999999   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD  928 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  928 (1035)
                      ......  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||......  .....+..  ..     
T Consensus       145 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--~~~~~i~~--~~-----  213 (330)
T cd05586         145 ANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QMYRNIAF--GK-----  213 (330)
T ss_pred             CCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--HHHHHHHc--CC-----
Confidence            543322  223356799999999987654 4789999999999999999999999754221  11111110  00     


Q ss_pred             ccccCCCcccHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHH
Q 039419          929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP----TMKDVAAM  969 (1035)
Q Consensus       929 ~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP----s~~el~~~  969 (1035)
                        ... +...+.  ....+++.+||++||++||    ++.+++++
T Consensus       214 --~~~-~~~~~~--~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         214 --VRF-PKNVLS--DEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             --CCC-CCccCC--HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence              000 000111  1234577889999999998    56666653

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=316.83  Aligned_cols=249  Identities=29%  Similarity=0.398  Sum_probs=194.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +-|...+-||.|+||.||.|++. +.+.||||++.........           --.++.+|+..+++++|||+|.+.|+
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~E-----------KWqDIlKEVrFL~~l~HPntieYkgC   94 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-----------KWQDILKEVRFLRQLRHPNTIEYKGC   94 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHH-----------HHHHHHHHHHHHHhccCCCcccccce
Confidence            34555678999999999999665 5889999999653322211           12578999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |..+.+.|+||||| -||-.+++...+ +++.+-.+..|..+.++||+|||+.   +.||||||..|||+++.|.||++|
T Consensus        95 yLre~TaWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaD  169 (948)
T KOG0577|consen   95 YLREHTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLAD  169 (948)
T ss_pred             eeccchHHHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeecc
Confidence            99999999999999 568888876654 3478888899999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ||.|....+      .+.++|||.|||||++.   .+.|+-++||||+|++..|+...++|+-....    +....+-..
T Consensus       170 FGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALYHIAQ  239 (948)
T KOG0577|consen  170 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQ  239 (948)
T ss_pred             ccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHHHHHh
Confidence            999987644      34789999999999864   56799999999999999999999999753311    111111111


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..    .+.+...     +-...+..++-.|+++-|.+|||.++++.+
T Consensus       240 Ne----sPtLqs~-----eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  240 NE----SPTLQSN-----EWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             cC----CCCCCCc-----hhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            11    0111111     111123457778999999999999998874

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.5e-34  Score=318.85  Aligned_cols=256  Identities=29%  Similarity=0.488  Sum_probs=199.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|...+.||+|+||.||+|...      +++.||+|++......             ...+.+.+|+.++++++||||+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~ei~~l~~l~h~~iv   71 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------------DMQADFQREAALMAEFDHPNIV   71 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH-------------HHHHHHHHHHHHHHhcCCCchh
Confidence            56888899999999999999763      4678999998643221             1246789999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------------CCCCHHHHHHHHHHHHHHHHHhhccCC
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------------SCLEWELRYRIILGAAQGLAYLHHDCV  819 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~  819 (1035)
                      ++++++.+.+..++||||+++|+|.+++.....                    ..+++..++.++.|++.||+|||+.  
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~--  149 (288)
T cd05050          72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER--  149 (288)
T ss_pred             eEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--
Confidence            999999999999999999999999999975321                    2367888999999999999999998  


Q ss_pred             CCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-
Q 039419          820 PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-  898 (1035)
Q Consensus       820 ~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-  898 (1035)
                       +++||||||+||+++.++.++|+|||.++...............++..|+|||...+..++.++|||||||++|||++ 
T Consensus       150 -~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~  228 (288)
T cd05050         150 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  228 (288)
T ss_pred             -CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhC
Confidence             999999999999999999999999999876543322222223345678999999888899999999999999999998 


Q ss_pred             CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          899 GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       899 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      |..||......  .....+...         .....+..   ....+.+++.+|++.||++||++.|+++.|+
T Consensus       229 ~~~p~~~~~~~--~~~~~~~~~---------~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         229 GMQPYYGMAHE--EVIYYVRDG---------NVLSCPDN---CPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCCCCCCCCHH--HHHHHHhcC---------CCCCCCCC---CCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            88888643221  111111110         00011111   1123456888999999999999999999876

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.3e-34  Score=320.24  Aligned_cols=259  Identities=23%  Similarity=0.374  Sum_probs=198.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|.+.+.||+|+||.||+|.+. ++..||+|.+......             ...+++.+|++++++++||||+++++++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   68 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP-------------AIRNQIIRELKVLHECNSPYIVGFYGAF   68 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH-------------HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            5788899999999999999765 5788999988643211             1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..|+||||+++++|.++++..+.  +++..+..++.|+++||.|||+..  +++||||||+||+++.++.++|+||
T Consensus        69 ~~~~~~~lv~ey~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~df  144 (308)
T cd06615          69 YSDGEISICMEHMDGGSLDQVLKKAGR--IPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDF  144 (308)
T ss_pred             eeCCEEEEEeeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccC
Confidence            999999999999999999999976543  889999999999999999999731  8999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch-
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI-  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-  924 (1035)
                      |++.......    .....|+..|+|||+..+..++.++||||||+++|||++|+.||......  ....+........ 
T Consensus       145 g~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~  218 (308)
T cd06615         145 GVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGE  218 (308)
T ss_pred             CCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCcccccc
Confidence            9987553321    23457899999999988888999999999999999999999998643211  1111111000000 


Q ss_pred             ----------------------hhhccccc----CCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          925 ----------------------EVLDKSLR----ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       925 ----------------------~~~~~~~~----~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                                            +..+....    ..+...  ......+++.+||..||++||++.+++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGA--FSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcc--cCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                                  00000000    000000  112345688999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-34  Score=313.38  Aligned_cols=257  Identities=28%  Similarity=0.422  Sum_probs=199.3

Q ss_pred             ccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      +|...+.||+|+||+||+|...+++.+|+|.+..........        ....+.+.+|++++++++|+||+++++++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   72 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAA--------EKEYEKLQEEVDLLKSLKHVNIVQYLGTCL   72 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhH--------HHHHHHHHHHHHHHHhcCCCCEeeEeeEee
Confidence            367788999999999999988889999999986543221100        012457899999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +.+..++||||+++++|.+++.....  +++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg  147 (265)
T cd06631          73 DDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFG  147 (265)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccch
Confidence            99999999999999999999976543  78999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCC----ccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          847 LAKLVVEGD----FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       847 ~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      .++......    .........|+..|+|||+..+..++.++||||||+++|||++|+.||....... .. ..+.....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-~~-~~~~~~~~  225 (265)
T cd06631         148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-AM-FYIGAHRG  225 (265)
T ss_pred             hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-HH-HHhhhccC
Confidence            987653211    1111224568999999999988889999999999999999999999997432111 10 01110000


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                          ..+......      ......++.+||+++|++||++.++++
T Consensus       226 ----~~~~~~~~~------~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 ----LMPRLPDSF------SAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ----CCCCCCCCC------CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                001111111      122355788899999999999999876

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.5e-34  Score=314.24  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=194.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++......             ...+.+.+|+.++++++||||++++++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~   67 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITV-------------ELQKQIMSELEILYKCDSPYIIGFYGA   67 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCCh-------------HHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            35777889999999999999764 6889999998543211             124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +...+..++||||+++++|..+.      .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|
T Consensus        68 ~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~d  138 (279)
T cd06619          68 FFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCD  138 (279)
T ss_pred             EEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEee
Confidence            99999999999999999997552      267888899999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh--HHHHHHHhcc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH--IVDWVRQKRG  922 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~--~~~~~~~~~~  922 (1035)
                      ||++......    ......|+..|+|||+..+..++.++||||||+++|+|++|+.||.........  ...+....  
T Consensus       139 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--  212 (279)
T cd06619         139 FGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI--  212 (279)
T ss_pred             CCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH--
Confidence            9999765332    123457899999999998888999999999999999999999999653221110  01111100  


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          .+......+..  .......+++.+|++.||++||++++++++
T Consensus       213 ----~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 ----VDEDPPVLPVG--QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ----hccCCCCCCCC--cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                00000000010  011234567888999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-34  Score=310.82  Aligned_cols=250  Identities=29%  Similarity=0.488  Sum_probs=200.2

Q ss_pred             CeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          692 SVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      +.||+|+||.||+|....    +..||+|.+.......             ..+.+.+|++++++++|+||+++++++.+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   67 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-------------ERKDFLKEARVMKKLGHPNVVRLLGVCTE   67 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-------------HHHHHHHHHHHHhhcCCCChheeeeeecC
Confidence            468999999999997654    7889999986543221             24678999999999999999999999999


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERR-------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ....++||||+++++|.+++....       ...+++..+..++.|+++|++|||+.   +++||||||+||+++.++.+
T Consensus        68 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~  144 (262)
T cd00192          68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVV  144 (262)
T ss_pred             CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcE
Confidence            999999999999999999998752       24589999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +|+|||.+................++..|+|||......++.++||||+|+++|||++ |..||....+  ......+..
T Consensus       145 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~  222 (262)
T cd00192         145 KISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--EEVLEYLRK  222 (262)
T ss_pred             EEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc
Confidence            9999999987655432233345567889999999888889999999999999999999 6999975522  112222111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                         .      .....+.   .......+++.+||..+|++||++.|++++|+
T Consensus       223 ---~------~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ---G------YRLPKPE---YCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---C------CCCCCCc---cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               0      0000011   11234456888899999999999999998763

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3e-34  Score=313.13  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=184.5

Q ss_pred             eeeeeCCcEEEEEEECC---CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCC
Q 039419          693 VVGKGCSGIVYRAEMEN---GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      .||+|+||.||+|...+   ...+|+|.+......             .....|.+|+.+++.++||||+++++++.+..
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~   68 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP-------------DEQLLFLQEVQPYRELNHPNVLQCLGQCIESI   68 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh-------------HHHHHHHHHHHHHHhCCCCCcceEEEEECCCC
Confidence            58999999999996543   356888876432211             12457889999999999999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRD---SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      ..|+||||+++|+|.+++.....   ...++.....++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        69 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  145 (269)
T cd05042          69 PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYG  145 (269)
T ss_pred             ceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccc
Confidence            99999999999999999976542   2346778889999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccc-------cCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHH
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-------MMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~  918 (1035)
                      ++................++..|+|||+..       ...++.++|||||||++|||++ |..||....+.  .......
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~  223 (269)
T cd05042         146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQVV  223 (269)
T ss_pred             cccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHh
Confidence            987543332222223445677899999853       3457789999999999999999 78888644221  1111110


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      . ........+......+    .  ....++..|| .||++||++++|++.|
T Consensus       224 ~-~~~~~~~~~~~~~~~~----~--~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         224 R-EQDIKLPKPQLDLKYS----D--RWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             h-ccCccCCCCcccccCC----H--HHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            0 0001111111111111    1  1223556687 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=318.92  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=211.6

Q ss_pred             cccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      .....+||-|-||.||.|.|+. .-.||||.++.+.+.               .++|.+|+.+|+.++|||+|+++|+|.
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe---------------veEFLkEAAvMKeikHpNLVqLLGVCT  333 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------------VEEFLKEAAVMKEIKHPNLVQLLGVCT  333 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh---------------HHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence            3445789999999999999986 567999999765443               468999999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      .+...|||+|||..|+|.+|+++..+..++.-..+.++.||+.|++||..+   ++||||+..+|.|+.++..|||+|||
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence            999999999999999999999998887788888899999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      +++++..+.. .......-..-|.|||-+....++.|+|||+|||+|||+.| |..||.+.     +..+..       +
T Consensus       411 LsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqVY-------~  477 (1157)
T KOG4278|consen  411 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVY-------G  477 (1157)
T ss_pred             hhhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHHH-------H
Confidence            9998866543 33333445678999999888899999999999999999998 88898643     222111       2


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .+.+..+..-+..  +..+..++++.||++.|.+||++.|+-+.++.+..
T Consensus       478 LLEkgyRM~~PeG--CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEG--CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHhccccccCCCC--CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            3344444333322  22345678888999999999999999998877643

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-34  Score=328.68  Aligned_cols=201  Identities=25%  Similarity=0.296  Sum_probs=169.4

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.++|...+.||+|+||.||+|... .++.||||++.......            ...+.+.+|+.+++.++||||+++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~   81 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIISL   81 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh------------HHHHHHHHHHHHHHHhCCCchhce
Confidence            45688999999999999999999765 58899999986532211            124577899999999999999999


Q ss_pred             EeEEEcCC------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          762 LGCCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       762 ~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++....      ..|+||||+++ ++.+++..    .+++..+..++.|+++||+|||+.   ||+||||||+||+++
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~  153 (355)
T cd07874          82 LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK  153 (355)
T ss_pred             eeeeeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEC
Confidence            99886543      46999999965 67776643    278889999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      .++.+||+|||+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         154 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             CCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999998653321   223457899999999998889999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-34  Score=309.94  Aligned_cols=249  Identities=28%  Similarity=0.424  Sum_probs=201.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|... |+.||+|.+.....               ..+++.+|+.++++++|+||+++++++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~~~~   69 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---------------AAQAFLAEASVMTTLRHPNLVQLLGVV   69 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---------------HHHHHHHHHHHHHhcCCcceeeeEEEE
Confidence            46788899999999999999876 78999999865322               246789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||+++++|.++++......+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+||
T Consensus        70 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~  146 (256)
T cd05039          70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDF  146 (256)
T ss_pred             cCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccc
Confidence            9989999999999999999999876655689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++.......     ...++..|+|||+..+..++.++||||||+++||+++ |..||......  .....+....   
T Consensus       147 g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~---  216 (256)
T cd05039         147 GLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGY---  216 (256)
T ss_pred             ccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCC---
Confidence            99986633211     2345668999999888889999999999999999997 99999654221  1111111100   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                         ........      .....+++.+|+..+|++||++.++++.|+.
T Consensus       217 ---~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         217 ---RMEAPEGC------PPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---CCCCccCC------CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               00000111      1234567888999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-34  Score=323.38  Aligned_cols=196  Identities=26%  Similarity=0.365  Sum_probs=160.3

Q ss_pred             CCeeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          691 DSVVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      .++||+|+||+||+|+.+   +++.||+|.+....                ....+.+|+.++++++||||+++++++..
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~   69 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----------------ISMSACREIALLRELKHPNVISLQKVFLS   69 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----------------CcHHHHHHHHHHHhcCCCCCcceeeeEec
Confidence            468999999999999765   46789999985422                12357789999999999999999999865


Q ss_pred             --CCcceEEEEeCCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE----
Q 039419          768 --RNTRLLMYDYMPNGSLGSLLHERR-------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI----  834 (1035)
Q Consensus       768 --~~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll----  834 (1035)
                        ....|+||||+ +++|.+++....       ...+++..+..++.||+.||+|||+.   +|+||||||+|||+    
T Consensus        70 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~  145 (317)
T cd07868          70 HADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG  145 (317)
T ss_pred             CCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCC
Confidence              34678999998 468888875321       23488899999999999999999999   99999999999999    


Q ss_pred             cCCCceEEeeccCccccccCCc-cccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          835 GPEFEPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      +..+.+||+|||+++....... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            4567899999999987643321 112235678999999998876 45889999999999999999999999743

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-34  Score=316.89  Aligned_cols=261  Identities=26%  Similarity=0.385  Sum_probs=199.2

Q ss_pred             ccccCCeeeeeCCcEEEEEEE-----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEM-----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      -|.+.+.||+|+||.||+|+.     .+++.||+|.+......             ...+.+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~   71 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------------NHIADLKKEIEILRNLYHENIVKY   71 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH-------------HHHHHHHHHHHHHHhCCCCCeeee
Confidence            467788999999999999974     24788999998643211             124679999999999999999999


Q ss_pred             EeEEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          762 LGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       762 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++++.+.  ...++||||++|++|.+++.... ..+++..+..++.|++.||+|+|+.   |++||||||+||+++.++.
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  147 (284)
T cd05079          72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ  147 (284)
T ss_pred             eeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCC
Confidence            9998875  56789999999999999986543 2479999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC----------
Q 039419          840 PYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP----------  908 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~----------  908 (1035)
                      ++|+|||+++........ .......++..|+|||+..+..++.++||||||+++|||++++.|+.....          
T Consensus       148 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd05079         148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH  227 (284)
T ss_pred             EEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccc
Confidence            999999999866443211 112245577889999998888899999999999999999998876532210          


Q ss_pred             CchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          909 EGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      .......++..       .........+.  .....+.+++.+||++||++||++.++++.++++
T Consensus       228 ~~~~~~~~~~~-------~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         228 GQMTVTRLVRV-------LEEGKRLPRPP--NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccccHHHHHHH-------HHcCccCCCCC--CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00011111110       00000111111  1123456688899999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.2e-34  Score=311.99  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=196.6

Q ss_pred             CeeeeeCCcEEEEEEECC--C--cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          692 SVVGKGCSGIVYRAEMEN--G--EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      +.||+|+||.||+|.+.+  +  ..||+|.+......             ...+.+.+|+.++++++||||+++++++.+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   67 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT   67 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------------HHHHHHHHHHHHHhhcCCCCccceeEEEcC
Confidence            468999999999997653  3  36999998664432             135689999999999999999999999988


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                       ...++||||+++++|.+++.......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        68 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~  143 (257)
T cd05040          68 -HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGL  143 (257)
T ss_pred             -CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccc
Confidence             8889999999999999999876534589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          848 AKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       848 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      ++....... ........++..|+|||+..+..++.++|||||||++|||++ |..||......  +....+.....   
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~---  218 (257)
T cd05040         144 MRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDKEGE---  218 (257)
T ss_pred             cccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHhcCC---
Confidence            987644321 112223557889999999988899999999999999999998 99999643221  11111111000   


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                          . ...+.   .......+++.+|++.+|++||++.++++.|.
T Consensus       219 ----~-~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 ----R-LERPE---ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----c-CCCCc---cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                0 00111   11123456788899999999999999998774

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.8e-34  Score=312.21  Aligned_cols=257  Identities=25%  Similarity=0.436  Sum_probs=200.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-C---cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-G---EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+|...+.||+|+||.||+|..+. +   ..+|+|++.......             ..+.+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~i~~~   71 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK-------------QRQDFLSEASIMGQFSHHNIIRL   71 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH-------------HHHHHHHHHHHHhcCCCCCeeEE
Confidence            457778899999999999997653 3   379999886532211             24578899999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+.+..|+||||+++++|.+++.... ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~k  147 (268)
T cd05063          72 EGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECK  147 (268)
T ss_pred             EEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEE
Confidence            999999999999999999999999997643 3489999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccc-cccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDFAR-SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ++|||++.......... .......+..|+|||+..+..++.++|||||||++||+++ |+.||.....  ......+..
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~~~~i~~  225 (268)
T cd05063         148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAIND  225 (268)
T ss_pred             ECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhc
Confidence            99999987664332111 1112234567999999888889999999999999999997 9999964322  111111111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      .          .......  .......+++.+||..+|++||++.++++.|+++
T Consensus       226 ~----------~~~~~~~--~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 G----------FRLPAPM--DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C----------CCCCCCC--CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0          0000000  1112345688899999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-34  Score=308.77  Aligned_cols=249  Identities=27%  Similarity=0.426  Sum_probs=195.1

Q ss_pred             CeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          692 SVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      +.||+|+||.||+|.+..    +..||+|.+......             ...+++.+|++++++++||||+++++++. 
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   66 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------------AGKKEFLREASVMAQLDHPCIVRLIGVCK-   66 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-
Confidence            468999999999996532    368999998654322             12467899999999999999999999876 


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                      .+..++||||+++|+|.+++....  .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        67 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~  141 (257)
T cd05060          67 GEPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGM  141 (257)
T ss_pred             CCceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccc
Confidence            456799999999999999997655  489999999999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          848 AKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       848 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      ++........ .......++..|+|||...+..++.++||||||+++|||++ |..||....+  .....++......  
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~--  217 (257)
T cd05060         142 SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL--  217 (257)
T ss_pred             cceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC--
Confidence            9866443321 11112234568999999988899999999999999999998 9999975422  2233333221100  


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                             ..+. .  ......+++.+||.++|++||++.++++.|+.+
T Consensus       218 -------~~~~-~--~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 -------PRPE-E--CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -------CCCC-C--CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                   0111 1  112345688899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.5e-34  Score=312.35  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=199.1

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|.+.+.||+|+||.||+|... +++.||+|.+..........     .......+.+.+|+.++++++||||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSK-----DRKRSMLDALAREIALLKELQHENIVQYLGSS   75 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchh-----HHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            3677889999999999999764 58899999886543221100     00012346789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||+++++|.+++...+.  +++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+||
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          76 LDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EeCCccEEEEEecCCCCHHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEeccc
Confidence            999999999999999999999976543  78899999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCcc----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          846 GLAKLVVEGDFA----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       846 G~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |.++........    .......|+..|+|||...+..++.++||||+|+++|+|++|+.||......  .   .+....
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~---~~~~~~  225 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--Q---AIFKIG  225 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--H---HHHHHh
Confidence            999876532111    1112346889999999998888999999999999999999999999753211  1   111100


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ....+.....      .......++.+||++||++||++.|++++
T Consensus       226 ---~~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         226 ---ENASPEIPSN------ISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ---ccCCCcCCcc------cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence               0001111111      11233457788999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-34  Score=317.74  Aligned_cols=265  Identities=29%  Similarity=0.422  Sum_probs=196.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      +.|+..+.||+|+||.||+|..+     +++.||+|++.....              ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~   69 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--------------EHLRDFEREIEILKSLQHDNIVK   69 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCCCeeE
Confidence            35777889999999999999643     478999999864321              12457899999999999999999


Q ss_pred             EEeEEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          761 FLGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       761 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +++++...  ...++||||+++|+|.+++...+ ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++
T Consensus        70 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~  145 (284)
T cd05081          70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESEN  145 (284)
T ss_pred             EEEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCC
Confidence            99987543  46789999999999999997543 2388999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      .+||+|||+++........ .......++..|+|||+..+..++.++|||||||++|||++|..|+......   ....+
T Consensus       146 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~  222 (284)
T cd05081         146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMM  222 (284)
T ss_pred             eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhc
Confidence            9999999999876443221 1111223455799999988888999999999999999999998776432110   00000


Q ss_pred             HHhcc-------chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          918 RQKRG-------AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       918 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      .....       ..+.+........+...  .....+++.+||+++|++|||+.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         223 GNDKQGQMIVYHLIELLKNNGRLPAPPGC--PAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ccccccccchHHHHHHHhcCCcCCCCCCC--CHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000       00001111010011111  12345688899999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.5e-34  Score=328.78  Aligned_cols=262  Identities=22%  Similarity=0.276  Sum_probs=194.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|+..+.||+|+||.||+|... +++.||||++.......            ...+++.+|+.+++.++||||+++++++
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~~~~   68 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL------------VSCKRVFRELKMLCFFKHDNVLSALDIL   68 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccch------------HHHHHHHHHHHHHHhCCCCCcCCHhhee
Confidence            3677889999999999999764 68999999985421111            1245788999999999999999999999


Q ss_pred             EcCC-----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          766 WNRN-----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       766 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ...+     ..|+||||+. ++|.+++....  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus        69 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~  142 (372)
T cd07853          69 QPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVL  142 (372)
T ss_pred             cCCCccccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCE
Confidence            8776     7899999995 68888876543  389999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++....... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||....+..  ....+..
T Consensus       143 kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~  219 (372)
T cd07853         143 KICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITD  219 (372)
T ss_pred             EeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH
Confidence            9999999986543321 222345688999999987764 47899999999999999999999997543211  1111100


Q ss_pred             hcc-------------chhhhcccccCCCc------ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRG-------------AIEVLDKSLRARPE------VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~-------------~~~~~~~~~~~~~~------~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+             ....+.......+.      ..........+++.+|++.||++|||+.|++++
T Consensus       220 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         220 LLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            000             00000000000000      000011234568889999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4e-35  Score=342.27  Aligned_cols=257  Identities=24%  Similarity=0.368  Sum_probs=194.9

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ..+..+|++.+.||+||||.||+++.+ ||+.||||++..... +            .....+.+|+.++++|+|||||+
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s-~------------~~~skI~rEVk~LArLnHpNVVR  541 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKAS-D------------KLYSKILREVKLLARLNHPNVVR  541 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchH-H------------HHHHHHHHHHHHHhhcCCcceee
Confidence            456788889999999999999999877 899999999977652 1            12467899999999999999999


Q ss_pred             EEeEEEcC------------------------------------------------------------------------
Q 039419          761 FLGCCWNR------------------------------------------------------------------------  768 (1035)
Q Consensus       761 l~~~~~~~------------------------------------------------------------------------  768 (1035)
                      +|..+.+.                                                                        
T Consensus       542 YysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~  621 (1351)
T KOG1035|consen  542 YYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEEND  621 (1351)
T ss_pred             eehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccc
Confidence            97431100                                                                        


Q ss_pred             -----------------------------------------------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHH
Q 039419          769 -----------------------------------------------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY  801 (1035)
Q Consensus       769 -----------------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~  801 (1035)
                                                                     ...||-||||+..++.++++..... -.....+
T Consensus       622 d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~w  700 (1351)
T KOG1035|consen  622 DSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAW  700 (1351)
T ss_pred             cccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHH
Confidence                                                           0137889999888887777654321 1467889


Q ss_pred             HHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccc------c----------CCccccccccCC
Q 039419          802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV------E----------GDFARSSNTVAG  865 (1035)
Q Consensus       802 ~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~------~----------~~~~~~~~~~~g  865 (1035)
                      +++.+|+.||+|+|++   |||||||||.||+++.++.|||+|||+|+...      +          +......+..+|
T Consensus       701 rLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VG  777 (1351)
T KOG1035|consen  701 RLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVG  777 (1351)
T ss_pred             HHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccc
Confidence            9999999999999999   99999999999999999999999999998722      1          011123446789


Q ss_pred             cccccCCcccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHH
Q 039419          866 SYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEM  942 (1035)
Q Consensus       866 t~~y~aPE~~~~~---~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  942 (1035)
                      |..|+|||++.+.   .|+.|+|+||+|||++||+.   ||.....    .+..+..      ..+..++.......+.+
T Consensus       778 TalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----Ra~iL~~------LR~g~iP~~~~f~~~~~  844 (1351)
T KOG1035|consen  778 TALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----RASILTN------LRKGSIPEPADFFDPEH  844 (1351)
T ss_pred             eeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH----HHHHHHh------cccCCCCCCcccccccc
Confidence            9999999997654   49999999999999999985   5764321    1111111      11222222223344555


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          943 LQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       943 ~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      .....++.++++.||.+||||.|++.
T Consensus       845 ~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  845 PEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            66677899999999999999999976

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-34  Score=312.92  Aligned_cols=258  Identities=28%  Similarity=0.413  Sum_probs=201.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-Cc----EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GE----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .+|...+.||+|+||.||+|.+++ |+    .+|+|.+......             .....+.+|+.++++++||||++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~   73 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP-------------KANKEILDEAYVMASVDHPHVVR   73 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH-------------HHHHHHHHHHHHHHhCCCCCcce
Confidence            567888999999999999997653 33    5899987654321             12467889999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++.. +..++||||+++|+|.+++..... .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+
T Consensus        74 ~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~  148 (279)
T cd05057          74 LLGICLS-SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHV  148 (279)
T ss_pred             EEEEEec-CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeE
Confidence            9999987 788999999999999999976543 389999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||.++...............++..|+|||......++.++|+||||+++||+++ |+.||......  .+...+..
T Consensus       149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~  226 (279)
T cd05057         149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEK  226 (279)
T ss_pred             EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhC
Confidence            9999999987654322111122334678999999888889999999999999999998 99999754321  12222211


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ..        . ...+..   .......++.+||..||++||++.++++.++++.+
T Consensus       227 ~~--------~-~~~~~~---~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         227 GE--------R-LPQPPI---CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CC--------C-CCCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            00        0 011111   11234567888999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.7e-34  Score=327.54  Aligned_cols=201  Identities=25%  Similarity=0.306  Sum_probs=169.4

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.++|...+.||+|+||.||+|.+. .++.||||++.......            ...+.+.+|+.+++.++||||+++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~ii~~   88 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIIGL   88 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc------------hhHHHHHHHHHHHHhcCCCCcccc
Confidence            45688999999999999999999765 58899999986432211            124568899999999999999999


Q ss_pred             EeEEEcC------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          762 LGCCWNR------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       762 ~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++...      ...|+||||++ ++|.+++..    .+++..+..++.|+++||+|||++   +|+||||||+||+++
T Consensus        89 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  160 (364)
T cd07875          89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK  160 (364)
T ss_pred             ceeecccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEEC
Confidence            9987643      34699999996 477777743    278889999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      .++.+||+|||+++......   ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       161 ~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         161 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             CCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            99999999999998653321   223457899999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.4e-34  Score=314.03  Aligned_cols=250  Identities=28%  Similarity=0.435  Sum_probs=194.3

Q ss_pred             CeeeeeCCcEEEEEEECC-------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          692 SVVGKGCSGIVYRAEMEN-------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.||+|+||.||+|++.+       ++.+|+|.+......             .....+.+|+.++++++||||++++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD-------------QEKKEFLKEAHLMSNFNHPNIVKLLGV   67 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccch-------------hhHHHHHHHHHHHHhcCCCCeeeEeee
Confidence            368999999999997653       257899987543211             124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC-
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF-  838 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~-  838 (1035)
                      +...+..++||||+++++|.+++....     ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++ 
T Consensus        68 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~  144 (269)
T cd05044          68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGY  144 (269)
T ss_pred             ecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCC
Confidence            999999999999999999999997532     23478899999999999999999998   999999999999999887 


Q ss_pred             ----ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhH
Q 039419          839 ----EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHI  913 (1035)
Q Consensus       839 ----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~  913 (1035)
                          .++++|||+++...............++..|+|||+..+..++.++|||||||++|||++ |+.||.....  ...
T Consensus       145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~  222 (269)
T cd05044         145 DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEV  222 (269)
T ss_pred             CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHH
Confidence                899999999986644332222233456788999999998899999999999999999998 9999964321  122


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      ...+....          ....+....  ..+.+++.+||.++|++||++.++++.|+
T Consensus       223 ~~~~~~~~----------~~~~~~~~~--~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         223 LQHVTAGG----------RLQKPENCP--DKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHHHhcCC----------ccCCcccch--HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            22211100          000111111  23456888999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-34  Score=307.27  Aligned_cols=249  Identities=25%  Similarity=0.431  Sum_probs=196.0

Q ss_pred             CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcc
Q 039419          692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR  771 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  771 (1035)
                      ++||+|+||.||+|.+.+++.||+|++......             ...+.+.+|++++++++||||+++++++.+.+..
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   67 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-------------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPI   67 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCe
Confidence            468999999999998777999999988654322             1246789999999999999999999999999999


Q ss_pred             eEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcccc
Q 039419          772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV  851 (1035)
Q Consensus       772 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~  851 (1035)
                      ++||||+++++|.+++..... .+++..+..++.+++.|++|||+.   +++||||||+||+++.++.++|+|||.++..
T Consensus        68 ~~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~  143 (251)
T cd05041          68 YIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREE  143 (251)
T ss_pred             EEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccc
Confidence            999999999999999976432 478899999999999999999999   9999999999999999999999999999865


Q ss_pred             ccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhhccc
Q 039419          852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS  930 (1035)
Q Consensus       852 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (1035)
                      .............++..|+|||...+..++.++|+||||+++|||++ |..||....+.  .....+..          .
T Consensus       144 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~~~----------~  211 (251)
T cd05041         144 EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERIES----------G  211 (251)
T ss_pred             cCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHHhc----------C
Confidence            43222111122334677999999888889999999999999999999 88888654321  11111111          0


Q ss_pred             ccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       931 ~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      .....+.  .......+++.+||..+|++||++.|+++.|+
T Consensus       212 ~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         212 YRMPAPQ--LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCCCc--cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            0000111  11123456888899999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5.7e-34  Score=316.39  Aligned_cols=260  Identities=30%  Similarity=0.444  Sum_probs=199.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCc----EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGE----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|+..+.||+|+||.||+|.+. +++    .||+|.+......             .....+.+|+.++++++||||++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~niv~   73 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP-------------KANVEFMDEALIMASMDHPHLVR   73 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCCccc
Confidence            45777889999999999999764 343    4788887543221             12346889999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++... ..++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        74 ~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~  148 (303)
T cd05110          74 LLGVCLSP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHV  148 (303)
T ss_pred             EEEEEcCC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCce
Confidence            99998754 4679999999999999987643 2478899999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++...............++..|+|||+..+..++.++||||||+++||+++ |+.||.....  .....++..
T Consensus       149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~  226 (303)
T cd05110         149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEK  226 (303)
T ss_pred             EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHC
Confidence            9999999987644322222223456778999999988889999999999999999997 9999964321  122222221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ..        .... +.   ....+...++..||..+|++||+++++++.++++....
T Consensus       227 ~~--------~~~~-~~---~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         227 GE--------RLPQ-PP---ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CC--------CCCC-CC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            10        0000 11   11124456788899999999999999999998875443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.7e-34  Score=308.01  Aligned_cols=252  Identities=25%  Similarity=0.339  Sum_probs=201.0

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|+..+.||.|+||.||.++.. +++.+++|++.......            ...+++.+|++++++++|+||+++++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------------~~~~~~~~e~~~l~~~~h~~i~~~~~~~   68 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE------------KERRDALNEIVILSLLQHPNIIAYYNHF   68 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch------------hHHHHHHHHHHHHHhCCCCCeeEEEeEE
Confidence            4778899999999999999654 58899999985433221            1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..+++|||+++++|.+++.......+++..+..++.|+++|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        69 ~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~  145 (256)
T cd08221          69 MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDF  145 (256)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcC
Confidence            9999999999999999999999876555689999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |.+........  ......|++.|+|||+..+..++.++||||||+++|||++|..||......  .....+..      
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~~~~~------  215 (256)
T cd08221         146 GISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--NLVVKIVQ------  215 (256)
T ss_pred             cceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHc------
Confidence            99986644331  223456899999999988888899999999999999999999999753221  11111110      


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ......+ .  ........++.+||.++|++||++++++++
T Consensus       216 ---~~~~~~~-~--~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         216 ---GNYTPVV-S--VYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ---CCCCCCc-c--ccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence               0011111 1  111234457888999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-34  Score=310.07  Aligned_cols=249  Identities=26%  Similarity=0.418  Sum_probs=190.8

Q ss_pred             CeeeeeCCcEEEEEEECC-Cc--EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEc
Q 039419          692 SVVGKGCSGIVYRAEMEN-GE--VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWN  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  767 (1035)
                      +.||+|+||.||+|.+++ +.  .+|+|.+......             ...+.+.+|+.+++++ +||||+++++++..
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   67 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-------------DDHRDFAGELEVLCKLGHHPNIINLLGACEH   67 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH-------------HHHHHHHHHHHHHHhhccCCCeeeEEEEEec
Confidence            368999999999997754 43  4688877532211             1245788999999999 79999999999999


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      .+..|+||||+++|+|.++++..+.              ..+++..+..++.|++.|++|||+.   +++||||||+||+
T Consensus        68 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil  144 (270)
T cd05047          68 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL  144 (270)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEE
Confidence            9999999999999999999975431              2478899999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchh
Q 039419          834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLH  912 (1035)
Q Consensus       834 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~  912 (1035)
                      ++.++.+|++|||++......   ........+..|+|||+.....++.++||||||+++|||++ |..||......  .
T Consensus       145 i~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~  219 (270)
T cd05047         145 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--E  219 (270)
T ss_pred             EcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--H
Confidence            999999999999998632211   11112234667999999888889999999999999999997 99999643211  1


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ....+..          ......+..  ......+++.+||+.||.+||++.++++.|+.+
T Consensus       220 ~~~~~~~----------~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         220 LYEKLPQ----------GYRLEKPLN--CDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             HHHHHhC----------CCCCCCCCc--CCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            1111110          000000111  112345688899999999999999999998876

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-33  Score=306.25  Aligned_cols=250  Identities=25%  Similarity=0.476  Sum_probs=198.2

Q ss_pred             ccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      +|...+.||+|+||.||+|.+.+++.+|+|++.....               ..+.|.+|++++++++||+|+++++++.
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---------------SEEDFIEEAQVMMKLSHPKLVQLYGVCT   69 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---------------CHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            5677889999999999999887788999998854322               1356889999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      .....++||||+++++|.+++.... ..+++..+..++.+++.|++|||+.   +++||||||+||+++.++.++|+|||
T Consensus        70 ~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g  145 (256)
T cd05112          70 ERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFG  145 (256)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCc
Confidence            9999999999999999999987643 2378999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      .++....... .......++..|+|||+..+..++.++||||||+++|||++ |+.||......  ........   ...
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~---~~~  219 (256)
T cd05112         146 MTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINA---GFR  219 (256)
T ss_pred             ceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhC---CCC
Confidence            9876543321 11123345678999999888889999999999999999998 99999753211  11111110   000


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      ..      .+..   ......+++.+||+.+|++||++.++++.|
T Consensus       220 ~~------~~~~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 LY------KPRL---ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CC------CCCC---CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            00      0111   112345688999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3e-34  Score=313.83  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=194.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .+.|...+.||+|+||+||+|.+. +++.||+|++....               .....+.+|+.+++++ +||||++++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---------------~~~~~~~~e~~~l~~~~~h~~i~~~~   69 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---------------DEEEEIKQEINMLKKYSHHRNIATYY   69 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---------------ccHHHHHHHHHHHHHhcCCCCeeeEe
Confidence            456777889999999999999765 58899999985421               1235688999999998 699999999


Q ss_pred             eEEEcC------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          763 GCCWNR------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       763 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                      +++...      ...|+||||+.+++|.+++.......+++..+..++.|++.|++|||+.   +|+||||||+||+++.
T Consensus        70 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~  146 (272)
T cd06637          70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTE  146 (272)
T ss_pred             eEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECC
Confidence            998753      3578999999999999999876555689999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch
Q 039419          837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL  911 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~  911 (1035)
                      ++.++|+|||++.......  .......|+..|+|||+..     ...++.++||||+||++|||++|+.||....+...
T Consensus       147 ~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~  224 (272)
T cd06637         147 NAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA  224 (272)
T ss_pred             CCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            9999999999987653322  2233567899999999875     34578899999999999999999999964322111


Q ss_pred             hHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ........   .........+      ....+++.+||..||.+||++.+++++
T Consensus       225 ----~~~~~~~~---~~~~~~~~~~------~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         225 ----LFLIPRNP---APRLKSKKWS------KKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ----HHHHhcCC---CCCCCCCCcC------HHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                11000000   0000001111      134567888999999999999999764

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.1e-34  Score=312.69  Aligned_cols=253  Identities=22%  Similarity=0.298  Sum_probs=196.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|... +++.||+|.+......              ....+.+|+.+++.++||||++++++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------------~~~~~~~e~~~~~~l~h~~ii~~~~~   74 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE--------------DFAVVQQEIIMMKDCKHSNIVAYFGS   74 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh--------------HHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            46777889999999999999665 5889999998543211              13467889999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++++|.+++...+.  +++..+..++.|++.|++|||+.   |++|+||||+||+++.++.++|+|
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~d  149 (267)
T cd06645          75 YLRRDKLWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLAD  149 (267)
T ss_pred             EEeCCEEEEEEeccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECc
Confidence            9999999999999999999999876543  89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ||.+.......  .......|+..|+|||+..   ...++.++||||+||++|||++|..||....+... ....  ...
T Consensus       150 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~--~~~  224 (267)
T cd06645         150 FGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLM--TKS  224 (267)
T ss_pred             ceeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhh--hcc
Confidence            99987654321  1223457899999999864   45588899999999999999999999864432111 0000  000


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .   ..........  ...  .....++.+|+..+|++||++++++++
T Consensus       225 ~---~~~~~~~~~~--~~~--~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         225 N---FQPPKLKDKM--KWS--NSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             C---CCCCcccccC--CCC--HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0   0000000000  011  123457888999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.4e-34  Score=308.86  Aligned_cols=239  Identities=19%  Similarity=0.343  Sum_probs=183.8

Q ss_pred             CeeeeeCCcEEEEEEECC-------------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          692 SVVGKGCSGIVYRAEMEN-------------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      +.||+|+||.||+|.+..             ...||+|.+.....              .....|.+|+.+++.++||||
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------------~~~~~~~~~~~~l~~l~hp~i   66 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--------------DISLAFFETASMMRQVSHKHI   66 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--------------hHHHHHHHHHHHHHhCCCCCE
Confidence            468999999999996532             23588888754221              124578899999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +++++++..+...++||||+++|+|..++.... ..+++..+..++.||++|++|||+.   +|+||||||+||+++.++
T Consensus        67 v~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~  142 (262)
T cd05077          67 VLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREG  142 (262)
T ss_pred             eeEEEEEecCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCC
Confidence            999999999999999999999999999886543 3489999999999999999999999   999999999999998766


Q ss_pred             c-------eEEeeccCccccccCCccccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHH-hCCCCCCCCCCC
Q 039419          839 E-------PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVL-TGKQPIDPTIPE  909 (1035)
Q Consensus       839 ~-------~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~ell-tg~~P~~~~~~~  909 (1035)
                      .       ++++|||++......      ....++..|+|||+.. +..++.++|||||||++|||+ +|..||......
T Consensus       143 ~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~  216 (262)
T cd05077         143 IDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA  216 (262)
T ss_pred             ccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh
Confidence            4       899999998754221      2346788999999876 566889999999999999998 588887643211


Q ss_pred             chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      ..   ....         ....... ....   .....++.+||+.||++||++.++++.+
T Consensus       217 ~~---~~~~---------~~~~~~~-~~~~---~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         217 EK---ERFY---------EGQCMLV-TPSC---KELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HH---HHHH---------hcCccCC-CCCh---HHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            10   0000         0000111 1111   2334678899999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.4e-34  Score=316.25  Aligned_cols=255  Identities=23%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             HHHHHhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          681 VEQVLKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       681 ~~~~~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      +.+..++|...+.||+|+||.||+|.. .+++.||+|.+......              ..+.+.+|+.+++.++||||+
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~i~   79 (297)
T cd06656          14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--------------KKELIINEILVMRENKNPNIV   79 (297)
T ss_pred             cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--------------hHHHHHHHHHHHHhCCCCCEe
Confidence            344557899999999999999999976 46899999998543211              235688999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++++++...+..|+||||+++++|.+++...   .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~  153 (297)
T cd06656          80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGS  153 (297)
T ss_pred             eEEEEEecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence            9999999999999999999999999998653   378899999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ++|+|||.+........  ......+++.|+|||...+..++.++|||||||++|++++|..||....+.......+ ..
T Consensus       154 ~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~-~~  230 (297)
T cd06656         154 VKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TN  230 (297)
T ss_pred             EEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec-cC
Confidence            99999999876543321  1234568899999999888889999999999999999999999997543321100000 00


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        .     .+..  ..+....  ....+++.+||+.||++||++++++++
T Consensus       231 --~-----~~~~--~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         231 --G-----TPEL--QNPERLS--AVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             --C-----CCCC--CCccccC--HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0     0000  0011111  123457888999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.2e-34  Score=307.96  Aligned_cols=252  Identities=23%  Similarity=0.287  Sum_probs=198.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|+..+.||+|++|.||+|..+ +++.||+|++.......            ...+.+.+|++++++++|||++++++.+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR------------RERKAAEQEAQLLSQLKHPNIVAYRESW   68 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH------------HHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            3778899999999999999765 47899999985432211            1245788999999999999999999988


Q ss_pred             EcC-CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          766 WNR-NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       766 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      ... ...|+||||+++++|.+++.......+++.++..++.+++.|++|||+.   +|+||||||+||+++.++.++|+|
T Consensus        69 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~d  145 (257)
T cd08223          69 EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGD  145 (257)
T ss_pred             cCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEec
Confidence            644 4578999999999999999876555689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||++.......  .......|++.|+|||+..+..++.++||||+|+++||+++|+.||.....     ..+.....   
T Consensus       146 f~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~---  215 (257)
T cd08223         146 LGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRII---  215 (257)
T ss_pred             ccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHH---
Confidence            99998664322  222345688999999999988999999999999999999999999974321     11111100   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ...... .+.  .......+++.+|+++||++||++.+++++
T Consensus       216 ---~~~~~~-~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         216 ---EGKLPP-MPK--DYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ---hcCCCC-Ccc--ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               000001 111  111234568888999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-33  Score=309.09  Aligned_cols=257  Identities=24%  Similarity=0.381  Sum_probs=199.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+.||+|+||.||+|.+.+    ...||||........             ...+.+.+|+.++++++||||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~-------------~~~~~~~~e~~~l~~~~h~~i~~~   72 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP-------------SVREKFLQEAYIMRQFDHPHIVKL   72 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH-------------HHHHHHHHHHHHHHhCCCCchhce
Confidence            457778899999999999997643    246899988643321             125679999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+ +..|+||||+++|+|.+++..... .+++..+..++.+++.|++|||+.   +++||||||+||+++.++.++
T Consensus        73 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~  147 (270)
T cd05056          73 IGVITE-NPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVK  147 (270)
T ss_pred             eEEEcC-CCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeE
Confidence            998875 557899999999999999976432 489999999999999999999998   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      ++|||+++......... .....++..|+|||......++.++||||||+++||+++ |..||......  ....++...
T Consensus       148 l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~  224 (270)
T cd05056         148 LGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIENG  224 (270)
T ss_pred             EccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHcC
Confidence            99999998664432211 123345678999999888889999999999999999986 99999754321  112222111


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .        .. ..++ ..  .....+++.+|+..+|++||++.++++.|+++..
T Consensus       225 ~--------~~-~~~~-~~--~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         225 E--------RL-PMPP-NC--PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             C--------cC-CCCC-CC--CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0        00 0011 11  1234557888999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.7e-34  Score=335.04  Aligned_cols=257  Identities=19%  Similarity=0.186  Sum_probs=188.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC------CCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR------HKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpn  757 (1035)
                      .++|.+.+.||+|+||+||+|.+. .++.||||++.....               ....+..|+.+++.++      |++
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---------------~~~~~~~e~~~l~~l~~~~~~~~~~  192 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---------------YTRDAKIEIQFMEKVRQADPADRFP  192 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---------------hHHHHHHHHHHHHHHhhcCcccCcc
Confidence            467999999999999999999765 578899999853210               1234556777776664      456


Q ss_pred             eeeEEeEEEcC-CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEc
Q 039419          758 IVRFLGCCWNR-NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       758 iv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++++++..+ ++.|+|||++ |++|.+++...+  .+++..+..|+.||+.||+|||+ .   ||+||||||+|||++
T Consensus       193 i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~  266 (467)
T PTZ00284        193 LMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILME  266 (467)
T ss_pred             eeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEe
Confidence            89999998765 4678999988 889999887654  38999999999999999999997 5   899999999999998


Q ss_pred             CCC----------------ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 039419          836 PEF----------------EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG  899 (1035)
Q Consensus       836 ~~~----------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg  899 (1035)
                      .++                .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             cCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence            765                49999999876422     122356899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHHHhccc--------------hhhhcccc---------------cCCCcccHHHHHHHHHHHH
Q 039419          900 KQPIDPTIPEGLHIVDWVRQKRGA--------------IEVLDKSL---------------RARPEVEIEEMLQTLGVAL  950 (1035)
Q Consensus       900 ~~P~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~---------------~~~~~~~~~~~~~~l~l~~  950 (1035)
                      +.||+.....  .....+....+.              .+......               ...+.........+.+++.
T Consensus       342 ~~pf~~~~~~--~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~  419 (467)
T PTZ00284        342 KLLYDTHDNL--EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIY  419 (467)
T ss_pred             CCCCCCCChH--HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHH
Confidence            9999754321  111111110000              00000000               0000000111223457899


Q ss_pred             hccCCCCCCCCCHHHHHHH
Q 039419          951 LCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       951 ~cl~~dP~~RPs~~el~~~  969 (1035)
                      +||+.||++|||++|++++
T Consensus       420 ~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        420 GLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HhCCcChhhCCCHHHHhcC
Confidence            9999999999999999985

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-34  Score=324.41  Aligned_cols=262  Identities=24%  Similarity=0.275  Sum_probs=194.5

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++.++|...+.||+|+||+||+|... +++.||||++.......            ...+.+.+|+.++++++||||+++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~   79 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL------------IHARRTYRELRLLKHMKHENVIGL   79 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh------------HHHHHHHHHHHHHHhcCCCchhhh
Confidence            44578999999999999999999764 58899999986432111            123567799999999999999999


Q ss_pred             EeEEEcC------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          762 LGCCWNR------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       762 ~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++...      ...|++||++ +++|.++++..   .+++..+..++.||+.||+|||+.   +|+||||||+||+++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~  152 (343)
T cd07878          80 LDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVN  152 (343)
T ss_pred             hhhhcccccccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEEC
Confidence            9987643      3468999988 88998887643   389999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                      .++.+||+|||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ....
T Consensus       153 ~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~  226 (343)
T cd07878         153 EDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLK  226 (343)
T ss_pred             CCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHH
Confidence            9999999999999865332     234578999999999766 56889999999999999999999999653211 0111


Q ss_pred             HHHHHhcc-chhhh-----------cccccCCCcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRG-AIEVL-----------DKSLRARPEVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~-~~~~~-----------~~~~~~~~~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+...... ..+..           ...+...+......     .....+++.+|++.||++|||+.|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         227 RIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11110000 00000           00001111111110     1124568889999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-34  Score=323.98  Aligned_cols=190  Identities=24%  Similarity=0.284  Sum_probs=163.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..|.+.+.||+|+||.||+|... .++.||+|+...                    .....|+.++++++||||++++++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------------------~~~~~E~~~l~~l~h~~iv~~~~~  125 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------------------GTTLIEAMLLQNVNHPSVIRMKDT  125 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------------------cccHHHHHHHHhCCCCCCcChhhe
Confidence            46999999999999999999776 467899997532                    123469999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +...+..++||||+ .++|.+++.... ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       126 ~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D  200 (357)
T PHA03209        126 LVSGAITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGD  200 (357)
T ss_pred             EEeCCeeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEec
Confidence            99999999999999 568888886543 3489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI  903 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~  903 (1035)
                      ||.++.....   .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       201 fG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        201 LGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             CccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            9999754322   1223467999999999999889999999999999999999865554

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-33  Score=306.99  Aligned_cols=252  Identities=28%  Similarity=0.420  Sum_probs=189.7

Q ss_pred             CeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE-
Q 039419          692 SVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW-  766 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  766 (1035)
                      +.||+|+||.||+|.+.+    ...||+|.+......             ...+.+.+|+.+++.++||||+++++++. 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   67 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-------------EEVEQFLKEGIIMKDFSHPNVLSLLGICLP   67 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCH-------------HHHHHHHHHHHHHccCCCCCcceEEEEeec
Confidence            468999999999997542    457999987432111             12467889999999999999999999876 


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      .++..++||||+.+|+|.+++..... ..++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||
T Consensus        68 ~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg  143 (262)
T cd05058          68 SEGSPLVVLPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFG  143 (262)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcc
Confidence            45567999999999999999976432 367788889999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCccc--cccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCchhHHHHHHHhccc
Q 039419          847 LAKLVVEGDFAR--SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG-KQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       847 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      +++.........  ......++..|+|||+..+..++.++||||||+++|||++| ..||....  .......+....  
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~--  219 (262)
T cd05058         144 LARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGR--  219 (262)
T ss_pred             ccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCC--
Confidence            997654322111  11233567789999998888899999999999999999995 55554321  111222211100  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                             ....+. ...  ....+++..||+++|++||++.++++.++++.
T Consensus       220 -------~~~~~~-~~~--~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 -------RLLQPE-YCP--DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -------CCCCCC-cCC--HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                   000010 011  13456888899999999999999999998874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=323.94  Aligned_cols=256  Identities=30%  Similarity=0.438  Sum_probs=206.3

Q ss_pred             cccCCeeeeeCCcEEEEEEE-CCC----cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEM-ENG----EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ...+++||+|+||+||+|.| ++|    -+||+|++......+             ..+++..|+-+|.+++|||+++++
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~-------------~s~e~LdeAl~masldHpnl~RLL  764 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK-------------ASIELLDEALRMASLDHPNLLRLL  764 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch-------------hhHHHHHHHHHHhcCCCchHHHHh
Confidence            34567999999999999955 344    368888886544332             256899999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.... ..+|++|+++|+|.+|++..+.. +.....+.|..|||+||.|||++   ++|||||..+|||+....++||
T Consensus       765 gvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~-igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvki  839 (1177)
T KOG1025|consen  765 GVCMLST-LQLVTQLMPLGCLLDYVREHRDN-IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKI  839 (1177)
T ss_pred             hhcccch-HHHHHHhcccchHHHHHHHhhcc-ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEE
Confidence            9998766 78999999999999999987653 77788899999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      .|||+|+....++..-......-.+-|||=|.+....++.++|||||||++||++| |..||+....+  .+.+.++.  
T Consensus       840 tdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--eI~dlle~--  915 (1177)
T KOG1025|consen  840 TDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--EIPDLLEK--  915 (1177)
T ss_pred             EecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--HhhHHHhc--
Confidence            99999998876655444445556778999999999999999999999999999999 99999865322  12222211  


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                           -+ .+.. |+   -..++...++.+||..|++.||+++++.+.+.++.+
T Consensus       916 -----ge-RLsq-Pp---iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  916 -----GE-RLSQ-PP---ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             -----cc-cCCC-CC---CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                 11 1222 22   233455668889999999999999999998876543

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.8e-34  Score=314.41  Aligned_cols=251  Identities=23%  Similarity=0.388  Sum_probs=199.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||.|+||.||+|.. .+++.||+|.+.....              ...+.+.+|+.+++.++||||+++++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~   83 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--------------PKKELIINEILVMKELKNPNIVNFLD   83 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--------------chHHHHHHHHHHHHhcCCCceeeeee
Confidence            35688889999999999999965 4689999999854221              12457889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++...+..|+||||+++++|.+++...   .+++..+..++.|++.|++|||+.   |++||||||+||+++.++.++|+
T Consensus        84 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~  157 (296)
T cd06655          84 SFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLT  157 (296)
T ss_pred             eEecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence            999999999999999999999988653   389999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||++........  ......|+..|+|||...+..++.++|||||||++|++++|+.||....+...  ...+....  
T Consensus       158 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~~~~~--  231 (296)
T cd06655         158 DFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATNG--  231 (296)
T ss_pred             cCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcC--
Confidence            9999886544321  12245688999999998888899999999999999999999999975432111  11111000  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          .+.... +. ..  .....+++.+||..||++||++.+++.+
T Consensus       232 ----~~~~~~-~~-~~--~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         232 ----TPELQN-PE-KL--SPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ----CcccCC-cc-cC--CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                000000 10 01  1123457888999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.8e-34  Score=313.49  Aligned_cols=258  Identities=27%  Similarity=0.375  Sum_probs=201.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|++.+.||+|+||+||+|.+. +++.||+|++......             ...+.+.+|+++++.++||||++++++
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~~~   71 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS-------------SVRKQILRELQIMHECRSPYIVSFYGA   71 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc-------------hHHHHHHHHHHHHHHcCCCCcceEeee
Confidence            45777889999999999999765 5889999987543211             235678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +...+..|+||||+++++|.+++...+  .+++..+..++.+++.|+.|||+..  +++||||||+||+++.++.++|+|
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d  147 (284)
T cd06620          72 FLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCD  147 (284)
T ss_pred             EecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEcc
Confidence            999999999999999999999987654  3899999999999999999999731  899999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc------hhHHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG------LHIVDWVR  918 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~------~~~~~~~~  918 (1035)
                      ||++.......    .....|+..|+|||++.+..++.++|||||||++|++++|+.||....+..      .....++.
T Consensus       148 ~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  223 (284)
T cd06620         148 FGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ  223 (284)
T ss_pred             CCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH
Confidence            99987543221    224578999999999888889999999999999999999999998543211      11111211


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                      ...      .......+..  .....+.+++.+|+++||++||++.|++++..-
T Consensus       224 ~~~------~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         224 QIV------QEPPPRLPSS--DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             HHh------hccCCCCCch--hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            110      0000000011  111234567888999999999999999986433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=295.17  Aligned_cols=204  Identities=25%  Similarity=0.287  Sum_probs=180.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +++|...+++|+|.||.|.+++.+ .++.||+|+++++.+-...           ...+-..|-++++..+||.+..+.-
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd-----------EVAHTlTE~RVL~~~~HPFLt~LKY  235 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD-----------EVAHTLTENRVLQNCRHPFLTSLKY  235 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH-----------HhhhhhhHHHHHHhccCcHHHHhhh
Confidence            477888999999999999999766 5899999999876554432           2346678999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .|+..+..++||||+.||.|.-++...+.  +++.....+-.+|+.||.|||++   +||.||+|.+|.|+|++|++||+
T Consensus       236 sFQt~drlCFVMeyanGGeLf~HLsrer~--FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKit  310 (516)
T KOG0690|consen  236 SFQTQDRLCFVMEYANGGELFFHLSRERV--FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKIT  310 (516)
T ss_pred             hhccCceEEEEEEEccCceEeeehhhhhc--ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEee
Confidence            99999999999999999999988866543  88888889999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      |||+++.-...  ...+..++|||.|+|||++....|+.++|.|.+|||+|||++|+.||...
T Consensus       311 DFGLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  311 DFGLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             ecccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence            99999864332  23456899999999999999999999999999999999999999999643

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.3e-34  Score=307.26  Aligned_cols=246  Identities=27%  Similarity=0.447  Sum_probs=196.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|.+.+.||+|+||.||+|.. .++.||+|++....                ..+.+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----------------~~~~~~~e~~~l~~~~~~~i~~~~~~~   68 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----------------TAQAFLEETAVMTKLHHKNLVRLLGVI   68 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----------------hHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence            5688899999999999999975 47889999985421                135788999999999999999999998


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ... ..++||||+++++|.+++.......+++..+..++.|++.|++|||+.   |++||||||+||+++.++.++|+||
T Consensus        69 ~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Df  144 (254)
T cd05083          69 LHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDF  144 (254)
T ss_pred             cCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCC
Confidence            764 479999999999999999876555689999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++......     .....+..|+|||+..+..++.++||||||+++|||++ |+.||......  .....+..     
T Consensus       145 g~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~-----  212 (254)
T cd05083         145 GLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--EVKECVEK-----  212 (254)
T ss_pred             ccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHHhC-----
Confidence            9987543221     12344678999999888889999999999999999998 99999754321  11111111     


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                           .....+....  .....+++.+||+.+|++||+++++++.|+
T Consensus       213 -----~~~~~~~~~~--~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         213 -----GYRMEPPEGC--PADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             -----CCCCCCCCcC--CHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence                 1111111111  123356888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.8e-34  Score=319.93  Aligned_cols=202  Identities=22%  Similarity=0.296  Sum_probs=166.9

Q ss_pred             cCCeeeee--CCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          690 EDSVVGKG--CSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       690 ~~~~iG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      ..++||+|  +||+||++... +|+.||+|++........            ..+.+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~l~~l~hpniv~~~~~~~   69 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNE------------MVTFLQGELHVSKLFNHPNIVPYRATFI   69 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHH------------HHHHHHHHHHHHHhcCCCCeeeEEEEEE
Confidence            35688999  78899999664 689999999865432211            2456788999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      .++..|+||||+++|+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||
T Consensus        70 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~  146 (327)
T cd08227          70 ADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLR  146 (327)
T ss_pred             ECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccc
Confidence            999999999999999999999765444589999999999999999999998   99999999999999999999999998


Q ss_pred             CccccccCCcc-----ccccccCCcccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          847 LAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       847 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      .+.........     .......++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            75543221110     01122356788999999865  45889999999999999999999999743

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7e-34  Score=318.33  Aligned_cols=196  Identities=26%  Similarity=0.367  Sum_probs=159.6

Q ss_pred             CCeeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          691 DSVVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      ..+||+|+||+||+|+.+   ++..||+|.+....                ....+.+|+.++++++||||+++++++..
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~   69 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----------------ISMSACREIALLRELKHPNVIALQKVFLS   69 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----------------CcHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            468999999999999765   35789999885421                12357899999999999999999999854


Q ss_pred             --CCcceEEEEeCCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE----
Q 039419          768 --RNTRLLMYDYMPNGSLGSLLHERR-------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI----  834 (1035)
Q Consensus       768 --~~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll----  834 (1035)
                        +...|+||||+. ++|.+++....       ...+++..+..++.||+.||+|||+.   +|+||||||+||++    
T Consensus        70 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~  145 (317)
T cd07867          70 HSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEG  145 (317)
T ss_pred             cCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCC
Confidence              456789999985 58888775321       23478899999999999999999999   99999999999999    


Q ss_pred             cCCCceEEeeccCccccccCCcc-ccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          835 GPEFEPYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      +.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       146 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         146 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            56678999999999876443211 12234578999999998766 45789999999999999999999999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.4e-34  Score=315.40  Aligned_cols=263  Identities=18%  Similarity=0.266  Sum_probs=195.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .+.|...+.||+|+||.||+|.++ +++.||+|.+......             .....+.+|+.++++++||||+++++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nI~~~~~   71 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-------------GAPCTAIREVSLLKDLKHANIVTLHD   71 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-------------CchhHHHHHHHHHHhcCCCCcceEEE
Confidence            356888999999999999999775 5789999998543211             12346778999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..++||||++ ++|.+++..... .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  146 (301)
T cd07873          72 IIHTEKSLTLVFEYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLA  146 (301)
T ss_pred             EEecCCeEEEEEeccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEEC
Confidence            9999999999999996 689998876533 478899999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||+++......  .......+++.|+|||+..+ ..++.++|||||||++|||++|+.||......  .....+.....
T Consensus       147 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~  222 (301)
T cd07873         147 DFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILG  222 (301)
T ss_pred             cCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcC
Confidence            999987543322  11223457899999998764 45788999999999999999999999754321  11111110000


Q ss_pred             --chhhh----------cccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 --AIEVL----------DKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 --~~~~~----------~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        .....          ............     .......+++.+|++.||.+|||++|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             CCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              00000          000000000000     001123468889999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-33  Score=307.21  Aligned_cols=255  Identities=26%  Similarity=0.359  Sum_probs=192.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|... +++.||+|++.........         ....+.+.+|+.++++++||||+++++++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   73 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET---------SKEVSALECEIQLLKNLQHERIVQYYGCL   73 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh---------HHHHHHHHHHHHHHHHcCCCCeeeEEEEE
Confidence            5778899999999999999765 5899999988644321110         01245788999999999999999999998


Q ss_pred             EcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          766 WNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       766 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .+.  ...+++|||+++++|.+++.....  +++.....++.|++.||+|||+.   +|+||||||+||+++.++.++|+
T Consensus        74 ~~~~~~~~~l~~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~  148 (266)
T cd06651          74 RDRAEKTLTIFMEYMPGGSVKDQLKAYGA--LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLG  148 (266)
T ss_pred             EcCCCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence            753  567899999999999999976543  78899999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||+++....... ........++..|+|||+..+..++.++||||+||++||+++|+.||......     ..+.....
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~~~~  223 (266)
T cd06651         149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFKIAT  223 (266)
T ss_pred             cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHHHhc
Confidence            9999876532211 11112345889999999998888999999999999999999999999743211     11111000


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        ....+..    +......   +..+..||..+|++||+++|++++
T Consensus       224 --~~~~~~~----~~~~~~~---~~~li~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         224 --QPTNPQL----PSHISEH---ARDFLGCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --CCCCCCC----chhcCHH---HHHHHHHhcCChhhCcCHHHHhcC
Confidence              0001111    1111111   122236888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-33  Score=310.37  Aligned_cols=262  Identities=28%  Similarity=0.420  Sum_probs=201.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      +.|...+.||+|+||.||+|.+.     .++.||||++......             ...+.|.+|++++++++||||++
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------------~~~~~~~~ei~~l~~l~~~~i~~   70 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------------QHRSDFEREIEILRTLDHENIVK   70 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------------HHHHHHHHHHHHHHhCCCCChhe
Confidence            45667789999999999999754     3688999998654322             12568999999999999999999


Q ss_pred             EEeEEEc--CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          761 FLGCCWN--RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       761 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +++++..  ....++||||+++++|.+++..... .+++..+..++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~  146 (284)
T cd05038          71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESED  146 (284)
T ss_pred             EEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCC
Confidence            9999887  5578999999999999999976543 489999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh-----
Q 039419          839 EPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH-----  912 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~-----  912 (1035)
                      .++|+|||.+........ ........++..|+|||...+..++.++||||||+++|||++|+.|+.........     
T Consensus       147 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~  226 (284)
T cd05038         147 LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA  226 (284)
T ss_pred             CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc
Confidence            999999999987653321 11122234566799999988888999999999999999999999998643221100     


Q ss_pred             -----HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          913 -----IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       913 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                           ...+..       .+........+.  .......+++.+||+++|++||++.|++++|+.+
T Consensus       227 ~~~~~~~~~~~-------~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         227 QGQMIVTRLLE-------LLKEGERLPRPP--SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cccccHHHHHH-------HHHcCCcCCCCc--cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence                 111111       011111111111  1113455688899999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.4e-33  Score=305.61  Aligned_cols=252  Identities=20%  Similarity=0.340  Sum_probs=183.1

Q ss_pred             eeeeeCCcEEEEEEECCC---cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCC
Q 039419          693 VVGKGCSGIVYRAEMENG---EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      .||+|+||.||+|+..++   ..+++|.+......             ...+.|.+|+.+++.++||||+++++++.+..
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   68 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS-------------KEQNEFLQQGDPYRILQHPNILQCLGQCVEAI   68 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh-------------HHHHHHHHHHHHHhccCCcchhheEEEecCCC
Confidence            589999999999965443   34566665432211             12568999999999999999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRD--SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                      ..|+||||+++|+|.++++....  ...++..+..++.||++||+|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~  145 (268)
T cd05086          69 PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI  145 (268)
T ss_pred             ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccc
Confidence            99999999999999999976432  3356677889999999999999998   999999999999999999999999999


Q ss_pred             ccccccCCccccccccCCcccccCCccccc-------CCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          848 AKLVVEGDFARSSNTVAGSYGYIAPEYGYM-------MKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       848 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +................|+..|+|||+...       ..++.++||||||+++|||++ |..||....+. ..+......
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~  224 (268)
T cd05086         146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKD  224 (268)
T ss_pred             ccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhh
Confidence            864322222122234568899999998642       345789999999999999997 56677543211 111111111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                        ......++.......      ....+++.+|| .+|++||+++++++.|
T Consensus       225 --~~~~~~~~~~~~~~~------~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         225 --QQVKLFKPQLELPYS------ERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             --cccccCCCccCCCCc------HHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence              111111222211111      12234666788 5799999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.8e-34  Score=313.38  Aligned_cols=247  Identities=23%  Similarity=0.281  Sum_probs=197.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|.+. +++.||+|++........           ...+.+.+|++++++++||||+++++++
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL-----------KQVEHVLNEKRILQSIRHPFLVNLYGSF   70 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHHhCCCCCccceeeEE
Confidence            5788899999999999999765 589999999864322111           2356789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||+++++|.+++....  .++...+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+||
T Consensus        71 ~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~df  145 (290)
T cd05580          71 QDDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDF  145 (290)
T ss_pred             EcCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeC
Confidence            99999999999999999999997764  388999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |+++.....     .....|++.|+|||...+...+.++||||||+++|+|++|+.||......  .....+.  ...  
T Consensus       146 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~--~~~--  214 (290)
T cd05580         146 GFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QIYEKIL--EGK--  214 (290)
T ss_pred             CCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh--cCC--
Confidence            999865443     23456899999999988888899999999999999999999999754311  1111110  000  


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                         ..+....      ......++.+||..||++|+     +++|++++
T Consensus       215 ---~~~~~~~------~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 ---VRFPSFF------SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ---ccCCccC------CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence               0011111      12334577889999999998     77777664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.5e-33  Score=309.04  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..|...+.||+|+||.||+|.+. +++.||+|.+.......             ..+.+.+|+.++++++||||++++++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-------------EIEDIQQEITVLSQCDSPYVTKYYGS   70 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH-------------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34667788999999999999775 58899999886432211             24678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+....|+||||++||+|.+++...   .+++..+..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~d  144 (277)
T cd06640          71 YLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLAD  144 (277)
T ss_pred             EEECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcc
Confidence            99999999999999999999998653   378889999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||.+........  ......++..|+|||+..+..++.++|+|||||++|||++|..||....+...     ...     
T Consensus       145 fg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~-----  212 (277)
T cd06640         145 FGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFL-----  212 (277)
T ss_pred             cccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----hhh-----
Confidence            999976644321  12335688899999998888899999999999999999999999975432211     000     


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        .....  .+...........+++.+||+.+|++||++.+++++
T Consensus       213 --~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         213 --IPKNN--PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --hhcCC--CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence              00000  011111222345568889999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=311.43  Aligned_cols=264  Identities=20%  Similarity=0.283  Sum_probs=194.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|..+ +++.||+|.+.......             ....+.+|++++++++||||++++++
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i~~~~~~   71 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-------------APFTAIREASLLKDLKHANIVTLHDI   71 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-------------CchhHHHHHHHHhhCCCcceeeEEEE
Confidence            56888899999999999999776 58999999986532211             12356789999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+. ++|.+++..... .+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|
T Consensus        72 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  146 (291)
T cd07844          72 IHTKKTLTLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLAD  146 (291)
T ss_pred             EecCCeEEEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECc
Confidence            999999999999997 499998876543 578999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc-
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG-  922 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-  922 (1035)
                      ||+++......  .......++..|+|||+..+ ..++.++||||+|+++|||++|+.||..............+.... 
T Consensus       147 fg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07844         147 FGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP  224 (291)
T ss_pred             cccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCC
Confidence            99987542211  11123356889999998765 457889999999999999999999996543111111000000000 


Q ss_pred             chhhh----------cccccCCCcc-------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVL----------DKSLRARPEV-------EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~----------~~~~~~~~~~-------~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+..          ..........       .........+++.+|++++|++||++.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         225 TEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            00000          0000000000       01111344568889999999999999998763

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.4e-34  Score=313.26  Aligned_cols=249  Identities=26%  Similarity=0.371  Sum_probs=197.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|.+. +++.||+|.+......             ...+.+.+|+.++++++||||++++++
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYITRYYGS   70 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-------------HHHHHHHHHHHHHHcCCCCccHhhhcc
Confidence            44666778999999999999665 5788999988543221             124678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +......|+||||+++++|.+++...   .+++..+..++.|+++|+.|||+.   +++|+||+|+||+++.++.++++|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06642          71 YLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLAD  144 (277)
T ss_pred             cccCCceEEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcc
Confidence            99999999999999999999988643   378999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||++........  ......|+..|+|||+..+..++.++||||||+++|||++|+.||....+..  ...++...    
T Consensus       145 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~----  216 (277)
T cd06642         145 FGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLIPKN----  216 (277)
T ss_pred             ccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhhhcC----
Confidence            999976543321  1223468899999999988889999999999999999999999986443221  11111100    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        ..+....      .......+++.+||+.+|++||++.+++++
T Consensus       217 --~~~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 --SPPTLEG------QYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             --CCCCCCc------ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence              0001111      112234567888999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-33  Score=307.09  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=201.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+..+.||.|+||+||+|... ++..+|+|++.......             ..+.+.+|+.+++.++||||+++++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i~~~~~~   67 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-------------SVDELRKEVQAMSQCNHPNVVKYYTS   67 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-------------HHHHHHHHHHHHHhcCCCCEEEEEEE
Confidence            36888899999999999999765 57899999986433221             24678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      +...+..|+||||+++++|.++++.... ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+
T Consensus        68 ~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~  144 (267)
T cd06610          68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIA  144 (267)
T ss_pred             EeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEc
Confidence            9999999999999999999999976433 4589999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCcc--ccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          844 DFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       844 DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |||++..+......  .......|+..|+|||+.... .++.++|+|||||++|||++|+.||....+.. ........ 
T Consensus       145 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~-  222 (267)
T cd06610         145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQN-  222 (267)
T ss_pred             ccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcC-
Confidence            99999876554322  122345689999999987766 78899999999999999999999997543221 11111111 


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        .    ......... .........+++.+||+.||++||++++++++
T Consensus       223 --~----~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         223 --D----PPSLETGAD-YKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --C----CCCcCCccc-cccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              0    000110000 00111233567888999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.9e-33  Score=309.80  Aligned_cols=264  Identities=21%  Similarity=0.272  Sum_probs=194.3

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|... +++.||+|++.......            ...+.+.+|+.++++++||||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE------------GVPSTAIREISLLKELQHPNIVCLQDVL   68 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC------------CchHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            3677889999999999999775 58999999986432111            1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      .+++..|+||||++ ++|.+++..... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|
T Consensus        69 ~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  144 (285)
T cd07861          69 MQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLAD  144 (285)
T ss_pred             eeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECc
Confidence            99999999999997 689888865432 4589999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||++.......  .......+++.|+|||+..+ ..++.++||||||+++|||++|+.||....... ............
T Consensus       145 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~  221 (285)
T cd07861         145 FGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTP  221 (285)
T ss_pred             ccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            99987553321  11223457889999998764 457889999999999999999999997542211 000000000000


Q ss_pred             ----------hhhhcccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 ----------IEVLDKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ----------~~~~~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                                ................     ....+..+++.+||+.||++|||+.+++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             ChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                      0000000000000000     001233468889999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=309.48  Aligned_cols=249  Identities=27%  Similarity=0.385  Sum_probs=198.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||.|+||.||+|.+. +++.||+|++......             ...+.+.+|+++++.++||||+++++++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   68 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE-------------DEIEDIQQEIQFLSQCRSPYITKYYGSF   68 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc-------------hHHHHHHHHHHHHHHcCCCCeeeeeEEE
Confidence            5777889999999999999765 5899999998543211             1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .++...|+|+||+++++|.++++..   .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~  142 (274)
T cd06609          69 LKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADF  142 (274)
T ss_pred             EECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccc
Confidence            9999999999999999999999765   489999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |.++......  .......|+..|+|||+..+..++.++||||||+++|+|++|+.||....+..  ....+...     
T Consensus       143 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~-----  213 (274)
T cd06609         143 GVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPKN-----  213 (274)
T ss_pred             ccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhhc-----
Confidence            9998765432  12234568889999999988889999999999999999999999997543211  11101000     


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ..+.....   .  ......+++.+||..||++||++++++++
T Consensus       214 -~~~~~~~~---~--~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         214 -NPPSLEGN---K--FSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -CCCCCccc---c--cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             00011111   0  11234557888999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.5e-34  Score=310.43  Aligned_cols=238  Identities=18%  Similarity=0.332  Sum_probs=182.7

Q ss_pred             eeeeeCCcEEEEEEECC-------------------------CcEEEEEEecCCCcccccccccccccccccHHHHHHHH
Q 039419          693 VVGKGCSGIVYRAEMEN-------------------------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI  747 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  747 (1035)
                      .||+|+||.||+|....                         ...||+|++.....              .....|.+|+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--------------~~~~~~~~~~   67 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--------------DIALAFFETA   67 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--------------HHHHHHHHHH
Confidence            68999999999996421                         13578888754221              1235788999


Q ss_pred             HHHhcCCCCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCC
Q 039419          748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI  827 (1035)
Q Consensus       748 ~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDi  827 (1035)
                      .+++.++||||+++++++.+....++||||+++|+|..++.... ..+++..+..++.||++||+|||++   +|+||||
T Consensus        68 ~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dl  143 (274)
T cd05076          68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNV  143 (274)
T ss_pred             HHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCC
Confidence            99999999999999999999999999999999999999986533 3478999999999999999999998   9999999


Q ss_pred             CcccEEEcCCC-------ceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHH-h
Q 039419          828 KANNILIGPEF-------EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVL-T  898 (1035)
Q Consensus       828 kp~NIll~~~~-------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~ell-t  898 (1035)
                      ||+||+++..+       .+|++|||.+......      ....++..|+|||...+ ..++.++||||||+++||++ +
T Consensus       144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             CcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            99999997654       3799999987643221      23457788999998765 56889999999999999985 6


Q ss_pred             CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          899 GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       899 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      |+.||....+...  ..+...          ... .+....   ....+++.+||+.+|++||++.++++.|
T Consensus       218 g~~p~~~~~~~~~--~~~~~~----------~~~-~~~~~~---~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         218 GEVPLKERTPSEK--ERFYEK----------KHR-LPEPSC---KELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             CCCCccccChHHH--HHHHHh----------ccC-CCCCCC---hHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            9999875432211  111111          000 011111   1345688899999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=306.11  Aligned_cols=254  Identities=23%  Similarity=0.327  Sum_probs=199.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|... +++.+|+|++......              ..+.+.+|++++++++||||++++++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--------------~~~~~~~e~~~l~~~~h~~i~~~~~~   68 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--------------DFEIIQQEISMLKECRHPNIVAYFGS   68 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--------------hHHHHHHHHHHHHhCCCCChhceEEE
Confidence            46888899999999999999775 5788999998643211              24678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|++|||+.+++|.+++.... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|
T Consensus        69 ~~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d  144 (262)
T cd06613          69 YLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLAD  144 (262)
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECc
Confidence            999999999999999999999987652 2388999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ||.+.......  .......++..|+|||...+.   .++.++||||||+++|||++|+.||....+... .. ....  
T Consensus       145 ~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~-~~~~--  218 (262)
T cd06613         145 FGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LF-LISK--  218 (262)
T ss_pred             cccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHh--
Confidence            99987654322  112345688899999998766   788999999999999999999999975432111 00 0000  


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .   ....   ............+.+++.+||.++|++||++.+++.+
T Consensus       219 ~---~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         219 S---NFPP---PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             c---cCCC---ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0   0000   0000111222345668889999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.8e-34  Score=307.05  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|+..+.||+|+||.||++... +++.||+|.+.......            ...+.+.+|+.++++++||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP------------KEREESRKEVAVLSNMKHPNIVQYQESF   68 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh------------HHHHHHHHHHHHHHhCCCCCeeeeEeee
Confidence            4778899999999999999664 58999999986432211            1245789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||+++++|.+++.......+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        69 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~  145 (256)
T cd08218          69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDF  145 (256)
T ss_pred             cCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeec
Confidence            9999999999999999999999775554578999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |.+........  ......|++.|+|||+..+..++.++|+|||||++|+|++|+.||.....     ...+...     
T Consensus       146 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~-----  213 (256)
T cd08218         146 GIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKI-----  213 (256)
T ss_pred             cceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHH-----
Confidence            99976543221  12234688899999999888899999999999999999999999964321     1111110     


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ........+.   .......+++.+||+.+|++||++.+++++
T Consensus       214 -~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         214 -IRGSYPPVSS---HYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -hcCCCCCCcc---cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             0000011111   112234567888999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-33  Score=310.57  Aligned_cols=250  Identities=23%  Similarity=0.327  Sum_probs=193.4

Q ss_pred             cccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |++.+.||+|+||.||+|.+.. +..+++|.+.....              ...+.+.+|+++++.++||||+++++++.
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ii~~~~~~~   72 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--------------EELEDYMVEIDILASCDHPNIVKLLDAFY   72 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--------------HHHHHHHHHHHHHHHCCCCCeeeEEEEEe
Confidence            5677889999999999997764 77888888854221              12457889999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      .++..|+||||+++++|..++.... ..+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+|||
T Consensus        73 ~~~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg  148 (282)
T cd06643          73 YENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFG  148 (282)
T ss_pred             eCCEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccc
Confidence            9999999999999999998876533 3489999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ++.......  .......|+..|+|||+..     +..++.++|||||||++|||++|+.||....+.. .......   
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~---  222 (282)
T cd06643         149 VSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK---  222 (282)
T ss_pred             ccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhh---
Confidence            987653321  2223456899999999863     4457789999999999999999999997532211 1111110   


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..    .+... .+. ..  ...+.+++.+||++||++||++.+++++
T Consensus       223 ~~----~~~~~-~~~-~~--~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         223 SE----PPTLA-QPS-RW--SSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             cC----CCCCC-Ccc-cc--CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00    00000 000 01  1234567888999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-33  Score=311.16  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=195.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|++.+.||+|+||.||+|+... ++.||+|.+.....              ...+.+.+|+.+++.++||||++++++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~~   77 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--------------EELEDYMVEIEILATCNHPYIVKLLGA   77 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCCcEeeeEEE
Confidence            567788899999999999997764 88999999854321              124678899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +..++..|+||||+++++|..++.... ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+|
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d  153 (292)
T cd06644          78 FYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLAD  153 (292)
T ss_pred             EEeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEcc
Confidence            999999999999999999998876543 3489999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||.+.......  .......++..|+|||+..     ...++.++|||||||++|||++|..||....+.     ..+..
T Consensus       154 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~  226 (292)
T cd06644         154 FGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLK  226 (292)
T ss_pred             Cccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHH
Confidence            99987543321  1223456889999999874     344678999999999999999999999653221     11111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....   ..+.... +.   .......+++.+||+.||++||++++++++
T Consensus       227 ~~~~---~~~~~~~-~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         227 IAKS---EPPTLSQ-PS---KWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             HhcC---CCccCCC-Cc---ccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000   0000000 00   111234567888999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-34  Score=315.13  Aligned_cols=248  Identities=26%  Similarity=0.337  Sum_probs=201.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      ...|.+.+.||+|.|+.|..|++. ++..||||.+.+......            ..+.+.+|+++|+.++|||||+++.
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~------------~~~k~~rev~imk~l~HPnIvkl~~  122 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS------------KRQKLGREVDIMKSLNHPNIVKLFS  122 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH------------HHHHHHHHHHHHHhcCCcceeeeee
Confidence            356888899999999999999765 589999999976544332            2355899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      +...+...|+||||+.+|.+++|+...+.  ..+..+..++.|+.+|++|||++   .|+|||||.+||+|+.+..+||+
T Consensus       123 v~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIa  197 (596)
T KOG0586|consen  123 VIETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIA  197 (596)
T ss_pred             eeeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeee
Confidence            99999999999999999999999988765  56688889999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||++.++..+.   .....+|++.|.|||++.+.+++ +.+|+||+|+++|-++.|..||++..-...         + 
T Consensus       198 DfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---------r-  264 (596)
T KOG0586|consen  198 DFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---------R-  264 (596)
T ss_pred             ccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc---------c-
Confidence            999999886543   34578999999999999987765 789999999999999999999985421100         0 


Q ss_pred             chhhhcccccC--CCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRA--RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~--~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ..++...++-  ....+++.      ++.+++-.+|.+|++++++.+.
T Consensus       265 -~rvl~gk~rIp~~ms~dce~------lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  265 -PRVLRGKYRIPFYMSCDCED------LLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             -chheeeeecccceeechhHH------HHHHhhccCccccCCHHHhhhh
Confidence             0111111111  11222333      5555788899999999999764

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-33  Score=304.08  Aligned_cols=251  Identities=27%  Similarity=0.472  Sum_probs=198.6

Q ss_pred             ccCCeeeeeCCcEEEEEEECC-----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          689 VEDSVVGKGCSGIVYRAEMEN-----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       689 ~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .+.+.||.|+||.||+|.+.+     +..||+|++.......             ..+.+..|++++++++||||+++++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i~~~~~   68 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ-------------QIEEFLREARIMRKLDHPNIVKLLG   68 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH-------------HHHHHHHHHHHHHhcCCCchheEEE
Confidence            456789999999999997764     3889999986543211             2568899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..+++|||+++++|.+++.......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++
T Consensus        69 ~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~  145 (258)
T smart00219       69 VCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKIS  145 (258)
T ss_pred             EEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEc
Confidence            999999999999999999999999775544389999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||.++........... ...+++.|+|||...+..++.++||||+|+++|+|++ |..||.....  ......+.... 
T Consensus       146 dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--~~~~~~~~~~~-  221 (258)
T smart00219      146 DFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--EEVLEYLKKGY-  221 (258)
T ss_pred             ccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC-
Confidence            99999876554322211 2337789999999888889999999999999999998 7888864311  12222221111 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                              ....+..   ....+.+++.+|+..||++|||+.|+++.|
T Consensus       222 --------~~~~~~~---~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 --------RLPKPEN---CPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------CCCCCCc---CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                    0011111   112345578889999999999999998753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=285.25  Aligned_cols=252  Identities=21%  Similarity=0.303  Sum_probs=193.2

Q ss_pred             ccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGC  764 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  764 (1035)
                      +.....-||.|+.|.||+++.+. |..+|||.+.......+             .+++...++++..- ++|+||+.+|+
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-------------~kRILmDldvv~~s~dcpyIV~c~Gy  159 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-------------NKRILMDLDVVLKSHDCPYIVQCFGY  159 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-------------HHHHHHhhhHHhhccCCCeeeeeeeE
Confidence            34456678999999999998774 89999999976544333             46788888887766 48999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |..+...++.||.| ......+++.-. ..+++..+-++...++.||.||.+++  +|+|||+||+|||+|+.|.+|+||
T Consensus       160 Fi~n~dV~IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCD  235 (391)
T KOG0983|consen  160 FITNTDVFICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCD  235 (391)
T ss_pred             EeeCchHHHHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeec
Confidence            99999999999988 445555555433 44888888899999999999999885  899999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ||++-++.+...   ....+|-+.|||||.+.   ...|+.++||||||++++|+.||+.||.....+- .....+-.. 
T Consensus       236 FGIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~ltkvln~-  310 (391)
T KOG0983|consen  236 FGISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLTKVLNE-  310 (391)
T ss_pred             ccccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHHHHHhc-
Confidence            999988766543   23557899999999764   4468999999999999999999999998643221 111111110 


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           ..+.++...    .-.....+++..|+.+|+.+||.+.+++++
T Consensus       311 -----ePP~L~~~~----gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 -----EPPLLPGHM----GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             -----CCCCCCccc----CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                 011222111    111233456777999999999999999885

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-33  Score=306.16  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|.+.+ ++.||+|.+....                ..+++.+|++++++++||||++++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------------~~~~~~~e~~~~~~l~~~~i~~~~~~   66 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----------------DLQEIIKEISILKQCDSPYIVKYYGS   66 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----------------HHHHHHHHHHHHHhCCCCcEeeeeee
Confidence            467788899999999999998775 7899999985421                14579999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|++|||+.+++|.+++.... ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|
T Consensus        67 ~~~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~d  142 (256)
T cd06612          67 YFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLAD  142 (256)
T ss_pred             eecCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcc
Confidence            999999999999999999999987543 3489999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||.+........  ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....+....    ..      
T Consensus       143 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~----~~------  210 (256)
T cd06612         143 FGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI----FM------  210 (256)
T ss_pred             cccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh----hh------
Confidence            999987644321  223455889999999998889999999999999999999999999754321110    00      


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        ..................+.+++.+||+.||++||++.|++++
T Consensus       211 --~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         211 --IPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             --hccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence              0000000000000111234567888999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-35  Score=314.36  Aligned_cols=251  Identities=20%  Similarity=0.295  Sum_probs=192.2

Q ss_pred             ccccCCeeeeeCCcEEEEEEECCCcE-EEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|.+..-+|.|+||.||+|..++... .|.|++....              ....++|.-|++|+..++||+||++++.|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--------------eEELEDylVEIeILa~CdHP~ivkLl~ay   98 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--------------EEELEDYLVEIEILAECDHPVIVKLLSAY   98 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--------------hhHHhhhhhhhhhhhcCCChHHHHHHHHH
Confidence            45566788999999999997776444 4555553221              12357899999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      +.++..|++.|||.||-+...+-+-++ .+.+.++.-+++|++.||.|||++   .|+|||+|..|||++-+|.++++||
T Consensus        99 y~enkLwiliEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADF  174 (1187)
T KOG0579|consen   99 YFENKLWILIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADF  174 (1187)
T ss_pred             hccCceEEEEeecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecc
Confidence            999999999999999999998876654 489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCccc-----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYG-----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |.+......  ......+.|||+|||||+.     ...+|+.++||||||+++.||..+.+|...-.+     ...+-..
T Consensus       175 GVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----MRVllKi  247 (1187)
T KOG0579|consen  175 GVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKI  247 (1187)
T ss_pred             cccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----HHHHHHH
Confidence            987643222  2234578999999999974     456799999999999999999999999764322     1111000


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ..-++..-..|..+-   ...-++..+|+.+||..||++++++++
T Consensus       248 ----aKSePPTLlqPS~Ws---~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  248 ----AKSEPPTLLQPSHWS---RSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ----hhcCCCcccCcchhh---hHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                000011111111111   122345666999999999999999874

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.8e-33  Score=304.65  Aligned_cols=251  Identities=24%  Similarity=0.382  Sum_probs=199.3

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|... +++.+|+|.+.......            ...+.+.+|+.++++++||||+++++.+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~   68 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK------------DERLAAQNECQVLKLLSHPNIIEYYENF   68 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc------------HHHHHHHHHHHHHhhCCCCchhheeeeE
Confidence            4778889999999999999664 58899999986543221            1246789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC-CceEEee
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIAD  844 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~kl~D  844 (1035)
                      ..++..++||||+++++|.+++.......+++..+..++.++++|++|||++   +++||||||+||+++.+ +.++++|
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d  145 (256)
T cd08220          69 LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGD  145 (256)
T ss_pred             ecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcc
Confidence            9999999999999999999999876655689999999999999999999998   99999999999999855 4579999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||.+.......   ......|+..|+|||...+..++.++||||||+++|+|++|+.||......  .....+..  ...
T Consensus       146 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~--~~~  218 (256)
T cd08220         146 FGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMS--GTF  218 (256)
T ss_pred             CCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--HHHHHHHh--cCC
Confidence            99998764432   122456889999999998888999999999999999999999999754321  11111111  000


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ......      .......++.+||++||++||++.|++++
T Consensus       219 ----~~~~~~------~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 ----APISDR------YSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ----CCCCCC------cCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                000111      11233467888999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.1e-33  Score=306.38  Aligned_cols=253  Identities=26%  Similarity=0.348  Sum_probs=191.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.+.....||+|+||.||+|.+. ++..||+|.+......              ..+.+.+|+.++++++||||++++++
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~iv~~~~~   73 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--------------YVQPLHEEIALHSYLKHRNIVQYLGS   73 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH--------------HHHHHHHHHHHHHhcCCCCeeeeeee
Confidence            34445568999999999999765 5788999987543211              24578999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCC-CCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-CCceEE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDS-CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-EFEPYI  842 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl  842 (1035)
                      +..++..++||||+++++|.+++...... ..++..+..++.||++|++|||+.   +|+||||||+||+++. ++.++|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l  150 (268)
T cd06624          74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKI  150 (268)
T ss_pred             eccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEE
Confidence            99999999999999999999999764321 127888889999999999999998   9999999999999986 678999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      +|||.+........  ......|+..|+|||+..+..  ++.++||||||+++|+|++|+.||........  ..+....
T Consensus       151 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~  226 (268)
T cd06624         151 SDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGM  226 (268)
T ss_pred             ecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhh
Confidence            99999876543221  122346889999999876543  78899999999999999999999964322111  1111000


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..    ..+..    +..  .......++.+||+++|++||++.|++++
T Consensus       227 ~~----~~~~~----~~~--~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         227 FK----IHPEI----PES--LSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hc----cCCCC----Ccc--cCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            00    00011    111  11223457888999999999999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.3e-33  Score=305.52  Aligned_cols=264  Identities=28%  Similarity=0.397  Sum_probs=197.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|... +++.||+|.+..........    ........+.+.+|+.++++++||||+++++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRH----DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhccc----chHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence            4677889999999999999654 58999999885432211110    000012245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ...+..++||||+++++|.++++...  .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++||
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~  152 (272)
T cd06629          78 TTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDF  152 (272)
T ss_pred             ccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeec
Confidence            99999999999999999999997764  488899999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |.++...............|+..|+|||......  ++.++|+||||+++||+++|..||.....    .....+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~  228 (272)
T cd06629         153 GISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKLGNKR  228 (272)
T ss_pred             cccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHhhccc
Confidence            9997654322112223456889999999876544  78999999999999999999999964321    11111110000


Q ss_pred             -hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 -IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 -~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ...+......      .......+++.+||++||++||++.+++++
T Consensus       229 ~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPIPPDVSM------NLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcCCccccc------cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence             0001111100      111234557788999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.3e-33  Score=307.50  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=200.3

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|+..+.||+|+||.||+|.++ +++.||+|.+......             ...+++.+|++++++++||||+++++.+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~   68 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-------------AIQKQILRELDILHKCNSPYIVGFYGAF   68 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-------------HHHHHHHHHHHHHHHCCCCchhhhheee
Confidence            4667788999999999999776 5899999998654322             1246789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      ...+..++||||+++++|.+++.... ..++...+..++.|++.|++|+|+ .   +++||||||+||+++.++.++|+|
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d  144 (265)
T cd06605          69 YNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCD  144 (265)
T ss_pred             ecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEee
Confidence            99999999999999999999997653 348899999999999999999999 7   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||.+........    ....++..|+|||+..+..++.++||||||+++|+|++|+.||.............+....   
T Consensus       145 ~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  217 (265)
T cd06605         145 FGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV---  217 (265)
T ss_pred             cccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh---
Confidence            999876543221    1267889999999998889999999999999999999999999754321112222221111   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         .......+...  ....+.+++.+||..||++||++.+++.+
T Consensus       218 ---~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         218 ---NEPPPRLPSGK--FSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---cCCCCCCChhh--cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence               00000011100  12234567888999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.3e-33  Score=305.74  Aligned_cols=257  Identities=24%  Similarity=0.424  Sum_probs=196.8

Q ss_pred             cccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          688 LVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      |.+.+.||+|+||.||+|.+.    .++.||||++..+....            ...+++.+|++++++++||||+++++
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~   68 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS------------SDIEEFLREAACMKEFDHPNVIKLIG   68 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh------------HHHHHHHHHHHHHhcCCCCCcceEEE
Confidence            456788999999999999653    36889999986543222            12467889999999999999999999


Q ss_pred             EEEcCC------cceEEEEeCCCCChhhhhhhcC----CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          764 CCWNRN------TRLLMYDYMPNGSLGSLLHERR----DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       764 ~~~~~~------~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      ++...+      ..++++||+.+|+|.+++....    ...+++..+..++.|++.|++|||+.   +|+||||||+||+
T Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nil  145 (273)
T cd05074          69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCM  145 (273)
T ss_pred             EEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEE
Confidence            886542      2378899999999998875322    12478889999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchh
Q 039419          834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLH  912 (1035)
Q Consensus       834 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~  912 (1035)
                      ++.++.+|++|||.++...............+++.|++||......++.++||||||+++|||++ |+.||.....  ..
T Consensus       146 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~  223 (273)
T cd05074         146 LNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SE  223 (273)
T ss_pred             EcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HH
Confidence            99999999999999987644332222334456788999999888889999999999999999999 8888864322  12


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ...++....        .....+    .......+++.+||+.+|++||++.++++.|+.+
T Consensus       224 ~~~~~~~~~--------~~~~~~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         224 IYNYLIKGN--------RLKQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHHHcCC--------cCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            222221110        000001    1112445688899999999999999999998865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=5.4e-36  Score=323.96  Aligned_cols=363  Identities=27%  Similarity=0.417  Sum_probs=177.9

Q ss_pred             CCcccceEeecCcccC-CCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccc
Q 039419           52 SLSFLQKLIISGSNLT-GPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKN  130 (1035)
Q Consensus        52 ~l~~L~~L~L~~~~l~-~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  130 (1035)
                      -|+..+-.|+++|.++ +..|.++..+++++.|.|...++. .+|+.+++|.+|++|.+++|++. .+...++.|+.|+.
T Consensus         5 VLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRs   82 (1255)
T KOG0444|consen    5 VLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRS   82 (1255)
T ss_pred             ccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHH
Confidence            3455556666666665 345555555666666666666655 56666666666666666666655 45555555566666


Q ss_pred             eeccccccCC-CCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeeccc
Q 039419          131 LLLFDNYLSG-NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTT  209 (1035)
Q Consensus       131 L~l~~n~l~~-~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n  209 (1035)
                      +.+++|+++. .+|..|..|..|.+|+|++|                         ++. +.|..+...+++-.|+|++|
T Consensus        83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShN-------------------------qL~-EvP~~LE~AKn~iVLNLS~N  136 (1255)
T KOG0444|consen   83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHN-------------------------QLR-EVPTNLEYAKNSIVLNLSYN  136 (1255)
T ss_pred             HhhhccccccCCCCchhcccccceeeecchh-------------------------hhh-hcchhhhhhcCcEEEEcccC
Confidence            6666655542 23344444444444444433                         333 34444444444444444444


Q ss_pred             ccccCCccc-cccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCC-CCC
Q 039419          210 MLSGEIPPQ-IGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFS-GSL  287 (1035)
Q Consensus       210 ~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~  287 (1035)
                      +|. .+|.. +-+|+.|-.|||++|++. .+|+.+..|.+|++|.|++|.+...--..+..+++|++|.+++.+=+ ..+
T Consensus       137 ~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~  214 (1255)
T KOG0444|consen  137 NIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNI  214 (1255)
T ss_pred             ccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcC
Confidence            444 23322 334444455555555544 44444455555555555555443322223333444555555544221 234


Q ss_pred             CccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCC
Q 039419          288 PQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTG  367 (1035)
Q Consensus       288 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~  367 (1035)
                      |.++..|.+|..+|+|.|.+. ..|+.+.++.+|+.|+|++|+|+.+.           .......+|++|+||+|+++ 
T Consensus       215 Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~-----------~~~~~W~~lEtLNlSrNQLt-  281 (1255)
T KOG0444|consen  215 PTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELN-----------MTEGEWENLETLNLSRNQLT-  281 (1255)
T ss_pred             CCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeee-----------ccHHHHhhhhhhccccchhc-
Confidence            445555555555555555555 44555555555555555555555331           23333445555566666655 


Q ss_pred             CCCCCcccCcccceEecccccccc-CCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEc
Q 039419          368 SLHPGLFQLQNLTKLLLISNGISG-LIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDI  446 (1035)
Q Consensus       368 ~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  446 (1035)
                      .+|..+..+++|+.|++.+|+++- -+|..++++              .+|+++..++|.+. .+|..++...+|+.|.|
T Consensus       282 ~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL--------------~~Levf~aanN~LE-lVPEglcRC~kL~kL~L  346 (1255)
T KOG0444|consen  282 VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKL--------------IQLEVFHAANNKLE-LVPEGLCRCVKLQKLKL  346 (1255)
T ss_pred             cchHHHhhhHHHHHHHhccCcccccCCccchhhh--------------hhhHHHHhhccccc-cCchhhhhhHHHHHhcc
Confidence            555555555555555555555541 123332222              23444444444444 44444444444444444


Q ss_pred             CCCccCCCCchhccCccccchhhccCC
Q 039419          447 SVNQFVGLIPESFGQLASLNRLILSKN  473 (1035)
Q Consensus       447 s~N~l~~~~~~~~~~l~~L~~L~Ls~N  473 (1035)
                      ++|++. ..|+.+.-++.|+.||+..|
T Consensus       347 ~~NrLi-TLPeaIHlL~~l~vLDlreN  372 (1255)
T KOG0444|consen  347 DHNRLI-TLPEAIHLLPDLKVLDLREN  372 (1255)
T ss_pred             ccccee-echhhhhhcCCcceeeccCC
Confidence            444444 23444444444444444444

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=310.47  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=196.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|.+. +++.||+|.+.....              ...+.|.+|++++++++||||++++++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE--------------EELEDFMVEIDILSECKHPNIVGLYEA   70 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH--------------HHHHHHHHHHHHHHhCCCCceeEEEEE
Confidence            45778889999999999999775 588999999854311              124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.++...|+||||+++++|.+++...+. .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d  146 (280)
T cd06611          71 YFYENKLWILIEFCDGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLAD  146 (280)
T ss_pred             EecCCeEEEEeeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEcc
Confidence            9999999999999999999999876432 489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||.+.......  .......|++.|+|||+..     ...++.++||||||+++|||++|+.||....... ....+.  
T Consensus       147 ~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~--  221 (280)
T cd06611         147 FGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKIL--  221 (280)
T ss_pred             Cccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHh--
Confidence            99987653322  1223456899999999864     3457789999999999999999999997542211 111110  


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ...    .+.+.. +.   .......+++..||+.+|++||++.+++++
T Consensus       222 -~~~----~~~~~~-~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         222 -KSE----PPTLDQ-PS---KWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -cCC----CCCcCC-cc---cCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             000    000000 00   011123457788999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.2e-33  Score=306.29  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=198.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|...+.||.|++|.||+|... +++.+|+|.+......             ...+++.+|++++++++||||+++++++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~   68 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-------------DLQKQILRELEINKSCKSPYIVKYYGAF   68 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-------------HHHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            5777889999999999999775 5889999998643221             1246789999999999999999999998


Q ss_pred             EcC--CcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          766 WNR--NTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       766 ~~~--~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      .+.  +..|+||||+++++|.+++...  ....++...+..++.|+++||+|||+.   +++|+||+|+||+++.++.++
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~  145 (287)
T cd06621          69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVK  145 (287)
T ss_pred             EccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEE
Confidence            654  3679999999999999887542  234478899999999999999999998   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC---chhHHHHHH
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE---GLHIVDWVR  918 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~---~~~~~~~~~  918 (1035)
                      |+|||++.......    .....++..|+|||...+..++.++||||+|+++|+|++|+.||......   ......++.
T Consensus       146 l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  221 (287)
T cd06621         146 LCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV  221 (287)
T ss_pred             Eeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh
Confidence            99999987553322    12456788999999988888999999999999999999999999865321   112222222


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....      ..+...+.........+.+++.+||+++|++||++.|++++
T Consensus       222 ~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         222 NMPN------PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             cCCc------hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            1110      11111111001112234578899999999999999999984

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.6e-33  Score=308.80  Aligned_cols=264  Identities=22%  Similarity=0.333  Sum_probs=198.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+..+.||+|+||.||+|.++ +++.||+|++.......            ...+.+.+|+.++++++||||++++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~~~h~~i~~~~~~   68 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP------------VIKKIALREIRMLKQLKHPNLVNLIEV   68 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc------------cccHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            36788899999999999999876 58999999985432111            124568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +......++||||++++++..++....  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|
T Consensus        69 ~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~d  143 (286)
T cd07847          69 FRRKRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCD  143 (286)
T ss_pred             EeeCCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECc
Confidence            999999999999999998888775443  389999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||++........  ......++..|+|||+..+ ..++.++||||||+++|||++|+.||......+ ....+.......
T Consensus       144 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~  220 (286)
T cd07847         144 FGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDL  220 (286)
T ss_pred             cccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCC
Confidence            999987644321  1224567889999998765 557889999999999999999999997543221 111111100000


Q ss_pred             h----hhhcc-----cccCC-C--cccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 I----EVLDK-----SLRAR-P--EVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~----~~~~~-----~~~~~-~--~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .    ...+.     ..... +  .....     ......+++.+||++||++||++.|++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0    00000     00000 0  00000     11335578899999999999999998764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.4e-34  Score=309.66  Aligned_cols=239  Identities=17%  Similarity=0.334  Sum_probs=183.7

Q ss_pred             CeeeeeCCcEEEEEEECC--------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          692 SVVGKGCSGIVYRAEMEN--------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +.||+|+||.||+|....        ...||+|.+.....              ...+.+..|+.+++.++||||+++++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~iv~~~~   66 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR--------------NYSESFFEAASMMSQLSHKHLVLNYG   66 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhH--------------HHHHHHHHHHHHHHhCCCCChhheee
Confidence            468999999999996642        23477777643211              12467889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc----
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE----  839 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~----  839 (1035)
                      ++..++..++||||+++|+|.++++..+. .+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.    
T Consensus        67 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~  142 (258)
T cd05078          67 VCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTG  142 (258)
T ss_pred             EEEeCCCcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccC
Confidence            99999999999999999999999976543 478999999999999999999999   9999999999999987765    


Q ss_pred             ----eEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCC-CCCCCCCCCchhH
Q 039419          840 ----PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGK-QPIDPTIPEGLHI  913 (1035)
Q Consensus       840 ----~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~-~P~~~~~~~~~~~  913 (1035)
                          ++++|||.+......      ....++..|+|||++.+ ..++.++||||||+++|||++|. .||....+.    
T Consensus       143 ~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~----  212 (258)
T cd05078         143 NPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----  212 (258)
T ss_pred             CCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH----
Confidence                589999988654322      23567889999999876 45789999999999999999985 555432211    


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                       .....       ...... .+.   ....+..+++.+||+.||++||+++++++.|
T Consensus       213 -~~~~~-------~~~~~~-~~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         213 -KKLQF-------YEDRHQ-LPA---PKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             -HHHHH-------HHcccc-CCC---CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence             00000       000000 111   1112345678889999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4e-33  Score=303.55  Aligned_cols=256  Identities=23%  Similarity=0.299  Sum_probs=192.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|... +++.||+|.+.........         ....+.+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~   72 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET---------SKEVNALECEIQLLKNLLHERIVQYYGC   72 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCccc---------HHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence            35778899999999999999765 5899999988543211110         0124678899999999999999999999


Q ss_pred             EEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          765 CWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       765 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +.+.  ...++||||+++++|.+++.....  +++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l  147 (265)
T cd06652          73 LRDPMERTLSIFMEHMPGGSIKDQLKSYGA--LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKL  147 (265)
T ss_pred             eccCCCceEEEEEEecCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEE
Confidence            8764  457899999999999999876543  78888999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          843 ADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      +|||.++........ .......|+..|+|||+..+..++.++|||||||++|||++|+.||...... .   . +....
T Consensus       148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~---~-~~~~~  222 (265)
T cd06652         148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-A---A-IFKIA  222 (265)
T ss_pred             CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-H---H-HHHHh
Confidence            999998765332111 1122356889999999988888999999999999999999999999643211 0   0 00000


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           ..+.....+.   ........++.+|+. +|++||++++++++
T Consensus       223 -----~~~~~~~~~~---~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         223 -----TQPTNPVLPP---HVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             -----cCCCCCCCch---hhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                 0000011111   111233446666774 89999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.1e-33  Score=312.22  Aligned_cols=258  Identities=20%  Similarity=0.239  Sum_probs=196.2

Q ss_pred             ccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|.... ++.||+|.+........           ...+.+.+|+.+++.++||||+++++.+
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~   70 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILR-----------NQIQQVFVERDILTFAENPFVVSMFCSF   70 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhH-----------HHHHHHHHHHHHHHhCCCCCeeeeEEEE
Confidence            57788999999999999997764 78999998865422111           1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ..++..++||||++|++|.+++...+  .+++..+..++.|++.|++|+|+.   +++||||||+||+++.++.++++||
T Consensus        71 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~df  145 (305)
T cd05609          71 ETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDF  145 (305)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeC
Confidence            99999999999999999999997654  388999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCc-------------cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          846 GLAKLVVEGDF-------------ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       846 G~a~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      |.++.......             ........|+..|+|||.+.+..++.++|+||||+++||+++|..||....+.   
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---  222 (305)
T cd05609         146 GLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---  222 (305)
T ss_pred             CCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence            99874211100             00112345788999999988888999999999999999999999999643221   


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                        .+....... ....+.....      .......++.+||++||++||++.++.+.++.
T Consensus       223 --~~~~~~~~~-~~~~~~~~~~------~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         223 --ELFGQVISD-DIEWPEGDEA------LPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             --HHHHHHHhc-ccCCCCcccc------CCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence              111111000 0000000001      11223568888999999999996555554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.7e-33  Score=308.67  Aligned_cols=256  Identities=27%  Similarity=0.387  Sum_probs=194.3

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceee
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVR  760 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  760 (1035)
                      +..++|+..+.||+|+||.||+|... .++.+|+|++....               .....+.+|+.+++++ +||||++
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---------------~~~~~~~~e~~~l~~l~~h~~i~~   79 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---------------DIDEEIEAEYNILKALSDHPNVVK   79 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---------------chHHHHHHHHHHHHHHhcCCCeee
Confidence            34578899999999999999999765 47899999875321               1135678899999999 6999999


Q ss_pred             EEeEEE-----cCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          761 FLGCCW-----NRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       761 l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      +++++.     ..+..++||||++|++|.+++...  ....+++..+..++.|+++|+.|||+.   +|+||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil  156 (286)
T cd06638          80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNIL  156 (286)
T ss_pred             eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEE
Confidence            999884     335679999999999999987632  223478889999999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       834 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      ++.++.++|+|||+++.......  ......|++.|+|||++.     +..++.++||||+||++|||++|+.||....+
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         157 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             ECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            99999999999999886543221  223456899999999864     34578899999999999999999999975422


Q ss_pred             CchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          909 EGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      ..    ........    ..... ..+..   .......++.+||+.||++||++.|++++.
T Consensus       235 ~~----~~~~~~~~----~~~~~-~~~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         235 MR----ALFKIPRN----PPPTL-HQPEL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hH----HHhhcccc----CCCcc-cCCCC---cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            11    11100000    00000 00110   011345678889999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=317.74  Aligned_cols=202  Identities=28%  Similarity=0.401  Sum_probs=172.2

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      +...+.||+||||.||+|+++ .|+.||||.+.......             ..++..+|+++|++++|||||++++.-.
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r-------------~~e~~~~EieilkKLnh~NIVk~f~iee   81 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR-------------PRERWCREIEILKKLNHPNIVKLFDIEE   81 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccc-------------hHHHHHHHHHHHHHcCchhhhhhcccCC
Confidence            345578999999999999854 69999999997644222             3678899999999999999999999865


Q ss_pred             cCC------cceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC--C
Q 039419          767 NRN------TRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP--E  837 (1035)
Q Consensus       767 ~~~------~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~--~  837 (1035)
                      +..      ...+|||||.||||+.+++.-.. ..+++.+.+.++.+++.||.|||+.   ||+||||||.||++-.  +
T Consensus        82 ~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Ged  158 (732)
T KOG4250|consen   82 TKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGED  158 (732)
T ss_pred             ccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCC
Confidence            543      45899999999999999976443 5699999999999999999999998   9999999999999943  2


Q ss_pred             C--ceEEeeccCccccccCCccccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          838 F--EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       838 ~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      |  ..||+|||.|+...++.   .....+||..|.+||... .+.|+..+|.|||||++|+++||..||.+...
T Consensus       159 gq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  159 GQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             CceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            3  36899999999876654   345789999999999988 48899999999999999999999999986543

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.6e-33  Score=306.86  Aligned_cols=256  Identities=24%  Similarity=0.390  Sum_probs=199.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      +.|...+.||+|+||.||+|+.+      +.+.|++|.+......             ...+.+.+|++++++++||||+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv   71 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-------------NLQSEFRRELDMFRKLSHKNVV   71 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch-------------HHHHHHHHHHHHHHhcCCccee
Confidence            56788889999999999999764      2467899887542211             1356799999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccE
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNI  832 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NI  832 (1035)
                      ++++++.+.+..|+||||+++|+|.+++.....       ..+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Ni  148 (275)
T cd05046          72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNC  148 (275)
T ss_pred             eeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceE
Confidence            999999999999999999999999999976552       1489999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCch
Q 039419          833 LIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL  911 (1035)
Q Consensus       833 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~  911 (1035)
                      +++.++.++++|||+++....... .......++..|+|||...+..++.++||||||+++|++++ |..||......  
T Consensus       149 li~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--  225 (275)
T cd05046         149 LVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--  225 (275)
T ss_pred             EEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--
Confidence            999999999999999875433221 12223456788999999888888999999999999999999 88888643221  


Q ss_pred             hHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      ............     ......    ..  ....+++.+||..+|++||++.|+++.|.
T Consensus       226 ~~~~~~~~~~~~-----~~~~~~----~~--~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         226 EVLNRLQAGKLE-----LPVPEG----CP--SRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHHHcCCcC-----CCCCCC----CC--HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            222222111000     000111    11  13445788899999999999999998874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-33  Score=303.68  Aligned_cols=253  Identities=28%  Similarity=0.375  Sum_probs=197.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||+||+|... +++.|++|.+........         .....+.+.+|++++++++||||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT---------GQEAVKQLEQEIALLSKLQHPNIVQYLGTE   71 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc---------chHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence            3667789999999999999776 689999999854322111         012346789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||+++++|.+++....  .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence            99999999999999999999997654  378999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.+.......   ......|+..|+|||...... ++.++|+||||+++|++++|+.||....+.     ......... 
T Consensus       147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~-  217 (258)
T cd06632         147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AAVFKIGRS-  217 (258)
T ss_pred             ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HHHHHHHhc-
Confidence            9987654332   123456889999999877666 889999999999999999999999754311     111110000 


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ......++ ..  .....+++.+||+.+|++||++.+++.+
T Consensus       218 ----~~~~~~~~-~~--~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         218 ----KELPPIPD-HL--SDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ----ccCCCcCC-Cc--CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                00001111 11  1223457788999999999999999763

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-33  Score=310.81  Aligned_cols=263  Identities=21%  Similarity=0.283  Sum_probs=193.1

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|+..+.||+|+||.||+|.+. +|+.||+|++.......            .....+.+|++++++++||||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~------------~~~~~~~~ei~~l~~l~h~~i~~~~~~~   68 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLYDVL   68 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc------------cCccchhHHHHHHHhcCCCCeeeHHHHh
Confidence            4777889999999999999775 58999999986532211            1234677899999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||++ ++|.+++.... ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.++|+||
T Consensus        69 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~df  143 (284)
T cd07839          69 HSDKKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADF  143 (284)
T ss_pred             ccCCceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECcc
Confidence            99999999999996 58888876543 3489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc-
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA-  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-  923 (1035)
                      |+++......  .......++..|+|||++.+. .++.++|||||||++|||++|..|+.......... ..+...... 
T Consensus       144 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~  220 (284)
T cd07839         144 GLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTP  220 (284)
T ss_pred             chhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HHHHHHhCCC
Confidence            9988653321  112234678999999987664 46889999999999999999999865432211111 111000000 


Q ss_pred             --------hhhhcc-cccCCCcc-c-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 --------IEVLDK-SLRARPEV-E-----IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 --------~~~~~~-~~~~~~~~-~-----~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                              ....+. ........ .     ........+++.+||+.||++|||+++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence                    000000 00000000 0     0011234568889999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7e-34  Score=313.66  Aligned_cols=250  Identities=22%  Similarity=0.369  Sum_probs=194.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|.....||+|+||.||+|... +++.||||++.....              ...+.+.+|+.+++.++||||+++++.
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~ii~~~~~   87 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--------------QRRELLFNEVVIMRDYHHENVVDMYNS   87 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--------------HHHHHHHHHHHHHHhCCCCcHHHHHHh
Confidence            44444567999999999999764 588999998743211              124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +...+..|+||||+++++|.+++...   .+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.++|+|
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~d  161 (292)
T cd06658          88 YLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSD  161 (292)
T ss_pred             eecCCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcc
Confidence            99999999999999999999988543   378999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||++.......  .......|+..|+|||...+..++.++||||||+++|||++|+.||....+.  .....+..     
T Consensus       162 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~-----  232 (292)
T cd06658         162 FGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRD-----  232 (292)
T ss_pred             Ccchhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-----
Confidence            99987653322  1223456899999999998888999999999999999999999999753221  11111110     


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ..........  ...  .....++.+||..||++||++++++++
T Consensus       233 -~~~~~~~~~~--~~~--~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         233 -NLPPRVKDSH--KVS--SVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             -cCCCcccccc--ccC--HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             1111111110  011  123346777999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=314.65  Aligned_cols=257  Identities=23%  Similarity=0.284  Sum_probs=201.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+|...+ ++.||+|.+........           ...+.+..|++++++++||||+++++.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~   69 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR-----------NKVKRVLTEQEILATLDHPFLPTLYAS   69 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchH-----------HHHHHHHHHHHHHHhCCCCCchhheee
Confidence            357888999999999999997764 89999999975433221           124678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+.|++|.+++.......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|
T Consensus        70 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d  146 (316)
T cd05574          70 FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSD  146 (316)
T ss_pred             eecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEee
Confidence            99999999999999999999999866555689999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCcc---------------------------ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHH
Q 039419          845 FGLAKLVVEGDFA---------------------------RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL  897 (1035)
Q Consensus       845 FG~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ell  897 (1035)
                      ||++.........                           .......|+..|+|||+..+..++.++||||||+++|+|+
T Consensus       147 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~  226 (316)
T cd05574         147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML  226 (316)
T ss_pred             cchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHh
Confidence            9998754322110                           0112346889999999998888999999999999999999


Q ss_pred             hCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC----HHHHHHH
Q 039419          898 TGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT----MKDVAAM  969 (1035)
Q Consensus       898 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs----~~el~~~  969 (1035)
                      +|+.||....... .   +..       ............  .....+.+++.+||..||++||+    ++|++.+
T Consensus       227 ~g~~pf~~~~~~~-~---~~~-------~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         227 YGTTPFKGSNRDE-T---FSN-------ILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hCCCCCCCCchHH-H---HHH-------HhcCCccCCCcc--ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            9999997542211 1   110       011111111110  01233456888899999999999    7766663

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-34  Score=316.03  Aligned_cols=248  Identities=24%  Similarity=0.367  Sum_probs=191.1

Q ss_pred             ccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          689 VEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       689 ~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      ...++||+|+|-+||+|-+. +|..||=--++....          .......++|..|+.+|+.|+|||||++|+++.+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~----------~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDV----------TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHh----------hcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            34578999999999999554 466665221211110          1112335899999999999999999999999987


Q ss_pred             CCc--ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc-CCCceEEee
Q 039419          768 RNT--RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG-PEFEPYIAD  844 (1035)
Q Consensus       768 ~~~--~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~~kl~D  844 (1035)
                      ...  ..+|+|.+..|+|..|.++.+.  .+......|++||++||.|||++ .|+|+|||||-+||+++ .-|.|||+|
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD  189 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD  189 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence            665  6789999999999999998876  88899999999999999999997 56999999999999997 458999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      .|+|.......    ...+.|||.|||||... ..|+..+||||||+.++||+|+.+||..-    .+.+...       
T Consensus       190 LGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC----~n~AQIY-------  253 (632)
T KOG0584|consen  190 LGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC----TNPAQIY-------  253 (632)
T ss_pred             hhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh----CCHHHHH-------
Confidence            99998764432    23478999999999855 78999999999999999999999999732    2222221       


Q ss_pred             hhhcccccCCCcccHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIE--EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~--~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         .+...+..+..+.  .......+|.+|+.. ..+|||+.|+++.
T Consensus       254 ---KKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  254 ---KKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ---HHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence               1222222221111  122345688889999 8999999999873

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.8e-33  Score=306.77  Aligned_cols=264  Identities=20%  Similarity=0.245  Sum_probs=193.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|... +++.||+|.+......             .....+.+|+.++++++|+||++++++
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~ni~~~~~~   71 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-------------GVPFTAIREASLLKGLKHANIVLLHDI   71 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-------------CCcHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            56888999999999999999664 5899999998643221             123467889999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||+. +++.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|
T Consensus        72 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~D  146 (291)
T cd07870          72 IHTKETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLAD  146 (291)
T ss_pred             EecCCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEec
Confidence            999999999999995 67877765433 3377888889999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc-c
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR-G  922 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-~  922 (1035)
                      ||+++......  .......+++.|+|||+..+. .++.++|||||||++|||++|+.||+...+....+........ .
T Consensus       147 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07870         147 FGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP  224 (291)
T ss_pred             cccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence            99987543321  112334578999999987653 5788999999999999999999999754332111111100000 0


Q ss_pred             chh----------hhcccccCCCcc-------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIE----------VLDKSLRARPEV-------EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~----------~~~~~~~~~~~~-------~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...          ............       .........+++.+|+..||++|||+.|++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            000          000000000000       01112344567888999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-33  Score=303.57  Aligned_cols=237  Identities=19%  Similarity=0.349  Sum_probs=185.8

Q ss_pred             CeeeeeCCcEEEEEEECCCc-----------EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          692 SVVGKGCSGIVYRAEMENGE-----------VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      +.||+|+||.||+|.+.+..           .+++|.+.....               ....|.+|+.++++++||||++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~   65 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---------------DSLAFFETASLMSQLSHKHLVK   65 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---------------hHHHHHHHHHHHHcCCCcchhh
Confidence            46899999999999776433           467776643211               1467899999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC--
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF--  838 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~--  838 (1035)
                      +++++.. ...++||||+++|+|.+++..... .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++  
T Consensus        66 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~  140 (259)
T cd05037          66 LYGVCVR-DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLN  140 (259)
T ss_pred             eeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccc
Confidence            9999988 778999999999999999986543 488999999999999999999998   999999999999999888  


Q ss_pred             -----ceEEeeccCccccccCCccccccccCCcccccCCcccccC--CCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 039419          839 -----EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEG  910 (1035)
Q Consensus       839 -----~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~  910 (1035)
                           .+||+|||++.....      .....++..|+|||+..+.  .++.++||||||+++||+++ |..||...... 
T Consensus       141 ~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-  213 (259)
T cd05037         141 EGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-  213 (259)
T ss_pred             cCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-
Confidence                 799999999886533      1234567789999998766  78899999999999999999 57777654221 


Q ss_pred             hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                       ....+...         ......+.     .....+++.+||+.+|++||++.++++.|
T Consensus       214 -~~~~~~~~---------~~~~~~~~-----~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         214 -EKERFYQD---------QHRLPMPD-----CAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             -hHHHHHhc---------CCCCCCCC-----chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence             11111110         00000111     13445688899999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-33  Score=308.00  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=195.1

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|+..+.||+|+||.||+|.+. .++.||+|.+......             ...+.+.+|+.++++++||||+++++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~   68 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-------------SKFNQIIMELDILHKAVSPYIVDFYGAF   68 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCH-------------HHHHHHHHHHHHHHhcCCCcHHhhhhhe
Confidence            5778889999999999999776 6899999988543211             1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERR-DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      ...+..|+||||+++++|.++++... ...+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.++|+|
T Consensus        69 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d  146 (286)
T cd06622          69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCD  146 (286)
T ss_pred             ecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEee
Confidence            99999999999999999999887632 234899999999999999999999632  899999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCC------CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK------ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      ||.+.......    .....|+..|+|||...+..      ++.++|||||||++|||++|+.||.......  ....+.
T Consensus       147 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~  220 (286)
T cd06622         147 FGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLS  220 (286)
T ss_pred             cCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHH
Confidence            99987653321    22346888999999875443      5789999999999999999999996532211  111110


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .      .........++   ........++.+||+.+|++||++.+++++
T Consensus       221 ~------~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         221 A------IVDGDPPTLPS---GYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             H------HhhcCCCCCCc---ccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            0      00000001111   112233457888999999999999999884

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.3e-33  Score=307.59  Aligned_cols=264  Identities=25%  Similarity=0.333  Sum_probs=196.8

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|+..+.||+|+||.||+|..+ +++.||||++.......            ...+.+.+|++++++++||||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~   68 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------------GVPSTAIREISLLKELNHPNIVKLLDVI   68 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc------------ccchHHHHHHHHHHhcCCCCCcchhhhc
Confidence            3677889999999999999775 58999999886432211            1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||+. ++|.+++.......+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+||
T Consensus        69 ~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~df  144 (284)
T cd07860          69 HTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADF  144 (284)
T ss_pred             ccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            99999999999995 6899998776556689999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |+++......  .......++..|+|||+..+.. ++.++||||||+++|||+||+.||...... ......+.......
T Consensus       145 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~  221 (284)
T cd07860         145 GLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPD  221 (284)
T ss_pred             cchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCC
Confidence            9987653322  1222345788999999876544 588999999999999999999999654221 11111111110000


Q ss_pred             hhh----------cccccCCCcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVL----------DKSLRARPEVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~----------~~~~~~~~~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...          ..............     .....+++.+||+.||++||++++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            000          00000000000000     1223468889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.3e-33  Score=304.06  Aligned_cols=261  Identities=26%  Similarity=0.380  Sum_probs=198.8

Q ss_pred             cccCCeeeeeCCcEEEEEEECC--CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhc-CCCCceeeEEeE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMEN--GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS-IRHKNIVRFLGC  764 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~  764 (1035)
                      |.+.+.||+|+||.||+|.++.  ++.+|+|.+.........    .+........++.+|+.++.+ ++||||++++++
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~----~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~   77 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGK----DKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT   77 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccccc----ccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee
Confidence            6677889999999999998765  788999998654322110    001111234567789998875 799999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      +.+.+..++||||+++++|.+++...  ....+++..++.++.|++.|+.|||+ .   +++||||||+||+++.++.++
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          78 FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             EccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEE
Confidence            99999999999999999999987542  23458899999999999999999996 5   899999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |+|||.+.......   ......|+..|+|||...+..++.++||||||+++|||++|+.||......  .....+..  
T Consensus       155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~--  227 (269)
T cd08528         155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLATKIVE--  227 (269)
T ss_pred             Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHHHHHhh--
Confidence            99999998654432   223456899999999998888999999999999999999999999643211  11111110  


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                             .........  .....+.+++.+||+.||++||++.|+.++++
T Consensus       228 -------~~~~~~~~~--~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 -------AVYEPLPEG--MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -------ccCCcCCcc--cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                   000000010  01123455788899999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.5e-33  Score=303.78  Aligned_cols=260  Identities=24%  Similarity=0.382  Sum_probs=198.8

Q ss_pred             ccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|.. .+++.||+|++..........        ....+.+.+|+.++++++||||+++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   72 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQ--------EEVVEALRKEIRLMARLNHPHIIRMLGAT   72 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhH--------HHHHHHHHHHHHHHHHcCCCceehhhcee
Confidence            367788999999999999965 468999999986433211100        01356889999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC-ceEEee
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF-EPYIAD  844 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~D  844 (1035)
                      .+.+..++||||+++++|.+++...+  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++ .++|+|
T Consensus        73 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~d  147 (268)
T cd06630          73 CEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIAD  147 (268)
T ss_pred             ccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcc
Confidence            99999999999999999999997654  388999999999999999999999   999999999999998776 599999


Q ss_pred             ccCccccccCCcc--ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          845 FGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       845 FG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      ||.+.........  .......|+..|+|||...+..++.++||||+|+++|++++|..||.......  ....+.... 
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~-  224 (268)
T cd06630         148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIA-  224 (268)
T ss_pred             cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHHh-
Confidence            9998876543211  11223568899999999888889999999999999999999999996432211  111111100 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           ..  ...+...........+++.+|++.+|++||++.+++++
T Consensus       225 -----~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         225 -----SA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -----cc--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                 00  00011111112234557888999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.9e-33  Score=303.70  Aligned_cols=249  Identities=24%  Similarity=0.371  Sum_probs=197.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|.+. +++.||+|.+......             ...+.+.+|+.++++++||||++++++
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~~~   70 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYVTKYYGS   70 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch-------------HHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            45677889999999999999764 5889999987533211             124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||+++++|.+++...   .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~d  144 (277)
T cd06641          71 YLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLAD  144 (277)
T ss_pred             EEeCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEee
Confidence            99999999999999999999998643   378999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||++........  ......|+..|+|||...+..++.++|+|||||++|+|++|..||....+.  .....+...  . 
T Consensus       145 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~--~-  217 (277)
T cd06641         145 FGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--KVLFLIPKN--N-  217 (277)
T ss_pred             cccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--HHHHHHhcC--C-
Confidence            999876544321  122356888999999988888899999999999999999999999643221  111111100  0 


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         .+.+....+      ....+++.+||+.+|++||++.+++++
T Consensus       218 ---~~~~~~~~~------~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         218 ---PPTLEGNYS------KPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---CCCCCcccC------HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               001111111      223457788999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.5e-33  Score=311.71  Aligned_cols=249  Identities=21%  Similarity=0.335  Sum_probs=194.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|.....||+|+||.||+|... +++.||+|.+.....              ...+.+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~hp~i~~~~~~~   87 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--------------QRRELLFNEVVIMRDYQHQNVVEMYKSY   87 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--------------chHHHHHHHHHHHHhCCCCchhhhhhhe
Confidence            3444557999999999999765 689999999853221              1245688999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ..++..|+||||+++++|.+++...   .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        88 ~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~df  161 (297)
T cd06659          88 LVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDF  161 (297)
T ss_pred             eeCCeEEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeec
Confidence            9999999999999999999987543   388999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |+++.......  ......|+..|+|||+..+..++.++|||||||++|||++|+.||....+.  .....+....   .
T Consensus       162 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~---~  234 (297)
T cd06659         162 GFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSP---P  234 (297)
T ss_pred             hhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccC---C
Confidence            99875543221  123456899999999998888999999999999999999999999743221  1111111100   0


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ..... ..   .......+++.+|++.+|++||++++++++
T Consensus       235 ---~~~~~-~~---~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         235 ---PKLKN-AH---KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ---CCccc-cC---CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence               00000 00   011123457788999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.8e-33  Score=304.23  Aligned_cols=263  Identities=24%  Similarity=0.334  Sum_probs=198.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|.+.+.||+|+||.||+|.+. +|+.||+|++.......            ...+.+.+|+.++++++||||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~   68 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG------------GIPNQALREIKALQACQHPYVVKLLDVF   68 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc------------hhhHHHHHHHHHHHhCCCCCCcceeeEE
Confidence            4778889999999999999775 58999999986543211            2346789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .++...|+||||+ +++|.+++.... ..+++..+..++.||++||+|||+.   +++|+||||+||+++.++.++|+||
T Consensus        69 ~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~df  143 (286)
T cd07832          69 PHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADF  143 (286)
T ss_pred             ecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeee
Confidence            9999999999999 999999987644 4489999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc-
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA-  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-  923 (1035)
                      |.+........ .......|+..|+|||+..+. .++.++||||+|+++|||++|..||....+.  ....++...... 
T Consensus       144 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~  220 (286)
T cd07832         144 GLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGTP  220 (286)
T ss_pred             eecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCCC
Confidence            99886644321 122345689999999987654 4688999999999999999998887643221  111111110000 


Q ss_pred             -h-------h--hhcc-cccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 -I-------E--VLDK-SLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 -~-------~--~~~~-~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       .       +  .... ..........     .......+++.+|+++||++||++++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0       0  0000 0000000000     011345668889999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-35  Score=341.87  Aligned_cols=254  Identities=29%  Similarity=0.380  Sum_probs=198.5

Q ss_pred             hccccCCeeeeeCCcEEEEE-EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      -++.....||.|.||.||.| ...+|+..|+|-+......            ....+.+.+|+.++..++|||+|++||+
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------------~k~~~~i~eEm~vlE~lnHpNlV~YyGV 1302 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------------HKTFKLIAEEMKVLEGLNHPNLVRYYGV 1302 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------------cccCcchHHHHHHHHhccCccccccCce
Confidence            35667789999999999999 4556999999988653332            1335678899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      -.+++..++.||||+||+|.+.+...+.  .++.....+..|++.|++|||+.   |||||||||.||+++.+|.+|++|
T Consensus      1303 EvHRekv~IFMEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~D 1377 (1509)
T KOG4645|consen 1303 EVHREKVYIFMEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGD 1377 (1509)
T ss_pred             eecHHHHHHHHHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeec
Confidence            9999999999999999999999876543  55566667788999999999999   999999999999999999999999


Q ss_pred             ccCccccccCC--ccccccccCCcccccCCcccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          845 FGLAKLVVEGD--FARSSNTVAGSYGYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       845 FG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||.|..+....  ....-....||+.|||||++.+..   ...++||||+|||+.||+||+.||.....+ ..+...|- 
T Consensus      1378 FGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~- 1455 (1509)
T KOG4645|consen 1378 FGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVA- 1455 (1509)
T ss_pred             ccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHh-
Confidence            99998776542  122234678999999999987544   557899999999999999999999754322 22222111 


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       .+.          .|..+..-.....+++..|+..||++|.++.|++++
T Consensus      1456 -~gh----------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 -AGH----------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -ccC----------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence             111          111111122234567888999999999999888775

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=300.37  Aligned_cols=203  Identities=25%  Similarity=0.289  Sum_probs=180.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|..-++||+||||.||-++.+ +|+.||.|++.++.....           ........|-.++.+++.+.||.+--.
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr-----------~ge~maLnEk~iL~kV~s~FiVslaYA  253 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKR-----------KGETMALNEKQILEKVSSPFIVSLAYA  253 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHh-----------hhhHHhhHHHHHHHHhccCcEEEEeee
Confidence            34556679999999999999665 499999999866544332           234556789999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |+..+..++||..|.||+|.-++...+...+++.++..++.+|+.||++||+.   +||+||+||+|||+|+.|+++|+|
T Consensus       254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISD  330 (591)
T KOG0986|consen  254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISD  330 (591)
T ss_pred             ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeec
Confidence            99999999999999999999998887777899999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      .|+|..+.++...   ...+||.+|||||+.....|+...|.||+||++|||+.|+.||..
T Consensus       331 LGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  331 LGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             cceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence            9999988766432   245899999999999999999999999999999999999999964

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=5.1e-33  Score=305.76  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=193.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .+.|+..+.||+|+||.||+|.+. +++.||+|++....               ....++..|+.+++++ +||||++++
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---------------~~~~~~~~e~~~l~~~~~h~~i~~~~   79 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---------------DEEEEIKLEINMLKKYSHHRNIATYY   79 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---------------HHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence            367888889999999999999775 58899999874321               1135688899999999 699999999


Q ss_pred             eEEEc------CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          763 GCCWN------RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       763 ~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                      +++..      ....|++|||+.+|+|.+++.......+++..+..++.|++.|++|||+.   +|+||||||+||+++.
T Consensus        80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~  156 (282)
T cd06636          80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTE  156 (282)
T ss_pred             eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence            99853      35679999999999999999876655688888999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch
Q 039419          837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL  911 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~  911 (1035)
                      ++.++|+|||++.......  .......|+..|+|||...     ...++.++|||||||++|||++|..||....+...
T Consensus       157 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~  234 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA  234 (282)
T ss_pred             CCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence            9999999999987553221  1223456899999999865     34678899999999999999999999965432110


Q ss_pred             hHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .    .....    .......   ..  .......+++.+||+.||.+||++.|++++
T Consensus       235 ~----~~~~~----~~~~~~~---~~--~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 L----FLIPR----NPPPKLK---SK--KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             h----hhHhh----CCCCCCc---cc--ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            0    00000    0000000   00  111234567888999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-33  Score=303.56  Aligned_cols=249  Identities=23%  Similarity=0.330  Sum_probs=195.8

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC---CCceeeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR---HKNIVRFL  762 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~  762 (1035)
                      .|...+.||+|+||.||+|.+. +++.||+|.+.......             ..+++.+|+.++++++   |||+++++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~-------------~~~~~~~e~~~l~~l~~~~~~~vi~~~   68 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD-------------DVSDIQREVALLSQLRQSQPPNITKYY   68 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch-------------hHHHHHHHHHHHHHhccCCCCCeeeEe
Confidence            4667789999999999999764 68999999986432211             2457889999999996   99999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+....|+||||+++++|.++++..   .+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|
T Consensus        69 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l  142 (277)
T cd06917          69 GSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKL  142 (277)
T ss_pred             eeeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEE
Confidence            9999999999999999999999998653   488999999999999999999998   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      +|||.+........  ......|+..|+|||...+ ..++.++||||||+++|+|++|+.||......     .+.....
T Consensus       143 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~  215 (277)
T cd06917         143 CDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIP  215 (277)
T ss_pred             ccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccc
Confidence            99999987654431  2234568999999998764 44688999999999999999999999754221     1111100


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .   ...+.+...   .  ....+.+++.+||+.||++||++.+++++
T Consensus       216 ~---~~~~~~~~~---~--~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         216 K---SKPPRLEDN---G--YSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             c---CCCCCCCcc---c--CCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            0   000111110   0  11234567888999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.6e-33  Score=305.37  Aligned_cols=253  Identities=27%  Similarity=0.392  Sum_probs=193.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .++|...+.||+|+||.||+|... +++.+|+|.+....               ...+.+.+|+.+++++ +|||+++++
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------------~~~~~~~~e~~~l~~l~~h~ni~~~~   85 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------------DVDEEIEAEYNILQSLPNHPNVVKFY   85 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------------cHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            567889999999999999999765 58899999985421               1235678899999999 799999999


Q ss_pred             eEEEcC-----CcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          763 GCCWNR-----NTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       763 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      +++...     +..|+||||+++++|.++++..  ....+++..+..++.|++.||+|||+.   +++||||||+||+++
T Consensus        86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~  162 (291)
T cd06639          86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLT  162 (291)
T ss_pred             EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEc
Confidence            998754     3579999999999999988642  224488999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccC-----CCCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG  910 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~  910 (1035)
                      .++.+||+|||.+........  ......|+..|+|||+....     .++.++|||||||++|||++|+.||....+. 
T Consensus       163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-  239 (291)
T cd06639         163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-  239 (291)
T ss_pred             CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-
Confidence            999999999999886543221  12345688999999986543     3678999999999999999999999754221 


Q ss_pred             hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....+.+   ...    .... .++   .....+..++.+||+.+|++||++.+++++
T Consensus       240 ~~~~~~~~---~~~----~~~~-~~~---~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         240 KTLFKIPR---NPP----PTLL-HPE---KWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHHHhc---CCC----CCCC-ccc---ccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11111110   000    0000 011   111234567888999999999999999874

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-33  Score=304.00  Aligned_cols=253  Identities=26%  Similarity=0.358  Sum_probs=195.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .++|...+.||+|+||.||+|..+ +++.+++|++.....               ..+.+.+|+.+++++ +||||++++
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------------~~~~~~~e~~~l~~~~~h~~i~~~~   69 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---------------EEEEIKEEYNILRKYSNHPNIATFY   69 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------------hHHHHHHHHHHHHHhcCCCChheEE
Confidence            467889999999999999999875 578999999854321               245789999999999 699999999


Q ss_pred             eEEEcCC------cceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE
Q 039419          763 GCCWNRN------TRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       763 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll  834 (1035)
                      +++.+..      ..|+||||+++++|.+++....  ...+++..+..++.|++.||+|||+.   +++||||+|+||++
T Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~  146 (275)
T cd06608          70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILL  146 (275)
T ss_pred             EEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEE
Confidence            9997654      4799999999999999987543  34589999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeccCccccccCCccccccccCCcccccCCccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 039419          835 GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE  909 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~  909 (1035)
                      +.++.++|+|||.+.......  .......|+..|+|||+...     ..++.++||||||+++|+|++|+.||....+.
T Consensus       147 ~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  224 (275)
T cd06608         147 TKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM  224 (275)
T ss_pred             ccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH
Confidence            999999999999987654322  22234568999999998643     34678999999999999999999999643221


Q ss_pred             chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ........           ...............+.+++.+||..||++|||+.+++++
T Consensus       225 -~~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         225 -RALFKIPR-----------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -HHHHHhhc-----------cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             11111100           0000000000111234467888999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=9.2e-33  Score=300.62  Aligned_cols=252  Identities=24%  Similarity=0.398  Sum_probs=197.3

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||.|+||.||+|... +++.||+|.+.......            ...+++..|++++++++||||+++++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE------------KEKQQLVSEVNILRELKHPNIVRYYDRI   68 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH------------HHHHHHHHHHHHHHhcCCCccceeeeee
Confidence            3677889999999999999654 58899999986533221            1246788999999999999999999988


Q ss_pred             Ec--CCcceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhh-----ccCCCCeeccCCCcccEEEcC
Q 039419          766 WN--RNTRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLH-----HDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       766 ~~--~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~ivHrDikp~NIll~~  836 (1035)
                      ..  ....|++|||+++++|.+++....  ...+++..+..++.|++.||+|+|     +.   +++||||||+||+++.
T Consensus        69 ~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~  145 (265)
T cd08217          69 IDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDA  145 (265)
T ss_pred             ecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEec
Confidence            64  345789999999999999987542  245899999999999999999999     66   9999999999999999


Q ss_pred             CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      ++.+||+|||.++.......  ......|++.|+|||+..+..++.++|+||||+++|+|++|+.||.....  ......
T Consensus       146 ~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~  221 (265)
T cd08217         146 NNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASK  221 (265)
T ss_pred             CCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHH
Confidence            99999999999987644321  12345689999999999888899999999999999999999999975431  111121


Q ss_pred             HHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +..         ......+.   .....+.+++.+|++.+|++||++.+|+++
T Consensus       222 ~~~---------~~~~~~~~---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         222 IKE---------GKFRRIPY---RYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             Hhc---------CCCCCCcc---ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            111         00111111   111234567888999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.1e-33  Score=307.24  Aligned_cols=266  Identities=23%  Similarity=0.295  Sum_probs=197.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|.+. +++.||||++..........         .....+..|++++++++||||+++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~---------~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKD---------GINFTALREIKLLQELKHPNIIGLLDVF   71 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccc---------hhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence            3677789999999999999765 58999999997544331111         2345678899999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||+ +|+|.+++.... ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.++|+||
T Consensus        72 ~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          72 GHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             ecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence            9999999999999 999999997654 3589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc-
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA-  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-  923 (1035)
                      |+++.......  ......++..|+|||.+.+ ..++.++|||||||++|||++|..||....+.. ............ 
T Consensus       147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~  223 (298)
T cd07841         147 GLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPT  223 (298)
T ss_pred             eeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCc
Confidence            99987644321  1223456788999998754 457889999999999999999987776433211 111110000000 


Q ss_pred             hh------hhcccc--cCCCccc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IE------VLDKSL--RARPEVE-----IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~------~~~~~~--~~~~~~~-----~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..      ......  ...+...     ......+.+++.+||++||++||+++|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00      000000  0000000     0112345578899999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.3e-32  Score=299.36  Aligned_cols=252  Identities=29%  Similarity=0.408  Sum_probs=201.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|++|.||+|.... ++.||+|++......             ...+.+.+|+.++++++||||+++++++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------------EFRKQLLRELKTLRSCESPYVVKCYGAF   68 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-------------HHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            57788999999999999997764 899999998654321             1256799999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      ...+..++||||+++++|.+++....  .+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++|+|
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~d  143 (264)
T cd06623          69 YKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIAD  143 (264)
T ss_pred             ccCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEcc
Confidence            99999999999999999999997653  48999999999999999999999 8   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC-CchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP-EGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~-~~~~~~~~~~~~~~~  923 (1035)
                      ||.+.........  .....++..|+|||...+..++.++|+||||+++|+|++|+.||..... .......++..    
T Consensus       144 f~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----  217 (264)
T cd06623         144 FGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----  217 (264)
T ss_pred             CccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----
Confidence            9999866443221  1245688999999998888899999999999999999999999976532 11111111110    


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        .........   .  .......++..||+++|++||++.+++++
T Consensus       218 --~~~~~~~~~---~--~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         218 --GPPPSLPAE---E--FSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --CCCCCCCcc---c--CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              000111111   0  11234557778999999999999999884

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4e-33  Score=302.27  Aligned_cols=251  Identities=25%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|...+.||.|+||.||+|.+. +++.||+|++........           ...+.+.+|++++++++||||+++++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   69 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK-----------GSVRNVLNERRILQELNHPFLVNLWYSF   69 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch-----------hHHHHHHHHHHHHHhCCCCChHHHHHhh
Confidence            3778889999999999999776 589999999965332221           2356899999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+....|+||||+.|++|.+++...  ..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+||
T Consensus        70 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~  144 (258)
T cd05578          70 QDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDF  144 (258)
T ss_pred             cCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeec
Confidence            9999999999999999999999765  3488999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |.+.......   ......|+..|+|||+..+..++.++|+||+|+++|+|++|..||......   ...+.......  
T Consensus       145 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~--  216 (258)
T cd05578         145 NIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET--  216 (258)
T ss_pred             ccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc--
Confidence            9988654432   223456889999999988888999999999999999999999999755332   11111111100  


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH--HHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM--KDVAA  968 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~--~el~~  968 (1035)
                       ........      ......+++.+||+.||++||++  +|+++
T Consensus       217 -~~~~~~~~------~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 -ADVLYPAT------WSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccccCccc------CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             00011111      11334567888999999999999  66543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-33  Score=310.00  Aligned_cols=206  Identities=25%  Similarity=0.353  Sum_probs=168.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +|...+.||+|+||.||+|...   +++.||+|.+........           ...+.+.+|+.++++++||||+++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-----------GISQSACREIALLRELKHENVVSLVE   69 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc-----------CccHHHHHHHHHHHhcCCCCccceEE
Confidence            3677889999999999999765   378999999976432111           22456789999999999999999999


Q ss_pred             EEEcC--CcceEEEEeCCCCChhhhhhhcC---CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC--
Q 039419          764 CCWNR--NTRLLMYDYMPNGSLGSLLHERR---DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP--  836 (1035)
Q Consensus       764 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~--  836 (1035)
                      ++.+.  +..|+||||++ +++.+++....   ...++...+..++.|++.||+|||+.   +|+||||||+||+++.  
T Consensus        70 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~  145 (316)
T cd07842          70 VFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEG  145 (316)
T ss_pred             EEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCC
Confidence            99988  78999999996 47777665332   13578899999999999999999999   9999999999999999  


Q ss_pred             --CCceEEeeccCccccccCCc-cccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCC
Q 039419          837 --EFEPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTI  907 (1035)
Q Consensus       837 --~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~  907 (1035)
                        ++.+||+|||+++....... ........++..|+|||+..+. .++.++||||||+++|||++|+.||....
T Consensus       146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence              99999999999986544322 1122345688999999987654 57899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.4e-33  Score=307.85  Aligned_cols=264  Identities=22%  Similarity=0.330  Sum_probs=196.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|.++ .++.||+|++.......            ...+.+.+|++++++++||||++++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~   68 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK------------MVKKIAMREIRMLKQLRHENLVNLIEV   68 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc------------hhhHHHHHHHHHHHhcCCcchhhHHHh
Confidence            35788899999999999999876 48999999985432211            124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||+++++|..+......  +++..+..++.||++|++|||+.   +++||||+|+||+++.++.++|+|
T Consensus        69 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~d  143 (286)
T cd07846          69 FRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCD  143 (286)
T ss_pred             cccCCeEEEEEecCCccHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEe
Confidence            9999999999999999999887765433  89999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||++.......  .......++..|+|||+..+ ..++.++||||||+++|||++|+.||...... .............
T Consensus       144 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~  220 (286)
T cd07846         144 FGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNL  220 (286)
T ss_pred             eeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCC
Confidence            99988654432  22234568899999998765 45778999999999999999999998643211 0000000000000


Q ss_pred             ----------hhhhccc-ccCCC-cccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 ----------IEVLDKS-LRARP-EVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ----------~~~~~~~-~~~~~-~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                                ....... ..... ....     .......+++.+||+.+|++||++.+++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             chhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence                      0000000 00000 0000     011234568889999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-32  Score=299.83  Aligned_cols=254  Identities=29%  Similarity=0.410  Sum_probs=198.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|... +++.||+|.+.......            ...+.+..|+.++++++|+||+++++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~   68 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDP------------KTIKEIADEMKVLELLKHPNLVKYYGVE   68 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccch------------HHHHHHHHHHHHHHhCCCCChhheeeeE
Confidence            4778899999999999999765 68999999986543221            2356899999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++|+||+++++|.+++....  .+++..+..++.++++|++|||+.   +++|+||+|+||+++.++.+||+||
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~  143 (264)
T cd06626          69 VHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDF  143 (264)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccc
Confidence            99999999999999999999997653  378899999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCcccc--ccccCCcccccCCcccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          846 GLAKLVVEGDFARS--SNTVAGSYGYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       846 G~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |.+...........  .....++..|+|||+..+..   ++.++||||||+++||+++|+.||...... ......+.. 
T Consensus       144 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-~~~~~~~~~-  221 (264)
T cd06626         144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-FQIMFHVGA-  221 (264)
T ss_pred             ccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-HHHHHHHhc-
Confidence            99987654332111  11356788999999987665   889999999999999999999999754221 111111110 


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                       .    ..+...    ..........+++.+||+.+|++||++.+++.
T Consensus       222 -~----~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 -G----HKPPIP----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -C----CCCCCC----cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0    000011    11111223346788899999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.5e-33  Score=305.74  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=198.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|... +++.||+|.+.....              ...+.+.+|+.++++++||||+++++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~hp~i~~~~~   83 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--------------PKKELIINEILVMRENKHPNIVNYLD   83 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--------------hHHHHHHHHHHHHhhcCCCCeeehhh
Confidence            467888999999999999999654 578999999843211              12457889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++...+..|+||||+++++|.+++....   +++..+..++.|++.|+.|||+.   |++||||||+||+++.++.++|+
T Consensus        84 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~  157 (293)
T cd06647          84 SYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT  157 (293)
T ss_pred             eeeeCCcEEEEEecCCCCcHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEc
Confidence            9999999999999999999999987542   78899999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||++........  ......|++.|+|||...+..++.++||||||+++|++++|+.||....+.... ..+.   .  
T Consensus       158 dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~---~--  229 (293)
T cd06647         158 DFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIA---T--  229 (293)
T ss_pred             cCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eehh---c--
Confidence            9999876544322  223456889999999988888899999999999999999999999754321110 0000   0  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ............  .....+++.+||+.+|++||++.+++.+
T Consensus       230 ----~~~~~~~~~~~~--~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 ----NGTPELQNPEKL--SAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ----CCCCCCCCcccc--CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                000000001111  1224457888999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-34  Score=283.11  Aligned_cols=261  Identities=23%  Similarity=0.268  Sum_probs=200.3

Q ss_pred             cCccHHHHHhccccC-CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-
Q 039419          677 LNFTVEQVLKCLVED-SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-  753 (1035)
Q Consensus       677 ~~~~~~~~~~~~~~~-~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-  753 (1035)
                      +.|.-..++++|.+. ++||-|-.|.|..+.++ +|+++|+|++..                   .....+|++.--.. 
T Consensus        52 m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------------------s~KARrEVeLHw~~s  112 (400)
T KOG0604|consen   52 MDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------------------SPKARREVELHWMAS  112 (400)
T ss_pred             cchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------------------CHHHHhHhhhhhhhc
Confidence            344445566777755 68999999999999665 589999999843                   23455788776555 


Q ss_pred             CCCceeeEEeEEEc----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCc
Q 039419          754 RHKNIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKA  829 (1035)
Q Consensus       754 ~hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp  829 (1035)
                      .|||||.+++++.+    .....+|||.++||.|.+.+.+++...+++.++..|+.||+.|+.|||+.   +|+||||||
T Consensus       113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKp  189 (400)
T KOG0604|consen  113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKP  189 (400)
T ss_pred             CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCCh
Confidence            59999999999864    34568999999999999999999999999999999999999999999999   999999999


Q ss_pred             ccEEEcC---CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          830 NNILIGP---EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       830 ~NIll~~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      +|+|...   +..+||+|||+|+.-..   .....+.+-|+.|+|||+....+|+...|+||+||++|-|++|.+||...
T Consensus       190 ENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  190 ENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_pred             hheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence            9999964   56799999999986432   22334567899999999999999999999999999999999999999765


Q ss_pred             CCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ......  .   .++..+..-...+....+..+.+.  .-+++...+.-+|.+|-|+.+++++
T Consensus       267 hg~ais--p---gMk~rI~~gqy~FP~pEWs~VSe~--aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  267 HGLAIS--P---GMKRRIRTGQYEFPEPEWSCVSEA--AKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             CCccCC--h---hHHhHhhccCccCCChhHhHHHHH--HHHHHHHHhcCCchhheeHHHhhcC
Confidence            432111  0   000011111111122222223333  3357888899999999999999874

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.5e-33  Score=303.41  Aligned_cols=247  Identities=21%  Similarity=0.243  Sum_probs=191.1

Q ss_pred             eeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcce
Q 039419          694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL  772 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  772 (1035)
                      ||+|+||+||+|... +|+.||+|.+........           ...+.+..|++++++++||||+++++++...+..|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   69 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR-----------KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLC   69 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhh-----------hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEE
Confidence            689999999999655 589999999865322211           12456778999999999999999999999999999


Q ss_pred             EEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccc
Q 039419          773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV  852 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~  852 (1035)
                      +||||+++++|.+++.......+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+....
T Consensus        70 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~  146 (277)
T cd05577          70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELK  146 (277)
T ss_pred             EEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence            999999999999999876655689999999999999999999999   99999999999999999999999999987654


Q ss_pred             cCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccccc
Q 039419          853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR  932 (1035)
Q Consensus       853 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (1035)
                      ..   .......++..|+|||+..+..++.++||||+|+++|+|++|+.||........ . ..+.....   .......
T Consensus       147 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~-~~~~~~~~---~~~~~~~  218 (277)
T cd05577         147 GG---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-K-EELKRRTL---EMAVEYP  218 (277)
T ss_pred             cC---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-H-HHHHhccc---cccccCC
Confidence            32   122345678899999998888899999999999999999999999975432110 0 00100000   0000011


Q ss_pred             CCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 039419          933 ARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAA  968 (1035)
Q Consensus       933 ~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~  968 (1035)
                      ...      .....+++.+||+.||++||     ++.++++
T Consensus       219 ~~~------~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         219 DKF------SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccC------CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            111      12335678889999999999     6666655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-32  Score=302.81  Aligned_cols=252  Identities=22%  Similarity=0.352  Sum_probs=189.7

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHH-HhcCCCCceeeEEeE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT-LGSIRHKNIVRFLGC  764 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~  764 (1035)
                      +|.+.+.||+|+||.||+|.+. +|+.||+|++.......             ...++..|+.+ ++..+||||++++++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~~~~iv~~~~~   68 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-------------EQKRLLMDLDISMRSVDCPYTVTFYGA   68 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-------------HHHHHHHHHHHHHHHcCCCCeeeeeEE
Confidence            5788899999999999999776 58999999986542211             12345566665 566789999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +..++..|+||||++ |+|.+++...  ....+++..+..++.||+.|++|||+++  +++||||||+||+++.++.+||
T Consensus        69 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl  145 (283)
T cd06617          69 LFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKL  145 (283)
T ss_pred             EecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEE
Confidence            999999999999996 6888887643  2245899999999999999999999852  7999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCccccc----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      +|||.+.......   ......|+..|+|||.+.+    ..++.++|+||||+++|||++|+.||...............
T Consensus       146 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  222 (283)
T cd06617         146 CDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE  222 (283)
T ss_pred             eeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence            9999988654321   1123468889999998754    45688999999999999999999999643221111111110


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .       ...   ..+.....  ..+..++.+||..+|++||++.+++++
T Consensus       223 ~-------~~~---~~~~~~~~--~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         223 E-------PSP---QLPAEKFS--PEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             c-------CCC---CCCccccC--HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0       000   00111111  224557888999999999999999884

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-33  Score=305.20  Aligned_cols=263  Identities=23%  Similarity=0.317  Sum_probs=197.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|.++ +++.||+|++.......            ...+.+.+|++++++++||||+++++++
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   69 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE------------DVKKTALREVKVLRQLRHENIVNLKEAF   69 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc------------cchhHHHHHHHHHHhcCCCCeeehhheE
Confidence            5788899999999999999776 48899999986532211            2356889999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||++++.+..+.....  .+++..+..++.||+.|++|||+.   +++||||+|+||+++.++.+||+||
T Consensus        70 ~~~~~~~iv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~  144 (288)
T cd07833          70 RRKGRLYLVFEYVERTLLELLEASPG--GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDF  144 (288)
T ss_pred             EECCEEEEEEecCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEee
Confidence            99999999999999877766654433  388999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc-
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA-  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-  923 (1035)
                      |.+........ .......++..|+|||+..+. .++.++||||||+++|+|++|+.||......  ............ 
T Consensus       145 g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~  221 (288)
T cd07833         145 GFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPL  221 (288)
T ss_pred             ecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCC
Confidence            99987654432 122345688999999998877 7889999999999999999999999743221  111000000000 


Q ss_pred             ----hhhh--ccccc-----CCC-cccH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 ----IEVL--DKSLR-----ARP-EVEI------EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ----~~~~--~~~~~-----~~~-~~~~------~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ....  +....     ... ....      .......+++.+||+.+|++||++++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             CHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                0000  00000     000 0000      012345678889999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-32  Score=299.86  Aligned_cols=245  Identities=22%  Similarity=0.307  Sum_probs=194.4

Q ss_pred             eeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcce
Q 039419          694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL  772 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  772 (1035)
                      ||.|+||.||+|.... ++.||+|++........           ...+.+.+|+.++++++||||+++++++.++...|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   69 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVET-----------GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIY   69 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhh-----------hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccE
Confidence            6999999999997764 89999999865432221           23567999999999999999999999999999999


Q ss_pred             EEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccc
Q 039419          773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV  852 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~  852 (1035)
                      +||||+++++|.+++.....  +++..+..++.|++.||+|+|+.   +++|+||||+||+++.++.++|+|||.++...
T Consensus        70 lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~  144 (262)
T cd05572          70 MLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK  144 (262)
T ss_pred             EEEecCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccC
Confidence            99999999999999976543  88999999999999999999998   99999999999999999999999999998764


Q ss_pred             cCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccccc
Q 039419          853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR  932 (1035)
Q Consensus       853 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (1035)
                      ...   ......|+..|+|||...+..++.++|+||+|+++|+|++|..||.....+..   ......      ......
T Consensus       145 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~------~~~~~~  212 (262)
T cd05572         145 SGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYNDI------LKGNGK  212 (262)
T ss_pred             ccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHHHH------hccCCC
Confidence            432   12345688999999998888899999999999999999999999975532111   111111      100000


Q ss_pred             CCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 039419          933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAA  968 (1035)
Q Consensus       933 ~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~  968 (1035)
                      ...+...  ......++.+||+.+|++||+     ++|+++
T Consensus       213 ~~~~~~~--~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         213 LEFPNYI--DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCCccc--CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1111111  224466888899999999999     777766

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.8e-32  Score=300.39  Aligned_cols=245  Identities=20%  Similarity=0.222  Sum_probs=184.8

Q ss_pred             eeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHh---cCCCCceeeEEeEEEcC
Q 039419          693 VVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG---SIRHKNIVRFLGCCWNR  768 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~---~l~hpniv~l~~~~~~~  768 (1035)
                      .||+|+||.||+|... +++.||+|.+........           .....+.+|..+++   ..+||+|+.+++++..+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~   69 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----------QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP   69 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-----------hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC
Confidence            4799999999999775 589999999865433221           01223444544433   34799999999999999


Q ss_pred             CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCc
Q 039419          769 NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA  848 (1035)
Q Consensus       769 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a  848 (1035)
                      +..++||||+++|+|.+++...+.  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||++
T Consensus        70 ~~~~lv~e~~~~~~L~~~i~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~  144 (279)
T cd05633          70 DKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (279)
T ss_pred             CeEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcc
Confidence            999999999999999999876543  89999999999999999999999   9999999999999999999999999998


Q ss_pred             cccccCCccccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhh
Q 039419          849 KLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVL  927 (1035)
Q Consensus       849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1035)
                      .......    .....|+..|+|||... +..++.++||||+||++|||++|..||................      ..
T Consensus       145 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------~~  214 (279)
T cd05633         145 CDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------TV  214 (279)
T ss_pred             eeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh------cC
Confidence            7543321    12346899999999876 4568899999999999999999999997543322111111000      00


Q ss_pred             cccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       928 ~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      ...+....      .....+++.+|++.||++||     ++++++++
T Consensus       215 ~~~~~~~~------~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 NVELPDSF------SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CcCCcccc------CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            11111111      12334577889999999999     59888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=4.7e-33  Score=301.55  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=198.3

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|..+ +|..||+|.+.......            ...+.+.+|++++++++||||+++++.+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~E~~~l~~~~h~~i~~~~~~~   68 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------------KEKEASKKEVILLAKMKHPNIVTFFASF   68 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------------hhhHHHHHHHHHHHhCCCCChhhhhhee
Confidence            3677889999999999999775 48899999985532211            1245788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC-ceEEee
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF-EPYIAD  844 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~D  844 (1035)
                      .+.+..|+||||+++++|.+++.......+++..+..++.|+++|++|||+.   +++|+||||+||++++++ .++++|
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d  145 (257)
T cd08225          69 QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGD  145 (257)
T ss_pred             ccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecc
Confidence            9999999999999999999999776555589999999999999999999998   999999999999999886 469999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||.+........  ......|++.|+|||+..+..++.++||||||+++|||++|+.||.....     ..++.....  
T Consensus       146 ~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~--  216 (257)
T cd08225         146 FGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQ--  216 (257)
T ss_pred             cccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhc--
Confidence            999986644321  12234688999999998888899999999999999999999999964321     122221111  


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          .......+   .......+++.+||..+|++||++.+++++
T Consensus       217 ----~~~~~~~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         217 ----GYFAPISP---NFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ----ccCCCCCC---CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                00111111   011234567888999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.5e-32  Score=306.61  Aligned_cols=273  Identities=22%  Similarity=0.316  Sum_probs=198.5

Q ss_pred             CccHHHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCC
Q 039419          678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHK  756 (1035)
Q Consensus       678 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  756 (1035)
                      .|.+.+..++|...+.||+|+||.||+|... +++.||||++.......            .....+.+|++++++++||
T Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~   71 (310)
T cd07865           4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE------------GFPITALREIKILQLLKHE   71 (310)
T ss_pred             cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC------------CchhHHHHHHHHHHhCCCC
Confidence            3455667788999999999999999999765 58999999985432111            1234567899999999999


Q ss_pred             ceeeEEeEEEcCCc--------ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCC
Q 039419          757 NIVRFLGCCWNRNT--------RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIK  828 (1035)
Q Consensus       757 niv~l~~~~~~~~~--------~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDik  828 (1035)
                      ||+++++++...+.        .++||||+. +++.+++.... ..+++..+..++.||+.||+|||+.   +++|+|||
T Consensus        72 ~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~  146 (310)
T cd07865          72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMK  146 (310)
T ss_pred             CccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence            99999999876543        499999995 58888876543 3489999999999999999999999   99999999


Q ss_pred             cccEEEcCCCceEEeeccCccccccCCcc--ccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          829 ANNILIGPEFEPYIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       829 p~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      |+||+++.++.+||+|||.+.........  .......++..|+|||...+. .++.++||||||+++|||++|+.||..
T Consensus       147 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             HHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999866433211  112234578899999987654 478899999999999999999999975


Q ss_pred             CCCCchhHHHHHHHhccc-----------hhhhcc-cccCCCcccHH-------HHHHHHHHHHhccCCCCCCCCCHHHH
Q 039419          906 TIPEGLHIVDWVRQKRGA-----------IEVLDK-SLRARPEVEIE-------EMLQTLGVALLCVNPTPDDRPTMKDV  966 (1035)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~-----------~~~~~~-~~~~~~~~~~~-------~~~~~l~l~~~cl~~dP~~RPs~~el  966 (1035)
                      ..+.  .....+....+.           .+..+. ...........       ......+++.+||..||++||+++++
T Consensus       227 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~  304 (310)
T cd07865         227 NTEQ--HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA  304 (310)
T ss_pred             CCHH--HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence            4321  111111110000           000000 00000000000       11234568999999999999999999


Q ss_pred             HHH
Q 039419          967 AAM  969 (1035)
Q Consensus       967 ~~~  969 (1035)
                      +++
T Consensus       305 l~h  307 (310)
T cd07865         305 LNH  307 (310)
T ss_pred             hcC
Confidence            864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-32  Score=323.28  Aligned_cols=283  Identities=16%  Similarity=0.149  Sum_probs=190.3

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEECC--CcEEEEEEecCCCcccc---cccccccccccccHHHHHHHHHHHhcCCCC
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEMEN--GEVIAVKKLWPTTMAAE---YDCQNDKIGIGGVRDSFSAEIKTLGSIRHK  756 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  756 (1035)
                      ....++|.+.+.||+|+||+||++..+.  +..+++|.+........   ....+...........+.+|+.++++++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            3456889999999999999999986543  33333332211100000   000000000112345788999999999999


Q ss_pred             ceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          757 NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD---SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      |||++++++.+.+..|+|||++ ++++.+++.....   .......+..++.||+.||+|||+.   +|+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            9999999999999999999998 5678777654321   1234566778999999999999998   9999999999999


Q ss_pred             EcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCC-CCCCCCC-ch
Q 039419          834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPE-GL  911 (1035)
Q Consensus       834 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P-~~~~~~~-~~  911 (1035)
                      ++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..| |...... ..
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999987654322 122346799999999999998999999999999999999998764 4322211 11


Q ss_pred             hHHHHHHHhccc-hh----------hhcccccCCCcccHHHH-------HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          912 HIVDWVRQKRGA-IE----------VLDKSLRARPEVEIEEM-------LQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       912 ~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~-------~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+...+...... .+          .+...........+...       .....++.+|++.||++||++.|++++
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            222211110000 00          00000000000001111       123345778999999999999999985

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.8e-32  Score=302.78  Aligned_cols=265  Identities=18%  Similarity=0.224  Sum_probs=182.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|.+.+.||+|+||+||+|.+.+    +..+|+|+..........+   ..............+...+..++|++|+++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e---~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVME---TLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhH---HHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            578999999999999999997764    3456666543221100000   000000001223345556677899999999


Q ss_pred             EeEEEcCC----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          762 LGCCWNRN----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       762 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++++....    ..+++||++ ..++.+.+....  ..++..+..++.|++.||+|||+.   +|+||||||+|||++.+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            99876543    346788877 346766665432  257788899999999999999998   99999999999999999


Q ss_pred             CceEEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          838 FEPYIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      +.++|+|||+|+.+......     .......||+.|+|||+..+..++.++|||||||++|||++|+.||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999876432211     1122356999999999999999999999999999999999999999765322111


Q ss_pred             H----HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          913 I----VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       913 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      .    .+++...      ......  ++...   ....+++..|+..+|++||++.++.+.+
T Consensus       243 ~~~~~~~~~~~~------~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        243 IHAAKCDFIKRL------HEGKIK--IKNAN---KFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHhHHHHHHHh------hhhhhc--cCCCC---HHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1    0111110      000000  01111   1234567779999999999999998865

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2e-32  Score=302.72  Aligned_cols=263  Identities=22%  Similarity=0.248  Sum_probs=195.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.+|+|.++......            .....+.+|+.++++++||||+++++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~ni~~~~~   71 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE------------GFPITSLREINILLKLQHPNIVTVKE   71 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc------------cchhhHHHHHHHHHhcCCCCEEEEEE
Confidence            356888899999999999999776 58899999986543221            12346778999999999999999999


Q ss_pred             EEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          764 CCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       764 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++...  ...|+||||++ ++|.+++..... .+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~  146 (293)
T cd07843          72 VVVGSNLDKIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILK  146 (293)
T ss_pred             EEEecCCCcEEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEE
Confidence            99877  78999999996 599998876443 589999999999999999999998   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |+|||++.......  .......+++.|+|||...+. .++.++|+||+|+++|||++|..||......  .....+...
T Consensus       147 l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~  222 (293)
T cd07843         147 ICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI--DQLNKIFKL  222 (293)
T ss_pred             EeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHH
Confidence            99999988664432  112234578899999987654 4688999999999999999999999754221  100000000


Q ss_pred             cc-----------chh---------hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RG-----------AIE---------VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~-----------~~~---------~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..           ...         .....+....+.. .......+++.+||+.||++||++.|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         223 LGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL-SLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hCCCchHHHHHhhccchhcccccccccchhhhcccccc-CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00           000         0000000000000 012234567888999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-32  Score=301.52  Aligned_cols=248  Identities=22%  Similarity=0.338  Sum_probs=194.8

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |...+.||+|++|.||+|... +++.+|+|++.....              ...+.+.+|+.++++++||||+++++++.
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--------------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~   86 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--------------QRRELLFNEVVIMRDYQHPNIVEMYSSYL   86 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--------------hHHHHHHHHHHHHHHcCCCChheEEEEEE
Confidence            444579999999999999764 688999998743211              12456889999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      ..+..++|+||++|++|.+++...   .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||
T Consensus        87 ~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g  160 (285)
T cd06648          87 VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG  160 (285)
T ss_pred             cCCeEEEEEeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccc
Confidence            999999999999999999998762   388999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      .+.......  .......|++.|+|||...+..++.++||||||+++|||++|+.||....+.     .........   
T Consensus       161 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-----~~~~~~~~~---  230 (285)
T cd06648         161 FCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-----QAMKRIRDN---  230 (285)
T ss_pred             cchhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHhc---
Confidence            887543322  1123456899999999988888999999999999999999999999653221     111111100   


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+......    .....+.+++.+||+.+|++||++.+++++
T Consensus       231 ~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         231 LPPKLKNLH----KVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCCCCcccc----cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            000111110    011234568888999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.6e-32  Score=302.79  Aligned_cols=255  Identities=25%  Similarity=0.327  Sum_probs=190.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEeE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLGC  764 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~  764 (1035)
                      +|...+.||+|+||.||++.+. +++.||+|++......             .....+.+|+.++.++. ||||++++++
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~e~~~l~~~~~~~~iv~~~~~   71 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------------KEQKRLLMDLDVVMRSSDCPYIVKFYGA   71 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-------------HHHHHHHHHHHHHHHhcCCCCEeeeeeE
Confidence            4556678999999999999765 5899999998643322             12457889999999996 9999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhh---hhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLL---HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      +..++..+++|||+. +++.++.   .......+++..+..++.+++.||+|||+..  +++||||||+||+++.++.++
T Consensus        72 ~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~k  148 (288)
T cd06616          72 LFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIK  148 (288)
T ss_pred             EecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEE
Confidence            999999999999985 4655543   3333345899999999999999999999742  899999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccC---CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      |+|||+++.......   .....|+..|+|||++.+.   .++.++||||+||++|||++|+.||.....    ....+.
T Consensus       149 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~  221 (288)
T cd06616         149 LCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLT  221 (288)
T ss_pred             EeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHh
Confidence            999999976543221   1234688999999997765   688999999999999999999999964321    111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....   ..+.+.....  ......+.+++.+||++||++||++++++++
T Consensus       222 ~~~~~---~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         222 QVVKG---DPPILSNSEE--REFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             hhcCC---CCCcCCCcCC--CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            10000   0011111110  0112234567888999999999999999884

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.7e-32  Score=308.59  Aligned_cols=201  Identities=26%  Similarity=0.331  Sum_probs=169.5

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.++|...+.||+|+||.||+|... +++.||+|++.......            ...+.+.+|+.++++++||||+++
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~   80 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV------------THAKRAYRELVLMKLVNHKNIIGL   80 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh------------hHHHHHHHHHHHHHhcCCCCCcce
Confidence            35688999999999999999999765 68999999985432111            124567789999999999999999


Q ss_pred             EeEEEcC------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          762 LGCCWNR------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       762 ~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++...      ...|+||||+. ++|.+++...    ++...+..++.|++.||+|||+.   ||+||||||+||+++
T Consensus        81 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~  152 (353)
T cd07850          81 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK  152 (353)
T ss_pred             eeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEC
Confidence            9998644      24699999995 5888877543    78889999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      .++.+||+|||.++......   ......|+..|+|||...+..++.++|||||||++|+|++|+.||...
T Consensus       153 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         153 SDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             CCCCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            99999999999998654322   123456889999999999889999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.3e-32  Score=300.28  Aligned_cols=265  Identities=22%  Similarity=0.284  Sum_probs=194.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|++|+||+|.+. +++.||+|++.......            ...+.+.+|++++++++||||++++++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~~   69 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE------------GVPSTAIREISLLKEMQHGNIVRLQDV   69 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc------------cchHHHHHHHHHHHhccCCCEeeEEEE
Confidence            46888899999999999999775 58899999985432211            124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-CCceEEe
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-EFEPYIA  843 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~  843 (1035)
                      +.+.+..|+||||++ +++.+++.......+++..+..++.||+.||+|||++   +++||||||+||+++. ++.+||+
T Consensus        70 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~  145 (294)
T PLN00009         70 VHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLA  145 (294)
T ss_pred             EecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEc
Confidence            999999999999995 5888888665554568888899999999999999999   9999999999999985 5579999


Q ss_pred             eccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh-c
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK-R  921 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-~  921 (1035)
                      |||++.......  .......+++.|+|||+..+ ..++.++||||+|+++|+|++|+.||......+ .+....... .
T Consensus       146 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~~  222 (294)
T PLN00009        146 DFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILGT  222 (294)
T ss_pred             ccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence            999997653321  11223467889999998765 457889999999999999999999997542211 111111000 0


Q ss_pred             cchhhhc---------ccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLD---------KSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~---------~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .......         ...........     .......+++.+|++.+|++||++.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        223 PNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             CChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000         00000000000     011224568888999999999999999874

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.1e-32  Score=295.49  Aligned_cols=244  Identities=21%  Similarity=0.256  Sum_probs=187.1

Q ss_pred             HhccccCCee--eeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceee
Q 039419          685 LKCLVEDSVV--GKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVR  760 (1035)
Q Consensus       685 ~~~~~~~~~i--G~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  760 (1035)
                      .+.|.+.+.+  |+|+||.||++..+ +++.+|+|.+.......                   .|+.....+ +||||++
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------------~e~~~~~~~~~h~~iv~   73 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------------IEPMVHQLMKDNPNFIK   73 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------------hhHHHHHHhhcCCCEEE
Confidence            3566666665  99999999999765 58889999985432110                   122222222 7999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC-c
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF-E  839 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~  839 (1035)
                      +++++..++..|+||||+++++|.+++....  .+++..+..++.|+++|++|||+.   +++||||||+||+++.++ .
T Consensus        74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~  148 (267)
T PHA03390         74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDR  148 (267)
T ss_pred             EEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCe
Confidence            9999999999999999999999999997764  489999999999999999999999   999999999999999998 9


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ++|+|||.++.....      ....|+..|+|||+..+..++.++||||+|+++|||++|+.||............+...
T Consensus       149 ~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  222 (267)
T PHA03390        149 IYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR  222 (267)
T ss_pred             EEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh
Confidence            999999998765322      23468899999999988889999999999999999999999998544333222333222


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-MKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-~~el~~~  969 (1035)
                      ...       ... .+.   .......+++.+||++||++||+ ++|++++
T Consensus       223 ~~~-------~~~-~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        223 QQK-------KLP-FIK---NVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             hcc-------cCC-ccc---ccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            110       000 000   11223455777899999999996 6888763

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.9e-32  Score=302.38  Aligned_cols=251  Identities=28%  Similarity=0.375  Sum_probs=193.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .+.|...+.||+|+||+||+|... +++.||+|++........           ...+.+.+|+.++++++||||+++++
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~-----------~~~~~~~~Ei~~l~~l~h~niv~~~~   82 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN-----------EKWQDIIKEVRFLQQLRHPNTIEYKG   82 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH-----------HHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            356888899999999999999765 589999999854321111           12457889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||+. |++.+++.... ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+
T Consensus        83 ~~~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~  157 (307)
T cd06607          83 CYLREHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLA  157 (307)
T ss_pred             EEEeCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEe
Confidence            9999999999999996 57777765433 2489999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |||++......      ....|+..|+|||+..   ...++.++||||||+++|||++|+.||.......  ....+.. 
T Consensus       158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~--~~~~~~~-  228 (307)
T cd06607         158 DFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQ-  228 (307)
T ss_pred             ecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH--HHHHHhc-
Confidence            99998754322      2456888999999864   4568889999999999999999999986432111  0001100 


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                              .........  .....+..++.+||..||++||++.+++.+.
T Consensus       229 --------~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         229 --------NDSPTLSSN--DWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             --------CCCCCCCch--hhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                    000000010  1112345678899999999999999998853

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.7e-32  Score=304.03  Aligned_cols=264  Identities=26%  Similarity=0.315  Sum_probs=194.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +|+.||+|++........            ....+.+|++++++++||||+++++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~i~~~~~   73 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG------------IPISSLREITLLLNLRHPNIVELKE   73 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC------------CcchhhHHHHHHHhCCCCCCcceEE
Confidence            457889999999999999999775 589999999864332111            1234668999999999999999999


Q ss_pred             EEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          764 CCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       764 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++.+.  +..|+||||+. ++|.+++.... ..+++..+..++.|+++|++|||+.   +++||||||+||+++.++.+|
T Consensus        74 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~k  148 (309)
T cd07845          74 VVVGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLK  148 (309)
T ss_pred             EEecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            98765  46799999996 58888886543 3489999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |+|||.+.......  .......++..|+|||...+ ..++.++||||+|+++|||++|+.||....+.  .....+...
T Consensus       149 L~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~  224 (309)
T cd07845         149 IADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQL  224 (309)
T ss_pred             ECccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHh
Confidence            99999998764432  11223345788999998765 45789999999999999999999999754321  111111110


Q ss_pred             cc-chhhhc---------c--cccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RG-AIEVLD---------K--SLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~-~~~~~~---------~--~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+ .....-         .  .....+.....     ......+++.+|+++||++||+++|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         225 LGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00 000000         0  00000000000     12234568889999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.1e-32  Score=301.61  Aligned_cols=265  Identities=19%  Similarity=0.230  Sum_probs=192.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      ++|...+.||+|+||.||+|.+. +++.||+|++.......            ...+.+.+|+.++++++ ||||+++++
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~i~~~~~   68 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE------------GIPPTALREISLLQMLSESIYIVRLLD   68 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc------------CCchHHHHHHHHHHHccCCCCccceee
Confidence            35788899999999999999775 58999999885532211            12457889999999995 699999999


Q ss_pred             EEEcCCc-----ceEEEEeCCCCChhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          764 CCWNRNT-----RLLMYDYMPNGSLGSLLHERRD---SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       764 ~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++...+.     .|+||||+++ +|.+++.....   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++
T Consensus        69 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~  144 (295)
T cd07837          69 VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVD  144 (295)
T ss_pred             eEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEe
Confidence            9987665     7999999975 89888865432   3579999999999999999999999   999999999999999


Q ss_pred             C-CCceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhH
Q 039419          836 P-EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI  913 (1035)
Q Consensus       836 ~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~  913 (1035)
                      . ++.+||+|||.++.+....  .......+++.|+|||+..+ ..++.++||||||+++|+|++|..||....+.. ..
T Consensus       145 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~  221 (295)
T cd07837         145 KQKGLLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QL  221 (295)
T ss_pred             cCCCeEEEeecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HH
Confidence            8 8899999999987653321  11223457889999998754 457899999999999999999999997532211 11


Q ss_pred             HHHHHHh-ccchhhhccc--------ccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          914 VDWVRQK-RGAIEVLDKS--------LRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       914 ~~~~~~~-~~~~~~~~~~--------~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....... ..........        .....+...     .....+.+++.+||++||++||++.|++.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             HHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            1111000 0000000000        000000000     011234568889999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.3e-32  Score=299.40  Aligned_cols=248  Identities=25%  Similarity=0.399  Sum_probs=193.7

Q ss_pred             eeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcce
Q 039419          694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL  772 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  772 (1035)
                      ||+|+||.||+|.+.. |+.||+|.+........           ...+.+.+|++++++++||||+++++.+...+..|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   69 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRK-----------NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLY   69 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhh-----------hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEE
Confidence            5899999999998774 89999999865433211           23567899999999999999999999999999999


Q ss_pred             EEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccc
Q 039419          773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV  852 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~  852 (1035)
                      +||||+++++|.+++...+  .+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||++....
T Consensus        70 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~  144 (265)
T cd05579          70 LVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL  144 (265)
T ss_pred             EEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence            9999999999999997755  489999999999999999999998   99999999999999999999999999987654


Q ss_pred             cCCc------cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          853 EGDF------ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       853 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      ....      ........++..|+|||.......+.++||||||+++||+++|..||....+.  .....+..       
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~-------  215 (265)
T cd05579         145 VRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--EIFQNILN-------  215 (265)
T ss_pred             cCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc-------
Confidence            3311      11223456888999999988888999999999999999999999999754321  11111110       


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                        ....  .+...........++.+||+.+|++||++.++.+.+
T Consensus       216 --~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         216 --GKIE--WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             --CCcC--CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence              0000  001110122345678889999999999995555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-32  Score=308.55  Aligned_cols=263  Identities=24%  Similarity=0.310  Sum_probs=193.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||.||+|.+. +|+.||+|++......             ....++.+|+.++++++||||+++++
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~   70 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-------------TFCQRTLREIKILRRFKHENIIGILD   70 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc-------------hhHHHHHHHHHHHHhCCCCCcCchhh
Confidence            367889999999999999999664 5899999998542111             12456889999999999999999999


Q ss_pred             EEEcCC-----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          764 CCWNRN-----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       764 ~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      ++...+     ..|+||||+. +++.+++...   .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++
T Consensus        71 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~  143 (336)
T cd07849          71 IIRPPSFESFNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNC  143 (336)
T ss_pred             eeecccccccceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCC
Confidence            876543     4799999995 5888777543   389999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCcc-ccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      .+||+|||+++........ .......|+..|+|||...+ ..++.++||||+||++|+|++|+.||......  .....
T Consensus       144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~  221 (336)
T cd07849         144 DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNL  221 (336)
T ss_pred             CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence            9999999998865432211 11234568999999998654 56889999999999999999999999643211  11111


Q ss_pred             HHHhcc--chhhhc-----------ccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRG--AIEVLD-----------KSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~--~~~~~~-----------~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +.....  ..+...           ......+.....     ......+++.+||++||++||++.|++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         222 ILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            100000  000000           000000000000     12235678899999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.4e-32  Score=292.13  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=199.1

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |...+.||+|++|.||+|... +++.+++|++.....              ...+.+.+|++++++++||+|+++++++.
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   67 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------------EKKEKIINEIQILKKCKHPNIVKYYGSYL   67 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------------hHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence            667789999999999999776 688999999865432              12467899999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      .....++++||+++++|.+++.... ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        68 ~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~  143 (253)
T cd05122          68 KKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFG  143 (253)
T ss_pred             cCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecc
Confidence            9999999999999999999987653 3489999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      .+........   .....|+..|+|||+..+..++.++||||||+++|+|++|+.||......  ........  ..   
T Consensus       144 ~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~--~~---  213 (253)
T cd05122         144 LSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKIAT--NG---  213 (253)
T ss_pred             cccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHh--cC---
Confidence            9987654331   23457889999999988888999999999999999999999999743211  10000000  00   


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ........    .....+.+++.+||+.||++||++.+++++
T Consensus       214 -~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         214 -PPGLRNPE----KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -CCCcCccc----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             00000000    001234567888999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=9.8e-32  Score=291.41  Aligned_cols=254  Identities=29%  Similarity=0.403  Sum_probs=201.9

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|++|.||+|... +++.|++|++.......            ...+.+.+|+.++++++||||+++++.+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE------------EELEALEREIRILSSLQHPNIVRYYGSE   68 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccch------------HHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence            3667789999999999999776 68999999986543221            2356889999999999999999999999


Q ss_pred             EcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          766 WNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       766 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .+.  +..++||||+++++|.+++....  .+++..+..++.|+++|++|||+.   +++|+||+|+||+++.++.++|+
T Consensus        69 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~  143 (260)
T cd06606          69 RDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLA  143 (260)
T ss_pred             ecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEc
Confidence            988  88999999999999999998765  489999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||.+................++..|+|||...+...+.++||||||+++|+|++|..||.......   ........  
T Consensus       144 d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~--  218 (260)
T cd06606         144 DFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIGS--  218 (260)
T ss_pred             ccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHhccc--
Confidence            9999987655432111234678899999999888889999999999999999999999997543110   00000000  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          .......+. ..  .....+++.+|+..||++||++.+++.+
T Consensus       219 ----~~~~~~~~~-~~--~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 ----SGEPPEIPE-HL--SEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ----cCCCcCCCc-cc--CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                000011111 11  2234567888999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=299.46  Aligned_cols=263  Identities=24%  Similarity=0.321  Sum_probs=195.4

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |+..+.||.|++|.||+|.+. +|+.||+|++.......            ...+.+.+|++++++++|||++++++++.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~iv~~~~~~~   68 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE------------GVPSTAIREISLLKELNHPNIVRLLDVVH   68 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc------------cchhHHHHHHHHHHhcCCCCccCHhheec
Confidence            566789999999999999765 69999999986543211            12456889999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +.+..|++|||+ +++|.+++.......+++..+..++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        69 ~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~  144 (283)
T cd07835          69 SENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFG  144 (283)
T ss_pred             cCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecc
Confidence            999999999999 46999998776544589999999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      .++......  .......++..|+|||+..+. .++.++||||||+++|+|++|+.||....+.. ......+......+
T Consensus       145 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~  221 (283)
T cd07835         145 LARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDE  221 (283)
T ss_pred             cccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCh
Confidence            997553221  111233568899999987654 56889999999999999999999997542211 11111111000000


Q ss_pred             -h---------hcccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          926 -V---------LDKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       926 -~---------~~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       .         .............     .......+++.+|+++||++||+++|++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             HHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             0         0000000000000     001234568899999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.5e-32  Score=298.62  Aligned_cols=263  Identities=21%  Similarity=0.328  Sum_probs=195.3

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|+..+.||.|++|.||+|++. +|+.||||++......             ...+.+.+|++++++++||||+++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~   67 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-------------GTPSTAIREISLMKELKHENIVRLHDVI   67 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-------------cchHHHHHHHHHHHhhcCCCEeeeeeeE
Confidence            4778899999999999999876 5899999998653221             1235677899999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERR-DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      .+.+..++||||+++ +|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|
T Consensus        68 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d  143 (284)
T cd07836          68 HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLAD  143 (284)
T ss_pred             eeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEee
Confidence            999999999999975 8888886543 23589999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.++......  .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||....... ......+.....
T Consensus       144 ~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~  220 (284)
T cd07836         144 FGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTP  220 (284)
T ss_pred             cchhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence            99997553321  12233457889999998765 356889999999999999999999997543221 111100000000


Q ss_pred             ----------hhhhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 ----------IEVLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ----------~~~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                                .................     ......+++.+|++.||++||++++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         221 TESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             ChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                      00000000000000000     11234568888999999999999999763

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.1e-32  Score=301.68  Aligned_cols=244  Identities=22%  Similarity=0.371  Sum_probs=191.9

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCc
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNT  770 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  770 (1035)
                      ..||+|+||.||+|..+ +++.||||++.....              ...+.+.+|+.+++.++||||+++++++...+.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   91 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--------------QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE   91 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--------------hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE
Confidence            57899999999999775 689999998743211              124578999999999999999999999999999


Q ss_pred             ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          771 RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       771 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      .++||||+++++|.+++...   .+++..+..++.|++.|++|||+.   |++||||||+||+++.++.++|+|||.+..
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~  165 (292)
T cd06657          92 LWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ  165 (292)
T ss_pred             EEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEccccccee
Confidence            99999999999999987543   378899999999999999999999   999999999999999999999999999876


Q ss_pred             cccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccc
Q 039419          851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS  930 (1035)
Q Consensus       851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (1035)
                      .....  .......|++.|+|||+..+..++.++|+||+|+++|+|++|..||.....  ......+...      ....
T Consensus       166 ~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~------~~~~  235 (292)
T cd06657         166 VSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDN------LPPK  235 (292)
T ss_pred             ccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhh------CCcc
Confidence            54322  122345688999999998888899999999999999999999999974321  1111111111      1111


Q ss_pred             ccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       931 ~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....    .......+++.+||+.||.+||++.+++++
T Consensus       236 ~~~~~----~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         236 LKNLH----KVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cCCcc----cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            10000    011123456778999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.1e-32  Score=304.30  Aligned_cols=199  Identities=25%  Similarity=0.313  Sum_probs=163.2

Q ss_pred             eeeee--CCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCC
Q 039419          693 VVGKG--CSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       693 ~iG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      .||+|  +||+||+|.+. +|+.||+|++........            ..+.+.+|+.+++.++||||+++++++..++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~   72 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEE------------HLKALQNEVVLSHFFRHPNIMTSWTVFTTGS   72 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHH------------HHHHHHHHHHHHHhCCCCCcceEeeeEecCC
Confidence            45665  99999999775 699999999865432211            2467899999999999999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..++||||+.++++.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+.
T Consensus        73 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~  149 (328)
T cd08226          73 WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLY  149 (328)
T ss_pred             ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHh
Confidence            999999999999999999876555588999999999999999999998   99999999999999999999999998654


Q ss_pred             ccccCCcc-----ccccccCCcccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          850 LVVEGDFA-----RSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       850 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ........     .......++..|+|||++.+  ..++.++||||+||++|||++|+.||...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         150 SLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             hhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            33221110     00112235667999999865  34789999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.3e-32  Score=300.60  Aligned_cols=252  Identities=29%  Similarity=0.376  Sum_probs=194.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|.+. +++.||+|++........           ...+.+.+|++++++++|||+++++++
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~~~~~   93 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN-----------EKWQDIIKEVKFLQRIKHPNSIEYKGC   93 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch-----------HHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            34677789999999999999765 589999999854322111           124578899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||+. |++.+.+.... ..+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|
T Consensus        94 ~~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~d  168 (317)
T cd06635          94 YLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLAD  168 (317)
T ss_pred             EeeCCeEEEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEec
Confidence            999999999999996 57877775433 3489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ||++.....      .....|+..|+|||+..   ...++.++|||||||++|||++|+.||...... .....+...  
T Consensus       169 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~--  239 (317)
T cd06635         169 FGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN--  239 (317)
T ss_pred             CCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhc--
Confidence            999875432      12456889999999863   456889999999999999999999998643211 111111111  


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                              .........  ....+.+++.+||+.+|.+||++.+++++...
T Consensus       240 --------~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         240 --------ESPTLQSNE--WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             --------cCCCCCCcc--ccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence                    000000111  11124567888999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.98  E-value=7e-32  Score=297.28  Aligned_cols=252  Identities=24%  Similarity=0.364  Sum_probs=199.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .+.|...+.||+|+||.||+|.+. +++.||+|++.....               ..+.+.+|++++++++|+||+++++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------------~~~~~~~e~~~l~~l~~~~i~~~~~   82 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------------NKELIINEILIMKDCKHPNIVDYYD   82 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------------hHHHHHHHHHHHHHCCCCCeeEEEE
Confidence            455777788999999999999776 688999999854321               1457889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++...+..|+|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.   |++|+||+|+||+++.++.++|+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~  158 (286)
T cd06614          83 SYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLA  158 (286)
T ss_pred             EEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEEC
Confidence            9999999999999999999999998765 3489999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||.+........  ......++..|+|||+..+..++.++||||||+++|+|++|+.||....+.. ....+...    
T Consensus       159 d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~----  231 (286)
T cd06614         159 DFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTK----  231 (286)
T ss_pred             ccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc----
Confidence            9999875543221  1223457889999999888889999999999999999999999997432211 01111000    


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                            ......... .....+..++.+||+.+|.+||++.+++++
T Consensus       232 ------~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         232 ------GIPPLKNPE-KWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ------CCCCCcchh-hCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  000000000 011234457888999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.6e-33  Score=290.39  Aligned_cols=265  Identities=22%  Similarity=0.345  Sum_probs=198.7

Q ss_pred             HhccccCCeeeeeCCcEEEEE-EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      -++|-....+|+|||+.||+| +....+.||||+-..+....+..-       ....+...+|.++-+.|+||.||++|+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKK-------eNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKK-------ENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhh-------hhHHHHHHHHHhhhhccCcceeeeeee
Confidence            366777889999999999999 556688999999765544332110       123466789999999999999999999


Q ss_pred             EEE-cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC---CCc
Q 039419          764 CCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP---EFE  839 (1035)
Q Consensus       764 ~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~  839 (1035)
                      +|. +.+..+-|.|||+|-+|.-|++..+.  +++.++..|+.||+.||.||.+. .++|+|-|+||.|||+-.   -|.
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence            996 55677899999999999999987654  89999999999999999999997 458999999999999954   478


Q ss_pred             eEEeeccCccccccCCccc-----cccccCCcccccCCccccc----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 039419          840 PYIADFGLAKLVVEGDFAR-----SSNTVAGSYGYIAPEYGYM----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG  910 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~  910 (1035)
                      +||+|||+++.+.++....     .+...+||.+|++||.+.-    .+++.|+||||+|||+|+++.|+.||...... 
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-  690 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-  690 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-
Confidence            9999999999887654321     2345689999999997643    35788999999999999999999999754221 


Q ss_pred             hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      .++   +.... ......-.++..|    ......-.+|.+|+...-++|..+.++..
T Consensus       691 QdI---LqeNT-IlkAtEVqFP~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 QDI---LQENT-ILKATEVQFPPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHH---Hhhhc-hhcceeccCCCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            111   11100 0000000111111    11122345788899999899988887754

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=7.1e-32  Score=296.71  Aligned_cols=258  Identities=22%  Similarity=0.231  Sum_probs=190.5

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLGCC  765 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  765 (1035)
                      |...+.||+|+||.||+|... +++.||+|++........             .....+|+.++.++. ||||+++++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-------------~~~~~~e~~~l~~l~~h~~i~~~~~~~   67 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-------------QVNNLREIQALRRLSPHPNILRLIEVL   67 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-------------hhhHHHHHHHHhhcCCCCCccceEEEE
Confidence            456788999999999999765 589999999865322111             223457999999985 99999999999


Q ss_pred             EcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          766 WNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       766 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .+.  +..++||||++ |++.+++.... ..+++..+..++.|++.||+|||+.   +++||||||+||+++. +.+||+
T Consensus        68 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~  141 (282)
T cd07831          68 FDRKTGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLA  141 (282)
T ss_pred             ecCCCCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEE
Confidence            987  88999999996 58888876543 3489999999999999999999999   9999999999999999 999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||.++.......   .....++..|+|||+.. +..++.++||||+||++|||++|..||....+.  ....+.....+
T Consensus       142 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~--~~~~~~~~~~~  216 (282)
T cd07831         142 DFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL--DQIAKIHDVLG  216 (282)
T ss_pred             ecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH--HHHHHHHHHcC
Confidence            9999986543321   12346789999999754 456788999999999999999999999754321  11122111100


Q ss_pred             c-hh----------hhcccccCCCccc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 A-IE----------VLDKSLRARPEVE-----IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~-~~----------~~~~~~~~~~~~~-----~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      . .+          .............     ........+++.+||+++|++||++++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             CCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0 00          0000000000000     0112455678999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=5.9e-32  Score=304.99  Aligned_cols=277  Identities=21%  Similarity=0.266  Sum_probs=196.9

Q ss_pred             Hhccc-cCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          685 LKCLV-EDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~-~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      .++|. ..+.||+|+||+||+|.+. +++.||||++...............+........+.+|++++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34565 3467999999999999765 589999999865433221111111111112234678999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++..++..++||||+. |+|.+++....  .+++.....++.|++.||+|||+.   +++||||||+||+++.++.++|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            99999999999999996 69999986543  388999999999999999999998   9999999999999999999999


Q ss_pred             eeccCccccccCCc------------cccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 039419          843 ADFGLAKLVVEGDF------------ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPE  909 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~  909 (1035)
                      +|||.++.......            ........++..|+|||+..+. .++.++||||+||++|||++|+.||....+.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999986641110            1111233568899999987654 4688999999999999999999999754321


Q ss_pred             chhHHHHHHHhcc--chhhhccc--------ccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          910 GLHIVDWVRQKRG--AIEVLDKS--------LRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       910 ~~~~~~~~~~~~~--~~~~~~~~--------~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .  ....+.....  ........        .....+....     ......+++.+|++.+|++||+++|++.+
T Consensus       241 ~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 D--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             H--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1  1111111000  00000000        0000000000     11234568889999999999999999874

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.98  E-value=4e-32  Score=306.00  Aligned_cols=264  Identities=22%  Similarity=0.288  Sum_probs=195.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|..+ +++.||+|++.......            ...+.+.+|+.++++++||||++++++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~   72 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVP------------TLAKRTLRELKILRHFKHDNIIAIRDI   72 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccc------------cchHHHHHHHHHHHhcCCCCccCHHHh
Confidence            67888899999999999999765 58999999986532211            124567889999999999999999998


Q ss_pred             EEc----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          765 CWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       765 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +..    ....|+||||+. ++|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~  146 (334)
T cd07855          73 LRPPGADFKDVYVVMDLME-SDLHHIIHSDQP--LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCEL  146 (334)
T ss_pred             ccccCCCCceEEEEEehhh-hhHHHHhccCCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence            763    346799999995 689998865543  89999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCccccccCCcc--ccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          841 YIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      ||+|||.++........  .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......  .....+
T Consensus       147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~  224 (334)
T cd07855         147 RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLI  224 (334)
T ss_pred             EecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHH
Confidence            99999999766443211  11224578899999998654 46889999999999999999999999654221  111111


Q ss_pred             HHhccc--hhhh-----------cccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGA--IEVL-----------DKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~--~~~~-----------~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....+.  .+..           ............     .....+.+++.+||+.||++||++++++++
T Consensus       225 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         225 LSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             HHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            100000  0000           000111111110     112345668889999999999999999885

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=3.6e-32  Score=301.07  Aligned_cols=254  Identities=22%  Similarity=0.350  Sum_probs=191.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  762 (1035)
                      .++|...+.||+|+||.||+|.+.+ ++.||||.+.......             ....+.+|+.++.+.. ||||++++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~~~~i~~~~   80 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-------------ENKRILMDLDVVLKSHDCPYIVKCY   80 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-------------HHHHHHHHHHHHHhccCCCchHhhh
Confidence            3567888999999999999998875 8999999986432211             1345677887777774 99999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+....|+||||+ ++++.+++.... ..+++..+..++.|+++|++|||+..  +|+||||+|+||+++.++.+||
T Consensus        81 ~~~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL  156 (296)
T cd06618          81 GYFITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKL  156 (296)
T ss_pred             eeeecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEE
Confidence            9999999999999998 457777765533 35899999999999999999999731  8999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK----ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      +|||.+........   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||...... ......+.
T Consensus       157 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~  232 (296)
T cd06618         157 CDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKIL  232 (296)
T ss_pred             CccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHh
Confidence            99999876543221   12345788999999876543    788999999999999999999999643211 11111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..  .    .+.....  .  .....+.+++.+||+.||++||++.+++++
T Consensus       233 ~~--~----~~~~~~~--~--~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         233 QE--E----PPSLPPN--E--GFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             cC--C----CCCCCCC--C--CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  0    0000000  0  011234567888999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=8.9e-32  Score=296.73  Aligned_cols=262  Identities=25%  Similarity=0.290  Sum_probs=195.2

Q ss_pred             cccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC---CCCceeeEEe
Q 039419          688 LVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI---RHKNIVRFLG  763 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~  763 (1035)
                      |.+.+.||+|+||.||+|+++. ++.||+|++.......            .....+.+|+.+++++   +||||+++++
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~h~~i~~~~~   68 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE------------GIPLSTLREIALLKQLESFEHPNIVRLLD   68 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc------------hhhhhHHHHHHHHHHhhccCCCCcceEEE
Confidence            5667899999999999998874 8999999996543211            1234566788877666   5999999999


Q ss_pred             EEEcCCc-----ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          764 CCWNRNT-----RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       764 ~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      ++.+.+.     .+++|||+. ++|.+++.......+++..+..++.|+++||+|||+.   +++|+||+|+||+++.++
T Consensus        69 ~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~  144 (287)
T cd07838          69 VCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDG  144 (287)
T ss_pred             EEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCC
Confidence            9988776     899999996 5899988765544589999999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .++|+|||.+........   .....++..|+|||+..+..++.++||||||+++|||++|+.||...... .....+..
T Consensus       145 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~  220 (287)
T cd07838         145 QVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFD  220 (287)
T ss_pred             CEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHH
Confidence            999999999987643321   12345788999999998888999999999999999999999998754321 11111111


Q ss_pred             Hhccchh-h-h------cccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIE-V-L------DKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~-~-~------~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....... . .      ............     .......+++.+||+.||++||++.+++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            1000000 0 0      000001111111     112344568889999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=5.6e-32  Score=298.71  Aligned_cols=255  Identities=22%  Similarity=0.263  Sum_probs=193.7

Q ss_pred             cccCCeeeeeCCcEEEEEEE----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      |+..+.||+|+||.||+|+.    .+|+.||+|++........          ....+++.+|+.+++++ +||+|++++
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~~i~~~~   71 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK----------AKTTEHTRTERQVLEHIRQSPFLVTLH   71 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc----------chHHHHHHHHHHHHHhcccCCChhcee
Confidence            67788999999999999976    3689999999864322111          12356788999999999 599999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++..+...|+||||+++++|.+++.....  +++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl  146 (290)
T cd05613          72 YAFQTDTKLHLILDYINGGELFTHLSQRER--FKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL  146 (290)
T ss_pred             eEeecCCeEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence            999999999999999999999999976543  78899999999999999999998   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      +|||++........ .......|+..|+|||...+.  .++.++||||||+++|+|++|..||....... ....+....
T Consensus       147 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~  224 (290)
T cd05613         147 TDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRI  224 (290)
T ss_pred             eeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHh
Confidence            99999986544322 122345689999999987653  46789999999999999999999996432211 111111110


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      ...    ....    +..  .......++.+|++.||++||     ++++++++
T Consensus       225 ~~~----~~~~----~~~--~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         225 LKS----EPPY----PQE--MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             hcc----CCCC----Ccc--CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            000    0000    111  112334578889999999997     67777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3e-33  Score=323.94  Aligned_cols=203  Identities=26%  Similarity=0.274  Sum_probs=177.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.++||+|+||.|..++++. ++.||+|++.+-.+-..           ....-|..|-++|..-+.+=||+++-.
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr-----------~~tA~F~EERDimv~~ns~Wiv~LhyA  143 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR-----------AETACFREERDIMVFGNSEWIVQLHYA  143 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-----------hhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence            678999999999999999998874 88999999965322111           124568999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |+++.+.|+||||++||+|-.++.+..  .+++..+..++..|+-||..+|+.   |+|||||||+|||+|..|++||+|
T Consensus       144 FQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  144 FQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             hcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeecc
Confidence            999999999999999999999998876  489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc----c-CCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY----M-MKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      ||.|-.+..+... .....+|||-|++||++.    + +.|++.+|.||+||.+|||+.|..||..
T Consensus       219 FGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  219 FGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             chhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            9999877654433 345678999999999854    3 6799999999999999999999999963

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=291.34  Aligned_cols=246  Identities=23%  Similarity=0.324  Sum_probs=184.9

Q ss_pred             CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHH-hcCCCCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL-GSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~  769 (1035)
                      +.||+|+||.||+|... +++.||+|++........           .....+..|..++ ...+||||+++++++...+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   70 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-----------NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD   70 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-----------HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC
Confidence            46899999999999765 589999999864322111           0122345555554 4458999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++++|.++++....  +++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+++
T Consensus        71 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  145 (260)
T cd05611          71 YLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR  145 (260)
T ss_pred             eEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccce
Confidence            99999999999999999976543  78999999999999999999998   99999999999999999999999999987


Q ss_pred             ccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcc
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK  929 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  929 (1035)
                      ....      .....|+..|+|||...+..++.++||||+|+++|||++|..||......  .....+...  ... ...
T Consensus       146 ~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~--~~~-~~~  214 (260)
T cd05611         146 NGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVFDNILSR--RIN-WPE  214 (260)
T ss_pred             eccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhc--ccC-CCC
Confidence            5432      22456889999999988888899999999999999999999999754321  111111100  000 000


Q ss_pred             cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       930 ~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      ....      .......+++.+||+.+|++||++.++.+.+
T Consensus       215 ~~~~------~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         215 EVKE------FCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cccc------cCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            0000      1112345688889999999999776554433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=5.7e-32  Score=305.23  Aligned_cols=266  Identities=26%  Similarity=0.344  Sum_probs=195.6

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceee
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVR  760 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  760 (1035)
                      .+.++|...+.||+|+||.||+|.+. +++.+|+|++........            ....+.+|+.+++++ +||||++
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~------------~~~~~~~E~~~l~~l~~h~ni~~   71 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT------------DAQRTFREIMFLQELGDHPNIVK   71 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch------------hhhhhhHHHHHHHHhcCCCCccc
Confidence            35678888999999999999999775 588999999854321111            134577899999999 9999999


Q ss_pred             EEeEEEcCC--cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          761 FLGCCWNRN--TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       761 l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +++++...+  ..|+||||+. ++|.+++...   .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~  144 (337)
T cd07852          72 LLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDC  144 (337)
T ss_pred             eeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCC
Confidence            999986543  5799999996 5999988654   478899999999999999999998   999999999999999999


Q ss_pred             ceEEeeccCccccccCCcc---ccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          839 EPYIADFGLAKLVVEGDFA---RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                      .+||+|||.++........   .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||....+... ..
T Consensus       145 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~  223 (337)
T cd07852         145 RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LE  223 (337)
T ss_pred             cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HH
Confidence            9999999999866443221   12234568999999998654 4578899999999999999999999965432110 00


Q ss_pred             HHHHHhcc------------c-hhhhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRG------------A-IEVLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~------------~-~~~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ........            . ...+.. ..........     ....+.+++.+||+.||++||++.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         224 KIIEVIGPPSAEDIESIKSPFAATMLDS-LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhCCCCHHHHHHHHhhhHHHhhhh-cccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000000            0 000000 0000000000     12234668889999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=1.9e-34  Score=283.43  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=191.7

Q ss_pred             cCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEc
Q 039419          690 EDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWN  767 (1035)
Q Consensus       690 ~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~  767 (1035)
                      ....||.|+||+|++..++ .|+..|||++.......             .++++..|.++..+- +.||||++||....
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k-------------eq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK-------------EQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH-------------HHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            4567899999999999765 59999999997665432             357888888876554 79999999999999


Q ss_pred             CCcceEEEEeCCCCChhhhh---hhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          768 RNTRLLMYDYMPNGSLGSLL---HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      ++..|+.||.| ..|+..+.   .......+++.-.-+|....++||.||-+..  .|+|||+||+|||++..|.+|+||
T Consensus       135 EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCD  211 (361)
T KOG1006|consen  135 EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCD  211 (361)
T ss_pred             CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeec
Confidence            99999999999 45766543   3333455888888889999999999998873  899999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc--cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY--MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      ||++-...+.-.   .+.-+|-..|||||.+.  ...|+.++||||+|+++||+.||..||.....--.++...+..   
T Consensus       212 FGIcGqLv~SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g---  285 (361)
T KOG1006|consen  212 FGICGQLVDSIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG---  285 (361)
T ss_pred             ccchHhHHHHHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC---
Confidence            999977654321   22456888999999765  3348899999999999999999999997543211111111111   


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           ++..-...............++..|+.+|-..||.+.++.++
T Consensus       286 -----dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  286 -----DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -----CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                 111111111223344555667888999999999999999774

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1.6e-31  Score=292.73  Aligned_cols=245  Identities=20%  Similarity=0.219  Sum_probs=184.6

Q ss_pred             eeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHH---HHHhcCCCCceeeEEeEEEcC
Q 039419          693 VVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI---KTLGSIRHKNIVRFLGCCWNR  768 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~l~~~~~~~  768 (1035)
                      .||+|+||.||+|... +++.||+|.+........           .....+..|.   ..++...||+|+++++++.+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~   69 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----------QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP   69 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-----------hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence            4799999999999765 588999999865432211           0112233343   344556899999999999999


Q ss_pred             CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCc
Q 039419          769 NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA  848 (1035)
Q Consensus       769 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a  848 (1035)
                      +..|+||||+.||+|..++....  .+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        70 ~~~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~  144 (278)
T cd05606          70 DKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA  144 (278)
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCc
Confidence            99999999999999999886543  489999999999999999999998   9999999999999999999999999998


Q ss_pred             cccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhh
Q 039419          849 KLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVL  927 (1035)
Q Consensus       849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1035)
                      .......    .....|+..|+|||+..+. .++.++||||+||++|||++|+.||................      ..
T Consensus       145 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~  214 (278)
T cd05606         145 CDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL------TM  214 (278)
T ss_pred             cccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh------cc
Confidence            7543321    2245789999999997644 68899999999999999999999997543221111111000      00


Q ss_pred             cccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       928 ~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      ........      .....+++.+|+..+|.+||     ++.+++++
T Consensus       215 ~~~~~~~~------s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         215 AVELPDSF------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CCCCCCcC------CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            11111111      22345577889999999999     99999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.3e-32  Score=290.75  Aligned_cols=249  Identities=28%  Similarity=0.427  Sum_probs=198.6

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|++|.||+|... +++.||+|.+.......            ...+.+.+|++++++++|||++++++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE------------EALKSIMQEIDLLKNLKHPNIVKYIGSI   68 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH------------HHHHHHHHHHHHHHhCCCCCccEEEEEE
Confidence            3677889999999999999765 57899999997543221            1356899999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||+++++|.+++....  .+++..+..++.|++.|+.|||+.   ||+||||||+||+++.++.++|+||
T Consensus        69 ~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~  143 (254)
T cd06627          69 ETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADF  143 (254)
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEecc
Confidence            99999999999999999999987653  489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |.+........  ......++..|+|||...+..++.++||||+|+++|+|++|+.||....+.    ..........  
T Consensus       144 ~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~--  215 (254)
T cd06627         144 GVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRIVQDD--  215 (254)
T ss_pred             ccceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhccC--
Confidence            99987654332  123456889999999988777899999999999999999999999743211    1111110000  


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                        ........    .  .....++.+|++.+|++||++.+++.
T Consensus       216 --~~~~~~~~----~--~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 --HPPLPEGI----S--PELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --CCCCCCCC----C--HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              01111111    1  22345778899999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.98  E-value=1.9e-32  Score=300.83  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=199.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      ++|...+.||+|+||.||+|... +++.||+|++........           ...+.+.+|+.++++++ ||||+++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~~e~~~~~~l~~~~~i~~~~~   69 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-----------KKVKYVKIEKEVLTRLNGHPGIIKLYY   69 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch-----------HHHHHHHHHHHHHHhcccCCCchhHHH
Confidence            36788899999999999999765 689999999865332211           12467889999999998 999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..++||||+++++|.+++...+  .+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++++
T Consensus        70 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~  144 (280)
T cd05581          70 TFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKIT  144 (280)
T ss_pred             HhcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEec
Confidence            9999999999999999999999998764  489999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCcc------------------ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          844 DFGLAKLVVEGDFA------------------RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       844 DFG~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      |||.+.........                  .......|+..|+|||+..+..++.++||||||+++|++++|+.||..
T Consensus       145 df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (280)
T cd05581         145 DFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG  224 (280)
T ss_pred             CCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence            99998866443211                  122244678999999998888899999999999999999999999975


Q ss_pred             CCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH----HHHHHH
Q 039419          906 TIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM----KDVAAM  969 (1035)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~----~el~~~  969 (1035)
                      ...  ......+.         . . ....+...  ......++.+||+.+|++||++    ++++++
T Consensus       225 ~~~--~~~~~~~~---------~-~-~~~~~~~~--~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         225 SNE--YLTFQKIL---------K-L-EYSFPPNF--PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ccH--HHHHHHHH---------h-c-CCCCCCcc--CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            421  11111110         0 0 00011111  1234567888999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.7e-31  Score=290.55  Aligned_cols=255  Identities=25%  Similarity=0.316  Sum_probs=192.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|... +++.||+|.+........         .....+.+.+|++++++++||||+++++++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~   73 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQE---------TSKEVNALECEIQLLKNLRHDRIVQYYGCL   73 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccch---------hhHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence            5788899999999999999765 589999998743221111         012246789999999999999999999998


Q ss_pred             EcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          766 WNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       766 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .+.  +..++||||+++++|.+++.....  +++..+..++.|++.|++|||+.   +++||||||+||+++.++.++|+
T Consensus        74 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~  148 (264)
T cd06653          74 RDPEEKKLSIFVEYMPGGSIKDQLKAYGA--LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLG  148 (264)
T ss_pred             EcCCCCEEEEEEEeCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence            764  457899999999999999876543  78889999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||+++........ .......|+..|+|||+..+..++.++|+|||||++||+++|+.||......     ..+.+...
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~  223 (264)
T cd06653         149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AAIFKIAT  223 (264)
T ss_pred             ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HHHHHHHc
Confidence            99999865321111 1112356899999999998888999999999999999999999999743211     11111000


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .  ...+.+   + ....  ....+++.+|+. +|..||++.+++.+
T Consensus       224 ~--~~~~~~---p-~~~~--~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         224 Q--PTKPML---P-DGVS--DACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             C--CCCCCC---C-cccC--HHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            0  000111   1 1111  123456777998 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=7.4e-32  Score=301.44  Aligned_cols=259  Identities=18%  Similarity=0.212  Sum_probs=187.3

Q ss_pred             eeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcceE
Q 039419          694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLL  773 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  773 (1035)
                      +|.|+++.||++.. +++.||||++.......            ...+.+.+|++++++++||||+++++++.+.+..|+
T Consensus        10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~------------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~   76 (314)
T cd08216          10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSK------------EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYV   76 (314)
T ss_pred             hcCCceEEEEEecC-CCCEEEEEEEeccccch------------hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEE
Confidence            34444444444433 58999999986542111            124679999999999999999999999999999999


Q ss_pred             EEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcccccc
Q 039419          774 MYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE  853 (1035)
Q Consensus       774 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~  853 (1035)
                      +|||+++|+|.+++.......+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+|++|||.+.....
T Consensus        77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecc
Confidence            99999999999999876555588999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCc-----cccccccCCcccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc----
Q 039419          854 GDF-----ARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG----  922 (1035)
Q Consensus       854 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~----  922 (1035)
                      ...     ........++..|+|||++.+  ..++.++|||||||++|||++|..||....... ...........    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  232 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLD  232 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccc
Confidence            221     111223457788999998765  357889999999999999999999997542211 11111100000    


Q ss_pred             --chhh------------hccccc--CCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 --AIEV------------LDKSLR--ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 --~~~~------------~~~~~~--~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        ....            ......  ..............+++.+||..||++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              0000            000000  0000011112345568889999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=1.1e-31  Score=295.34  Aligned_cols=261  Identities=23%  Similarity=0.312  Sum_probs=195.2

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLGCC  765 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  765 (1035)
                      |.+.+.||+|+||+||+|... +++.||||++.......             ......+|+..+++++ ||||+++++++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-------------~~~~~~~e~~~l~~~~~h~~i~~~~~~~   67 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-------------EECMNLREVKSLRKLNEHPNIVKLKEVF   67 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-------------hHHHHHHHHHHHHhccCCCCchhHHHHh
Confidence            566789999999999999876 47889999986432211             1234567999999999 99999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||+ +|+|.+++.......+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+||
T Consensus        68 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~  143 (283)
T cd07830          68 RENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADF  143 (283)
T ss_pred             hcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeec
Confidence            9999999999999 88999998876544589999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh--HH--------
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH--IV--------  914 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~--~~--------  914 (1035)
                      |.++.......   .....++..|+|||+.. ...++.++|+||||+++|||++|+.||.........  ..        
T Consensus       144 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  220 (283)
T cd07830         144 GLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK  220 (283)
T ss_pred             ccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh
Confidence            99986543221   22456888999999864 455789999999999999999999999654221100  00        


Q ss_pred             -HHHHHhccchhhhcccccCCCcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 -DWVRQKRGAIEVLDKSLRARPEVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 -~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       .|..... ...................     ......++.+||+.||++||+++|++.+
T Consensus       221 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         221 QDWPEGYK-LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhhhhHhh-hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence             0100000 0000000111111111111     2345678999999999999999999764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=1.5e-31  Score=297.38  Aligned_cols=264  Identities=25%  Similarity=0.318  Sum_probs=195.1

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ...++|.+.+.||+|+||.||+|.++ +++.||+|++.......            .....+.+|++++++++||||+++
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------------~~~~~~~~e~~~~~~l~h~~i~~~   71 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE------------GFPITAIREIKILRQLNHRNIVNL   71 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc------------CchHHHHHHHHHHHhCCCCCeeee
Confidence            45678999999999999999999876 48899999986432211            123567889999999999999999


Q ss_pred             EeEEEcCC----------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCccc
Q 039419          762 LGCCWNRN----------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANN  831 (1035)
Q Consensus       762 ~~~~~~~~----------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~N  831 (1035)
                      ++++.+..          ..++||||+++ ++.+.+... ...+++..+..++.|++.||+|||+.   +|+||||||+|
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~n  146 (302)
T cd07864          72 KEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSN  146 (302)
T ss_pred             eheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            99987654          78999999975 777776654 23489999999999999999999999   99999999999


Q ss_pred             EEEcCCCceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 039419          832 ILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG  910 (1035)
Q Consensus       832 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~  910 (1035)
                      |+++.++.+||+|||.+........ .......++..|+|||...+ ..++.++|||||||++|||++|+.||.....  
T Consensus       147 ili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--  223 (302)
T cd07864         147 ILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--  223 (302)
T ss_pred             EEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--
Confidence            9999999999999999986644321 11223356788999997654 4578899999999999999999999975321  


Q ss_pred             hhHHHHHHHhc-cc-hhhhc------------------ccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          911 LHIVDWVRQKR-GA-IEVLD------------------KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       911 ~~~~~~~~~~~-~~-~~~~~------------------~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ......+.... .. .....                  ......... +  .....+++.+||+.||++||++.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         224 LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF-I--PTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCC-C--CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11111111110 00 00000                  000000000 0  1234678888999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=5.1e-32  Score=298.75  Aligned_cols=259  Identities=22%  Similarity=0.253  Sum_probs=196.3

Q ss_pred             cccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      |...+.||+|+||.||+|...    +++.||||.+........          ....+.+.+|++++.++ +||+|++++
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~----------~~~~~~~~~E~~~l~~~~~~~~i~~~~   71 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQK----------AKTAEHTRTERQVLEAVRRCPFLVTLH   71 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhh----------hhHHHHHHHHHHHHHhccCCcchhhhh
Confidence            667789999999999999643    578899999864322111          12356788999999999 599999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +.+...+..++||||+++|+|.+++....  .+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l  146 (288)
T cd05583          72 YAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL  146 (288)
T ss_pred             eeeecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence            99999999999999999999999987643  388899999999999999999998   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      +|||+++....... .......|+..|+|||...+..  .+.++||||||+++|||++|..||....... ......+..
T Consensus       147 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~  224 (288)
T cd05583         147 TDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRI  224 (288)
T ss_pred             EECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHH
Confidence            99999876544321 1122356889999999876655  7789999999999999999999996432111 111111110


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ..    .......    .+.  ....+++.+||+.||++|||+.++.+.|+..
T Consensus       225 ~~----~~~~~~~----~~~--~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         225 LK----SKPPFPK----TMS--AEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             Hc----cCCCCCc----ccC--HHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            00    0001111    111  2234578889999999999988887766553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=5.7e-32  Score=292.83  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=199.7

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|++.+.||+|+||.||+|... +++.+|+|++.......            .....+.+|++++++++||||+++++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ------------KEREDAVNEIRILASVNHPNIISYKEAF   68 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH------------HHHHHHHHHHHHHHhCCCCCchhhhhhh
Confidence            3677889999999999999665 58899999986533221            1245778999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .+....|+||||+++++|.+++....  ...+++..+..++.|++.|++|||+.   |++||||+|+||+++.++.+|++
T Consensus        69 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~  145 (256)
T cd08530          69 LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIG  145 (256)
T ss_pred             ccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEe
Confidence            99999999999999999999986632  24588999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||.++.....    ......++..|+|||...+..++.++|+||+|+++||+++|+.||......  .+...+..    
T Consensus       146 d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~----  215 (256)
T cd08530         146 DLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR----  215 (256)
T ss_pred             eccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc----
Confidence            99999876543    122346888999999998888999999999999999999999999754321  11111110    


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           ......+.   .....+..++.+|+..+|++||++.+++++
T Consensus       216 -----~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         216 -----GKYPPIPP---IYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -----CCCCCCch---hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                 00011111   222335668889999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=6.7e-33  Score=294.90  Aligned_cols=246  Identities=22%  Similarity=0.344  Sum_probs=196.6

Q ss_pred             CCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCC
Q 039419          691 DSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      ++++|+|-||+||-|.++ +|+.||||++.+......            ..+++.+|+.+++.+.||.||.+.-.|+..+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k------------qesqlR~EVaILq~l~HPGiV~le~M~ET~e  636 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK------------QESQLRNEVAILQNLHHPGIVNLECMFETPE  636 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCc------------hHHHHHHHHHHHHhcCCCCeeEEEEeecCCc
Confidence            579999999999999665 599999999977655443            2467899999999999999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC---CceEEeecc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE---FEPYIADFG  846 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~~kl~DFG  846 (1035)
                      ..|+|||.+ .|+..+.+-..+...+++.....++.||+.||.|||.+   +|+|+|+||+|||+...   -.+||||||
T Consensus       637 rvFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  637 RVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             eEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccc
Confidence            999999999 56777777666666799999999999999999999999   99999999999999644   469999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      +|+.+.+..+.+   .++||+.|+|||++....|...-|+||.||++|--++|..||...    .++.+.+.   ....+
T Consensus       713 fARiIgEksFRr---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQ---NAaFM  782 (888)
T KOG4236|consen  713 FARIIGEKSFRR---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQ---NAAFM  782 (888)
T ss_pred             ceeecchhhhhh---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhh---ccccc
Confidence            999987765543   678999999999999999999999999999999999999999743    22222221   11112


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      +    ...|+.  +.....+++|...++..-.+|-++.+.+.
T Consensus       783 y----Pp~PW~--eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  783 Y----PPNPWS--EISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             c----CCCchh--hcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            2    122222  22233455666667777778888877655

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=1.5e-31  Score=289.77  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=200.8

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...+.||+|+||.||+|.+. +++.||+|++.......            ...+.+.+|+++++.++|||++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~~~~~~~~~   68 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE------------KEREDALNEVKILKKLNHPNIIKYYESF   68 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh------------HHHHHHHHHHHHHHhcCCCChhheEEEE
Confidence            4677889999999999999765 58999999986543221            1356788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ...+..++||||+++++|.+++....  ...+++..+..++.+++.|+.|||+.   |++|+||+|+||+++.++.++|+
T Consensus        69 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~  145 (258)
T cd08215          69 EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLG  145 (258)
T ss_pred             ecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEEC
Confidence            99999999999999999999998753  35589999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||.+.......  .......|++.|+|||...+..++.++||||+|+++|+|++|+.||......     ......   
T Consensus       146 d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~---  215 (258)
T cd08215         146 DFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKI---  215 (258)
T ss_pred             CccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHH---
Confidence            999998664432  1223457889999999988888999999999999999999999999654211     111110   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ........+. ..  .....+++.+||..+|++||++.+++++
T Consensus       216 ---~~~~~~~~~~-~~--~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         216 ---LKGQYPPIPS-QY--SSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ---hcCCCCCCCC-CC--CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               0000111111 11  1223457888999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=9.6e-32  Score=303.14  Aligned_cols=264  Identities=22%  Similarity=0.242  Sum_probs=194.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|... +++.||||.+.......            ...+.+.+|+.+++.++||||+++++
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~ni~~~~~   71 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR------------IDAKRTLREIKLLRHLDHENVIAIKD   71 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc------------chhHHHHHHHHHHHhcCCCCccchHH
Confidence            357888999999999999999765 58999999986432111            12346778999999999999999999


Q ss_pred             EEEcC-----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          764 CCWNR-----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       764 ~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      ++...     ...|+||||+. ++|.+++...+  .+++..+..++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~  145 (337)
T cd07858          72 IMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANC  145 (337)
T ss_pred             heecccccccCcEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence            88654     24799999995 78998887654  389999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      .+||+|||+++......  .......++..|+|||.... ..++.++|||||||++|+|++|+.||....... ......
T Consensus       146 ~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~  222 (337)
T cd07858         146 DLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLIT  222 (337)
T ss_pred             CEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHH
Confidence            99999999998664432  12234568899999998654 468899999999999999999999996432110 000000


Q ss_pred             HHhcc------------chhhhcccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRG------------AIEVLDKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~------------~~~~~~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....            ......+.....+....     .......+++.+||++||++||++++++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         223 ELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000            00000000000000000     112234578899999999999999999986

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=7.2e-33  Score=277.81  Aligned_cols=206  Identities=27%  Similarity=0.346  Sum_probs=171.3

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEECC-----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEMEN-----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .+..|+....||+|.||.||+|.-++     .+.+|+|+++......            ++....-+|+..++.++|||+
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t------------GiS~SAcREiaL~REl~h~nv   89 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT------------GISMSACREIALLRELKHPNV   89 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC------------CcCHHHHHHHHHHHHhcCCcc
Confidence            45678999999999999999994332     3479999996543211            344567799999999999999


Q ss_pred             eeEEeEEEc-CCcceEEEEeCCCCChhhhhhhcCC---CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE
Q 039419          759 VRFLGCCWN-RNTRLLMYDYMPNGSLGSLLHERRD---SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       759 v~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll  834 (1035)
                      +.+..++.. +...++++||.+ -+|...++..+.   ..++...+..|+.||+.|+.|||+.   -|+|||+||.|||+
T Consensus        90 i~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlv  165 (438)
T KOG0666|consen   90 ISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILV  165 (438)
T ss_pred             hhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEE
Confidence            999999877 778899999995 599998875433   5688899999999999999999999   79999999999999


Q ss_pred             cCC----CceEEeeccCccccccCCcc-ccccccCCcccccCCcccccCC-CCccccchhHHHHHHHHHhCCCCCCC
Q 039419          835 GPE----FEPYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       835 ~~~----~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      ..+    |.|||+|||+++.+.+.-.. .....++.|..|.|||.+.+.+ |+++.||||+|||+.||++-.+-|..
T Consensus       166 mgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  166 MGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             eccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            877    89999999999988654222 2345677899999999987654 89999999999999999998877753

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-32  Score=276.06  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=190.2

Q ss_pred             CeeeeeCCcEEEEE-EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  769 (1035)
                      +.+|+|+|+.|--+ ...+|.+||||++.+..              +..+.++.+|++++...+ |+||++++++|++++
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--------------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~  149 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--------------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT  149 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC--------------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence            57999999999998 56679999999996532              235778999999999995 999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC---ceEEeecc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF---EPYIADFG  846 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~---~~kl~DFG  846 (1035)
                      ..|+|||.|.||.|.+.++++..  +++.++.++..+||.||.+||.+   ||+|||+||+|||-....   -+|||||.
T Consensus       150 ~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  150 RFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             eEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccc
Confidence            99999999999999999988765  99999999999999999999999   999999999999996554   38999999


Q ss_pred             CccccccC-C----ccccccccCCcccccCCccc-----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          847 LAKLVVEG-D----FARSSNTVAGSYGYIAPEYG-----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       847 ~a~~~~~~-~----~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      +..-+... +    ......+.+|+..|||||+.     ....|+.+.|.||+|||+|-|++|..||.+.-.++   .-|
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d---CGW  301 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD---CGW  301 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc---CCc
Confidence            87643221 1    11222356799999999963     23458899999999999999999999998643210   111


Q ss_pred             HHHhcc--c-hhhhcccccCCCcccHHHHH----HHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          917 VRQKRG--A-IEVLDKSLRARPEVEIEEML----QTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       917 ~~~~~~--~-~~~~~~~~~~~~~~~~~~~~----~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      -+...-  . ...+.....+.+++.-.++.    ..-+++...+..||.+|-++.+++.
T Consensus       302 drGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  302 DRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             cCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            111000  0 01111111222222212221    2234555567789999998888877

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-31  Score=293.88  Aligned_cols=262  Identities=26%  Similarity=0.351  Sum_probs=196.7

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |...+.||+|++|.||+|... +++.+++|++.......            ...+.+.+|++++++++||||+++++++.
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   68 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE------------GIPKTALREIKLLKELNHPNIIKLLDVFR   68 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc------------hhHHHHHHHHHHHHHhcCCCcchHHHhhc
Confidence            456788999999999999765 68999999986543221            13467889999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +++..++||||+++ ++.+++.... ..+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||
T Consensus        69 ~~~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~  143 (283)
T cd05118          69 HKGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFG  143 (283)
T ss_pred             cCCCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeee
Confidence            99999999999965 8888887643 3489999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc-h
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA-I  924 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~  924 (1035)
                      .+.......  .......++..|+|||...+. .++.++||||+|+++|+|++|+.||......+ .+.......... .
T Consensus       144 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~  220 (283)
T cd05118         144 LARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDP  220 (283)
T ss_pred             eeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCch
Confidence            987665432  122235678899999987766 78899999999999999999999996543211 010000000000 0


Q ss_pred             hhhcc----------cccCCCccc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDK----------SLRARPEVE-----IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~----------~~~~~~~~~-----~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....          .........     .....+..+++..||++||.+||++.+++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             HhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000          000000000     0112345678999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.5e-31  Score=302.10  Aligned_cols=265  Identities=23%  Similarity=0.285  Sum_probs=195.4

Q ss_pred             cHHHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          680 TVEQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       680 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      ++..+.++|...+.||+|+||.||+|... +++.||||++.......            ...+.+.+|+.++++++||||
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i   76 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSE------------LFAKRAYRELRLLKHMKHENV   76 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccch------------HHHHHHHHHHHHHHhcCCCCc
Confidence            44556678999999999999999999654 68999999985432111            124578899999999999999


Q ss_pred             eeEEeEEEcCC------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccE
Q 039419          759 VRFLGCCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNI  832 (1035)
Q Consensus       759 v~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NI  832 (1035)
                      +++++++....      ..++||||+ +++|.+++...   .+++..+..++.|+++|++|||+.   ||+||||||+||
T Consensus        77 v~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Ni  149 (343)
T cd07880          77 IGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNL  149 (343)
T ss_pred             cceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            99999987654      358999999 78998888643   389999999999999999999998   999999999999


Q ss_pred             EEcCCCceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCch
Q 039419          833 LIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL  911 (1035)
Q Consensus       833 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~  911 (1035)
                      +++.++.++++|||.+......     .....+++.|+|||...+ ..++.++|+||+|+++|++++|..||...... .
T Consensus       150 ll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~  223 (343)
T cd07880         150 AVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-D  223 (343)
T ss_pred             EEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence            9999999999999998764321     123467889999998765 45888999999999999999999999754221 0


Q ss_pred             hHHHHHHHhccch-h-----------hhcccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          912 HIVDWVRQKRGAI-E-----------VLDKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       912 ~~~~~~~~~~~~~-~-----------~~~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ............. +           .....+........     .....+.+++.+|++.||++||++.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1111000000000 0           00000000000000     011134578889999999999999999863

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=3e-31  Score=292.54  Aligned_cols=262  Identities=24%  Similarity=0.318  Sum_probs=195.5

Q ss_pred             cccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |...+.||+|+||.||+|.+.+ ++.+|+|++.......            ...+.+.+|++++++++|||++++++++.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   68 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE------------GFPITAIREIKLLQKLRHPNIVRLKEIVT   68 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc------------cchHHHHHHHHHHHhccCCCeeeheeeEe
Confidence            5567899999999999997764 8899999997543111            23457889999999999999999999999


Q ss_pred             cC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          767 NR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       767 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.  +..++||||++ ++|.+++.... ..+++..+..++.|+++|++|||+.   +++|+||||+||++++++.++|+|
T Consensus        69 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d  143 (287)
T cd07840          69 SKGKGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLAD  143 (287)
T ss_pred             cCCCCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcc
Confidence            88  78999999996 48988886553 3489999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.+........ .......++..|+|||...+ ..++.++||||||+++|||++|+.||......  .....+......
T Consensus       144 ~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~  220 (287)
T cd07840         144 FGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGS  220 (287)
T ss_pred             ccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCC
Confidence            999987654321 11223457889999997654 45789999999999999999999999754321  111111110000


Q ss_pred             --hh------hh--ccccc--CCCcccH----HH--HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 --IE------VL--DKSLR--ARPEVEI----EE--MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 --~~------~~--~~~~~--~~~~~~~----~~--~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        ..      .+  .....  ......+    ..  .....+++.+||+.+|++||++++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             CchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              00      00  00000  0000000    01  2345678999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-31  Score=301.37  Aligned_cols=264  Identities=25%  Similarity=0.287  Sum_probs=193.8

Q ss_pred             HHHHHhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          681 VEQVLKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       681 ~~~~~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      +..+.++|...+.||+|+||.||+|.. .+++.||+|++.......            ...+.+.+|+.++++++||||+
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~Ei~~l~~l~h~~iv   79 (345)
T cd07877          12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI------------IHAKRTYRELRLLKHMKHENVI   79 (345)
T ss_pred             HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh------------HHHHHHHHHHHHHHHcCCCccc
Confidence            344558899999999999999999965 468999999986532111            1235688899999999999999


Q ss_pred             eEEeEEEcC------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          760 RFLGCCWNR------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       760 ~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      ++++++...      ...|++++++ +++|.+++...   .+++..+..++.|+++|++|||+.   +|+||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl  152 (345)
T cd07877          80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLA  152 (345)
T ss_pred             ceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEE
Confidence            999988643      3367888877 88998887653   388999999999999999999999   9999999999999


Q ss_pred             EcCCCceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       834 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      ++.++.+||+|||+++....     ......|+..|+|||+..+ ..++.++|||||||++|||++|+.||....... .
T Consensus       153 l~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~  226 (345)
T cd07877         153 VNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-Q  226 (345)
T ss_pred             EcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence            99999999999999875422     1234568899999998765 568889999999999999999999996432211 1


Q ss_pred             HHHHHHHhccc-hhhh-----------cccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          913 IVDWVRQKRGA-IEVL-----------DKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       913 ~~~~~~~~~~~-~~~~-----------~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ........... ....           ...+...+.....     ......+++..|+++||++||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            11111100000 0000           0000000110000     11234578889999999999999999885

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=3.3e-31  Score=294.87  Aligned_cols=250  Identities=28%  Similarity=0.367  Sum_probs=191.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|... +++.+|+|.+........           ...+++.+|+.+++.++|||+++++++
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~   83 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-----------EKWQDIIKEVRFLQKLRHPNTIQYRGC   83 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh-----------HHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence            34666788999999999999775 578899998854221111           124568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +......|+||||+. |++.+++.... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|
T Consensus        84 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~d  158 (308)
T cd06634          84 YLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  158 (308)
T ss_pred             EEcCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECC
Confidence            999999999999996 68887775443 3478999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ||++......      ....|+..|+|||+..   ...++.++|||||||++|||++|+.||....... ....+...  
T Consensus       159 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~--  229 (308)
T cd06634         159 FGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN--  229 (308)
T ss_pred             cccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhc--
Confidence            9998765332      2456889999999864   3567889999999999999999999986432110 00111100  


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                              ........  .....+..++.+||+++|++||++++++++.
T Consensus       230 --------~~~~~~~~--~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         230 --------ESPALQSG--HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --------CCCCcCcc--cccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence                    00000011  1112234578889999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=284.62  Aligned_cols=204  Identities=25%  Similarity=0.356  Sum_probs=175.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  763 (1035)
                      .+|....+||+|+||.|.+|+.+ ..+.||||+++++.+..+.+.           +--+.|-++|.-. +-|.+++++.
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv-----------ectm~EKrvLAL~~kppFL~qlHS  417 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV-----------ECTMVEKRVLALPGKPPFLVQLHS  417 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc-----------cceehhhhheecCCCCchHHHHHH
Confidence            56888899999999999999665 467899999988766544322           2234566677665 5789999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      +|+..+..|+||||+.||+|--.+++.+.  +.+..+..+|.+||-||-+||++   ||++||+|.+|||+|.+|++||+
T Consensus       418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~  492 (683)
T KOG0696|consen  418 CFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIA  492 (683)
T ss_pred             HhhhhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEee
Confidence            99999999999999999999888877665  78888899999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI  907 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~  907 (1035)
                      |||+++.-.-+.  ..+.+.+||+.|+|||++...+|+..+|.||+||++|||+.|+.||++..
T Consensus       493 DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD  554 (683)
T KOG0696|consen  493 DFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  554 (683)
T ss_pred             ecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999998644333  23457899999999999999999999999999999999999999998653

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.7e-31  Score=300.71  Aligned_cols=263  Identities=24%  Similarity=0.274  Sum_probs=197.7

Q ss_pred             ccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|.+.+.||.|+||.||+|.... ++.||+|++.......            ...+.+.+|+.+++.++||||+++++++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL------------IDAKRILREIKLLRHLRHENIIGLLDIL   68 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccc------------hhhhhHHHHHHHHHhcCCcchhhhhhhh
Confidence            47788999999999999997764 8999999986532211            2346789999999999999999999999


Q ss_pred             EcCC-----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          766 WNRN-----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       766 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ...+     ..|+||||+. ++|.+++....  .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+
T Consensus        69 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~  142 (330)
T cd07834          69 RPPSPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDL  142 (330)
T ss_pred             cccCcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence            8775     7899999996 58999887654  489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCcc-ccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      +|+|||.+......... .......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||......  .....+.
T Consensus       143 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~  220 (330)
T cd07834         143 KICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIV  220 (330)
T ss_pred             EEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHH
Confidence            99999999876543210 112345678899999998877 7899999999999999999999999754321  1011110


Q ss_pred             Hhccc--hhhh-----------cccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGA--IEVL-----------DKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~--~~~~-----------~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...+.  .+..           .............     ......+++.+||+++|++||++++++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         221 EVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00000  0000           0000000000000     11234568888999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=2.2e-31  Score=297.32  Aligned_cols=267  Identities=24%  Similarity=0.246  Sum_probs=191.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||+|++......+.            ....+.+|++++++++||||+++++
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~i~~~~~   74 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG------------FPITALREIKILKKLKHPNVVPLID   74 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC------------cchhHHHHHHHHHhcCCCCccchhh
Confidence            578999999999999999999765 589999999865332211            1245678999999999999999999


Q ss_pred             EEEcCC--------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          764 CCWNRN--------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       764 ~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++.+..        ..|+||||+. +++.+.+.... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++
T Consensus        75 ~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~  149 (311)
T cd07866          75 MAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILID  149 (311)
T ss_pred             heecccccccccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            876543        3599999995 47777765432 3489999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCcc---------ccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          836 PEFEPYIADFGLAKLVVEGDFA---------RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      .++.++|+|||+++........         .......|++.|+|||+..+ ..++.++||||||+++|||++|+.||..
T Consensus       150 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         150 NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             CCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999865432211         11123457888999998654 4588999999999999999999999975


Q ss_pred             CCCCchhHHHHHHHhccc-----------hhhhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          906 TIPEGLHIVDWVRQKRGA-----------IEVLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..... ............           ............+....     ......+++.+|+..||++|||+.+++.+
T Consensus       230 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         230 KSDID-QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             CCHHH-HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            43211 000000000000           00000000000000010     11235678899999999999999998763

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=3.9e-31  Score=296.47  Aligned_cols=260  Identities=23%  Similarity=0.304  Sum_probs=193.6

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.++|...+.||.|+||.||+|... +++.||+|++.......            ...+.+.+|++++++++||||++++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~   75 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP------------VLAKRTYRELKLLKHLRHENIISLS   75 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc------------chhHHHHHHHHHHHhcCCCCeeeEe
Confidence            4577999999999999999999765 68999999885432211            1245788999999999999999999


Q ss_pred             eEEEc-CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          763 GCCWN-RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       763 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      +++.. .+..|+||||+ +++|.++++..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++
T Consensus        76 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~  148 (328)
T cd07856          76 DIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLK  148 (328)
T ss_pred             eeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEE
Confidence            99876 45789999998 67898888643   278888889999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |+|||.+......     .....++..|+|||+..+ ..++.++||||||+++|+|++|+.||....... ....+.+..
T Consensus       149 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~~~~~~  222 (328)
T cd07856         149 ICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSIITDLL  222 (328)
T ss_pred             eCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence            9999998754221     123467889999998655 568899999999999999999999996543210 000011000


Q ss_pred             cc-------------chhhhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RG-------------AIEVLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~-------------~~~~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..             ..+.... ..........     ......+++.+|++.+|++||++++++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         223 GTPPDDVINTICSENTLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCCCHHHHHhccchhhHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00             0000000 0000000111     11345668889999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=314.92  Aligned_cols=261  Identities=27%  Similarity=0.434  Sum_probs=205.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC--------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCC
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME--------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHK  756 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  756 (1035)
                      ++..+.+.+|+|.||.||+|...        ....||||.++......             ..+.+..|+.+|+.+ +||
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~-------------~~~~~~~El~~m~~~g~H~  362 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSS-------------EKKDLMSELNVLKELGKHP  362 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcH-------------HHHHHHHHHHHHHHhcCCc
Confidence            33455569999999999999543        14579999987654432             267899999999999 699


Q ss_pred             ceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcC---------C-----CCCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 039419          757 NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR---------D-----SCLEWELRYRIILGAAQGLAYLHHDCVPPI  822 (1035)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  822 (1035)
                      ||+.++|++..++..++|+||+..|+|.++++..+         .     ..+.....+.++.|||.|++||++.   ++
T Consensus       363 niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~  439 (609)
T KOG0200|consen  363 NIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PC  439 (609)
T ss_pred             chhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cc
Confidence            99999999999999999999999999999998876         0     1378899999999999999999999   99


Q ss_pred             eccCCCcccEEEcCCCceEEeeccCccccccCCcccccccc-CCcccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 039419          823 VHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV-AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK  900 (1035)
Q Consensus       823 vHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~  900 (1035)
                      +|||+..+|||+.++..+||+|||+|+...+.+.+...... .-...|||||.+....++.++|||||||++||+++ |.
T Consensus       440 vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~  519 (609)
T KOG0200|consen  440 VHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG  519 (609)
T ss_pred             cchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence            99999999999999999999999999976665544322111 13456999999999999999999999999999999 88


Q ss_pred             CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       901 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .||.... ....+..+++....         ...|....+   +...++..||+.+|++||++.++.+.++....
T Consensus       520 ~PYp~~~-~~~~l~~~l~~G~r---------~~~P~~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  520 TPYPGIP-PTEELLEFLKEGNR---------MEQPEHCSD---EIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCCCCCC-cHHHHHHHHhcCCC---------CCCCCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            8996522 12222333332211         122222223   33568889999999999999999999988543

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=6.4e-31  Score=293.15  Aligned_cols=248  Identities=29%  Similarity=0.384  Sum_probs=190.6

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|...+.||+|+||+||+|... +++.||+|++........           ...+.+.+|+.++++++|||++++++++
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   90 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN-----------EKWQDIIKEVKFLQQLKHPNTIEYKGCY   90 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch-----------HHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            3566678999999999999765 588999999864322111           1235688999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+....|+||||+. |++.+++.... ..+++..+..++.|++.|++|||+.   |++||||||+||+++.++.++|+||
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~df  165 (313)
T cd06633          91 LKEHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADF  165 (313)
T ss_pred             EeCCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeec
Confidence            99999999999995 57877776543 3488999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |.+.....      .....|+..|+|||++.   ...++.++|||||||++|||++|..||......  .......... 
T Consensus       166 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~~-  236 (313)
T cd06633         166 GSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQND-  236 (313)
T ss_pred             CCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhcC-
Confidence            99864321      22456889999999874   456888999999999999999999998654221  1111111100 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          .........    .  ....+++.+||+++|++||++.+++.+
T Consensus       237 ----~~~~~~~~~----~--~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 ----SPTLQSNEW----T--DSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----CCCCCcccc----C--HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                000000011    1  123457888999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.2e-31  Score=299.39  Aligned_cols=259  Identities=24%  Similarity=0.273  Sum_probs=189.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      ..+|...+.||+|+||.||+|.+. +++.||||++.......            .....+.+|+.++++++||||+++++
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~niv~~~~   81 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE------------IFAKRAYRELTLLKHMQHENVIGLLD   81 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc------------cchhHHHHHHHHHHhcCCCCccchhh
Confidence            467888899999999999999765 58999999986532211            12456889999999999999999999


Q ss_pred             EEEcCC------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          764 CCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       764 ~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++....      ..|+||||+. .++.++..    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~  153 (342)
T cd07879          82 VFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNED  153 (342)
T ss_pred             eecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            987543      3589999995 47766542    2388999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      +.++|+|||+++.....     .....++..|+|||...+ ..++.++|||||||++|||++|+.||....... .....
T Consensus       154 ~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~  227 (342)
T cd07879         154 CELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQI  227 (342)
T ss_pred             CCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence            99999999998754221     224567889999998765 468899999999999999999999997542111 11111


Q ss_pred             HHHhccch-h-----------hhcccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRGAI-E-----------VLDKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~~~-~-----------~~~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ........ .           .........+....     .......+++.+||++||++||++++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000 0           00000000000000     011234568888999999999999999874

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=7.6e-31  Score=295.28  Aligned_cols=263  Identities=23%  Similarity=0.232  Sum_probs=189.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-C--CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-N--GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      +|...+.||+|+||.||+|+.. .  ++.||+|++.......            ...+.+.+|+++++++ +||||++++
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~h~~iv~~~   68 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK------------ILAKRALRELKLLRHFRGHKNITCLY   68 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccc------------hhHHHHHHHHHHHHHhcCCCChheee
Confidence            3667789999999999999765 3  6789999985422111            1245788999999999 599999999


Q ss_pred             eEEEcC----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          763 GCCWNR----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       763 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +.+...    ...|++|||+. ++|.+++....  .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++
T Consensus        69 ~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~  142 (332)
T cd07857          69 DMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADC  142 (332)
T ss_pred             eeeeeccccCCcEEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCC
Confidence            975432    35688899884 68999886544  389999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCcc--ccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          839 EPYIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                      .+||+|||.++........  .......|+..|+|||+..+ ..++.++||||+||++|+|++|..||......  ....
T Consensus       143 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~  220 (332)
T cd07857         143 ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLN  220 (332)
T ss_pred             CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHH
Confidence            9999999999865432211  11234578999999998655 46889999999999999999999999754311  0000


Q ss_pred             ------------HHHHhccc-hhhhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 ------------WVRQKRGA-IEVLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ------------~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                                  +....... ...........+...+.     .......++.+|+++||++||++.+++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         221 QILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                        00000000 00000000000000000     11245568889999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.7e-31  Score=322.60  Aligned_cols=149  Identities=30%  Similarity=0.407  Sum_probs=132.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +++|.+.+.||+|+||+||+|.+. +++.||||++........           .....+.+|+.+++.++||||+++++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~Iv~~~~   71 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK-----------NMVHQVQAERDALALSKSPFIVHLYY   71 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCH-----------HHHHHHHHHHHHHHhcCCCCcCeEEE
Confidence            467888999999999999999776 589999999865332211           23467889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++...+..|+||||+.|++|.+++...+.  +++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+
T Consensus        72 ~~~~~~~~~lVmEy~~g~~L~~li~~~~~--l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~  146 (669)
T cd05610          72 SLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLT  146 (669)
T ss_pred             EEEECCEEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEE
Confidence            99999999999999999999999976543  78899999999999999999998   99999999999999999999999


Q ss_pred             eccCcc
Q 039419          844 DFGLAK  849 (1035)
Q Consensus       844 DFG~a~  849 (1035)
                      |||+++
T Consensus       147 DFGls~  152 (669)
T cd05610         147 DFGLSK  152 (669)
T ss_pred             eCCCCc
Confidence            999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=300.93  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=201.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  763 (1035)
                      +.|++.++||.|.+|.||+++.. +++.+|||+.......               .+++..|+.+++.+ .|||++.+||
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---------------deEiE~eynil~~~~~hpnv~~fyg   83 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---------------EEEIELEYNMLKKYSHHPNVATFYG   83 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---------------cHHHHHHHHHHHhccCCCCcceEEE
Confidence            45778899999999999999655 5899999998765433               34678899999988 6999999999


Q ss_pred             EEEc-----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          764 CCWN-----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       764 ~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +|.-     ++..|+|||||.|||..++++...+..+.|..+.-|++.+++|+++||..   .++|||||-.|||++.++
T Consensus        84 ~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   84 AFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENA  160 (953)
T ss_pred             EEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccC
Confidence            9863     46789999999999999999887777799999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI  913 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~  913 (1035)
                      .||++|||.+.......  .......||+.|||||++..     ..|+.++|+||+|++..||.-|.+|+-+.+|-..  
T Consensus       161 ~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra--  236 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA--  236 (953)
T ss_pred             cEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh--
Confidence            99999999988764433  34567889999999998653     3477899999999999999999999976654211  


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         +-       .+.+..+......-.-..+.-++|..|+.+|.++||++.+++++
T Consensus       237 ---LF-------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  237 ---LF-------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---hc-------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence               00       00000000000111222234567888999999999999998764

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=2.7e-31  Score=288.30  Aligned_cols=254  Identities=21%  Similarity=0.264  Sum_probs=192.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|.+.+.||+|+||.||+|.+.. +..+++|+.+.........         ....++.+|+.++++++||||+++++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNP---------NETVQANQEAQLLSKLDHPAIVKFHASF   71 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCc---------chHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence            47788899999999999997654 4556666664422211100         1234577899999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      .+.+..++||||+++++|.+++...  ....+++..+..++.|++.|+.|||+.   +++|+||||+||+++. +.++|+
T Consensus        72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeec
Confidence            9999999999999999999988642  224589999999999999999999998   9999999999999975 569999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||.++.......  ......|+..|+|||...+..++.++|+||||+++|+|++|..||.....     ........  
T Consensus       148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~--  218 (260)
T cd08222         148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIV--  218 (260)
T ss_pred             ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHH--
Confidence            9999887644321  22345688999999998888889999999999999999999999964321     11111100  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          .......+ .  .......+++.+||+.+|++||++.+++++
T Consensus       219 ----~~~~~~~~-~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         219 ----EGPTPSLP-E--TYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ----cCCCCCCc-c--hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                00000111 1  112234568888999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=286.19  Aligned_cols=239  Identities=25%  Similarity=0.284  Sum_probs=190.3

Q ss_pred             eeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcce
Q 039419          694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL  772 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  772 (1035)
                      ||+|+||.||+|... +++.||+|.+........           ...+.+..|+.++++++||||+++++.+..++..|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   69 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR-----------KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLY   69 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch-----------HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeE
Confidence            699999999999776 489999999865433221           12567899999999999999999999999999999


Q ss_pred             EEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccc
Q 039419          773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV  852 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~  852 (1035)
                      +||||+++++|.+++....  .+++..+..++.|+++|+.|+|+.   +++|+||||+||+++.++.++|+|||.+....
T Consensus        70 ~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~  144 (250)
T cd05123          70 LVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELS  144 (250)
T ss_pred             EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecc
Confidence            9999999999999997654  389999999999999999999998   99999999999999999999999999988654


Q ss_pred             cCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccccc
Q 039419          853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR  932 (1035)
Q Consensus       853 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  932 (1035)
                      ...  .......++..|+|||...+...+.++|+||||+++|++++|..||.....  ......+..   .    .....
T Consensus       145 ~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~---~----~~~~~  213 (250)
T cd05123         145 SEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK---D----PLRFP  213 (250)
T ss_pred             cCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc---C----CCCCC
Confidence            432  122355688999999998888889999999999999999999999964422  111111111   0    00011


Q ss_pred             CCCcccHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 039419          933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKD  965 (1035)
Q Consensus       933 ~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~e  965 (1035)
                      ...      .....+++.+||..||++||++.+
T Consensus       214 ~~~------~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFL------SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCC------CHHHHHHHHHHhcCCHhhCCCccc
Confidence            111      122345788899999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.4e-31  Score=300.59  Aligned_cols=261  Identities=25%  Similarity=0.308  Sum_probs=194.7

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++.++|...+.||+|+||.||+|.+. +++.||||++.......            ...+.+.+|+.++++++||||+++
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~   79 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA------------IHAKRTYRELRLLKHMDHENVIGL   79 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh------------hHHHHHHHHHHHHHhccCCCHHHH
Confidence            34567888999999999999999776 57899999886432111            123567789999999999999999


Q ss_pred             EeEEEcCCc------ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          762 LGCCWNRNT------RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       762 ~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++...+.      .|+|+||+ +++|.+++...   .+++..+..++.|+++|++|||+.   ||+||||||+||+++
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~  152 (343)
T cd07851          80 LDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVN  152 (343)
T ss_pred             HHHhhccccccccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEC
Confidence            998876554      79999998 77999988653   389999999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                      .++.++|+|||.+......     .....++..|+|||...+ ..++.++|||||||++||+++|+.||......  ...
T Consensus       153 ~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~  225 (343)
T cd07851         153 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQL  225 (343)
T ss_pred             CCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHH
Confidence            9999999999999865332     234567889999998654 46788999999999999999999999644221  111


Q ss_pred             HHHHHhcc-ch-hhhc-----------ccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRG-AI-EVLD-----------KSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~-~~-~~~~-----------~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+....+ .. ....           ...........     .....+.+++.+|+++||++|||+.+++++
T Consensus       226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         226 KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            11110000 00 0000           00000000000     012345678899999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-32  Score=288.98  Aligned_cols=204  Identities=23%  Similarity=0.315  Sum_probs=182.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCc-EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGE-VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++.....+|-||||.|=+++....+ .+|+|++++..+-+.           ...+++..|-.+|...+.|.||++|..
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-----------kQqeHv~sEr~Im~~~~s~fIvrLYrT  488 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT-----------KQQEHVFSERNIMMECRSDFIVRLYRT  488 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch-----------hHHHHHHhHHHHHHhcCchHHHHHHHH
Confidence            55666778999999999999777543 489999876544333           346789999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |.+..+.|+.||-|-||.++..+++++.  ++......++..+.+|++|||++   +||+||+||+|.+++.+|-+||.|
T Consensus       489 frd~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVD  563 (732)
T KOG0614|consen  489 FRDSKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVD  563 (732)
T ss_pred             hccchhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEee
Confidence            9999999999999999999999988766  89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      ||+|+.+..+.   .+.+++||+.|.|||++.....+.++|.||+|+++||+++|.+||....+
T Consensus       564 FGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp  624 (732)
T KOG0614|consen  564 FGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP  624 (732)
T ss_pred             hhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch
Confidence            99999987654   34578999999999999999999999999999999999999999986543

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=3.7e-31  Score=298.84  Aligned_cols=262  Identities=23%  Similarity=0.275  Sum_probs=188.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .+|...+.||.|+||.||+|... +++.||+|++.....              ...+.+.+|++++++++||||++++++
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------------~~~~~~~~Ei~~l~~l~h~~i~~~~~~   70 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------------QSVKHALREIKIIRRLDHDNIVKVYEV   70 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------------chHHHHHHHHHHHHhcCCCcchhhHhh
Confidence            57888999999999999999765 589999999854322              124678899999999999999999987


Q ss_pred             EEcC--------------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 039419          765 CWNR--------------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN  830 (1035)
Q Consensus       765 ~~~~--------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~  830 (1035)
                      +...              ...|+||||++ ++|.+++...   .+++..+..++.||+.||+|||+.   ||+||||||+
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~  143 (342)
T cd07854          71 LGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPA  143 (342)
T ss_pred             hcccccccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHH
Confidence            6543              34689999996 5898887543   388999999999999999999998   9999999999


Q ss_pred             cEEEcC-CCceEEeeccCccccccCCcc-ccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 039419          831 NILIGP-EFEPYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTI  907 (1035)
Q Consensus       831 NIll~~-~~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~  907 (1035)
                      ||+++. ++.++++|||.++........ .......|+..|+|||.... ..++.++|||||||++|||++|+.||....
T Consensus       144 Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  223 (342)
T cd07854         144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH  223 (342)
T ss_pred             HEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999974 557899999999765332111 11123457889999997543 567889999999999999999999997543


Q ss_pred             CCchhHHHHHHHhc--------cchhhhccccc---CCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          908 PEGLHIVDWVRQKR--------GAIEVLDKSLR---ARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       908 ~~~~~~~~~~~~~~--------~~~~~~~~~~~---~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +... .........        ...........   ..+.....     ......+++.+||.+||++||++.+++++
T Consensus       224 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         224 ELEQ-MQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHH-HHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            2110 000000000        00000000000   00000000     11234568889999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-31  Score=293.00  Aligned_cols=240  Identities=22%  Similarity=0.262  Sum_probs=190.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .+.|.....+|.|+|+.|-++.+. +++..++|++.....                  +-.+|+.++... +||||+++.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------------------~~~~e~~~~~~~~~h~niv~~~  382 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------------------DNQDEIPISLLVRDHPNIVKSH  382 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc------------------ccccccchhhhhcCCCcceeec
Confidence            466788888999999999999554 588999999965421                  223577666666 699999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE-cCCCceE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI-GPEFEPY  841 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll-~~~~~~k  841 (1035)
                      +.+.+..+.|+|||++.|+-+.+.+...+.  +. ..+..|+.+|+.|+.|||++   |+||||+||+|||+ +..++++
T Consensus       383 ~v~~~~~~~~~v~e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lr  456 (612)
T KOG0603|consen  383 DVYEDGKEIYLVMELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLR  456 (612)
T ss_pred             ceecCCceeeeeehhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEE
Confidence            999999999999999999988888776554  33 67778999999999999998   99999999999999 6899999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |+|||.++...+.     ...-+-|..|.|||+.....+++++|+||||++||+|++|+.||... |.+..+...+    
T Consensus       457 ltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~-P~~~ei~~~i----  526 (612)
T KOG0603|consen  457 LTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH-PAGIEIHTRI----  526 (612)
T ss_pred             EEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC-CchHHHHHhh----
Confidence            9999999876543     22446789999999999999999999999999999999999999743 3322221111    


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                               ........+.  ..+.+++.+|++.||.+||++.++..+
T Consensus       527 ---------~~~~~s~~vS--~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  527 ---------QMPKFSECVS--DEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ---------cCCccccccC--HHHHHHHHHhccCChhhCcChhhhccC
Confidence                     1111111112  223457778999999999999999875

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-30  Score=286.73  Aligned_cols=261  Identities=25%  Similarity=0.326  Sum_probs=196.0

Q ss_pred             cccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |...+.||+|+||.||+|.... ++.||+|++.......            ...+.+..|+.++++++||||+++++++.
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   68 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE------------GIPSTALREISLLKELKHPNIVKLLDVIH   68 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc------------cccHHHHHHHHHHHhcCCCCHHHHHhhhh
Confidence            4556789999999999997764 8999999987543111            23467889999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +.+..++||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++.++|+|||
T Consensus        69 ~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g  143 (282)
T cd07829          69 TERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFG  143 (282)
T ss_pred             cCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCC
Confidence            9999999999997 59999998753 2489999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc-c-
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG-A-  923 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-~-  923 (1035)
                      .++.......  ......++..|+|||...+. .++.++||||||+++||+++|+.||......  .....+..... . 
T Consensus       144 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~  219 (282)
T cd07829         144 LARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQLFKIFQILGTPT  219 (282)
T ss_pred             cccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHHHhCCCc
Confidence            9986544321  12234567889999987766 7889999999999999999999999653211  11111100000 0 


Q ss_pred             h-------hh--hcccccCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 I-------EV--LDKSLRARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~-------~~--~~~~~~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .       ..  .+...........     .....+.+++..||..||++||++.+++.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             HHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0       00  0000000000000     012345678899999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.5e-31  Score=286.70  Aligned_cols=209  Identities=27%  Similarity=0.373  Sum_probs=176.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..|...+.||-|+||+|.+++.. +...||+|.+.+...-.           ......++.|.+||..-+.+-||++|-.
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-----------rnQvaHVKAERDILAEADn~WVVrLyyS  697 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-----------RNQVAHVKAERDILAEADNEWVVRLYYS  697 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-----------hhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence            35777889999999999999554 46779999986543222           1235678899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |.+.+..|+||+|++||++-++|-+.+-  |++..+..++.+++.|+++.|..   |+|||||||+|||||.+|++||+|
T Consensus       698 FQDkdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  698 FQDKDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             eccCCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeee
Confidence            9999999999999999999999876554  88999999999999999999999   999999999999999999999999


Q ss_pred             ccCcccc---------ccCCcccc-------------------------------ccccCCcccccCCcccccCCCCccc
Q 039419          845 FGLAKLV---------VEGDFARS-------------------------------SNTVAGSYGYIAPEYGYMMKITEKS  884 (1035)
Q Consensus       845 FG~a~~~---------~~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~  884 (1035)
                      ||+|.-+         ..++..+.                               ....+||+.|+|||++....++..+
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c  852 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC  852 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence            9998533         21111000                               1134699999999999999999999


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCCCCc
Q 039419          885 DVYSYGVVVLEVLTGKQPIDPTIPEG  910 (1035)
Q Consensus       885 Dv~SlGvvl~elltg~~P~~~~~~~~  910 (1035)
                      |.||.|||||||+.|+.||....+.+
T Consensus       853 dwws~gvil~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccCCCCCc
Confidence            99999999999999999998766543

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-31  Score=242.77  Aligned_cols=200  Identities=26%  Similarity=0.378  Sum_probs=169.0

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|...++||+|.||+||+|+.. .++.||+|.+..+..++            +......+|+-+++.++|.|||++++..
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde------------gvpssalreicllkelkhknivrl~dvl   70 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLHDVL   70 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC------------CCcHHHHHHHHHHHHhhhcceeehhhhh
Confidence            4666789999999999999655 58999999986543322            3566788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      ..+...-+|+||| ..+|..+.....+ .++.+.+..++.|+++|+.++|++   ++.|||+||+|.+++.+|+.|++||
T Consensus        71 hsdkkltlvfe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladf  145 (292)
T KOG0662|consen   71 HSDKKLTLVFEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADF  145 (292)
T ss_pred             ccCceeEEeHHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEeccc
Confidence            9999999999999 5688888866543 388899999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCC-CCccccchhHHHHHHHHHhCCCC-CCC
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQP-IDP  905 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvvl~elltg~~P-~~~  905 (1035)
                      |+++.+.-..  +.....+.|..|.+|.++.+.+ |+...|+||-||++.|+.....| |.+
T Consensus       146 glarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg  205 (292)
T KOG0662|consen  146 GLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_pred             chhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence            9999765432  2333456789999999988765 88899999999999999984444 543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=3.6e-30  Score=274.92  Aligned_cols=219  Identities=21%  Similarity=0.193  Sum_probs=172.8

Q ss_pred             eCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcceEEE
Q 039419          697 GCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMY  775 (1035)
Q Consensus       697 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  775 (1035)
                      |.||.||+|.+. +++.||+|++....                   .+.+|...+....||||+++++++.+.+..|+||
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~   64 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVL   64 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEE
Confidence            899999999765 58999999985421                   2334555556667999999999999999999999


Q ss_pred             EeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCC
Q 039419          776 DYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD  855 (1035)
Q Consensus       776 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~  855 (1035)
                      ||++||+|.+++.....  +++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.++++|||.+...... 
T Consensus        65 e~~~~~~L~~~l~~~~~--l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-  138 (237)
T cd05576          65 QHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-  138 (237)
T ss_pred             ecCCCCCHHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-
Confidence            99999999999876543  89999999999999999999998   9999999999999999999999999987655332 


Q ss_pred             ccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCC
Q 039419          856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARP  935 (1035)
Q Consensus       856 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  935 (1035)
                          .....++..|+|||...+..++.++||||+|+++|||++|..|+.......       .      .........  
T Consensus       139 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~------~~~~~~~~~--  199 (237)
T cd05576         139 ----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------N------THTTLNIPE--  199 (237)
T ss_pred             ----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------c------cccccCCcc--
Confidence                123456778999999888889999999999999999999998875321100       0      000000111  


Q ss_pred             cccHHHHHHHHHHHHhccCCCCCCCCCH
Q 039419          936 EVEIEEMLQTLGVALLCVNPTPDDRPTM  963 (1035)
Q Consensus       936 ~~~~~~~~~~l~l~~~cl~~dP~~RPs~  963 (1035)
                        ...  .....++.+|++.||++||++
T Consensus       200 --~~~--~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         200 --WVS--EEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             --cCC--HHHHHHHHHHccCCHHHhcCC
Confidence              111  233457888999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=246.62  Aligned_cols=203  Identities=24%  Similarity=0.371  Sum_probs=167.1

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGC  764 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  764 (1035)
                      .......||+|+||.|-+.++. +|+..|+|.+.......             ..++..+|+.+..+. .+|.+|++||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q-------------~q~r~L~dldi~~r~~~CPf~V~FyGa  113 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ-------------EQKRLLMDLDIIMRTVDCPFTVHFYGA  113 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH-------------HHHHHHHhhhhhccCCCCCeEEEeehh
Confidence            3445668999999999998775 69999999996544322             256788899887765 79999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      ..++...++.||.| ..||..+.++.  .....++...-+|+..+.+||.|||++.  .++|||+||+|||++.+|++|+
T Consensus       114 ~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKi  190 (282)
T KOG0984|consen  114 LFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKI  190 (282)
T ss_pred             hhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEE
Confidence            99999999999999 56887765432  2345888888999999999999999984  8999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccc----cCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      ||||.+-...+.-..   +--.|-..|||||.+.    ...|+.++||||+|+++.||.++++||+....
T Consensus       191 CDFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  191 CDFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             cccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            999999877554321   1245778999999754    34689999999999999999999999986543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-30  Score=262.34  Aligned_cols=203  Identities=22%  Similarity=0.334  Sum_probs=176.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      +..|...++||+|+|+.|..++++. .+.||+|+++++...++.+           .+-.+.|-.+...- +||.+|-++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded-----------idwvqtek~vfe~asn~pflvglh  317 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED-----------IDWVQTEKHVFEQASNNPFLVGLH  317 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc-----------chhHHhhHHHHHhccCCCeEEehh
Confidence            3578888999999999999998764 7889999998776555422           34455666666655 799999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      .+|+.+...++|.||++||+|--.++.++.  ++++.+..+-.+|.-||.|||++   ||+.||+|.+|||+|.+|++|+
T Consensus       318 scfqtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikl  392 (593)
T KOG0695|consen  318 SCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKL  392 (593)
T ss_pred             hhhcccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceee
Confidence            999999999999999999999888877665  89999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      +|+|.++.-....  ..+.+++||+.|.|||++.+..|+..+|.|++||+++||+.|+.||+-
T Consensus       393 tdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  393 TDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             cccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            9999998543322  334578999999999999999999999999999999999999999984

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=269.86  Aligned_cols=265  Identities=20%  Similarity=0.222  Sum_probs=203.7

Q ss_pred             ccHHHH-HhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-C
Q 039419          679 FTVEQV-LKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-H  755 (1035)
Q Consensus       679 ~~~~~~-~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h  755 (1035)
                      |.+.+. .++|.+...+|+|.||.|..+.+ +.+..||||+++.-.               ..++.-.-|+++++++. +
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---------------kYreAa~iEi~vLqki~~~  145 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---------------KYREAALIEIEVLQKINES  145 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---------------HHhhHHHHHHHHHHHHHhc
Confidence            334444 68899999999999999999944 457999999985321               23566778999999993 2


Q ss_pred             -C----ceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 039419          756 -K----NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN  830 (1035)
Q Consensus       756 -p----niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~  830 (1035)
                       |    -+|++.++|.-.++.++|+|.+ |-|++++++.....+++...+..++.|+++++++||+.   +++|.|+||+
T Consensus       146 DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPE  221 (415)
T KOG0671|consen  146 DPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPE  221 (415)
T ss_pred             CCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChh
Confidence             3    3788889999999999999988 77999999998888899999999999999999999999   9999999999


Q ss_pred             cEEEcC--------------------CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHH
Q 039419          831 NILIGP--------------------EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYG  890 (1035)
Q Consensus       831 NIll~~--------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  890 (1035)
                      ||++..                    ...++|+|||.|.+....     ...++.|..|.|||++.+-..+.++||||+|
T Consensus       222 NILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiG  296 (415)
T KOG0671|consen  222 NILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIG  296 (415)
T ss_pred             eEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeee
Confidence            999842                    234899999999875332     2467889999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCchhH--HHHHHHhccchhhhccc------------------------ccCCC-------cc
Q 039419          891 VVVLEVLTGKQPIDPTIPEGLHI--VDWVRQKRGAIEVLDKS------------------------LRARP-------EV  937 (1035)
Q Consensus       891 vvl~elltg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~~~------------------------~~~~~-------~~  937 (1035)
                      |||+|+.+|..-|+.... ..++  .+.+-+..+ ..++.+.                        ....+       ..
T Consensus       297 CIL~ElytG~~LFqtHen-~EHLaMMerIlGp~P-~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~  374 (415)
T KOG0671|consen  297 CILVELYTGETLFQTHEN-LEHLAMMERILGPIP-SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ  374 (415)
T ss_pred             eEEEEeeccceecccCCc-HHHHHHHHHhhCCCc-HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc
Confidence            999999999998875432 1111  111111000 0111110                        00000       01


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          938 EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       938 ~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .-.+...+++++.+|+..||.+|+|+.|++.+
T Consensus       375 ~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  375 DDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             CcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence            22445567889999999999999999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.5e-29  Score=299.27  Aligned_cols=260  Identities=19%  Similarity=0.206  Sum_probs=166.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      .++|...+.||+|+||.||+|.+.+     +..||||++.....                .+.+..|  .+++..+.+++
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----------------~e~~~~e--~l~~~~~~~~~  192 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----------------VEIWMNE--RVRRACPNSCA  192 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----------------hHHHHHH--HHHhhchhhHH
Confidence            4678999999999999999997753     68999998753211                1111111  11111222222


Q ss_pred             eEEeE------EEcCCcceEEEEeCCCCChhhhhhhcCCC------------------CCCHHHHHHHHHHHHHHHHHhh
Q 039419          760 RFLGC------CWNRNTRLLMYDYMPNGSLGSLLHERRDS------------------CLEWELRYRIILGAAQGLAYLH  815 (1035)
Q Consensus       760 ~l~~~------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~~L~~LH  815 (1035)
                      .++..      .......++||||+.+++|.+++......                  ......+..++.|++.||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH  272 (566)
T PLN03225        193 DFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH  272 (566)
T ss_pred             HHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH
Confidence            22111      23456789999999999999998754311                  0112345679999999999999


Q ss_pred             ccCCCCeeccCCCcccEEEcC-CCceEEeeccCccccccCCccccccccCCcccccCCcccccC----------------
Q 039419          816 HDCVPPIVHRDIKANNILIGP-EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM----------------  878 (1035)
Q Consensus       816 ~~~~~~ivHrDikp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------  878 (1035)
                      +.   +|+||||||+|||++. ++.+||+|||+|+....+.. .......|++.|+|||.+...                
T Consensus       273 ~~---gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~s  348 (566)
T PLN03225        273 ST---GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS  348 (566)
T ss_pred             HC---CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCcccccccccc
Confidence            98   9999999999999986 57999999999986543321 223456789999999954321                


Q ss_pred             ------CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHH--------HHH
Q 039419          879 ------KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEE--------MLQ  944 (1035)
Q Consensus       879 ------~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~  944 (1035)
                            .++.++||||+||++|||+++..|++...   ..+...+........................        ...
T Consensus       349 p~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  425 (566)
T PLN03225        349 PVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA  425 (566)
T ss_pred             chhccccCCCCcccHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence                  23456799999999999999877654210   0111111110000000000000111111111        112


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          945 TLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       945 ~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+++.+|+++||++|||+.|++++
T Consensus       426 ~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        426 GWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhCC
Confidence            2368889999999999999999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=291.83  Aligned_cols=246  Identities=29%  Similarity=0.419  Sum_probs=187.9

Q ss_pred             cccCCeeeeeCCcE-EEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEE
Q 039419          688 LVEDSVVGKGCSGI-VYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCC  765 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  765 (1035)
                      |.-.+++|.|+.|+ ||+|..+ |+.||||++-.+                 ..+...+|++.++.- +|||||++|+.-
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e-----------------~~~~A~rEi~lL~eSD~H~NviRyyc~E  572 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE-----------------FFDFAQREIQLLQESDEHPNVIRYYCSE  572 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH-----------------hHHHHHHHHHHHHhccCCCceEEEEeec
Confidence            34446789999885 7889887 889999998542                 234567999999988 599999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhc-CC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC---C--C
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHER-RD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP---E--F  838 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~---~--~  838 (1035)
                      .++...|+..|.| ..+|.+++... .. ........+.+..|++.||++||+.   +|||||+||+|||++.   +  .
T Consensus       573 ~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~  648 (903)
T KOG1027|consen  573 QDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTL  648 (903)
T ss_pred             cCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcce
Confidence            9999999999999 57999999874 11 1112144577899999999999998   9999999999999976   3  4


Q ss_pred             ceEEeeccCccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhC-CCCCCCCCCCchhHHHH
Q 039419          839 EPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG-KQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg-~~P~~~~~~~~~~~~~~  916 (1035)
                      +++|+|||+++....+.. ........||-+|+|||.+....-+.++||||+||++|+.++| ..||......+.++.. 
T Consensus       649 ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-  727 (903)
T KOG1027|consen  649 RAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-  727 (903)
T ss_pred             eEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-
Confidence            689999999998865532 2234577899999999999988888899999999999999995 8999864322211110 


Q ss_pred             HHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           +... +   ....+..  ++  .+.++|.+|+++||..||++.+|+.+
T Consensus       728 -----~~~~-L---~~L~~~~--d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  728 -----GNYT-L---VHLEPLP--DC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             -----Cccc-e---eeeccCc--hH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence                 0000 0   0011111  11  44568888999999999999999864

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=5.3e-29  Score=286.32  Aligned_cols=272  Identities=18%  Similarity=0.191  Sum_probs=179.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE-----------------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHH
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM-----------------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI  747 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~  747 (1035)
                      .++|.+.++||+|+||+||+|..                 .+++.||||++.........+..+.........+.+..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            46799999999999999999953                 2356899999864322111110000000112234566788


Q ss_pred             HHHhcCCCCce-----eeEEeEEEc--------CCcceEEEEeCCCCChhhhhhhcCC----------------------
Q 039419          748 KTLGSIRHKNI-----VRFLGCCWN--------RNTRLLMYDYMPNGSLGSLLHERRD----------------------  792 (1035)
Q Consensus       748 ~~l~~l~hpni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~----------------------  792 (1035)
                      .++.+++|.++     ++++++|..        ++..|+||||+++++|.++++....                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            88888876654     677777653        3567999999999999999874321                      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCC
Q 039419          793 SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP  872 (1035)
Q Consensus       793 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aP  872 (1035)
                      ..+++..+..++.|++.||+|+|+.   +|+||||||+||+++.++.+||+|||+++....+.. .......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence            1246778889999999999999998   999999999999999999999999999976543221 111223458899999


Q ss_pred             cccccCC--------------------CC--ccccchhHHHHHHHHHhCCC-CCCCCCCC-------chhHHHHHHHhcc
Q 039419          873 EYGYMMK--------------------IT--EKSDVYSYGVVVLEVLTGKQ-PIDPTIPE-------GLHIVDWVRQKRG  922 (1035)
Q Consensus       873 E~~~~~~--------------------~~--~~~Dv~SlGvvl~elltg~~-P~~~~~~~-------~~~~~~~~~~~~~  922 (1035)
                      |......                    ++  .+.||||+||++|||++|.. ||.....-       ......|......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9864322                    11  24799999999999999876 66432110       0011112111110


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTP---DDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP---~~RPs~~el~~~  969 (1035)
                      ..         ..+..-.......+++.+++.++|   .+|+|++|++++
T Consensus       460 ~~---------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        460 KY---------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             CC---------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            00         000000111223456777777655   689999999886

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-29  Score=258.90  Aligned_cols=260  Identities=20%  Similarity=0.298  Sum_probs=204.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      .+++....+-+|.||.||+|.|.      +.+.|.+|.++.....             .....+..|.-.+....|||+.
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~-------------iQv~~~L~es~lly~~sH~nll  350 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ-------------IQVNLLLQESMLLYGASHPNLL  350 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH-------------HHHHHHHHHHHHHhcCcCCCcc
Confidence            45666678899999999999554      2455677776443221             1246788999999999999999


Q ss_pred             eEEeEEEcC-CcceEEEEeCCCCChhhhhhhcC------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccE
Q 039419          760 RFLGCCWNR-NTRLLMYDYMPNGSLGSLLHERR------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNI  832 (1035)
Q Consensus       760 ~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NI  832 (1035)
                      .+.+.+.++ +..+.++.++.-|+|..++...+      ...++..+...++.|++.|++|||+.   ++||.||..+|.
T Consensus       351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNC  427 (563)
T KOG1024|consen  351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNC  427 (563)
T ss_pred             ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcc
Confidence            999998654 57799999999999999997332      23467778889999999999999999   999999999999


Q ss_pred             EEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCch
Q 039419          833 LIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL  911 (1035)
Q Consensus       833 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~  911 (1035)
                      ++|+.-++||+|=.+++...+.+...-....-.+..||+||.+....|+.++|||||||++|||+| |+.||....|.+ 
T Consensus       428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-  506 (563)
T KOG1024|consen  428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-  506 (563)
T ss_pred             eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-
Confidence            999999999999999998888776655555566789999999999999999999999999999999 999997654432 


Q ss_pred             hHHHHHHHhccchhhhcccccCCCcc-cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          912 HIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                       +..+++.          ..+-..+. ..++   ++.++..||..+|++||+++|++.-|.+...+
T Consensus       507 -m~~ylkd----------GyRlaQP~NCPDe---Lf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  507 -MEHYLKD----------GYRLAQPFNCPDE---LFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             -HHHHHhc----------cceecCCCCCcHH---HHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence             2222222          22211111 2233   35577889999999999999999999887543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1e-29  Score=274.57  Aligned_cols=204  Identities=22%  Similarity=0.326  Sum_probs=177.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC---CCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR---HKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l  761 (1035)
                      ..|.....+|+|+||.|+.|.++. ...|+||.+.++..-.+...++.+.+      .+-.|+++|.+++   |+||+++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLG------tVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLG------TVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccC------ccchhHHHHHHhhhcCccchhhh
Confidence            458888999999999999997764 67899999988766554444444432      3567999999997   9999999


Q ss_pred             EeEEEcCCcceEEEEeC-CCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          762 LGCCWNRNTRLLMYDYM-PNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++|++++++|++||-. +|.+|.+++..+..  +++.++..|+.||+.|+++||++   ||||||||-+||.++.+|-+
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeE
Confidence            99999999999999975 56789999987665  89999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCC-ccccchhHHHHHHHHHhCCCCCC
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID  904 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvvl~elltg~~P~~  904 (1035)
                      ||+|||.|.....+.+    ..++||..|.|||++.+.+|- ...|||++|+++|-++....||.
T Consensus       710 klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999988766554    367899999999999888765 66899999999999999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=1.7e-28  Score=263.07  Aligned_cols=239  Identities=28%  Similarity=0.388  Sum_probs=189.9

Q ss_pred             CCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcceEEEE
Q 039419          698 CSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD  776 (1035)
Q Consensus       698 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e  776 (1035)
                      +||.||+|.+.+ ++.+|+|++........             .+.+.+|++.+++++|+||+++++++......+++||
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   67 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-------------RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVME   67 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-------------HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEe
Confidence            689999998774 89999999865432211             4689999999999999999999999999999999999


Q ss_pred             eCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCc
Q 039419          777 YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF  856 (1035)
Q Consensus       777 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~  856 (1035)
                      |+.+++|.+++.....  +++..+..++.++++++.|||+.   +++|+||+|+||+++.++.++++|||.+....... 
T Consensus        68 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-  141 (244)
T smart00220       68 YCDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-  141 (244)
T ss_pred             CCCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-
Confidence            9999999999876544  78999999999999999999999   99999999999999999999999999998765432 


Q ss_pred             cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCc
Q 039419          857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPE  936 (1035)
Q Consensus       857 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  936 (1035)
                        ......++..|+|||...+..++.++||||+|+++|++++|..||..... ......+.....          .....
T Consensus       142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-~~~~~~~~~~~~----------~~~~~  208 (244)
T smart00220      142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-LLELFKKIGKPK----------PPFPP  208 (244)
T ss_pred             --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHhccC----------CCCcc
Confidence              22345688899999998888899999999999999999999999975311 111122211100          00000


Q ss_pred             ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          937 VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       937 ~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      ...........++.+|+..+|++||++.++++
T Consensus       209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            00001123456888899999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=9.3e-31  Score=255.09  Aligned_cols=270  Identities=23%  Similarity=0.320  Sum_probs=193.5

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .+...+|....+||+|.||.||+|+.++ |+.||+|+..-+..         +.   +......+|+.++..++|+|++.
T Consensus        13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene---------Ke---GfpitalreikiL~~lkHenv~n   80 (376)
T KOG0669|consen   13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE---------KE---GFPITALREIKILQLLKHENVVN   80 (376)
T ss_pred             eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc---------cc---CCcHHHHHHHHHHHHhcchhHHH
Confidence            3445677777899999999999997764 77889988643211         11   23456789999999999999999


Q ss_pred             EEeEEEc--------CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccE
Q 039419          761 FLGCCWN--------RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNI  832 (1035)
Q Consensus       761 l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NI  832 (1035)
                      +++.|..        ....|+||.+|+ .+|..++.... ..++..++.+++.++..||.|+|+.   .|+|||+||.|+
T Consensus        81 liEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNv  155 (376)
T KOG0669|consen   81 LIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANV  155 (376)
T ss_pred             HHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhE
Confidence            9888753        234799999995 58888886542 3488899999999999999999999   999999999999


Q ss_pred             EEcCCCceEEeeccCccccccCCc--cccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 039419          833 LIGPEFEPYIADFGLAKLVVEGDF--ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE  909 (1035)
Q Consensus       833 ll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~  909 (1035)
                      |++.+|.+||+|||+++.+...+.  ....+..+.|..|.+||.+.+ ..++++.|||+-|||+.||+++.+-+++... 
T Consensus       156 LIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte-  234 (376)
T KOG0669|consen  156 LITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE-  234 (376)
T ss_pred             EEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH-
Confidence            999999999999999976543321  112335567999999998765 4699999999999999999999988865422 


Q ss_pred             chhHHHHHHHhccc-----------hhhhccc----ccCCCcccHHH-------HHHHHHHHHhccCCCCCCCCCHHHHH
Q 039419          910 GLHIVDWVRQKRGA-----------IEVLDKS----LRARPEVEIEE-------MLQTLGVALLCVNPTPDDRPTMKDVA  967 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~~~-------~~~~l~l~~~cl~~dP~~RPs~~el~  967 (1035)
                       .+....+.+.-+.           .+.....    +.......+++       ....++++..++..||.+|+++.+++
T Consensus       235 -qqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al  313 (376)
T KOG0669|consen  235 -QQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL  313 (376)
T ss_pred             -HHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence             1111222211100           0000000    00000000111       11345677778999999999999998


Q ss_pred             HHH
Q 039419          968 AMI  970 (1035)
Q Consensus       968 ~~L  970 (1035)
                      .+-
T Consensus       314 nh~  316 (376)
T KOG0669|consen  314 NHD  316 (376)
T ss_pred             chh
Confidence            753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=5.3e-29  Score=239.64  Aligned_cols=256  Identities=23%  Similarity=0.253  Sum_probs=194.6

Q ss_pred             hccccCCeeeeeCCcEEEEEE-ECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      ++|++.+++|+|.|++||.|. ..+.++++||++++-.                 ++.+.+|+.++..|+ ||||+++++
T Consensus        38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------------kkKIkREikIL~nL~gg~NIi~L~D  100 (338)
T KOG0668|consen   38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------------KKKIKREIKILQNLRGGPNIIKLLD  100 (338)
T ss_pred             chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----------------HHHHHHHHHHHHhccCCCCeeehhh
Confidence            678888899999999999994 4568899999997632                 567899999999997 999999999


Q ss_pred             EEEcCC--cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC-Cce
Q 039419          764 CCWNRN--TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-FEP  840 (1035)
Q Consensus       764 ~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~~  840 (1035)
                      ...++.  ...+|+||+++.+...+...     ++...+..++.+++.||.|+|++   ||+|||+||.|+|+|.. ...
T Consensus       101 iV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkL  172 (338)
T KOG0668|consen  101 IVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKL  172 (338)
T ss_pred             hhcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhcee
Confidence            998764  56899999999888776543     66677888999999999999999   99999999999999965 468


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +|+|+|+|.++-++...   +..+.+..|--||.+- -..|+..-|+|||||++..|+..+.||-.......+.+..++.
T Consensus       173 rlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV  249 (338)
T KOG0668|consen  173 RLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV  249 (338)
T ss_pred             eeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence            99999999998776433   3456777889999765 4458889999999999999999999997665554455444332


Q ss_pred             hccc---------hhhhcccccC-------CCc-----cc--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGA---------IEVLDKSLRA-------RPE-----VE--IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~---------~~~~~~~~~~-------~~~-----~~--~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....         .-.+++....       .+.     .+  .-...+.++++-+.+..|..+|+|++|.+++
T Consensus       250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            1111         0001111100       000     00  0001244566677888999999999999885

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-30  Score=251.99  Aligned_cols=262  Identities=24%  Similarity=0.299  Sum_probs=190.3

Q ss_pred             ccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          689 VEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       689 ~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      +-++.||.|+||.||.+.++ +|+.||.|++..-. ..-           ...+++.+|+.++..++|.|+...++...-
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L-----------~s~krvFre~kmLcfFkHdNVLSaLDILQP  123 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNL-----------ASCKRVFREIKMLSSFRHDNVLSLLDILQP  123 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHH-----------HHHHHHHHHHHHHHhhccccHHHHHHhcCC
Confidence            34578999999999999665 69999999985321 111           235788999999999999999998887754


Q ss_pred             CC-----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          768 RN-----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       768 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      ..     ..|+++|.+ ..+|...+-.-.  .++...+.-++.||++||+|||+.   +|.||||||.|.|++.+...||
T Consensus       124 ph~dfFqEiYV~TELm-QSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKI  197 (449)
T KOG0664|consen  124 ANPSFFQELYVLTELM-QSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKI  197 (449)
T ss_pred             CCchHHHHHHHHHHHH-HhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEe
Confidence            43     457888888 458888775433  488888889999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ||||+|+....++. ..++..+.|..|.|||++.+. .|+.+.||||.||++.|++..+.-|+...|-+  ..+.+.+..
T Consensus       198 CDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq--QL~lItdLL  274 (449)
T KOG0664|consen  198 CDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE--QLQMIIDLL  274 (449)
T ss_pred             cccccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH--HHHHHHHHh
Confidence            99999997655443 334445678999999998765 48899999999999999999888887554421  111111100


Q ss_pred             -------------cc-hhhhcccccCC-----C--cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          922 -------------GA-IEVLDKSLRAR-----P--EVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       922 -------------~~-~~~~~~~~~~~-----~--~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                                   +. ..++....+..     +  ......--..+.+.++++++||+.|.+.++.+.++.
T Consensus       275 GTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  275 GTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             CCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence                         00 11111111100     0  000011122345667789999999999999887653

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3e-28  Score=240.38  Aligned_cols=258  Identities=20%  Similarity=0.282  Sum_probs=194.5

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceee
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVR  760 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  760 (1035)
                      +..+.|.+.+.+|+|.||.+-+++++. .+.+++|.+.....               -.++|.+|...--.| .|.||+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---------------t~~dF~rEfhY~~~Ls~H~hIi~   85 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---------------TQADFVREFHYSFFLSPHQHIID   85 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---------------hHHHHHHHhccceeeccchhhhH
Confidence            445778888999999999999998875 67888898865432               246799999877777 4899998


Q ss_pred             EEeE-EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc--CC
Q 039419          761 FLGC-CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG--PE  837 (1035)
Q Consensus       761 l~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~--~~  837 (1035)
                      -|+. |+..+.++++|||++-|+|.+-+...+   +.+....+++.|++.|+.|+|++   .+||||||.+|||+-  +.
T Consensus        86 tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df  159 (378)
T KOG1345|consen   86 TYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADF  159 (378)
T ss_pred             HHHHHhhcCceEEEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCc
Confidence            7765 566778889999999999999886643   77888899999999999999999   999999999999994  34


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      .++|+||||..+..+...     ....-+..|.|||....     -...+.+|||.||+++|.++||+.||+.....+..
T Consensus       160 ~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~  234 (378)
T KOG1345|consen  160 YRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP  234 (378)
T ss_pred             cEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch
Confidence            579999999987543221     12234567999997432     23667899999999999999999999976656666


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ++.|.....+....+.+.++...       .+++.+..+-+.++|++|--..++.++....
T Consensus       235 Y~~~~~w~~rk~~~~P~~F~~fs-------~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~  288 (378)
T KOG1345|consen  235 YWEWEQWLKRKNPALPKKFNPFS-------EKALRLFKKSLTPRFKDRCKIWTAKKMRKCL  288 (378)
T ss_pred             HHHHHHHhcccCccCchhhcccC-------HHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence            77776654444333333332221       2344566678899999996666665554443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-27  Score=254.28  Aligned_cols=137  Identities=23%  Similarity=0.325  Sum_probs=116.6

Q ss_pred             HHHHH--hccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC---
Q 039419          681 VEQVL--KCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR---  754 (1035)
Q Consensus       681 ~~~~~--~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---  754 (1035)
                      +.+.+  .+|.+.++||-|.|++||+|.+ ...+.||+|+.+...               ...+.-..|+.++++++   
T Consensus        71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---------------hYtEaAlDEIklL~~v~~~D  135 (590)
T KOG1290|consen   71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---------------HYTEAALDEIKLLQQVREGD  135 (590)
T ss_pred             ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---------------HHHHHHHHHHHHHHHHHhcC
Confidence            34444  5788999999999999999954 457889999986532               23456778999999983   


Q ss_pred             --C---CceeeEEeEEEc----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeecc
Q 039419          755 --H---KNIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR  825 (1035)
Q Consensus       755 --h---pniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHr  825 (1035)
                        |   .+||+++++|..    ..+++||+|++ |.+|..++.....+.++...+.+|+.||+.||.|||++|  ||+|.
T Consensus       136 p~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHT  212 (590)
T KOG1290|consen  136 PNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHT  212 (590)
T ss_pred             CCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--Ccccc
Confidence              3   379999999975    34789999999 889999999988888999999999999999999999998  99999


Q ss_pred             CCCcccEEEc
Q 039419          826 DIKANNILIG  835 (1035)
Q Consensus       826 Dikp~NIll~  835 (1035)
                      ||||+|||+.
T Consensus       213 DlKPENvLl~  222 (590)
T KOG1290|consen  213 DLKPENVLLC  222 (590)
T ss_pred             CCCcceeeee
Confidence            9999999983

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=6.2e-26  Score=237.23  Aligned_cols=211  Identities=32%  Similarity=0.515  Sum_probs=180.1

Q ss_pred             eeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcce
Q 039419          694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL  772 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  772 (1035)
                      ||+|++|.||++...+ ++.+++|++.......             ..+.+.+|++.+++++|++|+++++++......+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   67 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLY   67 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEE
Confidence            6899999999997765 8999999997543221             1467999999999999999999999999999999


Q ss_pred             EEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-CCceEEeeccCcccc
Q 039419          773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-EFEPYIADFGLAKLV  851 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~DFG~a~~~  851 (1035)
                      ++|||+.|++|.+++.... ..+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++|+|||.+...
T Consensus        68 ~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~  143 (215)
T cd00180          68 LVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL  143 (215)
T ss_pred             EEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence            9999999999999987652 2388999999999999999999999   9999999999999999 899999999999865


Q ss_pred             ccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhccc
Q 039419          852 VEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS  930 (1035)
Q Consensus       852 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  930 (1035)
                      .....  ......+...|++||..... ..+.++|+|++|++++++                                  
T Consensus       144 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------  187 (215)
T cd00180         144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------  187 (215)
T ss_pred             cCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence            44321  12345678899999998776 788999999999999998                                  


Q ss_pred             ccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       931 ~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                                  ....+++..|++.+|++||++.+++++
T Consensus       188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                        123456777999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-27  Score=263.23  Aligned_cols=252  Identities=25%  Similarity=0.308  Sum_probs=193.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|....++|+|.||.||+|+++ .++..|+|+++-+...+              .+-+++|+-+++..+|||||.+++.
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--------------~~~iqqei~~~~dc~h~nivay~gs   80 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--------------FSGIQQEIGMLRDCRHPNIVAYFGS   80 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--------------ccccccceeeeecCCCcChHHHHhh
Confidence            46777789999999999999766 58999999997654332              2446789999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +...+..+++||||.||+|.+..+..+.  +++.+...+.++..+|++|||++   |-+|||||-.||++++.|.+|++|
T Consensus        81 ylr~dklwicMEycgggslQdiy~~Tgp--lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaD  155 (829)
T KOG0576|consen   81 YLRRDKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLAD  155 (829)
T ss_pred             hhhhcCcEEEEEecCCCcccceeeeccc--chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecc
Confidence            9999999999999999999998876554  88899999999999999999999   889999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccc---ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYG---YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ||.+..+...-  .....+.||+.|||||+.   ..+.|..++|||+.|++..|+-.-+.|.-.-++-..   -+...+-
T Consensus       156 fgvsaqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~---l~LmTkS  230 (829)
T KOG0576|consen  156 FGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA---LFLMTKS  230 (829)
T ss_pred             cCchhhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH---HHHhhcc
Confidence            99987664432  223467899999999974   456688999999999999999888877543322111   0111110


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                          .+++.-...+... .+.  +-.++..|+.++|++||+++.++.
T Consensus       231 ----~~qpp~lkDk~kw-s~~--fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 ----GFQPPTLKDKTKW-SEF--FHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ----CCCCCcccCCccc-hHH--HHHHHHHHhcCCCccCCChhhhee
Confidence                0111111111111 111  123566699999999999988765

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=6.2e-27  Score=237.43  Aligned_cols=196  Identities=27%  Similarity=0.337  Sum_probs=164.6

Q ss_pred             hccccCCeeeeeCCcEEEEE-EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .+|.....+|.|.- .|..| +.-.++.||+|+........            ...++-.+|...+..++|+||++++.+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~------------~~akra~rel~l~~~v~~~nii~l~n~   83 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQ------------THAKRAYRELKLMKCVNHKNIISLLNV   83 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccC------------ccchhhhhhhhhhhhhcccceeeeeec
Confidence            46777788899998 66666 33358999999986652221            123567799999999999999999999


Q ss_pred             EEcCC------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          765 CWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       765 ~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      |.-.+      ..|+||||| .++|.+.+...    ++-.+...+..|++.|++|+|+.   ||+|||+||+||++..++
T Consensus        84 ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~  155 (369)
T KOG0665|consen   84 FTPQKTLEEFQEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDC  155 (369)
T ss_pred             cCccccHHHHHhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchh
Confidence            96543      469999999 67999988743    67788899999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      .+||.|||+|+.....   ...+.++.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+
T Consensus       156 ~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  156 TLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             heeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence            9999999999864332   345678899999999999888899999999999999999999988863

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=6e-27  Score=249.99  Aligned_cols=205  Identities=21%  Similarity=0.254  Sum_probs=174.2

Q ss_pred             cHHHHH-hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC---
Q 039419          680 TVEQVL-KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR---  754 (1035)
Q Consensus       680 ~~~~~~-~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---  754 (1035)
                      .+.+++ .+|.+....|+|-|++|.+|.+. .|..||||++..+..               ..+.=.+|+++|++|+   
T Consensus       425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---------------M~KtGl~EleiLkKL~~AD  489 (752)
T KOG0670|consen  425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---------------MHKTGLKELEILKKLNDAD  489 (752)
T ss_pred             ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---------------HhhhhhHHHHHHHHhhccC
Confidence            445555 68999999999999999999654 488999999965432               2345678999999995   


Q ss_pred             ---CCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 039419          755 ---HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN  830 (1035)
Q Consensus       755 ---hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~  830 (1035)
                         --|+++++..|....+.|+|+|-+ .-+|.+++++.+. ..+....+..++.|+.-||..|-..   ||+|.||||+
T Consensus       490 ~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPD  565 (752)
T KOG0670|consen  490 PEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPD  565 (752)
T ss_pred             chhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCcc
Confidence               348999999999999999999988 5689999987654 5688899999999999999999998   9999999999


Q ss_pred             cEEEcCCC-ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 039419          831 NILIGPEF-EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI  907 (1035)
Q Consensus       831 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~  907 (1035)
                      |||+++.. .+||||||.|.+..+.+.+    .+..+..|.|||++.|.+|+...|+||+||+|||+.||+.-|.+..
T Consensus       566 NiLVNE~k~iLKLCDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  566 NILVNESKNILKLCDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             ceEeccCcceeeeccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            99998764 5799999999887665543    3445678999999999999999999999999999999999987543

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=2e-27  Score=246.65  Aligned_cols=285  Identities=20%  Similarity=0.188  Sum_probs=159.0

Q ss_pred             EEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCC-CCCCCCCChhhhccccccceEec
Q 039419           32 VTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSS-NSLVGGVPSSIGKLINLQDLILN  110 (1035)
Q Consensus        32 v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~-n~l~~~~p~~i~~l~~L~~L~L~  110 (1035)
                      .++|+|-.|+|....|.+|+.+.+||+||||+|+|+..-|+.|..|..|..|-+.+ |+|+......|++|..|+.|.+.
T Consensus        69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllN  148 (498)
T KOG4237|consen   69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLN  148 (498)
T ss_pred             ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcC
Confidence            34455555555544444555555555555555555544455555555544444433 45553333344555555555555


Q ss_pred             ccCCCCCCchhhhhhccccceeccccccCCCCch-hhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccc
Q 039419          111 SNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPV-ELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG  189 (1035)
Q Consensus       111 ~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~  189 (1035)
                      -|++.-.....+..|++|..|.+.+|.+. .++. .+..+..++.+.+..|..+.      .++++.+..       +.-
T Consensus       149 an~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic------dCnL~wla~-------~~a  214 (498)
T KOG4237|consen  149 ANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC------DCNLPWLAD-------DLA  214 (498)
T ss_pred             hhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc------ccccchhhh-------HHh
Confidence            55554333344455555555555555554 3333 45555555555554443111      111111111       222


Q ss_pred             cCcccccccccccceeecccccccCCcccccc-CcCCceEEecCCcCCCCCCh-hhhcccchhHhhcccccccccCCccc
Q 039419          190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGN-CSELVDLFLYENDLSGSLPR-ELGKLQKLEKMLLWQNNFDGAIPEEI  267 (1035)
Q Consensus       190 ~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~-l~~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~l~~n~l~~~~p~~~  267 (1035)
                      ..|-.++.+.-.....+.+.++..+-+..|.. +..+..=..+.+..-++.|. .|..|++|+.|+|++|+++.+-+.+|
T Consensus       215 ~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF  294 (498)
T KOG4237|consen  215 MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF  294 (498)
T ss_pred             hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence            34455566666666666666665433333322 22332222233333334333 57777888888888888877777778


Q ss_pred             cCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccch
Q 039419          268 GNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQ  330 (1035)
Q Consensus       268 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  330 (1035)
                      ..+..++.|.|..|+|..+-...|.++..|+.|+|.+|+|+...|.+|..+.+|.+|.|-.|.
T Consensus       295 e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np  357 (498)
T KOG4237|consen  295 EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNP  357 (498)
T ss_pred             cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCc
Confidence            888888888888888776666777788888888888888887778888888888888777664

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=4.5e-25  Score=233.54  Aligned_cols=200  Identities=33%  Similarity=0.441  Sum_probs=171.7

Q ss_pred             cccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |...+.||+|++|.||+|...+ ++.+|+|.+......             ...+.+.+|++.+++++|+|++++++++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~   67 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------------KQREEFLREIRILKKLKHPNIVKLYGVFE   67 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------------HHHHHHHHHHHHHHhCCCCChhhheeeee
Confidence            4566889999999999998775 899999998654322             12568899999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      .....++++||+++++|.+++...... +++..+..++.++++++.++|+.   +++|+||+|+||+++.++.++|+|||
T Consensus        68 ~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g  143 (225)
T smart00221       68 DPEPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFG  143 (225)
T ss_pred             cCCceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCc
Confidence            999999999999999999999765432 78899999999999999999998   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCccc-ccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYG-YMMKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      .+........ .......++..|++||.. ....++.++|||+||+++|||++|+.||..
T Consensus       144 ~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      144 LARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            9987654321 122345678899999988 666788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=2.6e-25  Score=234.76  Aligned_cols=204  Identities=25%  Similarity=0.375  Sum_probs=168.1

Q ss_pred             HHHHHhccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-C
Q 039419          681 VEQVLKCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-H  755 (1035)
Q Consensus       681 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h  755 (1035)
                      ...+.+.|..+++||+|.|++||+|...    ..+.||+|.+....                ...++..|+++|..+. +
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----------------~p~ri~~El~~L~~~gG~   94 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----------------SPSRILNELEMLYRLGGS   94 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----------------CchHHHHHHHHHHHhccc
Confidence            4566688999999999999999999443    46889999986532                2456899999999995 8


Q ss_pred             CceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          756 KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       756 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      .||+++.+++..++...+|+||++..+..++...     ++...+..+++.+..||+++|..   |||||||||+|++.+
T Consensus        95 ~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n  166 (418)
T KOG1167|consen   95 DNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYN  166 (418)
T ss_pred             hhhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccc
Confidence            9999999999999999999999999888888755     66788889999999999999999   999999999999997


Q ss_pred             C-CCceEEeeccCccccccCC----------------------------------c--------cccccccCCcccccCC
Q 039419          836 P-EFEPYIADFGLAKLVVEGD----------------------------------F--------ARSSNTVAGSYGYIAP  872 (1035)
Q Consensus       836 ~-~~~~kl~DFG~a~~~~~~~----------------------------------~--------~~~~~~~~gt~~y~aP  872 (1035)
                      . -+.-.|+|||+|..+....                                  .        .......+||++|.||
T Consensus       167 ~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaP  246 (418)
T KOG1167|consen  167 RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAP  246 (418)
T ss_pred             cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCch
Confidence            5 4667899999997221000                                  0        0001134699999999


Q ss_pred             cccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          873 EYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       873 E~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      |+.. ....++++||||.||++.-++++++||-....
T Consensus       247 EvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~d  283 (418)
T KOG1167|consen  247 EVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKD  283 (418)
T ss_pred             HHHhhccCcCCccceeeccceeehhhccccccccCcc
Confidence            9864 56688999999999999999999999965443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.3e-23  Score=213.61  Aligned_cols=266  Identities=18%  Similarity=0.212  Sum_probs=201.1

Q ss_pred             hccccCCeeeeeCCcEEEEE-EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      -.|.++++||+|+||.++.| ..-+++.||||....+..+.                ++..|.+..+.|. .++|..+|-
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----------------QLrdEYr~YKlL~g~~GIP~vYY   91 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----------------QLRDEYRTYKLLGGTEGIPQVYY   91 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcc----------------hHHHHHHHHHHHcCCCCCCceee
Confidence            35888999999999999999 45679999999875543322                4677899988885 799999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC-----C
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-----F  838 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~-----~  838 (1035)
                      +..+..+-.+|||.+ |.||.+++.-.++. |+.+++..+|.|++.-++|+|++   .+|.|||||+|+||...     .
T Consensus        92 FGqeG~~NiLVidLL-GPSLEDLFD~CgR~-FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n  166 (449)
T KOG1165|consen   92 FGQEGKYNILVIDLL-GPSLEDLFDLCGRR-FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDAN  166 (449)
T ss_pred             eccccchhhhhhhhh-CcCHHHHHHHhcCc-ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCc
Confidence            988888889999998 99999998876644 89999999999999999999999   99999999999999743     3


Q ss_pred             ceEEeeccCccccccCCc-----cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-hh
Q 039419          839 EPYIADFGLAKLVVEGDF-----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG-LH  912 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~-~~  912 (1035)
                      .+.++|||+|+.+.+..+     ++......||.+||+-....+.+.+.+.|+-|+|-++++.+-|..||++-.... .+
T Consensus       167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~  246 (449)
T KOG1165|consen  167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE  246 (449)
T ss_pred             eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH
Confidence            588999999999987654     233446679999999999999999999999999999999999999998653221 11


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHHh
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREEC  980 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~  980 (1035)
                      -.+.+-.... ...+...... .   ..++..-+..+.. +  +-++-|.++-+...+.++-....+.
T Consensus       247 kYeKIGe~Kr-~T~i~~Lc~g-~---P~efa~Yl~yvR~-L--~F~E~PDYdylr~Lf~dvldr~g~t  306 (449)
T KOG1165|consen  247 KYEKIGETKR-STPIEVLCEG-F---PEEFATYLRYVRR-L--DFFETPDYDYLRKLFDDVLDRLGET  306 (449)
T ss_pred             HHHHhccccc-cCCHHHHHhc-C---HHHHHHHHHHHHh-c--CcccCCCHHHHHHHHHHHHHhcCCc
Confidence            1111100000 0111111111 1   2334443434333 3  5558899999988888876655443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.3e-24  Score=209.55  Aligned_cols=262  Identities=18%  Similarity=0.213  Sum_probs=196.4

Q ss_pred             HhccccCCeeeeeCCcEEEEE-EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC-CceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH-KNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~  762 (1035)
                      ..+|...++||+|+||.+|.| ...+|++||||.-..+...                -++..|..+.+.|++ ..|..+.
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----------------pqL~yEskvY~iL~~g~GiP~i~   77 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----------------PQLLYESKVYRILQGGVGIPHIR   77 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----------------cchhHHHHHHHHhccCCCCchhh
Confidence            378999999999999999999 4567999999998654332                247789999999975 7888888


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC---Cc
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE---FE  839 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~---~~  839 (1035)
                      .++.+..+-.+||+.+ |.||.+++....+ .++..+++-.+.|++.-++|+|.+   +++||||||+|+|+.-+   ..
T Consensus        78 ~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~k  152 (341)
T KOG1163|consen   78 HYGTEKDYNVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNK  152 (341)
T ss_pred             hhccccccceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccce
Confidence            9999999999999998 9999999876543 389999999999999999999999   99999999999999754   45


Q ss_pred             eEEeeccCccccccCCc-----cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-hhH
Q 039419          840 PYIADFGLAKLVVEGDF-----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG-LHI  913 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~-~~~  913 (1035)
                      +.++|||+|+.+.+...     ++......||.+|.+-....+...+.+.|+-|+|.++.++--|..||++-.+.. .+-
T Consensus       153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            78999999998866432     233446789999999998888889999999999999999999999998754321 111


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .+.+..+.-. ..+.....+ .+.   +.   ...+..|-..--++-|...-+.+.++.+.+
T Consensus       233 yEkI~EkK~s-~~ie~LC~G-~P~---EF---~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  233 YEKISEKKMS-TPIEVLCKG-FPA---EF---AMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             HHHHHHhhcC-CCHHHHhCC-CcH---HH---HHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            1111111100 000111111 111   11   112333555566788998888877666543

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=8.5e-25  Score=273.08  Aligned_cols=197  Identities=16%  Similarity=0.196  Sum_probs=138.5

Q ss_pred             hcCCC-CceeeEEeEE-------EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 039419          751 GSIRH-KNIVRFLGCC-------WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPI  822 (1035)
Q Consensus       751 ~~l~h-pniv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  822 (1035)
                      ++++| +||++++++|       .+.+..+.+|||+ +++|.+++.... ..+++..+..++.||++||+|||++   ||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            34556 6888888877       2234567788887 679999997532 3489999999999999999999998   99


Q ss_pred             eccCCCcccEEEcCC-------------------CceEEeeccCccccccCCc--------------cccccccCCcccc
Q 039419          823 VHRDIKANNILIGPE-------------------FEPYIADFGLAKLVVEGDF--------------ARSSNTVAGSYGY  869 (1035)
Q Consensus       823 vHrDikp~NIll~~~-------------------~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y  869 (1035)
                      +||||||+|||++..                   +.+|++|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999654                   4455666666653211000              0001124588999


Q ss_pred             cCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHH
Q 039419          870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVA  949 (1035)
Q Consensus       870 ~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~  949 (1035)
                      ||||++.+..++.++|||||||++|||++|..|+.....   .+... ..     ...       ++...........++
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~-~~-----~~~-------~~~~~~~~~~~~~~~  245 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSL-RH-----RVL-------PPQILLNWPKEASFC  245 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHH-HH-----hhc-------ChhhhhcCHHHHHHH
Confidence            999999999999999999999999999999887642110   00000 00     000       111111223344677


Q ss_pred             HhccCCCCCCCCCHHHHHH
Q 039419          950 LLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       950 ~~cl~~dP~~RPs~~el~~  968 (1035)
                      .+||++||.+||++.|+++
T Consensus       246 ~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHhCCCChhhCcChHHHhh
Confidence            7899999999999999976

>PLN03210 Resistant to P

Probab=99.91  E-value=2.5e-23  Score=267.36  Aligned_cols=338  Identities=21%  Similarity=0.247  Sum_probs=208.0

Q ss_pred             cCCCCCcccceEeecCcc------cCCCCCCCCCCCC-CCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCch
Q 039419           48 SNLSSLSFLQKLIISGSN------LTGPISPDLGDCT-QLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPK  120 (1035)
Q Consensus        48 ~~~~~l~~L~~L~L~~~~------l~~~~~~~~~~l~-~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~  120 (1035)
                      ..|..+.+|+.|.+..+.      +...+|+.+..++ +|+.|++.++.+. .+|..+ ...+|++|+|++|++. .+|.
T Consensus       552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence            457888999999886653      3345677777764 5899999988887 888777 5688999999998887 6788


Q ss_pred             hhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCccccccccc
Q 039419          121 ELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSK  200 (1035)
Q Consensus       121 ~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~  200 (1035)
                      .+..+++|+.|+|++|.....+| .++.+++|++|++++|.. ...+|..+..+++|+.|++++|.....+|..+ ++++
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~-L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s  705 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSS-LVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS  705 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCC-ccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence            88888899999998876544666 477888888888888763 45677777777777788777776556666655 6777


Q ss_pred             ccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhccccccc-------ccCCccccCCCCC
Q 039419          201 LQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFD-------GAIPEEIGNCKSL  273 (1035)
Q Consensus       201 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-------~~~p~~~~~l~~L  273 (1035)
                      |++|++++|.....+|..   ..+|+.|+|++|.+. .+|..+ .+++|++|.+.++...       ...+..+...++|
T Consensus       706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL  780 (1153)
T PLN03210        706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL  780 (1153)
T ss_pred             CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence            777777777554455533   346677777777766 455443 4566666666553321       1111112223455


Q ss_pred             cEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCC
Q 039419          274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCR  353 (1035)
Q Consensus       274 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~  353 (1035)
                      +.|+|++|.....+|..++++++|+.|++++|...+.+|..                                  + +++
T Consensus       781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~----------------------------------~-~L~  825 (1153)
T PLN03210        781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTG----------------------------------I-NLE  825 (1153)
T ss_pred             hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCC----------------------------------C-Ccc
Confidence            55555555444445555555555555555554322233332                                  2 345


Q ss_pred             CCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCC-CccCCCCc
Q 039419          354 SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSN-NTLGGTLP  432 (1035)
Q Consensus       354 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~-N~l~~~~~  432 (1035)
                      +|+.|+|++|.....+|..   ..+|+.|+|++|.|+. +|..+.              .+++|++|+|++ |++. .+|
T Consensus       826 sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~-iP~si~--------------~l~~L~~L~L~~C~~L~-~l~  886 (1153)
T PLN03210        826 SLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEE-VPWWIE--------------KFSNLSFLDMNGCNNLQ-RVS  886 (1153)
T ss_pred             ccCEEECCCCCcccccccc---ccccCEeECCCCCCcc-ChHHHh--------------cCCCCCEEECCCCCCcC-ccC
Confidence            5555555554332222221   2455555666655552 233332              234455556655 3344 345


Q ss_pred             ccccCCCCccEEEcCCCc
Q 039419          433 SSLASLTRLQVLDISVNQ  450 (1035)
Q Consensus       433 ~~l~~l~~L~~L~Ls~N~  450 (1035)
                      ..+..+++|+.|++++|.
T Consensus       887 ~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        887 LNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             cccccccCCCeeecCCCc
Confidence            556666677777777664

syringae 6; Provisional

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-25  Score=232.99  Aligned_cols=306  Identities=21%  Similarity=0.233  Sum_probs=206.0

Q ss_pred             eEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccc-c
Q 039419           58 KLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFD-N  136 (1035)
Q Consensus        58 ~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~-n  136 (1035)
                      ..+-++.+++ ++|..+..  .-+.++|..|+|+...|.+|+.+++|+.|||++|+|+..-|..|..|.+|..|-+-+ |
T Consensus        50 ~VdCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N  126 (498)
T KOG4237|consen   50 IVDCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN  126 (498)
T ss_pred             eEEccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence            4556677787 78876653  568899999999966677899999999999999999988899999999988887777 8


Q ss_pred             ccCCCCc-hhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCC
Q 039419          137 YLSGNLP-VELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEI  215 (1035)
Q Consensus       137 ~l~~~~p-~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~  215 (1035)
                      +|+ .+| ..|+.|..|+-|.+.-|. +.......+..|++|..|.+.+|.+...--.+|..+..++.+.+..|.+-   
T Consensus       127 kI~-~l~k~~F~gL~slqrLllNan~-i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i---  201 (498)
T KOG4237|consen  127 KIT-DLPKGAFGGLSSLQRLLLNANH-INCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI---  201 (498)
T ss_pred             chh-hhhhhHhhhHHHHHHHhcChhh-hcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc---
Confidence            888 455 578888888888887775 22222244555555555555555555222225555555555555555421   


Q ss_pred             ccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCcccc-CCCCCc-EEEccCccCCCCCCccccC
Q 039419          216 PPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIG-NCKSLK-TIDLSLNFFSGSLPQSFGN  293 (1035)
Q Consensus       216 p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~-~l~~L~-~L~L~~n~l~~~~~~~~~~  293 (1035)
                        ..++++.+..       +....|..++...-..-..+.++++...-+..|. .+..+. .+....+....-....|..
T Consensus       202 --cdCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~  272 (498)
T KOG4237|consen  202 --CDCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKK  272 (498)
T ss_pred             --cccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhh
Confidence              1112221111       1112233444444444455555555433333332 222221 1222222333222345888


Q ss_pred             CCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCc
Q 039419          294 LSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGL  373 (1035)
Q Consensus       294 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~  373 (1035)
                      |++|++|+|++|+|+.+.+++|.++..+++|+|..|+|..+..          ..|.++..|+.|+|.+|+|+...|..|
T Consensus       273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~----------~~f~~ls~L~tL~L~~N~it~~~~~aF  342 (498)
T KOG4237|consen  273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSS----------GMFQGLSGLKTLSLYDNQITTVAPGAF  342 (498)
T ss_pred             cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHH----------HhhhccccceeeeecCCeeEEEecccc
Confidence            9999999999999998888999999999999999999887654          678889999999999999998888888


Q ss_pred             ccCcccceEeccccccc
Q 039419          374 FQLQNLTKLLLISNGIS  390 (1035)
Q Consensus       374 ~~l~~L~~L~L~~N~i~  390 (1035)
                      ..+..|.+|.|-.|.+.
T Consensus       343 ~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  343 QTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             cccceeeeeehccCccc
Confidence            88999999999888765

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=1.7e-23  Score=212.32  Aligned_cols=172  Identities=20%  Similarity=0.184  Sum_probs=128.3

Q ss_pred             CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccc
Q 039419          781 GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS  860 (1035)
Q Consensus       781 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  860 (1035)
                      |+|.++++.++ ..+++..++.++.||++||+|||++   +      ||+||+++.++.+|+  ||.++.....      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence            68999997643 3489999999999999999999998   5      999999999999999  9999865332      


Q ss_pred             cccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHH
Q 039419          861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIE  940 (1035)
Q Consensus       861 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  940 (1035)
                       ...||+.|||||++.+..++.++|||||||++|||++|+.||............+.......    ..... .......
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~  136 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD----DPRDR-SNLESVS  136 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC----Ccccc-ccHHHHH
Confidence             22688999999999999999999999999999999999999965432222222222111100    00000 0111112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          941 EMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       941 ~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      +.....+++.+||+.||++||++.|+++++..+...
T Consensus       137 ~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      137 AARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             hhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence            212456789999999999999999999998777543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-22  Score=225.60  Aligned_cols=263  Identities=20%  Similarity=0.275  Sum_probs=193.4

Q ss_pred             ccccCCeeeeeCCcEEEEEEECCC--cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC----Cceee
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMENG--EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH----KNIVR  760 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~  760 (1035)
                      .|.+.+.||+|+||.||.|.....  +.+|+|.........              ...+..|+.++..+..    +++.+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--------------~~~l~~E~~vl~~l~~~~~~~~~~~   84 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--------------PSVLKIEIQVLKKLEKKNGPSHFPK   84 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--------------CccchhHHHHHHHHhhhcCCCCCCE
Confidence            788999999999999999977653  478888875432111              1157789999999873    69999


Q ss_pred             EEeEE-EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC--
Q 039419          761 FLGCC-WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE--  837 (1035)
Q Consensus       761 l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~--  837 (1035)
                      +++.+ ..+...|+||+.+ |.+|.++........++..++.+|+.|++.+|+++|+.   |++||||||+|+++...  
T Consensus        85 ~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~  160 (322)
T KOG1164|consen   85 LLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSR  160 (322)
T ss_pred             EEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCC
Confidence            99999 4777889999988 99999988766656799999999999999999999999   99999999999999865  


Q ss_pred             ---CceEEeeccCcc--ccccCCc-----ccc-ccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          838 ---FEPYIADFGLAK--LVVEGDF-----ARS-SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       838 ---~~~kl~DFG~a~--~~~~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                         ..+++.|||+|+  .+.....     .+. .....||..|+++....+...+++.|+||+++++.|+..|..||...
T Consensus       161 ~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  161 SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence               458999999998  3322221     111 23456999999999999999999999999999999999999999654


Q ss_pred             CCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ..... .........  ...... ....++   .+...   +...+-..+..++|.+..+.+.+++.....
T Consensus       241 ~~~~~-~~~~~~~~~--~~~~~~-~~~~~~---~~~~~---~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  241 EMTDL-KSKFEKDPR--KLLTDR-FGDLKP---EEFAK---ILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             cccch-HHHHHHHhh--hhcccc-ccCCCh---HHHHH---HHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            32111 111111000  000000 111111   22222   222234468899999999999988776544

>PLN03210 Resistant to P

Probab=99.90  E-value=5.8e-23  Score=264.05  Aligned_cols=318  Identities=21%  Similarity=0.265  Sum_probs=250.3

Q ss_pred             cccCCcCCCCCc-ccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchh
Q 039419           43 ELPFPSNLSSLS-FLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKE  121 (1035)
Q Consensus        43 ~~~~~~~~~~l~-~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~  121 (1035)
                      ...+|..+..++ +|+.|++.++.++ .+|..+ ...+|++|+|++|++. .+|..+..+++|++|+|++|.....+| .
T Consensus       577 ~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~  652 (1153)
T PLN03210        577 RWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-D  652 (1153)
T ss_pred             eeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-c
Confidence            446777787775 5999999999998 788877 5789999999999998 899999999999999999886555787 5


Q ss_pred             hhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccc
Q 039419          122 LGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKL  201 (1035)
Q Consensus       122 l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L  201 (1035)
                      ++.+++|++|+|++|.....+|..++++++|+.|++++|.. ...+|..+ ++++|+.|++++|.....+|..   ..+|
T Consensus       653 ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~-L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL  727 (1153)
T PLN03210        653 LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCEN-LEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNI  727 (1153)
T ss_pred             cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCC-cCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCc
Confidence            88999999999999887679999999999999999999874 45677665 7999999999999877677753   4678


Q ss_pred             cceeecccccccCCccccccCcCCceEEecCCcCC-------CCCChhhhcccchhHhhcccccccccCCccccCCCCCc
Q 039419          202 QSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLS-------GSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLK  274 (1035)
Q Consensus       202 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~-------~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~  274 (1035)
                      ++|++++|.+. .+|..+ .+++|+.|++.++...       ...+..+...++|+.|+|++|...+.+|..++++++|+
T Consensus       728 ~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~  805 (1153)
T PLN03210        728 SWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLE  805 (1153)
T ss_pred             CeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCC
Confidence            99999999987 678765 6889999998875422       12222334457899999999988888999999999999


Q ss_pred             EEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCC
Q 039419          275 TIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRS  354 (1035)
Q Consensus       275 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~  354 (1035)
                      .|+|++|..-+.+|..+ ++++|+.|++++|......|..   ..+|+.|+|++|.|+           .+|..+..+++
T Consensus       806 ~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-----------~iP~si~~l~~  870 (1153)
T PLN03210        806 HLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-----------EVPWWIEKFSN  870 (1153)
T ss_pred             EEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-----------cChHHHhcCCC
Confidence            99999986444677665 7999999999998654444443   356777777777776           34566777777


Q ss_pred             CcEEeccCc-CCCCCCCCCcccCcccceEecccc
Q 039419          355 LEAVDLSHN-ALTGSLHPGLFQLQNLTKLLLISN  387 (1035)
Q Consensus       355 L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N  387 (1035)
                      |+.|+|++| +++ .++..+..+++|+.|++++|
T Consensus       871 L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        871 LSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             CCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            777777774 344 45555555666666655554

syringae 6; Provisional

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1e-22  Score=224.49  Aligned_cols=180  Identities=21%  Similarity=0.192  Sum_probs=134.4

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC--CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME--NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .+.++|...+.||+|+||+||+|.+.  +++.||||++........         .....+.|.+|++++++++|+|+++
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~---------~~~~~~~~~~E~~iL~~L~h~~iv~   85 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWS---------KPLARHLAAREIRALKTVRGIGVVP   85 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccc---------cHHHHHHHHHHHHHHHhccCCCCCc
Confidence            34578999999999999999999765  477789998753211000         0012467999999999999999985


Q ss_pred             -EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCC-CcccEEEcCCC
Q 039419          761 -FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI-KANNILIGPEF  838 (1035)
Q Consensus       761 -l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDi-kp~NIll~~~~  838 (1035)
                       ++++    +..|+||||++|++|... ..     ..   ...++.++++||+|||+.   ||+|||| ||+|||++.++
T Consensus        86 ~l~~~----~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~  149 (365)
T PRK09188         86 QLLAT----GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDG  149 (365)
T ss_pred             EEEEc----CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCC
Confidence             5442    457999999999999632 11     11   146788999999999999   9999999 99999999999


Q ss_pred             ceEEeeccCccccccCCcc------ccccccCCcccccCCcccccCC------CCccccch
Q 039419          839 EPYIADFGLAKLVVEGDFA------RSSNTVAGSYGYIAPEYGYMMK------ITEKSDVY  887 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~  887 (1035)
                      .+||+|||+|+.+......      ..-....+++.|+|||+....+      .+..+|-|
T Consensus       150 ~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        150 EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            9999999999977554311      1113566888999999865332      33446766

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.88  E-value=5.2e-22  Score=235.91  Aligned_cols=265  Identities=26%  Similarity=0.340  Sum_probs=201.2

Q ss_pred             eEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhccc
Q 039419          177 LLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQ  256 (1035)
Q Consensus       177 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~  256 (1035)
                      -..|++++++++ .+|..+.  ++|+.|++.+|+++ .+|..   +++|++|+|++|+|+ .+|..   .++|+.|++++
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~  271 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS  271 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence            456778888787 6777665  37888899988888 56653   578999999999998 45543   46788899999


Q ss_pred             ccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhh
Q 039419          257 NNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFA  336 (1035)
Q Consensus       257 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~  336 (1035)
                      |.+. .+|..   .++|+.|+|++|+|+. +|.   .+++|+.|+|++|+|+++ |...   .+|+.|++++|+|+.+  
T Consensus       272 N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~lp---~~L~~L~Ls~N~L~~L--  337 (788)
T PRK15387        272 NPLT-HLPAL---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PALP---SELCKLWAYNNQLTSL--  337 (788)
T ss_pred             Cchh-hhhhc---hhhcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CCCc---ccccccccccCccccc--
Confidence            9988 45543   3578899999999984 554   247899999999999854 4332   4578889999988743  


Q ss_pred             hccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCc
Q 039419          337 WQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQ  416 (1035)
Q Consensus       337 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~  416 (1035)
                               |..   ..+|+.|+|++|+|+. +|..   ..+|+.|++++|+|++ +|..                 ..+
T Consensus       338 ---------P~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l-----------------~~~  383 (788)
T PRK15387        338 ---------PTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL-----------------PSG  383 (788)
T ss_pred             ---------ccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc-----------------ccc
Confidence                     321   1479999999999984 4443   3578889999999985 3321                 135


Q ss_pred             cceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCC
Q 039419          417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSS  496 (1035)
Q Consensus       417 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  496 (1035)
                      |+.|+|++|+|++ +|..   .++|+.|++++|+|+.+ |..   ..+|+.|++++|+|+ .+|..+..+++|+.|+|++
T Consensus       384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~LssI-P~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~  454 (788)
T PRK15387        384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTSL-PML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  454 (788)
T ss_pred             cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCCC-Ccc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence            8899999999995 4543   35799999999999964 543   346888999999998 6788899999999999999


Q ss_pred             CcCcCccchhhhh
Q 039419          497 NKLSGKIPVELFE  509 (1035)
Q Consensus       497 N~l~~~~p~~~~~  509 (1035)
                      |+|++.++..+..
T Consensus       455 N~Ls~~~~~~L~~  467 (788)
T PRK15387        455 NPLSERTLQALRE  467 (788)
T ss_pred             CCCCchHHHHHHH
Confidence            9999877776644

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.7e-23  Score=204.12  Aligned_cols=252  Identities=23%  Similarity=0.376  Sum_probs=188.2

Q ss_pred             cccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc
Q 039419          688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN  767 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  767 (1035)
                      .....+|.+...|+.|+|+|. |..+++|++.......            .+..+|..|.-.++-+.||||..+++.|..
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~------------risrdfneefp~lrifshpnilpvlgacns  258 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTA------------RISRDFNEEFPALRIFSHPNILPVLGACNS  258 (448)
T ss_pred             hhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcch------------hhcchhhhhCcceeeecCCchhhhhhhccC
Confidence            334567889999999999998 5556778875433222            234679999999999999999999999999


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeecc-CCCcccEEEcCCCceEEeecc
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR-DIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHr-Dikp~NIll~~~~~~kl~DFG  846 (1035)
                      +....++..||+.|+|+..+++......+..++.+++.+||+|++|||+..  +++-| -+....|++|++.+++|. .+
T Consensus       259 ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-ma  335 (448)
T KOG0195|consen  259 PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MA  335 (448)
T ss_pred             CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cc
Confidence            999999999999999999999988777888999999999999999999973  44444 688999999999888873 22


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCC---ccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT---EKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      -+++...      .....-.+.||+||.++..+.+   .++|+|||++++||+.|...||..-.+-+-       .+   
T Consensus       336 d~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------gm---  399 (448)
T KOG0195|consen  336 DTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------GM---  399 (448)
T ss_pred             cceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------hh---
Confidence            2232111      1233456899999998766544   579999999999999999999976543211       01   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                       .+.-..++...++.+...  .-+++.-|+..||.+||.+..++-.|+.+.
T Consensus       400 -kialeglrv~ippgis~h--m~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  400 -KIALEGLRVHIPPGISRH--MNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -hhhhccccccCCCCccHH--HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence             111222232222222221  223455599999999999999999888763

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.87  E-value=5.3e-22  Score=235.84  Aligned_cols=259  Identities=25%  Similarity=0.293  Sum_probs=147.6

Q ss_pred             HhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccch
Q 039419          251 KMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQ  330 (1035)
Q Consensus       251 ~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  330 (1035)
                      .|+|++|.++ .+|..+.  ++|+.|++.+|+|+. +|.   ..++|++|+|++|+|+.+ |..   .++|+.|+|++|+
T Consensus       205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls~N~  273 (788)
T PRK15387        205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVL---PPGLLELSIFSNP  273 (788)
T ss_pred             EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCc---ccccceeeccCCc
Confidence            3445555554 3444443  245555555555552 332   135556666666655532 321   2455566666665


Q ss_pred             hhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeec
Q 039419          331 ISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS  410 (1035)
Q Consensus       331 i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~  410 (1035)
                      |+.+           |..   ..+|+.|+|++|+|+. +|.   ..++|+.|+|++|+|+++ |...             
T Consensus       274 L~~L-----------p~l---p~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~L-p~lp-------------  321 (788)
T PRK15387        274 LTHL-----------PAL---PSGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASL-PALP-------------  321 (788)
T ss_pred             hhhh-----------hhc---hhhcCEEECcCCcccc-ccc---cccccceeECCCCccccC-CCCc-------------
Confidence            5533           111   1345566666666652 332   135566666666666643 2111             


Q ss_pred             cCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCc
Q 039419          411 FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQ  490 (1035)
Q Consensus       411 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  490 (1035)
                          .+|+.|++++|+|++ +|..   ..+|++|+|++|+|+++ |..   ..+|+.|++++|+|+. +|..   ..+|+
T Consensus       322 ----~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~  385 (788)
T PRK15387        322 ----SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---PSGLK  385 (788)
T ss_pred             ----ccccccccccCcccc-cccc---ccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-Cccc---ccccc
Confidence                235566666666663 3321   13567777777777653 322   2356666777777763 4432   24567


Q ss_pred             EEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCc
Q 039419          491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNN  570 (1035)
Q Consensus       491 ~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~  570 (1035)
                      .|+|++|+|+ .+|...    ..+..|++++|+|++ +|..   ..+|+.|+|++|+|+..|..+..+++|+.|+|++|+
T Consensus       386 ~LdLs~N~Lt-~LP~l~----s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~  456 (788)
T PRK15387        386 ELIVSGNRLT-SLPVLP----SELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNP  456 (788)
T ss_pred             eEEecCCccc-CCCCcc----cCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCC
Confidence            7777777776 455422    233467777777765 3432   246778888888888888788888888999999999


Q ss_pred             CcccCCC
Q 039419          571 FTGYLPD  577 (1035)
Q Consensus       571 l~~~~p~  577 (1035)
                      |++..+.
T Consensus       457 Ls~~~~~  463 (788)
T PRK15387        457 LSERTLQ  463 (788)
T ss_pred             CCchHHH
Confidence            8876664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=8.4e-23  Score=240.46  Aligned_cols=256  Identities=21%  Similarity=0.228  Sum_probs=186.2

Q ss_pred             cCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCC--CcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          690 EDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPT--TMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       690 ~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      ..+++|.|++|.|+.+... ..+.++.|.+...  ....+.          .....+..|+.+-.++.|||++..+..+.
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~----------~~~~~i~sE~~i~~~l~h~~~~e~l~~~~  391 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESER----------KYNYNITSEFCIGSSLSHPNIIETLDIVQ  391 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHH----------HHhhhhhhheeecccccCCchhhhHHHHh
Confidence            5578999999988877443 3444555544311  111110          11223777888899999999988888777


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      +....+-+||||++ +|...+.....  +....+..++.|+..|++|+|+.   ||.|||+||+|+++..+|.+||+|||
T Consensus       392 ~~~~~~~~mE~~~~-Dlf~~~~~~~~--~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  392 EIDGILQSMEYCPY-DLFSLVMSNGK--LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             hcccchhhhhcccH-HHHHHHhcccc--cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence            77766667999999 99999876532  77888889999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCcc--ccccccCCcccccCCcccccCCCCc-cccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          847 LAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMMKITE-KSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       847 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      .+....-+...  ......+|+..|+|||+..+..|++ ..||||.|++++.|.+|+.||......+..+........  
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~--  543 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ--  543 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc--
Confidence            98866544332  4456788999999999999999986 589999999999999999999866544332211000000  


Q ss_pred             hhhhcccccCCCcccHHHH-HHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEM-LQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~-~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                           ......+......+ .....++.+|+++||.+|.|+++|++
T Consensus       544 -----~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 -----RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -----cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                 00001111111111 12235778899999999999999987

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=1e-19  Score=205.43  Aligned_cols=262  Identities=26%  Similarity=0.325  Sum_probs=196.1

Q ss_pred             cccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCC-ceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHK-NIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~  766 (1035)
                      |...+.||.|+||.||++...  ..+++|.+........           .....+.+|+.+++.+.|+ +|+++++.+.
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   68 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-----------KEVERFLREIQILASLNHPPNIVKLYDFFQ   68 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-----------hHHHHHHHHHHHHHHccCCcceeeEEEEEe
Confidence            556778999999999999777  7889999876543321           1356899999999999988 7999999997


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC-ceEEee
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF-EPYIAD  844 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl~D  844 (1035)
                      .....+++++|+.++++.+++..... ..+.......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|
T Consensus        69 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~d  145 (384)
T COG0515          69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLID  145 (384)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEec
Confidence            77778999999999999977765432 1488899999999999999999999   899999999999999988 799999


Q ss_pred             ccCccccccCCccc----cccccCCcccccCCccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCC--chhHHH
Q 039419          845 FGLAKLVVEGDFAR----SSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE--GLHIVD  915 (1035)
Q Consensus       845 FG~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~--~~~~~~  915 (1035)
                      ||.++.........    ......|+..|+|||...+   ..+....|+||+|++++++++|..||......  ......
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~  225 (384)
T COG0515         146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK  225 (384)
T ss_pred             cCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence            99998655433221    2356789999999999887   57889999999999999999999997654321  112222


Q ss_pred             HHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+......  ...........  .........++..|+..+|..|.+..+....
T Consensus       226 ~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         226 IILELPTP--SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHhcCCc--ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            22111100  00000000000  0111234456777889999999999887765

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=5.1e-21  Score=195.58  Aligned_cols=180  Identities=12%  Similarity=0.070  Sum_probs=135.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..+|...+++|.|+||.||.+.. ++..+|||.+.+.....+...+.     ....+.+.+|+..+.+++||+|..+.++
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~-----f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKS-----FVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHh-----hhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            37889999999999999999866 47789999997654433211000     0002337899999999999999999998


Q ss_pred             EEcC--------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          765 CWNR--------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       765 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                      +...        +..++||||++|.+|.++..      .+.    ....+++.++..+|+.   |++|||+||+||+++.
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~  170 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK  170 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence            7643        24789999999999988732      222    2456899999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh
Q 039419          837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT  898 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt  898 (1035)
                      +| ++++|||...........              ..+.....+..++|+|+||+++.....
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             CC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            88 999999988654322110              013334456679999999999876543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=3.9e-20  Score=188.05  Aligned_cols=153  Identities=18%  Similarity=0.169  Sum_probs=110.8

Q ss_pred             CCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccc---------ccc---ccccccccHHHHHHHHHHHhcCCCCce
Q 039419          691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYD---------CQN---DKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~---~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      ...||+|+||.||+|...+|+.||||++++........         ..+   .............+|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            45799999999999988889999999997653211100         000   000000012334569999999988776


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHh-hccCCCCeeccCCCcccEEEcCC
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYL-HHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      .....+..  ...++||||++|+++.......  ..++...+..++.|++.+|+|+ |+.   ||+||||||+||+++ +
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence            44333322  2348999999988776553322  3488899999999999999999 687   999999999999998 4


Q ss_pred             CceEEeeccCcccc
Q 039419          838 FEPYIADFGLAKLV  851 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~  851 (1035)
                      +.++|+|||+|...
T Consensus       154 ~~v~LiDFG~a~~~  167 (190)
T cd05147         154 GKLYIIDVSQSVEH  167 (190)
T ss_pred             CcEEEEEccccccC
Confidence            78999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.82  E-value=8.8e-21  Score=227.34  Aligned_cols=266  Identities=26%  Similarity=0.392  Sum_probs=164.3

Q ss_pred             cceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccc
Q 039419           56 LQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFD  135 (1035)
Q Consensus        56 L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~  135 (1035)
                      ...|+|++++++ .+|..+.  +.|+.|+|++|+++ .+|..+.  .+|++|+|++|+++ .+|..+.  .+|+.|+|++
T Consensus       180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~  250 (754)
T PRK15370        180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI  250 (754)
T ss_pred             ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence            455666665555 4554443  35566666666655 4554443  35666666666555 4554432  2455555555


Q ss_pred             cccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCC
Q 039419          136 NYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEI  215 (1035)
Q Consensus       136 n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~  215 (1035)
                      |.+. .+|..+.  ++                         |+.|++++|++. .+|..+.  ++|+.|++++|+++ .+
T Consensus       251 N~L~-~LP~~l~--s~-------------------------L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~L  298 (754)
T PRK15370        251 NRIT-ELPERLP--SA-------------------------LQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TL  298 (754)
T ss_pred             CccC-cCChhHh--CC-------------------------CCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cC
Confidence            5555 4444432  24                         444555555554 3444443  36777777777776 45


Q ss_pred             ccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCC
Q 039419          216 PPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLS  295 (1035)
Q Consensus       216 p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  295 (1035)
                      |..+.  ++|+.|++++|.++ .+|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|+|++|+|+ .+|..+.  +
T Consensus       299 P~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~  367 (754)
T PRK15370        299 PAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--P  367 (754)
T ss_pred             cccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--C
Confidence            55443  36777788888777 3454332  577888888888874 665553  68899999999888 4666553  6


Q ss_pred             CCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCccc
Q 039419          296 SLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ  375 (1035)
Q Consensus       296 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  375 (1035)
                      +|+.|+|++|+|.. +|..+.  ..|+.|++++|+|+.+.       ..+|..+..++++..|++.+|.++.      ..
T Consensus       368 ~L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~LP-------~sl~~~~~~~~~l~~L~L~~Npls~------~t  431 (754)
T PRK15370        368 TITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVRLP-------ESLPHFRGEGPQPTRIIVEYNPFSE------RT  431 (754)
T ss_pred             CcCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcccCc-------hhHHHHhhcCCCccEEEeeCCCccH------HH
Confidence            89999999999884 444443  36888999999887442       1344455666889999999999972      34


Q ss_pred             CcccceEeccccccc
Q 039419          376 LQNLTKLLLISNGIS  390 (1035)
Q Consensus       376 l~~L~~L~L~~N~i~  390 (1035)
                      +.+|+.| +..+.+.
T Consensus       432 l~~L~~L-l~s~~~~  445 (754)
T PRK15370        432 IQNMQRL-MSSVGYQ  445 (754)
T ss_pred             HHHHHHh-hhccccc
Confidence            5556666 4445443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.82  E-value=1.9e-20  Score=224.41  Aligned_cols=288  Identities=25%  Similarity=0.397  Sum_probs=198.1

Q ss_pred             CCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeec
Q 039419           78 TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRA  157 (1035)
Q Consensus        78 ~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l  157 (1035)
                      .+.+.|++++++++ .+|..+.  ++|+.|+|++|+++ .+|..+.  .+|++|++++|+++ .+|..+.          
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~----------  240 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP----------  240 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh----------
Confidence            34566666666666 5665543  35666666666666 5555443  36666666666665 4444332          


Q ss_pred             CCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCC
Q 039419          158 GGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSG  237 (1035)
Q Consensus       158 ~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  237 (1035)
                                       .+|+.|+|++|++. .+|..+.  ++|++|++++|+++ .+|..+.  .+|+.|+|++|+++ 
T Consensus       241 -----------------~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-  296 (754)
T PRK15370        241 -----------------DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-  296 (754)
T ss_pred             -----------------ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-
Confidence                             24555555555665 4565554  58999999999999 6787664  58999999999999 


Q ss_pred             CCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccC
Q 039419          238 SLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSN  317 (1035)
Q Consensus       238 ~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  317 (1035)
                      .+|..+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|.++. +|..+.  ++|+.|+|++|+|. .+|..+  
T Consensus       297 ~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--  365 (754)
T PRK15370        297 TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--  365 (754)
T ss_pred             cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--
Confidence            4665543  579999999999994 565443  689999999999995 666554  79999999999998 456555  


Q ss_pred             CCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCc----ccCcccceEeccccccccCC
Q 039419          318 ATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGL----FQLQNLTKLLLISNGISGLI  393 (1035)
Q Consensus       318 l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~L~~N~i~~~~  393 (1035)
                      .++|+.|+|++|+|+.           +|..+.  .+|+.|++++|+|+ .+|..+    ..++++..|++.+|.++.. 
T Consensus       366 p~~L~~LdLs~N~Lt~-----------LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~~-  430 (754)
T PRK15370        366 PPTITTLDVSRNALTN-----------LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSER-  430 (754)
T ss_pred             cCCcCEEECCCCcCCC-----------CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccHH-
Confidence            3689999999999874           344443  36999999999998 455443    3458899999999998721 


Q ss_pred             CCCCCCCCcceeEeeeccCCCCccceeecCCCccCC-CCcccccCCCCccEEEcCCCccC
Q 039419          394 PPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGG-TLPSSLASLTRLQVLDISVNQFV  452 (1035)
Q Consensus       394 ~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~  452 (1035)
                                         .+.+|+.| ++.+.+.| .++.....+.+++....-.+.+.
T Consensus       431 -------------------tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~  470 (754)
T PRK15370        431 -------------------TIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQ  470 (754)
T ss_pred             -------------------HHHHHHHh-hhcccccCCcccccccccccccccchHHHHHh
Confidence                               12345555 33344332 33444555566666555444444

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=2.6e-19  Score=183.03  Aligned_cols=153  Identities=20%  Similarity=0.181  Sum_probs=113.2

Q ss_pred             CCeeeeeCCcEEEEEEECCCcEEEEEEecCCCccccccc-----cccc------c-cccccHHHHHHHHHHHhcCCCCce
Q 039419          691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDC-----QNDK------I-GIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~-----~~~~------~-~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .+.||+|+||.||+|...+|+.||||++.+.........     ....      . ........+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999877899999999987532211000     0000      0 000112345689999999999987


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhh-hhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcC
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSL-LHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~  836 (1035)
                      .....+...  ..|+||||++|+++... +..   ..++......++.|++.++.++|+ .   ||+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence            554444333  24899999998865443 332   236788889999999999999999 8   999999999999999 


Q ss_pred             CCceEEeeccCccccc
Q 039419          837 EFEPYIADFGLAKLVV  852 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~  852 (1035)
                      ++.++|+|||+|....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8899999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=2.4e-19  Score=178.76  Aligned_cols=189  Identities=14%  Similarity=0.041  Sum_probs=138.8

Q ss_pred             ccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEeEEEc
Q 039419          689 VEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWN  767 (1035)
Q Consensus       689 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  767 (1035)
                      .....|++|+||+||.+.. ++.+++.+.+.........          .....+.+|+++|+++. |++|++++++   
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~----------~~~~l~~rE~~iL~~L~~~~~vP~ll~~---   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRG----------VAWWLARREALALRQLDGLPRTPRLLHW---   70 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhh----------HHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence            3457899999999998866 5777777766443221110          11235889999999995 5889999886   


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCC-CcccEEEcCCCceEEeecc
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI-KANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDi-kp~NIll~~~~~~kl~DFG  846 (1035)
                       +..|++|||+.|.+|.+....        . ...++.|++++++++|+.   ||+|||| ||+||+++.++.++|+|||
T Consensus        71 -~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         71 -DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             -cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECC
Confidence             446999999999999764321        1 135778999999999999   9999999 7999999999999999999


Q ss_pred             CccccccCCcc------cc-----ccccCCcccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCC
Q 039419          847 LAKLVVEGDFA------RS-----SNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPID  904 (1035)
Q Consensus       847 ~a~~~~~~~~~------~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~elltg~~P~~  904 (1035)
                      +|....+....      ..     ......++.|++|+...-  ..--.+.+.++-|+-+|.++|++.|.-
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            99855432210      00     112236778888875321  222256799999999999999998864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.6e-20  Score=208.96  Aligned_cols=187  Identities=27%  Similarity=0.338  Sum_probs=160.9

Q ss_pred             eeeeCCcEEEEEEE----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEeEEEcC
Q 039419          694 VGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNR  768 (1035)
Q Consensus       694 iG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  768 (1035)
                      +|+|+||.|+.++.    +.|..||+|..+........            +.....|..++..++ ||.+|++...++.+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~------------~~~t~~er~il~~~~~~~f~v~lhyafqt~   69 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD------------RTHTKQERIILAFVHNTPFLVKLHYAFQTD   69 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccc------------ccccccHHHHHhhccCCCceeeeeeeeccc
Confidence            68999999998733    34788999998765543321            124567888898887 99999999999999


Q ss_pred             CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCc
Q 039419          769 NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA  848 (1035)
Q Consensus       769 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a  848 (1035)
                      ...+++++|..||++...+.....  ++......+...++-+++++|+.   +|+|||+|++||+++.+|++++.|||.+
T Consensus        70 ~kl~l~ld~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfgls  144 (612)
T KOG0603|consen   70 GKLYLILDFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLS  144 (612)
T ss_pred             cchhHhhhhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhh
Confidence            999999999999999988876655  77777788888999999999999   9999999999999999999999999999


Q ss_pred             cccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          849 KLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       849 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      +...+....      +||..|||||++.  ....++|.||||++.+||++|..||..
T Consensus       145 ke~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  145 KEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            977665432      8999999999987  567799999999999999999999974

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=8.6e-21  Score=175.18  Aligned_cols=158  Identities=31%  Similarity=0.440  Sum_probs=94.7

Q ss_pred             CCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccc
Q 039419           74 LGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLE  153 (1035)
Q Consensus        74 ~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~  153 (1035)
                      +.++++.+.|-||+|+++ .+|..|..|.+|+.|++.+|+++ .+|.+++.+++|++|++.-|.+. .+|..||.++.||
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            444566666677777776 66667777777777777777776 67777777777777777777766 6677777777777


Q ss_pred             eeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCC
Q 039419          154 VIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEN  233 (1035)
Q Consensus       154 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n  233 (1035)
                      +|++..|+.....+|.+                        |..|+.|+-|++++|.+. .+|..++++++|+.|.+..|
T Consensus       106 vldltynnl~e~~lpgn------------------------ff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdn  160 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGN------------------------FFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDN  160 (264)
T ss_pred             hhhccccccccccCCcc------------------------hhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccC
Confidence            77776665333333333                        334444444444444444 44555555555555555555


Q ss_pred             cCCCCCChhhhcccchhHhhccccccc
Q 039419          234 DLSGSLPRELGKLQKLEKMLLWQNNFD  260 (1035)
Q Consensus       234 ~l~~~~~~~l~~l~~L~~L~l~~n~l~  260 (1035)
                      .+- .+|.+++.+..|++|.+.+|.++
T Consensus       161 dll-~lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  161 DLL-SLPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             chh-hCcHHHHHHHHHHHHhcccceee
Confidence            544 45555555555555555555555

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.77  E-value=1.4e-19  Score=210.39  Aligned_cols=252  Identities=21%  Similarity=0.201  Sum_probs=176.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      +|...+.+|++.|=.|.+|++..|. |+||++......-.         ... .++-..|++ ...++|||.+.+.-...
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~s---------L~~-~~qrL~~ik-~~l~~~pn~lPfqk~~~   91 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTIS---------LRP-FKQRLEEIK-FALMKAPNCLPFQKVLV   91 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCC---------chH-HHHHHHHHH-HHhhcCCcccchHHHHH
Confidence            5667889999999999999998887 89999865432111         111 122233444 55568999999888877


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      .....|+|-+|+ .-+|++.+..+.-  +...+.+=|+.|++.|+..+|..   ||+|||||.+|||++.-.-+.|+||.
T Consensus        92 t~kAAylvRqyv-khnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   92 TDKAAYLVRQYV-KHNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             hhHHHHHHHHHH-hhhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence            778889999999 4599999976643  67777778999999999999999   99999999999999999999999998


Q ss_pred             Ccccc-ccCCccccc----cccCCcccccCCcccccC----------C-CCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 039419          847 LAKLV-VEGDFARSS----NTVAGSYGYIAPEYGYMM----------K-ITEKSDVYSYGVVVLEVLT-GKQPIDPTIPE  909 (1035)
Q Consensus       847 ~a~~~-~~~~~~~~~----~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~  909 (1035)
                      .-+.. .+.+.....    .+-..-..|.|||.+...          . .+++-||||+||++.|+++ |++||.-    
T Consensus       166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----  241 (1431)
T KOG1240|consen  166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----  241 (1431)
T ss_pred             ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----
Confidence            65532 122211111    122234579999975431          1 5678899999999999998 7888852    


Q ss_pred             chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                          .+....+.+........+..-.+.      ....+++.|++.||++|-++++.++.-
T Consensus       242 ----SQL~aYr~~~~~~~e~~Le~Ied~------~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  242 ----SQLLAYRSGNADDPEQLLEKIEDV------SLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             ----HHHHhHhccCccCHHHHHHhCcCc------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence                222222221111111111111111      234567779999999999999999863

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=3.7e-20  Score=171.06  Aligned_cols=167  Identities=28%  Similarity=0.483  Sum_probs=148.8

Q ss_pred             CCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccc
Q 039419           49 NLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKL  128 (1035)
Q Consensus        49 ~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  128 (1035)
                      .+..+.+++.|.||+|+++ ..|+.+..|.+|+.|++++|+|. .+|.+|+.|++|+.|++.-|++. .+|..++.++.|
T Consensus        28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l  104 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL  104 (264)
T ss_pred             cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence            4778888999999999999 78999999999999999999999 99999999999999999999998 899999999999


Q ss_pred             cceeccccccCC-CCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeec
Q 039419          129 KNLLLFDNYLSG-NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVY  207 (1035)
Q Consensus       129 ~~L~l~~n~l~~-~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~  207 (1035)
                      +.|||.+|++.. .+|+.|.-|..|+.|+++.|.  ...+|..++++++|+.|.+.+|.+. .+|..++.+++|++|.++
T Consensus       105 evldltynnl~e~~lpgnff~m~tlralyl~dnd--fe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq  181 (264)
T KOG0617|consen  105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDND--FEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ  181 (264)
T ss_pred             hhhhccccccccccCCcchhHHHHHHHHHhcCCC--cccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence            999999999875 579999999999999999997  5677888888888888888888887 778888888888888888


Q ss_pred             ccccccCCccccccC
Q 039419          208 TTMLSGEIPPQIGNC  222 (1035)
Q Consensus       208 ~n~l~~~~p~~l~~l  222 (1035)
                      +|+++ .+|+.++++
T Consensus       182 gnrl~-vlppel~~l  195 (264)
T KOG0617|consen  182 GNRLT-VLPPELANL  195 (264)
T ss_pred             cceee-ecChhhhhh
Confidence            88887 777776654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=9.5e-19  Score=182.23  Aligned_cols=196  Identities=21%  Similarity=0.259  Sum_probs=134.0

Q ss_pred             CCCceeeEEeEEEcC---------------------------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHH
Q 039419          754 RHKNIVRFLGCCWNR---------------------------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG  806 (1035)
Q Consensus       754 ~hpniv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  806 (1035)
                      +|||||++.++|.++                           ...|+||... ..+|.+|+..+.   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence            599999998887542                           2358999877 468999987654   455667788999


Q ss_pred             HHHHHHHhhccCCCCeeccCCCcccEEEc--CCC--ceEEeeccCccccccC----CccccccccCCcccccCCcccccC
Q 039419          807 AAQGLAYLHHDCVPPIVHRDIKANNILIG--PEF--EPYIADFGLAKLVVEG----DFARSSNTVAGSYGYIAPEYGYMM  878 (1035)
Q Consensus       807 ia~~L~~LH~~~~~~ivHrDikp~NIll~--~~~--~~kl~DFG~a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~  878 (1035)
                      +++|+.|||++   ||.|||+|.+|||+.  +++  ..+|+|||.+---...    ..........|...-||||+....
T Consensus       350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999999   999999999999993  444  3678999976432221    111222345688899999987643


Q ss_pred             C------CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhc
Q 039419          879 K------ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLC  952 (1035)
Q Consensus       879 ~------~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~c  952 (1035)
                      +      --.|+|.|+.|.+.||++....||.....-..+..       ...+.--+.+....++      ...+++...
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-------~Yqe~qLPalp~~vpp------~~rqlV~~l  493 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-------TYQESQLPALPSRVPP------VARQLVFDL  493 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-------hhhhhhCCCCcccCCh------HHHHHHHHH
Confidence            3      12489999999999999999999975321111110       1111112222232222      223466668


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 039419          953 VNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       953 l~~dP~~RPs~~el~~~  969 (1035)
                      +++||.+|++..-....
T Consensus       494 L~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  494 LKRDPSKRVSPNIAANV  510 (598)
T ss_pred             hcCCccccCCccHHHhH
Confidence            99999999987655443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.75  E-value=2.1e-18  Score=181.76  Aligned_cols=235  Identities=22%  Similarity=0.285  Sum_probs=145.1

Q ss_pred             ccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC----------
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH----------  755 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------  755 (1035)
                      .+...+.||.|+++.||.+++.. ++.+|||++........           ...+++++|.-....+.+          
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~-----------~~~~~~~~e~l~~~~~~~~~~p~~a~~~   81 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASA-----------NEYEQLKEEQLAITLFPGVKNPKEAYRH   81 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHT-----------THHHHHHHHHHGGGGSTT--SHHHHHHH
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccch-----------HHHHHHHHHHHHhhhhccCCCHHHHHHh
Confidence            45567899999999999997764 89999999865442221           235667777755555322          


Q ss_pred             CceeeEEeEEEc---------C---C-----cceEEEEeCCCCChhhhhhh---cCCC--CCCHHHHHHHHHHHHHHHHH
Q 039419          756 KNIVRFLGCCWN---------R---N-----TRLLMYDYMPNGSLGSLLHE---RRDS--CLEWELRYRIILGAAQGLAY  813 (1035)
Q Consensus       756 pniv~l~~~~~~---------~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~--~l~~~~~~~i~~~ia~~L~~  813 (1035)
                      -.++..++...-         .   .     ..+++|+-+ -+||.+++..   ....  .+....+..+..|+++.+++
T Consensus        82 ~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~  160 (288)
T PF14531_consen   82 LRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVAN  160 (288)
T ss_dssp             H-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHH
Confidence            122222222211         1   1     126678877 5688877542   2221  23345556677899999999


Q ss_pred             hhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCccccc--------CCCCcccc
Q 039419          814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM--------MKITEKSD  885 (1035)
Q Consensus       814 LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~D  885 (1035)
                      ||+.   |++|+||||+|++++.+|.++|+||+.....+...  .   ....+..|.+||....        ..++.+.|
T Consensus       161 Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~--~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D  232 (288)
T PF14531_consen  161 LHSY---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY--R---CSEFPVAFTPPELESCAGQFGQNNAPYTFATD  232 (288)
T ss_dssp             HHHT---TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE--E---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred             Hhhc---ceEecccceeeEEEcCCCCEEEcChHHHeecCcee--e---ccCCCcccCChhhhhhhcccCcccceeeeccC
Confidence            9999   99999999999999999999999998876543321  1   1234578999997533        24788999


Q ss_pred             chhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCC
Q 039419          886 VYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDR  960 (1035)
Q Consensus       886 v~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~R  960 (1035)
                      .|++|+++|.+.+|+.||+...++....               ..+. .+. ..++..+.  ++..+++++|.+|
T Consensus       233 aW~LG~~ly~lWC~~lPf~~~~~~~~~~---------------~~f~-~C~-~~Pe~v~~--LI~~lL~~~~~~R  288 (288)
T PF14531_consen  233 AWQLGITLYSLWCGRLPFGLSSPEADPE---------------WDFS-RCR-DMPEPVQF--LIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHHHSS-STCCCGGGSTSG---------------GGGT-TSS----HHHHH--HHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHHHccCCCCCCCcccccc---------------ccch-hcC-CcCHHHHH--HHHHHccCCcccC
Confidence            9999999999999999998553321110               0111 122 33444443  6777899999887

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=1e-17  Score=171.50  Aligned_cols=137  Identities=22%  Similarity=0.271  Sum_probs=105.3

Q ss_pred             cccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-----CCCceeeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-----RHKNIVRFL  762 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~  762 (1035)
                      +...+.||+|+||.||.  ++.....+||++.....              ...+.+.+|+.+++.+     +||||++++
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--------------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~y   67 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--------------GGDKEIRRELKYYAHLSRRLIDWSGIPRYY   67 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEecccc--------------chHHHHHHHHHHHHHhhccCCCCcccceee
Confidence            34567899999999995  54434447998865321              1245789999999999     579999999


Q ss_pred             eEEEcCC---cce-EEEEe--CCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHH-HHhhccCCCCeeccCCCcccEEEc
Q 039419          763 GCCWNRN---TRL-LMYDY--MPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL-AYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       763 ~~~~~~~---~~~-lv~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      |++.++.   ..+ +||||  +.+|+|.+++....   +++.  ..++.+++.++ +|||+.   +|+||||||+||+++
T Consensus        68 g~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~  139 (210)
T PRK10345         68 GTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQ  139 (210)
T ss_pred             EEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEe
Confidence            9998864   333 78999  55799999996532   5554  35677888777 999999   999999999999997


Q ss_pred             C----CCceEEeeccCc
Q 039419          836 P----EFEPYIADFGLA  848 (1035)
Q Consensus       836 ~----~~~~kl~DFG~a  848 (1035)
                      .    ++.++|+||+-+
T Consensus       140 ~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        140 RISESEVIPVVCDNIGE  156 (210)
T ss_pred             ccCCCCCcEEEEECCCC
Confidence            4    347999995443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=9.6e-18  Score=200.49  Aligned_cols=195  Identities=22%  Similarity=0.214  Sum_probs=158.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC---CCceeeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR---HKNIVRF  761 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l  761 (1035)
                      .+.|.+.+.||+|+||.||+|...+|+.||+|+-++....+-+.                 =.+++.||+   -+.|..+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----------------~~q~~~RLk~~~~~~~~~~  759 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----------------CLQVMERLKPQMLPSIMHI  759 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----------------hHHHHHhhchhhhcchHHH
Confidence            36788889999999999999988889999999998876554332                 234455555   2445556


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-----
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-----  836 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-----  836 (1035)
                      .....-.+..++|+||.+.|+|.+++...  +.+++..+..+..|+++.+++||..   +|||+||||+|+||..     
T Consensus       760 ~~a~~~~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~  834 (974)
T KOG1166|consen  760 SSAHVFQNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICAD  834 (974)
T ss_pred             HHHHccCCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCC
Confidence            66666678889999999999999999844  4499999999999999999999999   9999999999999953     


Q ss_pred             --CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 039419          837 --EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ  901 (1035)
Q Consensus       837 --~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~  901 (1035)
                        ...++|+|||.+--+.--.....-...++|-.+-.+|...|...++.+|-|.++.++|-|+.|++
T Consensus       835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence              34589999998864432211122345678899999999999999999999999999999999975

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.73  E-value=1.2e-17  Score=187.17  Aligned_cols=215  Identities=26%  Similarity=0.451  Sum_probs=159.3

Q ss_pred             HhcCCCCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCe-eccCCC
Q 039419          750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPI-VHRDIK  828 (1035)
Q Consensus       750 l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-vHrDik  828 (1035)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...+++.....++++|+.||+|+|..   .| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence            35678999999999999999999999999999999999763 34589999999999999999999997   44 999999


Q ss_pred             cccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccC-------CCCccccchhHHHHHHHHHhCCC
Q 039419          829 ANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-------KITEKSDVYSYGVVVLEVLTGKQ  901 (1035)
Q Consensus       829 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGvvl~elltg~~  901 (1035)
                      +.|.++|....+|++|||+.....+...........-..-|.|||.....       ..+.++||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998766431111111222344679999986653       14678999999999999999999


Q ss_pred             CCCCCCCCc--hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          902 PIDPTIPEG--LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       902 P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      ||+......  ..+...++.  .....+.+.+....    +.....+.++..||..+|++||+++++-..++.+.
T Consensus       157 ~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN----ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             ccccccccCChHHHHHHHHh--cCCCCcCcchhhhh----hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            998643221  233333332  11111222221110    11114566888999999999999999987665543

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.71  E-value=2.1e-19  Score=201.37  Aligned_cols=271  Identities=24%  Similarity=0.256  Sum_probs=155.4

Q ss_pred             EEecCCccc-ccCCcCCCCCcccceEeecCcccCCC----CCCCCCCCCCCceeeCCCCCCCC------CCChhhhcccc
Q 039419           35 INIQSIELE-LPFPSNLSSLSFLQKLIISGSNLTGP----ISPDLGDCTQLTTIDVSSNSLVG------GVPSSIGKLIN  103 (1035)
Q Consensus        35 l~~~~~~~~-~~~~~~~~~l~~L~~L~L~~~~l~~~----~~~~~~~l~~L~~L~ls~n~l~~------~~p~~i~~l~~  103 (1035)
                      |+|..+.+. ......+..+..|++|+++++.+++.    +++.+...+.|++|+++++.+.+      .++..+..+.+
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            344444443 23344455666677777777776432    44445566667777777766651      22344555667


Q ss_pred             ccceEecccCCCCCCchhhhhhcc---ccceeccccccCCC----Cchhhccc-cccceeecCCCcccCCCCCCcCCCcc
Q 039419          104 LQDLILNSNQLTGEIPKELGACIK---LKNLLLFDNYLSGN----LPVELGKL-VNLEVIRAGGNKDIAGKIPYEIGDCQ  175 (1035)
Q Consensus       104 L~~L~L~~n~l~~~~p~~l~~l~~---L~~L~l~~n~l~~~----~p~~l~~l-~~L~~L~l~~n~~~~~~~~~~~~~l~  175 (1035)
                      |++|+|++|.+.+..+..+..+.+   |++|++++|.+.+.    +...+..+ ++|++|++++|               
T Consensus        83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n---------------  147 (319)
T cd00116          83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRN---------------  147 (319)
T ss_pred             eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCC---------------
Confidence            777777777766555556665555   77777777766521    12223334 45555555554               


Q ss_pred             ceEEEEeccccccc----cCcccccccccccceeecccccccC----CccccccCcCCceEEecCCcCCCCCC----hhh
Q 039419          176 SLLVVGLADTKVAG----SLPASLGKLSKLQSLSVYTTMLSGE----IPPQIGNCSELVDLFLYENDLSGSLP----REL  243 (1035)
Q Consensus       176 ~L~~L~l~~~~~~~----~~p~~l~~l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~~----~~l  243 (1035)
                                .+++    .++..+..+++|++|++++|.+++.    ++..+..+++|+.|+|++|.+++...    ..+
T Consensus       148 ----------~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~  217 (319)
T cd00116         148 ----------RLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETL  217 (319)
T ss_pred             ----------cCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHh
Confidence                      4432    2233444555666666666666532    22334445567777777776653322    234


Q ss_pred             hcccchhHhhcccccccccCCcccc-----CCCCCcEEEccCccCCC----CCCccccCCCCCcEEEccCCccccC----
Q 039419          244 GKLQKLEKMLLWQNNFDGAIPEEIG-----NCKSLKTIDLSLNFFSG----SLPQSFGNLSSLEELMLSNNNISGS----  310 (1035)
Q Consensus       244 ~~l~~L~~L~l~~n~l~~~~p~~~~-----~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----  310 (1035)
                      ..+++|++|++++|.+.+.....+.     ..+.|+.|++++|.++.    .....+..+++|+++++++|.++..    
T Consensus       218 ~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~  297 (319)
T cd00116         218 ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQL  297 (319)
T ss_pred             cccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHH
Confidence            4556677777777766642222222     23678888888888762    2234455667888888888888744    


Q ss_pred             CCCcccCC-Cccceeccccch
Q 039419          311 IPPVLSNA-TSLLQLQLDTNQ  330 (1035)
Q Consensus       311 ~~~~~~~l-~~L~~L~L~~N~  330 (1035)
                      ....+... +.|++|++.+|.
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         298 LAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHHhhcCCchhhcccCCCC
Confidence            33344444 677888877765

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=4.6e-17  Score=171.33  Aligned_cols=155  Identities=17%  Similarity=0.121  Sum_probs=113.6

Q ss_pred             ccccCCeeeeeCCcEEEEEE--ECCCcEEEEEEecCCCccccccc------c----cccccccccHHHHHHHHHHHhcCC
Q 039419          687 CLVEDSVVGKGCSGIVYRAE--MENGEVIAVKKLWPTTMAAEYDC------Q----NDKIGIGGVRDSFSAEIKTLGSIR  754 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~~~~~------~----~~~~~~~~~~~~~~~E~~~l~~l~  754 (1035)
                      -|.+.+.||+|+||.||+|.  ..+|+.||+|++...........      .    ............+.+|+..++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            36778899999999999997  46799999999976432111000      0    000000112345678999999997


Q ss_pred             C--CceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCC-eeccCCCccc
Q 039419          755 H--KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPP-IVHRDIKANN  831 (1035)
Q Consensus       755 h--pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-ivHrDikp~N  831 (1035)
                      +  ..+++++++    ...++||||++|+++..+.....  .........++.|++.+++++|+.   | |+||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence            5  334455543    23589999999988877653222  255666788999999999999999   8 9999999999


Q ss_pred             EEEcCCCceEEeeccCcccc
Q 039419          832 ILIGPEFEPYIADFGLAKLV  851 (1035)
Q Consensus       832 Ill~~~~~~kl~DFG~a~~~  851 (1035)
                      |+++ ++.++|+|||.|...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 889999999998754

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.71  E-value=2.1e-19  Score=201.37  Aligned_cols=280  Identities=23%  Similarity=0.250  Sum_probs=189.1

Q ss_pred             eEeecCcccCC-CCCCCCCCCCCCceeeCCCCCCCCC----CChhhhccccccceEecccCCCC------CCchhhhhhc
Q 039419           58 KLIISGSNLTG-PISPDLGDCTQLTTIDVSSNSLVGG----VPSSIGKLINLQDLILNSNQLTG------EIPKELGACI  126 (1035)
Q Consensus        58 ~L~L~~~~l~~-~~~~~~~~l~~L~~L~ls~n~l~~~----~p~~i~~l~~L~~L~L~~n~l~~------~~p~~l~~l~  126 (1035)
                      .|+|+++.+++ .....+..+.+|++|++++|.+++.    ++..+...++|++|+++.+.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            46677777763 3333445567788888888777532    44455566667777777776652      2334455566


Q ss_pred             cccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccc----cCccccccc-ccc
Q 039419          127 KLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG----SLPASLGKL-SKL  201 (1035)
Q Consensus       127 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~----~~p~~l~~l-~~L  201 (1035)
                      +|++|++++|.+.+..+..+..+.+                     . ++|+.|++++|++.+    .+...+..+ ++|
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~---------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L  139 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLR---------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL  139 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhc---------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCc
Confidence            7777777777766545555544444                     0 124444444444442    334456677 899


Q ss_pred             cceeecccccccC----CccccccCcCCceEEecCCcCCCCC----ChhhhcccchhHhhccccccccc----CCccccC
Q 039419          202 QSLSVYTTMLSGE----IPPQIGNCSELVDLFLYENDLSGSL----PRELGKLQKLEKMLLWQNNFDGA----IPEEIGN  269 (1035)
Q Consensus       202 ~~L~l~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~l~~n~l~~~----~p~~~~~  269 (1035)
                      +.|++++|.+++.    ++..+..+.+|+.|+|++|.+++..    +..+..+++|++|++++|.+.+.    ++..+..
T Consensus       140 ~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~  219 (319)
T cd00116         140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLAS  219 (319)
T ss_pred             eEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcc
Confidence            9999999999843    3445677789999999999998532    33445566999999999998743    3455677


Q ss_pred             CCCCcEEEccCccCCCCCCcccc-----CCCCCcEEEccCCcccc----CCCCcccCCCccceeccccchhhhhhhhccc
Q 039419          270 CKSLKTIDLSLNFFSGSLPQSFG-----NLSSLEELMLSNNNISG----SIPPVLSNATSLLQLQLDTNQISVFFAWQNK  340 (1035)
Q Consensus       270 l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~  340 (1035)
                      +++|++|++++|.+++.....+.     ..+.|++|++++|.++.    .....+..+++|+++++++|.++.....   
T Consensus       220 ~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~---  296 (319)
T cd00116         220 LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ---  296 (319)
T ss_pred             cCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHH---
Confidence            89999999999999863333332     24799999999999972    2334566678999999999999854221   


Q ss_pred             cCCCCCcCCCCC-CCCcEEeccCcCC
Q 039419          341 LEGSIPSTLANC-RSLEAVDLSHNAL  365 (1035)
Q Consensus       341 l~~~~p~~l~~l-~~L~~L~Ls~N~l  365 (1035)
                         .+...+... +.|++|++.+|.+
T Consensus       297 ---~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         297 ---LLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             ---HHHHHHhhcCCchhhcccCCCCC
Confidence               122344444 7899999999874

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.1e-16  Score=167.53  Aligned_cols=142  Identities=16%  Similarity=0.271  Sum_probs=115.8

Q ss_pred             CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcc
Q 039419          692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR  771 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  771 (1035)
                      +.||+|++|.||+|.+ .|..+++|+..+.......      .........+.+|+.++..++|++|+....++.+.+..
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPE------LDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF   74 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChH------HHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence            5789999999999987 5778999987654322110      00001235688999999999999988877777778888


Q ss_pred             eEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       772 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      ++||||++|++|.+++....     . .+..++.+++.++.++|+.   +++|||++|+||+++ ++.++++|||.++.
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999999999986532     2 7788999999999999999   999999999999999 78899999998764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=7.4e-16  Score=183.49  Aligned_cols=144  Identities=19%  Similarity=0.294  Sum_probs=113.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ..|...+.||+|+||+||+|.+.+. .+++|+.........      ........+++.+|++++++++|++++..+.++
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~  405 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHP------ELDERLRTERTRAEARLLSEARRAGVPTPVIYD  405 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccch------hHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE
Confidence            4456678999999999999987644 344454322211110      000011246789999999999999999888888


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+....++||||++|++|.+++.          ....++.++++++.|||+.   +++||||||+||++ .++.++|+||
T Consensus       406 ~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        406 VDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             EeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeC
Confidence            88778899999999999999875          3467899999999999999   99999999999999 6788999999


Q ss_pred             cCccc
Q 039419          846 GLAKL  850 (1035)
Q Consensus       846 G~a~~  850 (1035)
                      |+++.
T Consensus       472 Gla~~  476 (535)
T PRK09605        472 GLGKY  476 (535)
T ss_pred             ccccc
Confidence            99875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.66  E-value=3.1e-16  Score=161.91  Aligned_cols=149  Identities=17%  Similarity=0.154  Sum_probs=110.9

Q ss_pred             cccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccc-ccccccc-------ccccHHHHHHHHHHHhcCCCC--c
Q 039419          688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYD-CQNDKIG-------IGGVRDSFSAEIKTLGSIRHK--N  757 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp--n  757 (1035)
                      |...+.||+|+||.||+|..++|+.||||++.......... ...+...       .......+.+|+.++..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            66778999999999999988889999999976543111000 0000000       011234578899999999877  4


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      +++.++    ....++||||++|++|......        .....++.+++.++.++|+.   ||+||||||+||+++++
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence            555544    2455899999999998765421        23457889999999999998   99999999999999999


Q ss_pred             CceEEeeccCcccc
Q 039419          838 FEPYIADFGLAKLV  851 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~  851 (1035)
                      +.++|+|||.+...
T Consensus       162 ~~~~liDfg~~~~~  175 (198)
T cd05144         162 EKIYIIDWPQMVST  175 (198)
T ss_pred             CcEEEEECCccccC
Confidence            99999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.65  E-value=3.9e-16  Score=161.66  Aligned_cols=138  Identities=21%  Similarity=0.369  Sum_probs=108.8

Q ss_pred             eeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcce
Q 039419          693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL  772 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  772 (1035)
                      .||+|+||.||+|.+. +..+++|+..........      .......+++.+|++++..++|+++.....++...+..+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPE------LDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCch------HHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence            3799999999999864 788999987543221110      000012357889999999999887666555666677789


Q ss_pred             EEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      +||||++|++|.+++.....         .++.++++++.++|+.   |++|||++|+||+++ ++.++++|||.++.
T Consensus        74 lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999999988754211         7899999999999999   999999999999999 88999999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=5.1e-17  Score=177.78  Aligned_cols=174  Identities=22%  Similarity=0.368  Sum_probs=130.0

Q ss_pred             cceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA  848 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a  848 (1035)
                      +.|+.|++|.-.+|.+|+..++. ...++.....++.|++.|++|   +   +.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            56899999999999999975433 446778889999999999999   5   8999999999999999999999999998


Q ss_pred             cccccCC----ccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          849 KLVVEGD----FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       849 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      .......    .........||..||+||.+.+..|+.++||||||++++|++. -..+++..        .      ..
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~--------~------t~  469 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI--------A------TL  469 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH--------H------hh
Confidence            7765544    1223456789999999999999999999999999999999998 33333211        0      00


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV  966 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el  966 (1035)
                      .+..+..+   |+....+......+..+++++.|.+||++.++
T Consensus       470 ~d~r~g~i---p~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  470 TDIRDGII---PPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhhcCCC---ChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence            01111111   11122333334556777999999999954443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=3.6e-16  Score=182.51  Aligned_cols=168  Identities=26%  Similarity=0.350  Sum_probs=121.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..|..++.|..|+||.||.++++. .+.+|+| +.+..                   .+.+-  ++..-..|.+|     
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-------------------lilRn--ilt~a~npfvv-----  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-------------------LILRN--ILTFAGNPFVV-----  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-------------------hhhhc--cccccCCccee-----
Confidence            357778899999999999998875 5678874 32211                   01111  22233344444     


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                                      |+=...++..+.  ++..        ++.+++|+|+.   ||+|||+||+|.+++.-|++|++|
T Consensus       136 ----------------gDc~tllk~~g~--lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTD  186 (1205)
T KOG0606|consen  136 ----------------GDCATLLKNIGP--LPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTD  186 (1205)
T ss_pred             ----------------chhhhhcccCCC--Ccch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccc
Confidence                            333344433332  2222        26789999999   999999999999999999999999


Q ss_pred             ccCccccccCC--------c-----cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 039419          845 FGLAKLVVEGD--------F-----ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE  909 (1035)
Q Consensus       845 FG~a~~~~~~~--------~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~  909 (1035)
                      ||+.+.....-        .     ......++||+.|.|||++....|+..+|.|++|+++||.+-|+.||.+..++
T Consensus       187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe  264 (1205)
T KOG0606|consen  187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE  264 (1205)
T ss_pred             hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence            99987542211        0     11123568999999999999999999999999999999999999999876554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=2e-16  Score=186.72  Aligned_cols=257  Identities=24%  Similarity=0.253  Sum_probs=190.0

Q ss_pred             ccccCCeeeeeCCcEEEEEEECC--CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMEN--GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      .|...+.||+|+|+.|-.+....  ...+|+|.+.......            ...++...|..+-+.+. |+|++++++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~------------~~~~~i~~e~~~~~~~s~h~n~~~~~~   88 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSE------------DSSEHIDTETDIQKKLSKHSNTVHMIE   88 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCcc------------chhhhcCccccccccccccccccccCC
Confidence            35566679999999999885533  4456666554432111            12345556787877886 999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhh-ccCCCCeeccCCCcccEEEcCCC-ceE
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEF-EPY  841 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivHrDikp~NIll~~~~-~~k  841 (1035)
                      ...+.+..++++||.+|+++.+-+........+....-.++.|+..++.|+| ..   +++||||||+|.+++..+ ..+
T Consensus        89 ~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~  165 (601)
T KOG0590|consen   89 PSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK  165 (601)
T ss_pred             ccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence            9999999999999999999999883222213555666789999999999999 77   999999999999999999 999


Q ss_pred             EeeccCcccccc-CCccccccccCC-cccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          842 IADFGLAKLVVE-GDFARSSNTVAG-SYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       842 l~DFG~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      +.|||+|..+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||+........+..|..
T Consensus       166 ~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~  245 (601)
T KOG0590|consen  166 IADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS  245 (601)
T ss_pred             CCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc
Confidence            999999998877 444555556778 9999999998774 4567899999999999999999999876555544445544


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      .....        ...+....  ......+..+++..+|..|.+.+++..
T Consensus       246 ~~~~~--------~~~~~~~~--~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  246 NKGRF--------TQLPWNSI--SDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ccccc--------ccCccccC--ChhhhhcccccccCCchhccccccccc
Confidence            32110        01111111  112234555677789999999888755

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.57  E-value=1e-14  Score=149.29  Aligned_cols=149  Identities=20%  Similarity=0.180  Sum_probs=101.3

Q ss_pred             CCeeeeeCCcEEEEEEECCCcEEEEEEecCCCccccccccc----------ccccccccHHHHHHHHHHHhcCCCC--ce
Q 039419          691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQN----------DKIGIGGVRDSFSAEIKTLGSIRHK--NI  758 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~E~~~l~~l~hp--ni  758 (1035)
                      .+.||+|+||+||+|...+++.||||++.+...........          ..............|...+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988889999999987543221100000          0000000111224677777777543  34


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhh-hhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcC
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGS-LLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~  836 (1035)
                      .+.++.    ...++||||++++.+.. .+....   .. .....++.+++.++.++|. .   +|+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            555543    24589999999854432 121111   11 5567899999999999999 7   999999999999999 


Q ss_pred             CCceEEeeccCcccc
Q 039419          837 EFEPYIADFGLAKLV  851 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~  851 (1035)
                      ++.++++|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.56  E-value=1.3e-14  Score=143.09  Aligned_cols=135  Identities=19%  Similarity=0.151  Sum_probs=113.3

Q ss_pred             cCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC--CceeeEEeEEEc
Q 039419          690 EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH--KNIVRFLGCCWN  767 (1035)
Q Consensus       690 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~  767 (1035)
                      +.+.||+|.++.||++...+ +.+++|.......                ...+.+|+..++.++|  +++++++++...
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~   64 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----------------GADREREVAILQLLARKGLPVPKVLASGES   64 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc----------------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence            34679999999999998864 7899998854321                2468899999999976  599999998888


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                      .+..+++|||++|+.+..+         +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.
T Consensus        65 ~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~  135 (155)
T cd05120          65 DGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY  135 (155)
T ss_pred             CCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence            8889999999998877654         4456677899999999999986434799999999999999989999999999


Q ss_pred             ccc
Q 039419          848 AKL  850 (1035)
Q Consensus       848 a~~  850 (1035)
                      +..
T Consensus       136 ~~~  138 (155)
T cd05120         136 AGY  138 (155)
T ss_pred             ccC
Confidence            864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=2.4e-14  Score=151.06  Aligned_cols=150  Identities=21%  Similarity=0.260  Sum_probs=109.8

Q ss_pred             cCCeee-eeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce--eeEEeEEE
Q 039419          690 EDSVVG-KGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI--VRFLGCCW  766 (1035)
Q Consensus       690 ~~~~iG-~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~  766 (1035)
                      ....|| .||.|+||.+... +..++||.+.......... ..+.........++.+|++++.+++|++|  ++.+++..
T Consensus        35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~-~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLS-KDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhh-hhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            346788 9999999999876 7789999885432111000 00000011234678999999999998875  67777654


Q ss_pred             cCCc----ceEEEEeCCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          767 NRNT----RLLMYDYMPN-GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       767 ~~~~----~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      .+..    .++||||++| .+|.+++...   .++..    .+.+++.++.++|+.   ||+||||||+|||++.++.++
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            4322    2599999997 6899887643   24433    367899999999999   999999999999999999999


Q ss_pred             EeeccCcccc
Q 039419          842 IADFGLAKLV  851 (1035)
Q Consensus       842 l~DFG~a~~~  851 (1035)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999988753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=2.3e-13  Score=156.28  Aligned_cols=167  Identities=18%  Similarity=0.245  Sum_probs=112.5

Q ss_pred             ccHHHHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCccccc-cc--------------c-ccccc----ccc
Q 039419          679 FTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEY-DC--------------Q-NDKIG----IGG  738 (1035)
Q Consensus       679 ~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-~~--------------~-~~~~~----~~~  738 (1035)
                      -.+++++..|. .+.||+|++|+||+|+.++|+.||||+..+.....-. +.              . .....    ...
T Consensus       111 ~~~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e  189 (437)
T TIGR01982       111 GPLEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKE  189 (437)
T ss_pred             cCHHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHH
Confidence            34566666665 4789999999999999999999999999775322100 00              0 00000    000


Q ss_pred             cH------HHHHHHHHHHhcCC----CCceeeEEeEEE-cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHH
Q 039419          739 VR------DSFSAEIKTLGSIR----HKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA  807 (1035)
Q Consensus       739 ~~------~~~~~E~~~l~~l~----hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~i  807 (1035)
                      ..      -+|.+|+..+.+++    |.+-+.+-..+. ..+..++||||++|++|.++....... .+   +..++..+
T Consensus       190 ~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~  265 (437)
T TIGR01982       190 FEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENL  265 (437)
T ss_pred             HHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHH
Confidence            01      14667777777763    333333333332 234579999999999999876543211 22   34566666


Q ss_pred             HH-HHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcccccc
Q 039419          808 AQ-GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE  853 (1035)
Q Consensus       808 a~-~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~  853 (1035)
                      ++ .+..+|..   |++|+|+||.||+++.++.++++|||++..+.+
T Consensus       266 ~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       266 ARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            66 47888988   999999999999999999999999999987644

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.43  E-value=2e-13  Score=164.18  Aligned_cols=127  Identities=34%  Similarity=0.592  Sum_probs=82.5

Q ss_pred             CCCCCCCCCC----ccceeEEeCCC-----CcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCC
Q 039419            9 SNWNPSDSNP----CKWSHITCSPQ-----NFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQ   79 (1035)
Q Consensus         9 ~~w~~~~~~~----c~w~gi~c~~~-----~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~   79 (1035)
                      .+|.. + .|    |.|.||+|+..     ..|+.|+|+++++.|.+|..++.|++|+.|+|++|.++|.+|+.++.+++
T Consensus       390 ~~W~g-~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~  467 (623)
T PLN03150        390 FGWNG-D-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITS  467 (623)
T ss_pred             CCCCC-C-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCC
Confidence            48974 2 33    27999999532     13667777777776666666666666666666666666666666666666


Q ss_pred             CceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhh-ccccceeccccc
Q 039419           80 LTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGAC-IKLKNLLLFDNY  137 (1035)
Q Consensus        80 L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~l~~n~  137 (1035)
                      |+.|+|++|+++|.+|+.+++|++|++|+|++|+++|.+|..+..+ .++..+++.+|.
T Consensus       468 L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~  526 (623)
T PLN03150        468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA  526 (623)
T ss_pred             CCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence            6666666666666666666666666666666666666666666542 344455555554

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.42  E-value=2e-14  Score=157.11  Aligned_cols=192  Identities=32%  Similarity=0.465  Sum_probs=110.1

Q ss_pred             eEeecCcccCCCCCCC--CCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccc
Q 039419           58 KLIISGSNLTGPISPD--LGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFD  135 (1035)
Q Consensus        58 ~L~L~~~~l~~~~~~~--~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~  135 (1035)
                      +|.|++-.+. ..|-.  =-.|+.-+..||+.|++. .+|..+..+..|+.|.|..|.+. .+|..+++|..|+.|||+.
T Consensus        54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~  130 (722)
T KOG0532|consen   54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS  130 (722)
T ss_pred             ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence            4556666555 33321  134666777888888887 78888877888888888888777 7777888888888888888


Q ss_pred             cccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCC
Q 039419          136 NYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEI  215 (1035)
Q Consensus       136 n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~  215 (1035)
                      |+++ .+|..++.|+                          |+.|-+++|+++ .+|+.++.+..|..|+.+.|.+    
T Consensus       131 NqlS-~lp~~lC~lp--------------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei----  178 (722)
T KOG0532|consen  131 NQLS-HLPDGLCDLP--------------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI----  178 (722)
T ss_pred             chhh-cCChhhhcCc--------------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhh----
Confidence            8776 5565555432                          333334444443 3444444444444444444444    


Q ss_pred             ccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCC
Q 039419          216 PPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLS  295 (1035)
Q Consensus       216 p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  295 (1035)
                                          . .+|..++++.+|+.|.+..|++. .+|..+..| .|..||++.|+|+ .+|-.|.+|+
T Consensus       179 --------------------~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~  234 (722)
T KOG0532|consen  179 --------------------Q-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMR  234 (722)
T ss_pred             --------------------h-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhh
Confidence                                4 34444444555555555555544 344444432 2455555555555 4555555555


Q ss_pred             CCcEEEccCCccc
Q 039419          296 SLEELMLSNNNIS  308 (1035)
Q Consensus       296 ~L~~L~L~~N~l~  308 (1035)
                      .|++|-|.+|.+.
T Consensus       235 ~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  235 HLQVLQLENNPLQ  247 (722)
T ss_pred             hheeeeeccCCCC
Confidence            5555555555554

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=3.1e-13  Score=155.81  Aligned_cols=213  Identities=30%  Similarity=0.409  Sum_probs=126.7

Q ss_pred             ccceeEEeCCCCcEE--EEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCC-CCceeeCCCCCCCCCCC
Q 039419           19 CKWSHITCSPQNFVT--EINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCT-QLTTIDVSSNSLVGGVP   95 (1035)
Q Consensus        19 c~w~gi~c~~~~~v~--~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~-~L~~L~ls~n~l~~~~p   95 (1035)
                      +.+.++.+...+...  .+.+..+.+... +..+..++.++.|++.+|.++ .+++..+.+. +|+.|++++|++. .+|
T Consensus        80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~  156 (394)
T COG4886          80 ISSLDGSENLLNLLPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP  156 (394)
T ss_pred             cccccccccccCCCCCceeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhh
Confidence            444444444332222  344544444221 223444566777777777777 5666666664 7777777777776 666


Q ss_pred             hhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCcc
Q 039419           96 SSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQ  175 (1035)
Q Consensus        96 ~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~  175 (1035)
                      ..++.+++|+.|++++|+++ .+|...+.+++|+.|++++|++. .+|..++.+..|++|.+++|.  .-..+..+.++.
T Consensus       157 ~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~--~~~~~~~~~~~~  232 (394)
T COG4886         157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS--IIELLSSLSNLK  232 (394)
T ss_pred             hhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc--ceecchhhhhcc
Confidence            66677777777777777776 56665556677777777777776 666666666667777777664  223444555566


Q ss_pred             ceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCCh
Q 039419          176 SLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPR  241 (1035)
Q Consensus       176 ~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~  241 (1035)
                      ++..+.+.+|++. .++..++.++.+++|++++|.++ .++. ++.+.+|+.|++++|.+....+.
T Consensus       233 ~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         233 NLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             cccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence            6666665555554 33555666666666666666665 3333 55566666666666666544443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.39  E-value=3.2e-14  Score=155.56  Aligned_cols=180  Identities=28%  Similarity=0.414  Sum_probs=134.4

Q ss_pred             cccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEE
Q 039419          198 LSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTID  277 (1035)
Q Consensus       198 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  277 (1035)
                      +.--...+++.|++. ++|..++.+..|..|.|+.|.+. .+|..++++..|+.|+|+.|+++ .+|..++.|+ |+.|-
T Consensus        74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli  149 (722)
T KOG0532|consen   74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI  149 (722)
T ss_pred             ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence            444566777778777 77888777777888888888877 67777888888888888888887 6777777765 78888


Q ss_pred             ccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcE
Q 039419          278 LSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA  357 (1035)
Q Consensus       278 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~  357 (1035)
                      +++|+++ .+|..++.+..|..||.+.|+|. ..|..++++.+|+.|.+..|++..           +|..+..|+ |..
T Consensus       150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-----------lp~El~~Lp-Li~  215 (722)
T KOG0532|consen  150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-----------LPEELCSLP-LIR  215 (722)
T ss_pred             EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-----------CCHHHhCCc-eee
Confidence            8888887 67777777778888888888877 566677788888888888887763           355666444 777


Q ss_pred             EeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCC
Q 039419          358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEI  397 (1035)
Q Consensus       358 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~  397 (1035)
                      ||+|.|++. .+|..|..|+.|++|.|.+|.+.+ .|..+
T Consensus       216 lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqI  253 (722)
T KOG0532|consen  216 LDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPAQI  253 (722)
T ss_pred             eecccCcee-ecchhhhhhhhheeeeeccCCCCC-ChHHH
Confidence            888888887 677777777777777777777763 44444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.37  E-value=8.9e-13  Score=152.03  Aligned_cols=198  Identities=36%  Similarity=0.510  Sum_probs=97.4

Q ss_pred             eeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhc-cccceeccccccCCCCchhhccccccceeecCCC
Q 039419           82 TIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACI-KLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGN  160 (1035)
Q Consensus        82 ~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n  160 (1035)
                      .|+++.|.+. ..+..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++.+++|+.|+++.|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            3444444443 22233344444555555555555 4444444442 5555555555544 33333444444444444333


Q ss_pred             cccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCC
Q 039419          161 KDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLP  240 (1035)
Q Consensus       161 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~  240 (1035)
                                               ++. .+|...+.++.|+.|++++|++. .+|..+..+..|++|.+++|.+. ..+
T Consensus       174 -------------------------~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~  225 (394)
T COG4886         174 -------------------------DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELL  225 (394)
T ss_pred             -------------------------hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecc
Confidence                                     333 33333345555555555555555 45554444445555555555433 334


Q ss_pred             hhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCC
Q 039419          241 RELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP  313 (1035)
Q Consensus       241 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  313 (1035)
                      ..+.++.++..|.+.+|++. .++..+..+++++.|++++|.++.. +. ++.+.+|+.|++++|.+....+.
T Consensus       226 ~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         226 SSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             hhhhhcccccccccCCceee-eccchhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchh
Confidence            44555555555555555554 2345555555666666666666532 22 55556666666666665544443

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.33  E-value=9.3e-13  Score=152.36  Aligned_cols=165  Identities=13%  Similarity=0.202  Sum_probs=106.6

Q ss_pred             CccHHHHHhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCccc---ccc------------c-ccccc----cc
Q 039419          678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAA---EYD------------C-QNDKI----GI  736 (1035)
Q Consensus       678 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~------------~-~~~~~----~~  736 (1035)
                      +-.+++++..|.. +.||+|++|+||+|+.++ |+.||||+..+.....   +..            . .....    ..
T Consensus       112 G~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v  190 (537)
T PRK04750        112 GGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVV  190 (537)
T ss_pred             CCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHH
Confidence            4457778888887 899999999999999987 9999999998753211   000            0 00000    00


Q ss_pred             cccHH------HHHHHHHHHhcCC----CCceeeEEeEEEc-CCcceEEEEeCCCCChhhhh--hhcCC--CCCCHHHHH
Q 039419          737 GGVRD------SFSAEIKTLGSIR----HKNIVRFLGCCWN-RNTRLLMYDYMPNGSLGSLL--HERRD--SCLEWELRY  801 (1035)
Q Consensus       737 ~~~~~------~~~~E~~~l~~l~----hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~--~~l~~~~~~  801 (1035)
                      .+..+      +|.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.++-  ...+.  ..+....+.
T Consensus       191 ~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~  270 (537)
T PRK04750        191 AEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE  270 (537)
T ss_pred             HHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence            01111      3556666666653    4444555555543 45678999999999998753  22211  012222222


Q ss_pred             HHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC----ceEEeeccCcccccc
Q 039419          802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF----EPYIADFGLAKLVVE  853 (1035)
Q Consensus       802 ~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~----~~kl~DFG~a~~~~~  853 (1035)
                      .++.       .++..   |++|+|+||.||+++.++    .++++|||++....+
T Consensus       271 ~~~~-------Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        271 VFFT-------QVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------HHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            2333       33455   999999999999999988    999999999987654

>PLN03150 hypothetical protein; Provisional

Probab=99.32  E-value=2.7e-12  Score=154.47  Aligned_cols=64  Identities=41%  Similarity=0.647  Sum_probs=36.8

Q ss_pred             ccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccc
Q 039419          441 LQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIP  504 (1035)
Q Consensus       441 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  504 (1035)
                      ++.|+|++|.+.+.+|..+..+++|+.|+|++|.|++.+|..++.+++|+.|+|++|+++|.+|
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP  483 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP  483 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCc
Confidence            4555555555555555555555555555555555555555555555566666666555554443

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=3.2e-12  Score=131.19  Aligned_cols=201  Identities=22%  Similarity=0.326  Sum_probs=138.3

Q ss_pred             HHHhcCCCCceeeEEeEEEcCC-----cceEEEEeCCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhccCCC
Q 039419          748 KTLGSIRHKNIVRFLGCCWNRN-----TRLLMYDYMPNGSLGSLLHERRD--SCLEWELRYRIILGAAQGLAYLHHDCVP  820 (1035)
Q Consensus       748 ~~l~~l~hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~  820 (1035)
                      ..+-.+.|.|||+++.|+.+..     ...+++||+..|++.+++++.+.  ..+....-.+|+.||..||.|||+. .|
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3344557999999999986543     46789999999999999986543  4466777789999999999999994 67


Q ss_pred             CeeccCCCcccEEEcCCCceEEee--ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh
Q 039419          821 PIVHRDIKANNILIGPEFEPYIAD--FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT  898 (1035)
Q Consensus       821 ~ivHrDikp~NIll~~~~~~kl~D--FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt  898 (1035)
                      .|+|+++..+-|++..+|-+|+.-  +...+...............+-++|.|||+......+.++|||+||+-..||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999999888742  111111111111112223457789999999888888889999999999999988


Q ss_pred             CCCC-CCCCCCC--chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          899 GKQP-IDPTIPE--GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       899 g~~P-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      |..- -......  +..+...       .......            + ....+..|++..|..||+|.+++.+
T Consensus       278 lEiq~tnseS~~~~ee~ia~~-------i~~len~------------l-qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANV-------IIGLENG------------L-QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             heeccCCCcceeehhhhhhhh-------eeeccCc------------c-ccCcCcccccCCCCCCcchhhhhcC
Confidence            7642 1111000  0000000       0000000            0 0234556999999999999988764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.29  E-value=3.9e-12  Score=142.94  Aligned_cols=250  Identities=23%  Similarity=0.244  Sum_probs=179.3

Q ss_pred             ccccCCeeee--eCCcEEEEEEE---CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceee
Q 039419          687 CLVEDSVVGK--GCSGIVYRAEM---ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVR  760 (1035)
Q Consensus       687 ~~~~~~~iG~--G~~g~V~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~  760 (1035)
                      .+.....+|.  |.+|.||.++.   .++..+|+|+-+........            ..+=.+|+...++++ |++.++
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~------------~~~k~~~~~s~~~i~~~~~~v~  182 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD------------SKRKLREFLSHHKIDSHENPVR  182 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc------------cccccchhhcccccCccccccc
Confidence            4566778899  99999999966   45888999985433221110            112246777777774 999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHH----HHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ----GLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                      .+..+...+..|+-+|++ +.++.++.+.... .++....+.+..+..+    |+.++|..   +++|-|+||.||++..
T Consensus       183 ~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~  257 (524)
T KOG0601|consen  183 DSPAWEGSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTS  257 (524)
T ss_pred             cCcccccCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccc
Confidence            888888888999999988 6889888876543 3677888888888888    99999999   9999999999999999


Q ss_pred             C-CceEEeeccCccccccCCccccc---cccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          837 E-FEPYIADFGLAKLVVEGDFARSS---NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       837 ~-~~~kl~DFG~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      + ...+++|||+...+.++......   ....|...|++||... ..++.++|+|++|.++.+..+|..+......    
T Consensus       258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----  332 (524)
T KOG0601|consen  258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN----  332 (524)
T ss_pred             ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC----
Confidence            9 88999999999888776543221   1225778899999854 4678899999999999999998776543211    


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                       ..|.......   +...+-..      ........+.++++.+|-.|++.+.+..
T Consensus       333 -~~W~~~r~~~---ip~e~~~~------~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  333 -SSWSQLRQGY---IPLEFCEG------GSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -CCcccccccc---CchhhhcC------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             1122111111   00000001      1111222666799999999999888766

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.25  E-value=2e-11  Score=122.75  Aligned_cols=130  Identities=17%  Similarity=0.101  Sum_probs=96.2

Q ss_pred             CCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce-eeEEeEEEcCC
Q 039419          691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI-VRFLGCCWNRN  769 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~  769 (1035)
                      .+.++.|.++.||+++.. ++.|++|........               ...+.+|+.+++.+.+.++ .+++.+.  .+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~---------------~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~   64 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL---------------LINRENEAENSKLAAEAGIGPKLYYFD--PE   64 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc---------------ccCHHHHHHHHHHHHHhCCCCceEEEe--CC
Confidence            356799999999999876 778999987543210               1246789999998865444 4555543  33


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC--CCCeeccCCCcccEEEcCCCceEEeeccC
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC--VPPIVHRDIKANNILIGPEFEPYIADFGL  847 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~ivHrDikp~NIll~~~~~~kl~DFG~  847 (1035)
                      ..++||||++|.++.+..       .   ....++.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.
T Consensus        65 ~~~lv~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~  133 (170)
T cd05151          65 TGVLITEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY  133 (170)
T ss_pred             CCeEEEEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence            468999999998876530       1   11245678999999999982  12369999999999999 67899999998


Q ss_pred             cc
Q 039419          848 AK  849 (1035)
Q Consensus       848 a~  849 (1035)
                      +.
T Consensus       134 a~  135 (170)
T cd05151         134 AG  135 (170)
T ss_pred             cc
Confidence            75

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.25  E-value=9e-11  Score=117.86  Aligned_cols=148  Identities=14%  Similarity=0.123  Sum_probs=102.5

Q ss_pred             CeeeeeCCcEEEEEEECC-------CcEEEEEEecCCCccccc---cc-ccccc----cccccHHHHH----HHHHHHhc
Q 039419          692 SVVGKGCSGIVYRAEMEN-------GEVIAVKKLWPTTMAAEY---DC-QNDKI----GIGGVRDSFS----AEIKTLGS  752 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~---~~-~~~~~----~~~~~~~~~~----~E~~~l~~  752 (1035)
                      ..||.|--+.||.|...+       +..+|||+.+.....-+.   .. +....    .....++.+.    +|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999996543       479999998753321110   00 00000    0112344555    89999999


Q ss_pred             CC--CCceeeEEeEEEcCCcceEEEEeCCCCChhh-hhhhcCCCCCCHHHHHHHHHHHHHHHHHh-hccCCCCeeccCCC
Q 039419          753 IR--HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGS-LLHERRDSCLEWELRYRIILGAAQGLAYL-HHDCVPPIVHRDIK  828 (1035)
Q Consensus       753 l~--hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~ivHrDik  828 (1035)
                      +.  .-++++++++    ...++||||+.++.+.. .++.   ..++......+..+++.++.++ |+.   |++|||++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence            95  3566777764    45689999997654432 2222   1245556677889999999999 787   99999999


Q ss_pred             cccEEEcCCCceEEeeccCccc
Q 039419          829 ANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       829 p~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      +.||+++ ++.++++|||.+-.
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCcee
Confidence            9999997 46799999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.22  E-value=2.6e-11  Score=148.54  Aligned_cols=290  Identities=21%  Similarity=0.212  Sum_probs=187.5

Q ss_pred             cEEEEEecCCcccccCCcCCCCCcccceEeecCcc--cCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceE
Q 039419           31 FVTEINIQSIELELPFPSNLSSLSFLQKLIISGSN--LTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLI  108 (1035)
Q Consensus        31 ~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~--l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~  108 (1035)
                      .|.+..+.++.+... +. =...+.|+.|-+.+|.  +.....+.|..++.|++|||++|.--+.+|+.|+.|-+|++|+
T Consensus       524 ~~rr~s~~~~~~~~~-~~-~~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~  601 (889)
T KOG4658|consen  524 SVRRMSLMNNKIEHI-AG-SSENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD  601 (889)
T ss_pred             heeEEEEeccchhhc-cC-CCCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence            455666666655421 11 1223368888888886  5523334477799999999998876669999999999999999


Q ss_pred             ecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCc-ccCCCCCCcCCCccceEEEEeccccc
Q 039419          109 LNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK-DIAGKIPYEIGDCQSLLVVGLADTKV  187 (1035)
Q Consensus       109 L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~-~~~~~~~~~~~~l~~L~~L~l~~~~~  187 (1035)
                      |+.+.+. .+|..+.+|.+|.+|++..+.-...+|..+..|.+|++|.+.... ......-..+..+.+|+.+.......
T Consensus       602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~  680 (889)
T KOG4658|consen  602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV  680 (889)
T ss_pred             ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence            9999998 899999999999999999888665667777789999999887654 12222234455566666666544433


Q ss_pred             cccCccccccccccc----ceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhc------ccchhHhhcccc
Q 039419          188 AGSLPASLGKLSKLQ----SLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGK------LQKLEKMLLWQN  257 (1035)
Q Consensus       188 ~~~~p~~l~~l~~L~----~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~------l~~L~~L~l~~n  257 (1035)
                        .+-..+..+..|.    .+.+.++... ..+..+..+.+|+.|.+.++.+.......+..      ++++..+...++
T Consensus       681 --~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~  757 (889)
T KOG4658|consen  681 --LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC  757 (889)
T ss_pred             --HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence              1122233334333    3443333333 56777888999999999999887544333222      334444444444


Q ss_pred             cccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccC-CCCcccCCCccceeccc
Q 039419          258 NFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGS-IPPVLSNATSLLQLQLD  327 (1035)
Q Consensus       258 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~  327 (1035)
                      ... ..+.+..-.++|+.|++..+.....+......+..+..+-+..+.+.+. .-....+++++..+.+.
T Consensus       758 ~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~  827 (889)
T KOG4658|consen  758 HML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLS  827 (889)
T ss_pred             ccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccC
Confidence            322 2233334567899999998877666666667777777777777777655 23344455555544443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=4.4e-12  Score=128.12  Aligned_cols=129  Identities=26%  Similarity=0.235  Sum_probs=70.1

Q ss_pred             ccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceec
Q 039419          246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQ  325 (1035)
Q Consensus       246 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  325 (1035)
                      .+.|+++||++|.|+ .+-++..-++.++.|++++|.|..+  +.++.+++|+.||||+|.++ ...+.=..+.++++|.
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            445666666666665 3445555556666666666666532  22556666666666666665 3333334555666666


Q ss_pred             cccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCC-CCCcccCcccceEeccccccc
Q 039419          326 LDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSL-HPGLFQLQNLTKLLLISNGIS  390 (1035)
Q Consensus       326 L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~i~  390 (1035)
                      |+.|.|..+            ..+..+.+|+.||+++|+|.... -..+++++-|+.+.|.+|.+.
T Consensus       359 La~N~iE~L------------SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  359 LAQNKIETL------------SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             hhhhhHhhh------------hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            666666544            34555556666666666664221 123444444445545444444

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.18  E-value=4.2e-12  Score=146.43  Aligned_cols=245  Identities=30%  Similarity=0.356  Sum_probs=125.8

Q ss_pred             cCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEc
Q 039419          223 SELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELML  302 (1035)
Q Consensus       223 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  302 (1035)
                      ..+..+.+..|.++. +-..+..+.+|+.|++.+|++... ...+..+++|++|+|++|.|+...  .+..++.|+.|++
T Consensus        72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l  147 (414)
T KOG0531|consen   72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNL  147 (414)
T ss_pred             HhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhhee
Confidence            334444444444442 222234444455555555554422 222444555555555555555332  2444455555555


Q ss_pred             cCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceE
Q 039419          303 SNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKL  382 (1035)
Q Consensus       303 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  382 (1035)
                      ++|.|+.+  ..+..+..|+.+++++|+|..+...         . ...+.+|+.+++.+|.+.  ....+..+..+..+
T Consensus       148 ~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~---------~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~  213 (414)
T KOG0531|consen  148 SGNLISDI--SGLESLKSLKLLDLSYNRIVDIEND---------E-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLL  213 (414)
T ss_pred             ccCcchhc--cCCccchhhhcccCCcchhhhhhhh---------h-hhhccchHHHhccCCchh--cccchHHHHHHHHh
Confidence            55555532  2233455555555555555543100         0 344555555666666554  22233334444444


Q ss_pred             eccccccccCCCCCCCCCCcceeEeeeccCCCC--ccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhcc
Q 039419          383 LLISNGISGLIPPEIGNCSSLIRLRLMSFGNCT--QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFG  460 (1035)
Q Consensus       383 ~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~--~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  460 (1035)
                      ++..|.++...+                +..+.  .|+.+++++|++. ..+..+..+..+..|++++|++...  ..+.
T Consensus       214 ~l~~n~i~~~~~----------------l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~  274 (414)
T KOG0531|consen  214 SLLDNKISKLEG----------------LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLE  274 (414)
T ss_pred             hcccccceeccC----------------cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--cccc
Confidence            555555553221                11112  2677777777777 3335566677777777777777754  3345


Q ss_pred             CccccchhhccCCccccc---Cccc-cCCCCCCcEEEcCCCcCcCccc
Q 039419          461 QLASLNRLILSKNSFSGA---IPSS-LGRCESLQSLDLSSNKLSGKIP  504 (1035)
Q Consensus       461 ~l~~L~~L~Ls~N~l~~~---~~~~-~~~l~~L~~L~Ls~N~l~~~~p  504 (1035)
                      ....+..+.+..|.+...   .... ....+.++.+.+..|.+....+
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  275 RLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            556667777777776521   1221 4556677777777777764443

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.18  E-value=4.1e-12  Score=146.54  Aligned_cols=266  Identities=31%  Similarity=0.319  Sum_probs=139.3

Q ss_pred             CCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEcc
Q 039419          224 ELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLS  303 (1035)
Q Consensus       224 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  303 (1035)
                      .++.++...+.+...--. ...+..++.+.+..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|+++
T Consensus        50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls  126 (414)
T KOG0531|consen   50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLS  126 (414)
T ss_pred             hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecc
Confidence            344455555544321111 1445566666666666663 23335566666666666666663 22225556666666666


Q ss_pred             CCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEe
Q 039419          304 NNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLL  383 (1035)
Q Consensus       304 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  383 (1035)
                      +|+|+.+.+  +..++.|+.|++++|.|+.+            ..+..+++|+.+++++|+++..-+.....+       
T Consensus       127 ~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~------------~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~-------  185 (414)
T KOG0531|consen  127 FNKITKLEG--LSTLTLLKELNLSGNLISDI------------SGLESLKSLKLLDLSYNRIVDIENDELSEL-------  185 (414)
T ss_pred             ccccccccc--hhhccchhhheeccCcchhc------------cCCccchhhhcccCCcchhhhhhhhhhhhc-------
Confidence            666654322  34444455555555555543            233334455555555555542221002223       


Q ss_pred             ccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCcc
Q 039419          384 LISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLA  463 (1035)
Q Consensus       384 L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  463 (1035)
                                                     ..++.+++.+|.+...  ..+..+..+..+++..|.++.+.+  +..+.
T Consensus       186 -------------------------------~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~  230 (414)
T KOG0531|consen  186 -------------------------------ISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELV  230 (414)
T ss_pred             -------------------------------cchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccch
Confidence                                           4455566666665522  234444455555666666664422  12222


Q ss_pred             --ccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEE
Q 039419          464 --SLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSIL  541 (1035)
Q Consensus       464 --~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L  541 (1035)
                        .|+.+++++|++. ..+..+..+..+..|++.+|++...                           ..+.....+..+
T Consensus       231 ~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~---------------------------~~~~~~~~~~~~  282 (414)
T KOG0531|consen  231 MLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL---------------------------EGLERLPKLSEL  282 (414)
T ss_pred             hHHHHHHhcccCccc-cccccccccccccccchhhcccccc---------------------------ccccccchHHHh
Confidence              3777777777776 3335566677777777777777611                           012233445555


Q ss_pred             eccCCcccCc---c--ccccccCCCcEEeccCCcCcccCC
Q 039419          542 DLSHNKLGGD---L--LALSGLDNLVSLNVSYNNFTGYLP  576 (1035)
Q Consensus       542 ~L~~N~l~~~---~--~~~~~l~~L~~L~ls~N~l~~~~p  576 (1035)
                      .+..|++...   .  ......+.+..+.+.+|+.....+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  283 WLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            5666655421   1  124556777777788877776544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.17  E-value=1.3e-10  Score=111.57  Aligned_cols=139  Identities=22%  Similarity=0.342  Sum_probs=105.5

Q ss_pred             CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcc
Q 039419          692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR  771 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  771 (1035)
                      ..+++|+-+.+|.+.+. |..+++|.-.++....+      .+...-..++-.+|+.++.+++--.|.-.+=+..+.+..
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p------~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHP------ELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCCh------HHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            35789999999999886 44566776544332211      111112356778999999999766666556666788888


Q ss_pred             eEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       772 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      .++|||++|..|.+++...         ...++..+-.-+.-||..   ||+|+|+.++||++..++ +.++|||++.+
T Consensus        75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999999999888764         245667777888889999   999999999999998775 99999999874

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.17  E-value=5.2e-12  Score=127.62  Aligned_cols=139  Identities=26%  Similarity=0.323  Sum_probs=112.6

Q ss_pred             ccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCC
Q 039419          216 PPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLS  295 (1035)
Q Consensus       216 p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  295 (1035)
                      -..+.....|+.|||++|.|+ .+..+..-+++++.|++++|.+...  +.+..+++|+.|||++|.++ .+.++-..+.
T Consensus       277 ~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLG  352 (490)
T KOG1259|consen  277 LVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLG  352 (490)
T ss_pred             EEecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhc
Confidence            334445567889999999988 6677777788999999999998843  33788899999999999998 5666667888


Q ss_pred             CCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCC
Q 039419          296 SLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSL  369 (1035)
Q Consensus       296 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~  369 (1035)
                      +.+.|.|+.|.|...  ..+..+-+|..|++++|+|..++.         -..+++++.|+.+.|.+|.|.+..
T Consensus       353 NIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~lde---------V~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  353 NIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDE---------VNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             CEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHH---------hcccccccHHHHHhhcCCCccccc
Confidence            999999999998743  357788899999999999987754         257899999999999999998543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.16  E-value=2.4e-10  Score=108.92  Aligned_cols=151  Identities=17%  Similarity=0.239  Sum_probs=112.7

Q ss_pred             cCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCC
Q 039419          690 EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       690 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      ....|-+|+-+.|+++.+. |+.+.||.-.++...-.      .....-.+++..+|++.+.+++--.|.-..-++.+..
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP------~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHP------ALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccch------HHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence            4568899999999999887 78888887554332211      1111234678889999999987556555555566777


Q ss_pred             cceEEEEeCCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc---eEEeec
Q 039419          770 TRLLMYDYMPN-GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE---PYIADF  845 (1035)
Q Consensus       770 ~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---~kl~DF  845 (1035)
                      .-.++|||++| .++.+++...............++..|-+.+.-||..   +|+|+|+..+||++..++.   +.++||
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEee
Confidence            77899999977 4788888765443333344468889999999999999   9999999999999976653   579999


Q ss_pred             cCccc
Q 039419          846 GLAKL  850 (1035)
Q Consensus       846 G~a~~  850 (1035)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99763

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.11  E-value=3.6e-11  Score=118.26  Aligned_cols=123  Identities=34%  Similarity=0.419  Sum_probs=37.3

Q ss_pred             CCccceeecCCCccCCCCccccc-CCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCcccc-CCCCCCcE
Q 039419          414 CTQLQMLNLSNNTLGGTLPSSLA-SLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSL-GRCESLQS  491 (1035)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~  491 (1035)
                      ..++++|+|++|+|+.+  +.+. .+.+|+.|+|++|.|+.+  +.+..+++|++|++++|+|+.+.+ .+ ..+++|++
T Consensus        18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~-~l~~~lp~L~~   92 (175)
T PF14580_consen   18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISE-GLDKNLPNLQE   92 (175)
T ss_dssp             --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CH-HHHHH-TT--E
T ss_pred             ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcccc-chHHhCCcCCE
Confidence            34466666666666632  2343 455666677777766654  245566666666666666663322 23 34566666


Q ss_pred             EEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcc----ccccccCCCcEEe
Q 039419          492 LDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL----LALSGLDNLVSLN  565 (1035)
Q Consensus       492 L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~l~~L~~L~  565 (1035)
                      |+|++|+|.. +.                       .-..++.+++|+.|+|.+|++....    ..+..+|+|+.||
T Consensus        93 L~L~~N~I~~-l~-----------------------~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   93 LYLSNNKISD-LN-----------------------ELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             EE-TTS---S-CC-----------------------CCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred             EECcCCcCCC-hH-----------------------HhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence            6666666651 10                       0123445666777777777766533    2456667776665

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.10  E-value=2.9e-12  Score=133.12  Aligned_cols=204  Identities=23%  Similarity=0.301  Sum_probs=131.9

Q ss_pred             cCCCCCCCCcEEeccCcCCCCCCCCCc----ccCcccceEeccccccccCCCCCCCCCCcceeEe-eeccCCCCccceee
Q 039419          347 STLANCRSLEAVDLSHNALTGSLHPGL----FQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR-LMSFGNCTQLQMLN  421 (1035)
Q Consensus       347 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~-~~~~~~l~~L~~L~  421 (1035)
                      .++..+++|++||||+|-+....+..|    ..+..|++|+|.+|.+.-.....++..  |..|. ......-++|+++.
T Consensus        86 ~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~a--l~~l~~~kk~~~~~~Lrv~i  163 (382)
T KOG1909|consen   86 KALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRA--LFELAVNKKAASKPKLRVFI  163 (382)
T ss_pred             HHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHH--HHHHHHHhccCCCcceEEEE
Confidence            355566677777777777764333332    245677777777777653222222110  00000 00123346788899


Q ss_pred             cCCCccCCC----CcccccCCCCccEEEcCCCccCCC----CchhccCccccchhhccCCcccc----cCccccCCCCCC
Q 039419          422 LSNNTLGGT----LPSSLASLTRLQVLDISVNQFVGL----IPESFGQLASLNRLILSKNSFSG----AIPSSLGRCESL  489 (1035)
Q Consensus       422 L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L  489 (1035)
                      .++|++..-    +...|...+.|+.+.++.|.|...    ....|..+++|+.|||.+|-++.    .+...++.+++|
T Consensus       164 ~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L  243 (382)
T KOG1909|consen  164 CGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHL  243 (382)
T ss_pred             eeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchh
Confidence            999988742    234466678889999999988632    23457788889999999998863    344567788888


Q ss_pred             cEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcc-----ccccccCCCcEE
Q 039419          490 QSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-----LALSGLDNLVSL  564 (1035)
Q Consensus       490 ~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L  564 (1035)
                      +.|+++++.++..-...++....                    ...++|++|.|.+|.++..-     ......+.|..|
T Consensus       244 ~El~l~dcll~~~Ga~a~~~al~--------------------~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kL  303 (382)
T KOG1909|consen  244 RELNLGDCLLENEGAIAFVDALK--------------------ESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKL  303 (382)
T ss_pred             eeecccccccccccHHHHHHHHh--------------------ccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHh
Confidence            99999998887544444443211                    12478899999999887532     345567889999


Q ss_pred             eccCCcCc
Q 039419          565 NVSYNNFT  572 (1035)
Q Consensus       565 ~ls~N~l~  572 (1035)
                      +|++|++.
T Consensus       304 nLngN~l~  311 (382)
T KOG1909|consen  304 NLNGNRLG  311 (382)
T ss_pred             cCCccccc
Confidence            99999884

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.09  E-value=3.3e-11  Score=128.66  Aligned_cols=208  Identities=19%  Similarity=0.152  Sum_probs=100.7

Q ss_pred             ccccccceEecccCCCCCCc--hhhhhhccccceeccccccCCCCc--hhhccccccceeecCCCcccCCCCCCcCCCcc
Q 039419          100 KLINLQDLILNSNQLTGEIP--KELGACIKLKNLLLFDNYLSGNLP--VELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQ  175 (1035)
Q Consensus       100 ~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~l~~n~l~~~~p--~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~  175 (1035)
                      ++++|++..|.++.+. ..+  .....|++++.|||++|-+....+  .-...|++||.|+++.|..........-..++
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            4555666666665554 222  244556666666666665543222  22345556666666555422211111122344


Q ss_pred             ceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcc
Q 039419          176 SLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLW  255 (1035)
Q Consensus       176 ~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~  255 (1035)
                      +|+.|.++.|+++...                       +-..+..+++|..|+|..|.....-.....-+..|++|+|+
T Consensus       198 ~lK~L~l~~CGls~k~-----------------------V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs  254 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKD-----------------------VQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLS  254 (505)
T ss_pred             hhheEEeccCCCCHHH-----------------------HHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcccc
Confidence            4555555555544211                       11112234555555555553221223333445556666666


Q ss_pred             cccccccCC--ccccCCCCCcEEEccCccCCCCC-Ccc-----ccCCCCCcEEEccCCcccc-CCCCcccCCCccceecc
Q 039419          256 QNNFDGAIP--EEIGNCKSLKTIDLSLNFFSGSL-PQS-----FGNLSSLEELMLSNNNISG-SIPPVLSNATSLLQLQL  326 (1035)
Q Consensus       256 ~n~l~~~~p--~~~~~l~~L~~L~L~~n~l~~~~-~~~-----~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L  326 (1035)
                      +|++-. .+  ...+.|+.|+.|+++.+.|..+- |+.     ...+++|++|+++.|+|.. ..-+.+..+.+|+.|..
T Consensus       255 ~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~  333 (505)
T KOG3207|consen  255 NNNLID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRI  333 (505)
T ss_pred             CCcccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhc
Confidence            665542 22  23455666666666666665321 111     2345667777777777642 12234455666666676


Q ss_pred             ccchhh
Q 039419          327 DTNQIS  332 (1035)
Q Consensus       327 ~~N~i~  332 (1035)
                      ..|.+.
T Consensus       334 ~~n~ln  339 (505)
T KOG3207|consen  334 TLNYLN  339 (505)
T ss_pred             cccccc
Confidence            666664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=8.2e-11  Score=132.39  Aligned_cols=249  Identities=20%  Similarity=0.167  Sum_probs=170.6

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEE--CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceee
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEM--ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVR  760 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  760 (1035)
                      .+.+|..+..||.|.|+.|+....  .++..|++|...........            ...-..|+.+...+ .|.+++.
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~------------di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS------------DIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh------------hhcchhhhhHhhHhhcccccCC
Confidence            346788889999999999999843  45788999987654332221            11124566666666 4999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC-Cc
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-FE  839 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~-~~  839 (1035)
                      .+..+..-+..|+--|||+++++.......  ..++...++++..|++.++.++|+.   .++|+|+||+||++..+ +.
T Consensus       331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             CCCCccccccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence            888888888888999999999887666332  2367778889999999999999998   99999999999999886 77


Q ss_pred             eEEeeccCccccccCCccccccccCCcccc-cCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGY-IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .++.|||.+..+.-    .......++..| .+|+......+..++|+||||..+.|.++|.. +....      ..|..
T Consensus       406 ~~~~~~~~~t~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~-ls~~~------~~~~~  474 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP-LSESG------VQSLT  474 (524)
T ss_pred             hhccccccccccce----ecccccccccccccchhhccccccccccccccccccccccccCcc-cCccc------cccee
Confidence            88999999864211    111122233344 35556666778899999999999999999864 22111      11211


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      .+.+.       .. ..+   ........+...+..+|+..||.+.++..+.+
T Consensus       475 i~~~~-------~p-~~~---~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  475 IRSGD-------TP-NLP---GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             eeccc-------cc-CCC---chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            11110       11 111   11122233444588899999999988766543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.06  E-value=8.2e-10  Score=125.22  Aligned_cols=167  Identities=18%  Similarity=0.231  Sum_probs=123.9

Q ss_pred             EECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCCcceEEEEeCCCCChhh
Q 039419          706 EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGS  785 (1035)
Q Consensus       706 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~  785 (1035)
                      +..++.+|.|+..+....              ...+...+.+..++.+|||+|+++++.+..+++.|+|+|-+.  -|..
T Consensus        33 ~k~~~~~vsVF~~~~~~~--------------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~   96 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG--------------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLET   96 (690)
T ss_pred             eeccCCceEEEEEeCCCc--------------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHH
Confidence            444578888887754322              124567788999999999999999999999999999999983  5777


Q ss_pred             hhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCC
Q 039419          786 LLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG  865 (1035)
Q Consensus       786 ~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g  865 (1035)
                      ++++..     ...+.-.+.||+.||.+||+.|  +++|++|.-+-|+++..|+.||++|-++.....-..  ......-
T Consensus        97 ~lk~l~-----~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~  167 (690)
T KOG1243|consen   97 VLKELG-----KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYL  167 (690)
T ss_pred             HHHHhH-----HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchh
Confidence            776643     4555667889999999999775  899999999999999999999999998764322111  0011111


Q ss_pred             cccccCCcccccCCCCccccchhHHHHHHHHHhC
Q 039419          866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG  899 (1035)
Q Consensus       866 t~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg  899 (1035)
                      -..|..|+......  -..|.|-||++++|++.|
T Consensus       168 ~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  168 IESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            12355565432211  246999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.06  E-value=1.1e-09  Score=115.64  Aligned_cols=143  Identities=22%  Similarity=0.277  Sum_probs=109.5

Q ss_pred             CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC--CceeeEEeEEEcC-
Q 039419          692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH--KNIVRFLGCCWNR-  768 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~-  768 (1035)
                      +.||.|.++.||+++..+|+.+++|........             .....+.+|+++++.+++  ..+.+++.+.... 
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~   70 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS   70 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-------------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC
Confidence            578999999999998877789999997543221             013468899999999975  3457777776654 


Q ss_pred             --CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC----------------------------
Q 039419          769 --NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC----------------------------  818 (1035)
Q Consensus       769 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------  818 (1035)
                        +..++||||++|.++.+.+..   ..++......++.++++++.+||+..                            
T Consensus        71 ~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (223)
T cd05154          71 VLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD  147 (223)
T ss_pred             ccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence              367899999999988876532   12667777788888888888888531                            


Q ss_pred             -------------------------CCCeeccCCCcccEEEcC--CCceEEeeccCccc
Q 039419          819 -------------------------VPPIVHRDIKANNILIGP--EFEPYIADFGLAKL  850 (1035)
Q Consensus       819 -------------------------~~~ivHrDikp~NIll~~--~~~~kl~DFG~a~~  850 (1035)
                                               ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                     236799999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.03  E-value=1e-11  Score=129.09  Aligned_cols=67  Identities=25%  Similarity=0.365  Sum_probs=34.1

Q ss_pred             CCCCCcccceEeecCcccCCC----CCCCCCCCCCCceeeCCC---CCCCCCCChhhh-------ccccccceEecccCC
Q 039419           49 NLSSLSFLQKLIISGSNLTGP----ISPDLGDCTQLTTIDVSS---NSLVGGVPSSIG-------KLINLQDLILNSNQL  114 (1035)
Q Consensus        49 ~~~~l~~L~~L~L~~~~l~~~----~~~~~~~l~~L~~L~ls~---n~l~~~~p~~i~-------~l~~L~~L~L~~n~l  114 (1035)
                      .+..+..+++|+||||.+..+    +.+.+...++|+..++|+   -++...+|+.+.       ..++|++|+||.|-+
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~  104 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF  104 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence            345556666777777766532    223344556666666664   234444554432       223455555555544


Q ss_pred             C
Q 039419          115 T  115 (1035)
Q Consensus       115 ~  115 (1035)
                      .
T Consensus       105 G  105 (382)
T KOG1909|consen  105 G  105 (382)
T ss_pred             C
Confidence            3

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=99.03  E-value=4e-10  Score=138.30  Aligned_cols=110  Identities=23%  Similarity=0.275  Sum_probs=87.2

Q ss_pred             CCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCC--CCCCCChhhhccccccceEecccCCCCCCchhhhhhc
Q 039419           49 NLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNS--LVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACI  126 (1035)
Q Consensus        49 ~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~--l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~  126 (1035)
                      ...+....+...+-+|.+. .++.... +++|++|-+..|.  +....++.|..++.|++|||++|.--+.+|.+|+.|-
T Consensus       518 ~~~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li  595 (889)
T KOG4658|consen  518 QVKSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV  595 (889)
T ss_pred             cccchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh
Confidence            3455577788888888876 4554433 4479999998886  5534444577899999999999876668999999999


Q ss_pred             cccceeccccccCCCCchhhccccccceeecCCCc
Q 039419          127 KLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK  161 (1035)
Q Consensus       127 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~  161 (1035)
                      +||+|+|+++.++ .+|..+++|+.|.+|++..+.
T Consensus       596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~  629 (889)
T KOG4658|consen  596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTG  629 (889)
T ss_pred             hhhcccccCCCcc-ccchHHHHHHhhheecccccc
Confidence            9999999999998 899999999999999888775

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.03  E-value=9.6e-11  Score=115.28  Aligned_cols=78  Identities=31%  Similarity=0.364  Sum_probs=24.3

Q ss_pred             CCccceeecCCCccCCCCcccc-cCCCCccEEEcCCCccCCCCc-hhccCccccchhhccCCcccccCc----cccCCCC
Q 039419          414 CTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLIP-ESFGQLASLNRLILSKNSFSGAIP----SSLGRCE  487 (1035)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~  487 (1035)
                      ++.|++|++++|+|+.+ ...+ ..+++|++|+|++|+|..... ..+..+++|+.|+|.+|.++.. +    -.+..+|
T Consensus        63 L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP  140 (175)
T PF14580_consen   63 LPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLP  140 (175)
T ss_dssp             -TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-T
T ss_pred             hhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcC
Confidence            34455555555555532 2222 235555555555555543221 2334455555555555555421 1    1234456


Q ss_pred             CCcEEE
Q 039419          488 SLQSLD  493 (1035)
Q Consensus       488 ~L~~L~  493 (1035)
                      +|+.||
T Consensus       141 ~Lk~LD  146 (175)
T PF14580_consen  141 SLKVLD  146 (175)
T ss_dssp             T-SEET
T ss_pred             hhheeC
Confidence            666665

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.03  E-value=6e-11  Score=126.73  Aligned_cols=214  Identities=22%  Similarity=0.159  Sum_probs=118.1

Q ss_pred             hhhccccceeccccccCCCCc--hhhccccccceeecCCCcccCCCCCCcCCCccceEEEEecccccccc--Cccccccc
Q 039419          123 GACIKLKNLLLFDNYLSGNLP--VELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGS--LPASLGKL  198 (1035)
Q Consensus       123 ~~l~~L~~L~l~~n~l~~~~p--~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~--~p~~l~~l  198 (1035)
                      .++.+|+...|+++... ..+  .....+++++.|+|++|                         -+...  +-.-...|
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~N-------------------------L~~nw~~v~~i~eqL  171 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRN-------------------------LFHNWFPVLKIAEQL  171 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhh-------------------------hHHhHHHHHHHHHhc
Confidence            35667777777776654 222  23444555555555544                         33321  22334567


Q ss_pred             ccccceeecccccccCCcccc-ccCcCCceEEecCCcCCCC-CChhhhcccchhHhhcccccccccCCccccCCCCCcEE
Q 039419          199 SKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGS-LPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTI  276 (1035)
Q Consensus       199 ~~L~~L~l~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  276 (1035)
                      ++|+.|+|+.|++........ ..+++|+.|.|+.|.++-. +...+..+|+|+.|+|..|............+..|+.|
T Consensus       172 p~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~L  251 (505)
T KOG3207|consen  172 PSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQEL  251 (505)
T ss_pred             ccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhc
Confidence            777777777777763222221 2467788888888887732 22234456777778887775333333344456667777


Q ss_pred             EccCccCCCCCC-ccccCCCCCcEEEccCCccccCC-CCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCC
Q 039419          277 DLSLNFFSGSLP-QSFGNLSSLEELMLSNNNISGSI-PPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRS  354 (1035)
Q Consensus       277 ~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~  354 (1035)
                      ||++|++-...- ...+.++.|+.|+++.|.|..+- |+.                             ..-.-...+++
T Consensus       252 dLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~-----------------------------~s~~kt~~f~k  302 (505)
T KOG3207|consen  252 DLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDV-----------------------------ESLDKTHTFPK  302 (505)
T ss_pred             cccCCcccccccccccccccchhhhhccccCcchhcCCCc-----------------------------cchhhhccccc
Confidence            777776653211 23455666666666666665321 111                             00011334566


Q ss_pred             CcEEeccCcCCCCC-CCCCcccCcccceEecccccccc
Q 039419          355 LEAVDLSHNALTGS-LHPGLFQLQNLTKLLLISNGISG  391 (1035)
Q Consensus       355 L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~  391 (1035)
                      |++|+++.|+|... .-..+..+++|+.|.+..|.++.
T Consensus       303 L~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  303 LEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             ceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            77777777777421 11234456677777777777763

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.91  E-value=3.2e-10  Score=133.62  Aligned_cols=208  Identities=26%  Similarity=0.293  Sum_probs=148.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.+.+.+.+-+|+++.++.++-.. |...++|...........           ..+...++-.+.-..+||-+++....
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-----------~~~s~r~~s~~~i~p~~P~v~~~~~s  872 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-----------DYESIRSKSNILITPRSPAVVRSFPS  872 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccc-----------cccccCCccCccccCCCCceecccCC
Confidence            456667788999999999885443 433444443221111100           01122233333334456777776666


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.-....+++|+|+.|++|...++..+  +.+.+........+.++.+|||..   .+.|||++|.|++...+++.++.|
T Consensus       873 ~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  873 FPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             CCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCc
Confidence            566677899999999999999998765  355555566777888999999997   799999999999999999999999


Q ss_pred             ccCccccccC---------------------C--------ccccccccCCcccccCCcccccCCCCccccchhHHHHHHH
Q 039419          845 FGLAKLVVEG---------------------D--------FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLE  895 (1035)
Q Consensus       845 FG~a~~~~~~---------------------~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~e  895 (1035)
                      ||........                     .        .........||+.|.|||...+......+|.|+.|++++|
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence            9843322100                     0        0011234569999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCCCC
Q 039419          896 VLTGKQPIDPTIPE  909 (1035)
Q Consensus       896 lltg~~P~~~~~~~  909 (1035)
                      .++|..||....+.
T Consensus      1028 ~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQ 1041 (1205)
T ss_pred             hhcCCCCCCCcchh
Confidence            99999999866543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.87  E-value=3.5e-08  Score=105.25  Aligned_cols=152  Identities=14%  Similarity=0.102  Sum_probs=103.3

Q ss_pred             CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc--eeeEEeEEEc--
Q 039419          692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN--IVRFLGCCWN--  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~--  767 (1035)
                      +.+-......|+++++. |+.|.||............   .-.....-...+.+|...+.++..-+  .++.++++..  
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k---~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~  103 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFK---NLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGS  103 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhh---hhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecC
Confidence            45555555567787664 7889999874432111000   00000011225789999998884333  3344555543  


Q ss_pred             ---CCcceEEEEeCCCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-------
Q 039419          768 ---RNTRLLMYDYMPNG-SLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-------  836 (1035)
Q Consensus       768 ---~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-------  836 (1035)
                         ....++|||++++. +|.+++........+...+..++.+++..+..||+.   ||+|+|++++|||++.       
T Consensus       104 ~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        104 NPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             CCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence               23468999999886 899988643223355667778999999999999999   9999999999999985       


Q ss_pred             CCceEEeeccCccc
Q 039419          837 EFEPYIADFGLAKL  850 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~  850 (1035)
                      ++.+.++||+.++.
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46789999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.85  E-value=1.6e-08  Score=101.42  Aligned_cols=139  Identities=22%  Similarity=0.241  Sum_probs=85.4

Q ss_pred             EEEEEEECCCcEEEEEEecCCCccccc---------ccc---cccccccccHHHHHHHHHHHhcCCCC--ceeeEEeEEE
Q 039419          701 IVYRAEMENGEVIAVKKLWPTTMAAEY---------DCQ---NDKIGIGGVRDSFSAEIKTLGSIRHK--NIVRFLGCCW  766 (1035)
Q Consensus       701 ~V~~~~~~~~~~vavK~~~~~~~~~~~---------~~~---~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~  766 (1035)
                      .||.|...+|..+|||+.......-..         ...   .........+....+|++.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999888999999998753221100         000   00111122356778999999999755  566776552 


Q ss_pred             cCCcceEEEEeCC--CCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHH-hhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          767 NRNTRLLMYDYMP--NGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY-LHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       767 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                         ..++||||++  |..+..+. ...   ++......++.++++.+.. +|..   ||+|+|+.+.||+++++ .+.++
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence               4579999997  54454433 222   1123345677778885555 5677   99999999999999887 89999


Q ss_pred             eccCcccc
Q 039419          844 DFGLAKLV  851 (1035)
Q Consensus       844 DFG~a~~~  851 (1035)
                      |||.+...
T Consensus       149 Df~qav~~  156 (188)
T PF01163_consen  149 DFGQAVDS  156 (188)
T ss_dssp             -GTTEEET
T ss_pred             ecCcceec
Confidence            99987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.83  E-value=9.9e-08  Score=102.05  Aligned_cols=266  Identities=16%  Similarity=0.206  Sum_probs=157.8

Q ss_pred             cCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeE----
Q 039419          690 EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGC----  764 (1035)
Q Consensus       690 ~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~----  764 (1035)
                      ....+|+|+.+.+|-...-  ...+.|++........                 .+.+..|... .||-+-.-+.+    
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~-----------------aqk~a~la~~p~~p~~~~rvaWPqa~   75 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQ-----------------AQKVAELAATPDAPLLNYRVAWPQAT   75 (637)
T ss_pred             CCccccCCccceeeecchh--hchhheeecCCCchHH-----------------HHHHHHhccCCCCcchhhhhcccHHH
Confidence            3467899999999976322  2234566654332211                 1122333333 56643321111    


Q ss_pred             --EEcCC-cceEEEEeCCCCC-hhhhhh---h-cCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          765 --CWNRN-TRLLMYDYMPNGS-LGSLLH---E-RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       765 --~~~~~-~~~lv~e~~~~gs-L~~~l~---~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                        .-+++ ..-+.|..+.|.. ...++.   . +......|...+++++.+|.+.+.||..   |.+-+|+.++|+|+.+
T Consensus        76 L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd  152 (637)
T COG4248          76 LHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSD  152 (637)
T ss_pred             hhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeec
Confidence              11122 2457788776642 222221   1 1123478999999999999999999999   8899999999999999


Q ss_pred             CCceEEeeccCccccccCCccccccccCCcccccCCcc-----cccCCCCccccchhHHHHHHHHHhC-CCCCCCCC---
Q 039419          837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTG-KQPIDPTI---  907 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~-----~~~~~~~~~~Dv~SlGvvl~elltg-~~P~~~~~---  907 (1035)
                      ++.+.+.|-..-....++   .....-+|...|.+||.     +.+...+...|.|.+||++++++.| +.||.+..   
T Consensus       153 ~~~V~LVdsDsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~  229 (637)
T COG4248         153 DSKVVLVDSDSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS  229 (637)
T ss_pred             CceEEEEcccceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC
Confidence            999999885443322222   22235578999999996     3355667789999999999999996 99997531   


Q ss_pred             ----CCchhHHH--HHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          908 ----PEGLHIVD--WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNP--TPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       908 ----~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~--dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                          +.+..+..  ++.... ...-..+.....|...+.-..+  .+..+|+..  .|.-||+++..+..|.++..+-..
T Consensus       230 ~ap~p~E~~Ia~g~f~ya~~-~~~g~~p~P~~~P~~~Lpp~vq--AlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         230 DAPNPLETDIAHGRFAYASD-QRRGLKPPPRSIPLSMLPPDVQ--ALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             CCCCcchhhhhcceeeechh-ccCCCCCCCCCCChhhcCHHHH--HHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence                11111111  000000 0000011111111111111112  244457653  367899999999999998887776


Q ss_pred             hhhc
Q 039419          980 CMKV  983 (1035)
Q Consensus       980 ~~~~  983 (1035)
                      |...
T Consensus       307 C~v~  310 (637)
T COG4248         307 CTVS  310 (637)
T ss_pred             hhhc
Confidence            6443

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.77  E-value=3.6e-09  Score=85.54  Aligned_cols=61  Identities=36%  Similarity=0.574  Sum_probs=38.6

Q ss_pred             CCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcC
Q 039419          439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKL  499 (1035)
Q Consensus       439 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  499 (1035)
                      ++|++|++++|+|+.+.+..|.++++|++|++++|+|+.+.+..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3566666666666666556666666666666666666655556666666666666666654

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.72  E-value=5.2e-09  Score=84.65  Aligned_cols=61  Identities=38%  Similarity=0.593  Sum_probs=45.2

Q ss_pred             CccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcc
Q 039419          415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF  475 (1035)
Q Consensus       415 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  475 (1035)
                      |+|++|++++|+|+.+.+..|.++++|++|++++|+++.+.+..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3567777777777766666777777777777777777777777777777777777777764

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.68  E-value=1e-07  Score=97.60  Aligned_cols=146  Identities=18%  Similarity=0.140  Sum_probs=99.3

Q ss_pred             ccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCccccccc---------ccccccccccHHHHHHHHHHHhcCCCC--c
Q 039419          689 VEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDC---------QNDKIGIGGVRDSFSAEIKTLGSIRHK--N  757 (1035)
Q Consensus       689 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~E~~~l~~l~hp--n  757 (1035)
                      .+++.||.|.-+.||.|..++|.++|||.=...... -...         ..........+...++|.++|.+|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~Grts-Frkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTS-FRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchh-hhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            456899999999999999999999999974322111 0000         001111122355678999999999644  6


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      +.+.+++    +...+||||++|-.|...--       +.+..-.++..|++-+..+-..   ||||+|+.+-||+++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d  238 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence            7776664    45579999999876655431       1222333444444444444455   99999999999999999


Q ss_pred             CceEEeeccCcc
Q 039419          838 FEPYIADFGLAK  849 (1035)
Q Consensus       838 ~~~kl~DFG~a~  849 (1035)
                      |.++++||--+.
T Consensus       239 g~~~vIDwPQ~v  250 (304)
T COG0478         239 GDIVVIDWPQAV  250 (304)
T ss_pred             CCEEEEeCcccc
Confidence            999999996554

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.65  E-value=6.3e-10  Score=125.34  Aligned_cols=180  Identities=27%  Similarity=0.262  Sum_probs=102.0

Q ss_pred             CCcCCCccceEEEEeccccccccCccccccc-ccccceeecccccc----------cCCccccccCcCCceEEecCCcCC
Q 039419          168 PYEIGDCQSLLVVGLADTKVAGSLPASLGKL-SKLQSLSVYTTMLS----------GEIPPQIGNCSELVDLFLYENDLS  236 (1035)
Q Consensus       168 ~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l-~~L~~L~l~~n~l~----------~~~p~~l~~l~~L~~L~L~~n~l~  236 (1035)
                      |..|..+.+|+.|.+.++.+..  ..++..+ .+|++|-..+ .+.          |.+.+++ ....|...+.+.|.+.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSP-VWNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccch-hhhhHhhhhcchhhHH
Confidence            5667778888888888887752  2222222 2444443222 111          0111111 1224666667777776


Q ss_pred             CCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCccc
Q 039419          237 GSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLS  316 (1035)
Q Consensus       237 ~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  316 (1035)
                       .+..++.-++.|+.|+|++|+++..  +.+..+++|++|||++|.++...-....++. |+.|.+++|.++..  ..+.
T Consensus       178 -~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie  251 (1096)
T KOG1859|consen  178 -LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIE  251 (1096)
T ss_pred             -hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHH
Confidence             5566666677777777777777643  2566777777777777777632222223333 77777777776632  2356


Q ss_pred             CCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCC
Q 039419          317 NATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALT  366 (1035)
Q Consensus       317 ~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~  366 (1035)
                      ++.+|+.|||++|-|.....         -..++.+..|..|+|.+|.+-
T Consensus       252 ~LksL~~LDlsyNll~~hse---------L~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSE---------LEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhhhhccchhHhhhhcchh---------hhHHHHHHHHHHHhhcCCccc
Confidence            66677777777776653311         123455566666677777665

>PRK09902 hypothetical protein; Provisional

Probab=98.59  E-value=8.5e-07  Score=89.23  Aligned_cols=145  Identities=14%  Similarity=0.051  Sum_probs=105.7

Q ss_pred             eeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC--CceeeEEeEEEc--C-
Q 039419          694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH--KNIVRFLGCCWN--R-  768 (1035)
Q Consensus       694 iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~--~-  768 (1035)
                      -|+||.+-|++.... |+.+-+|.-.......-.        .+.....|.+|...+.++..  -.+.++......  . 
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r--------~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~   96 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVR--------YPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEG   96 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCccccccc--------CCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCC
Confidence            378999999998876 447888886422111110        01245689999999999952  235555522222  1 


Q ss_pred             -CcceEEEEeCCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc--eEEee
Q 039419          769 -NTRLLMYDYMPN-GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE--PYIAD  844 (1035)
Q Consensus       769 -~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~--~kl~D  844 (1035)
                       -..++|+|-+.| .+|.+++........+...+..++.++++++.-||+.   |+.|+|+.+.||+++.++.  ++++|
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEE
Confidence             135799998854 5899998665444467777889999999999999999   9999999999999987777  89999


Q ss_pred             ccCccc
Q 039419          845 FGLAKL  850 (1035)
Q Consensus       845 FG~a~~  850 (1035)
                      |--++.
T Consensus       174 lEk~r~  179 (216)
T PRK09902        174 LEKSRR  179 (216)
T ss_pred             hhccch
Confidence            987654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.58  E-value=3.2e-07  Score=105.93  Aligned_cols=169  Identities=17%  Similarity=0.216  Sum_probs=108.5

Q ss_pred             CccHHHHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCccccc-c--------------ccc-ccccc----c
Q 039419          678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEY-D--------------CQN-DKIGI----G  737 (1035)
Q Consensus       678 ~~~~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-~--------------~~~-~~~~~----~  737 (1035)
                      +-.+++++.+|.. +.|+.++-|+||+|+.++|+.||||+..|.....-. +              ... .....    .
T Consensus       118 G~~iee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~  196 (517)
T COG0661         118 GRPIEELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVD  196 (517)
T ss_pred             CCCHHHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHH
Confidence            4467788877754 699999999999999999999999999885433100 0              000 00000    0


Q ss_pred             cc------HHHHHHHHHHHhcCC----CCceeeEEeEEEc-CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHH
Q 039419          738 GV------RDSFSAEIKTLGSIR----HKNIVRFLGCCWN-RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG  806 (1035)
Q Consensus       738 ~~------~~~~~~E~~~l~~l~----hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  806 (1035)
                      +.      .=+|.+|+..+.+++    +.--+++-..+++ .+...++|||++|-.+.+...... ...+.....   ..
T Consensus       197 e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~  272 (517)
T COG0661         197 EFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---EL  272 (517)
T ss_pred             HHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HH
Confidence            01      113556777666662    3333344444433 456789999999999988743222 224533332   22


Q ss_pred             HHHH-HHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccC
Q 039419          807 AAQG-LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG  854 (1035)
Q Consensus       807 ia~~-L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~  854 (1035)
                      ++++ +..+=..   |++|.|..|.||+++.+|++.+.|||+.....+.
T Consensus       273 ~~~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         273 LVRAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            2222 2222234   8999999999999999999999999998776543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.53  E-value=3.4e-09  Score=119.64  Aligned_cols=125  Identities=28%  Similarity=0.295  Sum_probs=59.2

Q ss_pred             cccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCc-cccCCCCCcEEEc
Q 039419          200 KLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPE-EIGNCKSLKTIDL  278 (1035)
Q Consensus       200 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~L~L  278 (1035)
                      .|.+-+.+.|.+. ....++.-++.|+.|+|++|+++...  .+..+++|++|||+.|.+. .+|. ....+. |..|.|
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence            4444555555554 44445555555555555555555322  4455555555555555555 2222 111222 555555


Q ss_pred             cCccCCCCCCccccCCCCCcEEEccCCccccCC-CCcccCCCccceeccccchh
Q 039419          279 SLNFFSGSLPQSFGNLSSLEELMLSNNNISGSI-PPVLSNATSLLQLQLDTNQI  331 (1035)
Q Consensus       279 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~i  331 (1035)
                      ++|.++..  -.+.+|++|+.||+++|-|.+.. -..+..+..|+.|+|.+|.+
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl  291 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL  291 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence            55555421  12445555555555555554311 11233444555555555554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.51  E-value=6.6e-07  Score=92.54  Aligned_cols=107  Identities=23%  Similarity=0.348  Sum_probs=85.2

Q ss_pred             HHHHHHHHHHHhcCCCC--ceeeEEeEEEcCC----cceEEEEeCCCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHH
Q 039419          740 RDSFSAEIKTLGSIRHK--NIVRFLGCCWNRN----TRLLMYDYMPNG-SLGSLLHERRDSCLEWELRYRIILGAAQGLA  812 (1035)
Q Consensus       740 ~~~~~~E~~~l~~l~hp--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~  812 (1035)
                      ..+..+|...+.++..-  .+++.+++.....    ..++|+|++++. +|.+++.....  .+......++.++++.++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence            44688899988888533  3455666665432    348999999884 79999876433  556677889999999999


Q ss_pred             HhhccCCCCeeccCCCcccEEEcCCC---ceEEeeccCcccc
Q 039419          813 YLHHDCVPPIVHRDIKANNILIGPEF---EPYIADFGLAKLV  851 (1035)
Q Consensus       813 ~LH~~~~~~ivHrDikp~NIll~~~~---~~kl~DFG~a~~~  851 (1035)
                      -||+.   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   999999999999999887   7899999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.48  E-value=7.2e-08  Score=98.30  Aligned_cols=188  Identities=20%  Similarity=0.213  Sum_probs=101.0

Q ss_pred             cccchhHhhccccccccc--CCccccCCCCCcEEEccCccCCCCCCccc-cCCCCCcEEEccCCccccCC-CCcccCCCc
Q 039419          245 KLQKLEKMLLWQNNFDGA--IPEEIGNCKSLKTIDLSLNFFSGSLPQSF-GNLSSLEELMLSNNNISGSI-PPVLSNATS  320 (1035)
Q Consensus       245 ~l~~L~~L~l~~n~l~~~--~p~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~  320 (1035)
                      ..+.++++||.+|+++..  +-..+.+++.|++|+|+.|.+... .+.+ ..+.+|+.|-|.+..+...- ...+..++.
T Consensus        69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~-I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~  147 (418)
T KOG2982|consen   69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSD-IKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPK  147 (418)
T ss_pred             HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCc-cccCcccccceEEEEEcCCCCChhhhhhhhhcchh
Confidence            346677777777777642  223355777777777777777632 2233 35567777777777665332 234556777


Q ss_pred             cceeccccchhhhhhhhccccCCCCC--cCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCC
Q 039419          321 LLQLQLDTNQISVFFAWQNKLEGSIP--STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIG  398 (1035)
Q Consensus       321 L~~L~L~~N~i~~l~~~~n~l~~~~p--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  398 (1035)
                      +++|+++.|.++.+....+-.+..-|  .++..+++++.+.++-|++...       .+++..+.+..|.|......   
T Consensus       148 vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~e---  217 (418)
T KOG2982|consen  148 VTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSE---  217 (418)
T ss_pred             hhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhc---
Confidence            77777777765544322221111111  1223344445555555555422       34555666666655432110   


Q ss_pred             CCCcceeEeeeccCCCCccceeecCCCccCCCC-cccccCCCCccEEEcCCCccCC
Q 039419          399 NCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTL-PSSLASLTRLQVLDISVNQFVG  453 (1035)
Q Consensus       399 ~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~Ls~N~l~~  453 (1035)
                                .++..++.+..|+|+.|+|.... -+.+.++++|..|.+++|.+..
T Consensus       218 ----------k~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  218 ----------KGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             ----------ccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence                      12334455556666666665321 1345566666666666666653

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.44  E-value=7.7e-08  Score=98.06  Aligned_cols=216  Identities=27%  Similarity=0.340  Sum_probs=130.2

Q ss_pred             CCcEEEccCCccccCCCC-cc-cCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCc
Q 039419          296 SLEELMLSNNNISGSIPP-VL-SNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGL  373 (1035)
Q Consensus       296 ~L~~L~L~~N~l~~~~~~-~~-~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~  373 (1035)
                      .++-|-+.++.|...... .| ...+.+++|+|.+|+|+....        +-..+.++|.|+.|+|+.|++...+...-
T Consensus        46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWse--------I~~ile~lP~l~~LNls~N~L~s~I~~lp  117 (418)
T KOG2982|consen   46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSE--------IGAILEQLPALTTLNLSCNSLSSDIKSLP  117 (418)
T ss_pred             chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHH--------HHHHHhcCccceEeeccCCcCCCccccCc
Confidence            455555666666432211 12 245678888888888875432        22356788899999999999974433222


Q ss_pred             ccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCC
Q 039419          374 FQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG  453 (1035)
Q Consensus       374 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  453 (1035)
                      ..+.+|+.|.|.+..+.-.....             .+..+|.++.|++|.|.+.              .+++..|-+..
T Consensus       118 ~p~~nl~~lVLNgT~L~w~~~~s-------------~l~~lP~vtelHmS~N~~r--------------q~n~Dd~c~e~  170 (418)
T KOG2982|consen  118 LPLKNLRVLVLNGTGLSWTQSTS-------------SLDDLPKVTELHMSDNSLR--------------QLNLDDNCIED  170 (418)
T ss_pred             ccccceEEEEEcCCCCChhhhhh-------------hhhcchhhhhhhhccchhh--------------hhccccccccc
Confidence            46778888888877665221111             1344566666666666433              23334444433


Q ss_pred             CCch--hccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCcc
Q 039419          454 LIPE--SFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQ  531 (1035)
Q Consensus       454 ~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~  531 (1035)
                      ..+.  .+..++.+..++++-|++...       .|++..+.+..|.|...-                        ....
T Consensus       171 ~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s------------------------~ek~  219 (418)
T KOG2982|consen  171 WSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTES------------------------SEKG  219 (418)
T ss_pred             cchhhhhhhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchh------------------------hccc
Confidence            2221  122344556666666666533       356777888888776211                        1123


Q ss_pred             ccCCccccEEeccCCcccC--ccccccccCCCcEEeccCCcCcccCCC
Q 039419          532 ISALNKLSILDLSHNKLGG--DLLALSGLDNLVSLNVSYNNFTGYLPD  577 (1035)
Q Consensus       532 ~~~l~~L~~L~L~~N~l~~--~~~~~~~l~~L~~L~ls~N~l~~~~p~  577 (1035)
                      +..++.+.-|+|+.|+|..  ...++.+++.|..|.+++|+|......
T Consensus       220 se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~  267 (418)
T KOG2982|consen  220 SEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRG  267 (418)
T ss_pred             CCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccC
Confidence            3345566678888888876  346788899999999999998755443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=2.5e-07  Score=105.92  Aligned_cols=154  Identities=21%  Similarity=0.242  Sum_probs=98.3

Q ss_pred             HHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccc-------cccccCCcccccCCccc
Q 039419          803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR-------SSNTVAGSYGYIAPEYG  875 (1035)
Q Consensus       803 i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~  875 (1035)
                      =+.+++.|+.|+|..  +++||+.|.|++|.++..+..||+.|+++........+.       ......-...|.|||+.
T Consensus       104 nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  104 NLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            344566999999997  589999999999999999999999999876544421110       11112245689999999


Q ss_pred             ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCC
Q 039419          876 YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNP  955 (1035)
Q Consensus       876 ~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~  955 (1035)
                      .+...+.++|+||+|+.+|-+..|..+.-...... ........   ..+.-........+.++.+.      +.+.+..
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-~~~~~~~~---~~~~~~~~~s~~~p~el~~~------l~k~l~~  251 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-LSYSFSRN---LLNAGAFGYSNNLPSELRES------LKKLLNG  251 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchhhccCCc-chhhhhhc---ccccccccccccCcHHHHHH------HHHHhcC
Confidence            99889999999999999999985554432211110 00011100   00111111112223333333      3347888


Q ss_pred             CCCCCCCHHHHHH
Q 039419          956 TPDDRPTMKDVAA  968 (1035)
Q Consensus       956 dP~~RPs~~el~~  968 (1035)
                      ++..||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998777654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.37  E-value=2.8e-06  Score=93.84  Aligned_cols=168  Identities=19%  Similarity=0.289  Sum_probs=124.6

Q ss_pred             CCcEEEEEE-ECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEc----CCcce
Q 039419          698 CSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN----RNTRL  772 (1035)
Q Consensus       698 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~  772 (1035)
                      --.+.|++. ..||..|++|+++.......              ..-..-+++++++.|+|+|++.++|..    +...+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--------------nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Slv  353 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST--------------NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLV  353 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc--------------ccchHHHHHHHHhccCceeehhhhhhhhccCcceEE
Confidence            345789994 45799999999954433221              122356788999999999999998873    23568


Q ss_pred             EEEEeCCC-CChhhhhhhc-------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          773 LMYDYMPN-GSLGSLLHER-------------RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       773 lv~e~~~~-gsL~~~l~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +|++|.++ ++|.++.-..             .....++...+.++.|++.||.++|+.   |+.-+-+.|.+|+++.+.
T Consensus       354 lvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~  430 (655)
T KOG3741|consen  354 LVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKM  430 (655)
T ss_pred             EEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcc
Confidence            99999876 5787754211             112367889999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCC
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ  901 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~  901 (1035)
                      +++|+..|.......+..                |.+.   --.+-|.=.||.++..+.||..
T Consensus       431 RIriS~C~i~Dvl~~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  431 RIRISGCGIMDVLQEDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             eEEEecccceeeecCCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            999988887665433320                1111   1236788899999999999953

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1035
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-48
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		7e-48
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-42
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-10
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		9e-42
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-09
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-34
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-31
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-31
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-30
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-28
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		6e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-11
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-11
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-11
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-11
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-11
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-11
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		8e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-10
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-10
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-10
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-10
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-10
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-10
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-10
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-10
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		9e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-08
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		1e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-07
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-06
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-06
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-06
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		8e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		9e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-04
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-04
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-04
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		2e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-04
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-04
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		7e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  191 bits (486), Expect = 1e-48,   Method: Composition-based stats.
 Identities = 116/308 (37%), Positives = 176/308 (57%), Gaps = 32/308 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           +++G+G  G VY+  + +G ++AVK+L       E   Q  ++        F  E++ + 
Sbjct: 36  NILGRGGFGKVYKGRLADGXLVAVKRL------KEERTQGGEL-------QFQTEVEMIS 82
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS--CLEWELRYRIILGAAQ 809
              H+N++R  G C     RLL+Y YM NGS+ S L ER +S   L+W  R RI LG+A+
Sbjct: 83  MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 142
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           GLAYLH  C P I+HRD+KA NIL+  EFE  + DFGLAKL+   D       V G  G+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXAVRGXIGH 201
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI---PEGLHIVDWVRQKRGAIEV 926
           IAPEY    K +EK+DV+ YGV++LE++TG++  D       + + ++DWV   +G ++ 
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV---KGLLK- 257
Query: 927 LDKSLRARPEVEI------EEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK--EIKQERE 978
            +K L A  +V++      EE+ Q + VALLC   +P +RP M +V  M++   + +  E
Sbjct: 258 -EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316
Query: 979 ECMKVDML 986
           E  K +M 
Sbjct: 317 EWQKEEMF 324

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  189 bits (480), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 116/308 (37%), Positives = 177/308 (57%), Gaps = 32/308 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           +++G+G  G VY+  + +G ++AVK+L       E   Q  ++        F  E++ + 
Sbjct: 44  NILGRGGFGKVYKGRLADGTLVAVKRL------KEERXQGGEL-------QFQTEVEMIS 90
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC--LEWELRYRIILGAAQ 809
              H+N++R  G C     RLL+Y YM NGS+ S L ER +S   L+W  R RI LG+A+
Sbjct: 91  MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR 150
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           GLAYLH  C P I+HRD+KA NIL+  EFE  + DFGLAKL+   D       V G+ G+
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXAVRGTIGH 209
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI---PEGLHIVDWVRQKRGAIEV 926
           IAPEY    K +EK+DV+ YGV++LE++TG++  D       + + ++DWV   +G ++ 
Sbjct: 210 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV---KGLLK- 265
Query: 927 LDKSLRARPEVEI------EEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK--EIKQERE 978
            +K L A  +V++      EE+ Q + VALLC   +P +RP M +V  M++   + +  E
Sbjct: 266 -EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 324
Query: 979 ECMKVDML 986
           E  K +M 
Sbjct: 325 EWQKEEMF 332

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  170 bits (430), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 169/598 (28%), Positives = 246/598 (41%), Gaps = 82/598 (13%)
Query: 57  QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTG 116
           Q L ISG+ L+G  S  +  CT+L  +++SSN  VG +P     L +LQ L L  N+ TG
Sbjct: 223 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 280
Query: 117 EIPKEL-GACIKLKNLLLFDNYLSGNLPVELG-------------------------KLV 150
           EIP  L GAC  L  L L  N+  G +P   G                         K+ 
Sbjct: 281 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 340
Query: 151 NLEVIRAGGNKDIAGKIPYEIGDCQ-SLLVVGLADTKVAGSLPAXXXXXXXXXXXXVY-- 207
            L+V+    N + +G++P  + +   SLL + L+    +G +              +Y  
Sbjct: 341 GLKVLDLSFN-EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 399
Query: 208 TTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEI 267
               +G+IPP + NCSELV L L  N LSG++P  LG L KL  + LW N  +G IP+E+
Sbjct: 400 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 459
Query: 268 GNCKSLKTIDLSLNFFSGSLPQSFGXXXXXXXXXXXXXXXXGSIPPVLSNATSLLQLQLD 327
              K+L+T+ L  N  +G +P                    G IP  +    +L  L+L 
Sbjct: 460 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 519
Query: 328 TNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGXXXXXXXXXXXXXXX 387
            N  S          G+IP+ L +CRSL  +DL+ N   G++ P                
Sbjct: 520 NNSFS----------GNIPAELGDCRSLIWLDLNTNLFNGTI-PAAMFKQSGKIAANFIA 568
Query: 388 XXXXXXPPEIGNCSSLIRLRLMSFGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDIS 447
                     G     ++      GN  + Q                L  L+     +I+
Sbjct: 569 GKRYVYIKNDG-----MKKECHGAGNLLEFQ----------GIRSEQLNRLSTRNPCNIT 613
Query: 448 VNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVEL 507
              + G    +F    S+  L +S N  SG IP  +G    L  L+L  N +SG IP E+
Sbjct: 614 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 673
Query: 508 FEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKXXXXXXXXXXXXXXXXXNVS 567
            ++ GL+I L+LS N L G IP  +SAL  L+ +DLS+                      
Sbjct: 674 GDLRGLNI-LDLSSNKLDGRIPQAMSALTMLTEIDLSN---------------------- 710
Query: 568 YNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATTVGMGNGGGFRKSEKL 625
            NN +G +P+   F      +   N GLC      C  SNA           R+ E L
Sbjct: 711 -NNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHGRRLENL 767

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 411 FGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLIL 470
            G+C+ LQ               ++++ T L++L+IS NQFVG IP     L SL  L L
Sbjct: 216 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 273
Query: 471 SKNSFSGAIPSSL-GRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIP 529
           ++N F+G IP  L G C++L  LDLS N   G +P   F    L  SL LS N  SG +P
Sbjct: 274 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP-PFFGSCSLLESLALSSNNFSGELP 332
Query: 530 -PQISALNKLSILDLSHNKXXXXXXXXXXXXXXXXXNVSYNNFTGYLPDS 578
              +  +  L +LDLS                       +N F+G LP+S
Sbjct: 333 MDTLLKMRGLKVLDLS-----------------------FNEFSGELPES 359

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  169 bits (427), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 166/581 (28%), Positives = 242/581 (41%), Gaps = 82/581 (14%)
Query: 57  QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTG 116
           Q L ISG+ L+G  S  +  CT+L  +++SSN  VG +P     L +LQ L L  N+ TG
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283
Query: 117 EIPKEL-GACIKLKNLLLFDNYLSGNLPVELG-------------------------KLV 150
           EIP  L GAC  L  L L  N+  G +P   G                         K+ 
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 151 NLEVIRAGGNKDIAGKIPYEIGDCQ-SLLVVGLADTKVAGSLPAXXXXXXXXXXXXVY-- 207
            L+V+    N + +G++P  + +   SLL + L+    +G +              +Y  
Sbjct: 344 GLKVLDLSFN-EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQ 402
Query: 208 TTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEI 267
               +G+IPP + NCSELV L L  N LSG++P  LG L KL  + LW N  +G IP+E+
Sbjct: 403 NNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
Query: 268 GNCKSLKTIDLSLNFFSGSLPQSFGXXXXXXXXXXXXXXXXGSIPPVLSNATSLLQLQLD 327
              K+L+T+ L  N  +G +P                    G IP  +    +L  L+L 
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 328 TNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGXXXXXXXXXXXXXXX 387
            N  S          G+IP+ L +CRSL  +DL+ N   G++ P                
Sbjct: 523 NNSFS----------GNIPAELGDCRSLIWLDLNTNLFNGTI-PAAMFKQSGKIAANFIA 571
Query: 388 XXXXXXPPEIGNCSSLIRLRLMSFGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDIS 447
                     G     ++      GN  + Q                L  L+     +I+
Sbjct: 572 GKRYVYIKNDG-----MKKECHGAGNLLEFQ----------GIRSEQLNRLSTRNPCNIT 616
Query: 448 VNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVEL 507
              + G    +F    S+  L +S N  SG IP  +G    L  L+L  N +SG IP E+
Sbjct: 617 SRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
Query: 508 FEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKXXXXXXXXXXXXXXXXXNVS 567
            ++ GL+I L+LS N L G IP  +SAL  L+ +DLS+                      
Sbjct: 677 GDLRGLNI-LDLSSNKLDGRIPQAMSALTMLTEIDLSN---------------------- 713
Query: 568 YNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNA 608
            NN +G +P+   F      +   N GLC      C  SNA
Sbjct: 714 -NNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNA 753

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 411 FGNCTQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLIL 470
            G+C+ LQ               ++++ T L++L+IS NQFVG IP     L SL  L L
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276
Query: 471 SKNSFSGAIPSSL-GRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIP 529
           ++N F+G IP  L G C++L  LDLS N   G +P   F    L  SL LS N  SG +P
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP-PFFGSCSLLESLALSSNNFSGELP 335
Query: 530 -PQISALNKLSILDLSHNKXXXXXXXXXXXXXXXXXNVSYNNFTGYLPDS 578
              +  +  L +LDLS                       +N F+G LP+S
Sbjct: 336 MDTLLKMRGLKVLDLS-----------------------FNEFSGELPES 362

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  148 bits (374), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 105/308 (34%), Positives = 160/308 (51%), Gaps = 34/308 (11%)
Query: 671 LTPFQKLNF---TVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEY 727
           L PF+        +E+         ++G G  G VY+  + +G  +A+K+  P +     
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI- 79
Query: 728 DCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 787
                        + F  EI+TL   RH ++V  +G C  RN  +L+Y YM NG+L   L
Sbjct: 80  -------------EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 788 H--ERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
           +  +     + WE R  I +GAA+GL YLH      I+HRD+K+ NIL+   F P I DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183
Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           G++K   E D       V G+ GYI PEY    ++TEKSDVYS+GVV+ EVL  +  I  
Sbjct: 184 GISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 906 TIP-EGLHIVDWVRQKR--GAIE-VLDKSL--RARPEVEIEEMLQTLG-VALLCVNPTPD 958
           ++P E +++ +W  +    G +E ++D +L  + RP     E L+  G  A+ C+  + +
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP-----ESLRKFGDTAVKCLALSSE 298
Query: 959 DRPTMKDV 966
           DRP+M DV
Sbjct: 299 DRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  145 bits (366), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 104/308 (33%), Positives = 159/308 (51%), Gaps = 34/308 (11%)
Query: 671 LTPFQKLNF---TVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEY 727
           L PF+        +E+         ++G G  G VY+  + +G  +A+K+  P +     
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI- 79
Query: 728 DCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 787
                        + F  EI+TL   RH ++V  +G C  RN  +L+Y YM NG+L   L
Sbjct: 80  -------------EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 788 H--ERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
           +  +     + WE R  I +GAA+GL YLH      I+HRD+K+ NIL+   F P I DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183
Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           G++K   E         V G+ GYI PEY    ++TEKSDVYS+GVV+ EVL  +  I  
Sbjct: 184 GISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243
Query: 906 TIP-EGLHIVDWVRQKR--GAIE-VLDKSL--RARPEVEIEEMLQTLG-VALLCVNPTPD 958
           ++P E +++ +W  +    G +E ++D +L  + RP     E L+  G  A+ C+  + +
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP-----ESLRKFGDTAVKCLALSSE 298
Query: 959 DRPTMKDV 966
           DRP+M DV
Sbjct: 299 DRPSMGDV 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  133 bits (334), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 95/291 (32%), Positives = 153/291 (52%), Gaps = 36/291 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY+  + N   +AVKKL     AA  D   +++     +  F  EIK +   
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKL-----AAMVDITTEEL-----KQQFDQEIKVMAKC 87
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE------WELRYRIILGA 807
           +H+N+V  LG   + +   L+Y YMPNGSL   L     SCL+      W +R +I  GA
Sbjct: 88  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-----SCLDGTPPLSWHMRCKIAQGA 142
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS--SNTVAG 865
           A G+ +LH +     +HRDIK+ NIL+   F   I+DFGLA+      FA++   + + G
Sbjct: 143 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQTVMXSRIVG 197
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI---VDWVRQKRG 922
           +  Y+APE     +IT KSD+YS+GVV+LE++TG   +D      L +    +   +++ 
Sbjct: 198 TTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 256
Query: 923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             + +DK +       +E M     VA  C++   + RP +K V  +++E+
Sbjct: 257 IEDYIDKKMNDADSTSVEAM---YSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  132 bits (333), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 95/291 (32%), Positives = 152/291 (52%), Gaps = 36/291 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY+  + N   +AVKKL     AA  D   +++     +  F  EIK +   
Sbjct: 39  MGEGGFGVVYKGYV-NNTTVAVKKL-----AAMVDITTEEL-----KQQFDQEIKVMAKC 87
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE------WELRYRIILGA 807
           +H+N+V  LG   + +   L+Y YMPNGSL   L     SCL+      W +R +I  GA
Sbjct: 88  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-----SCLDGTPPLSWHMRCKIAQGA 142
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS--SNTVAG 865
           A G+ +LH +     +HRDIK+ NIL+   F   I+DFGLA+      FA++     + G
Sbjct: 143 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQTVMXXRIVG 197
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI---VDWVRQKRG 922
           +  Y+APE     +IT KSD+YS+GVV+LE++TG   +D      L +    +   +++ 
Sbjct: 198 TTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 256
Query: 923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             + +DK +       +E M     VA  C++   + RP +K V  +++E+
Sbjct: 257 IEDYIDKKMNDADSTSVEAM---YSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  131 bits (330), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 95/291 (32%), Positives = 151/291 (51%), Gaps = 36/291 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY+  + N   +AVKKL     AA  D   +++     +  F  EIK +   
Sbjct: 33  MGEGGFGVVYKGYV-NNTTVAVKKL-----AAMVDITTEEL-----KQQFDQEIKVMAKC 81
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE------WELRYRIILGA 807
           +H+N+V  LG   + +   L+Y YMPNGSL   L     SCL+      W +R +I  GA
Sbjct: 82  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-----SCLDGTPPLSWHMRCKIAQGA 136
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS--SNTVAG 865
           A G+ +LH +     +HRDIK+ NIL+   F   I+DFGLA+      FA+      + G
Sbjct: 137 ANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR--ASEKFAQXVMXXRIVG 191
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI---VDWVRQKRG 922
           +  Y+APE     +IT KSD+YS+GVV+LE++TG   +D      L +    +   +++ 
Sbjct: 192 TTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT 250
Query: 923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             + +DK +       +E M     VA  C++   + RP +K V  +++E+
Sbjct: 251 IEDYIDKKMNDADSTSVEAM---YSVASQCLHEKKNKRPDIKKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  123 bits (308), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 139/284 (48%), Gaps = 26/284 (9%)
Query: 695 GKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR 754
           G+G  G+VY+  + N   +AVKKL     AA  D   +++     +  F  EIK     +
Sbjct: 31  GEGGFGVVYKGYV-NNTTVAVKKL-----AAMVDITTEEL-----KQQFDQEIKVXAKCQ 79
Query: 755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE------WELRYRIILGAA 808
           H+N+V  LG   + +   L+Y Y PNGSL   L     SCL+      W  R +I  GAA
Sbjct: 80  HENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-----SCLDGTPPLSWHXRCKIAQGAA 134
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
            G+ +LH +     +HRDIK+ NIL+   F   I+DFGLA+   +       + + G+  
Sbjct: 135 NGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTA 191
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           Y APE     +IT KSD+YS+GVV+LE++TG   +D      L +      +     + D
Sbjct: 192 YXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED 250
Query: 929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
              +   + +   +     VA  C++   + RP +K V  +++E
Sbjct: 251 YIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  106 bits (264), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 127/253 (50%), Gaps = 40/253 (15%)
Query: 651 GKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENG 710
           G M GDD+D       +PW        +  +++          +G G  G V+RAE  +G
Sbjct: 25  GAMDGDDMD-------IPW-------CDLNIKEK---------IGAGSFGTVHRAEW-HG 60
Query: 711 EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNT 770
             +AVK L       E D   +++      + F  E+  +  +RH NIV F+G       
Sbjct: 61  SDVAVKIL------MEQDFHAERV------NEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108
Query: 771 RLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKA 829
             ++ +Y+  GSL  LLH+      L+   R  +    A+G+ YLH+   PPIVHR++K+
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKS 167
Query: 830 NNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSY 889
            N+L+  ++   + DFGL++L  +     SS + AG+  ++APE        EKSDVYS+
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 890 GVVVLEVLTGKQP 902
           GV++ E+ T +QP
Sbjct: 226 GVILWELATLQQP 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (263), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/253 (31%), Positives = 125/253 (49%), Gaps = 40/253 (15%)
Query: 651 GKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENG 710
           G M GDD+D       +PW        +  +++          +G G  G V+RAE  +G
Sbjct: 25  GAMDGDDMD-------IPW-------CDLNIKEK---------IGAGSFGTVHRAEW-HG 60
Query: 711 EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNT 770
             +AVK L       E D   +++      + F  E+  +  +RH NIV F+G       
Sbjct: 61  SDVAVKIL------MEQDFHAERV------NEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108
Query: 771 RLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKA 829
             ++ +Y+  GSL  LLH+      L+   R  +    A+G+ YLH+   PPIVHRD+K+
Sbjct: 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRDLKS 167
Query: 830 NNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSY 889
            N+L+  ++   + DFGL++L  +      S   AG+  ++APE        EKSDVYS+
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 890 GVVVLEVLTGKQP 902
           GV++ E+ T +QP
Sbjct: 226 GVILWELATLQQP 238

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 139/291 (47%), Gaps = 47/291 (16%)
Query: 688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           L  + ++G G  G VYRA    G+ +AVK       AA +D   D   I    ++   E 
Sbjct: 9   LTLEEIIGIGGFGKVYRA-FWIGDEVAVK-------AARHDPDED---ISQTIENVRQEA 57
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR---DSCLEWELRYRII 804
           K    ++H NI+   G C       L+ ++   G L  +L  +R   D  + W ++    
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI--- 114
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP--------YIADFGLAKLVVEGDF 856
              A+G+ YLH + + PI+HRD+K++NILI  + E          I DFGLA+     ++
Sbjct: 115 ---ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EW 166
Query: 857 ARSSN-TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
            R++  + AG+Y ++APE       ++ SDV+SYGV++ E+LTG+ P      +GL +  
Sbjct: 167 HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--DGLAVAY 224
Query: 916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
            V   + A+ +   S    P  ++ E          C NP P  RP+  ++
Sbjct: 225 GVAMNKLALPI--PSTCPEPFAKLMED---------CWNPDPHSRPSFTNI 264

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 90/307 (29%), Positives = 148/307 (48%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 9   ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 54
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 55  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 110
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 111 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +F +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 226
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 283
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 284 LRVDQIR 290

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 111/231 (48%), Gaps = 32/231 (13%)
Query: 688 LVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           L+   V+GKGC G   +    E GEV+ +K+L        +D +  +        +F  E
Sbjct: 12  LIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL------IRFDEETQR--------TFLKE 57
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
           +K +  + H N+++F+G  +       + +Y+  G+L  ++ +  DS   W  R      
Sbjct: 58  VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKD 116
Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA--------- 857
            A G+AYLH      I+HRD+ ++N L+       +ADFGLA+L+V+             
Sbjct: 117 IASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 858 ---RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
              +   TV G+  ++APE        EK DV+S+G+V+ E++ G+   DP
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADP 223

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 50  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGLA+ V+E D   +  T  G    
Sbjct: 159 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLAR-VLEDDPEAAYTTRGGKIPI 214
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 262
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 111/234 (47%), Gaps = 26/234 (11%)
Query: 677 LNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENG----EV-IAVKKLWPTTMAAEYDCQN 731
           L FT E    C+    V+G G  G VY+  ++      EV +A+K     T+ A Y  + 
Sbjct: 35  LKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-----TLKAGYTEKQ 89
Query: 732 DKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR 791
                   R  F  E   +G   H NI+R  G        +++ +YM NG+L   L E+ 
Sbjct: 90  --------RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD 141
Query: 792 DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                 +L   ++ G A G+ YL +      VHRD+ A NIL+       ++DFGL++ V
Sbjct: 142 GEFSVLQL-VGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSR-V 196
Query: 852 VEGDFARSSNTVAGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           +E D   +  T  G     + APE     K T  SDV+S+G+V+ EV+T G++P
Sbjct: 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 37/284 (13%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G+V+     N + +A+K +   +M+                D F  E + +  +
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS---------------EDDFIEEAEVMMKL 79
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H  +V+  G C  +    L++++M +G L   L  +R      E    + L   +G+AY
Sbjct: 80  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAY 138
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           L   CV   +HRD+ A N L+G      ++DFG+ + V++  +  S+ T      + +PE
Sbjct: 139 LEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPE 194
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + + KSDV+S+GV++ EV + GK P +             R     +E +    R
Sbjct: 195 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN------------RSNSEVVEDISTGFR 242
Query: 933 -ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
             +P +    + Q +     C    P+DRP    +   + EI +
Sbjct: 243 LYKPRLASTHVYQIMN---HCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 50  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 159 GMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 214
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 262
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 21  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIAS 129
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 130 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 185
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 233
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 234 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 38  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIAS 146
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 147 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 202
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 203 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 250
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 251 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 50  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 159 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 214
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 262
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 113/257 (43%), Gaps = 28/257 (10%)
Query: 727 YDCQNDKIGIGGVRD------SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPN 780
           Y    DK+ I  +R+       F  E + +  + H  +V+  G C  +    L++++M +
Sbjct: 27  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 86
Query: 781 GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP 840
           G L   L  +R      E    + L   +G+AYL   CV   +HRD+ A N L+G     
Sbjct: 87  GCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVI 142
Query: 841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-G 899
            ++DFG+ + V++  +  S+ T      + +PE     + + KSDV+S+GV++ EV + G
Sbjct: 143 KVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 201
Query: 900 KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPD 958
           K P +             R     +E +    R  +P +    + Q +     C    P+
Sbjct: 202 KIPYEN------------RSNSEVVEDISTGFRLYKPRLASTHVYQIMN---HCWKERPE 246
Query: 959 DRPTMKDVAAMIKEIKQ 975
           DRP    +   + EI +
Sbjct: 247 DRPAFSRLLRQLAEIAE 263

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 113/257 (43%), Gaps = 28/257 (10%)
Query: 727 YDCQNDKIGIGGVRD------SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPN 780
           Y    DK+ I  +R+       F  E + +  + H  +V+  G C  +    L++++M +
Sbjct: 25  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84
Query: 781 GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP 840
           G L   L  +R      E    + L   +G+AYL   CV   +HRD+ A N L+G     
Sbjct: 85  GCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVI 140
Query: 841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-G 899
            ++DFG+ + V++  +  S+ T      + +PE     + + KSDV+S+GV++ EV + G
Sbjct: 141 KVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 900 KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPD 958
           K P +             R     +E +    R  +P +    + Q +     C    P+
Sbjct: 200 KIPYEN------------RSNSEVVEDISTGFRLYKPRLASTHVYQIMN---HCWKERPE 244
Query: 959 DRPTMKDVAAMIKEIKQ 975
           DRP    +   + EI +
Sbjct: 245 DRPAFSRLLRQLAEIAE 261

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 50  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 159 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 214
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 262
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 50  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 159 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 214
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 262
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 125/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 50  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL + V+E D   +  T  G    
Sbjct: 159 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPI 214
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 262
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 113/257 (43%), Gaps = 28/257 (10%)
Query: 727 YDCQNDKIGIGGVRD------SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPN 780
           Y    DK+ I  +R+       F  E + +  + H  +V+  G C  +    L++++M +
Sbjct: 30  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89
Query: 781 GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP 840
           G L   L  +R      E    + L   +G+AYL   CV   +HRD+ A N L+G     
Sbjct: 90  GCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVI 145
Query: 841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-G 899
            ++DFG+ + V++  +  S+ T      + +PE     + + KSDV+S+GV++ EV + G
Sbjct: 146 KVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 204
Query: 900 KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPD 958
           K P +             R     +E +    R  +P +    + Q +     C    P+
Sbjct: 205 KIPYEN------------RSNSEVVEDISTGFRLYKPRLASTHVYQIMN---HCWRERPE 249
Query: 959 DRPTMKDVAAMIKEIKQ 975
           DRP    +   + EI +
Sbjct: 250 DRPAFSRLLRQLAEIAE 266

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 48  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 156
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 157 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 212
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 213 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 260
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 261 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 126/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 50  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ +YM NGSL S L  + D+         ++ G A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 159 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 214
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 262
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 148/309 (47%), Gaps = 39/309 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 40  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 85
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 86  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 141
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 142 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 198 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 257
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 258 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 314
Query: 968 AMIKEIKQE 976
             + +I+ +
Sbjct: 315 LRVDQIRDQ 323

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 16  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 61
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 62  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 117
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 118 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 173
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 174 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 233
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 234 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 290
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 291 LRVDQIR 297

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 27  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 72
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 73  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 128
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 129 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 244
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 245 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 301
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 302 LRVDQIR 308

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 9   ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 54
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 55  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 110
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 111 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 167 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 226
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 283
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 284 LRVDQIR 290

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 27  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 72
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 73  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 128
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 129 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 244
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 245 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 301
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 302 LRVDQIR 308

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 87.0 bits (214), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 89/309 (28%), Positives = 148/309 (47%), Gaps = 39/309 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 7   ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 52
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 53  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 108
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 109 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 164
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 165 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 224
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 225 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 281
Query: 968 AMIKEIKQE 976
             + +I+ +
Sbjct: 282 LRVDQIRDQ 290

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 14  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 59
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 60  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 115
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 116 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 171
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 172 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 231
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 232 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 288
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 289 LRVDQIR 295

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 12  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 57
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 58  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 113
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 114 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 229
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 230 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 286
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 287 LRVDQIR 293

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 9   ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 54
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 55  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 110
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 111 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 167 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 226
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 283
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 284 LRVDQIR 290

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 15  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 60
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 61  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 116
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 117 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 172
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 173 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 232
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 233 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 289
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 290 LRVDQIR 296

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 13  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 58
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 59  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 114
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 115 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 170
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 171 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 230
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 231 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 287
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 288 LRVDQIR 294

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 148/307 (48%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 10  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 55
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 56  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 111
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HR++   NIL+  E    I DFGL K++  
Sbjct: 112 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ 167
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + ++ +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 168 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 227
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 228 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 284
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 285 LRVDQIR 291

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 8   ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 53
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L + ++ 
Sbjct: 54  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKER 109
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 110 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 165
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 166 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 225
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 226 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 282
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 283 LRVDQIR 289

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  I
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKI 70
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 71  RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 185
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 233
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 234 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 271

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 133/301 (44%), Gaps = 52/301 (17%)
Query: 694 VGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G V+ AE  N        ++AVK L   T+AA              R  F  E 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--------------RKDFQREA 68
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER------------RDSCL 795
           + L +++H++IV+F G C + +  +++++YM +G L   L               R +  
Sbjct: 69  ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 796 EWELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
           E  L   + + +  A G+ YL        VHRD+   N L+G      I DFG+++ V  
Sbjct: 129 ELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 854 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLH 912
            D+ R          ++ PE     K T +SDV+S+GV++ E+ T GKQP          
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL--SNTE 243
Query: 913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
           +++ + Q R    VL+     RP V  +E+     V L C    P  R  +K++  ++  
Sbjct: 244 VIECITQGR----VLE-----RPRVCPKEVYD---VMLGCWQREPQQRLNIKEIYKILHA 291
Query: 973 I 973
           +
Sbjct: 292 L 292

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 141/288 (48%), Gaps = 35/288 (12%)
Query: 694 VGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G+V++  + ++  V+A+K L    +  + + + + I        F  E+  + +
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSL----ILGDSEGETEMIE---KFQEFQREVFIMSN 79
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+  G   N   R++M +++P G L   L ++    ++W ++ R++L  A G+ 
Sbjct: 80  LNHPNIVKLYGLMHN-PPRMVM-EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIE 136
Query: 813 YLHHDCVPPIVHRDIKANNILIGP--EFEPY---IADFGLAKLVVEGDFARSSNTVAGSY 867
           Y+ +   PPIVHRD+++ NI +    E  P    +ADFGL++  V      S + + G++
Sbjct: 137 YMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLGNF 190
Query: 868 GYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE 925
            ++APE         TEK+D YS+ +++  +LTG+ P D      +  ++ +R++     
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE----- 245
Query: 926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                   RP +  +   +   V  LC +  P  RP    +   + E+
Sbjct: 246 ------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 112/257 (43%), Gaps = 28/257 (10%)
Query: 727 YDCQNDKIGIGGVRD------SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPN 780
           Y    DK+ I  +R+       F  E + +  + H  +V+  G C  +    L+ ++M +
Sbjct: 28  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87
Query: 781 GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP 840
           G L   L  +R      E    + L   +G+AYL   CV   +HRD+ A N L+G     
Sbjct: 88  GCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVI 143
Query: 841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-G 899
            ++DFG+ + V++  +  S+ T      + +PE     + + KSDV+S+GV++ EV + G
Sbjct: 144 KVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202
Query: 900 KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPD 958
           K P +             R     +E +    R  +P +    + Q +     C    P+
Sbjct: 203 KIPYEN------------RSNSEVVEDISTGFRLYKPRLASTHVYQIMN---HCWRERPE 247
Query: 959 DRPTMKDVAAMIKEIKQ 975
           DRP    +   + EI +
Sbjct: 248 DRPAFSRLLRQLAEIAE 264

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 63
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 64  RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 122
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 123 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 178
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 179 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 226
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 227 MPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFLED 264

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 319
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 320 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 379 VERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 434
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 482
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 483 MPCPPECPESLHDL--MCQCWRKEPEERPTFEYLQAFLED 520

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 70
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 71  RHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 185
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 233
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 234 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 271

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 59
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 60  RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 118
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 119 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 174
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 175 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 222
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 223 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 260

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 61
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 62  RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 120
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 121 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 176
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 224
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 225 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 262

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 70
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 71  RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 185
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 233
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 234 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 271

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 50  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ + M NGSL S L  + D+         ++ G A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 159 GMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 214
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 262
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 70
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+           ++M +YM  G L   L       L       +    A G+AY
Sbjct: 71  RHEKLVQLYAVVSEEPIYIVM-EYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 185
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 233
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 234 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 271

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 147/307 (47%), Gaps = 39/307 (12%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 12  ERHLKFLRQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 57
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLHERRDS 793
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +++P GSL   L + ++ 
Sbjct: 58  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EFLPYGSLREYLQKHKER 113
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-V 852
               +L  +      +G+ YL        +HRD+   NIL+  E    I DFGL K++  
Sbjct: 114 IDHIKL-LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
           + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 229
Query: 913 IVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
           ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +D+A
Sbjct: 230 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFRDLA 286
Query: 968 AMIKEIK 974
             + +I+
Sbjct: 287 LRVDQIR 293

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 236
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 237 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 351
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 399
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 400 MPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFLED 437

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 70
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 71  RHEKLVQLYAVV-SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 185
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 233
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 234 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 271

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 21  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ + M NGSL S L  + D+         ++ G A 
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR-KHDAQFTVIQLVGMLRGIAS 129
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 130 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 185
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 186 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 233
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 234 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 147/310 (47%), Gaps = 45/310 (14%)
Query: 682 EQVLKCLVEDSVVGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           E+ LK L +   +GKG  G V    Y    +N GEV+AVKKL  +T              
Sbjct: 12  ERHLKFLQQ---LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH----------- 57
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWN---RNTRLLMYDYMPNGSLGSLLH---ER 790
             +RD F  EI+ L S++H NIV++ G C++   RN +L+M +Y+P GSL   L    ER
Sbjct: 58  --LRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQAHAER 113
Query: 791 RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
            D     +   +I     +G+ YL        +HRD+   NIL+  E    I DFGL K+
Sbjct: 114 IDHIKLLQYTSQI----CKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKV 166
Query: 851 V-VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE 909
           +  + +  +          + APE     K +  SDV+S+GVV+ E+ T  +       E
Sbjct: 167 LPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226
Query: 910 GLHIVDWVRQKR----GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK 964
            + ++   +Q +      IE+L  + R  RP+   +E+     +   C N   + RP+ +
Sbjct: 227 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYM---IMTECWNNNVNQRPSFR 283
Query: 965 DVAAMIKEIK 974
           D+A  + +I+
Sbjct: 284 DLALRVDQIR 293

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 236
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 237 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 351
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 399
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 400 MPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFLED 437

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 33/287 (11%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKT 749
           D VVG G          E GEV + +   P+        +  K+G     R  F  E   
Sbjct: 50  DKVVGAG----------EFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +G   H NI+R  G        +++ + M NGSL S L  + D+         ++ G A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS--Y 867
           G+ YL        VHRD+ A NILI       ++DFGL++ V+E D   +  T  G    
Sbjct: 159 GMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPI 214
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
            + +PE     K T  SDV+SYG+V+ EV++ G++P             W    +  I+ 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------------WEMSNQDVIKA 262
Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +D+  R  P ++    L  L   L C     ++RP  + + +++ ++
Sbjct: 263 VDEGYRLPPPMDCPAALYQL--MLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 134/293 (45%), Gaps = 54/293 (18%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           + VVG+G  G+V +A+    +V A+K++         + +++       R +F  E++ L
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKDV-AIKQI---------ESESE-------RKAFIVELRQL 56
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-------SCLEWELRYRI 803
             + H NIV+  G C   N   L+ +Y   GSL ++LH             + W      
Sbjct: 57  SRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------ 108
Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFARSS 860
            L  +QG+AYLH      ++HRD+K  N+L+   G   +  I DFG A      D     
Sbjct: 109 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK--ICDFGTA-----CDIQTHM 161
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
               GS  ++APE       +EK DV+S+G+++ EV+T ++P D        I+ W    
Sbjct: 162 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-WAVHN 220
Query: 921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            G    L K+L  +P   IE ++        C +  P  RP+M+++  ++  +
Sbjct: 221 -GTRPPLIKNL-PKP---IESLMTR------CWSKDPSQRPSMEEIVKIMTHL 262

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 236
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 237 RHEKLVQLYAVV-SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 351
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 399
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 400 MPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFLED 437

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 35/288 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 20  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 65
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H    S  ++E++  I +    A+G+
Sbjct: 66  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGM 121
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA +      +     ++GS  ++A
Sbjct: 122 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 178
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           PE   M      + +SDVY++G+V+ E++TG+ P    I     I++ V   RG++    
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMV--GRGSLSPDL 235
Query: 929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
             +R+     ++ ++        C+    D+RP+   + A I+E+ +E
Sbjct: 236 SKVRSNCPKRMKRLMAE------CLKKKRDERPSFPRILAEIEELARE 277

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 67
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 68  RHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 127 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 182
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 230
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 231 MPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFLED 268

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 70
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 71  RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD+ A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 130 VER---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 185
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 233
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 234 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 271

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 70
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 71  RHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L +E +   +         + APE
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTAPE 185
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 233
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 234 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 271

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 134/293 (45%), Gaps = 54/293 (18%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           + VVG+G  G+V +A+    +V A+K++         + +++       R +F  E++ L
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDV-AIKQI---------ESESE-------RKAFIVELRQL 55
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-------SCLEWELRYRI 803
             + H NIV+  G C   N   L+ +Y   GSL ++LH             + W      
Sbjct: 56  SRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------ 107
Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFARSS 860
            L  +QG+AYLH      ++HRD+K  N+L+   G   +  I DFG A      D     
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK--ICDFGTA-----CDIQTHM 160
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
               GS  ++APE       +EK DV+S+G+++ EV+T ++P D        I+ W    
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-WAVHN 219
Query: 921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            G    L K+L  +P   IE ++        C +  P  RP+M+++  ++  +
Sbjct: 220 -GTRPPLIKNL-PKP---IESLMTR------CWSKDPSQRPSMEEIVKIMTHL 261

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 34/281 (12%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +    K  +      F  E   +
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKI----PVAIKILNETTGPKANV-----EFMDEALIM 94
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
            S+ H ++VR LG C +   +L+    MP+G L   +HE +D+ +  +L     +  A+G
Sbjct: 95  ASMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLEYVHEHKDN-IGSQLLLNWCVQIAKG 152
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY--G 868
           + YL       +VHRD+ A N+L+       I DFGLA+L +EGD  +  N   G     
Sbjct: 153 MMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGD-EKEYNADGGKMPIK 207
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVL 927
           ++A E  +  K T +SDV+SYGV + E++T G +P D  IP            R   ++L
Sbjct: 208 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIP-----------TREIPDLL 255
Query: 928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA 968
           +K  R  P+  I   +    V + C     D RP  K++AA
Sbjct: 256 EKGERL-PQPPI-CTIDVYMVMVKCWMIDADSRPKFKELAA 294

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 71/280 (25%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 60
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 61  RHEKLVQLYAVV-SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 119
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L +E +   +         + APE
Sbjct: 120 VER---MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTAPE 175
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 176 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 223
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 224 MPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFLED 261

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 34/281 (12%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +    K  +      F  E   +
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKI----PVAIKILNETTGPKANV-----EFMDEALIM 71
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
            S+ H ++VR LG C +   +L+    MP+G L   +HE +D+ +  +L     +  A+G
Sbjct: 72  ASMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLEYVHEHKDN-IGSQLLLNWCVQIAKG 129
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY--G 868
           + YL       +VHRD+ A N+L+       I DFGLA+L +EGD  +  N   G     
Sbjct: 130 MMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGD-EKEYNADGGKMPIK 184
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVL 927
           ++A E  +  K T +SDV+SYGV + E++T G +P D  IP            R   ++L
Sbjct: 185 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIP-----------TREIPDLL 232
Query: 928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA 968
           +K  R  P+  I   +    V + C     D RP  K++AA
Sbjct: 233 EKGERL-PQPPI-CTIDVYMVMVKCWMIDADSRPKFKELAA 271

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 140/288 (48%), Gaps = 35/288 (12%)
Query: 694 VGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G+V++  + ++  V+A+K L    +  + + + + I        F  E+  + +
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSL----ILGDSEGETEMIE---KFQEFQREVFIMSN 79
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+  G   N   R++M +++P G L   L ++    ++W ++ R++L  A G+ 
Sbjct: 80  LNHPNIVKLYGLMHN-PPRMVM-EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIE 136
Query: 813 YLHHDCVPPIVHRDIKANNILIGP--EFEPY---IADFGLAKLVVEGDFARSSNTVAGSY 867
           Y+ +   PPIVHRD+++ NI +    E  P    +ADFG ++  V      S + + G++
Sbjct: 137 YMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-----HSVSGLLGNF 190
Query: 868 GYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE 925
            ++APE         TEK+D YS+ +++  +LTG+ P D      +  ++ +R++     
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE----- 245
Query: 926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                   RP +  +   +   V  LC +  P  RP    +   + E+
Sbjct: 246 ------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 140/288 (48%), Gaps = 35/288 (12%)
Query: 694 VGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G+V++  + ++  V+A+K L    +  + + + + I        F  E+  + +
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSL----ILGDSEGETEMIE---KFQEFQREVFIMSN 79
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+  G   N   R++M +++P G L   L ++    ++W ++ R++L  A G+ 
Sbjct: 80  LNHPNIVKLYGLMHN-PPRMVM-EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIE 136
Query: 813 YLHHDCVPPIVHRDIKANNILIGP--EFEPY---IADFGLAKLVVEGDFARSSNTVAGSY 867
           Y+ +   PPIVHRD+++ NI +    E  P    +ADF L++  V      S + + G++
Sbjct: 137 YMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-----HSVSGLLGNF 190
Query: 868 GYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE 925
            ++APE         TEK+D YS+ +++  +LTG+ P D      +  ++ +R++     
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE----- 245
Query: 926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                   RP +  +   +   V  LC +  P  RP    +   + E+
Sbjct: 246 ------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 70/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 67
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 68  RHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAY 126
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 127 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWT-ARQGAKFPIKWTAPE 182
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 183 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 230
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 231 MPCPPECPESLHDLMCQ--CWRKEPEERPTFEYLQAFLED 268

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 80/304 (26%), Positives = 123/304 (40%), Gaps = 55/304 (18%)
Query: 694 VGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G V+ AE  N        ++AVK L   + +A              R  F  E 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--------------RQDFQREA 71
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC------------- 794
           + L  ++H++IVRF G C      L++++YM +G L   L                    
Sbjct: 72  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 131
Query: 795 LEWELRYRIILGAAQGLAYLH--HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
           L       +    A G+ YL   H      VHRD+   N L+G      I DFG+++ + 
Sbjct: 132 LGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 186
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL 911
             D+ R          ++ PE     K T +SDV+S+GVV+ E+ T GKQP         
Sbjct: 187 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNT 244
Query: 912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK 971
             +D + Q R     L++     PEV          +   C    P  R ++KDV A ++
Sbjct: 245 EAIDCITQGRE----LERPRACPPEV--------YAIMRGCWQREPQQRHSIKDVHARLQ 292
Query: 972 EIKQ 975
            + Q
Sbjct: 293 ALAQ 296

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 80/304 (26%), Positives = 123/304 (40%), Gaps = 55/304 (18%)
Query: 694 VGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G V+ AE  N        ++AVK L   + +A              R  F  E 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--------------RQDFQREA 65
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC------------- 794
           + L  ++H++IVRF G C      L++++YM +G L   L                    
Sbjct: 66  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 125
Query: 795 LEWELRYRIILGAAQGLAYLH--HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
           L       +    A G+ YL   H      VHRD+   N L+G      I DFG+++ + 
Sbjct: 126 LGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 180
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL 911
             D+ R          ++ PE     K T +SDV+S+GVV+ E+ T GKQP         
Sbjct: 181 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNT 238
Query: 912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK 971
             +D + Q R     L++     PEV          +   C    P  R ++KDV A ++
Sbjct: 239 EAIDCITQGRE----LERPRACPPEV--------YAIMRGCWQREPQQRHSIKDVHARLQ 286
Query: 972 EIKQ 975
            + Q
Sbjct: 287 ALAQ 290

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 80/304 (26%), Positives = 123/304 (40%), Gaps = 55/304 (18%)
Query: 694 VGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G V+ AE  N        ++AVK L   + +A              R  F  E 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--------------RQDFQREA 94
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC------------- 794
           + L  ++H++IVRF G C      L++++YM +G L   L                    
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 795 LEWELRYRIILGAAQGLAYLH--HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
           L       +    A G+ YL   H      VHRD+   N L+G      I DFG+++ + 
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL 911
             D+ R          ++ PE     K T +SDV+S+GVV+ E+ T GKQP         
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--SNT 267
Query: 912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK 971
             +D + Q R     L++     PEV          +   C    P  R ++KDV A ++
Sbjct: 268 EAIDCITQGRE----LERPRACPPEV--------YAIMRGCWQREPQQRHSIKDVHARLQ 315
Query: 972 EIKQ 975
            + Q
Sbjct: 316 ALAQ 319

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P TM+ E               +F  E + +  +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------------AFLQEAQVMKKL 70
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  G L   L       L       +    A G+AY
Sbjct: 71  RHEKLVQLYAVV-SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 129
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGLA+L+ + ++  +         + APE
Sbjct: 130 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 185
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 186 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 233
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 234 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 271

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 136/288 (47%), Gaps = 35/288 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 77
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H    S  ++E++  I +    A+G+
Sbjct: 78  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA        +     ++GS  ++A
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           PE   M      + +SDVY++G+V+ E++TG+ P    I     I++ V   RG++    
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMV--GRGSLSPDL 247
Query: 929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
             +R+     ++ ++        C+    D+RP+   + A I+E+ +E
Sbjct: 248 SKVRSNCPKRMKRLMAE------CLKKKRDERPSFPRILAEIEELARE 289

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/291 (29%), Positives = 129/291 (44%), Gaps = 69/291 (23%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY A ++ N EV+A+KK+  +   +    Q+              E++ L  
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-----------IIKEVRFLQK 110
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH N +++ GC    +T  L+ +Y   GS   LL   +    E E+   +  GA QGLA
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQGLA 168
Query: 813 YLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS-----NTVAGS 866
           YLH H+    ++HRD+KA NIL+    EP     GL KL   GDF  +S     N   G+
Sbjct: 169 YLHSHN----MIHRDVKAGNILLS---EP-----GLVKL---GDFGSASIMAPANXFVGT 213
Query: 867 YGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI----------------DPTI 907
             ++APE    M   +   K DV+S G+  +E+   K P+                 P +
Sbjct: 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 273
Query: 908 PEGLHIVDWVR-----------QKRGAIEVLDKS---LRARPEVEIEEMLQ 944
             G H  ++ R           Q R   EVL K    LR RP   I +++Q
Sbjct: 274 QSG-HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQ 323

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 136/288 (47%), Gaps = 35/288 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 77
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H    S  ++E++  I +    A+G+
Sbjct: 78  RHVNILLFMG--YSTAPQLAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA        +     ++GS  ++A
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           PE   M      + +SDVY++G+V+ E++TG+ P    I     I++ V   RG++    
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMV--GRGSLSPDL 247
Query: 929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
             +R+     ++ ++        C+    D+RP+   + A I+E+ +E
Sbjct: 248 SKVRSNCPKRMKRLMAE------CLKKKRDERPSFPRILAEIEELARE 289

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 107/245 (43%), Gaps = 28/245 (11%)
Query: 727 YDCQNDKIGIGGVRD------SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPN 780
           Y    DK+ I  +R+       F  E + +  + H  +V+  G C  +    L++++M +
Sbjct: 27  YWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 86
Query: 781 GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP 840
           G L   L  +R      E    + L   +G+AYL       ++HRD+ A N L+G     
Sbjct: 87  GCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ASVIHRDLAARNCLVGENQVI 142
Query: 841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-G 899
            ++DFG+ + V++  +  S+ T      + +PE     + + KSDV+S+GV++ EV + G
Sbjct: 143 KVSDFGMTRFVLDDQYTSSTGT-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 201
Query: 900 KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPD 958
           K P +             R     +E +    R  +P +    + Q +     C    P+
Sbjct: 202 KIPYEN------------RSNSEVVEDISTGFRLYKPRLASTHVYQIMN---HCWKERPE 246
Query: 959 DRPTM 963
           DRP  
Sbjct: 247 DRPAF 251

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+GC G V+         +A+K L P  M+ E               +F  E + +  +
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE---------------AFLQEAQVMKKL 237
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           RH+ +V+      +     ++ +YM  GSL   L       L       +    A G+AY
Sbjct: 238 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAY 296
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        VHRD++A NIL+G      +ADFGL +L+ + ++  +         + APE
Sbjct: 297 VER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYT-ARQGAKFPIKWTAPE 352
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P    +             R  ++ +++  R
Sbjct: 353 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR 400
Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                E  E L  L     C    P++RPT + + A +++
Sbjct: 401 MPCPPECPESLHDLMCQ--CWRKDPEERPTFEYLQAFLED 438

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 107/220 (48%), Gaps = 38/220 (17%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY A ++ N EV+A+KK+  +   +    Q+              E++ L  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-----------IIKEVRFLQK 71
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH N +++ GC    +T  L+ +Y   GS   LL   +    E E+   +  GA QGLA
Sbjct: 72  LRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA-AVTHGALQGLA 129
Query: 813 YLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS-----NTVAGS 866
           YLH H+    ++HRD+KA NIL+    EP     GL KL   GDF  +S     N   G+
Sbjct: 130 YLHSHN----MIHRDVKAGNILLS---EP-----GLVKL---GDFGSASIMAPANXFVGT 174
Query: 867 YGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPI 903
             ++APE    M   +   K DV+S G+  +E+   K P+
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 35/227 (15%)
Query: 694 VGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G V+ AE  N        ++AVK L              K      R  F  E 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTL--------------KDASDNARKDFHREA 66
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCL------EWELR 800
           + L +++H++IV+F G C   +  +++++YM +G L   L     D+ L        EL 
Sbjct: 67  ELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELT 126
Query: 801 YRIILGAAQ----GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
              +L  AQ    G+ YL        VHRD+   N L+G      I DFG+++ V   D+
Sbjct: 127 QSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 183
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            R          ++ PE     K T +SDV+S GVV+ E+ T GKQP
Sbjct: 184 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 22/237 (9%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F +E   +G   H NI+   G        +++ +YM NGSL + L +        +L
Sbjct: 74  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL 133
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              ++ G   G+ YL        VHRD+ A NIL+       ++DFG+++ V+E D   +
Sbjct: 134 -VGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAA 188
Query: 860 SNTVAGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDW 916
             T  G     + APE     K T  SDV+SYG+V+ EV++ G++P             W
Sbjct: 189 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------W 236
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
               +  I+ +++  R  P ++    L  L   L C      DRP    +  M+ ++
Sbjct: 237 DMSNQDVIKAIEEGYRLPPPMDCPIALHQL--MLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 115
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L+ + ++  
Sbjct: 116 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 171
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 172 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 224
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 225 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 273

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 63  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 119
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L+ + ++  
Sbjct: 120 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 175
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 176 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 228
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 229 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 277

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 58  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 114
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L+ + ++  
Sbjct: 115 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 170
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 171 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 223
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 224 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 272

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/312 (25%), Positives = 128/312 (41%), Gaps = 45/312 (14%)
Query: 673 PFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYD 728
           P+  + F  E  +  +  + V+G G  G V R  ++        +A+K     T+   Y 
Sbjct: 1   PWGSMEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIK-----TLKGGYT 55
Query: 729 CQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH 788
            +         R  F +E   +G   H NI+R  G   N    +++ ++M NG+L S L 
Sbjct: 56  ERQ--------RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR 107
Query: 789 ERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
                    +L   ++ G A G+ YL        VHRD+ A NIL+       ++DFGL+
Sbjct: 108 LNDGQFTVIQL-VGMLRGIASGMRYLAEMSY---VHRDLAARNILVNSNLVCKVSDFGLS 163
Query: 849 KLVVEGDFARSSNTVAGSYG------YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ 901
           + + E     S  T   S G      + APE     K T  SD +SYG+V+ EV++ G++
Sbjct: 164 RFLEENS---SDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGER 220
Query: 902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP 961
           P             W    +  I  +++  R  P  +    L  L   L C     + RP
Sbjct: 221 PY------------WDMSNQDVINAIEQDYRLPPPPDCPTSLHQL--MLDCWQKDRNARP 266
Query: 962 TMKDVAAMIKEI 973
               V + + ++
Sbjct: 267 RFPQVVSALDKM 278

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 22/237 (9%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F +E   +G   H NI+   G        +++ +YM NGSL + L +        +L
Sbjct: 53  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL 112
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              ++ G   G+ YL        VHRD+ A NIL+       ++DFG+++ V+E D   +
Sbjct: 113 -VGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAA 167
Query: 860 SNTVAGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDW 916
             T  G     + APE     K T  SDV+SYG+V+ EV++ G++P             W
Sbjct: 168 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------W 215
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
               +  I+ +++  R  P ++    L  L   L C      DRP    +  M+ ++
Sbjct: 216 DMSNQDVIKAIEEGYRLPPPMDCPIALHQL--MLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 22/237 (9%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F +E   +G   H NI+   G        +++ +YM NGSL + L +        +L
Sbjct: 59  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL 118
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              ++ G   G+ YL        VHRD+ A NIL+       ++DFG+++ V+E D   +
Sbjct: 119 -VGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAA 173
Query: 860 SNTVAGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDW 916
             T  G     + APE     K T  SDV+SYG+V+ EV++ G++P             W
Sbjct: 174 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------W 221
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
               +  I+ +++  R  P ++    L  L   L C      DRP    +  M+ ++
Sbjct: 222 DMSNQDVIKAIEEGYRLPPPMDCPIALHQL--MLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 117/238 (49%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 109
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L+ + ++  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 218
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 219 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 267

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 118/238 (49%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 48  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 104
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L+ + ++  
Sbjct: 105 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 160
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI-DPTIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T G+ P    T PE       
Sbjct: 161 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 213
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 214 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 262

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 87/310 (28%), Positives = 144/310 (46%), Gaps = 50/310 (16%)
Query: 671 LTPFQKLNFTVEQVLKC--LVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEY 727
           L P +K N  + ++ K   L +  V+G G  G V++   +  GE I +    P  +    
Sbjct: 14  LDPSEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKI----PVCIK--- 66
Query: 728 DCQNDKIGIGGVRDSFSA---EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLG 784
               DK G    R SF A    +  +GS+ H +IVR LG C   + +L+   Y+P GSL 
Sbjct: 67  -VIEDKSG----RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLL 120
Query: 785 SLLHERRDSC-----LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE 839
             + + R +      L W ++       A+G+ YL       +VHR++ A N+L+    +
Sbjct: 121 DHVRQHRGALGPQLLLNWGVQ------IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQ 171
Query: 840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT- 898
             +ADFG+A L+   D     +       ++A E  +  K T +SDV+SYGV V E++T 
Sbjct: 172 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF 231
Query: 899 GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTP 957
           G +P       GL + +         ++L+K  R A+P++     +    V + C     
Sbjct: 232 GAEPY-----AGLRLAE-------VPDLLEKGERLAQPQICT---IDVYMVMVKCWMIDE 276
Query: 958 DDRPTMKDVA 967
           + RPT K++A
Sbjct: 277 NIRPTFKELA 286

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 90
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 148
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 149 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 201
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+   +              GV      E++    
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSH 69
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G +   L  ++ S  + +     I   A  L+
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANALS 127
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 128 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 180
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 131/285 (45%), Gaps = 43/285 (15%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G +G V+         +AVK L   +M+                D+F AE   +  +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP---------------DAFLAEANLMKQL 65
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA--AQGL 811
           +H+ +VR       +    ++ +YM NGSL   L  +  S ++  +   + + A  A+G+
Sbjct: 66  QHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           A++        +HRD++A NIL+       IADFGLA+L+ + +   +         + A
Sbjct: 123 AFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTA 178
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDWVRQKRGAIEVLDK 929
           PE       T KSDV+S+G+++ E++T  +   P  T PE              I+ L++
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------------VIQNLER 225
Query: 930 SLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 226 GYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 267

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 129/295 (43%), Gaps = 52/295 (17%)
Query: 693 VVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G G + +V  A      E +A+K++          CQ          D    EI+ + 
Sbjct: 17  VIGSGATAVVQAAYCAPKKEKVAIKRI------NLEKCQTS-------MDELLKEIQAMS 63
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH------ERRDSCLEWELRYRIIL 805
              H NIV +      ++   L+   +  GS+  ++       E +   L+      I+ 
Sbjct: 64  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 123
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL-AKLVVEGDFARSS--NT 862
              +GL YLH +     +HRD+KA NIL+G +    IADFG+ A L   GD  R+    T
Sbjct: 124 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 863 VAGSYGYIAPEYGYMMKITE-KSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
             G+  ++APE    ++  + K+D++S+G+  +E+ TG  P     P             
Sbjct: 181 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP------------- 227
Query: 922 GAIEVLDKSLRARPE-----VEIEEMLQTLGVAL-----LCVNPTPDDRPTMKDV 966
             ++VL  +L+  P      V+ +EML+  G +      LC+   P+ RPT  ++
Sbjct: 228 --MKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAEL 280

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 51/293 (17%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 63
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQIS 119
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 120 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAKFPIK 175
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP---IDPTIPEGLHIVDWVRQKRGAI 924
           + APE     K + KSDV+++GV++ E+ T G  P   IDP+                  
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS---------------QVY 220
Query: 925 EVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           E+L+K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 221 ELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 128/314 (40%), Gaps = 59/314 (18%)
Query: 694 VGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+G  G V++A        E   ++AVK L      A  D Q D          F  E 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQAD----------FQREA 101
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL------EWELRY 801
             +    + NIV+ LG C       L+++YM  G L   L       +      +   R 
Sbjct: 102 ALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 802 R----------------IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
           R                I    A G+AYL        VHRD+   N L+G      IADF
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADF 218
Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
           GL++ +   D+ ++    A    ++ PE  +  + T +SDV++YGVV+ E+ + G QP  
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK 964
               E   ++ +VR         D ++ A PE      L+   +  LC +  P DRP+  
Sbjct: 279 GMAHE--EVIYYVR---------DGNILACPE---NCPLELYNLMRLCWSKLPADRPSFC 324
Query: 965 DVAAMIKEIKQERE 978
            +  +++ + +  E
Sbjct: 325 SIHRILQRMCERAE 338

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 52/291 (17%)
Query: 693 VVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G G + +V  A      E +A+K++          CQ          D    EI+ + 
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRI------NLEKCQTS-------MDELLKEIQAMS 68
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH------ERRDSCLEWELRYRIIL 805
              H NIV +      ++   L+   +  GS+  ++       E +   L+      I+ 
Sbjct: 69  QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL-AKLVVEGDFARSS--NT 862
              +GL YLH +     +HRD+KA NIL+G +    IADFG+ A L   GD  R+    T
Sbjct: 129 EVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 863 VAGSYGYIAPEYGYMMKITE-KSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
             G+  ++APE    ++  + K+D++S+G+  +E+ TG  P     P             
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP------------- 232
Query: 922 GAIEVLDKSLRARPE-----VEIEEMLQTLGVAL-----LCVNPTPDDRPT 962
             ++VL  +L+  P      V+ +EML+  G +      LC+   P+ RPT
Sbjct: 233 --MKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 61  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 117
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L +E +   
Sbjct: 118 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXT 173
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 174 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 226
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 227 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 275

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLW-PTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY+ +      + + K+  PT    +               +F  E+  L  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQ---------------AFRNEVAVLRK 88
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            RH NI+ F+G    ++   ++  +    SL   LH +      ++L   I    AQG+ 
Sbjct: 89  TRHVNILLFMGYM-TKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIARQTAQGMD 146
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH      I+HRD+K+NNI +       I DFGLA +      ++      GS  ++AP
Sbjct: 147 YLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 203
Query: 873 EYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           E   M      + +SDVYSYG+V+ E++TG+ P
Sbjct: 204 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 28/241 (11%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F +E   +G   H NI+R  G   N    +++ ++M NG+L S L          +L
Sbjct: 61  RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL 120
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              ++ G A G+ YL        VHRD+ A NIL+       ++DFGL++ + E     S
Sbjct: 121 -VGMLRGIASGMRYLAEMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENS---S 173
Query: 860 SNTVAGSYG------YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLH 912
             T   S G      + APE     K T  SD +SYG+V+ EV++ G++P          
Sbjct: 174 DPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY--------- 224
Query: 913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
              W    +  I  +++  R  P  +    L  L   L C     + RP    V + + +
Sbjct: 225 ---WDMSNQDVINAIEQDYRLPPPPDCPTSLHQL--MLDCWQKDRNARPRFPQVVSALDK 279
Query: 973 I 973
           +
Sbjct: 280 M 280

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 62  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 118
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L +E +   
Sbjct: 119 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXT 174
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 175 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 227
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 228 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 276

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+   +              GV      E++    
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSH 81
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 82  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 139
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 140 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 192
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 115
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L +E +   
Sbjct: 116 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXT 171
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 172 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 224
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 225 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 273

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 60/254 (23%), Positives = 113/254 (44%), Gaps = 21/254 (8%)
Query: 725 AEYDCQNDKIGIGGV-RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL 783
            +YD     I  G +  D F  E +T+  + H  +V+F G C       ++ +Y+ NG L
Sbjct: 31  GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL 90
Query: 784 GSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA 843
            + L       LE      +     +G+A+L        +HRD+ A N L+  +    ++
Sbjct: 91  LNYLRSHGKG-LEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVS 146
Query: 844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           DFG+ + V++  +  S  T      + APE  +  K + KSDV+++G+++ EV + GK P
Sbjct: 147 DFGMTRYVLDDQYVSSVGT-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
Query: 903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
                       D        ++V       RP +  + + Q   +   C +  P+ RPT
Sbjct: 206 -----------YDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ---IMYSCWHELPEKRPT 251
Query: 963 MKDVAAMIKEIKQE 976
            + + + I+ ++++
Sbjct: 252 FQQLLSSIEPLREK 265

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 51/293 (17%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 63
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQIS 119
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 120 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIK 175
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP---IDPTIPEGLHIVDWVRQKRGAI 924
           + APE     K + KSDV+++GV++ E+ T G  P   IDP+                  
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS---------------QVY 220
Query: 925 EVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           E+L+K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 221 ELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 109
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L +E +   
Sbjct: 110 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXT 165
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 218
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 219 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 267

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 55  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 111
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L +E +   
Sbjct: 112 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXT 167
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 168 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 220
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 221 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 269

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 54  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 110
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L +E +   
Sbjct: 111 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXT 166
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 167 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 219
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 220 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 268

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 53  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 109
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HRD++A NIL+       IADFGLA+L +E +   
Sbjct: 110 KLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXT 165
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T  +   P  T PE       
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 218
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 219 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 267

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 118/238 (49%), Gaps = 28/238 (11%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           D+F AE   +  ++H+ +VR       +    ++ +YM NGSL   L  +  S ++  + 
Sbjct: 49  DAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFL--KTPSGIKLTIN 105
Query: 801 YRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             + + A  A+G+A++        +HR+++A NIL+       IADFGLA+L+ + ++  
Sbjct: 106 KLLDMAAQIAEGMAFIEERNY---IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYT- 161
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI-DPTIPEGLHIVDW 916
           +         + APE       T KSDV+S+G+++ E++T G+ P    T PE       
Sbjct: 162 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 214
Query: 917 VRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                  I+ L++  R  RP+   EE+ Q +    LC    P+DRPT   + +++++ 
Sbjct: 215 ------VIQNLERGYRMVRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 69
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 127
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 128 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 180
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 67
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 125
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 126 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 178
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 124/293 (42%), Gaps = 51/293 (17%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 63
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQIS 119
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 120 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIK 175
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP---IDPTIPEGLHIVDWVRQKRGAI 924
           + APE     K + KSDV+++GV++ E+ T G  P   IDP+                  
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS---------------QVY 220
Query: 925 EVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           E+L+K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 221 ELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 270

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 66
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 67  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA +      +     ++GS  ++A
Sbjct: 123 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 64
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 122
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 123 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 175
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+   +              GV      E++    
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSH 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 123
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R  +T+ G+  Y+ P
Sbjct: 124 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSR-RDTLCGTLDYLPP 176
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 61
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 62  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA +      +     ++GS  ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 33/300 (11%)
Query: 678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG 737
            F  E    C+  + V+G G          E GEV + +   P         +  K+G  
Sbjct: 14  EFAKEIEASCITIERVIGAG----------EFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 738 -GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
              R  F  E   +G   H NI+   G        +++ +YM NGSL + L ++ D    
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQFT 122
Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
                 ++ G + G+ YL        VHRD+ A NILI       ++DFGL++ V+E D 
Sbjct: 123 VIQLVGMLRGISAGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDP 178
Query: 857 ARSSNTVAGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHI 913
             +  T  G     + APE     K T  SDV+SYG+V+ EV++ G++P           
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPY---------- 228
Query: 914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             W    +  I+ +++  R    ++    L  L   L C     + RP   ++  M+ ++
Sbjct: 229 --WEMTNQDVIKAVEEGYRLPSPMDCPAALYQL--MLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 66
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 67  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA +      +     ++GS  ++A
Sbjct: 123 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 18  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 63
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 64  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA +      +     ++GS  ++A
Sbjct: 120 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 63
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 64  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 121
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 122 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 174
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 68
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 126
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 127 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 179
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 44  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 89
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 90  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA +      +     ++GS  ++A
Sbjct: 146 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 202
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Composition-based stats.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 69
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE-RRDSCLEWELRYRIILGAAQGL 811
           +RH NI+R  G   +     L+ +Y P   LG++  E ++ S  + +     I   A  L
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 126
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           +Y H      ++HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ 
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLP 179
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           PE        EK D++S GV+  E L GK P +
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 43  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 88
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 89  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 144
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA +      +     ++GS  ++A
Sbjct: 145 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 201
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+   +              GV      E++    
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSH 90
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 91  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 148
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R  + + G+  Y+ P
Sbjct: 149 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDD-LCGTLDYLPP 201
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 67
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 125
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 126 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 178
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 61
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 62  RHVNILLFMG--YSTAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA +      +     ++GS  ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRAEMENGE-VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A  +N + ++A+K L        +  Q +K    GV      E++    
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 64
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 65  LRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 122
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R +  + G+  Y+ P
Sbjct: 123 YCHSKKV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRA-ALCGTLDYLPP 175
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/192 (31%), Positives = 94/192 (48%), Gaps = 22/192 (11%)
Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 769
           GE++AVK L       + DC          R  +  EI  L ++ H++I+++ GCC ++ 
Sbjct: 43  GEMVAVKAL-------KADCGPQH------RSGWKQEIDILRTLYHEHIIKYKGCCEDQG 89
Query: 770 TR--LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI 827
            +   L+ +Y+P GSL   L        +  L  + I    +G+AYLH       +HR++
Sbjct: 90  EKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI---CEGMAYLHSQ---HYIHRNL 143
Query: 828 KANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDV 886
            A N+L+  +    I DFGLAK V EG ++ R          + APE     K    SDV
Sbjct: 144 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 203
Query: 887 YSYGVVVLEVLT 898
           +S+GV + E+LT
Sbjct: 204 WSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 60/192 (31%), Positives = 94/192 (48%), Gaps = 22/192 (11%)
Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 769
           GE++AVK L       + DC          R  +  EI  L ++ H++I+++ GCC ++ 
Sbjct: 43  GEMVAVKAL-------KADCGPQH------RSGWKQEIDILRTLYHEHIIKYKGCCEDQG 89
Query: 770 TR--LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI 827
            +   L+ +Y+P GSL   L        +  L  + I    +G+AYLH       +HR++
Sbjct: 90  EKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI---CEGMAYLH---AQHYIHRNL 143
Query: 828 KANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDV 886
            A N+L+  +    I DFGLAK V EG ++ R          + APE     K    SDV
Sbjct: 144 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDV 203
Query: 887 YSYGVVVLEVLT 898
           +S+GV + E+LT
Sbjct: 204 WSFGVTLYELLT 215

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 28/230 (12%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R+  S EI    S+ H+++V F G   + +   ++ +     SL  L H+RR +  E E 
Sbjct: 61  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEA 119
Query: 800 RY---RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           RY   +I+LG      YLH + V   +HRD+K  N+ +  + E  I DFGLA   VE D 
Sbjct: 120 RYYLRQIVLGCQ----YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDG 171
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
            R   T+ G+  YIAPE       + + DV+S G ++  +L GK P + +  +      +
Sbjct: 172 ER-KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TY 226
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           +R K+    +  K +       I++MLQT           P  RPT+ ++
Sbjct: 227 LRIKKNEYSI-PKHINPVAASLIQKMLQT----------DPTARPTINEL 265

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 132/286 (46%), Gaps = 45/286 (15%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+ A       +AVK + P +M+ E               +F AE   + ++
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---------------AFLAEANVMKTL 240
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA--AQGL 811
           +H  +V+ L     +    ++ ++M  GSL   L  + D   +  L   I   A  A+G+
Sbjct: 241 QHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           A++        +HRD++A NIL+       IADFGLA+++ + ++  +         + A
Sbjct: 298 AFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTA 353
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI--PEGLHIVDWVRQKRGAIEVLD 928
           PE       T KSDV+S+G++++E++T G+ P  P +  PE              I  L+
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPE-------------VIRALE 399
Query: 929 KSLRA-RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +  R  RPE   EE+     + + C    P++RPT + + +++ + 
Sbjct: 400 RGYRMPRPENCPEEL---YNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 28/230 (12%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R+  S EI    S+ H+++V F G   + +   ++ +     SL  L H+RR +  E E 
Sbjct: 61  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEA 119
Query: 800 RY---RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           RY   +I+LG      YLH + V   +HRD+K  N+ +  + E  I DFGLA   VE D 
Sbjct: 120 RYYLRQIVLGCQ----YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDG 171
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
            R   T+ G+  YIAPE       + + DV+S G ++  +L GK P + +  +      +
Sbjct: 172 ER-KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TY 226
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           +R K+    +  K +       I++MLQT           P  RPT+ ++
Sbjct: 227 LRIKKNEYSI-PKHINPVAASLIQKMLQT----------DPTARPTINEL 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 123
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +        +R + T++G+  Y+ P
Sbjct: 124 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRT-TLSGTLDYLPP 176
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+   +              GV      E++    
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSH 69
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 127
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R ++ + G+  Y+ P
Sbjct: 128 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTD-LCGTLDYLPP 180
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 23/213 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E +   ++A+K L        +  Q +K    GV      E++    
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 61
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE-RRDSCLEWELRYRIILGAAQGL 811
           +RH NI+R  G   +     L+ +Y P   LG++  E ++ S  + +     I   A  L
Sbjct: 62  LRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANAL 118
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           +Y H      ++HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ 
Sbjct: 119 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-TLCGTLDYLP 171
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           PE        EK D++S GV+  E L GK P +
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E +N  ++A+K L+ + +  E           GV      EI+    
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-----------GVEHQLRREIEIQSH 70
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH------ERRDSCLEWELRYRIILG 806
           +RH NI+R      +R    LM ++ P G L   L       E+R +    EL       
Sbjct: 71  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL------- 123
Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
            A  L Y H      ++HRDIK  N+L+G + E  IADFG +   V     R    + G+
Sbjct: 124 -ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLR-RRXMCGT 175
Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
             Y+ PE        EK D++  GV+  E L G  P D
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 67/218 (30%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E +N  ++A+K L+ + +  E           GV      EI+    
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-----------GVEHQLRREIEIQSH 71
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH------ERRDSCLEWELRYRIILG 806
           +RH NI+R      +R    LM ++ P G L   L       E+R +    EL       
Sbjct: 72  LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL------- 124
Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
            A  L Y H      ++HRDIK  N+L+G + E  IADFG +   V     R    + G+
Sbjct: 125 -ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLR-RRXMCGT 176
Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
             Y+ PE        EK D++  GV+  E L G  P D
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+ T +              GV      E++    
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEK-----------AGVEHQLRREVEIQSH 68
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANALS 126
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R  +T+ G+  Y+ P
Sbjct: 127 YCHSKRV---IHRDIKPENLLLGSNGELKIADFGWS---VHAPSSR-RDTLCGTLDYLPP 179
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L G  P +
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 28/230 (12%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R+  S EI    S+ H+++V F G   + +   ++ +     SL  L H+RR +  E E 
Sbjct: 65  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEA 123
Query: 800 RY---RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           RY   +I+LG      YLH + V   +HRD+K  N+ +  + E  I DFGLA   VE D 
Sbjct: 124 RYYLRQIVLGCQ----YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDG 175
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
            R   T+ G+  YIAPE       + + DV+S G ++  +L GK P + +  +      +
Sbjct: 176 ER-KKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TY 230
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           +R K+    +  K +       I++MLQT           P  RPT+ ++
Sbjct: 231 LRIKKNEYSI-PKHINPVAASLIQKMLQT----------DPTARPTINEL 269

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 64
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 122
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R ++ + G+  Y+ P
Sbjct: 123 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTD-LCGTLDYLPP 175
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+   +              GV      E++    
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSH 64
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 122
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R ++ + G+  Y+ P
Sbjct: 123 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTD-LCGTLDYLPP 175
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+   +              GV      E++    
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSH 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 66  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 123
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R ++ + G+  Y+ P
Sbjct: 124 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTD-LCGTLDYLPP 176
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 133/287 (46%), Gaps = 45/287 (15%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+ A       +AVK + P +M+ E               +F AE   + ++
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---------------AFLAEANVMKTL 67
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA--AQGL 811
           +H  +V+ L     +    ++ ++M  GSL   L  + D   +  L   I   A  A+G+
Sbjct: 68  QHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGM 124
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           A++        +HRD++A NIL+       IADFGLA+++ + ++  +         + A
Sbjct: 125 AFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTA 180
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI--PEGLHIVDWVRQKRGAIEVLD 928
           PE       T KSDV+S+G++++E++T G+ P  P +  PE              I  L+
Sbjct: 181 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPE-------------VIRALE 226
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK 974
           +  R  RPE   EE+     + + C    P++RPT + + +++ + +
Sbjct: 227 RGYRMPRPENCPEEL---YNIMMRCWKNRPEERPTFEYIQSVLDDFE 270

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+ T +              GV      E++    
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEK-----------AGVEHQLRREVEIQSH 68
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 69  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANALS 126
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R + T+ G+  Y+ P
Sbjct: 127 YCHSKRV---IHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRT-TLCGTLDYLPP 179
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L G  P +
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 131/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 82
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 83  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 139
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ +L        VHRD+ A N ++  +F   +ADFGLA+ +++ +F    N  
Sbjct: 140 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKT 196
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 197 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 255
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 256 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 100
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 101 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 157
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + ++    N  
Sbjct: 158 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 214
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 215 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 273
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 274 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G VY+A   E G+++A+K++       E D Q               EI  +  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQV-----PVESDLQE-----------IIKEISIMQQ 80
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
               ++V++ G  +      ++ +Y   GS+  ++  R  +  E E+   I+    +GL 
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA-TILQSTLKGLE 139
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH       +HRDIKA NIL+  E    +ADFG+A  +   D     N V G+  ++AP
Sbjct: 140 YLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAP 194
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +     +D++S G+  +E+  GK P
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 99
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 100 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 156
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + ++    N  
Sbjct: 157 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 213
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 214 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 272
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 273 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 61
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 62  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA        +     ++GS  ++A
Sbjct: 118 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 174
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 136/301 (45%), Gaps = 45/301 (14%)
Query: 688 LVEDSVVGKGCSGIVYRAEMEN--GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +V + ++G+G  G VY     N  GE I V          + DC  D       ++ F +
Sbjct: 26  VVLNRILGEGFFGEVYEGVYTNHKGEKINV-----AVKTCKKDCTLDN------KEKFMS 74
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E   + ++ H +IV+ +G      T ++M  Y P G LG  L ER  + L+        L
Sbjct: 75  EAVIMKNLDHPHIVKLIGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLTLVLYSL 132
Query: 806 GAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
              + +AYL   +CV    HRDI   NIL+       + DFGL++ + + D+ ++S T  
Sbjct: 133 QICKAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA 923
               +++PE     + T  SDV+ + V + E+L+ GKQP             W+  K   
Sbjct: 189 -PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF-----------FWLENK-DV 235
Query: 924 IEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRP-------TMKDVAAMIKEIKQ 975
           I VL+K  R  +P++    +L TL     C +  P DRP       ++ DV  M K+I  
Sbjct: 236 IGVLEKGDRLPKPDL-CPPVLYTLMTR--CWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 292
Query: 976 E 976
           E
Sbjct: 293 E 293

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 24/239 (10%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F +E   +G   H N++   G        +++ ++M NGSL S L +        +L
Sbjct: 78  RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL 137
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              ++ G A G+ YL        VHRD+ A NIL+       ++DFGL++  +E D +  
Sbjct: 138 -VGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSDP 192
Query: 860 SNTVAGS----YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
           + T A        + APE     K T  SDV+SYG+V+ EV++ G++P            
Sbjct: 193 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY----------- 241
Query: 915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            W    +  I  +++  R  P ++    L  L   L C     + RP    +   + ++
Sbjct: 242 -WDMTNQDVINAIEQDYRLPPPMDCPSALHQL--MLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 66
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 124
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IA+FG +   V    +R + T+ G+  Y+ P
Sbjct: 125 YCHSKRV---IHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRT-TLCGTLDYLPP 177
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 48/287 (16%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA---EI 747
            V+G G  G V++   +  GE I +    P  +        DK G    R SF A    +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKI----PVCI----KVIEDKSG----RQSFQAVTDHM 66
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYR 802
             +GS+ H +IVR LG C   + +L+   Y+P GSL   + + R +      L W ++  
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNWGVQ-- 123
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                A+G+ YL       +VHR++ A N+L+    +  +ADFG+A L+   D     + 
Sbjct: 124 ----IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKR 921
                 ++A E  +  K T +SDV+SYGV V E++T G +P       GL + +      
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY-----AGLRLAE------ 225
Query: 922 GAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA 967
              ++L+K  R A+P++     +    V + C     + RPT K++A
Sbjct: 226 -VPDLLEKGERLAQPQICT---IDVYMVMVKCWMIDENIRPTFKELA 268

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 69
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G +   L  ++ S  + +     I   A  L+
Sbjct: 70  LRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANALS 127
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R    + G+  Y+ P
Sbjct: 128 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRX-XLXGTLDYLPP 180
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 125/291 (42%), Gaps = 60/291 (20%)
Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  GIVY   ++ N   IA+K++       E D +  +            EI    
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEI------PERDSRYSQ--------PLHEEIALHK 74
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER----RDSCLEWELRYRIILGA 807
            ++HKNIV++LG         +  + +P GSL +LL  +    +D+        + IL  
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-- 132
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-----IADFGLAKLVVEGDFARSSNT 862
            +GL YLH +    IVHRDIK +N+LI      Y     I+DFG +K +        + T
Sbjct: 133 -EGLKYLHDN---QIVHRDIKGDNVLIN----TYSGVLKISDFGTSKRLA--GINPCTET 182
Query: 863 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI-DPTIPEGLHIVD 915
             G+  Y+APE       GY     + +D++S G  ++E+ TGK P  +   P+      
Sbjct: 183 FTGTLQYMAPEIIDKGPRGY----GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-- 236
Query: 916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
               K G  +V        PE+      +     L C  P PD R    D+
Sbjct: 237 ----KVGMFKV-------HPEIPESMSAEAKAFILKCFEPDPDKRACANDL 276

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 136/301 (45%), Gaps = 45/301 (14%)
Query: 688 LVEDSVVGKGCSGIVYRAEMEN--GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +V + ++G+G  G VY     N  GE I V          + DC  D       ++ F +
Sbjct: 14  VVLNRILGEGFFGEVYEGVYTNHKGEKINV-----AVKTCKKDCTLDN------KEKFMS 62
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E   + ++ H +IV+ +G      T ++M  Y P G LG  L ER  + L+        L
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLTLVLYSL 120
Query: 806 GAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
              + +AYL   +CV    HRDI   NIL+       + DFGL++ + + D+ ++S T  
Sbjct: 121 QICKAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA 923
               +++PE     + T  SDV+ + V + E+L+ GKQP             W+  K   
Sbjct: 177 -PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF-----------FWLENK-DV 223
Query: 924 IEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRP-------TMKDVAAMIKEIKQ 975
           I VL+K  R  +P++    +L TL     C +  P DRP       ++ DV  M K+I  
Sbjct: 224 IGVLEKGDRLPKPDL-CPPVLYTLMTR--CWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 280
Query: 976 E 976
           E
Sbjct: 281 E 281

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 64
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 122
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R +  + G+  Y+ P
Sbjct: 123 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTE-LCGTLDYLPP 175
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 70
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 126
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 127 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 182
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 231
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 232 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 121
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 122 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 177
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 226
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 227 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 69
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 125
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 126 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 181
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 230
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 231 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 276

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 67
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 123
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 124 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 179
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 228
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 229 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 67
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 123
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 124 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 179
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 228
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 229 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 67
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 125
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IA+FG +   V    +R + T+ G+  Y+ P
Sbjct: 126 YCHSKRV---IHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRT-TLCGTLDYLPP 178
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 36  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 81
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 82  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 137
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA        +     ++GS  ++A
Sbjct: 138 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 194
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 67
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 125
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R +  + G+  Y+ P
Sbjct: 126 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRA-ALCGTLDYLPP 178
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 81
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 82  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 138
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + ++    N  
Sbjct: 139 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 195
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 254
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 255 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+ +  +G+V AVK L   T       Q           +F  E+  L   
Sbjct: 44  IGSGSFGTVYKGKW-HGDV-AVKML-NVTAPTPQQLQ-----------AFKNEVGVLRKT 89
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG--AAQGL 811
           RH NI+ F+G  ++   +L +      GS  SL H       ++E+   I +    AQG+
Sbjct: 90  RHVNILLFMG--YSTKPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+K+NNI +  +    I DFGLA        +     ++GS  ++A
Sbjct: 146 DYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 202
Query: 872 PEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQP 902
           PE   M      + +SDVY++G+V+ E++TG+ P
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 86
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 87  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 143
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ +L        VHRD+ A N ++  +F   +ADFGLA+ + + +F    N  
Sbjct: 144 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 200
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 201 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 259
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 260 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 73
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 74  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 130
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + ++    N  
Sbjct: 131 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 187
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 188 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 246
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 247 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 140
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 197
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ +L        VHRD+ A N ++  +F   +ADFGLA+ + + +F    N  
Sbjct: 198 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 254
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 313
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 314 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 64/196 (32%), Positives = 98/196 (50%), Gaps = 30/196 (15%)
Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 768
           GE++AVK L              K G G  +R  +  EI+ L ++ H++IV++ GCC ++
Sbjct: 37  GEMVAVKAL--------------KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQ 82
Query: 769 NTR--LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIV 823
             +   L+ +Y+P GSL   L      C+      +++L A Q   G+AYLH       +
Sbjct: 83  GEKSVQLVMEYVPLGSLRDYLPRH---CVGLA---QLLLFAQQICEGMAYLH---AQHYI 133
Query: 824 HRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITE 882
           HR + A N+L+  +    I DFGLAK V EG ++ R          + APE     K   
Sbjct: 134 HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYY 193
Query: 883 KSDVYSYGVVVLEVLT 898
            SDV+S+GV + E+LT
Sbjct: 194 ASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 64/196 (32%), Positives = 98/196 (50%), Gaps = 30/196 (15%)
Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIG-GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 768
           GE++AVK L              K G G  +R  +  EI+ L ++ H++IV++ GCC ++
Sbjct: 38  GEMVAVKAL--------------KEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQ 83
Query: 769 NTR--LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIV 823
             +   L+ +Y+P GSL   L      C+      +++L A Q   G+AYLH       +
Sbjct: 84  GEKSVQLVMEYVPLGSLRDYLPRH---CVGLA---QLLLFAQQICEGMAYLH---AQHYI 134
Query: 824 HRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITE 882
           HR + A N+L+  +    I DFGLAK V EG ++ R          + APE     K   
Sbjct: 135 HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYY 194
Query: 883 KSDVYSYGVVVLEVLT 898
            SDV+S+GV + E+LT
Sbjct: 195 ASDVWSFGVTLYELLT 210

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 74/299 (24%), Positives = 124/299 (41%), Gaps = 33/299 (11%)
Query: 679 FTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIG-IG 737
           F  E    C+  + V+G G          E GEV + +   P         +  K+G   
Sbjct: 36  FAKELDASCIKIERVIGAG----------EFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
             R  F  E   +G   H N+V   G        +++ ++M NG+L + L +        
Sbjct: 86  KQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI 145
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
           +L   ++ G A G+ YL        VHRD+ A NIL+       ++DFGL++ V+E D  
Sbjct: 146 QL-VGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSR-VIEDDPE 200
Query: 858 RSSNTVAGSYG--YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
               T  G     + APE     K T  SDV+SYG+V+ EV++ G++P            
Sbjct: 201 AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY----------- 249
Query: 915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            W    +  I+ +++  R    ++    L  L   L C      +RP  + +  ++ ++
Sbjct: 250 -WDMSNQDVIKAIEEGYRLPAPMDCPAGLHQL--MLDCWQKERAERPKFEQIVGILDKM 305

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 67
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 125
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R  + + G+  Y+ P
Sbjct: 126 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDD-LCGTLDYLPP 178
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 82
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 83  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 139
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ +L        VHRD+ A N ++  +F   +ADFGLA+ + + +F    N  
Sbjct: 140 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 196
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 197 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 255
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 256 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 79
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 80  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 136
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + ++    N  
Sbjct: 137 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 193
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 194 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 252
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 253 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 136/301 (45%), Gaps = 45/301 (14%)
Query: 688 LVEDSVVGKGCSGIVYRAEMEN--GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +V + ++G+G  G VY     N  GE I V          + DC  D       ++ F +
Sbjct: 10  VVLNRILGEGFFGEVYEGVYTNHKGEKINV-----AVKTCKKDCTLDN------KEKFMS 58
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E   + ++ H +IV+ +G      T ++M  Y P G LG  L ER  + L+        L
Sbjct: 59  EAVIMKNLDHPHIVKLIGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLTLVLYSL 116
Query: 806 GAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
              + +AYL   +CV    HRDI   NIL+       + DFGL++ + + D+ ++S T  
Sbjct: 117 QICKAMAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 172
Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA 923
               +++PE     + T  SDV+ + V + E+L+ GKQP             W+  K   
Sbjct: 173 -PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF-----------FWLENK-DV 219
Query: 924 IEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRP-------TMKDVAAMIKEIKQ 975
           I VL+K  R  +P++    +L TL     C +  P DRP       ++ DV  M K+I  
Sbjct: 220 IGVLEKGDRLPKPDL-CPPVLYTLMTR--CWDYDPSDRPRFTELVCSLSDVYQMEKDIAM 276
Query: 976 E 976
           E
Sbjct: 277 E 277

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 76
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 77  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 133
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + ++    N  
Sbjct: 134 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 249
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 250 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 70
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 126
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 127 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIK 182
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 231
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 232 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 81
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 82  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 138
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ +L        VHRD+ A N ++  +F   +ADFGLA+ + + +F    N  
Sbjct: 139 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 254
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 255 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 123/290 (42%), Gaps = 58/290 (20%)
Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  GIVY   ++ N   IA+K++       E D +  +            EI    
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEI------PERDSRYSQ--------PLHEEIALHK 60
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER----RDSCLEWELRYRIILGA 807
            ++HKNIV++LG         +  + +P GSL +LL  +    +D+        + IL  
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-- 118
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-----IADFGLAKLVVEGDFARSSNT 862
            +GL YLH +    IVHRDIK +N+LI      Y     I+DFG +K +        + T
Sbjct: 119 -EGLKYLHDN---QIVHRDIKGDNVLIN----TYSGVLKISDFGTSKRLA--GINPCTET 168
Query: 863 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
             G+  Y+APE       GY     + +D++S G  ++E+ TGK P            + 
Sbjct: 169 FTGTLQYMAPEIIDKGPRGY----GKAADIWSLGCTIIEMATGKPP----------FYEL 214
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
              +    +V     +  PE+      +     L C  P PD R    D+
Sbjct: 215 GEPQAAMFKV--GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDL 262

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 79
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 80  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 136
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ +L        VHRD+ A N ++  +F   +ADFGLA+ + + +F    N  
Sbjct: 137 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 193
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 194 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 252
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 253 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 81
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 82  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 138
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ +L        VHRD+ A N ++  +F   +ADFGLA+ + + +F    N  
Sbjct: 139 GLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 254
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 255 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 80
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 81  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 137
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + ++    N  
Sbjct: 138 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 194
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 195 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 253
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 254 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 78
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 135
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + ++    N  
Sbjct: 136 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 192
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 251
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 252 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 81
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 82  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 138
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + ++    N  
Sbjct: 139 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 195
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 254
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 255 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 64
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 122
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R +  + G+  Y+ P
Sbjct: 123 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRA-ALCGTLDYLPP 175
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 66
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 122
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 123 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIK 178
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 227
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 228 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 273

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 70
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 126
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 127 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 182
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 231
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 232 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 64
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 122
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R +  + G+  Y+ P
Sbjct: 123 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRT-XLCGTLDYLPP 175
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 70
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 126
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 127 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 182
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 231
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 232 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+   +              GV      E++    
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-----------AGVEHQLRREVEIQSH 66
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 67  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 124
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R    + G+  Y+ P
Sbjct: 125 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRX-XLCGTLDYLPP 177
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 78
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 79  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 134
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 135 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 190
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 191 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 239
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 240 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 285

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQIS 121
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 122 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 177
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 226
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 227 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQIS 121
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 122 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 177
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 226
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 227 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQIS 121
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 122 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 177
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 226
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 227 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 70
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQIS 126
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 127 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 182
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 183 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 231
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 232 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V + +     +I  +KL    +               +R+    E++ L 
Sbjct: 22  SELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKP------------AIRNQIIRELQVLH 69
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L E +   +  E+  ++ +   +GL
Sbjct: 70  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGL 127
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           AYL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y+A
Sbjct: 128 AYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMA 181
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 182 PERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 118/266 (44%), Gaps = 51/266 (19%)
Query: 661 EMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWP 720
           ++G  +L +Q  P Q L               V  +G  G V++A++ N E +AVK ++P
Sbjct: 13  DLGTENLYFQSMPLQLL--------------EVKARGRFGCVWKAQLLN-EYVAVK-IFP 56
Query: 721 TTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL-----LMY 775
                 +  QN+             E+ +L  ++H+NI++F+G    R T +     L+ 
Sbjct: 57  IQDKQSW--QNE------------YEVYSLPGMKHENILQFIGAE-KRGTSVDVDLWLIT 101
Query: 776 DYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC-------VPPIVHRDIK 828
            +   GSL   L   + + + W     I    A+GLAYLH D         P I HRDIK
Sbjct: 102 AFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158
Query: 829 ANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-----GYMMKITEK 883
           + N+L+       IADFGLA     G  A  ++   G+  Y+APE       +      +
Sbjct: 159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218
Query: 884 SDVYSYGVVVLEVLTGKQPIDPTIPE 909
            D+Y+ G+V+ E+ +     D  + E
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVDE 244

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQIS 121
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 122 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 177
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 226
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 227 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 66
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 122
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 123 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIK 178
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 179 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 227
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 228 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 273

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 28/230 (12%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R+  S EI    S+ H+++V F G   + +   ++ +     SL  L H+RR +  E E 
Sbjct: 83  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEA 141
Query: 800 RY---RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           RY   +I+LG      YLH + V   +HRD+K  N+ +  + E  I DFGLA   VE D 
Sbjct: 142 RYYLRQIVLGCQ----YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDG 193
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
            R    + G+  YIAPE       + + DV+S G ++  +L GK P + +  +      +
Sbjct: 194 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TY 248
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           +R K+    +  K +       I++MLQT           P  RPT+ ++
Sbjct: 249 LRIKKNEYSI-PKHINPVAASLIQKMLQT----------DPTARPTINEL 287

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 311
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 312 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 367
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HR++ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 368 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 423
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 424 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 472
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 473 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 518

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 43/240 (17%)
Query: 694 VGKGCSGIVYRAEM--------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +G+GC G V  AE         +    +AVK L     A E D  +             +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSD-----------LVS 135
Query: 746 EIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW------- 797
           E++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+       
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 798 ---ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
              ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLAR 251
Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
            +   D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 310

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 64
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 65  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 122
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R    + G+  Y+ P
Sbjct: 123 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRX-XLCGTLDYLPP 175
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 67
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 123
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 124 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAPAGAKFPIK 179
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 228
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 229 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 274

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 28/230 (12%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R+  S EI    S+ H+++V F G   + +   ++ +     SL  L H+RR +  E E 
Sbjct: 85  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEA 143
Query: 800 RY---RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           RY   +I+LG      YLH + V   +HRD+K  N+ +  + E  I DFGLA   VE D 
Sbjct: 144 RYYLRQIVLGCQ----YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDG 195
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
            R    + G+  YIAPE       + + DV+S G ++  +L GK P + +  +      +
Sbjct: 196 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TY 250
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           +R K+    +  K +       I++MLQT           P  RPT+ ++
Sbjct: 251 LRIKKNEYSI-PKHINPVAASLIQKMLQT----------DPTARPTINEL 289

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 129/292 (44%), Gaps = 41/292 (14%)
Query: 691 DSVVGKGCSGIVYRAEM--ENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           + V+G+G  G VY   +   +G+ I  AVK L            N    IG V   F  E
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL------------NRITDIGEV-SQFLTE 80
Query: 747 IKTLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +    H N++  LG C  +  + L++  YM +G L + +   R+      ++  I  
Sbjct: 81  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGF 137
Query: 806 G--AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           G   A+G+ YL        VHRD+ A N ++  +F   +ADFGLA+ + + +     N  
Sbjct: 138 GLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKT 194
Query: 864 AGS--YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
                  ++A E     K T KSDV+S+GV++ E++T   P  P +     I  ++ Q R
Sbjct: 195 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR 253
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             ++         PE   + + +   V L C +P  + RP+  ++ + I  I
Sbjct: 254 RLLQ---------PEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 120/289 (41%), Gaps = 43/289 (14%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 272
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQIS 328
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HR++ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 329 SAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 384
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 433
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K  R  RPE   E++ + +     C    P DRP+  ++    + + QE
Sbjct: 434 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEIHQAFETMFQE 479

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L        +  Q +K    GV      E++    
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVL--------FKAQLEK---AGVEHQLRREVEIQSH 67
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +RH NI+R  G   +     L+ +Y P G++   L  ++ S  + +     I   A  L+
Sbjct: 68  LRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALS 125
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +   V    +R    + G+  Y+ P
Sbjct: 126 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRX-XLCGTLDYLPP 178
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E        EK D++S GV+  E L GK P +
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 28/230 (12%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R+  S EI    S+ H+++V F G   + +   ++ +     SL  L H+RR +  E E 
Sbjct: 59  REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLEL-HKRRKALTEPEA 117
Query: 800 RY---RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           RY   +I+LG      YLH + V   +HRD+K  N+ +  + E  I DFGLA   VE D 
Sbjct: 118 RYYLRQIVLGCQ----YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDG 169
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
            R    + G+  YIAPE       + + DV+S G ++  +L GK P + +  +      +
Sbjct: 170 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TY 224
Query: 917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           +R K+    +  K +       I++MLQT           P  RPT+ ++
Sbjct: 225 LRIKKNEYSI-PKHINPVAASLIQKMLQT----------DPTARPTINEL 263

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F +E   +G   H NI+R  G        +++ +YM NGSL + L          +L
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              ++ G   G+ YL        VHRD+ A N+L+       ++DFGL++ V+E D   +
Sbjct: 154 -VGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR-VLEDDPDAA 208
Query: 860 SNTVAGSYG--YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
             T  G     + APE       +  SDV+S+GVV+ EVL  G++P
Sbjct: 209 XTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 73.2 bits (178), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 93/188 (49%), Gaps = 16/188 (8%)
Query: 728 DCQNDKIGIGGVRD-----SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNG 781
           D + +K+ +  +++     +F AE   +  +RH N+V+ LG        L ++ +YM  G
Sbjct: 26  DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85
Query: 782 SLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY 841
           SL   L  R  S L  +   +  L   + + YL  +     VHRD+ A N+L+  +    
Sbjct: 86  SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK 142
Query: 842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK 900
           ++DFGL K     + + + +T      + APE     K + KSDV+S+G+++ E+ + G+
Sbjct: 143 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
Query: 901 QPIDPTIP 908
            P  P IP
Sbjct: 198 VPY-PRIP 204

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 43/240 (17%)
Query: 694 VGKGCSGIVYRAEM--------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +G+GC G V  AE         +    +AVK L     A E D  +             +
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSD-----------LVS 76
Query: 746 EIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW------- 797
           E++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+       
Sbjct: 77  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 136
Query: 798 ---ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
              ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+
Sbjct: 137 PEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLTARNVLVTENNVMKIADFGLAR 192
Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
            +   D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 193 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 251

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 93/188 (49%), Gaps = 16/188 (8%)
Query: 728 DCQNDKIGIGGVRD-----SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNG 781
           D + +K+ +  +++     +F AE   +  +RH N+V+ LG        L ++ +YM  G
Sbjct: 41  DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100
Query: 782 SLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY 841
           SL   L  R  S L  +   +  L   + + YL  +     VHRD+ A N+L+  +    
Sbjct: 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK 157
Query: 842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK 900
           ++DFGL K     + + + +T      + APE     K + KSDV+S+G+++ E+ + G+
Sbjct: 158 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212
Query: 901 QPIDPTIP 908
            P  P IP
Sbjct: 213 VPY-PRIP 219

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 74/279 (26%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 694 VGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY    +   + +AVK L   TM  E                F  E   +  
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---------------EFLKEAAVMKE 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA---- 808
           I+H N+V+ LG C       ++ ++M  G+L   L E    C   E+   ++L  A    
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVNAVVLLYMATQIS 121
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             + YL        +HRD+ A N L+G      +ADFGL++L+  GD   +         
Sbjct: 122 SAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIK 177
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           + APE     K + KSDV+++GV++ E+ T      P I                 E+L+
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----------DLSQVYELLE 226
Query: 929 KSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           K  R  RPE   E++ + +     C    P DRP+  ++
Sbjct: 227 KDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 262

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 68/233 (29%), Positives = 107/233 (45%), Gaps = 27/233 (11%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGSLLHERRDSC 794
           R  F  E + L  ++H NIVRF    W    +     +L+ +   +G+L + L  +R   
Sbjct: 69  RQRFKEEAEXLKGLQHPNIVRFYDS-WESTVKGKKCIVLVTELXTSGTLKTYL--KRFKV 125
Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI-GPEFEPYIADFGLAKLVVE 853
            + ++         +GL +LH    PPI+HRD+K +NI I GP     I D GLA L   
Sbjct: 126 XKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KR 183
Query: 854 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI 913
             FA++   V G+  + APE  Y  K  E  DVY++G   LE  T + P      E  + 
Sbjct: 184 ASFAKA---VIGTPEFXAPEX-YEEKYDESVDVYAFGXCXLEXATSEYPYS----ECQNA 235
Query: 914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
               R+    ++       A PEV  +E+++       C+    D+R ++KD+
Sbjct: 236 AQIYRRVTSGVKPASFDKVAIPEV--KEIIEG------CIRQNKDERYSIKDL 280

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 43/240 (17%)
Query: 694 VGKGCSGIVYRAEM--------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +G+GC G V  AE         +    +AVK L     A E D  +             +
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSD-----------LVS 81
Query: 746 EIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW------- 797
           E++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+       
Sbjct: 82  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 141
Query: 798 ---ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
              ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+
Sbjct: 142 PEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLAR 197
Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
            +   D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 198 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 256

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 694 VGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +G+G  G V    Y  E +N GE +AVK L P +            G   + D    EI+
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES------------GGNHIAD-LKKEIE 75
Query: 749 TLGSIRHKNIVRFLGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIIL 805
            L ++ H+NIV++ G C     N   L+ +++P+GSL   L + ++   L+ +L+Y + +
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              +G+ YL        VHRD+ A N+L+  E +  I DFGL K  +E D  +   TV  
Sbjct: 136 --CKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETD--KEXXTVKD 187
Query: 866 SYG----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
                  + APE     K    SDV+S+GV + E+LT
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 109/240 (45%), Gaps = 43/240 (17%)
Query: 694 VGKGCSGIVYRAEM--------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +G+GC G V  AE         +    +AVK L     A E D  +             +
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSD-----------LVS 78
Query: 746 EIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW------- 797
           E++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+       
Sbjct: 79  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 138
Query: 798 ---ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
              ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+
Sbjct: 139 PEEQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLAR 194
Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
            +   D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 195 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 253

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F +E   +G   H NI+R  G        +++ +YM NGSL + L          +L
Sbjct: 94  RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL 153
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              ++ G   G+ YL        VHRD+ A N+L+       ++DFGL++ V+E D   +
Sbjct: 154 -VGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR-VLEDDPDAA 208
Query: 860 SNTVAGSYG--YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
             T  G     + APE       +  SDV+S+GVV+ EVL  G++P
Sbjct: 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 769
           GE++AVK L      A+   Q+        R  +  EI  L ++ H++I+++ GCC +  
Sbjct: 60  GEMVAVKAL-----KADAGPQH--------RSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106
Query: 770 --TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI 827
             +  L+ +Y+P GSL   L        +  L  + I    +G+AYLH       +HRD+
Sbjct: 107 AASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI---CEGMAYLH---AQHYIHRDL 160
Query: 828 KANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDV 886
            A N+L+  +    I DFGLAK V EG +  R          + APE     K    SDV
Sbjct: 161 AARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDV 220
Query: 887 YSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI---EVLDKSLR-ARPE---VEI 939
           +S+GV + E+LT          + L ++   + +   +   E+L++  R  RP+    E+
Sbjct: 221 WSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEV 280
Query: 940 EEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
             +++       C       RPT +++  ++K + ++ +
Sbjct: 281 YHLMKN------CWETEASFRPTFENLIPILKTVHEKYQ 313

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/279 (23%), Positives = 120/279 (43%), Gaps = 33/279 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+         +A+K L P TM+ E               SF  E + +  +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE---------------SFLEEAQIMKKL 61
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           +H  +V+      +     ++ +YM  GSL   L +     L+      +    A G+AY
Sbjct: 62  KHDKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 120
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           +        +HRD+++ NIL+G      IADFGLA+L +E +   +         + APE
Sbjct: 121 IERMNY---IHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTARQGAKFPIKWTAPE 176
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRA 933
                + T KSDV+S+G+++ E++T  +   P +             R  +E +++  R 
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-----------NNREVLEQVERGYRM 225
Query: 934 RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
               +    L  L +   C    P++RPT + + + +++
Sbjct: 226 PCPQDCPISLHELMIH--CWKKDPEERPTFEYLQSFLED 262

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 23/178 (12%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+         
Sbjct: 94  MKMIG--KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 798 -ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 116/257 (45%), Gaps = 27/257 (10%)
Query: 725 AEYDCQNDKIGIGGV-RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL 783
            +YD     I  G +  D F  E K + ++ H+ +V+  G C  +    ++ +YM NG L
Sbjct: 47  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106
Query: 784 GSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA 843
            + L E R      +L   +     + + YL        +HRD+ A N L+  +    ++
Sbjct: 107 LNYLREMRHRFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVS 162
Query: 844 DFGLAKLVVEGDFARSSNTVAGSY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK 900
           DFGL++ V++ ++   +++V   +   +  PE     K + KSD++++GV++ E+ + GK
Sbjct: 163 DFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219
Query: 901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDD 959
            P +                    E + + LR  RP +  E   +   +   C +   D+
Sbjct: 220 MPYERFT------------NSETAEHIAQGLRLYRPHLASE---KVYTIMYSCWHEKADE 264
Query: 960 RPTMKDVAAMIKEIKQE 976
           RPT K + + I ++  E
Sbjct: 265 RPTFKILLSNILDVMDE 281

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 694 VGKGCSGIV----YRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +G+G  G V    Y  E +N GE +AVK L P +            G   + D    EI+
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES------------GGNHIAD-LKKEIE 63
Query: 749 TLGSIRHKNIVRFLGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIIL 805
            L ++ H+NIV++ G C     N   L+ +++P+GSL   L + ++   L+ +L+Y + +
Sbjct: 64  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 123
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              +G+ YL        VHRD+ A N+L+  E +  I DFGL K  +E D  +   TV  
Sbjct: 124 --CKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETD--KEXXTVKD 175
Query: 866 SYG----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
                  + APE     K    SDV+S+GV + E+LT
Sbjct: 176 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 107/242 (44%), Gaps = 23/242 (9%)
Query: 726 EYDCQNDKIGIGGV-RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLG 784
           +YD     I  G +  D F  E K + ++ H+ +V+  G C  +    ++ +YM NG L 
Sbjct: 33  QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 92
Query: 785 SLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
           + L E R      +L   +     + + YL        +HRD+ A N L+  +    ++D
Sbjct: 93  NYLREMRHRFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 148
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
           FGL++ V++ ++  SS        +  PE     K + KSD++++GV++ E+ + GK P 
Sbjct: 149 FGLSRYVLDDEYT-SSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 207
Query: 904 DPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
           +                    E + + LR  RP +  E   +   +   C +   D+RPT
Sbjct: 208 ERFT------------NSETAEHIAQGLRLYRPHLASE---KVYTIMYSCWHEKADERPT 252
Query: 963 MK 964
            K
Sbjct: 253 FK 254

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 116/256 (45%), Gaps = 27/256 (10%)
Query: 726 EYDCQNDKIGIGGV-RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLG 784
           +YD     I  G +  D F  E K + ++ H+ +V+  G C  +    ++ +YM NG L 
Sbjct: 32  QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 91
Query: 785 SLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
           + L E R      +L   +     + + YL        +HRD+ A N L+  +    ++D
Sbjct: 92  NYLREMRHRFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 147
Query: 845 FGLAKLVVEGDFARSSNTVAGSY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ 901
           FGL++ V++ ++   +++V   +   +  PE     K + KSD++++GV++ E+ + GK 
Sbjct: 148 FGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 204
Query: 902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDR 960
           P +                    E + + LR  RP +  E   +   +   C +   D+R
Sbjct: 205 PYERFT------------NSETAEHIAQGLRLYRPHLASE---KVYTIMYSCWHEKADER 249
Query: 961 PTMKDVAAMIKEIKQE 976
           PT K + + I ++  E
Sbjct: 250 PTFKILLSNILDVMDE 265

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 103/239 (43%), Gaps = 24/239 (10%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           R  F +E   +G   H N++   G        +++ ++M NGSL S L +        +L
Sbjct: 52  RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL 111
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              ++ G A G+ YL        VHR + A NIL+       ++DFGL++  +E D +  
Sbjct: 112 -VGMLRGIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRF-LEDDTSDP 166
Query: 860 SNTVAGS----YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
           + T A        + APE     K T  SDV+SYG+V+ EV++ G++P            
Sbjct: 167 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY----------- 215
Query: 915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            W    +  I  +++  R  P ++    L  L   L C     + RP    +   + ++
Sbjct: 216 -WDMTNQDVINAIEQDYRLPPPMDCPSALHQL--MLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 83/293 (28%), Positives = 130/293 (44%), Gaps = 53/293 (18%)
Query: 692 SVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           S +GKG  G V     +      G ++AVK+L      +  D Q D          F  E
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQRD----------FQRE 74
Query: 747 IKTLGSIRHKNIVRFLGCCWN--RNTRLLMYDYMPNGSLGSLLHERR---DSCLEWELRY 801
           I+ L ++    IV++ G  +   R +  L+ +Y+P+G L   L   R   D+        
Sbjct: 75  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS------- 127
Query: 802 RIILGAAQ---GLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDF 856
           R++L ++Q   G+ YL    CV    HRD+ A NIL+  E    IADFGLAKL+ ++ D+
Sbjct: 128 RLLLYSSQICKGMEYLGSRRCV----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
                       + APE       + +SDV+S+GVV+ E+ T          E L ++  
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 243
Query: 917 VR-----QKRGAIEVLDKSLRARPE--VEIEEMLQTLGVALLCVNPTPDDRPT 962
            R      +   +    + L A P    E+ E+++      LC  P+P DRP+
Sbjct: 244 ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPS 290

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 25/217 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           VG+G  G+VY+A+   G ++A+K++         D +++ I    +R     EI  L  +
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIR-----EISLLKEL 76
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H NIV  +    +     L++++M    L  +L E +    + +++   +    +G+A+
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKI-YLYQLLRGVAH 134
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
            H      I+HRD+K  N+LI  +    +ADFGLA+    G   RS      +  Y AP+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 874 YGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTI 907
              +M   K +   D++S G +  E++TGK P+ P +
Sbjct: 190 --VLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGV 223

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 116/256 (45%), Gaps = 27/256 (10%)
Query: 726 EYDCQNDKIGIGGV-RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLG 784
           +YD     I  G +  D F  E K + ++ H+ +V+  G C  +    ++ +YM NG L 
Sbjct: 33  QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 92
Query: 785 SLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
           + L E R      +L   +     + + YL        +HRD+ A N L+  +    ++D
Sbjct: 93  NYLREMRHRFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 148
Query: 845 FGLAKLVVEGDFARSSNTVAGSY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ 901
           FGL++ V++ ++   +++V   +   +  PE     K + KSD++++GV++ E+ + GK 
Sbjct: 149 FGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 205
Query: 902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDR 960
           P +                    E + + LR  RP +  E   +   +   C +   D+R
Sbjct: 206 PYERFT------------NSETAEHIAQGLRLYRPHLASE---KVYTIMYSCWHEKADER 250
Query: 961 PTMKDVAAMIKEIKQE 976
           PT K + + I ++  E
Sbjct: 251 PTFKILLSNILDVMDE 266

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 25/217 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           VG+G  G+VY+A+   G ++A+K++         D +++ I    +R     EI  L  +
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIR-----EISLLKEL 76
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H NIV  +    +     L++++M    L  +L E +    + +++   +    +G+A+
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKI-YLYQLLRGVAH 134
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
            H      I+HRD+K  N+LI  +    +ADFGLA+    G   RS      +  Y AP+
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPD 189
Query: 874 YGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTI 907
              +M   K +   D++S G +  E++TGK P+ P +
Sbjct: 190 --VLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGV 223

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   LE+         
Sbjct: 76  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 133
Query: 798 -ELRYRIILG----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
            +L  + ++      A+G+ YL        +HRD+ A N+L+  +    IADFGLA+ + 
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 190
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
             D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 246

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 23/178 (12%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+         
Sbjct: 94  MKMIG--KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 798 -ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   LE+         
Sbjct: 87  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 144
Query: 798 -ELRYRIILG----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
            +L  + ++      A+G+ YL        +HRD+ A N+L+  +    IADFGLA+ + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
             D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 257

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 23/178 (12%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+         
Sbjct: 94  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 798 -ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D+ +++        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 208 NNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 116/256 (45%), Gaps = 27/256 (10%)
Query: 726 EYDCQNDKIGIGGV-RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLG 784
           +YD     I  G +  D F  E K + ++ H+ +V+  G C  +    ++ +YM NG L 
Sbjct: 28  QYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87
Query: 785 SLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
           + L E R      +L   +     + + YL        +HRD+ A N L+  +    ++D
Sbjct: 88  NYLREMRHRFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 143
Query: 845 FGLAKLVVEGDFARSSNTVAGSY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ 901
           FGL++ V++ ++   +++V   +   +  PE     K + KSD++++GV++ E+ + GK 
Sbjct: 144 FGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200
Query: 902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDR 960
           P +                    E + + LR  RP +  E   +   +   C +   D+R
Sbjct: 201 PYERFT------------NSETAEHIAQGLRLYRPHLASE---KVYTIMYSCWHEKADER 245
Query: 961 PTMKDVAAMIKEIKQE 976
           PT K + + I ++  E
Sbjct: 246 PTFKILLSNILDVMDE 261

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   LE+         
Sbjct: 128 MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 798 -ELRYRIILG----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
            +L  + ++      A+G+ YL        +HRD+ A N+L+  +    IADFGLA+ + 
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
             D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 298

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 47/266 (17%)
Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR------- 791
           +RD  S E   L  + H ++++  G C      LL+ +Y   GSL   L E R       
Sbjct: 70  LRDLLS-EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 792 -----------DSCLEWELRYRIILGAA----QGLAYLHHDCVPPIVHRDIKANNILIGP 836
                      D   E  L    ++  A    QG+ YL       +VHRD+ A NIL+  
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAE 185
Query: 837 EFEPYIADFGLAKLVVEGD--FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVL 894
             +  I+DFGL++ V E D    RS   +   +  I   + ++   T +SDV+S+GV++ 
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLW 243
Query: 895 EVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLC 952
           E++T G  P     PE L              +L    R  RP+   EEM + +   L C
Sbjct: 244 EIVTLGGNPYPGIPPERL------------FNLLKTGHRMERPDNCSEEMYRLM---LQC 288
Query: 953 VNPTPDDRPTMKDVAAMIKEIKQERE 978
               PD RP   D++  ++++  +R 
Sbjct: 289 WKQEPDKRPVFADISKDLEKMMVKRR 314

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 116/257 (45%), Gaps = 27/257 (10%)
Query: 725 AEYDCQNDKIGIGGV-RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL 783
            +YD     I  G +  D F  E K + ++ H+ +V+  G C  +    ++ +YM NG L
Sbjct: 38  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 97
Query: 784 GSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA 843
            + L E R      +L   +     + + YL        +HRD+ A N L+  +    ++
Sbjct: 98  LNYLREMRHRFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVS 153
Query: 844 DFGLAKLVVEGDFARSSNTVAGSY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK 900
           DFGL++ V++ ++   +++V   +   +  PE     K + KSD++++GV++ E+ + GK
Sbjct: 154 DFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 210
Query: 901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDD 959
            P +                    E + + LR  RP +  E   +   +   C +   D+
Sbjct: 211 MPYERFT------------NSETAEHIAQGLRLYRPHLASE---KVYTIMYSCWHEKADE 255
Query: 960 RPTMKDVAAMIKEIKQE 976
           RPT K + + I ++  E
Sbjct: 256 RPTFKILLSNILDVMDE 272

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   LE+         
Sbjct: 80  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 137
Query: 798 -ELRYRIILG----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
            +L  + ++      A+G+ YL        +HRD+ A N+L+  +    IADFGLA+ + 
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 194
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
             D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 250

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   LE+         
Sbjct: 79  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 136
Query: 798 -ELRYRIILG----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
            +L  + ++      A+G+ YL        +HRD+ A N+L+  +    IADFGLA+ + 
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 193
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
             D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 249

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 93/188 (49%), Gaps = 16/188 (8%)
Query: 728 DCQNDKIGIGGVRD-----SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNG 781
           D + +K+ +  +++     +F AE   +  +RH N+V+ LG        L ++ +YM  G
Sbjct: 213 DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272
Query: 782 SLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY 841
           SL   L  R  S L  +   +  L   + + YL  +     VHRD+ A N+L+  +    
Sbjct: 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK 329
Query: 842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK 900
           ++DFGL K     + + + +T      + APE     K + KSDV+S+G+++ E+ + G+
Sbjct: 330 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384
Query: 901 QPIDPTIP 908
            P  P IP
Sbjct: 385 VPY-PRIP 391

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 83/293 (28%), Positives = 130/293 (44%), Gaps = 53/293 (18%)
Query: 692 SVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           S +GKG  G V     +      G ++AVK+L      +  D Q D          F  E
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQRD----------FQRE 62
Query: 747 IKTLGSIRHKNIVRFLGCCWN--RNTRLLMYDYMPNGSLGSLLHERR---DSCLEWELRY 801
           I+ L ++    IV++ G  +   R +  L+ +Y+P+G L   L   R   D+        
Sbjct: 63  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS------- 115
Query: 802 RIILGAAQ---GLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDF 856
           R++L ++Q   G+ YL    CV    HRD+ A NIL+  E    IADFGLAKL+ ++ D+
Sbjct: 116 RLLLYSSQICKGMEYLGSRRCV----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 171
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
                       + APE       + +SDV+S+GVV+ E+ T          E L ++  
Sbjct: 172 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 231
Query: 917 VRQ-----KRGAIEVLDKSLRARPE--VEIEEMLQTLGVALLCVNPTPDDRPT 962
            R      +   +    + L A P    E+ E+++      LC  P+P DRP+
Sbjct: 232 ERDVPALCRLLELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPS 278

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 23/178 (12%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+         
Sbjct: 94  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 798 -ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMRIADFGLARDI 207
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   LE+         
Sbjct: 72  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 129
Query: 798 -ELRYRIILG----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
            +L  + ++      A+G+ YL        +HRD+ A N+L+  +    IADFGLA+ + 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
             D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 242

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 23/178 (12%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+         
Sbjct: 94  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 798 -ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 47/266 (17%)
Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR------- 791
           +RD  S E   L  + H ++++  G C      LL+ +Y   GSL   L E R       
Sbjct: 70  LRDLLS-EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 792 -----------DSCLEWELRYRIILGAA----QGLAYLHHDCVPPIVHRDIKANNILIGP 836
                      D   E  L    ++  A    QG+ YL       +VHRD+ A NIL+  
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAE 185
Query: 837 EFEPYIADFGLAKLVVEGD--FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVL 894
             +  I+DFGL++ V E D    RS   +   +  I   + ++   T +SDV+S+GV++ 
Sbjct: 186 GRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLW 243
Query: 895 EVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLC 952
           E++T G  P     PE L              +L    R  RP+   EEM + +   L C
Sbjct: 244 EIVTLGGNPYPGIPPERL------------FNLLKTGHRMERPDNCSEEMYRLM---LQC 288
Query: 953 VNPTPDDRPTMKDVAAMIKEIKQERE 978
               PD RP   D++  ++++  +R 
Sbjct: 289 WKQEPDKRPVFADISKDLEKMMVKRR 314

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 21/177 (11%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   LE+         
Sbjct: 87  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 144
Query: 798 -ELRYRIILG----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
            +L  + ++      A+G+ YL        +HRD+ A N+L+  +    IADFGLA+ + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
             D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 257

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 83/293 (28%), Positives = 130/293 (44%), Gaps = 53/293 (18%)
Query: 692 SVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           S +GKG  G V     +      G ++AVK+L      +  D Q D          F  E
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQRD----------FQRE 61
Query: 747 IKTLGSIRHKNIVRFLGCCWN--RNTRLLMYDYMPNGSLGSLLHERR---DSCLEWELRY 801
           I+ L ++    IV++ G  +   R +  L+ +Y+P+G L   L   R   D+        
Sbjct: 62  IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS------- 114
Query: 802 RIILGAAQ---GLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDF 856
           R++L ++Q   G+ YL    CV    HRD+ A NIL+  E    IADFGLAKL+ ++ D+
Sbjct: 115 RLLLYSSQICKGMEYLGSRRCV----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 170
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
                       + APE       + +SDV+S+GVV+ E+ T          E L ++  
Sbjct: 171 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGS 230
Query: 917 VR-----QKRGAIEVLDKSLRARPE--VEIEEMLQTLGVALLCVNPTPDDRPT 962
            R      +   +    + L A P    E+ E+++      LC  P+P DRP+
Sbjct: 231 ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPS 277

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 47/266 (17%)
Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR------- 791
           +RD  S E   L  + H ++++  G C      LL+ +Y   GSL   L E R       
Sbjct: 70  LRDLLS-EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYL 128
Query: 792 -----------DSCLEWELRYRIILGAA----QGLAYLHHDCVPPIVHRDIKANNILIGP 836
                      D   E  L    ++  A    QG+ YL       +VHRD+ A NIL+  
Sbjct: 129 GSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAE 185
Query: 837 EFEPYIADFGLAKLVVEGD--FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVL 894
             +  I+DFGL++ V E D    RS   +   +  I   + ++   T +SDV+S+GV++ 
Sbjct: 186 GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI--YTTQSDVWSFGVLLW 243
Query: 895 EVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLC 952
           E++T G  P     PE L              +L    R  RP+   EEM + +   L C
Sbjct: 244 EIVTLGGNPYPGIPPERL------------FNLLKTGHRMERPDNCSEEMYRLM---LQC 288
Query: 953 VNPTPDDRPTMKDVAAMIKEIKQERE 978
               PD RP   D++  ++++  +R 
Sbjct: 289 WKQEPDKRPVFADISKDLEKMMVKRR 314

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 92/188 (48%), Gaps = 16/188 (8%)
Query: 728 DCQNDKIGIGGVRD-----SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNG 781
           D + +K+ +  +++     +F AE   +  +RH N+V+ LG        L ++ +YM  G
Sbjct: 32  DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 91
Query: 782 SLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY 841
           SL   L  R  S L  +   +  L   + + YL  +     VHRD+ A N+L+  +    
Sbjct: 92  SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK 148
Query: 842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK 900
           ++DFGL K     + + + +T      + APE       + KSDV+S+G+++ E+ + G+
Sbjct: 149 VSDFGLTK-----EASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203
Query: 901 QPIDPTIP 908
            P  P IP
Sbjct: 204 VPY-PRIP 210

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY A E ++  ++A+K L+ + +  E           GV      EI+    
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKE-----------GVEHQLRREIEIQAH 79
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA-AQGL 811
           + H NI+R     ++R    L+ +Y P G L     E + SC   E R   I+   A  L
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYK---ELQKSCTFDEQRTATIMEELADAL 136
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            Y H   V   +HRDIK  N+L+G + E  IADFG +   V     R   T+ G+  Y+ 
Sbjct: 137 MYCHGKKV---IHRDIKPENLLLGLKGELKIADFGWS---VHAPSLR-RKTMCGTLDYLP 189
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           PE        EK D++  GV+  E+L G  P +
Sbjct: 190 PEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 115/257 (44%), Gaps = 27/257 (10%)
Query: 725 AEYDCQNDKIGIGGV-RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL 783
            +YD     I  G +  D F  E K + ++ H+ +V+  G C  +    ++ +YM NG L
Sbjct: 47  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106
Query: 784 GSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA 843
            + L E R      +L   +     + + YL        +HRD+ A N L+  +    ++
Sbjct: 107 LNYLREMRHRFQTQQL-LEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVS 162
Query: 844 DFGLAKLVVEGDFARSSNTVAGSY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK 900
           DFGL++ V++ +    +++V   +   +  PE     K + KSD++++GV++ E+ + GK
Sbjct: 163 DFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219
Query: 901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDD 959
            P +                    E + + LR  RP +  E   +   +   C +   D+
Sbjct: 220 MPYERFT------------NSETAEHIAQGLRLYRPHLASE---KVYTIMYSCWHEKADE 264
Query: 960 RPTMKDVAAMIKEIKQE 976
           RPT K + + I ++  E
Sbjct: 265 RPTFKILLSNILDVMDE 281

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 31/223 (13%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY+A+   GE  A+KK+         + +++ I    +R     EI  L  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIR-----EISILKEL 57
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC---LEWELRYRIILGAAQG 810
           +H NIV+       +   +L+++++ +  L  LL    D C   LE       +L    G
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL----DVCEGGLESVTAKSFLLQLLNG 112
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           +AY H   V   +HRD+K  N+LI  E E  IADFGLA+    G   R       +  Y 
Sbjct: 113 IAYCHDRRV---LHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYR 167
Query: 871 APEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG 910
           AP+   +M   K +   D++S G +  E++ G  P+ P + E 
Sbjct: 168 APD--VLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEA 207

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 31/223 (13%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY+A+   GE  A+KK+         + +++ I    +R     EI  L  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIR-----EISILKEL 57
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC---LEWELRYRIILGAAQG 810
           +H NIV+       +   +L+++++ +  L  LL    D C   LE       +L    G
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL----DVCEGGLESVTAKSFLLQLLNG 112
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           +AY H   V   +HRD+K  N+LI  E E  IADFGLA+    G   R       +  Y 
Sbjct: 113 IAYCHDRRV---LHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYR 167
Query: 871 APEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG 910
           AP+   +M   K +   D++S G +  E++ G  P+ P + E 
Sbjct: 168 APD--VLMGSKKYSTTIDIWSVGCIFAEMVNG-APLFPGVSEA 207

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   LE+         
Sbjct: 87  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPE 144
Query: 798 -ELRYRIILG----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
            +L  + ++      A+G+ YL        +HRD+ A N+L+  +    IADFGLA+ + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
             D  + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 257

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 23/178 (12%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   +E+         
Sbjct: 94  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 798 -ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D  + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 125 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 179
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 180 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 23/178 (12%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++  Y   G+L   L  RR   +E+         
Sbjct: 94  MKMIG--KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 798 -ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 23/178 (12%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++  Y   G+L   L  RR   +E+         
Sbjct: 94  MKMIG--KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 798 -ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   ++  +KL    +               +R+    E++ L 
Sbjct: 74  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------AIRNQIIRELQVLH 121
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 122 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 179
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 180 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 233
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 234 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+     N   +AVK L P TM+ +               +F  E   + ++
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ---------------AFLEEANLMKTL 65
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA--AQGL 811
           +H  +VR            ++ +YM  GSL   L  + D   +  L   I   A  A+G+
Sbjct: 66  QHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFL--KSDEGGKVLLPKLIDFSAQIAEGM 123
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           AY+        +HRD++A N+L+       IADFGLA+++ + ++  +         + A
Sbjct: 124 AYIERKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTA 179
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           PE       T KSDV+S+G+++ E++T GK P
Sbjct: 180 PEAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 31/223 (13%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY+A+   GE  A+KK+         + +++ I    +R     EI  L  +
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIR-----EISILKEL 57
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC---LEWELRYRIILGAAQG 810
           +H NIV+       +   +L+++++ +  L  LL    D C   LE       +L    G
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL----DVCEGGLESVTAKSFLLQLLNG 112
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           +AY H   V   +HRD+K  N+LI  E E  IADFGLA+    G   R       +  Y 
Sbjct: 113 IAYCHDRRV---LHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYR 167
Query: 871 APEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG 910
           AP+   +M   K +   D++S G +  E++ G  P+ P + E 
Sbjct: 168 APD--VLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEA 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 65
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 125 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 179
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 180 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   ++  +KL    +               +R+    E++ L 
Sbjct: 39  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------AIRNQIIRELQVLH 86
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 87  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 144
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 145 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 198
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 61
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L + +     + +   L    +    QGLA
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 121 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 21/177 (11%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  R    LE+         
Sbjct: 87  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPE 144
Query: 798 -ELRYRIILG----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
            +L  + ++      A+G+ YL        +HRD+ A N+L+  +    IADFGLA+ + 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
             D+ + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P +P
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVP 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 51/280 (18%)
Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTR 771
           +AVK L  T  A E             +++  +E+K +  + +H+NIV  LG C +    
Sbjct: 71  VAVKMLKSTAHADE-------------KEALMSELKIMSHLGQHENIVNLLGACTHGGPV 117
Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWE----LRYRIILG----AAQGLAYL-HHDCVPPI 822
           L++ +Y   G L + L  + ++ L+ E    L  R +L      AQG+A+L   +C    
Sbjct: 118 LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC---- 173
Query: 823 VHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG-----YIAPEYGYM 877
           +HRD+ A N+L+       I DFGLA+     D    SN +          ++APE  + 
Sbjct: 174 IHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESIFD 228
Query: 878 MKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPE 936
              T +SDV+SYG+++ E+ + G  P  P I         V+         D    A+P 
Sbjct: 229 CVYTVQSDVWSYGILLWEIFSLGLNPY-PGILVNSKFYKLVK---------DGYQMAQPA 278
Query: 937 VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
              + +   +     C    P  RPT + + + ++E  QE
Sbjct: 279 FAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQEQAQE 315

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 128/286 (44%), Gaps = 55/286 (19%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+ A       +AVK + P +M+ E               +F AE   + ++
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---------------AFLAEANVMKTL 234
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA--AQGL 811
           +H  +V+ L     +    ++ ++M  GSL   L  + D   +  L   I   A  A+G+
Sbjct: 235 QHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGM 291
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           A++        +HRD++A NIL+       IADFGLA++  +               + A
Sbjct: 292 AFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTA 337
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI--PEGLHIVDWVRQKRGAIEVLD 928
           PE       T KSDV+S+G++++E++T G+ P  P +  PE              I  L+
Sbjct: 338 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPE-------------VIRALE 383
Query: 929 KSLRA-RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +  R  RPE   EE+     + + C    P++RPT + + +++ + 
Sbjct: 384 RGYRMPRPENCPEEL---YNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 44/224 (19%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS----AEIKT 749
           VGKG  G V+R  + +GE +AVK                   I   RD  S     EI  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK-------------------IFSSRDEQSWFRETEIYN 55
Query: 750 LGSIRHKNIVRFLG---CCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
              +RH NI+ F+       N +T+L L+  Y  +GSL   L  +    LE  L  R+ +
Sbjct: 56  TVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ---TLEPHLALRLAV 112
Query: 806 GAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFAR- 858
            AA GLA+LH +       P I HRD K+ N+L+    +  IAD GLA +  +G D+   
Sbjct: 113 SAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDI 172
Query: 859 SSNTVAGSYGYIAPEY------GYMMKITEKSDVYSYGVVVLEV 896
            +N   G+  Y+APE           +  + +D++++G+V+ E+
Sbjct: 173 GNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   ++  +KL    +               +R+    E++ L 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------AIRNQIIRELQVLH 59
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 117
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 57
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 117 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 59
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 119 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 173
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   ++  +KL    +               +R+    E++ L 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------AIRNQIIRELQVLH 59
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 117
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 57
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 117 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 62
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 122 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 176
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   ++  +KL    +               +R+    E++ L 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------AIRNQIIRELQVLH 59
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 117
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 61
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 121 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 60
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 120 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 174
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 62
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 63  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 122 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 176
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   ++  +KL    +               +R+    E++ L 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------AIRNQIIRELQVLH 59
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 117
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   ++  +KL    +               +R+    E++ L 
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------AIRNQIIRELQVLH 59
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 60  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 117
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 118 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ PI P
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 60
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 120 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 174
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 57
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 117 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 171
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 39/279 (13%)
Query: 692 SVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +++GKG    VYRAE +  G  +A+K +    M              G+      E+K  
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-----------AGMVQRVQNEVKIH 65
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
             ++H +I+       + N   L+ +   NG +   L  R     E E R+  +     G
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-FMHQIITG 124
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA---KLVVEGDFARSSNTVAGSY 867
           + YLH      I+HRD+  +N+L+       IADFGLA   K+  E  +     T+ G+ 
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY-----TLCGTP 176
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVL 927
            YI+PE         +SDV+S G +   +L G+ P D          D V+     + + 
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD---------TDTVKNTLNKVVLA 227
Query: 928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           D  + +   +E ++++  L      +   P DR ++  V
Sbjct: 228 DYEMPSFLSIEAKDLIHQL------LRRNPADRLSLSSV 260

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 61
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 121 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 57
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L + +     + +   L    +    QGLA
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 117 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 57
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 117 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 171
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 61
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 121 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 59
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 119 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 173
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 57/286 (19%)
Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTR 771
           +AVK L  T  A E             +++  +E+K +  + +H+NIV  LG C +    
Sbjct: 79  VAVKMLKSTAHADE-------------KEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125
Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEW----------ELRYRIILG----AAQGLAYL-HH 816
           L++ +Y   G L + L  +R   LE+          +L  R +L      AQG+A+L   
Sbjct: 126 LVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASK 185
Query: 817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG-----YIA 871
           +C    +HRD+ A N+L+       I DFGLA+     D    SN +          ++A
Sbjct: 186 NC----IHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMA 236
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKS 930
           PE  +    T +SDV+SYG+++ E+ + G  P  P I         V+         D  
Sbjct: 237 PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-PGILVNSKFYKLVK---------DGY 286
Query: 931 LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
             A+P    + +   +     C    P  RPT + + + ++E  QE
Sbjct: 287 QMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQEQAQE 329

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 60
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 120 FCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 174
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 86/178 (48%), Gaps = 23/178 (12%)
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW--------- 797
           +K +G  +HKNI+  LG C       ++ +Y   G+L   L  RR   +E          
Sbjct: 94  MKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 798 -ELRYRIILGA----AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            ++ ++ ++      A+G+ YL    C+    HRD+ A N+L+       IADFGLA+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
              D  + +        ++APE  +    T +SDV+S+GV++ E+ T G  P  P IP
Sbjct: 208 NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIP 264

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 59
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 119 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 173
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG VY A ++  G+ +A++++               +     ++    EI  +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--------------NLQQQPKKELIINEILVMRE 73
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            ++ NIV +L      +   ++ +Y+  GSL  ++ E   +C++      +     Q L 
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH + V   +HRDIK++NIL+G +    + DFG    +      RS  T+ G+  ++AP
Sbjct: 131 FLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAP 185
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K D++S G++ +E++ G+ P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 51/280 (18%)
Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTR 771
           +AVK L  T  A E             +++  +E+K +  + +H+NIV  LG C +    
Sbjct: 79  VAVKMLKSTAHADE-------------KEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125
Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWE----LRYRIILG----AAQGLAYL-HHDCVPPI 822
           L++ +Y   G L + L  + ++ L+ E    L  R +L      AQG+A+L   +C    
Sbjct: 126 LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC---- 181
Query: 823 VHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG-----YIAPEYGYM 877
           +HRD+ A N+L+       I DFGLA+     D    SN +          ++APE  + 
Sbjct: 182 IHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAPESIFD 236
Query: 878 MKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPE 936
              T +SDV+SYG+++ E+ + G  P  P I         V+         D    A+P 
Sbjct: 237 CVYTVQSDVWSYGILLWEIFSLGLNPY-PGILVNSKFYKLVK---------DGYQMAQPA 286
Query: 937 VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
              + +   +     C    P  RPT + + + ++E  QE
Sbjct: 287 FAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQEQAQE 323

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 59
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 119 FCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 173
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 61
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 121 FCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 83/213 (38%), Gaps = 25/213 (11%)
Query: 415 TQLQMXXXXXXXXXXXXPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS 474
           TQL              P  L+ +  L  LD S N   G +P S   L +L  +    N 
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 475 FSGAIPSSLGRCESL-QSLDLSSNKLSGKIPVEL--FEIEGLDISLN------------- 518
            SGAIP S G    L  S+ +S N+L+GKIP       +  +D+S N             
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220
Query: 519 -------LSWNALSGAIPPQISALNKLSILDLSHNKXX-XXXXXXXXXXXXXXXNVSYNN 570
                  L+ N+L+  +  ++     L+ LDL +N+                  NVS+NN
Sbjct: 221 KNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 571 FTGYLPDSKLFRQLSATEMAGNQGLCSRGHESC 603
             G +P     ++   +  A N+ LC     +C
Sbjct: 280 LCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 60
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 61  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 120 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 174
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 59
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 60  LNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 119 FCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 173
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGL+
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 83/293 (28%), Positives = 128/293 (43%), Gaps = 53/293 (18%)
Query: 692 SVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           S +GKG  G V     +      G ++AVK+L      +  D Q D          F  E
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQRD----------FQRE 58
Query: 747 IKTLGSIRHKNIVRFLGCCWN--RNTRLLMYDYMPNGSLGSLLHERR---DSCLEWELRY 801
           I+ L ++    IV++ G  +   R    L+ +Y+P+G L   L   R   D+        
Sbjct: 59  IQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDAS------- 111
Query: 802 RIILGAAQ---GLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDF 856
           R++L ++Q   G+ YL    CV    HRD+ A NIL+  E    IADFGLAKL+ ++ D 
Sbjct: 112 RLLLYSSQICKGMEYLGSRRCV----HRDLAARNILVESEAHVKIADFGLAKLLPLDKDX 167
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW 916
                       + APE       + +SDV+S+GVV+ E+ T          E L ++  
Sbjct: 168 XVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC 227
Query: 917 VRQ-----KRGAIEVLDKSLRARPE--VEIEEMLQTLGVALLCVNPTPDDRPT 962
            R      +   +    + L A P    E+ E+++      LC  P+P DRP+
Sbjct: 228 ERDVPALCRLLELLEEGQRLPAPPACPAEVHELMK------LCWAPSPQDRPS 274

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+KK+         D + + +    +R     EI  L  
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIR-----EISLLKE 61
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 62  LNHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 121 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 57/195 (29%), Positives = 86/195 (44%), Gaps = 28/195 (14%)
Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL 772
           +AVK L   TM  E                F  E   +  I+H N+V+ LG C       
Sbjct: 60  VAVKTLKEDTMEVE---------------EFLKEAAVMKEIKHPNLVQLLGVCTLEPPFY 104
Query: 773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA----QGLAYLHHDCVPPIVHRDIK 828
           ++ +YMP G+L   L E    C   E+   ++L  A      + YL        +HRD+ 
Sbjct: 105 IVTEYMPYGNLLDYLRE----CNREEVTAVVLLYMATQISSAMEYLEKK---NFIHRDLA 157
Query: 829 ANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYS 888
           A N L+G      +ADFGL++L+  GD   +         + APE       + KSDV++
Sbjct: 158 ARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWA 216
Query: 889 YGVVVLEVLT-GKQP 902
           +GV++ E+ T G  P
Sbjct: 217 FGVLLWEIATYGMSP 231

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 683 QVLKCLVEDSVVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           + +K  +    +GKG     Y   +M+  EV A  K+ P +M  +   Q +K+       
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFA-GKVVPKSMLLKPH-QKEKM------- 89
Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
             S EI    S+ + ++V F G   + +   ++ +     SL  L H+RR +  E E RY
Sbjct: 90  --STEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARY 146
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA-KLVVEGDFARSS 860
             +    QG+ YLH++    ++HRD+K  N+ +  + +  I DFGLA K+  +G+     
Sbjct: 147 -FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RK 199
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 906
            T+ G+  YIAPE       + + D++S G ++  +L GK P + +
Sbjct: 200 KTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 30/225 (13%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL--HERRDSCLEWELRYRI 803
           EI+ L   RH +I++            ++ +Y+  G L   +  H R +   E E R R+
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEAR-RL 116
Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
                  + Y H   V   VHRD+K  N+L+       IADFGL+ ++ +G+F R+S   
Sbjct: 117 FQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--- 170
Query: 864 AGSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
            GS  Y APE   G +    E  D++S GV++  +L G  P D       H+    ++ R
Sbjct: 171 CGSPNYAAPEVISGRLYAGPE-VDIWSCGVILYALLCGTLPFDDE-----HVPTLFKKIR 224
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           G +  + + L       +  MLQ            P  R T+KD+
Sbjct: 225 GGVFYIPEYLNRSVATLLMHMLQV----------DPLKRATIKDI 259

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 38/107 (35%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSN 861
           +I  A Q L + H +    I+HRD+K  NILI       + DFG+A+ + + G+    + 
Sbjct: 121 VIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTA 177
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 908
            V G+  Y++PE      +  +SDVYS G V+ EVLTG+ P     P
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 72
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W       +
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNW------CV 125
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 126 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+ K+         D + + +    +R     EI  L  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKI-------RLDTETEGVPSTAIR-----EISLLKE 58
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 118 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 172
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+VY+A  +  GEV+A+ K+         D + + +    +R     EI  L  
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKI-------RLDTETEGVPSTAIR-----EISLLKE 57
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGLA
Sbjct: 58  LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           + H   V   +HRD+K  N+LI  E    +ADFGLA+    G   R+      +  Y AP
Sbjct: 117 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVLTGK 900
           E     K    + D++S G +  E++T +
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V+     N   +AVK L P TM+ +               +F  E   + ++
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ---------------AFLEEANLMKTL 64
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA--AQGL 811
           +H  +VR            ++ ++M  GSL   L  + D   +  L   I   A  A+G+
Sbjct: 65  QHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFL--KSDEGGKVLLPKLIDFSAQIAEGM 122
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           AY+        +HRD++A N+L+       IADFGLA+++ + ++  +         + A
Sbjct: 123 AYIERKNY---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTA 178
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           PE       T KS+V+S+G+++ E++T GK P
Sbjct: 179 PEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 37/110 (33%), Positives = 59/110 (53%), Gaps = 4/110 (3%)
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSN 861
           +I  A Q L + H +    I+HRD+K  NI+I       + DFG+A+ + + G+    + 
Sbjct: 121 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL 911
            V G+  Y++PE      +  +SDVYS G V+ EVLTG+ P     P+ +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSV 227

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 75
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W       +
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 128
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 129 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 185
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL--HERRDSCLEWELRYRI 803
           EI+ L   RH +I++            ++ +Y+  G L   +  H R +   E E R R+
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEAR-RL 116
Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
                  + Y H   V   VHRD+K  N+L+       IADFGL+ ++ +G+F R S   
Sbjct: 117 FQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--- 170
Query: 864 AGSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
            GS  Y APE   G +    E  D++S GV++  +L G  P D       H+    ++ R
Sbjct: 171 CGSPNYAAPEVISGRLYAGPE-VDIWSCGVILYALLCGTLPFDDE-----HVPTLFKKIR 224
Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           G +  +       PE  +   + TL + +L V+P    R T+KD+
Sbjct: 225 GGVFYI-------PEY-LNRSVATLLMHMLQVDPL--KRATIKDI 259

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/212 (22%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   ++  +KL    +               +R+    E++ L 
Sbjct: 31  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------AIRNQIIRELQVLH 78
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 79  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 136
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y++
Sbjct: 137 TYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 190
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           PE       + +SD++S G+ ++E+  G+ PI
Sbjct: 191 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 126/310 (40%), Gaps = 65/310 (20%)
Query: 693 VVGKGCSGIVYRA------EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
            +G G  G V  A      + +    +AVK L P+    E             R++  +E
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-------------REALMSE 76
Query: 747 IKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII- 804
           +K L  +  H NIV  LG C      L++ +Y   G L + L  +RDS +  +    I+ 
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 805 ---------------LGAAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
                             A+G+A+L   +C    +HRD+ A NIL+       I DFGLA
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA 192
Query: 849 KLVVEGDFARSSNTVAGSYG-----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           +     D    SN V          ++APE  +    T +SDV+SYG+ + E+ + G  P
Sbjct: 193 R-----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
             P +P        +++      +L       PE    EM   +     C +  P  RPT
Sbjct: 248 Y-PGMPVDSKFYKMIKE---GFRMLS------PEHAPAEMYDIMKT---CWDADPLKRPT 294
Query: 963 MKDVAAMIKE 972
            K +  +I++
Sbjct: 295 FKQIVQLIEK 304

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 71
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W       +
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K            E   +
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPK-----ANKEILDEAYVM 74
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W       +
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 127
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 128 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 685 LKCLVEDSVV----GKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGV 739
           +K  +ED ++    GKG  G V+ AE +   +  A+K L    +  + D +   +     
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV----- 66
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
                 E + L        +  + C +     L       NG  G L++  + SC +++L
Sbjct: 67  ------EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG--GDLMYHIQ-SCHKFDL 117
Query: 800 RYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
             R    AA+   GL +LH      IV+RD+K +NIL+  +    IADFG+ K  + GD 
Sbjct: 118 S-RATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 172
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
              +N   G+  YIAPE     K     D +S+GV++ E+L G+ P 
Sbjct: 173 -AKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSN 861
           +I  A Q L + H +    I+HRD+K  NI+I       + DFG+A+ + + G+    + 
Sbjct: 138 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 194
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 908
            V G+  Y++PE      +  +SDVYS G V+ EVLTG+ P     P
Sbjct: 195 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K            E   +
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPK-----ANKEILDEAYVM 73
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W       +
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 72
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W       +
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 125
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 126 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 126/309 (40%), Gaps = 65/309 (21%)
Query: 694 VGKGCSGIVYRA------EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G G  G V  A      + +    +AVK L P+    E             R++  +E+
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-------------REALMSEL 93
Query: 748 KTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII-- 804
           K L  +  H NIV  LG C      L++ +Y   G L + L  +RDS +  +    I+  
Sbjct: 94  KVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 153
Query: 805 --------------LGAAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
                            A+G+A+L   +C    +HRD+ A NIL+       I DFGLA+
Sbjct: 154 DELALDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR 209
Query: 850 LVVEGDFARSSNTVAGSYG-----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
                D    SN V          ++APE  +    T +SDV+SYG+ + E+ + G  P 
Sbjct: 210 -----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 264
Query: 904 DPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM 963
            P +P        +++      +L       PE    EM   +     C +  P  RPT 
Sbjct: 265 -PGMPVDSKFYKMIKE---GFRMLS------PEHAPAEMYDIMKT---CWDADPLKRPTF 311
Query: 964 KDVAAMIKE 972
           K +  +I++
Sbjct: 312 KQIVQLIEK 320

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 25/232 (10%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGS-LLHERRDS- 793
           + F +E   +    H N++R LG C   +++     +++  +M  G L + LL+ R ++ 
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 794 --CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
              +  +   + ++  A G+ YL +      +HRD+ A N ++  +    +ADFGL+K +
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL 911
             GD+ R          +IA E       T KSDV+++GV + E+ T      P + +  
Sbjct: 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNH 256
Query: 912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM 963
            + D+         +L      +PE  ++E+ +   +   C    P DRPT 
Sbjct: 257 EMYDY---------LLHGHRLKQPEDCLDELYE---IMYSCWRTDPLDRPTF 296

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 63/228 (27%), Positives = 111/228 (48%), Gaps = 27/228 (11%)
Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           +VG+G  G+V +    + G ++A+KK          +  +DK+    V+     EIK L 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKF--------LESDDDKM----VKKIAMREIKLLK 79
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            +RH+N+V  L  C  +    L+++++ +  L  L  E   + L++++  + +     G+
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFPNGLDYQVVQKYLFQIINGI 137
Query: 812 AYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTVAGSYGY 869
            + H H+    I+HRDIK  NIL+       + DFG A+ L   G+     + VA  + Y
Sbjct: 138 GFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVATRW-Y 190
Query: 870 IAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQ--PIDPTIPEGLHIV 914
            APE     +K  +  DV++ G +V E+  G+   P D  I +  HI+
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 108/237 (45%), Gaps = 50/237 (21%)
Query: 684 VLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF 743
           + + +V    +GKG  G V+R +   GE +AVK                   I   R+  
Sbjct: 40  IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVK-------------------IFSSREER 79
Query: 744 S----AEIKTLGSIRHKNIVRFLGCCWNRN---TRL-LMYDYMPNGSLGSLLHERRDSCL 795
           S    AEI     +RH+NI+ F+      N   T+L L+ DY  +GSL   L+    +  
Sbjct: 80  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 138
Query: 796 EWELRYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
             E   ++ L  A GLA+LH + V     P I HRD+K+ NIL+       IAD GLA  
Sbjct: 139 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-- 194
Query: 851 VVEGDFARSSNTVA-----GSYGYIAPEY---GYMMKITE---KSDVYSYGVVVLEV 896
            V  D A  +  +A     G+  Y+APE       MK  E   ++D+Y+ G+V  E+
Sbjct: 195 -VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG VY A ++  G+ +A++++               +     ++    EI  +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--------------NLQQQPKKELIINEILVMRE 73
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            ++ NIV +L      +   ++ +Y+  GSL  ++ E   +C++      +     Q L 
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH + V   +HRDIK++NIL+G +    + DFG    +      RS   + G+  ++AP
Sbjct: 131 FLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSE--MVGTPYWMAP 185
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K D++S G++ +E++ G+ P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 131/314 (41%), Gaps = 70/314 (22%)
Query: 693 VVGKGCSGIVYRAEMENGEV---IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V +A ++   +    A+K++       EY  ++D       RD F+ E++ 
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRM------KEYASKDDH------RD-FAGELEV 78
Query: 750 LGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSC 794
           L  +  H NI+  LG C +R    L  +Y P+G+L   L + R               S 
Sbjct: 79  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
           L  +         A+G+ YL        +HRD+ A NIL+G  +   IADFGL++    G
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----G 191
Query: 855 DFARSSNTVAG-SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP--------ID 904
                  T+      ++A E       T  SDV+SYGV++ E+++ G  P        + 
Sbjct: 192 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251
Query: 905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK 964
             +P+G                L+K L    EV  + M Q       C    P +RP+  
Sbjct: 252 EKLPQGYR--------------LEKPLNCDDEV-YDLMRQ-------CWREKPYERPSFA 289
Query: 965 DVAAMIKEIKQERE 978
            +   +  + +ER+
Sbjct: 290 QILVSLNRMLEERK 303

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 685 LKCLVED----SVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGV 739
           +K  +ED     ++GKG  G V+ AE +   +  A+K L    +  + D +   +     
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV----- 67
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
                 E + L        +  + C +     L       NG  G L++  + SC +++L
Sbjct: 68  ------EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG--GDLMYHIQ-SCHKFDL 118
Query: 800 RYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
             R    AA+   GL +LH      IV+RD+K +NIL+  +    IADFG+ K  + GD 
Sbjct: 119 S-RATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 173
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
              +N   G+  YIAPE     K     D +S+GV++ E+L G+ P 
Sbjct: 174 -AKTNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 219

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 80/314 (25%), Positives = 131/314 (41%), Gaps = 70/314 (22%)
Query: 693 VVGKGCSGIVYRAEMENGEV---IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V +A ++   +    A+K++       EY  ++D       RD F+ E++ 
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRM------KEYASKDDH------RD-FAGELEV 68
Query: 750 LGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSC 794
           L  +  H NI+  LG C +R    L  +Y P+G+L   L + R               S 
Sbjct: 69  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 128
Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
           L  +         A+G+ YL        +HRD+ A NIL+G  +   IADFGL++    G
Sbjct: 129 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR----G 181
Query: 855 DFARSSNTVAG-SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP--------ID 904
                  T+      ++A E       T  SDV+SYGV++ E+++ G  P        + 
Sbjct: 182 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 241
Query: 905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK 964
             +P+G                L+K L    EV  + M Q       C    P +RP+  
Sbjct: 242 EKLPQGYR--------------LEKPLNCDDEV-YDLMRQ-------CWREKPYERPSFA 279
Query: 965 DVAAMIKEIKQERE 978
            +   +  + +ER+
Sbjct: 280 QILVSLNRMLEERK 293

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 16/165 (9%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELR 800
           E   + S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W   
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW--- 129
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
               +  A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +
Sbjct: 130 ---CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
                   ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 108/237 (45%), Gaps = 50/237 (21%)
Query: 684 VLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF 743
           + + +V    +GKG  G V+R +   GE +AVK                   I   R+  
Sbjct: 27  IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVK-------------------IFSSREER 66
Query: 744 S----AEIKTLGSIRHKNIVRFLGCCWNRN---TRL-LMYDYMPNGSLGSLLHERRDSCL 795
           S    AEI     +RH+NI+ F+      N   T+L L+ DY  +GSL   L+    +  
Sbjct: 67  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 125
Query: 796 EWELRYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
             E   ++ L  A GLA+LH + V     P I HRD+K+ NIL+       IAD GLA  
Sbjct: 126 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-- 181
Query: 851 VVEGDFARSSNTVA-----GSYGYIAPEY---GYMMKITE---KSDVYSYGVVVLEV 896
            V  D A  +  +A     G+  Y+APE       MK  E   ++D+Y+ G+V  E+
Sbjct: 182 -VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSN 861
           +I  A Q L + H +    I+HRD+K  NI+I       + DFG+A+ + + G+    + 
Sbjct: 121 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 908
            V G+  Y++PE      +  +SDVYS G V+ EVLTG+ P     P
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 19/225 (8%)
Query: 683 QVLKCLVEDSVVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           + +K  +    +GKG     Y   +M+  EV A  K+ P +M  +   Q +K+       
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFA-GKVVPKSMLLKPH-QKEKM------- 89
Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
             S EI    S+ + ++V F G   + +   ++ +     SL  L H+RR +  E E RY
Sbjct: 90  --STEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARY 146
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
             +    QG+ YLH++    ++HRD+K  N+ +  + +  I DFGLA   +E D  R  +
Sbjct: 147 -FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT-KIEFDGERKKD 201
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 906
            + G+  YIAPE       + + D++S G ++  +L GK P + +
Sbjct: 202 -LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 19/225 (8%)
Query: 683 QVLKCLVEDSVVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           + +K  +    +GKG     Y   +M+  EV A  K+ P +M  +   Q +K+       
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFA-GKVVPKSMLLKPH-QKEKM------- 73
Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
             S EI    S+ + ++V F G   + +   ++ +     SL  L H+RR +  E E RY
Sbjct: 74  --STEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARY 130
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
             +    QG+ YLH++    ++HRD+K  N+ +  + +  I DFGLA   +E D  R  +
Sbjct: 131 -FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT-KIEFDGERKKD 185
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 906
            + G+  YIAPE       + + D++S G ++  +L GK P + +
Sbjct: 186 -LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSN 861
           +I  A Q L + H +    I+HRD+K  NI+I       + DFG+A+ + + G+    + 
Sbjct: 121 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 908
            V G+  Y++PE      +  +SDVYS G V+ EVLTG+ P     P
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSN 861
           +I  A Q L + H +    I+HRD+K  NI+I       + DFG+A+ + + G+    + 
Sbjct: 121 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 908
            V G+  Y++PE      +  +SDVYS G V+ EVLTG+ P     P
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG VY A ++  G+ +A++++               +     ++    EI  +  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM--------------NLQQQPKKELIINEILVMRE 74
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            ++ NIV +L      +   ++ +Y+  GSL  ++ E   +C++      +     Q L 
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 131
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH + V   +HR+IK++NIL+G +    + DFG    +      RS  T+ G+  ++AP
Sbjct: 132 FLHSNQV---IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAP 186
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K D++S G++ +E++ G+ P
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG VY A ++  G+ +A++++               +     ++    EI  +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM--------------NLQQQPKKELIINEILVMRE 73
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            ++ NIV +L      +   ++ +Y+  GSL  ++ E   +C++      +     Q L 
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH + V   +HRDIK++NIL+G +    + DFG    +      RS   + G+  ++AP
Sbjct: 131 FLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMAP 185
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K D++S G++ +E++ G+ P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 90/349 (25%), Positives = 139/349 (39%), Gaps = 73/349 (20%)
Query: 658 VDSEMGGNSL----PWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA------EM 707
           V  E+ GN+     P QL    K  F   +    L     +G G  G V  A      + 
Sbjct: 18  VVEEINGNNYVYIDPTQLPYDHKWEFPRNR----LSFGKTLGAGAFGKVVEATAYGLIKS 73
Query: 708 ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCW 766
           +    +AVK L P+    E             R++  +E+K L  +  H NIV  LG C 
Sbjct: 74  DAAMTVAVKMLKPSAHLTE-------------REALMSELKVLSYLGNHMNIVNLLGACT 120
Query: 767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII----------------LGAAQG 810
                L++ +Y   G L + L  +RDS +  +    I+                   A+G
Sbjct: 121 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 180
Query: 811 LAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG- 868
           +A+L   +C    +HRD+ A NIL+       I DFGLA+     D    SN V      
Sbjct: 181 MAFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYVVKGNAR 231
Query: 869 ----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA 923
               ++APE  +    T +SDV+SYG+ + E+ + G  P  P +P        +++    
Sbjct: 232 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVDSKFYKMIKE---G 287
Query: 924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
             +L       PE    EM   +     C +  P  RPT K +  +I++
Sbjct: 288 FRMLS------PEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLIEK 327

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG VY A ++  G+ +A++++               +     ++    EI  +  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQM--------------NLQQQPKKELIINEILVMRE 74
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            ++ NIV +L      +   ++ +Y+  GSL  ++ E   +C++      +     Q L 
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 131
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH + V   +HRDIK++NIL+G +    + DFG    +      RS   + G+  ++AP
Sbjct: 132 FLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMAP 186
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K D++S G++ +E++ G+ P
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 4/160 (2%)
Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           ++  F  E + L    H NIVR +G C  +    ++ + +  G   + L     + L  +
Sbjct: 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVK 213
Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
              +++  AA G+ YL   C    +HRD+ A N L+  +    I+DFG+++   +G +A 
Sbjct: 214 TLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
           S         + APE     + + +SDV+S+G+++ E  +
Sbjct: 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 118/284 (41%), Gaps = 59/284 (20%)
Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTR 771
           +AVK L P+    E             R++  +E+K L  +  H NIV  LG C      
Sbjct: 74  VAVKMLKPSAHLTE-------------REALMSELKVLSYLGNHMNIVNLLGACTIGGPT 120
Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRII----------------LGAAQGLAYL- 814
           L++ +Y   G L + L  +RDS +  +    I+                   A+G+A+L 
Sbjct: 121 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 180
Query: 815 HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG-----Y 869
             +C    +HRD+ A NIL+       I DFGLA+     D    SN V          +
Sbjct: 181 SKNC----IHRDLAARNILLTHGRITKICDFGLAR-----DIKNDSNYVVKGNARLPVKW 231
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           +APE  +    T +SDV+SYG+ + E+ + G  P  P +P        +++      +L 
Sbjct: 232 MAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVDSKFYKMIKE---GFRMLS 287
Query: 929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                 PE    EM   +     C +  P  RPT K +  +I++
Sbjct: 288 ------PEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLIEK 322

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 6/162 (3%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
           F  E+     + H+NIV  +      +   L+ +Y+   +L   +       ++  + + 
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINF- 116
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                 Q L  + H     IVHRDIK  NILI       I DFG+AK + E    ++ N 
Sbjct: 117 ----TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NH 171
Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           V G+  Y +PE        E +D+YS G+V+ E+L G+ P +
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 108/237 (45%), Gaps = 50/237 (21%)
Query: 684 VLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF 743
           + + +V    +GKG  G V+R +   GE +AVK                   I   R+  
Sbjct: 2   IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVK-------------------IFSSREER 41
Query: 744 S----AEIKTLGSIRHKNIVRFLGCCWNRN---TRL-LMYDYMPNGSLGSLLHERRDSCL 795
           S    AEI     +RH+NI+ F+      N   T+L L+ DY  +GSL   L+    +  
Sbjct: 42  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 100
Query: 796 EWELRYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
             E   ++ L  A GLA+LH + V     P I HRD+K+ NIL+       IAD GLA  
Sbjct: 101 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-- 156
Query: 851 VVEGDFARSSNTVA-----GSYGYIAPEY---GYMMKITE---KSDVYSYGVVVLEV 896
            V  D A  +  +A     G+  Y+APE       MK  E   ++D+Y+ G+V  E+
Sbjct: 157 -VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 108/237 (45%), Gaps = 50/237 (21%)
Query: 684 VLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF 743
           + + +V    +GKG  G V+R +   GE +AVK                   I   R+  
Sbjct: 7   IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVK-------------------IFSSREER 46
Query: 744 S----AEIKTLGSIRHKNIVRFLGCCWNRN---TRL-LMYDYMPNGSLGSLLHERRDSCL 795
           S    AEI     +RH+NI+ F+      N   T+L L+ DY  +GSL   L+    +  
Sbjct: 47  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 105
Query: 796 EWELRYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
             E   ++ L  A GLA+LH + V     P I HRD+K+ NIL+       IAD GLA  
Sbjct: 106 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-- 161
Query: 851 VVEGDFARSSNTVA-----GSYGYIAPEY---GYMMKITE---KSDVYSYGVVVLEV 896
            V  D A  +  +A     G+  Y+APE       MK  E   ++D+Y+ G+V  E+
Sbjct: 162 -VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 21/226 (9%)
Query: 683 QVLKCLVEDSVVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           + +K  +    +GKG     Y   +M+  EV A  K+ P +M  +   Q +K+       
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFA-GKVVPKSMLLKPH-QKEKM------- 89
Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
             S EI    S+ + ++V F G   + +   ++ +     SL  L H+RR +  E E RY
Sbjct: 90  --STEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL-HKRRKAVTEPEARY 146
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA-KLVVEGDFARSS 860
             +    QG+ YLH++    ++HRD+K  N+ +  + +  I DFGLA K+  +G+     
Sbjct: 147 -FMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE---RK 199
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 906
             + G+  YIAPE       + + D++S G ++  +L GK P + +
Sbjct: 200 KXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           S +G G  G+V++   +   ++  +KL    +               +R+    E++ L 
Sbjct: 15  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP------------AIRNQIIRELQVLH 62
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
                 IV F G  ++     +  ++M  GSL  +L  ++   +  ++  ++ +   +GL
Sbjct: 63  ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGL 120
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL       I+HRD+K +NIL+    E  + DFG++  +++      +N   G+  Y++
Sbjct: 121 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----EMANEFVGTRSYMS 174
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           PE       + +SD++S G+ ++E+  G+ P  P
Sbjct: 175 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 108/237 (45%), Gaps = 50/237 (21%)
Query: 684 VLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF 743
           + + +V    +GKG  G V+R +   GE +AVK                   I   R+  
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVK-------------------IFSSREER 40
Query: 744 S----AEIKTLGSIRHKNIVRFLGCCWNRN---TRL-LMYDYMPNGSLGSLLHERRDSCL 795
           S    AEI     +RH+NI+ F+      N   T+L L+ DY  +GSL   L+    +  
Sbjct: 41  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 99
Query: 796 EWELRYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
             E   ++ L  A GLA+LH + V     P I HRD+K+ NIL+       IAD GLA  
Sbjct: 100 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-- 155
Query: 851 VVEGDFARSSNTVA-----GSYGYIAPEY---GYMMKITE---KSDVYSYGVVVLEV 896
            V  D A  +  +A     G+  Y+APE       MK  E   ++D+Y+ G+V  E+
Sbjct: 156 -VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 108/237 (45%), Gaps = 50/237 (21%)
Query: 684 VLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF 743
           + + +V    +GKG  G V+R +   GE +AVK                   I   R+  
Sbjct: 4   IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVK-------------------IFSSREER 43
Query: 744 S----AEIKTLGSIRHKNIVRFLGCCWNRN---TRL-LMYDYMPNGSLGSLLHERRDSCL 795
           S    AEI     +RH+NI+ F+      N   T+L L+ DY  +GSL   L+    +  
Sbjct: 44  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 102
Query: 796 EWELRYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
             E   ++ L  A GLA+LH + V     P I HRD+K+ NIL+       IAD GLA  
Sbjct: 103 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-- 158
Query: 851 VVEGDFARSSNTVA-----GSYGYIAPEY---GYMMKITE---KSDVYSYGVVVLEV 896
            V  D A  +  +A     G+  Y+APE       MK  E   ++D+Y+ G+V  E+
Sbjct: 159 -VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 47/295 (15%)
Query: 683 QVLKCLVED------SVVGKGCSGIVYRAEME--NGEVI--AVKKLWPTTMAAEYDCQND 732
           Q L CL+ +        +G G  G+V R E +  +G+ +  AVK L P  ++     Q +
Sbjct: 9   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPE 63
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD 792
            +      D F  E+  + S+ H+N++R  G       +++  +  P GSL   L + + 
Sbjct: 64  AM------DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG 116
Query: 793 SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
             L   L  R  +  A+G+ YL        +HRD+ A N+L+       I DFGL + + 
Sbjct: 117 HFLLGTLS-RYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
Query: 853 EGD---FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP-IDPTI 907
           + D     +    V   + + APE       +  SD + +GV + E+ T G++P I    
Sbjct: 173 QNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230
Query: 908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
            + LH +D    K G  E L      RPE   +++     V + C    P+DRPT
Sbjct: 231 SQILHKID----KEG--ERL-----PRPEDCPQDIYN---VMVQCWAHKPEDRPT 271

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 47/295 (15%)
Query: 683 QVLKCLVED------SVVGKGCSGIVYRAEME--NGEVI--AVKKLWPTTMAAEYDCQND 732
           Q L CL+ +        +G G  G+V R E +  +G+ +  AVK L P  ++     Q +
Sbjct: 9   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPE 63
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD 792
            +      D F  E+  + S+ H+N++R  G       +++  +  P GSL   L + + 
Sbjct: 64  AM------DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG 116
Query: 793 SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
             L   L  R  +  A+G+ YL        +HRD+ A N+L+       I DFGL + + 
Sbjct: 117 HFLLGTLS-RYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
Query: 853 EGD---FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP-IDPTI 907
           + D     +    V   + + APE       +  SD + +GV + E+ T G++P I    
Sbjct: 173 QNDDHXVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230
Query: 908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
            + LH +D    K G  E L      RPE   +++     V + C    P+DRPT
Sbjct: 231 SQILHKID----KEG--ERL-----PRPEDCPQDIYN---VMVQCWAHKPEDRPT 271

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 129/284 (45%), Gaps = 42/284 (14%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +  +G  G V++A++ N + +AVK ++P           DK      R+ FS       
Sbjct: 21  EIKARGRFGCVWKAQLMN-DFVAVK-IFPL---------QDKQSWQSEREIFSTP----- 64
Query: 752 SIRHKNIVRFLGCCWNRNTRL-----LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
            ++H+N+++F+     R + L     L+  +   GSL   L   + + + W     +   
Sbjct: 65  GMKHENLLQFIAAE-KRGSNLEVELWLITAFHDKGSLTDYL---KGNIITWNELCHVAET 120
Query: 807 AAQGLAYLHHDC--------VPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
            ++GL+YLH D          P I HRD K+ N+L+  +    +ADFGLA     G    
Sbjct: 121 MSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPG 180
Query: 859 SSNTVAGSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI 913
            ++   G+  Y+APE       +      + D+Y+ G+V+ E+++  +  D  + E +  
Sbjct: 181 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLP 240
Query: 914 VDWVRQKRGAIEVLDKSL---RARPEVEIEEMLQTLGVALLCVN 954
            +    +  ++E L + +   + RP ++ +  L+  G+A LCV 
Sbjct: 241 FEEEIGQHPSLEELQEVVVHKKMRPTIK-DHWLKHPGLAQLCVT 283

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRII 804
           E++ +  + H NIV+         T  L+ +Y   G     L+   R    E   ++R I
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG +    E  F    +T  
Sbjct: 123 VSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDTFC 173
Query: 865 GSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
           GS  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           EI  L  +RH +I++      +++  +++ +Y  N     ++  +RD   E E R R   
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEAR-RFFQ 119
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
                + Y H      IVHRD+K  N+L+       IADFGL+ ++ +G+F ++S    G
Sbjct: 120 QIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CG 173
Query: 866 SYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           S  Y APE   G +    E  DV+S GV++  +L  + P D
Sbjct: 174 SPNYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFD 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRII 804
           E++ +  + H NIV+         T  L+ +Y   G     L+   R    E   ++R I
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG +    E  F    +T  
Sbjct: 123 VSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDTFC 173
Query: 865 GSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
           GS  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           EI  L  +RH +I++      +++  +++ +Y  N     ++  +RD   E E R R   
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEAR-RFFQ 120
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
                + Y H      IVHRD+K  N+L+       IADFGL+ ++ +G+F ++S    G
Sbjct: 121 QIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CG 174
Query: 866 SYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           S  Y APE   G +    E  DV+S GV++  +L  + P D
Sbjct: 175 SPNYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFD 214

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 57/285 (20%)
Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTR 771
           +AVK L  T  A E             +++  +E+K +  + +H+NIV  LG C +    
Sbjct: 79  VAVKMLKSTAHADE-------------KEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125
Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWE---------LRYRIILG----AAQGLAYL-HHD 817
           L++ +Y   G L + L  R+   LE +         L  R +L      AQG+A+L   +
Sbjct: 126 LVITEYCCYGDLLNFL-RRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN 184
Query: 818 CVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG-----YIAP 872
           C+    HRD+ A N+L+       I DFGLA+     D    SN +          ++AP
Sbjct: 185 CI----HRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAP 235
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           E  +    T +SDV+SYG+++ E+ + G  P  P I         V+         D   
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-PGILVNSKFYKLVK---------DGYQ 285
Query: 932 RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
            A+P    + +   +     C    P  RPT + + + ++E  QE
Sbjct: 286 MAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRII 804
           E++ +  + H NIV+         T  L+ +Y   G     L+   R    E   ++R I
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG +    E  F    +T  
Sbjct: 123 VSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDTFC 173
Query: 865 GSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
           GS  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 131/314 (41%), Gaps = 70/314 (22%)
Query: 693 VVGKGCSGIVYRAEMENGEV---IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V +A ++   +    A+K++       EY  ++D       RD F+ E++ 
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRM------KEYASKDDH------RD-FAGELEV 75
Query: 750 LGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSC 794
           L  +  H NI+  LG C +R    L  +Y P+G+L   L + R               S 
Sbjct: 76  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
           L  +         A+G+ YL        +HR++ A NIL+G  +   IADFGL++    G
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR----G 188
Query: 855 DFARSSNTVAG-SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP--------ID 904
                  T+      ++A E       T  SDV+SYGV++ E+++ G  P        + 
Sbjct: 189 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 248
Query: 905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK 964
             +P+G                L+K L    EV  + M Q       C    P +RP+  
Sbjct: 249 EKLPQGYR--------------LEKPLNCDDEV-YDLMRQ-------CWREKPYERPSFA 286
Query: 965 DVAAMIKEIKQERE 978
            +   +  + +ER+
Sbjct: 287 QILVSLNRMLEERK 300

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 136/344 (39%), Gaps = 63/344 (18%)
Query: 658 VDSEMGGNSL----PWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA------EM 707
           V  E+ GN+     P QL    K  F   +    L     +G G  G V  A      + 
Sbjct: 18  VVEEINGNNYVYIDPTQLPYDHKWEFPRNR----LSFGKTLGAGAFGKVVEATAYGLIKS 73
Query: 708 ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCW 766
           +    +AVK L P+    E             R++  +E+K L  +  H NIV  LG C 
Sbjct: 74  DAAMTVAVKMLKPSAHLTE-------------REALMSELKVLSYLGNHMNIVNLLGACT 120
Query: 767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII----------------LGAAQG 810
                L++ +Y   G L + L  +RDS +  +    I+                   A+G
Sbjct: 121 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKG 180
Query: 811 LAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           +A+L   +C    +HRD+ A NIL+       I DFGLA+ +                 +
Sbjct: 181 MAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKW 236
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
           +APE  +    T +SDV+SYG+ + E+ + G  P  P +P        +++      +L 
Sbjct: 237 MAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVDSKFYKMIKE---GFRMLS 292
Query: 929 KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                 PE    EM   +     C +  P  RPT K +  +I++
Sbjct: 293 ------PEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLIEK 327

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           EI  L  +RH +I++      +++  +++ +Y  N     ++  +RD   E E R R   
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEAR-RFFQ 110
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
                + Y H      IVHRD+K  N+L+       IADFGL+ ++ +G+F ++S    G
Sbjct: 111 QIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CG 164
Query: 866 SYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           S  Y APE   G +    E  DV+S GV++  +L  + P D
Sbjct: 165 SPNYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFD 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 71
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNW------CV 124
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIMELREATSPKANKEILDEAY-----VM 105
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 158
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 159 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           EI  L  +RH +I++      +++  +++ +Y  N     ++  +RD   E E R R   
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV--QRDKMSEQEAR-RFFQ 114
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
                + Y H      IVHRD+K  N+L+       IADFGL+ ++ +G+F ++S    G
Sbjct: 115 QIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CG 168
Query: 866 SYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           S  Y APE   G +    E  DV+S GV++  +L  + P D
Sbjct: 169 SPNYAAPEVISGKLYAGPE-VDVWSCGVILYVMLCRRLPFD 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 81
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 82  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 134
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 135 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 191
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 192 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 75
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W       +
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 128
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFG AKL+   +    +     
Sbjct: 129 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 185
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K            E   +
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPK-----ANKEILDEAYVM 73
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W       +
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFG AKL+   +    +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 98/239 (41%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G +G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 15/171 (8%)
Query: 736 IGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL 795
           +G +R     EI+ L   RH +I++        +   ++ +Y+  G L   +   ++  L
Sbjct: 60  VGKIR----REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CKNGRL 113
Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
           + +   R+      G+ Y H   V   VHRD+K  N+L+       IADFGL+ ++ +G+
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170
Query: 856 FARSSNTVAGSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           F R S    GS  Y APE   G +    E  D++S GV++  +L G  P D
Sbjct: 171 FLRXS---CGSPNYAAPEVISGRLYAGPE-VDIWSSGVILYALLCGTLPFD 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 51
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 109
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 73
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+M   MP G L   + E +D+      L W       +
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFG AKL+   +    +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K            E   +
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPK-----ANKEILDEAYVM 74
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 127
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 128 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K            E   +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPK-----ANKEILDEAYVM 71
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K            E   +
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPK-----ANKEILDEAYVM 74
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 127
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 128 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 78  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 130
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 131 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 187
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 188 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 74
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 127
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 128 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K            E   +
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPK-----ANKEILDEAYVM 73
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 183
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 71
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 57/285 (20%)
Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTR 771
           +AVK L  T  A E             +++  +E+K +  + +H+NIV  LG C +    
Sbjct: 79  VAVKMLKSTAHADE-------------KEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125
Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA-------------QGLAYL-HHD 817
           L++ +Y   G L + L  R+   LE +  + I    A             QG+A+L   +
Sbjct: 126 LVITEYCCYGDLLNFL-RRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN 184
Query: 818 CVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG-----YIAP 872
           C+    HRD+ A N+L+       I DFGLA+     D    SN +          ++AP
Sbjct: 185 CI----HRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNARLPVKWMAP 235
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           E  +    T +SDV+SYG+++ E+ + G  P  P I         V+         D   
Sbjct: 236 ESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-PGILVNSKFYKLVK---------DGYQ 285
Query: 932 RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
            A+P    + +   +     C    P  RPT + + + ++E  QE
Sbjct: 286 MAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQEQAQE 327

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K            E   +
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPK-----ANKEILDEAYVM 78
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 188
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 48/226 (21%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+A+ +   V+A  K+  T    E +              +  EI  L S 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-------------DYMVEIDILASC 91
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H NIV+ L   +  N   ++ ++   G++ +++ E      E +++  +       L Y
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-VCKQTLDALNY 150
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA------GSY 867
           LH +    I+HRD+KA NIL   + +  +ADFG++        A+++ T+       G+ 
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTP 199
Query: 868 GYIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            ++APE           Y Y      K+DV+S G+ ++E+   + P
Sbjct: 200 YWMAPEVVMCETSKDRPYDY------KADVWSLGITLIEMAEIEPP 239

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G VY+  +    EV+A+K +             D        +    EI  L  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKII-------------DLEEAEDEIEDIQQEITVLSQ 73
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
                I R+ G         ++ +Y+  GS   LL   +   LE      I+    +GL 
Sbjct: 74  CDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLD 130
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH +     +HRDIKA N+L+  + +  +ADFG+A  + +    R  N   G+  ++AP
Sbjct: 131 YLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAP 185
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K+D++S G+  +E+  G+ P
Sbjct: 186 EVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 68
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 69  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 121
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 122 QIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 178
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 179 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 76/160 (47%), Gaps = 4/160 (2%)
Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           ++  F  E + L    H NIVR +G C  +    ++ + +  G   + L     + L  +
Sbjct: 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVK 213
Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
              +++  AA G+ YL   C    +HRD+ A N L+  +    I+DFG+++   +G  A 
Sbjct: 214 TLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAA 270
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
           S         + APE     + + +SDV+S+G+++ E  +
Sbjct: 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 96
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 97  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 149
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 150 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 206
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 207 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 65
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 118
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 682 EQVLKCLVEDSVVGKGCSGIVYRA-EMENG-EVIAVKKLWPTTMAAEYDCQNDKIGIGGV 739
           +Q  +C+ E   +G+G  G V++A +++NG   +A+K++   T         + + +  +
Sbjct: 10  DQQYECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTI 59
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCW----NRNTRLLMYDYMPNGSLGSLLHERRDSCL 795
           R+   A ++ L +  H N+VR    C     +R T+L +     +  L + L +  +  +
Sbjct: 60  REV--AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
             E    ++    +GL +LH   V   VHRD+K  NIL+    +  +ADFGLA++     
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY---S 171
Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
           F  +  +V  +  Y APE           D++S G +  E+   K
Sbjct: 172 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 20  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 72
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 73  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D+ R       
Sbjct: 133 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 239
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 240 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 26  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 78
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 79  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D+ R       
Sbjct: 139 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 245
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 246 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 683 QVLKCLVEDS------VVGKGCSGIVYRAEME--NGEVI--AVKKLWPTTMAAEYDCQND 732
           Q L CL+ +        +G G  G+V R E +  +G+ +  AVK L P  ++     Q +
Sbjct: 3   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPE 57
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD 792
            +      D F  E+  + S+ H+N++R  G       +++  +  P GSL   L + + 
Sbjct: 58  AM------DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG 110
Query: 793 SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
             L   L  R  +  A+G+ YL        +HRD+ A N+L+       I DFGL + + 
Sbjct: 111 HFLLGTLS-RYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 166
Query: 853 EGD---FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP-IDPTI 907
           + D     +    V   + + APE       +  SD + +GV + E+ T G++P I    
Sbjct: 167 QNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 224
Query: 908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM 963
            + LH +D    K G  E L      RPE   +++     V + C    P+DRPT 
Sbjct: 225 SQILHKID----KEG--ERL-----PRPEDCPQDI---YNVMVQCWAHKPEDRPTF 266

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 51
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 52  IKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 109
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 167 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+A+ +   V+A  K+  T    E +              +  EI  L S 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-------------DYMVEIDILASC 91
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H NIV+ L   +  N   ++ ++   G++ +++ E      E +++  +       L Y
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-VCKQTLDALNY 150
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           LH +    I+HRD+KA NIL   + +  +ADFG++         +  ++  G+  ++APE
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDSFIGTPYWMAPE 205
Query: 874 -----------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                      Y Y      K+DV+S G+ ++E+   + P
Sbjct: 206 VVMCETSKDRPYDY------KADVWSLGITLIEMAEIEPP 239

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 33  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 85
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D+ R       
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 252
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 253 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 130/297 (43%), Gaps = 40/297 (13%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G V  A+    +  A  +     M  E    ++         +  +E+K L  I
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE-------HRALMSELKILIHI 87
Query: 754 -RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWELRYRIILG----- 806
             H N+V  LG C      L+ + ++   G+L + L  +R+  + ++  Y+  L      
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 807 -----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSS 860
                 A+G+ +L        +HRD+ A NIL+  +    I DFGLA+ + +  D+ R  
Sbjct: 148 XYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG 204
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ 919
           +       ++APE  +    T +SDV+S+GV++ E+ + G  P       G+ I +   +
Sbjct: 205 DARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFXR 258
Query: 920 KRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
           +      L +  R R P+    EM QT+   L C +  P  RPT  ++   +  + Q
Sbjct: 259 R------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 18  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 70
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 71  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 130
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D  R       
Sbjct: 131 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL 187
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 188 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 237
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L +  +C    P  RP+  ++ + IKE
Sbjct: 238 -VMEGGLLDKPD-NCPDML--LELMRMCWQYNPKMRPSFLEIISSIKE 281

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELR 800
           E   + S+ + ++ R LG C     +L+    MP G L   + E +D+      L W   
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--- 129
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
               +  A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +
Sbjct: 130 ---CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
                   ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +  + H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 95  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 155 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +  + H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 81  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 141 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 16/165 (9%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELR 800
           E   + S+ + ++ R LG C     +L+    MP G L   + E +D+      L W   
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW--- 122
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
               +  A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +
Sbjct: 123 ---CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
                   ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 24  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 76
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 77  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 136
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D+ R       
Sbjct: 137 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 193
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 194 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 243
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 244 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 287

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 694 VGKGCSGIVYRAEME--NGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           +G G  G+V R E +  +G+ +  AVK L P  ++     Q + +      D F  E+  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAM------DDFIREVNA 64
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           + S+ H+N++R  G       +++  +  P GSL   L + +   L   L  R  +  A+
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAE 122
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD---FARSSNTVAGS 866
           G+ YL        +HRD+ A N+L+       I DFGL + + + D     +    V   
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--P 177
Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP-IDPTIPEGLHIVDWVRQKRGAI 924
           + + APE       +  SD + +GV + E+ T G++P I     + LH +D    K G  
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID----KEG-- 231
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
           E L      RPE   +++     V + C    P+DRPT
Sbjct: 232 ERL-----PRPEDCPQDIYN---VMVQCWAHKPEDRPT 261

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 694 VGKGCSGIVYRAEME--NGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           +G G  G+V R E +  +G+ +  AVK L P  ++     Q + +      D F  E+  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAM------DDFIREVNA 64
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           + S+ H+N++R  G       +++  +  P GSL   L + +   L   L  R  +  A+
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAE 122
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD---FARSSNTVAGS 866
           G+ YL        +HRD+ A N+L+       I DFGL + + + D     +    V   
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV--P 177
Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP-IDPTIPEGLHIVDWVRQKRGAI 924
           + + APE       +  SD + +GV + E+ T G++P I     + LH +D    K G  
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID----KEG-- 231
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
           E L      RPE   +++     V + C    P+DRPT
Sbjct: 232 ERL-----PRPEDCPQDIYN---VMVQCWAHKPEDRPT 261

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 694 VGKGCSGIVYRAEME--NGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           +G G  G+V R E +  +G+ +  AVK L P  ++     Q + +      D F  E+  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPEAM------DDFIREVNA 64
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           + S+ H+N++R  G       +++  +  P GSL   L + +   L   L  R  +  A+
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAE 122
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD---FARSSNTVAGS 866
           G+ YL        +HRD+ A N+L+       I DFGL + + + D     +    V   
Sbjct: 123 GMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--P 177
Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP-IDPTIPEGLHIVDWVRQKRGAI 924
           + + APE       +  SD + +GV + E+ T G++P I     + LH +D    K G  
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID----KEG-- 231
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
           E L      RPE   +++     V + C    P+DRPT
Sbjct: 232 ERL-----PRPEDCPQDIYN---VMVQCWAHKPEDRPT 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 683 QVLKCLVEDS------VVGKGCSGIVYRAEME--NGEVI--AVKKLWPTTMAAEYDCQND 732
           Q L CL+ +        +G G  G+V R E +  +G+ +  AVK L P  ++     Q +
Sbjct: 3   QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-----QPE 57
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD 792
            +      D F  E+  + S+ H+N++R  G       +++  +  P GSL   L + + 
Sbjct: 58  AM------DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQG 110
Query: 793 SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
             L   L  R  +  A+G+ YL        +HRD+ A N+L+       I DFGL + + 
Sbjct: 111 HFLLGTLS-RYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 166
Query: 853 EGD---FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP-IDPTI 907
           + D     +    V   + + APE       +  SD + +GV + E+ T G++P I    
Sbjct: 167 QNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 224
Query: 908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM 963
            + LH +D    K G  E L      RPE   +++     V + C    P+DRPT 
Sbjct: 225 SQILHKID----KEG--ERL-----PRPEDCPQDI---YNVMVQCWAHKPEDRPTF 266

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 27  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 79
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 80  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D+ R       
Sbjct: 140 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 196
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 246
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 247 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 140 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 51
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 109
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 51
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 109
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 51
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 109
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 33  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 85
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 145
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D+ R       
Sbjct: 146 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 202
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 252
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 253 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 296

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 140 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 97  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 156
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 157 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 213
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 214 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 6/181 (3%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           ++   EI     + H+N+V+F G     N + L  +Y   G L   +    D  +     
Sbjct: 50  ENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDA 107
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
            R       G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  
Sbjct: 108 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 861 NTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
           N + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 920 K 920
           K
Sbjct: 225 K 225

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKK 224

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 694 VGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G V R    + GE +A+K+        E   +N        R+ +  EI+ +  
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQC-----RQELSPKN--------RERWCLEIQIMKK 69
Query: 753 IRHKNIVRF------LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
           + H N+V        L      +  LL  +Y   G L   L++  + C   E   R +L 
Sbjct: 70  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 129
Query: 807 -AAQGLAYLHHDCVPPIVHRDIKANNILIGP---EFEPYIADFGLAKLVVEGDFARSSNT 862
             +  L YLH +    I+HRD+K  NI++ P        I D G AK + +G+       
Sbjct: 130 DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TE 183
Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
             G+  Y+APE     K T   D +S+G +  E +TG +P  P
Sbjct: 184 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 694 VGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G V R    + GE +A+K+        E   +N        R+ +  EI+ +  
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQC-----RQELSPKN--------RERWCLEIQIMKK 68
Query: 753 IRHKNIVRF------LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
           + H N+V        L      +  LL  +Y   G L   L++  + C   E   R +L 
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 807 -AAQGLAYLHHDCVPPIVHRDIKANNILIGP---EFEPYIADFGLAKLVVEGDFARSSNT 862
             +  L YLH +    I+HRD+K  NI++ P        I D G AK + +G+       
Sbjct: 129 DISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TE 182
Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
             G+  Y+APE     K T   D +S+G +  E +TG +P  P
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 23  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 75
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 76  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 135
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D+ R       
Sbjct: 136 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 192
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 193 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 242
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 243 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 286

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 26  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 78
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 79  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 138
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D+ R       
Sbjct: 139 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 245
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 246 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 289

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 41/232 (17%)
Query: 694 VGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+   G VY+  +      E  + +A+K L             DK   G +R+ F  E 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL------------KDK-AEGPLREEFRHEA 80
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DS 793
                ++H N+V  LG         +++ Y  +G L   L  R                S
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 794 CLEWELRYRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            LE      ++   A G+ YL  HH     +VH+D+   N+L+  +    I+D GL + V
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV 195
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
              D+ +          ++APE     K +  SD++SYGVV+ EV + G QP
Sbjct: 196 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 131
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 132 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 189 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 141 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 20  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 72
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 73  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 132
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N  +  +F   I DFG+ + + E D+ R       
Sbjct: 133 EIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 189
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 239
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L +  +C    P  RP+  ++ + IKE
Sbjct: 240 -VMEGGLLDKPD-NCPDML--LELMRMCWQYNPKMRPSFLEIISSIKE 283

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 155 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+A+ +   V+A  K+  T    E +              +  EI  L S 
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-------------DYMVEIDILASC 91
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H NIV+ L   +  N   ++ ++   G++ +++ E      E +++  +       L Y
Sbjct: 92  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV-VCKQTLDALNY 150
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           LH +    I+HRD+KA NIL   + +  +ADFG++         +  +   G+  ++APE
Sbjct: 151 LHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPE 205
Query: 874 -----------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                      Y Y      K+DV+S G+ ++E+   + P
Sbjct: 206 VVMCETSKDRPYDY------KADVWSLGITLIEMAEIEPP 239

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 157
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 158 LDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 214
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 215 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 87  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 146
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 147 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 203
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 204 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 49
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 50  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 107
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 108 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 223

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 64/293 (21%)
Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTR 771
           +AVK L  T  A E             +++  +E+K +  + +H+NIV  LG C +    
Sbjct: 64  VAVKMLKSTAHADE-------------KEALMSELKIMSHLGQHENIVNLLGACTHGGPV 110
Query: 772 LLMYDYMPNGSLGSLLHERRDSCL-------------------EWELRYRIILGA--AQG 810
           L++ +Y   G L + L  + ++ L                     ELR  +   +  AQG
Sbjct: 111 LVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQG 170
Query: 811 LAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG- 868
           +A+L   +C+    HRD+ A N+L+       I DFGLA+     D    SN +      
Sbjct: 171 MAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNYIVKGNAR 221
Query: 869 ----YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA 923
               ++APE  +    T +SDV+SYG+++ E+ + G  P  P I         V+     
Sbjct: 222 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-PGILVNSKFYKLVK----- 275
Query: 924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
               D    A+P    + +   +     C    P  RPT + + + ++E  QE
Sbjct: 276 ----DGYQMAQPAFAPKNIYSIMQA---CWALEPTHRPTFQQICSFLQEQAQE 321

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 55  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 107
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 108 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 167
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D+ R       
Sbjct: 168 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 224
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 225 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 274
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 275 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 318

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 181 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G V++A+  E  E++A+K++         D  ++     GV  S   EI  L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDE-----GVPSSALREICLLKE 57
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC---LEWELRYRIILGAAQ 809
           ++HKNIVR      +     L++++         L +  DSC   L+ E+    +    +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-----LKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           GL + H   V   +HRD+K  N+LI    E  +ADFGLA+    G   R  +    +  Y
Sbjct: 113 GLGFCHSRNV---LHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVVTLWY 167
Query: 870 IAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDP 905
             P+  +  K+   S D++S G +  E+    +P+ P
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFP 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 51
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 109
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 140
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 141 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA 197
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 198 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 166
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 167 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 223
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 224 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 6/181 (3%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           ++   EI     + H+N+V+F G     N + L  +Y   G L   +    D  +     
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDA 106
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
            R       G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  
Sbjct: 107 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 861 NTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
           N + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 223
Query: 920 K 920
           K
Sbjct: 224 K 224

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 6/181 (3%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
           ++   EI     + H+N+V+F G     N + L  +Y   G L   +    D  +     
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDA 106
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
            R       G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  
Sbjct: 107 QRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 861 NTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
           N + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 223
Query: 920 K 920
           K
Sbjct: 224 K 224

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 5   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 51
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 109
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 110 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEW 797
           F  E   +    H+NIVR +G       R ++ + M  G L S L E R      S L  
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 154
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
                +    A G  YL  +     +HRDI A N L+   GP     I DFG+A+ +   
Sbjct: 155 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT 898
            + R          ++ PE       T K+D +S+GV++ E+ +
Sbjct: 212 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 122/288 (42%), Gaps = 33/288 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G+VY      G    V K  P T  A     N+   +   R  F  E   +   
Sbjct: 27  LGQGSFGMVY-----EGVAKGVVKDEPETRVA-IKTVNEAASMRE-RIEFLNEASVMKEF 79
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELRYRIILGA- 807
              ++VR LG        L++ + M  G L S L   R     +  L      ++I  A 
Sbjct: 80  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAG 139
Query: 808 --AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AYL+ +     VHRD+ A N ++  +F   I DFG+ + + E D  R       
Sbjct: 140 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLL 196
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              +++PE       T  SDV+S+GVV+ E+ T  +QP      +GL     +R      
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-----QGLSNEQVLRF----- 246
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
            V++  L  +P+    +ML  L    +C    P  RP+  ++ + IKE
Sbjct: 247 -VMEGGLLDKPD-NCPDMLFEL--MRMCWQYNPKMRPSFLEIISSIKE 290

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 50/227 (22%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +GKG  G V+  +   GE +AVK  + T  A+ +                  EI     +
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFR---------------ETEIYQTVLM 88
Query: 754 RHKNIVRFLGC------CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
           RH+NI+ F+         W +    L+ DY  NGSL   L   + + L+ +   ++   +
Sbjct: 89  RHENILGFIAADIKGTGSWTQ--LYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSS 143
Query: 808 AQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLA-KLVVE-GDFARSS 860
             GL +LH +       P I HRD+K+ NIL+       IAD GLA K + +  +     
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 861 NTVAGSYGYIAPEY-----------GYMMKITEKSDVYSYGVVVLEV 896
           NT  G+  Y+ PE             Y+M     +D+YS+G+++ EV
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIM-----ADMYSFGLILWEV 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 42/298 (14%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G V  A+    +  A  +     M  E    ++         +  +E+K L  I
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE-------HRALMSELKILIHI 87
Query: 754 -RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWELRYRIILG----- 806
             H N+V  LG C      L+ + ++   G+L + L  +R+  + ++  Y+  L      
Sbjct: 88  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 807 -----AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSS 860
                 A+G+ +L        +HRD+ A NIL+  +    I DFGLA+ + +  D+ R  
Sbjct: 148 CYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 204
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV-- 917
           +       ++APE  +    T +SDV+S+GV++ E+ + G  P       G+ I +    
Sbjct: 205 DARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCR 258
Query: 918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
           R K G        +RA P+    EM QT+   L C +  P  RPT  ++   +  + Q
Sbjct: 259 RLKEGT------RMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 97/239 (40%), Gaps = 24/239 (10%)
Query: 688 LVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
            VED      +G+G  G V  A      E +AVK +    M    DC           ++
Sbjct: 4   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV---DMKRAVDCP----------EN 50
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              EI     + H+N+V+F G     N + L  +Y   G L   +    D  +      R
Sbjct: 51  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQR 108
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
                  G+ YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N 
Sbjct: 109 FFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 863 VAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D          DW  +K
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRII 804
           E++ +  + H NIV+         T  L+ +Y   G     L+   R    E   ++R I
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG +    E  F    +   
Sbjct: 123 VSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDEFC 173
Query: 865 GSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
           GS  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 41/232 (17%)
Query: 694 VGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +G+   G VY+  +      E  + +A+K L             DK   G +R+ F  E 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL------------KDK-AEGPLREEFRHEA 63
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DS 793
                ++H N+V  LG         +++ Y  +G L   L  R                S
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 794 CLEWELRYRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
            LE      ++   A G+ YL  HH     +VH+D+   N+L+  +    I+D GL + V
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
              D+ +          ++APE     K +  SD++SYGVV+ EV + G QP
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 689 VEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E+
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NREL 98
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRY 801
           + +  + H NIVR     ++   +       L+ DY+P        H  R       +  
Sbjct: 99  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158
Query: 802 RIILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARS 859
           ++ +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   +
Sbjct: 159 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PN 213
Query: 860 SNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
            + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 214 VSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 258

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE--- 796
           R  F  E   +      ++VR LG        L++ + M +G L S L   R        
Sbjct: 63  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 122
Query: 797 ---WELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                L+  I + A  A G+AYL+       VHRD+ A N ++  +F   I DFG+ + +
Sbjct: 123 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 179
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            E D+ R          ++APE       T  SD++S+GVV+ E+ +  +QP
Sbjct: 180 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 231

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE--- 796
           R  F  E   +      ++VR LG        L++ + M +G L S L   R        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 797 ---WELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                L+  I + A  A G+AYL+       VHRD+ A N ++  +F   I DFG+ + +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            E D+ R          ++APE       T  SD++S+GVV+ E+ +  +QP
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 35/227 (15%)
Query: 689 VEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E+
Sbjct: 51  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NREL 92
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRY 801
           + +  + H NIVR     ++   +       L+ DY+P        H  R       +  
Sbjct: 93  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 152
Query: 802 RIILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARS 859
           ++ +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+    
Sbjct: 153 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---P 206
Query: 860 SNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   S  Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 207 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 252

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 689 VEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E+
Sbjct: 61  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NREL 102
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRY 801
           + +  + H NIVR     ++   +       L+ DY+P        H  R       +  
Sbjct: 103 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 162
Query: 802 RIILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARS 859
           ++ +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   +
Sbjct: 163 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PN 217
Query: 860 SNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
            + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 218 VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 262

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K            E   +
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPK-----ANKEILDEAYVM 78
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 131
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFG AKL+   +    +     
Sbjct: 132 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 188
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 189 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 32  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 73
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 74  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 133
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 134 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 188
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 189 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 232

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 35/227 (15%)
Query: 689 VEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E+
Sbjct: 59  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NREL 100
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRY 801
           + +  + H NIVR     ++   +       L+ DY+P        H  R       +  
Sbjct: 101 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 160
Query: 802 RIILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARS 859
           ++ +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+    
Sbjct: 161 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---P 214
Query: 860 SNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   S  Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 215 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 260

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 35/227 (15%)
Query: 689 VEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E+
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NREL 98
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRY 801
           + +  + H NIVR     ++   +       L+ DY+P        H  R       +  
Sbjct: 99  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 158
Query: 802 RIILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARS 859
           ++ +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+    
Sbjct: 159 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---P 212
Query: 860 SNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   S  Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 258

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 73
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 126
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFG AKL+   +    +     
Sbjct: 127 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 183
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 184 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 36  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 77
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 78  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 137
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 138 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 192
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 193 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 236

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G G  G VY+   +  GE + +    P  +    +  + K     + +++      +
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKI----PVAIKELREATSPKANKEILDEAY-----VM 71
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIIL 805
            S+ + ++ R LG C     +L+    MP G L   + E +D+      L W       +
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 124
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+ YL       +VHRD+ A N+L+       I DFG AKL+   +    +     
Sbjct: 125 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV 181
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
              ++A E       T +SDV+SYGV V E++T G +P D
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRII 804
           E++ +  + H NIV+         T  L+ +Y   G     L+   R    E   ++R I
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG +    E  F    +   
Sbjct: 123 VSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDAFC 173
Query: 865 GSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
           G+  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 38/221 (17%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS----AEIKT 749
           VGKG  G V+R   + GE +AVK                   I   RD  S     E+  
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVK-------------------IFSSRDEKSWFRETELYN 84
Query: 750 LGSIRHKNIVRFLGC-CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA 808
              +RH+NI+ F+     +R++   ++       +GSL    + + L+     RI+L  A
Sbjct: 85  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIA 144
Query: 809 QGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG--DFARSSN 861
            GLA+LH +       P I HRD+K+ NIL+    +  IAD GLA +  +        +N
Sbjct: 145 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 204
Query: 862 TVAGSYGYIAPEY-GYMMKIT-----EKSDVYSYGVVVLEV 896
              G+  Y+APE     +++      ++ D++++G+V+ EV
Sbjct: 205 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 689 VEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E+
Sbjct: 102 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NREL 143
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRY 801
           + +  + H NIVR     ++   +       L+ DY+P        H  R       +  
Sbjct: 144 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 203
Query: 802 RIILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARS 859
           ++ +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   +
Sbjct: 204 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PN 258
Query: 860 SNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
            + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 259 VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 303

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 69/304 (22%)
Query: 690 EDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           E +V+G+G  G V +A    +    A+KK+  T          +K+       +  +E+ 
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---------EEKLS------TILSEVM 54
Query: 749 TLGSIRHKNIVRFLGCCWNR-------------NTRLLMYDYMPNGSLGSLLH-----ER 790
            L S+ H+ +VR+      R             +T  +  +Y  NG+L  L+H     ++
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 791 RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
           RD    W L +R IL A   L+Y+H      I+HRD+K  NI I       I DFGLAK 
Sbjct: 115 RDEY--WRL-FRQILEA---LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 851 VVEG-DFAR-SSNTVAGSYGYIAPEYGYMMKIT-----------EKSDVYSYGVVVLEVL 897
           V    D  +  S  + GS   +    G  M +            EK D+YS G++  E++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 898 TGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTP 957
                       G+  V+ +++ R        S+   P+ +  +M     +  L ++  P
Sbjct: 226 Y-------PFSTGMERVNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDP 272
Query: 958 DDRP 961
           + RP
Sbjct: 273 NKRP 276

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 43  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 84
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 85  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 144
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 145 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 199
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 200 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 243

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 36  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 77
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 78  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 137
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 138 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 192
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 193 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 236

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 689 VEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E+
Sbjct: 28  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NREL 69
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRY 801
           + +  + H NIVR     ++   +       L+ DY+P        H  R       +  
Sbjct: 70  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 129
Query: 802 RIILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARS 859
           ++ +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   +
Sbjct: 130 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PN 184
Query: 860 SNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
            + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 185 VSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 229

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 99/236 (41%), Gaps = 34/236 (14%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH-----ERRDSCL 795
           +   AEI+ L S+ H NI++      + +    MY  M     G LL      + R   L
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFEDYHN---MYIVMETCEGGELLERIVSAQARGKAL 121
Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVV 852
                  ++      LAY H   V   VH+D+K  NIL     P     I DFGLA+L  
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQHV---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
             +    S   AG+  Y+APE  +   +T K D++S GVV+  +LTG  P   T  E + 
Sbjct: 179 SDE---HSTNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV- 233
Query: 913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTMKDV 966
                 Q++   +  + ++  RP       L    V LL   +   P+ RP+   V
Sbjct: 234 ------QQKATYKEPNYAVECRP-------LTPQAVDLLKQMLTKDPERRPSAAQV 276

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+A+ +    +A  K+  T    E +              +  EI+ L + 
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-------------DYIVEIEILATC 65
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H  IV+ LG  ++     +M ++ P G++ +++ E      E +++  +     + L +
Sbjct: 66  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNF 124
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           LH      I+HRD+KA N+L+  E +  +ADFG++   ++    +  ++  G+  ++APE
Sbjct: 125 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPE 179
Query: 874 YGY--MMKITE---KSDVYSYGVVVLEVLTGKQP 902
                 MK T    K+D++S G+ ++E+   + P
Sbjct: 180 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 213

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 48/238 (20%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  GIV+++ +   GEV+AVKK++          QN        R     EI  L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFR-----EIMILTE 64
Query: 753 IR-HKNIVRFLGCCWNRNTR--LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           +  H+NIV  L      N R   L++DYM    L +++   R + LE   +  ++    +
Sbjct: 65  LSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI---RANILEPVHKQYVVYQLIK 120
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV------ 863
            + YLH      ++HRD+K +NIL+  E    +ADFGL++  V  +  R +N +      
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV--NIRRVTNNIPLSINE 175
Query: 864 ---------------AGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
                            +  Y APE      K T+  D++S G ++ E+L GK PI P
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFP 232

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 740 RDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           R++  +E+K +  +  H+NIV  LG C       L+++Y   G L + L  +R+   E E
Sbjct: 92  REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 799 LRYR---------------------IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE 837
           + Y                           A+G+ +L        VHRD+ A N+L+   
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHG 208
Query: 838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYG-----YIAPEYGYMMKITEKSDVYSYGVV 892
               I DFGLA+     D    SN V          ++APE  +    T KSDV+SYG++
Sbjct: 209 KVVKICDFGLAR-----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 263
Query: 893 VLEVLT-GKQPIDPTIP 908
           + E+ + G  P  P IP
Sbjct: 264 LWEIFSLGVNPY-PGIP 279

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 25  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 66
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 67  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 126
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 127 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 181
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 182 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 225

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 65
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 126 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 180
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 181 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 37  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 78
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 79  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 138
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+    +
Sbjct: 139 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PN 192
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
            +   S  Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 193 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 237

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 62/233 (26%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS----AEIKT 749
           VGKG  G V+R   + GE +AVK                   I   RD  S     E+  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-------------------IFSSRDEKSWFRETELYN 55
Query: 750 LGSIRHKNIVRFLG---CCWNRNTRLLM----------YDYMPNGSLGSLLHERRDSCLE 796
              +RH+NI+ F+       + +T+L +          YDY+   +L ++      SCL 
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV------SCL- 108
Query: 797 WELRYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                RI+L  A GLA+LH +       P I HRD+K+ NIL+    +  IAD GLA + 
Sbjct: 109 -----RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 852 VEG--DFARSSNTVAGSYGYIAPEY-GYMMKIT-----EKSDVYSYGVVVLEV 896
            +        +N   G+  Y+APE     +++      ++ D++++G+V+ EV
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 105/233 (45%), Gaps = 62/233 (26%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS----AEIKT 749
           VGKG  G V+R   + GE +AVK                   I   RD  S     E+  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVK-------------------IFSSRDEKSWFRETELYN 55
Query: 750 LGSIRHKNIVRFLG---CCWNRNTRLLM----------YDYMPNGSLGSLLHERRDSCLE 796
              +RH+NI+ F+       + +T+L +          YDY+   +L ++      SCL 
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV------SCL- 108
Query: 797 WELRYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                RI+L  A GLA+LH +       P I HRD+K+ NIL+    +  IAD GLA + 
Sbjct: 109 -----RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 852 VEG--DFARSSNTVAGSYGYIAPEY-GYMMKIT-----EKSDVYSYGVVVLEV 896
            +        +N   G+  Y+APE     +++      ++ D++++G+V+ EV
Sbjct: 164 SQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRII 804
           E++    + H NIV+         T  L+ +Y   G +   L+   R    E   ++R I
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI 122
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG +    E  F    +   
Sbjct: 123 VSAVQ---YCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSN---EFTFGNKLDAFC 173
Query: 865 GSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
           G+  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRII 804
           E++ +  + H NIV+         T  L+ +Y   G     L+   R    E   ++R I
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 123
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG +     G+     +T  
Sbjct: 124 VSAVQ---YCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN---KLDTFC 174
Query: 865 GSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
           GS  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 175 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 65
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 126 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 180
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 181 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG  G V++  +    +V+A+K +             D        +    EI  L  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII-------------DLEEAEDEIEDIQQEITVLSQ 77
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
                + ++ G     +   ++ +Y+  GS   LL        +     + IL   +GL 
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLD 134
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH +     +HRDIKA N+L+  + +  +ADFG+A  + +    R  NT  G+  ++AP
Sbjct: 135 YLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAP 189
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E         K+D++S G+  +E+  G+ P
Sbjct: 190 EVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 28  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 69
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 70  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 129
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 130 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 184
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 185 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 228

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 12/172 (6%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE--- 796
           R  F  E   +      ++VR LG        L++ + M +G L S L   R        
Sbjct: 61  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 120
Query: 797 ---WELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                L+  I + A  A G+AYL+       VHRD+ A N ++  +F   I DFG+ + +
Sbjct: 121 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 177
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            E D  R          ++APE       T  SD++S+GVV+ E+ +  +QP
Sbjct: 178 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 229

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 65
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 126 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 180
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 181 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 36/225 (16%)
Query: 692 SVVGKGCSGIVYRA----EMENGEV-IAVKKLWP-TTMAAEYDCQNDKIGIGGVRDSFSA 745
            V+G G  G VY+     + EN ++ +A+K L   T+  A  +  ++   + GV   +  
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY-- 80
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----DSCLEWELR 800
                       + R LG C     +L+    MP G L   + E R        L W   
Sbjct: 81  ------------VSRLLGICLTSTVQLVT-QLMPYGCLLDHVRENRGRLGSQDLLNW--- 124
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
               +  A+G++YL       +VHRD+ A N+L+       I DFGLA+L+   +    +
Sbjct: 125 ---CMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 178
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
           +       ++A E     + T +SDV+SYGV V E++T G +P D
Sbjct: 179 DGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 12/172 (6%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE--- 796
           R  F  E   +      ++VR LG        L++ + M +G L S L   R        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 797 ---WELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                L+  I + A  A G+AYL+       VHRD+ A N ++  +F   I DFG+ + +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            E D  R          ++APE       T  SD++S+GVV+ E+ +  +QP
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q+ +          + E++
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QDKRFK--------NRELQ 65
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+    +
Sbjct: 126 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PN 179
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
            +   S  Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRII 804
           E++ +  + H NIV+         T  L+ +Y   G     L+   R    E   ++R I
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 120
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA-KLVVEGDFARSSNTV 863
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG + +  V G      +T 
Sbjct: 121 VSAVQ---YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL----DTF 170
Query: 864 AGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
            GS  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 171 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 12/172 (6%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE--- 796
           R  F  E   +      ++VR LG        L++ + M +G L S L   R        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 797 ---WELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                L+  I + A  A G+AYL+       VHRD+ A N ++  +F   I DFG+ + +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            E D  R          ++APE       T  SD++S+GVV+ E+ +  +QP
Sbjct: 181 XETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G VY+A+ +    +A  K+  T    E +              +  EI+ L + 
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-------------DYIVEIEILATC 73
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H  IV+ LG  ++     +M ++ P G++ +++ E      E +++  +     + L +
Sbjct: 74  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNF 132
Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           LH      I+HRD+KA N+L+  E +  +ADFG++   ++    +  ++  G+  ++APE
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPE 187
Query: 874 YGY--MMKITE---KSDVYSYGVVVLEVLTGKQP 902
                 MK T    K+D++S G+ ++E+   + P
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRII 804
           E++ +  + H NIV+         T  L+ +Y   G     L+        E   ++R I
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQI 115
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG +    E  F    +T  
Sbjct: 116 VSAVQ---YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSN---EFTFGNKLDTFC 166
Query: 865 GSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
           GS  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 167 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 745 AEIKTLGSIRHKNIVRFLGCCWNR-NTRL-LMYDYMPNGSLGSLL----HERRDSCLEWE 798
           +E+  L  ++H NIVR+     +R NT L ++ +Y   G L S++     ER+    E+ 
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFA 857
           LR    L  A    +   D    ++HRD+K  N+ +  +    + DFGLA+++  + DFA
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA 173
Query: 858 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
           +      G+  Y++PE    M   EKSD++S G ++ E+
Sbjct: 174 KE---FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  A + E G++ AVK L    +      Q+D +      +    E + L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-----LQDDDV------ECTMTEKRILS 78
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA-QG 810
             R+   +  L CC+    RL       NG  G L+   + S    E R R         
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNG--GDLMFHIQKSRRFDEARARFYAAEIISA 136
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L +LH      I++RD+K +N+L+  E    +ADFG+ K  +      ++ T  G+  YI
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDYI 191
Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           APE    M      D ++ GV++ E+L G  P +
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           EI  L       + ++ G         ++ +Y+  GS   LL        +     R IL
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 134
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              +GL YLH +     +HRDIKA N+L+    E  +ADFG+A  + +    R  NT  G
Sbjct: 135 ---KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVG 186
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +  ++APE         K+D++S G+  +E+  G+ P
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 45/243 (18%)
Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           ++G+G  G VY+  ++   V AVK     + A   +  N+K             I  +  
Sbjct: 20  LIGRGRYGAVYKGSLDERPV-AVKVF---SFANRQNFINEK------------NIYRVPL 63
Query: 753 IRHKNIVRFLG-----CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
           + H NI RF+          R   LL+ +Y PNGSL   L        +W    R+    
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSV 120
Query: 808 AQGLAYLHHDC------VPPIVHRDIKANNILIGPEFEPYIADFGLA------KLVVEGD 855
            +GLAYLH +        P I HRD+ + N+L+  +    I+DFGL+      +LV  G+
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 856 FARSSNTVAGSYGYIAPEY---GYMMKITEKS----DVYSYGVVVLEVLTGKQPIDP--T 906
              ++ +  G+  Y+APE       ++  E +    D+Y+ G++  E+      + P  +
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240
Query: 907 IPE 909
           +PE
Sbjct: 241 VPE 243

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A + + G+++AVKK+         D +  +      R+    E+  +  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 204
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H+N+V         +   ++ +++  G+L  ++   R   +  E    + L   Q L+
Sbjct: 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALS 261
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
            LH   V   +HRDIK+++IL+  +    ++DFG    V + +  R    V   Y ++AP
Sbjct: 262 VLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPY-WMAP 316
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +    + D++S G++V+E++ G+ P
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G V++A+  E  E++A+K++         D  ++     GV  S   EI  L  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDE-----GVPSSALREICLLKE 57
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC---LEWELRYRIILGAAQ 809
           ++HKNIVR      +     L++++         L +  DSC   L+ E+    +    +
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQD-----LKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           GL + H   V   +HRD+K  N+LI    E  +A+FGLA+    G   R  +    +  Y
Sbjct: 113 GLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWY 167
Query: 870 IAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDP 905
             P+  +  K+   S D++S G +  E+    +P+ P
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 745 AEIKTLGSIRHKNIVRFLGCCWNR-NTRL-LMYDYMPNGSLGSLL----HERRDSCLEWE 798
           +E+  L  ++H NIVR+     +R NT L ++ +Y   G L S++     ER+    E+ 
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFA 857
           LR    L  A    +   D    ++HRD+K  N+ +  +    + DFGLA+++  +  FA
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 858 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
           +   T  G+  Y++PE    M   EKSD++S G ++ E+
Sbjct: 174 K---TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A + + G+++AVKK+         D +  +      R+    E+  +  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 84
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H+N+V         +   ++ +++  G+L  ++   R   +  E    + L   Q L+
Sbjct: 85  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALS 141
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
            LH   V   +HRDIK+++IL+  +    ++DFG    V + +  R    V   Y ++AP
Sbjct: 142 VLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPY-WMAP 196
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +    + D++S G++V+E++ G+ P
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 16/215 (7%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G G  G V   + +NG      K+   +   +    +D   I    +    EI  L S+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGL 811
            H NI++      ++    L+ ++   G L   +  R   D C    +  +I+     G+
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL----SGI 159
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPE---FEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
            YLH      IVHRDIK  NIL+  +       I DFGL+    +    R      G+  
Sbjct: 160 CYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---LGTAY 213
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           YIAPE     K  EK DV+S GV++  +L G  P 
Sbjct: 214 YIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 693 VVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           V+G+G  G V+        ++G + A+K L   T+        D++     RD       
Sbjct: 35  VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVR-----DRVRTKMERD------- 82
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA 808
            L  + H  +V+            L+ D++  G L + L  +     E ++++  +   A
Sbjct: 83  ILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKF-YLAELA 140
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
            GL +LH      I++RD+K  NIL+  E    + DFGL+K  +  D  + + +  G+  
Sbjct: 141 LGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVE 195
Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           Y+APE       +  +D +SYGV++ E+LTG  P
Sbjct: 196 YMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE--- 796
           R  F  E   +      ++VR LG        L++ + M +G L S L   R        
Sbjct: 65  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 124
Query: 797 ---WELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                L+  I + A  A G+AYL+       VHR++ A N ++  +F   I DFG+ + +
Sbjct: 125 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI 181
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            E D+ R          ++APE       T  SD++S+GVV+ E+ +  +QP
Sbjct: 182 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 233

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 12/172 (6%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE--- 796
           R  F  E   +      ++VR LG        L++ + M +G L S L   R        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 797 ---WELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                L+  I + A  A G+AYL+       VHR++ A N ++  +F   I DFG+ + +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            E D+ R          ++APE       T  SD++S+GVV+ E+ +  +QP
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A + + G+++AVKK+         D +  +      R+    E+  +  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 82
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H+N+V         +   ++ +++  G+L  ++   R   +  E    + L   Q L+
Sbjct: 83  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALS 139
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
            LH   V   +HRDIK+++IL+  +    ++DFG    V + +  R    V   Y ++AP
Sbjct: 140 VLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPY-WMAP 194
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +    + D++S G++V+E++ G+ P
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A + + G+++AVKK+         D +  +      R+    E+  +  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 73
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H+N+V         +   ++ +++  G+L  ++   R   +  E    + L   Q L+
Sbjct: 74  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALS 130
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
            LH   V   +HRDIK+++IL+  +    ++DFG    V + +  R    V   Y ++AP
Sbjct: 131 VLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPY-WMAP 185
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +    + D++S G++V+E++ G+ P
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 682 EQVLKCLVEDSVVGKGCSGIVYRA-EMENG-EVIAVKKLWPTTMAAEYDCQNDKIGIGGV 739
           +Q  +C+ E   +G+G  G V++A +++NG   +A+K++   T         + + +  +
Sbjct: 10  DQQYECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTI 59
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCW----NRNTRLLMYDYMPNGSLGSLLHERRDSCL 795
           R+   A ++ L +  H N+VR    C     +R T+L +     +  L + L +  +  +
Sbjct: 60  REV--AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
             E    ++    +GL +LH      +VHRD+K  NIL+    +  +ADFGLA++     
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---S 171
Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
           F  +  +V  +  Y APE           D++S G +  E+   K
Sbjct: 172 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 24/225 (10%)
Query: 682 EQVLKCLVEDSVVGKGCSGIVYRA-EMENG-EVIAVKKLWPTTMAAEYDCQNDKIGIGGV 739
           +Q  +C+ E   +G+G  G V++A +++NG   +A+K++   T         + + +  +
Sbjct: 10  DQQYECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-------GEEGMPLSTI 59
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCW----NRNTRLLMYDYMPNGSLGSLLHERRDSCL 795
           R+   A ++ L +  H N+VR    C     +R T+L +     +  L + L +  +  +
Sbjct: 60  REV--AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV 117
Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
             E    ++    +GL +LH      +VHRD+K  NIL+    +  +ADFGLA++     
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---S 171
Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
           F  +  +V  +  Y APE           D++S G +  E+   K
Sbjct: 172 FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           EI  L  +RH +I++           +++ +Y        ++ ++R +  E    ++ I+
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII 118
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
            A   + Y H      IVHRD+K  N+L+       IADFGL+ ++ +G+F ++S    G
Sbjct: 119 CA---IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CG 169
Query: 866 SYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           S  Y APE   G +    E  DV+S G+V+  +L G+ P D
Sbjct: 170 SPNYAAPEVINGKLYAGPE-VDVWSCGIVLYVMLVGRLPFD 209

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A + + G+++AVKK+         D +  +      R+    E+  +  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 77
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H+N+V         +   ++ +++  G+L  ++   R   +  E    + L   Q L+
Sbjct: 78  YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALS 134
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
            LH   V   +HRDIK+++IL+  +    ++DFG    V + +  R    V   Y ++AP
Sbjct: 135 VLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPY-WMAP 189
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +    + D++S G++V+E++ G+ P
Sbjct: 190 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A + + G+++AVKK+         D +  +      R+    E+  +  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 127
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H+N+V         +   ++ +++  G+L  ++   R   +  E    + L   Q L+
Sbjct: 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALS 184
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
            LH   V   +HRDIK+++IL+  +    ++DFG    V + +  R    V   Y ++AP
Sbjct: 185 VLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKXLVGTPY-WMAP 239
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +    + D++S G++V+E++ G+ P
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 8/157 (5%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           EI  L       + ++ G         ++ +Y+  GS   LL        +     R IL
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 114
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              +GL YLH +     +HRDIKA N+L+    E  +ADFG+A  + +    R  NT  G
Sbjct: 115 ---KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVG 166
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +  ++APE         K+D++S G+  +E+  G+ P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 47/295 (15%)
Query: 691 DSVVGKGCSGIVYRAE----MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           D V+GKG  G+VY  E     +N    A+K L   T   + +             +F  E
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE-------------AFLRE 72
Query: 747 IKTLGSIRHKNIVRFLGCCWN-RNTRLLMYDYMPNGSLGSLLHE-RRDSCLEWELRYRII 804
              +  + H N++  +G          ++  YM +G L   +   +R+  ++  + +   
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG-- 130
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF--ARSSNT 862
           L  A+G+ YL        VHRD+ A N ++   F   +ADFGLA+ +++ ++   +    
Sbjct: 131 LQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187
Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP----IDPTIPEGLHIVDWVR 918
                 + A E     + T KSDV+S+GV++ E+LT   P    IDP       +  ++ 
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-----FDLTHFLA 242
Query: 919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           Q R            +PE   + + Q   V   C    P  RPT + +   +++I
Sbjct: 243 QGRRL---------PQPEYCPDSLYQ---VMQQCWEADPAVRPTFRVLVGEVEQI 285

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 20/214 (9%)
Query: 692 SVVGKGCSGIVYRAEMENGEVI-AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+GKG  G V  A  +  EV  AVK L    +      + ++  I   R+        L
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKHIMSERNVL------L 93
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA-AQ 809
            +++H  +V         +    + DY+  G L    H +R+ C   E R R      A 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCF-LEPRARFYAAEIAS 150
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      IV+RD+K  NIL+  +    + DFGL K  +E +   +++T  G+  Y
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEY 205
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE  +        D +  G V+ E+L G  P 
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 47/221 (21%)
Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+V++    + G+++A+KK     + +E D    KI +         EI+ L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF----LESEDDPVIKKIAL--------REIRMLKQ 58
Query: 753 IRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHE--RRDSCLEWELRYRIILGAAQ 809
           ++H N+V  L   + R  RL L+++Y  +    ++LHE  R    +   L   I     Q
Sbjct: 59  LKHPNLVNLLEV-FRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 810 GLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV----------VEGDFAR 858
            + + H H+C+    HRD+K  NILI       + DFG A+L+          V   + R
Sbjct: 114 AVNFCHKHNCI----HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
           S   + G   Y  P            DV++ G V  E+L+G
Sbjct: 170 SPELLVGDTQYGPP-----------VDVWAIGCVFAELLSG 199

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q             + E++
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QGKAFK--------NRELQ 65
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+    +
Sbjct: 126 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PN 179
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
            +   S  Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 117/254 (46%), Gaps = 39/254 (15%)
Query: 742 SFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWEL 799
           +  +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +++
Sbjct: 113 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 172
Query: 800 R----YRIILG----------AAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                Y+  L            A+G+ +L    C+    HRD+ A NIL+  +    I D
Sbjct: 173 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICD 228
Query: 845 FGLAKLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           FGLA+ + +  D+ R  +       ++APE  +    T +SDV+S+GV++ E+ + G  P
Sbjct: 229 FGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287
Query: 903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRP 961
                  G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RP
Sbjct: 288 Y-----PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRP 333
Query: 962 TMKDVAAMIKEIKQ 975
           T  ++   +  + Q
Sbjct: 334 TFSELVEHLGNLLQ 347

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q             + E++
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QGKAFK--------NRELQ 65
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVK 125
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+   + 
Sbjct: 126 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 180
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 181 SXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 76/172 (44%), Gaps = 12/172 (6%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE--- 796
           R  F  E   +      ++VR LG        L++ + M +G L S L   R        
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 797 ---WELRYRIILGA--AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
                L+  I + A  A G+AYL+       VHRD+ A N ++  +F   I DFG+ + +
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            E  + R          ++APE       T  SD++S+GVV+ E+ +  +QP
Sbjct: 181 YETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 117/254 (46%), Gaps = 39/254 (15%)
Query: 742 SFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWEL 799
           +  +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +++
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 800 R----YRIILG----------AAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                Y+  L            A+G+ +L    C+    HRD+ A NIL+  +    I D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICD 191
Query: 845 FGLAKLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           FGLA+ + +  D+ R  +       ++APE  +    T +SDV+S+GV++ E+ + G  P
Sbjct: 192 FGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
Query: 903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRP 961
                  G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RP
Sbjct: 251 Y-----PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRP 296
Query: 962 TMKDVAAMIKEIKQ 975
           T  ++   +  + Q
Sbjct: 297 TFSELVEHLGNLLQ 310

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 690 EDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           +  V+G G  G+VY+A++ ++GE++A+KK+           Q             + E++
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----------QGKAFK--------NRELQ 65
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
            +  + H NIVR     ++   +       L+ DY+P        H  R       +  +
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 803 IILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSS 860
           + +    + LAY+H      I HRDIK  N+L+ P+     + DFG AK +V G+    +
Sbjct: 126 LYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PN 179
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
            +   S  Y APE  +     T   DV+S G V+ E+L G QPI P
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFP 224

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 69/304 (22%)
Query: 690 EDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           E +V+G+G  G V +A    +    A+KK+  T          +K+       +  +E+ 
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---------EEKLS------TILSEVM 54
Query: 749 TLGSIRHKNIVRFLGCCWNR-------------NTRLLMYDYMPNGSLGSLLH-----ER 790
            L S+ H+ +VR+      R             +T  +  +Y  N +L  L+H     ++
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQ 114
Query: 791 RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
           RD    W L +R IL A   L+Y+H      I+HRD+K  NI I       I DFGLAK 
Sbjct: 115 RDEY--WRL-FRQILEA---LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 851 VVEG-DFAR-SSNTVAGSYGYIAPEYGYMMKIT-----------EKSDVYSYGVVVLEVL 897
           V    D  +  S  + GS   +    G  M +            EK D+YS G++  E++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 898 TGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTP 957
                       G+  V+ +++ R        S+   P+ +  +M     +  L ++  P
Sbjct: 226 Y-------PFSTGMERVNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDP 272
Query: 958 DDRP 961
           + RP
Sbjct: 273 NKRP 276

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            ++D   AE   +  + +  IVR +G C   +  L+M +    G L   L + R   ++ 
Sbjct: 48  ALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH--VKD 104
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDF 856
           +    ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  + ++
Sbjct: 105 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 161
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 162 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            ++D   AE   +  + +  IVR +G C   +  L+M +    G L   L + R   ++ 
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH--VKD 116
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDF 856
           +    ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  + ++
Sbjct: 117 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            ++D   AE   +  + +  IVR +G C   +  L+M +    G L   L + R   ++ 
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH--VKD 126
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDF 856
           +    ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  + ++
Sbjct: 127 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 184 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            ++D   AE   +  + +  IVR +G C   +  L+M +    G L   L + R   ++ 
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH--VKD 126
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDF 856
           +    ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  + ++
Sbjct: 127 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 183
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 184 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            ++D   AE   +  + +  IVR +G C   +  L+M +    G L   L + R   ++ 
Sbjct: 50  ALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH--VKD 106
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDF 856
           +    ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  + ++
Sbjct: 107 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            ++D   AE   +  + +  IVR +G C   +  L+M +    G L   L + R   ++ 
Sbjct: 54  ALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH--VKD 110
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDF 856
           +    ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  + ++
Sbjct: 111 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 167
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 168 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 8/167 (4%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            ++D   AE   +  + +  IVR +G C   +  L+M +    G L   L + R   ++ 
Sbjct: 68  ALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH--VKD 124
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDF 856
           +    ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  + ++
Sbjct: 125 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 181
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 182 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 35/232 (15%)
Query: 681 VEQVLKCLVEDSVVGKGC-SGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGV 739
            E + K       +G G  S +V   E   G++ AVK +              K  + G 
Sbjct: 17  AEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCI-------------PKKALKGK 63
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-----RDSC 794
             S   EI  L  I+H+NIV       + N   L+   +  G L   + E+     +D+ 
Sbjct: 64  ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS 123
Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIADFGLAKLV 851
                   +I      + YLH      IVHRD+K  N+L   + E     I+DFGL+K+ 
Sbjct: 124 T-------LIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKME 173
Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            +GD     +T  G+ GY+APE       ++  D +S GV+   +L G  P 
Sbjct: 174 GKGDVM---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 745 AEIKTLGSIRHKNIVRFLGCCWNR-NTRL-LMYDYMPNGSLGSLL----HERRDSCLEWE 798
           +E+  L  ++H NIVR+     +R NT L ++ +Y   G L S++     ER+    E+ 
Sbjct: 54  SEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV 113
Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFA 857
           LR    L  A    +   D    ++HRD+K  N+ +  +    + DFGLA+++  +  FA
Sbjct: 114 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 858 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
           ++     G+  Y++PE    M   EKSD++S G ++ E+
Sbjct: 174 KA---FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 115/250 (46%), Gaps = 37/250 (14%)
Query: 745 AEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWELR-- 800
           +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +++   
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 801 --YRIILG----------AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
             Y+  L            A+G+ +L        +HRD+ A NIL+  +    I DFGLA
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 849 KLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT 906
           + + +  D+ R  +       ++APE  +    T +SDV+S+GV++ E+ + G  P    
Sbjct: 187 RDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 242
Query: 907 IPEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKD 965
              G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RPT  +
Sbjct: 243 --PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSE 291
Query: 966 VAAMIKEIKQ 975
           +   +  + Q
Sbjct: 292 LVEHLGNLLQ 301

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD----S 793
            ++D   AE   +  + +  IVR +G C    + +L+ +    G L   L + R     +
Sbjct: 412 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN 470
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVV 852
            +E      ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  
Sbjct: 471 IIE------LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           + ++ ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 30/223 (13%)
Query: 693 VVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G S +V R      G   AVK +  T      +       +  VR++   E   L 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE------QLEEVREATRRETHILR 154
Query: 752 SIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
            +  H +I+  +    + +   L++D M  G L   L E+  +  E E R  I+    + 
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETR-SIMRSLLEA 212
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           +++LH +    IVHRD+K  NIL+    +  ++DFG +  +  G+  R    + G+ GY+
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYL 266
Query: 871 APEY----------GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           APE           GY  ++    D+++ GV++  +L G  P 
Sbjct: 267 APEILKCSMDETHPGYGKEV----DLWACGVILFTLLAGSPPF 305

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 694 VGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G    VY+A  +N  +++A+KK+     +   D         G+  +   EIK L  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD---------GINRTALREIKLLQE 68
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H NI+  L    +++   L++D+M    L  ++ +         ++  +++   QGL 
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLE 126
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH      I+HRD+K NN+L+       +ADFGLAK     + A     V  +  Y AP
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAP 181
Query: 873 EYGYMMKITEKS-DVYSYGVVVLEVL 897
           E  +  ++     D+++ G ++ E+L
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A E   G+ +AVKK+         D +  +      R+    E+  +  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKM---------DLRKQQ-----RRELLFNEVVIMRD 98
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
             H N+V         +   ++ +++  G+L  ++   R   +  E    + L   + L+
Sbjct: 99  YHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLSVLRALS 155
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH+  V   +HRDIK+++IL+  +    ++DFG    V +    R    + G+  ++AP
Sbjct: 156 YLHNQGV---IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KXLVGTPYWMAP 210
Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E    +    + D++S G++V+E++ G+ P
Sbjct: 211 EVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 115/250 (46%), Gaps = 37/250 (14%)
Query: 745 AEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWELR-- 800
           +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +++   
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 801 --YRIILG----------AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
             Y+  L            A+G+ +L        +HRD+ A NIL+  +    I DFGLA
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 849 KLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT 906
           + + +  D+ R  +       ++APE  +    T +SDV+S+GV++ E+ + G  P    
Sbjct: 187 RDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 242
Query: 907 IPEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKD 965
              G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RPT  +
Sbjct: 243 --PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSE 291
Query: 966 VAAMIKEIKQ 975
           +   +  + Q
Sbjct: 292 LVEHLGNLLQ 301

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 93/222 (41%), Gaps = 30/222 (13%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKL---WPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
            V+G+G  G V   +M+N E I   K+   W     AE  C             F  E  
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC-------------FREERD 126
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI--ILG 806
            L +   + I        + N   L+ DY   G L +LL +  D   E   R+ I  ++ 
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 186
Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
           A   +  LH+      VHRDIK +N+L+       +ADFG + L +  D    S+   G+
Sbjct: 187 AIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGT 239
Query: 867 YGYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQPI 903
             YI+PE    M     K   + D +S GV + E+L G+ P 
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 82/171 (47%), Gaps = 16/171 (9%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD----S 793
            ++D   AE   +  + +  IVR +G C    + +L+ +    G L   L + R     +
Sbjct: 413 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN 471
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVV 852
            +E      ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  
Sbjct: 472 IIE------LVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 522
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
           + ++ ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 523 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 114/250 (45%), Gaps = 37/250 (14%)
Query: 745 AEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEW----E 798
           +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +    E
Sbjct: 81  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPE 140
Query: 799 LRYRIILG----------AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
             Y+  L            A+G+ +L        +HRD+ A NIL+  +    I DFGLA
Sbjct: 141 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 197
Query: 849 KLVVEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT 906
           + + +  D+ R  +       ++APE  +    T +SDV+S+GV++ E+ + G  P    
Sbjct: 198 RDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--- 253
Query: 907 IPEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKD 965
              G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RPT  +
Sbjct: 254 --PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSE 302
Query: 966 VAAMIKEIKQ 975
           +   +  + Q
Sbjct: 303 LVEHLGNLLQ 312

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKL---WPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V   +M+N E I   K+   W     AE  C             F  E   
Sbjct: 97  VIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC-------------FREERDV 143
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI--ILGA 807
           L +   + I        + N   L+ DY   G L +LL +  D   E   R+ I  ++ A
Sbjct: 144 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 203
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
              +  LH+      VHRDIK +N+L+       +ADFG + L +  D    S+   G+ 
Sbjct: 204 IDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTP 256
Query: 868 GYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQPI 903
            YI+PE    M     K   + D +S GV + E+L G+ P 
Sbjct: 257 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 13/162 (8%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRII 804
           E++ +  + H NIV+         T  L+ +Y   G     L+   R    E   ++R I
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA-KLVVEGDFARSSNTV 863
           + A Q   Y H      IVHRD+KA N+L+  +    IADFG + +  V G      +  
Sbjct: 124 VSAVQ---YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL----DAF 173
Query: 864 AGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPID 904
            G+  Y APE     K    + DV+S GV++  +++G  P D
Sbjct: 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           EI  L       + ++ G         ++ +Y+  GS   LL        +     R IL
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 129
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              +GL YLH +     +HRDIKA N+L+    E  +ADFG+A  + +    R  N   G
Sbjct: 130 ---KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVG 181
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +  ++APE         K+D++S G+  +E+  G+ P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK--TLGSIRHKNIVRFLGCCWN 767
           G+V  VKK+  +     Y  +  K     VRD    +++   L  + H  IV+       
Sbjct: 39  GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 98
Query: 768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI 827
                L+ D++  G L + L  +     E ++++  +   A  L +LH      I++RD+
Sbjct: 99  EGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKF-YLAELALALDHLHS---LGIIYRDL 153
Query: 828 KANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVY 887
           K  NIL+  E    + DFGL+K  +  D  + + +  G+  Y+APE       T+ +D +
Sbjct: 154 KPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 211
Query: 888 SYGVVVLEVLTGKQP 902
           S+GV++ E+LTG  P
Sbjct: 212 SFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK--TLGSIRHKNIVRFLGCCWN 767
           G+V  VKK+  +     Y  +  K     VRD    +++   L  + H  IV+       
Sbjct: 38  GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97
Query: 768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI 827
                L+ D++  G L + L  +     E ++++  +   A  L +LH      I++RD+
Sbjct: 98  EGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKF-YLAELALALDHLHS---LGIIYRDL 152
Query: 828 KANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVY 887
           K  NIL+  E    + DFGL+K  +  D  + + +  G+  Y+APE       T+ +D +
Sbjct: 153 KPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 888 SYGVVVLEVLTGKQP 902
           S+GV++ E+LTG  P
Sbjct: 211 SFGVLMFEMLTGTLP 225

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 9/195 (4%)
Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK--TLGSIRHKNIVRFLGCCWN 767
           G+V  VKK+  +     Y  +  K     VRD    +++   L  + H  IV+       
Sbjct: 38  GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT 97
Query: 768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI 827
                L+ D++  G L + L  +     E ++++  +   A  L +LH      I++RD+
Sbjct: 98  EGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKF-YLAELALALDHLHS---LGIIYRDL 152
Query: 828 KANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVY 887
           K  NIL+  E    + DFGL+K  +  D  + + +  G+  Y+APE       T+ +D +
Sbjct: 153 KPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 888 SYGVVVLEVLTGKQP 902
           S+GV++ E+LTG  P
Sbjct: 211 SFGVLMFEMLTGTLP 225

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPAFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 42/299 (14%)
Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G V  A+    +  A  +     M  E    ++         +  +E+K L  I
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSE-------HRALMSELKILIHI 89
Query: 754 -RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEW--ELRYRIILG--- 806
             H N+V  LG C      L+ + ++   G+L + L  +R+  + +  E  Y+  L    
Sbjct: 90  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEH 149
Query: 807 -------AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
                   A+G+ +L        +HRD+ A NIL+  +    I DFGLA+ + +      
Sbjct: 150 LIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV- 917
                    ++APE  +    T +SDV+S+GV++ E+ + G  P       G+ I +   
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFC 261
Query: 918 -RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
            R K G        +RA P+    EM QT+   L C +  P  RPT  ++   +  + Q
Sbjct: 262 RRLKEGT------RMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 720 PTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMP 779
           P    A   C+N       VR+ F  E  T+    H +IV+ +G     N   ++ +   
Sbjct: 37  PAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT 93
Query: 780 NGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGP 836
            G L S L  R+ S     L    IL A Q    LAYL        VHRDI A N+L+  
Sbjct: 94  LGELRSFLQVRKFSLDLASL----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSA 146
Query: 837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
                + DFGL++ + +  + ++S        ++APE     + T  SDV+ +GV + E+
Sbjct: 147 TDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEI 205
Query: 897 LT-GKQPI 903
           L  G +P 
Sbjct: 206 LMHGVKPF 213

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 720 PTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMP 779
           P    A   C+N       VR+ F  E  T+    H +IV+ +G     N   ++ +   
Sbjct: 37  PAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT 93
Query: 780 NGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGP 836
            G L S L  R+ S     L    IL A Q    LAYL        VHRDI A N+L+  
Sbjct: 94  LGELRSFLQVRKYSLDLASL----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSS 146
Query: 837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
                + DFGL++ + +  + ++S        ++APE     + T  SDV+ +GV + E+
Sbjct: 147 NDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEI 205
Query: 897 LT-GKQPI 903
           L  G +P 
Sbjct: 206 LMHGVKPF 213

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 18/180 (10%)
Query: 728 DCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 787
           +C +D      VR+ F  E  T+    H +IV+ +G     N   ++ +    G L S L
Sbjct: 76  NCTSD-----SVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 129
Query: 788 HERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
             R+ S     L    IL A Q    LAYL        VHRDI A N+L+       + D
Sbjct: 130 QVRKYSLDLASL----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 182
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
           FGL++ + +  + ++S        ++APE     + T  SDV+ +GV + E+L  G +P 
Sbjct: 183 FGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 241

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 83/188 (44%), Gaps = 15/188 (7%)
Query: 720 PTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMP 779
           P    A   C+N       VR+ F  E  T+    H +IV+ +G     N   ++ +   
Sbjct: 37  PALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT 93
Query: 780 NGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGP 836
            G L S L  R+ S     L    IL A Q    LAYL        VHRDI A N+L+  
Sbjct: 94  LGELRSFLQVRKYSLDLASL----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSS 146
Query: 837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
                + DFGL++ + +  + ++S        ++APE     + T  SDV+ +GV + E+
Sbjct: 147 NDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEI 205
Query: 897 LT-GKQPI 903
           L  G +P 
Sbjct: 206 LMHGVKPF 213

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           VR+ F  E  T+    H +IV+ +G     N   ++ +    G L S L  R+ S     
Sbjct: 57  VREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLAS 115
Query: 799 LRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
           L    IL A Q    LAYL        VHRDI A N+L+       + DFGL++ + +  
Sbjct: 116 L----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 168
Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 897
           + ++S        ++APE     + T  SDV+ +GV + E+L
Sbjct: 169 YYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           EI  L       + ++ G         ++ +Y+  GS   LL        +     R IL
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL 114
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              +GL YLH +     +HRDIKA N+L+    E  +ADFG+A  + +    R  N   G
Sbjct: 115 ---KGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVG 166
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +  ++APE         K+D++S G+  +E+  G+ P
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 13/169 (7%)
Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           VR+ F  E  T+    H +IV+ +G     N   ++ +    G L S L  R+ S    +
Sbjct: 51  VREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSL---D 106
Query: 799 LRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
           L   +IL A Q    LAYL        VHRDI A N+L+       + DFGL++ + +  
Sbjct: 107 LA-SLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162
Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
           + ++S        ++APE     + T  SDV+ +GV + E+L  G +P 
Sbjct: 163 YYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 677 LNFTVEQVLKCLVEDSVV--GKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           L   V+Q    L+ DS V  G+G +GIV  A E  +G  +AVK +         D +  +
Sbjct: 34  LRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---------DLRKQQ 84
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS 793
                 R+    E+  +   +H N+V             ++ +++  G+L  ++ + R  
Sbjct: 85  -----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-- 137
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
            L  E    +     Q LAYLH   V   +HRDIK+++IL+  +    ++DFG     + 
Sbjct: 138 -LNEEQIATVCEAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQ-IS 192
Query: 854 GDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            D  +    V   Y ++APE         + D++S G++V+E++ G+ P
Sbjct: 193 KDVPKRKXLVGTPY-WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 18/180 (10%)
Query: 728 DCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 787
           +C +D      VR+ F  E  T+    H +IV+ +G     N   ++ +    G L S L
Sbjct: 53  NCTSD-----SVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 106
Query: 788 HERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
             R+ S     L    IL A Q    LAYL        VHRDI A N+L+       + D
Sbjct: 107 QVRKYSLDLASL----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 159
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
           FGL++ + +  + ++S        ++APE     + T  SDV+ +GV + E+L  G +P 
Sbjct: 160 FGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 111/251 (44%), Gaps = 34/251 (13%)
Query: 742 SFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEW-- 797
           +  +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +  
Sbjct: 77  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 136
Query: 798 -ELRYRIILG----------AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
            E  Y+  L            A+G+ +L        +HRD+ A NIL+  +    I DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP 905
           LA+ + +               ++APE  +    T +SDV+S+GV++ E+ + G  P   
Sbjct: 194 LARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-- 251
Query: 906 TIPEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMK 964
               G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RPT  
Sbjct: 252 ---PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFS 299
Query: 965 DVAAMIKEIKQ 975
           ++   +  + Q
Sbjct: 300 ELVEHLGNLLQ 310

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 17/173 (9%)
Query: 728 DCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 787
           +C +D      VR+ F  E  T+    H +IV+ +G     N   ++ +    G L S L
Sbjct: 50  NCTSD-----SVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL 103
Query: 788 HERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
             R+ S     L    IL A Q    LAYL        VHRDI A N+L+       + D
Sbjct: 104 QVRKYSLDLASL----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 156
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 897
           FGL++ + +  + ++S        ++APE     + T  SDV+ +GV + E+L
Sbjct: 157 FGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 113/253 (44%), Gaps = 37/253 (14%)
Query: 742 SFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWEL 799
           +  +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +++
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 800 R----YRIILG----------AAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                Y+  L            A+G+ +L    C+    HRD+ A NIL+  +    I D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI----HRDLAARNILLSEKNVVKICD 191
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
           FGLA+ + +               ++APE  +    T +SDV+S+GV++ E+ + G  P 
Sbjct: 192 FGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251
Query: 904 DPTIPEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPT 962
                 G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RPT
Sbjct: 252 -----PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPT 297
Query: 963 MKDVAAMIKEIKQ 975
             ++   +  + Q
Sbjct: 298 FSELVEHLGNLLQ 310

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 101/235 (42%), Gaps = 47/235 (20%)
Query: 688 LVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           LVE  +VG G  G VY+   ++ G++ A+K +  T               G   +    E
Sbjct: 28  LVE--LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---------------GDEEEEIKQE 70
Query: 747 IKTLGSI-RHKNIVRFLGCCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           I  L     H+NI  + G    +N         L+ ++   GS+  L+   + + L+ E 
Sbjct: 71  INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              I     +GL++LH   V   +HRDIK  N+L+    E  + DFG++  +      R 
Sbjct: 131 IAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR- 186
Query: 860 SNTVAGSYGYIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            NT  G+  ++APE           Y +      KSD++S G+  +E+  G  P+
Sbjct: 187 -NTFIGTPYWMAPEVIACDENPDATYDF------KSDLWSLGITAIEMAEGAPPL 234

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 112/252 (44%), Gaps = 35/252 (13%)
Query: 742 SFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWEL 799
           +  +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +++
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 800 R----YRIILG----------AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
                Y+  L            A+G+ +L        +HRD+ A NIL+  +    I DF
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
           GLA+ + +               ++APE  +    T +SDV+S+GV++ E+ + G  P  
Sbjct: 193 GLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY- 251
Query: 905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTM 963
                G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RPT 
Sbjct: 252 ----PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTF 298
Query: 964 KDVAAMIKEIKQ 975
            ++   +  + Q
Sbjct: 299 SELVEHLGNLLQ 310

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 35/249 (14%)
Query: 745 AEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWELR-- 800
           +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +++   
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 801 --YRIILG----------AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
             Y+  L            A+G+ +L        +HRD+ A NIL+  +    I DFGLA
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 849 KLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 907
           + + +               ++APE  +    T +SDV+S+GV++ E+ + G  P     
Sbjct: 187 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 242
Query: 908 PEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
             G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RPT  ++
Sbjct: 243 -PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSEL 292
Query: 967 AAMIKEIKQ 975
              +  + Q
Sbjct: 293 VEHLGNLLQ 301

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 35/249 (14%)
Query: 745 AEIKTLGSI-RHKNIVRFLGCCWNRNTRLL-MYDYMPNGSLGSLLHERRDSCLEWELR-- 800
           +E+K L  I  H N+V  LG C      L+ + ++   G+L + L  +R+  + +++   
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 801 --YRIILG----------AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
             Y+  L            A+G+ +L        +HRD+ A NIL+  +    I DFGLA
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 849 KLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 907
           + + +               ++APE  +    T +SDV+S+GV++ E+ + G  P     
Sbjct: 187 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 242
Query: 908 PEGLHIVDWVRQKRGAIEVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
             G+ I +   ++      L +  R R P+    EM QT+   L C +  P  RPT  ++
Sbjct: 243 -PGVKIDEEFCRR------LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSEL 292
Query: 967 AAMIKEIKQ 975
              +  + Q
Sbjct: 293 VEHLGNLLQ 301

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 30/221 (13%)
Query: 693 VVGKGCSGIVYRAEMENGE-VIAVKKL--WPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V   +++N + V A+K L  W     AE  C             F  E   
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-------------FREERDV 127
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI--ILGA 807
           L +   K I        + N   L+ DY   G L +LL +  D   E   R+ +  ++ A
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
              +  LH+      VHRDIK +NIL+       +ADFG    ++E    +SS  V G+ 
Sbjct: 188 IDSVHQLHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTP 240
Query: 868 GYIAPEYGYMM-----KITEKSDVYSYGVVVLEVLTGKQPI 903
            YI+PE    M     +   + D +S GV + E+L G+ P 
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 18/168 (10%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR----DSCLEWELRY 801
           EI  +  ++H+NIVR        N   L++++M N  L   +  R        LE  L  
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
                  QGLA+ H +    I+HRD+K  N+LI    +  + DFGLA+      F    N
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA-----FGIPVN 163
Query: 862 TVAG---SYGYIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDP 905
           T +    +  Y AP+     +    S D++S G ++ E++TGK P+ P
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK-PLFP 210

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 720 PTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMP 779
           P    A   C+N       VR+ F  E  T+    H +IV+ +G     N   ++ +   
Sbjct: 417 PAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT 473
Query: 780 NGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGP 836
            G L S L  R+ S     L    IL A Q    LAYL        VHRDI A N+L+  
Sbjct: 474 LGELRSFLQVRKFSLDLASL----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSA 526
Query: 837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
                + DFGL++ + +  + ++S        ++APE     + T  SDV+ +GV + E+
Sbjct: 527 TDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEI 585
Query: 897 L 897
           L
Sbjct: 586 L 586

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 8/167 (4%)
Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            ++D   AE   +  + +  IVR +G C   +  L+M +    G L   L + R   ++ 
Sbjct: 54  ALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRH--VKD 110
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDF 856
           +    ++   + G+ YL        VHRD+ A N+L+  +    I+DFGL+K L  + + 
Sbjct: 111 KNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENX 167
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            ++         + APE     K + KSDV+S+GV++ E  + G++P
Sbjct: 168 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 720 PTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMP 779
           P    A   C+N       VR+ F  E  T+    H +IV+ +G     N   ++ +   
Sbjct: 417 PAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT 473
Query: 780 NGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGP 836
            G L S L  R+ S     L    IL A Q    LAYL        VHRDI A N+L+  
Sbjct: 474 LGELRSFLQVRKFSLDLASL----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSS 526
Query: 837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
                + DFGL++ + +  + ++S        ++APE     + T  SDV+ +GV + E+
Sbjct: 527 NDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEI 585
Query: 897 L 897
           L
Sbjct: 586 L 586

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 10/154 (6%)
Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
           L  + H  I+R  G   +     ++ DY+  G L SLL  R+       +          
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCL 117
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I++RD+K  NIL+       I DFG AK V +  +      + G+  Y
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYX-----LCGTPDY 169
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           IAPE        +  D +S+G+++ E+L G  P 
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 32/234 (13%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q++  T  +V     +   VG G  G V  A +   G  +A+KKL+          Q++ 
Sbjct: 14  QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSEL 66
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDY---MP--NGSLGSLL- 787
                 R     E++ L  +RH+N++  L       T     D+   MP     LG L+ 
Sbjct: 67  FAKRAYR-----ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK 121
Query: 788 HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL 847
           HE+        L Y+++    +GL Y+H      I+HRD+K  N+ +  + E  I DFGL
Sbjct: 122 HEKLGEDRIQFLVYQML----KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 848 AKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           A+   + D       V  +  Y APE     M+ T+  D++S G ++ E++TGK
Sbjct: 175 AR---QADSEMXGXVV--TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 188
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 188
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 82/188 (43%), Gaps = 15/188 (7%)
Query: 720 PTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMP 779
           P    A   C+N       VR+ F  E  T+    H +IV+ +G     N   ++ +   
Sbjct: 37  PAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT 93
Query: 780 NGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGP 836
            G L S L  R+ S     L    IL A Q    LAYL        VHRDI A N+L+  
Sbjct: 94  LGELRSFLQVRKFSLDLASL----ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSS 146
Query: 837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV 896
                + DFGL++ + +    ++S        ++APE     + T  SDV+ +GV + E+
Sbjct: 147 NDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEI 205
Query: 897 LT-GKQPI 903
           L  G +P 
Sbjct: 206 LMHGVKPF 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 23/174 (13%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL--------GSLLHERR 791
           R+    E+  L +++H NIV++        +  ++ DY   G L        G L  E  
Sbjct: 67  REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-- 124
Query: 792 DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
           D  L+W       +     L ++H      I+HRDIK+ NI +  +    + DFG+A+++
Sbjct: 125 DQILDW------FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
Query: 852 VEG-DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
               + AR+     G+  Y++PE         KSD+++ G V+ E+ T K   +
Sbjct: 176 NSTVELARA---CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY+A +  +G  +A+K       +       + + I  VR+   A ++ L +
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALK-------SVRVPNGEEGLPISTVREV--ALLRRLEA 62
Query: 753 IRHKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
             H N+VR +  C    T       L+++++ +  L + L +     L  E    ++   
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            +GL +LH +C   IVHRD+K  NIL+       +ADFGLA++     +  + + V  + 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVTL 175
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            Y APE           D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 23/175 (13%)
Query: 738 GVRDS-FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-----R 791
             RDS    EI  L  I+H+NIV       +     L+   +  G L   + ER     +
Sbjct: 47  AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK 106
Query: 792 DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL-IGPE--FEPYIADFGLA 848
           D+ L       +I      + YLH +    IVHRD+K  N+L + PE   +  I DFGL+
Sbjct: 107 DASL-------VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
Query: 849 KLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           K+   G  +    T  G+ GY+APE       ++  D +S GV+   +L G  P 
Sbjct: 157 KMEQNGIMS----TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 12/171 (7%)
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
           G  R+    E+  L  I+H N++       N+   +L+ + +  G L   L E+    L 
Sbjct: 55  GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLT 112
Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI----GPEFEPYIADFGLAKLVV 852
            E     +     G+ YLH      I H D+K  NI++     P+    I DFGLA  + 
Sbjct: 113 EEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI- 168
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
             DF      + G+  ++APE      +  ++D++S GV+   +L+G  P 
Sbjct: 169 --DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 53/91 (58%), Gaps = 3/91 (3%)
Query: 70  ISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLK 129
           IS ++     LT + ++ NSL   +P+ I  L NL+ L L+ N+LT  +P ELG+C +LK
Sbjct: 239 ISANIFKYDFLTRLYLNGNSLTE-LPAEIKNLSNLRVLDLSHNRLTS-LPAELGSCFQLK 296
Query: 130 NLLLFDNYLSGNLPVELGKLVNLEVIRAGGN 160
               FDN ++  LP E G L NL+ +   GN
Sbjct: 297 YFYFFDNMVT-TLPWEFGNLCNLQFLGVEGN 326

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQ-----NDKIGIGGV-RDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   +Y  +       K    GV R+    E+  L  I+H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  N+   +L+ + +  G L   L E+    L  E     +     G+ YLH    
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 820 PPIVHRDIKANNILI----GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG 875
             I H D+K  NI++     P+    I DFGLA  +   DF      + G+  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAPEIV 189
Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               +  ++D++S GV+   +L+G  P 
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 39/237 (16%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q +N T  ++ K  V  + VG G  G V  A +  +GE +A+KKL           Q++ 
Sbjct: 31  QDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEI 83
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDY---MP------NGSLG 784
                 R     E+  L  ++H+N++  L      ++    YD+   MP         +G
Sbjct: 84  FAKRAYR-----ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG 138
Query: 785 SLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
               E +   L +++         +GL Y+H   V   VHRD+K  N+ +  + E  I D
Sbjct: 139 MEFSEEKIQYLVYQM--------LKGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILD 187
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           FGLA+     D   +   V  +  Y APE     M   +  D++S G ++ E+LTGK
Sbjct: 188 FGLAR---HADAEMTGYVV--TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 708 ENGEVIAVKKLWPTTMAAEYD---CQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC 764
           ++ +  A+KK   + +  + D     NDKI I    D F  E++ +  I+++  +   G 
Sbjct: 52  KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111
Query: 765 CWNRNTRLLMYDYMPNGSLGS-----LLHERRDSC-LEWELRYRIILGAAQGLAYLHHDC 818
             N +   ++Y+YM N S+        + ++  +C +  ++   II       +Y+H++ 
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE- 170
Query: 819 VPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEY 874
              I HRD+K +NIL+       ++DFG ++ +V+     S     G+Y ++ PE+
Sbjct: 171 -KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS----RGTYEFMPPEF 221

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 3/92 (3%)
Query: 824 HRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEK 883
           HRD+K  NIL+  +   Y+ DFG+A    +    +  NTV G+  Y APE       T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 884 SDVYSYGVVVLEVLTGKQPI--DPTIPEGLHI 913
           +D+Y+   V+ E LTG  P   D     G HI
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVXGAHI 247

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/178 (28%), Positives = 77/178 (43%), Gaps = 21/178 (11%)
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-- 790
           K  + G   S   EI  L  I+H NIV       +     L+   +  G L   + E+  
Sbjct: 53  KEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF 112
Query: 791 ---RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL---IGPEFEPYIAD 844
              RD+        R+I      + YLH      IVHRD+K  N+L   +  + +  I+D
Sbjct: 113 YTERDAS-------RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           FGL+K+   G      +T  G+ GY+APE       ++  D +S GV+   +L G  P
Sbjct: 163 FGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 39/237 (16%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q +N T  ++ K  V  + VG G  G V  A +  +GE +A+KKL           Q++ 
Sbjct: 13  QDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEI 65
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDY---MP------NGSLG 784
                 R     E+  L  ++H+N++  L      ++    YD+   MP         +G
Sbjct: 66  FAKRAYR-----ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG 120
Query: 785 SLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
               E +   L +++         +GL Y+H   V   VHRD+K  N+ +  + E  I D
Sbjct: 121 LKFSEEKIQYLVYQM--------LKGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILD 169
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           FGLA+     D A  +  V   + Y APE     M   +  D++S G ++ E+LTGK
Sbjct: 170 FGLAR---HAD-AEMTGYVVTRW-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E + +  + +  IVR +G C      L+M +    G L   L  +R+      +   ++ 
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVA-ELLH 117
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             + G+ YL        VHRD+ A N+L+       I+DFGL+K +   D   ++ + AG
Sbjct: 118 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-AG 173
Query: 866 SY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            +   + APE     K + +SDV+SYGV + E L+ G++P
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 119/302 (39%), Gaps = 47/302 (15%)
Query: 666 SLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAA 725
           S+P      + +NF   ++L+       +GKG  G V   +  +      KK++      
Sbjct: 1   SMPPVFDENEDVNFDHFEILRA------IGKGSFGKVCIVQKND-----TKKMYAMKYMN 49
Query: 726 EYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGS 785
           +  C    +    VR+ F  E++ +  + H  +V       +     ++ D +  G L  
Sbjct: 50  KQKC----VERNEVRNVFK-ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR- 103
Query: 786 LLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
             H +++   + E     I      L YL +     I+HRD+K +NIL+      +I DF
Sbjct: 104 -YHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF 159
Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEVLT 898
            +A ++          T+AG+  Y+APE        GY   +    D +S GV   E+L 
Sbjct: 160 NIAAMLPR---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLR 212
Query: 899 GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPD 958
           G++P         HI      K   +   + ++   P    +EM+  L   L    P PD
Sbjct: 213 GRRP--------YHIRSSTSSKE-IVHTFETTVVTYPSAWSQEMVSLLKKLL---EPNPD 260
Query: 959 DR 960
            R
Sbjct: 261 QR 262

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 45/227 (19%)
Query: 690 EDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           E  ++G G  G V++A+   +G+   +K++      AE                   E+K
Sbjct: 15  EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------------------REVK 56
Query: 749 TLGSIRHKNIVRFLGCCWN----------RNTR-------LLMYDYMPNGSLGSLLHERR 791
            L  + H NIV + G CW+          +N+         +  ++   G+L   + +RR
Sbjct: 57  ALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 115
Query: 792 DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL-AKL 850
              L+  L   +     +G+ Y+H      +++RD+K +NI +    +  I DFGL   L
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172
Query: 851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 897
             +G   RS     G+  Y++PE        ++ D+Y+ G+++ E+L
Sbjct: 173 KNDGKRXRSK----GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 693 VVGKGCSGIVYRAEM--ENGEVIAVK-KLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           ++GKG  G V  A++  E+G  + V  K+    + A  D +            F  E   
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-----------FLREAAC 78
Query: 750 LGSIRHKNIVRFLGCCWNRNTR------LLMYDYMPNGSLGSLLHERRDS----CLEWEL 799
           +    H ++ + +G       +      +++  +M +G L + L   R       L  + 
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 800 RYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
             R ++  A G+ YL        +HRD+ A N ++  +    +ADFGL++ +  GD+ R 
Sbjct: 139 LVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ 901
                    ++A E       T  SDV+++GV + E++T  Q
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ 237

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 27/191 (14%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRD--S 793
           R+    E        H NI+R +  C      ++   L+  +   G+L + +   +D  +
Sbjct: 70  REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129
Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG---LAKL 850
            L  +    ++LG  +GL  +H        HRD+K  NIL+G E +P + D G    A +
Sbjct: 130 FLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186
Query: 851 VVEG--------DFARSSNTVAGSYGYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTG 899
            VEG        D+A    T++    Y APE   +     I E++DV+S G V+  ++ G
Sbjct: 187 HVEGSRQALTLQDWAAQRCTIS----YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
Query: 900 KQPIDPTIPEG 910
           + P D    +G
Sbjct: 243 EGPYDMVFQKG 253

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 19/213 (8%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY+A +  +G  +A+K    +            + I  VR+   A ++ L +
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALK----SVRVPNGGGGGGGLPISTVREV--ALLRRLEA 70
Query: 753 IRHKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
             H N+VR +  C    T       L+++++ +  L + L +     L  E    ++   
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            +GL +LH +C   IVHRD+K  NIL+       +ADFGLA++     +  +   V  + 
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTL 183
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            Y APE           D++S G +  E+   K
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY+A +  +G  +A+K       +       + + I  VR+   A ++ L +
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALK-------SVRVPNGEEGLPISTVREV--ALLRRLEA 62
Query: 753 IRHKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
             H N+VR +  C    T       L+++++ +  L + L +     L  E    ++   
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            +GL +LH +C   IVHRD+K  NIL+       +ADFGLA++     +  +   V  + 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVVTL 175
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            Y APE           D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +S +G+G + IVYR + +  +     K+   T+       + KI    VR     EI  L
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-------DKKI----VR----TEIGVL 102
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-----RDSCLEWELRYRIIL 805
             + H NI++            L+ + +  G L   + E+     RD+          + 
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA-------DAVK 155
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFARSSNT 862
              + +AYLH +    IVHRD+K  N+L     P+    IADFGL+K+V      +   T
Sbjct: 156 QILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---T 209
Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           V G+ GY APE         + D++S G++   +L G +P 
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 109/248 (43%), Gaps = 47/248 (18%)
Query: 682 EQVLKCLV-EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           EQ LK LV  + ++G G SG V       G  +AVK+     M  ++ C           
Sbjct: 28  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR-----MLIDF-C----------- 70
Query: 741 DSFSAEIKTLG-SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEW 797
           D    EIK L  S  H N++R+  C    +  L +   + N +L  L+  +   D  L+ 
Sbjct: 71  DIALMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL 129
Query: 798 ELRYR---IILGAAQGLAYLHHDCVPPIVHRDIKANNILI------------GPE-FEPY 841
           +  Y    ++   A G+A+LH      I+HRD+K  NIL+            G E     
Sbjct: 130 QKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 186
Query: 842 IADFGLAKLVVEGD--FARSSNTVAGSYGYIAPEY---GYMMKITEKSDVYSYGVVVLEV 896
           I+DFGL K +  G   F  + N  +G+ G+ APE        ++T   D++S G V   +
Sbjct: 187 ISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYI 246
Query: 897 LT-GKQPI 903
           L+ GK P 
Sbjct: 247 LSKGKHPF 254

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G VY+A +  +G  +A+K       +       + + I  VR+   A ++ L +
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALK-------SVRVPNGEEGLPISTVREV--ALLRRLEA 62
Query: 753 IRHKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
             H N+VR +  C    T       L+++++ +  L + L +     L  E    ++   
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            +GL +LH +C   IVHRD+K  NIL+       +ADFGLA++     +  +   V  + 
Sbjct: 122 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVTL 175
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            Y APE           D++S G +  E+   K
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 109/248 (43%), Gaps = 47/248 (18%)
Query: 682 EQVLKCLV-EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           EQ LK LV  + ++G G SG V       G  +AVK+     M  ++ C           
Sbjct: 28  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR-----MLIDF-C----------- 70
Query: 741 DSFSAEIKTLG-SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEW 797
           D    EIK L  S  H N++R+  C    +  L +   + N +L  L+  +   D  L+ 
Sbjct: 71  DIALMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL 129
Query: 798 ELRYR---IILGAAQGLAYLHHDCVPPIVHRDIKANNILI------------GPE-FEPY 841
           +  Y    ++   A G+A+LH      I+HRD+K  NIL+            G E     
Sbjct: 130 QKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 186
Query: 842 IADFGLAKLVVEGD--FARSSNTVAGSYGYIAPEY---GYMMKITEKSDVYSYGVVVLEV 896
           I+DFGL K +  G   F  + N  +G+ G+ APE        ++T   D++S G V   +
Sbjct: 187 ISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYI 246
Query: 897 LT-GKQPI 903
           L+ GK P 
Sbjct: 247 LSKGKHPF 254

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 24/161 (14%)
Query: 802 RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           R +  AA+   GL  LH +    IV+RD+K  NIL+       I+D GLA  V EG   +
Sbjct: 287 RAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR 918
                 G+ GY+APE     + T   D ++ G ++ E++ G+ P               R
Sbjct: 344 GR---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ------------QR 388
Query: 919 QKRGAIEVLDKSLRARPEVEIEEM---LQTLGVALLCVNPT 956
           +K+   E +++ ++  PE   E      ++L   LLC +P 
Sbjct: 389 KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPA 429

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 74/161 (45%), Gaps = 24/161 (14%)
Query: 802 RIILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           R +  AA+   GL  LH +    IV+RD+K  NIL+       I+D GLA  V EG   +
Sbjct: 287 RAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR 918
                 G+ GY+APE     + T   D ++ G ++ E++ G+ P               R
Sbjct: 344 GR---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ------------QR 388
Query: 919 QKRGAIEVLDKSLRARPEVEIEEM---LQTLGVALLCVNPT 956
           +K+   E +++ ++  PE   E      ++L   LLC +P 
Sbjct: 389 KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPA 429

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 36/244 (14%)
Query: 670 QLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYD 728
           +++P Q  +FT E  LK L E   +G+G  G V +     +G+++AVK++  T    E  
Sbjct: 10  KISPEQHWDFTAED-LKDLGE---IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-- 63
Query: 729 CQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNG--SLGSL 786
            Q   +    V          + S     IV+F G  +      +  + M          
Sbjct: 64  -QKQLLMDLDV---------VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKY 113
Query: 787 LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
           ++   D  +  E+  +I L   + L +L  +    I+HRDIK +NIL+       + DFG
Sbjct: 114 VYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEY--------GYMMKITEKSDVYSYGVVVLEVLT 898
           ++  +V+   A++ +  AG   Y+APE         GY +    +SDV+S G+ + E+ T
Sbjct: 172 ISGQLVDS-IAKTRD--AGCRPYMAPERIDPSASRQGYDV----RSDVWSLGITLYELAT 224
Query: 899 GKQP 902
           G+ P
Sbjct: 225 GRFP 228

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDC------QNDKIGIGGVRDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   EY        Q+     G  R+    E+  L  + H NI+
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  NR   +L+ + +  G L   L ++    L  E     I     G+ YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---T 133
Query: 820 PPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEY 874
             I H D+K  NI++  +  P     + DFGLA  + +G +F      + G+  ++APE 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAPEI 189
Query: 875 GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
                +  ++D++S GV+   +L+G  P 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 22/151 (14%)
Query: 762 LGCCWNRNTRLLMY-DYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVP 820
           L  C+   +RL    +Y+  G L  + H +R   L  E         +  L YLH     
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG-- 173
Query: 821 PIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSNTVAGSYGYIAPE------ 873
            I++RD+K +N+L+  E    + D+G+ K  +  GD   +++T  G+  YIAPE      
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRGED 229
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           YG+ +      D ++ GV++ E++ G+ P D
Sbjct: 230 YGFSV------DWWALGVLMFEMMAGRSPFD 254

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 119 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++PE        + SD+++ G ++ +++ G  P
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 121 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++PE        + SD+++ G ++ +++ G  P
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 122 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++PE        + SD+++ G ++ +++ G  P
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 126 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++PE        + SD+++ G ++ +++ G  P
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 120 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++PE        + SD+++ G ++ +++ G  P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 141 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++PE        + SD+++ G ++ +++ G  P
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 56/240 (23%), Positives = 98/240 (40%), Gaps = 58/240 (24%)
Query: 690 EDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           E  ++G G  G V++A+   +G+   ++++      AE                   E+K
Sbjct: 16  EIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE------------------REVK 57
Query: 749 TLGSIRHKNIVRFLGCCWN--------RNTRLLMYDYMP--------------------- 779
            L  + H NIV + GC W+         +  L   DY P                     
Sbjct: 58  ALAKLDHVNIVHYNGC-WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFC 116
Query: 780 -NGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF 838
             G+L   + +RR   L+  L   +     +G+ Y+H      ++HRD+K +NI +    
Sbjct: 117 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTK 173
Query: 839 EPYIADFGL-AKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 897
           +  I DFGL   L  +G   RS     G+  Y++PE        ++ D+Y+ G+++ E+L
Sbjct: 174 QVKIGDFGLVTSLKNDGKRTRSK----GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 21/179 (11%)
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-- 790
           K  + G   S   EI  L  I+H NIV       +     L+   +  G L   + E+  
Sbjct: 53  KKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF 112
Query: 791 ---RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL---IGPEFEPYIAD 844
              RD+        R+I      + YLH      IVHRD+K  N+L   +  + +  I+D
Sbjct: 113 YTERDAS-------RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           FGL+K+   G      +T  G+ GY+APE       ++  D +S GV+   +L G  P 
Sbjct: 163 FGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 693 VVGKGCSG-IVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS-AEIKTL 750
           V+G G  G IVYR   +N +V AVK++ P                     SF+  E++ L
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDV-AVKRILPECF------------------SFADREVQLL 71
Query: 751 G-SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             S  H N++R+     +R  + +  + +   +L   + ++  + L  E    ++     
Sbjct: 72  RESDEHPNVIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLE-PITLLQQTTS 129
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGP-----EFEPYIADFGLAKLVVEG--DFARSSNT 862
           GLA+LH      IVHRD+K +NILI       + +  I+DFGL K +  G   F+R S  
Sbjct: 130 GLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG- 185
Query: 863 VAGSYGYIAPEY---GYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
           V G+ G+IAPE          T   D++S G V   V++ G  P 
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 25/220 (11%)
Query: 692 SVVGKGCSGIVYRAE----MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            V+G G  G V+        + G++ A+K L   T+  +              +    E 
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----------AKTTEHTRTER 109
Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
           + L  IR    +  L   +   T+L L+ DY+  G L + L  +R+   E E++  I +G
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERFTEHEVQ--IYVG 166
Query: 807 A-AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
                L +LH      I++RDIK  NIL+       + DFGL+K  V  +  R+ +   G
Sbjct: 167 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCG 222
Query: 866 SYGYIAPE--YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +  Y+AP+   G      +  D +S GV++ E+LTG  P 
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 21/179 (11%)
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-- 790
           K  + G   S   EI  L  I+H NIV       +     L+   +  G L   + E+  
Sbjct: 53  KEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF 112
Query: 791 ---RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL---IGPEFEPYIAD 844
              RD+        R+I      + YLH      IVHRD+K  N+L   +  + +  I+D
Sbjct: 113 YTERDAS-------RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           FGL+K+   G      +T  G+ GY+APE       ++  D +S GV+   +L G  P 
Sbjct: 163 FGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDC------QNDKIGIGGVRDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   EY        Q+     G  R+    E+  L  + H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  NR   +L+ + +  G L   L ++    L  E     I     G+ YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---T 133
Query: 820 PPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEY 874
             I H D+K  NI++  +  P     + DFGLA  + +G +F      + G+  ++APE 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAPEI 189
Query: 875 GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
                +  ++D++S GV+   +L+G  P 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDC------QNDKIGIGGVRDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   EY        Q+     G  R+    E+  L  + H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  NR   +L+ + +  G L   L ++    L  E     I     G+ YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---T 133
Query: 820 PPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEY 874
             I H D+K  NI++  +  P     + DFGLA  + +G +F      + G+  ++APE 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAPEI 189
Query: 875 GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
                +  ++D++S GV+   +L+G  P 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 21/179 (11%)
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-- 790
           K  + G   S   EI  L  I+H NIV       +     L+   +  G L   + E+  
Sbjct: 53  KEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF 112
Query: 791 ---RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL---IGPEFEPYIAD 844
              RD+        R+I      + YLH      IVHRD+K  N+L   +  + +  I+D
Sbjct: 113 YTERDAS-------RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           FGL+K+   G      +T  G+ GY+APE       ++  D +S GV+   +L G  P 
Sbjct: 163 FGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 23/170 (13%)
Query: 808 AQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAG 865
           A+G+ +L    C+    HRD+ A NIL+       I DFGLA+ + +  D+ R  +T   
Sbjct: 209 ARGMEFLSSRKCI----HRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL- 263
Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
              ++APE  +    + KSDV+SYGV++ E+ + G  P              V+      
Sbjct: 264 PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPG-----------VQMDEDFC 312
Query: 925 EVLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             L + +R R PE    E+ Q   + L C +  P +RP   ++   + ++
Sbjct: 313 SRLREGMRMRAPEYSTPEIYQ---IMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDC------QNDKIGIGGVRDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   EY        Q+     G  R+    E+  L  + H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  NR   +L+ + +  G L   L ++    L  E     I     G+ YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---T 133
Query: 820 PPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEY 874
             I H D+K  NI++  +  P     + DFGLA  + +G +F      + G+  ++APE 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAPEI 189
Query: 875 GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
                +  ++D++S GV+   +L+G  P 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 28/182 (15%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE-RRDSCLEW- 797
           R+    E+K L  + H  IVR+      +NT   +    P   L   +   R+++  +W 
Sbjct: 47  REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106
Query: 798 ------ELRYR-----IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
                 E R R     I L  A+ + +LH      ++HRD+K +NI    +    + DFG
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 163
Query: 847 LAKLVVEGD-----------FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLE 895
           L   + + +           +AR +  V G+  Y++PE  +    + K D++S G+++ E
Sbjct: 164 LVTAMDQDEEEQTVLTPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
Query: 896 VL 897
           +L
Sbjct: 223 LL 224

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 109/252 (43%), Gaps = 51/252 (20%)
Query: 682 EQVLKCLV-EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           EQ LK LV  + ++G G SG V       G  +AVK+     M  ++ C           
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR-----MLIDF-C----------- 52
Query: 741 DSFSAEIKTLG-SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEW 797
           D    EIK L  S  H N++R+  C    +  L +   + N +L  L+  +   D  L+ 
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL 111
Query: 798 ELRYR---IILGAAQGLAYLHHDCVPPIVHRDIKANNILI------------GPE-FEPY 841
           +  Y    ++   A G+A+LH      I+HRD+K  NIL+            G E     
Sbjct: 112 QKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 842 IADFGLAKLVVEGD--FARSSNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVV 892
           I+DFGL K +  G   F  + N  +G+ G+ APE            ++T   D++S G V
Sbjct: 169 ISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 893 VLEVLT-GKQPI 903
              +L+ GK P 
Sbjct: 229 FYYILSKGKHPF 240

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 109/252 (43%), Gaps = 51/252 (20%)
Query: 682 EQVLKCLV-EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           EQ LK LV  + ++G G SG V       G  +AVK+     M  ++ C           
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR-----MLIDF-C----------- 52
Query: 741 DSFSAEIKTLG-SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEW 797
           D    EIK L  S  H N++R+  C    +  L +   + N +L  L+  +   D  L+ 
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYY-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL 111
Query: 798 ELRYR---IILGAAQGLAYLHHDCVPPIVHRDIKANNILI------------GPE-FEPY 841
           +  Y    ++   A G+A+LH      I+HRD+K  NIL+            G E     
Sbjct: 112 QKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168
Query: 842 IADFGLAKLVVEGD--FARSSNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVV 892
           I+DFGL K +  G   F  + N  +G+ G+ APE            ++T   D++S G V
Sbjct: 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 893 VLEVLT-GKQPI 903
              +L+ GK P 
Sbjct: 229 FYYILSKGKHPF 240

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDC------QNDKIGIGGVRDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   EY        Q+     G  R+    E+  L  + H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  NR   +L+ + +  G L   L ++    L  E     I     G+ YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---T 133
Query: 820 PPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEY 874
             I H D+K  NI++  +  P     + DFGLA  + +G +F      + G+  ++APE 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAPEI 189
Query: 875 GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
                +  ++D++S GV+   +L+G  P 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 5/160 (3%)
Query: 744 SAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
           + E   +  + H   V+   C  +         Y  NG L  L + R+    +       
Sbjct: 85  TRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFY 142
Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
                  L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N  
Sbjct: 143 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 199
Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            G+  Y++PE        + SD+++ G ++ +++ G  P 
Sbjct: 200 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDC------QNDKIGIGGVRDSFSAEIKTLGSIRHKNIV 759
           E+ +G+   VKK    +   EY        Q+     G  R+    E+  L  + H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCV 819
                  NR   +L+ + +  G L   L ++    L  E     I     G+ YLH    
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---T 133
Query: 820 PPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEG-DFARSSNTVAGSYGYIAPEY 874
             I H D+K  NI++  +  P     + DFGLA  + +G +F      + G+  ++APE 
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF----KNIFGTPEFVAPEI 189
Query: 875 GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
                +  ++D++S GV+   +L+G  P 
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 27/224 (12%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWN-RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII 804
           E+  L  + H NI++      + RN  L+M  Y        ++H  + + ++  +   II
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---II 142
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIADFGLAKLVVEGDFARSSN 861
                G+ YLH      IVHRD+K  N+L+  + +     I DFGL+ +    +  +   
Sbjct: 143 KQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMK 196
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG--------KQPIDPTIPEGLHI 913
              G+  YIAPE     K  EK DV+S GV++  +L G         Q I   + +G + 
Sbjct: 197 ERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255
Query: 914 VD---WVRQKRGAIEVLDKSLR--ARPEVEIEEMLQTLGVALLC 952
            D   W     GA +++ + L+  ++  +  ++ L+   +  +C
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            V+G G  G+V++A++   + +A+KK+           Q+ +          + E++ + 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKV----------LQDKRFK--------NRELQIMR 87
Query: 752 SIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERR-DSCLEWELRYRII 804
            ++H N+V      ++   +       L+ +Y+P     +  H  +    +   L    +
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP----YIADFGLAKLVVEGDFARSS 860
               + LAY+H      I HRDIK  N+L+ P   P     + DFG AK+++ G+   + 
Sbjct: 148 YQLLRSLAYIHSIG---ICHRDIKPQNLLLDP---PSGVLKLIDFGSAKILIAGE--PNV 199
Query: 861 NTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           + +   Y Y APE  +     T   D++S G V+ E++ G QP+ P
Sbjct: 200 SXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFP 243

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 40/238 (16%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAG---SYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+         + + +AG   +  Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LAR--------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 40/238 (16%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAG---SYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+         + + +AG   +  Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LAR--------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 30/167 (17%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIG--IGGVRDSFSAEIKTL 750
           +G+G  G V++A   + G+ +A+KK+           +N+K G  I  +R     EIK L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITALR-----EIKIL 71
Query: 751 GSIRHKNIVRFLGCC------WNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
             ++H+N+V  +  C      +NR   +  L++D+  +   G L +      L  E++ R
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIK-R 129
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           ++     GL Y+H +    I+HRD+KA N+LI  +    +ADFGLA+
Sbjct: 130 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           V+GKG  G V  A+ +  E +   K+    +      Q+D +    V      E + L  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVV----IQDDDVECTMV------EKRVLAL 75
Query: 753 IRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ-- 809
           +     +  L  C+    RL  + +Y+  G L  + H ++    +     + +  AA+  
Sbjct: 76  LDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFK---EPQAVFYAAEIS 130
Query: 810 -GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTVAGSY 867
            GL +LH      I++RD+K +N+++  E    IADFG+ K  +++G    ++    G+ 
Sbjct: 131 IGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG---VTTREFCGTP 184
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
            YIAPE        +  D ++YGV++ E+L G+ P D
Sbjct: 185 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 64/243 (26%), Positives = 103/243 (42%), Gaps = 62/243 (25%)
Query: 690 EDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           E +V+G+G  G V +A    +    A+KK+  T          +K+       +  +E+ 
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---------EEKL------STILSEVX 54
Query: 749 TLGSIRHKNIVRFLGCCWNR-------------NTRLLMYDYMPNGSLGSLLH-----ER 790
            L S+ H+ +VR+      R             +T  +  +Y  N +L  L+H     ++
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQ 114
Query: 791 RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
           RD    W L +R IL   + L+Y+H      I+HR++K  NI I       I DFGLAK 
Sbjct: 115 RDE--YWRL-FRQIL---EALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKN 165
Query: 851 VVEG---------DFARSSNTVAGSYG---YIAPEY----GYMMKITEKSDVYSYGVVVL 894
           V            +   SS+ +  + G   Y+A E     G+     EK D YS G++  
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHY---NEKIDXYSLGIIFF 222
Query: 895 EVL 897
           E +
Sbjct: 223 EXI 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 110/238 (46%), Gaps = 40/238 (16%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-----------SRPF 55
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 56  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 115 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 847 LAKLVVEGDFARSSNTVAG---SYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+         + + +AG   +  Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 167 LAR--------HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 21/171 (12%)
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGS 866
           A+G+ +L        +HRD+ A NIL+  +    I DFGLA+ + +  D+ R  +     
Sbjct: 201 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-P 256
Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIE 925
             ++APE  +    T +SDV+S+GV++ E+ + G  P       G+ I +   ++     
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRR----- 306
Query: 926 VLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
            L +  R R P+    EM QT+   L C +  P  RPT  ++   +  + Q
Sbjct: 307 -LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 353

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 21/171 (12%)
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGS 866
           A+G+ +L        +HRD+ A NIL+  +    I DFGLA+ + +  D+ R  +     
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-P 258
Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIE 925
             ++APE  +    T +SDV+S+GV++ E+ + G  P       G+ I +   ++     
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRR----- 308
Query: 926 VLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
            L +  R R P+    EM QT+   L C +  P  RPT  ++   +  + Q
Sbjct: 309 -LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 355

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E + +  + +  IVR +G C      L+M +    G L   L  +R+      +   ++ 
Sbjct: 386 EAQIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNVA-ELLH 443
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             + G+ YL        VHR++ A N+L+       I+DFGL+K +   D   ++ + AG
Sbjct: 444 QVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-AG 499
Query: 866 SY--GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
            +   + APE     K + +SDV+SYGV + E L+ G++P
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 24/238 (10%)
Query: 669 WQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEY 727
           W+    Q +    + VL        +G G  G+V+R  E   G   A K +       E 
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHES 196
Query: 728 DCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 787
           D           +++   EI+T+  +RH  +V       + N  +++Y++M  G L   +
Sbjct: 197 D-----------KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 245
Query: 788 HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF--EPYIADF 845
            +  +   E E     +    +GL ++H +     VH D+K  NI+   +   E  + DF
Sbjct: 246 ADEHNKMSEDEA-VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF 301
Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           GL   +   D  +S     G+  + APE      +   +D++S GV+   +L+G  P 
Sbjct: 302 GLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
           G  R+    E+  L  IRH NI+       N+   +L+ + +  G L   L E ++S  E
Sbjct: 56  GVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTE 114
Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP----YIADFGLAKLVV 852
            E   + +     G+ YLH      I H D+K  NI++  +  P     + DFG+A  + 
Sbjct: 115 DEAT-QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 170
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            G+       + G+  ++APE      +  ++D++S GV+   +L+G  P 
Sbjct: 171 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 116/263 (44%), Gaps = 37/263 (14%)
Query: 693 VVGKGCSG-IVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G ++   +   G+  AVK +    +  + D           ++S   E++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----------KESLLREVQLLK 81
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRIILGAAQG 810
            + H NI++      ++    L+ +    G L   ++  +R S ++     RII     G
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSG 138
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIADFGLAKLVVEGDFARSSNTVAGSY 867
           + Y+H +    IVHRD+K  N+L+  + +     I DFGL+      + ++      G+ 
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTA 192
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID--------PTIPEGLHIVD---W 916
            YIAPE  +     EK DV+S GV++  +L+G  P +          + +G +  +   W
Sbjct: 193 YYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251
Query: 917 VRQKRGAIEVLDKSLRARPEVEI 939
            +    A +++ K L   P + I
Sbjct: 252 KKVSESAKDLIRKMLTYVPSMRI 274

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 116/263 (44%), Gaps = 37/263 (14%)
Query: 693 VVGKGCSG-IVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G ++   +   G+  AVK +    +  + D           ++S   E++ L 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----------KESLLREVQLLK 104
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRIILGAAQG 810
            + H NI++      ++    L+ +    G L   ++  +R S ++     RII     G
Sbjct: 105 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSG 161
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIADFGLAKLVVEGDFARSSNTVAGSY 867
           + Y+H +    IVHRD+K  N+L+  + +     I DFGL+      + ++      G+ 
Sbjct: 162 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTA 215
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID--------PTIPEGLHIVD---W 916
            YIAPE  +     EK DV+S GV++  +L+G  P +          + +G +  +   W
Sbjct: 216 YYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 274
Query: 917 VRQKRGAIEVLDKSLRARPEVEI 939
            +    A +++ K L   P + I
Sbjct: 275 KKVSESAKDLIRKMLTYVPSMRI 297

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 21/171 (12%)
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGS 866
           A+G+ +L        +HRD+ A NIL+  +    I DFGLA+ + +  D+ R  +     
Sbjct: 210 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-P 265
Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIE 925
             ++APE  +    T +SDV+S+GV++ E+ + G  P       G+ I +   ++     
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRR----- 315
Query: 926 VLDKSLRAR-PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
            L +  R R P+    EM QT+   L C +  P  RPT  ++   +  + Q
Sbjct: 316 -LKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 362

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N+  G+  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE       ++ SD+++ G ++ +++ G  P 
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 116/263 (44%), Gaps = 37/263 (14%)
Query: 693 VVGKGCSG-IVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G ++   +   G+  AVK +    +  + D           ++S   E++ L 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----------KESLLREVQLLK 105
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRIILGAAQG 810
            + H NI++      ++    L+ +    G L   ++  +R S ++     RII     G
Sbjct: 106 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSG 162
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIADFGLAKLVVEGDFARSSNTVAGSY 867
           + Y+H +    IVHRD+K  N+L+  + +     I DFGL+      + ++      G+ 
Sbjct: 163 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTA 216
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID--------PTIPEGLHIVD---W 916
            YIAPE  +     EK DV+S GV++  +L+G  P +          + +G +  +   W
Sbjct: 217 YYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 275
Query: 917 VRQKRGAIEVLDKSLRARPEVEI 939
            +    A +++ K L   P + I
Sbjct: 276 KKVSESAKDLIRKMLTYVPSMRI 298

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
           G  R+    E+  L  IRH NI+       N+   +L+ + +  G L   L E ++S  E
Sbjct: 49  GVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTE 107
Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP----YIADFGLAKLVV 852
            E   + +     G+ YLH      I H D+K  NI++  +  P     + DFG+A  + 
Sbjct: 108 DEA-TQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            G+       + G+  ++APE      +  ++D++S GV+   +L+G  P 
Sbjct: 164 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 23/172 (13%)
Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVAGS 866
           A+G+ +L        +HRD+ A NIL+  +    I DFGLA+ + +  D+ R  +     
Sbjct: 208 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-P 263
Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV--RQKRGA 923
             ++APE  +    T +SDV+S+GV++ E+ + G  P       G+ I +    R K G 
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRLKEGT 318
Query: 924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
                  +RA P+    EM QT+   L C +  P  RPT  ++   +  + Q
Sbjct: 319 ------RMRA-PDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQ 360

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 111/235 (47%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC-----CWNRNTRLLMYDYMPNGSLGSLLH 788
             I   + ++  E++ L  ++H+N++  L              + +  ++    L +++ 
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 789 ERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
            ++  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 XQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 30/167 (17%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIG--IGGVRDSFSAEIKTL 750
           +G+G  G V++A   + G+ +A+KK+           +N+K G  I  +R     EIK L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITALR-----EIKIL 71
Query: 751 GSIRHKNIVRFLGCC------WNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
             ++H+N+V  +  C      +NR   +  L++D+  +   G L +      L  E++ R
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIK-R 129
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           ++     GL Y+H +    I+HRD+KA N+LI  +    +ADFGLA+
Sbjct: 130 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
           G  R+    E+  L  IRH NI+       N+   +L+ + +  G L   L E ++S  E
Sbjct: 70  GVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTE 128
Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP----YIADFGLAKLVV 852
            E   + +     G+ YLH      I H D+K  NI++  +  P     + DFG+A  + 
Sbjct: 129 DEAT-QFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 184
Query: 853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            G+       + G+  ++APE      +  ++D++S GV+   +L+G  P 
Sbjct: 185 AGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/316 (21%), Positives = 132/316 (41%), Gaps = 48/316 (15%)
Query: 661 EMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLW 719
           +MG N+L          NF +E+          +G+G    VYRA  + +G  +A+KK+ 
Sbjct: 25  DMGYNTLA---------NFRIEKK---------IGRGQFSEVYRAACLLDGVPVALKKV- 65
Query: 720 PTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMP 779
                  +D  + K     ++     EI  L  + H N++++       N   ++ +   
Sbjct: 66  -----QIFDLMDAKARADCIK-----EIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115
Query: 780 NGSLGSLLH--ERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE 837
            G L  ++   +++   +     ++  +     L ++H   V   +HRDIK  N+ I   
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV---MHRDIKPANVFITAT 172
Query: 838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL 897
               + D GL +       A  ++++ G+  Y++PE  +      KSD++S G ++ E+ 
Sbjct: 173 GVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230
Query: 898 TGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTP 957
             + P      + +++    ++    IE  D      P     E L+ L    +C+NP P
Sbjct: 231 ALQSPF---YGDKMNLYSLCKK----IEQCDYP--PLPSDHYSEELRQL--VNMCINPDP 279
Query: 958 DDRPTMKDVAAMIKEI 973
           + RP +  V  + K +
Sbjct: 280 EKRPDVTYVYDVAKRM 295

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 113/261 (43%), Gaps = 48/261 (18%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRII 804
           E++ L  + H NI++      + ++  ++ +    G L   ++  +R S  +     RII
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---RII 127
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSN 861
                G+ Y+H      IVHRD+K  NIL+     + +  I DFGL+    +    +  +
Sbjct: 128 KQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKD 182
Query: 862 TVAGSYGYIAPEYGYMMKIT--EKSDVYSYGVVVLEVLTGKQP--------IDPTIPEGL 911
            +  +Y YIAPE   +++ T  EK DV+S GV++  +L+G  P        I   +  G 
Sbjct: 183 RIGTAY-YIAPE---VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238
Query: 912 HIVD---WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCV-----------NPTP 957
           +  D   W      A +++ K L   P + I         A  C+            PT 
Sbjct: 239 YAFDLPQWRTISDDAKDLIRKMLTFHPSLRI--------TATQCLEHPWIQKYSSETPTI 290
Query: 958 DDRPTMKDVAAMIKEIKQERE 978
            D P+++     I++ + E++
Sbjct: 291 SDLPSLESAMTNIRQFQAEKK 311

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 30/167 (17%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIG--IGGVRDSFSAEIKTL 750
           +G+G  G V++A   + G+ +A+KK+           +N+K G  I  +R     EIK L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITALR-----EIKIL 70
Query: 751 GSIRHKNIVRFLGCC------WNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
             ++H+N+V  +  C      +NR   +  L++D+  +   G L +      L  E++ R
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS-EIK-R 128
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           ++     GL Y+H +    I+HRD+KA N+LI  +    +ADFGLA+
Sbjct: 129 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 24/238 (10%)
Query: 669 WQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEY 727
           W+    Q +    + VL        +G G  G+V+R  E   G   A K +       E 
Sbjct: 34  WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHES 90
Query: 728 DCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 787
           D           +++   EI+T+  +RH  +V       + N  +++Y++M  G L   +
Sbjct: 91  D-----------KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV 139
Query: 788 HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF--EPYIADF 845
            +  +   E E     +    +GL ++H +     VH D+K  NI+   +   E  + DF
Sbjct: 140 ADEHNKMSEDEA-VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDF 195
Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           GL   +   D  +S     G+  + APE      +   +D++S GV+   +L+G  P 
Sbjct: 196 GLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 22/151 (14%)
Query: 762 LGCCWNRNTRLLMY-DYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVP 820
           L  C+   +RL    +Y+  G L  + H +R   L  E         +  L YLH     
Sbjct: 86  LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG-- 141
Query: 821 PIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSNTVAGSYGYIAPE------ 873
            I++RD+K +N+L+  E    + D+G+ K  +  GD   +++   G+  YIAPE      
Sbjct: 142 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGTPNYIAPEILRGED 197
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           YG+ +      D ++ GV++ E++ G+ P D
Sbjct: 198 YGFSV------DWWALGVLMFEMMAGRSPFD 222

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 30/167 (17%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIG--IGGVRDSFSAEIKTL 750
           +G+G  G V++A   + G+ +A+KK+           +N+K G  I  +R     EIK L
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITALR-----EIKIL 71
Query: 751 GSIRHKNIVRFLGCC------WNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
             ++H+N+V  +  C      +NR   +  L++D+  +   G L +      L  E++ R
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLS-EIK-R 129
Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           ++     GL Y+H +    I+HRD+KA N+LI  +    +ADFGLA+
Sbjct: 130 VMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 693 VVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G +  V+R   +  G++ A+K     +     D Q               E + L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-------------MREFEVLK 62
Query: 752 SIRHKNIVRFLGCCWNRNTR--LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL-GAA 808
            + HKNIV+         TR  +L+ ++ P GSL ++L E  ++    E  + I+L    
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 809 QGLAYLHHDCVPPIVHRDIKANNIL--IGPEFEPY--IADFGLAKLVVEGDFARSSNTVA 864
            G+ +L  +    IVHR+IK  NI+  IG + +    + DFG A+ + + +      ++ 
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLY 176
Query: 865 GSYGYIAP---EYGYMMKITEKS-----DVYSYGVVVLEVLTGKQPIDP 905
           G+  Y+ P   E   + K  +K      D++S GV      TG  P  P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 31  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--------- 81
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 82  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 138
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 139 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 190
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 191 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPF 66
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 67  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 126 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 178 LARHTAD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 85/194 (43%), Gaps = 19/194 (9%)
Query: 723 MAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS 782
           +A +Y  + +KI      ++   EI    S+RH NIVRF           ++ +Y   G 
Sbjct: 47  VAVKYIERGEKID-----ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 783 L-GSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI--GPEFE 839
           L   + +  R S  E    ++ ++    G++Y H      + HRD+K  N L+   P   
Sbjct: 102 LFERICNAGRFSEDEARFFFQQLIS---GVSYAH---AMQVAHRDLKLENTLLDGSPAPR 155
Query: 840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEK-SDVYSYGVVVLEVLT 898
             IADFG +K  V         +  G+  YIAPE     +   K +DV+S GV +  +L 
Sbjct: 156 LKIADFGYSKASV---LHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212
Query: 899 GKQPI-DPTIPEGL 911
           G  P  DP  P+  
Sbjct: 213 GAYPFEDPEEPKNF 226

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPF 66
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 67  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 126 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 178 LARHTAD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 30  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--------- 80
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 81  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 137
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 138 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 189
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 190 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPF 66
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 67  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 126 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 178 LARHTAD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            ++G+G S +V R   +        K+   T    +  +     +  +R++   E+  L 
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEE----VQELREATLKEVDILR 78
Query: 752 SIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
            +  H NI++            L++D M  G L   L E+  +  E E R +I+    + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR-KIMRALLEV 136
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           +  LH      IVHRD+K  NIL+  +    + DFG +  +  G+  RS   V G+  Y+
Sbjct: 137 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS---VCGTPSYL 190
Query: 871 APEY----------GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           APE           GY  ++    D++S GV++  +L G  P 
Sbjct: 191 APEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPPF 229

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 22/151 (14%)
Query: 762 LGCCWNRNTRLLMY-DYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVP 820
           L  C+   +RL    +Y+  G L  + H +R   L  E         +  L YLH     
Sbjct: 71  LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG-- 126
Query: 821 PIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSNTVAGSYGYIAPE------ 873
            I++RD+K +N+L+  E    + D+G+ K  +  GD   +++   G+  YIAPE      
Sbjct: 127 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGTPNYIAPEILRGED 182
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           YG+ +      D ++ GV++ E++ G+ P D
Sbjct: 183 YGFSV------DWWALGVLMFEMMAGRSPFD 207

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 693 VVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G +  V+R   +  G++ A+K     +     D Q               E + L 
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-------------MREFEVLK 62
Query: 752 SIRHKNIVRFLGCCWNRNTR--LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL-GAA 808
            + HKNIV+         TR  +L+ ++ P GSL ++L E  ++    E  + I+L    
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 809 QGLAYLHHDCVPPIVHRDIKANNIL--IGPEFEPY--IADFGLAKLVVEGDFARSSNTVA 864
            G+ +L  +    IVHR+IK  NI+  IG + +    + DFG A+ + + +       + 
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVXLY 176
Query: 865 GSYGYIAP---EYGYMMKITEKS-----DVYSYGVVVLEVLTGKQPIDP 905
           G+  Y+ P   E   + K  +K      D++S GV      TG  P  P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--------- 67
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 68  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 125 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 176
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 177 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 31  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--------- 81
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 82  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 138
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 139 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 190
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +         VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 191 LARHTDD----EMXGXVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-----------SRPF 55
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 56  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 115 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 167 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N+  G+  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 111/235 (47%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC-----CWNRNTRLLMYDYMPNGSLGSLLH 788
             I   + ++  E++ L  ++H+N++  L              + +  ++    L +++ 
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 789 ERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
            ++  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 XQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 116/263 (44%), Gaps = 37/263 (14%)
Query: 693 VVGKGCSG-IVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G ++   +   G+  AVK +    +  + D           ++S   E++ L 
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----------KESLLREVQLLK 87
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRIILGAAQG 810
            + H NI++      ++    L+ +    G L   ++  +R S ++     RII     G
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSG 144
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIADFGLAKLVVEGDFARSSNTVAGSY 867
           + Y+H +    IVHRD+K  N+L+  + +     I DFGL+      + ++      G+ 
Sbjct: 145 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTA 198
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID--------PTIPEGLHIVD---W 916
            YIAPE  +     EK DV+S GV++  +L+G  P +          + +G +  +   W
Sbjct: 199 YYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 257
Query: 917 VRQKRGAIEVLDKSLRARPEVEI 939
            +    A +++ K L   P + I
Sbjct: 258 KKVSESAKDLIRKMLTYVPSMRI 280

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 77/181 (42%), Gaps = 22/181 (12%)
Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-----R 791
             + ++   EI    S+RH NIVRF           ++ +Y   G     L+ER     R
Sbjct: 57  AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE----LYERICNAGR 112
Query: 792 DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI--GPEFEPYIADFGLAK 849
            S  E    ++ +L    G++Y H      I HRD+K  N L+   P     I DFG +K
Sbjct: 113 FSEDEARFFFQQLLS---GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166
Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEK-SDVYSYGVVVLEVLTGKQPI-DPTI 907
             V         +  G+  YIAPE     +   K +DV+S GV +  +L G  P  DP  
Sbjct: 167 SSV---LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223
Query: 908 P 908
           P
Sbjct: 224 P 224

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 22/151 (14%)
Query: 762 LGCCWNRNTRLLMY-DYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVP 820
           L  C+   +RL    +Y+  G L  + H +R   L  E         +  L YLH     
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERG-- 130
Query: 821 PIVHRDIKANNILIGPEFEPYIADFGLAKLVVE-GDFARSSNTVAGSYGYIAPE------ 873
            I++RD+K +N+L+  E    + D+G+ K  +  GD   +++   G+  YIAPE      
Sbjct: 131 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSXFCGTPNYIAPEILRGED 186
Query: 874 YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           YG+ +      D ++ GV++ E++ G+ P D
Sbjct: 187 YGFSV------DWWALGVLMFEMMAGRSPFD 211

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 22  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 72
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 73  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 129
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 130 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFG 181
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 182 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 23  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQS--------- 73
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 74  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 130
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 131 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 182
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 183 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 16  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 66
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 67  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 124 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFG 175
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 176 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     + VG G  G V  A + + G  +AVKKL     +         
Sbjct: 21  QELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS--------- 71
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 72  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 128
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 129 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 180
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 181 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGXVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 67
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 68  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 125 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFG 176
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 177 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N+  G+  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L YLH      I+HRD+K  NIL+  +    I DFG AK++        +N   G+  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        + SD+++ G ++ +++ G  P 
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 693 VVGKGCSG-IVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G ++   +   G+  AVK +    +  + D           ++S   E++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----------KESLLREVQLLK 81
Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRIILGAAQG 810
            + H NI +      ++    L+ +    G L   ++  +R S ++     RII     G
Sbjct: 82  QLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSG 138
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIADFGLAKLVVEGDFARSSNTVAGSY 867
           + Y H +    IVHRD+K  N+L+  + +     I DFGL+      + ++      G+ 
Sbjct: 139 ITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXKDKIGTA 192
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
            YIAPE  +     EK DV+S GV++  +L+G  P +
Sbjct: 193 YYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 67
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 68  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 125 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 176
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 177 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPF 59
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 60  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 23  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 73
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 74  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 130
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 131 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 182
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 183 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 23  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 73
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 74  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 130
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 131 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 182
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 183 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 63
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 64  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 121 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFG 172
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 173 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 31  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 81
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 82  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 138
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 139 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 190
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 191 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 63
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 64  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 121 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 172
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 173 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 63
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 64  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 121 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 172
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 173 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            ++G+G S +V R   +        K+   T    +  +     +  +R++   E+  L 
Sbjct: 10  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEE----VQELREATLKEVDILR 65
Query: 752 SIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
            +  H NI++            L++D M  G L   L E+  +  E E R +I+    + 
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR-KIMRALLEV 123
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           +  LH      IVHRD+K  NIL+  +    + DFG +  +  G+  R    V G+  Y+
Sbjct: 124 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYL 177
Query: 871 APEY----------GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           APE           GY  ++    D++S GV++  +L G  P 
Sbjct: 178 APEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPPF 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 90/215 (41%), Gaps = 31/215 (14%)
Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G V+R E  + G   AVKK+      AE                   E+     
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------------------ELMACAG 141
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA-QGL 811
           +    IV   G         +  + +  GSLG L+ E+   CL  E R    LG A +GL
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQ--GCLP-EDRALYYLGQALEGL 198
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKLVVEGDFARS---SNTVAGSY 867
            YLH      I+H D+KA+N+L+  +     + DFG A  +      +S    + + G+ 
Sbjct: 199 EYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTE 255
Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            ++APE         K DV+S   ++L +L G  P
Sbjct: 256 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 34  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 84
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 85  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 141
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 142 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 193
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 194 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 30  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 80
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 81  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 137
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 138 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 189
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 190 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 13  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 63
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 64  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 120
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 121 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 172
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 173 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S +G G  G V  A + + G  +AVKKL     +         
Sbjct: 16  QELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 66
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 67  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 124 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFG 175
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 176 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 22  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 72
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 73  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 129
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 130 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 181
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 182 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDK--IGIGGVRDSFSAEIK 748
           S++G+G  G+V  A  +  GE++A+KK+ P           DK    +  +R     EIK
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----------DKPLFALRTLR-----EIK 61
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL--EWELRYRIILG 806
            L   +H+NI+         +       Y+    + + LH    + +  +  ++Y  I  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-FIYQ 120
Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT---- 862
             + +  LH   V   +HRD+K +N+LI    +  + DFGLA+++ E     S  T    
Sbjct: 121 TLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 863 ----VAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDP 905
                  +  Y APE      K +   DV+S G ++ E+   ++PI P
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 16  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 66
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 67  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 124 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 175
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 176 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 10  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 60
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 61  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 117
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 118 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 169
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 170 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDK--IGIGGVRDSFSAEIK 748
           S++G+G  G+V  A  +  GE++A+KK+ P           DK    +  +R     EIK
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----------DKPLFALRTLR-----EIK 61
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL--EWELRYRIILG 806
            L   +H+NI+         +       Y+    + + LH    + +  +  ++Y  I  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-FIYQ 120
Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT---- 862
             + +  LH   V   +HRD+K +N+LI    +  + DFGLA+++ E     S  T    
Sbjct: 121 TLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 863 ----VAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDP 905
                  +  Y APE      K +   DV+S G ++ E+   ++PI P
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 88/335 (26%), Positives = 135/335 (40%), Gaps = 62/335 (18%)
Query: 688 LVEDSVVGKGCSGIVY-RAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           LV+D  +G G  G+     + ++ E++AVK          Y  + +KI      ++   E
Sbjct: 22  LVKD--IGSGNFGVARLMRDKQSNELVAVK----------YIERGEKID-----ENVKRE 64
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRIIL 805
           I    S+RH NIVRF           ++ +Y   G L   + +  R S  E    ++ ++
Sbjct: 65  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 124
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILI--GPEFEPYIADFGLAKLVVEGDFARSSNTV 863
               G++Y H      + HRD+K  N L+   P     I DFG +K  V         + 
Sbjct: 125 S---GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKST 175
Query: 864 AGSYGYIAPEYGYMMKITEK-SDVYSYGVVVLEVLTGKQPI-DP---------------- 905
            G+  YIAPE     +   K +DV+S GV +  +L G  P  DP                
Sbjct: 176 VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV 235
Query: 906 --TIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPEVEIEE-MLQTLGVALLCVNPTPDDRP 961
              IP+ +HI    R     I V D + R + PE+   E  L+ L   L+  N       
Sbjct: 236 QYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDN------- 288
Query: 962 TMKDVAAMIKEIKQEREECMKV---DMLPSEGSAN 993
           TM    A   +  Q  EE M++     +P  G+ N
Sbjct: 289 TMTTQFAASDQPGQSIEEIMQIIAEATVPPAGTQN 323

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 68
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 69  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 125
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 126 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 178 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 9   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPF 57
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 58  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 116
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 117 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 168
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 169 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 692 SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDK--IGIGGVRDSFSAEIK 748
           S++G+G  G+V  A  +  GE++A+KK+ P           DK    +  +R     EIK
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPF----------DKPLFALRTLR-----EIK 61
Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL--EWELRYRIILG 806
            L   +H+NI+         +       Y+    + + LH    + +  +  ++Y  I  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-FIYQ 120
Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT---- 862
             + +  LH   V   +HRD+K +N+LI    +  + DFGLA+++ E     S  T    
Sbjct: 121 TLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 863 ----VAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDP 905
                  +  Y APE      K +   DV+S G ++ E+   ++PI P
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFP 224

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 23/223 (10%)
Query: 686 KCLVEDSVVGKGCSGIVYRAE----MENGEVIAVKKLWPTTMAAE-YDCQNDKIGIGGVR 740
           +C     V+GKG  G V++         G++ A+K L    +     D  + K       
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK------- 69
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
               AE   L  ++H  IV  +          L+ +Y+  G L   +   R+     +  
Sbjct: 70  ----AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTA 123
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
              +   +  L +LH      I++RD+K  NI++  +    + DFGL K  +       +
Sbjct: 124 CFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVT 178
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +T  G+  Y+APE           D +S G ++ ++LTG  P 
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 16  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPF 64
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 65  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 123
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 124 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 175
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 176 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 78/183 (42%), Gaps = 14/183 (7%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G G  G V+ A + E  + + VK +    +    DC  +   +G V    + EI  L
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE--DCWIEDPKLGKV----TLEIAIL 83
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
             + H NI++ L    N+    L+ +   +G L       R   L+  L   I       
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           + YL    +  I+HRDIK  NI+I  +F   + DFG A  +  G   +   T  G+  Y 
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYC 196
Query: 871 APE 873
           APE
Sbjct: 197 APE 199

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 8   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPF 56
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 57  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 115
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 116 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 167
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 168 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 17  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 67
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 68  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 125 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 176
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 177 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPF 55
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 56  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 115 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 167 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 34  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 84
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 85  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 141
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 142 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 193
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +         VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 194 LARHTDD----EMXGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            ++G+G S +V R   +        K+   T    +  +     +  +R++   E+  L 
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEE----VQELREATLKEVDILR 78
Query: 752 SIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
            +  H NI++            L++D M  G L   L E+  +  E E R +I+    + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETR-KIMRALLEV 136
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           +  LH      IVHRD+K  NIL+  +    + DFG +  +  G+  R    V G+  Y+
Sbjct: 137 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTPSYL 190
Query: 871 APEY----------GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           APE           GY  ++    D++S GV++  +L G  P 
Sbjct: 191 APEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPPF 229

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 8   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-----------SRPF 56
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 57  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 115
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 116 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 167
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 168 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 704 RAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD--SFSAEIKTLGSIRHKNIVRF 761
           + E+  G    V++    T   E+  +         RD      E +    ++H NIVR 
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERR-------DSCLEWELRYRIILGAAQGLAYL 814
                  +   L++D +  G L   +  R          C++  L         + +AY 
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---------ESIAYC 144
Query: 815 HHDCVPPIVHRDIKANNILIGPEFE---PYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           H +    IVHR++K  N+L+  + +     +ADFGLA   +E + + + +  AG+ GY++
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLS 198
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           PE       ++  D+++ GV++  +L G  P 
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPPF 230

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC-----CWNRNTRLLMYDYMPNGSLGSLLH 788
             I   + ++  E++ L  ++H+N++  L              + +  ++    L +++ 
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 789 ERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
            ++  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 119 SQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           L +   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LCRHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 32/230 (13%)
Query: 688 LVEDSVVGKGCSGIVY-RAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           LV+D  +G G  G+     + ++ E++AVK          Y  + +KI     R     E
Sbjct: 23  LVKD--IGSGNFGVARLMRDKQSNELVAVK----------YIERGEKIAANVKR-----E 65
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRIIL 805
           I    S+RH NIVRF           ++ +Y   G L   + +  R S  E    ++ ++
Sbjct: 66  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 125
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILI--GPEFEPYIADFGLAKLVVEGDFARSSNTV 863
               G++Y H      + HRD+K  N L+   P     I DFG +K  V         + 
Sbjct: 126 S---GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKST 176
Query: 864 AGSYGYIAPEYGYMMKITEK-SDVYSYGVVVLEVLTGKQPI-DPTIPEGL 911
            G+  YIAPE     +   K +DV+S GV +  +L G  P  DP  P+  
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 733 KIGIGGVRDSFSA-----EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSL 786
           K  IG  R++  A     EI+ L  + H  I++ +   ++     ++ + M  G L   +
Sbjct: 46  KFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKV 104
Query: 787 LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIA 843
           +  +R      +L +  +L A Q   YLH +    I+HRD+K  N+L+  + E     I 
Sbjct: 105 VGNKRLKEATCKLYFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 158
Query: 844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEV 896
           DFG +K++ E    R   T+ G+  Y+APE        GY   +    D +S GV++   
Sbjct: 159 DFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFIC 211
Query: 897 LTGKQPI 903
           L+G  P 
Sbjct: 212 LSGYPPF 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 733 KIGIGGVRDSFSA-----EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSL 786
           K  IG  R++  A     EI+ L  + H  I++ +   ++     ++ + M  G L   +
Sbjct: 47  KFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKV 105
Query: 787 LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIA 843
           +  +R      +L +  +L A Q   YLH +    I+HRD+K  N+L+  + E     I 
Sbjct: 106 VGNKRLKEATCKLYFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEV 896
           DFG +K++ E    R   T+ G+  Y+APE        GY   +    D +S GV++   
Sbjct: 160 DFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFIC 212
Query: 897 LTGKQPI 903
           L+G  P 
Sbjct: 213 LSGYPPF 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+V +   + +G+++AVK++  T  + E             R     +I ++ +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-----------RLLMDLDI-SMRT 62
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS--CLEWELRYRIILGAAQG 810
           +     V F G  +      +  + M + SL     +  D    +  ++  +I +   + 
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L +LH      ++HRD+K +N+LI    +  + DFG++  +V+ D A+  +  AG   Y+
Sbjct: 122 LEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD-DVAKDID--AGCKPYM 176
Query: 871 APEY--------GYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           APE         GY    + KSD++S G+ ++E+   + P D
Sbjct: 177 APERINPELNQKGY----SVKSDIWSLGITMIELAILRFPYD 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 733 KIGIGGVRDSFSA-----EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSL 786
           K  IG  R++  A     EI+ L  + H  I++ +   ++     ++ + M  G L   +
Sbjct: 47  KFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKV 105
Query: 787 LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIA 843
           +  +R      +L +  +L A Q   YLH +    I+HRD+K  N+L+  + E     I 
Sbjct: 106 VGNKRLKEATCKLYFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEV 896
           DFG +K++ E    R   T+ G+  Y+APE        GY   +    D +S GV++   
Sbjct: 160 DFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFIC 212
Query: 897 LTGKQPI 903
           L+G  P 
Sbjct: 213 LSGYPPF 219

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 733 KIGIGGVRDSFSA-----EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSL 786
           K  IG  R++  A     EI+ L  + H  I++ +   ++     ++ + M  G L   +
Sbjct: 47  KFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKV 105
Query: 787 LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIA 843
           +  +R      +L +  +L A Q   YLH +    I+HRD+K  N+L+  + E     I 
Sbjct: 106 VGNKRLKEATCKLYFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEV 896
           DFG +K++ E    R   T+ G+  Y+APE        GY   +    D +S GV++   
Sbjct: 160 DFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFIC 212
Query: 897 LTGKQPI 903
           L+G  P 
Sbjct: 213 LSGYPPF 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 733 KIGIGGVRDSFSA-----EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSL 786
           K  IG  R++  A     EI+ L  + H  I++ +   ++     ++ + M  G L   +
Sbjct: 53  KFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKV 111
Query: 787 LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIA 843
           +  +R      +L +  +L A Q   YLH +    I+HRD+K  N+L+  + E     I 
Sbjct: 112 VGNKRLKEATCKLYFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 165
Query: 844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEV 896
           DFG +K++ E    R   T+ G+  Y+APE        GY   +    D +S GV++   
Sbjct: 166 DFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFIC 218
Query: 897 LTGKQPI 903
           L+G  P 
Sbjct: 219 LSGYPPF 225

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 87/182 (47%), Gaps = 21/182 (11%)
Query: 737 GGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL 795
           G +R     E++ L   + H+N++  +      +   L+++ M  GS+ S +H+RR    
Sbjct: 51  GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN- 109
Query: 796 EWELRYRIIL-GAAQGLAYLHHDCVPPIVHRDIKANNILIGP--EFEPY-IADFGLAK-L 850
             EL   +++   A  L +LH+     I HRD+K  NIL     +  P  I DFGL   +
Sbjct: 110 --ELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGI 164
Query: 851 VVEGDFARSSN----TVAGSYGYIAPE----YGYMMKITEKS-DVYSYGVVVLEVLTGKQ 901
            + GD +  S     T  GS  Y+APE    +     I +K  D++S GV++  +L+G  
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 902 PI 903
           P 
Sbjct: 225 PF 226

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 43/221 (19%)
Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G V+R E  + G   AVKK+      AE                   E+     
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-------------------ELMACAG 122
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA-QGL 811
           +    IV   G         +  + +  GSLG L+ E+   CL  E R    LG A +GL
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQ--GCLP-EDRALYYLGQALEGL 179
Query: 812 AYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADF---------GLAKLVVEGDFARSSN 861
            YLH      I+H D+KA+N+L+  +     + DF         GL K ++ GD+     
Sbjct: 180 EYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY----- 231
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            + G+  ++APE         K DV+S   ++L +L G  P
Sbjct: 232 -IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 95
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    +G+ L++  +   L  +     +    +
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 155
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 156 GLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 264

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 36/236 (15%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  + ++++G  IAVKKL               
Sbjct: 40  QELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKL-----------SRPF 88
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD--YMPNGSLGSLL---- 787
             I   + ++  E++ L  ++H+N++  L   +   T L  ++  Y+    +G+ L    
Sbjct: 89  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDV-FTPATSLEEFNDVYLVTHLMGADLNNIV 146
Query: 788 --HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
              +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DF
Sbjct: 147 KCQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 198
Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           GLA+   +      +  VA  + Y APE     M      D++S G ++ E+LTG+
Sbjct: 199 GLARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+V +   + +G+++AVK++  T  + E             R     +I ++ +
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-----------RLLMDLDI-SMRT 106
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS--CLEWELRYRIILGAAQG 810
           +     V F G  +      +  + M + SL     +  D    +  ++  +I +   + 
Sbjct: 107 VDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 165
Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L +LH      ++HRD+K +N+LI    +  + DFG++  +V+   + +    AG   Y+
Sbjct: 166 LEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---SVAKTIDAGCKPYM 220
Query: 871 APEY--------GYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           APE         GY +    KSD++S G+ ++E+   + P D
Sbjct: 221 APERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYD 258

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E++ L  + H NI++      + ++  ++ +    G L   + +R+          RII 
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIK 128
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNT 862
               G+ Y+H      IVHRD+K  NIL+     + +  I DFGL+    +    +  + 
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDR 183
Query: 863 VAGSYGYIAPEYGYMMKIT--EKSDVYSYGVVVLEVLTGKQPI 903
           +  +Y YIAPE   +++ T  EK DV+S GV++  +L+G  P 
Sbjct: 184 IGTAY-YIAPE---VLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 21/177 (11%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E+  L  ++H NIV          +  L+++Y+        L +  D C      + + L
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD-----LKQYLDDCGNIINMHNVKL 104
Query: 806 GAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
              Q   GLAY H   V   +HRD+K  N+LI    E  +ADFGLA+   +    ++ + 
Sbjct: 105 FLFQLLRGLAYCHRQKV---LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDN 159
Query: 863 VAGSYGYIAPEYGYMMKITEKS---DVYSYGVVVLEVLTGKQPIDP--TIPEGLHIV 914
              +  Y  P+   ++  T+ S   D++  G +  E+ TG+ P+ P  T+ E LH +
Sbjct: 160 EVVTLWYRPPD--ILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFI 213

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E++ L  + H NI++      + ++  ++ +    G L   + +R+          RII 
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIK 128
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNT 862
               G+ Y+H      IVHRD+K  NIL+     + +  I DFGL+    +    +  + 
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDR 183
Query: 863 VAGSYGYIAPEYGYMMKIT--EKSDVYSYGVVVLEVLTGKQPI 903
           +  +Y YIAPE   +++ T  EK DV+S GV++  +L+G  P 
Sbjct: 184 IGTAY-YIAPE---VLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 110/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I D+G
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 30/233 (12%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQN 731
           Q+LN TV +V + L     VG G  G V   Y A +     +AVKKL     +       
Sbjct: 17  QELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQS------- 67
Query: 732 DKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD--YMPNGSLGSLLHE 789
               +   R ++  E++ L  ++H+N++  L   +   T +  +   Y+    +G+ L+ 
Sbjct: 68  ----LIHARRTYR-ELRLLKHLKHENVIGLLDV-FTPATSIEDFSEVYLVTTLMGADLNN 121
Query: 790 -RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
             +   L  E    ++    +GL Y+H      I+HRD+K +N+ +  + E  I DFGLA
Sbjct: 122 IVKSQALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLA 178
Query: 849 KLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           +   E      +  VA  + Y APE     M   +  D++S G ++ E+L GK
Sbjct: 179 RQADE----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-----------SRPF 59
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 60  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DF 
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFY 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+L  T+ +V +     S VG G  G V  A + + G  +AVKKL               
Sbjct: 7   QELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKL-----------SRPF 55
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLH---- 788
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L+    
Sbjct: 56  QSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 789 --ERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I DFG
Sbjct: 115 CAKLTDDHVQF-LIYQIL----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 167 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 704 RAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD--SFSAEIKTLGSIRHKNIVRF 761
           + E+  G    V++    T   E+  +         RD      E +    ++H NIVR 
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERR-------DSCLEWELRYRIILGAAQGLAYL 814
                  +   L++D +  G L   +  R          C++  L         + +AY 
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---------ESIAYC 121
Query: 815 HHDCVPPIVHRDIKANNILIGPEFE---PYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           H +    IVHR++K  N+L+  + +     +ADFGLA   +E + + + +  AG+ GY++
Sbjct: 122 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLS 175
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           PE       ++  D+++ GV++  +L G  P 
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 704 RAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD--SFSAEIKTLGSIRHKNIVRF 761
           + E+  G    V++    T   E+  +         RD      E +    ++H NIVR 
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERR-------DSCLEWELRYRIILGAAQGLAYL 814
                  +   L++D +  G L   +  R          C++  L         + +AY 
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---------ESIAYC 121
Query: 815 HHDCVPPIVHRDIKANNILIGPEFE---PYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           H +    IVHR++K  N+L+  + +     +ADFGLA   +E + + + +  AG+ GY++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLS 175
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           PE       ++  D+++ GV++  +L G  P 
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 28/222 (12%)
Query: 684 VLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
           VLK   +   +G G  GIV  A +   G  +AVKKL           QN        R  
Sbjct: 20  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL-------SRPFQNQTHAKRAYR-- 70
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDY-----MPNGSLGSLLHERRDSCLEW 797
              E+  L  + HKNI+  L     + T     D      + + +L  ++H   D     
Sbjct: 71  ---ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMS 127
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
            L Y+++ G    + +LH      I+HRD+K +NI++  +    I DFGLA+     +F 
Sbjct: 128 YLLYQMLCG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TASTNFM 179
Query: 858 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
            +   V   Y   APE    M   E  D++S G ++ E++ G
Sbjct: 180 MTPYVVTRYYR--APEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT 881
           I++RD+K +N+++  E    IADFG+ K  +      ++    G+  YIAPE        
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPYG 520
Query: 882 EKSDVYSYGVVVLEVLTGKQPID 904
           +  D +++GV++ E+L G+ P +
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 37/197 (18%)
Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR--LLMYDYMPNGSLGSLLHERRDSCLEW 797
           RD F+ E   L    H N++  LG C +       L+  +MP GSL ++LHE  +  ++ 
Sbjct: 52  RD-FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQ 110
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRD-IKANNILIGPEFEPYIADFGLAKLVVEGDF 856
               +  L  A+G+A+LH   + P++ R  + + +++I  +    I+       + +  F
Sbjct: 111 SQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTARIS-------MADVKF 161
Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKS-----DVYSYGVVVLEVLTGKQP--------- 902
           +  S     +  ++APE   + K  E +     D++S+ V++ E++T + P         
Sbjct: 162 SFQSPGRMYAPAWVAPE--ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219
Query: 903 --------IDPTIPEGL 911
                   + PTIP G+
Sbjct: 220 GMKVALEGLRPTIPPGI 236

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/212 (23%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 704 RAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD--SFSAEIKTLGSIRHKNIVRF 761
           + E+  G    V++    T   E+  +         RD      E +    ++H NIVR 
Sbjct: 10  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERR-------DSCLEWELRYRIILGAAQGLAYL 814
                  +   L++D +  G L   +  R          C++  L         + +AY 
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---------ESIAYC 120
Query: 815 HHDCVPPIVHRDIKANNILIGPEFE---PYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           H +    IVHR++K  N+L+  + +     +ADFGLA   +E + + + +  AG+ GY++
Sbjct: 121 HSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLS 174
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           PE       ++  D+++ GV++  +L G  P 
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVGYPPF 206

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 733 KIGIGGVRDSFSA-----EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSL 786
           K  IG  R++  A     EI+ L  + H  I++ +   ++     ++ + M  G L   +
Sbjct: 186 KFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKV 244
Query: 787 LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIA 843
           +  +R      +L +  +L A Q   YLH +    I+HRD+K  N+L+  + E     I 
Sbjct: 245 VGNKRLKEATCKLYFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 298
Query: 844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEV 896
           DFG +K++ E    R   T+ G+  Y+APE        GY   +    D +S GV++   
Sbjct: 299 DFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFIC 351
Query: 897 LTGKQPI 903
           L+G  P 
Sbjct: 352 LSGYPPF 358

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 733 KIGIGGVRDSFSA-----EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSL 786
           K  IG  R++  A     EI+ L  + H  I++ +   ++     ++ + M  G L   +
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKV 230
Query: 787 LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIA 843
           +  +R      +L +  +L A Q   YLH +    I+HRD+K  N+L+  + E     I 
Sbjct: 231 VGNKRLKEATCKLYFYQMLLAVQ---YLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284
Query: 844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEV 896
           DFG +K++ E    R   T+ G+  Y+APE        GY   +    D +S GV++   
Sbjct: 285 DFGHSKILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFIC 337
Query: 897 LTGKQPI 903
           L+G  P 
Sbjct: 338 LSGYPPF 344

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 746 EIKTLGSIRHKNIVRFLGCC--WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
           EI  L  + H N+V+ +      N +   ++++ +  G +  +   +  S  +    ++ 
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQD 145
Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           ++   +G+ YLH+     I+HRDIK +N+L+G +    IADFG++    +G  A  SNTV
Sbjct: 146 LI---KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKGSDALLSNTV 198
Query: 864 AGSYGYIAPE-YGYMMKIT--EKSDVYSYGVVVLEVLTGKQPI 903
            G+  ++APE      KI   +  DV++ GV +   + G+ P 
Sbjct: 199 -GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 23/223 (10%)
Query: 686 KCLVEDSVVGKGCSGIVYRAE----MENGEVIAVKKLWPTTMAAE-YDCQNDKIGIGGVR 740
           +C     V+GKG  G V++         G++ A+K L    +     D  + K       
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK------- 69
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
               AE   L  ++H  IV  +          L+ +Y+  G L   +   R+     +  
Sbjct: 70  ----AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTA 123
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
              +   +  L +LH      I++RD+K  NI++  +    + DFGL K  +       +
Sbjct: 124 CFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVT 178
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +   G+  Y+APE           D +S G ++ ++LTG  P 
Sbjct: 179 HXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 16/163 (9%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWN-RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII 804
           E+  L  + H NI++      + RN  L+M  Y        ++  ++ S ++  +  + +
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 113
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIADFGL-AKLVVEGDFARSS 860
           L    G  YLH      IVHRD+K  N+L+  +       I DFGL A   V G      
Sbjct: 114 LS---GTTYLHK---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER- 166
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               G+  YIAPE     K  EK DV+S GV++  +L G  P 
Sbjct: 167 ---LGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 32/224 (14%)
Query: 684 VLKCLVEDSVVGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           VLK       +G G  GIV   Y A +E    +A+KKL           QN        R
Sbjct: 22  VLKRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKL-------SRPFQNQTHAKRAYR 72
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDY-----MPNGSLGSLLHERRDSCL 795
                E+  +  + HKNI+  L     + +     D      + + +L  ++    D   
Sbjct: 73  -----ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHER 127
Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
              L Y++++G    + +LH      I+HRD+K +NI++  +    I DFGLA+    G 
Sbjct: 128 MSYLLYQMLVG----IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGT 178
Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
               +  V   Y Y APE    M   E  D++S GV++ E++ G
Sbjct: 179 SFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 74/174 (42%), Gaps = 28/174 (16%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHER--RDSCLEW 797
           D F  EI+ + S+ H NI+R      +     L+ +    G L   ++H+R  R+S    
Sbjct: 51  DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA- 109
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
               RI+      +AY H   V    HRD+K  N L     P+    + DFGLA     G
Sbjct: 110 ----RIMKDVLSAVAYCHKLNV---AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162
Query: 855 DFARSSNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
              R   T  G+  Y++P+     YG       + D +S GV++  +L G  P 
Sbjct: 163 KMMR---TKVGTPYYVSPQVLEGLYG------PECDEWSAGVMMYVLLCGYPPF 207

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 24/220 (10%)
Query: 684 VLKCLVEDSVVGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           VLK       +G G  GIV   Y A +E    +A+KKL           QN        R
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKL-------SRPFQNQTHAKRAYR 72
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
                E+  +  + HKNI+  L     + +   + ++     +  L+       ++ EL 
Sbjct: 73  -----ELVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELD 124
Query: 801 Y-RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
           + R+     Q L  + H     I+HRD+K +NI++  +    I DFGLA+    G     
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMM 182
Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
           +  V   Y Y APE    M   E  D++S GV++ E++ G
Sbjct: 183 TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 74/174 (42%), Gaps = 28/174 (16%)
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHER--RDSCLEW 797
           D F  EI+ + S+ H NI+R      +     L+ +    G L   ++H+R  R+S    
Sbjct: 68  DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA- 126
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEG 854
               RI+      +AY H   V    HRD+K  N L     P+    + DFGLA     G
Sbjct: 127 ----RIMKDVLSAVAYCHKLNV---AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 179
Query: 855 DFARSSNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
              R   T  G+  Y++P+     YG       + D +S GV++  +L G  P 
Sbjct: 180 KMMR---TKVGTPYYVSPQVLEGLYG------PECDEWSAGVMMYVLLCGYPPF 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 31/235 (13%)
Query: 674 FQKLNFTVEQVLKCLVEDSVVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQND 732
            + +++   + +  +     VG+G  G V+R  + + G   AVKK+       E      
Sbjct: 46  LKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ 99
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD 792
                        E+     +    IV   G         +  + +  GSLG L+  ++ 
Sbjct: 100 -------------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQM 144
Query: 793 SCLEWELRYRIILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKL 850
            CL  E R    LG A +GL YLH      I+H D+KA+N+L+  +     + DFG A  
Sbjct: 145 GCLP-EDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 851 VVEGDFARS---SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +      +S    + + G+  ++APE         K D++S   ++L +L G  P
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 25/83 (30%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT 881
           I++RD+K +N+++  E    IADFG+ K  +      ++    G+  YIAPE        
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKXFCGTPDYIAPEIIAYQPYG 199
Query: 882 EKSDVYSYGVVVLEVLTGKQPID 904
           +  D +++GV++ E+L G+ P +
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 70/141 (49%), Gaps = 11/141 (7%)
Query: 767 NRNTRLLMYDYMPNGSLGSL-LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR 825
           N +  +L+ +Y   G + SL L E  +   E ++  R+I    +G+ YLH +    IVH 
Sbjct: 100 NTSEIILILEYAAGGEIFSLCLPELAEMVSENDV-IRLIKQILEGVYYLHQN---NIVHL 155
Query: 826 DIKANNIL---IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITE 882
           D+K  NIL   I P  +  I DFG+++ +      R    + G+  Y+APE      IT 
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEILNYDPITT 212
Query: 883 KSDVYSYGVVVLEVLTGKQPI 903
            +D+++ G++   +LT   P 
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPF 233

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 30/233 (12%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQN 731
           Q+LN TV +V + L     VG G  G V   Y A +     +AVKKL             
Sbjct: 9   QELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKL-----------SR 55
Query: 732 DKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD--YMPNGSLGSLLHE 789
               +   R ++  E++ L  ++H+N++  L   +   T +  +   Y+    +G+ L+ 
Sbjct: 56  PFQSLIHARRTYR-ELRLLKHLKHENVIGLLDV-FTPATSIEDFSEVYLVTTLMGADLNN 113
Query: 790 -RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
             +   L  E    ++    +GL Y+H      I+HRD+K +N+ +  + E  I DFGLA
Sbjct: 114 IVKCQALSDEHVQFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA 170
Query: 849 KLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           +   E      +  VA  + Y APE     M   +  D++S G ++ E+L GK
Sbjct: 171 RQADE----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 28/218 (12%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G+V  A     G+ +A+KK+ P          N K  +         E+K L  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDV---VTNAKRTL--------RELKILKH 110
Query: 753 IRHKNIV------RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
            +H NI+      R         +  ++ D M    L  ++H  +   LE  +RY  +  
Sbjct: 111 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLE-HVRY-FLYQ 167
Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK--LVVEGDFARSSNTVA 864
             +GL Y+H   V   +HRD+K +N+L+    E  I DFG+A+       +         
Sbjct: 168 LLRGLKYMHSAQV---IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 224
Query: 865 GSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQ 901
            +  Y APE    + + T+  D++S G +  E+L  +Q
Sbjct: 225 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 31/235 (13%)
Query: 674 FQKLNFTVEQVLKCLVEDSVVGKGCSGIVYR-AEMENGEVIAVKKLWPTTMAAEYDCQND 732
            + +++   + +  +     VG+G  G V+R  + + G   AVKK+       E      
Sbjct: 62  LKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ 115
Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD 792
                        E+     +    IV   G         +  + +  GSLG L+  ++ 
Sbjct: 116 -------------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQM 160
Query: 793 SCLEWELRYRIILGAA-QGLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKL 850
            CL  E R    LG A +GL YLH      I+H D+KA+N+L+  +     + DFG A  
Sbjct: 161 GCLP-EDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALC 216
Query: 851 VVEGDFARS---SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +      +S    + + G+  ++APE         K D++S   ++L +L G  P
Sbjct: 217 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG   +V R  ++  G+  A K +    ++A  D Q               E +    
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR-DHQK-----------LEREARICRL 59
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H NIVR            L++D +  G L   +  R     E+           Q L 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILE 114
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFE---PYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            ++H  +  IVHRD+K  N+L+  + +     +ADFGLA + V+GD  ++    AG+ GY
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGD-QQAWFGFAGTPGY 172
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        +  D+++ GV++  +L G  P 
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I  FG
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 30/233 (12%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQN 731
           Q+LN TV +V + L     VG G  G V   Y A +     +AVKKL     +       
Sbjct: 17  QELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQK--VAVKKLSRPFQS------- 67
Query: 732 DKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD--YMPNGSLGSLLHE 789
               +   R ++  E++ L  ++H+N++  L   +   T +  +   Y+    +G+ L+ 
Sbjct: 68  ----LIHARRTYR-ELRLLKHLKHENVIGLLDV-FTPATSIEDFSEVYLVTTLMGADLNN 121
Query: 790 -RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
             +   L  E    ++    +GL Y+H      I+HRD+K +N+ +  + E  I DFGLA
Sbjct: 122 IVKCQALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLA 178
Query: 849 KLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           +   E      +  VA  + Y APE     M   +  D++S G ++ E+L GK
Sbjct: 179 RQADE----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 56/109 (51%), Gaps = 10/109 (9%)
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSY 867
           +GL Y+H   V   +HRD+K +N+LI    +  I DFGLA++   E D          + 
Sbjct: 155 RGLKYIHSANV---LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 868 GYIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
            Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLD 255

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 10/108 (9%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS-NTVAGSYG 868
           GL ++H+  V   V+RD+K  NIL+       I+D GLA      DF++   +   G++G
Sbjct: 304 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 355
Query: 869 YIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
           Y+APE     +     +D +S G ++ ++L G  P      +  H +D
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 10/108 (9%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS-NTVAGSYG 868
           GL ++H+  V   V+RD+K  NIL+       I+D GLA      DF++   +   G++G
Sbjct: 303 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 354
Query: 869 YIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
           Y+APE     +     +D +S G ++ ++L G  P      +  H +D
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 402

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I D G
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
            + RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 137
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 138 GLKYIHSANV---LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 246

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 737 GGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL 795
           G +R     E++ L   + H+N++  +      +   L+++ M  GS+ S +H+RR    
Sbjct: 51  GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN- 109
Query: 796 EWELRYRIIL-GAAQGLAYLHHDCVPPIVHRDIKANNILIGP--EFEPY-IADFGLAK-L 850
             EL   +++   A  L +LH+     I HRD+K  NIL     +  P  I DF L   +
Sbjct: 110 --ELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164
Query: 851 VVEGDFARSSN----TVAGSYGYIAPE----YGYMMKITEKS-DVYSYGVVVLEVLTGKQ 901
            + GD +  S     T  GS  Y+APE    +     I +K  D++S GV++  +L+G  
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 902 PI 903
           P 
Sbjct: 225 PF 226

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
            + RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 137
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 138 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 246

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 10/108 (9%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS-NTVAGSYG 868
           GL ++H+  V   V+RD+K  NIL+       I+D GLA      DF++   +   G++G
Sbjct: 304 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 355
Query: 869 YIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
           Y+APE     +     +D +S G ++ ++L G  P      +  H +D
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 54/108 (50%), Gaps = 10/108 (9%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS-NTVAGSYG 868
           GL ++H+  V   V+RD+K  NIL+       I+D GLA      DF++   +   G++G
Sbjct: 304 GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHG 355
Query: 869 YIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
           Y+APE     +     +D +S G ++ ++L G  P      +  H +D
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLX 137
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I D G
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 28/218 (12%)
Query: 694 VGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G+V  A     G+ +A+KK+ P          N K  +         E+K L  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDV---VTNAKRTL--------RELKILKH 109
Query: 753 IRHKNIV------RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
            +H NI+      R         +  ++ D M    L  ++H  +   LE  +RY  +  
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLE-HVRY-FLYQ 166
Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK--LVVEGDFARSSNTVA 864
             +GL Y+H   V   +HRD+K +N+L+    E  I DFG+A+       +         
Sbjct: 167 LLRGLKYMHSAQV---IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYV 223
Query: 865 GSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQ 901
            +  Y APE    + + T+  D++S G +  E+L  +Q
Sbjct: 224 ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 73/163 (44%), Gaps = 16/163 (9%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWN-RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII 804
           E+  L  + H NI++      + RN  L+M  Y        ++  ++ S ++  +  + +
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQV 130
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP---YIADFGL-AKLVVEGDFARSS 860
           L    G  YLH      IVHRD+K  N+L+  +       I DFGL A   V G      
Sbjct: 131 LS---GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER- 183
Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               G+  YIAPE     K  EK DV+S GV++  +L G  P 
Sbjct: 184 ---LGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 75
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 136 GLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 244

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 25/228 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 75
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 136 GLKYIHSANV---LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLD 235

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 14/166 (8%)
Query: 746 EIKTLGSIRHKNIVRFLGCCWN--RNTRLLMYDYMPNGS---LGSLLHERRDSCLEWELR 800
           EI+ L  +RHKN+++ +   +N  +    ++ +Y   G    L S+  +R   C      
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
            ++I     GL YLH      IVH+DIK  N+L+       I+  G+A+ +       + 
Sbjct: 116 CQLI----DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 861 NTVAGSYGYIAPEYGYMMKITE--KSDVYSYGVVVLEVLTGKQPID 904
            T  GS  +  PE    +      K D++S GV +  + TG  P +
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +GKG   +V R  ++  G+  A K +    ++A  D Q               E +    
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSAR-DHQK-----------LEREARICRL 59
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H NIVR            L++D +  G L   +  R     E+           Q L 
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILE 114
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFE---PYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            ++H  +  IVHRD+K  N+L+  + +     +ADFGLA + V+GD  ++    AG+ GY
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGD-QQAWFGFAGTPGY 172
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        +  D+++ GV++  +L G  P 
Sbjct: 173 LSPEVLRKDPYGKPVDMWACGVILYILLVGYPPF 206

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 12/203 (5%)
Query: 706 EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD--SFSAEIKTLGSIRHKNIVRFLG 763
           E+  G    V++    T   EY  +         RD      E +    ++H NIVR   
Sbjct: 38  ELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 97
Query: 764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIV 823
                    L++D +  G L   +  R     E+           Q L  ++H     IV
Sbjct: 98  SISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHCIHQILESVNHIHQHDIV 152
Query: 824 HRDIKANNILIGPEFE---PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI 880
           HRD+K  N+L+  + +     +ADFGLA + V+G+  ++    AG+ GY++PE       
Sbjct: 153 HRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGE-QQAWFGFAGTPGYLSPEVLRKDPY 210
Query: 881 TEKSDVYSYGVVVLEVLTGKQPI 903
            +  D+++ GV++  +L G  P 
Sbjct: 211 GKPVDIWACGVILYILLVGYPPF 233

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 66/135 (48%), Gaps = 11/135 (8%)
Query: 773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA-QGLAYLHHDCVPPIVHRDIKANN 831
           +  + +  GSLG L+  ++  CL  E R    LG A +GL YLH      I+H D+KA+N
Sbjct: 141 IFMELLEGGSLGQLI--KQMGCLP-EDRALYYLGQALEGLEYLH---TRRILHGDVKADN 194
Query: 832 ILIGPE-FEPYIADFGLAKLVVEGDFARS---SNTVAGSYGYIAPEYGYMMKITEKSDVY 887
           +L+  +     + DFG A  +      +S    + + G+  ++APE         K D++
Sbjct: 195 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 254
Query: 888 SYGVVVLEVLTGKQP 902
           S   ++L +L G  P
Sbjct: 255 SSCCMMLHMLNGCHP 269

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 34/235 (14%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL     +         
Sbjct: 11  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--------- 61
Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLL----- 787
             I   + ++  E++ L  ++H+N++  L       +     D Y+    +G+ L     
Sbjct: 62  --IIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 788 -HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
             +  D  +++ L Y+I+    +GL Y+H      I+HRD+K +N+ +  + E  I D G
Sbjct: 119 CQKLTDDHVQF-LIYQIL----RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGG 170
Query: 847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGK 900
           LA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 171 LARHTDD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/127 (25%), Positives = 64/127 (50%), Gaps = 10/127 (7%)
Query: 781 GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP 840
           G+    L +R    +   +  ++ +   + L YL       ++HRD+K +NIL+    + 
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQI 164
Query: 841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITE-----KSDVYSYGVVVLE 895
            + DFG++  +V+    ++ +  AG   Y+APE       T+     ++DV+S G+ ++E
Sbjct: 165 KLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 896 VLTGKQP 902
           + TG+ P
Sbjct: 222 LATGQFP 228

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 98/230 (42%), Gaps = 32/230 (13%)
Query: 688 LVEDSVVGKGCSGIVY-RAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           LV+D  +G G  G+     + ++ E++AVK          Y  + +KI      ++   E
Sbjct: 23  LVKD--IGSGNFGVARLMRDKQSNELVAVK----------YIERGEKID-----ENVKRE 65
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRIIL 805
           I    S+RH NIVRF           ++ +Y   G L   + +  R S  E    ++ ++
Sbjct: 66  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 125
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILI--GPEFEPYIADFGLAKLVVEGDFARSSNTV 863
               G++Y H      + HRD+K  N L+   P     I  FG +K  V         + 
Sbjct: 126 S---GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSV---LHSQPKST 176
Query: 864 AGSYGYIAPEYGYMMKITEK-SDVYSYGVVVLEVLTGKQPI-DPTIPEGL 911
            G+  YIAPE     +   K +DV+S GV +  +L G  P  DP  P+  
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 75
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 136 GLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 244

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 37  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 83
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 84  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 143
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 144 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 252

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 75
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 136 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 244

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLX 137
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 79
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 139
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 140 GLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 248

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 31  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 78  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 137
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 138 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 246

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 49  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 95
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 155
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 156 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 264

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 70
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLX 130
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 184
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 692 SVVGKGCSGIVYRAEMENGE-VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+G+G  G V     +  + V A+K L    M    D             +F  E + +
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDS------------AFFWEERDI 128
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGSLLHERRDSCLEWELRYR----IIL 805
            +  +   V  L C +  +  L M  +YMP G L +L+    D   +W   Y     + L
Sbjct: 129 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLAL 187
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
            A   +          ++HRD+K +N+L+       +ADFG    + E       +T  G
Sbjct: 188 DAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVH-CDTAVG 237
Query: 866 SYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +  YI+PE        GY  +   + D +S GV + E+L G  P 
Sbjct: 238 TPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLFEMLVGDTPF 279

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 41/230 (17%)
Query: 692 SVVGKGCSGIV------YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +V+GKG   ++      Y+     GE + V+++    + A   C N+ +           
Sbjct: 15  TVIGKGFEDLMTVNLARYKP---TGEYVTVRRI---NLEA---CSNEMVTF------LQG 59
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRDSCLEWELRYRII 804
           E+       H NIV +       N   ++  +M  GS   L+     D   E  + Y I+
Sbjct: 60  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-IL 118
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA---------DFGLAKLVVEGD 855
            G  + L Y+HH      VHR +KA++ILI  + + Y++           G  + VV  D
Sbjct: 119 QGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH-D 174
Query: 856 FARSSNTVAGSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           F + S  V     +++PE     +     KSD+YS G+   E+  G  P 
Sbjct: 175 FPKYSVKVLP---WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 221

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A     +V +A+KK+ P     +  CQ               EIK L
Sbjct: 29  SYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 75
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 135
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 136 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 244

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 49/234 (20%)
Query: 692 SVVGKGCSGIV------YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +V+GKG   ++      Y+     GE + V+++    + A   C N+ +           
Sbjct: 31  TVIGKGFEDLMTVNLARYKP---TGEYVTVRRI---NLEA---CSNEMVTF------LQG 75
Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL-HERRDSCLEWELRYRII 804
           E+       H NIV +       N   ++  +M  GS   L+     D   E  + Y I+
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-IL 134
Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA---------DFGLAKLVVEGD 855
            G  + L Y+HH      VHR +KA++ILI  + + Y++           G  + VV  D
Sbjct: 135 QGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH-D 190
Query: 856 FARSSNTVAGSYGYIAPEY------GYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           F + S  V     +++PE       GY      KSD+YS G+   E+  G  P 
Sbjct: 191 FPKYSVKVLP---WLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVPF 237

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+ P     +  CQ               EIK L
Sbjct: 27  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 73
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 133
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 134 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 242

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+ P     +  CQ               EIK L
Sbjct: 34  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 80
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 140
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 141 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 249

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+ P     +  CQ               EIK L
Sbjct: 35  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 81
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 82  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 141
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 142 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 250

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+ P     +  CQ               EIK L
Sbjct: 26  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 72
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 73  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 132
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 133 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 241

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+ P     +  CQ               EIK L
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 79
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 139
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 140 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 248

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 75/322 (23%), Positives = 129/322 (40%), Gaps = 83/322 (25%)
Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVY--RAEMENG--EVIAVKKLWPTT----MAAE 726
           +KL   V Q+      +  +G+G    VY   A+++ G  E IA+K L PT+    +AAE
Sbjct: 10  EKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAE 69
Query: 727 YDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGS 785
             C    + + G +D+                V  +  C+ +N  +++   Y+ + S   
Sbjct: 70  LQC----LTVAGGQDN----------------VMGVKYCFRKNDHVVIAMPYLEHESFLD 109
Query: 786 LLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IAD 844
           +L+      L ++     +L   + L  +H      IVHRD+K +N L     + Y + D
Sbjct: 110 ILNS-----LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161
Query: 845 FGLAK------------LVVEGDFARSSNT--------------VAGSYGYIAPEYGYMM 878
           FGLA+            +  E    R S                 AG+ G+ APE   + 
Sbjct: 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE--VLT 219
Query: 879 KI---TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARP 935
           K    T   D++S GV+ L +L+G+ P      + L  +  +   RG+ E +  +     
Sbjct: 220 KCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA-SDDLTALAQIMTIRGSRETIQAA----- 273
Query: 936 EVEIEEMLQTLGVALLCVNPTP 957
                   +T G ++LC    P
Sbjct: 274 --------KTFGKSILCSKEVP 287

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+ P     +  CQ               EIK L
Sbjct: 27  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 73
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 133
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 134 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 242

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+ P     +  CQ               EIK L
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 79
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 139
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 140 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 248

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 28/222 (12%)
Query: 684 VLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
           VLK   +   +G G  GIV  A +   G  +AVKKL           QN        R  
Sbjct: 22  VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL-------SRPFQNQTHAKRAYR-- 72
Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDY-----MPNGSLGSLLHERRDSCLEW 797
              E+  L  + HKNI+  L     + T     D      + + +L  ++H   D     
Sbjct: 73  ---ELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMS 129
Query: 798 ELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
            L Y+++ G    + +LH      I+HRD+K +NI++  +    I DFGLA+     +F 
Sbjct: 130 YLLYQMLCG----IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC-TNFM 181
Query: 858 RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
            +   V   Y   APE    M      D++S G ++ E++ G
Sbjct: 182 MTPYVVTRYYR--APEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+ P     +  CQ               EIK L
Sbjct: 34  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 80
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 140
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 141 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 249

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 32/230 (13%)
Query: 688 LVEDSVVGKGCSGIVY-RAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           LV+D  +G G  G+     + ++ E++AVK          Y  + +KI      ++   E
Sbjct: 23  LVKD--IGSGNFGVARLMRDKQSNELVAVK----------YIERGEKID-----ENVKRE 65
Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRYRIIL 805
           I    S+RH NIVRF           ++ +Y   G L   + +  R S  E    ++ ++
Sbjct: 66  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 125
Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILI--GPEFEPYIADFGLAKLVVEGDFARSSNTV 863
               G++Y H      + HRD+K  N L+   P     I  FG +K  V    ++  +TV
Sbjct: 126 S---GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVL--HSQPKDTV 177
Query: 864 AGSYGYIAPEYGYMMKITEK-SDVYSYGVVVLEVLTGKQPI-DPTIPEGL 911
            G+  YIAPE     +   K +DV+S GV +  +L G  P  DP  P+  
Sbjct: 178 -GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H NIVR            L++D +  G L   +   R+   E +  + I     Q L 
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDI-VAREYYSEADASHCI----QQILE 114
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARSSNTVAGSYGY 869
            + H     +VHRD+K  N+L+  + +     +ADFGLA + V+GD  ++    AG+ GY
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGD-QQAWFGFAGTPGY 172
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++PE        +  D+++ GV++  +L G  P
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 24/220 (10%)
Query: 684 VLKCLVEDSVVGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           VLK       +G G  GIV   Y A +E    +A+KKL           QN        R
Sbjct: 22  VLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKL-------SRPFQNQTHAKRAYR 72
Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
                E+  +  + HKNI+  L     + +   + ++     +  L+       ++ EL 
Sbjct: 73  -----ELVLMKVVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELD 124
Query: 801 Y-RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
           + R+     Q L  + H     I+HRD+K +NI++  +    I DFGLA+    G     
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMM 182
Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
           +  V   Y Y APE    M   E  D++S G ++ E++ G
Sbjct: 183 TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYL 814
           H NIV+      ++    L+ + +  G L   + +++    E E  Y I+      ++++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS-ETEASY-IMRKLVSAVSHM 122
Query: 815 HHDCVPPIVHRDIKANNILIGPE---FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           H      +VHRD+K  N+L   E    E  I DFG A+L    +  +   T   +  Y A
Sbjct: 123 HD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAA 177
Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           PE        E  D++S GV++  +L+G+ P 
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 176 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 229
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 122 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 181
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 182 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 235
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 236 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 78  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 137
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 138 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 192 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 86  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 145
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 146 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 199
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 200 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 77  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 136
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 137 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 190
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 191 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY-RIILGAAQ 809
             + HKNI+  L     + T   + ++     +  L+       ++ EL + R+     Q
Sbjct: 78  KXVNHKNIISLLNVFTPQKT---LEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQ 134
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L  + H     I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 76  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 135
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 136 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 189
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 190 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A +E    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY-RIILGAAQ 809
             + HKNI+  L     + +   + ++     +  L+       ++ EL + R+     Q
Sbjct: 78  KCVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L  + H     I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
            APE    M   E  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 17/111 (15%)
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
           +I +   + L +LH      ++HRD+K +N+LI    +    DFG++  +V+ D A+  +
Sbjct: 140 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVD-DVAKDID 196
Query: 862 TVAGSYGYIAPEY--------GYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
             AG   Y APE         GY +    KSD++S G+  +E+   + P D
Sbjct: 197 --AGCKPYXAPERINPELNQKGYSV----KSDIWSLGITXIELAILRFPYD 241

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A++K+ P     +  CQ               EIK L
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIRKISP--FEHQTYCQRT-----------LREIKIL 79
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILR 139
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 140 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 248

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 70  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 129
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 130 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 183
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 184 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 71  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 130
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 131 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 184
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 185 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 25/237 (10%)
Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+ P     +  CQ               EIK L
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRT-----------LREIKIL 79
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    + + L++  +   L  +     +    +
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILR 139
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSYG 868
           GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          +  
Sbjct: 140 GLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 869 YIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 248

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A +E    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY-RIILGAAQ 809
             + HKNI+  L     + +   + ++     +  L+       ++ EL + R+     Q
Sbjct: 78  KVVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L  + H     I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
            APE    M   E  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 132 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 185
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 186 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A +E    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY-RIILGAAQ 809
             + HKNI+  L     + +   + ++     +  L+       ++ EL + R+     Q
Sbjct: 78  KCVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQ 134
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L  + H     I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
            APE    M   E  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 13/154 (8%)
Query: 757 NIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           +IVR +    N    R   L++ + +  G L S + +R D          I+    + + 
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 813 YLHHDCVPPIVHRDIKANNILIG---PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           YLH      I HRD+K  N+L     P     + DFG AK   E     S  T   +  Y
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYY 185
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           +APE     K  +  D++S GV++  +L G  P 
Sbjct: 186 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 2/102 (1%)
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
           R I   AQ ++ L H     I++RD+K  N+L+  +    I+D GLA  +  G     + 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTK 347
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
             AG+ G++APE     +     D ++ GV + E++  + P 
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 2/102 (1%)
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
           R I   AQ ++ L H     I++RD+K  N+L+  +    I+D GLA  +  G     + 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTK 347
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
             AG+ G++APE     +     D ++ GV + E++  + P 
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 2/102 (1%)
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
           R I   AQ ++ L H     I++RD+K  N+L+  +    I+D GLA  +  G     + 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTK 347
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
             AG+ G++APE     +     D ++ GV + E++  + P 
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 50/102 (49%), Gaps = 2/102 (1%)
Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
           R I   AQ ++ L H     I++RD+K  N+L+  +    I+D GLA  +  G     + 
Sbjct: 290 RAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTK 347
Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
             AG+ G++APE     +     D ++ GV + E++  + P 
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Composition-based stats.
 Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 33/165 (20%)
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            LA+LH      +VH D+K  NI +GP     + DFG   L+VE   A +     G   Y
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG---LLVELGTAGAGEVQEGDPRY 222
Query: 870 IAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           +APE     YG        +DV+S G+ +LEV    +     +P G     W + ++G +
Sbjct: 223 MAPELLQGSYG------TAADVFSLGLTILEVACNME-----LPHGGE--GWQQLRQGYL 269
Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
                     PE       +   V ++ + P P  R T + + A+
Sbjct: 270 P---------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 115
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 175
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 229
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 10/118 (8%)
Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV-VEGDFARSSNTVAGSY 867
           +GL Y+H   V   +HRD+K +N+L+    +  I DFGLA++   + D          + 
Sbjct: 139 RGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 868 GYIAPEYGYMMKITEKS-DVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
            Y APE     K   KS D++S G ++ E+L+ + PI P    G H +D +    G +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP----GKHYLDQLNHILGIL 248

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 65/145 (44%), Gaps = 17/145 (11%)
Query: 767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIV 823
           N N  ++M +YMP G + S  H RR      E   R    AAQ      YLH      ++
Sbjct: 113 NSNLYMVM-EYMPGGDMFS--HLRRIGRFS-EPHARFY--AAQIVLTFEYLHS---LDLI 163
Query: 824 HRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEK 883
           +RD+K  N+LI  +    +ADFG AK V        +  + G+  Y+APE        + 
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 884 SDVYSYGVVVLEVLTGKQPIDPTIP 908
            D ++ GV++ E+  G  P     P
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 65/145 (44%), Gaps = 17/145 (11%)
Query: 767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIV 823
           N N  ++M +YMP G + S  H RR      E   R    AAQ      YLH      ++
Sbjct: 113 NSNLYMVM-EYMPGGDMFS--HLRRIGRFS-EPHARFY--AAQIVLTFEYLHS---LDLI 163
Query: 824 HRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEK 883
           +RD+K  N+LI  +    +ADFG AK V        +  + G+  Y+APE        + 
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 884 SDVYSYGVVVLEVLTGKQPIDPTIP 908
            D ++ GV++ E+  G  P     P
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A +E    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY-RIILGAAQ 809
             + HKNI+  L     + +   + ++     +  L+       ++ EL + R+     Q
Sbjct: 78  KCVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            L  + H     I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
            APE    M   E  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 78
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 138
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 192
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H NIVR            L++D +  G L   +   R+   E +  + I     Q L 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI-VAREYYSEADASHCI----QQILE 132
Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFE---PYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            + H     +VHRD+K  N+L+  + +     +ADFGLA + VEG+  ++    AG+ GY
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGE-QQAWFGFAGTPGY 190
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
           ++PE        +  D+++ GV++  +L G  P 
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 224

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 58/136 (42%), Gaps = 12/136 (8%)
Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLH-HDCVPPIVHRDIKAN 830
           L++ + M  G L S + ER D          I+      + +LH H+    I HRD+K  
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKPE 157
Query: 831 NILIGPEFEPYI---ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVY 887
           N+L   + +  +    DFG AK   +        T      Y+APE     K  +  D++
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY----YVAPEVLGPEKYDKSCDMW 213
Query: 888 SYGVVVLEVLTGKQPI 903
           S GV++  +L G  P 
Sbjct: 214 SLGVIMYILLCGFPPF 229

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 78
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 138
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 192
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 76
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 77  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 136
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 137 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 190
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 71
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 131
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 132 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 185
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 115
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 175
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 229
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 70
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 184
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A ++    +A+KKL           QN        R     E+  +
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 71
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + T     D Y+    + + L +     L+ E    ++     
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 131
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 132 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 185
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
            APE    M   E  D++S G ++ E++  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 60/136 (44%), Gaps = 12/136 (8%)
Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLH-HDCVPPIVHRDIKAN 830
           L++ + M  G L S + ER D          I+      + +LH H+    I HRD+K  
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKPE 138
Query: 831 NILIGPEFEPYI---ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVY 887
           N+L   + +  +    DFG AK   +     +  T   +  Y+APE     K  +  D++
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMW 194
Query: 888 SYGVVVLEVLTGKQPI 903
           S GV++  +L G  P 
Sbjct: 195 SLGVIMYILLCGFPPF 210

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 694 VGKGCSGIV---YRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           +G G  GIV   Y A +E    +A+KKL           QN        R     E+  +
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKL-------SRPFQNQTHAKRAYR-----ELVLM 77
Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
             + HKNI+  L     + +     D Y+    + + L +     L+ E    ++     
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ +LH      I+HRD+K +NI++  +    I DFGLA+    G     +  V   Y Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-Y 191
Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTG 899
            APE    M   E  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1035
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-166
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-150
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-75
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-18
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-107
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-96
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-73
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-106
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-97
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-96
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-93
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-79
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-70
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-96
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-94
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-73
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-58
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-85
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-58
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-54
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-37
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-83
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-59
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-74
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-73
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-69
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-64
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-59
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-72
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-69
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-50
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-30
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-28
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-61
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-52
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-50
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-59
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-57
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-56
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-55
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-50
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-41
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-38
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-25
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-55
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-51
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-43
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-36
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-54
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-54
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-43
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-20
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-15
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-51
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-50
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-50
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-49
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-42
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-49
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-49
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-47
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-48
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-48
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-46
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-43
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-42
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-14
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-48
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-47
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-47
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-30
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-27
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-44
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-44
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-42
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-41
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-40
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-43
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-41
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-05
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-39
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-18
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-38
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-18
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-36
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-36
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-21
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-31
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-20
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-35
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-25
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-34
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-34
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-34
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-30
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-20
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-05
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-34
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-23
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-17
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-33
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-33
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-27
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-07
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-33
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-31
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-27
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	7e-16
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-32
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-31
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-31
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-12
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-30
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-30
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-29
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-21
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-05
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-29
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-29
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-29
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-05
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-29
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-04
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-28
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-26
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-26
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-10
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-17
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-25
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-25
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-24
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-24
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-24
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-06
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-23
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-23
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-22
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-20
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-22
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-21
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-21
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-04
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-22
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-06
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-05
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-18
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-21
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-10
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-20
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-20
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-10
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-20
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	9e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-19
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-19
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-05
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-04
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-19
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-18
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-18
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-18
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-08
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-06
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-04
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-18
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	9e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-04
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-17
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-16
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-16
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-04
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-15
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-15
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-14
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-14
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-09
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-14
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-14
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-14
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-13
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-04
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-13
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-13
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-13
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	9e-11
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	8e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-12
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-10
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-07
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-12
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-11
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	8e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-09
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	4e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-08
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-08
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-06
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	5e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	5e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	7e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	6e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	7e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	7e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-05
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  507 bits (1308), Expect = e-166
 Identities = 188/596 (31%), Positives = 282/596 (47%), Gaps = 39/596 (6%)

Query: 33  TEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVG 92
             + I   ++       +S    L+ L +S +N +  I P LGDC+ L  +D+S N L G
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSG 237

Query: 93  GVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVEL-GKLVN 151
               +I     L+ L ++SNQ  G IP        L+ L L +N  +G +P  L G    
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDT 295

Query: 152 LEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPA-SLGKLSKLQSLSVYTTM 210
           L  +   GN    G +P   G C  L  + L+    +G LP  +L K+  L+ L +    
Sbjct: 296 LTGLDLSGNH-FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354

Query: 211 LSGEIPPQIGNCS-ELVDLFLYENDLSGSLPRELGKLQK--LEKMLLWQNNFDGAIPEEI 267
            SGE+P  + N S  L+ L L  N+ SG +   L +  K  L+++ L  N F G IP  +
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414

Query: 268 GNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLD 327
            NC  L ++ LS N+ SG++P S G+LS L +L L  N + G IP  L    +L  L L 
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL- 473

Query: 328 TNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISN 387
                      N L G IPS L+NC +L  + LS+N LTG +   + +L+NL  L L +N
Sbjct: 474 ---------DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524

Query: 388 GISGLIPPEIGNCSSLIRLRL----------MSFGNCTQLQMLNLSNNTLGGTLPSSLAS 437
             SG IP E+G+C SLI L L           +    +      ++ N + G     + +
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKN 580

Query: 438 LTRLQVLDISVN--QFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLS 495
               +    + N  +F G+  E   +L++ N   ++   + G    +     S+  LD+S
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640

Query: 496 SNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LA 554
            N LSG IP E+  +  L   LNL  N +SG+IP ++  L  L+ILDLS NKL G +  A
Sbjct: 641 YNMLSGYIPKEIGSMPYL-FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699

Query: 555 LSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHESCFLSNATT 610
           +S L  L  +++S NN +G +P+   F      +   N GLC      C  SNA  
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADG 755

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  465 bits (1198), Expect = e-150
 Identities = 184/628 (29%), Positives = 289/628 (46%), Gaps = 73/628 (11%)

Query: 1   SSSIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELEL---PFPSNLSSLSF-- 55
                + L +W+ +  NPC +  +TC     VT I++ S  L +      S+L SL+   
Sbjct: 23  VLPDKNLLPDWSSN-KNPCTFDGVTCRDDK-VTSIDLSSKPLNVGFSAVSSSLLSLTGLE 80

Query: 56  ---------------------LQKLIISGSNLTGPISPD--LGDCTQLTTIDVSSNSLVG 92
                                L  L +S ++L+GP++    LG C+ L  ++VSSN+L  
Sbjct: 81  SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDF 140

Query: 93  GVPSSIG-KLINLQDLILNSNQLTGEIPKEL---GACIKLKNLLLFDNYLSGNLPVELGK 148
               S G KL +L+ L L++N ++G           C +LK+L +  N +SG++   + +
Sbjct: 141 PGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSR 198

Query: 149 LVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYT 208
            VNLE +    N   +  IP  +GDC +L  + ++  K++G    ++   ++L+ L++ +
Sbjct: 199 CVNLEFLDVSSNN-FSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256

Query: 209 TMLSGEIPPQIGNCSELVDLFLYENDLSGSLPREL-GKLQKLEKMLLWQNNFDGAIPEEI 267
               G IPP       L  L L EN  +G +P  L G    L  + L  N+F GA+P   
Sbjct: 257 NQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314

Query: 268 GNCKSLKTIDLSLNFFSGSLP-QSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQ-LQ 325
           G+C  L+++ LS N FSG LP  +   +  L+ L LS N  SG +P  L+N ++ L  L 
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374

Query: 326 LDTNQISVFFAWQNKLEGSIPSTLANC--RSLEAVDLSHNALTGSLHPGLFQLQNLTKLL 383
           L +N  S          G I   L      +L+ + L +N  TG + P L     L  L 
Sbjct: 375 LSSNNFS----------GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424

Query: 384 LISNGISGLIPPEIGNCSSLIRLRLM----------SFGNCTQLQMLNLSNNTLGGTLPS 433
           L  N +SG IP  +G+ S L  L+L                  L+ L L  N L G +PS
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484

Query: 434 SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLD 493
            L++ T L  + +S N+  G IP+  G+L +L  L LS NSFSG IP+ LG C SL  LD
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544

Query: 494 LSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKL---GG 550
           L++N  +G IP  +F+      S  ++ N ++G     I           + N L   G 
Sbjct: 545 LNTNLFNGTIPAAMFK-----QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599

Query: 551 DLLALSGLDNLVSLNVSYNNFTGYLPDS 578
               L+ L      N++   + G+   +
Sbjct: 600 RSEQLNRLSTRNPCNITSRVYGGHTSPT 627

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  261 bits (670), Expect = 9e-75
 Identities = 98/347 (28%), Positives = 152/347 (43%), Gaps = 40/347 (11%)

Query: 257 NNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPV-- 314
           N    A+   + +   L+++ LS +  +GS+   F   +SL  L LS N++SG +  +  
Sbjct: 63  NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTS 121

Query: 315 LSNATSLLQLQLDTNQISVFFAWQNKLEGSIP-STLANCRSLEAVDLSHNALTGSLHPGL 373
           L + + L  L + +N           L+     S      SLE +DLS N+++G+   G 
Sbjct: 122 LGSCSGLKFLNVSSNT----------LDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW 171

Query: 374 FQLQNLTKLLLI---SNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGT 430
                  +L  +    N ISG +                    C  L+ L++S+N     
Sbjct: 172 VLSDGCGELKHLAISGNKISGDVD----------------VSRCVNLEFLDVSSNNFSTG 215

Query: 431 LPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQ 490
           +P  L   + LQ LDIS N+  G    +      L  L +S N F G IP      +SLQ
Sbjct: 216 IP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQ 272

Query: 491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG 550
            L L+ NK +G+IP  L         L+LS N   GA+PP   + + L  L LS N   G
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332

Query: 551 DL--LALSGLDNLVSLNVSYNNFTGYLPDS--KLFRQLSATEMAGNQ 593
           +L    L  +  L  L++S+N F+G LP+S   L   L   +++ N 
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 88.8 bits (221), Expect = 4e-18
 Identities = 32/112 (28%), Positives = 52/112 (46%)

Query: 32  VTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLV 91
               NI S            +   +  L +S + L+G I  ++G    L  +++  N + 
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669

Query: 92  GGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLP 143
           G +P  +G L  L  L L+SN+L G IP+ + A   L  + L +N LSG +P
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 63.8 bits (156), Expect = 2e-10
 Identities = 18/74 (24%), Positives = 34/74 (45%), Gaps = 3/74 (4%)

Query: 515 ISLNLSWNALS---GAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNF 571
            S++LS   L+    A+   + +L  L  L LS++ + G +       +L SL++S N+ 
Sbjct: 53  TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSL 112

Query: 572 TGYLPDSKLFRQLS 585
           +G +         S
Sbjct: 113 SGPVTTLTSLGSCS 126

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  348 bits (894), Expect = e-107
 Identities = 82/611 (13%), Positives = 171/611 (27%), Gaps = 65/611 (10%)

Query: 11  WNPSDSNPCKWSHITCSPQ---NFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLT 67
           W+  +            P    NF  E+++   +       +L+S   +  L + G   +
Sbjct: 39  WDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQP----GVSLNSNGRVTGLSLEGFGAS 94

Query: 68  GPISPDLGDCTQLTTIDVSSNSLVGG----VPSSIGKLINLQDLILNSNQLTGEIPKELG 123
           G +   +G  T+L  + + S+          P  I   ++ +                  
Sbjct: 95  GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154

Query: 124 A--CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVG 181
                 L    +  +    ++       +    I    N      +   +     L    
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNN--ITFVSKAVMRLTKLRQFY 212

Query: 182 LADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPR 241
           + ++           +    +               +  N  +L D+ +Y       LP 
Sbjct: 213 MGNSPFVAENICEAWENENSEYAQ-----QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267

Query: 242 ELGKLQKLEKMLLWQNNF--------DGAIPEEIGNCKSLKTIDLSLN-FFSGSLPQSFG 292
            L  L +++ + +  N          D     +    + ++ I +  N   +  +  S  
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327

Query: 293 NLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC 352
            +  L  L    N + G   P   +   L  L L  NQI+              +     
Sbjct: 328 KMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQIT----------EIPANFCGFT 376

Query: 353 RSLEAVDLSHNALTG-SLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSF 411
             +E +  +HN L           +  ++ +    N I  +                   
Sbjct: 377 EQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP------- 429

Query: 412 GNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGL-------IPESFGQLAS 464
                +  +NLSNN +        ++ + L  +++  N    +         E+F     
Sbjct: 430 FKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489

Query: 465 LNRLILSKNSFSGAIPS-SLGRCESLQSLDLSSNKLSGKIPVELFEI---EGLDIS--LN 518
           L  + L  N  +             L  +DLS N  S   P +       +G  I    +
Sbjct: 490 LTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD 548

Query: 519 LSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDS 578
              N      P  I+    L+ L +  N +    +      N+  L++  N     +  S
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK--VNEKITPNISVLDIKDNPNIS-IDLS 605

Query: 579 KLFRQLSATEM 589
            +   + A   
Sbjct: 606 YVCPYIEAGMY 616

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  318 bits (816), Expect = 2e-96
 Identities = 77/566 (13%), Positives = 170/566 (30%), Gaps = 90/566 (15%)

Query: 74  LGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTG----EIPKELGACIKLK 129
           L    ++T + +      G VP +IG+L  L+ L L S+          PK + A +  +
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 130 NLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG 189
                  +          +                            L+   +       
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFS-----------------------DLIKDCINSDPQQK 173

Query: 190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKL 249
           S+  S     K   +   +  ++  +   +   ++L   ++  +        E  + +  
Sbjct: 174 SIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS 232

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNI-- 307
           E               +  N K L  +++        LP     L  ++ + ++ N    
Sbjct: 233 EY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287

Query: 308 ------SGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLS 361
                              +  + +  N +             + ++L   + L  ++  
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLK---------TFPVETSLQKMKKLGMLECL 338

Query: 362 HNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL-----------MS 410
           +N L G L P       L  L L  N I+ +     G    +  L               
Sbjct: 339 YNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFD 397

Query: 411 FGNCTQLQMLNLSNNTLGG-------TLPSSLASLTRLQVLDISVNQFVGLIPESFGQLA 463
             + + +  ++ S N +G         L  +      +  +++S NQ      E F   +
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457

Query: 464 SLNRLILSKNSFSG-------AIPSSLGRCESLQSLDLSSNKLSGKIPVELF--EIEGLD 514
            L+ + L  N  +            +      L S+DL  NKL+  +  +     +  L 
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYL- 515

Query: 515 ISLNLSWNALSGAIPPQISALNKLSILDLSHNK-------LGGDLLALSGLDNLVSLNVS 567
           + ++LS+N+ S   P Q    + L    + + +       L      ++   +L  L + 
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574

Query: 568 YNNFTGYLPDSKLFRQLSATEMAGNQ 593
            N+    + +  +   +S  ++  N 
Sbjct: 575 SNDIRK-VNEK-ITPNISVLDIKDNP 598

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  254 bits (651), Expect = 3e-73
 Identities = 74/530 (13%), Positives = 142/530 (26%), Gaps = 133/530 (25%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGP-------------------ISPDLGDCTQLTTIDVSS 87
              +  L+ L++  +  S                              +   LT ++V +
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258

Query: 88  NSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELG 147
              +  +P+ +  L  +Q + +  N+                               +  
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGIS----------------GEQLKDDWQALADAP 302

Query: 148 KLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVY 207
               +++I  G N                L             +  SL K+ KL  L   
Sbjct: 303 VGEKIQIIYIGYNN---------------LKT---------FPVETSLQKMKKLGMLECL 338

Query: 208 TTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPE-- 265
              L G   P  G+  +L  L L  N ++       G  +++E +    N     IP   
Sbjct: 339 YNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIF 396

Query: 266 EIGNCKSLKTIDLSLNFFSG-------SLPQSFGNLSSLEELMLSNNNISGSIPPVLSNA 318
           +  +   +  ID S N            L  +     ++  + LSNN IS     + S  
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456

Query: 319 TSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQN 378
           + L  + L  N ++                  N   L ++DL  N LT            
Sbjct: 457 SPLSSINLMGNMLTEIPKNSL---KDENENFKNTYLLTSIDLRFNKLTK----------- 502

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
                         +  +                    L  ++LS N+     P+   + 
Sbjct: 503 --------------LSDDFR------------ATTLPYLVGIDLSYNSFSK-FPTQPLNS 535

Query: 439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK 498
           + L+   I                          N      P  +  C SL  L + SN 
Sbjct: 536 STLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCPSLTQLQIGSND 577

Query: 499 LSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKL 548
           +   +  ++     +   L++  N         +    +  +  L ++K 
Sbjct: 578 IRK-VNEKIT--PNI-SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  333 bits (857), Expect = e-106
 Identities = 115/306 (37%), Positives = 177/306 (57%), Gaps = 26/306 (8%)

Query: 690 EDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
             +++G+G  G VY+  + +G ++AVK+L             ++   GG    F  E++ 
Sbjct: 34  NKNILGRGGFGKVYKGRLADGTLVAVKRL------------KEERTQGGELQ-FQTEVEM 80

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC--LEWELRYRIILGA 807
           +    H+N++R  G C     RLL+Y YM NGS+ S L ER +S   L+W  R RI LG+
Sbjct: 81  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
           A+GLAYLH  C P I+HRD+KA NIL+  EFE  + DFGLAKL+   D    +  V G+ 
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTI 199

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP---EGLHIVDWVR---QKR 921
           G+IAPEY    K +EK+DV+ YGV++LE++TG++  D       + + ++DWV+   +++
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259

Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK-EIKQER-EE 979
               ++D  L+   +   EE+ Q + VALLC   +P +RP M +V  M++ +   ER EE
Sbjct: 260 KLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEE 317

Query: 980 CMKVDM 985
             K +M
Sbjct: 318 WQKEEM 323

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  309 bits (793), Expect = 4e-97
 Identities = 100/314 (31%), Positives = 159/314 (50%), Gaps = 28/314 (8%)

Query: 671 LTPFQKLNFTVEQVL---KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEY 727
           L PF+     +  +           ++G G  G VY+  + +G  +A+K+  P +     
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---- 76

Query: 728 DCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL 787
             Q       G+ + F  EI+TL   RH ++V  +G C  RN  +L+Y YM NG+L   L
Sbjct: 77  --Q-------GIEE-FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126

Query: 788 HERRDSC--LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
           +        + WE R  I +GAA+GL YLH      I+HRD+K+ NIL+   F P I DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183

Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           G++K   E D    S  V G+ GYI PEY    ++TEKSDVYS+GVV+ EVL  +  I  
Sbjct: 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243

Query: 906 TIPEG-LHIVDWVR---QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP 961
           ++P   +++ +W           +++D +L    ++  E + +    A+ C+  + +DRP
Sbjct: 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRP 301

Query: 962 TMKDVAAMIKEIKQ 975
           +M DV   ++   +
Sbjct: 302 SMGDVLWKLEYALR 315

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  320 bits (821), Expect = 1e-96
 Identities = 125/575 (21%), Positives = 208/575 (36%), Gaps = 44/575 (7%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
            P +L   + +  L ++ + L    + +    +QLT++DV  N++    P    KL  L+
Sbjct: 19  VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLK 76

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAG 165
            L L  N+L+    K    C  L  L L  N +         K  NL  +    N  ++ 
Sbjct: 77  VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG-LSS 135

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLG--KLSKLQSLSVYTTMLSGEIPPQIGNCS 223
                    ++L  + L++ K+       L     S L+ L + +  +    P       
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195

Query: 224 ELVDLFLYENDLSGSLPRELG---KLQKLEKMLLWQNNFDGAIPEEIGNCK--SLKTIDL 278
            L  LFL    L  SL  +L        +  + L  +             K  +L  +DL
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255

Query: 279 SLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQ 338
           S N  +     SF  L  LE   L  NNI       L    ++  L L  +      +  
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL- 314

Query: 339 NKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEI 397
             L      +    + LE +++  N + G +   +F  L NL  L L ++  S L     
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTS-LRTLTN 372

Query: 398 GNCSSLIRLRLM---------------SFGNCTQLQMLNLSNNTLGGTLP-SSLASLTRL 441
               SL    L                +F     L++L+L  N +G  L       L  +
Sbjct: 373 ETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI 432

Query: 442 QVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG--AIPSSLGRCESLQSLDLSSNKL 499
             + +S N+++ L   SF  + SL RL+L + +     + PS      +L  LDLS+N +
Sbjct: 433 FEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNI 492

Query: 500 SGKIPVELFE----IEGLDISLN----LSWNALSGAIPPQISALNKLSILDLSHNKLGG- 550
           +  I  ++ E    +E LD+  N    L  +A  G     +  L+ L IL+L  N     
Sbjct: 493 AN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551

Query: 551 DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS 585
            +     L  L  +++  NN          F    
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASV--FNNQV 584

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  311 bits (799), Expect = 2e-93
 Identities = 124/588 (21%), Positives = 205/588 (34%), Gaps = 54/588 (9%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP 95
            I  +E     P     L  L+ L +  + L+         CT LT + + SNS+     
Sbjct: 60  TISKLE-----PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114

Query: 96  SSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELG--KLVNLE 153
           +   K  NL  L L+ N L+            L+ LLL +N +      EL      +L+
Sbjct: 115 NPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLK 174

Query: 154 VIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLG---KLSKLQSLSVYTTM 210
            +    N+ I    P        L  + L + ++  SL   L      + +++LS+  + 
Sbjct: 175 KLELSSNQ-IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233

Query: 211 LSGEIPPQIGNC--SELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIG 268
           LS            + L  L L  N+L+         L +LE   L  NN        + 
Sbjct: 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLH 293

Query: 269 NCKSLKTIDLSLNFFSGSL---------PQSFGNLSSLEELMLSNNNISGSIPPVLSNAT 319
              +++ ++L  +F   S+           SF  L  LE L + +N+I G    + +   
Sbjct: 294 GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLI 353

Query: 320 SLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQN 378
           +L  L L  +  S+       L      +LA+   L  ++L+ N ++  +    F  L +
Sbjct: 354 NLKYLSLSNSFTSLRT-----LTNETFVSLAH-SPLHILNLTKNKISK-IESDAFSWLGH 406

Query: 379 LTKLLLISNGISGLIPP-EIGNCSSLIRLRL----------MSFGNCTQLQMLNLSNNTL 427
           L  L L  N I   +   E     ++  + L           SF     LQ L L    L
Sbjct: 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466

Query: 428 GG--TLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS--------G 477
               + PS    L  L +LD+S N    +  +    L  L  L L  N+ +        G
Sbjct: 467 KNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPG 526

Query: 478 AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNK 537
                L     L  L+L SN           ++  L   ++L  N L+       +    
Sbjct: 527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL-KIIDLGLNNLNTLPASVFNNQVS 585

Query: 538 LSILDLSHNKLGG--DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQ 583
           L  L+L  N +      +      NL  L++ +N F         F  
Sbjct: 586 LKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  271 bits (695), Expect = 5e-79
 Identities = 101/560 (18%), Positives = 189/560 (33%), Gaps = 59/560 (10%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP 95
           +IQ I+      +       L  L +S + L+            L  + +S+N +     
Sbjct: 108 SIQKIK-----NNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS 162

Query: 96  S--SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELG---KLV 150
               I    +L+ L L+SNQ+    P    A  +L  L L +  L  +L  +L       
Sbjct: 163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT 222

Query: 151 NLEVIRAGGNKDIAGKIPYEIGDCQ--SLLVVGLADTKVAGSLPASLGKLSKLQSLSVYT 208
           ++  +    ++ ++          +  +L ++ L+   +      S   L +L+   +  
Sbjct: 223 SIRNLSLSNSQ-LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY 281

Query: 209 TMLSGEIPPQIGNCSELVDLFLYENDLSGSL---------PRELGKLQKLEKMLLWQNNF 259
             +       +     +  L L  +    S+               L+ LE + +  N+ 
Sbjct: 282 NNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341

Query: 260 DGAIPEEIGNCKSLKTIDLSLNFFSGS--LPQSFGNL--SSLEELMLSNNNISGSIPPVL 315
            G          +LK + LS +F S      ++F +L  S L  L L+ N IS       
Sbjct: 342 PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401

Query: 316 SNATSLLQLQLDTNQISVFFAWQNKLEGSIP-STLANCRSLEAVDLSHNALTGSLHPGLF 374
           S    L  L L  N+I             +         ++  + LS+N     L    F
Sbjct: 402 SWLGHLEVLDLGLNEIG----------QELTGQEWRGLENIFEIYLSYNKYLQ-LTRNSF 450

Query: 375 -QLQNLTKLLLISNGISGL--IPPEIGNCSSLIRLRL----------MSFGNCTQLQMLN 421
             + +L +L+L    +  +   P       +L  L L                 +L++L+
Sbjct: 451 ALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILD 510

Query: 422 LSNNTL--------GGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKN 473
           L +N L         G     L  L+ L +L++  N F  +  E F  L  L  + L  N
Sbjct: 511 LQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLN 570

Query: 474 SFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQIS 533
           + +    S      SL+SL+L  N ++                L++ +N           
Sbjct: 571 NLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630

Query: 534 ALNKLSILDLSHNKLGGDLL 553
            +N ++    +  +L    L
Sbjct: 631 FVNWINETHTNIPELSSHYL 650

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  246 bits (629), Expect = 6e-70
 Identities = 87/429 (20%), Positives = 144/429 (33%), Gaps = 49/429 (11%)

Query: 190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKL 249
            +P  L   + +  L++    L           S+L  L +  N +S   P    KL  L
Sbjct: 18  QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
           + + L  N       +    C +L  + L  N         F    +L  L LS+N +S 
Sbjct: 76  KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135

Query: 310 SIPPVLSNATSLLQLQLDTNQISVF----FAW------------QNKLEGSIPSTLANCR 353
           +         +L +L L  N+I                       N+++   P       
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195

Query: 354 SLEAVDLSHNALTGSLHPGLF---QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS 410
            L  + L++  L  SL   L       ++  L L ++ +S                    
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL---------- 245

Query: 411 FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLIL 470
               T L ML+LS N L      S A L +L+   +  N    L   S   L ++  L L
Sbjct: 246 --KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303

Query: 471 SKN---------SFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSW 521
            ++         S       S    + L+ L++  N + G        +  L   L+LS 
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL-KYLSLSN 362

Query: 522 NALSGAIPPQIS----ALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLP 576
           +  S       +    A + L IL+L+ NK+   +  A S L +L  L++  N     L 
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422

Query: 577 DSKLFRQLS 585
               +R L 
Sbjct: 423 GQ-EWRGLE 430

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  306 bits (787), Expect = 2e-96
 Identities = 89/303 (29%), Positives = 147/303 (48%), Gaps = 31/303 (10%)

Query: 678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIG 737
           NF    +       + +G+G  G+VY+  + N   +AVKKL             D     
Sbjct: 26  NFDERPISV---GGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA---------MVDITTEE 72

Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-LE 796
             +  F  EIK +   +H+N+V  LG   + +   L+Y YMPNGSL   L     +  L 
Sbjct: 73  LKQQ-FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131

Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           W +R +I  GAA G+ +LH +     +HRDIK+ NIL+   F   I+DFGLA+   +   
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188

Query: 857 ARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV 914
              ++ + G+  Y+APE    +  +IT KSD+YS+GVV+LE++TG   +D        ++
Sbjct: 189 TVMTSRIVGTTAYMAPEA---LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244

Query: 915 DWVR----QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
           D       +++   + +DK +          +     VA  C++   + RP +K V  ++
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADS---TSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

Query: 971 KEI 973
           +E+
Sbjct: 302 QEM 304

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  310 bits (797), Expect = 4e-94
 Identities = 117/570 (20%), Positives = 192/570 (33%), Gaps = 48/570 (8%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
            P NL      + L +S + L    S       +L  +D+S   +      +   L +L 
Sbjct: 22  IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAG 165
            LIL  N +             L+ L+  +  L+      +G L  L+ +    N   + 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLS---GEIPPQIGNC 222
           K+P    +  +L  + L+  K+       L  L ++  L++   +       I P     
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199

Query: 223 SELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLWQNNFDGAIPEE---IGNCKSLKTIDL 278
             L  L L  N  S ++ +  +  L  LE   L    F      E       + L  + +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259

Query: 279 S------LNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQIS 332
                  L+++   +   F  L+++    L +  I        S       L+L   +  
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFG 317

Query: 333 VFFAWQ---------NKLEGSIPSTLANCRSLEAVDLSHNALT--GSLHPGLFQLQNLTK 381
            F   +            +G    +  +  SLE +DLS N L+  G      F   +L  
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377

Query: 382 LLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSS-LASLTR 440
           L L  NG+  +                 +F    QL+ L+  ++ L      S   SL  
Sbjct: 378 LDLSFNGVITMSS---------------NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422

Query: 441 LQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAI-PSSLGRCESLQSLDLSSNKL 499
           L  LDIS           F  L+SL  L ++ NSF     P       +L  LDLS  +L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482

Query: 500 SGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG-DLLALSGL 558
               P     +  L   LN+S N            LN L +LD S N +       L   
Sbjct: 483 EQLSPTAFNSLSSL-QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541

Query: 559 -DNLVSLNVSYNNFTGYLPDSKLFRQLSAT 587
             +L  LN++ N+F          + +   
Sbjct: 542 PSSLAFLNLTQNDFACTCEHQSFLQWIKDQ 571

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  253 bits (647), Expect = 4e-73
 Identities = 118/543 (21%), Positives = 184/543 (33%), Gaps = 57/543 (10%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGG-VPSSIGKLINLQ 105
               S LS LQKL+   +NL    +  +G    L  ++V+ N +    +P     L NL+
Sbjct: 93  LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGN----LPVELGKLVNLEVIRAGGNK 161
            L L+SN++      +L    ++  L L    LS N    +     K + L  +    N 
Sbjct: 153 HLDLSSNKIQSIYCTDLRVLHQMPLLNL-SLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211

Query: 162 DIAGKIPYEIGDCQSLLVVGLADTKVAGS---LPASLGKLSKLQSLSV------YTTMLS 212
           D    +   I     L V  L   +              L  L +L++      Y     
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271

Query: 213 GEIPPQIGNCSELVDLFLYENDLSGSLPR-ELGKLQKLEKMLLWQNNFDGAIPEEIGNCK 271
            +I       + +    L    +            Q LE   L    F      ++ + K
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE---LVNCKFGQFPTLKLKSLK 328

Query: 272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS--GSIPPVLSNATSLLQLQLDTN 329
            L     +     G    S  +L SLE L LS N +S  G         TSL  L L  N
Sbjct: 329 RL-----TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383

Query: 330 QISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNG 388
            +            ++ S       LE +D  H+ L       +F  L+NL  L +    
Sbjct: 384 GVI-----------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432

Query: 389 ISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTL-GGTLPSSLASLTRLQVLDIS 447
                                 F   + L++L ++ N+     LP     L  L  LD+S
Sbjct: 433 TRVAFNG--------------IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 448 VNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVEL 507
             Q   L P +F  L+SL  L +S N+F            SLQ LD S N +      EL
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538

Query: 508 FEIEGLDISLNLSWNALSGAIPPQ--ISALNKLSILDLSHNKLGGDL-LALSGLDNLVSL 564
                    LNL+ N  +     Q  +  +     L +   ++         G+  ++SL
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSL 597

Query: 565 NVS 567
           N++
Sbjct: 598 NIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  210 bits (536), Expect = 4e-58
 Identities = 82/421 (19%), Positives = 142/421 (33%), Gaps = 51/421 (12%)

Query: 190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKL 249
            +P +L      ++L +    L         +  EL  L L   ++          L  L
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNI-S 308
             ++L  N              SL+ +       +       G+L +L+EL +++N I S
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 309 GSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAV----DLSHNA 364
             +P   SN T+L  L L +N+I               + L     +  +    DLS N 
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQ----------SIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 365 LTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSN 424
           +   + PG F+   L KL L +N  S  +                       L++  L  
Sbjct: 189 MNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKT-------------CIQGLAGLEVHRLVL 234

Query: 425 NTLGGTL------PSSLASLTRLQVLDIS---VNQFVGLIPESFGQLASLNRLILSKNSF 475
                         S+L  L  L + +     ++ ++  I + F  L +++   L   + 
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

Query: 476 SGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISAL 535
                 S       Q L+L + K      ++L  ++ L  + N   NA S         L
Sbjct: 295 ERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS------EVDL 346

Query: 536 NKLSILDLSHNKL---GGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGN 592
             L  LDLS N L   G    +  G  +L  L++S+N       +     QL   +   +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406

Query: 593 Q 593
            
Sbjct: 407 N 407

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 51.2 bits (123), Expect = 1e-06
 Identities = 25/117 (21%), Positives = 44/117 (37%), Gaps = 3/117 (2%)

Query: 33  TEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVG 92
           T +++   +LE   P+  +SLS LQ L +S +N     +        L  +D S N ++ 
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532

Query: 93  GVPSSIGKLI-NLQDLILNSNQLTGEIP-KELGACIKLKNLLLFD-NYLSGNLPVEL 146
                +     +L  L L  N        +     IK +  LL +   +    P + 
Sbjct: 533 SKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  294 bits (753), Expect = 2e-85
 Identities = 88/627 (14%), Positives = 175/627 (27%), Gaps = 90/627 (14%)

Query: 6   SALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSN 65
               NWN  +     W                           +L +   +  L ++G  
Sbjct: 297 IHSLNWN-FNKELDMWGDQPGV---------------------DLDNNGRVTGLSLAGFG 334

Query: 66  LTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKE-LGA 124
             G +   +G  T+L  +   ++S          + +         +++     K  L  
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394

Query: 125 CIKLKNLLLFDNYLSGNL---PVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVG 181
             +L    L  + ++ N    P++    ++L+  + G   +    I   I     L ++ 
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIY 454

Query: 182 LADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPR 241
            A++       A   + +                     N  +L D+ LY       LP 
Sbjct: 455 FANSPFTYDNIAVDWEDANSDYAK-----QYENEELSWSNLKDLTDVELYNCPNMTQLPD 509

Query: 242 ELGKLQKLEKMLLWQNNFDG---------AIPEEIGNCKSLKTIDLSLNFFSGSLPQS-- 290
            L  L +L+ + +  N              + ++      ++   +  N      P S  
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASAS 568

Query: 291 FGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTL- 349
              +  L  L   +N +             L  L+LD NQI             IP    
Sbjct: 569 LQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-----------EIPEDFC 615

Query: 350 ANCRSLEAVDLSHNALTGSLHP-GLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
           A    +E +  SHN L    +      +  +  +    N I       I           
Sbjct: 616 AFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISC--------S 666

Query: 409 MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQF-------VGLIPESFGQ 461
           M          + LS N +        A+ + +  + +S N         +     ++  
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726

Query: 462 LASLNRLILSKNSFSGAIPSSL--GRCESLQSLDLSSNKLSGKIPVELFEI---EGLDIS 516
              L  + L  N  +  +           L ++D+S N  S   P +       +   I 
Sbjct: 727 TYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIR 784

Query: 517 LN--LSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGY 574
                  N +    P  I+    L  L +  N +    +       L  L+++ N     
Sbjct: 785 HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK--VDEKLTPQLYILDIADNPNIS- 841

Query: 575 LPDSKLFRQLSATEMA----GNQGLCS 597
           +  + +   + A          Q +  
Sbjct: 842 IDVTSVCPYIEAGMYVLLYDKTQDIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  215 bits (550), Expect = 2e-58
 Identities = 85/581 (14%), Positives = 154/581 (26%), Gaps = 144/581 (24%)

Query: 8   LSNWNPSDSNPCKWSHITCSPQNFVTEIN-IQSIELELPFPSNLSSLSFLQKLIISGSNL 66
             N NP      K S I+          N I  I         +  L+ LQ +  + S  
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITFI------SKAIQRLTKLQIIYFANSPF 460

Query: 67  TGP-------------------ISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDL 107
           T                           +   LT +++ +   +  +P  +  L  LQ L
Sbjct: 461 TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520

Query: 108 ILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKI 167
            +  N+                            L  +      +++   G N  +    
Sbjct: 521 NIACNRGIS---------------AAQLKADWTRLADDEDTGPKIQIFYMGYNN-LEE-F 563

Query: 168 PYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVD 227
           P                        ASL K+ KL  L      +        G   +L D
Sbjct: 564 P----------------------ASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTD 599

Query: 228 LFLYENDLSGSLPRELGK-LQKLEKMLLWQNNFDGAIPE--EIGNCKSLKTIDLSLNFFS 284
           L L  N +   +P +      ++E +    N     IP      +   + ++D S N   
Sbjct: 600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIG 657

Query: 285 GSLPQSFG-----NLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQN 339
                           +   + LS N I      + +  + +  + L  N ++       
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSI---PE 714

Query: 340 KLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGN 399
                      N   L  +DL  N LT                          +  +   
Sbjct: 715 NSLKPKDGNYKNTYLLTTIDLRFNKLTS-------------------------LSDDFR- 748

Query: 400 CSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESF 459
                            L  +++S N    + P+   + ++L+   I             
Sbjct: 749 -----------ATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQ---------- 786

Query: 460 GQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNL 519
                        N      P+ +  C SL  L + SN +  K+  +L     L I L++
Sbjct: 787 --------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLT--PQLYI-LDI 834

Query: 520 SWNALSGAIPPQISALNKLSILDLSHNKL----GGDLLALS 556
           + N         +    +  +  L ++K     G D L + 
Sbjct: 835 ADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  202 bits (514), Expect = 9e-54
 Identities = 73/511 (14%), Positives = 156/511 (30%), Gaps = 48/511 (9%)

Query: 99  GKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAG 158
                L+ + +   + + E      A  K  ++ +     +  LP    ++V        
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTY--- 224

Query: 159 GNKDIAGKIPYEIGDCQSLLVV-----GLADTKVAGSLPASLGKLSKLQSLSVYTTMLSG 213
            ++    +   E    +             D  V   L  +   +   ++L      L G
Sbjct: 225 -SQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDG 283

Query: 214 E---IPPQIGNCSELVDLFLYENDLS---GSLPRELGKLQKLEKMLLWQNNFDGAIPEEI 267
           +         N +     + +  +L         +L    ++  + L      G +P+ I
Sbjct: 284 KNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAI 343

Query: 268 GNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQL 326
           G    LK +    +  + S         + +      + I        L     L    L
Sbjct: 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403

Query: 327 DTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLIS 386
             + I+       +++     +  + +  + +    N +T  +   + +L  L  +   +
Sbjct: 404 LQDAINRN----PEMKPIKKDSRISLKDTQ-IGNLTNRIT-FISKAIQRLTKLQIIYFAN 457

Query: 387 NGISGLIPPEIGNCSSLIRLRLM-----SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRL 441
           +  +          ++    +       S+ N   L  + L N      LP  L  L  L
Sbjct: 458 SPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPEL 517

Query: 442 QVLDISVNQFVGL---------IPESFGQLASLNRLILSKNSFSGAIPS-SLGRCESLQS 491
           Q L+I+ N+ +           + +       +    +  N+      S SL +   L  
Sbjct: 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577

Query: 492 LDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQISA-LNKLSILDLSHNKL 548
           LD   NK+   +               L L +N +   IP    A  +++  L  SHNKL
Sbjct: 578 LDCVHNKVR-HLE----AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKL 631

Query: 549 GG--DLLALSGLDNLVSLNVSYNNFTGYLPD 577
               ++     +  + S++ SYN       +
Sbjct: 632 KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  150 bits (381), Expect = 2e-37
 Identities = 48/371 (12%), Positives = 104/371 (28%), Gaps = 49/371 (13%)

Query: 1   SSSIPSALSN----------WNPSDSNPCKWSHITCSPQNFVTEINIQSIEL------EL 44
            + +P  L +           N   S     +  T    +  T   IQ   +      E 
Sbjct: 504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEF 563

Query: 45  PFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGK-LIN 103
           P  ++L  +  L  L    + +        G   +LT + +  N +   +P         
Sbjct: 564 PASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQ 620

Query: 104 LQDLILNSNQLTGEIPK--ELGACIKLKNLLLFDNYLSGN-----LPVELGKLVNLEVIR 156
           ++ L  + N+L   IP      +   + ++    N +          ++  K +N   + 
Sbjct: 621 VEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679

Query: 157 AGGNKDIAGKIPYEIGDCQSLLVVGLADTK-------VAGSLPASLGKLSKLQSLSVYTT 209
              N+ I             +  + L++                +      L ++ +   
Sbjct: 680 LSYNE-IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFN 738

Query: 210 MLSGEIPPQI--GNCSELVDLFLYENDLSGSLPRELGKLQKLEK------MLLWQNNFDG 261
            L+  +           L ++ +  N  S S P +     +L+            N    
Sbjct: 739 KLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSL 321
             P  I  C SL  + +  N     + +       L  L +++N         +      
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEA 853

Query: 322 LQLQLDTNQIS 332
               L  ++  
Sbjct: 854 GMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 70.3 bits (172), Expect = 3e-12
 Identities = 20/190 (10%), Positives = 50/190 (26%), Gaps = 30/190 (15%)

Query: 420 LNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAI 479
           L+  N        ++          +  ++ +             +  L L+     G +
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339

Query: 480 PSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLS 539
           P ++G+   L+ L   ++  +    +   E    D+S               +    +L+
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399

Query: 540 ILDLSHNKLGGDLL-----------------------------ALSGLDNLVSLNVSYNN 570
           + DL  + +  +                               A+  L  L  +  + + 
Sbjct: 400 LSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSP 459

Query: 571 FTGYLPDSKL 580
           FT        
Sbjct: 460 FTYDNIAVDW 469

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  281 bits (722), Expect = 1e-83
 Identities = 112/551 (20%), Positives = 199/551 (36%), Gaps = 39/551 (7%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
            P  L +    + L  S + L    +        LT +D++   +      +      L 
Sbjct: 27  IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAG 165
            L+L +N L       L     LK+L      +S    + L     LE +  G N  I+ 
Sbjct: 85  TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH-ISS 143

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLS-GEIPPQIGNCSE 224
               +    + L V+   +  +       +  L +  +LS+         I P   + + 
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203

Query: 225 LVDLFLYENDLSGSLPRELG--KLQKLEKMLLWQNNFDGAIPEEIGNCK--SLKTIDLSL 280
              L          + + L    +Q L        + +   P         S+++I+L  
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263

Query: 281 NFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNK 340
           ++F      +F   S L+EL L+  ++S  +P  L   ++L +L L  N+          
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENL------ 316

Query: 341 LEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGI--SGLIPPEI 397
                  + +N  SL  + +  N     L  G  + L+NL +L L  + I  S     ++
Sbjct: 317 ----CQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372

Query: 398 GNCSSLIRLRL----------MSFGNCTQLQMLNLSNNTLGGTLP-SSLASLTRLQVLDI 446
            N S L  L L           +F  C QL++L+L+   L      S   +L  L+VL++
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432

Query: 447 SVNQFVGLIPESFGQLASLNRLILSKNSFSGAI---PSSLGRCESLQSLDLSSNKLSGKI 503
           S +       + F  L +L  L L  N F        +SL     L+ L LS   LS   
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492

Query: 504 PVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLV 562
                 ++ +   ++LS N L+ +    +S L  +  L+L+ N +       L  L    
Sbjct: 493 QHAFTSLKMM-NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQR 550

Query: 563 SLNVSYNNFTG 573
           ++N+  N    
Sbjct: 551 TINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  222 bits (567), Expect = 4e-62
 Identities = 84/413 (20%), Positives = 139/413 (33%), Gaps = 32/413 (7%)

Query: 192 PASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEK 251
             +  +L  L  L +    +         +   L  L L  N L       L   + L+ 
Sbjct: 50  NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKH 109

Query: 252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSI 311
           +   Q          + N K+L+++ L  N  S            L+ L   NN I    
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169

Query: 312 PPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHP 371
              +S+      L L+ N         N +   I     +    ++++         +  
Sbjct: 170 KEDMSSLQQATNLSLNLN--------GNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFK 220

Query: 372 GLF--QLQNLTKLLLISNGISGLIPPEIGNCS--SLIRLRL----------MSFGNCTQL 417
           GL    +Q+L            + P         S+  + L           +F   + L
Sbjct: 221 GLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGL 280

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG 477
           Q L+L+   L   LPS L  L+ L+ L +S N+F  L   S     SL  L +  N+   
Sbjct: 281 QELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRL 339

Query: 478 AIPS-SLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQISA 534
            + +  L   E+L+ LDLS + +         ++  L    SLNLS+N            
Sbjct: 340 ELGTGCLENLENLRELDLSHDDIE-TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE 398

Query: 535 LNKLSILDLSHNKLGG--DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS 585
             +L +LDL+  +L           L  L  LN+S++          LF  L 
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ--LFDGLP 449

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  212 bits (542), Expect = 8e-59
 Identities = 79/414 (19%), Positives = 138/414 (33%), Gaps = 32/414 (7%)

Query: 190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKL 249
            +P +L   +  + L     +L             L  L L    +            +L
Sbjct: 26  EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
           + ++L  N         +   K+LK +       S        N  +LE L L +N+IS 
Sbjct: 84  DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143

Query: 310 SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSL 369
              P       L  L    N I         L     S+L    +L  ++L+ N +   +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIH-------YLSKEDMSSLQQATNLS-LNLNGNDIA-GI 194

Query: 370 HPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNC--------------- 414
            PG F       L         +I   + N  ++  L L +F +                
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNS-TIQSLWLGTFEDMDDEDISPAVFEGLCE 253

Query: 415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS 474
             ++ +NL  +       ++    + LQ LD++       +P     L++L +L+LS N 
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANK 312

Query: 475 FSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNAL--SGAIPPQI 532
           F      S     SL  L +  N    ++     E       L+LS + +  S     Q+
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372

Query: 533 SALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS 585
             L+ L  L+LS+N+       A      L  L++++         S  F+ L 
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS-PFQNLH 425

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  122 bits (309), Expect = 5e-29
 Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 6/194 (3%)

Query: 417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS 476
            + L  S N L     ++ + L  L  LD++  Q   +  ++F     L+ L+L+ N   
Sbjct: 35  TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94

Query: 477 GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALN 536
               ++L   ++L+ L      +S    + L   + L  SL L  N +S    P+     
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL-ESLYLGSNHISSIKLPKGFPTE 153

Query: 537 KLSILDLSHNKL----GGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGN 592
           KL +LD  +N +      D+ +L    NL SLN++ N+  G  P +       +    G 
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212

Query: 593 QGLCSRGHESCFLS 606
           Q L          +
Sbjct: 213 QNLLVIFKGLKNST 226

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  245 bits (628), Expect = 8e-74
 Identities = 79/326 (24%), Positives = 129/326 (39%), Gaps = 59/326 (18%)

Query: 5   PSALSNWNPS-DSNPCKWSHITCSPQ---NFVTEINIQSIEL--ELPFPSNLSSLSFLQK 58
           P+ LS+W P+ D     W  + C        V  +++  + L    P PS+L++L +L  
Sbjct: 21  PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80

Query: 59  LIISGSN-LTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGE 117
           L I G N L GPI P +   TQL  + ++  ++ G +P  + ++  L  L  + N L+G 
Sbjct: 81  LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT 140

Query: 118 IPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSL 177
           +P  + +   L  +    N +SG +P   G    L                         
Sbjct: 141 LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL------------------------- 175

Query: 178 LVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSG 237
                                    S+++    L+G+IPP   N + L  + L  N L G
Sbjct: 176 -----------------------FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG 211

Query: 238 SLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSL 297
                 G  +  +K+ L +N+    +  ++G  K+L  +DL  N   G+LPQ    L  L
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL 270

Query: 298 EELMLSNNNISGSIPP--VLSNATSL 321
             L +S NN+ G IP    L      
Sbjct: 271 HSLNVSFNNLCGEIPQGGNLQRFDVS 296

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  245 bits (627), Expect = 1e-73
 Identities = 78/334 (23%), Positives = 136/334 (40%), Gaps = 44/334 (13%)

Query: 74  LGDCTQL----TTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLK 129
           LG+ T L     T D  + + +G +  +  +   + +L L+   L               
Sbjct: 18  LGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK------------- 64

Query: 130 NLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG 189
                       +P  L  L  L  +  GG  ++ G IP  I     L  + +  T V+G
Sbjct: 65  ---------PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115

Query: 190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKL 249
           ++P  L ++  L +L      LSG +PP I +   LV +    N +SG++P   G   KL
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175

Query: 250 EKML-LWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS 308
              + + +N   G IP    N  +L  +DLS N   G     FG+  + +++ L+ N+++
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234

Query: 309 GSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS 368
             +   +  + +L  L L  N+I           G++P  L   + L ++++S N L G 
Sbjct: 235 FDLGK-VGLSKNLNGLDLRNNRIY----------GTLPQGLTQLKFLHSLNVSFNNLCGE 283

Query: 369 LHPGLFQLQNLTKLLLISN-GISGLIPPEIGNCS 401
           + P    LQ        +N  + G   P    C+
Sbjct: 284 I-PQGGNLQRFDVSAYANNKCLCGSPLP---ACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  233 bits (596), Expect = 2e-69
 Identities = 76/326 (23%), Positives = 126/326 (38%), Gaps = 57/326 (17%)

Query: 165 GKIPYEIGDCQSLLVVGLADTKVAGS--LPASLGKLSKLQSLSVYTT-MLSGEIPPQIGN 221
           G +         +  + L+   +     +P+SL  L  L  L +     L G IPP I  
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99

Query: 222 CSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLN 281
            ++L  L++   ++SG++P  L +++ L  +    N   G +P  I +  +L  I    N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159

Query: 282 FFSGSLPQSFGNLSSL-EELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNK 340
             SG++P S+G+ S L   + +S N ++G IPP  +N  +L  + L           +N 
Sbjct: 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLS----------RNM 208

Query: 341 LEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNC 400
           LEG       + ++ + + L+ N+L                           +       
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFD------------------------LG------ 238

Query: 401 SSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFG 460
                      G    L  L+L NN + GTLP  L  L  L  L++S N   G IP+  G
Sbjct: 239 ---------KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-G 288

Query: 461 QLASLNRLILSKNSFSGAIPSSLGRC 486
            L   +    + N      P  L  C
Sbjct: 289 NLQRFDVSAYANNKCLCGSP--LPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  218 bits (558), Expect = 4e-64
 Identities = 72/295 (24%), Positives = 108/295 (36%), Gaps = 46/295 (15%)

Query: 338 QNKLEGSIPSTLANCRSLEAVDLSHNALTGSLH--PGLFQLQNLTKLLLIS-NGISGLIP 394
                G +  T      +  +DLS   L         L  L  L  L +   N + G IP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 395 PEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGL 454
           P I   +              QL  L +++  + G +P  L+ +  L  LD S N   G 
Sbjct: 95  PAIAKLT--------------QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGT 140

Query: 455 IPESFGQLASLNRLILSKNSFSGAIPSSLGRCESL-QSLDLSSNKLSGKIPVELFEIEGL 513
           +P S   L +L  +    N  SGAIP S G    L  S+ +S N+L+GKIP        L
Sbjct: 141 LPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA---NL 197

Query: 514 DIS-LNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT 572
           +++ ++LS N L G       +      + L+ N L  DL  +    NL  L++  N   
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257

Query: 573 GYLPDS------------------------KLFRQLSATEMAGNQGLCSRGHESC 603
           G LP                             ++   +  A N+ LC     +C
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  204 bits (522), Expect = 3e-59
 Identities = 68/257 (26%), Positives = 106/257 (41%), Gaps = 21/257 (8%)

Query: 344 SIPSTLANCRSL----EAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISG--LIPPEI 397
            I   L N  +L       D  +    G L     Q   +  L L    +     IP  +
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 398 GNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPE 457
            N   L  L +                N L G +P ++A LT+L  L I+     G IP+
Sbjct: 73  ANLPYLNFLYIGG-------------INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119

Query: 458 SFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISL 517
              Q+ +L  L  S N+ SG +P S+    +L  +    N++SG IP        L  S+
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179

Query: 518 NLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LALSGLDNLVSLNVSYNNFTGYLP 576
            +S N L+G IPP  + LN L+ +DLS N L GD  +      N   ++++ N+    L 
Sbjct: 180 TISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

Query: 577 DSKLFRQLSATEMAGNQ 593
              L + L+  ++  N+
Sbjct: 239 KVGLSKNLNGLDLRNNR 255

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  240 bits (614), Expect = 9e-72
 Identities = 73/320 (22%), Positives = 124/320 (38%), Gaps = 43/320 (13%)

Query: 682 EQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
                 L    V  +G  G V++A++   E +AVK   P      +              
Sbjct: 20  YFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF-PIQDKQSWQ------------- 64

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNT----RLLMYDYMPNGSLGSLLHERRDSCLEW 797
               E+ +L  ++H+NI++F+G      +      L+  +   GSL   L       + W
Sbjct: 65  -NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSW 120

Query: 798 ELRYRIILGAAQGLAYLHHDCV-------PPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
                I    A+GLAYLH D         P I HRDIK+ N+L+       IADFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 851 VVEGDFARSSNTVAGSYGYIAPEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
              G  A  ++   G+  Y+APE       +      + D+Y+ G+V+ E+ +     D 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 906 TIPEGLHIVDWVRQKRGAIE-----VLDKSLR--ARPEVEIEEMLQTLG-VALLCVNPTP 957
            + E +   +    +  ++E     V+ K  R   R   +    +  L      C +   
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 958 DDRPTMKDVAAMIKEIKQER 977
           + R +   V   I ++++  
Sbjct: 301 EARLSAGCVGERITQMQRLT 320

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  241 bits (617), Expect = 7e-69
 Identities = 104/569 (18%), Positives = 195/569 (34%), Gaps = 51/569 (8%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
            P ++ S    + + +S + L    S    + ++L  +D+S   +      +   L +L 
Sbjct: 26  VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAG 165
           +LIL  N +    P        L+NL+  +  L+      +G+L+ L+ +    N   + 
Sbjct: 84  NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLS---GEIPPQIGNC 222
           K+P    +  +L+ V L+   +       L  L +   +++   M       I  Q    
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203

Query: 223 SELVDLFLYENDLSGSLPRELGK-LQKLEKMLLWQNNFDGAIPEEIGNCKSLK------- 274
            +L +L L  N  S ++ +   + L  L    L    F      EI     ++       
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263

Query: 275 -TIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISV 333
               L+           F  L+++  + L+  +I       +        L +   Q+  
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK- 320

Query: 334 FFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLI 393
                       P+   +   L+++ L+ N  + S       L +L+ L L  N +S   
Sbjct: 321 ----------QFPT--LDLPFLKSLTLTMNKGSIS--FKKVALPSLSYLDLSRNALSFSG 366

Query: 394 PPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG 453
                           S      L+ L+LS N     + ++   L  LQ LD   +    
Sbjct: 367 C------------CSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKR 413

Query: 454 LIPES-FGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEG 512
           +   S F  L  L  L +S  +             SL +L ++ N         +F    
Sbjct: 414 VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA--N 471

Query: 513 LD--ISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYN 569
                 L+LS   L          L++L +L++SHN L   D    + L +L +L+ S+N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531

Query: 570 NFTGYLPDS-KLFRQLSATEMAGNQGLCS 597
                        + L+   +  N   C 
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSVACI 560

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  186 bits (474), Expect = 5e-50
 Identities = 78/415 (18%), Positives = 136/415 (32%), Gaps = 58/415 (13%)

Query: 214 EIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSL 273
           ++P  I   S   ++ L  N L            +L+ + L +   +    +       L
Sbjct: 25  KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82

Query: 274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISV 333
             + L+ N      P SF  L+SLE L+     ++      +    +L +L +  N I  
Sbjct: 83  SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142

Query: 334 FFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLI----SNGI 389
                      +P+  +N  +L  VDLS+N +       L  L+   ++ L      N I
Sbjct: 143 C---------KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI 193

Query: 390 SGLIPPEIGNCSSLIRLRL-----------MSFGNCTQLQMLNLSNNTLGGTL------P 432
              I  +      L  L L               N   L +  L               P
Sbjct: 194 DF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252

Query: 433 SSLASLTRLQV--LDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQ 490
           S +  L  + +    ++           F  LA+++ + L+  S        + +    Q
Sbjct: 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQ 310

Query: 491 SLDLSSNKLSGKIPVELFEIEGLDIS------------------LNLSWNALS--GAIPP 530
           SL +   +L     ++L  ++ L ++                  L+LS NALS  G    
Sbjct: 311 SLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSY 370

Query: 531 QISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS 585
                N L  LDLS N          GL+ L  L+  ++     + +   F  L 
Sbjct: 371 SDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKR-VTEFSAFLSLE 424

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  127 bits (320), Expect = 2e-30
 Identities = 46/252 (18%), Positives = 92/252 (36%), Gaps = 27/252 (10%)

Query: 343 GSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSS 402
           GS+   +    ++         L+  +   +    +   + L  N +  L          
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSY------- 50

Query: 403 LIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQL 462
                  SF N ++LQ L+LS   +      +   L  L  L ++ N      P SF  L
Sbjct: 51  -------SFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103

Query: 463 ASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSG-KIPVELFEIEGLDISLNLSW 521
            SL  L+  +   +      +G+  +L+ L+++ N +   K+P     +  L + ++LS+
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNL-VHVDLSY 162

Query: 522 NALSGAIPPQISALNKLSI----LDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLP 576
           N +       +  L +       LD+S N +      A  G+  L  L +  N  +  + 
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIM 221

Query: 577 DSKLFRQLSATE 588
            +   + L+   
Sbjct: 222 KT-CLQNLAGLH 232

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  120 bits (304), Expect = 2e-28
 Identities = 50/309 (16%), Positives = 92/309 (29%), Gaps = 13/309 (4%)

Query: 28  PQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSS 87
               + E  +               L+ +  + ++G ++      D+    +  ++ +  
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIR 316

Query: 88  NSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLS--GNLPVE 145
             L    P+    L  L+ L L  N+ +  I  +  A   L  L L  N LS  G     
Sbjct: 317 CQL-KQFPTL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYS 371

Query: 146 LGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPAS-LGKLSKLQSL 204
                +L  +    N  I   +       + L  +    + +      S    L KL  L
Sbjct: 372 DLGTNSLRHLDLSFNGAII--MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429

Query: 205 SVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLWQNNFDGAI 263
            +  T    +        + L  L +  N    +           L  + L +   +   
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489

Query: 264 PEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQ 323
                    L+ +++S N         +  L SL  L  S N I  S   +     SL  
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAF 549

Query: 324 LQLDTNQIS 332
             L  N ++
Sbjct: 550 FNLTNNSVA 558

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  215 bits (550), Expect = 3e-61
 Identities = 107/526 (20%), Positives = 186/526 (35%), Gaps = 85/526 (16%)

Query: 48  SNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDL 107
              ++L+   K ++  +N+T  +S    D  Q+TT+      +       +  L NL  +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 73

Query: 108 ILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKI 167
             ++NQLT   P  L    KL ++L+ +N ++      L  L NL  +    N+ I    
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQ-ITDID 128

Query: 168 PYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVD 227
           P                          L  L+ L  L + +  +S      +   + L  
Sbjct: 129 P--------------------------LKNLTNLNRLELSSNTISD--ISALSGLTSLQQ 160

Query: 228 LFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSL 287
           L    N ++   P  L  L  LE++ +  N         +    +L+++  + N  S   
Sbjct: 161 LSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDIT 215

Query: 288 PQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS 347
           P   G L++L+EL L+ N +       L++ T+L  L L  NQIS              +
Sbjct: 216 P--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL------------A 259

Query: 348 TLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR 407
            L+    L  + L  N ++      L  L  LT L L  N +  + P             
Sbjct: 260 PLSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNENQLEDISP------------- 304

Query: 408 LMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNR 467
                N   L  L L  N +  +  S ++SLT+LQ L    N+   +   S   L ++N 
Sbjct: 305 ---ISNLKNLTYLTLYFNNI--SDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINW 357

Query: 468 LILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGA 527
           L    N  S   P  L     +  L L+    +         +   +   N++   ++  
Sbjct: 358 LSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIA-- 413

Query: 528 IPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTG 573
            P  IS     +  D++ N               V++      F+G
Sbjct: 414 -PATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSG 458

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  189 bits (481), Expect = 6e-52
 Identities = 96/395 (24%), Positives = 160/395 (40%), Gaps = 47/395 (11%)

Query: 194 SLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKML 253
           +   L++     +  T ++  +     +  ++  L      +       +  L  L ++ 
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQIN 74

Query: 254 LWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP 313
              N      P  + N   L  I ++ N  +        NL++L  L L NN I+   P 
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP- 129

Query: 314 VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGL 373
            L N T+L +L+L +N IS              S L+   SL+ +   +          L
Sbjct: 130 -LKNLTNLNRLELSSNTISD------------ISALSGLTSLQQLSFGNQVTD---LKPL 173

Query: 374 FQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS--------FGNCTQLQMLNLSNN 425
             L  L +L + SN +S +    +   ++L  L   +         G  T L  L+L+ N
Sbjct: 174 ANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 231

Query: 426 TLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGR 485
            L      +LASLT L  LD++ NQ   L P     L  L  L L  N  S    S L  
Sbjct: 232 QL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAG 285

Query: 486 CESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSH 545
             +L +L+L+ N+L    P+    ++ L   L L +N +S   P  +S+L KL  L   +
Sbjct: 286 LTALTNLELNENQLEDISPIS--NLKNLTY-LTLYFNNISDISP--VSSLTKLQRLFFYN 340

Query: 546 NKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKL 580
           NK+  D+ +L+ L N+  L+  +N  +   P + L
Sbjct: 341 NKVS-DVSSLANLTNINWLSAGHNQISDLTPLANL 374

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  185 bits (471), Expect = 1e-50
 Identities = 98/488 (20%), Positives = 178/488 (36%), Gaps = 82/488 (16%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQD 106
              +  L+ L ++  S + LT  I+P L + T+L  I +++N +     + +  L NL  
Sbjct: 61  IDGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD--ITPLANLTNLTG 116

Query: 107 LILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGK 166
           L L +NQ+T   P  L     L  L L  N +S      L  L +L+ +  G        
Sbjct: 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV----- 167

Query: 167 IPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELV 226
                                  +    L  L+ L+ L + +  +S      +   + L 
Sbjct: 168 -----------------------TDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLE 202

Query: 227 DLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGS 286
            L    N +S   P  LG L  L+++ L  N         + +  +L  +DL+ N  S  
Sbjct: 203 SLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 258

Query: 287 LPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP 346
            P     L+ L EL L  N IS   P  L+  T+L  L+L+ NQ+               
Sbjct: 259 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI------------ 302

Query: 347 STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
           S ++N ++L  + L  N ++      +  L  L +L   +N +S +              
Sbjct: 303 SPISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFYNNKVSDVSS------------ 348

Query: 407 RLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
                 N T +  L+  +N +     + LA+LTR+  L ++   +          ++  N
Sbjct: 349 ----LANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402

Query: 467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSG 526
            +     +     P+++    S    D++ N  S       +      +++       SG
Sbjct: 403 TVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFS-QPVTIGKGTTTFSG 458

Query: 527 AIPPQISA 534
            +   + A
Sbjct: 459 TVTQPLKA 466

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  202 bits (516), Expect = 9e-59
 Identities = 70/296 (23%), Positives = 138/296 (46%), Gaps = 39/296 (13%)

Query: 688 LVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           +  +  +GKG  G+V++   +++  V+A+K L              +  +      F  E
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL-------ILGDSEGETEMIEKFQEFQRE 73

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
           +  + ++ H NIV+  G   N   R++M +++P G L   L ++    ++W ++ R++L 
Sbjct: 74  VFIMSNLNHPNIVKLYGLMHN-PPRMVM-EFVPCGDLYHRLLDKAHP-IKWSVKLRLMLD 130

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-----IADFGLAKLVVEGDFARSSN 861
            A G+ Y+ +   PPIVHRD+++ NI +    E       +ADFGL++  V      S +
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVS 184

Query: 862 TVAGSYGYIAPE--YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
            + G++ ++APE         TEK+D YS+ +++  +LTG+ P D      +  ++ +R+
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244

Query: 920 KRGAIEVLDKSLRARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           +             RP +  +    L+ +     C +  P  RP    +   + E+
Sbjct: 245 E-----------GLRPTIPEDCPPRLRNVIEL--CWSGDPKKRPHFSYIVKELSEL 287

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (504), Expect = 7e-57
 Identities = 81/292 (27%), Positives = 131/292 (44%), Gaps = 34/292 (11%)

Query: 688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           L     +G G  G V+RAE  +G  +AVK L      AE              + F  E+
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAE------------RVNEFLREV 85

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIILG 806
             +  +RH NIV F+G         ++ +Y+  GSL  LLH+      L+   R  +   
Sbjct: 86  AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
            A+G+ YLH+   PPIVHR++K+ N+L+  ++   + DFGL++L        SS + AG+
Sbjct: 146 VAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGT 202

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
             ++APE        EKSDVYS+GV++ E+ T +QP        L+             V
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW-----GNLNPAQV------VAAV 251

Query: 927 LDKSLRARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
             K    R E+   +   +  +     C    P  RP+   +  +++ + + 
Sbjct: 252 GFKCK--RLEIPRNLNPQVAAI--IEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  198 bits (506), Expect = 8e-57
 Identities = 72/332 (21%), Positives = 121/332 (36%), Gaps = 58/332 (17%)

Query: 685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS 744
           L  L    ++G+G  G VY+  + +   +AVK              N        R +F 
Sbjct: 12  LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---------SFAN--------RQNFI 53

Query: 745 AE--IKTLGSIRHKNIVRFLGCCW-----NRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
            E  I  +  + H NI RF+          R   LL+ +Y PNGSL   L        +W
Sbjct: 54  NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDW 110

Query: 798 ELRYRIILGAAQGLAYLHHD------CVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
               R+     +GLAYLH +        P I HRD+ + N+L+  +    I+DFGL+  +
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

Query: 852 VEGDFAR------SSNTVAGSYGYIAPEY-------GYMMKITEKSDVYSYGVVVLEVLT 898
                 R      ++ +  G+  Y+APE               ++ D+Y+ G++  E+  
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

Query: 899 GKQPIDPT-IPEGLHIV--DWVRQKRGAIEVLDKSL--RARPEVEIEEMLQTLGVALL-- 951
               + P        +     V       ++       + RP+        +L V  L  
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290

Query: 952 ----CVNPTPDDRPTMKDVAAMIKEIKQEREE 979
               C +   + R T +     + E+    E 
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMIWER 322

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  193 bits (493), Expect = 9e-56
 Identities = 57/299 (19%), Positives = 117/299 (39%), Gaps = 49/299 (16%)

Query: 688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           L   + + +  SG +++     G  I VK L     +                  F+ E 
Sbjct: 12  LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTR------------KSRDFNEEC 58

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMY--DYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
             L    H N++  LG C +           +MP GSL ++LHE  +  ++     +  L
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A+G+A+LH    P I    + + +++I  +    I+   +        F+  S     
Sbjct: 119 DMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMY 170

Query: 866 SYGYIAPEYGYMMK------ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
           +  ++APE    ++          +D++S+ V++ E++T + P        L  ++   +
Sbjct: 171 APAWVAPE---ALQKKPEDTNRRSADMWSFAVLLWELVTREVPF-----ADLSNMEIGMK 222

Query: 920 KRGAIEVLDKSLRARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
                 V  + L  RP +   I   +  L    +C+N  P  RP    +  ++++++ +
Sbjct: 223 ------VALEGL--RPTIPPGISPHVSKL--MKICMNEDPAKRPKFDMIVPILEKMQDK 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  193 bits (493), Expect = 9e-56
 Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 41/295 (13%)

Query: 688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           L  + ++G G  G VYRA    G+ +AVK          +D   D   I    ++   E 
Sbjct: 9   LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAA-------RHDPDED---ISQTIENVRQEA 57

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
           K    ++H NI+   G C       L+ ++   G L  +L  +R   +  ++     +  
Sbjct: 58  KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQI 114

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY--------IADFGLAKLVVEGDFARS 859
           A+G+ YLH + + PI+HRD+K++NILI  + E          I DFGLA+         +
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----T 170

Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
             + AG+Y ++APE       ++ SDV+SYGV++ E+LTG+ P       G+  +     
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGIDGLAVAYG 225

Query: 920 KRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                 V    L    P     E    L     C NP P  RP+  ++   +  I
Sbjct: 226 ------VAMNKLALPIPS-TCPEPFAKL--MEDCWNPDPHSRPSFTNILDQLTTI 271

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  202 bits (516), Expect = 1e-55
 Identities = 108/556 (19%), Positives = 192/556 (34%), Gaps = 53/556 (9%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
            P NL      + L +S + L    S       +L  +D+S   +      +   L +L 
Sbjct: 22  IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAG 165
            LIL  N +             L+ L+  +  L+      +G L  L+ +    N   + 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSG----EIPPQIGN 221
           K+P    +  +L  + L+  K+       L  L ++  L++ +  LS      I P    
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL-SLDLSLNPMNFIQPGAFK 198

Query: 222 CSELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLWQNNFDG-----AIPEEI-GNCKSLK 274
              L  L L  N  S ++ +  +  L  LE   L    F          +       +L 
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258

Query: 275 TIDLSLN---FFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
             +  L    ++   +   F  L+++    L +  I   +    S       L+L   + 
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKD-FSYNFGWQHLELVNCKF 316

Query: 332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISG 391
             F                  +SL+ +  + N            L +L  L L  NG+S 
Sbjct: 317 GQF-------------PTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLS- 360

Query: 392 LIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQF 451
                 G CS        S    T L+ L+LS N +  T+ S+   L +L+ LD   +  
Sbjct: 361 ----FKGCCS-------QSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNL 408

Query: 452 VGLIPES-FGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFE- 509
             +   S F  L +L  L +S      A         SL+ L ++ N        ++F  
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

Query: 510 IEGLDISLNLSWNALSGAIPPQI-SALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVS 567
           +  L   L+LS   L   + P   ++L+ L +L+++ N+L          L +L  + + 
Sbjct: 469 LRNLTF-LDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH 526

Query: 568 YNNFTGYLPDSKLFRQ 583
            N +    P      +
Sbjct: 527 TNPWDCSCPRIDYLSR 542

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  186 bits (473), Expect = 4e-50
 Identities = 98/531 (18%), Positives = 174/531 (32%), Gaps = 63/531 (11%)

Query: 78  TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNY 137
                +D+S N L      S      LQ L L+  ++         +   L  L+L  N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 138 LSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGK 197
           +          L +L+ +                            +T +A      +G 
Sbjct: 88  IQSLALGAFSGLSSLQKLV-------------------------AVETNLASLENFPIGH 122

Query: 198 LSKLQSLSVYTTML-SGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLW- 255
           L  L+ L+V   ++ S ++P    N + L  L L  N +      +L  L ++  + L  
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 256 --QNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQ-SFGNLSSLEELML------SNNN 306
               N    I         L  + L  NF S ++ +     L+ LE   L      +  N
Sbjct: 183 DLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 307 ISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALT 366
           +       L    +L   +     +  +          I        ++ +  L    + 
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYL-------DDIIDLFNCLTNVSSFSLVSVTIE 295

Query: 367 GSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR-----LMSFGNCTQLQMLN 421
             +    +       L L++         ++ +   L           S  +   L+ L+
Sbjct: 296 -RVKDFSY-NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLD 353

Query: 422 LSNN--TLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAI 479
           LS N  +  G    S    T L+ LD+S N  +  +  +F  L  L  L    ++     
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMS 412

Query: 480 PSS-LGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQI-SAL 535
             S      +L  LD+S           +F   GL     L ++ N+      P I + L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRV-AFNGIF--NGLSSLEVLKMAGNSFQENFLPDIFTEL 469

Query: 536 NKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS 585
             L+ LDLS  +L      A + L +L  LN++ N     +PD  +F +L+
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDG-IFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  158 bits (402), Expect = 6e-41
 Identities = 88/436 (20%), Positives = 143/436 (32%), Gaps = 69/436 (15%)

Query: 185 TKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELG 244
            K+  +LP S       ++L +    L         +  EL  L L   ++         
Sbjct: 20  YKIPDNLPFST------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73

Query: 245 KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSN 304
            L  L  ++L  N              SL+ +       +       G+L +L+EL +++
Sbjct: 74  SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133

Query: 305 NNI-SGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAV----D 359
           N I S  +P   SN T+L  L L +N+I               + L     +  +    D
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI----------YCTDLRVLHQMPLLNLSLD 183

Query: 360 LSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPP-----------------EIGNCSS 402
           LS N +   + PG F+   L KL L +N  S  +                   E  N  +
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242

Query: 403 LIRLRLMSFGNCTQLQMLNLSNNTL---GGTLPSSLASLTRLQVLDISVNQFVGLIPESF 459
           L +    +      L +       L      +      LT +    +       +   S+
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302

Query: 460 -------------------GQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS 500
                               +L SL RL  + N    A   S     SL+ LDLS N LS
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLS 360

Query: 501 GKIPVELFEIEGLDI--SLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG--DLLALS 556
                      G      L+LS+N +   +      L +L  LD  H+ L    +     
Sbjct: 361 -FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 557 GLDNLVSLNVSYNNFT 572
            L NL+ L++S+ +  
Sbjct: 419 SLRNLIYLDISHTHTR 434

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  151 bits (384), Expect = 1e-38
 Identities = 82/422 (19%), Positives = 134/422 (31%), Gaps = 71/422 (16%)

Query: 214 EIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSL 273
           +IP  +       +L L  N L            +L+ + L +            +   L
Sbjct: 21  KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISV 333
            T+ L+ N        +F  LSSL++L+    N++      + +  +L +L +  N I  
Sbjct: 79  STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138

Query: 334 FFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTG-------------------------- 367
           F          +P   +N  +LE +DLS N +                            
Sbjct: 139 F---------KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189

Query: 368 -SLHPGLFQLQNLTKLLLISNGISGLIPP-----------------EIGNCSSLIRLRLM 409
             + PG F+   L KL L +N  S  +                   E  N  +L +    
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 410 SFGNCTQLQMLNLSNNTL---GGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
           +      L +       L      +      LT +    +       +   S+       
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQ 307

Query: 467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIP-VELFEIEGLDISLNLSWNALS 525
            L L    F       L    SL+ L  +SNK       V+L  +E     L+LS N LS
Sbjct: 308 HLELVNCKFGQFPTLKLK---SLKRLTFTSNKGGNAFSEVDLPSLE----FLDLSRNGLS 360

Query: 526 --GAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQ 583
             G           L  LDLS N +        GL+ L  L+  ++N    + +  +F  
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLS 419

Query: 584 LS 585
           L 
Sbjct: 420 LR 421

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  110 bits (277), Expect = 3e-25
 Identities = 47/237 (19%), Positives = 90/237 (37%), Gaps = 26/237 (10%)

Query: 358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQL 417
                      +   L    +   L L  N +  L                 SF +  +L
Sbjct: 12  YQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSY--------------SFFSFPEL 54

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG 477
           Q+L+LS   +      +  SL+ L  L ++ N    L   +F  L+SL +L+  + + + 
Sbjct: 55  QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114

Query: 478 AIPSSLGRCESLQSLDLSSNKL-SGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALN 536
                +G  ++L+ L+++ N + S K+P     +  L   L+LS N +       +  L+
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL-EHLDLSSNKIQSIYCTDLRVLH 173

Query: 537 KLSI----LDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATE 588
           ++ +    LDLS N +      A   +  L  L +  N  +  +      + L+  E
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMK-TCIQGLAGLE 228

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  195 bits (499), Expect = 1e-55
 Identities = 82/382 (21%), Positives = 151/382 (39%), Gaps = 47/382 (12%)

Query: 201 LQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFD 260
             +L+     ++ +I P   + +E +   L +  ++  +     +L+ + K+++      
Sbjct: 2   AATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 261 GAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATS 320
               + I    +L+ ++L+ N  +   P    NL  L  L +  N I+      L N T+
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLT 380
           L +L L+ + IS              S LAN   + +++L  N     L   L  +  L 
Sbjct: 112 LRELYLNEDNISDI------------SPLANLTKMYSLNLGANHNLSDL-SPLSNMTGLN 158

Query: 381 KLLLISNGISGLIPPEIGNCSSLIRLRLMS--------FGNCTQLQMLNLSNNTLGGTLP 432
            L +  + +  + P  I N + L  L L            + T L       N +  T  
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQI--TDI 214

Query: 433 SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSL 492
           + +A++TRL  L I  N+   L P     L+ L  L +  N  S    +++     L+ L
Sbjct: 215 TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKML 270

Query: 493 DLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG 550
           ++ SN++S     ++  +  L    SL L+ N L       I  L  L+ L LS N +  
Sbjct: 271 NVGSNQIS-----DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT- 324

Query: 551 DLLALSGLDNLVSLNVSYNNFT 572
           D+  L+ L  + S + +     
Sbjct: 325 DIRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  181 bits (463), Expect = 9e-51
 Identities = 87/421 (20%), Positives = 155/421 (36%), Gaps = 76/421 (18%)

Query: 80  LTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLS 139
             T+      +          L      +L    +T  +         +  L++    ++
Sbjct: 2   AATLATLPAPI--NQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 140 GNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLS 199
            ++   +  L NLE +   GN+ I    P                          L  L 
Sbjct: 58  -SIQ-GIEYLTNLEYLNLNGNQ-ITDISP--------------------------LSNLV 88

Query: 200 KLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNF 259
           KL +L + T  ++      + N + L +L+L E+++S   P  L  L K+  + L  N+ 
Sbjct: 89  KLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN 144

Query: 260 DGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNAT 319
                  + N   L  + ++ +      P    NL+ L  L L+ N I    P  L++ T
Sbjct: 145 LS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLT 199

Query: 320 SLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNL 379
           SL       NQI+              + +AN   L ++ + +N +T      L  L  L
Sbjct: 200 SLHYFTAYVNQITDI------------TPVANMTRLNSLKIGNNKITDL--SPLANLSQL 245

Query: 380 TKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLT 439
           T L + +N IS +                    + T+L+MLN+ +N +  +  S L +L+
Sbjct: 246 TWLEIGTNQISDINA----------------VKDLTKLKMLNVGSNQI--SDISVLNNLS 287

Query: 440 RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKL 499
           +L  L ++ NQ      E  G L +L  L LS+N  +   P  L     + S D ++  +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345

Query: 500 S 500
            
Sbjct: 346 K 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  178 bits (453), Expect = 2e-49
 Identities = 76/386 (19%), Positives = 144/386 (37%), Gaps = 66/386 (17%)

Query: 171 IGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFL 230
             D    +   L    V   +     +L  +  L V    ++  I   I   + L  L L
Sbjct: 18  DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73

Query: 231 YENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQS 290
             N ++   P  L  L KL  + +  N         + N  +L+ + L+ +  S   P  
Sbjct: 74  NGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP-- 127

Query: 291 FGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLA 350
             NL+ +  L L  N+    + P LSN T L  L +  +++               + +A
Sbjct: 128 LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDV------------TPIA 174

Query: 351 NCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS 410
           N   L ++ L++N +       L  L +L       N I+ + P  + N + L  L++ +
Sbjct: 175 NLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGN 230

Query: 411 --------FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQL 462
                     N +QL  L +  N +  +  +++  LT+L++L++  NQ   +       L
Sbjct: 231 NKITDLSPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISDI--SVLNNL 286

Query: 463 ASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWN 522
           + LN L L+ N         +G   +L +L LS N ++   P                  
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP------------------ 328

Query: 523 ALSGAIPPQISALNKLSILDLSHNKL 548
                    +++L+K+   D ++  +
Sbjct: 329 ---------LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  161 bits (410), Expect = 1e-43
 Identities = 77/381 (20%), Positives = 138/381 (36%), Gaps = 72/381 (18%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQD 106
                 L  + KL+++G  +       +   T L  ++++ N +     S +  L+ L +
Sbjct: 37  VVTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTN 92

Query: 107 LILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGK 166
           L + +N++T      L     L+ L L ++ +S   P  L  L  +  +  G N ++   
Sbjct: 93  LYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL--- 145

Query: 167 IPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELV 226
                                  S  + L  ++ L  L+V  + +   + P I N ++L 
Sbjct: 146 -----------------------SDLSPLSNMTGLNYLTVTESKVKD-VTP-IANLTDLY 180

Query: 227 DLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGS 286
            L L  N +    P  L  L  L     + N      P  + N   L ++ +  N  +  
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL 236

Query: 287 LPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP 346
            P    NLS L  L +  N IS      + + T L  L + +NQI            S  
Sbjct: 237 SP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI------------SDI 280

Query: 347 STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
           S L N   L ++ L++N L       +  L NLT L L  N I+ + P            
Sbjct: 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP------------ 328

Query: 407 RLMSFGNCTQLQMLNLSNNTL 427
                 + +++   + +N  +
Sbjct: 329 ----LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  138 bits (351), Expect = 6e-36
 Identities = 56/286 (19%), Positives = 102/286 (35%), Gaps = 47/286 (16%)

Query: 297 LEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLE 356
              L      I+   P   ++    ++  L    ++               T     S+ 
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD------------VVTQEELESIT 47

Query: 357 AVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQ 416
            + ++   +  S+  G+  L NL  L L  N I+ + P                  N  +
Sbjct: 48  KLVVAGEKVA-SI-QGIEYLTNLEYLNLNGNQITDISP----------------LSNLVK 89

Query: 417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS 476
           L  L +  N +  T  S+L +LT L+ L ++ +    + P     L  +  L L  N   
Sbjct: 90  LTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL 145

Query: 477 GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQISA 534
               S L     L  L ++ +K+    P     I  L    SL+L++N +    P  +++
Sbjct: 146 S-DLSPLSNMTGLNYLTVTESKVKDVTP-----IANLTDLYSLSLNYNQIEDISP--LAS 197

Query: 535 LNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKL 580
           L  L       N++  D+  ++ +  L SL +  N  T   P + L
Sbjct: 198 LTSLHYFTAYVNQIT-DITPVANMTRLNSLKIGNNKITDLSPLANL 242

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  137 bits (347), Expect = 2e-35
 Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 20/285 (7%)

Query: 48  SNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDL 107
           S LS+L  L  L I  + +T      L + T L  + ++ +++     S +  L  +  L
Sbjct: 82  SPLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISD--ISPLANLTKMYSL 137

Query: 108 ILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKI 167
            L +N         L     L  L + ++ +    P  +  L +L  +    N+ I    
Sbjct: 138 NLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ-IEDIS 193

Query: 168 PYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVD 227
           P  +    SL        ++    P  +  +++L SL +    ++   P  + N S+L  
Sbjct: 194 P--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTW 247

Query: 228 LFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSL 287
           L +  N +S      +  L KL+ + +  N         + N   L ++ L+ N      
Sbjct: 248 LEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNED 303

Query: 288 PQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQIS 332
            +  G L++L  L LS N+I+   P  L++ + +         I 
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  192 bits (489), Expect = 5e-55
 Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 49/301 (16%)

Query: 688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +     +G G  G VY+ +  +G+V AVK L  T    +               +F  E+
Sbjct: 26  ITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQ------------QLQAFKNEV 71

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
             L   RH NI+ F+G        ++   +    SL   LH       E +    I    
Sbjct: 72  GVLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHASETK-FEMKKLIDIARQT 129

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
           A+G+ YLH      I+HRD+K+NNI +  +    I DFGLA        +     ++GS 
Sbjct: 130 ARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 868 GYIAPE---YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
            ++APE          + +SDVY++G+V+ E++TG+ P        ++  D +      I
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQI------I 235

Query: 925 EVLDKSLRARPEV---------EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
           E++ +     P++          ++ ++        C+    D+RP+   + A I+E+ +
Sbjct: 236 EMVGRGSL-SPDLSKVRSNCPKRMKRLMAE------CLKKKRDERPSFPRILAEIEELAR 288

Query: 976 E 976
           E
Sbjct: 289 E 289

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  192 bits (490), Expect = 5e-55
 Identities = 72/322 (22%), Positives = 132/322 (40%), Gaps = 50/322 (15%)

Query: 688  LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            +  + VVG+G  G+V +A+    + +A+K++   +                 R +F  E+
Sbjct: 10   IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE----------------RKAFIVEL 52

Query: 748  KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC-LEWELRYRIILG 806
            + L  + H NIV+  G C N    L+M +Y   GSL ++LH                 L 
Sbjct: 53   RQLSRVNHPNIVKLYGACLN-PVCLVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110

Query: 807  AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFARSSNTVAG 865
             +QG+AYLH      ++HRD+K  N+L+        I DFG A  +             G
Sbjct: 111  CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKG 165

Query: 866  SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE 925
            S  ++APE       +EK DV+S+G+++ EV+T ++P      + +    +       + 
Sbjct: 166  SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP-----FDEIGGPAFR-----IMW 215

Query: 926  VLDKSLRARPEV------EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE 979
             +      RP +       IE ++        C +  P  RP+M+++  ++  + +    
Sbjct: 216  AVHNGT--RPPLIKNLPKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267

Query: 980  CMKVDMLPSEGSANGQRENNNS 1001
              +    P + S     +    
Sbjct: 268  ADEPLQYPCQHSLPPGEDGRVE 289

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  201 bits (513), Expect = 9e-54
 Identities = 109/563 (19%), Positives = 198/563 (35%), Gaps = 61/563 (10%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGV-PSSIGKLINLQ 105
           P  L++    ++L++S + +    +       QL  +++ S      +   +   L NL+
Sbjct: 20  PQVLNTT---ERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLR 76

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNL--PVELGKLVNLEVIRAGGNKDI 163
            L L S+++    P        L  L L+   LS  +        L  L  +    N+  
Sbjct: 77  ILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136

Query: 164 AGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLS--KLQSLSVYTTMLSGEIPPQIGN 221
           +  +    G   SL  +  +  ++       L  L    L   S+    L   +    G 
Sbjct: 137 SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK 196

Query: 222 CSE-LVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSL 280
           C     ++ L   D+SG+          ++    + N    +    +     +       
Sbjct: 197 CMNPFRNMVLEILDVSGNG-------WTVDITGNFSNAISKSQAFSLILAHHIMGAGFGF 249

Query: 281 NFFSGSLPQSFGNL--SSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQ 338
           +        +F  L  SS+  L LS+  +      V      L  L L  N+I+      
Sbjct: 250 HNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA--- 306

Query: 339 NKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEI 397
                          +L+ ++LS+N L   L+   F  L  +  + L  N I+ +I  + 
Sbjct: 307 -------DEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIA-IIQDQ- 356

Query: 398 GNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPE 457
                       +F    +LQ L+L +N L     +++  +  +  + +S N+ V L   
Sbjct: 357 ------------TFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKI 399

Query: 458 SFGQLASLNRLILSKNSFSG-AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDIS 516
           +     + N + LS+N      I   L R   LQ L L+ N+ S     +          
Sbjct: 400 NL----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQ 455

Query: 517 LNLSWNALSGAIPPQISA-----LNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNN 570
           L L  N L  A   ++       L+ L +L L+HN L        S L  L  L+++ N 
Sbjct: 456 LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNR 515

Query: 571 FTGYLPDSKLFRQLSATEMAGNQ 593
            T  L  + L   L   +++ NQ
Sbjct: 516 LT-VLSHNDLPANLEILDISRNQ 537

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  168 bits (427), Expect = 6e-43
 Identities = 100/500 (20%), Positives = 176/500 (35%), Gaps = 43/500 (8%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPD--LGDCTQLTTIDVSSNSLVG- 92
            I  +      P     L  L +L +    L+  +  D    +   LT +D+S N +   
Sbjct: 84  KIYFLH-----PDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138

Query: 93  GVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNL 152
            +  S GKL +L+ +  +SNQ+   + +     ++ K L  F   L+ N       +   
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFS--LAANSLYSRVSVDWG 195

Query: 153 EVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLS 212
           + +    N  +  +I    G+  ++ + G     ++ S   SL     +         + 
Sbjct: 196 KCMNPFRNMVL--EILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253

Query: 213 GEIPPQI---GNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGN 269
            +           S +  L L    +     R    L+ L+ + L  N  +    E    
Sbjct: 254 -DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG 312

Query: 270 CKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTN 329
             +L+ ++LS N        +F  L  +  + L  N+I+            L  L L  N
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372

Query: 330 QISVFFAWQN----KLEGSIPSTL-ANCRSLEAVDLSHNALTG-SLHPGLFQLQNLTKLL 383
            ++      +     L G+   TL     +   + LS N L    +   L ++ +L  L+
Sbjct: 373 ALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILI 432

Query: 384 LISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL-----ASL 438
           L  N  S                   +      L+ L L  N L     + L       L
Sbjct: 433 LNQNRFSSCSGD-------------QTPSENPSLEQLFLGENMLQLAWETELCWDVFEGL 479

Query: 439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK 498
           + LQVL ++ N    L P  F  L +L  L L+ N  +    + L    +L+ LD+S N+
Sbjct: 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQ 537

Query: 499 LSGKIPVELFEIEGLDISLN 518
           L    P     +  LDI+ N
Sbjct: 538 LLAPNPDVFVSLSVLDITHN 557

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 95.3 bits (237), Expect = 4e-20
 Identities = 83/458 (18%), Positives = 148/458 (32%), Gaps = 45/458 (9%)

Query: 36  NIQSIELELPFPSNLSSLSF--LQKLIISGSNLTGPIS------------PDLGDCTQLT 81
           ++ S    + +   ++      L+ L +SG+  T  I+              L     + 
Sbjct: 185 SLYSRV-SVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243

Query: 82  TIDVSSNSLVGGVPSSIGKL--INLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLS 139
                 +++     ++   L   +++ L L+   +     +       LK L L  N ++
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303

Query: 140 GNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLS 199
                    L NL+V+    N  +             +  + L    +A     +   L 
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNL-LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362

Query: 200 KLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNF 259
           KLQ+L +    L+      I     + D+FL  N L  +LP+       +        N 
Sbjct: 363 KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKINLTANLIHLSENRLENL 416

Query: 260 DGAIPEEIGNCKSLKTIDLSLNFFSG-SLPQSFGNLSSLEELMLSNNNISGSIPP----- 313
           D      +     L+ + L+ N FS  S  Q+     SLE+L L  N +  +        
Sbjct: 417 DILYF--LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474

Query: 314 VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGL 373
           V    + L  L L+ N ++             P   ++  +L  + L+ N LT  L    
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSL----------PPGVFSHLTALRGLSLNSNRLT-VLSHND 523

Query: 374 FQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS 433
               NL  L +  N +    P    + S L          C     +N  N+T   T+  
Sbjct: 524 L-PANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHT-NVTIAG 581

Query: 434 SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILS 471
             A +  +     S      L  E   +   L  L  S
Sbjct: 582 PPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFS 619

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 80.6 bits (199), Expect = 1e-15
 Identities = 70/409 (17%), Positives = 124/409 (30%), Gaps = 80/409 (19%)

Query: 27  SPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVS 86
                +  +N+   ++          L  LQ L +S + L    S +     ++  ID+ 
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346

Query: 87  SNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVEL 146
            N +      +   L  LQ L L  N LT      +     + ++ L  N          
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGN---------- 391

Query: 147 GKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSV 206
            KLV L  I    N                              +  S  +L  L  L  
Sbjct: 392 -KLVTLPKINLTAN-----------------------------LIHLSENRLENLDILYF 421

Query: 207 YTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPREL-GKLQKLEKMLLWQNNFDGAIPE 265
              +              L  L L +N  S     +   +   LE++ L +N    A   
Sbjct: 422 LLRVPH------------LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWET 469

Query: 266 EI-----GNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATS 320
           E+          L+ + L+ N+ +   P  F +L++L  L L++N ++  +        +
Sbjct: 470 ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSH-NDLPAN 527

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLT 380
           L  L +  NQ+                      SL  +D++HN          F      
Sbjct: 528 LEILDISRNQLLAPNPDV-------------FVSLSVLDITHNKFICECELSTFINWLNH 574

Query: 381 KLLLISNGISGLIP--PEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTL 427
             + I+   + +    P+  +  SL  L          L+ L  S   +
Sbjct: 575 TNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIV 623

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  182 bits (464), Expect = 2e-51
 Identities = 56/303 (18%), Positives = 116/303 (38%), Gaps = 46/303 (15%)

Query: 688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           L    ++GKG  G VY     +GEV A++ +       +               +F  E+
Sbjct: 35  LEIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNED------------QLKAFKREV 80

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
                 RH+N+V F+G C +     ++       +L S++ + +   L+     +I    
Sbjct: 81  MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEI 139

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN---TVA 864
            +G+ YLH      I+H+D+K+ N+      +  I DFGL  +       R  +      
Sbjct: 140 VKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 865 GSYGYIAPE---------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
           G   ++APE             +  ++ SDV++ G +  E+   + P      +      
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-----KTQPAEA 250

Query: 916 WVRQKRGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK 974
                   I  +   ++    ++ + + +  +   L C     ++RPT   +  M++++ 
Sbjct: 251 -------IIWQMGTGMKPNLSQIGMGKEISDI--LLFCWAFEQEERPTFTKLMDMLEKLP 301

Query: 975 QER 977
           +  
Sbjct: 302 KRN 304

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  179 bits (455), Expect = 3e-50
 Identities = 71/306 (23%), Positives = 126/306 (41%), Gaps = 49/306 (16%)

Query: 687 CLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
            L+   V+GKGC G   +    E GEV+ +K+L                     + +F  
Sbjct: 11  DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET--------------QRTFLK 56

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E+K +  + H N+++F+G  +       + +Y+  G+L  ++    DS   W  R     
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAK 115

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA-------- 857
             A G+AYLH      I+HRD+ ++N L+       +ADFGLA+L+V+            
Sbjct: 116 DIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172

Query: 858 ----RSSNTVAGSYGYIAPEYGYMM---KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG 910
               +   TV G+  ++APE   M+      EK DV+S+G+V+ E++         +P  
Sbjct: 173 KPDRKKRYTVVGNPYWMAPE---MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP-- 227

Query: 911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
                  R     + V     R  P            + + C +  P+ RP+   +   +
Sbjct: 228 -------RTMDFGLNVRGFLDRYCPPNCPPSFFP---ITVRCCDLDPEKRPSFVKLEHWL 277

Query: 971 KEIKQE 976
           + ++  
Sbjct: 278 ETLRMH 283

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  182 bits (463), Expect = 9e-50
 Identities = 108/524 (20%), Positives = 174/524 (33%), Gaps = 98/524 (18%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQD 106
           P N+S  +FLQ+ +   SNLT  +  +  +    T    + +      P   G+   +  
Sbjct: 5   PRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 107 LILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGK 166
             L                 +   L L +  LS +LP       +LE + A  N     +
Sbjct: 63  SRLRDCLDR-----------QAHELELNNLGLS-SLPELPP---HLESLVASCNSLT--E 105

Query: 167 IPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELV 226
           +P      +SLLV       ++   P        L+ L V    L  ++P  + N S L 
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLK 156

Query: 227 DLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGS 286
            + +  N L   LP     L+ +       N  +  +PE + N   L  I    N    S
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE-ELPE-LQNLPFLTAIYADNN----S 206

Query: 287 LPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP 346
           L +      SLE ++  NN +     P L N   L  +  D N +            ++P
Sbjct: 207 LKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-----------TLP 253

Query: 347 STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
               +  +L   ++  N LT  L      L  L     I +G+S L P       +L  L
Sbjct: 254 DLPPSLEAL---NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYL 302

Query: 407 RLMS------FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFG 460
              S            L+ LN+SNN L   LP+      RL+ L  S N    +      
Sbjct: 303 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLAEVPEL--- 355

Query: 461 QLASLNRLILSKNSFSGAIPSSLGRCE----------------SLQSLDLSSNKLSGKIP 504
              +L +L +  N      P      E                +L+ L + +N L  + P
Sbjct: 356 -PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFP 412

Query: 505 VELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKL 548
                +E     L ++   +           +KL      H+  
Sbjct: 413 DIPESVE----DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  179 bits (456), Expect = 7e-49
 Identities = 103/522 (19%), Positives = 174/522 (33%), Gaps = 102/522 (19%)

Query: 70  ISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLK 129
           I+P     T L      S++L   +P     + +  +     ++     P   G   ++ 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 130 NLLLFDN--------YLSGN----LPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSL 177
              L D          L+      LP       +LE + A  N     ++P      +SL
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPELPP---HLESLVASCNSLT--ELPELPQSLKSL 116

Query: 178 LVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSG 237
           LV       ++   P        L+ L V    L  ++P  + N S L  + +  N L  
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK- 166

Query: 238 SLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSL 297
            LP     L+ +       N  +  +P E+ N   L  I    N    SL +      SL
Sbjct: 167 KLPDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNN----SLKKLPDLPLSL 217

Query: 298 EELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA 357
           E ++  NN +     P L N   L  +  D N +            ++P    +  +L  
Sbjct: 218 ESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-----------TLPDLPPSLEAL-- 262

Query: 358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQL 417
            ++  N LT  L      L  L     I +G+S L P                      L
Sbjct: 263 -NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP---------------------NL 299

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG 477
             LN S+N +  +L         L+ L++S N+ + L P        L RLI S N  + 
Sbjct: 300 YYLNASSNEI-RSLCD---LPPSLEELNVSNNKLIEL-PALPP---RLERLIASFNHLA- 350

Query: 478 AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNK 537
            +P       +L+ L +  N L  + P     +E L ++ +L+       +P        
Sbjct: 351 EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLA------EVPELPQ---N 397

Query: 538 LSILDLSHNKLGGDLLAL-SGLDNLVSLNVSYNNFTGYLPDS 578
           L  L +  N     L       +++  L ++          +
Sbjct: 398 LKQLHVETNP----LREFPDIPESVEDLRMNSERVVDPYEFA 435

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  159 bits (405), Expect = 4e-42
 Identities = 84/502 (16%), Positives = 168/502 (33%), Gaps = 82/502 (16%)

Query: 31  FVTEINIQSIELELPF---------PSNLSSLSFLQKLIISGSNLTGPISPDLGD----- 76
           F+   N+ +  L+ P          P    ++    +   + S       P  G+     
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 77  --------CTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKL 128
                     Q   +++++  L   +P       +L+ L+ + N LT E+P+   +   L
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSS-LPELPP---HLESLVASCNSLT-ELPELPQSLKSL 116

Query: 129 KNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVA 188
                    LS   P        LE +    N+    K+P E+ +   L ++ + +  + 
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQ--LEKLP-ELQNSSFLKIIDVDNNSLK 166

Query: 189 GSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQK 248
             LP     L   + ++     L  E  P++ N   L  ++   N L   LP     L+ 
Sbjct: 167 -KLPDLPPSL---EFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPLSLES 219

Query: 249 LEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS 308
           +       N  +     E+ N   L TI    N    +LP    +L   E L + +N ++
Sbjct: 220 IV---AGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSL---EALNVRDNYLT 270

Query: 309 GSIPPVLSNATSLLQLQLDTNQISVFF-------AWQNKLEGSIPSTLANCRSLEAVDLS 361
             +P +  + T L   +   + +S          A  N++  S+     +   LE +++S
Sbjct: 271 -DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR-SLCDLPPS---LEELNVS 325

Query: 362 HNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI--RLRLMSF-GNCTQLQ 418
           +N L   L         L +L+   N ++ + P    N   L      L  F      ++
Sbjct: 326 NNKLI-ELPALP---PRLERLIASFNHLAEV-PELPQNLKQLHVEYNPLREFPDIPESVE 380

Query: 419 MLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGA 478
            L ++++     L         L+ L +  N      P+    +  L    ++       
Sbjct: 381 DLRMNSH-----LAEVPELPQNLKQLHVETNPLREF-PDIPESVEDLR---MNSERVVDP 431

Query: 479 IPSSLGRCESLQSLDLSSNKLS 500
              +    + L+      +   
Sbjct: 432 YEFAHETTDKLEDDVFEHHHHH 453

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  176 bits (449), Expect = 2e-49
 Identities = 72/315 (22%), Positives = 112/315 (35%), Gaps = 53/315 (16%)

Query: 688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE- 746
           +     VGKG  G V+R     GE +AVK             +++K        S+  E 
Sbjct: 10  ITLLECVGKGRYGEVWRGSW-QGENVAVKIF---------SSRDEK--------SWFRET 51

Query: 747 -IKTLGSIRHKNIVRFLGCCWNRNTRLLMY----DYMPNGSLGSLLHERRDSCLEWELRY 801
            +     +RH+NI+ F+                  Y   GSL   L       L+     
Sbjct: 52  ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCL 108

Query: 802 RIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           RI+L  A GLA+LH +       P I HRD+K+ NIL+    +  IAD GLA +  +   
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168

Query: 857 AR--SSNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 908
                +N   G+  Y+APE              ++ D++++G+V+ EV            
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

Query: 909 EGLHIVDWVRQKRGAIE----VLDKSLRARPEVEIEEMLQTLGVALL------CVNPTPD 958
                 D V       +    V     + RP +          +  L      C    P 
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVD--QQRPNIP-NRWFSDPTLTSLAKLMKECWYQNPS 285

Query: 959 DRPTMKDVAAMIKEI 973
            R T   +   + +I
Sbjct: 286 ARLTALRIKKTLTKI 300

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  176 bits (449), Expect = 3e-49
 Identities = 52/333 (15%), Positives = 106/333 (31%), Gaps = 28/333 (8%)

Query: 219 IGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDL 278
             + S   +L+   +         L + Q+       + +          N  + +    
Sbjct: 8   HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETR 63

Query: 279 SLNFFSGSLPQSFGNLSS--LEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFA 336
           +      +      + +      L L +  +    P      + L  + +D   +     
Sbjct: 64  TGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM---- 117

Query: 337 WQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPE 396
                   +P T+     LE + L+ N L  +L   +  L  L +L + +      +P  
Sbjct: 118 -------ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169

Query: 397 IGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIP 456
           + +  +              LQ L L    +  +LP+S+A+L  L+ L I  +    L  
Sbjct: 170 LASTDAS-----GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL-G 222

Query: 457 ESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDIS 516
            +   L  L  L L   +     P   G    L+ L L        +P+++  +  L   
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL-EK 281

Query: 517 LNLSWNALSGAIPPQISALNKLSILDLSHNKLG 549
           L+L        +P  I+ L    I+ +  +   
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  171 bits (435), Expect = 2e-47
 Identities = 48/343 (13%), Positives = 96/343 (27%), Gaps = 41/343 (11%)

Query: 189 GSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQK 248
           GS        S  ++L    +         +       +                     
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57

Query: 249 LEKMLLWQNNFDGAIPEEIGNCKS--LKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNN 306
            +           A  + + +        ++L         P     LS L+ + +    
Sbjct: 58  PQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 307 ISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH-NAL 365
           +   +P  +     L  L L  N +            ++P+++A+   L  + +     L
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-----------ALPASIASLNRLRELSIRACPEL 163

Query: 366 T--------GSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLM-------- 409
           T                 L NL  L L   GI  L P  I N  +L  L++         
Sbjct: 164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIRNSPLSALG 222

Query: 410 -SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDIS-VNQFVGLIPESFGQLASLNR 467
            +  +  +L+ L+L   T     P        L+ L +   +  + L P    +L  L +
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL-PLDIHRLTQLEK 281

Query: 468 LILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEI 510
           L L        +PS + +  +   + +  +  +          
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  163 bits (415), Expect = 1e-44
 Identities = 56/274 (20%), Positives = 106/274 (38%), Gaps = 18/274 (6%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQ--LTTIDVSSNSLVGGVPSSIGKLIN 103
                ++ +  Q    +G  L    +  L D TQ     +++ S  L    P    +L +
Sbjct: 48  SAWRQANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSH 105

Query: 104 LQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDI 163
           LQ + +++  L  E+P  +     L+ L L  N L   LP  +  L  L  +      ++
Sbjct: 106 LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163

Query: 164 AGKIPYEIGDCQSLLVVG---------LADTKVAGSLPASLGKLSKLQSLSVYTTMLSGE 214
             ++P  +    +              L  T +  SLPAS+  L  L+SL +  + LS  
Sbjct: 164 -TELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220

Query: 215 IPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLK 274
           + P I +  +L +L L       + P   G    L++++L   +    +P +I     L+
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE 280

Query: 275 TIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS 308
            +DL        LP     L +   +++  +  +
Sbjct: 281 KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  143 bits (364), Expect = 6e-38
 Identities = 54/300 (18%), Positives = 107/300 (35%), Gaps = 21/300 (7%)

Query: 3   SIPSALSNW----NPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQK 58
                LS W    N   +          S    +     ++++       + +       
Sbjct: 27  PYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPG-RVA 85

Query: 59  LIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEI 118
           L +    L           + L  + + +  L+  +P ++ +   L+ L L  N L   +
Sbjct: 86  LELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-AL 142

Query: 119 PKELGACIKLKNLLLFDNYLSGNLPVELGK---------LVNLEVIRAGGNKDIAGKIPY 169
           P  + +  +L+ L +        LP  L           LVNL+ +R      I   +P 
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTG-IR-SLPA 200

Query: 170 EIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLF 229
            I + Q+L  + + ++ ++ +L  ++  L KL+ L +         PP  G  + L  L 
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259

Query: 230 LYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQ 289
           L +     +LP ++ +L +LEK+ L        +P  I    +   I +  +     L Q
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  133 bits (336), Expect = 3e-34
 Identities = 46/280 (16%), Positives = 86/280 (30%), Gaps = 43/280 (15%)

Query: 309 GSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS 368
           GS      +++    L                L       L+  +     D +       
Sbjct: 2   GSSHHHHHHSSGRENLYF---------QGSTALR-PYHDVLSQWQRHYNADRNRWHS--- 48

Query: 369 LHPGLFQLQNLTKLLLISNGISGL--IPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNT 426
                ++  N     + +     L      + + +                  L L +  
Sbjct: 49  ----AWRQANSNNPQIETRTGRALKATADLLEDATQP------------GRVALELRSVP 92

Query: 427 LGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRC 486
           L    P     L+ LQ + I     + L P++  Q A L  L L++N    A+P+S+   
Sbjct: 93  LP-QFPDQAFRLSHLQHMTIDAAGLMEL-PDTMQQFAGLETLTLARNPLR-ALPASIASL 149

Query: 487 ESLQSLDLSSNKLSGKIPVELFEIEGLDI--------SLNLSWNALSGAIPPQISALNKL 538
             L+ L + +     ++P  L   +            SL L W  +  ++P  I+ L  L
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208

Query: 539 SILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDS 578
             L + ++ L     A+  L  L  L++         P  
Sbjct: 209 KSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPI 248

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  181 bits (460), Expect = 1e-48
 Identities = 97/531 (18%), Positives = 183/531 (34%), Gaps = 46/531 (8%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
            PS L++   ++ L +S + +T     DL  C  L  + + S+ +      +   L +L+
Sbjct: 20  IPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE 77

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSG-NLPVELGKLVNLEVIRAGGNKDIA 164
            L L+ N L+       G    LK L L  N      +      L NL+ +R G  +  +
Sbjct: 78  HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137

Query: 165 GKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSE 224
                +     SL  + +    +      SL  +  +  L+++ +  +  +       S 
Sbjct: 138 EIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197

Query: 225 LVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFS 284
           +  L L + +L+      L   +    M            E       L    L L+   
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV- 256

Query: 285 GSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGS 344
                 F + +       + +        V+S    +  + +    I      Q  L   
Sbjct: 257 -----EFDDCTLNGLGDFNPSESD-----VVSELGKVETVTIRRLHIP-----QFYLFYD 301

Query: 345 IPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSSL 403
           + +  +    ++ + + ++ +   +     Q L++L  L L  N +              
Sbjct: 302 LSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKN------- 353

Query: 404 IRLRLMSFGNCTQLQMLNLSNNTLG--GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQ 461
                   G    LQ L LS N L         L +L  L  LDIS N F   +P+S   
Sbjct: 354 ----SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQW 408

Query: 462 LASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSW 521
              +  L LS       + + + +  +L+ LD+S+N L     + L  ++     L +S 
Sbjct: 409 PEKMRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLD-SFSLFLPRLQ----ELYISR 460

Query: 522 NALSGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNF 571
           N L   +P   S    L ++ +S N+L          L +L  + +  N +
Sbjct: 461 NKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  174 bits (443), Expect = 3e-46
 Identities = 93/505 (18%), Positives = 162/505 (32%), Gaps = 73/505 (14%)

Query: 77  CTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDN 136
           C      D  S S    +PS +     ++ L L+ N++T     +L AC  L+ L+L  +
Sbjct: 4   CDASGVCDGRSRSFTS-IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60

Query: 137 YLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLG 196
            ++                           I                          +  
Sbjct: 61  RIN--------------------------TIE-----------------------GDAFY 71

Query: 197 KLSKLQSLSVYTTMLSGEIPPQ-IGNCSELVDLFLYENDLSG-SLPRELGKLQKLEKMLL 254
            L  L+ L +    LS  +     G  S L  L L  N      +      L  L+ + +
Sbjct: 72  SLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130

Query: 255 WQNNFDGAIPEE-IGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP 313
                   I         SL  +++          QS  ++  +  L L  +  +  +  
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190

Query: 314 VLSNATSLLQLQLDTNQISVFFAWQ-NKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPG 372
                +S+  L+L    ++ F        E S P      R     D S N L   L   
Sbjct: 191 FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL-KLLRY 249

Query: 373 LFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP 432
           + +L  +       NG+    P E    S L ++          ++ L++    L   L 
Sbjct: 250 ILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET------VTIRRLHIPQFYLFYDLS 303

Query: 433 SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAI---PSSLGRCESL 489
           +  + L +++ + +  ++   +       L SL  L LS+N          +  G   SL
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363

Query: 490 QSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQISALNKLSILDLSHNK 547
           Q+L LS N L   +      +  L    SL++S N     +P       K+  L+LS   
Sbjct: 364 QTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421

Query: 548 LGGDLLALSGLDNLVSLNVSYNNFT 572
           +   ++       L  L+VS NN  
Sbjct: 422 I--RVVKTCIPQTLEVLDVSNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  165 bits (420), Expect = 2e-43
 Identities = 88/494 (17%), Positives = 159/494 (32%), Gaps = 51/494 (10%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPD-LGDCTQLTTIDVSSNSLVGGV 94
            I  I        +L + + LQ LI+  S +   I  D       L  +D+S N L    
Sbjct: 37  KITYIG-----HGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHLSSLS 90

Query: 95  PSSIGKLINLQDLILNSNQLTG-EIPKELGACIKLKNLLLFDNYLSGNLPVE-LGKLVNL 152
            S  G L +L+ L L  N      +         L+ L + +      +       L +L
Sbjct: 91  SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150

Query: 153 EVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLS 212
             +       +       +   + +  + L  ++ A  L      LS ++ L +  T L+
Sbjct: 151 NELEIKALS-LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA 209

Query: 213 GEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLL-----------------W 255
                 +        +       S        +L KL + +L                 +
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269

Query: 256 QNNFDGAIPEEIG-NCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPV 314
             +    + E       +++ + +   +    L   +  L  ++ + + N+ +       
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329

Query: 315 LSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTG-SLHPGL 373
             +  SL  L L  N +        +      +      SL+ + LS N L        +
Sbjct: 330 SQHLKSLEFLDLSENLMV-------EEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382

Query: 374 F-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL-------MSFGNCTQLQMLNLSNN 425
              L+NLT L +  N     +P        +  L L       +       L++L++SNN
Sbjct: 383 LLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNN 441

Query: 426 TLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGR 485
            L  +    L    RLQ L IS N+   L   S      L  + +S+N           R
Sbjct: 442 NLD-SFSLFL---PRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDR 495

Query: 486 CESLQSLDLSSNKL 499
             SLQ + L +N  
Sbjct: 496 LTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  162 bits (413), Expect = 2e-42
 Identities = 72/429 (16%), Positives = 146/429 (34%), Gaps = 30/429 (6%)

Query: 190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQ-IGNCSELVDLFLYENDLSGSLPRELGKLQK 248
           S+P+ L   + ++SL +    ++  I    +  C+ L  L L  + ++         L  
Sbjct: 19  SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75

Query: 249 LEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSG-SLPQSFGNLSSLEELMLSNNNI 307
           LE + L  N+         G   SLK ++L  N +    +   F NL++L+ L + N   
Sbjct: 76  LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135

Query: 308 SGSIPP-VLSNATSLLQLQLDTNQISVF----FAW----------QNKLEGSIPSTLANC 352
              I     +  TSL +L++    +  +                  ++    +       
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195

Query: 353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR----LRL 408
            S+  ++L    L       L   +  + +  ++   S L          L+R    L  
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255

Query: 409 MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRL 468
           + F +CT   + + + +               ++ L I        +   +  L  + R+
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315

Query: 469 ILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALS- 525
            +  +       S     +SL+ LDLS N +  +               +L LS N L  
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375

Query: 526 -GAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQL 584
                  +  L  L+ LD+S N       +    + +  LN+S       +  + + + L
Sbjct: 376 MQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVK-TCIPQTL 433

Query: 585 SATEMAGNQ 593
              +++ N 
Sbjct: 434 EVLDVSNNN 442

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  139 bits (353), Expect = 8e-35
 Identities = 62/399 (15%), Positives = 126/399 (31%), Gaps = 48/399 (12%)

Query: 221 NCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSL 280
           +C             + S+P  L     ++ + L  N        ++  C +L+ + L  
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 281 NFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISVFFAWQN 339
           +  +     +F +L SLE L LS+N++S S+        +SL  L L  N          
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTL----- 113

Query: 340 KLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIG 398
                + S   N  +L+ + + +      +    F  L +L +L + +  +       + 
Sbjct: 114 ----GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLK 169

Query: 399 NCSSLIRLRL----------MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISV 448
           +   +  L L          +     + ++ L L +  L     S L        +    
Sbjct: 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229

Query: 449 NQFVGLIPESFGQLASLNRLI------------------LSKNSFSGAIPSSLGRCESLQ 490
            +   L  ESF +L  L R I                   + +              +++
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289

Query: 491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLG- 549
            L +    L   +      +E +   + +  + +          L  L  LDLS N +  
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKR-ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVE 348

Query: 550 ---GDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS 585
               +        +L +L +S N+        ++   L 
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  139 bits (351), Expect = 1e-34
 Identities = 67/433 (15%), Positives = 135/433 (31%), Gaps = 57/433 (13%)

Query: 43  ELPFPSNLSSLSFLQKLIISGSNLTGPISP-DLGDCTQLTTIDVSSNSLVGGVPSSIGKL 101
            L   S   +L+ LQ L I        I   D    T L  +++ + SL      S+  +
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171

Query: 102 INLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK 161
            ++  L L+ ++    +         ++ L L D  L+      L        ++    +
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231

Query: 162 DIA---------GKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLS 212
                        K+   I +   +         +    P+    +S+L  +        
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV-------- 283

Query: 213 GEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKS 272
                       +  L + +  L   L      L+K++++ +  +           + KS
Sbjct: 284 --------ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS 335

Query: 273 LKTIDLSLNFFSGSLPQS---FGNLSSLEELMLSNNNIS--GSIPPVLSNATSLLQLQLD 327
           L+ +DLS N       ++    G   SL+ L+LS N++        +L    +L  L + 
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDIS 395

Query: 328 TNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISN 387
            N               +P +      +  ++LS   +   +   + Q   L  L + +N
Sbjct: 396 RNTFH-----------PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNN 441

Query: 388 GISGLIPPEIGNCSSLIRLRLM--------SFGNCTQLQMLNLSNNTLGGTLPSSLASLT 439
            +             L  L +                L ++ +S N L          LT
Sbjct: 442 NLDSFSL----FLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLT 497

Query: 440 RLQVLDISVNQFV 452
            LQ + +  N + 
Sbjct: 498 SLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 76.3 bits (188), Expect = 2e-14
 Identities = 56/303 (18%), Positives = 103/303 (33%), Gaps = 62/303 (20%)

Query: 8   LSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLT 67
           L ++NPS+S+    S +       +  ++I    L     +  S L  ++++ +  S + 
Sbjct: 266 LGDFNPSESD--VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323

Query: 68  GPISPDLGDCTQLTTIDVSSNSLVGGV---PSSIGKLINLQDLILNSNQLTGEIPKELGA 124
                       L  +D+S N +V       +  G   +LQ L+L+ N L   + K    
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEI 382

Query: 125 CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLAD 184
            + LKNL   D  +S N                                           
Sbjct: 383 LLTLKNLTSLD--ISRN---------TFH------------------------------- 400

Query: 185 TKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELG 244
                 +P S     K++ L++ +T +   +         L  L +  N+L  S    L 
Sbjct: 401 -----PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLD-SFSLFLP 451

Query: 245 KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSN 304
           +LQ+L    + +N     +P+       L  + +S N         F  L+SL+++ L  
Sbjct: 452 RLQEL---YISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506

Query: 305 NNI 307
           N  
Sbjct: 507 NPW 509

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  174 bits (442), Expect = 4e-48
 Identities = 69/315 (21%), Positives = 114/315 (36%), Gaps = 43/315 (13%)

Query: 688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +     +GKG  G V+  +   GE +AVK  + T  A+ +                  EI
Sbjct: 39  IQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWF---------------RETEI 82

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTR----LLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
                +RH+NI+ F+              L+ DY  NGSL   L       L+ +   ++
Sbjct: 83  YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKL 139

Query: 804 ILGAAQGLAYLH-----HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG--DF 856
              +  GL +LH         P I HRD+K+ NIL+       IAD GLA   +    + 
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 857 ARSSNTVAGSYGYIAPE--YGYMMKI----TEKSDVYSYGVVVLEVLTGKQPIDPTIPEG 910
               NT  G+  Y+ PE     + +        +D+YS+G+++ EV              
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

Query: 911 LHIVDWVRQKRGAIEVLDK--SLRARPEVEIEEMLQTLGVALL-----CVNPTPDDRPTM 963
           L   D V       ++ +     + RP              +      C    P  R T 
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

Query: 964 KDVAAMIKEIKQERE 978
             V   + ++ + ++
Sbjct: 320 LRVKKTLAKMSESQD 334

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  172 bits (438), Expect = 1e-47
 Identities = 73/319 (22%), Positives = 117/319 (36%), Gaps = 43/319 (13%)

Query: 682 EQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
             + + +V    +GKG  G V+R +   GE +AVK        + +              
Sbjct: 38  RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-------------- 82

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTR----LLMYDYMPNGSLGSLLHERRDSCLEW 797
              AEI     +RH+NI+ F+      N       L+ DY  +GSL   L+      +  
Sbjct: 83  -REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTV 138

Query: 798 ELRYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
           E   ++ L  A GLA+LH + V     P I HRD+K+ NIL+       IAD GLA    
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198

Query: 853 EG--DFARSSNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
                   + N   G+  Y+APE           +  +++D+Y+ G+V  E+        
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258

Query: 905 PTIPEGLHIVDWVRQKRGAIEVLDK--SLRARPEVEIEEMLQTLGVALL-----CVNPTP 957
                 L   D V       E+       + RP +            +      C     
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 318

Query: 958 DDRPTMKDVAAMIKEIKQE 976
             R T   +   + ++ Q+
Sbjct: 319 AARLTALRIKKTLSQLSQQ 337

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  172 bits (439), Expect = 3e-47
 Identities = 73/391 (18%), Positives = 142/391 (36%), Gaps = 35/391 (8%)

Query: 215 IPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLK 274
           I   +       D+ +           E   L   + +    +         + + + ++
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 275 TIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISV 333
            ++L+          +F    ++++L +  N I   +PP V  N   L  L L+ N +S 
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS- 130

Query: 334 FFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISG 391
                     S+P     N   L  + +S+N L   +    FQ   +L  L L SN ++ 
Sbjct: 131 ----------SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH 179

Query: 392 LIPPEIGNCSSLIRL-----RLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDI 446
           +   ++    SL         L +      ++ L+ S+N++   +   +     L +L +
Sbjct: 180 V---DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKL 233

Query: 447 SVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVE 506
             N               L  + LS N     +     + + L+ L +S+N+L   + + 
Sbjct: 234 QHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY 290

Query: 507 LFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNV 566
              I  L + L+LS N L   +       ++L  L L HN +    L LS    L +L +
Sbjct: 291 GQPIPTLKV-LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVT--LKLSTHHTLKNLTL 346

Query: 567 SYNNFTGYLPDSKLFRQLSATEMAGNQGLCS 597
           S+N++        LFR ++   +      C 
Sbjct: 347 SHNDWD-CNSLRALFRNVARPAVDDADQHCK 376

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  124 bits (314), Expect = 1e-30
 Identities = 56/293 (19%), Positives = 99/293 (33%), Gaps = 49/293 (16%)

Query: 310 SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSL 369
            I   L        + +D     V+F +++              + + V   ++ +   L
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFED----------ITLNNQKIVTFKNSTMR-KL 60

Query: 370 HPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG 428
              L    + +  L L    I   I                 F     +Q L +  N + 
Sbjct: 61  PAALLDSFRQVELLNLNDLQIEE-IDTYA-------------FAYAHTIQKLYMGFNAIR 106

Query: 429 GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCES 488
              P    ++  L VL +  N    L    F     L  L +S N+       +     S
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 166

Query: 489 LQSLDLSSNKLSGKIPVELFE-IEGLDIS---------------LNLSWNALSGAIPPQI 532
           LQ+L LSSN+L+  + + L   +   ++S               L+ S N+++  +    
Sbjct: 167 LQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG-- 222

Query: 533 SALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS 585
               +L+IL L HN L  D   L     LV +++SYN     +     F ++ 
Sbjct: 223 PVNVELTILKLQHNNL-TDTAWLLNYPGLVEVDLSYNELE-KIMYH-PFVKMQ 272

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  114 bits (287), Expect = 2e-27
 Identities = 69/439 (15%), Positives = 128/439 (29%), Gaps = 109/439 (24%)

Query: 23  HITCSPQN------FVTEINIQSIEL------ELPFPSNLSSLSFLQKLIISGSNLTGPI 70
           HI    Q+       +T  N + +        +LP  + L S   ++ L ++   +   I
Sbjct: 27  HIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP-AALLDSFRQVELLNLNDLQIEE-I 84

Query: 71  SPD-LGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLK 129
                     +  + +  N++    P     +  L  L+L  N L+  +P+ +       
Sbjct: 85  DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGI------- 136

Query: 130 NLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG 189
                                 L  +    N  +  +I                      
Sbjct: 137 ----------------FHNTPKLTTLSMSNNN-LE-RIE--------------------- 157

Query: 190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKL 249
               +    + LQ+L + +  L+  +         L    +  N LS      L     +
Sbjct: 158 --DDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAV 207

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
           E++    N+ +  +   +     L  + L  N  +        N   L E+ LS N +  
Sbjct: 208 EELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE- 261

Query: 310 SIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS 368
            I          L +L +  N++            ++        +L+ +DLSHN L   
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLV-----------ALNLYGQPIPTLKVLDLSHNHLL-H 309

Query: 369 LHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG 428
           +     Q   L  L L  N I  L                        L+ L LS+N   
Sbjct: 310 VERNQPQFDRLENLYLDHNSIVTL-----------------KLSTHHTLKNLTLSHNDWD 352

Query: 429 GT-LPSSLASLTRLQVLDI 446
              L +   ++ R  V D 
Sbjct: 353 CNSLRALFRNVARPAVDDA 371

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  169 bits (429), Expect = 3e-44
 Identities = 75/412 (18%), Positives = 147/412 (35%), Gaps = 36/412 (8%)

Query: 198 LSKLQSLSVYTTMLS-GEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQ 256
           +   Q  +V         I   +       D+ +           E   L   + +    
Sbjct: 1   VGGQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKN 60

Query: 257 NNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VL 315
           +         + + + ++ ++L+          +F    ++++L +  N I   +PP V 
Sbjct: 61  STMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVF 119

Query: 316 SNATSLLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLF 374
            N   L  L L+ N +S           S+P     N   L  + +S+N L   +    F
Sbjct: 120 QNVPLLTVLVLERNDLS-----------SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 167

Query: 375 Q-LQNLTKLLLISNGISGLIPPEIGNCSSLIRL-----RLMSFGNCTQLQMLNLSNNTLG 428
           Q   +L  L L SN ++ +   ++    SL         L +      ++ L+ S+N++ 
Sbjct: 168 QATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSI- 223

Query: 429 GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCES 488
             +   +     L +L +  N               L  + LS N     +     + + 
Sbjct: 224 NVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 279

Query: 489 LQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKL 548
           L+ L +S+N+L   + +    I  L + L+LS N L   +       ++L  L L HN +
Sbjct: 280 LERLYISNNRLV-ALNLYGQPIPTLKV-LDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 336

Query: 549 GGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGH 600
               L LS    L +L +S+N++        LFR ++   +      C   +
Sbjct: 337 VT--LKLSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHCKIDY 385

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  120 bits (301), Expect = 4e-28
 Identities = 89/571 (15%), Positives = 164/571 (28%), Gaps = 124/571 (21%)

Query: 2   SSIPSALSNWNPSDSNPCKWSHITCSPQN------FVTEINIQSIEL------ELPFPSN 49
             I S L              HI    Q+       +T  N + +        +LP  + 
Sbjct: 17  KCIDSNLQYDCVFYDV-----HIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP-AAL 70

Query: 50  LSSLSFLQKLIISGSNLTGPISPD-LGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLI 108
           L S   ++ L ++   +   I          +  + +  N++    P     +  L  L+
Sbjct: 71  LDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129

Query: 109 LNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIP 168
           L  N L+  +P+ +                             L  +    N  +  +I 
Sbjct: 130 LERNDLS-SLPRGI-----------------------FHNTPKLTTLSMSNNN-LE-RIE 163

Query: 169 YEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDL 228
                                    +    + LQ+L + +  L+  +         L   
Sbjct: 164 -----------------------DDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHA 197

Query: 229 FLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLP 288
            +  N LS      L     +E++    N+ +  +   +     L  + L  N  +    
Sbjct: 198 NVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA 248

Query: 289 QSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS 347
               N   L E+ LS N +   I          L +L +  N++            ++  
Sbjct: 249 -WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-----------ALNL 295

Query: 348 TLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR 407
                 +L+ +DLSHN L   +     Q   L  L L  N I  L               
Sbjct: 296 YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL--------------- 339

Query: 408 LMSFGNCTQLQMLNLSNNTLGGT-LPSSLASLTRLQVLDISVNQFVGLI-------PESF 459
                    L+ L LS+N      L +   ++ R  V D   +  +           ES 
Sbjct: 340 --KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESD 397

Query: 460 GQLASLNRLILSKNSFSGAIPSSLGRCESLQ---SLDLSSNKLSGKIPVELFEIEGLDIS 516
                     ++  S    +  + GRC +     S+   S+ ++ +  V L   E L+  
Sbjct: 398 KPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAE 457

Query: 517 LNLSWNALSGAIPPQISALNKLSILDLSHNK 547
           +N     +      QI     L  L    + 
Sbjct: 458 VNELRAEVQQLTNEQIQQEQLLQGLHAEIDT 488

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  161 bits (410), Expect = 4e-44
 Identities = 64/312 (20%), Positives = 108/312 (34%), Gaps = 40/312 (12%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSL 321
           AI E   N    K   ++ +    +L     +  +++EL LS N +S      L+  T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 322 LQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTK 381
             L L +N +                 L +  +L  +DL++N +       L    ++  
Sbjct: 61  ELLNLSSNVLY-----------ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIET 103

Query: 382 LLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRL 441
           L   +N IS  +    G                   + + L+NN +           +R+
Sbjct: 104 LHAANNNISR-VSCSRG----------------QGKKNIYLANNKITMLRDLDEGCRSRV 146

Query: 442 QVLDISVNQFVGL-IPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS 500
           Q LD+ +N+   +   E      +L  L L  N     +   +     L++LDLSSNKL+
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA 204

Query: 501 GKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDN 560
             +  E     G+   ++L  N L   I   +     L   DL  N      L      N
Sbjct: 205 -FMGPEFQSAAGV-TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261

Query: 561 LVSLNVSYNNFT 572
                V+     
Sbjct: 262 QRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  155 bits (395), Expect = 4e-42
 Identities = 59/336 (17%), Positives = 113/336 (33%), Gaps = 42/336 (12%)

Query: 238 SLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSL 297
           ++        + +   +  ++   A+     +  ++K +DLS N  S          + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 298 EELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA 357
           E L LS+N +       L + ++L  L L+ N +                 L    S+E 
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV---------------QELLVGPSIET 103

Query: 358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL--------- 408
           +  ++N ++  +       Q    + L +N I+ L   + G  S +  L L         
Sbjct: 104 LHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160

Query: 409 --MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
                 +   L+ LNL  N +   +        +L+ LD+S N+    +   F   A + 
Sbjct: 161 FAELAASSDTLEHLNLQYNFI-YDVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVT 217

Query: 467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELF----EIEGLDISLN--LS 520
            + L  N     I  +L   ++L+  DL  N        + F     ++ +       L+
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276

Query: 521 WNALSGAIPPQISALNKLSILDLSHNKLGGDLLALS 556
                    P +         DL        L+AL 
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAP-FADRLIALG 311

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  119 bits (301), Expect = 1e-29
 Identities = 60/410 (14%), Positives = 110/410 (26%), Gaps = 96/410 (23%)

Query: 93  GVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNL 152
            +          +   +  + L   +     +   +K L L  N LS     +L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 153 EVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLS 212
           E++    N                                        L           
Sbjct: 61  ELLNLSSN---------------------------------------VLYET-------- 73

Query: 213 GEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKS 272
                 + + S L  L L  N +      EL     +E +    NN    +    G  + 
Sbjct: 74  ----LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRG--QG 121

Query: 273 LKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG-SIPPVLSNATSLLQLQLDTNQI 331
            K I L+ N  +       G  S ++ L L  N I   +   + +++ +L  L L  N I
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

Query: 332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISG 391
                        +         L+ +DLS N L   + P       +T + L +N +  
Sbjct: 182 Y-----------DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228

Query: 392 LIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTL-GGTLPSSLASLTRLQVLDISVNQ 450
            I                       L+  +L  N    GTL    +   R+Q +     +
Sbjct: 229 -IEKA--------------LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

Query: 451 FVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS 500
               +     +  ++  L          +P+        + + L  +   
Sbjct: 274 ---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFA----DRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  118 bits (299), Expect = 2e-29
 Identities = 56/339 (16%), Positives = 113/339 (33%), Gaps = 48/339 (14%)

Query: 52  SLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNS 111
           + +  +   ++ S+L   ++        +  +D+S N L     + +     L+ L L+S
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 112 NQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEI 171
           N L  E   +L +   L+ L      L+ N   EL    ++E + A  N           
Sbjct: 68  NVLY-ETL-DLESLSTLRTL-----DLNNNYVQELLVGPSIETLHAANNN---------- 110

Query: 172 GDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLY 231
                              +  S       +++ +    ++       G  S +  L L 
Sbjct: 111 ----------------ISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK 152

Query: 232 ENDLSG-SLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQS 290
            N++   +          LE + L  N     +  ++     LKT+DLS N  +  +   
Sbjct: 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPE 209

Query: 291 FGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQIS-----VFFAWQNKLEGSI 345
           F + + +  + L NN +   I   L  + +L    L  N         FF+   +++   
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268

Query: 346 PSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLL 384
             T+         + +   L    H G +  ++L     
Sbjct: 269 KQTVKKLTGQNEEECTVPTL---GHYGAYCCEDLPAPFA 304

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 25/124 (20%), Positives = 47/124 (37%), Gaps = 5/124 (4%)

Query: 43  ELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLI 102
            + F    +S   L+ L +  + +   +   +    +L T+D+SSN L   +        
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAA 214

Query: 103 NLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLS-GNLPVELGKLVNLEVIRAGGNK 161
            +  + L +N+L   I K L     L++  L  N    G L     K   ++ +     K
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

Query: 162 DIAG 165
            + G
Sbjct: 274 KLTG 277

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  164 bits (416), Expect = 3e-43
 Identities = 56/346 (16%), Positives = 113/346 (32%), Gaps = 39/346 (11%)

Query: 238 SLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSL 297
           ++        + +   +  ++   A+     +  ++K +DLS N  S          + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 298 EELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA 357
           E L LS+N +       L + ++L  L L+ N +                 L    S+E 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV---------------QELLVGPSIET 103

Query: 358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL--------- 408
           +  ++N ++  +       Q    + L +N I+ L   + G  S +  L L         
Sbjct: 104 LHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160

Query: 409 --MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
                 +   L+ LNL  N +   +        +L+ LD+S N+    +   F   A + 
Sbjct: 161 FAELAASSDTLEHLNLQYNFI-YDVKGQ-VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVT 217

Query: 467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSG 526
            + L  N     I  +L   ++L+  DL  N        + F          ++   +  
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF--SKNQRVQTVAKQTVKK 274

Query: 527 AIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT 572
                       ++          + L     D L++L    +   
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCC--EDLPAPFADRLIALKRKEHALL 318

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  158 bits (402), Expect = 2e-41
 Identities = 76/516 (14%), Positives = 156/516 (30%), Gaps = 69/516 (13%)

Query: 75  GDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLF 134
            +  +     V+ +SL   + S      N+++L L+ N L+     +L    KL+ L L 
Sbjct: 7   QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 135 DNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPAS 194
            N L      +L  L  L  +    N                                  
Sbjct: 67  SNVLY-ETL-DLESLSTLRTLDLNNNY------------------------------VQE 94

Query: 195 LGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLL 254
           L     +++L      +S  +    G      +++L  N ++     + G   +++ + L
Sbjct: 95  LLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151

Query: 255 WQNNFDG-AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP 313
             N  D     E   +  +L+ ++L  NF    +       + L+ L LS+N ++  + P
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGP 208

Query: 314 VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGL 373
              +A  +  + L  N++             I   L   ++LE  DL  N          
Sbjct: 209 EFQSAAGVTWISLRNNKLV-----------LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257

Query: 374 FQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS----------FGNCTQLQMLNLS 423
           F  +N     +    +  L       C+        +                L+    +
Sbjct: 258 F-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHA 316

Query: 424 NNTLGG----TLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAI 479
             +  G     L     +  R + +D    Q+  +I +   +  +   L   K +    +
Sbjct: 317 LLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376

Query: 480 PSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLS 539
            +       L      +     ++     E   L +   +        +  Q    N + 
Sbjct: 377 SNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIR 435

Query: 540 ILDLSHNKLG---GDLLALSGLDNLVSLNVSYNNFT 572
             D+  +K      +   L  L+    L ++  N T
Sbjct: 436 DWDMYQHKETQLAEENARLKKLNGEADLALASANAT 471

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  154 bits (390), Expect = 7e-40
 Identities = 57/406 (14%), Positives = 125/406 (30%), Gaps = 42/406 (10%)

Query: 171 IGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFL 230
             +     +  + D+ +  +L +       ++ L +    LS      +   ++L  L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 231 YENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQS 290
             N L      +L  L  L  + L  N       +E+    S++T+  + N  S  +   
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS-- 115

Query: 291 FGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLA 350
                  + + L+NN I+          + +  L L  N+I            +     A
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV---------NFAELAA 166

Query: 351 NCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS 410
           +  +LE ++L +N +   +   +     L  L L SN ++ + P                
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGP---------------E 209

Query: 411 FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLIL 470
           F +   +  ++L NN L   +  +L     L+  D+  N F       F    +     +
Sbjct: 210 FQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTV 267

Query: 471 SKNSFSGAIPSSLGRCESLQSLDLSSNK---LSGKIPVELFEIEGLDISLNLSWNALSGA 527
           +K +       +   C         +     L       L  ++  + +L     + +  
Sbjct: 268 AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER 327

Query: 528 IPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFT 572
           +  +     +   +D    +               ++L        
Sbjct: 328 LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  162 bits (413), Expect = 5e-43
 Identities = 81/332 (24%), Positives = 129/332 (38%), Gaps = 42/332 (12%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
           A+PE I      + +DL  N         F +   LEEL L+ N +S ++ P   +N  +
Sbjct: 25  AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN 81

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQN 378
           L  L L +N++             IP        +L  +D+S N +   L   +FQ L N
Sbjct: 82  LRTLGLRSNRLK-----------LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYN 129

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
           L  L +  N +                +   +F     L+ L L    L      +L+ L
Sbjct: 130 LKSLEVGDNDLV--------------YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHL 175

Query: 439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK 498
             L VL +       +   SF +L  L  L +S   +   +  +     +L SL ++   
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235

Query: 499 LSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQI-SALNKLSILDLSHNKLGG-DLLA 554
           L+  +P        L     LNLS+N +S  I   +   L +L  + L   +L   +  A
Sbjct: 236 LT-AVPYLAV--RHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYA 291

Query: 555 LSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSA 586
             GL+ L  LNVS N  T  L +S +F  +  
Sbjct: 292 FRGLNYLRVLNVSGNQLT-TLEES-VFHSVGN 321

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  156 bits (396), Expect = 9e-41
 Identities = 69/314 (21%), Positives = 126/314 (40%), Gaps = 32/314 (10%)

Query: 251 KMLLWQNNFDGAIPEEI-GNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
           ++L    N    + ++   +   L+ ++L+ N  S   P +F NL +L  L L +N +  
Sbjct: 35  RLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK- 93

Query: 310 SIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS 368
            IP  V +  ++L +L +  N+I +                 +  +L+++++  N L   
Sbjct: 94  LIPLGVFTGLSNLTKLDISENKIVILL----------DYMFQDLYNLKSLEVGDNDLV-Y 142

Query: 369 LHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL----------MSFGNCTQL 417
           +    F  L +L +L L    ++ +    + +   LI LRL           SF    +L
Sbjct: 143 ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG 477
           ++L +S+     T+  +      L  L I+      +   +   L  L  L LS N  S 
Sbjct: 203 KVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST 262

Query: 478 AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQI-SA 534
              S L     LQ + L   +L+  +    F   GL+    LN+S N L+  +   +  +
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLA-VVEPYAF--RGLNYLRVLNVSGNQLT-TLEESVFHS 318

Query: 535 LNKLSILDLSHNKL 548
           +  L  L L  N L
Sbjct: 319 VGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  118 bits (297), Expect = 5e-28
 Identities = 67/347 (19%), Positives = 130/347 (37%), Gaps = 47/347 (13%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
            P  + +    + L +  + +      +      L  ++++ N +    P +   L NL+
Sbjct: 26  VPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLR 83

Query: 106 DLILNSNQLTGEIPKE-LGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIA 164
            L L SN+L   IP         L  L + +N +   L      L NL+ +  G N  + 
Sbjct: 84  TLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND-LV 141

Query: 165 GKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQI-GNCS 223
             I                          +   L+ L+ L++    L+  IP +   +  
Sbjct: 142 -YIS-----------------------HRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLH 176

Query: 224 ELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFF 283
            L+ L L   +++        +L +L+ + +    +   +        +L ++ ++    
Sbjct: 177 GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236

Query: 284 SGSLP-QSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISVFFAWQNKL 341
           + ++P  +  +L  L  L LS N IS +I   +L     L ++QL   Q++V        
Sbjct: 237 T-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVE------ 288

Query: 342 EGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISN 387
               P        L  +++S N LT +L   +F  + NL  L+L SN
Sbjct: 289 ----PYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 39/226 (17%), Positives = 68/226 (30%), Gaps = 58/226 (25%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP 95
           N+ SI         LS L  L  L +   N+            +L  +++S    +  + 
Sbjct: 163 NLTSIP-----TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217

Query: 96  SSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVI 155
            +    +NL  L +    LT  +P    A   L  L   +  LS N          +  I
Sbjct: 218 PNCLYGLNLTSLSITHCNLT-AVPY--LAVRHLVYLRFLN--LSYN---------PISTI 263

Query: 156 RAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEI 215
                                                  L +L +LQ + +    L+  +
Sbjct: 264 EGS-----------------------------------MLHELLRLQEIQLVGGQLA-VV 287

Query: 216 PPQI-GNCSELVDLFLYENDLSGSLPREL-GKLQKLEKMLLWQNNF 259
            P      + L  L +  N L+ +L   +   +  LE ++L  N  
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  148 bits (375), Expect = 3e-39
 Identities = 66/320 (20%), Positives = 121/320 (37%), Gaps = 47/320 (14%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
            +P+++        +DL  N  +      F NL +L  L+L NN IS  I P   +    
Sbjct: 45  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVK 101

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNL 379
           L +L L  NQ+             +P  +   ++L+ + +  N +T  +   +F  L  +
Sbjct: 102 LERLYLSKNQLK-----------ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQM 147

Query: 380 TKLLLISNGI-SGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
             + L +N + S  I                +F    +L  + +++  +  T+P  L   
Sbjct: 148 IVVELGTNPLKSSGIENG-------------AFQGMKKLSYIRIADTNI-TTIPQGL--P 191

Query: 439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK 498
             L  L +  N+   +   S   L +L +L LS NS S     SL     L+ L L++NK
Sbjct: 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251

Query: 499 LSGKIPVELFEIEGLDISLNLSWNALSG------AIPPQISALNKLSILDLSHNKLGGDL 552
           L  K+P  L + + +   + L  N +S         P   +     S + L  N +    
Sbjct: 252 LV-KVPGGLADHKYI-QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309

Query: 553 L---ALSGLDNLVSLNVSYN 569
           +       +    ++ +   
Sbjct: 310 IQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  105 bits (264), Expect = 9e-25
 Identities = 64/344 (18%), Positives = 115/344 (33%), Gaps = 62/344 (18%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
            P +L        L +  + +T     D  +   L T+ + +N +    P +   L+ L+
Sbjct: 46  VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 103

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAG 165
            L L+ NQL  E+P+++     L+ L + +N ++         L  + V+  G N   + 
Sbjct: 104 RLYLSKNQLK-ELPEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 160

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSEL 225
            I                          +   + KL  + +  T ++  IP   G    L
Sbjct: 161 GIE-----------------------NGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSL 194

Query: 226 VDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSG 285
            +L L  N ++  +                     G          +L  + LS N  S 
Sbjct: 195 TELHLDGNKIT-KVDAAS---------------LKG--------LNNLAKLGLSFNSISA 230

Query: 286 SLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSI 345
               S  N   L EL L+NN +   +P  L++   +  + L  N IS         +   
Sbjct: 231 VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI----GSNDFCP 285

Query: 346 PSTLANCRSLEAVDLSHNALT-GSLHPGLFQ-LQNLTKLLLISN 387
           P       S   V L  N +    + P  F+ +     + L + 
Sbjct: 286 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 97.0 bits (242), Expect = 7e-22
 Identities = 54/242 (22%), Positives = 90/242 (37%), Gaps = 32/242 (13%)

Query: 350 ANCR-SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
             C+  L  V  S   L   +   L    +   L L +N I+  I               
Sbjct: 27  FRCQCHLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITE-IKDG------------ 70

Query: 409 MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRL 468
             F N   L  L L NN +    P + A L +L+ L +S NQ   L  +      +L  L
Sbjct: 71  -DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMP---KTLQEL 126

Query: 469 ILSKNSFSGAIPSSLGRCESLQSLDLSSNKL-SGKIPVELFEIEGLD--ISLNLSWNALS 525
            + +N  +    S       +  ++L +N L S  I    F+  G+     + ++   ++
Sbjct: 127 RVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ--GMKKLSYIRIADTNIT 184

Query: 526 GAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQL 584
             IP        L+ L L  NK+   D  +L GL+NL  L +S+N+ +  + +       
Sbjct: 185 -TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA-VDNG-SLANT 239

Query: 585 SA 586
             
Sbjct: 240 PH 241

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 86.6 bits (215), Expect = 3e-18
 Identities = 40/182 (21%), Positives = 73/182 (40%), Gaps = 33/182 (18%)

Query: 415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS 474
               +L+L NN +         +L  L  L +  N+   + P +F  L  L RL LSKN 
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111

Query: 475 FSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISA 534
               +P  + +  +LQ L +  N+++ K+   +F                        + 
Sbjct: 112 LK-ELPEKMPK--TLQELRVHENEIT-KVRKSVF------------------------NG 143

Query: 535 LNKLSILDLSHNKLGGDLL---ALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAG 591
           LN++ +++L  N L    +   A  G+  L  + ++  N T  +P   L   L+   + G
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG-LPPSLTELHLDG 201

Query: 592 NQ 593
           N+
Sbjct: 202 NK 203

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  145 bits (367), Expect = 1e-38
 Identities = 75/281 (26%), Positives = 122/281 (43%), Gaps = 42/281 (14%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G    VY+  + E    +A  +L             D+      R  F  E + L 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCEL------------QDRKLTKSERQRFKEEAEMLK 80

Query: 752 SIRHKNIVRFLGCC---WNRNTRLLMY-DYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
            ++H NIVRF             +++  + M +G+L + L  +R   ++ ++        
Sbjct: 81  GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQI 138

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILI-GPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
            +GL +LH    PPI+HRD+K +NI I GP     I D GLA L     FA++   V G+
Sbjct: 139 LKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKA---VIGT 193

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ--KRGAI 924
             ++APE  Y  K  E  DVY++G+ +LE+ T + P                Q  +R   
Sbjct: 194 PEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYRRVTS 244

Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKD 965
            V   S     +V I E+ + +     C+    D+R ++KD
Sbjct: 245 GVKPASF---DKVAIPEVKEII---EGCIRQNKDERYSIKD 279

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  145 bits (369), Expect = 5e-38
 Identities = 63/294 (21%), Positives = 110/294 (37%), Gaps = 53/294 (18%)

Query: 695 GKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G+G  G V+   +      +AVK    T                  +  F  E + L   
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL-------------KAKFLQEARILKQY 169

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H NIVR +G C  +    ++ + +  G   + L       L  +   +++  AA G+ Y
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEY 228

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI--- 870
           L        +HRD+ A N L+  +    I+DFG+++   +G +A S          +   
Sbjct: 229 LESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL-----RQVPVK 280

Query: 871 --APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVL 927
             APE     + + +SDV+S+G+++ E  + G  P        L             E +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY-----PNLSNQQ-------TREFV 328

Query: 928 DKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           +K  R   PE     +   M Q       C    P  RP+   +   ++ I++ 
Sbjct: 329 EKGGRLPCPELCPDAVFRLMEQ-------CWAYEPGQRPSFSTIYQELQSIRKR 375

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  148 bits (374), Expect = 4e-37
 Identities = 84/485 (17%), Positives = 152/485 (31%), Gaps = 119/485 (24%)

Query: 77  CTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDN 136
                 ++V  + L   +P  +    ++  L++  N LT  +P       +L+ L +  N
Sbjct: 39  NNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGN 91

Query: 137 YLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLG 196
            L+                                                  SLP    
Sbjct: 92  QLT--------------------------------------------------SLPVLPP 101

Query: 197 KLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQ 256
            L +L   S   T L           S L  L+++ N L+ SLP     LQ+L    +  
Sbjct: 102 GLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLPPGLQELS---VSD 150

Query: 257 NNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLS 316
           N    ++P        L   +  L     SLP     L   +EL +S+N ++ S+P + S
Sbjct: 151 NQLA-SLPALPSELCKLWAYNNQLT----SLPMLPSGL---QELSVSDNQLA-SLPTLPS 201

Query: 317 NATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQL 376
               L +L    N+++           S+P+  +  + L    +S N LT SL       
Sbjct: 202 E---LYKLWAYNNRLT-----------SLPALPSGLKEL---IVSGNRLT-SLPV---LP 240

Query: 377 QNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLA 436
             L +L++  N ++ L P                      L  L++  N L   LP SL 
Sbjct: 241 SELKELMVSGNRLTSL-PMLPSG-----------------LLSLSVYRNQLT-RLPESLI 281

Query: 437 SLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSS 496
            L+    +++  N       ++  ++ S          F  A  S+     +L     ++
Sbjct: 282 HLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAAA 339

Query: 497 NKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALS 556
           + L      E    +   +               ++S             ++   L  L+
Sbjct: 340 DWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLA 399

Query: 557 GLDNL 561
             + L
Sbjct: 400 EDEAL 404

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  134 bits (338), Expect = 1e-32
 Identities = 68/321 (21%), Positives = 125/321 (38%), Gaps = 72/321 (22%)

Query: 261 GAIPEEIGNC--KSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNA 318
            A+ +++  C       +++  +  + +LP        +  L++ +NN++ S+P +    
Sbjct: 28  AAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPE- 82

Query: 319 TSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQN 378
             L  L++  NQ++           S+P        L         L             
Sbjct: 83  --LRTLEVSGNQLT-----------SLPVLPPGLLELSIFSNPLTHLPALP-------SG 122

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
           L KL +  N ++ L P                      LQ L++S+N L  +LP+  + L
Sbjct: 123 LCKLWIFGNQLTSL-PVLPPG-----------------LQELSVSDNQLA-SLPALPSEL 163

Query: 439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK 498
            +L   +   NQ   L P     L  L+   +S N  + ++P+       L  L   +N+
Sbjct: 164 CKLWAYN---NQLTSL-PMLPSGLQELS---VSDNQLA-SLPTLPS---ELYKLWAYNNR 212

Query: 499 LSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLAL-SG 557
           L+  +P     ++     L +S N L+ ++P   S L +L    +S N+L     +L   
Sbjct: 213 LT-SLPALPSGLK----ELIVSGNRLT-SLPVLPSELKEL---MVSGNRLT----SLPML 259

Query: 558 LDNLVSLNVSYNNFTGYLPDS 578
              L+SL+V  N  T  LP+S
Sbjct: 260 PSGLLSLSVYRNQLT-RLPES 279

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  131 bits (331), Expect = 9e-32
 Identities = 83/396 (20%), Positives = 132/396 (33%), Gaps = 59/396 (14%)

Query: 51  SSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILN 110
              + +  L+I  +NLT  +        +L T++VS N L   +P     L+ L      
Sbjct: 58  CLPAHITTLVIPDNNLTS-LPALPP---ELRTLEVSGNQLTS-LPVLPPGLLELSIFSNP 112

Query: 111 SNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYE 170
              L             L  L +F N L+ +LPV    L  L V     N+     +P  
Sbjct: 113 LTHLPALPS-------GLCKLWIFGNQLT-SLPVLPPGLQELSV---SDNQ--LASLPAL 159

Query: 171 IGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFL 230
             +   L       T    SLP        LQ LSV    L+  +P        L  L+ 
Sbjct: 160 PSELCKLWAYNNQLT----SLPMLPS---GLQELSVSDNQLA-SLPTLPSE---LYKLWA 208

Query: 231 YENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQS 290
           Y N L+ SLP     L++L        N   ++P        LK + +S N  + SLP  
Sbjct: 209 YNNRLT-SLPALPSGLKELIV----SGNRLTSLPVLPSE---LKELMVSGNRLT-SLPML 259

Query: 291 FGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLA 350
                 L  L +  N ++  +P  L + +S   + L+ N +S               TL 
Sbjct: 260 PSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER-------------TLQ 302

Query: 351 NCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS 410
             R + +       +              T+ L ++     L+P   G  +   R     
Sbjct: 303 ALREITSAPGYSGPII-RFDMAGASAPRETRALHLAAADW-LVPAREGEPAPADRWH--M 358

Query: 411 FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDI 446
           FG        +L  + L  T      +  + Q+   
Sbjct: 359 FGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSW 394

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 90.0 bits (223), Expect = 1e-18
 Identities = 39/186 (20%), Positives = 60/186 (32%), Gaps = 26/186 (13%)

Query: 394 PPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG 453
            P   +      ++ M         +LN+  + L  TLP  L     +  L I  N    
Sbjct: 19  APAEESRGRAAVVQKMRACLNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLTS 75

Query: 454 LIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGL 513
           L P    +L +L    +S N  + ++P        L         L            GL
Sbjct: 76  L-PALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGL 123

Query: 514 DISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLAL-SGLDNLVSLNVSYNNFT 572
              L +  N L+ ++P        L  L +S N+L     +L +    L  L    N  T
Sbjct: 124 -CKLWIFGNQLT-SLPVLPP---GLQELSVSDNQLA----SLPALPSELCKLWAYNNQLT 174

Query: 573 GYLPDS 578
             LP  
Sbjct: 175 -SLPML 179

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  142 bits (361), Expect = 2e-36
 Identities = 87/523 (16%), Positives = 159/523 (30%), Gaps = 111/523 (21%)

Query: 56  LQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLT 115
               + +   +    +        LT++D  ++S+     + I KL  L  LI  SN +T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77

Query: 116 GEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQ 175
             +   L     L  L    N L+                                    
Sbjct: 78  -TLD--LSQNTNLTYLACDSNKLT------------------------------------ 98

Query: 176 SLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDL 235
                         +L   +  L+KL  L+  T  L+ ++   +     L  L    N L
Sbjct: 99  --------------NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTL 139

Query: 236 SGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLS 295
           +  +   +    +L ++    N     +   +     L T+D S N  +  L        
Sbjct: 140 T-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNK 191

Query: 296 SLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSL 355
            L  L    NNI+  +   L+    L  L   +N+++            I   +     L
Sbjct: 192 LLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-----------EID--VTPLTQL 235

Query: 356 EAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL------- 408
              D S N LT  L      L  LT L  I   +  +   ++ + + LI  +        
Sbjct: 236 TYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIK 289

Query: 409 -MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNR 467
            +   + TQL +L+     +   L   L+   +L  L ++  +   L          L  
Sbjct: 290 ELDVTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELTEL---DVSHNTKLKS 343

Query: 468 LILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGA 527
           L            SS+G+  +L +   +  +    +P E      L I+++       G 
Sbjct: 344 LSCVNAHIQDF--SSVGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGN 400

Query: 528 IPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNN 570
                       + D + N +      LS  +  V+   +  N
Sbjct: 401 PMNIEPGDG--GVYDQATNTIT--WENLSTDNPAVTYTFTSEN 439

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  126 bits (318), Expect = 8e-31
 Identities = 73/426 (17%), Positives = 139/426 (32%), Gaps = 60/426 (14%)

Query: 48  SNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDL 107
           + +  L+ L KLI + +N+T   + DL   T LT +   SN L       +  L  L  L
Sbjct: 58  TGIEKLTGLTKLICTSNNIT---TLDLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYL 111

Query: 108 ILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKI 167
             ++N+LT ++   +     L  L    N L+    +++     L  +    NK I    
Sbjct: 112 NCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKI---T 162

Query: 168 PYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVD 227
             ++     L  +  +  K+   L   + +   L  L+  T  ++ ++   +    +L  
Sbjct: 163 KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF 216

Query: 228 LFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSL 287
           L    N L+  +   +  L +L       N     +   +     L T+          +
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EI 269

Query: 288 PQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS 347
                + + L             +   +++ T L  L      I+            +  
Sbjct: 270 D--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-----------ELD- 313

Query: 348 TLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR 407
            L+    L  + L++  LT  L         L  L  ++  I       +G   +L    
Sbjct: 314 -LSQNPKLVYLYLNNTELT-ELDVS--HNTKLKSLSCVNAHIQDF--SSVGKIPALNNNF 367

Query: 408 LMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNR 467
             + G    +    L+NN+L   +   L        LD   N  + + P   G       
Sbjct: 368 E-AEGQTITMPKETLTNNSLTIAVSPDL--------LDQFGNP-MNIEPGDGGVYDQATN 417

Query: 468 LILSKN 473
            I  +N
Sbjct: 418 TITWEN 423

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  102 bits (256), Expect = 6e-23
 Identities = 53/252 (21%), Positives = 97/252 (38%), Gaps = 34/252 (13%)

Query: 338 QNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEI 397
             +++ +   +     +L ++D  ++++T  +  G+ +L  LTKL+  SN I+ L   ++
Sbjct: 27  AFEMQATDTISEEQLATLTSLDCHNSSIT-DM-TGIEKLTGLTKLICTSNNITTL---DL 81

Query: 398 GNCSSLIRLRL-------MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQ 450
              ++L  L         +     T+L  LN   N L   L  S      L  L+ + N 
Sbjct: 82  SQNTNLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKL-TKLDVS--QNPLLTYLNCARNT 138

Query: 451 FVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEI 510
              +          L  L    N     +   +     L +LD S NK++        ++
Sbjct: 139 LTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE------LDV 187

Query: 511 EGLD--ISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSY 568
                   LN   N ++  +   ++   +L+ LD S NKL    + ++ L  L   + S 
Sbjct: 188 SQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL--TEIDVTPLTQLTYFDCSV 242

Query: 569 NNFTGYLPDSKL 580
           N  T  L  S L
Sbjct: 243 NPLT-ELDVSTL 253

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  139 bits (352), Expect = 3e-36
 Identities = 67/304 (22%), Positives = 111/304 (36%), Gaps = 37/304 (12%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
           A+P+EI        +DL  N  S      F  L  L  L+L NN IS  I     S    
Sbjct: 47  AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRK 103

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNL 379
           L +L +  N +             IP  L    SL  + +  N +   +  G+F  L+N+
Sbjct: 104 LQKLYISKNHLV-----------EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNM 149

Query: 380 TKLLLISNGISGL-IPPEIGNCSSLIRLRL-------MSFGNCTQLQMLNLSNNTLGGTL 431
             + +  N +      P   +   L  LR+       +       L  L+L +N +    
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIE 209

Query: 432 PSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQS 491
              L   ++L  L +  NQ   +   S   L +L  L L  N  S  +P+ L   + LQ 
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQV 268

Query: 492 LDLSSNKLSGKIPVELFEIEGLDI------SLNLSWNALS-GAIPPQI-SALNKLSILDL 543
           + L +N ++ K+ V  F   G  +       ++L  N +    + P     +     +  
Sbjct: 269 VYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQF 327

Query: 544 SHNK 547
            + K
Sbjct: 328 GNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  125 bits (315), Expect = 2e-31
 Identities = 62/326 (19%), Positives = 103/326 (31%), Gaps = 51/326 (15%)

Query: 272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQ 330
            L+ +  S      ++P+          L L NN+IS  +          L  L L  N+
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89

Query: 331 ISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGI 389
           IS            I     +  R L+ + +S N L   + P L    +L +L +  N I
Sbjct: 90  IS-----------KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVELRIHDNRI 135

Query: 390 SGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGT-LPSSLASLTRLQVLDISV 448
              +P                F     +  + +  N L  +          +L  L IS 
Sbjct: 136 R-KVPKG-------------VFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181

Query: 449 NQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELF 508
            +  G+  +      +LN L L  N         L R   L  L L  N++   I     
Sbjct: 182 AKLTGIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSL 237

Query: 509 EIEGLD--ISLNLSWNALSGAIPPQISALNKLSILDLSHNKLG-------GDLLALSGLD 559
               L     L+L  N LS  +P  +  L  L ++ L  N +          +       
Sbjct: 238 S--FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRA 294

Query: 560 NLVSLNVSYNNFTGYLPDSKLFRQLS 585
               +++  N    +      FR ++
Sbjct: 295 YYNGISLFNNPVPYWEVQPATFRCVT 320

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 94.7 bits (236), Expect = 4e-21
 Identities = 60/346 (17%), Positives = 109/346 (31%), Gaps = 69/346 (19%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGPISPD-LGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
           P  +S       L +  ++++  +  D       L  + + +N +      +   L  LQ
Sbjct: 49  PKEISP--DTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAG 165
            L ++ N L  EIP  L +   L  L + DN +                           
Sbjct: 106 KLYISKNHLV-EIPPNLPS--SLVELRIHDNRIR-------------------------- 136

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTML-SGEIPPQIGNCSE 224
           K+P                             L  +  + +    L +    P   +  +
Sbjct: 137 KVP-----------------------KGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK 173

Query: 225 LVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEI-GNCKSLKTIDLSLNFF 283
           L  L + E  L+  +P++L   + L ++ L  N    AI  E       L  + L  N  
Sbjct: 174 LNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI 229

Query: 284 SGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEG 343
                 S   L +L EL L NN +S  +P  L +   L  + L TN I+         + 
Sbjct: 230 RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV----GVNDF 284

Query: 344 SIPSTLANCRSLEAVDLSHNALT-GSLHPGLFQ-LQNLTKLLLISN 387
                         + L +N +    + P  F+ + +   +   + 
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 28/137 (20%), Positives = 52/137 (37%), Gaps = 20/137 (14%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPD-LGDCTQLTTIDVSSNSLVGGV 94
            IQ+IE       +L   S L +L +  + +   I    L     L  + + +N L   V
Sbjct: 204 KIQAIE-----LEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLSR-V 256

Query: 95  PSSIGKLINLQDLILNSNQLTGEIPKE-------LGACIKLKNLLLFDNYLSGNLPVELG 147
           P+ +  L  LQ + L++N +T ++                   + LF+N +     V+  
Sbjct: 257 PAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP-YWEVQPA 314

Query: 148 ---KLVNLEVIRAGGNK 161
               + +   I+ G  K
Sbjct: 315 TFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 45.8 bits (109), Expect = 4e-05
 Identities = 27/103 (26%), Positives = 40/103 (38%), Gaps = 12/103 (11%)

Query: 485 RCESLQSLDLSSNKLSGKIPVELFEIEGLDI-SLNLSWNALSGAIPP-QISALNKLSILD 542
            C  L+ +  S   L   +P E+      D   L+L  N +S  +       L  L  L 
Sbjct: 32  HC-HLRVVQCSDLGLK-AVPKEISP----DTTLLDLQNNDIS-ELRKDDFKGLQHLYALV 84

Query: 543 LSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQL 584
           L +NK+      A S L  L  L +S N+    +P + L   L
Sbjct: 85  LVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPN-LPSSL 125

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  141 bits (356), Expect = 1e-35
 Identities = 81/367 (22%), Positives = 126/367 (34%), Gaps = 20/367 (5%)

Query: 192 PASLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPRE-LGKLQKL 249
             S  +L  LQ L V        I        S L+ L L  N     L       L  L
Sbjct: 47  ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANL 105

Query: 250 EKMLLWQNNF-DGAIPEEI-GNCKSLKTIDLSLNFFSGSLPQS-FGNLSSLEELMLSNNN 306
           E + L Q N     +         SL+ + L  N      P S F N+     L L+ N 
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165

Query: 307 ISGSIPPVLSN--ATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNA 364
           +       L N        L+L +  +      +  L            S+  +DLS N 
Sbjct: 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMN--EYWLGWEKCGNPFKNTSITTLDLSGNG 223

Query: 365 LTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGN--CTQLQMLNL 422
              S+    F     TK+  +    S  +    G  ++       +F     + ++  +L
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG-HTNFKDPDNFTFKGLEASGVKTCDL 282

Query: 423 SNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSS 482
           S + +   L S  +  T L+ L ++ N+   +   +F  L  L +L LS+N         
Sbjct: 283 SKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRM 342

Query: 483 LGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQI-SALNKLS 539
               + L+ LDLS N +   +  + F   GL     L L  N L  ++P  I   L  L 
Sbjct: 343 FENLDKLEVLDLSYNHIRA-LGDQSF--LGLPNLKELALDTNQLK-SVPDGIFDRLTSLQ 398

Query: 540 ILDLSHN 546
            + L  N
Sbjct: 399 KIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  127 bits (321), Expect = 3e-31
 Identities = 77/420 (18%), Positives = 134/420 (31%), Gaps = 64/420 (15%)

Query: 78  TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKN---LLLF 134
             +  +D+S NS+     +S  +L +LQ L +        I         L +   L L 
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN--NTFRGLSSLIILKLD 87

Query: 135 DNYLSGNLPVE-LGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPA 193
            N     L       L NLEV+           +                          
Sbjct: 88  YNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLS-----------------------GN 123

Query: 194 SLGKLSKLQSLSVYTTMLSGEIPPQI--GNCSELVDLFLYENDLSGSLPRELGKLQKLEK 251
               L+ L+ L +    +  +I P     N      L L  N +      +L   Q    
Sbjct: 124 FFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHF 182

Query: 252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSI 311
            LL                 S+   D++  +       +    +S+  L LS N    S+
Sbjct: 183 TLL--------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESM 228

Query: 312 PPVLSNATSLLQLQ---LDTNQISVFFAWQNKLEGSIPSTLAN--CRSLEAVDLSHNALT 366
                +A +  ++Q   L  +            +     T        ++  DLS + + 
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288

Query: 367 GSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL----------MSFGNCT 415
            +L   +F    +L +L L  N I+ +        + L++L L            F N  
Sbjct: 289 -ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD 347

Query: 416 QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF 475
           +L++L+LS N +      S   L  L+ L +  NQ   +    F +L SL ++ L  N +
Sbjct: 348 KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  121 bits (304), Expect = 4e-29
 Identities = 63/324 (19%), Positives = 110/324 (33%), Gaps = 39/324 (12%)

Query: 271 KSLKTIDLSLNFFSGSLPQ-SFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDT 328
           + L+ + +        +   +F  LSSL  L L  N     +     +   +L  L L  
Sbjct: 54  QDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQ 112

Query: 329 NQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHP-GLFQ-LQNLTKLLLI 385
             +             +         SLE + L  N +   + P   F  ++    L L 
Sbjct: 113 CNLD---------GAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLT 162

Query: 386 SNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLD 445
            N +  +   ++ N        L          + +++   LG     +    T +  LD
Sbjct: 163 FNKVKSICEEDLLNFQGKHFTLLRLSSI----TLQDMNEYWLGWEKCGNPFKNTSITTLD 218

Query: 446 ISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCE---------------SLQ 490
           +S N F   + + F    +  ++     S S  + SS G                   ++
Sbjct: 219 LSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK 278

Query: 491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQI-SALNKLSILDLSHNKLG 549
           + DLS +K+   +   +F        L L+ N ++  I       L  L  L+LS N LG
Sbjct: 279 TCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG 336

Query: 550 G-DLLALSGLDNLVSLNVSYNNFT 572
             D      LD L  L++SYN+  
Sbjct: 337 SIDSRMFENLDKLEVLDLSYNHIR 360

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 93.7 bits (233), Expect = 5e-20
 Identities = 48/287 (16%), Positives = 85/287 (29%), Gaps = 54/287 (18%)

Query: 310 SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSL 369
            +P + ++   +    L  N I+       +L     ++ +  + L+ + +        +
Sbjct: 24  QVPELPAHVNYV---DLSLNSIA-------ELN---ETSFSRLQDLQFLKVEQQTPGLVI 70

Query: 370 HPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTL- 427
               F+ L +L  L L  N    L                  F     L++L L+   L 
Sbjct: 71  RNNTFRGLSSLIILKLDYNQFLQL-ETGA-------------FNGLANLEVLTLTQCNLD 116

Query: 428 GGTLPS-SLASLTRLQVLDISVNQFVGLIPES-FGQLASLNRLILSKNSFSGAIPSSLGR 485
           G  L       LT L++L +  N    + P S F  +   + L L+ N         L  
Sbjct: 117 GAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLN 176

Query: 486 CES--LQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDL 543
            +      L LSS  L                  +++   L             ++ LDL
Sbjct: 177 FQGKHFTLLRLSSITL-----------------QDMNEYWLGWEKCGNPFKNTSITTLDL 219

Query: 544 SHNKLG----GDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSA 586
           S N                  + SL +S +   G       F+    
Sbjct: 220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDN 266

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  135 bits (341), Expect = 4e-35
 Identities = 71/249 (28%), Positives = 107/249 (42%), Gaps = 56/249 (22%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  GIVY   ++ N   IA+K         E   ++ +            EI    
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIK---------EIPERDSR-----YSQPLHEEIALHK 74

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI----ILGA 807
            ++HKNIV++LG         +  + +P GSL +LL  +     + E         IL  
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-- 132

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEF-EPYIADFGLAKLVVEGDFARSSNTVAGS 866
            +GL YLH +    IVHRDIK +N+LI        I+DFG +K +        + T  G+
Sbjct: 133 -EGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA--GINPCTETFTGT 186

Query: 867 YGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP------------------ 902
             Y+APE       GY     + +D++S G  ++E+ TGK P                  
Sbjct: 187 LQYMAPEIIDKGPRGY----GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK 242

Query: 903 IDPTIPEGL 911
           + P IPE +
Sbjct: 243 VHPEIPESM 251

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  135 bits (342), Expect = 5e-35
 Identities = 79/316 (25%), Positives = 121/316 (38%), Gaps = 51/316 (16%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEM-----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           + L   S +GKG  G V            G ++AVK+L  +    + D            
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD------------ 70

Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMY--DYMPNGSLGSLLHERRDSCLEWE 798
             F  EI+ L ++    IV++ G  +    + L    +Y+P+G L   L   R       
Sbjct: 71  --FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 128

Query: 799 LRYRIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
           L         +G+ YL    C    VHRD+ A NIL+  E    IADFGLAKL+      
Sbjct: 129 LLL-YSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK-- 181

Query: 858 RSSNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL 911
                V    G       APE       + +SDV+S+GVV+ E+ T   +   P+     
Sbjct: 182 --DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239

Query: 912 HIVDWVRQKRGA--IEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMK 964
            +         +  +E+L++  R   P     E+ E M         C  P+P DRP+  
Sbjct: 240 MMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKL-------CWAPSPQDRPSFS 292

Query: 965 DVAAMIKEIKQEREEC 980
            +   +  +      C
Sbjct: 293 ALGPQLDMLWSGSRGC 308

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  139 bits (351), Expect = 7e-35
 Identities = 71/292 (24%), Positives = 119/292 (40%), Gaps = 47/292 (16%)

Query: 695 GKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G G  G VY    +   + +AVK L   TM                 + F  E   +  I
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------------VEEFLKEAAVMKEI 273

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           +H N+V+ LG C       ++ ++M  G+L   L E     +   +   +    +  + Y
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333

Query: 814 LH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           L   +     +HR++ A N L+G      +ADFGL++ ++ GD   +         + AP
Sbjct: 334 LEKKNF----IHRNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 388

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           E     K + KSDV+++GV++ E+ T G  P       G+ +           E+L+K  
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQ-------VYELLEKDY 436

Query: 932 R-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
           R  RPE    ++ E M         C    P DRP+  ++    + + QE  
Sbjct: 437 RMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFETMFQESS 481

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  133 bits (338), Expect = 1e-34
 Identities = 67/311 (21%), Positives = 113/311 (36%), Gaps = 50/311 (16%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           + L     +G+G  G V     +      GE +AVK L P +                  
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH-------------I 67

Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLM--YDYMPNGSLGSLLHERRDSCLEWE 798
                EI+ L ++ H+NIV++ G C       +    +++P+GSL   L + ++     +
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127

Query: 799 LRYRIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
                 +   +G+ YL     V    HRD+ A N+L+  E +  I DFGL K +      
Sbjct: 128 QLK-YAVQICKGMDYLGSRQYV----HRDLAARNVLVESEHQVKIGDFGLTKAIETDK-- 180

Query: 858 RSSNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL 911
                             APE     K    SDV+S+GV + E+LT       P      
Sbjct: 181 --EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238

Query: 912 HIVDWVRQKRGA--IEVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMK 964
            I     Q      +  L +  R   P     E+ + M +       C    P +R + +
Sbjct: 239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRK-------CWEFQPSNRTSFQ 291

Query: 965 DVAAMIKEIKQ 975
           ++    + + +
Sbjct: 292 NLIEGFEALLK 302

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  133 bits (337), Expect = 2e-34
 Identities = 83/315 (26%), Positives = 131/315 (41%), Gaps = 52/315 (16%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           + L     +GKG  G V     +      GEV+AVKKL  +T                  
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--------------L 86

Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLM--YDYMPNGSLGSLLHERRDSCLEWE 798
             F  EI+ L S++H NIV++ G C++   R L    +Y+P GSL   L + ++     +
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 146

Query: 799 LRYRIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
           L         +G+ YL     +    HRD+   NIL+  E    I DFGL K++ +    
Sbjct: 147 LLQ-YTSQICKGMEYLGTKRYI----HRDLATRNILVENENRVKIGDFGLTKVLPQDK-- 199

Query: 858 RSSNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
                     G       APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 200 --EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 257

Query: 913 IVDWVRQK----RGAIEVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTM 963
           ++   +Q        IE+L  + R  RP+    EI   M +       C N   + RP+ 
Sbjct: 258 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSF 310

Query: 964 KDVAAMIKEIKQERE 978
           +D+A  + +I+ +  
Sbjct: 311 RDLALRVDQIRDQMA 325

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (335), Expect = 3e-34
 Identities = 72/316 (22%), Positives = 124/316 (39%), Gaps = 63/316 (19%)

Query: 678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGE----VIAVKKLWPTTMAAEYDCQNDK 733
           +  +      +  + V+G+G  G VY   + + +      AVK L   T   E       
Sbjct: 17  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE------- 69

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGSLLHERRD 792
                    F  E   +    H N++  LG C       L+   YM +G L + +     
Sbjct: 70  ------VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 123

Query: 793 SCLEWELRYRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
           +    +L     L  A+G+ YL          VHRD+ A N ++  +F   +ADFGLA+ 
Sbjct: 124 NPTVKDL-IGFGLQVAKGMKYLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARD 177

Query: 851 VVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQ 901
           + + ++    N    +   +     A E        K T KSDV+S+GV++ E++T G  
Sbjct: 178 MYDKEYYSVHNK---TGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAP 231

Query: 902 P---IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTP 957
           P   ++        I  ++ Q R     L +       + E+  ML+       C +P  
Sbjct: 232 PYPDVNTF-----DITVYLLQGR----RLLQPEYCPDPLYEV--MLK-------CWHPKA 273

Query: 958 DDRPTMKDVAAMIKEI 973
           + RP+  ++ + I  I
Sbjct: 274 EMRPSFSELVSRISAI 289

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  132 bits (334), Expect = 3e-34
 Identities = 80/316 (25%), Positives = 131/316 (41%), Gaps = 80/316 (25%)

Query: 695 GKGCSGIVYRAEMENGE------VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           G+G  G V+ AE  N        ++AVK L   T+AA  D              F  E +
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--------------FQREAE 69

Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY------- 801
            L +++H++IV+F G C + +  +++++YM +G L   L       +             
Sbjct: 70  LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129

Query: 802 -------RIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
                   I    A G+ YL   H      VHRD+   N L+G      I DFG+++ V 
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVY 184

Query: 853 EGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
             D+ R      G +  +      PE   Y    K T +SDV+S+GV++ E+ T GKQP 
Sbjct: 185 STDYYR-----VGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQPW 236

Query: 904 DPTIPEGLH---IVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDD 959
                  L    +++ + Q R    VL++      EV ++  ML        C    P  
Sbjct: 237 -----FQLSNTEVIECITQGR----VLERPRVCPKEVYDV--MLG-------CWQREPQQ 278

Query: 960 RPTMKDVAAMIKEIKQ 975
           R  +K++  ++  + +
Sbjct: 279 RLNIKEIYKILHALGK 294

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  132 bits (334), Expect = 4e-34
 Identities = 63/291 (21%), Positives = 98/291 (33%), Gaps = 55/291 (18%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS--GSIPPVLSNAT 319
           ++P  I    S   ++L  N         F  L+ L +L LS+N +S  G         T
Sbjct: 21  SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 320 SLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQN 378
           SL  L L  N +            ++ S       LE +D  H+ L       +F  L+N
Sbjct: 79  SLKYLDLSFNGVI-----------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS-SLAS 437
           L  L +       +    I             F   + L++L ++ N+            
Sbjct: 128 LIYLDISHTHTR-VAFNGI-------------FNGLSSLEVLKMAGNSFQENFLPDIFTE 173

Query: 438 LTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN 497
           L  L  LD+S  Q   L P +F  L+SL  L +S N+F            SLQ LD S N
Sbjct: 174 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233

Query: 498 KLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKL 548
            +      +  +                          + L+ L+L+ N  
Sbjct: 234 HIM-TSKKQELQ-----------------------HFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  121 bits (306), Expect = 2e-30
 Identities = 66/263 (25%), Positives = 103/263 (39%), Gaps = 29/263 (11%)

Query: 344 SIPSTL-ANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCS 401
           S+P+ + ++   L   +L  N L  SL  G+F  L  LTKL L SNG+S           
Sbjct: 21  SVPTGIPSSATRL---ELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS----------- 65

Query: 402 SLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPES-FG 460
                   S    T L+ L+LS N +  T+ S+   L +L+ LD   +    +   S F 
Sbjct: 66  -FKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123

Query: 461 QLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLN 518
            L +L  L +S      A         SL+ L ++ N        ++F    L     L+
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT--ELRNLTFLD 181

Query: 519 LSWNALSGAIPPQISA-LNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLP 576
           LS   L   + P     L+ L +L++SHN     D      L++L  L+ S N+      
Sbjct: 182 LSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240

Query: 577 D--SKLFRQLSATEMAGNQGLCS 597
                    L+   +  N   C+
Sbjct: 241 QELQHFPSSLAFLNLTQNDFACT 263

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 90.5 bits (225), Expect = 8e-20
 Identities = 59/294 (20%), Positives = 98/294 (33%), Gaps = 52/294 (17%)

Query: 81  TTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLS- 139
           T I  +S  L   VP+ I    +   L L SN+L            +L  L L  N LS 
Sbjct: 10  TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66

Query: 140 -GNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKL 198
            G          +L+ +    N  I                          ++ ++   L
Sbjct: 67  KGCCSQSDFGTTSLKYLDLSFNGVI--------------------------TMSSNFLGL 100

Query: 199 SKLQSLSVYTTMLSGEIPPQ--IGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQ 256
            +L+ L    + L  ++       +   L+ L +       +       L  LE + +  
Sbjct: 101 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 159

Query: 257 NNFDGAIPEEI-GNCKSLKTIDLSLNFFSGSLPQ-SFGNLSSLEELMLSNNNISGSIPP- 313
           N+F      +I    ++L  +DLS       L   +F +LSSL+ L +S+NN   S+   
Sbjct: 160 NSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTF 217

Query: 314 VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP-STLAN-CRSLEAVDLSHNAL 365
                 SL  L    N I            +     L +   SL  ++L+ N  
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-----------TSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.0 bits (107), Expect = 6e-05
 Identities = 23/113 (20%), Positives = 38/113 (33%), Gaps = 10/113 (8%)

Query: 485 RCESLQSLDLSSNKLSGKIPVELFEIEGLDI-SLNLSWNALSGAIPPQISALNKLSILDL 543
            C S   +  +S  L+  +P  +          L L  N L          L +L+ L L
Sbjct: 6   SC-SGTEIRCNSKGLT-SVPTGIPS----SATRLELESNKLQSLPHGVFDKLTQLTKLSL 59

Query: 544 SHNKLGGDLL---ALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQ 593
           S N L        +  G  +L  L++S+N       +     QL   +   + 
Sbjct: 60  SSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 112

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  136 bits (343), Expect = 4e-34
 Identities = 64/266 (24%), Positives = 105/266 (39%), Gaps = 34/266 (12%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
            +P+ I    + + ++L  N        +F +L  LE L L  N+I   I     +   S
Sbjct: 68  EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLAS 124

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQN 378
           L  L+L  N ++            IPS        L  + L +N +  S+    F  + +
Sbjct: 125 LNTLELFDNWLT-----------VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPS 172

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
           L +L L             G    L  +   +F     L+ LNL    +      +L  L
Sbjct: 173 LMRLDL-------------GELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPL 217

Query: 439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK 498
             L+ L++S N F  + P SF  L+SL +L +  +  S    ++     SL  L+L+ N 
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277

Query: 499 LSGKIPVELFEIEGLDISLNLSWNAL 524
           LS  +P +LF      + L+L  N  
Sbjct: 278 LS-SLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  117 bits (296), Expect = 5e-28
 Identities = 60/296 (20%), Positives = 112/296 (37%), Gaps = 62/296 (20%)

Query: 295 SSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCR 353
           +   +++ +   +S  +P  + + T  L L    N I             I + T  +  
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIPSNTRYLNLM--ENNIQ-----------MIQADTFRHLH 99

Query: 354 SLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFG 412
            LE + L  N++   +  G F  L +L  L L  N ++ +IP               +F 
Sbjct: 100 HLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSG-------------AFE 144

Query: 413 NCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDIS-VNQFVGLIPESFGQLASLNRLILS 471
             ++L+ L L NN +      +   +  L  LD+  + +   +   +F  L +L  L L 
Sbjct: 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204

Query: 472 KNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQ 531
             +    +P+ L     L+ L++S N                     +   +  G     
Sbjct: 205 MCNIK-DMPN-LTPLVGLEELEMSGNHFP-----------------EIRPGSFHG----- 240

Query: 532 ISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSA 586
              L+ L  L + ++++   +  A  GL +LV LN+++NN +  LP   LF  L  
Sbjct: 241 ---LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHD-LFTPLRY 291

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  103 bits (258), Expect = 3e-23
 Identities = 51/229 (22%), Positives = 80/229 (34%), Gaps = 27/229 (11%)

Query: 350 ANCR---SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
           + C        V  +   L+  +  G+    N   L L+ N I   I  +          
Sbjct: 48  SVCSCSNQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQM-IQAD---------- 93

Query: 407 RLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
              +F +   L++L L  N++      +   L  L  L++  N    +   +F  L+ L 
Sbjct: 94  ---TFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLR 150

Query: 467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNAL 524
            L L  N        +  R  SL  LDL   K    I    F  EGL     LNL    +
Sbjct: 151 ELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAF--EGLFNLKYLNLGMCNI 208

Query: 525 SGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFT 572
                P ++ L  L  L++S N        +  GL +L  L V  +  +
Sbjct: 209 KD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 83.3 bits (206), Expect = 9e-17
 Identities = 56/319 (17%), Positives = 106/319 (33%), Gaps = 66/319 (20%)

Query: 46  FPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQ 105
            P  + S    + L +  +N+    +        L  + +  NS+      +   L +L 
Sbjct: 69  VPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLN 126

Query: 106 DLILNSNQLTGEIPKE-LGACIKLKNLLLFDNYLSGNLPVE-LGKLVNLEVIRAGGNKDI 163
            L L  N LT  IP        KL+ L L +N +  ++P     ++ +L  +  G  K +
Sbjct: 127 TLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKL 184

Query: 164 AGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCS 223
              I                          +   L  L+ L++    +     P +    
Sbjct: 185 E-YIS-----------------------EGAFEGLFNLKYLNLGMCNIKD--MPNLTPLV 218

Query: 224 ELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNF 282
            L +L +  N     +       L  L+K+ +  +               +  I+     
Sbjct: 219 GLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQ--------------VSLIE----- 258

Query: 283 FSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTN------QISVFF 335
                  +F  L+SL EL L++NN+S S+P  + +    L++L L  N       I    
Sbjct: 259 -----RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCDILWLA 312

Query: 336 AWQNKLEGSIPSTLANCRS 354
            W  +   +  +    C +
Sbjct: 313 WWLREYIPTNSTCCGRCHA 331

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  132 bits (333), Expect = 5e-34
 Identities = 84/315 (26%), Positives = 131/315 (41%), Gaps = 52/315 (16%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           + L     +GKG  G V     +      GEV+AVKKL  +T     D            
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD------------ 57

Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMY--DYMPNGSLGSLLHERRDSCLEWE 798
             F  EI+ L S++H NIV++ G C++   R L    +Y+P GSL   L + ++     +
Sbjct: 58  --FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 115

Query: 799 LRYRIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
           L         +G+ YL         +HRD+   NIL+  E    I DFGL K++ +    
Sbjct: 116 LLQ-YTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK-- 168

Query: 858 RSSNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
                     G       APE     K +  SDV+S+GVV+ E+ T  +       E + 
Sbjct: 169 --EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 226

Query: 913 IVDWVRQK----RGAIEVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTM 963
           ++   +Q        IE+L  + R  RP+    EI   M +       C N   + RP+ 
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSF 279

Query: 964 KDVAAMIKEIKQERE 978
           +D+A  + +I+    
Sbjct: 280 RDLALRVDQIRDNMA 294

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  135 bits (341), Expect = 7e-34
 Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 45/295 (15%)

Query: 695 GKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR 754
           G+GC G V+         +A+K L P TM+                ++F  E + +  +R
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLR 237

Query: 755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYL 814
           H+ +V+           ++  +YM  GSL   L       L       +    A G+AY+
Sbjct: 238 HEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 815 HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEY 874
                   VHRD++A NIL+G      +ADFGLA+L+ + ++            + APE 
Sbjct: 297 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEA 352

Query: 875 GYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR- 932
               + T KSDV+S+G+++ E+ T G+ P       G+   +        ++ +++  R 
Sbjct: 353 ALYGRFTIKSDVWSFGILLTELTTKGRVPY-----PGMVNRE-------VLDQVERGYRM 400

Query: 933 ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKV 983
             P      + + M Q       C    P++RPT + + A +++     E   + 
Sbjct: 401 PCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  132 bits (334), Expect = 8e-34
 Identities = 85/329 (25%), Positives = 130/329 (39%), Gaps = 73/329 (22%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGE------VIAVKKLWPTTMAAEYDCQNDKIGIGGV 739
           + +V    +G+G  G V+ AE  N        ++AVK L   + +A  D           
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD----------- 89

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
              F  E + L  ++H++IVRF G C      L++++YM +G L   L            
Sbjct: 90  ---FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146

Query: 800 RYR-------------IILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                           +    A G+ YL   H      VHRD+   N L+G      I D
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGD 201

Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEV 896
           FG+++ +   D+ R      G    +      PE   Y    K T +SDV+S+GVV+ E+
Sbjct: 202 FGMSRDIYSTDYYR-----VGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEI 253

Query: 897 LT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVN 954
            T GKQP    +      +D + Q R     L++     PEV  I  M         C  
Sbjct: 254 FTYGKQPW-YQLS-NTEAIDCITQGR----ELERPRACPPEVYAI--MRG-------CWQ 298

Query: 955 PTPDDRPTMKDVAAMIKEIKQEREECMKV 983
             P  R ++KDV A ++ + Q     + V
Sbjct: 299 REPQQRHSIKDVHARLQALAQAPPVYLDV 327

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  131 bits (332), Expect = 1e-33
 Identities = 71/305 (23%), Positives = 122/305 (40%), Gaps = 62/305 (20%)

Query: 693 VVGKGCSGIVYRA----EMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           V+G G  G VY+     E E  ++ +A+K+L   T                       E 
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-------------NKEILDEA 68

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
             + S+ + ++ R LG C     +L+    MP G L   + E +D+     L     +  
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN-WCVQI 126

Query: 808 AQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
           A+G+ YL         +VHRD+ A N+L+       I DFGLAKL+   +    +     
Sbjct: 127 AKGMNYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----- 176

Query: 866 SYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ 919
             G +     A E       T +SDV+SYGV V E++T G +P      +G+   +    
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASE---- 227

Query: 920 KRGAIEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK 974
                 +L+K  R  +P    +++   M +       C     D RP  +++     ++ 
Sbjct: 228 ---ISSILEKGERLPQPPICTIDVYMIMRK-------CWMIDADSRPKFRELIIEFSKMA 277

Query: 975 QEREE 979
           ++ + 
Sbjct: 278 RDPQR 282

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  128 bits (325), Expect = 2e-33
 Identities = 64/307 (20%), Positives = 124/307 (40%), Gaps = 65/307 (21%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           + +     +G G  G+V   + +    +AVK +   +M+                D F  
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---------------EDEFFQ 52

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E +T+  + H  +V+F G C       ++ +Y+ NG L + L          +L   +  
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE-MCY 111

Query: 806 GAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
              +G+A+L  H       +HRD+ A N L+  +    ++DFG+ + V++  +  S    
Sbjct: 112 DVCEGMAFLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG-- 164

Query: 864 AGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
                       APE   Y    K + KSDV+++G+++ EV + GK P      +     
Sbjct: 165 ----TKFPVKWSAPEVFHYF---KYSSKSDVWAFGILMWEVFSLGKMPY-----DLYTNS 212

Query: 915 DWVRQKRGAIEVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAM 969
           +        +  + +  R  RP      I + M         C +  P+ RPT + + + 
Sbjct: 213 E-------VVLKVSQGHRLYRPHLASDTIYQIMYS-------CWHELPEKRPTFQQLLSS 258

Query: 970 IKEIKQE 976
           I+ ++++
Sbjct: 259 IEPLREK 265

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  128 bits (325), Expect = 3e-33
 Identities = 65/306 (21%), Positives = 119/306 (38%), Gaps = 65/306 (21%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
             L     +G G  G+V+     N + +A+K +    M+                + F  
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------------EEDFIE 52

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E + +  + H  +V+  G C  +    L+ ++M +G L   L  +R       L   + L
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG-MCL 111

Query: 806 GAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
              +G+AYL         ++HRD+ A N L+G      ++DFG+ + V++  +  S+   
Sbjct: 112 DVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-- 164

Query: 864 AGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
                       +PE   +    + + KSDV+S+GV++ EV + GK P      E     
Sbjct: 165 ----TKFPVKWASPEVFSFS---RYSSKSDVWSFGVLMWEVFSEGKIPY-----ENRSNS 212

Query: 915 DWVRQKRGAIEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
           +        +E +    R  +P      + + M         C    P+DRP    +   
Sbjct: 213 E-------VVEDISTGFRLYKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQ 258

Query: 970 IKEIKQ 975
           + EI +
Sbjct: 259 LAEIAE 264

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  132 bits (335), Expect = 4e-33
 Identities = 60/266 (22%), Positives = 109/266 (40%), Gaps = 34/266 (12%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
            +P+ I    + + ++L  N        SF +L  LE L LS N+I  +I     +   +
Sbjct: 57  EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQN 378
           L  L+L  N+++           +IP+        L+ + L +N +  S+    F  + +
Sbjct: 114 LNTLELFDNRLT-----------TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPS 161

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
           L +L L             G    L  +   +F   + L+ LNL+   L      +L  L
Sbjct: 162 LRRLDL-------------GELKRLSYISEGAFEGLSNLRYLNLAMCNL--REIPNLTPL 206

Query: 439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK 498
            +L  LD+S N    + P SF  L  L +L + ++       ++    +SL  ++L+ N 
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266

Query: 499 LSGKIPVELFEIEGLDISLNLSWNAL 524
           L+  +P +LF        ++L  N  
Sbjct: 267 LT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  114 bits (287), Expect = 5e-27
 Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 62/303 (20%)

Query: 288 PQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP- 346
           P      +   +++    N+   +P  +S  T LL L    NQI             I  
Sbjct: 36  PSVCSCSNQFSKVICVRKNLR-EVPDGISTNTRLLNLH--ENQIQ-----------IIKV 81

Query: 347 STLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSSLIR 405
           ++  + R LE + LS N +  ++  G F  L NL  L L  N ++  IP           
Sbjct: 82  NSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNG--------- 130

Query: 406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDIS-VNQFVGLIPESFGQLAS 464
               +F   ++L+ L L NN +      +   +  L+ LD+  + +   +   +F  L++
Sbjct: 131 ----AFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSN 186

Query: 465 LNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNAL 524
           L  L L+  +    IP+ L     L  LDLS N LS                  +   + 
Sbjct: 187 LRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-----------------AIRPGSF 227

Query: 525 SGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQ 583
            G        L  L  L +  +++   +  A   L +LV +N+++NN T  LP   LF  
Sbjct: 228 QG--------LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD-LFTP 277

Query: 584 LSA 586
           L  
Sbjct: 278 LHH 280

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 86.3 bits (214), Expect = 9e-18
 Identities = 63/288 (21%), Positives = 109/288 (37%), Gaps = 42/288 (14%)

Query: 78  TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNY 137
           T    +++  N +     +S   L +L+ L L+ N +             L  L LFDN 
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123

Query: 138 LSGNLPVE-LGKLVNLEVIRAGGNKDIAGKIPYEI-GDCQSLLVVGLADTKVAGSLPA-S 194
           L+  +P      L  L+ +    N  I   IP        SL  + L + K    +   +
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNP-IE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180

Query: 195 LGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRE-LGKLQKLEKML 253
              LS L+ L++    L  EIP  +    +L +L L  N LS ++       L  L+K+ 
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237

Query: 254 LWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP 313
           + Q+               ++ I+            +F NL SL E+ L++NN++  +P 
Sbjct: 238 MIQSQ--------------IQVIE----------RNAFDNLQSLVEINLAHNNLT-LLPH 272

Query: 314 -VLSNATSLLQLQLDTN------QISVFFAWQNKLEGSIPSTLANCRS 354
            + +    L ++ L  N       I     W   +  S  +  A C +
Sbjct: 273 DLFTPLHHLERIHLHHNPWNCNCDILWLSWWIKDMAPSNTACCARCNT 320

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 32/113 (28%), Positives = 50/113 (44%), Gaps = 6/113 (5%)

Query: 50  LSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLIL 109
              LS L+ L ++  NL     P+L    +L  +D+S N L    P S   L++LQ L +
Sbjct: 181 FEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238

Query: 110 NSNQLTGEIPKELGACI-KLKNLLLFDNYLSGNLPVE-LGKLVNLEVIRAGGN 160
             +Q+   I +     +  L  + L  N L+  LP +    L +LE I    N
Sbjct: 239 IQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  128 bits (325), Expect = 5e-33
 Identities = 71/331 (21%), Positives = 129/331 (38%), Gaps = 61/331 (18%)

Query: 657 DVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGE----V 712
           D+DS +        + P +++    ++V+         GKG  G+VY  E  +       
Sbjct: 2   DLDSALLAEVKDVLI-PHERVVTHSDRVI---------GKGHFGVVYHGEYIDQAQNRIQ 51

Query: 713 IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN-TR 771
            A+K L   T   +              ++F  E   +  + H N++  +G         
Sbjct: 52  CAIKSLSRITEMQQ-------------VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98

Query: 772 LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYL--HHDCVPPIVHRDIKA 829
            ++  YM +G L   +   + +    +L     L  A+G+ YL          VHRD+ A
Sbjct: 99  HVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISFGLQVARGMEYLAEQK-----FVHRDLAA 152

Query: 830 NNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY--GYIAPE---YGYMMKITEKS 884
            N ++   F   +ADFGLA+ +++ ++              + A E        + T KS
Sbjct: 153 RNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY---RFTTKS 209

Query: 885 DVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEM 942
           DV+S+GV++ E+LT G  P    I     +  ++ Q R     L +       + ++  M
Sbjct: 210 DVWSFGVLLWELLTRGAPPY-RHID-PFDLTHFLAQGR----RLPQPEYCPDSLYQV--M 261

Query: 943 LQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            Q       C    P  RPT + +   +++I
Sbjct: 262 QQ-------CWEADPAVRPTFRVLVGEVEQI 285

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  129 bits (327), Expect = 6e-33
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 39/219 (17%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           VG+G  G V+R  + + G   AVKK+                    +      E+     
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-------------------RLEVFRVEELVACAG 106

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA-QGL 811
           +    IV   G         +  + +  GSLG L+  ++  CL  E R    LG A +GL
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLP-EDRALYYLGQALEGL 163

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKLVVEGDFARS---SNTVAGSY 867
            YLH      I+H D+KA+N+L+  +     + DFG A  +      +S    + + G+ 
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220

Query: 868 GYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            ++APE             K D++S   ++L +L G  P
Sbjct: 221 THMAPEVVMGKPC----DAKVDIWSSCCMMLHMLNGCHP 255

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  133 bits (336), Expect = 8e-33
 Identities = 69/296 (23%), Positives = 124/296 (41%), Gaps = 47/296 (15%)

Query: 695 GKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR 754
           G+GC G V+         +A+K L P TM+                ++F  E + +  +R
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------------PEAFLQEAQVMKKLR 320

Query: 755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYL 814
           H+ +V+           ++  +YM  GSL   L       L       +    A G+AY+
Sbjct: 321 HEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 815 H-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
              + V    HRD++A NIL+G      +ADFGLA+L+ + ++            + APE
Sbjct: 380 ERMNYV----HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPE 434

Query: 874 YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
                + T KSDV+S+G+++ E+ T G+ P       G+   +        ++ +++  R
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPY-----PGMVNRE-------VLDQVERGYR 482

Query: 933 -ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKV 983
              P      + + M Q       C    P++RPT + + A +++     E   + 
Sbjct: 483 MPCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 531

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (325), Expect = 8e-33
 Identities = 79/317 (24%), Positives = 124/317 (39%), Gaps = 58/317 (18%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMEN-----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
           + L +   +G+G  G V     +      GE++AVK L                     R
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-------------R 77

Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLM--YDYMPNGSLGSLLHERRDSCLEWE 798
             +  EI  L ++ H++I+++ GCC +     L    +Y+P GSL   L        +  
Sbjct: 78  SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ-- 135

Query: 799 LRYRIILGAAQ---GLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
               ++L A Q   G+AYLH    +    HRD+ A N+L+  +    I DFGLAK V EG
Sbjct: 136 ----LLLFAQQICEGMAYLHAQHYI----HRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187

Query: 855 DFARSSNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIP 908
                        G       APE     K    SDV+S+GV + E+LT       P   
Sbjct: 188 H----EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243

Query: 909 EGLHIVD--WVRQKRGAIEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRP 961
               I             E+L++  R  RP+    E+   M         C       RP
Sbjct: 244 FLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKN-------CWETEASFRP 296

Query: 962 TMKDVAAMIKEIKQERE 978
           T +++  ++K + ++ +
Sbjct: 297 TFENLIPILKTVHEKYQ 313

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  130 bits (328), Expect = 9e-33
 Identities = 72/313 (23%), Positives = 123/313 (39%), Gaps = 57/313 (18%)

Query: 678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGE----VIAVKKLWPTTMAAEYDCQNDK 733
           +  +      +  + V+G+G  G VY   + + +      AVK L   T   E       
Sbjct: 81  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE------- 133

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGSLLHERRD 792
                    F  E   +    H N++  LG C       L+   YM +G L + +     
Sbjct: 134 ------VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH 187

Query: 793 SCLEWELRYRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
           +    +L     L  A+G+ +L          VHRD+ A N ++  +F   +ADFGLA+ 
Sbjct: 188 NPTVKDL-IGFGLQVAKGMKFLASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARD 241

Query: 851 VVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQ 901
           + + +F         +   +     A E        K T KSDV+S+GV++ E++T G  
Sbjct: 242 MYDKEFDS---VHNKTGAKLPVKWMALESLQTQ---KFTTKSDVWSFGVLLWELMTRGAP 295

Query: 902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDR 960
           P  P +     I  ++ Q R     L +       + E+  ML+       C +P  + R
Sbjct: 296 PY-PDVN-TFDITVYLLQGR----RLLQPEYCPDPLYEV--MLK-------CWHPKAEMR 340

Query: 961 PTMKDVAAMIKEI 973
           P+  ++ + I  I
Sbjct: 341 PSFSELVSRISAI 353

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  126 bits (320), Expect = 2e-32
 Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 65/307 (21%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           K L     +G G  G+V   +      +A+K +   +M+                D F  
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------------EDEFIE 68

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E K + ++ H+ +V+  G C  +    ++ +YM NG L + L E R      +L   +  
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE-MCK 127

Query: 806 GAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
              + + YL          +HRD+ A N L+  +    ++DFGL++ V++ ++  S    
Sbjct: 128 DVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-- 180

Query: 864 AGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
                        PE   Y    K + KSD++++GV++ E+ + GK P      E     
Sbjct: 181 ----SKFPVRWSPPEVLMYS---KFSSKSDIWAFGVLMWEIYSLGKMPY-----ERFTNS 228

Query: 915 DWVRQKRGAIEVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAM 969
           +         E + + LR  RP     ++   M         C +   D+RPT K + + 
Sbjct: 229 E-------TAEHIAQGLRLYRPHLASEKVYTIMYS-------CWHEKADERPTFKILLSN 274

Query: 970 IKEIKQE 976
           I ++  E
Sbjct: 275 ILDVMDE 281

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  126 bits (319), Expect = 2e-32
 Identities = 73/299 (24%), Positives = 124/299 (41%), Gaps = 63/299 (21%)

Query: 695 GKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR 754
           G G  G V+         +AVK L   +M+                D+F AE   +  ++
Sbjct: 22  GAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------------PDAFLAEANLMKQLQ 66

Query: 755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYL 814
           H+ +VR           ++  +YM NGSL   L       L       +    A+G+A++
Sbjct: 67  HQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 815 -HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI--- 870
              + +    HRD++A NIL+       IADFGLA+L+ + ++                 
Sbjct: 126 EERNYI----HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG------AKFPIK 175

Query: 871 --APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
             APE   YG     T KSDV+S+G+++ E++T G+ P       G+   +        I
Sbjct: 176 WTAPEAINYG---TFTIKSDVWSFGILLTEIVTHGRIPY-----PGMTNPE-------VI 220

Query: 925 EVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
           + L++  R  RP+    E+ + M         C    P+DRPT   + +++++     E
Sbjct: 221 QNLERGYRMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYLRSVLEDFFTATE 272

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (324), Expect = 2e-32
 Identities = 73/329 (22%), Positives = 118/329 (35%), Gaps = 81/329 (24%)

Query: 695 GKGCSGIVYRAEMENGE------VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           G+G  G V++A            ++AVK L     A               +  F  E  
Sbjct: 56  GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-------------QADFQREAA 102

Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA- 807
            +    + NIV+ LG C       L+++YM  G L   L       +       +   A 
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 808 ---------------------AQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                                A G+AYL          VHRD+   N L+G      IAD
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIAD 217

Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEV 896
           FGL++ +   D+ +     A     I      PE   Y    + T +SDV++YGVV+ E+
Sbjct: 218 FGLSRNIYSADYYK-----ADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEI 269

Query: 897 LT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVN 954
            + G QP    +     ++ +VR       +L        E+  +  M         C +
Sbjct: 270 FSYGLQPY-YGMA-HEEVIYYVRDGN----ILACPENCPLELYNL--MRL-------CWS 314

Query: 955 PTPDDRPTMKDVAAMIKEIKQEREECMKV 983
             P DRP+   +  +++ + +  E  + V
Sbjct: 315 KLPADRPSFCSIHRILQRMCERAEGTVGV 343

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  127 bits (322), Expect = 2e-32
 Identities = 72/310 (23%), Positives = 117/310 (37%), Gaps = 67/310 (21%)

Query: 693 VVGKGCSGIVYRAEMENGE------VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
            +G+G  G+VY    +          +A+K +       E             R  F  E
Sbjct: 32  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-------------RIEFLNE 78

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
              +      ++VR LG        L++ + M  G L S L   R +     +     L 
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 807 --------AAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
                    A G+AYL  +       VHRD+ A N ++  +F   I DFG+ + + E D+
Sbjct: 139 KMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 193

Query: 857 ARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 907
            R      G  G +     +PE    G     T  SDV+S+GVV+ E+ T  +QP    +
Sbjct: 194 YR-----KGGKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVVLWEIATLAEQPY-QGL 244

Query: 908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                ++ +V +      +LDK       + E+  M         C    P  RP+  ++
Sbjct: 245 S-NEQVLRFVMEGG----LLDKPDNCPDMLFEL--MRM-------CWQYNPKMRPSFLEI 290

Query: 967 AAMIKEIKQE 976
            + IKE  + 
Sbjct: 291 ISSIKEEMEP 300

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  131 bits (332), Expect = 2e-32
 Identities = 93/514 (18%), Positives = 174/514 (33%), Gaps = 74/514 (14%)

Query: 78  TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNY 137
            + T +++S N +     S I  L  L+ LI++ N++            +L+ L L  N 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 138 LSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGK 197
           L   +       VNL+ +    N               +L             +    G 
Sbjct: 81  LV-KIS--CHPTVNLKHLDLSFNAF------------DAL------------PICKEFGN 113

Query: 198 LSKLQSLSVYTTMLSGEIPPQIGNCSEL-VDLFLYENDLSGSLPRELGKL--QKLEKMLL 254
           +S+L+ L + TT L       I + +   V L L E       P  L     + L  +  
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173

Query: 255 WQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEE------LMLSNNNIS 308
               F   +   +    +L+  ++               L+ L+       L L+N   +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233

Query: 309 GSI---PPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNAL 365
            +       L   T++    +   ++     ++         +  + ++L    +  +  
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR-----DFDYSGTSLKALSIHQVVSDVF 288

Query: 366 TGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNN 425
                       N+       +G   +                      +    L+ SNN
Sbjct: 289 GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--------------CPSKISPFLHLDFSNN 334

Query: 426 TLGGTLPSSLASLTRLQVLDISVNQFVGL--IPESFGQLASLNRLILSKNSFSGAIPSSL 483
            L  T+  +   LT L+ L + +NQ   L  I E   Q+ SL +L +S+NS S       
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394

Query: 484 -GRCESLQSLDLSSNKLS----GKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKL 538
               +SL SL++SSN L+      +P  +         L+L  N +  +IP Q+  L  L
Sbjct: 395 CSWTKSLLSLNMSSNILTDTIFRCLPPRIKV-------LDLHSNKIK-SIPKQVVKLEAL 446

Query: 539 SILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNF 571
             L+++ N+L          L +L  + +  N +
Sbjct: 447 QELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  128 bits (322), Expect = 5e-31
 Identities = 92/507 (18%), Positives = 168/507 (33%), Gaps = 51/507 (10%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQD 106
           P +LS       L IS + ++   + D+   ++L  + +S N +     S       L+ 
Sbjct: 16  PKDLSQK--TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEY 73

Query: 107 LILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPV--ELGKLVNLEVIRAGGNKDIA 164
           L L+ N+L             LK+L L  N     LP+  E G +  L+ +       + 
Sbjct: 74  LDLSHNKLVKISCHPTV---NLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTH-LE 128

Query: 165 GKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSE 224
                 I       V+ +               L    + S++    + +    I + S 
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186

Query: 225 LVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFS 284
                L  +++   L              L  N           +  +L  I+ + N F 
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKL--------SNLTLNNIETTWNSFI 238

Query: 285 GSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGS 344
             L       +++    +SN  + G +     + +      L  +Q+       +     
Sbjct: 239 RIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS-----DVFGFP 291

Query: 345 IPSTLANCRSLEAVDLSHNALTGSLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSL 403
                    ++   + + +     +H     ++     L   +N ++  +     NC  L
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVF---ENCGHL 347

Query: 404 IRLRLMSFGNCTQLQMLNLSNNTLG--GTLPSSLASLTRLQVLDISVNQF-VGLIPESFG 460
                      T+L+ L L  N L     +      +  LQ LDIS N            
Sbjct: 348 -----------TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396

Query: 461 QLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLS 520
              SL  L +S N  +  I   L     ++ LDL SNK+   IP ++ ++E L   LN++
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEAL-QELNVA 452

Query: 521 WNALSGAIPPQI-SALNKLSILDLSHN 546
            N L  ++P  I   L  L  + L  N
Sbjct: 453 SNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  122 bits (308), Expect = 3e-29
 Identities = 87/484 (17%), Positives = 161/484 (33%), Gaps = 59/484 (12%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP 95
            I  +       S++ SLS L+ LIIS + +            +L  +D+S N LV    
Sbjct: 32  YISELW-----TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK--- 83

Query: 96  SSIGKLINLQDLILNSNQLTG-EIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEV 154
            S    +NL+ L L+ N      I KE G   +LK L L   +L       +  + +L +
Sbjct: 84  ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNI 140

Query: 155 IRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSG- 213
            +             +    Q      L            +  +S     ++  + +   
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200

Query: 214 ----------EIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQK---LEKMLLWQNNFD 260
                      I  ++    +L +L L   + + +    + +L     +    +      
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260

Query: 261 GAIPEEIGNC-----KSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVL 315
           G +     +      K+L    +  + F       +   S++     + +          
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320

Query: 316 SNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTG-SLHPGLF 374
           S  +  L L    N ++                L    +L    L  N L   S    + 
Sbjct: 321 SKISPFLHLDFSNNLLT-------DTVFENCGHLTELETL---ILQMNQLKELSKIAEMT 370

Query: 375 -QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS 433
            Q+++L +L +  N +S       G+CS               L  LN+S+N L  T+  
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKK--GDCSWT-----------KSLLSLNMSSNILTDTIFR 417

Query: 434 SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLD 493
            L    R++VLD+  N+   + P+   +L +L  L ++ N           R  SLQ + 
Sbjct: 418 CL--PPRIKVLDLHSNKIKSI-PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIW 474

Query: 494 LSSN 497
           L +N
Sbjct: 475 LHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  116 bits (293), Expect = 2e-27
 Identities = 72/498 (14%), Positives = 152/498 (30%), Gaps = 72/498 (14%)

Query: 81  TTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSG 140
             +D S N L+  VP  + +      L ++ N ++     ++ +  KL+ L++  N +  
Sbjct: 3   FLVDRSKNGLIH-VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59

Query: 141 NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSK 200
                      LE +    NK                                       
Sbjct: 60  LDISVFKFNQELEYLDLSHNK--------------------------------------- 80

Query: 201 LQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPR--ELGKLQKLEKMLLWQNN 258
           L  +S                   L  L L  N    +LP   E G + +L+ + L   +
Sbjct: 81  LVKIS-------------CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTH 126

Query: 259 FDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNA 318
            + +    I +    K + +    +     +    L       L     +      + + 
Sbjct: 127 LEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPTNKEFHFILDV 184

Query: 319 TSLLQLQLDTNQISVF-FAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQ 377
           +      L+ + I       +     SI + L     L  + L++   T +    + QL 
Sbjct: 185 SVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244

Query: 378 NLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLAS 437
             T +   S  IS +      +          S  +   L +  + ++  G         
Sbjct: 245 WHTTVWYFS--ISNVKLQGQLDFRDFD----YSGTSLKALSIHQVVSDVFGFPQSYIYEI 298

Query: 438 LTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN 497
            + + + + +V+    +      +++    L  S N  +  +  + G    L++L L  N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358

Query: 498 KLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQI-SALNKLSILDLSHNKLGGDLLA 554
           +L  ++         +     L++S N++S        S    L  L++S N L  D + 
Sbjct: 359 QLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL-TDTIF 416

Query: 555 LSGLDNLVSLNVSYNNFT 572
                 +  L++  N   
Sbjct: 417 RCLPPRIKVLDLHSNKIK 434

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.9 bits (223), Expect = 9e-19
 Identities = 58/386 (15%), Positives = 121/386 (31%), Gaps = 48/386 (12%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSL 321
            +P+++   +    +++S N+ S        +LS L  L++S+N I      V      L
Sbjct: 14  HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71

Query: 322 LQLQLDTNQI-SVFFAW----------QNKLEGSIP--STLANCRSLEAVDLSHNALTGS 368
             L L  N++  +               N  + ++P      N   L+ + LS   L  S
Sbjct: 72  EYLDLSHNKLVKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKS 130

Query: 369 LHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL-------------MSFGNCT 415
               +  L     LL++         PE     +   L +             +S     
Sbjct: 131 SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVA 190

Query: 416 QLQMLNLSNNTLGGTLPSSLA--------------SLTRLQVLDISVNQFVGLIPESFGQ 461
            L++ N+            L+              +L  ++    S  + + L+  +   
Sbjct: 191 NLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVW 250

Query: 462 LASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSW 521
             S++ + L           S    ++L    + S+         ++EI       N + 
Sbjct: 251 YFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF-PQSYIYEIFSNMNIKNFTV 309

Query: 522 NALSGAIPPQISALNKLSILDLSHNKLGGDLL-ALSGLDNLVSLNVSYNNFTGYLPDSKL 580
           +          S ++    LD S+N L   +      L  L +L +  N        +++
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369

Query: 581 FRQLSATE---MAGNQGLCSRGHESC 603
             Q+ + +   ++ N          C
Sbjct: 370 TTQMKSLQQLDISQNSVSYDEKKGDC 395

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 81.1 bits (200), Expect = 7e-16
 Identities = 49/230 (21%), Positives = 79/230 (34%), Gaps = 25/230 (10%)

Query: 358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQL 417
           VD S N L   +   L Q    T L +  N IS L                    + ++L
Sbjct: 5   VDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWT--------------SDILSLSKL 47

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF-S 476
           ++L +S+N +     S       L+ LD+S N+ V +   S     +L  L LS N+F +
Sbjct: 48  RILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKI---SCHPTVNLKHLDLSFNAFDA 104

Query: 477 GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALN 536
             I    G    L+ L LS+  L     + +  +    + L L               L 
Sbjct: 105 LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGE---KEDPEGLQ 161

Query: 537 KLSILDLSHNKL-GGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS 585
             +   L        +   +  +      N+  +N    L D+K    LS
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 67.6 bits (165), Expect = 1e-11
 Identities = 45/209 (21%), Positives = 77/209 (36%), Gaps = 15/209 (7%)

Query: 32  VTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLV 91
           ++   + S     P        S +     + S             +    +D S+N L 
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT 337

Query: 92  GGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLL---LFDNYLSGNLPVEL-G 147
             V  + G L  L+ LIL  NQL  E+ K      ++K+L    +  N +S +       
Sbjct: 338 DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396

Query: 148 KLVNLEVIRAGGNKDIAGKIPYEIGDC--QSLLVVGLADTKVAGSLPASLGKLSKLQSLS 205
              +L  +    N      +   I  C    + V+ L   K+  S+P  + KL  LQ L+
Sbjct: 397 WTKSLLSLNMSSN-----ILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELN 450

Query: 206 VYTTMLSGEIPPQI-GNCSELVDLFLYEN 233
           V +  L   +P  I    + L  ++L+ N
Sbjct: 451 VASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 63.0 bits (153), Expect = 3e-10
 Identities = 47/292 (16%), Positives = 97/292 (33%), Gaps = 34/292 (11%)

Query: 22  SHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCT--- 78
              T    + +T  NI++          L   + +    IS   L G +     D +   
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274

Query: 79  --QLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDN 136
              L+   V S+              N+       +                 +L   +N
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334

Query: 137 YLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLG 196
            L+  +    G L  LE +    N+             + L             +     
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQ------------LKEL-----------SKIAEMTT 371

Query: 197 KLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLW 255
           ++  LQ L +    +S +           L+ L +  N L+ ++ R L    +++ + L 
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLH 429

Query: 256 QNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQ-SFGNLSSLEELMLSNNN 306
            N    +IP+++   ++L+ ++++ N    S+P   F  L+SL+++ L  N 
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNP 479

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  130 bits (329), Expect = 3e-32
 Identities = 68/306 (22%), Positives = 127/306 (41%), Gaps = 57/306 (18%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           + L  +  +G G  G V+ A       +AVK + P +M+                ++F A
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---------------VEAFLA 232

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E   + +++H  +V+           ++  ++M  GSL   L     S            
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291

Query: 806 GAAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
             A+G+A++   + +    HRD++A NIL+       IADFGLA+++ + ++        
Sbjct: 292 QIAEGMAFIEQRNYI----HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG--- 344

Query: 865 GSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVR 918
                      APE       T KSDV+S+G++++E++T G+ P       G+   +   
Sbjct: 345 ---AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-----PGMSNPE--- 393

Query: 919 QKRGAIEVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
                I  L++  R  RPE    E+   M++       C    P++RPT + + +++ + 
Sbjct: 394 ----VIRALERGYRMPRPENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDDF 442

Query: 974 KQEREE 979
               E 
Sbjct: 443 YTATES 448

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (327), Expect = 4e-32
 Identities = 70/305 (22%), Positives = 117/305 (38%), Gaps = 60/305 (19%)

Query: 676 KLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIG 735
           K++F  + VL         G G  G +    M +   +AVK++ P               
Sbjct: 23  KISFCPKDVL---------GHGAEGTIVYRGMFDNRDVAVKRILPECF------------ 61

Query: 736 IGGVRDSFSAEIKTL-GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC 794
                     E++ L  S  H N++R+     +R  + +  +     +L   + ++  + 
Sbjct: 62  -----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAH 115

Query: 795 LEWELRYRIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY-----IADFGLA 848
           L  E    ++     GLA+LH  +    IVHRD+K +NILI            I+DFGL 
Sbjct: 116 LGLEPI-TLLQQTTSGLAHLHSLN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170

Query: 849 KLVVEGDFARSS-NTVAGSYGYIAPEY---GYMMKITEKSDVYSYGVVVLEVLT-GKQPI 903
           K +  G  + S  + V G+ G+IAPE          T   D++S G V   V++ G  P 
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF 230

Query: 904 DPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVE--IEEMLQTLGVALLCVNPTPDDRP 961
             ++    +I         +++ L             IE+M+             P  RP
Sbjct: 231 GKSLQRQANI----LLGACSLDCLHPEKHEDVIARELIEKMIA----------MDPQKRP 276

Query: 962 TMKDV 966
           + K V
Sbjct: 277 SAKHV 281

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  127 bits (320), Expect = 5e-32
 Identities = 72/312 (23%), Positives = 111/312 (35%), Gaps = 67/312 (21%)

Query: 693 VVGKGCSGIVYRAEMENGE------VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
            +G G  G VY  ++           +AVK L       +                F  E
Sbjct: 37  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-------------ELDFLME 83

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE-LRYRIIL 805
              +    H+NIVR +G       R ++ + M  G L S L E R    +   L    +L
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143

Query: 806 G----AAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDF 856
                 A G  YL  +H      +HRDI A N L+          I DFG+A+ +    +
Sbjct: 144 HVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198

Query: 857 ARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 907
            R      G    +      PE    G     T K+D +S+GV++ E+ + G  P  P+ 
Sbjct: 199 YRK-----GGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPY-PSK 249

Query: 908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                ++++V         +D        V  I  M Q       C    P+DRP    +
Sbjct: 250 S-NQEVLEFVTSGG----RMDPPKNCPGPVYRI--MTQ-------CWQHQPEDRPNFAII 295

Query: 967 AAMIKEIKQERE 978
              I+   Q+ +
Sbjct: 296 LERIEYCTQDPD 307

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  126 bits (319), Expect = 6e-32
 Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 65/313 (20%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEM---ENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
             +  + ++G G SG V    +      +V +A+K L       +             R 
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-------------RR 95

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
            F +E   +G   H NI+R  G        +++ +YM NGSL + L          +L  
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-V 154

Query: 802 RIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
            ++ G   G+ YL          VHRD+ A N+L+       ++DFGL++++ +   A  
Sbjct: 155 GMLRGVGAGMRYLSDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA-- 207

Query: 860 SNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEG 910
                 + G I     APE   +      +  SDV+S+GVV+ EVL  G++P        
Sbjct: 208 --AYTTTGGKIPIRWTAPEAIAFR---TFSSASDVWSFGVVMWEVLAYGERPYW------ 256

Query: 911 LHIVDWVRQKRGAIEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKD 965
               +   +    I  +++  R   P      + + ML        C +     RP    
Sbjct: 257 ----NMTNRD--VISSVEEGYRLPAPMGCPHALHQLMLD-------CWHKDRAQRPRFSQ 303

Query: 966 VAAMIKEIKQERE 978
           + +++  + +  E
Sbjct: 304 IVSVLDALIRSPE 316

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  126 bits (318), Expect = 6e-32
 Identities = 75/320 (23%), Positives = 119/320 (37%), Gaps = 75/320 (23%)

Query: 695 GKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           G G  G V  A        +    +AVK L P+    E             R++  +E+K
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-------------REALMSELK 78

Query: 749 TLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
            L  +  H NIV  LG C      L++ +Y   G L + L  +RDS +  +    I+   
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 808 ----------------AQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
                           A+G+A+L   +      +HRD+ A NIL+       I DFGLA+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 850 LVVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GK 900
            +                  +     APE          T +SDV+SYG+ + E+ + G 
Sbjct: 194 DIKNDSNYV-----VKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGS 245

Query: 901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDD 959
            P  P +P        +++       +     A  E+ +I  M         C +  P  
Sbjct: 246 SPY-PGMPVDSKFYKMIKEGF----RMLSPEHAPAEMYDI--MKT-------CWDADPLK 291

Query: 960 RPTMKDVAAMIKEIKQEREE 979
           RPT K +  +I++   E   
Sbjct: 292 RPTFKQIVQLIEKQISESTN 311

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  125 bits (317), Expect = 8e-32
 Identities = 65/319 (20%), Positives = 117/319 (36%), Gaps = 74/319 (23%)

Query: 695 GKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           G+G  G V  A+            +AVK L      +E               +  +E+K
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-------------HRALMSELK 82

Query: 749 TLGSI-RHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
            L  I  H N+V  LG C      L++  ++   G+L + L  +R+  + +++    +  
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 807 A--------------AQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
                          A+G+ +L          +HRD+ A NIL+  +    I DFGLA+ 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARD 197

Query: 851 VVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQ 901
           + +                +     APE          T +SDV+S+GV++ E+ + G  
Sbjct: 198 IYKDPDYV-----RKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGAS 249

Query: 902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDR 960
           P  P +         +++       +       PE+ +   ML        C +  P  R
Sbjct: 250 PY-PGVKIDEEFCRRLKEGT----RMRAPDYTTPEMYQT--MLD-------CWHGEPSQR 295

Query: 961 PTMKDVAAMIKEIKQEREE 979
           PT  ++   +  + Q   +
Sbjct: 296 PTFSELVEHLGNLLQANAQ 314

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  126 bits (319), Expect = 9e-32
 Identities = 76/341 (22%), Positives = 126/341 (36%), Gaps = 82/341 (24%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGE------VIAVKKLWPTTMAAEYDCQNDKIGIGGV 739
           + L    V+G G  G V  A             +AVK L     ++E             
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE------------- 91

Query: 740 RDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           R++  +E+K +  +  H+NIV  LG C       L+++Y   G L + L  +R+   E E
Sbjct: 92  REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151

Query: 799 LRYRIILGA---------------------AQGLAYL--HHDCVPPIVHRDIKANNILIG 835
           + Y                           A+G+ +L          VHRD+ A N+L+ 
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVT 206

Query: 836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVY 887
                 I DFGLA+ ++                 +     APE    G     T KSDV+
Sbjct: 207 HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEG---IYTIKSDVW 258

Query: 888 SYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ-KRGAIEVLDKSLRARPEV-EIEEMLQ 944
           SYG+++ E+ + G  P  P IP   +    ++   +     +D+   A  E+  I  M  
Sbjct: 259 SYGILLWEIFSLGVNPY-PGIPVDANFYKLIQNGFK-----MDQPFYATEEIYII--MQS 310

Query: 945 TLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDM 985
                  C       RP+  ++ + +     + EE M  ++
Sbjct: 311 -------CWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV 344

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  125 bits (317), Expect = 9e-32
 Identities = 69/319 (21%), Positives = 124/319 (38%), Gaps = 65/319 (20%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGE----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
             L+   ++G+G  G V    ++  +     +AVK     TM  +   Q +        +
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK-----TMKLDNSSQRE-------IE 81

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-----YMPNGSLGSLLHERRDSCLE 796
            F +E   +    H N++R LG C   +++ +        +M  G L + L   R     
Sbjct: 82  EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141

Query: 797 WELRYR----IILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
             +  +     ++  A G+ YL   +      +HRD+ A N ++  +    +ADFGL+K 
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKK 196

Query: 851 VVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQ 901
           +  GD+ R      G    +     A E          T KSDV+++GV + E+ T G  
Sbjct: 197 IYSGDYYR-----QGRIAKMPVKWIAIESLADR---VYTSKSDVWAFGVTMWEIATRGMT 248

Query: 902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDR 960
           P  P +     + D++         L +      E+ EI  M         C    P DR
Sbjct: 249 PY-PGVQ-NHEMYDYLLHGH----RLKQPEDCLDELYEI--MYS-------CWRTDPLDR 293

Query: 961 PTMKDVAAMIKEIKQEREE 979
           PT   +   ++++ +   +
Sbjct: 294 PTFSVLRLQLEKLLESLPD 312

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  125 bits (315), Expect = 9e-32
 Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 57/297 (19%)

Query: 695 GKGCSGIVYRAEMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G G  G VY    +   + +AVK L   TM                 + F  E   +  I
Sbjct: 22  GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------------VEEFLKEAAVMKEI 66

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           +H N+V+ LG C       ++ ++M  G+L   L E     +   +   +    +  + Y
Sbjct: 67  KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126

Query: 814 L-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI-- 870
           L   + +    HRD+ A N L+G      +ADFGL++L+    +   +            
Sbjct: 127 LEKKNFI----HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG------AKFPI 176

Query: 871 ---APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
              APE     K + KSDV+++GV++ E+ T G  P       G+ +           E+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQ-------VYEL 224

Query: 927 LDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
           L+K  R  RPE    ++ E M         C    P DRP+  ++    + + QE  
Sbjct: 225 LEKDYRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFETMFQESS 274

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  125 bits (317), Expect = 1e-31
 Identities = 75/326 (23%), Positives = 125/326 (38%), Gaps = 80/326 (24%)

Query: 687 CLVEDSVVGKGCSGIVYRAEMENGEV---IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF 743
            +    V+G+G  G V +A ++   +    A+K++       +                F
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-------------HRDF 72

Query: 744 SAEIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY- 801
           + E++ L  +  H NI+  LG C +R    L  +Y P+G+L   L + R    +      
Sbjct: 73  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132

Query: 802 -------------RIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
                              A+G+ YL          +HRD+ A NIL+G  +   IADFG
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFG 187

Query: 847 LAKLVVEGDFARSSNT-VAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVL 897
           L         +R     V  + G +     A E   Y      T  SDV+SYGV++ E++
Sbjct: 188 L---------SRGQEVYVKKTMGRLPVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIV 235

Query: 898 T-GKQPIDPTIP--EGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCV 953
           + G  P    +   E    +      +G    L+K L    EV ++  M Q       C 
Sbjct: 236 SLGGTPY-CGMTCAELYEKL-----PQG--YRLEKPLNCDDEVYDL--MRQ-------CW 278

Query: 954 NPTPDDRPTMKDVAAMIKEIKQEREE 979
              P +RP+   +   +  + +ER+ 
Sbjct: 279 REKPYERPSFAQILVSLNRMLEERKT 304

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (320), Expect = 1e-31
 Identities = 71/312 (22%), Positives = 110/312 (35%), Gaps = 67/312 (21%)

Query: 693 VVGKGCSGIVYRAEMENGE------VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
            +G G  G VY  ++           +AVK L       +                F  E
Sbjct: 78  GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-------------ELDFLME 124

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW-ELRYR--- 802
              +    H+NIVR +G       R ++ + M  G L S L E R    +   L      
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184

Query: 803 -IILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDF 856
            +    A G  YL  +H      +HRDI A N L+          I DFG+A+ +    +
Sbjct: 185 HVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239

Query: 857 ARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI 907
            R      G    +      PE    G     T K+D +S+GV++ E+ + G  P  P+ 
Sbjct: 240 YRK-----GGCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPY-PSK 290

Query: 908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                ++++V         +D        V  I  M Q       C    P+DRP    +
Sbjct: 291 S-NQEVLEFVTSGG----RMDPPKNCPGPVYRI--MTQ-------CWQHQPEDRPNFAII 336

Query: 967 AAMIKEIKQERE 978
              I+   Q+ +
Sbjct: 337 LERIEYCTQDPD 348

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  124 bits (314), Expect = 1e-31
 Identities = 55/239 (23%), Positives = 87/239 (36%), Gaps = 57/239 (23%)

Query: 695 GKGCSGIVYRAEMENGE------VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           G+   G VY+  +           +A+K L                     R+ F  E  
Sbjct: 18  GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-------------REEFRHEAM 64

Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR------ 802
               ++H N+V  LG         +++ Y  +G L   L  R                  
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 803 --------IILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV 852
                   ++   A G+ YL  HH     +VH+D+   N+L+  +    I+D GL + V 
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

Query: 853 EGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQP 902
             D+ +           +     APE   YG   K +  SD++SYGVV+ EV + G QP
Sbjct: 180 AADYYK-----LLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFSYGLQP 230

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  125 bits (316), Expect = 1e-31
 Identities = 77/325 (23%), Positives = 121/325 (37%), Gaps = 85/325 (26%)

Query: 695 GKGCSGIVYRAEM-----ENGEVI-AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           G+G  G V +A         G    AVK L      +E                  +E  
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE-------------LRDLLSEFN 78

Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA- 807
            L  + H ++++  G C      LL+ +Y   GSL   L E R     +         + 
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 808 ---------------------AQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                                +QG+ YL         +VHRD+ A NIL+    +  I+D
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISD 193

Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEV 896
           FGL++ V E D          S G I     A E          T +SDV+S+GV++ E+
Sbjct: 194 FGLSRDVYEEDSYV-----KRSQGRIPVKWMAIESLFDH---IYTTQSDVWSFGVLLWEI 245

Query: 897 LT-GKQPIDPTIP--EGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLC 952
           +T G  P  P IP     +++     K G    +++      E+  +  MLQ       C
Sbjct: 246 VTLGGNPY-PGIPPERLFNLL-----KTG--HRMERPDNCSEEMYRL--MLQ-------C 288

Query: 953 VNPTPDDRPTMKDVAAMIKEIKQER 977
               PD RP   D++  ++++  +R
Sbjct: 289 WKQEPDKRPVFADISKDLEKMMVKR 313

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  125 bits (315), Expect = 2e-31
 Identities = 63/320 (19%), Positives = 119/320 (37%), Gaps = 66/320 (20%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGE----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           +      ++GKG  G V  A+++  +     +AVK L    +A+               +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS------------DIE 70

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD------YMPNGSLGSLLHERRDSCL 795
            F  E   +    H ++ + +G       +  +        +M +G L + L   R    
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130

Query: 796 EWELRYRIILG----AAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
            + L  + ++      A G+ YL   +      +HRD+ A N ++  +    +ADFGL++
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSR 185

Query: 850 LVVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GK 900
            +  GD+ R      G    +     A E          T  SDV+++GV + E++T G+
Sbjct: 186 KIYSGDYYR-----QGCASKLPVKWLALESLADN---LYTVHSDVWAFGVTMWEIMTRGQ 237

Query: 901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDD 959
            P    I     I +++         L +      EV ++  M Q       C +  P  
Sbjct: 238 TPY-AGIE-NAEIYNYLIGGN----RLKQPPECMEEVYDL--MYQ-------CWSADPKQ 282

Query: 960 RPTMKDVAAMIKEIKQEREE 979
           RP+   +   ++ I      
Sbjct: 283 RPSFTCLRMELENILGHLSV 302

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  124 bits (313), Expect = 2e-31
 Identities = 61/291 (20%), Positives = 106/291 (36%), Gaps = 27/291 (9%)

Query: 291 FGNLSSLEELMLSNNNISGSIPPV-LSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTL 349
           +G   SLE L+   +  +       +  + SL +L +   +I       +++       L
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIP------SRILFGALRVL 92

Query: 350 ANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLM 409
                L+ + L +  +TG+  P L +       +L    +S               L  +
Sbjct: 93  -GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW--------LAEL 143

Query: 410 SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPES----FGQLASL 465
                  L++L+++           +     L  LD+S N  +G           +  +L
Sbjct: 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203

Query: 466 NRLILSKN---SFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWN 522
             L L      + SG   +       LQ LDLS N L         +      SLNLS+ 
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263

Query: 523 ALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTG 573
            L   +P  + A  KLS+LDLS+N+L     +   L  + +L++  N F  
Sbjct: 264 GLK-QVPKGLPA--KLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.1 bits (226), Expect = 6e-20
 Identities = 59/310 (19%), Positives = 97/310 (31%), Gaps = 62/310 (20%)

Query: 182 LADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQ---IGNCSELVDLFLYENDLSGS 238
             DT+        + K   L+ L+V    +   I      +   S L +L L   +++G+
Sbjct: 51  RVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGT 110

Query: 239 LPRELGKLQ--KLEKMLLWQNNFDG--AIPEEIGNC--KSLKTIDLSLNFFSGSLPQSFG 292
            P  L +     L  + L   ++    A   E+       LK + ++         +   
Sbjct: 111 APPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVR 170

Query: 293 NLSSLEELMLSNNNISGSIP----PVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPST 348
              +L  L LS+N   G              +L  L L    +           G   + 
Sbjct: 171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM-------ETPSGVCSAL 223

Query: 349 LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
            A    L+ +DLSHN+L  +                                        
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCD--------------------------------- 250

Query: 409 MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRL 468
                 +QL  LNLS   L   +P  L +  +L VLD+S N+       S  +L  +  L
Sbjct: 251 ----WPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNL 301

Query: 469 ILSKNSFSGA 478
            L  N F  +
Sbjct: 302 SLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 79.6 bits (196), Expect = 5e-16
 Identities = 41/246 (16%), Positives = 75/246 (30%), Gaps = 38/246 (15%)

Query: 349 LANCRSLEAVDLSHNALTGSLH-PGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR 407
               RSLE +    +          + +  +L +L + +  I   I              
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFG----------- 87

Query: 408 LMSFGNCTQLQMLNLSNNTLGGTLPSSLASLT--RLQVLDISVNQFVGLIPE----SFGQ 461
            +     + LQ L L N  + GT P  L   T   L +L++    +              
Sbjct: 88  ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWL 147

Query: 462 LASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSW 521
              L  L +++          +    +L +LDLS N   G+  +                
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL---------------- 191

Query: 522 NALSGAIPPQISALNKLSILDLSHNKLGGDLLAL-SGLDNLVSLNVSYNNFTGYLPDSKL 580
             +S   P +   L  L++ +       G   AL +    L  L++S+N+       +  
Sbjct: 192 --ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD-AAGAPS 248

Query: 581 FRQLSA 586
               S 
Sbjct: 249 CDWPSQ 254

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 49/287 (17%), Positives = 83/287 (28%), Gaps = 49/287 (17%)

Query: 95  PSSIGKLINLQDLILNSNQLTGEIPKELGACI---KLKNLLLFDNYLSGNLPVELGKLV- 150
            + I K ++L+ L + + ++   I       +    L+ L L +  ++G  P  L +   
Sbjct: 61  FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120

Query: 151 -NLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTT 209
            +L ++               + + Q  L                      L+ LS+   
Sbjct: 121 PDLNILNLRNVSWA--TRDAWLAELQQWL-------------------KPGLKVLSIAQA 159

Query: 210 MLSGEIPPQIGNCSELVDLFLYENDLSGSLPRE----LGKLQKLEKMLLWQNNF---DGA 262
                   Q+     L  L L +N   G           K   L+ + L         G 
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219

Query: 263 IPEEIGNCKSLKTIDLSLNFFSGSLP-QSFGNLSSLEELMLSNNNISGSIPPVLSNATSL 321
                     L+ +DLS N    +    S    S L  L LS   +   +P  L     L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKL 276

Query: 322 LQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS 368
             L L  N++              PS       +  + L  N    S
Sbjct: 277 SVLDLSYNRLD-----------RNPSPD-ELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.8 bits (163), Expect = 7e-12
 Identities = 47/301 (15%), Positives = 88/301 (29%), Gaps = 39/301 (12%)

Query: 23  HITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPD---LGDCTQ 79
            +    ++    +     E +L   +++     L++L +  + +   I      +   + 
Sbjct: 37  ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96

Query: 80  LTTIDVSSNSLVGGVPSSIGKLI--NLQDLILNSNQLTGE--IPKELGACIK--LKNLLL 133
           L  + + +  + G  P  + +    +L  L L +           EL   +K  LK L +
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156

Query: 134 FDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPA 193
              +       ++     L  +    N    G+       C                   
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNP-ELGERGLISALC------------------- 196

Query: 194 SLGKLSKLQSLSV---YTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPREL-GKLQKL 249
              K   LQ L++        SG          +L  L L  N L  +          +L
Sbjct: 197 -PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
             + L        +P+ +     L  +DLS N      P S   L  +  L L  N    
Sbjct: 256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310

Query: 310 S 310
           S
Sbjct: 311 S 311

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  127 bits (321), Expect = 3e-31
 Identities = 69/297 (23%), Positives = 114/297 (38%), Gaps = 63/297 (21%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +GKG  G V   +    +V AVK +     A                  F AE   +  
Sbjct: 200 TIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA----------------FLAEASVMTQ 242

Query: 753 IRHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           +RH N+V+ LG        L +  +YM  GSL   L  R  S L  +   +  L   + +
Sbjct: 243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302

Query: 812 AYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
            YL  ++ V    HRD+ A N+L+  +    ++DFGL K                  G +
Sbjct: 303 EYLEGNNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----------DTGKL 348

Query: 871 -----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
                APE     K + KSDV+S+G+++ E+ + G+ P  P IP            +  +
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIP-----------LKDVV 396

Query: 925 EVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
             ++K  +   P+     + + M         C +     RPT   +   ++ I+  
Sbjct: 397 PRVEKGYKMDAPDGCPPAVYDVMKN-------CWHLDAATRPTFLQLREQLEHIRTH 446

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  123 bits (310), Expect = 3e-31
 Identities = 68/297 (22%), Positives = 113/297 (38%), Gaps = 63/297 (21%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +GKG  G V   +    +V AVK +     A                  F AE   +  
Sbjct: 28  TIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQA----------------FLAEASVMTQ 70

Query: 753 IRHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           +RH N+V+ LG        L +  +YM  GSL   L  R  S L  +   +  L   + +
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130

Query: 812 AYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
            YL  ++ V    HRD+ A N+L+  +    ++DFGL K                  G +
Sbjct: 131 EYLEGNNFV----HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----------DTGKL 176

Query: 871 -----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI 924
                APE     K + KSDV+S+G+++ E+ + G+ P        + + D        +
Sbjct: 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKD-------VV 224

Query: 925 EVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
             ++K  +   P+     + E M         C +     RP+   +   ++ IK  
Sbjct: 225 PRVEKGYKMDAPDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEHIKTH 274

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  124 bits (314), Expect = 3e-31
 Identities = 76/316 (24%), Positives = 130/316 (41%), Gaps = 70/316 (22%)

Query: 686 KCLVEDSVVGKGCSGIVYRA----EMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVR 740
            C+    V+G G  G VY+          EV +A+K L       +             R
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-------------R 90

Query: 741 DSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR 800
             F  E   +G   H NI+R  G        +++ +YM NG+L   L E+       +L 
Sbjct: 91  VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL- 149

Query: 801 YRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
             ++ G A G+ YL   +      VHRD+ A NIL+       ++DFGL++++   D   
Sbjct: 150 VGMLRGIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPE 202

Query: 859 SSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPE 909
           ++ T +G  G I     APE   Y    K T  SDV+S+G+V+ EV+T G++P       
Sbjct: 203 ATYTTSG--GKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERPYW----- 252

Query: 910 GLHIVDWVRQKRGAIEVLDKSLR-ARPEV------EIEEMLQTLGVALLCVNPTPDDRPT 962
                +    +   ++ ++   R   P        ++  M+Q       C       RP 
Sbjct: 253 -----ELSNHE--VMKAINDGFRLPTPMDCPSAIYQL--MMQ-------CWQQERARRPK 296

Query: 963 MKDVAAMIKEIKQERE 978
             D+ +++ ++ +  +
Sbjct: 297 FADIVSILDKLIRAPD 312

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  124 bits (313), Expect = 4e-31
 Identities = 71/313 (22%), Positives = 116/313 (37%), Gaps = 71/313 (22%)

Query: 695 GKGCSGIVYRAEM-----ENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           G G  G V  A       E+  + +AVK L  T  A E             +++  +E+K
Sbjct: 55  GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE-------------KEALMSELK 101

Query: 749 TLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY------ 801
            +  + +H+NIV  LG C +    L++ +Y   G L + L  +                 
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 802 ------RIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
                       AQG+A+L   +      +HRD+ A N+L+       I DFGLA+ ++ 
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216

Query: 854 GDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPID 904
                           +     APE          T +SDV+SYG+++ E+ + G  P  
Sbjct: 217 DSNYI-----VKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFSLGLNPY- 267

Query: 905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDRPTM 963
           P I         V+        + +   A   +  I  M         C    P  RPT 
Sbjct: 268 PGILVNSKFYKLVKDGY----QMAQPAFAPKNIYSI--MQA-------CWALEPTHRPTF 314

Query: 964 KDVAAMIKEIKQE 976
           + + + ++E  QE
Sbjct: 315 QQICSFLQEQAQE 327

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  123 bits (312), Expect = 5e-31
 Identities = 71/303 (23%), Positives = 123/303 (40%), Gaps = 58/303 (19%)

Query: 693 VVGKGCSGIVYRA----EMENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           V+G G  G VY+     E E  ++ +A+K+L   T                       E 
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA-------------NKEILDEA 68

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
             + S+ + ++ R LG C     +L+    MP G L   + E +D+     L     +  
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLN-WCVQI 126

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
           A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +       
Sbjct: 127 AKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EG 178

Query: 868 GYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKR 921
           G +     A E       T +SDV+SYGV V E++T G +P      +G+   +      
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY-----DGIPASE------ 227

Query: 922 GAIEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
               +L+K  R  +P    +++   M++       C     D RP  +++     ++ ++
Sbjct: 228 -ISSILEKGERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFRELIIEFSKMARD 279

Query: 977 REE 979
            + 
Sbjct: 280 PQR 282

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (315), Expect = 5e-31
 Identities = 78/328 (23%), Positives = 122/328 (37%), Gaps = 80/328 (24%)

Query: 686 KCLVEDSVVGKGCSGIVYRAE--------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIG 737
             L     +G+GC G V  AE         +    +AVK L       +           
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD----------- 129

Query: 738 GVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
                  +E++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR   +E
Sbjct: 130 --LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187

Query: 797 WELRYRIILGA--------------AQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEP 840
           +      +                 A+G+ YL          +HRD+ A N+L+      
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVM 242

Query: 841 YIADFGLAKLVVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVV 892
            IADFGLA+ +   D+ +       + G +     APE          T +SDV+S+GV+
Sbjct: 243 KIADFGLARDINNIDYYK-----KTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVL 294

Query: 893 VLEVLT-GKQPIDPTIP--EGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGV 948
           + E+ T G  P  P IP  E   ++     K G    +DK      E+  +  M      
Sbjct: 295 MWEIFTLGGSPY-PGIPVEELFKLL-----KEG--HRMDKPANCTNELYMM--MRD---- 340

Query: 949 ALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
              C +  P  RPT K +   +  I   
Sbjct: 341 ---CWHAVPSQRPTFKQLVEDLDRILTL 365

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (312), Expect = 5e-31
 Identities = 77/340 (22%), Positives = 125/340 (36%), Gaps = 77/340 (22%)

Query: 686 KCLVEDSVVGKGCSGIVYRAE--------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIG 737
             L     +G+G  G V  AE         +    +AVK L       +           
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD----------- 83

Query: 738 GVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
                  +E++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR   +E
Sbjct: 84  --LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 141

Query: 797 WELRYRIILGA--------------AQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEP 840
           +      +                 A+G+ YL          +HRD+ A N+L+      
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVM 196

Query: 841 YIADFGLAKLVVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVV 892
            IADFGLA+ +   D+ +       + G +     APE          T +SDV+S+GV+
Sbjct: 197 KIADFGLARDINNIDYYK-----KTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVL 248

Query: 893 VLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVAL 950
           + E+ T G  P  P IP    +   +++       +DK      E+  +  M        
Sbjct: 249 MWEIFTLGGSPY-PGIP-VEELFKLLKEGH----RMDKPANCTNELYMM--MRD------ 294

Query: 951 LCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDM-LPSE 989
            C +  P  RPT K +   +  I         +D+  P E
Sbjct: 295 -CWHAVPSQRPTFKQLVEDLDRILTLTTNEEYLDLSQPLE 333

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  122 bits (308), Expect = 6e-31
 Identities = 67/313 (21%), Positives = 115/313 (36%), Gaps = 66/313 (21%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEM---ENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           + +     +G+G  G V++      EN  + +A+K     T  +              R+
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-------------RE 61

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
            F  E  T+    H +IV+ +G     N   ++ +    G L S L  R+ S     L  
Sbjct: 62  KFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASL-I 119

Query: 802 RIILGAAQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
                 +  LAYL     V    HRDI A N+L+       + DFGL++ + +  + ++S
Sbjct: 120 LYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175

Query: 861 NTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL 911
                  G +     APE   +    + T  SDV+ +GV + E+L  G +P         
Sbjct: 176 K------GKLPIKWMAPESINFR---RFTSASDVWMFGVCMWEILMHGVKPF-------- 218

Query: 912 HIVDWVRQKRGAIEVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDV 966
                  +    I  ++   R   P      +   M +       C    P  RP   ++
Sbjct: 219 ----QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTEL 267

Query: 967 AAMIKEIKQEREE 979
            A +  I +E + 
Sbjct: 268 KAQLSTILEEEKA 280

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  122 bits (308), Expect = 7e-31
 Identities = 73/316 (23%), Positives = 128/316 (40%), Gaps = 72/316 (22%)

Query: 686 KCLVEDSVVGKGCSGIVYRAE--MENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           + +V + ++G+G  G VY        GE I  AVK                       ++
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN-------------KE 58

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
            F +E   + ++ H +IV+ +G      T ++M +  P G LG  L   ++S     L  
Sbjct: 59  KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTL-V 116

Query: 802 RIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
              L   + +AYL   +      VHRDI   NIL+       + DFGL++ + + D+ ++
Sbjct: 117 LYSLQICKAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171

Query: 860 SNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEG 910
           S         +     +PE   +    + T  SDV+ + V + E+L+ GKQP        
Sbjct: 172 SV------TRLPIKWMSPESINFR---RFTTASDVWMFAVCMWEILSFGKQPF-----FW 217

Query: 911 LHIVDWVRQKRGAIEVLDKSLR-ARPEV------EIEEMLQTLGVALLCVNPTPDDRPTM 963
           L   D        I VL+K  R  +P++       +  M +       C +  P DRP  
Sbjct: 218 LENKD-------VIGVLEKGDRLPKPDLCPPVLYTL--MTR-------CWDYDPSDRPRF 261

Query: 964 KDVAAMIKEIKQEREE 979
            ++   + ++ Q  ++
Sbjct: 262 TELVCSLSDVYQMEKD 277

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (314), Expect = 9e-31
 Identities = 76/322 (23%), Positives = 118/322 (36%), Gaps = 80/322 (24%)

Query: 695 GKGCSGIVYRAE--------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           G+G  G V  AE              +AVK L       +                  +E
Sbjct: 78  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-------------LSDLISE 124

Query: 747 IKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           ++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR   LE+        
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 806 GA--------------AQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
                           A+G+ YL          +HRD+ A N+L+  +    IADFGLA+
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLAR 239

Query: 850 LVVEGDFARSSNTVAGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GK 900
            +   D+ +       + G +     APE          T +SDV+S+GV++ E+ T G 
Sbjct: 240 DIHHIDYYK-----KTTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVLLWEIFTLGG 291

Query: 901 QPIDPTIP--EGLHIVDWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTP 957
            P  P +P  E   ++     K G    +DK      E+  +  M         C +  P
Sbjct: 292 SPY-PGVPVEELFKLL-----KEG--HRMDKPSNCTNELYMM--MRD-------CWHAVP 334

Query: 958 DDRPTMKDVAAMIKEIKQEREE 979
             RPT K +   +  I      
Sbjct: 335 SQRPTFKQLVEDLDRIVALTSN 356

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  122 bits (309), Expect = 1e-30
 Identities = 61/317 (19%), Positives = 112/317 (35%), Gaps = 61/317 (19%)

Query: 678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           ++   Q L         G+G    V   E + +G   A+K++         + Q      
Sbjct: 30  HYLFIQKL---------GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR----- 75

Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGSLLHERR 791
                    E        H NI+R +  C           LL+  +   G+L + +   +
Sbjct: 76  ---------EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL-PFFKRGTLWNEIERLK 125

Query: 792 DSCL---EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
           D      E ++   ++LG  +GL  +H        HRD+K  NIL+G E +P + D G  
Sbjct: 126 DKGNFLTEDQIL-WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181

Query: 849 KLVVEGDFARSSN-------TVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVL 897
                                   +  Y APE      + + I E++DV+S G V+  ++
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMM 240

Query: 898 TGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTP 957
            G+ P D    +G  +             +   L           L  L  +++ V+  P
Sbjct: 241 FGEGPYDMVFQKGDSVA----------LAVQNQLSIPQSPRHSSALWQLLNSMMTVD--P 288

Query: 958 DDRPTMKDVAAMIKEIK 974
             RP +  + + ++ ++
Sbjct: 289 HQRPHIPLLLSQLEALQ 305

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  122 bits (309), Expect = 1e-30
 Identities = 78/329 (23%), Positives = 140/329 (42%), Gaps = 66/329 (20%)

Query: 686 KCLVEDSVVGKGCSGIVYRA----EMENGEV-IAVK--KLWPTTMAAEYDCQNDKIGIGG 738
             L +  V+G G  G V++     E E+ ++ + +K  +      +              
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-------------- 58

Query: 739 VRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
              + +  +  +GS+ H +IVR LG C   + +L+   Y+P GSL   + + R +     
Sbjct: 59  -FQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQL 116

Query: 799 LRYRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           L     +  A+G+ YL  H      +VHR++ A N+L+    +  +ADFG+A L+   D 
Sbjct: 117 LLN-WGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170

Query: 857 ARSSNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEG 910
                    S         A E  +  K T +SDV+SYGV V E++T G +P       G
Sbjct: 171 QLLY-----SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY-----AG 220

Query: 911 LHIVDWVRQKRGAIEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKD 965
           L + +         ++L+K  R A+P+   +++   M++       C     + RPT K+
Sbjct: 221 LRLAE-------VPDLLEKGERLAQPQICTIDVYMVMVK-------CWMIDENIRPTFKE 266

Query: 966 VAAMIKEIKQEREECMKVDMLPSEGSANG 994
           +A     + ++    + +      G A G
Sbjct: 267 LANEFTRMARDPPRYLVIKRESGPGIAPG 295

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  124 bits (312), Expect = 1e-30
 Identities = 74/307 (24%), Positives = 122/307 (39%), Gaps = 59/307 (19%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEM---ENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
             +  D VVG G  G V    +      E+ +A+K L       +             R 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-------------RR 91

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
            F  E   +G   H NI+R  G        +++ +YM NGSL S L +        +L  
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-V 150

Query: 802 RIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
            ++ G A G+ YL          VHRD+ A NILI       ++DFGL +++ +      
Sbjct: 151 GMLRGIASGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLED----DP 201

Query: 860 SNTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHI 913
                   G I     +PE     K T  SDV+SYG+V+ EV++ G++P           
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY---------- 251

Query: 914 VDWVRQKRGAIEVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAA 968
             W    +  I+ +D+  R   P      + + ML        C     ++RP  + + +
Sbjct: 252 --WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVS 302

Query: 969 MIKEIKQ 975
           ++ ++ +
Sbjct: 303 ILDKLIR 309

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  123 bits (310), Expect = 1e-30
 Identities = 64/299 (21%), Positives = 116/299 (38%), Gaps = 42/299 (14%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
           +IP  +   +++K++DLS N  +           +L+ L+L++N I+ +I     S+  S
Sbjct: 45  SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQN 378
           L  L L  N +S           ++ S       SL  ++L  N         LF  L  
Sbjct: 102 LEHLDLSYNYLS-----------NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTK 150

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
           L  L +             GN  +  +++   F   T L+ L +  + L    P SL S+
Sbjct: 151 LQILRV-------------GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197

Query: 439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG----AIPS----SLGRCESLQ 490
             +  L + + Q + L+       +S+  L L            + +    SL +  + +
Sbjct: 198 QNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFR 257

Query: 491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQI-SALNKLSILDLSHNKL 548
           ++ ++   L  ++   L +I GL + L  S N L   +P  I   L  L  + L  N  
Sbjct: 258 NVKITDESLF-QVMKLLNQISGL-LELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  118 bits (297), Expect = 8e-29
 Identities = 69/320 (21%), Positives = 122/320 (38%), Gaps = 52/320 (16%)

Query: 270 CKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDT 328
           C        S    + S+P   G   +++ L LSNN I+  I    L    +L  L L +
Sbjct: 30  CDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTS 85

Query: 329 NQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLIS 386
           N I+           +I   + ++  SLE +DLS+N L+ +L    F+ L +LT L L+ 
Sbjct: 86  NGIN-----------TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133

Query: 387 NGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS-SLASLTRLQVLD 445
           N    L    +             F + T+LQ+L + N      +     A LT L+ L+
Sbjct: 134 NPYKTLGETSL-------------FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180

Query: 446 ISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPV 505
           I  +      P+S   + +++ LIL        +   +    S++ L+L    L      
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD----- 235

Query: 506 ELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLN 565
                          ++ LS      +        + ++   L   +  L+ +  L+ L 
Sbjct: 236 ------------TFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELE 283

Query: 566 VSYNNFTGYLPDSKLFRQLS 585
            S N     +PD  +F +L+
Sbjct: 284 FSRNQLKS-VPDG-IFDRLT 301

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  104 bits (260), Expect = 5e-24
 Identities = 58/314 (18%), Positives = 106/314 (33%), Gaps = 47/314 (14%)

Query: 283 FSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLE 342
              S  Q+  +         S+ +++ SIP  L+   ++  L L  N+I+        + 
Sbjct: 19  KEESSNQASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRIT-------YIS 68

Query: 343 GSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCS 401
               S L  C +L+A+ L+ N +  ++    F  L +L  L L  N +S  +        
Sbjct: 69  ---NSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW---- 119

Query: 402 SLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLIPE-SF 459
                    F   + L  LNL  N       +SL + LT+LQ+L +        I    F
Sbjct: 120 ---------FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170

Query: 460 GQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNL 519
             L  L  L +  +      P SL   +++  L L   +    +     ++      L L
Sbjct: 171 AGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLEL 229

Query: 520 SWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSK 579
               L      ++S                G+  +L       ++ ++  +    +    
Sbjct: 230 RDTDLDTFHFSELST---------------GETNSLIKKFTFRNVKITDESLFQVMKLLN 274

Query: 580 LFRQLSATEMAGNQ 593
               L   E + NQ
Sbjct: 275 QISGLLELEFSRNQ 288

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 94.8 bits (236), Expect = 5e-21
 Identities = 60/379 (15%), Positives = 120/379 (31%), Gaps = 79/379 (20%)

Query: 53  LSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSN 112
                  +I   +     +     C +      SS SL   +PS +     ++ L L++N
Sbjct: 6   WMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSL-NSIPSGL--TEAVKSLDLSNN 62

Query: 113 QLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIG 172
           ++T     +L  C+ L+ L+L  N ++                                 
Sbjct: 63  RITYISNSDLQRCVNLQALVLTSNGIN--------------------------------- 89

Query: 173 DCQSLLVVGLADTKVAGSLPA-SLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFL 230
                            ++   S   L  L+ L +    LS  +        S L  L L
Sbjct: 90  -----------------TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131

Query: 231 YENDLSGSLPRE--LGKLQKLEKMLLWQNNFDGAIPEEI-GNCKSLKTIDLSLNFFSGSL 287
             N    +L        L KL+ + +   +    I  +       L+ +++  +      
Sbjct: 132 LGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190

Query: 288 PQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP 346
           P+S  ++ ++  L+L        +    +   +S+  L+L    +  F    ++L     
Sbjct: 191 PKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHF--SELSTGET 247

Query: 347 STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
           ++L    +   V ++  +L   +   L Q+  L +L    N +   +P  I         
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGI--------- 296

Query: 407 RLMSFGNCTQLQMLNLSNN 425
               F   T LQ + L  N
Sbjct: 297 ----FDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 41/221 (18%), Positives = 71/221 (32%), Gaps = 47/221 (21%)

Query: 43  ELPFPSNLSSLSFLQKLIISGSNLTGPISPD-LGDCTQLTTIDVSSNSLVGGVPSSIGKL 101
            L   S  S L+ LQ L +   +    I        T L  +++ ++ L    P S+  +
Sbjct: 138 TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSI 197

Query: 102 INLQDLILNSNQLTGEIPKELGACI-KLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGN 160
            N+  LIL+  Q    + +        ++ L L D  L      EL              
Sbjct: 198 QNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET--------- 247

Query: 161 KDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIG 220
                                            SL K    +++ +    L  ++   + 
Sbjct: 248 --------------------------------NSLIKKFTFRNVKITDESLF-QVMKLLN 274

Query: 221 NCSELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLWQNNFD 260
             S L++L    N L  S+P     +L  L+K+ L  N +D
Sbjct: 275 QISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  122 bits (308), Expect = 2e-30
 Identities = 68/344 (19%), Positives = 131/344 (38%), Gaps = 43/344 (12%)

Query: 693  VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
             +G+G  G     +  E+G    +K++            + K      R+    E+  L 
Sbjct: 31   KIGEGSFGKAILVKSTEDGRQYVIKEI-------NISRMSSK-----EREESRREVAVLA 78

Query: 752  SIRHKNIVRFLGCCWNRNTRLLMY-DYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
            +++H NIV++    +  N  L +  DY   G L   ++ ++    + +      +     
Sbjct: 79   NMKHPNIVQYRES-FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA 137

Query: 811  LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTVAGSYGY 869
            L ++H      I+HRDIK+ NI +  +    + DFG+A+ L    + A       G+  Y
Sbjct: 138  LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA---RACIGTPYY 191

Query: 870  IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH--IVDWVRQKRGAIEVL 927
            ++PE         KSD+++ G V+ E+ T K   +    + L   I+       G+   +
Sbjct: 192  LSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII------SGSFPPV 245

Query: 928  DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDMLP 987
                           L++L   L   N  P DRP++  +      I +  E+ +   ++ 
Sbjct: 246  SLH--------YSYDLRSLVSQLFKRN--PRDRPSVNSILEK-GFIAKRIEKFLSPQLIA 294

Query: 988  SEGSANGQRENNNSSSTAMMPNLYPQSNNTSFSASSLLYSSASK 1031
             E       +  +    A  P      N+ S   +  +   A+K
Sbjct: 295  EEFCLKTFSKFGSQPIPAKRPA--SGQNSISVMPAQKITKPAAK 336

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (305), Expect = 3e-30
 Identities = 60/321 (18%), Positives = 112/321 (34%), Gaps = 57/321 (17%)

Query: 691 DSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
             ++G+G +  V+R    + G++ A+K               + I      D    E + 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVF-------------NNISFLRPVDVQMREFEV 60

Query: 750 LGSIRHKNIVRFLGCCWNRNTR---LLMYDYMPNGSLGSLLHERRDSCL--EWELRYRII 804
           L  + HKNIV+         TR   L+M ++ P GSL ++L E  ++    E E    ++
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKVLIM-EFCPCGSLYTVLEEPSNAYGLPESEFL-IVL 118

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEGDFARSS 860
                G+ +L  +    IVHR+IK  NI+     +      + DFG A+ + + +     
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV-- 173

Query: 861 NTVAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
            ++ G+  Y+ P+          +  K     D++S GV      TG  P  P      +
Sbjct: 174 -SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232

Query: 913 IVDWVRQKRGAIEVLDKSLRARPEVEIE----------------EMLQTLGVALLCVNPT 956
                +   G        ++      I+                 +L  +   +L  +  
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD-- 290

Query: 957 PDDRPTMKDVAAMIKEIKQER 977
            +         A   +I    
Sbjct: 291 QEKCWGFDQFFAETSDILHRG 311

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  121 bits (306), Expect = 4e-30
 Identities = 71/373 (19%), Positives = 126/373 (33%), Gaps = 61/373 (16%)

Query: 683  QVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGG-VRD 741
             +LK +      G G S  V++   E  ++ A+K +             +         D
Sbjct: 12   SILKQI------GSGGSSKVFQVLNEKKQIYAIKYV-------------NLEEADNQTLD 52

Query: 742  SFSAEIKTLGSIRHKN--IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
            S+  EI  L  ++  +  I+R           + M     N  L S L +++ S   WE 
Sbjct: 53   SYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWLKKKK-SIDPWER 110

Query: 800  RYRIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
            +        + +  +H H     IVH D+K  N LI  +    + DFG+A  +     + 
Sbjct: 111  KS-YWKNMLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164

Query: 859  SSNTVAGSYGYIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI 907
              ++  G+  Y+ PE                KI+ KSDV+S G ++  +  GK P     
Sbjct: 165  VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--- 221

Query: 908  PEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTMKD 965
                       Q    I  L   +    E+E  ++ +     +L  C+   P  R ++ +
Sbjct: 222  -----------QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 270

Query: 966  VAA---MIKEIKQEREECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYPQSNNTSFSAS 1022
            + A   +  +     +                   N+ +S       LY   +      S
Sbjct: 271  LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330

Query: 1023 SLLYSSASKTTFK 1035
            S   +   K   K
Sbjct: 331  SSSKTFEKKRGKK 343

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  120 bits (302), Expect = 7e-30
 Identities = 63/303 (20%), Positives = 111/303 (36%), Gaps = 62/303 (20%)

Query: 683 QVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGI-GGVRD 741
            +LK +      G G S  V++   E  ++ A+K +             +         D
Sbjct: 31  SILKQI------GSGGSSKVFQVLNEKKQIYAIKYV-------------NLEEADNQTLD 71

Query: 742 SFSAEIKTLGSIRHKN--IVRFLGCCWNRNTRLLMYDYM--PNGSLGSLLHERRDSCLEW 797
           S+  EI  L  ++  +  I+R             +Y  M   N  L S L +++ S   W
Sbjct: 72  SYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKK-SIDPW 127

Query: 798 ELRYRIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           E +        + +  +H H     IVH D+K  N LI  +    + DFG+A  +     
Sbjct: 128 ERKS-YWKNMLEAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181

Query: 857 ARSSNTVAGSYGYIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           +   ++  G+  Y+ PE                KI+ KSDV+S G ++  +  GK P   
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ- 240

Query: 906 TIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTM 963
                        Q    I  L   +    E+E  ++ +     +L  C+   P  R ++
Sbjct: 241 -------------QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287

Query: 964 KDV 966
            ++
Sbjct: 288 PEL 290

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  121 bits (304), Expect = 1e-29
 Identities = 34/309 (11%), Positives = 69/309 (22%), Gaps = 62/309 (20%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +  G   +V+   ++E  E  A+K        +               +          
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR-----------SELERLHEATFAAA 117

Query: 752 SIRHKNIVRFLGCC---------------------------WNRNTRLLMYDYMPNGSLG 784
            +  ++                                      N  LLM     +  L 
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP--AASVDLE 175

Query: 785 SLLHE-----RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE 839
            L                   + +     +  A L       +VH     +N+ I P+  
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGR 232

Query: 840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEY--GYMMKITEKSDVYSYGVVVLEVL 897
             + D      V            +    Y   E+        T   + +  G+ +  V 
Sbjct: 233 LMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

Query: 898 TGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTP 957
               P     P     +    ++         SL       + + ++TL    L  +   
Sbjct: 288 CLFLPFGLVTPG----IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD--R 341

Query: 958 DDRPTMKDV 966
             R    + 
Sbjct: 342 RRRLLPLEA 350

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  118 bits (299), Expect = 1e-29
 Identities = 68/304 (22%), Positives = 119/304 (39%), Gaps = 59/304 (19%)

Query: 689 VEDSVVGKGCSGIVYRAE--MENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +ED  +G G  G V +    M+     +AVK L                    ++D   A
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA------------LKDELLA 67

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E   +  + +  IVR +G C   +  L+M +    G L   L + R    +  +    + 
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRHVKDKNIIEL--VH 124

Query: 806 GAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
             + G+ YL   +      VHRD+ A N+L+  +    I+DFGL+K +   +    +   
Sbjct: 125 QVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE----NYYK 175

Query: 864 AGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV 917
           A ++G       APE     K + KSDV+S+GV++ E  + G++P       G+   +  
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY-----RGMKGSE-- 228

Query: 918 RQKRGAIEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE 972
                   +L+K  R   P     E+ + M         C     ++RP    V   ++ 
Sbjct: 229 -----VTAMLEKGERMGCPAGCPREMYDLMNL-------CWTYDVENRPGFAAVELRLRN 276

Query: 973 IKQE 976
              +
Sbjct: 277 YYYD 280

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  118 bits (297), Expect = 2e-29
 Identities = 60/243 (24%), Positives = 92/243 (37%), Gaps = 34/243 (13%)

Query: 286 SLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGS 344
           ++P      ++ + + L  N IS  +P        +L  L L +N ++            
Sbjct: 25  AVPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-----------R 70

Query: 345 IPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSS 402
           I +        LE +DLS NA   S+ P  F  L  L  L L   G+   + P +     
Sbjct: 71  IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL----- 124

Query: 403 LIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS-SLASLTRLQVLDISVNQFVGLIPESFGQ 461
                   F     LQ L L +N L   LP  +   L  L  L +  N+   +   +F  
Sbjct: 125 --------FRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175

Query: 462 LASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSW 521
           L SL+RL+L +N  +   P +      L +L L +N LS  +P E          L L+ 
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234

Query: 522 NAL 524
           N  
Sbjct: 235 NPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  112 bits (282), Expect = 2e-27
 Identities = 54/230 (23%), Positives = 82/230 (35%), Gaps = 29/230 (12%)

Query: 249 LEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS 308
            +++ L  N            C++L  + L  N  +     +F  L+ LE+L LS+N   
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 309 GSIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALT 366
            S+ P        L  L LD   +             +         +L+ + L  NAL 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQ-----------ELGPGLFRGLAALQYLYLQDNALQ 142

Query: 367 GSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNN 425
            +L    F+ L NLT L L  N IS +                 +F     L  L L  N
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRISSVPE--------------RAFRGLHSLDRLLLHQN 187

Query: 426 TLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF 475
            +    P +   L RL  L +  N    L  E+   L +L  L L+ N +
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (252), Expect = 1e-23
 Identities = 56/235 (23%), Positives = 87/235 (37%), Gaps = 30/235 (12%)

Query: 358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQL 417
                  L  ++  G+       ++ L  N IS               +   SF  C  L
Sbjct: 16  TSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRIS--------------HVPAASFRACRNL 58

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVN-QFVGLIPESFGQLASLNRLILSKNSFS 476
            +L L +N L     ++   L  L+ LD+S N Q   + P +F  L  L+ L L +    
Sbjct: 59  TILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118

Query: 477 GAIPS-SLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQI- 532
             +         +LQ L L  N L   +P + F    L     L L  N +S ++P +  
Sbjct: 119 -ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR--DLGNLTHLFLHGNRIS-SVPERAF 173

Query: 533 SALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSA 586
             L+ L  L L  N++      A   L  L++L +  NN +  LP       L A
Sbjct: 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTE-ALAPLRA 226

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 56/256 (21%), Positives = 88/256 (34%), Gaps = 56/256 (21%)

Query: 78  TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNY 137
                I +  N +     +S     NL  L L+SN L   I               F   
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAA-----------AFTG- 78

Query: 138 LSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGK 197
                      L  LE +    N  +   +                        PA+   
Sbjct: 79  -----------LALLEQLDLSDNAQLR-SVD-----------------------PATFHG 103

Query: 198 LSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLW 255
           L +L +L +    L  E+ P +    + L  L+L +N L  +LP +    L  L  + L 
Sbjct: 104 LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLH 161

Query: 256 QNNFDGAIPEEI-GNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP- 313
            N    ++PE       SL  + L  N  +   P +F +L  L  L L  NN+S ++P  
Sbjct: 162 GNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219

Query: 314 VLSNATSLLQLQLDTN 329
            L+   +L  L+L+ N
Sbjct: 220 ALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 32/128 (25%), Positives = 51/128 (39%), Gaps = 11/128 (8%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPD-LGDCTQLTTIDVSSNSLVGGV 94
            +Q +      P     L+ LQ L +  + L   +  D   D   LT + +  N +    
Sbjct: 116 GLQELG-----PGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVP 169

Query: 95  PSSIGKLINLQDLILNSNQLTGEIPKE-LGACIKLKNLLLFDNYLSGNLPVE-LGKLVNL 152
             +   L +L  L+L+ N++   +         +L  L LF N LS  LP E L  L  L
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRAL 227

Query: 153 EVIRAGGN 160
           + +R   N
Sbjct: 228 QYLRLNDN 235

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  120 bits (303), Expect = 2e-29
 Identities = 63/303 (20%), Positives = 113/303 (37%), Gaps = 62/303 (20%)

Query: 683 QVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGG-VRD 741
            +LK +      G G S  V++   E  ++ A+K +             +         D
Sbjct: 59  SILKQI------GSGGSSKVFQVLNEKKQIYAIKYV-------------NLEEADNQTLD 99

Query: 742 SFSAEIKTLGSIRHKN--IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
           S+  EI  L  ++  +  I+R           + M     N  L S L +++ S   WE 
Sbjct: 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-IYMVMECGNIDLNSWLKKKK-SIDPWER 157

Query: 800 RY--RIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
           +   + +L   + +  +H H     IVH D+K  N LI  +    + DFG+A  +     
Sbjct: 158 KSYWKNML---EAVHTIHQHG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209

Query: 857 ARSSNTVAGSYGYIAPE-----------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           +   ++  G+  Y+ PE                KI+ KSDV+S G ++  +  GK P   
Sbjct: 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ- 268

Query: 906 TIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTM 963
                        Q    I  L   +    E+E  ++ +     +L  C+   P  R ++
Sbjct: 269 -------------QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315

Query: 964 KDV 966
            ++
Sbjct: 316 PEL 318

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  117 bits (296), Expect = 2e-29
 Identities = 65/288 (22%), Positives = 107/288 (37%), Gaps = 63/288 (21%)

Query: 695 GKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           GKG    VYRA  +  G  +A+K +               +   G+      E+K    +
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMI-----------DKKAMYKAGMVQRVQNEVKIHCQL 68

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
           +H +I+       + N   L+ +   NG +   L  R     E E R   +     G+ Y
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLY 127

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           LH   +   +HRD+  +N+L+       IADFGLA  +          T+ G+  YI+PE
Sbjct: 128 LHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPE 182

Query: 874 ------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI-DPTIPE--------GLHIVDWVR 918
                 +G       +SDV+S G +   +L G+ P    T+             +  ++ 
Sbjct: 183 IATRSAHGL------ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236

Query: 919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
               A     K L       I ++L+            P DR ++  V
Sbjct: 237 I--EA-----KDL-------IHQLLR----------RNPADRLSLSSV 260

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  118 bits (297), Expect = 2e-29
 Identities = 67/310 (21%), Positives = 115/310 (37%), Gaps = 65/310 (20%)

Query: 689 VEDSVVGKGCSGIVYRAE--MENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           + D  +G G  G V +    M   ++ +A+K L   T  A+              +    
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------------TEEMMR 59

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E + +  + +  IVR +G C      +L+ +    G L   L  +R+      +   ++ 
Sbjct: 60  EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE-LLH 117

Query: 806 GAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
             + G+ YL   +      VHRD+ A N+L+       I+DFGL+K +   D    S   
Sbjct: 118 QVSMGMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD----SYYT 168

Query: 864 AGSYGYI-----APE---YGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
           A S G       APE   +    K + +SDV+SYGV + E L+ G++P            
Sbjct: 169 ARSAGKWPLKWYAPECINFR---KFSSRSDVWSYGVTMWEALSYGQKPY----------- 214

Query: 915 DWVRQKRGAIEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
               +    +  +++  R   P     E+   M         C     +DRP    V   
Sbjct: 215 -KKMKGPEVMAFIEQGKRMECPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQR 266

Query: 970 IKEIKQEREE 979
           ++        
Sbjct: 267 MRACYYSLAS 276

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  120 bits (302), Expect = 3e-29
 Identities = 57/321 (17%), Positives = 108/321 (33%), Gaps = 57/321 (17%)

Query: 691 DSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
             ++G+G +  V+R    + G++ A+K               + I      D    E + 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVF-------------NNISFLRPVDVQMREFEV 60

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMY---DYMPNGSLGSLLHERRDSCL--EWELRYRII 804
           L  + HKNIV+         T        ++ P GSL ++L E  ++    E E    ++
Sbjct: 61  LKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVL 118

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEGDFARSS 860
                G+ +L  +    IVHR+IK  NI+     +      + DFG A+ + + +     
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF--- 172

Query: 861 NTVAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH 912
            ++ G+  Y+ P+          +  K     D++S GV      TG  P  P      +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232

Query: 913 IVDWVRQKRGAIEVLDKSLRARPEVEIE----------------EMLQTLGVALLCVNPT 956
                +   G        ++      I+                 +L  +   +L  +  
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD-- 290

Query: 957 PDDRPTMKDVAAMIKEIKQER 977
            +         A   +I    
Sbjct: 291 QEKCWGFDQFFAETSDILHRM 311

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  123 bits (311), Expect = 3e-29
 Identities = 67/309 (21%), Positives = 114/309 (36%), Gaps = 60/309 (19%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEM---ENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           + +     +G+G  G V++      EN  + +A+K     T  +              R+
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-------------RE 436

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
            F  E  T+    H +IV+ +G     N   ++ +    G L S L  R+ S     L  
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASL-I 494

Query: 802 RIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
                 +  LAYL     V    HRDI A N+L+       + DFGL++ + +  + ++S
Sbjct: 495 LYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550

Query: 861 NTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
                  G +     APE     + T  SDV+ +GV + E+L  G +P            
Sbjct: 551 K------GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF----------- 593

Query: 915 DWVRQKRGAIEVLDKSLR-ARPE---VEIEE-MLQTLGVALLCVNPTPDDRPTMKDVAAM 969
               +    I  ++   R   P      +   M +       C    P  RP   ++ A 
Sbjct: 594 -QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQ 645

Query: 970 IKEIKQERE 978
           +  I +E +
Sbjct: 646 LSTILEEEK 654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  117 bits (295), Expect = 4e-29
 Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 51/298 (17%)

Query: 693 VVGKGCSGIVYRAE--MENGEVI--AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
            +G G  G+V R E    +G+ +  AVK L P  ++                D F  E+ 
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-----------EAMDDFIREVN 73

Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA 808
            + S+ H+N++R  G       +++  +  P GSL   L + +   L   L     +  A
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLLGTLSR-YAVQVA 131

Query: 809 QGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
           +G+ YL          +HRD+ A N+L+       I DFGL + + + D     + V   
Sbjct: 132 EGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND----DHYVMQE 182

Query: 867 YGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQP-IDPTIPEGLHIVDWVRQ 919
           +  +     APE       +  SD + +GV + E+ T G++P I     + LH +D    
Sbjct: 183 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID---- 238

Query: 920 KRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           K G  E L +      ++  +  M+Q       C    P+DRPT   +   + E +  
Sbjct: 239 KEG--ERLPRPEDCPQDIYNV--MVQ-------CWAHKPEDRPTFVALRDFLLEAQPT 285

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  122 bits (308), Expect = 5e-29
 Identities = 68/304 (22%), Positives = 117/304 (38%), Gaps = 59/304 (19%)

Query: 686 KCLVEDSVVGKGCSGIVYRAE--MENGEV-IAVKKLWPTTMAAEYDCQNDKIGIGGVRDS 742
             L+ D  +G G  G V +    M   ++ +A+K L   T  A+              + 
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------------TEE 382

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
              E + +  + +  IVR +G C      L+M +    G L   L  +R+      +   
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREEIPVSNV-AE 440

Query: 803 IILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
           ++   + G+ YL   +      VHR++ A N+L+       I+DFGL+K +   D    S
Sbjct: 441 LLHQVSMGMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD----S 491

Query: 861 NTVAGSYGYI-----APEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
              A S G       APE     K + +SDV+SYGV + E L+ G++P      + +   
Sbjct: 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY-----KKMKGP 546

Query: 915 DWVRQKRGAIEVLDKSLR-ARPE---VEI-EEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
           +        +  +++  R   P     E+   M         C     +DRP    V   
Sbjct: 547 E-------VMAFIEQGKRMECPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQR 592

Query: 970 IKEI 973
           ++  
Sbjct: 593 MRAC 596

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  118 bits (298), Expect = 2e-28
 Identities = 68/308 (22%), Positives = 111/308 (36%), Gaps = 62/308 (20%)

Query: 689 VEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           V + ++G G SG V       G  +AVK++                      D    EIK
Sbjct: 18  VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----------------DIALMEIK 60

Query: 749 TLG-SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL------GSLLHERRDSCLEWELRY 801
            L  S  H N++R+           +  +   N +L       ++  E      E+    
Sbjct: 61  LLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI- 118

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-------------IADFGLA 848
            ++   A G+A+LH      I+HRD+K  NIL+                    I+DFGL 
Sbjct: 119 SLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175

Query: 849 KLVVEGD--FARSSNTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLT- 898
           K +  G   F  + N  +G+ G+ APE            ++T   D++S G V   +L+ 
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

Query: 899 GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPD 958
           GK P         +I       RG   +    ++   +  +      L   ++  +  P 
Sbjct: 236 GKHPFGDKYSRESNI------IRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHD--PL 285

Query: 959 DRPTMKDV 966
            RPT   V
Sbjct: 286 KRPTAMKV 293

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  115 bits (290), Expect = 2e-28
 Identities = 59/308 (19%), Positives = 119/308 (38%), Gaps = 66/308 (21%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G G  G V++A+   +G+   +K++            N+K            E+K L 
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRV---------KYNNEKA---------EREVKALA 59

Query: 752 SIRHKNIVRFLGC---------------CWNRNTRL--LMYDYMPNGSLGSLLHERRDSC 794
            + H NIV + GC                 ++   L   M ++   G+L   + +RR   
Sbjct: 60  KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM-EFCDKGTLEQWIEKRRGEK 118

Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
           L+  L   +     +G+ Y+H      +++RD+K +NI +    +  I DFGL   +   
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175

Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV 914
                     G+  Y++PE        ++ D+Y+ G+++ E+L                 
Sbjct: 176 GKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKF 227

Query: 915 DWVRQKRGAI-EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM--IK 971
            +   + G I ++ DK  +      ++++L             P+DRP   ++     + 
Sbjct: 228 -FTDLRDGIISDIFDKKEKTL----LQKLLS----------KKPEDRPNTSEILRTLTVW 272

Query: 972 EIKQEREE 979
           +   E+ E
Sbjct: 273 KKSPEKNE 280

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  120 bits (302), Expect = 2e-28
 Identities = 74/516 (14%), Positives = 155/516 (30%), Gaps = 80/516 (15%)

Query: 78  TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKN---LLLF 134
            +   + +S NS+       I  L  L+ L L+ N++   +       +  ++   L + 
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF--HVFLFNQDLEYLDVS 108

Query: 135 DNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPAS 194
            N L  N+      + +L  +    N                  V+ +            
Sbjct: 109 HNRLQ-NIS--CCPMASLRHLDLSFND---------------FDVLPVC---------KE 141

Query: 195 LGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLY--ENDLSGSLPRELGKLQKLEKM 252
            G L+KL  L +       ++         L  + L      + G     L         
Sbjct: 142 FGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200

Query: 253 LLWQNNFDGAIPEEIG----NCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS 308
           L++  N   ++   +         L  I L+       +            L ++  +I 
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260

Query: 309 GSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS 368
            +    +          ++   I      +         +    +SL    + +      
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-F 319

Query: 369 LHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTL 427
               L+     +   +L  +    +                    + +    LN + N  
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMV--------------CPPSPSSFTFLNFTQNVF 365

Query: 428 GGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF----SGAIPSSL 483
             ++    ++L RLQ L +  N       +      +++ L     S     S A   + 
Sbjct: 366 TDSVFQGCSTLKRLQTLILQRNGLKNF-FKVALMTKNMSSLETLDVSLNSLNSHAYDRTC 424

Query: 484 GRCESLQSLDLSSNKLSG----KIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLS 539
              ES+  L+LSSN L+G     +P ++         L+L  N +  +IP  ++ L  L 
Sbjct: 425 AWAESILVLNLSSNMLTGSVFRCLPPKVKV-------LDLHNNRIM-SIPKDVTHLQALQ 476

Query: 540 ILDLSHNKL----GGDLLALSGLDNLVSLNVSYNNF 571
            L+++ N+L     G       L +L  + +  N +
Sbjct: 477 ELNVASNQLKSVPDG---VFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  114 bits (286), Expect = 2e-26
 Identities = 85/482 (17%), Positives = 161/482 (33%), Gaps = 57/482 (11%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDC-TQLTTIDVSSNSLVGGV 94
           +I  +        ++S LS L+ L +S + +   +   +      L  +DVS N L   +
Sbjct: 63  SISELR-----MPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRLQ-NI 115

Query: 95  PSSIGKLINLQDLILNSNQLTGEIP--KELGACIKLKNLLLFDNYLSGNLPVELGKLVNL 152
                 + +L+ L L+ N     +P  KE G   KL  L L          ++L  + +L
Sbjct: 116 SC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHL 169

Query: 153 EVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASL--GKLSKLQSLSVYTTM 210
            +     +         E    Q      L       SL +      ++ L  L +    
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229

Query: 211 LSG-------EIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQK---LEKMLLWQNNFD 260
           L+            ++     L+++ L   + +     +L +      +E + ++     
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289

Query: 261 GAIPEEIGNC-----KSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVL 315
             I  E         KSL    +    F  S    +   + +   MLS ++         
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349

Query: 316 SNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ 375
            + +S   L    N  +              STL     L+ + L  N L  +       
Sbjct: 350 PSPSSFTFLNFTQNVFT-------DSVFQGCSTLKR---LQTLILQRNGLK-NFFKVALM 398

Query: 376 LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL 435
            +N++ L  +   ++ L                        + +LNLS+N L G++   L
Sbjct: 399 TKNMSSLETLDVSLNSLNS---HAYDRT-------CAWAESILVLNLSSNMLTGSVFRCL 448

Query: 436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLS 495
               +++VLD+  N+ + + P+    L +L  L ++ N           R  SLQ + L 
Sbjct: 449 PP--KVKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLH 505

Query: 496 SN 497
            N
Sbjct: 506 DN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 98.8 bits (246), Expect = 2e-21
 Identities = 65/416 (15%), Positives = 139/416 (33%), Gaps = 56/416 (13%)

Query: 192 PASLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPRELGKLQKLE 250
              +  LS+L+ L +    +   +   +     +L  L +  N L  ++      +  L 
Sbjct: 69  MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLR 124

Query: 251 KMLLWQNNFDGAIPE--EIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS 308
            + L  N+FD  +P   E GN   L  + LS   F   L      ++ L    +  + +S
Sbjct: 125 HLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR-QLD--LLPVAHLHLSCILLDLVS 180

Query: 309 GSIPPVLSNA-----TSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHN 363
             I    + +     T++L L    N +             +  ++     L+  ++  N
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ---------VNMSVNALGHLQLSNIKLN 231

Query: 364 ALTG----SLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCT---- 415
                   +    L +   L  + L     +     ++        +  ++  N T    
Sbjct: 232 DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITER 291

Query: 416 --------------QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQ 461
                          L + ++ N     +  +  +    + +  +S++    +       
Sbjct: 292 IDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS 351

Query: 462 LASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS-----GKIPVELFEIEGLDIS 516
            +S   L  ++N F+ ++       + LQ+L L  N L        +   +  +E LD+S
Sbjct: 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVS 411

Query: 517 LNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT 572
           LN   +  S A     +    + +L+LS N L G +        +  L++  N   
Sbjct: 412 LN---SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRIM 463

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 79.1 bits (195), Expect = 3e-15
 Identities = 61/338 (18%), Positives = 112/338 (33%), Gaps = 43/338 (12%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
            +P+++      K + LS N  S         LS L  L LS+N I  S+   V      
Sbjct: 45  HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNL 379
           L  L +  N++            +I        SL  +DLS N          F  L  L
Sbjct: 102 LEYLDVSHNRLQ-----------NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKL 148

Query: 380 TKLLLISNGISGLIPPEIGN-----------CSSLIRLRLMSF--GNCTQLQMLNLSNNT 426
           T L L +     L    + +              +      S    N T L ++   N+ 
Sbjct: 149 TFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSL 208

Query: 427 LGGTLPSSLASLTRLQVLDISVNQFVGLIPESF----GQLASLNRLILSKNSFSGAIPSS 482
               +  S+ +L  LQ+ +I +N        +F     +  +L  + L     +      
Sbjct: 209 FSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK 268

Query: 483 LGRC---ESLQSLDLSSNKLSGKIPVELFEIEGLDIS----LNLSWNALSGAIPPQISAL 535
           L +      ++ L++ +  ++ +I  E F      +      ++       +     S  
Sbjct: 269 LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328

Query: 536 NKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFT 572
            +++I  LS +      ++      +   LN + N FT
Sbjct: 329 AEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT 366

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 62.2 bits (151), Expect = 5e-10
 Identities = 44/206 (21%), Positives = 78/206 (37%), Gaps = 12/206 (5%)

Query: 414 CTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKN 473
                M++ SN  L   +P  L    R + L +S N    L       L+ L  L LS N
Sbjct: 30  NELESMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHN 86

Query: 474 SFSGAIPSSL-GRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNAL-SGAIPPQ 531
               ++   +    + L+ LD+S N+L   I         L   L+LS+N      +  +
Sbjct: 87  RIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPM--ASL-RHLDLSFNDFDVLPVCKE 141

Query: 532 ISALNKLSILDLSHNKL-GGDLLALSGLD-NLVSLNVSYNNFTGYLPDSKLFRQLSATEM 589
              L KL+ L LS  K    DLL ++ L  + + L++   +  G   +S      +   +
Sbjct: 142 FGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201

Query: 590 AGNQGLCSRGHESCFLSNATTVGMGN 615
             +         +  ++    + + N
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSN 227

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 58.0 bits (140), Expect = 1e-08
 Identities = 40/226 (17%), Positives = 78/226 (34%), Gaps = 27/226 (11%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP 95
           ++++        +  S  + +   ++S S+            +  T ++ + N     V 
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVF 370

Query: 96  SSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVI 155
                L  LQ LIL  N L     K       + +L   D  L+        +       
Sbjct: 371 QGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA-- 427

Query: 156 RAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEI 215
                              +S+LV+ L+   + GS+   L    K++ L ++   +   I
Sbjct: 428 -------------------ESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SI 465

Query: 216 PPQIGNCSELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLWQNNFD 260
           P  + +   L +L +  N L  S+P     +L  L+ + L  N +D
Sbjct: 466 PKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.5 bits (118), Expect = 5e-06
 Identities = 32/144 (22%), Positives = 56/144 (38%), Gaps = 30/144 (20%)

Query: 464 SLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVEL-FEIEGLDIS------ 516
           S + +           P S    E    +D S+  L+  +P +L    + L +S      
Sbjct: 11  SFHFVCALALIVGSMTPFS---NELESMVDYSNRNLT-HVPKDLPPRTKALSLSQNSISE 66

Query: 517 --------------LNLSWNALSGAIPPQI-SALNKLSILDLSHNKLGGDLLALSGLDNL 561
                         L LS N +  ++   +      L  LD+SHN+L    ++   + +L
Sbjct: 67  LRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN--ISCCPMASL 123

Query: 562 VSLNVSYNNFTGYLPDSKLFRQLS 585
             L++S+N+F   LP  K F  L+
Sbjct: 124 RHLDLSFNDFDV-LPVCKEFGNLT 146

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 31/207 (14%), Positives = 62/207 (29%), Gaps = 35/207 (16%)

Query: 32  VTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLV 91
           +    +   +          S S    L  + +  T  +        +L T+ +  N L 
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390

Query: 92  GGVPSSIGKLINLQDLILNSNQLT----GEIPKELGACIKLKNLLLFDNYLSGNLPVELG 147
                      N+  L      L         +       +  L L  N L+G++   L 
Sbjct: 391 -NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449

Query: 148 KLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVY 207
               ++V+    N+                    +       S+P  +  L  LQ L+V 
Sbjct: 450 P--KVKVLDLHNNR--------------------IM------SIPKDVTHLQALQELNVA 481

Query: 208 TTMLSGEIPPQI-GNCSELVDLFLYEN 233
           +  L   +P  +    + L  ++L++N
Sbjct: 482 SNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  114 bits (288), Expect = 3e-28
 Identities = 45/319 (14%), Positives = 108/319 (33%), Gaps = 78/319 (24%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGEV--------IAVKKLWPTTMAAEYDCQNDKIGIG 737
           + L+ +  +G+G    +++                + +K L                   
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY------------ 55

Query: 738 GVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW 797
              +SF      +  + HK++V   G C   +  +L+ +++  GSL + L + ++     
Sbjct: 56  --SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL 113

Query: 798 ELRYRIILGAAQGLAYL--HHDCVPPIVHRDIKANNILIGPEFEPY--------IADFGL 847
                +    A  + +L  +      ++H ++ A NIL+  E +          ++D G+
Sbjct: 114 WK-LEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167

Query: 848 AKLVVEGDFARSSNTVAGSYGYI-----APE-YGYMMKITEKSDVYSYGVVVLEVLT-GK 900
           +  V+  D                     PE       +   +D +S+G  + E+ + G 
Sbjct: 168 SITVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD 216

Query: 901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR-ARPE-VEIEE-MLQTLGVALLCVNPTP 957
           +P+       L            ++  +   +   P+  E+   +         C++  P
Sbjct: 217 KPL-----SALDSQR-------KLQFYEDRHQLPAPKAAELANLINN-------CMDYEP 257

Query: 958 DDRPTMKDVAAMIKEIKQE 976
           D RP+ + +   +  +   
Sbjct: 258 DHRPSFRAIIRDLNSLFTP 276

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  115 bits (290), Expect = 3e-28
 Identities = 56/300 (18%), Positives = 112/300 (37%), Gaps = 50/300 (16%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G    VYRA  + +G  +A+KK+    +                R     EI  L 
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKA-----------RADCIKEIDLLK 87

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMY-DYMPNGSLGSLL--HERRDSCLEWELRYRIILGAA 808
            + H N++++    +  +  L +  +    G L  ++   +++   +     ++  +   
Sbjct: 88  QLNHPNVIKYYAS-FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTVAGSY 867
             L ++H      ++HRDIK  N+ I       + D GL +    +   A   +++ G+ 
Sbjct: 147 SALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTP 200

Query: 868 GYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA 923
            Y++PE     GY      KSD++S G ++ E+   + P             +   K   
Sbjct: 201 YYMSPERIHENGY----NFKSDIWSLGCLLYEMAALQSP-------------FYGDKMNL 243

Query: 924 IEVLDKSLRAR----PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE 979
             +  K  +      P     E L+ L    +  +  P+ RP +  V  + K +      
Sbjct: 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD--PEKRPDVTYVYDVAKRMHACTAS 301

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  115 bits (291), Expect = 4e-28
 Identities = 70/288 (24%), Positives = 111/288 (38%), Gaps = 64/288 (22%)

Query: 695 GKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           GKG     +   + +  EV A K +               +     R+  S EI    S+
Sbjct: 50  GKGGFAKCFEISDADTKEVFAGKIV-----------PKSLLLKPHQREKMSMEISIHRSL 98

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H+++V F G   + +   ++ +     SL  L  +RR +  E E RY  +     G  Y
Sbjct: 99  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARY-YLRQIVLGCQY 156

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           LH + V   +HRD+K  N+ +  + E  I DFGLA  V      +    + G+  YIAPE
Sbjct: 157 LHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPE 211

Query: 874 ------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI-DPTIPE--------GLHIVDWVR 918
                 + +      + DV+S G ++  +L GK P     + E           I   + 
Sbjct: 212 VLSKKGHSF------EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 265

Query: 919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
               A      SL       I++MLQ            P  RPT+ ++
Sbjct: 266 P--VA-----ASL-------IQKMLQ----------TDPTARPTINEL 289

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  113 bits (286), Expect = 8e-28
 Identities = 70/288 (24%), Positives = 111/288 (38%), Gaps = 64/288 (22%)

Query: 695 GKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           GKG     +   + +  EV A K +               +     R+  S EI    S+
Sbjct: 24  GKGGFAKCFEISDADTKEVFAGKIV-----------PKSLLLKPHQREKMSMEISIHRSL 72

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAY 813
            H+++V F G   + +   ++ +     SL  L  +RR +  E E RY  +     G  Y
Sbjct: 73  AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEPEARY-YLRQIVLGCQY 130

Query: 814 LHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE 873
           LH + V   +HRD+K  N+ +  + E  I DFGLA  V      +    + G+  YIAPE
Sbjct: 131 LHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK--KVLCGTPNYIAPE 185

Query: 874 ------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI-DPTIPE--------GLHIVDWVR 918
                 + +      + DV+S G ++  +L GK P     + E           I   + 
Sbjct: 186 VLSKKGHSF------EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 239

Query: 919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
               A      SL       I++MLQ            P  RPT+ ++
Sbjct: 240 P--VA-----ASL-------IQKMLQ----------TDPTARPTINEL 263

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (288), Expect = 9e-28
 Identities = 56/292 (19%), Positives = 108/292 (36%), Gaps = 31/292 (10%)

Query: 695 GKGCSGIVYRAEMENGEVIAVK---KLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G    +   E ++ +  A+K   K             NDKI I    D F  E++ + 
Sbjct: 40  NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
            I+++  +   G   N +   ++Y+YM N S+         L            ++  II
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CII 157

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
                  +Y+H++    I HRD+K +NIL+       ++DFG ++ +V+           
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI----KGSR 211

Query: 865 GSYGYIAPE--YGYMMKITEKSDVYSYGVVVLEVLTGKQP--IDPTIPEGLH------IV 914
           G+Y ++ PE           K D++S G+ +  +     P  +  ++ E L        +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-LFNNIRTKNI 270

Query: 915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           ++   +   +  L           +           L  NP   +R T +D 
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA--ERITSEDA 320

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  112 bits (283), Expect = 1e-27
 Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 41/284 (14%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G   +     +G+++  K+L       +Y    +       +    +E+  L 
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKEL-------DYGSMTEA-----EKQMLVSEVNLLR 60

Query: 752 SIRHKNIVRFLGCCWNRNTRLL---MYDYMPNGSLGSLL--HERRDSCLEWELRYRIILG 806
            ++H NIVR+     +R    L   M +Y   G L S++    +    L+ E   R++  
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVM-EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119

Query: 807 AAQGLAYLH--HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTV 863
               L   H   D    ++HRD+K  N+ +  +    + DFGLA+ L  +  FA    T 
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KTF 176

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ-KRG 922
            G+  Y++PE    M   EKSD++S G ++ E+     P            +   + + G
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGKIREG 231

Query: 923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
               +             + L  +   +L +      RP+++++
Sbjct: 232 KFRRIPY--------RYSDELNEIITRMLNLK--DYHRPSVEEI 265

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  116 bits (293), Expect = 3e-27
 Identities = 52/292 (17%), Positives = 100/292 (34%), Gaps = 47/292 (16%)

Query: 185 TKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELG 244
           +       ++  K  K              +       ++  +L L   +LS SLP  L 
Sbjct: 23  SGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFSELQLNRLNLS-SLPDNLP 79

Query: 245 KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSN 304
              ++  + + QN    ++PE   +   L+ +D   N  S +LP+   +L  L+   + N
Sbjct: 80  --PQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLPELPASLKHLD---VDN 129

Query: 305 NNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNA 364
           N ++  +P + +    L  +  D NQ++            +P    +   LE + + +N 
Sbjct: 130 NQLT-MLPELPAL---LEYINADNNQLT-----------MLPELPTS---LEVLSVRNNQ 171

Query: 365 LTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSN 424
           LT  L       ++L  L + +N +  L P                              
Sbjct: 172 LT-FLPE---LPESLEALDVSTNLLESL-PAVPVRNHHSEET----------EIFFRCRE 216

Query: 425 NTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS 476
           N +   +P ++ SL     + +  N     I ES  Q  +       +  FS
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  115 bits (289), Expect = 9e-27
 Identities = 71/425 (16%), Positives = 129/425 (30%), Gaps = 66/425 (15%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLT-GPISPDLGDCTQLTTIDVSSNSLVGGV 94
            I     +       S+    +K  + G N              Q + + ++  +L   +
Sbjct: 21  TISGTYADYF-----SAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-L 74

Query: 95  PSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEV 154
           P ++     +  L +  N L   +P+       L+ L   DN LS  LP     L +L+V
Sbjct: 75  PDNLPP--QITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLKHLDV 127

Query: 155 IRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGE 214
                N+     +P      + +      + ++   LP     L   + LSV    L+  
Sbjct: 128 ---DNNQ--LTMLPELPALLEYI---NADNNQL-TMLPELPTSL---EVLSVRNNQLT-F 174

Query: 215 IPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLW---QNNFDGAIPEEIGNCK 271
           +P    +   L  L +  N L  SLP    +    E+  ++   + N    IPE I +  
Sbjct: 175 LPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLD 230

Query: 272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
              TI L  N  S  + +S    ++  +        S                Q +T   
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM------------SDGQQNTLHR 278

Query: 332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISG 391
            +  A       +  S ++        +   N  +  L   L    +          ++ 
Sbjct: 279 PLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDR-LSDTVSARNTSGFREQVAA 337

Query: 392 LIPPEIGNCSSLIRLRLMSF-------GNCTQLQMLNLSN--------NTLGGTLPSSLA 436
            +       S+   LR  SF        +C     L  +N            G   +   
Sbjct: 338 WLE----KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTG 393

Query: 437 SLTRL 441
           +L  L
Sbjct: 394 ALLSL 398

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  114 bits (287), Expect = 2e-26
 Identities = 61/322 (18%), Positives = 102/322 (31%), Gaps = 34/322 (10%)

Query: 286 SLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSI 345
           S+     N  SL +     N ISG+     S      +  L           +N+    +
Sbjct: 2   SIMLPINNNFSLSQN-SFYNTISGTYADYFSAWDKWEKQALPGEN-------RNEAVSLL 53

Query: 346 PSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI- 404
              L        + L+   L+ SL   L     +T L +  N +  L P    +   L  
Sbjct: 54  KECL--INQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALISL-PELPASLEYLDA 107

Query: 405 -RLRLMSF-GNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQL 462
              RL +       L+ L++ NN L   LP   A L  +   +   NQ   L PE     
Sbjct: 108 CDNRLSTLPELPASLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLTML-PEL---P 159

Query: 463 ASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGL---DISLNL 519
            SL  L +  N  +  +P       SL++LD+S+N L   +P            +I    
Sbjct: 160 TSLEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRC 214

Query: 520 SWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSK 579
             N ++  IP  I +L+    + L  N L   +                  +       +
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273

Query: 580 LFRQLSATEMAGNQGLCSRGHE 601
                   +        ++  +
Sbjct: 274 NTLHRPLADAVTAWFPENKQSD 295

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  112 bits (282), Expect = 3e-27
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 34/217 (15%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +GKG  G V++  +    +V+A+K +       + +   D+I      +    EI  L 
Sbjct: 29  KIGKGSFGEVFKGIDNRTQKVVAIKII-------DLEEAEDEI------EDIQQEITVLS 75

Query: 752 SIRHKNIVRFLGCCWNRNTRL--LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
                 + ++ G  + ++T+L  +M +Y+  GS   LL        E ++   I+    +
Sbjct: 76  QCDSPYVTKYYGS-YLKDTKLWIIM-EYLGGGSALDLLEPGPLD--ETQIAT-ILREILK 130

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           GL YLH +     +HRDIKA N+L+    E  +ADFG+A  + +    R  NT  G+  +
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFW 185

Query: 870 IAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +APE      Y      K+D++S G+  +E+  G+ P
Sbjct: 186 MAPEVIKQSAY----DSKADIWSLGITAIELARGEPP 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  112 bits (281), Expect = 6e-27
 Identities = 77/319 (24%), Positives = 132/319 (41%), Gaps = 62/319 (19%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           +VG G  G VY+   ++ G++ A+K +         D   D+       +    EI  L 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVM---------DVTGDEE------EEIKQEINMLK 75

Query: 752 SI-RHKNIVRFLGC-----CWNRNTRL--LMYDYMPNGSLGSLLHERRDSCL-EWELRYR 802
               H+NI  + G          + +L  +M ++   GS+  L+   + + L E  + Y 
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVM-EFCGAGSVTDLIKNTKGNTLKEEWIAY- 133

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
           I     +GL++LH   V   +HRDIK  N+L+    E  + DFG++  +      R  NT
Sbjct: 134 ICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR--NT 188

Query: 863 VAGSYGYIAPE---------YGYMMKITEKSDVYSYGVVVLEVLTGKQP---IDPT---- 906
             G+  ++APE           Y      KSD++S G+  +E+  G  P   + P     
Sbjct: 189 FIGTPYWMAPEVIACDENPDATY----DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 244

Query: 907 -IPE----GLHIVDWVRQKRGAIEV-LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDR 960
            IP      L    W ++ +  IE  L K+   RP    E++++   +           R
Sbjct: 245 LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT--EQLMKHPFIRDQPNERQV--R 300

Query: 961 PTMKDVAAMIKEIKQEREE 979
             +KD     K+ + E++E
Sbjct: 301 IQLKDHIDRTKKKRGEKDE 319

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (281), Expect = 1e-26
 Identities = 49/313 (15%), Positives = 90/313 (28%), Gaps = 64/313 (20%)

Query: 688 LVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR------ 740
           LV  +V+G+        A + E GE   V   + T        +  K  +  +R      
Sbjct: 75  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134

Query: 741 --------DSFSAEIKTLGSIRHKNIVRFLGC---CWNRNTRLLMYDYMPNGSLGSLLHE 789
                     F      +   + K ++R        W  +   L        +L +    
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP--RMQSNLQTFGEV 192

Query: 790 -----RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                     L    R ++ L   + LA LHH     +VH  ++  +I++      ++  
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 249

Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEY-----------GYMMKITEKSDVYSYGVVV 893
           F       +G         + S G+  PE                 +T   D ++ G+V+
Sbjct: 250 FEHLVR--DGARV----VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

Query: 894 LEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCV 953
             +     PI                K  A+   +   R+     I + ++ L    L  
Sbjct: 304 YWIWCADLPIT---------------KDAALGGSEWIFRSCK--NIPQPVRALLEGFLRY 346

Query: 954 NPTPDDRPTMKDV 966
                DR      
Sbjct: 347 PKE--DRLLPLQA 357

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  112 bits (282), Expect = 1e-26
 Identities = 55/228 (24%), Positives = 87/228 (38%), Gaps = 41/228 (17%)

Query: 693 VVGKGCS--GIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+GKG      V  A     GE + V++     +  E  C N+ +           E+  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRR-----INLE-ACSNEMV------TFLQGELHV 79

Query: 750 LGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL-GA 807
                H NIV +    +  +  L ++  +M  GS   L+       +  EL    IL G 
Sbjct: 80  SKLFNHPNIVPYRAT-FIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQGV 137

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            + L Y+HH      VHR +KA++ILI  + + Y++       ++     +    V    
Sbjct: 138 LKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ--RVVHDFP 192

Query: 868 GYI-------APE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            Y        +PE       GY      KSD+YS G+   E+  G  P
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGY----DAKSDIYSVGITACELANGHVP 236

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  110 bits (276), Expect = 2e-26
 Identities = 61/331 (18%), Positives = 119/331 (35%), Gaps = 45/331 (13%)

Query: 243 LGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELML 302
              L    K+   ++N          +   + T+       + ++      L++L  L L
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70

Query: 303 SNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH 362
            +N I+  + P L N T + +L+L  N +               S +A  +S++ +DL+ 
Sbjct: 71  KDNQIT-DLAP-LKNLTKITELELSGNPLKNV------------SAIAGLQSIKTLDLTS 116

Query: 363 NALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNL 422
             +T      L  L NL  L L  N I+ + P                    T LQ L++
Sbjct: 117 TQITDV--TPLAGLSNLQVLYLDLNQITNISP----------------LAGLTNLQYLSI 158

Query: 423 SNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSS 482
            N  +  +  + LA+L++L  L    N+   +       L +L  + L  N  S    S 
Sbjct: 159 GNAQV--SDLTPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDV--SP 212

Query: 483 LGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILD 542
           L    +L  + L++  ++ +       +   ++    S   ++   P  IS     +  +
Sbjct: 213 LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPN 269

Query: 543 LSHNKLGGDLLALSGLDNLVSLNVSYNNFTG 573
           L+ N            +  V+   +   F+G
Sbjct: 270 LTWNLTSFINNVSYTFNQSVTFKNTTVPFSG 300

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  105 bits (264), Expect = 7e-25
 Identities = 50/236 (21%), Positives = 95/236 (40%), Gaps = 28/236 (11%)

Query: 347 STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
                  +   +    + +T +       L  +T L     G++ +    +   ++LI L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGL 68

Query: 407 RLMS--------FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPES 458
            L            N T++  L LS N L     S++A L  ++ LD++  Q   + P  
Sbjct: 69  ELKDNQITDLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP-- 124

Query: 459 FGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--IS 516
              L++L  L L  N  +    S L    +LQ L + + ++S     +L  +  L    +
Sbjct: 125 LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-----DLTPLANLSKLTT 177

Query: 517 LNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT 572
           L    N +S  I P +++L  L  + L +N++  D+  L+   NL  + ++    T
Sbjct: 178 LKADDNKISD-ISP-LASLPNLIEVHLKNNQI-SDVSPLANTSNLFIVTLTNQTIT 230

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 55/284 (19%), Positives = 96/284 (33%), Gaps = 43/284 (15%)

Query: 48  SNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDL 107
               +L+   K+    SN+T  ++    D   +TT+      +       +  L NL  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68

Query: 108 ILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKI 167
            L  NQ+T ++   L    K+  L L  N L  N+   +  L +++ +     +      
Sbjct: 69  ELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQ------ 118

Query: 168 PYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVD 227
              I D                     L  LS LQ L +    ++  I P +   + L  
Sbjct: 119 ---ITD------------------VTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQY 155

Query: 228 LFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSL 287
           L +    +S  L   L  L KL  +    N         + +  +L  + L  N  S   
Sbjct: 156 LSIGNAQVS-DLT-PLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVS 211

Query: 288 PQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
           P    N S+L  + L+N  I+       +N      ++  +   
Sbjct: 212 P--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 29/138 (21%), Positives = 61/138 (44%), Gaps = 19/138 (13%)

Query: 461 QLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD-----I 515
            LA+  ++   K++ +     +    + + +L      ++         IEG+      I
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT--------TIEGVQYLNNLI 66

Query: 516 SLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYL 575
            L L  N ++  + P +  L K++ L+LS N L  ++ A++GL ++ +L+++    T   
Sbjct: 67  GLELKDNQITD-LAP-LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 576 PDSKLFRQLSATEMAGNQ 593
           P + L   L    +  NQ
Sbjct: 124 PLAGL-SNLQVLYLDLNQ 140

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  109 bits (275), Expect = 2e-26
 Identities = 61/300 (20%), Positives = 117/300 (39%), Gaps = 66/300 (22%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKT 749
            +G G  G V++  +  +G + A+K+               K  + G  D  +A  E+  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRS--------------KKPLAGSVDEQNALREVYA 63

Query: 750 LGSI-RHKNIVRFLGCCWNRNTRLLMY-DYMPNGSLGSLLHERRDSCL---EWELRYRII 804
              + +H ++VR+    W  +  +L+  +Y   GSL   + E         E EL+  ++
Sbjct: 64  HAVLGQHSHVVRYFSA-WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-DLL 121

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILI-------GPEFEPYIADFGLAKLVVE-GDF 856
           L   +GL Y+H      +VH DIK +NI I           E    D+   K++ + GD 
Sbjct: 122 LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 857 ARSS-----NTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 906
              +         G   ++A E     Y +      K+D+++  + V+     +      
Sbjct: 179 GHVTRISSPQVEEGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL---- 230

Query: 907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
            P       W   ++G +  + + L      E  E+L+      + ++P P+ RP+   +
Sbjct: 231 -PRNGD--QWHEIRQGRLPRIPQVLSQ----EFTELLK------VMIHPDPERRPSAMAL 277

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  109 bits (275), Expect = 2e-26
 Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 44/226 (19%)

Query: 691 DSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
             +VG+G  G VY AE      ++A+K      M+      +D       R     E +T
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALK-----LMSETL--SSDP----VFRTRMQREART 87

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYD-------------YMPNGSLGSLLHERRDSCLE 796
            G ++  ++V              ++D              +    L ++L  RR   L 
Sbjct: 88  AGRLQEPHVVP-------------IHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLA 132

Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
                 I+      L   H        HRD+K  NIL+  +   Y+ DFG+A    +   
Sbjct: 133 PPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189

Query: 857 ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            +      G+  Y+APE       T ++D+Y+   V+ E LTG  P
Sbjct: 190 TQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  110 bits (277), Expect = 3e-26
 Identities = 67/313 (21%), Positives = 119/313 (38%), Gaps = 61/313 (19%)

Query: 688 LVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
             + S +G G  G+V++     +G V+A K +      A              R+    E
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-------------RNQIIRE 81

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
           ++ L       IV F G  ++     +  ++M  GSL  +L +      E  L   + + 
Sbjct: 82  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGK-VSIA 139

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS-SNTVAG 865
             +GL YL       I+HRD+K +NIL+    E  + DFG     V G    S +N+  G
Sbjct: 140 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG-----VSGQLIDSMANSFVG 192

Query: 866 SYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR 921
           +  Y++PE      Y    + +SD++S G+ ++E+  G+ PI P   + L ++   + + 
Sbjct: 193 TRSYMSPERLQGTHY----SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

Query: 922 GAIEVLDKSLRARPEVEIEEMLQTLGVALL-----------------------------C 952
            A E   +       +    M     +A+                              C
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308

Query: 953 VNPTPDDRPTMKD 965
           +   P +R  +K 
Sbjct: 309 LIKNPAERADLKQ 321

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  108 bits (273), Expect = 4e-26
 Identities = 64/281 (22%), Positives = 97/281 (34%), Gaps = 49/281 (17%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G V++    E+G + AVK+        +             R    AE+ +  
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD------------RARKLAEVGSHE 111

Query: 752 SI-RHKNIVRFLGCCWNRNTRLLMY-DYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
            + +H   VR     W     L +  +     SL         S  E ++    +     
Sbjct: 112 KVGQHPCCVRLEQA-WEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW-GYLRDTLL 168

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            LA+LH      +VH D+K  NI +GP     + DFGL   +             G   Y
Sbjct: 169 ALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG---EVQEGDPRY 222

Query: 870 IAPEY---GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
           +APE     Y       +DV+S G+ +LEV    +      P G      +RQ     E 
Sbjct: 223 MAPELLQGSY----GTAADVFSLGLTILEVACNMEL-----PHGGEGWQQLRQGYLPPEF 273

Query: 927 LDK-SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
               S   R  V +  ML+          P P  R T + +
Sbjct: 274 TAGLSSELR-SV-LVMMLE----------PDPKLRATAEAL 302

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  109 bits (275), Expect = 4e-26
 Identities = 61/344 (17%), Positives = 113/344 (32%), Gaps = 74/344 (21%)

Query: 693  VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            V+ +G    VY A+ + +G   A+K+L                           E+  + 
Sbjct: 35   VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ--------------EVCFMK 80

Query: 752  SIR-HKNIVRFLGCCWNRNTR---------LLMY-------DYMPNGSLGSLLHERRDSC 794
             +  H NIV+F                   LL         +++        L       
Sbjct: 81   KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD---- 136

Query: 795  LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
                +  +I     + + ++H    PPI+HRD+K  N+L+  +    + DFG A  +   
Sbjct: 137  ---TVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

Query: 855  DFARSS----------NTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGK 900
                 S           T   +  Y  PE    Y     I EK D+++ G ++  +   +
Sbjct: 192  PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQ 250

Query: 901  QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDR 960
             P +                   + +++      P      +  +L  A+L VN  P++R
Sbjct: 251  HPFEDG---------------AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEER 293

Query: 961  PTMKDVAAMIKEIKQEREECMKVDMLPSEGSANGQRENNNSSST 1004
             ++ +V   ++EI   R    K   +      NG   +   S  
Sbjct: 294  LSIAEVVHQLQEIAAARNVNPKSP-ITELLEQNGGYGSATLSRG 336

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (272), Expect = 6e-26
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 39/227 (17%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G G + +V  A      E +A+K++         +     +      D    EI+ + 
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRI-------NLEKCQTSM------DELLKEIQAMS 68

Query: 752 SIRHKNIVRFLGCCWNRNTRL--LMYDYMPNGSLGSLLHERRDSCLEWELRYR------I 803
              H NIV +    +     L  +M   +  GS+  ++                     I
Sbjct: 69  QCHHPNIVSYY-TSFVVKDELWLVM-KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL-AKLVVEGDFARSS-- 860
           +    +GL YLH +     +HRD+KA NIL+G +    IADFG+ A L   GD  R+   
Sbjct: 127 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 861 NTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            T  G+  ++APE      GY      K+D++S+G+  +E+ TG  P
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAP 226

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  109 bits (274), Expect = 1e-25
 Identities = 47/308 (15%), Positives = 87/308 (28%), Gaps = 55/308 (17%)

Query: 688 LVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR------ 740
           LV  +V+G+        A   E GE   V   + T        +  K  +  +R      
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 741 --------DSFSAEIKTLGSIRHKNIVRFLGC---CWNRNTRLLM-YDYMPNGSLGSLLH 788
                     F      +   + K ++R        W  +   L         + G +L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 789 E--RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG 846
                   L    R ++ L   + LA LHH     +VH  ++  +I++      ++  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 847 LAKLVVEGDFARSSNTVAGSYG---YIAPEYGYMMK-----ITEKSDVYSYGVVVLEVLT 898
                 +G  A S       +      A       +     +T   D ++ G+ +  +  
Sbjct: 257 HLV--RDGASAVSPIGRG--FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

Query: 899 GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPD 958
              P       G    +W+                R    I + ++ L    L      +
Sbjct: 313 ADLPNTDDAALG--GSEWIF---------------RSCKNIPQPVRALLEGFLRYP--KE 353

Query: 959 DRPTMKDV 966
           DR      
Sbjct: 354 DRLLPLQA 361

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  111 bits (279), Expect = 2e-25
 Identities = 59/276 (21%), Positives = 94/276 (34%), Gaps = 66/276 (23%)

Query: 297 LEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLE 356
           + E +  +  I   I P        ++  L    ++               T     S++
Sbjct: 1   MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDA------------VTQNELNSID 46

Query: 357 AVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQ 416
            +  +++ +  S+  G+  L N+TKL L  N ++ + P                  N   
Sbjct: 47  QIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP----------------LTNLKN 88

Query: 417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS 476
           L  L L  N +     SSL  L +L+ L +  N    +       L  L  L L  N  +
Sbjct: 89  LGWLFLDENKI--KDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT 144

Query: 477 GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALN 536
               + L R   L +L L  N++S             DI                ++ L 
Sbjct: 145 --DITVLSRLTKLDTLSLEDNQIS-------------DIV--------------PLAGLT 175

Query: 537 KLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT 572
           KL  L LS N +  DL AL+GL NL  L +      
Sbjct: 176 KLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECL 210

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 93.6 bits (232), Expect = 1e-19
 Identities = 52/325 (16%), Positives = 107/325 (32%), Gaps = 36/325 (11%)

Query: 221 NCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSL 280
             +E +   L +  ++ ++     +L  +++++   ++      + I    ++  + L+ 
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 74

Query: 281 NFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNK 340
           N  +   P    NL +L  L L  N I   +   L +   L  L L+ N IS        
Sbjct: 75  NKLTDIKP--LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-------D 123

Query: 341 LEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNC 400
           + G     L +   LE++ L +N +T  +   L +L  L  L L  N IS +    +   
Sbjct: 124 ING-----LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDI--VPLAGL 174

Query: 401 SSLIRLRLM--------SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFV 452
           + L  L L         +      L +L L +        +  ++L     +  +    V
Sbjct: 175 TKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234

Query: 453 GLIPESFGQ----LASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELF 508
                S             L    N  S      +   ++         +   ++    +
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSY 294

Query: 509 EIEGLDISLNLSWNALSGAIPPQIS 533
           +++G  I   +       A  P   
Sbjct: 295 DVDGTVIKTKVEAGTRITAPKPPTK 319

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.9 bits (212), Expect = 2e-17
 Identities = 58/310 (18%), Positives = 102/310 (32%), Gaps = 65/310 (20%)

Query: 104 LQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGN--K 161
           + + I  S  +  +I     A  +     L    ++  +     +L +++ I A  +  K
Sbjct: 1   MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 162 DIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGN 221
            + G                             +  L  +  L +    L+ +I P + N
Sbjct: 57  SVQG-----------------------------IQYLPNVTKLFLNGNKLT-DIKP-LTN 85

Query: 222 CSELVDLFLYEN---DLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDL 278
              L  LFL EN   DLS      L  L+KL+ + L  N    +    + +   L+++ L
Sbjct: 86  LKNLGWLFLDENKIKDLSS-----LKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYL 138

Query: 279 SLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQ 338
             N  +         L+ L+ L L +N IS  I P L+  T L  L L  N IS      
Sbjct: 139 GNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISDL---- 190

Query: 339 NKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIG 398
                     LA  ++L+ ++L               L     +      +    P  I 
Sbjct: 191 --------RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIIS 240

Query: 399 NCSSLIRLRL 408
           +     +  +
Sbjct: 241 DDGDYEKPNV 250

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 85.5 bits (211), Expect = 3e-17
 Identities = 43/223 (19%), Positives = 84/223 (37%), Gaps = 45/223 (20%)

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRL--------MSFGNCTQLQMLNLSNNTLGGT 430
           + + + +S  I  + P      +  I+  L        ++      +  +  +N+ +   
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDI--K 56

Query: 431 LPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQ 490
               +  L  +  L ++ N+   +  +    L +L  L L +N     + SSL   + L+
Sbjct: 57  SVQGIQYLPNVTKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLK 112

Query: 491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG 550
           SL L  N +S        +I GL                     L +L  L L +NK+  
Sbjct: 113 SLSLEHNGIS--------DINGL-------------------VHLPQLESLYLGNNKIT- 144

Query: 551 DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQ 593
           D+  LS L  L +L++  N  +  +P + L  +L    ++ N 
Sbjct: 145 DITVLSRLTKLDTLSLEDNQISDIVPLAGL-TKLQNLYLSKNH 186

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.4 bits (208), Expect = 7e-17
 Identities = 47/279 (16%), Positives = 109/279 (39%), Gaps = 25/279 (8%)

Query: 56  LQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLT 115
           + + I   + +   I PD     +    ++   S+      +  +L ++  +I N++ + 
Sbjct: 1   MGETITVSTPIKQ-IFPD-DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK 56

Query: 116 GEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK--DIAGKIPYEIGD 173
             + + +     +  L L  N L+   P  L  L NL  +    NK  D++      + D
Sbjct: 57  -SV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS-----LKD 107

Query: 174 CQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEN 233
            + L  + L    ++  +   L  L +L+SL +    ++ +I   +   ++L  L L +N
Sbjct: 108 LKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDN 163

Query: 234 DLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGN 293
            +S  +   L  L KL+ + L +N+   +    +   K+L  ++L              N
Sbjct: 164 QIS-DIV-PLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSN 219

Query: 294 LSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQIS 332
           L     +  ++ ++    P ++S+     +  +  +   
Sbjct: 220 LVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  112 bits (280), Expect = 2e-25
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 32/227 (14%)

Query: 691 DSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
              +G G  G V R    + GE +A+K+               +      R+ +  EI+ 
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQC-------------RQELSPKNRERWCLEIQI 65

Query: 750 LGSIRHKNIVRFL-------GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
           +  + H N+V              N    L M +Y   G L   L++  + C   E   R
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM-EYCEGGDLRKYLNQFENCCGLKEGPIR 124

Query: 803 IILGA-AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFAR 858
            +L   +  L YLH +    I+HRD+K  NI++ P  +     I D G AK + +G+   
Sbjct: 125 TLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
                 G+  Y+APE     K T   D +S+G +  E +TG +P  P
Sbjct: 182 ---EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  107 bits (268), Expect = 2e-25
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G VY+A   E G+++A+K++         +    +I           EI  +  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQV-------PVESDLQEI---------IKEISIMQQ 80

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
               ++V++ G  +      ++ +Y   GS+  ++  R  +  E E+   I+    +GL 
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-ILQSTLKGLE 139

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH       +HRDIKA NIL+  E    +ADFG+A  + +    R  NTV G+  ++AP
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NTVIGTPFWMAP 194

Query: 873 E----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E     GY       +D++S G+  +E+  GK P
Sbjct: 195 EVIQEIGY----NCVADIWSLGITAIEMAEGKPP 224

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  106 bits (266), Expect = 3e-25
 Identities = 51/298 (17%), Positives = 106/298 (35%), Gaps = 56/298 (18%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  G+V+ A+   +    A+K++                     R+    E+K L 
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-------------REKVMREVKALA 58

Query: 752 SIRHKNIVRFLGC-------CWNRNTRLLMY-----DYMPNGSLGSLLHERRDSC-LEWE 798
            + H  IVR+             + +   +Y           +L   ++ R      E  
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           +   I L  A+ + +LH      ++HRD+K +NI    +    + DFGL   + + +  +
Sbjct: 119 VCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 859 SSNTVAGSYG----------YIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 908
           +  T   +Y           Y++PE  +    + K D++S G+++ E+L       P   
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFST 229

Query: 909 EGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           +   +      +      L          +       +   +L  +  P +RP   ++
Sbjct: 230 QMERVRTLTDVRNLKFPPL-------FTQKYPC-EYVMVQDMLSPS--PMERPEAINI 277

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  106 bits (266), Expect = 3e-25
 Identities = 63/307 (20%), Positives = 112/307 (36%), Gaps = 71/307 (23%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G  G V +A    +    A+KK+             +K        +  +E+  L 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI---------RHTEEK------LSTILSEVMLLA 57

Query: 752 SIRHKNIVRFLGC----------CWNRNTRLLMY---DYMPNGSLGSLLHERRDSCLEWE 798
           S+ H+ +VR+                   +  ++   +Y  NG+L  L+H    +    E
Sbjct: 58  SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
              R+     + L+Y+H      I+HRD+K  NI I       I DFGLAK V       
Sbjct: 118 YW-RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 859 SS------------NTVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTG 899
                          +  G+  Y+A E       Y       EK D+YS G++  E++  
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN------EKIDMYSLGIIFFEMIYP 227

Query: 900 KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDD 959
                 T  E ++I+  +R                 +    ++ + +   L+  +  P+ 
Sbjct: 228 F----STGMERVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHD--PNK 274

Query: 960 RPTMKDV 966
           RP  + +
Sbjct: 275 RPGARTL 281

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  111 bits (279), Expect = 3e-25
 Identities = 57/282 (20%), Positives = 100/282 (35%), Gaps = 39/282 (13%)

Query: 691 DSVVGKGCSGIVYRAE--MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
              +  G  G +Y A     NG  + +K L  +  A               +    AE +
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE-------------AQAMAMAERQ 131

Query: 749 TLGSIRHKNIVRFL--GCCWNRNTRLLMY---DYMPNGSLGSLLHERRDSCLEWELRYRI 803
            L  + H +IV+        +R+   + Y   +Y+   SL     ++    L        
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAY 187

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           +L     L+YLH      +V+ D+K  NI++  E +  + D G    +       S   +
Sbjct: 188 LLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYL 237

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA 923
            G+ G+ APE       T  +D+Y+ G  +  +       +    +GL   D V +   +
Sbjct: 238 YGTPGFQAPEI-VRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDS 296

Query: 924 IE-VLDKSLRARPE---VEIEEMLQTLGVALLCVNPTPDDRP 961
              +L +++   P       EEM   L   L  V       P
Sbjct: 297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  105 bits (265), Expect = 3e-25
 Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 695 GKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           GKG  G VY A E ++  ++A+K L              ++   GV      E++    +
Sbjct: 18  GKGKFGNVYLAREKQSKFILALKVL-----------FKAQLEKAGVEHQLRREVEIQSHL 66

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL-EWELRYRIILGAAQGLA 812
           RH NI+R  G   +     L+ +Y P G++   L  ++ S   E       I   A  L+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTA-TYITELANALS 123

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H   V   +HRDIK  N+L+G   E  IADFG +        +R    + G+  Y+ P
Sbjct: 124 YCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHA---PSSR-RTDLCGTLDYLPP 176

Query: 873 E------YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           E      +       EK D++S GV+  E L GK P +
Sbjct: 177 EMIEGRMHD------EKVDLWSLGVLCYEFLVGKPPFE 208

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (264), Expect = 5e-25
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 35/216 (16%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G SG VY A ++  G+ +A++++           Q  K  I         EI  +  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQM-------NLQQQPKKELI-------INEILVMRE 73

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            ++ NIV +L      +   ++ +Y+  GSL  ++ E      E ++   +     Q L 
Sbjct: 74  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAA-VCRECLQALE 130

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           +LH +    ++HRDIK++NIL+G +    + DFG    +      R  +T+ G+  ++AP
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAP 185

Query: 873 E------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E      YG       K D++S G++ +E++ G+ P
Sbjct: 186 EVVTRKAYGP------KVDIWSLGIMAIEMIEGEPP 215

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  105 bits (264), Expect = 6e-25
 Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 18/213 (8%)

Query: 691 DSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
              +G G    VY AE       +A+K      +      +  +         F  E+  
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIK-----AIFIPP--REKE----ETLKRFEREVHN 64

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
              + H+NIV  +      +   L+ +Y+   +L   +       L  +           
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILD 122

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
           G+ + H      IVHRDIK  NILI       I DFG+AK + E      +N V G+  Y
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQY 178

Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            +PE        E +D+YS G+V+ E+L G+ P
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  105 bits (264), Expect = 6e-25
 Identities = 51/220 (23%), Positives = 102/220 (46%), Gaps = 34/220 (15%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G VY+A   E G + A K +       E   + +        + +  EI+ L 
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVI-------ETKSEEEL-------EDYIVEIEILA 71

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           +  H  IV+ LG  ++     +M ++ P G++ +++ E      E +++  +     + L
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEAL 130

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            +LH   +   +HRD+KA N+L+  E +  +ADFG++   ++    R  ++  G+  ++A
Sbjct: 131 NFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMA 185

Query: 872 PE---------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           PE           Y      K+D++S G+ ++E+   + P
Sbjct: 186 PEVVMCETMKDTPY----DYKADIWSLGITLIEMAQIEPP 221

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  104 bits (261), Expect = 2e-24
 Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 22/218 (10%)

Query: 691 DSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
             ++G G    V+ A  + +   +AVK      + A+     D          F  E + 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVK-----VLRADL--ARDPS----FYLRFRREAQN 65

Query: 750 LGSIRHKNIVRFLGCCWNRNTRLLMY----DYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
             ++ H  IV              +     +Y+   +L  ++H      +  +    +I 
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIA 123

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR-SSNTVA 864
            A Q L + H +    I+HRD+K  NI+I       + DFG+A+ + +   +   +  V 
Sbjct: 124 DACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180

Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           G+  Y++PE      +  +SDVYS G V+ EVLTG+ P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (258), Expect = 4e-24
 Identities = 49/216 (22%), Positives = 100/216 (46%), Gaps = 35/216 (16%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G +GIV  A E  +G  +AVK +       +   Q  +       +    E+  +  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM-------DLRKQQRR-------ELLFNEVVIMRD 98

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            +H N+V             ++ +++  G+L  ++ + R +  E ++   +     Q LA
Sbjct: 99  YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN--EEQIAT-VCEAVLQALA 155

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH      ++HRDIK+++IL+  +    ++DFG    + +    R   ++ G+  ++AP
Sbjct: 156 YLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAP 210

Query: 873 E------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           E      Y        + D++S G++V+E++ G+ P
Sbjct: 211 EVISRSLYAT------EVDIWSLGIMVIEMVDGEPP 240

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  102 bits (256), Expect = 5e-24
 Identities = 60/243 (24%), Positives = 91/243 (37%), Gaps = 36/243 (14%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
            IP+ +    S K +DLS N        SF +   L+ L LS   I  +I      + + 
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQN 378
           L  L L  N I            S+     +   SL+ +      L  SL       L+ 
Sbjct: 78  LSTLILTGNPIQ-----------SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKT 125

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
           L +L +  N I     PE              F N T L+ L+LS+N +     + L  L
Sbjct: 126 LKELNVAHNLIQSFKLPEY-------------FSNLTNLEHLDLSSNKIQSIYCTDLRVL 172

Query: 439 TRLQV----LDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL 494
            ++ +    LD+S+N    + P +F ++  L  L L  N           R  SLQ + L
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWL 231

Query: 495 SSN 497
            +N
Sbjct: 232 HTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 49/237 (20%), Positives = 87/237 (36%), Gaps = 39/237 (16%)

Query: 295 SSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS-TLANC 352
            S + L LS N +   +      +   L  L L   +I            +I      + 
Sbjct: 28  FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-----------TIEDGAYQSL 75

Query: 353 RSLEAVDLSHNALTGSLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSF 411
             L  + L+ N +  SL  G F  L +L KL+ +   ++ L                   
Sbjct: 76  SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASL-ENFP-------------I 120

Query: 412 GNCTQLQMLNLSNNTLGGTLPSS--LASLTRLQVLDISVNQFVGLIPESFGQLASL---- 465
           G+   L+ LN+++N +  +       ++LT L+ LD+S N+   +       L  +    
Sbjct: 121 GHLKTLKELNVAHNLI-QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179

Query: 466 NRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWN 522
             L LS N  +  I     +   L+ L L +N+L   +P  +F+       + L  N
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 59/238 (24%), Positives = 89/238 (37%), Gaps = 36/238 (15%)

Query: 344 SIPSTL-ANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCS 401
            IP  L  + ++L   DLS N L   L    F     L  L L    I   I        
Sbjct: 21  KIPDNLPFSTKNL---DLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGA---- 71

Query: 402 SLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLIPESFG 460
                    + + + L  L L+ N +  +L     + L+ LQ L         L     G
Sbjct: 72  ---------YQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIG 121

Query: 461 QLASLNRLILSKNSF-SGAIPSSLGRCESLQSLDLSSNKLSGKIPVELF----EIEGLDI 515
            L +L  L ++ N   S  +P       +L+ LDLSSNK+   I         ++  L++
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180

Query: 516 SLNLSWNALSGAIPPQISALNKLSILDLSHNKL----GGDLLALSGLDNLVSLNVSYN 569
           SL+LS N ++  I P      +L  L L  N+L     G       L +L  + +  N
Sbjct: 181 SLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDG---IFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 49/188 (26%), Positives = 78/188 (41%), Gaps = 13/188 (6%)

Query: 415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS 474
              + L+LS N L      S  S   LQVLD+S  +   +   ++  L+ L+ LIL+ N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 475 FSGAIPSSL-GRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQI- 532
              ++         SLQ L      L+  +             LN++ N +     P+  
Sbjct: 88  IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145

Query: 533 SALNKLSILDLSHNKL----GGDLLALSGLDNL-VSLNVSYNNFTGYLPDSKLFRQLSAT 587
           S L  L  LDLS NK+      DL  L  +  L +SL++S N    ++     F+++   
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPG-AFKEIRLK 203

Query: 588 E--MAGNQ 593
           E  +  NQ
Sbjct: 204 ELALDTNQ 211

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 47/234 (20%), Positives = 81/234 (34%), Gaps = 18/234 (7%)

Query: 81  TTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSG 140
            T      +    +P ++    + ++L L+ N L         +  +L+ L L    +  
Sbjct: 10  ITYQCMELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ- 65

Query: 141 NLPVEL-GKLVNLEVIRAGGNK--DIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASL-G 196
            +       L +L  +   GN    +A           SL  +   +T +A SL     G
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAF---SGLSSLQKLVAVETNLA-SLENFPIG 121

Query: 197 KLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPRE----LGKLQKLEK 251
            L  L+ L+V   ++     P+   N + L  L L  N +  S+       L ++  L  
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL 180

Query: 252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN 305
            L    N    I         LK + L  N         F  L+SL+++ L  N
Sbjct: 181 SLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 50/224 (22%), Positives = 87/224 (38%), Gaps = 19/224 (8%)

Query: 47  PSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSN---SLVGGVPSSIGKLIN 103
           P NL      + L +S + L    S       +L  +D+S     ++  G       L +
Sbjct: 23  PDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ---SLSH 77

Query: 104 LQDLILNSNQLTGEIPKEL-GACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKD 162
           L  LIL  N +   +          L+ L+  +  L+      +G L  L+ +    N  
Sbjct: 78  LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 163 IAGKIPYEIGDCQSLLVVGLADTKVAGSLPA-SLGKLSKLQSLSVYTTMLSG----EIPP 217
            + K+P    +  +L  + L+  K+  S+    L  L ++  L++ +  LS      I P
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL-SLDLSLNPMNFIQP 194

Query: 218 QIGNCSELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLWQNNFD 260
                  L +L L  N L  S+P     +L  L+K+ L  N +D
Sbjct: 195 GAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 237

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  103 bits (258), Expect = 7e-24
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 34/218 (15%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G VY A ++ N EV+A+KK+        Y  +               E++ L 
Sbjct: 61  EIGHGSFGAVYFARDVRNSEVVAIKKM-------SYSGKQSNEKW----QDIIKEVRFLQ 109

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            +RH N +++ GC    +T  L+ +Y   GS   LL   +    E E+   +  GA QGL
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA-VTHGALQGL 167

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           AYLH      ++HRD+KA NIL+       + DFG A ++        +N+  G+  ++A
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMA 218

Query: 872 PE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           PE         Y      K DV+S G+  +E+   K P
Sbjct: 219 PEVILAMDEGQY----DGKVDVWSLGITCIELAERKPP 252

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (256), Expect = 9e-24
 Identities = 60/253 (23%), Positives = 94/253 (37%), Gaps = 46/253 (18%)

Query: 676 KLNFTVEQVLKCLVED----SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQ 730
           KL  + EQ      ED      +G+G  G V +     +G+++AVK++  T    E    
Sbjct: 8   KLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE---- 63

Query: 731 NDKIGIGGVRDSFSAEIKT-LGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE 789
                    +     ++   + S     IV+F G  +      +  + M + S       
Sbjct: 64  ---------QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKY 113

Query: 790 RRDSCL----EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
                     E  L   I L   + L +L  +    I+HRDIK +NIL+       + DF
Sbjct: 114 VYSVLDDVIPEEILGK-ITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170

Query: 846 GLAKLVVEGDFARSS--NTVAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLE 895
           G     + G    S      AG   Y+APE         GY      +SDV+S G+ + E
Sbjct: 171 G-----ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY----DVRSDVWSLGITLYE 221

Query: 896 VLTGKQPIDPTIP 908
           + TG+ P      
Sbjct: 222 LATGRFPYPKWNS 234

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  101 bits (253), Expect = 1e-23
 Identities = 50/233 (21%), Positives = 96/233 (41%), Gaps = 41/233 (17%)

Query: 688 LVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           L     +G+G  G+V +   + +G+++AVK      + A  + Q         +     +
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVK-----RIRATVNSQ--------EQKRLLMD 55

Query: 747 IK-TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL---HERRDSCLEWELRYR 802
           +  ++ ++     V F G  +      +  + M + SL        ++  +  E  L   
Sbjct: 56  LDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK- 113

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS-- 860
           I +   + L +LH      ++HRD+K +N+LI    +  + DFG     + G        
Sbjct: 114 IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG-----ISGYLVDDVAK 166

Query: 861 NTVAGSYGYIAPE--------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
           +  AG   Y+APE         GY    + KSD++S G+ ++E+   + P D 
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGY----SVKSDIWSLGITMIELAILRFPYDS 215

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  100 bits (252), Expect = 2e-23
 Identities = 64/224 (28%), Positives = 93/224 (41%), Gaps = 32/224 (14%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +GKG  G VY A E +N  ++A+K L              ++   GV      EI+   
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVL-----------FKSQLEKEGVEHQLRREIEIQS 69

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL-EWELRYRIILGAAQG 810
            +RH NI+R      +R    LM ++ P G L   L  ++     E       +   A  
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSA-TFMEELADA 126

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L Y H   V   +HRDIK  N+L+G + E  IADFG +             T+ G+  Y+
Sbjct: 127 LHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVH-APSLRR---RTMCGTLDYL 179

Query: 871 APE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPI-DPTIPE 909
            PE      +     EK D++  GV+  E L G  P   P+  E
Sbjct: 180 PPEMIEGKTH----DEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score =  100 bits (252), Expect = 2e-22
 Identities = 69/397 (17%), Positives = 131/397 (32%), Gaps = 63/397 (15%)

Query: 223 SELVDLFLYENDLSGSLPRELGK-LQKLEKMLLWQNNFD----GAIPEEIGNCKSLKTID 277
            ++  L +   +LS +   EL   LQ+ + + L            I   +    +L  ++
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 278 LSLNFFSGSLPQSFGNL-----SSLEELMLSNNNIS----GSIPPVLSNATSLLQLQLDT 328
           L  N                    +++L L N  ++    G +   L    +L +L L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 329 NQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALT----GSLHPGLFQLQNLTKLLL 384
           N +         L   +   L     LE + L + +L+      L   L    +  +L +
Sbjct: 123 NLLGDAGL--QLLCEGL---LDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV 177

Query: 385 ISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG----GTLPSSLASLTR 440
            +N I+          + +  L      +  QL+ L L +  +       L   +AS   
Sbjct: 178 SNNDINE---------AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS 228

Query: 441 LQVLDISVNQF-----VGLIPESFGQLASLNRLILSKNSFS----GAIPSSLGRCESLQS 491
           L+ L +  N+        L P      + L  L + +   +    G +   L   ESL+ 
Sbjct: 229 LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKE 288

Query: 492 LDLSSNKLSGKIPVELFEIEGLDI------SLNLSWNALSG----AIPPQISALNKLSIL 541
           L L+ N+L  +    L   E L        SL +   + +          ++    L  L
Sbjct: 289 LSLAGNELGDEGARLL--CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346

Query: 542 DLSHNKLGGD---LLA---LSGLDNLVSLNVSYNNFT 572
            +S+N+L       L          L  L ++  + +
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 92.7 bits (231), Expect = 8e-20
 Identities = 89/513 (17%), Positives = 167/513 (32%), Gaps = 105/513 (20%)

Query: 103 NLQDLILNSNQLTGEIPKELGACIK-LKNLLLFDNYLS----GNLPVELGKLVNLEVIRA 157
           ++Q L +   +L+     EL   ++  + + L D  L+     ++   L     L  +  
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 158 GGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLS-KLQSLSVYTTMLSGE-- 214
             N+         +GD                 +   L   S K+Q LS+    L+G   
Sbjct: 64  RSNE---------LGD------------VGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 102

Query: 215 --IPPQIGNCSELVDLFLYENDLSGSLPRELGKLQ-----KLEKMLLWQNNFD----GAI 263
             +   +     L +L L +N L  +  + L +       +LEK+ L   +        +
Sbjct: 103 GVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162

Query: 264 PEEIGNCKSLKTIDLSLNFFSGS----LPQSFG-NLSSLEELMLSNNNIS----GSIPPV 314
              +      K + +S N  + +    L Q    +   LE L L +  ++      +  +
Sbjct: 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222

Query: 315 LSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALT----GSLH 370
           +++  SL +L L +N++              P  L     L  + +    +T    G L 
Sbjct: 223 VASKASLRELALGSNKLGDVGM-----AELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277

Query: 371 PGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGT 430
             L   ++L +L L  N +                L         QL+ L + + +    
Sbjct: 278 RVLRAKESLKELSLAGNELGD---------EGARLLCETLLEPGCQLESLWVKSCSFTAA 328

Query: 431 ----LPSSLASLTRLQVLDISVNQF----VGLIPESFGQ-LASLNRLILSKNSFS----G 477
                 S LA    L  L IS N+     V  + +  GQ  + L  L L+    S     
Sbjct: 329 CCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCS 388

Query: 478 AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNK 537
           ++ ++L    SL+ LDLS+N L                  +     L  ++         
Sbjct: 389 SLAATLLANHSLRELDLSNNCLG-----------------DAGILQLVESVRQPGC---L 428

Query: 538 LSILDLSHNKLGGDLL-----ALSGLDNLVSLN 565
           L  L L       ++            +L  ++
Sbjct: 429 LEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 78.9 bits (195), Expect = 2e-15
 Identities = 86/453 (18%), Positives = 142/453 (31%), Gaps = 88/453 (19%)

Query: 50  LSSLSFLQKLIISGSNLT----GPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLI--- 102
           L  L   Q + +    LT      IS  L     L  +++ SN L       + + +   
Sbjct: 24  LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83

Query: 103 --NLQDLILNSNQLTGE----IPKELGACIKLKNLLLFDNYLSGNLPVELGKLV-----N 151
              +Q L L +  LTG     +   L     L+ L L DN L       L + +      
Sbjct: 84  SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143

Query: 152 LEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTML 211
           LE ++              +                   L + L      + L+V    +
Sbjct: 144 LEKLQLEYCS---------LSA------------ASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 212 SGEIPPQIG-----NCSELVDLFLYENDLS----GSLPRELGKLQKLEKMLLWQNNF--D 260
           +      +      +  +L  L L    ++      L   +     L ++ L  N     
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242

Query: 261 GAI---PEEIGNCKSLKTIDLSLNFFS----GSLPQSFGNLSSLEELMLSNNNISGSIPP 313
           G     P  +     L+T+ +     +    G L +      SL+EL L+ N +      
Sbjct: 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302

Query: 314 VLSNA-----TSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS 368
           +L          L  L + +   +              S LA  R L  + +S+N L  +
Sbjct: 303 LLCETLLEPGCQLESLWVKSCSFTAACC------SHFSSVLAQNRFLLELQISNNRLEDA 356

Query: 369 ----LHPGLFQLQ-NLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLS 423
               L  GL Q    L  L L    +S     +   CSSL      +      L+ L+LS
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVS-----DSS-CSSLAA----TLLANHSLRELDLS 406

Query: 424 NNTLGGT----LPSSLASL-TRLQVLDISVNQF 451
           NN LG      L  S+      L+ L +    +
Sbjct: 407 NNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 61/305 (20%), Positives = 114/305 (37%), Gaps = 43/305 (14%)

Query: 269 NCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDT 328
                   +L     + ++ Q+   L+S+++++ +N++I  S+   +    ++ +L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77

Query: 329 NQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNG 388
           N+++                LAN ++L  + L  N +   L   L  L+ L  L L  NG
Sbjct: 78  NKLTDI------------KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNG 123

Query: 389 ISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISV 448
           IS +                    +  QL+ L L NN +  T  + L+ LT+L  L +  
Sbjct: 124 ISDING----------------LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLED 165

Query: 449 NQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELF 508
           NQ   +       L  L  L LSKN  S     +L   ++L  L+L S +   K      
Sbjct: 166 NQISDI--VPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 221

Query: 509 EIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSY 568
            +   +   N   + ++   P  IS        ++  +               V++  + 
Sbjct: 222 NLVVPNTVKNTDGSLVT---PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAK 278

Query: 569 NNFTG 573
             F G
Sbjct: 279 ARFHG 283

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 53/241 (21%), Positives = 94/241 (39%), Gaps = 32/241 (13%)

Query: 243 LGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELML 302
                +  K  L + +   A+        S+  I  + +    S+ Q    L ++ +L L
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75

Query: 303 SNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH 362
           + N ++  I P L+N  +L  L LD N++         L       L + + L+++ L H
Sbjct: 76  NGNKLT-DIKP-LANLKNLGWLFLDENKVK-------DLSS-----LKDLKKLKSLSLEH 121

Query: 363 NALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS--------FGNC 414
           N ++  +  GL  L  L  L L +N I+ +    +   + L  L L              
Sbjct: 122 NGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVPLAGL 177

Query: 415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS 474
           T+LQ L LS N +  +   +LA L  L VL++   + +         L   N +  +  S
Sbjct: 178 TKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 475 F 475
            
Sbjct: 236 L 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 58/274 (21%), Positives = 91/274 (33%), Gaps = 66/274 (24%)

Query: 299 ELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAV 358
           E +     I   I          ++  L    ++               T     S++ +
Sbjct: 6   ETITVPTPIK-QIFS-DDAFAETIKDNLKKKSVTD------------AVTQNELNSIDQI 51

Query: 359 DLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQ 418
             +++ +  S+  G+  L N+TKL L  N ++ + P                  N   L 
Sbjct: 52  IANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKP----------------LANLKNLG 93

Query: 419 MLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGA 478
            L L  N +     SSL  L +L+ L +  N    +       L  L  L L  N  +  
Sbjct: 94  WLFLDENKV--KDLSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT-- 147

Query: 479 IPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKL 538
             + L R   L +L L  N++S             DI                ++ L KL
Sbjct: 148 DITVLSRLTKLDTLSLEDNQIS-------------DIV--------------PLAGLTKL 180

Query: 539 SILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT 572
             L LS N +  DL AL+GL NL  L +      
Sbjct: 181 QNLYLSKNHIS-DLRALAGLKNLDVLELFSQECL 213

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 46/265 (17%), Positives = 94/265 (35%), Gaps = 32/265 (12%)

Query: 221 NCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSL 280
             +E +   L +  ++ ++     +L  +++++   ++      + I    ++  + L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77

Query: 281 NFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNK 340
           N  +   P    NL +L  L L  N +   +   L +   L  L L+ N IS        
Sbjct: 78  NKLTDIKP--LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-------D 126

Query: 341 LEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNC 400
           + G     L +   LE++ L +N +T  +   L +L  L  L L  N IS ++P  +   
Sbjct: 127 ING-----LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVP--LAGL 177

Query: 401 SSLIRLRLM--------SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFV 452
           + L  L L         +      L +L L +        +  ++L     +  +    V
Sbjct: 178 TKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

Query: 453 GLIPESFGQLASLNRLILSKNSFSG 477
                S         +      F+ 
Sbjct: 238 TPEIISDDGDYEKPNVKWHLPEFTN 262

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 82.4 bits (204), Expect = 3e-17
 Identities = 44/214 (20%), Positives = 78/214 (36%), Gaps = 38/214 (17%)

Query: 372 GLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTL 431
                    K  L    ++  +                       +  +  +N+ +    
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVT----------------QNELNSIDQIIANNSDI--KS 60

Query: 432 PSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQS 491
              +  L  +  L ++ N+   +  +    L +L  L L +N       SSL   + L+S
Sbjct: 61  VQGIQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKS 116

Query: 492 LDLSSNKLSGKIPVELFEIEGLD-----ISLNLSWNALSGAIPPQISALNKLSILDLSHN 546
           L L  N +S        +I GL       SL L  N ++  I   +S L KL  L L  N
Sbjct: 117 LSLEHNGIS--------DINGLVHLPQLESLYLGNNKITD-ITV-LSRLTKLDTLSLEDN 166

Query: 547 KLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKL 580
           ++  D++ L+GL  L +L +S N+ +     + L
Sbjct: 167 QI-SDIVPLAGLTKLQNLYLSKNHISDLRALAGL 199

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 51/278 (18%), Positives = 99/278 (35%), Gaps = 46/278 (16%)

Query: 56  LQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLT 115
           L    I+       I  D     +    ++   S+      +  +L ++  +I N++ + 
Sbjct: 3   LGSETITVPTPIKQIFSD-DAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK 59

Query: 116 GEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK--DIAGKIPYEIGD 173
             + + +     +  L L  N L+ ++   L  L NL  +    NK  D++         
Sbjct: 60  -SV-QGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVKDLSS-------- 107

Query: 174 CQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEN 233
                                L  L KL+SLS+    +S +I   + +  +L  L+L  N
Sbjct: 108 ---------------------LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNN 144

Query: 234 DLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGN 293
            ++      L +L KL+ + L  N     +P  +     L+ + LS N  S  L ++   
Sbjct: 145 KITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAG 198

Query: 294 LSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
           L +L+ L L +           SN      ++     +
Sbjct: 199 LKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 49/265 (18%), Positives = 101/265 (38%), Gaps = 26/265 (9%)

Query: 48  SNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDL 107
              + L+ + ++I + S++   +   +     +T + ++ N L       +  L NL  L
Sbjct: 40  VTQNELNSIDQIIANNSDIKS-VQG-IQYLPNVTKLFLNGNKLT--DIKPLANLKNLGWL 95

Query: 108 ILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK--DIAG 165
            L+ N++  ++   L    KLK+L L  N +S ++   L  L  LE +  G NK  DI  
Sbjct: 96  FLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV 151

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSEL 225
                +     L  + L D +++  +   L  L+KLQ+L +    +S ++   +     L
Sbjct: 152 -----LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNL 202

Query: 226 VDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSG 285
             L L+  +           L       +   +     PE I +    +  ++  +    
Sbjct: 203 DVLELFSQECLNKPINHQSNLVVPNT--VKNTDGSLVTPEIISDDGDYEKPNVKWH---- 256

Query: 286 SLPQSFGNLSSLEELMLSNNNISGS 310
            LP+    +S +    ++       
Sbjct: 257 -LPEFTNEVSFIFYQPVTIGKAKAR 280

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 15/77 (19%), Positives = 33/77 (42%), Gaps = 8/77 (10%)

Query: 509 EIEGLD-----ISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVS 563
           +I   D     I  NL   +++ A+    + LN +  +  +++ +   +  +  L N+  
Sbjct: 16  QIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQYLPNVTK 72

Query: 564 LNVSYNNFTGYLPDSKL 580
           L ++ N  T   P + L
Sbjct: 73  LFLNGNKLTDIKPLANL 89

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 98.5 bits (245), Expect = 4e-22
 Identities = 33/232 (14%), Positives = 70/232 (30%), Gaps = 37/232 (15%)

Query: 691 DSVVGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS 744
             ++G+G    VY A        +N +   +K   P      Y                 
Sbjct: 70  HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ------------- 116

Query: 745 AEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS---CLEWELRY 801
             ++ L        ++F      +N  +L+ +    G+L + ++  +++    +   L  
Sbjct: 117 -LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-----------IADFGLAKL 850
              +     +  +H      I+H DIK +N ++G  F              + D G +  
Sbjct: 176 SFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +              + G+   E         + D +     V  +L G   
Sbjct: 233 MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 99.0 bits (247), Expect = 5e-22
 Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 58/294 (19%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G V  A E +  + +A++ +     A     + D         +   EI+ L 
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPA------LNVETEIEILK 195

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
            + H  I++        +  +++ + M  G L         L  E           +  +
Sbjct: 196 KLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRL-KEATCKLY-----FYQM 248

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARSSN 861
           L A   + YLH +    I+HRD+K  N+L+  + E     I DFG +K++ E    R   
Sbjct: 249 LLA---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--- 299

Query: 862 TVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPEGLHI 913
           T+ G+  Y+APE        GY        D +S GV++   L+G  P  +      L  
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGY----NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK- 354

Query: 914 VDWVRQ-KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                Q   G               E+ E    L   LL V+  P  R T ++ 
Sbjct: 355 ----DQITSGKYN-----FIPEVWAEVSEKALDLVKKLLVVD--PKARFTTEEA 397

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 49/233 (21%), Positives = 89/233 (38%), Gaps = 35/233 (15%)

Query: 688 LVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           L     +G G  G V++    + G VIAVK      M    + +               +
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVK-----QMRRSGNKE--------ENKRILMD 73

Query: 747 IKTL-GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           +  +  S     IV+  G         +  + M       L    +    E  L   + +
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK-MTV 131

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              + L YL       ++HRD+K +NIL+    +  + DFG++  +V+    ++ +  AG
Sbjct: 132 AIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAG 186

Query: 866 SYGYIAPE---------YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE 909
              Y+APE           Y      ++DV+S G+ ++E+ TG+ P      +
Sbjct: 187 CAAYMAPERIDPPDPTKPDY----DIRADVWSLGISLVELATGQFPYKNCKTD 235

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.4 bits (248), Expect = 8e-22
 Identities = 63/293 (21%), Positives = 103/293 (35%), Gaps = 55/293 (18%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G V   +        A+K +   +   +    +D   I    +    EI  L 
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVI-KKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY---------R 802
           S+ H NI++      ++    L+ ++   G L   +  R         ++         +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--------KFDECDAANIMK 153

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFARS 859
            IL     + YLH      IVHRDIK  NIL+          I DFGL+    +      
Sbjct: 154 QILSG---ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-- 205

Query: 860 SNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPEGLHI 913
                G+  YIAPE     Y       EK DV+S GV++  +L G  P       + +  
Sbjct: 206 -RDRLGTAYYIAPEVLKKKYN------EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258

Query: 914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           V     ++G                I +  + L   +L  +   + R T ++ 
Sbjct: 259 V-----EKGKY-----YFDFNDWKNISDEAKELIKLMLTYD--YNKRCTAEEA 299

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 57/203 (28%), Positives = 83/203 (40%), Gaps = 18/203 (8%)

Query: 354 SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS--- 410
           S   V+     LT +L P L +  + T L L  N +       +   + L +L L     
Sbjct: 11  SHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 411 -----FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASL 465
                 G    L  L+LS+N L  +LP    +L  L VLD+S N+   L   +   L  L
Sbjct: 68  TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL 126

Query: 466 NRLILSKNSFSGAIPSSL-GRCESLQSLDLSSNKLSGKIPVELFE-IEGLDISLNLSWNA 523
             L L  N     +P  L      L+ L L++N L+ ++P  L   +E LD +L L  N+
Sbjct: 127 QELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD-TLLLQENS 183

Query: 524 LSGAIPPQISALNKLSILDLSHN 546
           L   IP      + L    L  N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 58/228 (25%), Positives = 80/228 (35%), Gaps = 35/228 (15%)

Query: 272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
           S   ++      + +LP           L LS N +       L   T L QL LD  ++
Sbjct: 11  SHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

Query: 332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGIS 390
           +            +         L  +DLSHN L  SL P L Q L  LT L +  N ++
Sbjct: 68  T-----------KLQ-VDGTLPVLGTLDLSHNQLQ-SL-PLLGQTLPALTVLDVSFNRLT 113

Query: 391 GLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVN 449
            L P                     +LQ L L  N L  TLP  L     +L+ L ++ N
Sbjct: 114 SL-PLGA-------------LRGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANN 158

Query: 450 QFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN 497
               L       L +L+ L+L +NS    IP        L    L  N
Sbjct: 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 48/165 (29%), Positives = 74/165 (44%), Gaps = 17/165 (10%)

Query: 415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS 474
               +L+LS N L     ++L   TRL  L++   +   L  +  G L  L  L LS N 
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQ 88

Query: 475 FSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQI 532
              ++P       +L  LD+S N+L+  +P+      GL     L L  N L   +PP +
Sbjct: 89  LQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALR--GLGELQELYLKGNELK-TLPPGL 143

Query: 533 -SALNKLSILDLSHNKL----GGDLLALSGLDNLVSLNVSYNNFT 572
            +   KL  L L++N L     G    L+GL+NL +L +  N+  
Sbjct: 144 LTPTPKLEKLSLANNNLTELPAG---LLNGLENLDTLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 56/263 (21%), Positives = 84/263 (31%), Gaps = 61/263 (23%)

Query: 69  PISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKL 128
           PI            ++    +L   +P  +    +   L L+ N L       L    +L
Sbjct: 2   PICEVSKVA-SHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRL 57

Query: 129 KNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVA 188
             L L    L+  L V+ G L  L  +    N+                    L      
Sbjct: 58  TQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQ--------------------LQ----- 90

Query: 189 GSLPASLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPREL-GKL 246
            SLP     L  L  L V    L+  +P        EL +L+L  N+L  +LP  L    
Sbjct: 91  -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147

Query: 247 QKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNN 306
            KLEK+ L  NN    +P  +                          L +L+ L+L  N+
Sbjct: 148 PKLEKLSLANNNLT-ELPAGL-----------------------LNGLENLDTLLLQENS 183

Query: 307 ISGSIPPVLSNATSLLQLQLDTN 329
           +  +IP     +  L    L  N
Sbjct: 184 LY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 38/182 (20%), Positives = 55/182 (30%), Gaps = 42/182 (23%)

Query: 410 SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLI 469
                     +N     L   LP  L       +L +S N        +      L +L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 470 LSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIP 529
           L +   +  +    G    L +LDLS N+L                           ++P
Sbjct: 62  LDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ--------------------------SLP 93

Query: 530 PQISALNKLSILDLSHNKL-----GGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQL 584
                L  L++LD+S N+L     G    AL GL  L  L +  N     LP   L    
Sbjct: 94  LLGQTLPALTVLDVSFNRLTSLPLG----ALRGLGELQELYLKGNELK-TLPPG-LLTPT 147

Query: 585 SA 586
             
Sbjct: 148 PK 149

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 48/208 (23%), Positives = 73/208 (35%), Gaps = 35/208 (16%)

Query: 56  LQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLT 115
              L +S + L       L   T+LT +++    L        G L  L  L L+ NQL 
Sbjct: 33  TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ 90

Query: 116 GEIPKELGACIKLKNLLLFDNYLSGNLPVEL-GKLVNLEVIRAGGNKDIAGKIPYEIGDC 174
             +P        L  L +  N L+ +LP+     L  L+ +   GN+             
Sbjct: 91  -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNE------------- 135

Query: 175 QSLLVVGLADTKVAGSLPASL-GKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYE 232
                  L       +LP  L     KL+ LS+    L+ E+P  +      L  L L E
Sbjct: 136 -------LK------TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181

Query: 233 NDLSGSLPRELGKLQKLEKMLLWQNNFD 260
           N L  ++P+       L    L  N + 
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 46/200 (23%), Positives = 65/200 (32%), Gaps = 38/200 (19%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP 95
            + +        + L   + L +L +  + LT       G    L T+D+S N L   +P
Sbjct: 42  LLYTFS-----LATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQS-LP 93

Query: 96  SSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVEL-GKLVNLEV 154
                L  L  L ++ N+LT      L    +L+ L L  N L   LP  L      LE 
Sbjct: 94  LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEK 152

Query: 155 IRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASL-GKLSKLQSLSVYTTMLSG 213
           +    N                     L        LPA L   L  L +L +    L  
Sbjct: 153 LSLANNN--------------------LT------ELPAGLLNGLENLDTLLLQENSLYT 186

Query: 214 EIPPQIGNCSELVDLFLYEN 233
            IP        L   FL+ N
Sbjct: 187 -IPKGFFGSHLLPFAFLHGN 205

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 91.2 bits (227), Expect = 4e-21
 Identities = 30/164 (18%), Positives = 61/164 (37%), Gaps = 7/164 (4%)

Query: 410 SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLI 469
           +      L  + L+N  +  T  + +     ++ L I+              L++L RL 
Sbjct: 39  TEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94

Query: 470 LSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIP 529
           +     +     +L    SL  LD+S +     I  ++  +  ++ S++LS+N     I 
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN-SIDLSYNGAITDIM 153

Query: 530 PQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTG 573
           P +  L +L  L++  + +  D   +     L  L        G
Sbjct: 154 P-LKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.5 bits (220), Expect = 4e-20
 Identities = 46/253 (18%), Positives = 79/253 (31%), Gaps = 61/253 (24%)

Query: 298 EELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA 357
           E+  L  +  + +IP   S   + L   L  +  +               T A   SL  
Sbjct: 4   EQTGLKASQDNVNIP--DSTFKAYLNGLLGQSSTA-------------NITEAQMNSLTY 48

Query: 358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQL 417
           + L++  +T  L  G+    N+  L + +   +   P                    + L
Sbjct: 49  ITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP----------------ISGLSNL 90

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG 477
           + L +    +      +L+ LT L +LDIS +     I      L  +N + LS N    
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150

Query: 478 AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNK 537
            I   L     L+SL++  + +              D                 I    K
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVH-------------DYR--------------GIEDFPK 182

Query: 538 LSILDLSHNKLGG 550
           L+ L      +GG
Sbjct: 183 LNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 84.6 bits (210), Expect = 9e-19
 Identities = 28/209 (13%), Positives = 71/209 (33%), Gaps = 34/209 (16%)

Query: 293 NLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC 352
              +    +L  ++ +       +   SL  + L    ++        L G     +   
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-------DLTG-----IEYA 65

Query: 353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFG 412
            +++ + +++   T      +  L NL +L ++   ++    P              +  
Sbjct: 66  HNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIP--------------NLS 109

Query: 413 NCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSK 472
             T L +L++S++    ++ + + +L ++  +D+S N  +  I      L  L  L +  
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQF 168

Query: 473 NSFSGAIPSSLGRCESLQSLDLSSNKLSG 501
           +         +     L  L   S  + G
Sbjct: 169 DGVHDY--RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 32/207 (15%), Positives = 62/207 (29%), Gaps = 36/207 (17%)

Query: 128 LKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGN--KDIAGKIPYEIGDCQSLLVVGLADT 185
            K  L      S    +   ++ +L  I        D+ G     I    ++  + + + 
Sbjct: 22  FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNI 76

Query: 186 KVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGK 245
                 P  +  LS L+ L                         +   D++      L  
Sbjct: 77  HATNYNP--ISGLSNLERLR------------------------IMGKDVTSDKIPNLSG 110

Query: 246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN 305
           L  L  + +  +  D +I  +I     + +IDLS N     +      L  L+ L +  +
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFD 169

Query: 306 NISGSIPPVLSNATSLLQLQLDTNQIS 332
            +       + +   L QL   +  I 
Sbjct: 170 GVH-DYRG-IEDFPKLNQLYAFSQTIG 194

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 25/177 (14%), Positives = 59/177 (33%), Gaps = 23/177 (12%)

Query: 219 IGNCSELVDLFLYEN---DLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKT 275
               + L  + L      DL+G     +     ++ + +   +     P  I    +L+ 
Sbjct: 40  EAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHATNYNP--ISGLSNLER 92

Query: 276 IDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFF 335
           + +     +     +   L+SL  L +S++    SI   ++    +  + L  N      
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN------ 146

Query: 336 AWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGL 392
                +  +    L     L+++++  + +      G+     L +L   S  I G 
Sbjct: 147 ---GAI--TDIMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 25/187 (13%), Positives = 64/187 (34%), Gaps = 32/187 (17%)

Query: 51  SSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILN 110
           + ++ L  + ++  N+T  ++  +     +  + +++        + I  L NL+ L + 
Sbjct: 41  AQMNSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIM 96

Query: 111 SNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYE 170
              +T +    L     L  L +  +    ++  ++  L  +  I    N  I       
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI------- 149

Query: 171 IGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFL 230
                              +    L  L +L+SL++    +  +    I +  +L  L+ 
Sbjct: 150 -------------------TDIMPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYA 188

Query: 231 YENDLSG 237
           +   + G
Sbjct: 189 FSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 26/114 (22%), Positives = 50/114 (43%), Gaps = 3/114 (2%)

Query: 48  SNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDL 107
           + +S LS L++L I G ++T    P+L   T LT +D+S ++    + + I  L  +  +
Sbjct: 82  NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSI 141

Query: 108 ILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK 161
            L+ N    +I   L    +LK+L +  + +       +     L  + A    
Sbjct: 142 DLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 24/213 (11%), Positives = 65/213 (30%), Gaps = 56/213 (26%)

Query: 97  SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIR 156
           +  ++ +L  + L +  +T ++   +     +K+L + + + +                 
Sbjct: 39  TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT----------------- 79

Query: 157 AGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIP 216
                +                                +  LS L+ L +    ++ +  
Sbjct: 80  -----NYNP-----------------------------ISGLSNLERLRIMGKDVTSDKI 105

Query: 217 PQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTI 276
           P +   + L  L +  +    S+  ++  L K+  + L  N     I   +     LK++
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSL 164

Query: 277 DLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
           ++  +           +   L +L   +  I G
Sbjct: 165 NIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 23/108 (21%), Positives = 41/108 (37%), Gaps = 3/108 (2%)

Query: 33  TEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVG 92
             + I   ++      NLS L+ L  L IS S     I   +    ++ +ID+S N  + 
Sbjct: 91  ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150

Query: 93  GVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSG 140
            +   +  L  L+ L +  + +       +    KL  L  F   + G
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 18/134 (13%), Positives = 46/134 (34%), Gaps = 33/134 (24%)

Query: 445 DISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIP 504
            +  +Q    IP+S     +    +L ++S +    + +    SL  + L++  ++    
Sbjct: 7   GLKASQDNVNIPDS--TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT---- 57

Query: 505 VELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSL 564
               ++ G+                      + +  L +++     +   +SGL NL  L
Sbjct: 58  ----DLTGI-------------------EYAHNIKDLTINNIHAT-NYNPISGLSNLERL 93

Query: 565 NVSYNNFTGYLPDS 578
            +   + T     +
Sbjct: 94  RIMGKDVTSDKIPN 107

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 13/85 (15%), Positives = 33/85 (38%), Gaps = 3/85 (3%)

Query: 33  TEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVG 92
           T ++I     +    + +++L  +  + +S +     I P L    +L ++++  + +  
Sbjct: 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD 173

Query: 93  GVPSSIGKLINLQDLILNSNQLTGE 117
                I     L  L   S  + G+
Sbjct: 174 --YRGIEDFPKLNQLYAFSQTIGGK 196

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 94.3 bits (235), Expect = 6e-21
 Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 44/218 (20%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G V  A E +  + +A+K +     A     + D         +   EI+ L 
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA------LNVETEIEILK 70

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
            + H  I++        +  +++ + M  G L         L  E           +  +
Sbjct: 71  KLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRL-KEATCKLY-----FYQM 123

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARSSN 861
           L A   + YLH +    I+HRD+K  N+L+  + E     I DFG +K++ E    R   
Sbjct: 124 LLA---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR--- 174

Query: 862 TVAGSYGYIAPE-------YGYMMKITEKSDVYSYGVV 892
           T+ G+  Y+APE        GY        D +S GV+
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGY----NRAVDCWSLGVI 208

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 94.1 bits (234), Expect = 8e-21
 Identities = 53/314 (16%), Positives = 97/314 (30%), Gaps = 86/314 (27%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
            IP ++   ++   +   L         +F     LE++ +S N++   I   V SN   
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 321 LLQLQL-DTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQ 377
           L ++++   N +             I      N  +L+ + +S+  +   L         
Sbjct: 81  LHEIRIEKANNLL-----------YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSL 128

Query: 378 NLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCT-QLQMLNLSNNTLGGTLPSSLA 436
               L +  N     I                SF   + +  +L L+ N +   + +S  
Sbjct: 129 QKVLLDIQDNINIHTIERN-------------SFVGLSFESVILWLNKNGI-QEIHNSAF 174

Query: 437 SLTRLQVLDISVNQFVGLIPESFGQLASLNRL-ILSKNSFSGAIPSSLGRCESLQSLDLS 495
           + T+L  L++S N                N L  L  + F GA             LD+S
Sbjct: 175 NGTQLDELNLSDN----------------NNLEELPNDVFHGA--------SGPVILDIS 210

Query: 496 SNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLAL 555
             ++   +P    E                         L KL      + K    L  L
Sbjct: 211 RTRIH-SLPSYGLE------------------------NLKKLRARSTYNLK---KLPTL 242

Query: 556 SGLDNLVSLNVSYN 569
             L  L+  +++Y 
Sbjct: 243 EKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 90.7 bits (225), Expect = 1e-19
 Identities = 48/288 (16%), Positives = 74/288 (25%), Gaps = 58/288 (20%)

Query: 214 EIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSL 273
           EIP  +      ++L      L             LEK+ + QN+    I          
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE--------- 71

Query: 274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQIS 332
                            F NL  L E+ +   N    I P    N  +L  L +    I 
Sbjct: 72  --------------ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 117

Query: 333 VFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ--LQNLTKLLLISNGI 389
                       +P     +      +D+  N    ++    F         L L  NGI
Sbjct: 118 -----------HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166

Query: 390 SGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVN 449
              I                 F      ++    NN L           +   +LDIS  
Sbjct: 167 QE-IHNSA-------------FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 212

Query: 450 QFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN 497
           +   L       L  L             +P +L +  +L    L+  
Sbjct: 213 RIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 87.6 bits (217), Expect = 1e-18
 Identities = 42/247 (17%), Positives = 79/247 (31%), Gaps = 28/247 (11%)

Query: 346 PSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR 405
              + +C S        + +T  +   L +  N  +L  +   +   I            
Sbjct: 3   HHRICHC-SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRV-IQKG--------- 48

Query: 406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSS-LASLTRLQVLDIS-VNQFVGLIPESFGQLA 463
               +F     L+ + +S N +   + +   ++L +L  + I   N  + + PE+F  L 
Sbjct: 49  ----AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLP 104

Query: 464 SLNRLILSKNSFSGAIPS-SLGRCESLQSLDLSSNKLSGKIPVELFE-IEGLDISLNLSW 521
           +L  L++S       +P            LD+  N     I    F  +    + L L+ 
Sbjct: 105 NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163

Query: 522 NALSGAIPPQI-SALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSK 579
           N +   I     +      +    +N L         G    V L++S       LP S 
Sbjct: 164 NGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLP-SY 220

Query: 580 LFRQLSA 586
               L  
Sbjct: 221 GLENLKK 227

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 45/295 (15%), Positives = 83/295 (28%), Gaps = 53/295 (17%)

Query: 76  DCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKE-LGACIKLKNLLLF 134
            C+         + +   +PS +    N  +L     +L   I K        L+ + + 
Sbjct: 8   HCSN-RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEIS 62

Query: 135 DNYLSGNLPVE-LGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPA 193
            N +   +  +    L  L  IR     ++   I                        P 
Sbjct: 63  QNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YIN-----------------------PE 98

Query: 194 SLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPREL--GKLQKLE 250
           +   L  LQ L +  T +   +P     +  + V L + +N    ++ R    G   +  
Sbjct: 99  AFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV 157

Query: 251 KMLLWQNNFDGAIPEEI-GNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
            + L +N     I        +  +      N         F   S    L +S   I  
Sbjct: 158 ILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH- 215

Query: 310 SIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHN 363
           S+P   L N   L        +              +P+ L    +L    L++ 
Sbjct: 216 SLPSYGLENLKKLRARSTYNLK-------------KLPT-LEKLVALMEASLTYP 256

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 92.4 bits (230), Expect = 9e-21
 Identities = 49/282 (17%), Positives = 92/282 (32%), Gaps = 34/282 (12%)

Query: 299 ELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAV 358
           E +     I+  + P      + ++  L    ++               +      ++  
Sbjct: 1   ESIQRPTPIN-QVFP-DPGLANAVKQNLGKQSVTDL------------VSQKELSGVQNF 46

Query: 359 DLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL-------MSF 411
           +  ++ +  SL  G+    NL +L L  N IS L P  + + + L  L +       ++ 
Sbjct: 47  NGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG 102

Query: 412 GNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILS 471
                L  L L NN L      SL  L  L++L I  N+   +     G L+ L  L L 
Sbjct: 103 IPSACLSRLFLDNNEL--RDTDSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLH 158

Query: 472 KNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQ 531
            N  +      L R + +  +DL+  K   +      E+   +   +     +S   P  
Sbjct: 159 GNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYY 213

Query: 532 ISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTG 573
           IS         +                  +++  +   F G
Sbjct: 214 ISNGGSYVDGCVLWELPVYTDEVSYKFSEYINVGETEAIFDG 255

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 38/172 (22%), Positives = 61/172 (35%), Gaps = 21/172 (12%)

Query: 413 NCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSK 472
                   NL   ++  T   S   L+ +Q  +   +    L         +L  L LS 
Sbjct: 17  GLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHLSH 72

Query: 473 NSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD----ISLNLSWNALSGAI 528
           N  S  + S L     L+ L ++ N+L          + G+       L L  N L    
Sbjct: 73  NQIS-DL-SPLKDLTKLEELSVNRNRLK--------NLNGIPSACLSRLFLDNNELRDTD 122

Query: 529 PPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKL 580
              +  L  L IL + +NKL   ++ L  L  L  L++  N  T     ++L
Sbjct: 123 S--LIHLKNLEILSIRNNKL-KSIVMLGFLSKLEVLDLHGNEITNTGGLTRL 171

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 44/219 (20%), Positives = 78/219 (35%), Gaps = 33/219 (15%)

Query: 194 SLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEN---DLSGSLPRELGKLQKLE 250
           S  +LS +Q+ +   + +   +   +   + L +L L  N   DLS      L  L KLE
Sbjct: 36  SQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQISDLSP-----LKDLTKLE 88

Query: 251 KMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGS 310
           ++ + +N       + +    S     L L+        S  +L +LE L + NN +  S
Sbjct: 89  ELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-S 142

Query: 311 IPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLH 370
           I   L   + L  L L  N+I+                L   + +  +DL+        +
Sbjct: 143 IVM-LGFLSKLEVLDLHGNEITNT------------GGLTRLKKVNWIDLTGQKCV---N 186

Query: 371 PGLFQLQNLTKLLLISNGISGLIPPE-IGNCSSLIRLRL 408
             +     L     + +     I P  I N  S +   +
Sbjct: 187 EPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCV 225

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 41/265 (15%), Positives = 86/265 (32%), Gaps = 50/265 (18%)

Query: 48  SNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDL 107
                L+   K  +   ++T  +     + + +   +  ++++     + +    NL++L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTD-LVS-QKELSGVQNFNGDNSNIQ--SLAGMQFFTNLKEL 68

Query: 108 ILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK--DIAG 165
            L+ NQ++ ++   L    KL+ L +  N L     +       L  +    N+  D   
Sbjct: 69  HLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRDTDS 123

Query: 166 KIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSEL 225
                                        L  L  L+ LS+    L   I   +G  S+L
Sbjct: 124 -----------------------------LIHLKNLEILSIRNNKLK-SIVM-LGFLSKL 152

Query: 226 VDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSG 285
             L L+ N+++ +    L +L+K+  + L           E    +    I  ++    G
Sbjct: 153 EVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQK----CVNEPVKYQPELYITNTVKDPDG 206

Query: 286 SL--PQSFGNLSSLEELMLSNNNIS 308
               P    N  S  +  +      
Sbjct: 207 RWISPYYISNGGSYVDGCVLWELPV 231

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 95.1 bits (237), Expect = 2e-20
 Identities = 65/293 (22%), Positives = 111/293 (37%), Gaps = 65/293 (22%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V   +    G+  AVK +    +  + D           ++S   E++ L 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----------KESLLREVQLLK 81

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY---------R 802
            + H NI++      ++    L+ +    G L   +  R+        R+         R
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--------RFSEVDAARIIR 133

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFARS 859
            +L     + Y+H +    IVHRD+K  N+L+     +    I DFGL+         + 
Sbjct: 134 QVLSG---ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK- 186

Query: 860 SNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPEGLHI 913
                G+  YIAPE     Y       EK DV+S GV++  +L+G  P       + L  
Sbjct: 187 --DKIGTAYYIAPEVLHGTYD------EKCDVWSTGVILYILLSGCPPFNGANEYDILKK 238

Query: 914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           V     ++G       +       ++ E  + L   +L     P  R + +D 
Sbjct: 239 V-----EKGKY-----TFELPQWKKVSESAKDLIRKMLTYV--PSMRISARDA 279

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 52/284 (18%), Positives = 99/284 (34%), Gaps = 62/284 (21%)

Query: 295 SSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCR 353
              E+  ++  +I   IP +  +      L+L    +            +IPS   +N  
Sbjct: 11  HQEEDFRVTCKDIQ-RIPSLPPSTQ---TLKLIETHLR-----------TIPSHAFSNLP 55

Query: 354 SLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFG 412
           ++  + +S +     L    F  L  +T + + +      I P+                
Sbjct: 56  NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA-------------LK 102

Query: 413 NCTQLQMLNLSNNTLGGTLP--SSLASLTRLQVLDISVNQFVGLIPE-SFGQLASLNR-L 468
               L+ L + N  L    P  + + S     +L+I+ N ++  IP  +F  L +    L
Sbjct: 103 ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161

Query: 469 ILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAI 528
            L  N F+ ++         L ++ L+ NK    I  + F   G+               
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG--GV--------------- 203

Query: 529 PPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT 572
                  +  S+LD+S   +    L   GL++L  L  + N +T
Sbjct: 204 ------YSGPSLLDVSQTSV--TALPSKGLEHLKELI-ARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 45/258 (17%), Positives = 82/258 (31%), Gaps = 32/258 (12%)

Query: 216 PPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKT 275
                 C +  D  +   D+   +P      Q L+   L + +          N  ++  
Sbjct: 4   SSPPCECHQEEDFRVTCKDIQ-RIPSLPPSTQTLK---LIETHLRTIPSHAFSNLPNISR 59

Query: 276 IDLSLNFFSGSLP-QSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISV 333
           I +S++     L   SF NLS +  + + N      I P  L     L  L +    + +
Sbjct: 60  IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM 119

Query: 334 FFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLL-LISNGISG 391
           F            + + +      ++++ N    S+    FQ L N T  L L +NG + 
Sbjct: 120 F---------PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS 170

Query: 392 LIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL-TRLQVLDISVNQ 450
            +     N + L  + L               N  L      +   + +   +LD+S   
Sbjct: 171 -VQGYAFNGTKLDAVYL-------------NKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216

Query: 451 FVGLIPESFGQLASLNRL 468
              L  +    L  L   
Sbjct: 217 VTALPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 39/234 (16%), Positives = 86/234 (36%), Gaps = 37/234 (15%)

Query: 272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQL-DTN 329
           S +T+ L           +F NL ++  + +S +     +      N + +  +++ +T 
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 330 QISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPG--LFQLQNLTKLLLIS 386
            ++            I    L     L+ + + +  L         ++       L +  
Sbjct: 92  NLT-----------YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139

Query: 387 NGISGLIPPEIGNCSSLIRLRLMSFGN-CTQLQMLNLSNNTLGGTLPSSLASLTRLQVLD 445
           N     IP               +F   C +   L L NN    ++     + T+L  + 
Sbjct: 140 NPYMTSIPVN-------------AFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVY 185

Query: 446 ISVNQFVGLIPE-SFGQLAS-LNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN 497
           ++ N+++ +I + +FG + S  + L +S+ S + A+PS     E L+ L   + 
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 45/239 (18%), Positives = 82/239 (34%), Gaps = 20/239 (8%)

Query: 76  DCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKE-LGACIKLKNLLLF 134
           +C Q     V+   +   +PS      + Q L L    L   IP         +  + + 
Sbjct: 9   ECHQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63

Query: 135 DNYLSGNLPVEL-GKLVNLEVIRAGGNKDIAGKIPYEI-GDCQSLLVVGLADTKVAGSLP 192
            +     L       L  +  I     +++   I  +   +   L  +G+ +T +    P
Sbjct: 64  IDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLLKFLGIFNTGLK-MFP 121

Query: 193 A--SLGKLSKLQSLSVYTTMLSGEIPPQI--GNCSELVDLFLYENDLSGSLPRELGKLQK 248
               +        L +        IP     G C+E + L LY N  + S+        K
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTK 180

Query: 249 LEKMLLWQNNFDGAIPEEI--GNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN 305
           L+ + L +N +   I ++   G       +D+S    + +LP     L  L+EL+  N 
Sbjct: 181 LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP--SKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 33/194 (17%), Positives = 71/194 (36%), Gaps = 19/194 (9%)

Query: 414 CTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKN 473
           C Q +   ++   +   +PS   S   L    +       +   +F  L +++R+ +S +
Sbjct: 10  CHQEEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSID 65

Query: 474 SFSGAIPS-SLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPP 530
                + S S      +  +++ + +    I  +    + L     L +    L    P 
Sbjct: 66  VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL--KELPLLKFLGIFNTGLK-MFPD 122

Query: 531 Q--ISALNKLSILDLSHNKLGGDL--LALSGLDN-LVSLNVSYNNFTGYLPDSKLFR--Q 583
              + + +   IL+++ N     +   A  GL N  ++L +  N FT  +     F   +
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY-AFNGTK 180

Query: 584 LSATEMAGNQGLCS 597
           L A  +  N+ L  
Sbjct: 181 LDAVYLNKNKYLTV 194

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 32/312 (10%), Positives = 74/312 (23%), Gaps = 78/312 (25%)

Query: 691 DSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
               G       ++A        +A+  + P  +  +            V     +    
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD-----------DVLQETLSRTLR 84

Query: 750 LGSIRHKNIVRFL------GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
           L  I    + R L               ++  +++  GSL  +               R 
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGL-----VVA-EWIRGGSLQEVADTS----PSPVGAIRA 134

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           +   A      H      +       + + +  +        G   L             
Sbjct: 135 MQSLAAAADAAHRA---GVALSIDHPSRVRVSID--------GDVVL---AYP------- 173

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID-PTIPEGLHIVDWVRQKRG 922
                 +            + D+   G  +  +L  + P+    +  GL   +     R 
Sbjct: 174 ----ATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-----RD 217

Query: 923 AIEVLDKSLRARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREEC 980
                 +      ++  +I        VA   V      R      + ++  ++Q     
Sbjct: 218 TAGQPIEPADIDRDIPFQISA------VAARSVQGDGGIRSA----STLLNLMQQATAVA 267

Query: 981 MKVDMLPSEGSA 992
            + ++L     A
Sbjct: 268 DRTEVLGPIDEA 279

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 94.4 bits (235), Expect = 3e-20
 Identities = 59/294 (20%), Positives = 99/294 (33%), Gaps = 68/294 (23%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGV-RDSFSAEIKTL 750
            +G G  G V            A+K +              K  +          E+  L
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKII-------------RKTSVSTSSNSKLLEEVAVL 90

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY--------- 801
             + H NI++      ++    L+ +    G L   +  R         ++         
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--------KFNEVDAAVII 142

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFAR 858
           + +L     + YLH      IVHRD+K  N+L+     +    I DFGL+ +       +
Sbjct: 143 KQVLSG---VTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196

Query: 859 SSNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPI-DPTIPEGLH 912
                 G+  YIAPE     Y       EK DV+S GV++  +L G  P    T  E L 
Sbjct: 197 ---ERLGTAYYIAPEVLRKKYD------EKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247

Query: 913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
            V     ++G       +  +     + E  + L   +L  +     R + +  
Sbjct: 248 KV-----EKGKY-----TFDSPEWKNVSEGAKDLIKQMLQFD--SQRRISAQQA 289

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 90.0 bits (224), Expect = 9e-20
 Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 35/215 (16%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G S +V R       +  AVK      +            +  +R++   E+  L 
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVK-----IIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 752 SI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRI 803
            +  H NI++            L++D M  G L        +L  E+    +      R 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL-SEKETRKI-----MRA 132

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           +L     +  LH      IVHRD+K  NIL+  +    + DFG +  +  G+  R    V
Sbjct: 133 LLEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EV 183

Query: 864 AGSYGYIAPE------YGYMMKITEKSDVYSYGVV 892
            G+  Y+APE              ++ D++S GV+
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 59/228 (25%), Positives = 91/228 (39%), Gaps = 50/228 (21%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G V+  E   +G    +K +             +K       +   AEI+ L 
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTI-------------NKDRSQVPMEQIEAEIEVLK 75

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL----------GSLLHERRDSCLEWELRY 801
           S+ H NI++      + +   ++ +    G L          G  L E   + L      
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-----M 130

Query: 802 RIILGAAQGLAYLH-HDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFA 857
           + ++ A   LAY H       +VH+D+K  NIL     P     I DFGLA+L    + +
Sbjct: 131 KQMMNA---LAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183

Query: 858 RSSNTVAGSYGYIAPE---YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                 AG+  Y+APE          T K D++S GVV+  +LTG  P
Sbjct: 184 ---TNAAGTALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 48/238 (20%), Positives = 96/238 (40%), Gaps = 30/238 (12%)

Query: 740 RDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-SCLEWE 798
            D+ S +I+ +     KN V  L     +    +        +L   ++ R      E  
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
           +   I +  A+ + +LH      ++HRD+K +NI    +    + DFGL   + + +  +
Sbjct: 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221

Query: 859 SSNTVA----------GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP 908
           +  T            G+  Y++PE  +    + K D++S G+++ E+L        T  
Sbjct: 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF----STQM 277

Query: 909 EGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           E + I+  VR  +  +    K  +    + +++ML           P+P +RP   D+
Sbjct: 278 ERVRIITDVRNLKFPLLFTQKYPQEH--MMVQDMLS----------PSPTERPEATDI 323

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 90.4 bits (224), Expect = 2e-19
 Identities = 66/366 (18%), Positives = 115/366 (31%), Gaps = 104/366 (28%)

Query: 688 LVEDSVVGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           L     +G+G  G V  A+            +AVK L      +E               
Sbjct: 24  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-------------HR 70

Query: 742 SFSAEIKTLGSI-RHKNIVR--------------------------FLGCCWNRN----- 769
           +  +E+K L  I  H N+V                           +L    N       
Sbjct: 71  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 130

Query: 770 --------------------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA-- 807
                                RL       + +    + E+  S +E E     +     
Sbjct: 131 KGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFL 190

Query: 808 ------------AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
                       A+G+ +L        +HRD+ A NIL+  +    I DFGLA+ + +  
Sbjct: 191 TLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247

Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV 914
                        ++APE  +    T +SDV+S+GV++ E+ + G  P  P +       
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEEFC 306

Query: 915 DWVRQKRGAIEVLDKSLRARPEV-EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
             +++       +       PE+ +   ML        C +  P  RPT  ++   +  +
Sbjct: 307 RRLKEGT----RMRAPDYTTPEMYQT--MLD-------CWHGEPSQRPTFSELVEHLGNL 353

Query: 974 KQEREE 979
            Q   +
Sbjct: 354 LQANAQ 359

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 91.3 bits (227), Expect = 3e-19
 Identities = 60/294 (20%), Positives = 106/294 (36%), Gaps = 68/294 (23%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGV-RDSFSAEIKTL 750
           ++GKG  G V + +     +  AVK +             +K         +   E++ L
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVI-------------NKASAKNKDTSTILREVELL 75

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY--------- 801
             + H NI++      + ++  ++ +    G L   + +R+        R+         
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--------RFSEHDAARII 127

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFAR 858
           + +      + Y+H      IVHRD+K  NIL+     + +  I DFGL+    +     
Sbjct: 128 KQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--- 178

Query: 859 SSNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP-IDPTIPEGLH 912
                 G+  YIAPE     Y       EK DV+S GV++  +L+G  P       + L 
Sbjct: 179 KMKDRIGTAYYIAPEVLRGTYD------EKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232

Query: 913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
            V     + G       +        I +  + L   +L  +  P  R T    
Sbjct: 233 RV-----ETGKY-----AFDLPQWRTISDDAKDLIRKMLTFH--PSLRITATQC 274

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 58/206 (28%), Positives = 87/206 (42%), Gaps = 30/206 (14%)

Query: 295 SSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCR 353
           +  ++L L +N +S S+P       T L  L L+ N++         L   I   L N  
Sbjct: 37  ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-------TLPAGIFKELKN-- 86

Query: 354 SLEAVDLSHNALTGSLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFG 412
            LE + ++ N L  +L  G+F QL NL +L L  N +  L PP +             F 
Sbjct: 87  -LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSL-PPRV-------------FD 130

Query: 413 NCTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILS 471
           + T+L  L+L  N L  +LP  +   LT L+ L +  NQ   +   +F +L  L  L L 
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLD 189

Query: 472 KNSFSGAIPSSLGRCESLQSLDLSSN 497
            N        +    E L+ L L  N
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 56/215 (26%), Positives = 84/215 (39%), Gaps = 32/215 (14%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
           AIP  I      K +DL  N  S    ++F  L+ L  L L++N +  ++P  +     +
Sbjct: 30  AIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLF-QLQN 378
           L  L +  N++            ++P        +L  + L  N L  SL P +F  L  
Sbjct: 87  LETLWVTDNKLQ-----------ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK 134

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
           LT L L  N +  L P  +             F   T L+ L L NN L      +   L
Sbjct: 135 LTYLSLGYNELQSL-PKGV-------------FDKLTSLKELRLYNNQLKRVPEGAFDKL 180

Query: 439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILSKN 473
           T L+ L +  NQ   +   +F  L  L  L L +N
Sbjct: 181 TELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 54/225 (24%)

Query: 228 LFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSL 287
           L L  N           KL  L         F             L+ + L+ N    +L
Sbjct: 42  LDLQSN-----------KLSSLPS-----KAFHR--------LTKLRLLYLNDNKLQ-TL 76

Query: 288 PQS-FGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSI 345
           P   F  L +LE L +++N +  ++P  V     +L +L+LD NQ+         L   +
Sbjct: 77  PAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-------SLPPRV 128

Query: 346 PSTLANCRSLEAVDLSHNALTGSLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLI 404
             +L     L    L +N L  SL  G+F +L +L +L L +N +   +P          
Sbjct: 129 FDSLTKLTYL---SLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGA------- 176

Query: 405 RLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVN 449
                 F   T+L+ L L NN L      +  SL +L++L +  N
Sbjct: 177 ------FDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 10/163 (6%)

Query: 415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS 474
              + L+L +N L      +   LT+L++L ++ N+   L    F +L +L  L ++ N 
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96

Query: 475 FSGAIPSSL-GRCESLQSLDLSSNKLSGKIPVELFEIEGLD--ISLNLSWNALSGAIPPQ 531
              A+P  +  +  +L  L L  N+L   +P  +F  + L     L+L +N L  ++P  
Sbjct: 97  LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVF--DSLTKLTYLSLGYNELQ-SLPKG 151

Query: 532 I-SALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFT 572
           +   L  L  L L +N+L      A   L  L +L +  N   
Sbjct: 152 VFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 54/235 (22%), Positives = 85/235 (36%), Gaps = 63/235 (26%)

Query: 78  TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNL---LLF 134
                +D+ SN L      +  +L  L+ L LN N+L   +P   G   +LKNL    + 
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA--GIFKELKNLETLWVT 93

Query: 135 DNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPAS 194
           DN L                                                   +LP  
Sbjct: 94  DNKLQ--------------------------------------------------ALPIG 103

Query: 195 L-GKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPREL-GKLQKLEK 251
           +  +L  L  L +    L   +PP++  + ++L  L L  N+L  SLP+ +  KL  L++
Sbjct: 104 VFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161

Query: 252 MLLWQNNFDGAIPEEI-GNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN 305
           + L+ N     +PE        LKT+ L  N        +F +L  L+ L L  N
Sbjct: 162 LRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 41.9 bits (99), Expect = 6e-04
 Identities = 50/230 (21%), Positives = 82/230 (35%), Gaps = 64/230 (27%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDC-TQLTTIDVSSNSLVGGV 94
            + S+            L+ L+ L ++ + L   +   +      L T+ V+ N L   +
Sbjct: 48  KLSSLP-----SKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQA-L 100

Query: 95  PSSI-GKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLE 153
           P  +  +L+NL +L L+ NQL   +P              FD             L  L 
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLK-SLPP--RV---------FD------------SLTKLT 136

Query: 154 VIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASL-GKLSKLQSLSVYTTMLS 212
            +  G N+                    L       SLP  +  KL+ L+ L +Y   L 
Sbjct: 137 YLSLGYNE--------------------LQ------SLPKGVFDKLTSLKELRLYNNQLK 170

Query: 213 GEIPPQI-GNCSELVDLFLYENDLSGSLPREL-GKLQKLEKMLLWQNNFD 260
             +P       +EL  L L  N L   +P      L+KL+ + L +N +D
Sbjct: 171 -RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQENPWD 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 89.5 bits (222), Expect = 3e-19
 Identities = 58/325 (17%), Positives = 96/325 (29%), Gaps = 80/325 (24%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVK-----KLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
            +G+G  G+V  A E +   + A+K     K+           +               E
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT--------------E 78

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL----------------------- 783
           ++ +  + H NI R      +     L+ +    G L                       
Sbjct: 79  VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138

Query: 784 ---------GSLLHERRDSCLEWELRY------RIILGAAQGLAYLHHDCVPPIVHRDIK 828
                     ++           +          I+      L YLH+     I HRDIK
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIK 195

Query: 829 ANNILIG--PEFEPYIADFGLAKLVVEGDFARSS--NTVAGSYGYIAPE--YGYMMKITE 882
             N L      FE  + DFGL+K   + +        T AG+  ++APE           
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 883 KSDVYSYGVVVLEVLTGKQP-IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEE 941
           K D +S GV++  +L G  P       + +  V         +              +  
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV-----LNKKLC-----FENPNYNVLSP 305

Query: 942 MLQTLGVALLCVNPTPDDRPTMKDV 966
           + + L   LL  N   D+R      
Sbjct: 306 LARDLLSNLLNRN--VDERFDAMRA 328

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 87.6 bits (218), Expect = 4e-19
 Identities = 53/227 (23%), Positives = 84/227 (37%), Gaps = 53/227 (23%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  G V  A +       A KK+              K  +  V   F  EI+ + 
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKI-------------PKYFVEDVDR-FKQEIEIMK 61

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
           S+ H NI+R      +     L+ +    G L            E   + +      + +
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVF-RESDAARI-----MKDV 115

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFARSS 860
           L A   +AY H  +    + HRD+K  N L     P+    + DFGLA     G      
Sbjct: 116 LSA---VAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--- 165

Query: 861 NTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            T  G+  Y++P+     YG       + D +S GV++  +L G  P
Sbjct: 166 RTKVGTPYYVSPQVLEGLYG------PECDEWSAGVMMYVLLCGYPP 206

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 49/226 (21%), Positives = 87/226 (38%), Gaps = 49/226 (21%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++GKG  G V +  +    +  AVK +   +   +               +   E++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------------TSTILREVELLK 76

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
            + H NI++      + ++  ++ +    G L            E   + +      + +
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF-SEHDAARI-----IKQV 130

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFARSSN 861
                 + Y+H      IVHRD+K  NIL+     + +  I DFGL+    +        
Sbjct: 131 FSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---K 181

Query: 862 TVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
              G+  YIAPE     Y       EK DV+S GV++  +L+G  P
Sbjct: 182 DRIGTAYYIAPEVLRGTYD------EKCDVWSAGVILYILLSGTPP 221

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 87.8 bits (218), Expect = 2e-18
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 36/215 (16%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G S +V R      G   AVK +  T      +   +      VR++   E   L 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE------VREATRRETHILR 154

Query: 752 SIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRI 803
            +  H +I+  +    + +   L++D M  G L        +L  E+    +      R 
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL-SEKETRSI-----MRS 208

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           +L A   +++LH +    IVHRD+K  NIL+    +  ++DFG +  +  G+  R    +
Sbjct: 209 LLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---EL 259

Query: 864 AGSYGYIAPE------YGYMMKITEKSDVYSYGVV 892
            G+ GY+APE              ++ D+++ GV+
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 60/340 (17%), Positives = 104/340 (30%), Gaps = 65/340 (19%)

Query: 271 KSLKTIDLSLNFFSG----SLPQSFGNLSSLEELMLSNNNISG----SIPPVLSNATSLL 322
            S++   L L+  +     S+        S++E++LS N I       +   +++   L 
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 323 QLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTG----SLHPGLFQLQN 378
             +              +    +   L  C  L  V LS NA        L   L +   
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 379 LTKLLLISNGISGLIPPEIGN--CSSLIRLRLMSFG-NCTQLQMLNLSNNTLGG----TL 431
           L  L L +NG+     P+ G     +L  L +     N   L+ +    N L        
Sbjct: 124 LEHLYLHNNGLG----PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 432 PSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQS 491
             +  S   L  + +  N                    +        +   L  C+ L+ 
Sbjct: 180 AKTFQSHRLLHTVKMVQNG-------------------IRPEGIEHLLLEGLAYCQELKV 220

Query: 492 LDLSSNKLSGKIPVELFEIEGLD-----ISLNLSWN--------ALSGAIPPQISALNKL 538
           LDL  N  +      L     L        L L+          A+  A          L
Sbjct: 221 LDLQDNTFTHLGSSALA--IALKSWPNLRELGLNDCLLSARGAAAVVDAF--SKLENIGL 276

Query: 539 SILDLSHNKLGGD-LLAL-----SGLDNLVSLNVSYNNFT 572
             L L +N++  D +  L       + +L+ L ++ N F+
Sbjct: 277 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 86.3 bits (214), Expect = 5e-18
 Identities = 59/326 (18%), Positives = 110/326 (33%), Gaps = 54/326 (16%)

Query: 219 IGNCSELVDLFLYENDLSG----SLPRELGKLQKLEKMLLWQNNF--DGA--IPEEIGNC 270
           +   S +    L  + ++     S+   L +   +++++L  N    + A  + E I + 
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59

Query: 271 KSLKTIDLSLNFFS----------GSLPQSFGNLSSLEELMLSNNNISG----SIPPVLS 316
           K L+  + S  F              L Q+      L  + LS+N         +   LS
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 317 NATSLLQLQLDTNQISVFFAW---QNKLEGSIPSTLANCRSLEAVDLSHNALTG----SL 369
             T L  L L  N +         +   E ++     N   L ++    N L        
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 370 HPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGG 429
                  + L  + ++ NGI        G    L+         C +L++L+L +NT   
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIR-----PEG-IEHLLL---EGLAYCQELKVLDLQDNTFTH 230

Query: 430 T----LPSSLASLTRLQVLDISVNQF----VGLIPESFGQLA--SLNRLILSKNSFSG-- 477
                L  +L S   L+ L ++           + ++F +L    L  L L  N      
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 290

Query: 478 --AIPSSLGR-CESLQSLDLSSNKLS 500
              + + +      L  L+L+ N+ S
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 51/336 (15%), Positives = 99/336 (29%), Gaps = 72/336 (21%)

Query: 48  SNLSSLSFLQKLIISGSNLTG----PISPDLGDCTQLTTIDVSSNSL-VGGVPSSIGKLI 102
           +  S    ++   +    +T      +   L +   +  I +S N++        + + I
Sbjct: 2   ARFS----IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAA-RWLSENI 56

Query: 103 ----NLQDLILNSNQ---LTGEIPKELGA-------CIKLKNLLLFDNYLSGNLPVELGK 148
               +L+    +      +  EIP+ L         C KL  + L DN         L  
Sbjct: 57  ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 116

Query: 149 L----VNLEVIRAGGNKDIAGKIPYEIGD--CQSLLVVGLADTKVAGSLPASLGKLSKLQ 202
                  LE +    N          +G           +A      ++         L+
Sbjct: 117 FLSKHTPLEHLYLHNNG---------LGPQAGAK-----IARALQELAVNKKAKNAPPLR 162

Query: 203 SLSVYTTMLSGE----IPPQIGNCSELVDLFLYENDL-----SGSLPRELGKLQKLEKML 253
           S+      L             +   L  + + +N +        L   L   Q+L+ + 
Sbjct: 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD 222

Query: 254 LWQNNF--DGA--IPEEIGNCKSLKTIDLSLN--------FFSGSLPQSFGNLSSLEELM 301
           L  N F   G+  +   + +  +L+ + L+              +  +       L+ L 
Sbjct: 223 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK--LENIGLQTLR 280

Query: 302 LSNNNISGSIPPVLSNA-----TSLLQLQLDTNQIS 332
           L  N I       L          LL L+L+ N+ S
Sbjct: 281 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 86.4 bits (214), Expect = 4e-18
 Identities = 40/193 (20%), Positives = 78/193 (40%), Gaps = 32/193 (16%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLP--QSFGNLSSLEELMLSNNNISGSIPP-VLSNA 318
            +P+ + +      +DLS N  S  L    +   L++L  L+LS+N+++  I        
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 319 TSLLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-L 376
            +L  L L +N +            ++     ++ ++LE + L +N +   +    F+ +
Sbjct: 88  PNLRYLDLSSNHLH-----------TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDM 135

Query: 377 QNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLA 436
             L KL L  N IS      I + + L            +L +L+LS+N L     + L 
Sbjct: 136 AQLQKLYLSQNQISRFPVELIKDGNKL-----------PKLMLLDLSSNKLKKLPLTDLQ 184

Query: 437 SLTRLQVLDISVN 449
            L       + ++
Sbjct: 185 KLPAWVKNGLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 77.2 bits (190), Expect = 4e-15
 Identities = 45/196 (22%), Positives = 73/196 (37%), Gaps = 36/196 (18%)

Query: 310 SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS--TLANCRSLEAVDLSHNALTG 367
           ++P  L + T+   L L  N +S            + +  T     +L ++ LSHN L  
Sbjct: 32  NVPQSLPSYTA--LLDLSHNNLS-----------RLRAEWTPTRLTNLHSLLLSHNHLN- 77

Query: 368 SLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNT 426
            +    F  + NL  L L SN +  L    +             F +   L++L L NN 
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLHTL-DEFL-------------FSDLQALEVLLLYNNH 123

Query: 427 LGGTLPSSLASLTRLQVLDISVNQFVGLIPESFG---QLASLNRLILSKNSFSGAIPSSL 483
           +     ++   + +LQ L +S NQ      E      +L  L  L LS N       + L
Sbjct: 124 IVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183

Query: 484 GRCESL--QSLDLSSN 497
            +  +     L L +N
Sbjct: 184 QKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 38/142 (26%), Positives = 66/142 (46%), Gaps = 12/142 (8%)

Query: 439 TRLQVLDISVNQFVGLIPE-SFGQLASLNRLILSKNSFSGAIPS-SLGRCESLQSLDLSS 496
           +   +LD+S N    L  E +  +L +L+ L+LS N  +  I S +     +L+ LDLSS
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 497 NKLSGKIPVELFE-IEGLDISLNLSWNALSGAIPPQI-SALNKLSILDLSHNKL----GG 550
           N L   +   LF  ++ L++ L L  N +   +       + +L  L LS N++      
Sbjct: 98  NHLH-TLDEFLFSDLQALEV-LLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVE 154

Query: 551 DLLALSGLDNLVSLNVSYNNFT 572
            +   + L  L+ L++S N   
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 33/145 (22%), Positives = 56/145 (38%), Gaps = 33/145 (22%)

Query: 194 SLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPRE-LGKLQKLEK 251
           +  +L+ L SL +    L+  I  +       L  L L  N L  +L       LQ LE 
Sbjct: 59  TPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV 116

Query: 252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSI 311
           +LL+ N+              +  +D            +F +++ L++L LS N IS   
Sbjct: 117 LLLYNNH--------------IVVVD----------RNAFEDMAQLQKLYLSQNQIS-RF 151

Query: 312 PP----VLSNATSLLQLQLDTNQIS 332
           P       +    L+ L L +N++ 
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLK 176

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 33/133 (24%), Positives = 57/133 (42%), Gaps = 15/133 (11%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPD-LGDCTQLTTIDVSSNSLVGGV 94
           N+  +  E       + L+ L  L++S ++L   IS +       L  +D+SSN L   +
Sbjct: 50  NLSRLRAEWTP----TRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLHT-L 103

Query: 95  PSSI-GKLINLQDLILNSNQLTGEIPKE-LGACIKLKNLLLFDNYLSGNLPVE----LGK 148
              +   L  L+ L+L +N +   + +       +L+ L L  N +S   PVE      K
Sbjct: 104 DEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK 161

Query: 149 LVNLEVIRAGGNK 161
           L  L ++    NK
Sbjct: 162 LPKLMLLDLSSNK 174

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 42/215 (19%), Positives = 69/215 (32%), Gaps = 43/215 (20%)

Query: 77  CT-QLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKE--LGACIKLKNLLL 133
           C      +  S   L   VP S+        L L+ N L+  +  E        L +LLL
Sbjct: 16  CLCASNILSCSKQQLPN-VPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLL 71

Query: 134 FDNYLSGNLPVE-LGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLP 192
             N+L+  +  E    + NL  +    N                 L           +L 
Sbjct: 72  SHNHLN-FISSEAFVPVPNLRYLDLSSNH----------------LH----------TLD 104

Query: 193 A-SLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPRE----LGKL 246
                 L  L+ L +Y   +   +      + ++L  L+L +N +S   P E      KL
Sbjct: 105 EFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL 162

Query: 247 QKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLN 281
            KL  + L  N        ++    +     L L+
Sbjct: 163 PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 84.9 bits (211), Expect = 5e-18
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 21/159 (13%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKTL 750
           +G+G  G+VY+A     GEV+A+KK+    +  E +         GV    +A  EI  L
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKI---RLDTETE---------GV--PSTAIREISLL 56

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
             + H NIV+ L      N   L+++++    L   +     + +   L    +    QG
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQG 115

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           LA+ H      ++HRD+K  N+LI  E    +ADFGLA+
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.4 bits (212), Expect = 5e-18
 Identities = 71/330 (21%), Positives = 123/330 (37%), Gaps = 48/330 (14%)

Query: 695  GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
            G+G  G V  A      E +AVK +             D        ++   EI     +
Sbjct: 16   GEGAYGEVQLAVNRVTEEAVAVKIV-------------DMKRAVDCPENIKKEICINKML 62

Query: 754  RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY---RIILGAAQG 810
             H+N+V+F G     N + L  +Y   G L   + E      E + +    +++     G
Sbjct: 63   NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLM----AG 117

Query: 811  LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
            + YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N + G+  Y+
Sbjct: 118  VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 871  APE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPID---PTIPE-------GLHIVDW 916
            APE      +     E  DV+S G+V+  +L G+ P D    +  E         ++  W
Sbjct: 175  APELLKRREF---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231

Query: 917  VRQKRGAIEVLDKSLRARPE--VEIEEMLQ----TLGVALLCVNPTPDDRPTMKDVAAMI 970
             +     + +L K L   P   + I ++ +       +      P        +  +   
Sbjct: 232  KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFS 291

Query: 971  KEIKQEREECMKVDMLPSEGSANGQRENNN 1000
            K I+   +         + GS   +  +++
Sbjct: 292  KHIQSNLDFSPVNSASRTPGSGWSKEHHHH 321

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.0 bits (211), Expect = 6e-18
 Identities = 63/269 (23%), Positives = 104/269 (38%), Gaps = 57/269 (21%)

Query: 653 MVGDDVDSEMGGNSLPWQLTPFQKLNFTVE--QVLKCLVEDSVVGKGCSGIVYRA-EMEN 709
           M G   +   G  SL     P Q      E  +  K      ++G+G    V  A E+  
Sbjct: 1   MDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGK------ILGEGSFSTVVLARELAT 54

Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVR----DSFSAEIKTLGSIRHKNIVRFLGCC 765
               A+K L             +K  I  ++       + E   +  + H   V+ L   
Sbjct: 55  SREYAIKIL-------------EKRHI--IKENKVPYVTRERDVMSRLDHPFFVK-LYFT 98

Query: 766 WNRNTRLLM-YDYMPNGSLGSLLHERRDSCLEWELRYR-----IILGAAQGLAYLH-HDC 818
           +  + +L     Y  NG L   +  R+    + E   R     I+      L YLH    
Sbjct: 99  FQDDEKLYFGLSYAKNGELLKYI--RKIGSFD-ETCTRFYTAEIVSA----LEYLHGKG- 150

Query: 819 VPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM 878
              I+HRD+K  NIL+  +    I DFG AK++        +N+  G+  Y++PE     
Sbjct: 151 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL---- 203

Query: 879 KITEK-----SDVYSYGVVVLEVLTGKQP 902
            +TEK     SD+++ G ++ +++ G  P
Sbjct: 204 -LTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 84.5 bits (210), Expect = 7e-18
 Identities = 58/228 (25%), Positives = 88/228 (38%), Gaps = 55/228 (24%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G G    V+   +   G++ A+K +              K        S   EI  L 
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCI-------------KKSPAFR-DSSLENEIAVLK 61

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
            I+H+NIV       +     L+   +  G L       G    E+  S +      + +
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY-TEKDASLV-----IQQV 115

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFARSS 860
           L A   + YLH +     IVHRD+K  N+L        +  I DFGL+K+   G      
Sbjct: 116 LSA---VKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---- 164

Query: 861 NTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +T  G+ GY+APE      Y       +  D +S GV+   +L G  P
Sbjct: 165 STACGTPGYVAPEVLAQKPYS------KAVDCWSIGVITYILLCGYPP 206

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.4 bits (212), Expect = 7e-18
 Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 50/221 (22%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG   +V R    E G+  AVK +      +      + +           E     
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL---------KREASICH 81

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL----------GSLLHERRDSCLEWELRY 801
            ++H +IV  L    +     +++++M    L          G +  E   S        
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-----M 136

Query: 802 RIILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFA 857
           R IL A   L Y H ++    I+HRD+K + +L+  +       +  FG+A  + E    
Sbjct: 137 RQILEA---LRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV 189

Query: 858 RSSNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVV 892
             +    G+  ++APE      YG      +  DV+  GV+
Sbjct: 190 --AGGRVGTPHFMAPEVVKREPYG------KPVDVWGCGVI 222

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 84.1 bits (209), Expect = 9e-18
 Identities = 51/218 (23%), Positives = 82/218 (37%), Gaps = 52/218 (23%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +GKG   +V R      G   A K +            N K            E +   
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKII------------NTKKLSARDFQKLEREARICR 60

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
            ++H NIVR        +   L++D +  G L            E   S        + I
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADASHC-----IQQI 114

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARSS 860
           L +   +AY H +     IVHR++K  N+L+  + +     +ADFGLA  V + +     
Sbjct: 115 LES---IAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH-- 165

Query: 861 NTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVV 892
              AG+ GY++PE      Y       +  D+++ GV+
Sbjct: 166 -GFAGTPGYLSPEVLKKDPYS------KPVDIWACGVI 196

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.1 bits (209), Expect = 1e-17
 Identities = 44/161 (27%), Positives = 82/161 (50%), Gaps = 27/161 (16%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKTLG 751
           VG+G  G+VY+A+   G ++A+K++    + AE +         G+    +A  EI  L 
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDE---------GI--PSTAIREISLLK 74

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR---YRIILGAA 808
            + H NIV  +    +     L++++M    L  +L E +    + +++   Y+++    
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---- 129

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           +G+A+ H      I+HRD+K  N+LI  +    +ADFGLA+
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 83.3 bits (207), Expect = 2e-17
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 21/158 (13%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKTLG 751
           +G+G  G+VY+A+   GE  A+KK+    +  E +         G+    +   EI  L 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI---RLEKEDE---------GI--PSTTIREISILK 55

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            ++H NIV+       +   +L+++++    L  LL            +   +L    G+
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKS-FLLQLLNGI 113

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           AY H      ++HRD+K  N+LI  E E  IADFGLA+
Sbjct: 114 AYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 22/158 (13%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+V++    + G+++A+KK      + +            ++     EI+ L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDP---------VIKKIALREIRMLKQ 58

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI--ILGAAQG 810
           ++H N+V  L     +    L+++Y  + ++   L   +    E  ++      L   Q 
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL---QA 114

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
           + + H       +HRD+K  NILI       + DFG A
Sbjct: 115 VNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA 149

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 85.6 bits (211), Expect = 3e-17
 Identities = 53/275 (19%), Positives = 90/275 (32%), Gaps = 34/275 (12%)

Query: 227 DLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGS 286
                 + L     R +      +K  +   +       +    + L   +LS+   S  
Sbjct: 305 PAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK-STV 363

Query: 287 LPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP 346
           L     +   L+EL   N     +I  ++    +L  L  +   +  F    + L+   P
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLM---RALDPLLYEKETLQYF----STLKAVDP 416

Query: 347 STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL 406
              A    L +  L  N++         +  ++  L L    ++                
Sbjct: 417 MRAAYLDDLRSKFLLENSVL------KMEYADVRVLHLAHKDLT---------------- 454

Query: 407 RLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
            L        +  L+LS+N L   LP +LA+L  L+VL  S N    +  +    L  L 
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQ 511

Query: 467 RLILSKNSFSG-AIPSSLGRCESLQSLDLSSNKLS 500
            L+L  N     A    L  C  L  L+L  N L 
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 83.7 bits (206), Expect = 1e-16
 Identities = 46/289 (15%), Positives = 90/289 (31%), Gaps = 54/289 (18%)

Query: 270 CKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTN 329
              L    L+      +    +    S +E +L  +          +    L + +L   
Sbjct: 301 LCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVE 359

Query: 330 QISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGI 389
           + +V             S L +C+ L+ ++  +     ++   +  L  L          
Sbjct: 360 KSTVL-----------QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYF 408

Query: 390 SGL-------IPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQ 442
           S L               S  +    +       +++L+L++  L  T+   L  L  + 
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVT 466

Query: 443 VLDISVNQFVGLIPESFGQLASLNRLILSKN---SFSGAIPSSLGRCESLQSLDLSSNKL 499
            LD+S N+    +P +   L  L  L  S N   +  G     +     LQ L L +N+L
Sbjct: 467 HLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVDG-----VANLPRLQELLLCNNRL 520

Query: 500 SGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKL 548
                                  A+       + +  +L +L+L  N L
Sbjct: 521 Q-------------------QSAAIQ-----PLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 79.0 bits (194), Expect = 3e-15
 Identities = 42/244 (17%), Positives = 80/244 (32%), Gaps = 48/244 (19%)

Query: 190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKL 249
                     +L    +     +  +  ++ +C EL +L         ++   +  L  L
Sbjct: 340 CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL 398

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTID--------LSLNFFSGSLPQSFGNLSSLEELM 301
                          E +    +LK +D           + F           + +  L 
Sbjct: 399 LY-----------EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH 447

Query: 302 LSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLS 361
           L++ +++  +   L     +  L L  N++            ++P  LA  R LE +  S
Sbjct: 448 LAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-----------ALPPALAALRCLEVLQAS 494

Query: 362 HNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLN 421
            NAL  ++  G+  L  L +LLL +N +       I               +C +L +LN
Sbjct: 495 DNALE-NV-DGVANLPRLQELLLCNNRLQQS--AAI-----------QPLVSCPRLVLLN 539

Query: 422 LSNN 425
           L  N
Sbjct: 540 LQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 76.3 bits (187), Expect = 2e-14
 Identities = 49/307 (15%), Positives = 98/307 (31%), Gaps = 30/307 (9%)

Query: 293 NLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC 352
           ++     +      +S      L+  + +  L L  ++  +   W+     + PS +  C
Sbjct: 243 DVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLC 302

Query: 353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL---- 408
                    ++ L       ++   +  K  ++          +      L R  L    
Sbjct: 303 DLPA--ASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK 360

Query: 409 -----MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLA 463
                    +C +LQ L   N     T+   + +L  L     ++  F  L      + A
Sbjct: 361 STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAA 420

Query: 464 SLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD-----ISLN 518
            L+     ++ F             ++ L L+   L+         +  L+       L+
Sbjct: 421 YLDD---LRSKFLLENSVLKMEYADVRVLHLAHKDLT--------VLCHLEQLLLVTHLD 469

Query: 519 LSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDS 578
           LS N L  A+PP ++AL  L +L  S N L  ++  ++ L  L  L +  N         
Sbjct: 470 LSHNRLR-ALPPALAALRCLEVLQASDNAL-ENVDGVANLPRLQELLLCNNRLQQ-SAAI 526

Query: 579 KLFRQLS 585
           +      
Sbjct: 527 QPLVSCP 533

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 74.4 bits (182), Expect = 9e-14
 Identities = 51/305 (16%), Positives = 101/305 (33%), Gaps = 29/305 (9%)

Query: 69  PISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKL 128
           P++      T L  +D +  S+    P    +  ++    L +  L  ++P+     I  
Sbjct: 264 PLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWT 323

Query: 129 KNLLLFDNYLS----GNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLAD 184
            +    +  L          +      L        K     +  E+  C+ L  +   +
Sbjct: 324 GSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST--VLQSELESCKELQELEPEN 381

Query: 185 TKVAGSLPASLGKLSKLQSLS---VYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPR 241
                ++   +  L  L        Y + L    P +     +L   FL EN +      
Sbjct: 382 KWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYA 441

Query: 242 ELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELM 301
           ++  L       L   +    +   +     +  +DLS N    +LP +   L  LE L 
Sbjct: 442 DVRVLH------LAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQ 492

Query: 302 LSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLS 361
            S+N +  ++   ++N   L +L L  N++            +    L +C  L  ++L 
Sbjct: 493 ASDNALE-NVDG-VANLPRLQELLLCNNRLQQS---------AAIQPLVSCPRLVLLNLQ 541

Query: 362 HNALT 366
            N+L 
Sbjct: 542 GNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 43.2 bits (101), Expect = 4e-04
 Identities = 26/164 (15%), Positives = 50/164 (30%), Gaps = 6/164 (3%)

Query: 430 TLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESL 489
                 A+  +L   ++SV +          +L S   L   +      + + +    +L
Sbjct: 340 CWCRDSATDEQLFRCELSVEK----STVLQSELESCKELQELEPENKWCLLTIILLMRAL 395

Query: 490 QSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLG 549
             L      L     ++  +        +L    L             + +L L+H  L 
Sbjct: 396 DPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLE-NSVLKMEYADVRVLHLAHKDLT 454

Query: 550 GDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQ 593
             L  L  L  +  L++S+N      P     R L   + + N 
Sbjct: 455 -VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA 497

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.0 bits (206), Expect = 4e-17
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 29/177 (16%)

Query: 674 FQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQND 732
           ++KL+F              +G+G    VY+A +    +++A+KK+    +        D
Sbjct: 12  YEKLDF--------------LGEGQFATVYKARDKNTNQIVAIKKI---KLGHR-SEAKD 53

Query: 733 KIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD 792
            I    +R     EIK L  + H NI+  L    +++   L++D+M    L  ++ +   
Sbjct: 54  GINRTALR-----EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL 107

Query: 793 SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
                 ++   +L   QGL YLH      I+HRD+K NN+L+       +ADFGLAK
Sbjct: 108 VLTPSHIK-AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.8 bits (203), Expect = 4e-17
 Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 28/162 (17%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKTL 750
           +G+G  G V++A   E  E++A+K++    +  + +         GV    SA  EI  L
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDE---------GV--PSSALREICLL 55

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR---YRIILGA 807
             ++HKNIVR      +     L++++     L               ++   ++++   
Sbjct: 56  KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL--- 111

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
            +GL + H      ++HRD+K  N+LI    E  +A+FGLA+
Sbjct: 112 -KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.7 bits (205), Expect = 6e-17
 Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 54/219 (24%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGV-RDSFSAEIKTL 750
            +GKG   +V R      G   A K +             +   +          E +  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKII-------------NTKKLSARDFQKLEREARIC 82

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRI 803
             ++H NIVR        +   L++D +  G L            E   S        + 
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY-SEADASHC-----IQQ 136

Query: 804 ILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARS 859
           IL +   +AY H +     IVHR++K  N+L+  + +     +ADFGLA  V + +    
Sbjct: 137 ILES---IAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH- 188

Query: 860 SNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVV 892
               AG+ GY++PE      Y       +  D+++ GV+
Sbjct: 189 --GFAGTPGYLSPEVLKKDPYS------KPVDIWACGVI 219

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 82.8 bits (205), Expect = 7e-17
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 35/222 (15%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G   IV +  E   G   A K +     +               R+    E+  L 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFI-KKRQSRASRRGVC-------REEIEREVSILR 70

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER---RDSCLEWELRY--RIILG 806
            + H NI+       NR   +L+ + +  G L     +    ++S  E E     + IL 
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQIL- 125

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEGDFARSSNT 862
              G+ YLH      I H D+K  NI++  +  P     + DFGLA  + +G   +    
Sbjct: 126 --DGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---N 177

Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVV--VLEVLTGKQP 902
           + G+  ++APE      +  ++D++S GV+  +L  L+G  P
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSGASP 217

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.1 bits (208), Expect = 8e-17
 Identities = 62/265 (23%), Positives = 99/265 (37%), Gaps = 48/265 (18%)

Query: 651 GKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEM-EN 709
                D +DS      L W+    Q +     +  +      V+GKG  G V   ++   
Sbjct: 155 VAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR------VLGKGGFGEVCACQVRAT 208

Query: 710 GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN 769
           G++ A KKL           +  +I           E + L  +  + +V  L   +   
Sbjct: 209 GKMYACKKL-----------EKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETK 256

Query: 770 TRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----IILGAAQGLAYLHHDCVPPIV 823
             L L+   M  G L   ++    +    E R       I  G    L  LH +    IV
Sbjct: 257 DALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCG----LEDLHRER---IV 308

Query: 824 HRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE------YGYM 877
           +RD+K  NIL+       I+D GLA  V EG    +     G+ GY+APE      Y + 
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFS 365

Query: 878 MKITEKSDVYSYGVVVLEVLTGKQP 902
                  D ++ G ++ E++ G+ P
Sbjct: 366 P------DWWALGCLLYEMIAGQSP 384

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 81.9 bits (203), Expect = 8e-17
 Identities = 39/160 (24%), Positives = 71/160 (44%), Gaps = 26/160 (16%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKTL 750
           VG+G  G+V +    + G ++A+KK      + +            V+    A  EIK L
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKF---LESDDDK---------MVK--KIAMREIKLL 78

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI--ILGAA 808
             +RH+N+V  L  C  +    L+++++ + ++   L    +      ++  +  I+   
Sbjct: 79  KQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQII--- 134

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
            G+ + H      I+HRDIK  NIL+       + DFG A
Sbjct: 135 NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA 171

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 80.7 bits (200), Expect = 9e-17
 Identities = 59/218 (27%), Positives = 91/218 (41%), Gaps = 32/218 (14%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G+G  G V  A      E +AVK +             D        ++   EI     +
Sbjct: 16  GEGAYGEVQLAVNRVTEEAVAVKIV-------------DMKRAVDCPENIKKEICINKML 62

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY---RIILGAAQG 810
            H+N+V+F G     N + L  +Y   G L   + E      E + +    +++     G
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLM----AG 117

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           + YLH      I HRDIK  N+L+       I+DFGLA +    +  R  N + G+  Y+
Sbjct: 118 VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 871 APE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           APE      +     E  DV+S G+V+  +L G+ P D
Sbjct: 175 APELLKRREF---HAEPVDVWSCGIVLTAMLAGELPWD 209

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 22/160 (13%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G    VY+      G  +A+K++    + +E     +      +R     EI  +  
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV---KLDSE-----EGTPSTAIR-----EISLMKE 59

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII----LGAA 808
           ++H+NIVR        N   L++++M N  L   +  R        L   ++        
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
           QGLA+ H +    I+HRD+K  N+LI    +  + DFGLA
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 35/222 (15%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G   IV +  E   G   A K +     +               R+    E+  L 
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFI-KKRQSRASRRGVS-------REEIEREVSILR 70

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER---RDSCLEWELRY--RIILG 806
            + H N++       NR   +L+ + +  G L     +    ++S  E E     + IL 
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQIL- 125

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEGDFARSSNT 862
              G+ YLH      I H D+K  NI++  +  P     + DFGLA  + +G   +    
Sbjct: 126 --DGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---N 177

Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVV--VLEVLTGKQP 902
           + G+  ++APE      +  ++D++S GV+  +L  L+G  P
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSGASP 217

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 49/295 (16%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVK-----KLWPTTMAAEYDCQNDKIGIGGVRDSFSA--- 745
           GKG  G+V  A    +    A+K     KL                   G          
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 746 ----EIKTLGSIRHKNIVRFLGCCWNRNTRLLMY---DYMPNGSLGSLLHERRDSCLEWE 798
               EI  L  + H N+V+ L    +      +Y   + +  G +  +   +  S  E +
Sbjct: 82  QVYQEIAILKKLDHPNVVK-LVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS--EDQ 138

Query: 799 LRY---RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
            R+    +I G    + YLH+     I+HRDIK +N+L+G +    IADFG++      D
Sbjct: 139 ARFYFQDLIKG----IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191

Query: 856 FARSSNTVAGSYGYIAPE--YGYMMKIT-EKSDVYSYGVVVLEVLTGKQP-IDPTIPEGL 911
              S     G+  ++APE         + +  DV++ GV +   + G+ P +D  I   L
Sbjct: 192 ALLS--NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC-L 248

Query: 912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           H       K     +  ++L    + +I E L+ L   +L  N  P+ R  + ++
Sbjct: 249 H------SK-----IKSQALEFPDQPDIAEDLKDLITRMLDKN--PESRIVVPEI 290

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 59/216 (27%), Positives = 88/216 (40%), Gaps = 52/216 (24%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G + IVYR  +    +  A+K L               +    VR     EI  L 
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVL------------KKTVDKKIVRT----EIGVLL 103

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
            + H NI++            L+ + +  G L       G    ER  +        + I
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY-SERDAADA-----VKQI 157

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFARSS 860
           L A   +AYLH +     IVHRD+K  N+L     P+    IADFGL+K+V      +  
Sbjct: 158 LEA---VAYLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK-- 208

Query: 861 NTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVV 892
            TV G+ GY APE      Y      + D++S G++
Sbjct: 209 -TVCGTPGYCAPEILRGCAY----GPEVDMWSVGII 239

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 81.1 bits (201), Expect = 2e-16
 Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 56/235 (23%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKTL 750
           +G+G  G V++A   + G+ +A+KK+    M  E +         G     +A  EIK L
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV---LMENEKE---------GFP--ITALREIKIL 70

Query: 751 GSIRHKNIVRFLGCCWNRNTRL--------LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
             ++H+N+V  +  C  + +          L++D+  +  L  LL          E++ R
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK-R 128

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
           ++     GL Y+H +    I+HRD+KA N+LI  +    +ADFGLA+      F+ + N+
Sbjct: 129 VMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA-----FSLAKNS 180

Query: 863 VAGSYG-------YIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
               Y        Y  PE       YG         D++  G ++ E+ T   PI
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYG------PPIDLWGAGCIMAEMWTRS-PI 228

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 37/157 (23%), Positives = 68/157 (43%), Gaps = 19/157 (12%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G    VY+        ++A+K++    +  E     +      +R     E+  L  
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEI---RLEHE-----EGAPCTAIR-----EVSLLKD 56

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H NIV          +  L+++Y+    L   L +  +      ++   +    +GLA
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL-FLFQLLRGLA 114

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           Y H      ++HRD+K  N+LI    E  +ADFGLA+
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.1 bits (203), Expect = 3e-16
 Identities = 59/264 (22%), Positives = 103/264 (39%), Gaps = 41/264 (15%)

Query: 650 AGKMVGDDVDSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEM-E 708
                 + +DS      L W+    Q +        +      V+G+G  G V+  +M  
Sbjct: 155 GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFR------VLGRGGFGEVFACQMKA 208

Query: 709 NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR 768
            G++ A KKL              ++           E K L  +  + IV  L   +  
Sbjct: 209 TGKLYACKKL-----------NKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LAYAFET 256

Query: 769 NTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ---GLAYLHHDCVPPIVH 824
            T L L+   M  G +   ++   +    ++   R I   AQ   GL +LH      I++
Sbjct: 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLHQRN---IIY 312

Query: 825 RDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE------YGYMM 878
           RD+K  N+L+  +    I+D GLA  +  G     +   AG+ G++APE      Y + +
Sbjct: 313 RDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSV 370

Query: 879 KITEKSDVYSYGVVVLEVLTGKQP 902
                 D ++ GV + E++  + P
Sbjct: 371 ------DYFALGVTLYEMIAARGP 388

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 51/240 (21%), Positives = 88/240 (36%), Gaps = 63/240 (26%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS------A 745
           + G+G  G V    E   G  +A+KK                     V            
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKK---------------------VIQDPRFRNRELQ 68

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTR-------LLMYDYMPNGSLGSLL--HERRDSCLE 796
            ++ L  + H NIV+     +    R        ++ +Y+P+ +L      + RR     
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP 127

Query: 797 WEL-RYRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKLVV 852
             L +  +  ++   + +  LH   V  + HRDIK +N+L+        + DFG AK + 
Sbjct: 128 PILIKVFLFQLI---RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 853 EGDFARSSNT--VAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
             +     N   +   Y Y APE       Y   +    D++S G +  E++ G +PI  
Sbjct: 184 PSEP----NVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLG-EPIFR 233

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)

Query: 689 VEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +   V+G G +G V        G+  A+K L                           E+
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLL-------------YD------SPKARQEV 72

Query: 748 KTLGSI-RHKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGSLLHERRDSCL-EWELR 800
                     +IV  L    N +       ++M + M  G L S + ER D    E E  
Sbjct: 73  DHHWQASGGPHIVCILDVYENMHHGKRCLLIIM-ECMEGGELFSRIQERGDQAFTEREAA 131

Query: 801 Y--RIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGD 855
              R I  A   + +LH      I HRD+K  N+L      +    + DFG AK   +  
Sbjct: 132 EIMRDIGTA---IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185

Query: 856 FARSSNTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                 T   +  Y+APE      Y     +  D++S GV++  +L G  P
Sbjct: 186 L----QTPCYTPYYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGFPP 228

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.1 bits (198), Expect = 4e-16
 Identities = 68/321 (21%), Positives = 124/321 (38%), Gaps = 39/321 (12%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G G  G V+ A   E  + + VK +    +  +   ++ K+G        + EI  L  +
Sbjct: 33  GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG------KVTLEIAILSRV 86

Query: 754 RHKNIVRFLGCCWNRNT-RLLMYDYMPNGSLGSLLHERRDSCLEWELRY--RIILGAAQG 810
            H NI++ L    N+   +L+M  +     L + + +R     E    Y  R ++ A   
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQLVSA--- 142

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           + YL       I+HRDIK  NI+I  +F   + DFG A  +  G       T  G+  Y 
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFCGTIEYC 196

Query: 871 APEY----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT--IPEG-LHIVDWVRQKRGA 923
           APE      Y      + +++S GV +  ++  + P        E  +H    V +    
Sbjct: 197 APEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSK--EL 251

Query: 924 IEVLDKSLRARPE--VEIEEMLQ----TLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER 977
           + ++   L+  PE    +E+++     T  V L       +     K  + ++     E 
Sbjct: 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTW-EEVFRVNKPESGVLSAASLEM 310

Query: 978 EECMKVDMLPSEGSANGQREN 998
                 D+  ++    G+  +
Sbjct: 311 GNRSLSDVAQAQELCGGEGHH 331

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 81.2 bits (201), Expect = 4e-16
 Identities = 50/218 (22%), Positives = 85/218 (38%), Gaps = 51/218 (23%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +GKG   +V R  ++  G+  A   +  T   +  D Q        +      E +   
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQK-------LER----EARICR 65

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
            ++H NIVR            L++D +  G L            E   S        + I
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYY-SEADASHC-----IQQI 119

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARSS 860
           L A   + + H       +VHR++K  N+L+  + +     +ADFGLA  V      ++ 
Sbjct: 120 LEA---VLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAW 170

Query: 861 NTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVV 892
              AG+ GY++PE      YG      +  D+++ GV+
Sbjct: 171 FGFAGTPGYLSPEVLRKDPYG------KPVDLWACGVI 202

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 68/287 (23%), Positives = 111/287 (38%), Gaps = 63/287 (21%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVK-----KLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           GKG    V  A  +  G  +A+K     +L PT++         K+           E++
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL--------QKL---------FREVR 66

Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR--YRIILG 806
            +  + H NIV+         T  L+ +Y   G +   L        E E R  +R I+ 
Sbjct: 67  IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVS 125

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
           A   + Y H      IVHRD+KA N+L+  +    IADFG +     G          G+
Sbjct: 126 A---VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---AFCGA 176

Query: 867 YGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQPID-PTIPEGLHIVDWVRQKR 921
             Y APE      Y      + DV+S GV++  +++G  P D   +              
Sbjct: 177 PPYAAPELFQGKKY---DGPEVDVWSLGVILYTLVSGSLPFDGQNLK------------- 220

Query: 922 GAIEVLDKSLRARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
              E+ ++ LR +  +   +    + L    L +NP    R T++ +
Sbjct: 221 ---ELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPI--KRGTLEQI 262

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 79.2 bits (196), Expect = 5e-16
 Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 26/167 (15%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EI--- 747
           +G G  G VY+A +  +G  +A+K +            N   G GG+    S   E+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVR---------VPNGGGGGGGL--PISTVREVALL 65

Query: 748 KTLGSIRHKNIVR----FLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
           + L +  H N+VR          +R  ++ L+++++    L + L +     L  E    
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
           ++    +GL +LH +C   IVHRD+K  NIL+       +ADFGLA+
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 35/222 (15%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G   IV +  +   G+  A K +      +              R+    E+  L 
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFI-KKRRLSSSRRGVS-------REEIEREVNILR 63

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER---RDSCLEWELRY--RIILG 806
            IRH NI+       N+   +L+ + +  G L     +    ++S  E E     + IL 
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQIL- 118

Query: 807 AAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEGDFARSSNT 862
              G+ YLH      I H D+K  NI++  +  P     + DFG+A  +  G+  +    
Sbjct: 119 --DGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---N 170

Query: 863 VAGSYGYIAPEYGYMMKITEKSDVYSYGVV--VLEVLTGKQP 902
           + G+  ++APE      +  ++D++S GV+  +L  L+G  P
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL--LSGASP 210

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.5 bits (199), Expect = 5e-16
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 57/234 (24%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G G  G+VY+A   ++GE++A+KK+             DK      R     E++ + 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKV-----------LQDKRFKN--R-----ELQIMR 102

Query: 752 SIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCL---EWELRYR 802
            + H NIVR     ++   +       L+ DY+P  ++  +      +        ++  
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLY 161

Query: 803 I--ILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFAR 858
           +  +    + LAY+H       I HRDIK  N+L+ P+     + DFG AK +V G+   
Sbjct: 162 MYQLF---RSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-- 212

Query: 859 SSNT--VAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
             N   +   Y Y APE       Y   I    DV+S G V+ E+L G QPI P
Sbjct: 213 --NVSYICSRY-YRAPELIFGATDYTSSI----DVWSAGCVLAELLLG-QPIFP 258

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.8 bits (195), Expect = 9e-16
 Identities = 37/164 (22%), Positives = 70/164 (42%), Gaps = 28/164 (17%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKTL 750
           +G+G  G VY+A +    E +A+K++    +  E +         GV    +A  E+  L
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEE---------GV--PGTAIREVSLL 87

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
             ++H+NI+       + +   L+++Y  N  L   + +  D  +   +    +     G
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLING 144

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPY-----IADFGLAK 849
           + + H       +HRD+K  N+L+            I DFGLA+
Sbjct: 145 VNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 44/221 (19%), Positives = 81/221 (36%), Gaps = 40/221 (18%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G+V+R  E   G V   K +             +       + +   EI  + 
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFI-------------NTPYPLD-KYTVKNEISIMN 103

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-------GSLLHERRDSCLEWELRYRII 804
            + H  ++       ++   +L+ +++  G L          + E            R  
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQA 158

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY--IADFGLAKLVVEGDFARSSN 861
               +GL ++H H     IVH DIK  NI+   +      I DFGLA  +   +  +   
Sbjct: 159 C---EGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK--- 208

Query: 862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
               +  + APE      +   +D+++ GV+   +L+G  P
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.1 bits (193), Expect = 3e-15
 Identities = 57/257 (22%), Positives = 105/257 (40%), Gaps = 61/257 (23%)

Query: 666 SLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMA 724
           S+P      + +NF   ++L+       +GKG  G V   +  +  ++ A+K +      
Sbjct: 1   SMPPVFDENEDVNFDHFEILR------AIGKGSFGKVCIVQKNDTKKMYAMKYM------ 48

Query: 725 AEYDCQNDKIGI---GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLM-YDYMPN 780
                  +K        VR+ F  E++ +  + H  +V  L   +     + M  D +  
Sbjct: 49  -------NKQKCVERNEVRNVF-KELQIMQGLEHPFLVN-LWYSFQDEEDMFMVVDLLLG 99

Query: 781 GSLGSLLHERRDSCLEWELRYR-----IILGAAQGLAYLH-HDCVPPIVHRDIKANNILI 834
           G L   L  +++   + E   +     +++     L YL        I+HRD+K +NIL+
Sbjct: 100 GDLRYHL--QQNVHFK-EETVKLFICELVMA----LDYLQNQR----IIHRDMKPDNILL 148

Query: 835 GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE---------YGYMMKITEKSD 885
                 +I DF +A ++          T+AG+  Y+APE         Y + +      D
Sbjct: 149 DEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAV------D 199

Query: 886 VYSYGVVVLEVLTGKQP 902
            +S GV   E+L G++P
Sbjct: 200 WWSLGVTAYELLRGRRP 216

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 28/167 (16%)

Query: 310 SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSL 369
            IP  L    +  +++L+ N I         +    P   +  + L  +DLS+N ++  L
Sbjct: 25  EIPTNLPETIT--EIRLEQNTIK-------VIP---PGAFSPYKKLRRIDLSNNQIS-EL 71

Query: 370 HPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG 428
            P  F  L++L  L+L  N I+ L P  +             F     LQ+L L+ N + 
Sbjct: 72  APDAFQGLRSLNSLVLYGNKITEL-PKSL-------------FEGLFSLQLLLLNANKIN 117

Query: 429 GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF 475
                +   L  L +L +  N+   +   +F  L ++  + L++N F
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 22/157 (14%)

Query: 344 SIPSTL-ANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCS 401
            IP+ L      +    L  N +   + PG F   + L ++ L +N IS L  P+     
Sbjct: 25  EIPTNLPETITEI---RLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISEL-APDA---- 75

Query: 402 SLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLIPESFG 460
                    F     L  L L  N +   LP SL   L  LQ+L ++ N+   L  ++F 
Sbjct: 76  ---------FQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQ 125

Query: 461 QLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN 497
            L +LN L L  N        +     ++Q++ L+ N
Sbjct: 126 DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 40/167 (23%), Positives = 58/167 (34%), Gaps = 32/167 (19%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
            IP  +    ++  I L  N      P +F     L  + LSNN IS  + P       S
Sbjct: 25  EIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQN 378
           L  L L  N+I+            +P        SL+ + L+ N +   L    FQ L N
Sbjct: 82  LNSLVLYGNKIT-----------ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHN 129

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNN 425
           L  L L  N +   I                 F     +Q ++L+ N
Sbjct: 130 LNLLSLYDNKLQT-IAKGT-------------FSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 32/163 (19%), Positives = 57/163 (34%), Gaps = 40/163 (24%)

Query: 228 LFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSL 287
           + L +N +    P      +KL ++ L  N               +  +           
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNN--------------QISELA---------- 72

Query: 288 PQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP 346
           P +F  L SL  L+L  N I+  +P  +     SL  L L+ N+I+            + 
Sbjct: 73  PDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-----------CLR 120

Query: 347 S-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISN 387
                +  +L  + L  N L  ++  G F  L+ +  + L  N
Sbjct: 121 VDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 28/113 (24%), Positives = 56/113 (49%), Gaps = 6/113 (5%)

Query: 463 ASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFE-IEGLDISLNLSW 521
            ++  + L +N+     P +    + L+ +DLS+N++S ++  + F+ +  L+ SL L  
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLN-SLVLYG 89

Query: 522 NALSGAIPPQI-SALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFT 572
           N ++  +P  +   L  L +L L+ NK+    + A   L NL  L++  N   
Sbjct: 90  NKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 29/141 (20%), Positives = 51/141 (36%), Gaps = 30/141 (21%)

Query: 192 PASLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPREL-GKLQKL 249
           P +     KL+ + +    +S E+ P        L  L LY N ++  LP+ L   L  L
Sbjct: 49  PGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSL 106

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
           + +LL  N               +  +             +F +L +L  L L +N +  
Sbjct: 107 QLLLLNANK--------------INCLR----------VDAFQDLHNLNLLSLYDNKLQ- 141

Query: 310 SIPP-VLSNATSLLQLQLDTN 329
           +I     S   ++  + L  N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 29/130 (22%), Positives = 55/130 (42%), Gaps = 15/130 (11%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDC-TQLTTIDVSSNSLVGGV 94
            I+ I      P   S    L+++ +S + ++  ++PD       L ++ +  N +   +
Sbjct: 43  TIKVIP-----PGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKITE-L 95

Query: 95  PSSI-GKLINLQDLILNSNQLTGEIPKELGACIKLKNL---LLFDNYLSGNLPVELGKLV 150
           P S+   L +LQ L+LN+N++   +     A   L NL    L+DN L          L 
Sbjct: 96  PKSLFEGLFSLQLLLLNANKIN-CLRV--DAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152

Query: 151 NLEVIRAGGN 160
            ++ +    N
Sbjct: 153 AIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 37/184 (20%), Positives = 66/184 (35%), Gaps = 36/184 (19%)

Query: 81  TTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSG 140
             +D     L   +P+++     + ++ L  N +    P       KL+ + L +N +S 
Sbjct: 14  NIVDCRGKGLTE-IPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS- 69

Query: 141 NLPVEL-GKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASL-GKL 198
            L  +    L +L  +   GNK                    +        LP SL   L
Sbjct: 70  ELAPDAFQGLRSLNSLVLYGNK--------------------IT------ELPKSLFEGL 103

Query: 199 SKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLWQ 256
             LQ L +    ++  +      +   L  L LY+N L  ++ +     L+ ++ M L Q
Sbjct: 104 FSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQ 161

Query: 257 NNFD 260
           N F 
Sbjct: 162 NPFI 165

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 48/230 (20%), Positives = 87/230 (37%), Gaps = 45/230 (19%)

Query: 689 VEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           +    +G+G   +V +      G+  A K L       +             R     EI
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFL-KKRRRGQDC-----------RAEILHEI 79

Query: 748 KTLGSIRH-KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL-EWELRY--RI 803
             L   +    ++       N +  +L+ +Y   G + SL        + E ++    + 
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARSS 860
           IL   +G+ YLH +    IVH D+K  NIL+   +      I DFG+++ +      R  
Sbjct: 140 IL---EGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR-- 191

Query: 861 NTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVV--VLEVLTGKQP 902
             + G+  Y+APE                +D+++ G++  +L  LT   P
Sbjct: 192 -EIMGTPEYLAPEILNYDPIT------TATDMWNIGIIAYML--LTHTSP 232

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 52/225 (23%)

Query: 694 VGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G    V+ A  + N E + VK L P         +  KI     R     EIK L +
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPV--------KKKKI----KR-----EIKILEN 86

Query: 753 IR-HKNIVRFLGCCWNRNTR--LLMYDYMPNGSLGSLLHERRDSCLEWELRYRI--ILGA 807
           +R   NI+       +  +R   L+++++ N     L     D     ++R+ +  IL  
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY----DIRFYMYEIL-- 140

Query: 808 AQGLAYLH-HDCVPPIVHRDIKANNILIGPEF-EPYIADFGLAKLVVEGDFARSSNTVAG 865
            + L Y H       I+HRD+K +N++I  E  +  + D+GLA+    G     +  VA 
Sbjct: 141 -KALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVAS 193

Query: 866 SYGYIAPE-------YGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            Y +  PE       Y Y +      D++S G ++  ++  K+P 
Sbjct: 194 RY-FKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEPF 231

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 45/229 (19%), Positives = 81/229 (35%), Gaps = 57/229 (24%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  GIV+R  E  + +    K +       +   +               EI  L 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKK--------------EISILN 56

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY---------R 802
             RH+NI+       +    +++++++    +     ER                     
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDI----FER---INTSAFELNEREIVSYVH 109

Query: 803 IILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY--IADFGLAKLVVEGDFARS 859
            +    + L +LH H+    I H DI+  NI+          I +FG A+ +  GD  R 
Sbjct: 110 QVC---EALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR- 161

Query: 860 SNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
              +  +  Y APE                +D++S G +V  +L+G  P
Sbjct: 162 --LLFTAPEYYAPEVHQHDVVST------ATDMWSLGTLVYVLLSGINP 202

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 77.9 bits (192), Expect = 4e-15
 Identities = 43/181 (23%), Positives = 71/181 (39%), Gaps = 42/181 (23%)

Query: 689 VEDSVVGKGCSGIVYRA---EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
            E   VG+G  G VY+A   + ++ +  A+K+                I   G+  S   
Sbjct: 24  YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQ----------------IEGTGISMSACR 67

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLM--YDYMPNGSLGSLLHERRDSCLEWELRYRI 803
           EI  L  ++H N++       +   R +   +DY  +  L  ++   R S      +  +
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN---KKPV 123

Query: 804 ILGAAQ----------GLAYLHHDCVPPIVHRDIKANNILIGPEFEPY----IADFGLAK 849
            L              G+ YLH +    ++HRD+K  NIL+  E        IAD G A+
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180

Query: 850 L 850
           L
Sbjct: 181 L 181

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 31/222 (13%)

Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA-----E 746
             +  G  G V       G  +A+K++        ++  +D   +  + DSF       E
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRV--------FNTVSDGRTVNILSDSFLCKRVLRE 79

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRL-----LMYDYMPNGSLGSLLHERRDSCLEWELRY 801
           I+ L    H NI+       +          L+ + M    L  ++H++R       ++Y
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY 138

Query: 802 RI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
            +  IL    GL  LH   V   VHRD+   NIL+    +  I DF LA+          
Sbjct: 139 FMYHIL---LGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADAN--K 190

Query: 860 SNTVAGSYGYIAPEY-GYMMKITEKSDVYSYGVVVLEVLTGK 900
           ++ V   + Y APE        T+  D++S G V+ E+   K
Sbjct: 191 THYVTHRW-YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 78.3 bits (193), Expect = 5e-15
 Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 28/215 (13%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G+V+R  E   G   A K +                     +++   EI+T+ 
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFV-------------MTPHESD-KETVRKEIQTMS 209

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY--RIILGAAQ 809
            +RH  +V       + N  +++Y++M  G L   + +  +   E E     R +    +
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC---K 266

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI--ADFGLAKLVVEGDFARSSNTVAGSY 867
           GL ++H +     VH D+K  NI+   +    +   DFGL   +      +      G+ 
Sbjct: 267 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTA 320

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            + APE      +   +D++S GV+   +L+G  P
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 50/224 (22%), Positives = 94/224 (41%), Gaps = 46/224 (20%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G G  G V++  E   G  +A K +                G+   ++    EI  + 
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKII-------------KTRGMKD-KEEVKNEISVMN 141

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER---RDSCL-EWELRY--RIIL 805
            + H N+++      ++N  +L+ +Y+  G L     +R       L E +     + I 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQIC 197

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI--ADFGLAKLVVEGDFARSSNTV 863
              +G+ ++H      I+H D+K  NIL        I   DFGLA+     +  +     
Sbjct: 198 ---EGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK---VN 248

Query: 864 AGSYGYIAPE---YGYMMKITEKSDVYSYGVV--VLEVLTGKQP 902
            G+  ++APE   Y +   ++  +D++S GV+  +L  L+G  P
Sbjct: 249 FGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYML--LSGLSP 287

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 75.7 bits (187), Expect = 9e-15
 Identities = 41/168 (24%), Positives = 76/168 (45%), Gaps = 30/168 (17%)

Query: 694 VGKGCSGIVYRA--EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA--EIKT 749
           +G+G  G V++A      G  +A+K++    +    +         G+    S   E+  
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEE---------GM--PLSTIREVAV 64

Query: 750 LGSIR---HKNIVR----FLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRY 801
           L  +    H N+VR          +R T+L L+++++    L + L +  +  +  E   
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK 123

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
            ++    +GL +LH      +VHRD+K  NIL+    +  +ADFGLA+
Sbjct: 124 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 76.7 bits (189), Expect = 9e-15
 Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 32/221 (14%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G  G V   ++    +V A+K L    M    +              F  E   L 
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE-----------TACFREERDVLV 129

Query: 752 SIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRY---RIILGA 807
           +   K I   L   +  +  L L+ DY   G L +LL +  D   E   R+    +++  
Sbjct: 130 NGDSKWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA- 187

Query: 808 AQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGS 866
              +  +H        VHRDIK +NIL+       +ADFG    ++E    + S+   G+
Sbjct: 188 ---IDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGT 239

Query: 867 YGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
             YI+PE      G   +   + D +S GV + E+L G+ P
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 76.2 bits (188), Expect = 9e-15
 Identities = 72/352 (20%), Positives = 125/352 (35%), Gaps = 65/352 (18%)

Query: 695  GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
            G G  G+          E++AVK +             ++     + ++   EI    S+
Sbjct: 29   GSGNFGVARLMRDKLTKELVAVKYI-------------ERGAA--IDENVQREIINHRSL 73

Query: 754  RHKNIVRFLGCCWNRNTRLLMYDYMPNGSL-GSLLHERRDSCLEWELRY---RIILGAAQ 809
            RH NIVRF           ++ +Y   G L   + +  R S  E E R+   +++     
Sbjct: 74   RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS--EDEARFFFQQLL----S 127

Query: 810  GLAYLHHDCVPPIVHRDIKANNILIGPEFEPY--IADFGLAKLVVEGDFARSSNTVAGSY 867
            G++Y H   +    HRD+K  N L+     P   I DFG +K  V     +   +  G+ 
Sbjct: 128  GVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTP 181

Query: 868  GYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPI-DPTIPEGLHIVDWVRQKRG 922
             YIAPE      Y  K    +DV+S GV +  +L G  P  DP  P              
Sbjct: 182  AYIAPEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYPFEDPEEPRDYR---------- 228

Query: 923  AIEVLDKSLRAR----PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA---MIKEIKQ 975
              + + + L  +     ++ I      L   +   +  P  R ++ ++      +K +  
Sbjct: 229  --KTIQRILSVKYSIPDDIRISPECCHLISRIFVAD--PATRISIPEIKTHSWFLKNLPA 284

Query: 976  E--REECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYPQSNNTSFSASSLL 1025
            +   E          E             S A +P +  +  +   + +  L
Sbjct: 285  DLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDL 336

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 51/223 (22%), Positives = 85/223 (38%), Gaps = 50/223 (22%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G    V     +   +  AVK +             +K         F  E++ L 
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKII-------------EKQPGHIRSRVFR-EVEMLY 65

Query: 752 SIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY--RIILGAA 808
             + H+N++  +      +   L+++ M  GS+ S +H+RR    E E     + +  A 
Sbjct: 66  QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASA- 123

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARSSN---- 861
             L +LH+     I HRD+K  NIL     +     I DF L   +         +    
Sbjct: 124 --LDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 862 -TVAGSYGYIAPE-----------YGYMMKITEKSDVYSYGVV 892
            T  GS  Y+APE           Y       ++ D++S GV+
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYD------KRCDLWSLGVI 215

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 74.5 bits (184), Expect = 1e-14
 Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 36/225 (16%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G G  G V   E    G  +AVK L              KI    V      EI+ L   
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKIL-----------NRQKIRSLDVVGKIKREIQNLKLF 68

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL--HERRDSCLEWELR--YRIILGAAQ 809
           RH +I++            ++ +Y+  G L   +  H R +   E E R  ++ IL A  
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVE---EMEARRLFQQILSA-- 123

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            + Y H      +VHRD+K  N+L+       IADFGL+ ++ +G+F R   T  GS  Y
Sbjct: 124 -VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSCGSPNY 176

Query: 870 IAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPID-PTIPE 909
            APE      Y      + D++S GV++  +L G  P D   +P 
Sbjct: 177 AAPEVISGRLY---AGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 52/229 (22%), Positives = 88/229 (38%), Gaps = 49/229 (21%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G   +V +  E   G   A K +                     R+    E+  L 
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFI-KKRRTKSSRRGVS-------REDIEREVSILK 69

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER---RDSCLEWELRY--RIILG 806
            I+H N++       N+   +L+ + +  G L     +    ++S  E E     + IL 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILN 125

Query: 807 AAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEGDFARSSN 861
               + YLH       I H D+K  NI++     P     I DFGLA  +  G+  +   
Sbjct: 126 G---VYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--- 175

Query: 862 TVAGSYGYIAPE------YGYMMKITEKSDVYSYGVV--VLEVLTGKQP 902
            + G+  ++APE       G       ++D++S GV+  +L  L+G  P
Sbjct: 176 NIFGTPEFVAPEIVNYEPLG------LEADMWSIGVITYIL--LSGASP 216

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 40/207 (19%)

Query: 272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
                +L     +     +   L+S+++++ +N++I       +    ++  L L  N++
Sbjct: 20  ETIKANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKL 75

Query: 332 S---VFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISN 387
                      +L            +L  + L+ N L  SL  G+F  L NL +L+L+ N
Sbjct: 76  HDISAL----KEL-----------TNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVEN 119

Query: 388 GISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDI 446
            +  L P  +             F   T L  LNL++N L  +LP  +   LT L  LD+
Sbjct: 120 QLQSL-PDGV-------------FDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDL 164

Query: 447 SVNQFVGLIPESFGQLASLNRLILSKN 473
           S NQ   L    F +L  L  L L +N
Sbjct: 165 SYNQLQSLPEGVFDKLTQLKDLRLYQN 191

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 37/215 (17%), Positives = 73/215 (33%), Gaps = 55/215 (25%)

Query: 338 QNKLEGSIPSTLANC-RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPE 396
              ++   P    +        +L   ++T        +L ++ +++  ++ I  +    
Sbjct: 6   STPIKQIFPD---DAFAETIKANLKKKSVT-DA-VTQNELNSIDQIIANNSDIKSVQG-- 58

Query: 397 IGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLA---SLTRLQVLDISVNQFVG 453
                               ++ L L  N L       ++    LT L  L ++ NQ   
Sbjct: 59  --------------IQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQS 99

Query: 454 LIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGL 513
           L    F +L +L  L+L +N           +  +L  L+L+ N+L   +P  +F+    
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFD---- 154

Query: 514 DISLNLSWNALSGAIPPQISALNKLSILDLSHNKL 548
                                L  L+ LDLS+N+L
Sbjct: 155 --------------------KLTNLTELDLSYNQL 169

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 51/242 (21%), Positives = 86/242 (35%), Gaps = 69/242 (28%)

Query: 72  PDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNL 131
               +   +  I  +++ +       I  L N++ L L  N+L      ++ A       
Sbjct: 35  VTQNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH-----DISA------- 80

Query: 132 LLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSL 191
                           +L NL  +   GN+                    L       SL
Sbjct: 81  --LK------------ELTNLTYLILTGNQ--------------------LQ------SL 100

Query: 192 PASL-GKLSKLQSLSVYTTMLSGEIPPQIGNC-SELVDLFLYENDLSGSLPR----ELGK 245
           P  +  KL+ L+ L +    L   +P  + +  + L  L L  N L  SLP+    +L  
Sbjct: 101 PNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTN 158

Query: 246 LQKLEKMLLWQNNFDGAIPEEI-GNCKSLKTIDLSLNFFSGSLPQ-SFGNLSSLEELMLS 303
           L +L+   L  N    ++PE +      LK + L  N    S+P   F  L+SL+ + L 
Sbjct: 159 LTELD---LSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLH 213

Query: 304 NN 305
           +N
Sbjct: 214 DN 215

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 50/225 (22%), Positives = 85/225 (37%), Gaps = 38/225 (16%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G    V   +M + G+V A+K +    M      +  ++        F  E   L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-----KRGEV------SCFREERDVLV 116

Query: 752 SIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----IIL 805
           +   + I + L   +     L L+ +Y   G L +LL  +    +      R     I++
Sbjct: 117 NGDRRWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIP-AEMARFYLAEIVM 173

Query: 806 GAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
                +  +H        VHRDIK +NIL+       +ADFG    +      R S    
Sbjct: 174 A----IDSVHRLG----YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAV 224

Query: 865 GSYGYIAPEYGYMMKITEKSDVY-------SYGVVVLEVLTGKQP 902
           G+  Y++PE    +     +  Y       + GV   E+  G+ P
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 75.9 bits (187), Expect = 2e-14
 Identities = 53/222 (23%), Positives = 85/222 (38%), Gaps = 37/222 (16%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G  G V         +V A+K L    M    D              F  E   + 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-----------FWEERDIMA 124

Query: 752 SIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----IIL 805
                 +V+ L   +  +  L ++ +YMP G L +L+          E   R     ++L
Sbjct: 125 FANSPWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP----EKWARFYTAEVVL 179

Query: 806 GAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
                L  +H        +HRD+K +N+L+       +ADFG    + +    R  +T  
Sbjct: 180 A----LDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAV 230

Query: 865 GSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           G+  YI+PE     G       + D +S GV + E+L G  P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 76.1 bits (187), Expect = 2e-14
 Identities = 73/465 (15%), Positives = 150/465 (32%), Gaps = 60/465 (12%)

Query: 50  LSSLSFLQKLIISGSNLTGP-ISPDLGDCTQLTTIDVSSNSLVG--GVPSSIGKLINLQD 106
            SS ++L+++ +    +T   +            + +SS       G+ +      NL++
Sbjct: 101 SSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKE 160

Query: 107 LILNSNQLTGEIPKELGA----CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKD 162
           L L  + +       L         L +L +            L   V+   +       
Sbjct: 161 LDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC----------LASEVSFSALER----- 205

Query: 163 IAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNC 222
           +  +       C +L  + L        L   L +  +L+ L               G  
Sbjct: 206 LVTR-------CPNLKSLKLNRAVPLEKLATLLQRAPQLEELG-------------TGGY 245

Query: 223 SELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNF 282
           +  V   +Y       L   L   ++L  +  + +     +P     C  L T++LS   
Sbjct: 246 TAEVRPDVYS-----GLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYAT 300

Query: 283 FSG-SLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKL 341
                L +       L+ L + +      +  + S    L +L++  ++  V        
Sbjct: 301 VQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALT 360

Query: 342 EGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQL-QNLTKLLLISNGISGLIPPEIGNC 400
           E  + S    C  LE+V      +T +    L  + +N   +      I     P+    
Sbjct: 361 EQGLVSVSMGCPKLESVLYFCRQMTNA---ALITIARNRPNMTRFRLCIIEPKAPDYLTL 417

Query: 401 SSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFG 460
             L         +C  L+ L+LS                ++++L ++   F G       
Sbjct: 418 EPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVA---FAGDSDLGMH 474

Query: 461 QLAS----LNRLILSKNSFSG-AIPSSLGRCESLQSLDLSSNKLS 500
            + S    L +L +    F   A+ ++  + E+++SL +SS  +S
Sbjct: 475 HVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 60.3 bits (146), Expect = 2e-09
 Identities = 48/330 (14%), Positives = 102/330 (30%), Gaps = 47/330 (14%)

Query: 270 CKSLKTIDLSLNFFSGS----LPQSFGNLSSLEELMLSNNNIS-GSIPPVLSNATSLLQL 324
                  +L  + + G     +     + + LEE+ L    ++   +  +  +  +   L
Sbjct: 76  KPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVL 135

Query: 325 QLD-TNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQL-QNLTKL 382
            L      S            + +  A CR+L+ +DL  + +       L       T L
Sbjct: 136 VLSSCEGFS---------TDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSL 186

Query: 383 LLISNGISGLIPPEIGNCSSLIRLRLMSF--GNCTQLQMLNLSNNTLGGTLPSSLASLTR 440
           + ++          I   +S +    +      C  L+ L L+       L + L    +
Sbjct: 187 VSLN----------ISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQ 236

Query: 441 LQVLDISV------NQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL 494
           L+ L                +  +      L  L    ++    +P+    C  L +L+L
Sbjct: 237 LEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNL 296

Query: 495 SSNKLSGKIPVELFE----IEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG 550
           S   +     V+L      ++ L +   +    L   +      L +L +       +  
Sbjct: 297 SYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE-VLASTCKDLRELRVFPSEPFVMEP 355

Query: 551 D-------LLALS-GLDNLVSLNVSYNNFT 572
           +       L+++S G   L S+       T
Sbjct: 356 NVALTEQGLVSVSMGCPKLESVLYFCRQMT 385

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 74.8 bits (184), Expect = 4e-14
 Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 42/224 (18%)

Query: 692 SVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            ++GKG  G V   +    G   A+K      +  E     D++           E + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMK-----ILKKEVIVAKDEV------AHTLTENRVL 202

Query: 751 GSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----II 804
            + RH  +   L   +  + RL  + +Y   G L    H  R+     E R R     I+
Sbjct: 203 QNSRHPFLTA-LKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFS-EDRARFYGAEIV 258

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
                 L YLH +    +V+RD+K  N+++  +    I DFGL K  ++     +  T  
Sbjct: 259 SA----LDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFC 310

Query: 865 GSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           G+  Y+APE      YG  +      D +  GVV+ E++ G+ P
Sbjct: 311 GTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 348

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 73.9 bits (182), Expect = 5e-14
 Identities = 49/228 (21%), Positives = 82/228 (35%), Gaps = 55/228 (24%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G   +  R          AVK +             DK      +   + EI+ L 
Sbjct: 29  DIGVGSYSVCKRCIHKATNMEFAVKII-------------DK-----SKRDPTEEIEILL 70

Query: 752 -SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-----RDSCLEWELRYRIIL 805
              +H NI+       +     ++ + M  G L   +  +     R++         ++ 
Sbjct: 71  RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-------AVLF 123

Query: 806 GAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY----IADFGLAKLVVEGDFARSS 860
              + + YLH       +VHRD+K +NIL   E        I DFG AK +   +     
Sbjct: 124 TITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLL 177

Query: 861 NTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            T   +  ++APE      Y          D++S GV++  +LTG  P
Sbjct: 178 MTPCYTANFVAPEVLERQGYD------AACDIWSLGVLLYTMLTGYTP 219

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 73.1 bits (180), Expect = 5e-14
 Identities = 57/231 (24%), Positives = 86/231 (37%), Gaps = 40/231 (17%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDK---IGIGGVRDSFSAEIKTL 750
           G+G  G V      E     AVK L              K     I     +   EI+ L
Sbjct: 14  GEGSYGKVKEVLDSETLCRRAVKIL-------------KKKKLRRIPNGEANVKKEIQLL 60

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMY---DYMPNGS---LGSLLHERRDSCLEWELRY--- 801
             +RHKN+++ L        +  MY   +Y   G    L S+  +R       +      
Sbjct: 61  RRLRHKNVIQ-LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP---VCQAHGYFC 116

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
           ++I     GL YLH      IVH+DIK  N+L+       I+  G+A+ +       +  
Sbjct: 117 QLI----DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169

Query: 862 TVAGSYGYIAPEYGYMMKITE--KSDVYSYGVVVLEVLTGKQPI-DPTIPE 909
           T  GS  +  PE    +      K D++S GV +  + TG  P     I +
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 47/226 (20%), Positives = 86/226 (38%), Gaps = 51/226 (22%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G   I  +    ++ +  AVK +              K      +     EI  L 
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKII-------------SKRMEANTQK----EITALK 60

Query: 752 SIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-----RDSCLEWELRYRIIL 805
               H NIV+      ++    L+ + +  G L   + ++      ++         I+ 
Sbjct: 61  LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS-------YIMR 113

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARSSNT 862
                ++++H      +VHRD+K  N+L   E +     I DFG A+L    +  +   T
Sbjct: 114 KLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKT 168

Query: 863 VAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
              +  Y APE      Y       E  D++S GV++  +L+G+ P
Sbjct: 169 PCFTLHYAAPELLNQNGYD------ESCDLWSLGVILYTMLSGQVP 208

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 30/233 (12%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
            ++  +   VLK       +G G  GIV  A +      +A+KKL       +   +   
Sbjct: 14  VEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPFQNQTHAK--- 69

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLL 787
                 R     E+  +  + HKNI+  L     + +        ++ + M   +L  ++
Sbjct: 70  ---RAYR-----ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI 120

Query: 788 HERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGL 847
               D      L Y+++     G+ +LH   +   +HRD+K +NI++  +    I DFGL
Sbjct: 121 QMELDHERMSYLLYQML----CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGL 173

Query: 848 AKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK 900
           A+          +  V   Y Y APE    M   E  D++S G ++ E++ G 
Sbjct: 174 ARTAGTSFM--MTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 73.9 bits (182), Expect = 6e-14
 Identities = 59/234 (25%), Positives = 101/234 (43%), Gaps = 58/234 (24%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G G  G+V++A  +E+ EV A+KK+             DK      R     E++ + 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEV-AIKKV-----------LQDKRFKN--R-----ELQIMR 87

Query: 752 SIRHKNIVRFLGCCWNRNTRL------LMYDYMPNGSLGSLLHERRDSCL---EWELRYR 802
            ++H N+V      ++   +       L+ +Y+P  ++                  ++  
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLY 146

Query: 803 I--ILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPY-IADFGLAKLVVEGDFAR 858
           +  +L   + LAY+H       I HRDIK  N+L+ P      + DFG AK+++ G+   
Sbjct: 147 MYQLL---RSLAYIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-- 197

Query: 859 SSNT--VAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
             N   +   Y Y APE       Y   I    D++S G V+ E++ G QP+ P
Sbjct: 198 --NVSYICSRY-YRAPELIFGATNYTTNI----DIWSTGCVMAELMQG-QPLFP 243

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 36/169 (21%), Positives = 68/169 (40%), Gaps = 31/169 (18%)

Query: 310 SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPST--LANCRSLEAVDLSHNALTG 367
            IP  +   T+  +L+L+ N+ +            + +T        L  ++ S+N +T 
Sbjct: 25  KIPEHIPQYTA--ELRLNNNEFT-----------VLEATGIFKKLPQLRKINFSNNKIT- 70

Query: 368 SLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNT 426
            +  G F     + ++LL SN +  +   ++             F     L+ L L +N 
Sbjct: 71  DIEEGAFEGASGVNEILLTSNRLENV-QHKM-------------FKGLESLKTLMLRSNR 116

Query: 427 LGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF 475
           +      S   L+ +++L +  NQ   + P +F  L SL+ L L  N F
Sbjct: 117 ITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 36/168 (21%), Positives = 60/168 (35%), Gaps = 33/168 (19%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQ-SFGNLSSLEELMLSNNNISGSIPP-VLSNAT 319
            IPE I   +    + L+ N F+       F  L  L ++  SNN I+  I       A+
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 320 SLLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHPGLFQ-LQ 377
            + ++ L +N++            ++         SL+ + L  N +T  +    F  L 
Sbjct: 82  GVNEILLTSNRLE-----------NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLS 129

Query: 378 NLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNN 425
           ++  L L  N I+  + P               F     L  LNL  N
Sbjct: 130 SVRLLSLYDNQITT-VAPGA-------------FDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 31/152 (20%), Positives = 58/152 (38%), Gaps = 17/152 (11%)

Query: 358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQL 417
           VD S+  L   +   + Q     +L L +N  + L    I             F    QL
Sbjct: 16  VDCSNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEATGI-------------FKKLPQL 59

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG 477
           + +N SNN +      +    + +  + ++ N+   +  + F  L SL  L+L  N  + 
Sbjct: 60  RKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC 119

Query: 478 AIPSSLGRCESLQSLDLSSNKLSGKIPVELFE 509
               S     S++ L L  N+++  +    F+
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 29/152 (19%), Positives = 59/152 (38%), Gaps = 30/152 (19%)

Query: 415 TQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKN 473
                L L+NN       + +   L +L+ ++ S N+   +   +F   + +N ++L+ N
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 474 SFSGAIPSSL-GRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQI 532
                +   +    ESL++L L SN+++  +  + F                        
Sbjct: 92  RLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSF------------------------ 125

Query: 533 SALNKLSILDLSHNKLGGDLLALSGLDNLVSL 564
             L+ + +L L  N++    +A    D L SL
Sbjct: 126 IGLSSVRLLSLYDNQITT--VAPGAFDTLHSL 155

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 31/140 (22%), Positives = 54/140 (38%), Gaps = 30/140 (21%)

Query: 193 ASLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSLPRELGKLQKLEK 251
               KL +L+ ++     ++ +I        S + ++ L  N L  ++  ++        
Sbjct: 51  GIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE-NVQHKM-------- 100

Query: 252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQ-SFGNLSSLEELMLSNNNISGS 310
                  F G         +SLKT+ L  N  +  +   SF  LSS+  L L +N I+ +
Sbjct: 101 -------FKG--------LESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-T 143

Query: 311 IPP-VLSNATSLLQLQLDTN 329
           + P       SL  L L  N
Sbjct: 144 VAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 19/100 (19%), Positives = 40/100 (40%), Gaps = 11/100 (11%)

Query: 478 AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQI-SALN 536
            IP  +   +    L L++N+ +      +F+       +N S N ++  I        +
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 537 KLSILDLSHNKL----GGDLLALSGLDNLVSLNVSYNNFT 572
            ++ + L+ N+L            GL++L +L +  N  T
Sbjct: 82  GVNEILLTSNRLENVQHK---MFKGLESLKTLMLRSNRIT 118

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 72.7 bits (179), Expect = 9e-14
 Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 55/234 (23%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G+G  G V  A   +  + +A+K +               +    +      EI  L  +
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFI-----------SRQLLKKSDMHMRVEREISYLKLL 66

Query: 754 RHKNIVRFLGCCWNRNTRLLM---------YDY-MPNGSLGSLLHERRDSCLEWELRY-- 801
           RH +I++ L       T ++M         +DY +    +            E E R   
Sbjct: 67  RHPHIIK-LYDVITTPTDIVMVIEYAGGELFDYIVEKKRMT-----------EDEGRRFF 114

Query: 802 -RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS 860
            +II      + Y H      IVHRD+K  N+L+       IADFGL+ ++ +G+F +  
Sbjct: 115 QQII----CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK-- 165

Query: 861 NTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPID-PTIPE 909
            T  GS  Y APE      Y      + DV+S G+V+  +L G+ P D   IP 
Sbjct: 166 -TSCGSPNYAAPEVINGKLY---AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.3 bits (180), Expect = 1e-13
 Identities = 57/254 (22%), Positives = 97/254 (38%), Gaps = 47/254 (18%)

Query: 662 MGGNSLPWQLTPFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWP 720
           M  + +  Q    + +  +   VLK       +G G  GIV  A +      +A+KK   
Sbjct: 39  MSKSKVDNQFYSVE-VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK--- 94

Query: 721 TTMAAEYDCQNDKIGIGGVRDSFSA---------EIKTLGSIRHKNIVRFLGCCWNRNTR 771
                             +   F           E+  +  + HKNI+  L     + T 
Sbjct: 95  ------------------LSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136

Query: 772 LLMYD-YMPNGSLGSLLHERRDSCLEWE----LRYRIILGAAQGLAYLHHDCVPPIVHRD 826
               D Y+    + + L +     L+ E    L Y+++ G    + +LH   +   +HRD
Sbjct: 137 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCG----IKHLHSAGI---IHRD 189

Query: 827 IKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDV 886
           +K +NI++  +    I DFGLA+          +  V   Y Y APE    M   E  D+
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRY-YRAPEVILGMGYKENVDI 246

Query: 887 YSYGVVVLEVLTGK 900
           +S G ++ E++  K
Sbjct: 247 WSVGCIMGEMVRHK 260

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 51/229 (22%), Positives = 82/229 (35%), Gaps = 54/229 (23%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G G +G V +       E  A+K L                           E++   
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKML-------------QD------CPKARREVELHW 109

Query: 752 SI-RHKNIVRFLG-----CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL-EWELRY--R 802
              +  +IVR +          +   ++M + +  G L S + +R D    E E     +
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVM-ECLDGGELFSRIQDRGDQAFTEREASEIMK 168

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARS 859
            I  A   + YLH      I HRD+K  N+L   +       + DFG AK     +    
Sbjct: 169 SIGEA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT- 221

Query: 860 SNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
             T   +  Y+APE      Y       +  D++S GV++  +L G  P
Sbjct: 222 --TPCYTPYYVAPEVLGPEKYD------KSCDMWSLGVIMYILLCGYPP 262

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 45/259 (17%), Positives = 84/259 (32%), Gaps = 75/259 (28%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  GIV    ++E+G+  A+KK+             D       R     E+  + 
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKV-----------LQDPRYK--NR-----ELDIMK 55

Query: 752 SIRHKNIVR----FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELR------- 800
            + H NI++    F              D        +         +            
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115

Query: 801 ---------YRIILGAAQ-------------------GLAYLH-HDCVPPIVHRDIKANN 831
                    ++++    +                    + ++H       I HRDIK  N
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHRDIKPQN 171

Query: 832 ILIGPE-FEPYIADFGLAKLVVEGDFARSSNT--VAGSYGYIAPE--YGYMMKITEKSDV 886
           +L+  +     + DFG AK ++  +     +   +   + Y APE   G   + T   D+
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRF-YRAPELMLGA-TEYTPSIDL 225

Query: 887 YSYGVVVLEVLTGKQPIDP 905
           +S G V  E++ G +P+  
Sbjct: 226 WSIGCVFGELILG-KPLFS 243

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 73.3 bits (180), Expect = 2e-13
 Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 36/225 (16%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           G G  G V   +    G  +AVK L              KI    V      EI+ L   
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKIL-----------NRQKIRSLDVVGKIRREIQNLKLF 73

Query: 754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLL--HERRDSCLEWELR--YRIILGAAQ 809
           RH +I++        +   ++ +Y+  G L   +  + R D   E E R  ++ IL    
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLD---EKESRRLFQQILSG-- 128

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGY 869
            + Y H   V   VHRD+K  N+L+       IADFGL+ ++ +G+F R   T  GS  Y
Sbjct: 129 -VDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TSCGSPNY 181

Query: 870 IAPE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPID-PTIPE 909
            APE      Y      + D++S GV++  +L G  P D   +P 
Sbjct: 182 AAPEVISGRLY---AGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.5 bits (176), Expect = 3e-13
 Identities = 58/224 (25%), Positives = 89/224 (39%), Gaps = 45/224 (20%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++GKG  G V        G   A+K      +  E     D++           E + L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMK-----ILRKEVIIAKDEV------AHTVTESRVLQ 60

Query: 752 SIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----IIL 805
           + RH  +   L   +  + RL  + +Y   G L    H  R+     E R R     I+ 
Sbjct: 61  NTRHPFLTA-LKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT-EERARFYGAEIVS 116

Query: 806 GAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
                L YLH  D    +V+RDIK  N+++  +    I DFGL K  +      +  T  
Sbjct: 117 A----LEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFC 166

Query: 865 GSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           G+  Y+APE      YG  +      D +  GVV+ E++ G+ P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 204

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 73.0 bits (179), Expect = 3e-13
 Identities = 53/228 (23%), Positives = 87/228 (38%), Gaps = 51/228 (22%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT-- 749
           ++G+G  G VY     + G++ A+K L             DK  I               
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCL-------------DKKRI--KMKQGETLALNER 240

Query: 750 -----LGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLL-HERRDSCLEWELRYR 802
                + +     IV  +   ++   +L  + D M  G L   L      S    E   R
Sbjct: 241 IMLSLVSTGDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMR 295

Query: 803 IILGAAQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
               AA+   GL ++H+     +V+RD+K  NIL+       I+D GLA    +      
Sbjct: 296 FY--AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 346

Query: 860 SNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            +   G++GY+APE       Y       +D +S G ++ ++L G  P
Sbjct: 347 PHASVGTHGYMAPEVLQKGVAY----DSSADWFSLGCMLFKLLRGHSP 390

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 72.7 bits (178), Expect = 3e-13
 Identities = 79/531 (14%), Positives = 149/531 (28%), Gaps = 94/531 (17%)

Query: 19  CK-WSHITCSPQNFVTEINIQSIELELPFP--SNLSSLSFLQKLIISGSNLTGPISPDLG 75
           C+ W  I    +  VT     +   +       NL SL    K   +  NL         
Sbjct: 41  CRRWFKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYV 100

Query: 76  D---------CTQLTTIDVSSNSL--VGGVPSSIGKLINLQDLILNS-NQLTGEIPKELG 123
                       QL ++      +  +     +  +  +L+ L L+  +  T +    + 
Sbjct: 101 TPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIV 160

Query: 124 A-CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGL 182
             C K+K LL+ ++  S      L +L                          SL V+  
Sbjct: 161 THCRKIKTLLMEESSFSEKDGKWLHELAQH---------------------NTSLEVLNF 199

Query: 183 ADTKVAG----SLPASLGKLSKLQSLSV-YTTMLSGE-IPPQIGNCSELVDLFLYENDLS 236
             T+ A      L         L S+ V    +L          N  E     L E+   
Sbjct: 200 YMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGM 259

Query: 237 GSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLS-LNFFSGSLPQSFGNLS 295
                 L   +KL ++ L        +P        ++ +DL      +           
Sbjct: 260 PEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCP 318

Query: 296 SLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKL--EGSIPSTLANCR 353
           +LE L   N      +  +      L +L+++          +  L  +  + +    C+
Sbjct: 319 NLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQ 378

Query: 354 SLEAVDLSHNALT-GSLHPGLFQLQNLTKL-LLISNGISGL--------IPPEIGNCSSL 403
            LE + +  + +T  SL      L+NL    L++ +    +        +   +  C  L
Sbjct: 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL 438

Query: 404 IRLRLMSFG-------------NCTQLQMLNLSNNTLGGT-LPSSLASLTRLQVLDISVN 449
            R                        ++ + L         L         LQ L++   
Sbjct: 439 RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC 498

Query: 450 QFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS 500
            F                          AI +++ +  SL+ L +   + S
Sbjct: 499 CFS-----------------------ERAIAAAVTKLPSLRYLWVQGYRAS 526

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 65.0 bits (158), Expect = 9e-11
 Identities = 67/473 (14%), Positives = 143/473 (30%), Gaps = 51/473 (10%)

Query: 51  SSLSFLQKLIISGSNLT--GPISPDLGDCTQLTTIDVSSNSLVG--GVPSSIGKLINLQD 106
           ++L  L+ +      ++              L T+ +   S     G+ S +     ++ 
Sbjct: 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKT 168

Query: 107 LILNSNQLTGEIPKELGA----CIKLKNLLLFDNYLSGNLPVELGKLV----NLEVIRAG 158
           L++  +  + +  K L         L+ L  +    +   P +L  +     +L  ++ G
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG 228

Query: 159 GNKDIAGKIPYEIG-DCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPP 217
             + +     ++   + +      L +         +L    KL  L +     +  +P 
Sbjct: 229 DFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPI 287

Query: 218 QIGNCSELVDLFL-YENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTI 276
                +++  L L Y    +      + K   LE +       D  +      CK LK +
Sbjct: 288 LFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRL 347

Query: 277 DLSLNFFSGSLPQSFGNLS------------SLEELMLSNNNIS-GSIPPVLSNATSLLQ 323
            +        +    G +S             LE + +  ++I+  S+  + +   +L  
Sbjct: 348 RIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCD 407

Query: 324 LQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHN--ALTGSLHPGLFQL----Q 377
            +L                G + S L  C+ L           LT     GL  +     
Sbjct: 408 FRLVLLDREERITDLPLDNG-VRSLLIGCKKLRRFAFYLRQGGLTDL---GLSYIGQYSP 463

Query: 378 NLTKLLLISNGISGLIPPEIG-NCSSLIRLRLMS-----------FGNCTQLQMLNLSNN 425
           N+  +LL   G S     E    C +L +L +                   L+ L +   
Sbjct: 464 NVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGY 523

Query: 426 TLGGTLPSSLA-SLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG 477
               T    +  +     +  I   +   +  +   +       IL+  S +G
Sbjct: 524 RASMTGQDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHILAYYSLAG 576

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 55.3 bits (133), Expect = 8e-08
 Identities = 49/336 (14%), Positives = 102/336 (30%), Gaps = 54/336 (16%)

Query: 267 IGNCKSLKTIDLSLNFFSGSLPQSF----GNLSSLEELMLSNNNISGSIPPVL--SNATS 320
           +         +L    + G +         NL  L+ +      +S      L  + A  
Sbjct: 80  LKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADD 139

Query: 321 LLQLQLDT-NQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQL--- 376
           L  L+LD  +  +            + S + +CR ++ + +  ++ +      L +L   
Sbjct: 140 LETLKLDKCSGFT---------TDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQH 190

Query: 377 -QNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL 435
             +L  L       + +      +   L  +      NC  L  + + +  +   L    
Sbjct: 191 NTSLEVLNFYMTEFAKI------SPKDLETI----ARNCRSLVSVKVGDFEIL-ELVGFF 239

Query: 436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG--AIPSSLGRCESLQSLD 493
            +   L+            +PE +  L    +L     S+ G   +P        ++ LD
Sbjct: 240 KAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLD 299

Query: 494 LSSNKLSGKIPVELFE----IEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLG 549
           L    L  +    L +    +E L+    +    L   +        +L  L +      
Sbjct: 300 LLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE-VL---AQYCKQLKRLRIERGADE 355

Query: 550 GD------------LLALS-GLDNLVSLNVSYNNFT 572
                         L+AL+ G   L  + V  ++ T
Sbjct: 356 QGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 51.1 bits (122), Expect = 2e-06
 Identities = 33/254 (12%), Positives = 75/254 (29%), Gaps = 34/254 (13%)

Query: 344 SIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSL 403
           +         +L ++ L      G     +F L        ++  ++ +      N   L
Sbjct: 64  TPDRLSRRFPNLRSLKLK-----GKPRAAMFNLIPENWGGYVTPWVTEIS----NNLRQL 114

Query: 404 IRLRL------------MSFGNCTQLQMLNLSN-NTLGGTLPSSLAS-LTRLQVLDISVN 449
             +              ++      L+ L L   +        S+ +   +++ L +  +
Sbjct: 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEES 174

Query: 450 QFVGLIPESFGQLA----SLNRLILSKNSFSGAIPSSL----GRCESLQSLDLSSNKLSG 501
            F     +   +LA    SL  L      F+   P  L      C SL S+ +   ++  
Sbjct: 175 SFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE 234

Query: 502 KIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLA--LSGLD 559
            +         L+     S N   G     ++ +    +  L  + +G + +        
Sbjct: 235 LVGF-FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAA 293

Query: 560 NLVSLNVSYNNFTG 573
            +  L++ Y     
Sbjct: 294 QIRKLDLLYALLET 307

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 49/349 (14%), Positives = 103/349 (29%), Gaps = 67/349 (19%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFG-----NLSSLEELMLSNNNIS----GSIP 312
            + E       + ++DLSLN                  +S+  L LS N++       + 
Sbjct: 13  PVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV 72

Query: 313 PVL-SNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC-RSLEAVDLSHNALTGSLH 370
            +L +   ++  L L  N +S   +        +  TLA    ++  +DL  N  +    
Sbjct: 73  QILAAIPANVTSLNLSGNFLSYKSS------DELVKTLAAIPFTITVLDLGWNDFSSKSS 126

Query: 371 PGLFQL-----QNLTKLLLISNGIS-----GLIPPEIGNCSSLIRLRLMS---------- 410
               Q       ++T L L  N +       LI       +++  L L            
Sbjct: 127 SEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAE 186

Query: 411 -----FGNCTQLQMLNLSNNTLGGTLPSSLASL-----TRLQVLDISVNQF----VGLIP 456
                      +  L+LS N LG    + LA +       +  L++ +N      +  + 
Sbjct: 187 LAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLK 246

Query: 457 ESFGQLASLNRLILSKNSFSG-------AIPSSLGRCESLQSLDLSSNKLSGKIPVELFE 509
                L  L  + L  +           A+ ++    + +  +D +  ++     + +  
Sbjct: 247 LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISN 306

Query: 510 --------IEGLDISLNLSWNALSGAIPPQISALNK-LSILDLSHNKLG 549
                    +   +       A       +   +   L     +   L 
Sbjct: 307 LIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 62.0 bits (151), Expect = 4e-10
 Identities = 53/320 (16%), Positives = 94/320 (29%), Gaps = 84/320 (26%)

Query: 293 NLSSLEELMLSNNNISGSIPPVLSNA-----TSLLQLQLDTNQISVFFAWQNKLEG--SI 345
               +  L LS NN+       L  A      S+  L L  N +          +    +
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF--------KNSDEL 71

Query: 346 PSTLA-NCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI 404
              LA    ++ +++LS N L+                         L         +L 
Sbjct: 72  VQILAAIPANVTSLNLSGNFLSYK-------------------SSDEL-------VKTLA 105

Query: 405 RLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL-----TRLQVLDISVNQF----VGLI 455
                       + +L+L  N       S            +  L++  N         +
Sbjct: 106 A-------IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158

Query: 456 PESFGQL-ASLNRLILSKNSFS----GAIPSSL-GRCESLQSLDLSSNKLSGKIPVELFE 509
            +    + A++N L L  N+ +      +   L     S+ SLDLS+N L  K   EL  
Sbjct: 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAEL-- 216

Query: 510 IEGLD------ISLNLSWNALSGAIPPQISAL----NKLSILDLSHNKLG--GD------ 551
                      +SLNL  N L G     +  L      L  + L ++ +           
Sbjct: 217 AYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKAL 276

Query: 552 LLALSGLDNLVSLNVSYNNF 571
             A   +  ++ ++ +    
Sbjct: 277 GAAFPNIQKIILVDKNGKEI 296

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 61.3 bits (149), Expect = 6e-10
 Identities = 58/258 (22%), Positives = 98/258 (37%), Gaps = 43/258 (16%)

Query: 349 LANCRSLEAVDLSHNALTGS----LHPGL-FQLQNLTKLLLISNGISGLIPPEIGNCSSL 403
            +    + ++DLS N L       L         ++T L L  N +             L
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG-----FKN-SDEL 71

Query: 404 IRLRLMSFGNCTQLQMLNLSNNTLGGT----LPSSLASL-TRLQVLDISVNQF----VGL 454
           +++ L +      +  LNLS N L       L  +LA++   + VLD+  N F       
Sbjct: 72  VQI-LAA--IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSE 128

Query: 455 IPESFGQL-ASLNRLILSKNSFSG----AIPSSLGRC-ESLQSLDLSSNKLSGKIPVELF 508
             ++F  L AS+  L L  N         +   L     ++ SL+L  N L+ K   EL 
Sbjct: 129 FKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELA 188

Query: 509 E-IEGLDIS---LNLSWNALSGAIPPQISAL-----NKLSILDLSHNKLGGD-----LLA 554
           + +  +  S   L+LS N L      +++ +     N +  L+L  N L G       L 
Sbjct: 189 KFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL 248

Query: 555 LSGLDNLVSLNVSYNNFT 572
              L +L ++ + Y+   
Sbjct: 249 KDSLKHLQTVYLDYDIVK 266

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 52.0 bits (125), Expect = 5e-07
 Identities = 52/393 (13%), Positives = 104/393 (26%), Gaps = 93/393 (23%)

Query: 74  LGDCTQLTTIDVSSNSLVGGVPSSIGKLI-----NLQDLILNSNQLTGEIPKELGACIKL 128
                 +T++D+S N+L       + +       ++  L L+ N L  +   EL   +  
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 129 KNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVA 188
               +    LSGN             +    + ++                  LA     
Sbjct: 78  IPANVTSLNLSGNF------------LSYKSSDELVK---------------TLAAIP-- 108

Query: 189 GSLPASLGKLSKLQSLSVYTTMLSGEIPPQIG------NCSELVDLFLYEND-------- 234
                       +  L +     S +   +          S +  L L  ND        
Sbjct: 109 ----------FTITVLDLGWNDFSSKSSSEFKQAFSNLPAS-ITSLNLRGNDLGIKSSDE 157

Query: 235 LSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIG-----NCKSLKTIDLSLNFFSGSLPQ 289
           L   L      +  L    L  NN       E+         S+ ++DLS N        
Sbjct: 158 LIQILAAIPANVNSLN---LRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYA 214

Query: 290 SFG-----NLSSLEELMLSNNNISGS----IPPVLSNATSLLQLQLDTNQISVFFAWQNK 340
                     + +  L L  N + G     +  +  +   L  + LD + +        +
Sbjct: 215 ELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSK---E 271

Query: 341 LEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQL-----QNLTKLLLISNGISGLIPP 395
              ++ +   N + +  VD +   +  S    +  L            L++  +      
Sbjct: 272 QCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI----- 326

Query: 396 EIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG 428
                 + I           +L+    +   L 
Sbjct: 327 FAQKHQTNIEDL----NIPDELRESIQTCKPLL 355

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.3 bits (168), Expect = 2e-12
 Identities = 63/230 (27%), Positives = 92/230 (40%), Gaps = 60/230 (26%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS----FSAEI 747
            +G G  G V+      NG   A+K L              K  +  VR       + E 
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVL-------------KKEIV--VRLKQVEHTNDER 57

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGSLL-HERRDSCLEWELRYR--- 802
             L  + H  I+R +   +    ++ M  DY+  G L SLL   +R          +   
Sbjct: 58  LMLSIVTHPFIIR-MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----NPVAKFYA 112

Query: 803 --IILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
             + L     L YLH  D    I++RD+K  NIL+       I DFG AK V +      
Sbjct: 113 AEVCLA----LEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 159

Query: 860 SNTVAGSYGYIAPE------YGYMMKITEKS-DVYSYGVVVLEVLTGKQP 902
           + T+ G+  YIAPE      Y        KS D +S+G+++ E+L G  P
Sbjct: 160 TYTLCGTPDYIAPEVVSTKPYN-------KSIDWWSFGILIYEMLAGYTP 202

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 69/267 (25%), Positives = 102/267 (38%), Gaps = 59/267 (22%)

Query: 659 DSEMGGNSLPWQLTPFQKLNFTVEQVLKCLVED----SVVGKGCSGIVYRAEM-ENGEVI 713
              M  N  P    P Q++N            D     V+GKG  G V  A         
Sbjct: 8   PELMNANPAP-PPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFY 66

Query: 714 AVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT-----LGSIRHKNIVRFLGCCWNR 768
           AVK L           Q   I    ++      I +     L +++H  +V  L   +  
Sbjct: 67  AVKVL-----------QKKAI----LKKKEEKHIMSERNVLLKNVKHPFLVG-LHFSFQT 110

Query: 769 NTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----IILGAAQGLAYLH-HDCVPP 821
             +L  + DY+  G L    H +R+ C   E R R     I       L YLH  +    
Sbjct: 111 ADKLYFVLDYINGGEL--FYHLQRERCFL-EPRARFYAAEIASA----LGYLHSLN---- 159

Query: 822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPE------YG 875
           IV+RD+K  NIL+  +    + DFGL K  +E +   +++T  G+  Y+APE      Y 
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYD 217

Query: 876 YMMKITEKSDVYSYGVVVLEVLTGKQP 902
             +      D +  G V+ E+L G  P
Sbjct: 218 RTV------DWWCLGAVLYEMLYGLPP 238

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 59/227 (25%), Positives = 92/227 (40%), Gaps = 54/227 (23%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDS----FSAEI 747
            +G G  G V   +  E+G   A+K L             DK  +  V+         E 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKIL-------------DKQKV--VKLKQIEHTLNEK 92

Query: 748 KTLGSIRHKNIVRFLGCCWNRNTRLLM-YDYMPNGSLGSLLHERRDSCLEWELRYRIILG 806
           + L ++    +V+ L   +  N+ L M  +Y+  G + S L  RR      E   R    
Sbjct: 93  RILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHL--RRIGRFS-EPHARFY-- 146

Query: 807 AAQ---GLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT 862
           AAQ      YLH  D    +++RD+K  N+LI  +    + DFG AK V        + T
Sbjct: 147 AAQIVLTFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWT 197

Query: 863 VAGSYGYIAPE------YGYMMKITEKS-DVYSYGVVVLEVLTGKQP 902
           + G+   +APE      Y        K+ D ++ GV++ E+  G  P
Sbjct: 198 LCGTPEALAPEIILSKGYN-------KAVDWWALGVLIYEMAAGYPP 237

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 67.7 bits (166), Expect = 5e-12
 Identities = 62/248 (25%), Positives = 107/248 (43%), Gaps = 47/248 (18%)

Query: 672 TPFQKLNFTVEQVLKCLVE-------DSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTM 723
            P  +  F  ++V K   E          VG G  G V  A +   G  +A+KKL     
Sbjct: 4   PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPF 62

Query: 724 AAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYD-YMPNGS 782
            +E   +         R     E++ L  +RH+N++  L       T     D Y+    
Sbjct: 63  QSELFAK------RAYR-----ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 111

Query: 783 LGSLLHE--RRDSCLEWELRYRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF 838
           +G+ L +  + +   E  +++ +  +L   +GL Y+H   +   +HRD+K  N+ +  + 
Sbjct: 112 MGTDLGKLMKHEKLGEDRIQFLVYQML---KGLRYIHAAGI---IHRDLKPGNLAVNEDC 165

Query: 839 EPYIADFGLAKLVVEGDFARSSNT-----VAGSYGYIAPEY-GYMMKITEKSDVYSYGVV 892
           E  I DFGL         AR +++     V   + Y APE     M+ T+  D++S G +
Sbjct: 166 ELKILDFGL---------ARQADSEMTGYVVTRW-YRAPEVILNWMRYTQTVDIWSVGCI 215

Query: 893 VLEVLTGK 900
           + E++TGK
Sbjct: 216 MAEMITGK 223

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.3 bits (165), Expect = 6e-12
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 49/230 (21%)

Query: 693 VVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           V+G G  G V+        + G++ A+K L   T+      Q  K       +    E +
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV-----QKAK-----TTEHTRTERQ 110

Query: 749 TLGSIRHKN-IVRFLGCCWNRNTRL-LMYDYMPNGSLGSLL-HERRDSCLEWELRYR--- 802
            L  IR    +V  L   +   T+L L+ DY+  G L + L    R +    E   +   
Sbjct: 111 VLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLSQRERFT----EHEVQIYV 165

Query: 803 --IILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
             I+L     L +LH       I++RDIK  NIL+       + DFGL+K  V  +  R 
Sbjct: 166 GEIVLA----LEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER- 216

Query: 860 SNTVAGSYGYIAPE------YGYMMKITEKS-DVYSYGVVVLEVLTGKQP 902
           +    G+  Y+AP+       G+     +K+ D +S GV++ E+LTG  P
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGH-----DKAVDWWSLGVLMYELLTGASP 261

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.4 bits (163), Expect = 9e-12
 Identities = 51/231 (22%), Positives = 93/231 (40%), Gaps = 57/231 (24%)

Query: 693 VVGKGCSGIVYRAE----MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           V+G+G  G V+  +     +  ++ A+K L           +   +             K
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVL-----------KKATL----KVRD-RVRTK 74

Query: 749 T----LGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR- 802
                L  + H  IV+ L   +    +L L+ D++  G L       ++     E   + 
Sbjct: 75  MERDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFT-EEDVKF 130

Query: 803 ----IILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA 857
               + L     L +LH       I++RD+K  NIL+  E    + DFGL+K  ++ +  
Sbjct: 131 YLAELALA----LDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 180

Query: 858 RSSNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           + + +  G+  Y+APE      +          D +S+GV++ E+LTG  P
Sbjct: 181 KKAYSFCGTVEYMAPEVVNRRGHTQSA------DWWSFGVLMFEMLTGTLP 225

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 66.9 bits (164), Expect = 1e-11
 Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 38/239 (15%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           + +   V  V       S +G+G  G+V  A +  N   +A+KK+ P     +  CQ   
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQ--- 70

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL-----LMYDYMPNGSLGSLLH 788
                +R     EIK L   RH+NI+                  ++ D M      + L+
Sbjct: 71  ---RTLR-----EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLY 117

Query: 789 ER-RDSCLEWE-LRYRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
           +  +   L  + + Y +  IL   +GL Y+H   V   +HRD+K +N+L+    +  I D
Sbjct: 118 KLLKTQHLSNDHICYFLYQIL---RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICD 171

Query: 845 FGLAKLVVEGDFARSSNT--VAGSYGYIAPEY-GYMMKITEKSDVYSYGVVVLEVLTGK 900
           FGLA++           T  VA  + Y APE        T+  D++S G ++ E+L+ +
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRW-YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 66.5 bits (163), Expect = 1e-11
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 46/225 (20%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G    V    + +   + A+K      +  E    ++ I      D    E     
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMK-----VVKKELVNDDEDI------DWVQTEKHVFE 64

Query: 752 SI-RHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----II 804
               H  +V  L  C+   +RL  + +Y+  G L  + H +R   L  E   R     I 
Sbjct: 65  QASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLP-EEHARFYSAEIS 120

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           L     L YLH       I++RD+K +N+L+  E    + D+G+ K  +      +++T 
Sbjct: 121 LA----LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTF 170

Query: 864 AGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            G+  YIAPE      YG+ +      D ++ GV++ E++ G+ P
Sbjct: 171 CGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 209

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.7 bits (165), Expect = 1e-11
 Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 42/224 (18%)

Query: 692 SVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
            V+GKG  G V  +E     E+ AVK      +  +   Q+D +      +    E + L
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVK-----ILKKDVVIQDDDV------ECTMVEKRVL 395

Query: 751 GSI-RHKNIVRFLGCCWNRNTRL-LMYDYMPNGSL-GSLLHERRDSCLEWELRYRIILGA 807
               +   + + L  C+    RL  + +Y+  G L   +    R      E        A
Sbjct: 396 ALPGKPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHAVFY--A 448

Query: 808 AQ---GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
           A+   GL +L       I++RD+K +N+++  E    IADFG+ K  +      ++ T  
Sbjct: 449 AEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFC 503

Query: 865 GSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           G+  YIAPE      YG  +      D +++GV++ E+L G+ P
Sbjct: 504 GTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAP 541

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 62/310 (20%), Positives = 109/310 (35%), Gaps = 71/310 (22%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA-----EIK 748
           G G  G VY    + +   +A+K +             +K  I    +  +      E+ 
Sbjct: 52  GSGGFGSVYSGIRVSDNLPVAIKHV-------------EKDRISDWGELPNGTRVPMEVV 98

Query: 749 TLGSIRHK--NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH--ERRDSCLEWELRYRII 804
            L  +      ++R L      ++ +L+ +         L      R +  E   R    
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGALQEELAR-SFF 155

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKLVVEGDFARSSNTV 863
               + + + H+  V   +HRDIK  NILI     E  + DFG   L+ +  +       
Sbjct: 156 WQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDF 208

Query: 864 AGSYGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
            G+  Y  PE+     Y  +    + V+S G+++ +++ G  P +               
Sbjct: 209 DGTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFE--------------- 250

Query: 920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE 979
                E++   +  R  V  E   Q L    L +   P DRPT        +EI+     
Sbjct: 251 --HDEEIIRGQVFFRQRVSSE--CQHLIRWCLALR--PSDRPT-------FEEIQNHP-- 295

Query: 980 CMKVDMLPSE 989
            M+  +LP E
Sbjct: 296 WMQDVLLPQE 305

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.6 bits (161), Expect = 2e-11
 Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 51/229 (22%)

Query: 693 VVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS--AE 746
           V+GKG  G V++         G++ A+K L           +   I +   +D+    AE
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVL-----------KKAMI-VRNAKDTAHTKAE 71

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR--- 802
              L  ++H  IV  L   +    +L L+ +Y+  G L   +   R+     E       
Sbjct: 72  RNILEEVKHPFIVD-LIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFM-EDTACFYL 127

Query: 803 --IILGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARS 859
             I +     L +LH       I++RD+K  NI++  +    + DFGL K  +       
Sbjct: 128 AEISMA----LGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TV 177

Query: 860 SNTVAGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           ++T  G+  Y+APE      +   +      D +S G ++ ++LTG  P
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAV------DWWSLGALMYDMLTGAPP 220

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 46/225 (20%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G+G    V    + +   + A++      +  E    ++ I      D    E     
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMR-----VVKKELVNDDEDI------DWVQTEKHVFE 107

Query: 752 SI-RHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----II 804
               H  +V  L  C+   +RL  + +Y+  G L  + H +R   L  E   R     I 
Sbjct: 108 QASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLP-EEHARFYSAEIS 163

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           L     L YLH       I++RD+K +N+L+  E    + D+G+ K  +      +++T 
Sbjct: 164 LA----LNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTF 213

Query: 864 AGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            G+  YIAPE      YG+ +      D ++ GV++ E++ G+ P
Sbjct: 214 CGTPNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSP 252

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 64.6 bits (158), Expect = 4e-11
 Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 47/241 (19%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q +N T  ++ K  V  + VG G  G V  A +  +GE +A+KKL      +E   +   
Sbjct: 13  QDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKR-- 69

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFL------GCCWNRNTRLLMYDYMPNGSLGSLL 787
                 R     E+  L  ++H+N++  L          N     L+  +M    L  ++
Sbjct: 70  ----AYR-----ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM 119

Query: 788 HERRDSCLEWELRYRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
             +     E +++Y +  +L   +GL Y+H   V   VHRD+K  N+ +  + E  I DF
Sbjct: 120 GLKFS---EEKIQYLVYQML---KGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDF 170

Query: 846 GLAKLVVEGDFARSSNT-----VAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTG 899
           GL         AR ++      V   + Y APE     M   +  D++S G ++ E+LTG
Sbjct: 171 GL---------ARHADAEMTGYVVTRW-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

Query: 900 K 900
           K
Sbjct: 221 K 221

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 64.3 bits (157), Expect = 4e-11
 Identities = 53/284 (18%), Positives = 96/284 (33%), Gaps = 54/284 (19%)

Query: 695 GKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           GKG  G V+    + +   +A+K + P      +   +D +           E+  L  +
Sbjct: 40  GKGGFGTVFAGHRLTDRLQVAIKVI-PRNRVLGWSPLSDSVTC-------PLEVALLWKV 91

Query: 754 R----HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH--ERRDSCLEWELRYRIILGA 807
                H  ++R L     +   +L+ +         L      +    E   R       
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGPSR-CFFGQV 148

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKLVVEGDFARSSNTVAGS 866
              + + H   V   VHRDIK  NILI        + DFG   L+ +  +        G+
Sbjct: 149 VAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGT 201

Query: 867 YGYIAPEY----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG 922
             Y  PE+     Y       + V+S G+++ +++ G  P +                  
Sbjct: 202 RVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGDIPFE-----------------R 241

Query: 923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
             E+L+  L     V  +     L    L     P  RP+++++
Sbjct: 242 DQEILEAELHFPAHVSPD--CCALIRRCLAPK--PSSRPSLEEI 281

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.2 bits (157), Expect = 7e-11
 Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 42/223 (18%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  A + E G++ AVK      +  +   Q+D +      +    E + L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVK-----VLKKDVILQDDDV------ECTMTEKRILS 78

Query: 752 SI-RHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
               H  + + L CC+    RL  + +++  G L  + H ++    + E R R    AA+
Sbjct: 79  LARNHPFLTQ-LFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFD-EARARFY--AAE 132

Query: 810 ---GLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
               L +LH       I++RD+K +N+L+  E    +ADFG+ K  +      ++ T  G
Sbjct: 133 IISALMFLHDKG----IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCG 186

Query: 866 SYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
           +  YIAPE      YG  +      D ++ GV++ E+L G  P
Sbjct: 187 TPDYIAPEILQEMLYGPAV------DWWAMGVLLYEMLCGHAP 223

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 63.8 bits (156), Expect = 8e-11
 Identities = 54/228 (23%), Positives = 93/228 (40%), Gaps = 43/228 (18%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S++G+G  G+V  A     GE++A+KK+ P                  +R     EIK L
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEP--FDKPLFAL------RTLR-----EIKIL 63

Query: 751 GSIRHKNIVRFLGCCWNRNTRL-----LMYDYMPNGSLGSLLHE--RRDSCLEWELRYRI 803
              +H+NI+         +        ++ + M      + LH         +  ++Y I
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFI 118

Query: 804 --ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
              L   + +  LH   V   +HRD+K +N+LI    +  + DFGLA+++ E     S  
Sbjct: 119 YQTL---RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172

Query: 862 TVAGSY--GYI------APEY-GYMMKITEKSDVYSYGVVVLEVLTGK 900
           T   S    ++      APE      K +   DV+S G ++ E+   +
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.4 bits (152), Expect = 9e-11
 Identities = 50/198 (25%), Positives = 74/198 (37%), Gaps = 41/198 (20%)

Query: 269 NC--KSLKTI-----------DLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-V 314
           +C  KSL ++           DL     +     +F  L+ L  L L  N +  ++   V
Sbjct: 20  DCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGV 78

Query: 315 LSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLF 374
             + T L  L L  NQ++        L   +   L     L    L  N L  SL  G+F
Sbjct: 79  FDDLTELGTLGLANNQLA-------SLPLGVFDHLTQLDKL---YLGGNQLK-SLPSGVF 127

Query: 375 -QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS 433
            +L  L +L L +N +  + P                F   T LQ L+LS N L      
Sbjct: 128 DRLTKLKELRLNTNQLQSI-PAGA-------------FDKLTNLQTLSLSTNQLQSVPHG 173

Query: 434 SLASLTRLQVLDISVNQF 451
           +   L +LQ + +  NQF
Sbjct: 174 AFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 45/171 (26%), Positives = 66/171 (38%), Gaps = 14/171 (8%)

Query: 399 NCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPES 458
           +C     L  +  G     + L+L +  L     ++   LT+L  L++  NQ   L    
Sbjct: 20  DCQGK-SLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78

Query: 459 FGQLASLNRLILSKN---SFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFE-IEGLD 514
           F  L  L  L L+ N   S    +   L     L  L L  N+L   +P  +F+ +  L 
Sbjct: 79  FDDLTELGTLGLANNQLASLPLGVFDHLT---QLDKLYLGGNQLK-SLPSGVFDRLTKLK 134

Query: 515 ISLNLSWNALSGAIPPQI-SALNKLSILDLSHNKLGGDLLALSGLDNLVSL 564
             L L+ N L  +IP      L  L  L LS N+L    +     D L  L
Sbjct: 135 E-LRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS--VPHGAFDRLGKL 181

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.7 bits (154), Expect = 1e-10
 Identities = 35/238 (14%), Positives = 59/238 (24%), Gaps = 45/238 (18%)

Query: 694 VGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI 753
           +G+G  G V++   ++  V A+K +                         S E+  L   
Sbjct: 28  IGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 754 ---RHKNIVRFLG--CCWNRNTRLLMYDYM----PNGSL--------------------- 783
              R +  +      C       LL+  +       GS                      
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 784 GSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA 843
           G  L + R           I+      LA           HRD+   N+L+       + 
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLKKTSLKKLH 204

Query: 844 DFGLAKL---------VVEGDFARSSNTVAGSYGYI---APEYGYMMKITEKSDVYSY 889
                K          V   D+  S     G   +      E  +      + D+Y  
Sbjct: 205 YTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.8 bits (156), Expect = 1e-10
 Identities = 56/225 (24%), Positives = 98/225 (43%), Gaps = 46/225 (20%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+GKG  G V  +E     E+ AVK      +  +   Q+D +      +    E + L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVK-----ILKKDVVIQDDDV------ECTMVEKRVLA 75

Query: 752 SI-RHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----II 804
              +   + + L  C+    RL  + +Y+  G L  + H ++    + E         I 
Sbjct: 76  LPGKPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFK-EPHAVFYAAEIA 131

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           +G    L +L        I++RD+K +N+++  E    IADFG+ K  +      ++ T 
Sbjct: 132 IG----LFFLQSKG----IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTF 181

Query: 864 AGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            G+  YIAPE      YG  +      D +++GV++ E+L G+ P
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAP 220

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 63.4 bits (155), Expect = 1e-10
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 46/225 (20%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++GKG  G V+ AE  +  +  A+K L           + D + +    +    E + L 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKAL-----------KKDVVLMDDDVECTMVEKRVLS 72

Query: 752 -SIRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYR-----II 804
            +  H  +   + C +     L  + +Y+  G L  + H +     +   R       II
Sbjct: 73  LAWEHPFLTH-MFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFD-LSRATFYAAEII 128

Query: 805 LGAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTV 863
           LG    L +LH       IV+RD+K +NIL+  +    IADFG+ K  + GD    +NT 
Sbjct: 129 LG----LQFLHSKG----IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTF 178

Query: 864 AGSYGYIAPE------YGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            G+  YIAPE      Y + +      D +S+GV++ E+L G+ P
Sbjct: 179 CGTPDYIAPEILLGQKYNHSV------DWWSFGVLLYEMLIGQSP 217

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 46/165 (27%), Positives = 67/165 (40%), Gaps = 29/165 (17%)

Query: 310 SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSL 369
           S+P  +        L L  NQI+       KLE  +  +L N   L+ + L  N L  +L
Sbjct: 33  SVPAGIPTNAQ--ILYLHDNQIT-------KLEPGVFDSLIN---LKELYLGSNQLG-AL 79

Query: 370 HPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG 428
             G+F  L  LT L L +N ++ L P  +             F     L+ L +  N L 
Sbjct: 80  PVGVFDSLTQLTVLDLGTNQLTVL-PSAV-------------FDRLVHLKELFMCCNKLT 125

Query: 429 GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKN 473
             LP  +  LT L  L +  NQ   +   +F +L+SL    L  N
Sbjct: 126 -ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 36/154 (23%), Positives = 57/154 (37%), Gaps = 27/154 (17%)

Query: 298 EELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA 357
           + L L +N I+   P V  +  +L +L L +NQ+         L   +  +L     L  
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-------ALPVGVFDSLTQ---LTV 92

Query: 358 VDLSHNALTGSLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQ 416
           +DL  N LT  L   +F +L +L +L +  N ++ L  P                   T 
Sbjct: 93  LDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTEL--PR-------------GIERLTH 136

Query: 417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQ 450
           L  L L  N L      +   L+ L    +  N 
Sbjct: 137 LTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 43/170 (25%), Positives = 59/170 (34%), Gaps = 37/170 (21%)

Query: 399 NCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPES 458
           +C S  R   +  G  T  Q+L L +N +    P    SL  L+ L +  NQ   L    
Sbjct: 25  DCRS-KRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV 83

Query: 459 FGQLASLNRLILSKNSFSGAIPS----SLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD 514
           F  L  L  L L  N  +  +PS     L     L+ L +  NKL+              
Sbjct: 84  FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVH---LKELFMCCNKLT-------------- 125

Query: 515 ISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSL 564
                        +P  I  L  L+ L L  N+L    +     D L SL
Sbjct: 126 ------------ELPRGIERLTHLTHLALDQNQLKS--IPHGAFDRLSSL 161

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 61.9 bits (151), Expect = 3e-10
 Identities = 53/247 (21%), Positives = 102/247 (41%), Gaps = 49/247 (19%)

Query: 677 LNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIG 735
           +N     +    ++   +G G +G+V+ A + +  + +A+KK+    +      ++    
Sbjct: 2   MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKH---- 54

Query: 736 IGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRL--------------LMYDYMPNG 781
              +R     EIK +  + H NIV+         ++L              ++ +YM   
Sbjct: 55  --ALR-----EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--- 104

Query: 782 SLGSLLHE--RRDSCLEWELRYRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE 837
              + L     +   LE   R  +  +L   +GL Y+H   V   +HRD+K  N+ I  E
Sbjct: 105 --ETDLANVLEQGPLLEEHARLFMYQLL---RGLKYIHSANV---LHRDLKPANLFINTE 156

Query: 838 F-EPYIADFGLAKLVVEGDFARSSNT--VAGSYGYIAPE-YGYMMKITEKSDVYSYGVVV 893
                I DFGLA+++      +   +  +   + Y +P         T+  D+++ G + 
Sbjct: 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIF 215

Query: 894 LEVLTGK 900
            E+LTGK
Sbjct: 216 AEMLTGK 222

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.9 bits (152), Expect = 5e-10
 Identities = 63/408 (15%), Positives = 118/408 (28%), Gaps = 136/408 (33%)

Query: 27  SPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDC--TQLTTID 84
             Q F  + N+  ++  L     L  L   + ++I G          +     T +  +D
Sbjct: 122 DNQVF-AKYNVSRLQPYLKLRQALLELRPAKNVLIDG----------VLGSGKTWVA-LD 169

Query: 85  VSSNSLV-----GGV----------PSSIGKLINLQDLIL----NSNQL---TGEIPKEL 122
           V  +  V       +          P ++  L  LQ L+     N       +  I   +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETV--LEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227

Query: 123 GACI-KLKNLLLFDNYLSGNLPVELGKLV-----NLEVIRAGGNKDIAGKIPYEIGDCQS 176
            +   +L+ LL    Y        L  LV     N +   A           + +  C+ 
Sbjct: 228 HSIQAELRRLLKSKPY-----ENCL--LVLLNVQNAKAWNA-----------FNLS-CKI 268

Query: 177 LLVVGLADTKVAGSLPASLGK----------LSKLQSLSV---YTTMLSGEIPPQIGNCS 223
           LL       +V   L A+             L+  +  S+   Y      ++P ++   +
Sbjct: 269 LLTT--RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326

Query: 224 ELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQN----NFDGAIPEEIGNCKSLKTIDLS 279
                      LS      + +  + + +  W N    N D          K    I+ S
Sbjct: 327 PRR--------LSI-----IAESIR-DGLATWDNWKHVNCD----------KLTTIIESS 362

Query: 280 LNFFSGSLPQS-FGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQ 338
           LN    +  +  F  LS        + +I      +LS    L+              W 
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPP----SAHIP---TILLS----LI--------------WF 397

Query: 339 NKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQ----NLTKL 382
           + ++  +   +        V+      T S+     +L+    N   L
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 1e-06
 Identities = 54/374 (14%), Positives = 108/374 (28%), Gaps = 101/374 (27%)

Query: 673  PFQKLNFT----VEQVLKCLVEDS------VVGKGCSGIVYRAEMENGEVIAVKKLWPTT 722
             F K N +      ++ + L+E        + G   SG                K   T 
Sbjct: 125  VFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG----------------K---TW 165

Query: 723  MAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF---LGCCWNRNTRL-----LM 774
            +A +  C + K     V+     +I             F   L  C +  T L     L+
Sbjct: 166  VALDV-CLSYK-----VQCKMDFKI-------------FWLNLKNCNSPETVLEMLQKLL 206

Query: 775  YDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL 833
            Y   PN +  S      +      +   R +L +       + +C+  +V  +++     
Sbjct: 207  YQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-----YENCL--LVLLNVQNAKAW 259

Query: 834  IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVV 893
                F     +     L+      +       +         +        +V S  +  
Sbjct: 260  --NAF-----NLSCKILLTTRF--KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310

Query: 894  LEVLTGKQP-----IDP----TIPEGL--HIVDWVRQKRGAIE----VLDKSLRARPEVE 938
            L+      P      +P     I E +   +  W   K    +    +++ SL      E
Sbjct: 311  LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAE 370

Query: 939  IEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI-KEIKQEREECMKVDMLPSEGSANGQRE 997
              +M   L V        P        + ++I  ++ +     + V+ L        Q +
Sbjct: 371  YRKMFDRLSV-------FPPSAHIPTILLSLIWFDVIKSDVMVV-VNKLHKYSLVEKQPK 422

Query: 998  NNNSSSTAMMPNLY 1011
             +  S    +P++Y
Sbjct: 423  ESTIS----IPSIY 432

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.3 bits (114), Expect = 1e-05
 Identities = 81/528 (15%), Positives = 153/528 (28%), Gaps = 176/528 (33%)

Query: 467 RLILSKNSFSGAI--PSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNAL 524
           + ILSK      I    ++     L       +K   +  V+ F  E L I  N  +   
Sbjct: 43  KSILSKEEIDHIIMSKDAVSGTLRL--FWTLLSK--QEEMVQKFVEEVLRI--NYKFLMS 96

Query: 525 SGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQL 584
                 +  ++     ++   ++L  D            +   YN     +   + + +L
Sbjct: 97  PIKTEQRQPSMMTRMYIE-QRDRLYND----------NQVFAKYN-----VSRLQPYLKL 140

Query: 585 SATEMAGNQGLCSRGHESCFLSNATTV---GMGNGGGFRKSEKLKIAIALLVTFTIALAI 641
                   Q L         L  A  V   G+    G  K+                +A+
Sbjct: 141 -------RQALLE-------LRPAKNVLIDGVL---GSGKT---------------WVAL 168

Query: 642 FGAFAVVRAGKMVGDDVDSEMGGNSLPW-----------QLTPFQKLNFTVEQVLKCLVE 690
                V  +       V  +M      W            L   QKL + ++       +
Sbjct: 169 ----DVCLS-----YKVQCKMDFKIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218

Query: 691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEY--------DCQNDKIGIGGVRDS 742
            S      S I  R      E+   ++L     +  Y        + QN K       ++
Sbjct: 219 HS------SNIKLRIHSIQAEL---RRLL---KSKPYENCLLVLLNVQNAKA-W----NA 261

Query: 743 FSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEW----- 797
           F+   K L + R K +  FL       T + +  +    S+     E +   L++     
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSA--ATTTHISLDHH----SMTLTPDEVKSLLLKYLDCRP 315

Query: 798 -ELRYRI---------ILGAA--QGLA----YLHHDCVPPIVHRDIKAN-NILIGPEFEP 840
            +L   +         I+  +   GLA    + H +C    +   I+++ N+L   E+  
Sbjct: 316 QDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRK 373

Query: 841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL-TG 899
                 +        F  S++                  I            +L ++   
Sbjct: 374 MFDRLSV--------FPPSAH------------------IPTI---------LLSLIWFD 398

Query: 900 KQPIDP-TIPEGLH---IVDWVRQKRGAIEVLDKSLRARPEVEIEEML 943
               D   +   LH   +V+  + K   I +    L  + ++E E  L
Sbjct: 399 VIKSDVMVVVNKLHKYSLVE-KQPKESTISIPSIYLELKVKLENEYAL 445

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 37/161 (22%), Positives = 64/161 (39%), Gaps = 22/161 (13%)

Query: 263 IPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLL 322
           +   +   K+ K + LS N     +  S   + +L  L L  N I   I  + + A +L 
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 323 QLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALT--GSLHPGLFQLQNLT 380
           +L +  NQI+        L G     +    +L  + +S+N +T  G +   L  L  L 
Sbjct: 97  ELWISYNQIA-------SLSG-----IEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLE 143

Query: 381 KLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLN 421
            LLL  N +         N +S  R+ ++       L+ L+
Sbjct: 144 DLLLAGNPLYNDYKEN--NATSEYRIEVVK--RLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 37/193 (19%), Positives = 67/193 (34%), Gaps = 40/193 (20%)

Query: 379 LTKLLLISNGISGLIPPEIGNCSSLIRLRL-----------MSFGNCTQLQMLNLSNNTL 427
           + K   I + I      +    +   ++ L            +       + L LS N +
Sbjct: 1   MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI 60

Query: 428 GGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCE 487
                SSL+ +  L++L +  N     I        +L  L +S N  +    S + +  
Sbjct: 61  EKI--SSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLV 115

Query: 488 SLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNK 547
           +L+ L +S+NK++        EI+ L                   +AL+KL  L L+ N 
Sbjct: 116 NLRVLYMSNNKIT-----NWGEIDKL-------------------AALDKLEDLLLAGNP 151

Query: 548 LGGDLLALSGLDN 560
           L  D    +    
Sbjct: 152 LYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 44/183 (24%), Positives = 70/183 (38%), Gaps = 21/183 (11%)

Query: 265 EEIGNCKSLKTIDLSLNFFS-GSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQ 323
            +       + ++L         +  +   L + + L LS NNI   I   LS   +L  
Sbjct: 17  RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRI 74

Query: 324 LQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLL 383
           L L  N I             I +  A   +LE + +S+N +  SL  G+ +L NL  L 
Sbjct: 75  LSLGRNLIK-----------KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLY 121

Query: 384 LISNGISGLIPPEIGNCSSLIRLRLMSF-GNCTQLQMLNLSNNTLGGTLPSSLASLTRLQ 442
           + +N I+     EI   ++L +L  +   GN   L      NN         +  L  L+
Sbjct: 122 MSNNKITNW--GEIDKLAALDKLEDLLLAGN--PLYNDYKENNATSEYRIEVVKRLPNLK 177

Query: 443 VLD 445
            LD
Sbjct: 178 KLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 19/110 (17%), Positives = 33/110 (30%), Gaps = 36/110 (32%)

Query: 467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSG 526
            L          + ++L   ++ + L LS+N +         +I  L             
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE--------KISSLS------------ 67

Query: 527 AIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVS----LNVSYNNFT 572
                   +  L IL L  N +      +  LD +      L +SYN   
Sbjct: 68  -------GMENLRILSLGRNLIK----KIENLDAVADTLEELWISYNQIA 106

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 13/103 (12%)

Query: 36  NIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP 95
           NI+ I        +LS +  L+ L +  + +   I         L  + +S N +     
Sbjct: 59  NIEKIS-------SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIA--SL 108

Query: 96  SSIGKLINLQDLILNSNQLT--GEIPKELGACIKLKNLLLFDN 136
           S I KL+NL+ L +++N++T  GEI  +L A  KL++LLL  N
Sbjct: 109 SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGN 150

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 60.4 bits (145), Expect = 1e-09
 Identities = 31/191 (16%), Positives = 66/191 (34%), Gaps = 27/191 (14%)

Query: 343 GSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSS 402
             +   L     L  + +     T +L  G     NL  L +IS G+   +  +I     
Sbjct: 162 VDLSPVLDAMPLLNNLKIK---GTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD- 217

Query: 403 LIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL------TRLQVLDISVNQFVGLIP 456
                     N  +L +     +       +    L        L+ L I   +   ++ 
Sbjct: 218 --------LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269

Query: 457 ESFGQ---LASLNRLILSKNSFSG----AIPSSLGRCESLQSLDLSSNKLSGKIPVELFE 509
           E F +   L  L  + +S    +      +   + + + L+ +++  N LS ++  EL  
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL-- 327

Query: 510 IEGLDISLNLS 520
            + L + +++S
Sbjct: 328 QKSLPMKIDVS 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 56.5 bits (135), Expect = 2e-08
 Identities = 29/263 (11%), Positives = 70/263 (26%), Gaps = 30/263 (11%)

Query: 337 WQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPE 396
            +     ++       +                   + ++    KL  +     G    E
Sbjct: 61  TKKGYVETLEEVAKEMKVEAKKYALSYDEAEEGVNLMDKILKDKKLPSLKQITIGXWGYE 120

Query: 397 IGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG---------GTLPSSLASLTRLQVLDIS 447
             +CS +    + +       + L   +               L   L ++  L  L I 
Sbjct: 121 GEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIK 180

Query: 448 VNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCE--SLQSLDL---SSNKLSGK 502
               + +  +      +L  L +       ++   +   +  +L+ L L     +     
Sbjct: 181 GTNNLSIGKK---PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG 237

Query: 503 IPVELFEIEGLD-----ISLNLSWNALSGAIPPQISA---LNKLSILDLSHNKLGGD--- 551
                  +   D       L +        +         L +L  +D+S   L  +   
Sbjct: 238 DMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGAR 297

Query: 552 --LLALSGLDNLVSLNVSYNNFT 572
             L  +  + +L  +N+ YN  +
Sbjct: 298 LLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 55.7 bits (133), Expect = 4e-08
 Identities = 26/198 (13%), Positives = 61/198 (30%), Gaps = 32/198 (16%)

Query: 385 ISNGISGLIPPEIGNCSSLIRLRLMSFGN-------CTQLQMLNLSNNTLGGTLPSSLAS 437
           IS      + P +     L  L++    N          L+ L + +  L  ++   +  
Sbjct: 156 ISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILG 215

Query: 438 --LTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLS 495
             L  L+ L + V                L                S  R  +L+ L + 
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPL---------------FSKDRFPNLKWLGIV 260

Query: 496 SNKLSGKIPVELFEIEGLD--ISLNLSWNALSG----AIPPQISALNKLSILDLSHNKLG 549
             +    +     E + L    ++++S   L+      +   +  +  L  +++ +N L 
Sbjct: 261 DAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

Query: 550 GDLLAL--SGLDNLVSLN 565
            ++       L   + ++
Sbjct: 321 DEMKKELQKSLPMKIDVS 338

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 36/195 (18%), Positives = 65/195 (33%), Gaps = 54/195 (27%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
                +  Q+        ++G G  G V  A +     V+A+KK                
Sbjct: 42  MPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKK---------------- 85

Query: 734 IGIGGVRDSFSA---------EIKTLGSIRHKNIVRFLGCCWNRNTRL-----LMYDYMP 779
                +   F           EI  L  + H ++V+ L     ++        ++ +   
Sbjct: 86  -----ILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA- 139

Query: 780 NGSLGSLLHE--RRDSCLEWE-LRYRI--ILGAAQGLAYLH-HDCVPPIVHRDIKANNIL 833
                S   +  R    L    ++  +  +L    G+ Y+H       I+HRD+K  N L
Sbjct: 140 ----DSDFKKLFRTPVYLTELHIKTLLYNLL---VGVKYVHSAG----ILHRDLKPANCL 188

Query: 834 IGPEFEPYIADFGLA 848
           +  +    + DFGLA
Sbjct: 189 VNQDCSVKVCDFGLA 203

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 25/124 (20%), Positives = 43/124 (34%), Gaps = 15/124 (12%)

Query: 352 CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSF 411
                 +  + +    SLH  L   +NLT+L + +      +                  
Sbjct: 7   PHGSSGLRCTRDGALDSLH-HLPGAENLTELYIENQQHLQHLELR-------------DL 52

Query: 412 GNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILS 471
               +L+ L +  + L    P +     RL  L++S N    L  ++   L SL  L+LS
Sbjct: 53  RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLS 111

Query: 472 KNSF 475
            N  
Sbjct: 112 GNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.7 bits (136), Expect = 2e-08
 Identities = 22/114 (19%), Positives = 34/114 (29%), Gaps = 9/114 (7%)

Query: 414 CTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIP-ESFGQLASLNRLILSK 472
                 L  + +         L     L  L I   Q +  +       L  L  L + K
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 473 NSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSG 526
           +      P +      L  L+LS N L   +  +  +       L+L    LSG
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ------GLSLQELVLSG 112

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.9 bits (134), Expect = 3e-08
 Identities = 22/110 (20%), Positives = 37/110 (33%), Gaps = 16/110 (14%)

Query: 344 SIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPEIGNCSS 402
                L    +L  + + +      L     + L  L  L ++ +G+   + P+      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD------ 74

Query: 403 LIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFV 452
                  +F    +L  LNLS N L  +L         LQ L +S N   
Sbjct: 75  -------AFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 19/127 (14%), Positives = 34/127 (26%), Gaps = 36/127 (28%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLP-QSFGNLSSLEELMLSNNNISGSIPPVLSNATS 320
                +   ++L  + +        L  +    L  L  L +  + +   +         
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA-------- 72

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLT 380
                                    P        L  ++LS NAL  SL     Q  +L 
Sbjct: 73  -------------------------PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ 106

Query: 381 KLLLISN 387
           +L+L  N
Sbjct: 107 ELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.7 bits (131), Expect = 7e-08
 Identities = 26/93 (27%), Positives = 37/93 (39%), Gaps = 2/93 (2%)

Query: 408 LMSFGNCTQLQMLNLSNNTLGGTLPS-SLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
           L        L  L + N      L    L  L  L+ L I  +    + P++F     L+
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKL 499
           RL LS N+   ++     +  SLQ L LS N L
Sbjct: 84  RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.4 bits (117), Expect = 4e-06
 Identities = 19/115 (16%), Positives = 38/115 (33%), Gaps = 6/115 (5%)

Query: 25  TCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISP-DLGDCTQLTTI 83
                + +      +++       +L     L +L I        +   DL    +L  +
Sbjct: 6   CPHGSSGLRCTRDGALDS----LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61

Query: 84  DVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYL 138
            +  + L    P +      L  L L+ N L   +  +    + L+ L+L  N L
Sbjct: 62  TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 6e-06
 Identities = 20/117 (17%), Positives = 36/117 (30%), Gaps = 26/117 (22%)

Query: 214 EIPPQIGNCSELVDLFLYENDLSGSLPRE-LGKLQKLEKMLLWQNNFDGAIPEEIGNCKS 272
           +    +     L +L++        L    L  L +L  + + ++               
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-------------- 67

Query: 273 LKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTN 329
           L+ +           P +F     L  L LS N +  S+        SL +L L  N
Sbjct: 68  LRFVA----------PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.7 bits (110), Expect = 2e-05
 Identities = 23/123 (18%), Positives = 35/123 (28%), Gaps = 29/123 (23%)

Query: 478 AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNK 537
                L   E+L  L + + +    +                    L G        L +
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLE----------------LRDLRG--------LGE 57

Query: 538 LSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMA--GNQG 594
           L  L +  + L      A      L  LN+S+N            + LS  E+   GN  
Sbjct: 58  LRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWK--TVQGLSLQELVLSGNPL 115

Query: 595 LCS 597
            CS
Sbjct: 116 HCS 118

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 58.5 bits (142), Expect = 5e-09
 Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 36/236 (15%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A + + G  +AVKKL      +    +   
Sbjct: 18  QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAK--- 73

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFL------GCCWNRNTRLLMYDYMPNGSLGSLL 787
                 R     E++ L  ++H+N++  L            N   L+   M    L +++
Sbjct: 74  ---RTYR-----ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV 124

Query: 788 HERRDSCLEWELRYRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF 845
             ++ +  +  +++ I  IL   +GL Y+H      I+HRD+K +N+ +  + E  I DF
Sbjct: 125 KCQKLT--DDHVQFLIYQIL---RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDF 176

Query: 846 GLAKLVVEGDFARSSNTVAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGK 900
           GLA+   +      +  VA  + Y APE     M   +  D++S G ++ E+LTG+
Sbjct: 177 GLARHTAD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 58.6 bits (142), Expect = 5e-09
 Identities = 35/207 (16%), Positives = 71/207 (34%), Gaps = 46/207 (22%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGV-RDSFSA----- 745
           ++G+G  G VY A +    + +A+KK                  +  +  D         
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKK------------------VNRMFEDLIDCKRILR 74

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRL-----LMYDYMPNGSLGSLLHE--RRDSCLEWE 798
           EI  L  ++   I+R        +        ++ +        S L +  +    L  E
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEE 129

Query: 799 -LRYRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
            ++  +  +L    G  ++H   +   +HRD+K  N L+  +    + DFGLA+ +    
Sbjct: 130 HIKTILYNLL---LGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183

Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITE 882
                N +  +            ++T 
Sbjct: 184 DTNIVNDLEENEEPGPHNKNLKKQLTS 210

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 28/144 (19%), Positives = 53/144 (36%), Gaps = 28/144 (19%)

Query: 403 LIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQL 462
           LI  +   + N  + + L+L    +   + +  A+L +   +D S N+   L  + F  L
Sbjct: 8   LIE-QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLL 63

Query: 463 ASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWN 522
             L  L+++ N               L  L L++N L      EL +++ L         
Sbjct: 64  RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPL--------- 109

Query: 523 ALSGAIPPQISALNKLSILDLSHN 546
                     ++L  L+ L +  N
Sbjct: 110 ----------ASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 29/160 (18%), Positives = 53/160 (33%), Gaps = 29/160 (18%)

Query: 289 QSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPST 348
             + N     EL L    I   I  + +       +    N+I        KL+G     
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-------KLDG----- 59

Query: 349 LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
               R L+ + +++N +          L +LT+L+L +N +  L          L  L  
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL--------GDLDPLA- 110

Query: 409 MSFGNCTQLQMLNLSNN---TLGGTLPSSLASLTRLQVLD 445
               +   L  L +  N            +  + +++VLD
Sbjct: 111 ----SLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 25/123 (20%), Positives = 46/123 (37%), Gaps = 16/123 (13%)

Query: 457 ESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDI- 515
             +        L L        I +     +   ++D S N++         +++G  + 
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--------KLDGFPLL 63

Query: 516 ----SLNLSWNALSGAIPPQISALNKLSILDLSHNKLG--GDLLALSGLDNLVSLNVSYN 569
               +L ++ N +         AL  L+ L L++N L   GDL  L+ L +L  L +  N
Sbjct: 64  RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

Query: 570 NFT 572
             T
Sbjct: 124 PVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 25/120 (20%), Positives = 46/120 (38%), Gaps = 10/120 (8%)

Query: 217 PQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIP--EEIGNCKSLK 274
            Q  N     +L L    +   +      L + + +    N     I   +     + LK
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----IRKLDGFPLLRRLK 67

Query: 275 TIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS--GSIPPVLSNATSLLQLQLDTNQIS 332
           T+ ++ N            L  L EL+L+NN++   G + P L++  SL  L +  N ++
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 25/116 (21%), Positives = 46/116 (39%), Gaps = 8/116 (6%)

Query: 48  SNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSL--VGGVPSSIGKLINLQ 105
           +  ++    ++L + G  +   I        Q   ID S N +  + G P     L  L+
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLK 67

Query: 106 DLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVE-LGKLVNLEVIRAGGN 160
            L++N+N++         A   L  L+L +N L     ++ L  L +L  +    N
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 54.7 bits (132), Expect = 7e-09
 Identities = 27/116 (23%), Positives = 45/116 (38%), Gaps = 16/116 (13%)

Query: 462 LASLNRLILSKNSFS-GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDI----- 515
            + +  L+L  +  + G +       E L+ L   +  L+         I  L       
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--------SIANLPKLNKLK 67

Query: 516 SLNLSWNALSGAIPPQISALNKLSILDLSHNKLG--GDLLALSGLDNLVSLNVSYN 569
            L LS N +SG +         L+ L+LS NK+     +  L  L+NL SL++   
Sbjct: 68  KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 34/157 (21%), Positives = 57/157 (36%), Gaps = 29/157 (18%)

Query: 293 NLSSLEELMLSNNNIS-GSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLAN 351
             S ++EL+L N+  + G +  +      L  L      ++        +       L  
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-------SIAN-----LPK 62

Query: 352 CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSF 411
              L+ ++LS N ++G L     +  NLT L L  N I  L        S++  L+    
Sbjct: 63  LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL--------STIEPLK---- 110

Query: 412 GNCTQLQMLNLSNN---TLGGTLPSSLASLTRLQVLD 445
                L+ L+L N     L     +    L +L  LD
Sbjct: 111 -KLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 4/114 (3%)

Query: 221 NCSELVDLFLYENDLS-GSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLS 279
             S++ +L L  +  + G L     + ++LE +              +     LK ++LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 280 LNFFSGSLPQSFGNLSSLEELMLSNNNISG-SIPPVLSNATSLLQLQLDTNQIS 332
            N  SG L        +L  L LS N I   S    L    +L  L L   +++
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 33/141 (23%), Positives = 50/141 (35%), Gaps = 28/141 (19%)

Query: 406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASL 465
           LR  +  +  +L + N  +N   G L         L+ L         +   +  +L  L
Sbjct: 11  LRNRTPSDVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKL 66

Query: 466 NRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALS 525
            +L LS N  SG +     +C +L  L+LS NK+      +L  IE L            
Sbjct: 67  KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK-----DLSTIEPL------------ 109

Query: 526 GAIPPQISALNKLSILDLSHN 546
                    L  L  LDL + 
Sbjct: 110 -------KKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 30/125 (24%), Positives = 52/125 (41%), Gaps = 12/125 (9%)

Query: 40  IELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGD-CTQLTTIDVSSNSL--VGGVPS 96
           I LEL       + S +++L++  S         L D   +L  +   +  L  +  +P 
Sbjct: 7   IHLEL----RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP- 61

Query: 97  SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVE-LGKLVNLEVI 155
              KL  L+ L L+ N+++G +      C  L +L L  N +     +E L KL NL+ +
Sbjct: 62  ---KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118

Query: 156 RAGGN 160
                
Sbjct: 119 DLFNC 123

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.3 bits (139), Expect = 7e-09
 Identities = 47/224 (20%), Positives = 75/224 (33%), Gaps = 65/224 (29%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           V+G G +G V +       E  A+K L                           E++   
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKML-------------QD------CPKARREVELHW 65

Query: 752 SI-RHKNIVRFLG-----CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL-EWELRY--R 802
              +  +IVR +          +   ++M + +  G L S + +R D    E E     +
Sbjct: 66  RASQCPHIVRIVDVYENLYAGRKCLLIVM-ECLDGGELFSRIQDRGDQAFTEREASEIMK 124

Query: 803 IILGAAQGLAYLH-HDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGDFAR 858
            I  A   + YLH  +    I HRD+K  N+L     P     + DFG AK         
Sbjct: 125 SIGEA---IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET------- 170

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
                   Y              +  D++S GV++  +L G  P
Sbjct: 171 ----TGEKYD-------------KSCDMWSLGVIMYILLCGYPP 197

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 29/116 (25%), Positives = 44/116 (37%), Gaps = 16/116 (13%)

Query: 462 LASLNRLILSKNSFS-GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD-----I 515
            A++  L+L     + G I        +L+ L L +  L          +  L       
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------SVSNLPKLPKLK 74

Query: 516 SLNLSWNALSGAIPPQISALNKLSILDLSHNKLG--GDLLALSGLDNLVSLNVSYN 569
            L LS N + G +      L  L+ L+LS NKL     L  L  L+ L SL++   
Sbjct: 75  KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 36/157 (22%), Positives = 58/157 (36%), Gaps = 29/157 (18%)

Query: 293 NLSSLEELMLSNNNIS-GSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLAN 351
             +++ EL+L N   + G I  + +   +L  L L    +         +       L  
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-------SVSN-----LPK 69

Query: 352 CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSF 411
              L+ ++LS N + G L     +L NLT L L  N +  +        S+L  L+    
Sbjct: 70  LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI--------STLEPLK---- 117

Query: 412 GNCTQLQMLNLSNN---TLGGTLPSSLASLTRLQVLD 445
                L+ L+L N     L     S    L +L  LD
Sbjct: 118 -KLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 28/139 (20%), Positives = 48/139 (34%), Gaps = 27/139 (19%)

Query: 409 MSFGNCTQLQMLNLSNNTLG-GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNR 467
           +       ++ L L N     G +    A    L+ L +     + +   +  +L  L +
Sbjct: 18  LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKK 75

Query: 468 LILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGA 527
           L LS+N   G +     +  +L  L+LS NKL      ++  +E L              
Sbjct: 76  LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-----DISTLEPL-------------- 116

Query: 528 IPPQISALNKLSILDLSHN 546
                  L  L  LDL + 
Sbjct: 117 -----KKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.7 bits (111), Expect = 5e-06
 Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 6/115 (5%)

Query: 221 NCSELVDLFLYENDLSGSLPRELG-KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLS 279
             + + +L L     +      L  +   LE + L            +     LK ++LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 280 LNFFSGSLPQSFGNLSSLEELMLSNNNIS--GSIPPVLSNATSLLQLQLDTNQIS 332
            N   G L      L +L  L LS N +    ++ P L     L  L L   +++
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 24/113 (21%), Positives = 45/113 (39%), Gaps = 8/113 (7%)

Query: 52  SLSFLQKLIISGSNLT-GPISPDLGDCTQLTTIDVSSNSL--VGGVPSSIGKLINLQDLI 108
           + + +++L++       G I     +   L  + + +  L  V  +P    KL  L+ L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLE 77

Query: 109 LNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVE-LGKLVNLEVIRAGGN 160
           L+ N++ G +         L +L L  N L     +E L KL  L+ +     
Sbjct: 78  LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 56/294 (19%), Positives = 97/294 (32%), Gaps = 66/294 (22%)

Query: 294 LSSLEELMLSNNNISGS----IPPVL-SNATSLLQLQLDTNQISVFFAWQNKLEGSIPST 348
           LSSL +L L+   ++      +  VL S   +L ++ L + Q+                 
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDP--------------- 115

Query: 349 LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
            A  R+L  V                      KL L  N +              +R  L
Sbjct: 116 -AGLRTLLPV-----------------FLRARKLGLQLNSLG-------PEACKDLRDLL 150

Query: 409 MSFGNCTQLQMLNLSNNTLGGT----LPSSLASLTRLQVLDISVNQF----VGLIPESFG 460
           +   +  Q+  L LSNN L       L   LA  T +  L +         + L+     
Sbjct: 151 LH--DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLD 208

Query: 461 QLASLNRLILSKNSFSG----AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD-- 514
           +   L  L ++ N        A+  +     SL+ L L  N+LS +    L ++ G    
Sbjct: 209 RNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEG 268

Query: 515 ----ISLNLSWNALSGAIPPQISALNK-LSILDLSHNKLGGDLLALSGLDNLVS 563
               +       A+S      +S + + L+  D +  +   +LL     D+  +
Sbjct: 269 GARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGA 322

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 42/302 (13%), Positives = 90/302 (29%), Gaps = 51/302 (16%)

Query: 225 LVDLFLYENDLSGSLPRELGKL-----QKLEKMLLWQNNFDGAIPEEIGNC-KSLKTIDL 278
           L  L L    ++      +  +       L+++ L     D A    +       + + L
Sbjct: 74  LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGL 133

Query: 279 SLNFFSGSLPQSFG-----NLSSLEELMLSNNNISGS----IPPVLSNATSLLQLQLDTN 329
            LN       +        +   +  L LSNN ++ +    +   L+  TS+  L L   
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHT 193

Query: 330 QISVFFAWQNKLEG--SIPSTLANCRSLEAVDLSHNALTGS----LHPGLFQLQNLTKLL 383
            +          EG   + + L   R L+ +++++N    +    L     +  +L  L 
Sbjct: 194 GLGD--------EGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLH 245

Query: 384 LISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLAS-LTRLQ 442
           L  N +S       G    ++R    +     ++ +       +       L+     L 
Sbjct: 246 LYFNELS-----SEG--RQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLN 298

Query: 443 VLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRC----ESLQSLDLSSNK 498
             D +  Q          +   L    L  +  +   P    +       +++L      
Sbjct: 299 SWDRARVQ----------RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGS 348

Query: 499 LS 500
             
Sbjct: 349 SG 350

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 37/224 (16%), Positives = 69/224 (30%), Gaps = 38/224 (16%)

Query: 376 LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL 435
           L +L +L L    ++      +  C+ +  +          L  +NL++  L      +L
Sbjct: 71  LSSLRQLNLAGVRMT-----PVK-CTVVAAVLGSG--RHA-LDEVNLASCQLDPAGLRTL 121

Query: 436 AS-LTRLQVLDISVNQF----VGLIPESF-GQLASLNRLILSKNSFSG----AIPSSLGR 485
                R + L + +N         + +        +  L LS N  +      +   L  
Sbjct: 122 LPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181

Query: 486 CESLQSLDLSSNKLSGKIPVELFEIEGLDI-----SLNLSWNALSGAIPPQIS-AL---N 536
             S+  L L    L  +    L     LD       LN+++N         ++ A     
Sbjct: 182 NTSVTHLSLLHTGLGDEGLELLAA--QLDRNRQLQELNVAYNGAGDTAALALARAAREHP 239

Query: 537 KLSILDLSHNKLGGD--------LLALSGLDNLVSLNVSYNNFT 572
            L +L L  N+L  +          A  G   +V         +
Sbjct: 240 SLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 44/239 (18%), Positives = 71/239 (29%), Gaps = 51/239 (21%)

Query: 361 SHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSL-IRLRLMSFGNC----- 414
            + A+   L   +  L  L     I   +  L    +     L        F N      
Sbjct: 10  HNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAE 69

Query: 415 --TQLQMLNLSNNTLGGTLPSSLA-----SLTRLQVLDISVNQFVGLIPESFGQLA---- 463
             + L+ LNL+   +     + +A         L  ++++  Q   L P     L     
Sbjct: 70  VLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQ---LDPAGLRTLLPVFL 126

Query: 464 SLNRLILSKNSFS----GAIPSSL-GRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLN 518
              +L L  NS        +   L      + +L LS+N L+                  
Sbjct: 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAA---------------- 170

Query: 519 LSWNALSGAIPPQISALNKLSILDLSHNKL---GGDLL--ALSGLDNLVSLNVSYNNFT 572
                L   +    +    ++ L L H  L   G +LL   L     L  LNV+YN   
Sbjct: 171 -GVAVLMEGL----AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 42.4 bits (100), Expect = 6e-04
 Identities = 29/166 (17%), Positives = 52/166 (31%), Gaps = 17/166 (10%)

Query: 420 LNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAI 479
           L+  N  +   L   + +L  L+       +   L  +       L+ L           
Sbjct: 7   LSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEF--QNQ 64

Query: 480 PSSLGRCESLQSLDLSSNKLSGKIPVELFEI-----EGLDISLNLSWNALSGAIPPQI-S 533
             S     SL+ L+L+  +++      +  +       LD  +NL+   L  A    +  
Sbjct: 65  RFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALD-EVNLASCQLDPAGLRTLLP 123

Query: 534 ALNKLSILDLSHNKL---GGDLLALSGLD----NLVSLNVSYNNFT 572
              +   L L  N L       L    L      + +L +S N  T
Sbjct: 124 VFLRARKLGLQLNSLGPEACKDLR-DLLLHDQCQITTLRLSNNPLT 168

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 48/162 (29%), Positives = 70/162 (43%), Gaps = 20/162 (12%)

Query: 338 QNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGISGLIPPE 396
            ++   S+P+ +        +DL  N+L  SL  G+F  L +LT+L L  N +  L P  
Sbjct: 15  YSQGRTSVPTGIPA--QTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSL-PNG 70

Query: 397 IGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLI 455
           +             F   T L  LNLS N L  +LP+ +   LT+L+ L ++ NQ   L 
Sbjct: 71  V-------------FNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLP 116

Query: 456 PESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN 497
              F +L  L  L L +N           R  SLQ + L  N
Sbjct: 117 DGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 45/166 (27%), Positives = 65/166 (39%), Gaps = 30/166 (18%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATS 320
           ++P  I        +DL  N         F  L+SL +L L  N +  S+P  V +  TS
Sbjct: 21  SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLF-QLQNL 379
           L  L L TNQ+         L   +   L     L+ + L+ N L  SL  G+F +L  L
Sbjct: 78  LTYLNLSTNQLQ-------SLPNGVFDKLTQ---LKELALNTNQLQ-SLPDGVFDKLTQL 126

Query: 380 TKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNN 425
             L L  N +   +P  +             F   T LQ + L +N
Sbjct: 127 KDLRLYQNQLKS-VPDGV-------------FDRLTSLQYIWLHDN 158

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 41/138 (29%), Positives = 59/138 (42%), Gaps = 31/138 (22%)

Query: 351 NC--RSLEAV-----------DLSHNALTGSLHPGLF-QLQNLTKLLLISNGISGLIPPE 396
            C  + L +V           +L  N L  SL  G+F +L  LTKL L  N I  L P  
Sbjct: 13  RCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSL-PDG 70

Query: 397 IGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLI 455
           +             F   T+L +L L  N L  +LP+ +   LT+L+ L +  NQ   + 
Sbjct: 71  V-------------FDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVP 116

Query: 456 PESFGQLASLNRLILSKN 473
              F +L SL ++ L  N
Sbjct: 117 DGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 2/86 (2%)

Query: 415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS 474
           +    L L +N L          LT+L  L +S NQ   L    F +L  L  L L +N 
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87

Query: 475 FSGAIPSSL-GRCESLQSLDLSSNKL 499
              ++P+ +  +   L+ L L +N+L
Sbjct: 88  LQ-SLPNGVFDKLTQLKELALDTNQL 112

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 86/269 (31%)

Query: 676 KLNFTVE---QVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQN 731
           +++  V    +++K       +GKG  GIV+++ +   GEV+AVKK              
Sbjct: 2   RVDRHVLRKYELVK------KLGKGAYGIVWKSIDRRTGEVVAVKK-------------- 41

Query: 732 DKIGIGGVRDSFSA---------EIKTLGSIR-HKNIVRFLGCCWNRNTR--LLMYDYMP 779
                  + D+F           EI  L  +  H+NIV  L      N R   L++DYM 
Sbjct: 42  -------IFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM- 93

Query: 780 NGSLGSLLHE--RRDSCLEWELRYRI--ILGAAQGLAYLHHDCVPPIVHRDIKANNILIG 835
                + LH   R +       +Y +  ++   + + YLH   +   +HRD+K +NIL+ 
Sbjct: 94  ----ETDLHAVIRANILEPVHKQYVVYQLI---KVIKYLHSGGL---LHRDMKPSNILLN 143

Query: 836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG-------------------YIAPE--- 873
            E    +ADFGL++  V      ++  ++ +                     Y APE   
Sbjct: 144 AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL 203

Query: 874 --YGYMMKITEKSDVYSYGVVVLEVLTGK 900
               Y    T+  D++S G ++ E+L GK
Sbjct: 204 GSTKY----TKGIDMWSLGCILGEILCGK 228

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 26/84 (30%), Positives = 38/84 (45%), Gaps = 3/84 (3%)

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG 477
             L L  N     +P  L++   L ++D+S N+   L  +SF  +  L  LILS N    
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91

Query: 478 AIPSSL-GRCESLQSLDLSSNKLS 500
            IP       +SL+ L L  N +S
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS 115

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 4/89 (4%)

Query: 411 FGNCTQLQMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLI 469
             N   L +++LSNN +  TL +   +++T+L  L +S N+   + P +F  L SL  L 
Sbjct: 50  LSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLS 108

Query: 470 LSKNSFSGAIP-SSLGRCESLQSLDLSSN 497
           L  N  S  +P  +     +L  L + +N
Sbjct: 109 LHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 25/118 (21%)

Query: 277 DLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP-VLSNATSLLQLQLDTNQIS--- 332
            L  N F+  +P+   N   L  + LSNN IS ++     SN T LL L L  N++    
Sbjct: 37  YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIP 94

Query: 333 --VFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLF-QLQNLTKLLLISN 387
              F    + L           +SL  + L  N ++  +  G F  L  L+ L + +N
Sbjct: 95  PRTF----DGL-----------KSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 44/242 (18%), Positives = 76/242 (31%), Gaps = 36/242 (14%)

Query: 225 LVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFS 284
           ++      + +   L       +     L         +   +  C  L+ + L     S
Sbjct: 72  VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLS 131

Query: 285 GSLPQSFGNLSSLEELMLSN-NNIS-GSIPPVLSNATSLLQL------QLDTNQISVFFA 336
             +  +    S+L  L LS  +  S  ++  +LS+ + L +L            + V  A
Sbjct: 132 DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA 191

Query: 337 WQN------KLEG--------SIPSTLANCRSLEAVDLSH-NALTGSLHPGLFQLQNLTK 381
             +       L G         + + +  C +L  +DLS    L        FQL  L  
Sbjct: 192 HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 251

Query: 382 LLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRL 441
           L L               C  +I   L+  G    L+ L +      GTL     +L  L
Sbjct: 252 LSL-------------SRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL 298

Query: 442 QV 443
           Q+
Sbjct: 299 QI 300

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 39/249 (15%), Positives = 77/249 (30%), Gaps = 25/249 (10%)

Query: 270 CKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTN 329
           CK    +    + +             +   +LS   I+   P    +   L +      
Sbjct: 36  CKRWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQ-PLAEHFSPFR 94

Query: 330 QISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLL----- 384
              +  +       ++   L+ C  L+ + L    L+  +   L +  NL +L L     
Sbjct: 95  VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG 154

Query: 385 --------ISNGISGLIPPEIGNCSSL--IRLRLMSFGNCTQLQMLNLSNNTLG---GTL 431
                   + +  S L    +  C       +++        +  LNLS          L
Sbjct: 155 FSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDL 214

Query: 432 PSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRL---ILSK-NSFSGAIPSSLGRCE 487
            + +     L  LD+S +  +    + F +   LN L    LS+           LG   
Sbjct: 215 STLVRRCPNLVHLDLSDSVMLK--NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 272

Query: 488 SLQSLDLSS 496
           +L++L +  
Sbjct: 273 TLKTLQVFG 281

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 56/296 (18%), Positives = 102/296 (34%), Gaps = 40/296 (13%)

Query: 134 FDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKV-AGSLP 192
            D       P   G+L++  VI     +    +   E      +  + L+++ +   +L 
Sbjct: 52  LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLH 111

Query: 193 ASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSG----------SLPRE 242
             L + SKLQ+LS+    LS  I   +   S LV L     +LSG          +L   
Sbjct: 112 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL-----NLSGCSGFSEFALQTLLSS 166

Query: 243 LGKLQKLEKMLLWQNNF-DGAIPEEIG-NCKSLKTIDLS---LNFFSGSLPQSFGNLSSL 297
             +L +L   L W  +F +  +   +    +++  ++LS    N     L        +L
Sbjct: 167 CSRLDELN--LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 224

Query: 298 EELMLSN-NNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLE 356
             L LS+   +             L  L L         +    +       L    +L+
Sbjct: 225 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSL---------SRCYDIIPETLLELGEIPTLK 275

Query: 357 AVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSS----LIRLRL 408
            + +      G+L       + L  L +  +  + +  P IGN  +     I+ RL
Sbjct: 276 TLQVFGIVPDGTLQ---LLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKCRL 328

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 45.3 bits (107), Expect = 7e-05
 Identities = 39/174 (22%), Positives = 62/174 (35%), Gaps = 26/174 (14%)

Query: 413 NCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDIS-----VNQFVGLIPESFGQLASLNR 467
            C++LQ L+L    L   + ++LA  + L  L++S         +  +  S  +L  LN 
Sbjct: 116 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELN- 174

Query: 468 LI----LSKNSFSGAIPSSLGRCESLQSLDLS--SNKLSGKIPVELFE----IEGLDISL 517
           L      ++     A+       E++  L+LS     L       L      +      L
Sbjct: 175 LSWCFDFTEKHVQVAVAHV---SETITQLNLSGYRKNLQKSDLSTLVRRCPNLV----HL 227

Query: 518 NLSW-NALSGAIPPQISALNKLSILDLSHNKLGGD--LLALSGLDNLVSLNVSY 568
           +LS    L      +   LN L  L LS         LL L  +  L +L V  
Sbjct: 228 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 34/119 (28%), Positives = 53/119 (44%), Gaps = 17/119 (14%)

Query: 359 DLSHNALTGSLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQL 417
            L+ N L      GLF +L +L KL L  N ++G+  P               F   + +
Sbjct: 35  LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI-EPNA-------------FEGASHI 80

Query: 418 QMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF 475
           Q L L  N +   + + +   L +L+ L++  NQ   ++P SF  L SL  L L+ N F
Sbjct: 81  QELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 35/134 (26%), Positives = 54/134 (40%), Gaps = 27/134 (20%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQS--FGNLSSLEELMLSNNNISGSIPP-VLSNA 318
            IP +I        + L+ N     +     FG L  L +L L  N ++  I P     A
Sbjct: 22  EIPRDIPL--HTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA 77

Query: 319 TSLLQLQLDTNQISVFFAWQNKLEGSIPS----TLANCRSLEAVDLSHNALTGSLHPGLF 374
           + + +LQL  N+I             I +     L   ++L   +L  N ++  + PG F
Sbjct: 78  SHIQELQLGENKIK-----------EISNKMFLGLHQLKTL---NLYDNQIS-CVMPGSF 122

Query: 375 -QLQNLTKLLLISN 387
             L +LT L L SN
Sbjct: 123 EHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 23/85 (27%), Positives = 39/85 (45%), Gaps = 3/85 (3%)

Query: 418 QMLNLSNNTLGGTLPSSL-ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS 476
             L L++N LG      L   L  L  L++  NQ  G+ P +F   + +  L L +N   
Sbjct: 32  TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91

Query: 477 GAIPSSL-GRCESLQSLDLSSNKLS 500
             I + +      L++L+L  N++S
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQIS 115

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 13/41 (31%), Positives = 21/41 (51%), Gaps = 5/41 (12%)

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEP--YIADFGLAK 849
           L +LH +     VH ++ A NI + PE +    +A +G A 
Sbjct: 172 LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 17/41 (41%), Positives = 25/41 (60%), Gaps = 5/41 (12%)

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEP--YIADFGLAK 849
           L Y+H +     VH DIKA N+L+G +     Y+AD+GL+ 
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.6 bits (116), Expect = 6e-06
 Identities = 16/41 (39%), Positives = 23/41 (56%), Gaps = 5/41 (12%)

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEP--YIADFGLAK 849
           L Y+H       VH DIKA+N+L+  +     Y+ D+GLA 
Sbjct: 165 LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 46/235 (19%), Positives = 85/235 (36%), Gaps = 53/235 (22%)

Query: 692 SVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
             +G G    V+ A+ M N   +A+K +           + DK       ++   EIK L
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-----------RGDK----VYTEAAEDEIKLL 69

Query: 751 GSIR-----------HKNIVRFLGCCWNRNTRL----LMYDYMPNGSLGSLLHERRDSCL 795
             +              +I++ L    ++        ++++ +   +L +L+ +     +
Sbjct: 70  QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI 128

Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY------IADFGLAK 849
                 +I      GL Y+H  C   I+H DIK  N+L+     P       IAD G A 
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186

Query: 850 LVVEGDFARSSNTVAGSYGYIAPE----YGYMMKITEKSDVYSYGVVVLEVLTGK 900
              E            +  Y +PE      +        D++S   ++ E++TG 
Sbjct: 187 WYDE-----HYTNSIQTREYRSPEVLLGAPWGCGA----DIWSTACLIFELITGD 232

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 45.7 bits (108), Expect = 5e-05
 Identities = 44/262 (16%), Positives = 67/262 (25%), Gaps = 79/262 (30%)

Query: 782 SLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE---- 837
            L   + +     L      +II    QGL YLH  C   I+H DIK  NIL+       
Sbjct: 130 HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187

Query: 838 -------------------------------------FEPYIADFGLAKLVVEGDFARSS 860
                                                 EP  A+    K+   G+     
Sbjct: 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247

Query: 861 NTVAG---SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL------ 911
                   +  Y + E          +D++S   +  E+ TG    +P   E        
Sbjct: 248 KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307

Query: 912 --HIV-------------------------DWVRQKRGAIEVLDKSLRARPEVEIEEMLQ 944
              I+                         D     +     L + L  + E   EE   
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367

Query: 945 TLGVALLCVNPTPDDRPTMKDV 966
                L  +   P+ R T  + 
Sbjct: 368 FTDFLLPMLELIPEKRATAAEC 389

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 31/172 (18%), Positives = 57/172 (33%), Gaps = 46/172 (26%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G G  G +   + +   E +A+K           +    +            E +    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIK----------LEPMKSR------APQLHLEYRFYKQ 60

Query: 753 IRH-KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR------IIL 805
           +     I +            ++ +      LG  L +  D C       R      +++
Sbjct: 61  LGSGDGIPQVYYFGPCGKYNAMVLEL-----LGPSLEDLFDLC------DRTFSLKTVLM 109

Query: 806 GAAQGLA---YLHHDCVPPIVHRDIKANNILIGPEFEP-----YIADFGLAK 849
            A Q ++   Y+H      +++RD+K  N LIG          +I DF LAK
Sbjct: 110 IAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 55/249 (22%), Positives = 87/249 (34%), Gaps = 68/249 (27%)

Query: 692 SVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S++GKG  G V +A      E +A+K +           +N K       +    E++ L
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII-----------KNKKA----FLNQAQIEVRLL 104

Query: 751 GSIRH------KNIVRFLGCCWNRN-----TRLL---MYDYM-PNGSLG-SLLHERRDSC 794
             +          IV        RN       +L   +YD +      G SL   R+   
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK--- 161

Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
                           L +L    +  I+H D+K  NIL+       I      K+V   
Sbjct: 162 --------FAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAI------KIV--- 203

Query: 855 DFARSSNTVAGSYGYI------APE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           DF  S       Y YI      +PE      Y + I    D++S G +++E+ TG+ P+ 
Sbjct: 204 DFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAI----DMWSLGCILVEMHTGE-PLF 258

Query: 905 PTIPEGLHI 913
               E   +
Sbjct: 259 SGANEVDQM 267

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.1 bits (107), Expect = 9e-05
 Identities = 58/240 (24%), Positives = 89/240 (37%), Gaps = 64/240 (26%)

Query: 691 DSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
             V+GKG  G V +A   +  + +A+K +           +N+K          + EI+ 
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMV-----------RNEKR----FHRQAAEEIRI 146

Query: 750 LGSIRHK------NIVRFLGCCWNRN-----TRLLMYDYMPNGSLGSLLHERRDSCLEWE 798
           L  +R +      N++  L     RN       LL        +L  L+ + +       
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM------NLYELIKKNKFQGFSLP 200

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI--ADFGLAKLVVEGDF 856
           L  +      Q L  LH      I+H D+K  NIL+  +    I   DFG +        
Sbjct: 201 LVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE----- 252

Query: 857 ARSSNTVAGSYGYI------APE----YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 906
                 V   Y YI      APE      Y M I    D++S G ++ E+LTG  P+ P 
Sbjct: 253 ---HQRV---YTYIQSRFYRAPEVILGARYGMPI----DMWSLGCILAELLTGY-PLLPG 301

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 17/122 (13%), Positives = 44/122 (36%), Gaps = 20/122 (16%)

Query: 342 EGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLL-----ISNGISGLIPPE 396
              +P+   +   ++A+D + + +       +  LQ + K+ L     I +G    +   
Sbjct: 50  YNHLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQL 109

Query: 397 IGNCSSLIRLR-----------LMSFGNCTQLQMLNLSNNT----LGGTLPSSLASLTRL 441
                S++ +            +++  +   L+ L LS+          + +   SL  L
Sbjct: 110 ENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLPGVKEKEKIVQAFKTSLPSL 169

Query: 442 QV 443
           ++
Sbjct: 170 EL 171

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.3 bits (100), Expect = 5e-04
 Identities = 33/167 (19%), Positives = 60/167 (35%), Gaps = 36/167 (21%)

Query: 694 VGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
           +G+G  G+++    + N + +A+K          ++ +               E +T   
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIK----------FEPRRSD------APQLRDEYRTYKL 61

Query: 753 IRH-KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA--- 808
           +     I             +L+ D      LG  L +  D C   +   + +  AA   
Sbjct: 62  LAGCTGIPNVYYFGQEGLHNVLVIDL-----LGPSLEDLLDLCGR-KFSVKTVAMAAKQM 115

Query: 809 -QGLAYLHHDCVPPIVHRDIKANNILIGPEFEP-----YIADFGLAK 849
              +  +H      +V+RDIK +N LIG          Y+ DFG+ K
Sbjct: 116 LARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	1035
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.98
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.94
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.94
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.93
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.93
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.91
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.91
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.91
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.91
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.9
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.89
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.89
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.88
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.88
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.86
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.86
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.86
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.86
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.86
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.85
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.85
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.85
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.85
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.84
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.83
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.81
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.81
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.81
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.79
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.77
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.77
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.76
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.76
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.75
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.75
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.75
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.75
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.75
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.75
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.74
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.73
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.73
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.71
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.7
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.69
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.69
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.69
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.67
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.66
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.64
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.6
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.59
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.59
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.56
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.55
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.55
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.54
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.52
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.51
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.5
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.5
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.48
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.45
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.43
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.41
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.39
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.36
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.35
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.33
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.29
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.21
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.18
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.17
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.17
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.14
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.99
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.91
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.89
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.86
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.85
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.84
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.62
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.6
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.45
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.33
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.33
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.32
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.27
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.26
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.26
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.21
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.16
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.14
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.84
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.84
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.82
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.6
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.46
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.21
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.06
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.03
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.01
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.98
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.85
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.85
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.81
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.69
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.58
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.36
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.19
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.11
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.2
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.84
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.56
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.02
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.92
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.67

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4.7e-77  Score=744.43  Aligned_cols=595  Identities=35%  Similarity=0.550  Sum_probs=470.3

Q ss_pred             CCCcccCCCCCCCCCCccceeEEeCCCCcEEEEEecCCccccc---CCcC-----------------------CCCCccc
Q 039419            3 SIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELP---FPSN-----------------------LSSLSFL   56 (1035)
Q Consensus         3 ~~~~~l~~w~~~~~~~c~w~gi~c~~~~~v~~l~~~~~~~~~~---~~~~-----------------------~~~l~~L   56 (1035)
                      .+|.+|++|+.+ .+||+|+||+|+ .++|++|+++++++.|.   +|+.                       ++.+++|
T Consensus        25 ~~~~~l~~W~~~-~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L  102 (768)
T 3rgz_A           25 PDKNLLPDWSSN-KNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASL  102 (768)
T ss_dssp             SCTTSSTTCCTT-SCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEECCCCCCCCTTC
T ss_pred             CCcccccCCCCC-CCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCCCchhhccCCCC
Confidence            367789999854 589999999999 78999999999999887   5554                       4555555


Q ss_pred             ceEeecCcccCCCCCC--CCCCCCCCceeeCCCCCCCCCCChhh-hccccccceEecccCCCCCCchh---hhhhccccc
Q 039419           57 QKLIISGSNLTGPISP--DLGDCTQLTTIDVSSNSLVGGVPSSI-GKLINLQDLILNSNQLTGEIPKE---LGACIKLKN  130 (1035)
Q Consensus        57 ~~L~L~~~~l~~~~~~--~~~~l~~L~~L~ls~n~l~~~~p~~i-~~l~~L~~L~L~~n~l~~~~p~~---l~~l~~L~~  130 (1035)
                      ++|+|++|.++|.+|.  .++.+++|++|+|++|.+.+.+|..+ .++++|++|+|++|++++..|..   +..+++|++
T Consensus       103 ~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~  182 (768)
T 3rgz_A          103 TSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKH  182 (768)
T ss_dssp             CEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCE
T ss_pred             CEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCE
Confidence            5555555555555554  55555555555555555555555443 45555555555555555444444   455555555


Q ss_pred             eeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccc
Q 039419          131 LLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTM  210 (1035)
Q Consensus       131 L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~  210 (1035)
                      |++++|.+.+..|.  +.+++|++|++++|. +.+.+|. ++.+++|++|++++|.+.+..|..++.+++|++|++++|.
T Consensus       183 L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~-l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~  258 (768)
T 3rgz_A          183 LAISGNKISGDVDV--SRCVNLEFLDVSSNN-FSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ  258 (768)
T ss_dssp             EECCSSEEESCCBC--TTCTTCCEEECCSSC-CCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSC
T ss_pred             EECCCCcccccCCc--ccCCcCCEEECcCCc-CCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCc
Confidence            55555555543332  566677777777665 4444554 7777777777777777777777777777777777777777


Q ss_pred             cccCCccccccCcCCceEEecCCcCCCCCChhhhcc-cchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCc
Q 039419          211 LSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKL-QKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQ  289 (1035)
Q Consensus       211 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~  289 (1035)
                      +.+.+|..  .+++|++|+|++|.+++.+|..+..+ ++|++|++++|++.+.+|..|+++++|++|+|++|++++.+|.
T Consensus       259 l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~  336 (768)
T 3rgz_A          259 FVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM  336 (768)
T ss_dssp             CEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCH
T ss_pred             ccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCH
Confidence            77666654  66777777777777777777777664 7788888888888777788888888888888888888766665


Q ss_pred             c-ccCCCCCcEEEccCCccccCCCCcccCCC-ccceeccccchhh----------------hhhhhccccCCCCCcCCCC
Q 039419          290 S-FGNLSSLEELMLSNNNISGSIPPVLSNAT-SLLQLQLDTNQIS----------------VFFAWQNKLEGSIPSTLAN  351 (1035)
Q Consensus       290 ~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~----------------~l~~~~n~l~~~~p~~l~~  351 (1035)
                      . |.++++|++|++++|++.+..|..+.+++ +|++|++++|+++                .+...+|.+.+.+|..+.+
T Consensus       337 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~  416 (768)
T 3rgz_A          337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN  416 (768)
T ss_dssp             HHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGG
T ss_pred             HHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhc
Confidence            4 77888888888888888777777777776 7888888777653                2334456777788899999


Q ss_pred             CCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeee----------ccCCCCccceee
Q 039419          352 CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLM----------SFGNCTQLQMLN  421 (1035)
Q Consensus       352 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~----------~~~~l~~L~~L~  421 (1035)
                      +++|++|+|++|.+++..|..+..+++|++|++++|++++.+|..+..+++|+.|++.          .|.++++|++|+
T Consensus       417 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  496 (768)
T 3rgz_A          417 CSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS  496 (768)
T ss_dssp             CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred             CCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEE
Confidence            9999999999999998999999999999999999999999999999999999999874          367789999999


Q ss_pred             cCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccc-------------------
Q 039419          422 LSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSS-------------------  482 (1035)
Q Consensus       422 L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------------  482 (1035)
                      |++|++++.+|.++..+++|++|+|++|++++.+|..+..+++|+.|++++|++++.+|..                   
T Consensus       497 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~  576 (768)
T 3rgz_A          497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV  576 (768)
T ss_dssp             CCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEE
T ss_pred             ccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccc
Confidence            9999999999999999999999999999999999999999999999999999988766653                   


Q ss_pred             ---------------------------------------------------cCCCCCCcEEEcCCCcCcCccchhhhhhc
Q 039419          483 ---------------------------------------------------LGRCESLQSLDLSSNKLSGKIPVELFEIE  511 (1035)
Q Consensus       483 ---------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  511 (1035)
                                                                         +..+++|++|||++|+++|.+|..+..+.
T Consensus       577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~  656 (768)
T 3rgz_A          577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP  656 (768)
T ss_dssp             EEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCT
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccc
Confidence                                                               34467899999999999999999999888


Q ss_pred             cCcceeeccCccCCCCCCccccCCccccEEeccCCcccC-ccccccccCCCcEEeccCCcCcccCCChhhhhcccccccc
Q 039419          512 GLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMA  590 (1035)
Q Consensus       512 ~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~  590 (1035)
                      .+. .|+|++|+++|.+|..|+.+++|++|||++|++++ .|..+..+++|++|+|++|+|+|.+|....|.++....+.
T Consensus       657 ~L~-~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~  735 (768)
T 3rgz_A          657 YLF-ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFL  735 (768)
T ss_dssp             TCC-EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGC
T ss_pred             cCC-EEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhc
Confidence            776 79999999999999999999999999999999997 4578999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCcCC
Q 039419          591 GNQGLCSRGHESCFLS  606 (1035)
Q Consensus       591 ~N~~~c~~~~~~c~~~  606 (1035)
                      ||+++||.|...|...
T Consensus       736 gN~~Lcg~~l~~C~~~  751 (768)
T 3rgz_A          736 NNPGLCGYPLPRCDPS  751 (768)
T ss_dssp             SCTEEESTTSCCCCSC
T ss_pred             CCchhcCCCCcCCCCC
Confidence            9999999998888654

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.8e-62  Score=612.77  Aligned_cols=538  Identities=33%  Similarity=0.477  Sum_probs=480.6

Q ss_pred             cccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCCh--hhhccccccceEecccCCCCCCchhh-hhhccccc
Q 039419           54 SFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPS--SIGKLINLQDLILNSNQLTGEIPKEL-GACIKLKN  130 (1035)
Q Consensus        54 ~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~--~i~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~  130 (1035)
                      ++|+.++++.+.+. .+|+.++.+++|++|||++|.+.|.+|.  .++++++|++|+|++|.+++.+|..+ ..+++|++
T Consensus        77 ~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~  155 (768)
T 3rgz_A           77 TGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV  155 (768)
T ss_dssp             TTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSE
T ss_pred             CcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCE
Confidence            34555555555554 3568899999999999999999988998  99999999999999999998888776 88999999


Q ss_pred             eeccccccCCCCchh---hccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeec
Q 039419          131 LLLFDNYLSGNLPVE---LGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVY  207 (1035)
Q Consensus       131 L~l~~n~l~~~~p~~---l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~  207 (1035)
                      |+|++|.+++..|..   ++++++|++|++++|. +.+..+  +..+++|++|++++|.+.+..|. ++++++|++|+++
T Consensus       156 L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls  231 (768)
T 3rgz_A          156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNK-ISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDIS  231 (768)
T ss_dssp             EECCSSCCEEETHHHHHHTTCCTTCCEEECCSSE-EESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECC
T ss_pred             EECCCCccCCcCChhhhhhccCCCCCEEECCCCc-ccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECc
Confidence            999999999888877   8899999999999997 444444  38899999999999999988887 9999999999999


Q ss_pred             ccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCC-CCCcEEEccCccCCCC
Q 039419          208 TTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNC-KSLKTIDLSLNFFSGS  286 (1035)
Q Consensus       208 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l-~~L~~L~L~~n~l~~~  286 (1035)
                      +|.+++.+|..+.++++|++|+|++|.+++.+|..  .+++|++|++++|++.+.+|..+..+ ++|++|+|++|++++.
T Consensus       232 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~  309 (768)
T 3rgz_A          232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA  309 (768)
T ss_dssp             SSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEEC
T ss_pred             CCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCc
Confidence            99999999999999999999999999999887765  89999999999999999999998875 9999999999999999


Q ss_pred             CCccccCCCCCcEEEccCCccccCCCCc-ccCCCccceeccccchhh---------------hhhhhccccCCCCCcCCC
Q 039419          287 LPQSFGNLSSLEELMLSNNNISGSIPPV-LSNATSLLQLQLDTNQIS---------------VFFAWQNKLEGSIPSTLA  350 (1035)
Q Consensus       287 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~i~---------------~l~~~~n~l~~~~p~~l~  350 (1035)
                      .|..|+++++|++|+|++|++.+.+|.. |.++++|++|+|++|+++               .+....|.+.+.+|..+.
T Consensus       310 ~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~  389 (768)
T 3rgz_A          310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLC  389 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTT
T ss_pred             cchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhh
Confidence            9999999999999999999999777765 999999999999999875               122345777777888777


Q ss_pred             C--CCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeee----------ccCCCCccc
Q 039419          351 N--CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLM----------SFGNCTQLQ  418 (1035)
Q Consensus       351 ~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~----------~~~~l~~L~  418 (1035)
                      .  +++|++|++++|.+++.+|..+..+++|++|++++|++++..|..++.+++|+.|++.          .|..+++|+
T Consensus       390 ~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  469 (768)
T 3rgz_A          390 QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE  469 (768)
T ss_dssp             CSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred             hcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCce
Confidence            6  8899999999999998899999999999999999999999999999999999999974          366789999


Q ss_pred             eeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCc
Q 039419          419 MLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK  498 (1035)
Q Consensus       419 ~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  498 (1035)
                      +|+|++|++++.+|..+..+++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..+..+++|++|+|++|+
T Consensus       470 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~  549 (768)
T 3rgz_A          470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL  549 (768)
T ss_dssp             EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             EEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCccchhhhhhc-------------------------------------------------------------------
Q 039419          499 LSGKIPVELFEIE-------------------------------------------------------------------  511 (1035)
Q Consensus       499 l~~~~p~~~~~~~-------------------------------------------------------------------  511 (1035)
                      ++|.+|..++...                                                                   
T Consensus       550 l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~  629 (768)
T 3rgz_A          550 FNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD  629 (768)
T ss_dssp             EESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCS
T ss_pred             cCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhh
Confidence            9999998876531                                                                   


Q ss_pred             --cCcceeeccCccCCCCCCccccCCccccEEeccCCcccC-ccccccccCCCcEEeccCCcCcccCCCh-hhhhccccc
Q 039419          512 --GLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDS-KLFRQLSAT  587 (1035)
Q Consensus       512 --~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~l~~~  587 (1035)
                        ..+..|+|++|+++|.+|..++.+++|+.|+|++|++++ .|..+..+++|+.|||++|+++|.+|.. ..+..++.+
T Consensus       630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L  709 (768)
T 3rgz_A          630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI  709 (768)
T ss_dssp             SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred             ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence              123479999999999999999999999999999999997 5578999999999999999999999975 446677888


Q ss_pred             cccccccCCCC
Q 039419          588 EMAGNQGLCSR  598 (1035)
Q Consensus       588 ~~~~N~~~c~~  598 (1035)
                      ++.+|+..-..
T Consensus       710 ~ls~N~l~g~i  720 (768)
T 3rgz_A          710 DLSNNNLSGPI  720 (768)
T ss_dssp             ECCSSEEEEEC
T ss_pred             ECcCCcccccC
Confidence            99999865433

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.4e-58  Score=572.82  Aligned_cols=571  Identities=21%  Similarity=0.142  Sum_probs=410.3

Q ss_pred             ccceeEEeCCC----------CcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCC
Q 039419           19 CKWSHITCSPQ----------NFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSN   88 (1035)
Q Consensus        19 c~w~gi~c~~~----------~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n   88 (1035)
                      |.++-|.|+..          ..++.|+++++++.+..+..+.++++|++|+|++|.+++..|..++.+++|++|+|++|
T Consensus         4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n   83 (680)
T 1ziw_A            4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN   83 (680)
T ss_dssp             CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred             eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence            55555666432          25677778877777766667777888888888888777766777777788888888888


Q ss_pred             CCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCC
Q 039419           89 SLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIP  168 (1035)
Q Consensus        89 ~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~  168 (1035)
                      ++++..+..|+.+++|++|+|++|++++..|..++.+++|++|+|++|.+++..|..++++++|++|++++|. +.+..+
T Consensus        84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~  162 (680)
T 1ziw_A           84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK-IQALKS  162 (680)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSC-CCCBCH
T ss_pred             ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCc-ccccCH
Confidence            7774444467778888888888887775555677777888888888887777677777778888888887775 333333


Q ss_pred             CcC--CCccceEEEEeccccccccCcccccccccccceeecccccccCCccccc---cCcCCceEEecCCcCCCCCChhh
Q 039419          169 YEI--GDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIG---NCSELVDLFLYENDLSGSLPREL  243 (1035)
Q Consensus       169 ~~~--~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~---~l~~L~~L~L~~n~l~~~~~~~l  243 (1035)
                      ..+  ..+++|+.|++++|.+.+..|..+..+.+|+.|++.++.+.+.....+.   ..++|+.|++++|.+++..|..|
T Consensus       163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~  242 (680)
T 1ziw_A          163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF  242 (680)
T ss_dssp             HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred             HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence            333  2457778888888877777777777666655555555444321111111   12556666666666666666666


Q ss_pred             hcccc--hhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCcccc---------CCC
Q 039419          244 GKLQK--LEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG---------SIP  312 (1035)
Q Consensus       244 ~~l~~--L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~---------~~~  312 (1035)
                      ..++.  |++|++++|++.+..|..|..+++|++|+|++|++++..|..|.++++|++|++++|...+         +..
T Consensus       243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~  322 (680)
T 1ziw_A          243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD  322 (680)
T ss_dssp             GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred             hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence            66654  6667777776666666666666677777777776666666666666666666666654332         111


Q ss_pred             CcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCC--CCCCcccC--cccceEeccccc
Q 039419          313 PVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS--LHPGLFQL--QNLTKLLLISNG  388 (1035)
Q Consensus       313 ~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~~~~~~~l--~~L~~L~L~~N~  388 (1035)
                      ..|..+++|++|++++|+|+.          ..+..|.++++|++|++++|.+...  ....|..+  ++|+.|++++|+
T Consensus       323 ~~~~~l~~L~~L~l~~n~l~~----------~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~  392 (680)
T 1ziw_A          323 FSFQWLKCLEHLNMEDNDIPG----------IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK  392 (680)
T ss_dssp             TTTTTCTTCCEEECCSCCBCC----------CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSC
T ss_pred             hhcccCCCCCEEECCCCccCC----------CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCC
Confidence            255666666666666665542          3345566666666666666654321  12222222  456666666666


Q ss_pred             cccCCCCCCCCCCcceeEeee-----------ccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccC--CCC
Q 039419          389 ISGLIPPEIGNCSSLIRLRLM-----------SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFV--GLI  455 (1035)
Q Consensus       389 i~~~~~~~~~~l~~L~~L~~~-----------~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~--~~~  455 (1035)
                      +++..|..+..+++|+.|++.           .|.++++|++|++++|++++..+..|..+++|+.|++++|.+.  +..
T Consensus       393 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  472 (680)
T 1ziw_A          393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSS  472 (680)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCS
T ss_pred             CCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccC
Confidence            666666666666666666642           4678899999999999999888999999999999999999987  567


Q ss_pred             chhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccch-------hhhhhccCcceeeccCccCCCCC
Q 039419          456 PESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPV-------ELFEIEGLDISLNLSWNALSGAI  528 (1035)
Q Consensus       456 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-------~~~~~~~l~~~L~Ls~N~l~~~~  528 (1035)
                      |..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++..+.       ..+.....+..|+|++|+++.+.
T Consensus       473 p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~  552 (680)
T 1ziw_A          473 PSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP  552 (680)
T ss_dssp             SCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCC
Confidence            88999999999999999999988888899999999999999999843211       11233334458999999999877


Q ss_pred             CccccCCccccEEeccCCcccCccc-cccccCCCcEEeccCCcCcccCCChh--hhhccccccccccccCCCCCC
Q 039419          529 PPQISALNKLSILDLSHNKLGGDLL-ALSGLDNLVSLNVSYNNFTGYLPDSK--LFRQLSATEMAGNQGLCSRGH  600 (1035)
Q Consensus       529 ~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~ls~N~l~~~~p~~~--~~~~l~~~~~~~N~~~c~~~~  600 (1035)
                      +..|..+++|++|+|++|+|++.+. .|..+++|+.|+|++|+|++.+|...  .+.+++.+++.+|||.|+|+.
T Consensus       553 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             HHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            7889999999999999999999775 57899999999999999999877632  578899999999999999864

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.9e-54  Score=535.77  Aligned_cols=538  Identities=23%  Similarity=0.228  Sum_probs=441.9

Q ss_pred             CcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEe
Q 039419           30 NFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLIL  109 (1035)
Q Consensus        30 ~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L  109 (1035)
                      ..++.|+++++.+.+..|..+.++++|++|+|++|.+++..+..|+.+++|++|+|++|++++..|..|+++++|++|+|
T Consensus        49 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  128 (680)
T 1ziw_A           49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL  128 (680)
T ss_dssp             TTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEEC
T ss_pred             CcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEEC
Confidence            36889999999999988999999999999999999999544457999999999999999999777789999999999999


Q ss_pred             cccCCCCCCchhhhhhccccceeccccccCCCCchhhc--cccccceeecCCCcccCCCCCCcCCCccceEEEEeccccc
Q 039419          110 NSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELG--KLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKV  187 (1035)
Q Consensus       110 ~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~--~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  187 (1035)
                      ++|.+++..|..++.+++|++|++++|.+++..+..++  .+++|++|++++|. +.+..|..+..+.+|+.|++.++.+
T Consensus       129 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~l~~~~l  207 (680)
T 1ziw_A          129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ-IKEFSPGCFHAIGRLFGLFLNNVQL  207 (680)
T ss_dssp             CSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCC-CCCBCTTGGGGSSEECEEECTTCCC
T ss_pred             CCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCc-ccccChhhhhhhhhhhhhhcccccc
Confidence            99999988888899999999999999999977777665  55899999999996 6667788888899999998888877


Q ss_pred             cccCccccc---ccccccceeecccccccCCccccccCcC--CceEEecCCcCCCCCChhhhcccchhHhhccccccccc
Q 039419          188 AGSLPASLG---KLSKLQSLSVYTTMLSGEIPPQIGNCSE--LVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGA  262 (1035)
Q Consensus       188 ~~~~p~~l~---~l~~L~~L~l~~n~l~~~~p~~l~~l~~--L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~  262 (1035)
                      .+.....+.   ..++|++|++++|.+.+..|..+..++.  |+.|+|++|.+++..|..|+.+++|++|++++|++.+.
T Consensus       208 ~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  287 (680)
T 1ziw_A          208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL  287 (680)
T ss_dssp             HHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEE
T ss_pred             ChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCcc
Confidence            644333222   3478888999999888888888888765  89999999988887788888888999999999988888


Q ss_pred             CCccccCCCCCcEEEccCccCCC-----CCC----ccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhh
Q 039419          263 IPEEIGNCKSLKTIDLSLNFFSG-----SLP----QSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISV  333 (1035)
Q Consensus       263 ~p~~~~~l~~L~~L~L~~n~l~~-----~~~----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~  333 (1035)
                      .|..|.++++|+.|++++|...+     .+|    ..|..+++|++|++++|++.+..+..|.++++|++|++++|.++.
T Consensus       288 ~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~  367 (680)
T 1ziw_A          288 FSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL  367 (680)
T ss_dssp             CTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCC
T ss_pred             ChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhh
Confidence            88888888899999988875543     122    267888889999999998888888888888899999988886431


Q ss_pred             hhhhccccCCCCCcCCCCC--CCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCC-CCCCCCCcceeEeee-
Q 039419          334 FFAWQNKLEGSIPSTLANC--RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIP-PEIGNCSSLIRLRLM-  409 (1035)
Q Consensus       334 l~~~~n~l~~~~p~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~~~-  409 (1035)
                      .        ...+..|..+  ++|+.|++++|++++..+..|..+++|+.|++++|++++.+| ..+..+++|+.|++. 
T Consensus       368 ~--------~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~  439 (680)
T 1ziw_A          368 R--------TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY  439 (680)
T ss_dssp             C--------EECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCS
T ss_pred             h--------hcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCC
Confidence            0        0011222222  466777777777766666666667777777777777665433 456666666666653 


Q ss_pred             ---------ccCCCCccceeecCCCccC--CCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCccccc
Q 039419          410 ---------SFGNCTQLQMLNLSNNTLG--GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGA  478 (1035)
Q Consensus       410 ---------~~~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  478 (1035)
                               .|..+++|+.|++++|.++  +..|..|..+++|++|+|++|+|+++++..|..+++|+.|+|++|++++.
T Consensus       440 n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~  519 (680)
T 1ziw_A          440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL  519 (680)
T ss_dssp             CSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGG
T ss_pred             CCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCcccc
Confidence                     3667889999999999987  57889999999999999999999999999999999999999999999865


Q ss_pred             Cc--------cccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccC
Q 039419          479 IP--------SSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG  550 (1035)
Q Consensus       479 ~~--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  550 (1035)
                      .+        ..|..+++|++|+|++|+|+ .+|...+.....+..|+|++|+++++.+..|..+++|+.|+|++|+|++
T Consensus       520 ~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~  598 (680)
T 1ziw_A          520 WKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS  598 (680)
T ss_dssp             GSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCB
T ss_pred             chhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCc
Confidence            32        23789999999999999998 7887655554555689999999999999999999999999999999999


Q ss_pred             ccc-ccc-ccCCCcEEeccCCcCcccCCC
Q 039419          551 DLL-ALS-GLDNLVSLNVSYNNFTGYLPD  577 (1035)
Q Consensus       551 ~~~-~~~-~l~~L~~L~ls~N~l~~~~p~  577 (1035)
                      .+. .+. .+++|+.|++++|+|.+.++.
T Consensus       599 ~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          599 VEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             CCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cChhHhcccccccCEEEccCCCcccCCcc
Confidence            775 455 789999999999999987764

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=7.5e-55  Score=532.03  Aligned_cols=521  Identities=22%  Similarity=0.242  Sum_probs=345.7

Q ss_pred             cCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhh
Q 039419           45 PFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGA  124 (1035)
Q Consensus        45 ~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~  124 (1035)
                      .+|..+..  .+++|+|++|.|++..|..|+.+++|++|+|++|++.+..|..|+++++|++|+|++|++++..|..++.
T Consensus        26 ~iP~~l~~--~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  103 (606)
T 3t6q_A           26 EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG  103 (606)
T ss_dssp             SCCTTSCT--TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSS
T ss_pred             cCcCCCCC--cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcc
Confidence            45555543  6899999999999877889999999999999999999888999999999999999999999778889999


Q ss_pred             hccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCccccccccccc--
Q 039419          125 CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQ--  202 (1035)
Q Consensus       125 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~--  202 (1035)
                      +++|++|++++|.+++..+..++++++|++|++++|....-..|. +..+++|++|++++|.+.+..|..++.+++|+  
T Consensus       104 l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l  182 (606)
T 3t6q_A          104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK-GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL  182 (606)
T ss_dssp             CTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCT-TCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSE
T ss_pred             cccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCccc-ccCCcccCEEEcccCcccccChhhhhhhccccee
Confidence            999999999999998666788999999999999999732223344 44499999999999999988889999999999  


Q ss_pred             ceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccc-----cccCCccccCCC--CCcE
Q 039419          203 SLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNF-----DGAIPEEIGNCK--SLKT  275 (1035)
Q Consensus       203 ~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l-----~~~~p~~~~~l~--~L~~  275 (1035)
                      +|++++|.+.+..|..+. ..+|+.|++++|.   ..+..+..+.++....+..+.+     ....+..+..+.  +|+.
T Consensus       183 ~L~l~~n~l~~~~~~~~~-~~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~  258 (606)
T 3t6q_A          183 SLNLNGNDIAGIEPGAFD-SAVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVES  258 (606)
T ss_dssp             EEECTTCCCCEECTTTTT-TCEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEE
T ss_pred             EEecCCCccCccChhHhh-hccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeE
Confidence            889999999976666554 4689999999886   2333344433322222221111     111122222222  5666


Q ss_pred             EEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCC
Q 039419          276 IDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSL  355 (1035)
Q Consensus       276 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L  355 (1035)
                      |++++|.+++..+..|+++++|++|++++|+++ .+|..+.++++|++|++++|+++.+          .|..+..+++|
T Consensus       259 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~----------~~~~~~~l~~L  327 (606)
T 3t6q_A          259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENL----------CQISASNFPSL  327 (606)
T ss_dssp             EECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBG----------GGGCGGGCTTC
T ss_pred             EEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcC----------chhhhhccCcC
Confidence            666666666555555666666666666666666 4455566666666666666655432          23455666666


Q ss_pred             cEEeccCcCCCCCCCC-CcccCcccceEeccccccccCC--CCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc
Q 039419          356 EAVDLSHNALTGSLHP-GLFQLQNLTKLLLISNGISGLI--PPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP  432 (1035)
Q Consensus       356 ~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~  432 (1035)
                      ++|++++|.+.+.++. .+..+++|++|++++|.+++..  +..              |.++++|++|++++|++++..|
T Consensus       328 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--------------~~~l~~L~~L~l~~n~l~~~~~  393 (606)
T 3t6q_A          328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ--------------LRNLSHLQSLNLSYNEPLSLKT  393 (606)
T ss_dssp             SEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTT--------------TTTCTTCCEEECCSCSCEEECT
T ss_pred             CEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchh--------------cccCCCCCEEECCCCcCCcCCH
Confidence            6666666666544433 3556666666666666665433  222              3334556666666666665556


Q ss_pred             ccccCCCCccEEEcCCCccCCCCch-hccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCc-cc--hhhh
Q 039419          433 SSLASLTRLQVLDISVNQFVGLIPE-SFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGK-IP--VELF  508 (1035)
Q Consensus       433 ~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p--~~~~  508 (1035)
                      ..|..+++|++|++++|++.+..+. .|..+++|+.|++++|.+++..|..|..+++|++|+|++|++++. ++  ..+.
T Consensus       394 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~  473 (606)
T 3t6q_A          394 EAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQ  473 (606)
T ss_dssp             TTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGG
T ss_pred             HHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhc
Confidence            6666666666666666666655433 356666666666666666655666666666666666666666542 11  2233


Q ss_pred             hhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcc-ccccccCCCcEEeccCCcCcccCCCh-hhhhcccc
Q 039419          509 EIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LALSGLDNLVSLNVSYNNFTGYLPDS-KLFRQLSA  586 (1035)
Q Consensus       509 ~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~l~~  586 (1035)
                      .+..+ ..|++++|.+++..|..|..+++|++|+|++|++++.+ ..+..++.| .|++++|++++.+|.. ..+.+++.
T Consensus       474 ~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~  551 (606)
T 3t6q_A          474 TLGRL-EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRT  551 (606)
T ss_dssp             GCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSE
T ss_pred             cCCCc-cEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCE
Confidence            33332 35666666666666666666666666666666666543 456666666 6666666666655542 34555666


Q ss_pred             ccccccccCCCCC
Q 039419          587 TEMAGNQGLCSRG  599 (1035)
Q Consensus       587 ~~~~~N~~~c~~~  599 (1035)
                      +++.+||+.|.++
T Consensus       552 L~l~~N~~~c~c~  564 (606)
T 3t6q_A          552 INLRQNPLDCTCS  564 (606)
T ss_dssp             EECTTCCEECSGG
T ss_pred             EeCCCCCccccCC
Confidence            6666666666554

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=5e-54  Score=542.13  Aligned_cols=523  Identities=21%  Similarity=0.189  Sum_probs=403.0

Q ss_pred             ecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCC-ChhhhccccccceEecccCCC
Q 039419           37 IQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGV-PSSIGKLINLQDLILNSNQLT  115 (1035)
Q Consensus        37 ~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~-p~~i~~l~~L~~L~L~~n~l~  115 (1035)
                      .++++++ .+|.   -.++|++|+|++|.|++..|..|+.+++|++|+|++|.+.+.+ |..|+++++|++|+|++|.++
T Consensus        11 cs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~   86 (844)
T 3j0a_A           11 YRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY   86 (844)
T ss_dssp             ESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCC
T ss_pred             ccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCc
Confidence            3344554 3444   3467888888888888777778888888888888888655555 677888888888888888888


Q ss_pred             CCCchhhhhhccccceeccccccCCCCchh--hccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcc
Q 039419          116 GEIPKELGACIKLKNLLLFDNYLSGNLPVE--LGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPA  193 (1035)
Q Consensus       116 ~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~--l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~  193 (1035)
                      +..|..++.+++|++|+|++|.+++.+|..  ++++++|++|++++|.......+..++++++|++|++++|.+.+..+.
T Consensus        87 ~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~  166 (844)
T 3j0a_A           87 FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEH  166 (844)
T ss_dssp             EECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSG
T ss_pred             ccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHH
Confidence            777888888888888888888887766665  788888888888888633323345678888888888888888888888


Q ss_pred             ccccc--ccccceeecccccccCCccccccCcC------CceEEecCCcCCCCCChhhhcc---cchhHhhcc-------
Q 039419          194 SLGKL--SKLQSLSVYTTMLSGEIPPQIGNCSE------LVDLFLYENDLSGSLPRELGKL---QKLEKMLLW-------  255 (1035)
Q Consensus       194 ~l~~l--~~L~~L~l~~n~l~~~~p~~l~~l~~------L~~L~L~~n~l~~~~~~~l~~l---~~L~~L~l~-------  255 (1035)
                      .+..+  ++|+.|++++|.+.+..|..++.+.+      |+.|++++|.+++..+..+...   .+++.|.++       
T Consensus       167 ~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~  246 (844)
T 3j0a_A          167 ELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG  246 (844)
T ss_dssp             GGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCS
T ss_pred             HcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccc
Confidence            88877  78888888888888878777776665      8888888888887777776643   455566555       


Q ss_pred             --cccccccCCccccCC--CCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchh
Q 039419          256 --QNNFDGAIPEEIGNC--KSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI  331 (1035)
Q Consensus       256 --~n~l~~~~p~~~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i  331 (1035)
                        .+++.+..+..|..+  ++|+.|+|++|.+.+..+..|..+++|+.|+|++|++.+..+..|.++++|++|+|++|+|
T Consensus       247 ~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l  326 (844)
T 3j0a_A          247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL  326 (844)
T ss_dssp             SSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCC
T ss_pred             ccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCC
Confidence              233333344455554  6899999999999888888889999999999999999888888899999999999998877


Q ss_pred             hhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeecc
Q 039419          332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSF  411 (1035)
Q Consensus       332 ~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~  411 (1035)
                      +.          ..|..|.++++|+.|+|++|.++...+..|..+++|++|+|++|.+++..                  
T Consensus       327 ~~----------~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~------------------  378 (844)
T 3j0a_A          327 GE----------LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH------------------  378 (844)
T ss_dssp             SC----------CCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS------------------
T ss_pred             Cc----------cCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc------------------
Confidence            53          45678888999999999999998777778888999999999999887431                  


Q ss_pred             CCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCc-hhccCccccchhhccCCcccccCcc-ccCCCCCC
Q 039419          412 GNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIP-ESFGQLASLNRLILSKNSFSGAIPS-SLGRCESL  489 (1035)
Q Consensus       412 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L  489 (1035)
                       .+++|+.|++++|+++ .+|..   ..+++.|++++|++++... ..+..+++|+.|+|++|++++..+. .+..+++|
T Consensus       379 -~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L  453 (844)
T 3j0a_A          379 -FIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL  453 (844)
T ss_dssp             -SCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTC
T ss_pred             -CCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCcc
Confidence             2466888899999888 34443   4578889999999887533 3356788899999999998865443 45668889


Q ss_pred             cEEEcCCCcCcCc-----cchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEE
Q 039419          490 QSLDLSSNKLSGK-----IPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSL  564 (1035)
Q Consensus       490 ~~L~Ls~N~l~~~-----~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L  564 (1035)
                      ++|+|++|.+++.     .+..+..+ ..+..|+|++|+|++..|..|..+++|++|+|++|+|++.+..... ++|+.|
T Consensus       454 ~~L~Ls~N~l~~~~~~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L  531 (844)
T 3j0a_A          454 EQLFLGENMLQLAWETELCWDVFEGL-SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEIL  531 (844)
T ss_dssp             CBCEEESCCCSSSCCSCCCSSCSSCB-CCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEE
T ss_pred             ccccCCCCccccccccccchhhhcCc-ccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEE
Confidence            9999999988732     22333333 3345789999999988888899999999999999999887654333 889999


Q ss_pred             eccCCcCcccCCChhhhhccccccccccccCCCCCC
Q 039419          565 NVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGH  600 (1035)
Q Consensus       565 ~ls~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~~  600 (1035)
                      +|++|+|++.+|..  |.++..+++.+||+.|.|+.
T Consensus       532 ~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          532 DISRNQLLAPNPDV--FVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             EEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSC
T ss_pred             ECCCCcCCCCChhH--hCCcCEEEecCCCccccccc
Confidence            99999999888864  67888888999999997763

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.4e-54  Score=529.53  Aligned_cols=496  Identities=23%  Similarity=0.203  Sum_probs=334.3

Q ss_pred             cccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceec
Q 039419           54 SFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLL  133 (1035)
Q Consensus        54 ~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l  133 (1035)
                      ++|++|+|++|.+++..+..|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++.+++|++|+|
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            45555555555555444445555555555555555555444555555555555555555555444555555555555555


Q ss_pred             cccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCccccccccccc----ceeeccc
Q 039419          134 FDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQ----SLSVYTT  209 (1035)
Q Consensus       134 ~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~----~L~l~~n  209 (1035)
                      ++|.+++..+..++++++|++|++++|......+|..++++++|+.|++++|.+++..|..++.+++|+    +|++++|
T Consensus       112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n  191 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN  191 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred             cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence            555555433345555555555555555422224455555555555555555555555555555555443    4555555


Q ss_pred             ccccCCccccccCcCCceEEecCCcCC-CCCChhhhcccchhH--------------------------------hhc-c
Q 039419          210 MLSGEIPPQIGNCSELVDLFLYENDLS-GSLPRELGKLQKLEK--------------------------------MLL-W  255 (1035)
Q Consensus       210 ~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~--------------------------------L~l-~  255 (1035)
                      .+++..+..+ ...+|+.|++++|.++ +..|..+..++.|+.                                +++ .
T Consensus       192 ~l~~~~~~~~-~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~  270 (606)
T 3vq2_A          192 PIDFIQDQAF-QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY  270 (606)
T ss_dssp             CCCEECTTTT-TTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred             CcceeCcccc-cCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence            5553222222 2225555555555543 123333444444333                                333 5


Q ss_pred             cccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhh
Q 039419          256 QNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFF  335 (1035)
Q Consensus       256 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~  335 (1035)
                      .|.+.+.+|. +..+++|+.|++++|.+.. +| .+..+++|++|++++|++ +.+| .+ .+++|++|++++|+...  
T Consensus       271 ~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~--  342 (606)
T 3vq2_A          271 TNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSI--  342 (606)
T ss_dssp             CTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCE--
T ss_pred             cccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCcc--
Confidence            6667776766 7888888888888888874 55 788888888888888888 4566 44 88888888888884321  


Q ss_pred             hhccccCCCCCcCCCCCCCCcEEeccCcCCCCC--CCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCC
Q 039419          336 AWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS--LHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGN  413 (1035)
Q Consensus       336 ~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~  413 (1035)
                                +..+..+++|++|++++|.+++.  .+..+..+++|++|++++|.+++. |..              |.+
T Consensus       343 ----------~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~--------------~~~  397 (606)
T 3vq2_A          343 ----------SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SAN--------------FMG  397 (606)
T ss_dssp             ----------ECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEE-CCC--------------CTT
T ss_pred             ----------chhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccc-hhh--------------ccC
Confidence                      12566788888888888888755  366777888888888888888753 233              445


Q ss_pred             CCccceeecCCCccCCCCc-ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccc-cCccccCCCCCCcE
Q 039419          414 CTQLQMLNLSNNTLGGTLP-SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG-AIPSSLGRCESLQS  491 (1035)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~  491 (1035)
                      +++|++|++++|++++..| ..+..+++|++|++++|++.+..|..|..+++|++|++++|++++ .+|..|..+++|++
T Consensus       398 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  477 (606)
T 3vq2_A          398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF  477 (606)
T ss_dssp             CTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             CCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCE
Confidence            5778888899998887776 678888899999999999888888888888899999999998886 47888888899999


Q ss_pred             EEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccC-CCcEEeccCCc
Q 039419          492 LDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLD-NLVSLNVSYNN  570 (1035)
Q Consensus       492 L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~-~L~~L~ls~N~  570 (1035)
                      |+|++|++++..|..+..+..+. .|++++|++++..|..|..+++|++|+|++|+|+..+..+..++ +|+.|++++|+
T Consensus       478 L~Ls~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~  556 (606)
T 3vq2_A          478 LDLSKCQLEQISWGVFDTLHRLQ-LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS  556 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCC-EEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCC
T ss_pred             EECCCCcCCccChhhhcccccCC-EEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCC
Confidence            99999988866666666665554 78888888888888888888888888888888888777788886 58888888888


Q ss_pred             CcccCCChhhhhcc
Q 039419          571 FTGYLPDSKLFRQL  584 (1035)
Q Consensus       571 l~~~~p~~~~~~~l  584 (1035)
                      |.+.++.......+
T Consensus       557 ~~c~c~~~~~~~~l  570 (606)
T 3vq2_A          557 VACICEHQKFLQWV  570 (606)
T ss_dssp             CCCSSTTHHHHTTT
T ss_pred             cccCCccHHHHHHH
Confidence            88877764333333

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=2.7e-54  Score=527.03  Aligned_cols=526  Identities=21%  Similarity=0.190  Sum_probs=436.6

Q ss_pred             ceeEEeCCC----------CcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCC
Q 039419           21 WSHITCSPQ----------NFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSL   90 (1035)
Q Consensus        21 w~gi~c~~~----------~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l   90 (1035)
                      +..+.|...          ..++.|+++++.+.+..|..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|++
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            445778543          3688999999999998899999999999999999999988899999999999999999999


Q ss_pred             CCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCc
Q 039419           91 VGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYE  170 (1035)
Q Consensus        91 ~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~  170 (1035)
                      ++..|..|+.+++|++|+|++|++++..|..++.+++|++|++++|.+.+..++.+..+++|++|++++|. +.+..+..
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~  172 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA-IHYLSKED  172 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC-CCEECHHH
T ss_pred             cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc-ccccChhh
Confidence            98889999999999999999999996667889999999999999999996444555569999999999996 45555677


Q ss_pred             CCCccceE--EEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCC-----CCCChhh
Q 039419          171 IGDCQSLL--VVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLS-----GSLPREL  243 (1035)
Q Consensus       171 ~~~l~~L~--~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~-----~~~~~~l  243 (1035)
                      ++.+++|+  .|++++|.+.+..|..+.. .+|++|++++|.   .++..+..+.++....+..+.+.     ...+..|
T Consensus       173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~  248 (606)
T 3t6q_A          173 MSSLQQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVF  248 (606)
T ss_dssp             HHTTTTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGG
T ss_pred             hhhhcccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHh
Confidence            88889998  8999999999877777655 689999999987   34556666666554444433222     2234445


Q ss_pred             hccc--chhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCcc
Q 039419          244 GKLQ--KLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSL  321 (1035)
Q Consensus       244 ~~l~--~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  321 (1035)
                      ..+.  +|+.|++++|.+.+..+..|..+++|++|+|++|+++ .+|..+.++++|++|++++|++.+..|..+.++++|
T Consensus       249 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  327 (606)
T 3t6q_A          249 EGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL  327 (606)
T ss_dssp             GGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTC
T ss_pred             chhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcC
Confidence            5554  7888999999998887888899999999999999998 677788899999999999999988888888999999


Q ss_pred             ceeccccchhhhhhhhccccCCCCC-cCCCCCCCCcEEeccCcCCCCCC--CCCcccCcccceEeccccccccCCCCCCC
Q 039419          322 LQLQLDTNQISVFFAWQNKLEGSIP-STLANCRSLEAVDLSHNALTGSL--HPGLFQLQNLTKLLLISNGISGLIPPEIG  398 (1035)
Q Consensus       322 ~~L~L~~N~i~~l~~~~n~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  398 (1035)
                      ++|++++|++.          +.+| ..+..+++|++|++++|.+++..  +..+..+++|++|++++|++++..|..+.
T Consensus       328 ~~L~l~~n~~~----------~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  397 (606)
T 3t6q_A          328 THLSIKGNTKR----------LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK  397 (606)
T ss_dssp             SEEECCSCSSC----------CBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTT
T ss_pred             CEEECCCCCcc----------cccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhc
Confidence            99999988764          2333 45888899999999999998665  67788899999999999998877776654


Q ss_pred             CCCcceeEeeeccCCCCccceeecCCCccCCCCcc-cccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccc
Q 039419          399 NCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS-SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG  477 (1035)
Q Consensus       399 ~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  477 (1035)
                      .              +++|++|++++|++++..+. .+..+++|++|++++|++.+..|..|..+++|++|++++|++++
T Consensus       398 ~--------------l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  463 (606)
T 3t6q_A          398 E--------------CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK  463 (606)
T ss_dssp             T--------------CTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGG
T ss_pred             C--------------CccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCc
Confidence            4              46688899999998876554 48888999999999999988888888899999999999999876


Q ss_pred             c---CccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccc-
Q 039419          478 A---IPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL-  553 (1035)
Q Consensus       478 ~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-  553 (1035)
                      .   .+..+..+++|++|+|++|++++..|..+..+..+. .|+|++|++++..|..+..+++| +|+|++|++++.++ 
T Consensus       464 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~  541 (606)
T 3t6q_A          464 GNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN-HVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS  541 (606)
T ss_dssp             GEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGG
T ss_pred             cccccchhhccCCCccEEECCCCccCccChhhhccccCCC-EEECCCCccCcCChhHhCccccc-EEECcCCcccccCHh
Confidence            2   335688889999999999999866677666665554 79999999999999999999999 99999999998664 


Q ss_pred             cccccCCCcEEeccCCcCcccCCCh
Q 039419          554 ALSGLDNLVSLNVSYNNFTGYLPDS  578 (1035)
Q Consensus       554 ~~~~l~~L~~L~ls~N~l~~~~p~~  578 (1035)
                      .+..+++|+.|++++|+|++.++..
T Consensus       542 ~~~~l~~L~~L~l~~N~~~c~c~~~  566 (606)
T 3t6q_A          542 LLPILSQQRTINLRQNPLDCTCSNI  566 (606)
T ss_dssp             GHHHHHTSSEEECTTCCEECSGGGH
T ss_pred             hcccCCCCCEEeCCCCCccccCCcH
Confidence            5788999999999999999877754

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.3e-54  Score=529.20  Aligned_cols=520  Identities=15%  Similarity=0.192  Sum_probs=297.3

Q ss_pred             cCCCCCCCCCCccc---eeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceee
Q 039419            8 LSNWNPSDSNPCKW---SHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTID   84 (1035)
Q Consensus         8 l~~w~~~~~~~c~w---~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~   84 (1035)
                      .++|+.+ .+||.|   +||+|+..++|++|+++++++.|.+|+.++.|++|++|+|++|.+.. .+.-++...      
T Consensus        57 ~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~-~~~~~~~~~------  128 (636)
T 4eco_A           57 GANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV-NERLFGPKG------  128 (636)
T ss_dssp             -CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGG-TCCSBSTTS------
T ss_pred             CCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccceEEECcCCcccc-CCccccccc------
Confidence            4589875 589999   99999988999999999999999999999999999999999997742 222122110      


Q ss_pred             CCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhh-hccccceeccccccCCCCchhhccccccceeecCCCccc
Q 039419           85 VSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGA-CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDI  163 (1035)
Q Consensus        85 ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~  163 (1035)
                           +.-.+|..+  +.+|+ ++++.|.+.+.+|..+.. +..+..+++....+..      .....++.+++..    
T Consensus       129 -----~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~----  190 (636)
T 4eco_A          129 -----ISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQ----  190 (636)
T ss_dssp             -----BCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTC----
T ss_pred             -----cccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc------ccccchhhhhhcc----
Confidence                 111344444  55666 777777777666666653 3344444444332220      1111222222221    


Q ss_pred             CCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccC-----------------Cccccc--cCcC
Q 039419          164 AGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGE-----------------IPPQIG--NCSE  224 (1035)
Q Consensus       164 ~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~-----------------~p~~l~--~l~~  224 (1035)
                                         ..|++++ +|..|+++++|++|+|++|.+++.                 +|..++  ++++
T Consensus       191 -------------------~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~  250 (636)
T 4eco_A          191 -------------------LSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKD  250 (636)
T ss_dssp             -------------------CSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTT
T ss_pred             -------------------ccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCC
Confidence                               1223333 344444444444444444444432                 444444  4444


Q ss_pred             CceEEecCCcCCCCCChhhhcccchhHhhccccc-ccc-cCCccccCC------CCCcEEEccCccCCCCCCc--cccCC
Q 039419          225 LVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNN-FDG-AIPEEIGNC------KSLKTIDLSLNFFSGSLPQ--SFGNL  294 (1035)
Q Consensus       225 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~-l~~-~~p~~~~~l------~~L~~L~L~~n~l~~~~~~--~~~~l  294 (1035)
                      |++|+|++|.+.+.+|..|+++++|++|++++|+ +++ .+|..++.+      ++|++|+|++|+++ .+|.  .|+++
T Consensus       251 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l  329 (636)
T 4eco_A          251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKM  329 (636)
T ss_dssp             CCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTC
T ss_pred             CCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccC
Confidence            4444444444444444444444444444444444 444 444444443      55555555555555 4444  55555


Q ss_pred             CCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCC-CcEEeccCcCCCCCCCCCc
Q 039419          295 SSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRS-LEAVDLSHNALTGSLHPGL  373 (1035)
Q Consensus       295 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~~~~~  373 (1035)
                      ++|++|++++|++.+.+| .|..+++|++|+|++|+++           .+|..+..+++ |++|++++|.++ .+|..+
T Consensus       330 ~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-----------~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~  396 (636)
T 4eco_A          330 KKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-----------EIPANFCGFTEQVENLSFAHNKLK-YIPNIF  396 (636)
T ss_dssp             TTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-----------ECCTTSEEECTTCCEEECCSSCCS-SCCSCC
T ss_pred             CCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-----------cccHhhhhhcccCcEEEccCCcCc-ccchhh
Confidence            555555555555554444 5555555555555555554           23445555555 666666666655 444444


Q ss_pred             ccCc--ccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCcc
Q 039419          374 FQLQ--NLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQF  451 (1035)
Q Consensus       374 ~~l~--~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  451 (1035)
                      ..++  +|++|++++|++++..|..+..+..       ....+++|++|+|++|++++..+..+..+++|++|+|++|++
T Consensus       397 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~-------~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l  469 (636)
T 4eco_A          397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP-------TPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML  469 (636)
T ss_dssp             CTTCSSCEEEEECCSSCTTTTTTCSSCTTCS-------SCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCC
T ss_pred             hhcccCccCEEECcCCcCCCcchhhhccccc-------ccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCC
Confidence            4433  5666666666665555554441110       001223456666666666643333444556666666666666


Q ss_pred             CCCCchhccCcc-------ccchhhccCCcccccCccccC--CCCCCcEEEcCCCcCcCccchhhhhhccCcceeec---
Q 039419          452 VGLIPESFGQLA-------SLNRLILSKNSFSGAIPSSLG--RCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNL---  519 (1035)
Q Consensus       452 ~~~~~~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~L---  519 (1035)
                      +.+++..+..+.       +|+.|+|++|+|+ .+|..+.  .+++|++|+|++|+|++ +|..++.+..+. .|+|   
T Consensus       470 ~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~-~L~Ls~N  546 (636)
T 4eco_A          470 TEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLK-GFGIRNQ  546 (636)
T ss_dssp             SBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCC-EEECCSC
T ss_pred             CCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCC-EEECCCC
Confidence            643333333222       5666666666665 4454454  56666666666666654 555555544443 4555   


Q ss_pred             ---cCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCCh---hhhhccccccccccc
Q 039419          520 ---SWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDS---KLFRQLSATEMAGNQ  593 (1035)
Q Consensus       520 ---s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~---~~~~~l~~~~~~~N~  593 (1035)
                         ++|++.+.+|..+..+++|++|+|++|++...+..+.  ++|+.|+|++|++.......   ........+.+..++
T Consensus       547 ~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~~~~~  624 (636)
T 4eco_A          547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ  624 (636)
T ss_dssp             BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCCSCCC--TTCCEEECCSCTTCEEECTTTHHHHHTTCCEEECCTTS
T ss_pred             cccccCcccccChHHHhcCCCCCEEECCCCcCCccCHhHh--CcCCEEECcCCCCccccHHhcchhhhcccceeecCCcc
Confidence               6788999999999999999999999999977776655  89999999999988654432   112233334445555


Q ss_pred             cCCCCC
Q 039419          594 GLCSRG  599 (1035)
Q Consensus       594 ~~c~~~  599 (1035)
                      ..|+|+
T Consensus       625 ~i~~C~  630 (636)
T 4eco_A          625 DIRGCD  630 (636)
T ss_dssp             EEESCG
T ss_pred             ccCCCc
Confidence            555654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-53  Score=532.91  Aligned_cols=520  Identities=21%  Similarity=0.219  Sum_probs=442.9

Q ss_pred             ccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCC-CCCCCCCCCCceeeCCCCCCCCCCChh
Q 039419           19 CKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPI-SPDLGDCTQLTTIDVSSNSLVGGVPSS   97 (1035)
Q Consensus        19 c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~-~~~~~~l~~L~~L~ls~n~l~~~~p~~   97 (1035)
                      |.|..|.+ -...++.|+++.+.+.+..|..+.++++|++|+|++|.+.+.+ |..|+.+++|++|+|++|++.+..|..
T Consensus        14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~   92 (844)
T 3j0a_A           14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA   92 (844)
T ss_dssp             CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred             CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence            67888888 5567999999999999999999999999999999999766666 778999999999999999999888999


Q ss_pred             hhccccccceEecccCCCCCCchh--hhhhccccceeccccccCCCCc-hhhccccccceeecCCCcccCCCCCCcCCCc
Q 039419           98 IGKLINLQDLILNSNQLTGEIPKE--LGACIKLKNLLLFDNYLSGNLP-VELGKLVNLEVIRAGGNKDIAGKIPYEIGDC  174 (1035)
Q Consensus        98 i~~l~~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l  174 (1035)
                      |+++++|++|+|++|.+++.+|..  +..+++|++|+|++|.+.+..+ ..|+++++|++|++++|. +.+..+..+..+
T Consensus        93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~-i~~~~~~~l~~l  171 (844)
T 3j0a_A           93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ-IFLVCEHELEPL  171 (844)
T ss_dssp             SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSC-CCCCCSGGGHHH
T ss_pred             ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCc-CCeeCHHHcccc
Confidence            999999999999999999877776  8999999999999999987655 689999999999999996 566677778877


Q ss_pred             --cceEEEEeccccccccCccccccccc------ccceeecccccccCCccccccC---cCCceEEecCC---------c
Q 039419          175 --QSLLVVGLADTKVAGSLPASLGKLSK------LQSLSVYTTMLSGEIPPQIGNC---SELVDLFLYEN---------D  234 (1035)
Q Consensus       175 --~~L~~L~l~~~~~~~~~p~~l~~l~~------L~~L~l~~n~l~~~~p~~l~~l---~~L~~L~L~~n---------~  234 (1035)
                        ++|+.|+++.|.+.+..|..++.+.+      |++|++++|.+.+.++..+...   .+++.|.++.+         .
T Consensus       172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~  251 (844)
T 3j0a_A          172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN  251 (844)
T ss_dssp             HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred             cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence              89999999999999999988887776      9999999999998888887654   57788887733         3


Q ss_pred             CCCCCChhhhcc--cchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCC
Q 039419          235 LSGSLPRELGKL--QKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIP  312 (1035)
Q Consensus       235 l~~~~~~~l~~l--~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  312 (1035)
                      +.+.....|..+  ++|++|++++|.+.+..|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|++.+..+
T Consensus       252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  331 (844)
T 3j0a_A          252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS  331 (844)
T ss_dssp             STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred             cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence            443344455554  689999999999998889999999999999999999998889999999999999999999998889


Q ss_pred             CcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccC
Q 039419          313 PVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGL  392 (1035)
Q Consensus       313 ~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  392 (1035)
                      ..|.++++|+.|+|++|+|+.          ..+..|.++++|+.|+|++|.+++..     .+++|+.|++++|+++.+
T Consensus       332 ~~~~~l~~L~~L~L~~N~i~~----------~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~~l  396 (844)
T 3j0a_A          332 SNFYGLPKVAYIDLQKNHIAI----------IQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLVTL  396 (844)
T ss_dssp             CSCSSCTTCCEEECCSCCCCC----------CCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCCCC
T ss_pred             HHhcCCCCCCEEECCCCCCCc----------cChhhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCcccc
Confidence            999999999999999998863          34567899999999999999998432     378999999999999844


Q ss_pred             CCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc-ccccCCCCccEEEcCCCccCCCCch-hccCccccchhhc
Q 039419          393 IPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP-SSLASLTRLQVLDISVNQFVGLIPE-SFGQLASLNRLIL  470 (1035)
Q Consensus       393 ~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L  470 (1035)
                       |..                 ..+++.|++++|++++... ..+.++++|+.|+|++|++++..+. .+..+++|+.|+|
T Consensus       397 -~~~-----------------~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~L  458 (844)
T 3j0a_A          397 -PKI-----------------NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL  458 (844)
T ss_dssp             -CCC-----------------CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEE
T ss_pred             -ccc-----------------ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccC
Confidence             322                 2458899999999986432 2456889999999999999876543 4667889999999


Q ss_pred             cCCccc-----ccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccC
Q 039419          471 SKNSFS-----GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSH  545 (1035)
Q Consensus       471 s~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  545 (1035)
                      ++|.++     +..+..|..+++|+.|+|++|+|++..|..+..+..+ ..|+|++|+|++..+..+.  ++|+.|||++
T Consensus       459 s~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~  535 (844)
T 3j0a_A          459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL-RGLSLNSNRLTVLSHNDLP--ANLEILDISR  535 (844)
T ss_dssp             ESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC-SEEEEESCCCSSCCCCCCC--SCCCEEEEEE
T ss_pred             CCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh-heeECCCCCCCccChhhhh--ccccEEECCC
Confidence            999997     3445678899999999999999996655555555555 4799999999988888777  8999999999


Q ss_pred             CcccCccccccccCCCcEEeccCCcCcccCCCh
Q 039419          546 NKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDS  578 (1035)
Q Consensus       546 N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~  578 (1035)
                      |+|++.++..  +.+|+.|++++|++.+.++..
T Consensus       536 N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~~  566 (844)
T 3j0a_A          536 NQLLAPNPDV--FVSLSVLDITHNKFICECELS  566 (844)
T ss_dssp             ECCCCCCSCC--CSSCCEEEEEEECCCCSSSCC
T ss_pred             CcCCCCChhH--hCCcCEEEecCCCcccccccH
Confidence            9999876533  458999999999999877653

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=3.2e-53  Score=517.60  Aligned_cols=505  Identities=21%  Similarity=0.184  Sum_probs=424.6

Q ss_pred             ceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceecccc
Q 039419           57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDN  136 (1035)
Q Consensus        57 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n  136 (1035)
                      +.++.++++++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|++++..|..+..+++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n   90 (606)
T 3vq2_A           14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN   90 (606)
T ss_dssp             TEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             CceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCC
Confidence            35667778888 7887665  79999999999999777889999999999999999999777889999999999999999


Q ss_pred             ccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccc-cCcccccccccccceeecccccccCC
Q 039419          137 YLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG-SLPASLGKLSKLQSLSVYTTMLSGEI  215 (1035)
Q Consensus       137 ~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~-~~p~~l~~l~~L~~L~l~~n~l~~~~  215 (1035)
                      .+++..|..|+++++|++|++++|. +.+..+..++.+++|++|++++|.+.+ .+|..|+++++|++|++++|.+++..
T Consensus        91 ~l~~~~p~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~  169 (606)
T 3vq2_A           91 PIQSFSPGSFSGLTSLENLVAVETK-LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT  169 (606)
T ss_dssp             CCCCCCTTSSTTCTTCCEEECTTSC-CCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred             cccccChhhcCCcccCCEEEccCCc-cccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence            9997779999999999999999997 444555789999999999999999986 57999999999999999999999888


Q ss_pred             ccccccCcCCc----eEEecCCcCCCCCChhhhcccchhHhhccccccc-ccCCccccCCCCCcEEEc------------
Q 039419          216 PPQIGNCSELV----DLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFD-GAIPEEIGNCKSLKTIDL------------  278 (1035)
Q Consensus       216 p~~l~~l~~L~----~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~L------------  278 (1035)
                      |..++.+.+|+    .|++++|.+++..+..+... +|++|++++|.+. +..|..+.++++|+.+++            
T Consensus       170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~  248 (606)
T 3vq2_A          170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE  248 (606)
T ss_dssp             TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCS
T ss_pred             hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccc
Confidence            88888888775    79999999996666655554 8999999999986 466778888888888877            


Q ss_pred             ---------------------cCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhh
Q 039419          279 ---------------------SLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAW  337 (1035)
Q Consensus       279 ---------------------~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~  337 (1035)
                                           ..|.+.+..|. +..+++|+.|++++|.+.. +| .+..+++|++|++++|++.     
T Consensus       249 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l~-----  320 (606)
T 3vq2_A          249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQLK-----  320 (606)
T ss_dssp             CCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCCS-----
T ss_pred             ccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccCc-----
Confidence                                 45555555555 7777777777777777763 34 6777777777777777664     


Q ss_pred             ccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCC--CCCCCCCCcceeEeeeccCCCC
Q 039419          338 QNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLI--PPEIGNCSSLIRLRLMSFGNCT  415 (1035)
Q Consensus       338 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~~~~~~~l~  415 (1035)
                            .+| .+ .+++|+.|++++|...+..  .+..+++|++|++++|++++..  |.              .+.+++
T Consensus       321 ------~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~--------------~~~~~~  376 (606)
T 3vq2_A          321 ------QFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSY--------------SDLGTN  376 (606)
T ss_dssp             ------SCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCH--------------HHHCCS
T ss_pred             ------ccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhh--------------hhccCC
Confidence                  344 34 7777778888777544222  5567777888888877776442  22              345678


Q ss_pred             ccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCc-hhccCccccchhhccCCcccccCccccCCCCCCcEEEc
Q 039419          416 QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIP-ESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL  494 (1035)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  494 (1035)
                      +|++|+|++|++++ +|..+..+++|+.|++++|++.+..+ ..|..+++|+.|++++|.+++..|..|..+++|++|+|
T Consensus       377 ~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  455 (606)
T 3vq2_A          377 SLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKM  455 (606)
T ss_dssp             CCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred             cccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEEC
Confidence            89999999999995 56889999999999999999998887 78999999999999999999999999999999999999


Q ss_pred             CCCcCcCc-cchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCc-cccccccCCCcEEeccCCcCc
Q 039419          495 SSNKLSGK-IPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGD-LLALSGLDNLVSLNVSYNNFT  572 (1035)
Q Consensus       495 s~N~l~~~-~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~ls~N~l~  572 (1035)
                      ++|++++. +|..+..+..+. .|++++|++++..|..|..+++|++|+|++|++++. +..+..+++|++|+|++|+|+
T Consensus       456 ~~n~l~~~~~~~~~~~l~~L~-~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  534 (606)
T 3vq2_A          456 AGNSFKDNTLSNVFANTTNLT-FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE  534 (606)
T ss_dssp             TTCEEGGGEECSCCTTCTTCC-EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred             CCCcCCCcchHHhhccCCCCC-EEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence            99999974 666666665554 799999999999999999999999999999999996 578999999999999999999


Q ss_pred             ccCCChhhhh-ccccccccccccCCCCCC
Q 039419          573 GYLPDSKLFR-QLSATEMAGNQGLCSRGH  600 (1035)
Q Consensus       573 ~~~p~~~~~~-~l~~~~~~~N~~~c~~~~  600 (1035)
                      ..++....+. +++.+++.+||+.|+++.
T Consensus       535 ~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          535 TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            7666655554 588899999999998764

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=8.8e-52  Score=511.11  Aligned_cols=485  Identities=19%  Similarity=0.230  Sum_probs=327.0

Q ss_pred             CCCCCC----CCC--ccc------------eeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEee-cCcccCCCC
Q 039419           10 NWNPSD----SNP--CKW------------SHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLII-SGSNLTGPI   70 (1035)
Q Consensus        10 ~w~~~~----~~~--c~w------------~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L-~~~~l~~~~   70 (1035)
                      +|+.++    .+|  |.|            .||+|+..++|++|+|+++++.|.+|+.+++|++|++|+| ++|.+.|..
T Consensus       285 ~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~  364 (876)
T 4ecn_A          285 NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR  364 (876)
T ss_dssp             GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTT
T ss_pred             CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCchHHhccccceEeeecccccccccc
Confidence            797664    345  999            9999998899999999999999999999999999999999 889888774


Q ss_pred             CCCCCCCC-CCc-----ee---------eCC-CCCCCC-----------CCChhhhccccccceEecc--cCCCCCCchh
Q 039419           71 SPDLGDCT-QLT-----TI---------DVS-SNSLVG-----------GVPSSIGKLINLQDLILNS--NQLTGEIPKE  121 (1035)
Q Consensus        71 ~~~~~~l~-~L~-----~L---------~ls-~n~l~~-----------~~p~~i~~l~~L~~L~L~~--n~l~~~~p~~  121 (1035)
                      |.....+. .+.     .+         +.. ...+.+           ..+........++.+.+..  |++++ +|..
T Consensus       365 ~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~  443 (876)
T 4ecn_A          365 LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKA  443 (876)
T ss_dssp             CBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGG
T ss_pred             cccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccc-hhHH
Confidence            43211110 000     00         000 000000           0000001112233333332  45554 5555


Q ss_pred             hhhhccccceeccccccCC-----------------CCchhhc--cccccceeecCCCcccCCCCCCcCCCccceEEEEe
Q 039419          122 LGACIKLKNLLLFDNYLSG-----------------NLPVELG--KLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGL  182 (1035)
Q Consensus       122 l~~l~~L~~L~l~~n~l~~-----------------~~p~~l~--~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l  182 (1035)
                      ++++++|++|+|++|.+++                 .+|..++  ++++|++|++++|. +.+.+|..++++++|+.|++
T Consensus       444 l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~-l~~~iP~~l~~L~~L~~L~L  522 (876)
T 4ecn_A          444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCP-NMTQLPDFLYDLPELQSLNI  522 (876)
T ss_dssp             GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCT-TCCSCCGGGGGCSSCCEEEC
T ss_pred             HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCC-CCccChHHHhCCCCCCEEEC
Confidence            5555555555555555554                 2666665  66667777766664 45566666677777777777


Q ss_pred             cccc-ccc-cCcccccccc-------cccceeecccccccCCcc--ccccCcCCceEEecCCcCCCCCChhhhcccchhH
Q 039419          183 ADTK-VAG-SLPASLGKLS-------KLQSLSVYTTMLSGEIPP--QIGNCSELVDLFLYENDLSGSLPRELGKLQKLEK  251 (1035)
Q Consensus       183 ~~~~-~~~-~~p~~l~~l~-------~L~~L~l~~n~l~~~~p~--~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~  251 (1035)
                      ++|+ +++ .+|..++.++       +|++|++++|.++ .+|.  .++++++|+.|+|++|.++ .+| .|+.+++|+.
T Consensus       523 s~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~  599 (876)
T 4ecn_A          523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTD  599 (876)
T ss_dssp             TTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESE
T ss_pred             cCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceE
Confidence            7776 666 6777777666       8888888888888 7887  8888888888888888888 777 7888888888


Q ss_pred             hhcccccccccCCccccCCCC-CcEEEccCccCCCCCCccccCCCC--CcEEEccCCccccCCCCcc---c--CCCccce
Q 039419          252 MLLWQNNFDGAIPEEIGNCKS-LKTIDLSLNFFSGSLPQSFGNLSS--LEELMLSNNNISGSIPPVL---S--NATSLLQ  323 (1035)
Q Consensus       252 L~l~~n~l~~~~p~~~~~l~~-L~~L~L~~n~l~~~~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~  323 (1035)
                      |+|++|++. .+|..+..+++ |+.|+|++|+|+ .+|..+..++.  |+.|+|++|++.+.+|...   .  .+++|+.
T Consensus       600 L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~  677 (876)
T 4ecn_A          600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST  677 (876)
T ss_dssp             EECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEE
T ss_pred             EECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCE
Confidence            888888888 78888888888 999999999888 67777776654  8899999998887655432   2  3457889


Q ss_pred             eccccchhhhhhhhccccCCCCCcC-CCCCCCCcEEeccCcCCCCCCCCCccc--------CcccceEeccccccccCCC
Q 039419          324 LQLDTNQISVFFAWQNKLEGSIPST-LANCRSLEAVDLSHNALTGSLHPGLFQ--------LQNLTKLLLISNGISGLIP  394 (1035)
Q Consensus       324 L~L~~N~i~~l~~~~n~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~--------l~~L~~L~L~~N~i~~~~~  394 (1035)
                      |+|++|+|+.           +|.. +..+++|+.|+|++|+|+ .+|..+..        +++|+.|+|++|+|+ .+|
T Consensus       678 L~Ls~N~L~~-----------lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp  744 (876)
T 4ecn_A          678 VTLSYNEIQK-----------FPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLS  744 (876)
T ss_dssp             EECCSSCCCS-----------CCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCC
T ss_pred             EEccCCcCCc-----------cCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cch
Confidence            9999888863           3444 347889999999999998 45554433        238999999999998 445


Q ss_pred             CCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCc
Q 039419          395 PEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNS  474 (1035)
Q Consensus       395 ~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  474 (1035)
                      ..+.            ...+++|+.|+|++|+|++ +|..+..+++|+.|+|++|+                  ++++|+
T Consensus       745 ~~l~------------~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~ls~N~  793 (876)
T 4ecn_A          745 DDFR------------ATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------DAEGNR  793 (876)
T ss_dssp             GGGS------------TTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------CTTCCB
T ss_pred             HHhh------------hccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------------------Cccccc
Confidence            4432            0256779999999999997 68888899999999998854                  344444


Q ss_pred             ccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCccc
Q 039419          475 FSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLG  549 (1035)
Q Consensus       475 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  549 (1035)
                      +.+.+|..|..+++|+.|+|++|+| +.+|..++   ..+..|+|++|.+..+.+..+.....+..+.|.+|++.
T Consensus       794 l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~---~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~  864 (876)
T 4ecn_A          794 ILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT---PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ  864 (876)
T ss_dssp             CCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC---SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred             ccccChHHHhcCCCCCEEECCCCCC-CccCHhhc---CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence            4444444444455555555555554 34444433   12234555555554444445555555666666666654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.8e-51  Score=443.70  Aligned_cols=259  Identities=28%  Similarity=0.470  Sum_probs=210.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|...+.||+|+||+||+|++.      +++.||||+++....              ...++|.+|+++|++++|||||
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--------------~~~~~f~~E~~il~~l~HpnIV   78 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD--------------NARKDFHREAELLTNLQHEHIV   78 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH--------------HHHHHHHHHHHHHTTCCCTTBC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh--------------HHHHHHHHHHHHHHhCCCCCCc
Confidence            56888899999999999999864      478899999964321              1356899999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCC
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-----------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIK  828 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDik  828 (1035)
                      +++|+|.+++..|+|||||++|+|.++++..+           ...+++..+..|+.|||+||+|||++   +|+|||||
T Consensus        79 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlK  155 (299)
T 4asz_A           79 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLA  155 (299)
T ss_dssp             CEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             cEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccC
Confidence            99999999999999999999999999997643           24599999999999999999999999   99999999


Q ss_pred             cccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 039419          829 ANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTI  907 (1035)
Q Consensus       829 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~  907 (1035)
                      |+|||++.++.+||+|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus       156 p~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~  235 (299)
T 4asz_A          156 TRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  235 (299)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             HhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999999999999999987765544444445679999999999999999999999999999999999 899997542


Q ss_pred             CCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .  ..+...+.....         ...|.. +.  ..+.+++.+||+.||++|||++||.+.|+++.+
T Consensus       236 ~--~~~~~~i~~~~~---------~~~p~~-~~--~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          236 N--NEVIECITQGRV---------LQRPRT-CP--QEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             H--HHHHHHHHHTCC---------CCCCTT-CC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H--HHHHHHHHcCCC---------CCCCcc-ch--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            2  222333222110         111111 11  134567888999999999999999999988754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.5e-51  Score=444.92  Aligned_cols=258  Identities=25%  Similarity=0.398  Sum_probs=209.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ..++..+.||+|+||+||+|++.      +++.||||++......             ...++|.+|+.++++++|||||
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-------------~~~~~f~~E~~il~~l~HpNIV   92 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-------------PLREEFRHEAMLRARLQHPNVV   92 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-------------HHHHHHHHHHHHHHhCCCCCCC
Confidence            45667789999999999999863      4688999999643211             2357899999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeecc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR  825 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHr  825 (1035)
                      +++|+|.+++..|+|||||++|+|.++++.+.              ...+++..+..|+.|||+||+|||++   +||||
T Consensus        93 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHR  169 (308)
T 4gt4_A           93 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHK  169 (308)
T ss_dssp             CEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCC
Confidence            99999999999999999999999999996542              13589999999999999999999999   99999


Q ss_pred             CCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 039419          826 DIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID  904 (1035)
Q Consensus       826 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~  904 (1035)
                      ||||+|||+++++.+||+|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||.
T Consensus       170 DLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~  249 (308)
T 4gt4_A          170 DLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  249 (308)
T ss_dssp             CCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999997765554444556789999999999999999999999999999999998 899997


Q ss_pred             CCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ....  .++...+....         ....++.. .  ..+.+++.+||+.||++|||++||++.|+.+
T Consensus       250 ~~~~--~~~~~~i~~~~---------~~~~p~~~-~--~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          250 GYSN--QDVVEMIRNRQ---------VLPCPDDC-P--AWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TCCH--HHHHHHHHTTC---------CCCCCTTC-C--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCH--HHHHHHHHcCC---------CCCCcccc-h--HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            5432  23333332211         01111111 1  2245678899999999999999999998754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=446.12  Aligned_cols=259  Identities=29%  Similarity=0.475  Sum_probs=202.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|...+.||+|+||+||+|++.      +++.||||+++....              ...++|.+|+++|++++|||||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--------------~~~~~f~~E~~il~~l~HpnIV  106 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--------------SARQDFQREAELLTMLQHQHIV  106 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH--------------HHHHHHHHHHHHHTTCCCTTBC
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH--------------HHHHHHHHHHHHHHhCCCCCCC
Confidence            46777889999999999999864      478899999964321              2356899999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccC
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRD  826 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrD  826 (1035)
                      +++|+|.+.+..|+|||||++|+|.++++....             ..++|.+++.|+.|||+||+|||++   +|+|||
T Consensus       107 ~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRD  183 (329)
T 4aoj_A          107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRD  183 (329)
T ss_dssp             CEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             cEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---Ceeccc
Confidence            999999999999999999999999999976432             3589999999999999999999998   999999


Q ss_pred             CCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 039419          827 IKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDP  905 (1035)
Q Consensus       827 ikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~  905 (1035)
                      |||+|||++.++.+||+|||+|+.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||..
T Consensus       184 LKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          184 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             CCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             ccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence            999999999999999999999997765544444456789999999999999999999999999999999999 8999975


Q ss_pred             CCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          906 TIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ...  ......+.....      .   ..|.. +.  ..+.+++.+||++||++|||++||+++|+.+.+
T Consensus       264 ~~~--~~~~~~i~~g~~------~---~~p~~-~~--~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          264 LSN--TEAIDCITQGRE------L---ERPRA-CP--PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             SCH--HHHHHHHHHTCC------C---CCCTT-CC--HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCH--HHHHHHHHcCCC------C---CCccc-cc--HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            422  222222222110      0   11111 11  233557888999999999999999999998854

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.2e-51  Score=451.76  Aligned_cols=254  Identities=19%  Similarity=0.310  Sum_probs=202.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +++|++.+.||+|+||+||+|++. +|+.||||++........            ..+.|.+|+.+|++++|||||++++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIV~~~~   90 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK------------EREESRREVAVLANMKHPNIVQYRE   90 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHH------------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHH------------HHHHHHHHHHHHHHCCCCCCCcEEE
Confidence            368999999999999999999875 589999999975433221            2568999999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+|||||+||+|.+++...+...+++..+..|+.||+.||+|||++   ||+||||||+|||++.+|.+||+
T Consensus        91 ~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~  167 (350)
T 4b9d_A           91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLG  167 (350)
T ss_dssp             EEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEEC
T ss_pred             EEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEc
Confidence            999999999999999999999999877666689999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+|+......  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....  ......+....  
T Consensus       168 DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~--  241 (350)
T 4b9d_A          168 DFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--KNLVLKIISGS--  241 (350)
T ss_dssp             STTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTC--
T ss_pred             ccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCC--
Confidence            999998764322  122356799999999999999999999999999999999999999975421  11111111110  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         . +......+      ..+.+++.+||++||++|||++|++++
T Consensus       242 ---~-~~~~~~~s------~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          242 ---F-PPVSLHYS------YDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ---C-CCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---C-CCCCccCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               0 01111111      123457888999999999999999874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.8e-51  Score=441.15  Aligned_cols=253  Identities=18%  Similarity=0.229  Sum_probs=208.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|+++ +++.||||++........           ...+.+.+|+++|++++|||||+++++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~-----------~~~~~~~~E~~il~~l~HpnIv~l~~~  100 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-----------NKVPYVTRERDVMSRLDHPFFVKLYFT  100 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCH-----------HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            57999999999999999999775 589999999965332221           235689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+|||||+||+|.++++..+.  +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       101 ~~~~~~~yivmEy~~gG~L~~~i~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~D  175 (311)
T 4aw0_A          101 FQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD  175 (311)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEE
Confidence            9999999999999999999999987654  99999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|+.+............+||+.|||||++.+..|+.++||||+||++|||++|+.||.....  ......+....   
T Consensus       176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~---  250 (311)
T 4aw0_A          176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--GLIFAKIIKLE---  250 (311)
T ss_dssp             CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC---
T ss_pred             cCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCC---
Confidence            9999987654444445578999999999999999999999999999999999999999975421  12222211110   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ..+....+      ..+.+++.+||++||++|||++|+..+
T Consensus       251 ----~~~p~~~s------~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          251 ----YDFPEKFF------PKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             ----CCCCTTCC------HHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             ----CCCCcccC------HHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                01111111      134567888999999999999987543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8e-50  Score=434.83  Aligned_cols=261  Identities=26%  Similarity=0.368  Sum_probs=199.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +++...+.||+|+||+||+|++.+  .||||+++......            ...+.|.+|+.++++++|||||++++++
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~------------~~~~~f~~E~~il~~l~HpNIV~l~g~~  101 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTP------------EQFQAFRNEVAVLRKTRHVNILLFMGYM  101 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCH------------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCH------------HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            466778899999999999998763  59999986433221            2356899999999999999999999987


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+ +..|+|||||+||+|.++++..+ ..+++..+..|+.|||+||+|||++   +||||||||+|||++.++.+||+||
T Consensus       102 ~~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DF  176 (307)
T 3omv_A          102 TK-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDF  176 (307)
T ss_dssp             CS-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCC
T ss_pred             EC-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeec
Confidence            54 56899999999999999997654 3489999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |+|+..............+||+.|||||++.+   ..|+.++|||||||++|||+||+.||...... ..+...+.... 
T Consensus       177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~~~~~~~~~-  254 (307)
T 3omv_A          177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFMVGRGY-  254 (307)
T ss_dssp             SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHTTC-
T ss_pred             cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcCC-
Confidence            99987655443334456789999999999753   46899999999999999999999999754321 11111111110 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                          ..+.....+.. +.  ..+.+++.+||+.||++|||+.||+++|+.++
T Consensus       255 ----~~p~~~~~~~~-~~--~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          255 ----ASPDLSKLYKN-CP--KAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             ----CCCCSTTSCTT-SC--HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             ----CCCCccccccc-ch--HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                11111111111 11  12345788899999999999999999998775

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.6e-49  Score=479.05  Aligned_cols=504  Identities=19%  Similarity=0.196  Sum_probs=345.2

Q ss_pred             CccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChh
Q 039419           18 PCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSS   97 (1035)
Q Consensus        18 ~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~   97 (1035)
                      .|.|.|| |+..         +++++ .+|..+.  ++|++|+|++|.+++..|..++.+++|++|+|++|++++..|..
T Consensus         3 ~C~~~~~-c~~~---------~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~   69 (549)
T 2z81_A            3 SCDASGV-CDGR---------SRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA   69 (549)
T ss_dssp             EECTTSE-EECT---------TSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTT
T ss_pred             cCCCCce-EECC---------CCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhh
Confidence            4999999 9643         34444 5666665  78999999999999888889999999999999999999888889


Q ss_pred             hhccccccceEecccCCCCCCchhhhhhccccceeccccccCC-CCchhhccccccceeecCCCcccCCCCCCcCCCccc
Q 039419           98 IGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSG-NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS  176 (1035)
Q Consensus        98 i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  176 (1035)
                      |+++++|++|+|++|++++..|..++.+++|++|+|++|.+++ ..|..++++++|++|++++|..+....+..++.+++
T Consensus        70 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~  149 (549)
T 2z81_A           70 FYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS  149 (549)
T ss_dssp             TTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred             ccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccc
Confidence            9999999999999999997777779999999999999999985 356788899999999999886333333356778888


Q ss_pred             eEEEEeccccccccCcccccccccccceeecccccccCCcccc-ccCcCCceEEecCCcCCCCC--C-hhhhcccchhHh
Q 039419          177 LLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQI-GNCSELVDLFLYENDLSGSL--P-RELGKLQKLEKM  252 (1035)
Q Consensus       177 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~--~-~~l~~l~~L~~L  252 (1035)
                      |++|++++|.+.+..|..++.+++|++|+++.|.+. .+|..+ ..+++|+.|++++|.+++..  + .....+++|+.|
T Consensus       150 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L  228 (549)
T 2z81_A          150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL  228 (549)
T ss_dssp             EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEE
T ss_pred             cCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccce
Confidence            888888888888777888888888888888887776 444443 45777888888887777532  1 112234555555


Q ss_pred             hcccccccccCC----ccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceecccc
Q 039419          253 LLWQNNFDGAIP----EEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDT  328 (1035)
Q Consensus       253 ~l~~n~l~~~~p----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  328 (1035)
                      ++++|.+.+..+    ..+..+++|+.|++++|.+.+.....                  ......+..+.+|+.|++.+
T Consensus       229 ~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~------------------~~~~~~~~~l~~L~~L~l~~  290 (549)
T 2z81_A          229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFN------------------PSESDVVSELGKVETVTIRR  290 (549)
T ss_dssp             EEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCC------------------CCTTTCCCCCTTCCEEEEES
T ss_pred             eccccccchhHHHHHHHHhhhhcccccccccccccccccccc------------------ccchhhhhhhcccccccccc
Confidence            666655554322    22334455555555555554321000                  00011233444455555555


Q ss_pred             chhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCc-ccCcccceEeccccccccCCCCCCCCCCcceeEe
Q 039419          329 NQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGL-FQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR  407 (1035)
Q Consensus       329 N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  407 (1035)
                      +.+.....     ...++..+..+++|+.|++++|.++ .+|..+ ..+++|++|++++|++++..|...          
T Consensus       291 ~~i~~~~~-----~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~----------  354 (549)
T 2z81_A          291 LHIPQFYL-----FYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNS----------  354 (549)
T ss_dssp             CBCSCGGG-----SCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHH----------
T ss_pred             cccchhhh-----cccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccch----------
Confidence            44432211     0112222333466777777777776 455444 457778888888887775432110          


Q ss_pred             eeccCCCCccceeecCCCccCCCCc--ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCC
Q 039419          408 LMSFGNCTQLQMLNLSNNTLGGTLP--SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGR  485 (1035)
Q Consensus       408 ~~~~~~l~~L~~L~L~~N~l~~~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  485 (1035)
                       ..+..+++|++|+|++|++++..+  ..+..+++|++|++++|+++. +|..+..+++|++|++++|+|+ .+|..+. 
T Consensus       355 -~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~-  430 (549)
T 2z81_A          355 -ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCIP-  430 (549)
T ss_dssp             -TCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCC-CCSCCCCCTTCCEEECTTSCCS-CCCTTSC-
T ss_pred             -hhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCcc-CChhhcccccccEEECCCCCcc-cccchhc-
Confidence             013345667788888888775432  457777788888888888874 5666777778888888888876 3343332 


Q ss_pred             CCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccc-cccccCCCcEE
Q 039419          486 CESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL-ALSGLDNLVSL  564 (1035)
Q Consensus       486 l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L  564 (1035)
                       ++|++|+|++|+|++.+ .   .+. .+..|+|++|+|+. +|. ...+++|++|+|++|+|++.++ .+..+++|+.|
T Consensus       431 -~~L~~L~Ls~N~l~~~~-~---~l~-~L~~L~Ls~N~l~~-ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  502 (549)
T 2z81_A          431 -QTLEVLDVSNNNLDSFS-L---FLP-RLQELYISRNKLKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKI  502 (549)
T ss_dssp             -TTCSEEECCSSCCSCCC-C---CCT-TCCEEECCSSCCSS-CCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEE
T ss_pred             -CCceEEECCCCChhhhc-c---cCC-hhcEEECCCCccCc-CCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEE
Confidence             57788888888887432 1   222 23467788888774 443 4568899999999999998765 58889999999


Q ss_pred             eccCCcCcccCCChhhh
Q 039419          565 NVSYNNFTGYLPDSKLF  581 (1035)
Q Consensus       565 ~ls~N~l~~~~p~~~~~  581 (1035)
                      ++++|++++.+|....+
T Consensus       503 ~l~~N~~~~~~~~~~~l  519 (549)
T 2z81_A          503 WLHTNPWDCSCPRIDYL  519 (549)
T ss_dssp             ECCSSCBCCCHHHHHHH
T ss_pred             EecCCCccCCCccHHHH
Confidence            99999999887754333

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-49  Score=477.07  Aligned_cols=520  Identities=20%  Similarity=0.199  Sum_probs=411.1

Q ss_pred             cCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhh
Q 039419           45 PFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGA  124 (1035)
Q Consensus        45 ~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~  124 (1035)
                      .+|..+.  +.++.|+|++|.+++..+..|+.+++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++.
T Consensus        21 ~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (570)
T 2z63_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (570)
T ss_dssp             SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcC
Confidence            3455443  46899999999999777778999999999999999999777788999999999999999998666788999


Q ss_pred             hccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccc---
Q 039419          125 CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKL---  201 (1035)
Q Consensus       125 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L---  201 (1035)
                      +++|++|++++|.+++..+..++++++|++|++++|......+|..++++++|++|++++|.+.+..+..++.+++|   
T Consensus        99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~  178 (570)
T 2z63_A           99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL  178 (570)
T ss_dssp             CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTC
T ss_pred             ccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchh
Confidence            99999999999999854445799999999999999974333578889999999999999999998888889999888   


Q ss_pred             -cceeecccccccCCccccccCcCCceEEecCCcCCC-CCChhhhcccchhHhhcccccc------cccCCccccCCC--
Q 039419          202 -QSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSG-SLPRELGKLQKLEKMLLWQNNF------DGAIPEEIGNCK--  271 (1035)
Q Consensus       202 -~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~~~~l~~l~~L~~L~l~~n~l------~~~~p~~~~~l~--  271 (1035)
                       +.|++++|.+.+..|..+..+ +|+.|++++|.... .++..+..+++++.+.+..+.+      .......+..+.  
T Consensus       179 ~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l  257 (570)
T 2z63_A          179 NLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL  257 (570)
T ss_dssp             CCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGS
T ss_pred             hhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcccccc
Confidence             889999999997777777665 79999999886442 2344556666665555443222      212222333333  


Q ss_pred             CCcEEEccCc-cCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCC
Q 039419          272 SLKTIDLSLN-FFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLA  350 (1035)
Q Consensus       272 ~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~  350 (1035)
                      .++.+++++| .+.+..+..|..+++|++|++++|.+. .+|..+..+ +|++|++++|++..           +|.  .
T Consensus       258 ~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~-----------l~~--~  322 (570)
T 2z63_A          258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQ-----------FPT--L  322 (570)
T ss_dssp             EEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSS-----------CCB--C
T ss_pred             chhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccc-----------cCc--c
Confidence            3567777777 777778888888999999999999888 567777777 89999999888763           333  4


Q ss_pred             CCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCC
Q 039419          351 NCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGT  430 (1035)
Q Consensus       351 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~  430 (1035)
                      .+++|+.|++++|.+.+..+.  ..+++|++|++++|++++...            ....+.++++|++|++++|++++.
T Consensus       323 ~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~------------~~~~~~~~~~L~~L~l~~n~l~~~  388 (570)
T 2z63_A          323 KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGC------------CSQSDFGTTSLKYLDLSFNGVITM  388 (570)
T ss_dssp             BCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEE------------EEHHHHTCSCCCEEECCSCSEEEE
T ss_pred             cccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCcccc------------ccccccccCccCEEECCCCccccc
Confidence            678899999999988755544  678899999999998874320            012355678899999999999865


Q ss_pred             CcccccCCCCccEEEcCCCccCCCCc-hhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCc-Cccchhhh
Q 039419          431 LPSSLASLTRLQVLDISVNQFVGLIP-ESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS-GKIPVELF  508 (1035)
Q Consensus       431 ~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~  508 (1035)
                      .+. +..+++|+.|++++|++.+..+ ..|..+++|++|++++|++.+..|..|..+++|++|+|++|+++ +.+|..+.
T Consensus       389 ~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~  467 (570)
T 2z63_A          389 SSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT  467 (570)
T ss_dssp             EEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT
T ss_pred             ccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhh
Confidence            444 8889999999999999987765 57888999999999999998888888999999999999999987 56887776


Q ss_pred             hhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccc-cccccCCCcEEeccCCcCcccCCChhhh-hcccc
Q 039419          509 EIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL-ALSGLDNLVSLNVSYNNFTGYLPDSKLF-RQLSA  586 (1035)
Q Consensus       509 ~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~-~~l~~  586 (1035)
                      .+..+. .|++++|++++..|..|..+++|++|+|++|++++.+. .+..+++|+.|++++|++++.+|....+ ..+..
T Consensus       468 ~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~  546 (570)
T 2z63_A          468 ELRNLT-FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNK  546 (570)
T ss_dssp             TCTTCC-EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHH
T ss_pred             cccCCC-EEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHh
Confidence            666654 79999999998889999999999999999999999774 5889999999999999999999876444 33322


Q ss_pred             --ccccccccCCCCC
Q 039419          587 --TEMAGNQGLCSRG  599 (1035)
Q Consensus       587 --~~~~~N~~~c~~~  599 (1035)
                        ..+.+.+ .|..+
T Consensus       547 ~~~~~~~~~-~C~~~  560 (570)
T 2z63_A          547 NSQKEQGSA-KCSGS  560 (570)
T ss_dssp             TGGGEESCC-BBTTT
T ss_pred             ccccCCCch-hhCCC
Confidence              2344555 67654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.6e-50  Score=439.31  Aligned_cols=250  Identities=22%  Similarity=0.355  Sum_probs=203.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|+..+.||+|+||+||+|+++ +|+.||||++.....              ...+.+.+|+.+|++++|||||+++++
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--------------~~~~~~~~Ei~il~~l~HpnIV~l~~~  139 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--------------QRRELLFNEVVIMRDYQHENVVEMYNS  139 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--------------SSGGGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--------------hHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            46888899999999999999876 599999999964321              123568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+|||||+||+|.+++...   .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|
T Consensus       140 ~~~~~~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D  213 (346)
T 4fih_A          140 YLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSD  213 (346)
T ss_dssp             EEETTEEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEec
Confidence            99999999999999999999999763   389999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|+.+....  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||....+  ......+....   
T Consensus       214 FGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~---  286 (346)
T 4fih_A          214 FGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNL---  286 (346)
T ss_dssp             CTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSS---
T ss_pred             CcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCC---
Confidence            99998765433  223467899999999999999999999999999999999999999975421  12222222110   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ......  ...+  ...+.+++.+||.+||++|||++|++++
T Consensus       287 ---~~~~~~--~~~~--s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          287 ---PPRLKN--LHKV--SPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             ---CCCCSC--GGGS--CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---CCCCCc--cccC--CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               001110  0111  1233457888999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.9e-49  Score=430.08  Aligned_cols=256  Identities=22%  Similarity=0.280  Sum_probs=204.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .+.|...++||+|+||+||+|+++ +|+.||||++..+.                   ...+|+.++++++|||||++++
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------------------~~~~E~~il~~l~HpnIV~l~~  117 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------------------FRVEELVACAGLSSPRIVPLYG  117 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------------------CCTHHHHTTTTCCCTTBCCEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------------------hHHHHHHHHHhCCCCCCCcEEE
Confidence            456888899999999999999876 58999999996421                   1236999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC-ceEE
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF-EPYI  842 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~kl  842 (1035)
                      ++.+++..|+|||||+||+|.++++..+.  +++..+..++.||+.||+|||++   +|+||||||+|||++.+| ++||
T Consensus       118 ~~~~~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl  192 (336)
T 4g3f_A          118 AVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAAL  192 (336)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEE
T ss_pred             EEEECCEEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEE
Confidence            99999999999999999999999987654  99999999999999999999999   999999999999999987 6999


Q ss_pred             eeccCccccccCCcc---ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          843 ADFGLAKLVVEGDFA---RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +|||+|+........   ......+||+.|||||++.+..|+.++||||+||++|||++|+.||........  ...+..
T Consensus       193 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~~  270 (336)
T 4g3f_A          193 CDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKIAS  270 (336)
T ss_dssp             CCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHHHHH
T ss_pred             eeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHHHc
Confidence            999999977554321   123356899999999999999999999999999999999999999976543321  111211


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      .....    ..+....+      ..+.+++.+||++||++|||+.|+++++.....+
T Consensus       271 ~~~~~----~~~~~~~s------~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          271 EPPPI----REIPPSCA------PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             SCCGG----GGSCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCc----hhcCccCC------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            11100    01111111      1234577889999999999999999998776543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.7e-49  Score=422.52  Aligned_cols=250  Identities=22%  Similarity=0.321  Sum_probs=189.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|++.+.||+|+||+||+|++. +|+.||||++........           ...+++.+|++++++++|||||++++
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~~~~   80 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS-----------DMQGRIEREISYLRLLRHPHIIKLYD   80 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCH-----------HHHHHHHHHHHHHHHCCCCCCCeEEE
Confidence            468999999999999999999775 589999999976443322           23568999999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+||||+ +|+|.+++...+.  +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        81 ~~~~~~~~~ivmEy~-~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~  154 (275)
T 3hyh_A           81 VIKSKDEIIMVIEYA-GNELFDYIVQRDK--MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIA  154 (275)
T ss_dssp             EEECSSEEEEEEECC-CEEHHHHHHHSCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEEC
T ss_pred             EEEECCEEEEEEeCC-CCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEe
Confidence            999999999999999 7899999977654  99999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||+|+...+..   .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||.....  ......+.... 
T Consensus       155 DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--~~~~~~i~~~~-  228 (275)
T 3hyh_A          155 DFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--PVLFKNISNGV-  228 (275)
T ss_dssp             CSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC-
T ss_pred             ecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHcCC-
Confidence            999998765432   2335789999999999988776 5799999999999999999999975321  11112111111 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                            ..++...+      ....+++.+||++||++|||++|++++
T Consensus       229 ------~~~p~~~s------~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 ------YTLPKFLS------PGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ------CCCCTTSC------HHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ------CCCCCCCC------HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                  01111111      123457888999999999999999885

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-48  Score=421.30  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=195.1

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |+..+.||+|+||+||+|.+. +++.||||++.......            ...++|.+|++++++++|||||++++++.
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------------~~~~~~~~E~~il~~l~HpnIV~~~~~~~   95 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK------------SERQRFKEEAEMLKGLQHPNIVRFYDSWE   95 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH------------HHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH------------HHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            356678999999999999776 58899999996543222            13568999999999999999999999986


Q ss_pred             c----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-CCceE
Q 039419          767 N----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-EFEPY  841 (1035)
Q Consensus       767 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~k  841 (1035)
                      +    ++..|+|||||+||+|.++++..+.  +++..+..++.||+.||+|||+++. +|+||||||+|||++. ++.+|
T Consensus        96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vK  172 (290)
T 3fpq_A           96 STVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVK  172 (290)
T ss_dssp             EEETTEEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEE
T ss_pred             eccCCCcEEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEE
Confidence            5    3457999999999999999987654  8999999999999999999999821 3999999999999984 78999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |+|||+|+.....    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ..+...+....
T Consensus       173 l~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-~~~~~~i~~~~  246 (290)
T 3fpq_A          173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSGV  246 (290)
T ss_dssp             ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHHHTTTC
T ss_pred             EEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-HHHHHHHHcCC
Confidence            9999999864332    2345789999999998765 6999999999999999999999999643221 11111111100


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           .........+   +   .+.+++.+||++||++|||++|++++
T Consensus       247 -----~~~~~~~~~~---~---~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          247 -----KPASFDKVAI---P---EVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -----CCGGGGGCCC---H---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCCCccCC---H---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0001111111   1   23457888999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=440.87  Aligned_cols=250  Identities=22%  Similarity=0.367  Sum_probs=204.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|+..+.||+|+||+||+|+++ +|+.||||++......              ..+.+.+|+.+|++++|||||+++++
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIV~l~~~  216 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHENVVEMYNS  216 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--------------SGGGHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--------------HHHHHHHHHHHHHhCCCCCCCceEEE
Confidence            56889999999999999999876 5899999999643211              24568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      |.+++..|+|||||+||+|.++++..+   +++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|
T Consensus       217 ~~~~~~~~iVmEy~~gG~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~D  290 (423)
T 4fie_A          217 YLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSD  290 (423)
T ss_dssp             EEETTEEEEEEECCTTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEec
Confidence            999999999999999999999997543   89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|+.+....  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....+  ......+....   
T Consensus       291 FGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~---  363 (423)
T 4fie_A          291 FGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNL---  363 (423)
T ss_dssp             CTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSC---
T ss_pred             CccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCC---
Confidence            99998765433  223467899999999999999999999999999999999999999975422  12222222111   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ...+....  .+  ...+.+++.+||.+||++|||++|++++
T Consensus       364 ---~~~~~~~~--~~--s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          364 ---PPRLKNLH--KV--SPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             ---CCCCSCTT--SS--CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---CCCCcccc--cC--CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               01111100  01  1123457888999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.7e-49  Score=428.35  Aligned_cols=250  Identities=22%  Similarity=0.277  Sum_probs=195.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|++.+.||+|+||+||+|+..    .++.||||++........            ...++.+|++++++++|||||++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIv~l   91 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR------------DRVRTKMERDILVEVNHPFIVKL   91 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE------------ECC------CCCCCCCCTTEECE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH------------HHHHHHHHHHHHHHCCCCCCCeE
Confidence            46999999999999999999763    478999999975433221            12368899999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+++..|+|||||+||+|.+++...+.  +++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+|
T Consensus        92 ~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vK  166 (304)
T 3ubd_A           92 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVM--FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIK  166 (304)
T ss_dssp             EEEEEETTEEEEEECCCTTCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEE
T ss_pred             EEEEEECCEEEEEEEcCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEE
Confidence            9999999999999999999999999987654  99999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |+|||+|+......  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....  ......+....
T Consensus       167 l~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i~~~~  242 (304)
T 3ubd_A          167 LTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--KETMTMILKAK  242 (304)
T ss_dssp             EESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC
T ss_pred             ecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--HHHHHHHHcCC
Confidence            99999998654432  223467899999999999999999999999999999999999999975422  12222211110


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM-----KDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~-----~el~~~  969 (1035)
                             .......+      ..+.+++.+||++||++|||+     +|++++
T Consensus       243 -------~~~p~~~s------~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          243 -------LGMPQFLS------PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             -------CCCCTTSC------HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             -------CCCCCcCC------HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                   01111111      123457888999999999984     566653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.7e-48  Score=434.22  Aligned_cols=263  Identities=24%  Similarity=0.366  Sum_probs=211.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC-Cc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH-KN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pn  757 (1035)
                      .++|++.+.||+|+||+||+|++..      ++.||||++.......             ..+.|.+|+.+|++++| ||
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~-------------~~~~~~~E~~il~~l~hhpn  129 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------------EHRALMSELKILIHIGHHLN  129 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHH-------------HHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChH-------------HHHHHHHHHHHHHHcCCCCc
Confidence            3789999999999999999997643      3689999996543322             24679999999999975 99


Q ss_pred             eeeEEeEEEcC-CcceEEEEeCCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 039419          758 IVRFLGCCWNR-NTRLLMYDYMPNGSLGSLLHERR--------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPI  822 (1035)
Q Consensus       758 iv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  822 (1035)
                      ||+++|+|.++ +..|+|||||++|+|.++++..+              ...+++..+..++.|||+||+|||++   +|
T Consensus       130 IV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~i  206 (353)
T 4ase_A          130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC  206 (353)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ce
Confidence            99999999765 56899999999999999997643              23489999999999999999999999   99


Q ss_pred             eccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 039419          823 VHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ  901 (1035)
Q Consensus       823 vHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~  901 (1035)
                      |||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.
T Consensus       207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~  286 (353)
T 4ase_A          207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  286 (353)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence            9999999999999999999999999987655443334456789999999999999999999999999999999998 999


Q ss_pred             CCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       902 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      ||...... ..+...+.....      .   ..|+...+   .+.+++.+||+.||++|||++||+++|+.+.+.
T Consensus       287 Pf~~~~~~-~~~~~~i~~g~~------~---~~p~~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          287 PYPGVKID-EEFCRRLKEGTR------M---RAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             SSTTCCCS-HHHHHHHHHTCC------C---CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHH-HHHHHHHHcCCC------C---CCCccCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            99764322 222222222110      0   11111112   345578889999999999999999999988654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=463.70  Aligned_cols=506  Identities=20%  Similarity=0.196  Sum_probs=427.6

Q ss_pred             ceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceecccc
Q 039419           57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDN  136 (1035)
Q Consensus        57 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n  136 (1035)
                      +.++.++.+++ .+|..+.  +++++|+|++|++++..+..|.++++|++|+|++|++++..|..++.+++|++|+|++|
T Consensus        10 ~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n   86 (570)
T 2z63_A           10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN   86 (570)
T ss_dssp             TEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             cEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCC
Confidence            45667777788 6887664  57999999999999777889999999999999999999766788999999999999999


Q ss_pred             ccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccc-cCcccccccccccceeecccccccCC
Q 039419          137 YLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG-SLPASLGKLSKLQSLSVYTTMLSGEI  215 (1035)
Q Consensus       137 ~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~-~~p~~l~~l~~L~~L~l~~n~l~~~~  215 (1035)
                      .+++..|..|+.+++|++|++++|. +....+..++.+++|++|++++|.+.+ .+|..|+++++|++|++++|.+++..
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~L~~n~-l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~  165 (570)
T 2z63_A           87 PIQSLALGAFSGLSSLQKLVAVETN-LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY  165 (570)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTSC-CCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred             cCCccCHhhhcCccccccccccccc-cccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence            9997777899999999999999996 443334469999999999999999987 47999999999999999999999888


Q ss_pred             ccccccCcCC----ceEEecCCcCCCCCChhhhcccchhHhhccccccc-ccCCccccCCCCCcEEEccCccCC------
Q 039419          216 PPQIGNCSEL----VDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFD-GAIPEEIGNCKSLKTIDLSLNFFS------  284 (1035)
Q Consensus       216 p~~l~~l~~L----~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~L~L~~n~l~------  284 (1035)
                      +..++.+.+|    +.|++++|.+++..+..|... +|+.|++++|... ..++..+..+++++.+.+..+.+.      
T Consensus       166 ~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~  244 (570)
T 2z63_A          166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE  244 (570)
T ss_dssp             GGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCE
T ss_pred             HHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhh
Confidence            8889999988    899999999998888777766 7999999988543 245667788888888777654332      


Q ss_pred             CCCCccccCCC--CCcEEEccCC-ccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEecc
Q 039419          285 GSLPQSFGNLS--SLEELMLSNN-NISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLS  361 (1035)
Q Consensus       285 ~~~~~~~~~l~--~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls  361 (1035)
                      ......|..++  .++.+++++| .+.+..+..|..+++|++|++++|+++           .+|..+..+ +|++|+++
T Consensus       245 ~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-----------~l~~~~~~~-~L~~L~l~  312 (570)
T 2z63_A          245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-----------RVKDFSYNF-GWQHLELV  312 (570)
T ss_dssp             ECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-----------SCCBCCSCC-CCSEEEEE
T ss_pred             hcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-----------hhhhhhccC-CccEEeec
Confidence            22223344433  3577888888 788888999999999999999999886           467788888 99999999


Q ss_pred             CcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCC--cccccCCC
Q 039419          362 HNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTL--PSSLASLT  439 (1035)
Q Consensus       362 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~l~  439 (1035)
                      +|.++ .+|.  ..+++|++|++++|.+.+..+.                ..+++|++|++++|++++..  +..+..++
T Consensus       313 ~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~----------------~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~  373 (570)
T 2z63_A          313 NCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE----------------VDLPSLEFLDLSRNGLSFKGCCSQSDFGTT  373 (570)
T ss_dssp             SCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC----------------CBCTTCCEEECCSSCCBEEEEEEHHHHTCS
T ss_pred             cCccc-ccCc--ccccccCEEeCcCCcccccccc----------------ccCCCCCEEeCcCCccCccccccccccccC
Confidence            99998 4444  4788999999999998765443                34578999999999998654  67889999


Q ss_pred             CccEEEcCCCccCCCCchhccCccccchhhccCCcccccCc-cccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceee
Q 039419          440 RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIP-SSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLN  518 (1035)
Q Consensus       440 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~  518 (1035)
                      +|++|++++|++.+..+. |..+++|+.|++++|.+.+..+ ..+..+++|++|+|++|.+++..|..+..+..+. .|+
T Consensus       374 ~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~  451 (570)
T 2z63_A          374 SLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE-VLK  451 (570)
T ss_dssp             CCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC-EEE
T ss_pred             ccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCc-EEE
Confidence            999999999999977655 9999999999999999997766 5789999999999999999977777776666554 799


Q ss_pred             ccCccCC-CCCCccccCCccccEEeccCCcccCc-cccccccCCCcEEeccCCcCcccCCCh-hhhhccccccccccccC
Q 039419          519 LSWNALS-GAIPPQISALNKLSILDLSHNKLGGD-LLALSGLDNLVSLNVSYNNFTGYLPDS-KLFRQLSATEMAGNQGL  595 (1035)
Q Consensus       519 Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~ls~N~l~~~~p~~-~~~~~l~~~~~~~N~~~  595 (1035)
                      +++|.++ +.+|..+..+++|++|+|++|++++. +..+..+++|++|++++|++++.+|.. ..+.+++.+++.+|++.
T Consensus       452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~  531 (570)
T 2z63_A          452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD  531 (570)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCccc
Confidence            9999998 57889999999999999999999987 568999999999999999999987753 45678888999999999


Q ss_pred             CCCCC
Q 039419          596 CSRGH  600 (1035)
Q Consensus       596 c~~~~  600 (1035)
                      |.++.
T Consensus       532 ~~~~~  536 (570)
T 2z63_A          532 CSCPR  536 (570)
T ss_dssp             CCTTT
T ss_pred             CCCcc
Confidence            98764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-48  Score=428.60  Aligned_cols=266  Identities=26%  Similarity=0.303  Sum_probs=198.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||+||+|++. |+.||||++.....               ....+.+|+..+.+++|||||++++++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~---------------~~~~~e~Ei~~~~~l~HpNIv~l~g~~   66 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---------------RSWFREAEIYQTVMLRHENILGFIAAD   66 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH---------------HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch---------------hhHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            56788899999999999999885 89999999854211               012334566667789999999999999


Q ss_pred             EcCC----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC-----CCCeeccCCCcccEEEcC
Q 039419          766 WNRN----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC-----VPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       766 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivHrDikp~NIll~~  836 (1035)
                      .+++    ..|+|||||++|+|.++++...   +++..+.+++.|+|+||+|||+++     .++|+||||||+|||++.
T Consensus        67 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~  143 (303)
T 3hmm_A           67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  143 (303)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred             EecCCCceEEEEEecCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC
Confidence            8754    4699999999999999997653   899999999999999999999752     348999999999999999


Q ss_pred             CCceEEeeccCccccccCCcc--ccccccCCcccccCCcccccC------CCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          837 EFEPYIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMM------KITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      ++++||+|||+|+........  ......+||+.|||||++.+.      .++.++|||||||++|||+||+.||.....
T Consensus       144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~  223 (303)
T 3hmm_A          144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  223 (303)
T ss_dssp             TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred             CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccc
Confidence            999999999999876544321  122356799999999997654      467899999999999999999887653221


Q ss_pred             C----------chhHHHHHHHhccchhhhcccccCCCc---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          909 E----------GLHIVDWVRQKRGAIEVLDKSLRARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       909 ~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .          ......+...      ......+...+   ...+....+.+++.+||+.||++||||.||++.|+++.+
T Consensus       224 ~~~p~~~~~~~~~~~~~~~~~------~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          224 YQLPYYDLVPSDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHH------HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccchhcccccchHHHHHHH------HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            1          1111111111      11111111111   112333345678999999999999999999999998865


Q ss_pred             h
Q 039419          976 E  976 (1035)
Q Consensus       976 ~  976 (1035)
                      +
T Consensus       298 ~  298 (303)
T 3hmm_A          298 Q  298 (303)
T ss_dssp             C
T ss_pred             H
Confidence            4

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=6.7e-48  Score=464.85  Aligned_cols=486  Identities=18%  Similarity=0.161  Sum_probs=364.3

Q ss_pred             eEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccc
Q 039419           58 KLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNY  137 (1035)
Q Consensus        58 ~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~  137 (1035)
                      ..++++++++ .+|+.+.  ++|++|+|++|++++..|..++++++|++|+|++|++++..|..++.+++|++|+|++|.
T Consensus         9 ~c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   85 (549)
T 2z81_A            9 VCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH   85 (549)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             eEECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCc
Confidence            3577889998 7888775  799999999999998888999999999999999999997777899999999999999999


Q ss_pred             cCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCc-ccccccccccceeecccccccCCc
Q 039419          138 LSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLP-ASLGKLSKLQSLSVYTTMLSGEIP  216 (1035)
Q Consensus       138 l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p-~~l~~l~~L~~L~l~~n~l~~~~p  216 (1035)
                      +++..|..|+++++|++|++++|.......|..++.+++|++|++++|.+.+.+| ..|+++++|++|++++|.+++..|
T Consensus        86 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  165 (549)
T 2z81_A           86 LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS  165 (549)
T ss_dssp             CCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECT
T ss_pred             cCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccCh
Confidence            9977777799999999999999973332455667777777777777777433443 567777777777777777777677


Q ss_pred             cccccCcCCceEEecCCcCCCCCChhh-hcccchhHhhcccccccccC--C-ccccCCCCCcEEEccCccCCCCCC----
Q 039419          217 PQIGNCSELVDLFLYENDLSGSLPREL-GKLQKLEKMLLWQNNFDGAI--P-EEIGNCKSLKTIDLSLNFFSGSLP----  288 (1035)
Q Consensus       217 ~~l~~l~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~l~~n~l~~~~--p-~~~~~l~~L~~L~L~~n~l~~~~~----  288 (1035)
                      ..+..+++|+.|++++|.+. .+|..+ ..+++|++|++++|++.+..  | .....+++|+.|++++|.+++..+    
T Consensus       166 ~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~  244 (549)
T 2z81_A          166 QSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELL  244 (549)
T ss_dssp             TTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHH
T ss_pred             hhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHH
Confidence            77777777777777777765 333332 34556666666666655421  1 112234455555555555543222    


Q ss_pred             ccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCC
Q 039419          289 QSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS  368 (1035)
Q Consensus       289 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  368 (1035)
                      ..+..+++|+.|++++|.+.+...                            +.......+..+++|+.|++.++.+...
T Consensus       245 ~~~~~~~~L~~l~l~~~~~~~~~~----------------------------~~~~~~~~~~~l~~L~~L~l~~~~i~~~  296 (549)
T 2z81_A          245 KLLRYILELSEVEFDDCTLNGLGD----------------------------FNPSESDVVSELGKVETVTIRRLHIPQF  296 (549)
T ss_dssp             GGGGGCTTCCEEEEESCEEECCSC----------------------------CCCCTTTCCCCCTTCCEEEEESCBCSCG
T ss_pred             HHhhhhcccccccccccccccccc----------------------------ccccchhhhhhhcccccccccccccchh
Confidence            122334455555555554443211                            0001123466788999999999988632


Q ss_pred             C-----CCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc---ccccCCCC
Q 039419          369 L-----HPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP---SSLASLTR  440 (1035)
Q Consensus       369 ~-----~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~---~~l~~l~~  440 (1035)
                      .     +..+....+|++|++++|+++. +|..+             +.++++|++|+|++|++++..|   ..+..+++
T Consensus       297 ~~~~~l~~~~~~~~~L~~L~l~~n~l~~-ip~~~-------------~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~  362 (549)
T 2z81_A          297 YLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSF-------------SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS  362 (549)
T ss_dssp             GGSCCCCHHHHHSTTCCEEEEESSCCCC-CCHHH-------------HHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTT
T ss_pred             hhcccchhhhhhcccceEEEeccCcccc-CCHHH-------------HhcCccccEEEccCCccccccccchhhhhcccc
Confidence            1     1112345789999999999873 33322             2356789999999999997664   34788999


Q ss_pred             ccEEEcCCCccCCCCc--hhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceee
Q 039419          441 LQVLDISVNQFVGLIP--ESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLN  518 (1035)
Q Consensus       441 L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~  518 (1035)
                      |++|+|++|++++..+  ..+..+++|++|++++|+|+ .+|..+..+++|++|+|++|+|+ .+|..+.   ..+..|+
T Consensus       363 L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~---~~L~~L~  437 (549)
T 2z81_A          363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP---QTLEVLD  437 (549)
T ss_dssp             CCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC---TTCSEEE
T ss_pred             CcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc---CCceEEE
Confidence            9999999999997653  56899999999999999998 67888999999999999999998 5665443   3456899


Q ss_pred             ccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCC-hhhhhccccccccccccCCC
Q 039419          519 LSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPD-SKLFRQLSATEMAGNQGLCS  597 (1035)
Q Consensus       519 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~~~l~~~~~~~N~~~c~  597 (1035)
                      +++|+|++.+    ..+++|++|+|++|+|+..+. ...+++|++|+|++|++++.+|. ...+..++.+++.+|++.|.
T Consensus       438 Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  512 (549)
T 2z81_A          438 VSNNNLDSFS----LFLPRLQELYISRNKLKTLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  512 (549)
T ss_dssp             CCSSCCSCCC----CCCTTCCEEECCSSCCSSCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred             CCCCChhhhc----ccCChhcEEECCCCccCcCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence            9999999764    578999999999999997665 56799999999999999998887 35678888999999999997


Q ss_pred             CC
Q 039419          598 RG  599 (1035)
Q Consensus       598 ~~  599 (1035)
                      ++
T Consensus       513 ~~  514 (549)
T 2z81_A          513 CP  514 (549)
T ss_dssp             HH
T ss_pred             Cc
Confidence            54

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=456.01  Aligned_cols=455  Identities=21%  Similarity=0.175  Sum_probs=290.7

Q ss_pred             ceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceecccc
Q 039419           57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDN  136 (1035)
Q Consensus        57 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n  136 (1035)
                      ++|++++|+++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..++.+++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            46777777777 5776665  67777777777777666677777777777777777777666777777777777777777


Q ss_pred             ccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccc--cceeeccccc--c
Q 039419          137 YLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKL--QSLSVYTTML--S  212 (1035)
Q Consensus       137 ~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L--~~L~l~~n~l--~  212 (1035)
                      +++ .+|..  .+++|++|++++|......+|..++.+++|++|++++|.+.+   ..+..+++|  ++|++++|.+  .
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~  153 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE  153 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence            777 56655  677777777777753222455666666666666666666654   345556666  7777777777  5


Q ss_pred             cCCccccccCc-CCceEEecCCcCCCCCCh-hhhcccchhHhhccccc-------ccccCCccccCCCCCcEEEccCccC
Q 039419          213 GEIPPQIGNCS-ELVDLFLYENDLSGSLPR-ELGKLQKLEKMLLWQNN-------FDGAIPEEIGNCKSLKTIDLSLNFF  283 (1035)
Q Consensus       213 ~~~p~~l~~l~-~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~l~~n~-------l~~~~p~~~~~l~~L~~L~L~~n~l  283 (1035)
                      +..|..+..+. +...+++++|.+.+.++. .+..+++|+.|++++|.       +.+.+| .+..+++|+.|++++|.+
T Consensus       154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l  232 (520)
T 2z7x_B          154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET  232 (520)
T ss_dssp             SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred             ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence            66666666654 344556666766654443 45667777777777776       555554 566777777777777766


Q ss_pred             CCCCCcccc---CCCCCcEEEccCCccccCCCCcc-----cCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCC
Q 039419          284 SGSLPQSFG---NLSSLEELMLSNNNISGSIPPVL-----SNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSL  355 (1035)
Q Consensus       284 ~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L  355 (1035)
                      ++..+..+.   ..++|++|++++|++.+.+|..+     ..+++|+.+++                             
T Consensus       233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l-----------------------------  283 (520)
T 2z7x_B          233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV-----------------------------  283 (520)
T ss_dssp             EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEE-----------------------------
T ss_pred             CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccc-----------------------------
Confidence            543221111   13467777777777666555555     44444444444                             


Q ss_pred             cEEeccCcCCCCCCC-CCcccC---cccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCC
Q 039419          356 EAVDLSHNALTGSLH-PGLFQL---QNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTL  431 (1035)
Q Consensus       356 ~~L~Ls~N~l~~~~~-~~~~~l---~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~  431 (1035)
                           ++|.+  .+| ..+..+   .+|+.|++++|.+....   +             +..+++|++|+|++|++++..
T Consensus       284 -----~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~---~-------------~~~l~~L~~L~Ls~n~l~~~~  340 (520)
T 2z7x_B          284 -----VSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML---C-------------PSKISPFLHLDFSNNLLTDTV  340 (520)
T ss_dssp             -----EECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC---C-------------CSSCCCCCEEECCSSCCCTTT
T ss_pred             -----cccce--ecchhhhhcccccCceeEEEcCCCcccccc---c-------------hhhCCcccEEEeECCccChhh
Confidence                 44444  122 222222   34555555555443211   0             123345666666666666656


Q ss_pred             cccccCCCCccEEEcCCCccCC--CCchhccCccccchhhccCCcccccCcc-ccCCCCCCcEEEcCCCcCcCccchhhh
Q 039419          432 PSSLASLTRLQVLDISVNQFVG--LIPESFGQLASLNRLILSKNSFSGAIPS-SLGRCESLQSLDLSSNKLSGKIPVELF  508 (1035)
Q Consensus       432 ~~~l~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~  508 (1035)
                      |..+..+++|++|+|++|++++  ..|..|..+++|++|++++|++++.+|. .+..+++|++|+|++|++++.+|..+.
T Consensus       341 ~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  420 (520)
T 2z7x_B          341 FENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP  420 (520)
T ss_dssp             TTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC
T ss_pred             hhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc
Confidence            6666666666666666666665  2345566666666666666666653333 366666677777777766655554442


Q ss_pred             hhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcccc-ccccCCCcEEeccCCcCcccCCC
Q 039419          509 EIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLA-LSGLDNLVSLNVSYNNFTGYLPD  577 (1035)
Q Consensus       509 ~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~ls~N~l~~~~p~  577 (1035)
                         ..+..|++++|+++ .+|..+..+++|++|+|++|+|+..+.. +..+++|++|++++|++++.++.
T Consensus       421 ---~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          421 ---PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             ---TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             ---ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence               23346677777776 5566666889999999999999987765 88899999999999999987654

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=3e-47  Score=464.31  Aligned_cols=470  Identities=16%  Similarity=0.236  Sum_probs=381.9

Q ss_pred             cccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceec
Q 039419           54 SFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLL  133 (1035)
Q Consensus        54 ~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l  133 (1035)
                      .+++.|+|+++++.|.+|++++.|++|++|+|++|.+. ..+..++..           .+.-.+|...  +.+|+ +++
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~~-----------~~~~~~~~~~--~~~l~-l~l  145 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VNERLFGPK-----------GISANMSDEQ--KQKMR-MHY  145 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGG-GTCCSBSTT-----------SBCTTCCHHH--HHHHH-THH
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccc-cCCcccccc-----------ccccCchHHH--HHHHH-hhH
Confidence            35778888888888888888888888888888887664 111111110           1112466655  77888 999


Q ss_pred             cccccCCCCchhhcc-ccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceee--cccc
Q 039419          134 FDNYLSGNLPVELGK-LVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSV--YTTM  210 (1035)
Q Consensus       134 ~~n~l~~~~p~~l~~-l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l--~~n~  210 (1035)
                      ++|.+.+.+|..+.. +..+..+++....                         +.      ......++.+.+  .+|+
T Consensus       146 ~~~~l~~~~~~~~~~~~~~l~~~~l~~~~-------------------------~~------~~~~~~l~~l~l~~~~n~  194 (636)
T 4eco_A          146 QKTFVDYDPREDFSDLIKDCINSDPQQKS-------------------------IK------KSSRITLKDTQIGQLSNN  194 (636)
T ss_dssp             HHHHTCCCGGGGSCHHHHHHHHHCTTSCC-------------------------CC------CCCCCCCCTTTTTCCSCE
T ss_pred             HHhhhccCchhhHHHHHHHHhhcCccccc-------------------------cc------cccccchhhhhhccccCC
Confidence            999999888877764 3344444443321                         00      011122333333  4689


Q ss_pred             cccCCccccccCcCCceEEecCCcCCCC-----------------CChhhh--cccchhHhhcccccccccCCccccCCC
Q 039419          211 LSGEIPPQIGNCSELVDLFLYENDLSGS-----------------LPRELG--KLQKLEKMLLWQNNFDGAIPEEIGNCK  271 (1035)
Q Consensus       211 l~~~~p~~l~~l~~L~~L~L~~n~l~~~-----------------~~~~l~--~l~~L~~L~l~~n~l~~~~p~~~~~l~  271 (1035)
                      +++ +|..++++++|++|+|++|.+++.                 +|..++  ++++|++|++++|++.+.+|..|++++
T Consensus       195 l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~  273 (636)
T 4eco_A          195 ITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP  273 (636)
T ss_dssp             EEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCS
T ss_pred             Ccc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCC
Confidence            997 999999999999999999999985                 899998  999999999999999999999999999


Q ss_pred             CCcEEEccCcc-CCC-CCCccccCC------CCCcEEEccCCccccCCCC--cccCCCccceeccccchhhhhhhhcccc
Q 039419          272 SLKTIDLSLNF-FSG-SLPQSFGNL------SSLEELMLSNNNISGSIPP--VLSNATSLLQLQLDTNQISVFFAWQNKL  341 (1035)
Q Consensus       272 ~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~i~~l~~~~n~l  341 (1035)
                      +|++|+|++|+ +++ .+|..++++      ++|++|++++|+++ .+|.  .|.++++|++|++++|+++         
T Consensus       274 ~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~---------  343 (636)
T 4eco_A          274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLE---------  343 (636)
T ss_dssp             SCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCE---------
T ss_pred             CCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCc---------
Confidence            99999999998 998 788888876      99999999999999 7888  8999999999999998875         


Q ss_pred             CCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcc-cceEeccccccccCCCCCCCCCCcceeEeeeccCCCCcccee
Q 039419          342 EGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQN-LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQML  420 (1035)
Q Consensus       342 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L  420 (1035)
                       |.+| .+..+++|++|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..+            .+++|++|
T Consensus       344 -g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~------------~l~~L~~L  407 (636)
T 4eco_A          344 -GKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK------------SVSVMSAI  407 (636)
T ss_dssp             -EECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTT------------CSSCEEEE
T ss_pred             -cchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhc------------ccCccCEE
Confidence             4567 8999999999999999999 78888999999 999999999999 566665443            23579999


Q ss_pred             ecCCCccCCCCccccc-------CCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCC------
Q 039419          421 NLSNNTLGGTLPSSLA-------SLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCE------  487 (1035)
Q Consensus       421 ~L~~N~l~~~~~~~l~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~------  487 (1035)
                      +|++|++++..|..+.       .+++|++|+|++|+++.+++..+..+++|+.|+|++|+|+.+.+..+....      
T Consensus       408 ~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l  487 (636)
T 4eco_A          408 DFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNT  487 (636)
T ss_dssp             ECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTG
T ss_pred             ECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccccccccc
Confidence            9999999999999888       888999999999999987777788899999999999999944444444333      


Q ss_pred             -CCcEEEcCCCcCcCccchhhh--hhccCcceeeccCccCCCCCCccccCCccccEEecc------CCcccC-ccccccc
Q 039419          488 -SLQSLDLSSNKLSGKIPVELF--EIEGLDISLNLSWNALSGAIPPQISALNKLSILDLS------HNKLGG-DLLALSG  557 (1035)
Q Consensus       488 -~L~~L~Ls~N~l~~~~p~~~~--~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~------~N~l~~-~~~~~~~  557 (1035)
                       +|++|+|++|+|+ .+|..++  .+..+. .|+|++|++++ +|..+..+++|++|+|+      +|++.+ .+..+..
T Consensus       488 ~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~-~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~  564 (636)
T 4eco_A          488 YLLTSIDLRFNKLT-KLSDDFRATTLPYLV-GIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL  564 (636)
T ss_dssp             GGCCEEECCSSCCC-BCCGGGSTTTCTTCC-EEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGG
T ss_pred             CCccEEECcCCcCC-ccChhhhhccCCCcC-EEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhc
Confidence             9999999999999 8998887  555554 79999999998 88999999999999995      466655 5568999


Q ss_pred             cCCCcEEeccCCcCcccCCChhhhhccccccccccccCCCCCCC
Q 039419          558 LDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRGHE  601 (1035)
Q Consensus       558 l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~~~  601 (1035)
                      +++|+.|+|++|++ +.+|.. .+++++.+++.+|++.|-....
T Consensus       565 l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~~~~~~  606 (636)
T 4eco_A          565 CPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNISIDLSY  606 (636)
T ss_dssp             CSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCEEECTT
T ss_pred             CCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCccccHHh
Confidence            99999999999999 566654 4588999999999999865433

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=7.4e-47  Score=467.17  Aligned_cols=483  Identities=18%  Similarity=0.201  Sum_probs=257.0

Q ss_pred             cccceEeecCcccCCCCCCCCCCCCCCceeeC-CCCCCCCCCChhhhcc---------ccccceEec-------ccCCCC
Q 039419           54 SFLQKLIISGSNLTGPISPDLGDCTQLTTIDV-SSNSLVGGVPSSIGKL---------INLQDLILN-------SNQLTG  116 (1035)
Q Consensus        54 ~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~l-s~n~l~~~~p~~i~~l---------~~L~~L~L~-------~n~l~~  116 (1035)
                      .+++.|+|+++++.|.+|++|+.|++|++|+| ++|.+.|..|-....+         ..++...+.       ...+.+
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            56889999999999999999999999999999 8888776644221111         001100000       001110


Q ss_pred             CCchhh-----------hhhccccceeccc--cccCCCCchhhccccccceeecCCCcccCC-CCCCcCCCccceEEEEe
Q 039419          117 EIPKEL-----------GACIKLKNLLLFD--NYLSGNLPVELGKLVNLEVIRAGGNKDIAG-KIPYEIGDCQSLLVVGL  182 (1035)
Q Consensus       117 ~~p~~l-----------~~l~~L~~L~l~~--n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~-~~~~~~~~l~~L~~L~l  182 (1035)
                      .++..+           .....++.+.+..  |.+++ +|..|++|++|++|++++|. +.+ .++..+..        .
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~-Lsg~~i~~~~~~--------~  472 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSP-FTYDNIAVDWED--------A  472 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCC-CCGGGBSSSCSC--------T
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCc-CCCCcccccccc--------c
Confidence            011111           1122333333333  55554 56666666666666666554 222 11111111        0


Q ss_pred             ccccccccCccccc--ccccccceeecccccccCCccccccCcCCceEEecCCc-CCC-CCChhhhccc-------chhH
Q 039419          183 ADTKVAGSLPASLG--KLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEND-LSG-SLPRELGKLQ-------KLEK  251 (1035)
Q Consensus       183 ~~~~~~~~~p~~l~--~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~~~~l~~l~-------~L~~  251 (1035)
                      +.+...+.+|..++  ++++|++|+|++|.+.+.+|..|+++++|+.|+|++|+ +++ .+|..++.++       +|+.
T Consensus       473 s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~  552 (876)
T 4ecn_A          473 NSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI  552 (876)
T ss_dssp             TSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCE
T ss_pred             ccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccE
Confidence            11222234677766  77777777777777777777777777777777777776 665 5666666554       5555


Q ss_pred             hhcccccccccCCc--cccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCc-cceecccc
Q 039419          252 MLLWQNNFDGAIPE--EIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATS-LLQLQLDT  328 (1035)
Q Consensus       252 L~l~~n~l~~~~p~--~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~  328 (1035)
                      |+|++|++. .+|.  .|.++++|+.|+|++|+++ .+| .|+++++|+.|+|++|++. .+|..|.++++ |+.|+|++
T Consensus       553 L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~  628 (876)
T 4ecn_A          553 FYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH  628 (876)
T ss_dssp             EECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCS
T ss_pred             EEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcC
Confidence            555555555 4444  4555555555555555555 344 4555555555555555554 44444444444 55555544


Q ss_pred             chhhhhhhhccccCCCCCcCCCCCCC--CcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeE
Q 039419          329 NQISVFFAWQNKLEGSIPSTLANCRS--LEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL  406 (1035)
Q Consensus       329 N~i~~l~~~~n~l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  406 (1035)
                      |+|+           .+|..+..++.  |+.|+|++|++++.+                        |.....+.     
T Consensus       629 N~L~-----------~lp~~~~~~~~~~L~~L~Ls~N~l~g~i------------------------p~l~~~l~-----  668 (876)
T 4ecn_A          629 NKLK-----------YIPNIFNAKSVYVMGSVDFSYNKIGSEG------------------------RNISCSMD-----  668 (876)
T ss_dssp             SCCC-----------SCCSCCCTTCSSCEEEEECCSSCTTTTS------------------------SSCSSCTT-----
T ss_pred             CCCC-----------cCchhhhccccCCCCEEECcCCcCCCcc------------------------ccchhhhc-----
Confidence            4443           22333333322  445555555444333                        22111110     


Q ss_pred             eeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccC-------ccccchhhccCCcccccC
Q 039419          407 RLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQ-------LASLNRLILSKNSFSGAI  479 (1035)
Q Consensus       407 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-------l~~L~~L~Ls~N~l~~~~  479 (1035)
                          ...+++|+.|+|++|+++...+..+..+++|+.|+|++|+|+.+++..+..       +++|+.|+|++|+|+ .+
T Consensus       669 ----~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~l  743 (876)
T 4ecn_A          669 ----DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SL  743 (876)
T ss_dssp             ----TCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CC
T ss_pred             ----cccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cc
Confidence                001223444444444444222222234444444444444444322222221       124444444444444 33


Q ss_pred             ccccC--CCCCCcEEEcCCCcCcCccchhhhhhccCcceeec------cCccCCCCCCccccCCccccEEeccCCcccCc
Q 039419          480 PSSLG--RCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNL------SWNALSGAIPPQISALNKLSILDLSHNKLGGD  551 (1035)
Q Consensus       480 ~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~L------s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  551 (1035)
                      |..+.  .+++|+.|+|++|+|++ +|..++.+..+. .|+|      ++|++.+.+|..|..+++|+.|+|++|+|...
T Consensus       744 p~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~-~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~I  821 (876)
T 4ecn_A          744 SDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLK-AFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKV  821 (876)
T ss_dssp             CGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCC-EEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBC
T ss_pred             hHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCC-EEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCCCcc
Confidence            44443  44444444444444443 444444433332 3444      56889999999999999999999999999767


Q ss_pred             cccccccCCCcEEeccCCcCcccCCChh-hhhccccccccccccCC--CCC
Q 039419          552 LLALSGLDNLVSLNVSYNNFTGYLPDSK-LFRQLSATEMAGNQGLC--SRG  599 (1035)
Q Consensus       552 ~~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~~~l~~~~~~~N~~~c--~~~  599 (1035)
                      |..+.  ++|+.|+|++|++....+... .........+.+|+..|  +|+
T Consensus       822 p~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~  870 (876)
T 4ecn_A          822 DEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD  870 (876)
T ss_dssp             CSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCG
T ss_pred             CHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCC
Confidence            76655  699999999999987655431 22334455667776654  554

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.5e-47  Score=414.46  Aligned_cols=253  Identities=21%  Similarity=0.328  Sum_probs=188.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++......             ...+.+.+|+++|++++|||||++++
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------------~~~~~~~~E~~il~~l~HpnIV~~~~   70 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-------------LAREKVMREVKALAKLEHPGIVRYFN   70 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSH-------------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCH-------------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            467999999999999999999876 5899999998643211             13567999999999999999999999


Q ss_pred             EEEcCC------------cceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 039419          764 CCWNRN------------TRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN  830 (1035)
Q Consensus       764 ~~~~~~------------~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~  830 (1035)
                      ++.+.+            ..|+|||||+||+|.++++.+.. ...++..+..++.||+.||+|||++   +|+||||||+
T Consensus        71 ~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~  147 (299)
T 4g31_A           71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPS  147 (299)
T ss_dssp             EEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             EEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHH
Confidence            997654            36899999999999999986543 2356677889999999999999999   9999999999


Q ss_pred             cEEEcCCCceEEeeccCccccccCCcc----------ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCC
Q 039419          831 NILIGPEFEPYIADFGLAKLVVEGDFA----------RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK  900 (1035)
Q Consensus       831 NIll~~~~~~kl~DFG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~  900 (1035)
                      |||++.++.+||+|||+|+........          ......+||+.|||||++.+..|+.++|||||||++|||++  
T Consensus       148 NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--  225 (299)
T 4g31_A          148 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--  225 (299)
T ss_dssp             GEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred             HeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence            999999999999999999877543221          11234679999999999999999999999999999999996  


Q ss_pred             CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       901 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ||...    ......+...      ...   ..++...........++.+||++||++|||+.|++++
T Consensus       226 -Pf~~~----~~~~~~~~~~------~~~---~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          226 -PFSTQ----MERVRTLTDV------RNL---KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -CCSSH----HHHHHHHHHH------HTT---CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -CCCCc----cHHHHHHHHH------hcC---CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             77531    1111111110      000   0111111222334568889999999999999999873

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=448.28  Aligned_cols=456  Identities=20%  Similarity=0.141  Sum_probs=333.4

Q ss_pred             EEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEeccc
Q 039419           33 TEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSN  112 (1035)
Q Consensus        33 ~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n  112 (1035)
                      +.+++++++++ .+|..+.  ++|++|+|++|.+++..|..++.+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            36889999998 5888777  89999999999999777788999999999999999999777999999999999999999


Q ss_pred             CCCCCCchhhhhhccccceeccccccCC-CCchhhccccccceeecCCCcccCCCCCCcCCCccce--EEEEeccccc--
Q 039419          113 QLTGEIPKELGACIKLKNLLLFDNYLSG-NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSL--LVVGLADTKV--  187 (1035)
Q Consensus       113 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L--~~L~l~~~~~--  187 (1035)
                      +++ .+|..  .+++|++|+|++|.+++ .+|..++++++|++|++++|. +.+   ..+..+++|  +.|++++|.+  
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~-l~~---~~~~~l~~L~L~~L~l~~n~l~~  152 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH-LEK---SSVLPIAHLNISKVLLVLGETYG  152 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESS-CCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcc-cch---hhccccccceeeEEEeecccccc
Confidence            999 78877  89999999999999986 578999999999999999997 333   346667777  9999999999  


Q ss_pred             cccCcccccccc-cccceeecccccccCCcc-ccccCcCCceEEecCCc-------CCCCCChhhhcccchhHhhccccc
Q 039419          188 AGSLPASLGKLS-KLQSLSVYTTMLSGEIPP-QIGNCSELVDLFLYEND-------LSGSLPRELGKLQKLEKMLLWQNN  258 (1035)
Q Consensus       188 ~~~~p~~l~~l~-~L~~L~l~~n~l~~~~p~-~l~~l~~L~~L~L~~n~-------l~~~~~~~l~~l~~L~~L~l~~n~  258 (1035)
                      .+..|..+..+. +...+++++|.+.+.++. .+.++++|+.|++++|.       +.+.+| .++.+++|+.|++++|.
T Consensus       153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~  231 (520)
T 2z7x_B          153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIE  231 (520)
T ss_dssp             SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEE
T ss_pred             cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccc
Confidence            888898888876 455678888888776654 67789999999999997       665555 78899999999999998


Q ss_pred             ccccCCcccc---CCCCCcEEEccCccCCCCCCccc-----cCCCCCcEEEccCCccccCCCCcccCC---Cccceeccc
Q 039419          259 FDGAIPEEIG---NCKSLKTIDLSLNFFSGSLPQSF-----GNLSSLEELMLSNNNISGSIPPVLSNA---TSLLQLQLD  327 (1035)
Q Consensus       259 l~~~~p~~~~---~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~  327 (1035)
                      +.+..+..+.   ..++|++|++++|++++.+|..+     .++++|+.+++++|.+ ......+..+   .+|+.|+++
T Consensus       232 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~  310 (520)
T 2z7x_B          232 TTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVS  310 (520)
T ss_dssp             EEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEE
T ss_pred             cCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcC
Confidence            8764333221   24699999999999998899888     9999999999999999 2322344333   456666666


Q ss_pred             cchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEe
Q 039419          328 TNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR  407 (1035)
Q Consensus       328 ~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  407 (1035)
                      +|++..+            ..+..+++|++|++++|++++..|..+..+++|++|++++|+|++..              
T Consensus       311 ~n~l~~~------------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~--------------  364 (520)
T 2z7x_B          311 GTRMVHM------------LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELS--------------  364 (520)
T ss_dssp             SSCCCCC------------CCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHH--------------
T ss_pred             CCccccc------------cchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccc--------------
Confidence            6655421            11145555566666666655545555555555555555555444210              


Q ss_pred             eeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCC-CCchhccCccccchhhccCCcccccCccccCCC
Q 039419          408 LMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG-LIPESFGQLASLNRLILSKNSFSGAIPSSLGRC  486 (1035)
Q Consensus       408 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  486 (1035)
                                            .+|..+..+++|++|++++|++++ +++..|..+++|+.|++++|++++..|..+.  
T Consensus       365 ----------------------~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--  420 (520)
T 2z7x_B          365 ----------------------KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--  420 (520)
T ss_dssp             ----------------------HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--
T ss_pred             ----------------------cchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--
Confidence                                  233445555555555555555555 2222355555555555555555544444443  


Q ss_pred             CCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcc
Q 039419          487 ESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL  552 (1035)
Q Consensus       487 ~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  552 (1035)
                      ++|++|+|++|+|+ .+|..++.+..+. .|++++|+++++.+..|..+++|++|+|++|++.+..
T Consensus       421 ~~L~~L~Ls~N~l~-~ip~~~~~l~~L~-~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c  484 (520)
T 2z7x_B          421 PRIKVLDLHSNKIK-SIPKQVVKLEALQ-ELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  484 (520)
T ss_dssp             TTCCEEECCSSCCC-CCCGGGGGCTTCC-EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ccCCEEECCCCccc-ccchhhhcCCCCC-EEECCCCcCCccCHHHhccCCcccEEECcCCCCcccC
Confidence            45666666666665 5565555444433 5666666666444445888999999999999999865

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=3.6e-45  Score=449.41  Aligned_cols=557  Identities=20%  Similarity=0.179  Sum_probs=354.9

Q ss_pred             CCcccCCCCCCCCCCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCcee
Q 039419            4 IPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTI   83 (1035)
Q Consensus         4 ~~~~l~~w~~~~~~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L   83 (1035)
                      +...+++|..+.  |..|+.-.|...+.  ..+-++.+++ .+|..+.  +++++|||++|.|++..+.+|..+++|++|
T Consensus         9 ~~~~~~~~~~~~--p~~~~~c~~~~~~~--~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L   81 (635)
T 4g8a_A            9 DDDKLAAANSSI--PESWEPCVEVVPNI--TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVL   81 (635)
T ss_dssp             ------------------CCSEEEETTT--EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CcchhhcccCCC--CCCCCCccccCCCC--EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEE
Confidence            345677787654  34555433332221  1233344454 4666554  478999999999997666789999999999


Q ss_pred             eCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCccc
Q 039419           84 DVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDI  163 (1035)
Q Consensus        84 ~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~  163 (1035)
                      ||++|+|++..|..|++|++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|+++++|++|++++|...
T Consensus        82 ~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~  161 (635)
T 4g8a_A           82 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ  161 (635)
T ss_dssp             ECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccc
Confidence            99999999666778999999999999999999555567899999999999999999655667999999999999999855


Q ss_pred             CCCCCCcCCCccceEEEEeccccccccCccccccccccc----ceeecccccccCCccccccCcCCceEEecCCcCCCC-
Q 039419          164 AGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQ----SLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGS-  238 (1035)
Q Consensus       164 ~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~----~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-  238 (1035)
                      ...+|..++.+++|+.|++++|++.+..+..+..+.+++    .++++.|.+.. ++........+..+++.+|..... 
T Consensus       162 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~-i~~~~~~~~~~~~l~l~~n~~~~~~  240 (635)
T 4g8a_A          162 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNV  240 (635)
T ss_dssp             CCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCE-ECTTTTTTCEEEEEEEESCCSSHHH
T ss_pred             cCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccc-cCcccccchhhhhhhhhcccccccc
Confidence            556788899999999999999999988888888877665    57788888884 444444555678888888865522 


Q ss_pred             CChhhhcccchhHhhccccc------ccccCCccccCCCCCcEEEccCccCCC---CCCccccCCCCCcEEEccCCcccc
Q 039419          239 LPRELGKLQKLEKMLLWQNN------FDGAIPEEIGNCKSLKTIDLSLNFFSG---SLPQSFGNLSSLEELMLSNNNISG  309 (1035)
Q Consensus       239 ~~~~l~~l~~L~~L~l~~n~------l~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~~~~l~~L~~L~L~~N~l~~  309 (1035)
                      .+..+..+..++...+..+.      +.......+..+..+..+++..+....   .....+..+.+++.+++.+|.+..
T Consensus       241 ~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~  320 (635)
T 4g8a_A          241 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIER  320 (635)
T ss_dssp             HHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEE
T ss_pred             cchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccc
Confidence            23345555555544443222      222233444555556666555544331   123345556677777777776654


Q ss_pred             CCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEecccccc
Q 039419          310 SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGI  389 (1035)
Q Consensus       310 ~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i  389 (1035)
                      ..  .+.....|+.|++.+|++..+             ....+..|+.+++++|.+...  .....+++|+.|++++|.+
T Consensus       321 ~~--~~~~~~~L~~L~l~~~~~~~~-------------~~~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l  383 (635)
T 4g8a_A          321 VK--DFSYNFGWQHLELVNCKFGQF-------------PTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGL  383 (635)
T ss_dssp             CG--GGGSCCCCSEEEEESCEESSC-------------CCCBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCC
T ss_pred             cc--ccccchhhhhhhcccccccCc-------------CcccchhhhhcccccccCCCC--cccccccccccchhhcccc
Confidence            32  245556677777777766422             123455667777777766532  2334567777777777766


Q ss_pred             ccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCc-hhccCccccchh
Q 039419          390 SGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIP-ESFGQLASLNRL  468 (1035)
Q Consensus       390 ~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L  468 (1035)
                      ....+..            ..+..+.+|++|++..|.+.. .+..+..+++|+.+++++|++....+ ..|..+.+++.+
T Consensus       384 ~~~~~~~------------~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l  450 (635)
T 4g8a_A          384 SFKGCCS------------QSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL  450 (635)
T ss_dssp             BEEEECC------------HHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEE
T ss_pred             ccccccc------------cchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccc
Confidence            5321110            112334556666666666652 34455666666666666665544332 345666666666


Q ss_pred             hccCCcccccCccccCCCCCCcEEEcCCCcCcCc-cchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCc
Q 039419          469 ILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGK-IPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNK  547 (1035)
Q Consensus       469 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  547 (1035)
                      ++++|.+.+..+..+..++.|+.|+|++|.+.+. +|..+..+.. +..|+|++|+|++..|..|..+++|++|+|++|+
T Consensus       451 ~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~-L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~  529 (635)
T 4g8a_A          451 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN-LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN  529 (635)
T ss_dssp             ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT-CCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             cccccccccccccccccchhhhhhhhhhcccccccCchhhhhccc-cCEEECCCCccCCcChHHHcCCCCCCEEECCCCc
Confidence            6666666666666666666666666666654322 3333333333 3356666666666667777777777777777777


Q ss_pred             ccCcc-ccccccCCCcEEeccCCcCcccCCChh-hh-hccccccccccccCCCCC
Q 039419          548 LGGDL-LALSGLDNLVSLNVSYNNFTGYLPDSK-LF-RQLSATEMAGNQGLCSRG  599 (1035)
Q Consensus       548 l~~~~-~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~-~~l~~~~~~~N~~~c~~~  599 (1035)
                      |++.+ ..|.++++|++|+|++|+|++.+|..- .+ .+++.+++.+|||.|+|.
T Consensus       530 l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          530 FFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             CCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             CCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            77654 456777777777777777777666531 12 456666777777777653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=407.93  Aligned_cols=264  Identities=23%  Similarity=0.290  Sum_probs=199.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.......            ...+++.+|+.+|++++|||||+++++
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~HpnIv~l~~~  121 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV------------TNAKRTLRELKILKHFKHDNIIAIKDI  121 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch------------HHHHHHHHHHHHHHhcCCCCcceEeee
Confidence            57999999999999999999775 59999999996543221            124678899999999999999999999


Q ss_pred             EEcC------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          765 CWNR------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       765 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +...      +..|+|||||+ |+|.+++...+  .+++..+..++.||+.||+|||++   ||+||||||+|||++.++
T Consensus       122 ~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~  195 (398)
T 4b99_A          122 LRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENC  195 (398)
T ss_dssp             CCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTC
T ss_pred             eecccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCC
Confidence            7643      56799999995 68999997654  499999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCc--cccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          839 EPYIADFGLAKLVVEGDF--ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                      .+||+|||+|+.+.....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+...  .+...
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~--~~~l~  273 (398)
T 4b99_A          196 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY--VHQLQ  273 (398)
T ss_dssp             CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH--HHHHH
T ss_pred             CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH--HHHHH
Confidence            999999999987644321  2234467899999999997765 568999999999999999999999975422  11111


Q ss_pred             HHHHhccc--hhhh-----------cccccCCCcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGA--IEVL-----------DKSLRARPEVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~--~~~~-----------~~~~~~~~~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+....+.  ....           ...+....+.....     .....+++.+||..||++|||++|++++
T Consensus       274 ~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          274 LIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             HHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11111100  0000           00001111111111     1234668889999999999999999885

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=4.2e-43  Score=431.05  Aligned_cols=535  Identities=21%  Similarity=0.191  Sum_probs=417.3

Q ss_pred             cEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEec
Q 039419           31 FVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILN  110 (1035)
Q Consensus        31 ~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~  110 (1035)
                      .++.|++++|+|+...+..|.++++|++|+|++|+|++..+..|+.|++|++|+|++|+|++..+..|.+|++|++|+|+
T Consensus        53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls  132 (635)
T 4g8a_A           53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  132 (635)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred             CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence            57899999999998888899999999999999999997667789999999999999999996666779999999999999


Q ss_pred             ccCCCCCCchhhhhhccccceeccccccCC-CCchhhccccccceeecCCCcccCCCCCCcCCCccce----EEEEeccc
Q 039419          111 SNQLTGEIPKELGACIKLKNLLLFDNYLSG-NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSL----LVVGLADT  185 (1035)
Q Consensus       111 ~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L----~~L~l~~~  185 (1035)
                      +|++++..+..++++++|++|+|++|.+.+ .+|..++.+++|++|++++|. +.+..+..+..+.++    ..++++.|
T Consensus       133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~l~~L~~l~~~~~~~~ls~n  211 (635)
T 4g8a_A          133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLDLSLN  211 (635)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC-CCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred             CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc-ccccccccccchhhhhhhhhhhhcccC
Confidence            999996555679999999999999999975 468889999999999999996 454555666655544    36788999


Q ss_pred             cccccCcccccccccccceeeccccccc-CCccccccCcCCceEEecCCc------CCCCCChhhhcccchhHhhccccc
Q 039419          186 KVAGSLPASLGKLSKLQSLSVYTTMLSG-EIPPQIGNCSELVDLFLYEND------LSGSLPRELGKLQKLEKMLLWQNN  258 (1035)
Q Consensus       186 ~~~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~L~~n~------l~~~~~~~l~~l~~L~~L~l~~n~  258 (1035)
                      .+....+.. .....++.|++.+|.... ..+..+..+..++...+..+.      +.......+..+..+..+.+..+.
T Consensus       212 ~l~~i~~~~-~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~  290 (635)
T 4g8a_A          212 PMNFIQPGA-FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY  290 (635)
T ss_dssp             CCCEECTTT-TTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred             cccccCccc-ccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence            998555544 444567889998886553 334566777877777665432      333344455556666555555443


Q ss_pred             cc---ccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhh
Q 039419          259 FD---GAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFF  335 (1035)
Q Consensus       259 l~---~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~  335 (1035)
                      ..   ...+..+..+.+++.+++.+|.+...  ..+....+|+.|++.+|.+....+.   .+..|+.+++..|.+..  
T Consensus       291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~--  363 (635)
T 4g8a_A          291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGN--  363 (635)
T ss_dssp             CCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCC--
T ss_pred             hcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCC--
Confidence            32   23445567788999999999998744  3466778999999999999865543   45678888888887652  


Q ss_pred             hhccccCCCCCcCCCCCCCCcEEeccCcCCCC--CCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCC
Q 039419          336 AWQNKLEGSIPSTLANCRSLEAVDLSHNALTG--SLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGN  413 (1035)
Q Consensus       336 ~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~  413 (1035)
                                +.....+++|+.|++++|.+..  ..+..+..+.+|+.|++..|.+....+               .|..
T Consensus       364 ----------~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~---------------~~~~  418 (635)
T 4g8a_A          364 ----------AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSS---------------NFLG  418 (635)
T ss_dssp             ----------BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECS---------------CCTT
T ss_pred             ----------Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccc---------------cccc
Confidence                      2345678999999999999863  345556678899999999998875432               2445


Q ss_pred             CCccceeecCCCccCCCCc-ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcc-cccCccccCCCCCCcE
Q 039419          414 CTQLQMLNLSNNTLGGTLP-SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSF-SGAIPSSLGRCESLQS  491 (1035)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~  491 (1035)
                      +++|+.+++++|++....+ ..|..+++++.+++++|++.+..+..+..++.|+.|+|++|.+ .+..|..|..+++|++
T Consensus       419 l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~  498 (635)
T 4g8a_A          419 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  498 (635)
T ss_dssp             CTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             cccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCE
Confidence            6779999999888765443 5678899999999999999999999999999999999999974 4467888999999999


Q ss_pred             EEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcc-cccccc-CCCcEEeccCC
Q 039419          492 LDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LALSGL-DNLVSLNVSYN  569 (1035)
Q Consensus       492 L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l-~~L~~L~ls~N  569 (1035)
                      |+|++|+|++..|..+..+..+. .|+|++|+|++..|..|..+++|++|||++|+|++.+ ..+..+ ++|+.|+|++|
T Consensus       499 L~Ls~N~L~~l~~~~f~~l~~L~-~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~N  577 (635)
T 4g8a_A          499 LDLSQCQLEQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN  577 (635)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCC-EEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTC
T ss_pred             EECCCCccCCcChHHHcCCCCCC-EEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCC
Confidence            99999999976677776666654 7999999999999999999999999999999999976 567777 68999999999


Q ss_pred             cCcccCCChhhhhccc---cccccccccCCCCCC
Q 039419          570 NFTGYLPDSKLFRQLS---ATEMAGNQGLCSRGH  600 (1035)
Q Consensus       570 ~l~~~~p~~~~~~~l~---~~~~~~N~~~c~~~~  600 (1035)
                      +|++.+.-......++   ..........|..|.
T Consensus       578 p~~C~C~~~~~~~wl~~~~~~~~~~~~~~C~~P~  611 (635)
T 4g8a_A          578 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  611 (635)
T ss_dssp             CBCCSGGGHHHHHHHHHTTTTBSCGGGCBBCSST
T ss_pred             CCcccCCcHHHHHHHHhCCCccCCCCCceeCCch
Confidence            9998765432222222   111223445677664

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.2e-43  Score=428.14  Aligned_cols=454  Identities=19%  Similarity=0.163  Sum_probs=249.3

Q ss_pred             EEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEeccc
Q 039419           33 TEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSN  112 (1035)
Q Consensus        33 ~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n  112 (1035)
                      +.+++++++++. +|..+.  ++|++|+|++|.+++..|..++.+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            456666666663 555443  56666666666666544456666666666666666666555666666666666666666


Q ss_pred             CCCCCCchhhhhhccccceeccccccCC-CCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccC
Q 039419          113 QLTGEIPKELGACIKLKNLLLFDNYLSG-NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSL  191 (1035)
Q Consensus       113 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~  191 (1035)
                      +++ .+|..  .+++|++|+|++|++++ .+|..++++++|++|++++|.                         +.+. 
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~-------------------------l~~~-  161 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAK-------------------------FRQL-  161 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSB-------------------------CCTT-
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCc-------------------------cccC-
Confidence            666 45544  56666666666666653 234556666666666665554                         3321 


Q ss_pred             cccccccccc--cceeeccccc--ccCCccccccCc-CCceEEecCCcCCCCCCh-hhhcccchhHhhccccc-----cc
Q 039419          192 PASLGKLSKL--QSLSVYTTML--SGEIPPQIGNCS-ELVDLFLYENDLSGSLPR-ELGKLQKLEKMLLWQNN-----FD  260 (1035)
Q Consensus       192 p~~l~~l~~L--~~L~l~~n~l--~~~~p~~l~~l~-~L~~L~L~~n~l~~~~~~-~l~~l~~L~~L~l~~n~-----l~  260 (1035)
                        .+..+++|  ++|++++|.+  ++..|..+..+. ....+++++|.+.+.++. .+..+++|+.|++++|+     +.
T Consensus       162 --~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~  239 (562)
T 3a79_B          162 --DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM  239 (562)
T ss_dssp             --TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHH
T ss_pred             --chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHH
Confidence              12222222  4445555444  444444444432 111334455554443332 23345555555555543     12


Q ss_pred             ccCCccccCCCCCcEEEccCccCCCCC----CccccCCCCCcEEEccCCccccCCCCcc-----cCCCccceeccccchh
Q 039419          261 GAIPEEIGNCKSLKTIDLSLNFFSGSL----PQSFGNLSSLEELMLSNNNISGSIPPVL-----SNATSLLQLQLDTNQI  331 (1035)
Q Consensus       261 ~~~p~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~i  331 (1035)
                      + .+..+..+++|+.|+|+++.+.+..    +.. ...++|++|++++|++.+.+|..+     ..++.|+.+++..|.+
T Consensus       240 ~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~-~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~  317 (562)
T 3a79_B          240 T-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQF-FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF  317 (562)
T ss_dssp             H-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHH-HTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC
T ss_pred             H-HHHHHhccCcceEEEecCCcCcHHHHHHHHHh-hhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee
Confidence            1 1234566677777777666654321    111 122467777777777766555554     3444444444433332


Q ss_pred             hhhhhhccccCCCCC-cCCC---CCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEe
Q 039419          332 SVFFAWQNKLEGSIP-STLA---NCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR  407 (1035)
Q Consensus       332 ~~l~~~~n~l~~~~p-~~l~---~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  407 (1035)
                       .           +| ..+.   ...+|+.|++++|.+....  ....                                
T Consensus       318 -~-----------~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~--------------------------------  351 (562)
T 3a79_B          318 -L-----------FSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPS--------------------------------  351 (562)
T ss_dssp             -S-----------SCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSS--------------------------------
T ss_pred             -e-----------cChhhhhhhhccCcceEEEccCCCccccc--CccC--------------------------------
Confidence             0           11 0000   1133455555555443111  0123                                


Q ss_pred             eeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCC--chhccCccccchhhccCCcccccCc-cccC
Q 039419          408 LMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLI--PESFGQLASLNRLILSKNSFSGAIP-SSLG  484 (1035)
Q Consensus       408 ~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~  484 (1035)
                            +++|++|+|++|++++..|..+..+++|++|+|++|+++++.  |..|..+++|+.|++++|++++.+| ..+.
T Consensus       352 ------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  425 (562)
T 3a79_B          352 ------PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCA  425 (562)
T ss_dssp             ------CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCC
T ss_pred             ------CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhc
Confidence                  344555555555555555555555666666666666665432  2445556666666666666655233 3355


Q ss_pred             CCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcccc-ccccCCCcE
Q 039419          485 RCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLA-LSGLDNLVS  563 (1035)
Q Consensus       485 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~  563 (1035)
                      .+++|++|+|++|++++.+|..+.   ..+..|+|++|+|+ .+|..+..+++|++|+|++|+|+..+.. +..+++|+.
T Consensus       426 ~l~~L~~L~l~~n~l~~~~~~~l~---~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~  501 (562)
T 3a79_B          426 WAESILVLNLSSNMLTGSVFRCLP---PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQY  501 (562)
T ss_dssp             CCTTCCEEECCSSCCCGGGGSSCC---TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCC
T ss_pred             CcccCCEEECCCCCCCcchhhhhc---CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCE
Confidence            566666666666666554444332   22335666666666 3444455888999999999999987765 888999999


Q ss_pred             EeccCCcCcccCCCh
Q 039419          564 LNVSYNNFTGYLPDS  578 (1035)
Q Consensus       564 L~ls~N~l~~~~p~~  578 (1035)
                      |++++|+|++.++..
T Consensus       502 L~l~~N~~~c~c~~~  516 (562)
T 3a79_B          502 IWLHDNPWDCTCPGI  516 (562)
T ss_dssp             EECCSCCBCCCHHHH
T ss_pred             EEecCCCcCCCcchH
Confidence            999999999877654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.8e-44  Score=401.50  Aligned_cols=202  Identities=26%  Similarity=0.378  Sum_probs=171.5

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      ++.+.|++.+.||+|+||+||+|+++    .++.||||++....                ...++.+|+++++.+ +|||
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----------------~~~~~~~E~~~l~~~~~h~n   81 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----------------HPIRIAAELQCLTVAGGQDN   81 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----------------CHHHHHHHHHHHHHTCSBTT
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----------------CHHHHHHHHHHHHHhcCCCC
Confidence            34577999999999999999999753    46889999985432                135688999999998 6999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ||++++++.+.++.|+||||++||+|.++++.     +++..+..++.||+.||+|||++   ||+||||||+|||++.+
T Consensus        82 Iv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~  153 (361)
T 4f9c_A           82 VMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRR  153 (361)
T ss_dssp             BCCCSEEEEETTEEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT
T ss_pred             CceEEEEEEECCEEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCC
Confidence            99999999999999999999999999999842     89999999999999999999999   99999999999999877


Q ss_pred             -CceEEeeccCccccccCCcc--------------------------ccccccCCcccccCCcccccC-CCCccccchhH
Q 039419          838 -FEPYIADFGLAKLVVEGDFA--------------------------RSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSY  889 (1035)
Q Consensus       838 -~~~kl~DFG~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~Sl  889 (1035)
                       +.+||+|||+|+...+....                          ......+||+.|||||++.+. .++.++||||+
T Consensus       154 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl  233 (361)
T 4f9c_A          154 LKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA  233 (361)
T ss_dssp             TTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred             CCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence             79999999999865432210                          112345799999999998765 58999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCC
Q 039419          890 GVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       890 Gvvl~elltg~~P~~~~~~  908 (1035)
                      ||++|||++|+.||.....
T Consensus       234 G~il~ell~G~~Pf~~~~~  252 (361)
T 4f9c_A          234 GVIFLSLLSGRYPFYKASD  252 (361)
T ss_dssp             HHHHHHHHHTCSSSSCCSS
T ss_pred             HHHHHHHHHCCCCCCCCCC
Confidence            9999999999999975443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.7e-44  Score=418.55  Aligned_cols=252  Identities=19%  Similarity=0.194  Sum_probs=199.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHH---HHHHHHHhcCCCCceee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF---SAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~E~~~l~~l~hpniv~  760 (1035)
                      +++|.+.++||+|+||+||+|+++ +|+.||||++........           .....+   ..++.+++.++|||||+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~-----------~~~~~~~~E~~~l~ll~~~~HP~IV~  256 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----------QGETLALNERIMLSLVSTGDCPFIVC  256 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHHSSSCCTTBCC
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchh-----------hhHHHHHHHHHHHHHHhhCCCCCEeE
Confidence            367999999999999999999876 589999999965432221           112233   34467778889999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ++++|.+++..|+|||||+||+|.+++...+.  +++..+..++.||+.||+|||++   |||||||||+|||++.+|++
T Consensus       257 l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~--l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~v  331 (689)
T 3v5w_A          257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV  331 (689)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCE
T ss_pred             EEEEEEECCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCE
Confidence            99999999999999999999999999987654  99999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch-hHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-HIVDWVR  918 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~-~~~~~~~  918 (1035)
                      ||+|||+|+......    ....+||+.|||||++. +..|+.++||||+||++|||++|+.||........ .+...+.
T Consensus       332 KL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~  407 (689)
T 3v5w_A          332 RISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL  407 (689)
T ss_dssp             EECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH
T ss_pred             EecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc
Confidence            999999998765432    23578999999999986 45799999999999999999999999975432221 1111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                      ..       ........+      ..+.+++.+||.+||++|++     ++||.++
T Consensus       408 ~~-------~~~~p~~~S------~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          408 TM-------AVELPDSFS------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HC-------CCCCCTTSC------HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CC-------CCCCCccCC------HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            10       011111111      22345788899999999998     6888774

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.8e-43  Score=423.64  Aligned_cols=440  Identities=18%  Similarity=0.168  Sum_probs=303.9

Q ss_pred             CcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEe
Q 039419           30 NFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLIL  109 (1035)
Q Consensus        30 ~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L  109 (1035)
                      ..++.|+++++++.+..|..+..+++|++|+|++|.+++..|+.|+.+++|++|||++|+++ .+|..  .+++|++|+|
T Consensus        52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L  128 (562)
T 3a79_B           52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL  128 (562)
T ss_dssp             TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred             CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence            36889999999999888889999999999999999999888899999999999999999999 78877  8999999999


Q ss_pred             cccCCCC-CCchhhhhhccccceeccccccCCCCchhhcccccc--ceeecCCCccc-CCCCCCcCCCcc-ceEEEEecc
Q 039419          110 NSNQLTG-EIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNL--EVIRAGGNKDI-AGKIPYEIGDCQ-SLLVVGLAD  184 (1035)
Q Consensus       110 ~~n~l~~-~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L--~~L~l~~n~~~-~~~~~~~~~~l~-~L~~L~l~~  184 (1035)
                      ++|++++ .+|..++.+++|++|++++|.+.+.   .+..+++|  ++|++++|... .+..|..+..+. ....+++++
T Consensus       129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~  205 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP  205 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECS
T ss_pred             CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecC
Confidence            9999996 3568999999999999999999853   34445555  88888888621 445555555544 122446666


Q ss_pred             ccccccCcc-cccccccccceeecccc-----cccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhccccc
Q 039419          185 TKVAGSLPA-SLGKLSKLQSLSVYTTM-----LSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNN  258 (1035)
Q Consensus       185 ~~~~~~~p~-~l~~l~~L~~L~l~~n~-----l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~  258 (1035)
                      |.+.+..+. .+..+++|+.|++++|.     +. ..+..+..+++|+.|+++++.+++.                   .
T Consensus       206 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~-~~~~~l~~l~~L~~L~L~~~~l~~~-------------------~  265 (562)
T 3a79_B          206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM-TFLSELTRGPTLLNVTLQHIETTWK-------------------C  265 (562)
T ss_dssp             SSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHH-HHHHHHHSCSSCEEEEEEEEEECHH-------------------H
T ss_pred             ccchhhhhhhcccccceEEEecccccccccchHH-HHHHHHhccCcceEEEecCCcCcHH-------------------H
Confidence            666554443 34556666666666663     11 1223455556666666665554421                   1


Q ss_pred             ccccCCccccCCCCCcEEEccCccCCCCCCccc-----cCCCCCcEEEccCCccccCCC-CcccC---CCccceeccccc
Q 039419          259 FDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSF-----GNLSSLEELMLSNNNISGSIP-PVLSN---ATSLLQLQLDTN  329 (1035)
Q Consensus       259 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~---l~~L~~L~L~~N  329 (1035)
                      +.+ ++..+ ..++|++|++++|.+++.+|..+     .+++.|+.++++.|.+  ..| ..+..   ..+|++|++++|
T Consensus       266 ~~~-~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n  341 (562)
T 3a79_B          266 SVK-LFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDT  341 (562)
T ss_dssp             HHH-HHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESS
T ss_pred             HHH-HHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCC
Confidence            111 11111 23467777777777776666665     5566666666666665  222 22222   246777888777


Q ss_pred             hhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCC--CCCCCCCCcceeEe
Q 039419          330 QISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLI--PPEIGNCSSLIRLR  407 (1035)
Q Consensus       330 ~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~  407 (1035)
                      ++..+            .....+++|++|++++|++++..+..+..+++|++|++++|++++..  |..           
T Consensus       342 ~~~~~------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----------  398 (562)
T 3a79_B          342 PFIHM------------VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALM-----------  398 (562)
T ss_dssp             CCCCC------------CCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHT-----------
T ss_pred             Ccccc------------cCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhh-----------
Confidence            76521            11267788999999999998878888888888888888888877532  122           


Q ss_pred             eeccCCCCccceeecCCCccCC-CCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCC
Q 039419          408 LMSFGNCTQLQMLNLSNNTLGG-TLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRC  486 (1035)
Q Consensus       408 ~~~~~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  486 (1035)
                         |.++++|++|+|++|++++ ..+..+..+++|++|+|++|++++..|..+.  ++|+.|+|++|+|+ .+|..+..+
T Consensus       399 ---~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l  472 (562)
T 3a79_B          399 ---TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHL  472 (562)
T ss_dssp             ---TTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSS
T ss_pred             ---hcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCC
Confidence               3445667777777777776 3334566777777777777777655444433  56777777777776 455555567


Q ss_pred             CCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccc
Q 039419          487 ESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL  553 (1035)
Q Consensus       487 ~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  553 (1035)
                      ++|++|+|++|+|+ .+|                        +..+..+++|++|+|++|++.++..
T Consensus       473 ~~L~~L~L~~N~l~-~l~------------------------~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          473 QALQELNVASNQLK-SVP------------------------DGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CCCSEEECCSSCCC-CCC------------------------TTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CCCCEEECCCCCCC-CCC------------------------HHHHhcCCCCCEEEecCCCcCCCcc
Confidence            77777777777666 232                        2236778899999999999998653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.7e-42  Score=411.12  Aligned_cols=255  Identities=20%  Similarity=0.283  Sum_probs=205.7

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .++++|.+.+.||+|+||+||+|.++ +|+.||||++.....              ...+.+.+|+.+|+.++|||||++
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~--------------~~~~~~~~Ei~il~~l~hpnIv~l  219 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--------------SDKETVRKEIQTMSVLRHPTLVNL  219 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--------------HHHHHHHHHHHHHHHTCCTTBCCE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch--------------hhHHHHHHHHHHHHhCCCCCCCeE
Confidence            34678999999999999999999776 589999999864321              124678899999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC--Cc
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE--FE  839 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~--~~  839 (1035)
                      ++++.+++..|+|||||+||+|.+++.... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.
T Consensus       220 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~  295 (573)
T 3uto_A          220 HDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE  295 (573)
T ss_dssp             EEEEECSSEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCC
T ss_pred             EEEEEECCEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCC
Confidence            999999999999999999999999986543 3489999999999999999999999   99999999999999854  89


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +||+|||+|+.+.....   ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.....  ......+..
T Consensus       296 vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--~~~~~~i~~  370 (573)
T 3uto_A          296 LKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKS  370 (573)
T ss_dssp             EEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHT
T ss_pred             EEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHh
Confidence            99999999998755432   2356899999999999999999999999999999999999999975422  122222211


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...   .+........+      ....+++.+||+.||++||++.|++++
T Consensus       371 ~~~---~~~~~~~~~~s------~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          371 CDW---NMDDSAFSGIS------EDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             TCC---CCCSGGGTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCC---CCCcccccCCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            110   00111111111      123467888999999999999999884

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.5e-41  Score=375.10  Aligned_cols=255  Identities=26%  Similarity=0.337  Sum_probs=205.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++.......             ..+.+.+|+.+++.++||||+++++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~hpnIv~~~~   72 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-------------CPENIKKEICINKMLNHENVVKFYG   72 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc-------------hHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            467999999999999999999776 68999999986433221             1356889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||++||+|.+++.....  +++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~  147 (323)
T 3tki_A           73 HRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKIS  147 (323)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGSBTTTB--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCeEEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEE
Confidence            99999999999999999999999976543  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||+++.+.............||+.|+|||++.+..+ +.++|||||||++|||++|+.||............|......
T Consensus       148 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  227 (323)
T 3tki_A          148 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY  227 (323)
T ss_dssp             CCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT
T ss_pred             EeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc
Confidence            9999987654443333456789999999999877765 778999999999999999999998655443333333221110


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                                ..+....  .....+++.+||+.||++|||++|++++
T Consensus       228 ----------~~~~~~~--~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 ----------LNPWKKI--DSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ----------STTGGGS--CHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----------CCccccC--CHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                      0000111  1123457888999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-40  Score=372.46  Aligned_cols=275  Identities=35%  Similarity=0.601  Sum_probs=222.0

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ....++|...+.||+|+||.||+|.+.+++.||||++.....              ...+.+.+|+.++++++||||+++
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~~  100 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--------------QGIEEFETEIETLSFCRHPHLVSL  100 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--------------SHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--------------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            344578999999999999999999988899999999865321              125679999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++++.+.+..|+||||+++|+|.+++.....  ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.
T Consensus       101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~  177 (321)
T 2qkw_B          101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV  177 (321)
T ss_dssp             EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCC
T ss_pred             EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCC
Confidence            9999999999999999999999999976542  3489999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-chhHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE-GLHIVDWVR  918 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~-~~~~~~~~~  918 (1035)
                      +||+|||+++...............||+.|+|||+..+..++.++||||||+++|||++|+.||....+. ......|..
T Consensus       178 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~  257 (321)
T 2qkw_B          178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV  257 (321)
T ss_dssp             EEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTH
T ss_pred             EEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhh
Confidence            9999999998754433333334566999999999998889999999999999999999999999865443 233444433


Q ss_pred             Hhccc---hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          919 QKRGA---IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       919 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .....   ...+++......  .......+.+++.+||+.||++||++.|++++|+.+.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          258 ESHNNGQLEQIVDPNLADKI--RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             HHHTTTCCCSSSSSSCTTCS--CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccccccHHHhcChhhcccc--CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            22111   122222222222  22444556678999999999999999999999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-40  Score=378.87  Aligned_cols=262  Identities=26%  Similarity=0.392  Sum_probs=211.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC--------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CC
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME--------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RH  755 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1035)
                      .++|...+.||+|+||.||+|++.        ++..||||++......             ...+.+.+|+++++++ +|
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~h  146 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE-------------KDLSDLVSEMEMMKMIGKH  146 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH-------------HHHHHHHHHHHHHHHSCCC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH-------------HHHHHHHHHHHHHHHhcCC
Confidence            367889999999999999999762        3567999999654221             1246799999999999 89


Q ss_pred             CceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 039419          756 KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPP  821 (1035)
Q Consensus       756 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  821 (1035)
                      |||+++++++.+.+..|+||||+++|+|.+++...+.              ..+++..+..++.||++||+|||+.   +
T Consensus       147 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~  223 (370)
T 2psq_A          147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---K  223 (370)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             CCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            9999999999999999999999999999999986542              3478999999999999999999999   9


Q ss_pred             eeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 039419          822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK  900 (1035)
Q Consensus       822 ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~  900 (1035)
                      |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+
T Consensus       224 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~  303 (370)
T 2psq_A          224 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  303 (370)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999987655443333445678899999999999999999999999999999999 99


Q ss_pred             CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       901 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      .||......  .....+....      ........+      ..+..++.+||+.||++||++.|+++.|+.+...
T Consensus       304 ~p~~~~~~~--~~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          304 SPYPGIPVE--ELFKLLKEGH------RMDKPANCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             CSSTTCCGG--GHHHHHHTTC------CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCHH--HHHHHHhcCC------CCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            999754322  2222222111      000111111      1234578889999999999999999999998653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.4e-41  Score=373.32  Aligned_cols=250  Identities=22%  Similarity=0.292  Sum_probs=203.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|++ .+|+.||||++.......            ...+++.+|+.+++.++||||+++++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~l~~   81 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP------------TSLQKLFREVRIMKILNHPNIVKLFE   81 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH------------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            35799999999999999999987 469999999996533221            12467889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||++||+|.+++...+.  +++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~  156 (328)
T 3fe3_A           82 VIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIA  156 (328)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred             EEEECCEEEEEEECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEe
Confidence            99999999999999999999999977654  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||+++......   .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||......  .....+.... 
T Consensus       157 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~-  230 (328)
T 3fe3_A          157 DFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK--ELRERVLRGK-  230 (328)
T ss_dssp             STTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC-
T ss_pred             eccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC-
Confidence            999998765432   23456899999999998887765 7999999999999999999999754211  1111111100 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                            .......+      ....+++.+||..||++|||++|++++
T Consensus       231 ------~~~p~~~s------~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 ------YRIPFYMS------TDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ------CCCCTTSC------HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ------CCCCCCCC------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  00111111      223457888999999999999999874

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.4e-40  Score=385.62  Aligned_cols=422  Identities=26%  Similarity=0.272  Sum_probs=240.0

Q ss_pred             CCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccce
Q 039419           52 SLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNL  131 (1035)
Q Consensus        52 ~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  131 (1035)
                      ..++|++|++++|.+ |.+|++++.+++|++|++++|++.|.+|..++.+++|+++++..|..           .+|++|
T Consensus         9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L   76 (454)
T 1jl5_A            9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL   76 (454)
T ss_dssp             --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred             ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence            457888899998888 58888888899999999988888888888888888887777766542           467778


Q ss_pred             eccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeeccccc
Q 039419          132 LLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTML  211 (1035)
Q Consensus       132 ~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l  211 (1035)
                      ++++|.++ .+|..   .++|++|++++|. +. .+|..   +++|+.|++++|.+.+ +|..   .++|++|++++|.+
T Consensus        77 ~l~~~~l~-~lp~~---~~~L~~L~l~~n~-l~-~lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l  143 (454)
T 1jl5_A           77 ELNNLGLS-SLPEL---PPHLESLVASCNS-LT-ELPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQL  143 (454)
T ss_dssp             ECTTSCCS-CCCSC---CTTCSEEECCSSC-CS-SCCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCC
T ss_pred             EecCCccc-cCCCC---cCCCCEEEccCCc-CC-ccccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCC
Confidence            88888877 34442   3577777777775 22 25532   3677777787777764 2221   16788888888888


Q ss_pred             ccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccc
Q 039419          212 SGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSF  291 (1035)
Q Consensus       212 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~  291 (1035)
                      ++ +| .++++++|++|++++|++++ +|..+   .+|++|++++|++++ +| .+.++++|+.|++++|++++ +|...
T Consensus       144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~  214 (454)
T 1jl5_A          144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP  214 (454)
T ss_dssp             SS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC
T ss_pred             CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc
Confidence            74 66 58888888888888888874 55433   477788888888875 55 57788888888888888874 34322


Q ss_pred             cCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCC
Q 039419          292 GNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHP  371 (1035)
Q Consensus       292 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~  371 (1035)
                         ++|++|++++|++. .+| .|..+++|++|++++|+++.           +|..   +++|+.|++++|++++ +|.
T Consensus       215 ---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-----------l~~~---~~~L~~L~l~~N~l~~-l~~  274 (454)
T 1jl5_A          215 ---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-----------LPDL---PPSLEALNVRDNYLTD-LPE  274 (454)
T ss_dssp             ---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-----------CCSC---CTTCCEEECCSSCCSC-CCC
T ss_pred             ---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-----------cccc---ccccCEEECCCCcccc-cCc
Confidence               57888888888887 445 37778888888888877763           2322   3677888888888875 343


Q ss_pred             CcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCC-CCccEEEcCCCc
Q 039419          372 GLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL-TRLQVLDISVNQ  450 (1035)
Q Consensus       372 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l-~~L~~L~Ls~N~  450 (1035)
                      .   .++|++|++++|++++...  +                .++|++|++++|++++. +    .+ ++|++|++++|+
T Consensus       275 ~---~~~L~~L~ls~N~l~~l~~--~----------------~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~  328 (454)
T 1jl5_A          275 L---PQSLTFLDVSENIFSGLSE--L----------------PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNK  328 (454)
T ss_dssp             C---CTTCCEEECCSSCCSEESC--C----------------CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSC
T ss_pred             c---cCcCCEEECcCCccCcccC--c----------------CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCc
Confidence            2   3677888888887775311  0                14577788888877742 2    23 477888888888


Q ss_pred             cCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcC--ccchhhhhhccCcceeeccCccCCCCC
Q 039419          451 FVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSG--KIPVELFEIEGLDISLNLSWNALSGAI  528 (1035)
Q Consensus       451 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~~~~l~~~L~Ls~N~l~~~~  528 (1035)
                      ++++ |..   +++|+.|++++|+++ .+|.   .+++|++|+|++|++++  .+|..+.         +|+.|.+.+.+
T Consensus       329 l~~l-p~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~---------~L~~n~~~~~i  391 (454)
T 1jl5_A          329 LIEL-PAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVE---------DLRMNSHLAEV  391 (454)
T ss_dssp             CSCC-CCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCC---------EEECCC-----
T ss_pred             cccc-ccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHH---------hhhhccccccc
Confidence            7763 332   467777888888777 3454   36777888888888775  4554432         23445555555


Q ss_pred             CccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCC
Q 039419          529 PPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLP  576 (1035)
Q Consensus       529 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p  576 (1035)
                      |..   +++|++|||++|++++.+..-   ++|+.|.+.+|.+.+..+
T Consensus       392 ~~~---~~~L~~L~ls~N~l~~~~~iP---~sl~~L~~~~~~~~~~~~  433 (454)
T 1jl5_A          392 PEL---PQNLKQLHVETNPLREFPDIP---ESVEDLRMNSERVVDPYE  433 (454)
T ss_dssp             ------------------------------------------------
T ss_pred             ccc---cCcCCEEECCCCcCCccccch---hhHhheeCcCcccCCccc
Confidence            542   355666666666665422110   234455555555554433

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.6e-40  Score=364.52  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=203.4

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ..++|...+.||+|+||+||+|.+. +++.||||++.....              ...+.+.+|+.++++++||||++++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~E~~~l~~l~hp~iv~~~   83 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------------PKKELIINEILVMRENKNPNIVNYL   83 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--------------SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--------------cHHHHHHHHHHHHhcCCCCCCCeEe
Confidence            3468999999999999999999764 689999999854321              1246789999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+.+..|+||||++||+|.+++....   +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl  157 (297)
T 3fxz_A           84 DSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL  157 (297)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEECCEEEEEEECCCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999997653   89999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||++........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+..  ....+.....
T Consensus       158 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~  233 (297)
T 3fxz_A          158 TDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIATNGT  233 (297)
T ss_dssp             CCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHHCS
T ss_pred             eeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC
Confidence            99999987654332  2345689999999999999999999999999999999999999997543211  1111111000


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                            ...  ..+....  ....+++.+||+.||++|||++|++++
T Consensus       234 ------~~~--~~~~~~~--~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          234 ------PEL--QNPEKLS--AIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ------CCC--SCGGGSC--HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CCC--CCccccC--HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                  000  0011111  123457888999999999999999874

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.9e-40  Score=389.87  Aligned_cols=382  Identities=21%  Similarity=0.197  Sum_probs=279.3

Q ss_pred             CceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCC-chhhccccccceeecC
Q 039419           80 LTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNL-PVELGKLVNLEVIRAG  158 (1035)
Q Consensus        80 L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~-p~~l~~l~~L~~L~l~  158 (1035)
                      -+.++.++++++ .+|. +  .++|++|+|++|.+++..|..++.+++|++|+|++|.+.+.+ +..|..+++|++|+++
T Consensus        12 ~~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A           12 GYNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             TTEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             ccccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            456888888888 7776 3  268999999999998767888888999999999998887555 4567888888888888


Q ss_pred             CCcccCCCCCCcCCCccceEEEEeccccccccCccc--ccccccccceeecccccccCCccc-cccCcCCceEEecCCcC
Q 039419          159 GNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPAS--LGKLSKLQSLSVYTTMLSGEIPPQ-IGNCSELVDLFLYENDL  235 (1035)
Q Consensus       159 ~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~--l~~l~~L~~L~l~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l  235 (1035)
                      +|. +.+..|..++.+++|++|++++|.+++..|..  |+.+++|++|++++|.+++..|.. +.++++|++|++++|.+
T Consensus        88 ~n~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l  166 (455)
T 3v47_A           88 YNQ-FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV  166 (455)
T ss_dssp             TCT-TCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred             CCc-cCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence            875 44455666777777777777777776644444  667777777777777776555554 66677777777777777


Q ss_pred             CCCCChhhhcc--cchhHhhcccccccccCCcc--------ccCCCCCcEEEccCccCCCCCCccccCC---CCCcEEEc
Q 039419          236 SGSLPRELGKL--QKLEKMLLWQNNFDGAIPEE--------IGNCKSLKTIDLSLNFFSGSLPQSFGNL---SSLEELML  302 (1035)
Q Consensus       236 ~~~~~~~l~~l--~~L~~L~l~~n~l~~~~p~~--------~~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~L  302 (1035)
                      ++..+..+..+  .+|+.|++++|.+.+..+..        +..+++|+.|+|++|++++..|..+..+   ++|+.|++
T Consensus       167 ~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l  246 (455)
T 3v47_A          167 KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL  246 (455)
T ss_dssp             SCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEEC
T ss_pred             cccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEee
Confidence            76666666655  56666666666666443332        2244556666666666655555444333   55666666


Q ss_pred             cCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCC--CCCCcEEeccCcCCCCCCCCCcccCcccc
Q 039419          303 SNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLAN--CRSLEAVDLSHNALTGSLHPGLFQLQNLT  380 (1035)
Q Consensus       303 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  380 (1035)
                      ++|.+.+..                        ...+.+.+..+..+..  .++|+.|++++|.+++..+..+..+++|+
T Consensus       247 ~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  302 (455)
T 3v47_A          247 SNSYNMGSS------------------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLE  302 (455)
T ss_dssp             TTCTTTSCC------------------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             ccccccccc------------------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCC
Confidence            665544221                        1111122222233333  36899999999999988888899999999


Q ss_pred             eEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhcc
Q 039419          381 KLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFG  460 (1035)
Q Consensus       381 ~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  460 (1035)
                      +|+|++|++++..|..|..              +++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|.
T Consensus       303 ~L~Ls~n~l~~~~~~~~~~--------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  368 (455)
T 3v47_A          303 QLTLAQNEINKIDDNAFWG--------------LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL  368 (455)
T ss_dssp             EEECTTSCCCEECTTTTTT--------------CTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred             EEECCCCcccccChhHhcC--------------cccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcc
Confidence            9999999998877766554              46699999999999988888999999999999999999988889999


Q ss_pred             CccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccc
Q 039419          461 QLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIP  504 (1035)
Q Consensus       461 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  504 (1035)
                      .+++|++|+|++|+|++..+..|..+++|++|+|++|++++..|
T Consensus       369 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            99999999999999997777778899999999999999997776

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-40  Score=370.79  Aligned_cols=273  Identities=39%  Similarity=0.691  Sum_probs=218.9

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      ..++|...+.||+|+||.||+|++.+++.||||++........             ...+.+|+.++++++||||+++++
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------------~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-------------ELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-------------CCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             HhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-------------HHHHHHHHHHHHhccCCCccceEE
Confidence            3488999999999999999999988899999999975432221             236899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRD--SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++.+.+..++||||+++|+|.++++....  ..+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999986543  3489999999999999999999998666899999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC---CCCchhHHHHHH
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT---IPEGLHIVDWVR  918 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~---~~~~~~~~~~~~  918 (1035)
                      |+|||+++....... .......||+.|+|||+..+..++.++||||||+++|||++|+.||+..   .........|+.
T Consensus       175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            999999987654332 2234566999999999998888999999999999999999999999621   122334445544


Q ss_pred             Hhccc---hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          919 QKRGA---IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       919 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                      .....   ....+......  ........+.+++.+||+.||++|||++|++++|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGN--YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTS--CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHhhchhhhhhcChhhccc--cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            32211   11222222222  223455567778999999999999999999999975

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-40  Score=372.01  Aligned_cols=272  Identities=26%  Similarity=0.340  Sum_probs=207.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|+..+.||+|+||+||+|++. ++.||||++.....               ....+.+|+.++++++||||+++++++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~~~~~~   87 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK---------------QSWQNEYEVYSLPGMKHENILQFIGAE   87 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH---------------HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch---------------HHHHHHHHHHHHhcCCCCCchhhccee
Confidence            57889999999999999999887 79999999854211               134566799999999999999999999


Q ss_pred             EcCCc----ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC-------CCCeeccCCCcccEEE
Q 039419          766 WNRNT----RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC-------VPPIVHRDIKANNILI  834 (1035)
Q Consensus       766 ~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~ivHrDikp~NIll  834 (1035)
                      .+...    .|+||||+++|+|.++++...   +++..+..++.|+++||+|||+..       .++|+||||||+||++
T Consensus        88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill  164 (322)
T 3soc_A           88 KRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL  164 (322)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE
T ss_pred             ccCCCCCceEEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE
Confidence            87553    599999999999999997643   899999999999999999999851       2279999999999999


Q ss_pred             cCCCceEEeeccCccccccCCccccccccCCcccccCCccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 039419          835 GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE  909 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~  909 (1035)
                      +.++.+||+|||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||......
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            9999999999999987765544333445689999999999876     34567889999999999999999999765332


Q ss_pred             chh-HHHHHHHhccchh----hhcccccCCCc---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          910 GLH-IVDWVRQKRGAIE----VLDKSLRARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       910 ~~~-~~~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      ... .............    ...........   ........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            111 1110000000000    00111111110   1112333456789999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=362.68  Aligned_cols=263  Identities=25%  Similarity=0.456  Sum_probs=209.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+|.+. +++.||+|++.....              ...+.|.+|++++++++||||++++++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~--------------~~~~~~~~E~~~l~~l~hp~iv~~~~~   75 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--------------ETQRTFLKEVKVMRCLEHPNVLKFIGV   75 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH--------------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCcCcccEEEE
Confidence            57888999999999999999876 589999999854211              235689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..++||||+++|+|.++++... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D  151 (310)
T 3s95_A           76 LYKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVAD  151 (310)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECC
T ss_pred             EecCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEee
Confidence            999999999999999999999998743 3489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccc------------cccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          845 FGLAKLVVEGDFAR------------SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       845 FG~a~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      ||+++.........            ......||+.|+|||++.+..++.++||||||+++|||++|..||....+....
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~  231 (310)
T 3s95_A          152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD  231 (310)
T ss_dssp             CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred             cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence            99998764432211            112467999999999999999999999999999999999999998754332211


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      ....      .............+..      +..++.+||+.||++||++.++++.|+.+.....
T Consensus       232 ~~~~------~~~~~~~~~~~~~~~~------l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          232 FGLN------VRGFLDRYCPPNCPPS------FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             SSBC------HHHHHHHTCCTTCCTT------HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             Hhhh------hhccccccCCCCCCHH------HHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            0000      0011111112222222      3447778999999999999999999999876543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.9e-40  Score=384.97  Aligned_cols=403  Identities=26%  Similarity=0.305  Sum_probs=179.8

Q ss_pred             CcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCC-------------ceeeCCCCCCCCCCCh
Q 039419           30 NFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQL-------------TTIDVSSNSLVGGVPS   96 (1035)
Q Consensus        30 ~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L-------------~~L~ls~n~l~~~~p~   96 (1035)
                      ..++.++++++++ +.+|..+++|++|++|++++|.++|.+|.+++.+.+|             ++|++++|+++ .+|.
T Consensus        11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~   88 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE   88 (454)
T ss_dssp             ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCS
T ss_pred             ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCC
Confidence            4578899999999 8999999999999999999999999999999999987             55666666555 3333


Q ss_pred             hhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccc
Q 039419           97 SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS  176 (1035)
Q Consensus        97 ~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  176 (1035)
                      .   .++|++|++++|++++ +|..   +++|++|++++|++++ +|..   .++|++|++                   
T Consensus        89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L-------------------  138 (454)
T 1jl5_A           89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGV-------------------  138 (454)
T ss_dssp             C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEEC-------------------
T ss_pred             C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEEC-------------------
Confidence            1   2455566666665553 4432   2455555555555542 2211   134444544                   


Q ss_pred             eEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhccc
Q 039419          177 LLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQ  256 (1035)
Q Consensus       177 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~  256 (1035)
                            ++|.+.+ +| .|+++++|++|++++|++++ +|..+   .+|++|++++|.+++ +| .++.+++|++|++++
T Consensus       139 ------~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~  204 (454)
T 1jl5_A          139 ------SNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADN  204 (454)
T ss_dssp             ------CSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred             ------cCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCC
Confidence                  4444443 33 35555555555555555552 33322   255555555555553 33 355555555555555


Q ss_pred             ccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhh
Q 039419          257 NNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFA  336 (1035)
Q Consensus       257 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~  336 (1035)
                      |++.+ +|...   ++|++|++++|+++ .+| .|+.+++|++|++++|++++ +|..   +++|++|++++|+++.   
T Consensus       205 N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~---  271 (454)
T 1jl5_A          205 NSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD---  271 (454)
T ss_dssp             SCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC---
T ss_pred             CcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc---
Confidence            55553 33221   35566666666555 344 25555666666666665553 2221   2455566666555542   


Q ss_pred             hccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCc
Q 039419          337 WQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQ  416 (1035)
Q Consensus       337 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~  416 (1035)
                              +|..   .++|++|++++|++++. +..   .++|++|++++|++++.. .    +             .++
T Consensus       272 --------l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i~-~----~-------------~~~  318 (454)
T 1jl5_A          272 --------LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSLC-D----L-------------PPS  318 (454)
T ss_dssp             --------CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEEC-C----C-------------CTT
T ss_pred             --------cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCccc-C----C-------------cCc
Confidence                    2221   24566666666666531 110   145666666666655321 0    0             024


Q ss_pred             cceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccc--cCccccCCCCCCcEEEc
Q 039419          417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG--AIPSSLGRCESLQSLDL  494 (1035)
Q Consensus       417 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L  494 (1035)
                      |++|++++|++++ +|..   +++|++|++++|+++++ |.   .+++|++|++++|++++  .+|..+..+        
T Consensus       319 L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~l-p~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------  382 (454)
T 1jl5_A          319 LEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEV-PE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------  382 (454)
T ss_dssp             CCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------
T ss_pred             CCEEECCCCcccc-cccc---CCcCCEEECCCCccccc-cc---hhhhccEEECCCCCCCcCCCChHHHHhh--------
Confidence            6666666666664 3332   35566666666666643 22   24566666666666665  344433321        


Q ss_pred             CCCcCcCccchhhhhhccCcceeeccCccCCC--CCCccccCCccccEEeccCCcccC
Q 039419          495 SSNKLSGKIPVELFEIEGLDISLNLSWNALSG--AIPPQISALNKLSILDLSHNKLGG  550 (1035)
Q Consensus       495 s~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~  550 (1035)
                      +.|.+.|.+|...    ..+..|++++|.+++  .+|      ..|+.|.+.+|.+.+
T Consensus       383 ~~n~~~~~i~~~~----~~L~~L~ls~N~l~~~~~iP------~sl~~L~~~~~~~~~  430 (454)
T 1jl5_A          383 RMNSHLAEVPELP----QNLKQLHVETNPLREFPDIP------ESVEDLRMNSERVVD  430 (454)
T ss_dssp             ECCC------------------------------------------------------
T ss_pred             hhccccccccccc----CcCCEEECCCCcCCccccch------hhHhheeCcCcccCC
Confidence            2344444444321    112245555555554  233      234555666666554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.3e-40  Score=366.90  Aligned_cols=261  Identities=30%  Similarity=0.432  Sum_probs=200.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++|.+.+.||+|+||+||+|++. ++.||||++.......            ...+.+.+|+.++++++||||++++++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~~~~  102 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHA------------ERVNEFLREVAIMKRLRHPNIVLFMGA  102 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSH------------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCH------------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            467899999999999999999874 8899999986543222            124678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeccCCCcccEEEcCCCceE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPP--IVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivHrDikp~NIll~~~~~~k  841 (1035)
                      +.+.+..++||||+++|+|.+++..... ..+++..+..++.|+++||+|||+.   +  |+||||||+||+++.++.+|
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~k  179 (309)
T 3p86_A          103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVK  179 (309)
T ss_dssp             ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEE
T ss_pred             EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEE
Confidence            9999999999999999999999976432 2388999999999999999999999   7  99999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |+|||+++......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....+.  .....+....
T Consensus       180 L~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~  255 (309)
T 3p86_A          180 VCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKC  255 (309)
T ss_dssp             ECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSC
T ss_pred             ECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC
Confidence            99999998654332  2233567999999999999999999999999999999999999999754321  1111111111


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      .     ........+      ..+.+++.+||+.||++||+++++++.|+.+.+.
T Consensus       256 ~-----~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          256 K-----RLEIPRNLN------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             C-----CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             C-----CCCCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0     001111111      1234578889999999999999999999888643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.3e-40  Score=368.06  Aligned_cols=252  Identities=21%  Similarity=0.242  Sum_probs=203.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|+.+ +|+.||+|++........           ...+.+.+|+.+++.++||||+++++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~l~~   72 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----------DEVAHTVTESRVLQNTRHPFLTALKY   72 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh-----------hHHHHHHHHHHHHHhCCCCcCcceEE
Confidence            367899999999999999999876 589999999964322111           23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||++   ||+||||||+||+++.+|.+||+
T Consensus        73 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~  147 (337)
T 1o6l_A           73 AFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEe
Confidence            99999999999999999999999987654  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+...   
T Consensus       148 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~---  220 (337)
T 1o6l_A          148 DFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILME---  220 (337)
T ss_dssp             CCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHC---
T ss_pred             eccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--HHHHHHHHcC---
Confidence            999998643322  223456899999999999999999999999999999999999999975321  1111111110   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                          ........+      ..+..++.+||++||++||     +++|++++
T Consensus       221 ----~~~~p~~~s------~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          221 ----EIRFPRTLS------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----CCCCCTTSC------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCCCCCCCC------HHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                001111111      1234577889999999999     89999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-40  Score=378.90  Aligned_cols=260  Identities=23%  Similarity=0.377  Sum_probs=208.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|.+. +++.||||++.......             ..+.|.+|++++++++||||++++++
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~hpniv~~~~~  180 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD-------------LKAKFLQEARILKQYSHPNIVRLIGV  180 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHH-------------HHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHH-------------HHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            57888999999999999999886 68999999986532211             23468899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||+++|+|.++++..+ ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~D  256 (377)
T 3cbl_A          181 CTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISD  256 (377)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECc
Confidence            999999999999999999999997653 2389999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....  ......+...   
T Consensus       257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~~---  331 (377)
T 3cbl_A          257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKG---  331 (377)
T ss_dssp             GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHTT---
T ss_pred             CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC---
Confidence            999986544332222223346788999999988889999999999999999998 9999975422  1222222111   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                             .+...+....  ..+.+++.+||+.||++|||++++++.|+++.+.
T Consensus       332 -------~~~~~~~~~~--~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          332 -------GRLPCPELCP--DAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             -------CCCCCCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCC--HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                   0111111111  1234578889999999999999999999998653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=367.89  Aligned_cols=262  Identities=23%  Similarity=0.357  Sum_probs=206.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .++|.+.+.||+|+||+||+|.+.    .+..||||++.......             ..+.|.+|+.++++++||||++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~iv~  114 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER-------------QRRDFLSEASIMGQFDHPNIIR  114 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH-------------HHHHHHHHHHHHTTCCCTTBCC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH-------------HHHHHHHHHHHHHhCCCCCCCc
Confidence            367889999999999999999875    35569999996543221             2567999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++.+.+..|+||||+++|+|.++++... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  190 (325)
T 3kul_A          115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVC  190 (325)
T ss_dssp             EEEEECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCE
Confidence            9999999999999999999999999997543 3489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHH
Q 039419          841 YIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~  918 (1035)
                      ||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....  ......+.
T Consensus       191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~  268 (325)
T 3kul_A          191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVE  268 (325)
T ss_dssp             EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHH
T ss_pred             EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH
Confidence            9999999987654322 112233456889999999988899999999999999999999 9999965422  11111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ...      ........+      ..+..++.+||+.||++||++.++++.|+.+....
T Consensus       269 ~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          269 EGY------RLPAPMGCP------HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             TTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             cCC------CCCCCCCcC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            110      000111111      23345788899999999999999999999986543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=375.45  Aligned_cols=265  Identities=25%  Similarity=0.361  Sum_probs=211.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .++|...+.||+|+||+||+|++.      +++.||||++.......             ...++.+|+.++++++||||
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~hpnI  136 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-------------DELDFLMEALIISKFNHQNI  136 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHH-------------HHHHHHHHHHHHHHCCCTTB
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChh-------------hHHHHHHHHHHHHhCCCCCC
Confidence            367889999999999999999853      46789999986432221             24578899999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      +++++++.+.+..|+||||+++|+|.+++...+.     ..+++..++.++.||++||+|||++   +|+||||||+|||
T Consensus       137 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl  213 (367)
T 3l9p_A          137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL  213 (367)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEE
Confidence            9999999999999999999999999999987543     3489999999999999999999999   9999999999999


Q ss_pred             EcCCC---ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 039419          834 IGPEF---EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPE  909 (1035)
Q Consensus       834 l~~~~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~  909 (1035)
                      ++.++   .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||..... 
T Consensus       214 l~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-  292 (367)
T 3l9p_A          214 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-  292 (367)
T ss_dssp             ESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             EecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            99555   599999999986654433334445678999999999988899999999999999999998 9999975422 


Q ss_pred             chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                       ......+....          ....+....  ..+..++.+||+.||++||++.+++++|+.+......
T Consensus       293 -~~~~~~i~~~~----------~~~~~~~~~--~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          293 -QEVLEFVTSGG----------RMDPPKNCP--GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             -HHHHHHHHTTC----------CCCCCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             -HHHHHHHHcCC----------CCCCCccCC--HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence             12222221111          001111111  1234578889999999999999999999998766554

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.3e-39  Score=358.56  Aligned_cols=262  Identities=23%  Similarity=0.331  Sum_probs=203.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|++. +++.||+|++........           ...+.+.+|+.++++++||||++++++
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~hp~iv~~~~~   79 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE-----------ETLKRFEREVHNSSQLSHQNIVSMIDV   79 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH-----------HHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH-----------HHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence            57899999999999999999765 589999999865432222           235689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||++|++|.+++...+.  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~D  154 (294)
T 4eqm_A           80 DEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFD  154 (294)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             eeeCCeEEEEEeCCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEe
Confidence            9999999999999999999999987654  89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+++....... .......||+.|+|||+..+..++.++||||+|+++|||++|+.||.......    ..........
T Consensus       155 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~----~~~~~~~~~~  229 (294)
T 4eqm_A          155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS----IAIKHIQDSV  229 (294)
T ss_dssp             CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH----HHHHHHSSCC
T ss_pred             CCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHhhccC
Confidence            999987644322 22335679999999999999999999999999999999999999997542211    1111111111


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-TMKDVAAMIKEIK  974 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-s~~el~~~L~~~~  974 (1035)
                      ...........+.      .+..++.+||++||++|| +++++.+.|+.+.
T Consensus       230 ~~~~~~~~~~~~~------~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          230 PNVTTDVRKDIPQ------SLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             CCHHHHSCTTSCH------HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             CCcchhcccCCCH------HHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            1111111111221      234577889999999998 8888888887653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.7e-40  Score=356.25  Aligned_cols=256  Identities=24%  Similarity=0.436  Sum_probs=208.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||+||+|.+.+++.||+|++.....               ..+++.+|++++++++||||+++++++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~~~   74 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---------------SEEDFIEEAEVMMKLSHPKLVQLYGVC   74 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---------------CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---------------CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            56888999999999999999998899999999965322               245789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..|+||||+++++|.+++.... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  150 (269)
T 4hcu_A           75 LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF  150 (269)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCT
T ss_pred             ecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccc
Confidence            99999999999999999999997644 3489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |+++....... .......||+.|+|||+..+..++.++||||+|+++|||++ |+.||......  .....+...    
T Consensus       151 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--~~~~~~~~~----  223 (269)
T 4hcu_A          151 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTG----  223 (269)
T ss_dssp             TGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTT----
T ss_pred             ccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhcC----
Confidence            99987644322 22334567889999999988899999999999999999999 99999754221  111111110    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                        .........+      ....+++.+||++||++||+++|++++|+++..
T Consensus       224 --~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          224 --FRLYKPRLAS------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             --CCCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --ccCCCCCcCC------HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence              0001111111      223457888999999999999999999998864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-39  Score=365.03  Aligned_cols=259  Identities=21%  Similarity=0.273  Sum_probs=206.0

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.+.|.+.+.||+|+||+||+|.++ +|+.||+|++.........        .....+.+.+|+.++++++||||++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~--------~~~~~~~~~~E~~il~~l~hpnIv~l~   81 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR--------RGVCREEIEREVSILRQVLHPNIITLH   81 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCS--------SSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccccc--------chhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence            4567999999999999999999876 5899999999764432211        012357899999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC----
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF----  838 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~----  838 (1035)
                      +++.+.+..|+||||++||+|.+++....  .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++    
T Consensus        82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           82 DVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred             EEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence            99999999999999999999999997654  489999999999999999999999   999999999999998877    


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++||||+||++|+|++|..||.....  ......+.
T Consensus       157 ~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--~~~~~~i~  231 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANIT  231 (361)
T ss_dssp             CEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHH
T ss_pred             CEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Confidence            79999999998765432   22356799999999999988999999999999999999999999975421  11111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...   ...........+      ..+.+++.+||.+||++|||+.|++++
T Consensus       232 ~~~---~~~~~~~~~~~s------~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          232 AVS---YDFDEEFFSQTS------ELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             TTC---CCCCHHHHTTSC------HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hcC---CCCCchhccCCC------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            110   000111111111      123457888999999999999999873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-38  Score=354.20  Aligned_cols=276  Identities=32%  Similarity=0.542  Sum_probs=213.6

Q ss_pred             HHHHHhccccC------CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC
Q 039419          681 VEQVLKCLVED------SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR  754 (1035)
Q Consensus       681 ~~~~~~~~~~~------~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  754 (1035)
                      +..+.+.|...      +.||+|+||.||+|.+ +++.||||++........          ....+.+.+|+.++++++
T Consensus        20 l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           20 LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITT----------EELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             HHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCT----------TTHHHHHHHHHHHHHHCC
T ss_pred             HHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcch----------HHHHHHHHHHHHHHHhcC
Confidence            34444555555      8999999999999987 488999999865322111          123578999999999999


Q ss_pred             CCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcC-CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          755 HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR-DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       755 hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      ||||+++++++.+.+..++||||+++|+|.+++.... ...+++..+..++.|+++||+|||+.   +|+||||||+||+
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            9999999999999999999999999999999987543 34589999999999999999999999   9999999999999


Q ss_pred             EcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch--
Q 039419          834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL--  911 (1035)
Q Consensus       834 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~--  911 (1035)
                      ++.++.+||+|||.++...............||+.|+|||+..+ .++.++||||||+++|+|++|+.||........  
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  244 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL  244 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence            99999999999999987654333233345679999999998765 588999999999999999999999986533221  


Q ss_pred             hHHHHHHHhccc-hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          912 HIVDWVRQKRGA-IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       912 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      .+...+...... ...+++.....   .......+..++.+||+.||++||++.+++++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKMNDA---DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSCSCC---CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHhhhhhhhhhhhcccccccc---chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            111111111111 12222222221   2233345567899999999999999999999998874

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.2e-39  Score=380.76  Aligned_cols=376  Identities=20%  Similarity=0.203  Sum_probs=274.3

Q ss_pred             CCcccee--EEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCC
Q 039419           17 NPCKWSH--ITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGV   94 (1035)
Q Consensus        17 ~~c~w~g--i~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~   94 (1035)
                      ..|.|.+  |.|+..+           +. .+|. +.  ++|++|+|++|.+++..|..++.+++|++|+|++|.+.+.+
T Consensus         6 ~~c~~~~~~~~c~~~~-----------l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i   70 (455)
T 3v47_A            6 SECSVIGYNAICINRG-----------LH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVI   70 (455)
T ss_dssp             -CCEEETTEEECCSSC-----------CS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEE
T ss_pred             ceeEEEccccCcCCCC-----------cc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceE
Confidence            4577776  8887543           11 2333 22  56777777777777666667777777777777777766444


Q ss_pred             -ChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchh--hccccccceeecCCCcccCCCCCCc-
Q 039419           95 -PSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVE--LGKLVNLEVIRAGGNKDIAGKIPYE-  170 (1035)
Q Consensus        95 -p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~--l~~l~~L~~L~l~~n~~~~~~~~~~-  170 (1035)
                       |..|.++++|++|+|++|++++..|..++.+++|++|+|++|.+++.+|..  ++.+++|++|++++|. +.+..|.. 
T Consensus        71 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~  149 (455)
T 3v47_A           71 RNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN-IKKIQPASF  149 (455)
T ss_dssp             CTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSB-CCSCCCCGG
T ss_pred             CcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCc-cCccCcccc
Confidence             455677777777777777777656667777777777777777776545544  7777777777777775 34444544 


Q ss_pred             CCCccceEEEEeccccccccCccccccc--ccccceeecccccccCCccc--------cccCcCCceEEecCCcCCCCCC
Q 039419          171 IGDCQSLLVVGLADTKVAGSLPASLGKL--SKLQSLSVYTTMLSGEIPPQ--------IGNCSELVDLFLYENDLSGSLP  240 (1035)
Q Consensus       171 ~~~l~~L~~L~l~~~~~~~~~p~~l~~l--~~L~~L~l~~n~l~~~~p~~--------l~~l~~L~~L~L~~n~l~~~~~  240 (1035)
                      +..+++|++|++++|.+.+..|..+..+  .+|+.|++++|.+.+..+..        +..+++|+.|+|++|.+++..|
T Consensus       150 ~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~  229 (455)
T 3v47_A          150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA  229 (455)
T ss_dssp             GGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHH
T ss_pred             cCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccch
Confidence            6677777777777777777777777665  57777777777776433332        2355677777777777776666


Q ss_pred             hhhhcc---cchhHhhccccccccc----------CCccccC--CCCCcEEEccCccCCCCCCccccCCCCCcEEEccCC
Q 039419          241 RELGKL---QKLEKMLLWQNNFDGA----------IPEEIGN--CKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN  305 (1035)
Q Consensus       241 ~~l~~l---~~L~~L~l~~n~l~~~----------~p~~~~~--l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  305 (1035)
                      ..+..+   ++|+.|++++|.+.+.          .+..+..  .++|+.|++++|.+++..|..|..+++|++|+|++|
T Consensus       230 ~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n  309 (455)
T 3v47_A          230 KRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN  309 (455)
T ss_dssp             HHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             hhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCC
Confidence            666554   6777777776654322          2222222  368999999999999888889999999999999999


Q ss_pred             ccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEecc
Q 039419          306 NISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLI  385 (1035)
Q Consensus       306 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  385 (1035)
                      ++.+..+..|.++++|++|+|++|+|+.          ..|..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus       310 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----------~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  379 (455)
T 3v47_A          310 EINKIDDNAFWGLTHLLKLNLSQNFLGS----------IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD  379 (455)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCE----------ECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             cccccChhHhcCcccCCEEECCCCccCC----------cChhHhcCcccCCEEECCCCcccccChhhccccccccEEECC
Confidence            9998888899999999999999998864          345778899999999999999998888899999999999999


Q ss_pred             ccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc
Q 039419          386 SNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP  432 (1035)
Q Consensus       386 ~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~  432 (1035)
                      +|+|++..+..+.              .+++|++|+|++|.+++..|
T Consensus       380 ~N~l~~~~~~~~~--------------~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          380 TNQLKSVPDGIFD--------------RLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             SSCCSCCCTTTTT--------------TCTTCCEEECCSSCBCCCTT
T ss_pred             CCccccCCHhHhc--------------cCCcccEEEccCCCcccCCC
Confidence            9999976665544              45679999999999998777

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1e-39  Score=371.27  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=197.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+.||+|+||.||+|++.    ++..||||++......             ...+.|.+|+.++++++||||+++
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~  111 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE-------------KQRRDFLGEASIMGQFDHPNIIRL  111 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH-------------HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH-------------HHHHHHHHHHHHHHhCCCCCCCeE
Confidence            57899999999999999999765    4778999999653221             125679999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+.+..|+||||+++|+|.++++..+ ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+|
T Consensus       112 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  187 (373)
T 2qol_A          112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK  187 (373)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             EEEEeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEE
Confidence            999999999999999999999999997653 3489999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      |+|||+++........ .......+++.|+|||+..+..++.++||||||+++|||++ |+.||.....  ......+..
T Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i~~  265 (373)
T 2qol_A          188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDE  265 (373)
T ss_dssp             ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHHHT
T ss_pred             ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc
Confidence            9999999876543211 11123346788999999998999999999999999999998 9999965422  112222111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                                ......+..  ....+..++.+||+.||++||++.++++.|+.+.....
T Consensus       266 ----------~~~~~~~~~--~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  312 (373)
T 2qol_A          266 ----------GYRLPPPMD--CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG  312 (373)
T ss_dssp             ----------TEECCCCTT--CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred             ----------CCCCCCCcc--ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence                      111111111  11234557888999999999999999999999876543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-39  Score=362.89  Aligned_cols=262  Identities=26%  Similarity=0.392  Sum_probs=211.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .++|...+.||+|+||.||+|.+      .+++.||||++.......             ..+.+.+|+.++++++||||
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~hp~i   88 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-------------ELRDLLSEFNVLKQVNHPHV   88 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHH-------------HHHHHHHHHHHHTTCCCTTB
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHH-------------HHHHHHHHHHHHhhCCCCce
Confidence            46788999999999999999976      235889999996543211             24678999999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhc
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD----------------------SCLEWELRYRIILGAAQGLAYLHH  816 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~  816 (1035)
                      +++++++.+.+..|+||||+++|+|.+++.....                      ..+++..+..++.||++||+|||+
T Consensus        89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  168 (314)
T 2ivs_A           89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE  168 (314)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999986543                      337899999999999999999999


Q ss_pred             cCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHH
Q 039419          817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV  896 (1035)
Q Consensus       817 ~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~el  896 (1035)
                      .   +|+||||||+||+++.++.+||+|||+++...............+|+.|+|||+..+..++.++||||||+++|||
T Consensus       169 ~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el  245 (314)
T 2ivs_A          169 M---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI  245 (314)
T ss_dssp             T---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred             C---CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHH
Confidence            9   9999999999999999999999999999876554433334455688999999999888899999999999999999


Q ss_pred             Hh-CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          897 LT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       897 lt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ++ |+.||......  .....+....      ........+      ..+..++.+||+.||++||++.++++.|+++..
T Consensus       246 ~t~g~~p~~~~~~~--~~~~~~~~~~------~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          246 VTLGGNPYPGIPPE--RLFNLLKTGH------RMERPDNCS------EEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             HTTSCCSSTTCCGG--GHHHHHHTTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhCCCCCCCCCCHH--HHHHHhhcCC------cCCCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99 99999765332  2222222111      000111111      223457888999999999999999999999865


Q ss_pred             h
Q 039419          976 E  976 (1035)
Q Consensus       976 ~  976 (1035)
                      .
T Consensus       312 ~  312 (314)
T 2ivs_A          312 K  312 (314)
T ss_dssp             T
T ss_pred             h
Confidence            4

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.1e-40  Score=355.00  Aligned_cols=257  Identities=25%  Similarity=0.400  Sum_probs=208.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|++.++..||+|++.....               ..+++.+|++++++++||||+++++++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~~~   72 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---------------SEDEFFQEAQTMMKLSHPKLVKFYGVC   72 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---------------cHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            67889999999999999999999888999999965322               245789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Df  148 (268)
T 3sxs_A           73 SKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDF  148 (268)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCT
T ss_pred             ccCCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccC
Confidence            99999999999999999999997653 2489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++....... .......+|+.|+|||+..+..++.++||||+|+++|||++ |+.||......  .....+....   
T Consensus       149 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~---  222 (268)
T 3sxs_A          149 GMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--EVVLKVSQGH---  222 (268)
T ss_dssp             TCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTC---
T ss_pred             ccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--HHHHHHHcCC---
Confidence            99987655432 22234567888999999988889999999999999999999 99999754221  1111111100   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                         ........+      ..+..++.+||+.||++|||+.|+++.|+.+...
T Consensus       223 ---~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 ---RLYRPHLAS------DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---CCCCCTTSC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---CCCCCCcCh------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence               000011111      1234578889999999999999999999887543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-39  Score=357.34  Aligned_cols=269  Identities=19%  Similarity=0.262  Sum_probs=206.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||+||+|.+.. ++.||||++......             ...+.+.+|++++++++||||++++++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~   75 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-------------RPVDVQMREFEVLKKLNHKNIVKLFAI   75 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-------------SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-------------chHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            578899999999999999998764 899999999643221             125678899999999999999999999


Q ss_pred             EEcCC--cceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE----cCC
Q 039419          765 CWNRN--TRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI----GPE  837 (1035)
Q Consensus       765 ~~~~~--~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll----~~~  837 (1035)
                      +...+  ..|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.   +|+||||||+||++    +.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~  152 (319)
T 4euu_A           76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQ  152 (319)
T ss_dssp             EECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSC
T ss_pred             eecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCC
Confidence            98765  67999999999999999976543 3389999999999999999999999   99999999999999    788


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccc--------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY--------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE  909 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~  909 (1035)
                      +.+||+|||+++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||......
T Consensus       153 ~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  229 (319)
T 4euu_A          153 SVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (319)
T ss_dssp             EEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG
T ss_pred             ceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            8899999999987654332   23467999999999865        577899999999999999999999999754322


Q ss_pred             ch--hHHHHHHHhccch--hhh----------cccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          910 GL--HIVDWVRQKRGAI--EVL----------DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       910 ~~--~~~~~~~~~~~~~--~~~----------~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ..  .....+.......  ..+          .................+..++.+||+.||++||+++|++++..+.
T Consensus       230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             GGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             chhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            21  1111111111100  000          0011111111122233345688899999999999999999987664

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=372.04  Aligned_cols=252  Identities=21%  Similarity=0.289  Sum_probs=198.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .++|...+.||+|+||+||+|+++ +++.||||++........           ...+.+.+|..+++.+ +||||++++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~-----------~~~~~~~~E~~il~~~~~hp~Iv~l~   90 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-----------DDVECTMTEKRILSLARNHPFLTQLF   90 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHH-----------TTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcch-----------hHHHHHHHHHHHHHhccCCCceeeEE
Confidence            478999999999999999999876 489999999965322211           2256788999999988 699999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+.+..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||
T Consensus        91 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL  165 (353)
T 3txo_A           91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKL  165 (353)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999987654  89999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+|+......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ......+.... 
T Consensus       166 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~-  240 (353)
T 3txo_A          166 ADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--DDLFEAILNDE-  240 (353)
T ss_dssp             CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-
T ss_pred             ccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--HHHHHHHHcCC-
Confidence            9999998543322  223456899999999999888899999999999999999999999975422  11111111110 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM------KDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~------~el~~~  969 (1035)
                            .......+      ....+++.+||++||++||++      +|++++
T Consensus       241 ------~~~p~~~~------~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          241 ------VVYPTWLH------EDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ------CCCCTTSC------HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ------CCCCCCCC------HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                  00111111      123457888999999999998      777764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2e-39  Score=369.04  Aligned_cols=258  Identities=22%  Similarity=0.330  Sum_probs=200.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .++|...++||+|+||+||+|+++. ++.||||++........           ...+.+.+|..++.++ +|||||+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~-----------~~~~~~~~E~~il~~~~~hp~Iv~l~  119 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-----------EDIDWVQTEKHVFEQASNHPFLVGLH  119 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------------CCHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-----------HHHHHHHHHHHHHHhcCCCCCcCeeE
Confidence            3679999999999999999998764 78999999975433222           1235688999999887 899999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+++..|+||||++||+|..++...+.  +++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       120 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL  194 (396)
T 4dc2_A          120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKL  194 (396)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEECCEEEEEEEcCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEE
Confidence            999999999999999999999999987654  89999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch---hHHHHHHH
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL---HIVDWVRQ  919 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~---~~~~~~~~  919 (1035)
                      +|||+|+......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........   .....+..
T Consensus       195 ~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~  272 (396)
T 4dc2_A          195 TDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  272 (396)
T ss_dssp             CCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred             eecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence            9999998633322  223467899999999999999999999999999999999999999964321110   00011110


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM------KDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~------~el~~~  969 (1035)
                      .     ........ + ..+  ...+.+++.+||++||++||++      +|++++
T Consensus       273 ~-----i~~~~~~~-p-~~~--s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          273 V-----ILEKQIRI-P-RSL--SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             H-----HHHCCCCC-C-TTS--CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             H-----HhccccCC-C-CcC--CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            0     00111111 1 111  1233557888999999999985      566553

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.1e-40  Score=372.22  Aligned_cols=263  Identities=24%  Similarity=0.360  Sum_probs=208.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      .++|...+.||+|+||.||+|++      .+++.||||++.......             ..+.+.+|+++++++ +|||
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~hpn   87 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------------EHRALMSELKILIHIGHHLN   87 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------------HHHHHHHHHHHHHHHCCCTT
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHH-------------HHHHHHHHHHHHHhhcCCcc
Confidence            47899999999999999999974      236889999996543221             246799999999999 7999


Q ss_pred             eeeEEeEEEcCCc-ceEEEEeCCCCChhhhhhhcCC--------------------------------------------
Q 039419          758 IVRFLGCCWNRNT-RLLMYDYMPNGSLGSLLHERRD--------------------------------------------  792 (1035)
Q Consensus       758 iv~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------  792 (1035)
                      |+++++++.+.+. .++||||+++|+|.++++....                                            
T Consensus        88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            9999999987654 8999999999999999976542                                            


Q ss_pred             --------------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccc
Q 039419          793 --------------------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVV  852 (1035)
Q Consensus       793 --------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~  852 (1035)
                                          ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY  244 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence                                1288999999999999999999999   99999999999999999999999999998765


Q ss_pred             cCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhhcccc
Q 039419          853 EGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL  931 (1035)
Q Consensus       853 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  931 (1035)
                      ............||+.|+|||+..+..++.++||||||+++|||++ |+.||....... .....+....      ....
T Consensus       245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~------~~~~  317 (359)
T 3vhe_A          245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGT------RMRA  317 (359)
T ss_dssp             SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTC------CCCC
T ss_pred             ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCC------CCCC
Confidence            5433333445678999999999988999999999999999999998 999997653322 1112211110      0001


Q ss_pred             cCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          932 RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       932 ~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      ....+      ..+.+++.+||++||++||+++|++++|+++...
T Consensus       318 ~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          318 PDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCC------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            11111      1235578889999999999999999999998754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.3e-40  Score=365.79  Aligned_cols=250  Identities=23%  Similarity=0.372  Sum_probs=201.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||.||+|.+ .+++.||||++........           ...+.+.+|+.+++.++||||+++++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpnIv~l~~   76 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS-----------DMHMRVEREISYLKLLRHPHIIKLYD   76 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccch-----------hHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            35789999999999999999987 4689999999864322111           12457899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+||||+ +|+|.+++...+.  +++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        77 ~~~~~~~~~lv~E~~-~g~l~~~l~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~  150 (336)
T 3h4j_B           77 VITTPTDIVMVIEYA-GGELFDYIVEKKR--MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIA  150 (336)
T ss_dssp             EEECSSEEEEEECCC-CEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEEC
T ss_pred             EEEeCCEEEEEEECC-CCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEE
Confidence            999999999999999 7899999877654  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||++........   ....+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||........           
T Consensus       151 DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-----------  216 (336)
T 3h4j_B          151 DFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-----------  216 (336)
T ss_dssp             CSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-----------
T ss_pred             EeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-----------
Confidence            9999987654432   235679999999999887775 6899999999999999999999975422110           


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ...+.......+.. .  .....+++.+||+.||++|||++|++++
T Consensus       217 -~~~i~~~~~~~p~~-~--s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          217 -FKKVNSCVYVMPDF-L--SPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             -BCCCCSSCCCCCTT-S--CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             -HHHHHcCCCCCccc-C--CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence             00011111111111 1  1123457888999999999999999885

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=370.25  Aligned_cols=262  Identities=26%  Similarity=0.365  Sum_probs=211.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC--------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CC
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME--------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RH  755 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1035)
                      .++|.+.+.||+|+||+||+|++.        .+..||||++.......             ..+++.+|+++++++ +|
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~h  134 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-------------DLSDLISEMEMMKMIGKH  134 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHH-------------HHHHHHHHHHHHHHHCCC
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHH-------------HHHHHHHHHHHHHHhcCC
Confidence            367889999999999999999752        24679999996543221             246789999999999 89


Q ss_pred             CceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 039419          756 KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPP  821 (1035)
Q Consensus       756 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  821 (1035)
                      |||+++++++.+++..++||||+++|+|.+++.....              ..+++..+..++.||+.||+|||+.   +
T Consensus       135 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  211 (382)
T 3tt0_A          135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---K  211 (382)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             chhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            9999999999999999999999999999999987542              3489999999999999999999999   9


Q ss_pred             eeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 039419          822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK  900 (1035)
Q Consensus       822 ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~  900 (1035)
                      |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus       212 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~  291 (382)
T 3tt0_A          212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG  291 (382)
T ss_dssp             CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987655443344445678899999999999999999999999999999999 99


Q ss_pred             CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       901 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      .||.....  ......+....      ........+      ..+..++.+||++||++||+++|+++.|+.+...
T Consensus       292 ~p~~~~~~--~~~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          292 SPYPGVPV--EELFKLLKEGH------RMDKPSNCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             CSSTTCCH--HHHHHHHHTTC------CCCCCSSCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCH--HHHHHHHHcCC------CCCCCccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            99975421  12222221111      000111111      1234578889999999999999999999998643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.5e-39  Score=360.75  Aligned_cols=263  Identities=14%  Similarity=0.156  Sum_probs=208.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  763 (1035)
                      ++|...+.||+|+||+||+|.. .+++.||||++.....                .+.+.+|+.+++++ +||||+++++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------~~~~~~E~~~l~~l~~h~~i~~~~~   72 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----------------APQLHLEYRFYKQLGSGDGIPQVYY   72 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----------------SCCHHHHHHHHHHHCSCTTSCCEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----------------hHHHHHHHHHHHHhhCCCCCCEEEE
Confidence            5688899999999999999976 4689999999854321                23588999999999 8999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc----
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE----  839 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~----  839 (1035)
                      ++.+.+..|+||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.    
T Consensus        73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~  147 (330)
T 2izr_A           73 FGPCGKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQ  147 (330)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTT
T ss_pred             EEecCCccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCc
Confidence            999999999999999 999999998652 3489999999999999999999999   9999999999999998887    


Q ss_pred             -eEEeeccCccccccCCccc-----cccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch-h
Q 039419          840 -PYIADFGLAKLVVEGDFAR-----SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-H  912 (1035)
Q Consensus       840 -~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~-~  912 (1035)
                       +||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus       148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~  227 (330)
T 2izr_A          148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE  227 (330)
T ss_dssp             SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred             eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence             9999999998765433211     12456899999999999999999999999999999999999999986543321 1


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      ....+....  ............    +   .+..++..||+.||.+||+++++.+.|+++.....
T Consensus       228 ~~~~i~~~~--~~~~~~~~~~~~----p---~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          228 RYQKIGDTK--RATPIEVLCENF----P---EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHHHHHHHH--HHSCHHHHTTTC----H---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHhhh--ccCCHHHHhccC----h---HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            111111100  000000000111    1   44567888999999999999999999998866543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=367.47  Aligned_cols=264  Identities=27%  Similarity=0.433  Sum_probs=209.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .++|...+.||+|+||.||+|++.      +++.||||++......             ...+.+.+|+.++++++||||
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~i  112 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------------DMQADFQREAALMAEFDNPNI  112 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------------HHHHHHHHHHHHHHTCCCTTB
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH-------------HHHHHHHHHHHHHHhCCCCCE
Confidence            368899999999999999999774      3488999999654321             125689999999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhc
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD----------------------SCLEWELRYRIILGAAQGLAYLHH  816 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~  816 (1035)
                      +++++++.+.+..|+||||+++|+|.+++.....                      ..+++..++.++.||++||+|||+
T Consensus       113 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~  192 (343)
T 1luf_A          113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE  192 (343)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999976421                      458999999999999999999999


Q ss_pred             cCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHH
Q 039419          817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV  896 (1035)
Q Consensus       817 ~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~el  896 (1035)
                      .   +|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||
T Consensus       193 ~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el  269 (343)
T 1luf_A          193 R---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI  269 (343)
T ss_dssp             T---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             C---CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHH
Confidence            9   9999999999999999999999999999876544333334456789999999999888999999999999999999


Q ss_pred             Hh-CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          897 LT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       897 lt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ++ |..||.....  ......+.....      .......+      ..+..++.+||+.||++||++.++++.|+++..
T Consensus       270 ~t~g~~p~~~~~~--~~~~~~~~~~~~------~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          270 FSYGLQPYYGMAH--EEVIYYVRDGNI------LACPENCP------LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             HTTTCCTTTTSCH--HHHHHHHHTTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             HhcCCCcCCCCCh--HHHHHHHhCCCc------CCCCCCCC------HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            99 9999975422  112222111100      00111111      134457888999999999999999999998865


Q ss_pred             hHH
Q 039419          976 ERE  978 (1035)
Q Consensus       976 ~~~  978 (1035)
                      ..+
T Consensus       336 ~~~  338 (343)
T 1luf_A          336 RAE  338 (343)
T ss_dssp             ---
T ss_pred             hhh
Confidence            443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-39  Score=355.37  Aligned_cols=258  Identities=24%  Similarity=0.391  Sum_probs=206.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++|...+.||+|+||+||+|++.++..||+|++.....               ..+++.+|++++++++||||++++++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~~   87 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---------------SEDEFIEEAKVMMNLSHEKLVQLYGV   87 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---------------CHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---------------CHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence            367889999999999999999999888999999965322               24578999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++++|.+++..... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~D  163 (283)
T 3gen_A           88 CTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD  163 (283)
T ss_dssp             ECSSSSEEEEECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECS
T ss_pred             EecCCCeEEEEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcc
Confidence            9999999999999999999999976432 389999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.++....... .......+|+.|+|||+..+..++.++||||+|+++|||++ |+.||......  .....+...   
T Consensus       164 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~---  237 (283)
T 3gen_A          164 FGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQG---  237 (283)
T ss_dssp             TTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTT---
T ss_pred             cccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcc---
Confidence            999987644321 22334567889999999988899999999999999999998 99999754221  111111110   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                         .........+      ..+.+++.+||+.||++||++++++++|+++..+
T Consensus       238 ---~~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          238 ---LRLYRPHLAS------EKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ---CCCCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---cCCCCCCcCC------HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence               0000111111      1234578889999999999999999999988643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.9e-39  Score=361.61  Aligned_cols=261  Identities=25%  Similarity=0.404  Sum_probs=201.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcE----EEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEV----IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|...+.||+|+||+||+|++. +++.    ||+|.+......             ...+.|.+|+.++++++||||++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~   81 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-------------KANKEILDEAYVMASVDNPHVCR   81 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------------CHHHHHHHHHHHHHCCBTTBCC
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH-------------HHHHHHHHHHHHHHhCCCCCEeE
Confidence            56889999999999999999865 3443    577777532211             23568999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++.+.+ .++||||+.+|+|.+++.... ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+
T Consensus        82 ~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~  156 (327)
T 3poz_A           82 LLGICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV  156 (327)
T ss_dssp             EEEEEESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred             EEEEEecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCE
Confidence            999998754 789999999999999998754 3489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+..
T Consensus       157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~  234 (327)
T 3poz_A          157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK  234 (327)
T ss_dssp             EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred             EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHc
Confidence            9999999987765443333445567889999999999999999999999999999999 99999764332  22222221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      ...        . ..+..   ....+..++.+||+.||++||++.+++++|+.+.+...
T Consensus       235 ~~~--------~-~~~~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~  281 (327)
T 3poz_A          235 GER--------L-PQPPI---CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  281 (327)
T ss_dssp             TCC--------C-CCCTT---BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHH
T ss_pred             CCC--------C-CCCcc---CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhhh
Confidence            110        0 01111   11234567888999999999999999999999876544

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-39  Score=359.73  Aligned_cols=249  Identities=23%  Similarity=0.293  Sum_probs=202.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|+.+ +|+.||+|++........           ...+.+.+|+.+++.++||||+++++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~Iv~~~~   73 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-----------KQVEHTNDERLMLSIVTHPFIIRMWG   73 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHhhCCCCCCceEeE
Confidence            367899999999999999999876 589999999965322111           23567889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||++||+|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+||+++.+|.+||+
T Consensus        74 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  148 (318)
T 1fot_A           74 TFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT  148 (318)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEeCCEEEEEEeCCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEe
Confidence            99999999999999999999999987544  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+....  
T Consensus       149 Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~i~~~~--  219 (318)
T 1fot_A          149 DFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--MKTYEKILNAE--  219 (318)
T ss_dssp             CCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHCC--
T ss_pred             ecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCC--
Confidence            99999865332     2356899999999999999999999999999999999999999975321  11111111100  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                           .......+      ..+.+++.+|+..||++||     ++++++++
T Consensus       220 -----~~~p~~~~------~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          220 -----LRFPPFFN------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -----CCCCTTSC------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCCCCC------HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                 00111111      1234577889999999999     88888874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.3e-39  Score=355.46  Aligned_cols=260  Identities=27%  Similarity=0.364  Sum_probs=199.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhc--CCCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS--IRHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~  762 (1035)
                      .++|...+.||+|+||+||+|++ +++.||||++...                 ..+.+.+|.+++..  ++||||++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----------------~~~~~~~e~~~~~~~~l~h~niv~~~   68 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----------------DEKSWFRETELYNTVMLRHENILGFI   68 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----------------GHHHHHHHHHHHHHTCCCCTTBCCEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----------------cchhhHHHHHHHHHhhccCcCeeeEE
Confidence            46789999999999999999988 5899999998542                 13456667777666  7999999999


Q ss_pred             eEEEcC----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhh--------ccCCCCeeccCCCcc
Q 039419          763 GCCWNR----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLH--------HDCVPPIVHRDIKAN  830 (1035)
Q Consensus       763 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivHrDikp~  830 (1035)
                      +++.+.    ...|+||||+++|+|.++++..   .+++..+..++.|++.||+|||        +.   +|+||||||+
T Consensus        69 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~  142 (301)
T 3q4u_A           69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSK  142 (301)
T ss_dssp             EEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGG
T ss_pred             EeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChH
Confidence            997653    4579999999999999999653   3899999999999999999999        77   9999999999


Q ss_pred             cEEEcCCCceEEeeccCccccccCCcc--ccccccCCcccccCCcccccC------CCCccccchhHHHHHHHHHhC---
Q 039419          831 NILIGPEFEPYIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMM------KITEKSDVYSYGVVVLEVLTG---  899 (1035)
Q Consensus       831 NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvvl~elltg---  899 (1035)
                      ||+++.++.+||+|||+++........  .......||+.|+|||++.+.      .++.++|||||||++|||++|   
T Consensus       143 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~  222 (301)
T 3q4u_A          143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS  222 (301)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             hEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcC
Confidence            999999999999999999876543321  112345799999999998766      455799999999999999999   


Q ss_pred             -------CCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCc--ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          900 -------KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPE--VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       900 -------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                             +.||....+..............     .......+.  ........+.+++.+||+.||++|||+.|+++.|
T Consensus       223 ~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  297 (301)
T 3q4u_A          223 NGIVEDYKPPFYDVVPNDPSFEDMRKVVCV-----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL  297 (301)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             ccccccccccccccCCCCcchhhhhHHHhc-----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence                   88886554433322222211100     000011111  1112334456789999999999999999999999


Q ss_pred             HHH
Q 039419          971 KEI  973 (1035)
Q Consensus       971 ~~~  973 (1035)
                      +++
T Consensus       298 ~~i  300 (301)
T 3q4u_A          298 TKI  300 (301)
T ss_dssp             HHH
T ss_pred             hcc
Confidence            875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.8e-39  Score=371.81  Aligned_cols=258  Identities=19%  Similarity=0.212  Sum_probs=205.1

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ....++|...+.||+|+||+||+|.+. +|+.||+|++........            ..+.+.+|+.++++++||||++
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~------------~~~~~~~E~~il~~l~hpnIv~   74 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR------------DHQKLEREARICRLLKHPNIVR   74 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHH------------HHHHHHHHHHHHHHCCBTTBCC
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHH------------HHHHHHHHHHHHHhCCCcCCCe
Confidence            456688999999999999999999765 689999999976543221            2467899999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc---CC
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG---PE  837 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~---~~  837 (1035)
                      +++++.+++..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   ||+||||||+||+++   .+
T Consensus        75 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~--~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~  149 (444)
T 3soa_A           75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKG  149 (444)
T ss_dssp             EEEEEECSSEEEEEECCCBCCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTT
T ss_pred             EEEEEEECCEEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCC
Confidence            99999999999999999999999999987654  89999999999999999999999   999999999999998   46


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||+++......  .......||+.|+|||++.+..++.++||||+||++|+|++|..||....  .......+
T Consensus       150 ~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i  225 (444)
T 3soa_A          150 AAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQI  225 (444)
T ss_dssp             CCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHH
T ss_pred             CcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHH
Confidence            789999999998765432  22235689999999999998899999999999999999999999996532  11222222


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....  ....+ .....+      ..+.+++.+||++||++|||+.|++++
T Consensus       226 ~~~~~--~~~~~-~~~~~s------~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          226 KAGAY--DFPSP-EWDTVT------PEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HHTCC--CCCTT-TTTTSC------HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhCCC--CCCcc-ccccCC------HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11110  00000 001111      223457888999999999999999884

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=359.29  Aligned_cols=260  Identities=21%  Similarity=0.274  Sum_probs=206.3

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.+.|...+.||+|+||.||+|.+. +++.||+|++.........        .....+.+.+|+.++++++||||+++
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~   79 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--------RGVSREDIEREVSILKEIQHPNVITL   79 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCS--------SSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccccc--------chhhHHHHHHHHHHHHhCCCCCCCcE
Confidence            45578999999999999999999876 5899999999754332211        01235789999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC---
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF---  838 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~---  838 (1035)
                      ++++.+.+..|+||||+++|+|.+++....  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++   
T Consensus        80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~  154 (326)
T 2y0a_A           80 HEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPK  154 (326)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSS
T ss_pred             EEEEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCC
Confidence            999999999999999999999999997654  389999999999999999999999   999999999999999887   


Q ss_pred             -ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 -EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 -~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                       .+||+|||+++......   ......||+.|+|||+..+..++.++|||||||++|+|++|+.||.....  ......+
T Consensus       155 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~~  229 (326)
T 2y0a_A          155 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANV  229 (326)
T ss_dssp             CCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHH
T ss_pred             CCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--HHHHHHH
Confidence             79999999998764432   22356799999999999888999999999999999999999999975321  1111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....   ..........+      ....+++.+||++||++|||+.|++++
T Consensus       230 ~~~~~---~~~~~~~~~~~------~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          230 SAVNY---EFEDEYFSNTS------ALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHTCC---CCCHHHHTTSC------HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhcCC---CcCccccccCC------HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11100   00000001111      123457888999999999999999984

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=366.65  Aligned_cols=252  Identities=21%  Similarity=0.292  Sum_probs=201.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||.||+|++. +++.||+|++........           ...+.+.+|+.+++.++|||||++++
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~-----------~~~~~~~~E~~il~~l~hp~Iv~l~~   82 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-----------NEVRNVFKELQIMQGLEHPFLVNLWY   82 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccH-----------HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            367999999999999999999776 488999999864322111           23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||+.||+|.+++.....  +++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~  157 (384)
T 4fr4_A           83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHIT  157 (384)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHTTCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEeCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEe
Confidence            99999999999999999999999976543  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCch-hHHHHHHH
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-HIVDWVRQ  919 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~  919 (1035)
                      |||+++......   .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||........ .....+..
T Consensus       158 DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~  234 (384)
T 4fr4_A          158 DFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET  234 (384)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred             ccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence            999998764432   2346789999999999763   4589999999999999999999999975433221 11111111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-MKDVAA  968 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-~~el~~  968 (1035)
                      .       ........+      ..+..++.+||++||++||+ ++++.+
T Consensus       235 ~-------~~~~p~~~s------~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 T-------VVTYPSAWS------QEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             C-------CCCCCTTSC------HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             c-------ccCCCCcCC------HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            0       000111111      23355788899999999998 777765

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.7e-39  Score=357.90  Aligned_cols=248  Identities=21%  Similarity=0.336  Sum_probs=200.3

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |...+.||+|+||.||+|+.. +|+.||||++.....              ...+.+.+|+.++++++||||+++++++.
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~  112 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--------------QRRELLFNEVVIMRDYQHFNVVEMYKSYL  112 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------------CSHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--------------hHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            666679999999999999876 699999999864321              12467899999999999999999999999


Q ss_pred             cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          767 NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       767 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                      ..+..|+||||+++|+|.+++...   .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       113 ~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  186 (321)
T 2c30_A          113 VGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFG  186 (321)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeee
Confidence            999999999999999999998653   389999999999999999999999   99999999999999999999999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      +++.......  ......||+.|+|||+..+..++.++||||||+++|||++|+.||.....  ......+....     
T Consensus       187 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~~~~~~~~-----  257 (321)
T 2c30_A          187 FCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKRLRDSP-----  257 (321)
T ss_dssp             TCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSS-----
T ss_pred             eeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCC-----
Confidence            9987654322  22456799999999999988999999999999999999999999975422  11111211110     


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       .+....  ....  ...+.+++.+||+.||++||+++|++++
T Consensus       258 -~~~~~~--~~~~--~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          258 -PPKLKN--SHKV--SPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -CCCCTT--GGGS--CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -CCCcCc--cccC--CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000000  0001  1123457788999999999999999885

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.2e-40  Score=366.38  Aligned_cols=251  Identities=23%  Similarity=0.348  Sum_probs=202.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .++|...+.||+|+||.||+|+++ +++.||||++........           ...+.+.+|..+++.+ +||||++++
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~E~~il~~~~~hp~iv~l~   84 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-----------DDVECTMVEKRVLSLAWEHPFLTHMF   84 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhh-----------hhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence            478999999999999999999876 589999999965322111           1246788999999987 899999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+.+..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   ||+||||||+||+++.+|.+||
T Consensus        85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEE
Confidence            999999999999999999999999987654  89999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+++......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ......+.... 
T Consensus       160 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~-  234 (345)
T 1xjd_A          160 ADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSIRMDN-  234 (345)
T ss_dssp             CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-
T ss_pred             eEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHhCC-
Confidence            9999998643322  223467899999999999998999999999999999999999999975421  11222111110 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK-DVAA  968 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~-el~~  968 (1035)
                            .......+      ..+.+++.+||+.||++||++. ++++
T Consensus       235 ------~~~p~~~s------~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 ------PFYPRWLE------KEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ------CCCCTTSC------HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------CCCCcccC------HHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                  11111111      1234578889999999999997 7765

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3e-39  Score=361.22  Aligned_cols=261  Identities=26%  Similarity=0.365  Sum_probs=202.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcE----EEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEV----IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|...+.||+|+||+||+|.+.. ++.    ||+|.+.......             ..+.+.+|+.++++++||||++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~-------------~~~~~~~e~~~l~~l~h~~iv~   79 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ-------------SFQAVTDHMLAIGSLDHAHIVR   79 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS-------------CBCSCCHHHHHHHTCCCTTBCC
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH-------------HHHHHHHHHHHHhcCCCCCcCe
Confidence            468888999999999999997653 443    7788775432211             1235678999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++. .+..++||||+++|+|.+++...+ ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus        80 ~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~  154 (325)
T 3kex_A           80 LLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQV  154 (325)
T ss_dssp             EEEEEC-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCE
T ss_pred             EEEEEc-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeE
Confidence            999886 466889999999999999997643 2488899999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++...............||..|+|||++.+..++.++||||||+++|||++ |+.||......  .....+..
T Consensus       155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~  232 (325)
T 3kex_A          155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEK  232 (325)
T ss_dssp             EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHT
T ss_pred             EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHc
Confidence            9999999998765544334455678889999999998899999999999999999999 99999764332  22222221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      ...      .......+.      .+..++.+||+.||++||++.+++++|+.+.+...
T Consensus       233 ~~~------~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          233 GER------LAQPQICTI------DVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             TCB------CCCCTTBCT------TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             CCC------CCCCCcCcH------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            110      000111111      23447778999999999999999999998865543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.4e-39  Score=360.95  Aligned_cols=257  Identities=22%  Similarity=0.329  Sum_probs=200.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  763 (1035)
                      ++|...+.||+|+||.||+|+++ +++.||+|++........           ...+.+.+|..+++++ +||||+++++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~~~~hp~iv~l~~   77 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-----------EDIDWVQTEKHVFEQASNHPFLVGLHS   77 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH-----------HHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch-----------HHHHHHHHHHHHHHhcCCCCccCeEEE
Confidence            57889999999999999999876 489999999965432221           2246788999999988 8999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++++||+
T Consensus        78 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  152 (345)
T 3a8x_A           78 CFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLT  152 (345)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEE
Confidence            99999999999999999999999987654  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch---hHHHHHHHh
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL---HIVDWVRQK  920 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~---~~~~~~~~~  920 (1035)
                      |||+++......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||........   .....+...
T Consensus       153 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  230 (345)
T 3a8x_A          153 DYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV  230 (345)
T ss_dssp             CGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred             eccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence            999998643322  223457899999999999999999999999999999999999999974321100   000011000


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM------KDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~------~el~~~  969 (1035)
                           ........ +. ..  ...+.+++.+||+.||++||++      +|++++
T Consensus       231 -----i~~~~~~~-p~-~~--s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          231 -----ILEKQIRI-PR-SL--SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -----HHHCCCCC-CT-TS--CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -----HHcCCCCC-CC-CC--CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                 00111110 11 11  1234457888999999999995      566553

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.7e-39  Score=363.97  Aligned_cols=249  Identities=18%  Similarity=0.206  Sum_probs=203.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|++. +|+.||||++........           ...+.+.+|+.++++++||||+++++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~  108 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-----------KQIEHTLNEKRILQAVNFPFLVKLEF  108 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccH-----------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            367899999999999999999876 589999999864322111           23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus       109 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~  183 (350)
T 1rdq_E          109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEc
Confidence            99999999999999999999999987654  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+....  
T Consensus       184 DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~--  254 (350)
T 1rdq_E          184 DFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGK--  254 (350)
T ss_dssp             CCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC--
T ss_pred             ccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--HHHHHHHHcCC--
Confidence            99999865432     2356799999999999998999999999999999999999999975421  11111111110  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                           .......+      ..+..++.+||+.||++||+     ++|++++
T Consensus       255 -----~~~p~~~~------~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          255 -----VRFPSHFS------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -----CCCCTTCC------HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCCCCC------HHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                 00111111      12345788899999999998     8888774

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.9e-39  Score=362.84  Aligned_cols=256  Identities=21%  Similarity=0.274  Sum_probs=204.2

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.++|...+.||+|+||.||+|.++ +++.||+|++........            ..+.+.+|+.++++++||||+++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------------~~~~~~~E~~il~~l~hpnIv~~   93 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------------DFQKLEREARICRKLQHPNIVRL   93 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHH------------HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHH------------HHHHHHHHHHHHHhCCCCCCCeE
Confidence            44578999999999999999999776 589999999965433221            24678999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC---C
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE---F  838 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~---~  838 (1035)
                      ++++.+.+..|+||||++||+|.+++....  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.+   +
T Consensus        94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~  168 (362)
T 2bdw_A           94 HDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA  168 (362)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTC
T ss_pred             EEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence            999999999999999999999999987654  389999999999999999999999   99999999999999865   4


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....  ......+.
T Consensus       169 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~  243 (362)
T 2bdw_A          169 AVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIK  243 (362)
T ss_dssp             CEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred             CEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH
Confidence            59999999998765432   22356899999999999988999999999999999999999999975321  12222221


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....  ..     .......+  ...+.+++.+||++||++||++.|++++
T Consensus       244 ~~~~--~~-----~~~~~~~~--~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          244 AGAY--DY-----PSPEWDTV--TPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HTCC--CC-----CTTGGGGS--CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hCCC--CC-----CcccccCC--CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1110  00     00000001  1223457888999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.9e-39  Score=364.92  Aligned_cols=259  Identities=18%  Similarity=0.244  Sum_probs=202.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .+.|...+.||+|+||+||+|.++ +++.||||++.........         ....+.+.+|+.+++.++||||+++++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~hpnIv~~~~   93 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP---------GLSTEDLKREASICHMLKHPHIVELLE   93 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS---------SCCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc---------cchHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            467999999999999999999775 5899999998543211110         013567999999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc--
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE--  839 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~--  839 (1035)
                      ++.+.+..|+||||++||+|.+++....  ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.  
T Consensus        94 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~  170 (351)
T 3c0i_A           94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSA  170 (351)
T ss_dssp             EEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTC
T ss_pred             EEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCC
Confidence            9999999999999999999998886542  23489999999999999999999999   9999999999999987654  


Q ss_pred             -eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          840 -PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       840 -~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                       +||+|||+++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ......+.
T Consensus       171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~i~  245 (351)
T 3c0i_A          171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLFEGII  245 (351)
T ss_dssp             CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHHHHHH
T ss_pred             cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHHHHHH
Confidence             99999999987654322  2335679999999999998899999999999999999999999997531   11111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....   ..........+      ..+.+++.+||+.||++||++.|++++
T Consensus       246 ~~~~---~~~~~~~~~~s------~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          246 KGKY---KMNPRQWSHIS------ESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HTCC---CCCHHHHTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCC---CCCccccccCC------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1100   00000001111      234567888999999999999999874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-39  Score=358.61  Aligned_cols=252  Identities=18%  Similarity=0.213  Sum_probs=203.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|.+. +++.||+|++....               ...+.+.+|+.+++.++||||+++++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---------------~~~~~~~~E~~~l~~l~hpnIv~~~~   68 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---------------TDQVLVKKEISILNIARHRNILHLHE   68 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---------------HHHHHHHHHHHHHHHSCCTTBCCEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---------------ccHHHHHHHHHHHHhCCCCCCCeEeE
Confidence            467999999999999999999776 48899999986432               12456889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC--CCceE
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP--EFEPY  841 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~--~~~~k  841 (1035)
                      ++.+.+..|+||||++||+|.+++.... ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.  ++.+|
T Consensus        69 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~k  144 (321)
T 1tki_A           69 SFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIK  144 (321)
T ss_dssp             EEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEE
T ss_pred             EEecCCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEE
Confidence            9999999999999999999999997643 3489999999999999999999999   9999999999999987  78999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |+|||+++.......   .....||+.|+|||+..+..++.++||||+||++|+|++|..||.....  ......+....
T Consensus       145 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~~~  219 (321)
T 1tki_A          145 IIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--QQIIENIMNAE  219 (321)
T ss_dssp             ECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHHTC
T ss_pred             EEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--HHHHHHHHcCC
Confidence            999999987654332   2345799999999999888899999999999999999999999975422  11111111111


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..   .........      ...+.+++.+||++||++|||+.|++++
T Consensus       220 ~~---~~~~~~~~~------s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          220 YT---FDEEAFKEI------SIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CC---CCHHHHTTS------CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CC---CChhhhccC------CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            00   000000111      1234568889999999999999999985

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3e-39  Score=363.43  Aligned_cols=252  Identities=21%  Similarity=0.278  Sum_probs=202.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .++|...+.||+|+||.||+|+++. ++.||||++........           ...+.+.+|..++..+ +||+|++++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~~~~hp~iv~l~   87 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-----------DDVECTMVEKRVLALPGKPPFLTQLH   87 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcc-----------hHHHHHHHHHHHHHhcCCCCEEeeEE
Confidence            4679999999999999999998875 78999999965322111           2356788999999988 799999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+.+..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   ||+||||||+||+++.+|++||
T Consensus        88 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL  162 (353)
T 2i0e_A           88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI  162 (353)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEcCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEE
Confidence            999999999999999999999999987654  89999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+.... 
T Consensus       163 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~-  237 (353)
T 2i0e_A          163 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEHN-  237 (353)
T ss_dssp             CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-
T ss_pred             EeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--HHHHHHHHhCC-
Confidence            9999998643322  223467899999999999999999999999999999999999999975421  11111111110 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                            .......+      ..+..++.+||++||++||+     +++++++
T Consensus       238 ------~~~p~~~s------~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          238 ------VAYPKSMS------KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ------CCCCTTSC------HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ------CCCCCCCC------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                  00111111      23345788899999999995     5677664

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-39  Score=364.28  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=208.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      .++|...+.||+|+||.||+|.+      .+++.||||++......             ...+.+.+|+.+++++ +|||
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~~hp~  110 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-------------SEREALMSELKMMTQLGSHEN  110 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHCCCTT
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH-------------HHHHHHHHHHHHHHhhcCCCC
Confidence            47899999999999999999976      24668999999653221             1246899999999999 8999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhc
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD---------------------SCLEWELRYRIILGAAQGLAYLHH  816 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~  816 (1035)
                      |+++++++.+.+..|+||||+++|+|.+++.....                     ..+++..+..++.||++||+|||+
T Consensus       111 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  190 (344)
T 1rjb_A          111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF  190 (344)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999976543                     237899999999999999999999


Q ss_pred             cCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHH
Q 039419          817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV  896 (1035)
Q Consensus       817 ~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~el  896 (1035)
                      .   ||+||||||+||+++.++.+||+|||+++...............||+.|+|||+..+..++.++||||||+++|||
T Consensus       191 ~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el  267 (344)
T 1rjb_A          191 K---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI  267 (344)
T ss_dssp             T---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             C---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHH
Confidence            9   9999999999999999999999999999876554433333455678899999999888999999999999999999


Q ss_pred             Hh-CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          897 LT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       897 lt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ++ |..||...... ......+....      ........+      ..+..++.+||+.||++||++.+++++|+.+..
T Consensus       268 ~t~g~~p~~~~~~~-~~~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          268 FSLGVNPYPGIPVD-ANFYKLIQNGF------KMDQPFYAT------EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             TTTSCCSSTTCCCS-HHHHHHHHTTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HcCCCCCcccCCcH-HHHHHHHhcCC------CCCCCCCCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            98 99999765332 12222222110      000111111      223457888999999999999999999988754


Q ss_pred             hH
Q 039419          976 ER  977 (1035)
Q Consensus       976 ~~  977 (1035)
                      ..
T Consensus       335 ~~  336 (344)
T 1rjb_A          335 DA  336 (344)
T ss_dssp             --
T ss_pred             HH
Confidence            43

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.8e-38  Score=352.29  Aligned_cols=266  Identities=21%  Similarity=0.305  Sum_probs=201.3

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +.++|...+.||+|+||+||+|++.+++.||+|++.......            ...+.+.+|+.++++++||||+++++
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hp~iv~~~~   86 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE------------GIPSTAIREISLLKELHHPNIVSLID   86 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------------CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccc------------hhhHHHHHHHHHHHHcCCCCEeeeee
Confidence            457899999999999999999999889999999996543211            23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~  161 (311)
T 3niz_A           87 VIHSERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLA  161 (311)
T ss_dssp             EECCSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEccCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEc
Confidence            9999999999999997 58888876543 3489999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||+++......  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ...........
T Consensus       162 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~  238 (311)
T 3niz_A          162 DFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGT  238 (311)
T ss_dssp             CCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCC
T ss_pred             cCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCC
Confidence            999998764332  22334578999999998765 568999999999999999999999997654332 11111111100


Q ss_pred             ch-hhh----------cccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AI-EVL----------DKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~-~~~----------~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .. ...          .............     ......+++.+||++||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            00 000          0000000000000     01234568889999999999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.1e-39  Score=359.29  Aligned_cols=254  Identities=20%  Similarity=0.315  Sum_probs=197.4

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ..++|...+.||+|+||.||+|++. +++.||||++......             ...+.+.+|+.++++++||||++++
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~~   70 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-------------LAREKVMREVKALAKLEHPGIVRYF   70 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT-------------THHHHHHHHHHHHTSCCCTTBCCEE
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch-------------hHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            4578999999999999999999886 6999999999643211             2357899999999999999999999


Q ss_pred             eEEEcCC---------------------------------------------------------cceEEEEeCCCCChhh
Q 039419          763 GCCWNRN---------------------------------------------------------TRLLMYDYMPNGSLGS  785 (1035)
Q Consensus       763 ~~~~~~~---------------------------------------------------------~~~lv~e~~~~gsL~~  785 (1035)
                      +++.+..                                                         ..++||||+++|+|.+
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~  150 (332)
T 3qd2_B           71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD  150 (332)
T ss_dssp             EEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHH
T ss_pred             EEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHH
Confidence            9986543                                                         2789999999999999


Q ss_pred             hhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCcc-------
Q 039419          786 LLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFA-------  857 (1035)
Q Consensus       786 ~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~-------  857 (1035)
                      ++..... ...++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++........       
T Consensus       151 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~  227 (332)
T 3qd2_B          151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM  227 (332)
T ss_dssp             HHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC----------
T ss_pred             HHhcccCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccc
Confidence            9976543 3356677899999999999999999   9999999999999999999999999999876554211       


Q ss_pred             ---ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCC
Q 039419          858 ---RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRAR  934 (1035)
Q Consensus       858 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  934 (1035)
                         .......||+.|+|||+..+..++.++|||||||++|||++|..|+..       .........      ..   ..
T Consensus       228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~~------~~---~~  291 (332)
T 3qd2_B          228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDVR------NL---KF  291 (332)
T ss_dssp             ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHHH------TT---CC
T ss_pred             cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHhh------cc---CC
Confidence               122346799999999999998999999999999999999998766421       111111100      00   11


Q ss_pred             CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          935 PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       935 ~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +...........+++.+||++||++||+++|++++
T Consensus       292 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            11111222334568889999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.6e-39  Score=349.87  Aligned_cols=260  Identities=23%  Similarity=0.356  Sum_probs=196.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .++|...+.||+|+||.||+|.+..    +..||+|++......             ...+.+.+|+.++++++||||++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~   80 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-------------SVREKFLQEALTMRQFDHPHIVK   80 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-------------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH-------------HHHHHHHHHHHHHHhCCCCccce
Confidence            3678899999999999999997753    457999998653221             23567999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++ .++..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        81 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  155 (281)
T 1mp8_A           81 LIGVI-TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV  155 (281)
T ss_dssp             EEEEE-CSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred             EEEEE-ccCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCE
Confidence            99997 4567899999999999999997653 3489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++....... .......+|+.|+|||+..+..++.++||||||+++|||++ |..||......  .....+..
T Consensus       156 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~  232 (281)
T 1mp8_A          156 KLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIEN  232 (281)
T ss_dssp             EECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred             EECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHc
Confidence            9999999987654332 12234567889999999988899999999999999999997 99999754332  22222221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ...      .......+      ..+..++.+||+.||++||++.|+++.|+++..+.
T Consensus       233 ~~~------~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          233 GER------LPMPPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             TCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCC------CCCCCCCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            110      00111111      12345788899999999999999999999986654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.1e-38  Score=354.99  Aligned_cols=263  Identities=27%  Similarity=0.395  Sum_probs=211.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      .++|...+.||+|+||.||+|++      .+++.||||++.......             ..+.+.+|+.+++++ +|||
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~h~~   88 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-------------EREALMSELKVLSYLGNHMN   88 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------------HHHHHHHHHHHHHHHCCCTT
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH-------------HHHHHHHHHHHHhhcccCCC
Confidence            36788999999999999999975      246889999997543221             246799999999999 8999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCC----------------CCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS----------------CLEWELRYRIILGAAQGLAYLHHDCVPP  821 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~  821 (1035)
                      |+++++++.+.+..++||||+++|+|.+++......                .+++..+..++.|+++||+|||+.   +
T Consensus        89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~  165 (313)
T 1t46_A           89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---N  165 (313)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             eeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            999999999999999999999999999999865432                489999999999999999999999   9


Q ss_pred             eeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 039419          822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK  900 (1035)
Q Consensus       822 ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~  900 (1035)
                      |+||||||+||+++.++.+||+|||+++...............||+.|+|||+..+..++.++||||||+++|||++ |+
T Consensus       166 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  245 (313)
T 1t46_A          166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS  245 (313)
T ss_dssp             CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987655443333345567889999999988899999999999999999999 99


Q ss_pred             CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       901 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      .||...... ......+....      ........+      ..+..++.+||++||++||++.|++++|+++...
T Consensus       246 ~p~~~~~~~-~~~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          246 SPYPGMPVD-SKFYKMIKEGF------RMLSPEHAP------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             CSSTTCCSS-HHHHHHHHHTC------CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcccch-hHHHHHhccCC------CCCCcccCC------HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            999765332 11222221110      011111111      1234578889999999999999999999887643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.5e-39  Score=360.76  Aligned_cols=266  Identities=25%  Similarity=0.377  Sum_probs=211.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      .++|...+.||+|+||.||+|.+..      ...||+|++.......             ..+.+.+|+.+++++ +|||
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~h~~  111 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-------------EKEALMSELKIMSHLGQHEN  111 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH-------------HHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH-------------HHHHHHHHHHHHHhhcCCCC
Confidence            3678899999999999999998753      2479999996543221             256799999999999 8999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeecc
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR  825 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHr  825 (1035)
                      |+++++++.+.+..|+||||+++|+|.+++....            ...+++..+..++.||+.||+|||+.   +|+||
T Consensus       112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~  188 (333)
T 2i1m_A          112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHR  188 (333)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccC
Confidence            9999999999999999999999999999997643            23478999999999999999999999   99999


Q ss_pred             CCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCC
Q 039419          826 DIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPID  904 (1035)
Q Consensus       826 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~  904 (1035)
                      ||||+||+++.++.+||+|||+++...............||+.|+|||+..+..++.++||||||+++|||++ |..||.
T Consensus       189 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  268 (333)
T 2i1m_A          189 DVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP  268 (333)
T ss_dssp             CCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence            9999999999999999999999987655433333345567889999999888899999999999999999999 999997


Q ss_pred             CCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       905 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                      ...... .....+....      ........+      ..+..++.+||+.||++||++.|++++|+++..+.+.
T Consensus       269 ~~~~~~-~~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  330 (333)
T 2i1m_A          269 GILVNS-KFYKLVKDGY------QMAQPAFAP------KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR  330 (333)
T ss_dssp             TCCSSH-HHHHHHHHTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ccchhH-HHHHHHhcCC------CCCCCCCCC------HHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhhc
Confidence            543321 1222222111      000011111      1234578889999999999999999999998765443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.7e-39  Score=378.22  Aligned_cols=256  Identities=23%  Similarity=0.414  Sum_probs=206.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++|...+.||+|+||+||+|.+.+++.||||++.....               ..+.|.+|+.++++++||||++++++
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~iv~l~~~  251 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------------SVEAFLAEANVMKTLQHDKLVKLHAV  251 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---------------CHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---------------cHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            357888899999999999999998899999999965321               25689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +. .+..|+||||+++|+|.++++......+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECS
T ss_pred             Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEee
Confidence            86 56789999999999999999865444588999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++....... .......++..|+|||++....++.++|||||||++|||++ |+.||.....  ......+...   
T Consensus       328 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~---  401 (454)
T 1qcf_A          328 FGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERG---  401 (454)
T ss_dssp             TTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHHT---
T ss_pred             CCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC---
Confidence            999987644321 22234557889999999988899999999999999999999 9999975422  1222222111   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                             .+...+..+.  ..+..++.+||+.||++|||+++|++.|+++.
T Consensus       402 -------~~~~~~~~~~--~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          402 -------YRMPRPENCP--EELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             -------CCCCCCTTSC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -------CCCCCCCCCC--HHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                   1111111111  22455788899999999999999999998763

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.8e-38  Score=347.99  Aligned_cols=264  Identities=17%  Similarity=0.189  Sum_probs=208.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~  763 (1035)
                      ++|...+.||+|+||.||+|.+ .+++.||||++.....                .+.+.+|+.+++++ +|+|++++++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~i~~~~~   73 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------------APQLRDEYRTYKLLAGCTGIPNVYY   73 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------------SCCHHHHHHHHHHTTTCTTCCCEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----------------cHHHHHHHHHHHHHhcCCCCCeEEe
Confidence            5688999999999999999976 4689999999854321                23578899999999 7999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc----
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE----  839 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~----  839 (1035)
                      ++.+....++||||+ +++|.+++...+ ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.    
T Consensus        74 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~  148 (298)
T 1csn_A           74 FGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN  148 (298)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred             ecCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCC
Confidence            999999999999999 999999998653 3489999999999999999999999   9999999999999987776    


Q ss_pred             -eEEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch-h
Q 039419          840 -PYIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-H  912 (1035)
Q Consensus       840 -~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~-~  912 (1035)
                       +||+|||+++........     .......||+.|+|||+..+..++.++||||||+++|||++|+.||........ .
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  228 (298)
T 1csn_A          149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  228 (298)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence             999999999876554321     123456799999999999998999999999999999999999999986543221 1


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      ....+.....  ...........+      ..+..++.+||+.||++||+++++++.|+++.....
T Consensus       229 ~~~~~~~~~~--~~~~~~~~~~~~------~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          229 KYERIGEKKQ--STPLRELCAGFP------EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHHHHHHH--HSCHHHHTTTSC------HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHhhcc--CccHHHHHhhCc------HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            1111111100  000001111111      123457788999999999999999999999876543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.9e-39  Score=359.00  Aligned_cols=263  Identities=25%  Similarity=0.369  Sum_probs=210.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC--------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CC
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME--------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RH  755 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h  755 (1035)
                      .++|...+.||+|+||.||+|++.        +++.||||++.......             ..+.+.+|+.+++++ +|
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~h  100 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK-------------DLSDLVSEMEMMKMIGKH  100 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHH-------------HHHHHHHHHHHHHHHCCC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHH-------------HHHHHHHHHHHHHHhhcC
Confidence            367899999999999999999863        46789999996543211             246789999999999 89


Q ss_pred             CceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 039419          756 KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPP  821 (1035)
Q Consensus       756 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  821 (1035)
                      |||+++++++.+.+..|+||||+++|+|.+++.....              ..+++..+..++.||++||+|||+.   +
T Consensus       101 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~  177 (334)
T 2pvf_A          101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---K  177 (334)
T ss_dssp             TTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             CCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            9999999999999999999999999999999976542              2488999999999999999999999   9


Q ss_pred             eeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CC
Q 039419          822 IVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GK  900 (1035)
Q Consensus       822 ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~  900 (1035)
                      |+||||||+||+++.++.+||+|||+++...............+|+.|+|||+..+..++.++||||||+++|||++ |+
T Consensus       178 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~  257 (334)
T 2pvf_A          178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  257 (334)
T ss_dssp             EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999987655443333445568899999999888889999999999999999999 99


Q ss_pred             CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          901 QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       901 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      .||.....  ......+....      ........+      ..+..++.+||+.||++||++.|+++.|+.+....
T Consensus       258 ~p~~~~~~--~~~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          258 SPYPGIPV--EELFKLLKEGH------RMDKPANCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             CSSTTCCH--HHHHHHHHHTC------CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCcCcCCH--HHHHHHHhcCC------CCCCCccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            99975421  11222221111      000111111      12345788899999999999999999999986543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.8e-39  Score=358.37  Aligned_cols=263  Identities=22%  Similarity=0.378  Sum_probs=192.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCC----cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENG----EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+.||+|+||+||+|.+...    ..||||++.......            ...+.+.+|++++++++||||+++
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~   90 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS------------SDIEEFLREAACMKEFDHPHVAKL   90 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C------------HHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH------------HHHHHHHHHHHHHHHCCCCceehh
Confidence            5788999999999999999977643    279999996543222            125689999999999999999999


Q ss_pred             EeEEEcCCcc------eEEEEeCCCCChhhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCccc
Q 039419          762 LGCCWNRNTR------LLMYDYMPNGSLGSLLHERRD----SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANN  831 (1035)
Q Consensus       762 ~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~N  831 (1035)
                      ++++...+..      ++||||+++|+|.+++.....    ..+++..+..++.|+++||+|||+.   ||+||||||+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~N  167 (323)
T 3qup_A           91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARN  167 (323)
T ss_dssp             CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcce
Confidence            9999887655      999999999999999975432    2489999999999999999999999   99999999999


Q ss_pred             EEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 039419          832 ILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEG  910 (1035)
Q Consensus       832 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~  910 (1035)
                      |+++.++.+||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |+.||...... 
T Consensus       168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-  246 (323)
T 3qup_A          168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-  246 (323)
T ss_dssp             EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-
T ss_pred             EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-
Confidence            9999999999999999987755544333445567889999999998899999999999999999999 99999754322 


Q ss_pred             hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                       .....+....         ....+..   ....+.+++.+||+.||++||++.++++.|+++....
T Consensus       247 -~~~~~~~~~~---------~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          247 -EIYNYLIGGN---------RLKQPPE---CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             -GHHHHHHTTC---------CCCCCTT---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             -HHHHHHhcCC---------CCCCCCc---cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence             2222211110         0001111   1123456788899999999999999999999986543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.2e-39  Score=358.64  Aligned_cols=252  Identities=21%  Similarity=0.293  Sum_probs=192.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEE----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+.||+|+||.||+|+.    .+++.||+|++.........          .....+.+|+.++++++||||+++
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~   86 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNA----------KDTAHTKAERNILEEVKHPFIVDL   86 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------------HHHHHHHCCCTTBCCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhh----------hHHHHHHHHHHHHHhCCCCCccce
Confidence            6799999999999999999987    46899999999764322110          124567899999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+.+..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k  161 (327)
T 3a62_A           87 IYAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK  161 (327)
T ss_dssp             EEEEECSSCEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred             eEEEEcCCEEEEEEeCCCCCcHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence            9999999999999999999999999987654  88999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |+|||+++......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ......+....
T Consensus       162 l~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~i~~~~  237 (327)
T 3a62_A          162 LTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--KKTIDKILKCK  237 (327)
T ss_dssp             ECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHTC
T ss_pred             EEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHhCC
Confidence            99999998643322  123356799999999999888999999999999999999999999975421  11111111100


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                             .......+      ....+++.+||+.||++||     ++.|++++
T Consensus       238 -------~~~p~~~~------~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 -------LNLPPYLT------QEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -------CCCCTTSC------HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -------CCCCCCCC------HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                   01111111      1234577889999999999     77788774

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.7e-38  Score=370.77  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=205.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|.+. ++.||||+++...                ..+.|.+|+.++++++||||+++++++
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~~~~~  255 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQLLGVI  255 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT----------------TSHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch----------------HHHHHHHHHHHHHhccCCCEEEEEEEE
Confidence            57888899999999999999887 7899999996532                145799999999999999999999998


Q ss_pred             EcCC-cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          766 WNRN-TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       766 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      .+.+ ..|+||||+++|+|.++++..+...+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~D  332 (450)
T 1k9a_A          256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD  332 (450)
T ss_dssp             ECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECC
T ss_pred             EcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEee
Confidence            7765 789999999999999999887666689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++.....     .....++..|+|||++.+..++.++|||||||++|||++ |+.||......  .....+...   
T Consensus       333 fG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~---  402 (450)
T 1k9a_A          333 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKG---  402 (450)
T ss_dssp             CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTT---
T ss_pred             CCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC---
Confidence            9999854321     123467889999999999999999999999999999998 99999765332  222222211   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                             .+...+..+  ...+.+++.+||+.||++|||+.++++.|+++...
T Consensus       403 -------~~~~~p~~~--~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          403 -------YKMDAPDGC--PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -------CCCCCCTTC--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------CCCCCCCcC--CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                   011111111  12334578889999999999999999999988643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.8e-38  Score=346.46  Aligned_cols=256  Identities=27%  Similarity=0.352  Sum_probs=207.0

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ..++|...+.||+|+||.||+|.+. +++.||||++......             ...+.+.+|+.+++.++||||++++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~   71 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------------DCPENIKKEICINKMLNHENVVKFY   71 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-------------THHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-------------hhhHHHHHHHHHHHhcCCCCceeee
Confidence            4678999999999999999999876 6899999998643221             1256789999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+.+..|+||||+++++|.+++....  .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||
T Consensus        72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl  146 (276)
T 2yex_A           72 GHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKI  146 (276)
T ss_dssp             EEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             eEEEcCCEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEE
Confidence            99999999999999999999999997543  489999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      +|||.+................||+.|+|||+..+..+ +.++||||||+++|||++|+.||............|.....
T Consensus       147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  226 (276)
T 2yex_A          147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT  226 (276)
T ss_dssp             CCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT
T ss_pred             eeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc
Confidence            99999987654433333446679999999999887665 67899999999999999999999866544333333322110


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ..      .+.....  ....+++.+||+.||++||+++|++++
T Consensus       227 ----~~------~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          227 ----YL------NPWKKID--SAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ----TS------TTGGGSC--HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----cc------CchhhcC--HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                00      0000111  123457888999999999999999773

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5e-39  Score=357.17  Aligned_cols=257  Identities=23%  Similarity=0.328  Sum_probs=193.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||.||+|++ .+++.||||++........           ...+.+.+|+.++++++||||+++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hp~iv~~~~   79 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP-----------SFYLRFRREAQNAAALNHPAIVAVYD   79 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH-----------HHHHHHHHHHTTCCCCCCTTBCCEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH-----------HHHHHHHHHHHHHHcCCCCCcceEEE
Confidence            46799999999999999999987 4689999999976433222           23567899999999999999999999


Q ss_pred             EEEcCCcc----eEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          764 CCWNRNTR----LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       764 ~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++......    |+||||++|++|.++++..+.  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~  154 (311)
T 3ork_A           80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA  154 (311)
T ss_dssp             EEEEEETTEEEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSC
T ss_pred             eeeccCCCCcccEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCC
Confidence            99876544    999999999999999987654  89999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      +||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||....+... ......
T Consensus       155 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-~~~~~~  233 (311)
T 3ork_A          155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVR  233 (311)
T ss_dssp             EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred             EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHhc
Confidence            999999999876543221 223346799999999999998999999999999999999999999975432111 011111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      ...    ..........+      ..+..++.+||++||++||++.++++
T Consensus       234 ~~~----~~~~~~~~~~~------~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          234 EDP----IPPSARHEGLS------ADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             CCC----CCHHHHSTTCC------HHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             CCC----CCcccccCCCC------HHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            000    00000011111      12345788899999999997776655

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.3e-39  Score=352.29  Aligned_cols=268  Identities=27%  Similarity=0.407  Sum_probs=201.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|+..+.||+|+||+||+|++     .+++.||||++.....              ...+.+.+|+.++++++||||++
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~   75 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--------------EHLRDFEREIEILKSLQHDNIVK   75 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH--------------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH--------------HHHHHHHHHHHHHHhCCCCCEee
Confidence            6788999999999999999984     2589999999864321              12467899999999999999999


Q ss_pred             EEeEEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          761 FLGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       761 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +++++...  ...++||||+++|+|.+++..... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        76 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~  151 (295)
T 3ugc_A           76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENEN  151 (295)
T ss_dssp             EEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred             EEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCC
Confidence            99998654  468999999999999999976542 489999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      .+||+|||+++....... ........++..|+|||+..+..++.++||||||+++|||++|..||.....   ....+.
T Consensus       152 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---~~~~~~  228 (295)
T 3ugc_A          152 RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMI  228 (295)
T ss_dssp             EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH---HHHHHH
T ss_pred             eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH---HHHhhh
Confidence            999999999987654322 1223345678889999999988999999999999999999999999864211   000000


Q ss_pred             HHhcc-------chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          918 RQKRG-------AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       918 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      .....       ..+.+........+...  ...+..++.+||+.||++|||++|+++.|+++...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          229 GNDKQGQMIVFHLIELLKNNGRLPRPDGC--PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             CTTCCTHHHHHHHHHHHHTTCCCCCCTTC--CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCccccchhHHHHHHHHhccCcCCCCcCc--CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            00000       00011111111111111  12345578889999999999999999999998653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.8e-39  Score=357.00  Aligned_cols=262  Identities=26%  Similarity=0.403  Sum_probs=199.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcE----EEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEV----IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|...+.||+|+||+||+|.+. +++.    ||+|.+......             ...+.+.+|+.++++++||||++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~   81 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-------------KANKEILDEAYVMASVDNPHVCR   81 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC-------------CCHHHHHHHHHHHTTCCBTTBCC
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH-------------HHHHHHHHHHHHHHhCCCCCeeE
Confidence            56889999999999999999765 3444    577766432211             23578999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++.... .++||||+.+|+|.+++..... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        82 ~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~  156 (327)
T 3lzb_A           82 LLGICLTST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV  156 (327)
T ss_dssp             CCEEEESSS-EEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred             EEEEEecCC-ceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCE
Confidence            999998765 7899999999999999986543 489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......  .....+..
T Consensus       157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~  234 (327)
T 3lzb_A          157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK  234 (327)
T ss_dssp             EECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred             EEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc
Confidence            9999999987655443333345567889999999999999999999999999999999 99999765332  22222221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                      ...        . ..+..   ....+..++.+||+.||++||++.|+++.|+.+......
T Consensus       235 ~~~--------~-~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  282 (327)
T 3lzb_A          235 GER--------L-PQPPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR  282 (327)
T ss_dssp             TCC--------C-CCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred             CCC--------C-CCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence            110        0 00111   111245578889999999999999999999998765543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-38  Score=346.09  Aligned_cols=256  Identities=24%  Similarity=0.427  Sum_probs=208.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|.+.+++.||+|++.....               ..+.+.+|++++++++||||+++++++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~e~~~l~~l~h~~i~~~~~~~   72 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---------------SEEDFIEEAEVMMKLSHPKLVQLYGVC   72 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---------------CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---------------CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            56888899999999999999998899999999965322               235789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..++||||+++++|.+++.... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~df  148 (267)
T 3t9t_A           73 LEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF  148 (267)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCT
T ss_pred             ccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccc
Confidence            99999999999999999999997653 3489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++....... .......|++.|+|||+..+..++.++||||||+++|||++ |+.||......  .....+...    
T Consensus       149 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~i~~~----  221 (267)
T 3t9t_A          149 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTG----  221 (267)
T ss_dssp             TGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTT----
T ss_pred             ccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--HHHHHHhcC----
Confidence            99987644221 22234567889999999988889999999999999999999 89999754211  111111110    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                        .........+      ..+.+++.+||+.||++||++++++++|+++..
T Consensus       222 --~~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 --FRLYKPRLAS------THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --CCCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CcCCCCccCc------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              0000011111      223457888999999999999999999998864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.8e-39  Score=348.20  Aligned_cols=254  Identities=21%  Similarity=0.313  Sum_probs=202.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++|...+.||+|+||+||+|++. ++.||||++........            ..+.+.+|+.++++++||||++++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~~   75 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTR------------KSRDFNEECPRLRIFSHPNVLPVLGA   75 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHH------------HHHHHHHHGGGGCCCSCTTEECEEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHH------------HHHHHHHHHHHHHhcCCCchhheEEE
Confidence            357888999999999999999986 88999999976432221            24679999999999999999999999


Q ss_pred             EEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeccCCCcccEEEcCCCce
Q 039419          765 CWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPP--IVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       765 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivHrDikp~NIll~~~~~~  840 (1035)
                      +.+.  +..++||||+++|+|.++++......+++..+..++.|++.||+|||+.   +  |+||||||+||+++.++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~  152 (271)
T 3kmu_A           76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTA  152 (271)
T ss_dssp             ECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCE
T ss_pred             EccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcce
Confidence            9887  7789999999999999999877655689999999999999999999998   7  9999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCc---cccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITE---KSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +|+|||++....       .....||+.|+|||++.+..++.   ++||||||+++|||++|+.||......  .....+
T Consensus       153 ~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~  223 (271)
T 3kmu_A          153 RISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM--EIGMKV  223 (271)
T ss_dssp             EEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH--HHHHHH
T ss_pred             eEEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH--HHHHHH
Confidence            999998875422       22457899999999987655444   799999999999999999999754221  111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      ...     ..........+      ..+..++.+||+.||++|||++++++.|+++.
T Consensus       224 ~~~-----~~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          224 ALE-----GLRPTIPPGIS------PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHS-----CCCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             Hhc-----CCCCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            000     00111111111      12345778899999999999999999998874

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.5e-38  Score=348.29  Aligned_cols=265  Identities=21%  Similarity=0.272  Sum_probs=199.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+..+.||+|+||+||+|.+. +++.||||++.......            ...+.+.+|+.++++++||||++++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~~   69 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLHDV   69 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST------------THHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC------------CcchHHHHHHHHHhcCCCCCEeeEEeE
Confidence            57889999999999999999876 58999999996543221            235678899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..++||||+++ ++.+++.... ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus        70 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~D  144 (292)
T 3o0g_A           70 LHSDKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLAN  144 (292)
T ss_dssp             EEETTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEeCCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            9999999999999975 6666665432 3489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.++......  .......||+.|+|||+..+.. ++.++||||+||++|||++|..||..............+.....
T Consensus       145 fg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~  222 (292)
T 3o0g_A          145 FGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             CTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            99998764332  2234567899999999987665 79999999999999999999988654332222222222111110


Q ss_pred             h-hhh---ccc--ccC---------CCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 I-EVL---DKS--LRA---------RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~-~~~---~~~--~~~---------~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      . +..   ...  ...         .............+++.+||+.||++|||++|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0 000   000  000         000000011233467888999999999999999874

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.5e-39  Score=373.09  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=202.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|++. +|+.||||++........           ...+.+.+|+.+++.++||||++++++
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~~l~~l~HpnIv~l~~~   84 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL-----------DVVGKIRREIQNLKLFRHPHIIKLYQV   84 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHT-----------TTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-----------HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            57889999999999999999876 699999999964322111           235678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||++||+|.+++...+  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        85 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~D  159 (476)
T 2y94_A           85 ISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIAD  159 (476)
T ss_dssp             EECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEe
Confidence            999999999999999999999997654  389999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++.......   ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||......  .....+...   
T Consensus       160 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~~---  231 (476)
T 2y94_A          160 FGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP--TLFKKICDG---  231 (476)
T ss_dssp             CSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH--HHHHHHHTT---
T ss_pred             ccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH--HHHHHHhcC---
Confidence            999987654332   235679999999999887765 68999999999999999999999754221  111111110   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                            .. ..+.. +  ...+.+++.+||+.||++|||++|++++
T Consensus       232 ------~~-~~p~~-~--s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          232 ------IF-YTPQY-L--NPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ------CC-CCCTT-C--CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ------Cc-CCCcc-C--CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                  00 01110 1  1123557888999999999999999984

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.5e-38  Score=363.20  Aligned_cols=208  Identities=22%  Similarity=0.285  Sum_probs=180.1

Q ss_pred             HhccccCCeeeee--CCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          685 LKCLVEDSVVGKG--CSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       685 ~~~~~~~~~iG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .++|++.+.||+|  +||+||+|++. +++.||||++.......            ...+.+.+|+.++++++|||||++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~   91 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN------------EMVTFLQGELHVSKLFNHPNIVPY   91 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh------------HHHHHHHHHHHHHHhCCCCCCCcE
Confidence            3679999999999  99999999876 58999999996543221            235678899999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+.+..|+||||+++|+|.+++.......+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~k  168 (389)
T 3gni_B           92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVY  168 (389)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             eEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            99999999999999999999999999877555699999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCc-----cccccccCCcccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 039419          842 IADFGLAKLVVEGDF-----ARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTI  907 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~elltg~~P~~~~~  907 (1035)
                      |+|||.+........     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       169 l~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          169 LSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             ECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             EcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence            999999875533221     112234579999999999877  679999999999999999999999997643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=8.1e-39  Score=366.25  Aligned_cols=255  Identities=18%  Similarity=0.207  Sum_probs=200.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+|+++ +++.||+|++........           ...+.+.+|+.+++.++|||||+++++
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-----------~~~~~~~~E~~il~~l~hp~Iv~l~~~  137 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-----------SDSAFFWEERDIMAFANSPWVVQLFYA  137 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------CCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh-----------HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            67999999999999999999876 488999999864322111           123458899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||++||+|.++++...   +++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|
T Consensus       138 ~~~~~~~~lV~E~~~gg~L~~~l~~~~---~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          138 FQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEec
Confidence            999999999999999999999997643   89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCC----CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK----ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      ||+|+....... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||......  .....+...
T Consensus       212 FG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~  288 (410)
T 3v8s_A          212 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYSKIMNH  288 (410)
T ss_dssp             CTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHTH
T ss_pred             cceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHHHHHhc
Confidence            999987654332 1234678999999999987655    788999999999999999999999754221  111111110


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDD--RPTMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~--RPs~~el~~~  969 (1035)
                         ...+........+      ..+.+++.+|+..+|++  ||+++|++++
T Consensus       289 ---~~~~~~p~~~~~s------~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          289 ---KNSLTFPDDNDIS------KEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ---HHHCCCCTTCCCC------HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ---cccccCCCccccc------HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence               0000000000111      12345677899989988  9999999885

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.9e-39  Score=348.23  Aligned_cols=257  Identities=28%  Similarity=0.430  Sum_probs=191.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|.+. ++.||||++........          ....+.+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDI----------SQTIENVRQEAKLFAMLKHPNIIALRGVC   75 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC--------------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccH----------HHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            57888999999999999999886 89999999865432221          12356899999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC--------C
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP--------E  837 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~--------~  837 (1035)
                      .+++..++||||+++++|.+++...   .+++..+..++.|+++||+|||+.+..+|+||||||+||+++.        +
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           76 LKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             CCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             ecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence            9999999999999999999998643   3899999999999999999999993223999999999999986        7


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||.++......    .....||+.|+|||+..+..++.++||||||+++|||++|+.||......  .....+
T Consensus       153 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~  226 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--AVAYGV  226 (271)
T ss_dssp             CCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHH
T ss_pred             cceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHhh
Confidence            789999999998654432    22457999999999998889999999999999999999999999754211  111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ....     .........+      ....+++.+||+.||++||++.|++++|+.+
T Consensus       227 ~~~~-----~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 AMNK-----LALPIPSTCP------EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HTSC-----CCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hcCC-----CCCCCCcccC------HHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1000     0001111111      1234578889999999999999999998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.2e-38  Score=347.85  Aligned_cols=264  Identities=23%  Similarity=0.303  Sum_probs=197.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||+||+|++.+++.||+|++.......            ...+.+.+|+.++++++||||+++++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   69 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------------GIPSTTIREISILKELKHSNIVKLYDVI   69 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG------------CCCHHHHHHHHGGGGCCCTTBCCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc------------ccchhHHHHHHHHHhcCCCCEeeeeeEE
Confidence            5688999999999999999988889999999996543221            1246788999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+.+..|+||||+++ +|.+++.... ..+++..+..++.|+++||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        70 ~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  144 (288)
T 1ob3_A           70 HTKKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (288)
T ss_dssp             ECSSCEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             ccCCeEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeEC
Confidence            999999999999975 9999887643 3489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc-
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA-  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-  923 (1035)
                      |+++......  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .......+..... 
T Consensus       145 g~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~  221 (288)
T 1ob3_A          145 GLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPN  221 (288)
T ss_dssp             THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred             ccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCC
Confidence            9998664322  12234578999999999865 45899999999999999999999999754221 1111111110000 


Q ss_pred             h---------hhhcccccCCCccc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 I---------EVLDKSLRARPEVE-----IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~---------~~~~~~~~~~~~~~-----~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .         ...++......+..     ........+++.+||+.||++|||++|++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0         00000000000000     0001223468888999999999999999874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=349.50  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=196.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||+||+|++. ++.||||++...                ...+.|.+|+.++++++||||+++++++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~   70 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE----------------SERKAFIVELRQLSRVNHPNIVKLYGAC   70 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST----------------THHHHHHHHHHHHHHCCCTTBCCEEEBC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh----------------hHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            57888999999999999999886 788999998532                1246799999999999999999999987


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc-eEEe
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE-PYIA  843 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~-~kl~  843 (1035)
                      .  +..++||||+++|+|.+++..... ..+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+
T Consensus        71 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~  148 (307)
T 2eva_A           71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKIC  148 (307)
T ss_dssp             T--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred             c--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEc
Confidence            6  458999999999999999976543 24788999999999999999999932228999999999999998886 7999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+++.....     .....||+.|+|||+..+..++.++||||||+++|||++|+.||.............+....  
T Consensus       149 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--  221 (307)
T 2eva_A          149 DFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--  221 (307)
T ss_dssp             CCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC--
T ss_pred             ccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC--
Confidence            99999755332     22446999999999999889999999999999999999999999754333222111111100  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                          ........+.      .+.+++.+||+.||++||+++++++.|+.+.+..
T Consensus       222 ----~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          222 ----RPPLIKNLPK------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             ----CCCCBTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             ----CCCcccccCH------HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence                0111111111      2345788899999999999999999999885443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.7e-39  Score=378.34  Aligned_cols=256  Identities=23%  Similarity=0.365  Sum_probs=209.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|.+.. +..||||++.....               ..+.|.+|+.+|++++||||++++++
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~l~~~  284 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQLLGV  284 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---------------chHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            568888999999999999998875 88999999864321               24679999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++|+|.++++......+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus       285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~D  361 (495)
T 1opk_A          285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVAD  361 (495)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred             EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEee
Confidence            99999999999999999999999876666689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||......  .....+..    
T Consensus       362 FG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~----  434 (495)
T 1opk_A          362 FGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK----  434 (495)
T ss_dssp             TTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT----
T ss_pred             cccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc----
Confidence            99998764432 222334567889999999988889999999999999999999 99999754322  22222221    


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                            ..+...+..+.  ..+..++.+||+.||++||++.++++.|+.+.
T Consensus       435 ------~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          435 ------DYRMERPEGCP--EKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ------TCCCCCCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ------CCCCCCCCCCC--HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                  11111111111  22345788899999999999999999998763

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.4e-39  Score=363.88  Aligned_cols=248  Identities=24%  Similarity=0.249  Sum_probs=190.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHH-HhcCCCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT-LGSIRHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~  762 (1035)
                      .++|...+.||+|+||.||+|+++. ++.||||++........           ...+.+.+|..+ ++.++||||++++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-----------~~~~~~~~e~~~ll~~~~hp~Iv~l~  105 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-----------KEEKHIMSERNVLLKNVKHPFLVGLH  105 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------------CCBCCCCCTTBCCEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-----------HHHHHHHHHHHHHHHhCCCCCCCCEE
Confidence            3679999999999999999998764 88999999965433221           123456677777 5678999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+.+..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   ||+||||||+||+++.+|++||
T Consensus       106 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL  180 (373)
T 2r5t_A          106 FSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVL  180 (373)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999987654  88999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+.... 
T Consensus       181 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--~~~~~~i~~~~-  255 (373)
T 2r5t_A          181 TDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--AEMYDNILNKP-  255 (373)
T ss_dssp             CCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--HHHHHHHHHSC-
T ss_pred             eeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHhcc-
Confidence            9999998643322  223467899999999999999999999999999999999999999975321  11111111100 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKD  965 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~e  965 (1035)
                            .......+      ..+..++.+||++||++||++.+
T Consensus       256 ------~~~~~~~~------~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          256 ------LQLKPNIT------NSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ------CCCCSSSC------HHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ------cCCCCCCC------HHHHHHHHHHcccCHHhCCCCCC
Confidence                  00111111      12345778899999999999853

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.9e-39  Score=351.19  Aligned_cols=263  Identities=23%  Similarity=0.357  Sum_probs=214.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|.+.. ++.||+|++.....               ..+.+.+|+.++++++||||+++++
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~   76 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQLLG   76 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---------------HHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---------------HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            4678889999999999999998775 88999999864321               2467899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+||||+++++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        77 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~  153 (288)
T 3kfa_A           77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA  153 (288)
T ss_dssp             EECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEc
Confidence            999999999999999999999999886666799999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||.+........ .......+|+.|+|||+..+..++.++||||||+++|+|++ |..||......  .....+.... 
T Consensus       154 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~~~-  229 (288)
T 3kfa_A          154 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKDY-  229 (288)
T ss_dssp             CCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHTTC-
T ss_pred             cCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhccC-
Confidence            9999987654332 22334567889999999988899999999999999999999 99999754322  2222221110 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHHh
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREEC  980 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~  980 (1035)
                           ........+      ..+.+++.+|++.||++||++.++++.|+.+..+....
T Consensus       230 -----~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~~  276 (288)
T 3kfa_A          230 -----RMERPEGCP------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS  276 (288)
T ss_dssp             -----CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCC------HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence                 000111111      22345788899999999999999999999987665443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.9e-39  Score=363.78  Aligned_cols=278  Identities=15%  Similarity=0.201  Sum_probs=206.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|.+.+.||+|+||+||+|.+..      ++.||||++.........+.   .+........+.+|+..++.++||||+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~---~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL---KFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHH---HHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHH---HHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            589999999999999999998764      47899999865432111000   000001123466778888899999999


Q ss_pred             eEEeEEEcC----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          760 RFLGCCWNR----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       760 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++++...    ...|+||||+ |++|.+++.... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            999998765    4579999999 999999997653 3489999999999999999999999   999999999999999


Q ss_pred             --CCCceEEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          836 --PEFEPYIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       836 --~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                        .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876543221     112345699999999999999999999999999999999999999985432


Q ss_pred             CchhHHHHHHHh--ccchhhhccccc-CCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          909 EGLHIVDWVRQK--RGAIEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       909 ~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      .. ....+....  .......++.+. ...+.      .+..++..||+.||++||++.++++.|+++.....
T Consensus       267 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          267 DP-KYVRDSKIRYRENIASLMDKCFPAANAPG------EIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             CH-HHHHHHHHHHHHCHHHHHHHHSCTTCCCH------HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CH-HHHHHHHHHhhhhHHHHHHHhcccccCHH------HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            21 122211111  111122222221 11111      23457778999999999999999999999876543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.1e-39  Score=374.16  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=200.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|.+.++..||||++.....               ..+.|.+|+.++++++||||+++++++
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------------SPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---------------CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            56888899999999999999999888999999965321               246799999999999999999999998


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+ +..|+||||+++|+|.++++......+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCC
Confidence            76 6789999999999999999865445589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |+++....... .......++..|+|||+..+..++.++||||||+++|||++ |+.||.....  ......+...    
T Consensus       325 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~----  397 (452)
T 1fmk_A          325 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG----  397 (452)
T ss_dssp             CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTT----
T ss_pred             ccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC----
Confidence            99987654322 22234557889999999988899999999999999999999 9999975422  1122221111    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                            .+...+..+.  ..+.+++.+||+.||++|||++++++.|+++.
T Consensus       398 ------~~~~~~~~~~--~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          398 ------YRMPCPPECP--ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ------CCCCCCTTSC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ------CCCCCCCCCC--HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                  1111111111  12345788899999999999999999988763

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-38  Score=353.64  Aligned_cols=263  Identities=24%  Similarity=0.401  Sum_probs=200.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|...+.||+|+||+||+|.+..     +..||||++......             .....+.+|+.++++++||||++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~  110 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-------------KQRVDFLGEAGIMGQFSHHNIIR  110 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH-------------HHHHHHHHHHHHHHhCCCCCCCc
Confidence            567778999999999999997653     246999999654321             12457899999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++.+.+..++||||+++|+|.+++.... ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+
T Consensus       111 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~  186 (333)
T 1mqb_A          111 LEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC  186 (333)
T ss_dssp             EEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred             EEEEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcE
Confidence            9999999999999999999999999997643 3489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~  918 (1035)
                      ||+|||.++........ .......+|+.|+|||+..+..++.++||||||+++|||++ |+.||.....  ......+.
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~~  264 (333)
T 1mqb_A          187 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAIN  264 (333)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHH
T ss_pred             EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHH
Confidence            99999999876543211 11223456889999999988899999999999999999999 9999965422  11111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                      ...      ........+      ..+..++.+||+.||++||++.++++.|+.+......
T Consensus       265 ~~~------~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          265 DGF------RLPTPMDCP------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             TTC------CCCCCTTCB------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             CCC------cCCCcccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence            110      000011111      2234578889999999999999999999998765444

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-38  Score=356.67  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=208.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .++|...+.||+|+||.||+|.+.      .++.||||++.......             ....+.+|+.++++++||||
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i   90 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-------------ERIEFLNEASVMKEFNCHHV   90 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-------------HHHHHHHHHHHGGGCCCTTB
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH-------------HHHHHHHHHHHHHhcCCCCE
Confidence            467999999999999999999664      36889999986432211             24578999999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN  830 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~  830 (1035)
                      +++++++.+.+..++||||+++|+|.+++...+.        ..+++..+..++.||+.||+|||+.   ||+||||||+
T Consensus        91 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~  167 (322)
T 1p4o_A           91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAAR  167 (322)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGG
T ss_pred             eeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccc
Confidence            9999999999999999999999999999976431        3468999999999999999999999   9999999999


Q ss_pred             cEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 039419          831 NILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPE  909 (1035)
Q Consensus       831 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~  909 (1035)
                      ||+++.++.+||+|||+++...............||+.|+|||+..+..++.++||||||+++|||++ |+.||..... 
T Consensus       168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-  246 (322)
T 1p4o_A          168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-  246 (322)
T ss_dssp             GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-
T ss_pred             eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-
Confidence            99999999999999999987655443333345567899999999988899999999999999999999 8999975421 


Q ss_pred             chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                       ......+...         .....+.. ..  ..+..++.+||+.||++||++.|++++|+++..
T Consensus       247 -~~~~~~~~~~---------~~~~~~~~-~~--~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          247 -EQVLRFVMEG---------GLLDKPDN-CP--DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -HHHHHHHHTT---------CCCCCCTT-CC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHHHHHcC---------CcCCCCCC-CC--HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             1111111111         01111111 11  123457888999999999999999999988644

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.3e-38  Score=371.19  Aligned_cols=367  Identities=20%  Similarity=0.210  Sum_probs=238.5

Q ss_pred             cCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhh
Q 039419           45 PFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGA  124 (1035)
Q Consensus        45 ~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~  124 (1035)
                      ..+..++.+++|++|+|++|.+++ +| .++.+++|++|+|++|++++ +|  ++.+++|++|+|++|++++ +|  ++.
T Consensus        33 ~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~  104 (457)
T 3bz5_A           33 TDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTP  104 (457)
T ss_dssp             TSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTT
T ss_pred             ccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCC
Confidence            344456666777777777777764 34 46667777777777777763 33  6666777777777777664 33  666


Q ss_pred             hccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccce
Q 039419          125 CIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSL  204 (1035)
Q Consensus       125 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L  204 (1035)
                      +++|++|++++|++++ +|  ++.+++|++|++++|                         ++++.   .++.+++|++|
T Consensus       105 l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N-------------------------~l~~l---~l~~l~~L~~L  153 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARN-------------------------TLTEI---DVSHNTQLTEL  153 (457)
T ss_dssp             CTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTS-------------------------CCSCC---CCTTCTTCCEE
T ss_pred             CCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCC-------------------------cccee---ccccCCcCCEE
Confidence            6667777777666663 33  555555555555555                         44432   15555666666


Q ss_pred             eecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCC
Q 039419          205 SVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFS  284 (1035)
Q Consensus       205 ~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~  284 (1035)
                      ++++|...+.+  .+..+++|+.|++++|++++ +|  ++.+++|+.|++++|++++.   .+..+++|+.|+|++|+++
T Consensus       154 ~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~  225 (457)
T 3bz5_A          154 DCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT  225 (457)
T ss_dssp             ECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCS
T ss_pred             ECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccc
Confidence            66666433333  35566666666666666664 33  56666666666666666653   2666777777777777777


Q ss_pred             CCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcC
Q 039419          285 GSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNA  364 (1035)
Q Consensus       285 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~  364 (1035)
                      + +|  ++.+++|+.|++++|++++..   +..+++|+.|+++.|+++.+....|.+.+.+|  +..+++|+.|++++|.
T Consensus       226 ~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~  297 (457)
T 3bz5_A          226 E-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNT  297 (457)
T ss_dssp             C-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCT
T ss_pred             c-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCc
Confidence            5 34  667777777777777777653   34556667777666555444333344444444  3455556666666655


Q ss_pred             CCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEE
Q 039419          365 LTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVL  444 (1035)
Q Consensus       365 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L  444 (1035)
                      +.+.+|.   ...+|+.|+                           +.++++|++|+|++|+|++.   .+..+++|+.|
T Consensus       298 ~l~~l~~---~~~~L~~L~---------------------------l~~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L  344 (457)
T 3bz5_A          298 QLYLLDC---QAAGITELD---------------------------LSQNPKLVYLYLNNTELTEL---DVSHNTKLKSL  344 (457)
T ss_dssp             TCCEEEC---TTCCCSCCC---------------------------CTTCTTCCEEECTTCCCSCC---CCTTCTTCSEE
T ss_pred             ccceecc---CCCcceEec---------------------------hhhcccCCEEECCCCccccc---ccccCCcCcEE
Confidence            4433332   122333333                           34456799999999999974   38999999999


Q ss_pred             EcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhcc
Q 039419          445 DISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEG  512 (1035)
Q Consensus       445 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  512 (1035)
                      ++++|+|+++        +.|..|++++|.+.|.     ..+..|+.++|++|+++|.+|..++...+
T Consensus       345 ~l~~N~l~~l--------~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~~~~~~~  399 (457)
T 3bz5_A          345 SCVNAHIQDF--------SSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPDLLDQFG  399 (457)
T ss_dssp             ECCSSCCCBC--------TTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTTCBCTTS
T ss_pred             ECCCCCCCCc--------cccccccccCCcEEec-----ceeeecCccccccCcEEEEcChhHhcccC
Confidence            9999999963        5678889999999865     35567888999999999999987765443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-38  Score=348.64  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=199.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||+||+|.+. +++.||+|++........           ...+.+.+|+.++++++||||+++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~   76 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-----------GVEHQLRREVEIQSHLRHPNILRLYG   76 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHH-----------TCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchh-----------hHHHHHHHHHHHHHcCCCCCCcchhh
Confidence            467999999999999999999776 477999999854322211           23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..++||||+++|+|.+++.....  +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  151 (279)
T 3fdn_A           77 YFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA  151 (279)
T ss_dssp             EEECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEEC
T ss_pred             eEecCCEEEEEEecCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEE
Confidence            99999999999999999999999987654  89999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||++.......    .....||+.|+|||+..+..++.++||||||+++|+|++|+.||......  .....+..    
T Consensus       152 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~----  221 (279)
T 3fdn_A          152 DFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISR----  221 (279)
T ss_dssp             SCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHH----
T ss_pred             eccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--HHHHHHHh----
Confidence            999986543322    23467999999999999889999999999999999999999999753211  11111111    


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         .........+      ....+++.+||++||++||++.|++++
T Consensus       222 ---~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 ---VEFTFPDFVT------EGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---TCCCCCTTSC------HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---CCCCCCCcCC------HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0111111111      123457888999999999999999986

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=350.70  Aligned_cols=263  Identities=20%  Similarity=0.275  Sum_probs=193.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCccccccccc------------ccccccccHHHHHHHHHHHhc
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQN------------DKIGIGGVRDSFSAEIKTLGS  752 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~E~~~l~~  752 (1035)
                      ++|...+.||+|+||.||+|.+. +++.||||++.............            .........+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            67899999999999999999775 58999999997654322110000            000011224678999999999


Q ss_pred             CCCCceeeEEeEEEc--CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 039419          753 IRHKNIVRFLGCCWN--RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKAN  830 (1035)
Q Consensus       753 l~hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~  830 (1035)
                      ++||||+++++++.+  .+..|+||||+++++|.+++..   ..+++..+..++.||++||+|||+.   +|+||||||+
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  166 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS  166 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence            999999999999987  5678999999999999987643   2489999999999999999999999   9999999999


Q ss_pred             cEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCC---CCccccchhHHHHHHHHHhCCCCCCCCC
Q 039419          831 NILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTI  907 (1035)
Q Consensus       831 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvvl~elltg~~P~~~~~  907 (1035)
                      ||+++.++.+||+|||+++.......  ......||+.|+|||+..+..   ++.++|||||||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999987654322  223567999999999987655   4778999999999999999999997532


Q ss_pred             CCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          908 PEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       908 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .  ......+....     .........+      ..+.+++.+||++||++||++.|++++
T Consensus       245 ~--~~~~~~~~~~~-----~~~~~~~~~~------~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          245 I--MCLHSKIKSQA-----LEFPDQPDIA------EDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             H--HHHHHHHHHCC-----CCCCSSSCCC------HHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             H--HHHHHHHhccc-----CCCCCccccC------HHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            1  11111111100     0000001111      123457888999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-38  Score=355.06  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=209.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpn  757 (1035)
                      .++|...+.||+|+||+||+|++      .+++.||||++.......             ..+.+.+|+.+++++ +|||
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~hp~   92 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------------EHRALMSELKILIHIGHHLN   92 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------------HHHHHHHHHHHHHHHCCCTT
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH-------------HHHHHHHHHHHHHhcccCCC
Confidence            37899999999999999999974      246889999996543221             245789999999999 7999


Q ss_pred             eeeEEeEEEcCC-cceEEEEeCCCCChhhhhhhcCCC--------------CCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 039419          758 IVRFLGCCWNRN-TRLLMYDYMPNGSLGSLLHERRDS--------------CLEWELRYRIILGAAQGLAYLHHDCVPPI  822 (1035)
Q Consensus       758 iv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~--------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  822 (1035)
                      |+++++++...+ ..++||||+++|+|.+++......              .+++..+..++.|+++||+|||+.   +|
T Consensus        93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i  169 (316)
T 2xir_A           93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC  169 (316)
T ss_dssp             BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence            999999988755 589999999999999999765431              278999999999999999999999   99


Q ss_pred             eccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 039419          823 VHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ  901 (1035)
Q Consensus       823 vHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~  901 (1035)
                      +||||||+||+++.++.+||+|||+++...............||+.|+|||+..+..++.++||||||+++|||++ |+.
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  249 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  249 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654433233345568899999999988899999999999999999998 999


Q ss_pred             CCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       902 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ||....... .....+.....      .......+      ..+..++.+||+.||++||++.|++++|+.+.+..
T Consensus       250 p~~~~~~~~-~~~~~~~~~~~------~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          250 PYPGVKIDE-EFCRRLKEGTR------MRAPDYTT------PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             SSTTCCCSH-HHHHHHHHTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCcccchhH-HHHHHhccCcc------CCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            997543321 12222211110      00111111      12455788899999999999999999999987544

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-38  Score=360.85  Aligned_cols=255  Identities=19%  Similarity=0.246  Sum_probs=203.2

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.+.|.+.+.||+|+||+||+|.+. +++.||+|++......              ....+.+|+.++++++||||+++
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--------------~~~~~~~E~~il~~l~hpnIv~~  113 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--------------DKYTVKNEISIMNQLHHPKLINL  113 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--------------HHHHHHHHHHHHTTCCSTTBCCE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--------------hHHHHHHHHHHHHhCCCcCCCeE
Confidence            34578999999999999999999776 5899999998643211              13578899999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC--CCc
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP--EFE  839 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~--~~~  839 (1035)
                      ++++.+.+..|+||||++||+|.+++.... ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.  ++.
T Consensus       114 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~  189 (387)
T 1kob_A          114 HDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASS  189 (387)
T ss_dssp             EEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCC
T ss_pred             EEEEEeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCc
Confidence            999999999999999999999999987543 3489999999999999999999999   9999999999999974  577


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+..
T Consensus       190 vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~~~~i~~  264 (387)
T 1kob_A          190 VKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKR  264 (387)
T ss_dssp             EEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHH
T ss_pred             eEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHHHHHHHh
Confidence            99999999987654322   2245799999999999988999999999999999999999999975421  111221111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...   ..........+      ..+.+++.+||+.||++||++.|++++
T Consensus       265 ~~~---~~~~~~~~~~s------~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          265 CDW---EFDEDAFSSVS------PEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCC---CCCSSTTTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCC---CCCccccccCC------HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            100   00111111111      234567888999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.1e-38  Score=346.45  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=207.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|.+.+++.||||++.....               ..+.+.+|++++++++||||+++++++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~h~~i~~~~~~~   77 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---------------SPDAFLAEANLMKQLQHQRLVRLYAVV   77 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---------------cHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence            67889999999999999999998888999999864321               246799999999999999999999987


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      . .+..++||||+++++|.+++.......+++..+..++.|+++||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        78 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Df  153 (279)
T 1qpc_A           78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF  153 (279)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             c-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCC
Confidence            6 45689999999999999999765433489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |.++....... .......++..|+|||+..+..++.++||||||+++|||++ |+.||......  .....+...    
T Consensus       154 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~----  226 (279)
T 1qpc_A          154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERG----  226 (279)
T ss_dssp             TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT----
T ss_pred             cccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHHhcc----
Confidence            99987654332 22234567889999999988889999999999999999999 99999754221  111111111    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                        .........+      ..+..++.+||+.||++||++.++++.|+++...
T Consensus       227 --~~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          227 --YRMVRPDNCP------EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             --CCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --cCCCCccccc------HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence              0001111111      1334578889999999999999999999988654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.9e-39  Score=376.74  Aligned_cols=254  Identities=22%  Similarity=0.268  Sum_probs=205.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|++. +|+.||||++........           ...+.+.+|+.++++++|||||+++++
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~-----------~~~~~~~~E~~iL~~l~hp~Iv~l~~~  252 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR-----------KGEAMALNEKQILEKVNSRFVVSLAYA  252 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhh-----------HHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence            56888899999999999999876 589999999964322211           234678899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||++||+|.+++...+...+++..+..++.||+.||+|||+.   ||+||||||+|||++.+|++||+|
T Consensus       253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~D  329 (576)
T 2acx_A          253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISD  329 (576)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEe
Confidence            99999999999999999999999876655699999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc--hhHHHHHHHhcc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG--LHIVDWVRQKRG  922 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~  922 (1035)
                      ||+++.......   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+...+...  
T Consensus       330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--  404 (576)
T 2acx_A          330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--  404 (576)
T ss_dssp             CTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--
T ss_pred             cccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--
Confidence            999987654322   234589999999999998889999999999999999999999997643221  1111111110  


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                           ........+      ..+.+++.+||++||++||     +++|++++
T Consensus       405 -----~~~~p~~~s------~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 -----PEEYSERFS------PQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -----CCCCCTTSC------HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -----cccCCccCC------HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                 011111111      2334577889999999999     78888875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=359.02  Aligned_cols=254  Identities=22%  Similarity=0.282  Sum_probs=194.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC--CceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH--KNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~  763 (1035)
                      +.|.+.+.||+|+||.||+|...+++.||||++.......            ...+.+.+|+.++++++|  |||+++++
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~iv~~~~   76 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN------------QTLDSYRNEIAYLNKLQQHSDKIIRLYD   76 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCH------------HHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccch------------HHHHHHHHHHHHHHhhhhcCCceEEEee
Confidence            5688999999999999999998889999999986543221            124678999999999986  99999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+|||+ .+++|.+++...+.  +++..+..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+
T Consensus        77 ~~~~~~~~~lv~e~-~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~  149 (343)
T 3dbq_A           77 YEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLI  149 (343)
T ss_dssp             EEECSSEEEEEECC-CSEEHHHHHHHSCC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEEC
T ss_pred             eEeeCCEEEEEEeC-CCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEe
Confidence            99999999999995 58899999987544  89999999999999999999999   999999999999997 6789999


Q ss_pred             eccCccccccCCccccccccCCcccccCCccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      |||+++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........
T Consensus       150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  229 (343)
T 3dbq_A          150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  229 (343)
T ss_dssp             CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH
Confidence            9999987655433333345689999999998754           67889999999999999999999999754221111


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      ...          .++.......+....  ..+.+++.+||+.||++|||+.|++++.
T Consensus       230 ~~~----------~~~~~~~~~~~~~~~--~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          230 LHA----------IIDPNHEIEFPDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             HHH----------HHCTTSCCCCCCCSC--HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHH----------HhcCCcccCCcccCC--HHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            111          111111111111111  1234578889999999999999999864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.9e-38  Score=345.06  Aligned_cols=258  Identities=26%  Similarity=0.471  Sum_probs=201.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+|++. +++.||||++...........       ....+.+.+|+.++++++||||++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM-------IEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHH-------HCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhH-------HHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            57888999999999999999875 689999999865433222110       0123679999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeccCCCcccEEEcCCCc---
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPP--IVHRDIKANNILIGPEFE---  839 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivHrDikp~NIll~~~~~---  839 (1035)
                      +.+..  ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.   +  |+||||||+||+++.++.   
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCc
Confidence            86554  79999999999999886543 3489999999999999999999999   7  999999999999988776   


Q ss_pred             --eEEeeccCccccccCCccccccccCCcccccCCccc--ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          840 --PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG--YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       840 --~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                        +||+|||+++....     ......||+.|+|||++  ....++.++||||||+++|||++|+.||............
T Consensus       166 ~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  240 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN  240 (287)
T ss_dssp             CCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred             eeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence              99999999975433     22346799999999997  3455788999999999999999999999865443332222


Q ss_pred             HHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                      .+....     .........+      ..+.+++.+||+.||++||+++|+++.|++
T Consensus       241 ~~~~~~-----~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          241 MIREEG-----LRPTIPEDCP------PRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHSC-----CCCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHhccC-----CCCCCCcccC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            222111     1111111111      123457888999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=357.78  Aligned_cols=252  Identities=23%  Similarity=0.288  Sum_probs=187.0

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.+.|...+.||+|+||+||+|++. +++.||||++....                ..+.+.+|+.++++++||||++++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~~~  114 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----------------DKKIVRTEIGVLLRLSHPNIIKLK  114 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------------CHHHHHCCCTTBCCEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----------------hHHHHHHHHHHHHhCCCCCCccee
Confidence            3467899999999999999999887 47899999986432                134678899999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC---CCc
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP---EFE  839 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~  839 (1035)
                      +++.+.+..++||||+++|+|.+++...+.  +++..+..++.||+.||+|||+.   +|+||||||+||+++.   ++.
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~  189 (349)
T 2w4o_A          115 EIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAP  189 (349)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHTTCSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCC
T ss_pred             eeEecCCeEEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCC
Confidence            999999999999999999999999976543  89999999999999999999999   9999999999999975   889


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+..
T Consensus       190 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~i~~  265 (349)
T 2w4o_A          190 LKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MFRRILN  265 (349)
T ss_dssp             EEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HHHHHHT
T ss_pred             EEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HHHHHHh
Confidence            9999999998654432   22356799999999999998999999999999999999999999975432211 1111111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .  ... .........      ...+.+++.+||+.||++||++.|++++
T Consensus       266 ~--~~~-~~~~~~~~~------~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          266 C--EYY-FISPWWDEV------SLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             T--CCC-CCTTTTTTS------CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C--CCc-cCCchhhhC------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0  000 000000111      1234567888999999999999999874

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=346.22  Aligned_cols=253  Identities=24%  Similarity=0.352  Sum_probs=182.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||.||+|++. +++.||||++........           ...+.+.+|+.++++++||||+++++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~   78 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA-----------GMVQRVQNEVKIHCQLKHPSILELYN   78 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTTBCCTTBCCEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhh-----------hHHHHHHHHHHHHHhCCCCCeEeEEE
Confidence            467999999999999999999874 689999999854322111           23568999999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||+++++|.+++.... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~  154 (278)
T 3cok_A           79 YFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIA  154 (278)
T ss_dssp             EEECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEEC
T ss_pred             EEccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEE
Confidence            9999999999999999999999997643 3489999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||.+........  ......||+.|+|||+..+..++.++||||||+++|||++|+.||........     .....  
T Consensus       155 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~--  225 (278)
T 3cok_A          155 DFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVV--  225 (278)
T ss_dssp             CCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC--
T ss_pred             eecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHh--
Confidence            9999986543221  22346799999999999888899999999999999999999999975432211     00000  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        ..+.......+      ....+++.+||+.||++||++++++++
T Consensus       226 --~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          226 --LADYEMPSFLS------IEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             --SSCCCCCTTSC------HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --hcccCCccccC------HHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence              00001111111      133467888999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.1e-38  Score=354.93  Aligned_cols=265  Identities=24%  Similarity=0.341  Sum_probs=205.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE------CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .++|...+.||+|+||.||+|++      .+++.||||++.......             ...++.+|+.++++++||||
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i   95 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ-------------DELDFLMEALIISKFNHQNI   95 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHH-------------HHHHHHHHHHHHHHCCCTTB
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchh-------------hHHHHHHHHHHHhhCCCCCC
Confidence            36789999999999999999974      247789999996432211             24578999999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD-----SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      +++++++.+.+..|+||||+++|+|.+++.....     ..+++..++.++.|++.||+|||+.   +|+||||||+||+
T Consensus        96 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIl  172 (327)
T 2yfx_A           96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCL  172 (327)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEE
Confidence            9999999999999999999999999999987543     3488999999999999999999999   9999999999999


Q ss_pred             EcC---CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCC
Q 039419          834 IGP---EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPE  909 (1035)
Q Consensus       834 l~~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~  909 (1035)
                      ++.   +..+||+|||+++...............||+.|+|||+..+..++.++||||||+++|||++ |+.||..... 
T Consensus       173 i~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-  251 (327)
T 2yfx_A          173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-  251 (327)
T ss_dssp             ESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             EecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-
Confidence            984   44699999999986655443333445678999999999988899999999999999999998 9999975421 


Q ss_pred             chhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                       ......+.....      .......+      ..+..++.+||+.||++||++.+++++|+.+......
T Consensus       252 -~~~~~~~~~~~~------~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          252 -QEVLEFVTSGGR------MDPPKNCP------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             -HHHHHHHHTTCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             -HHHHHHHhcCCC------CCCCCCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence             122222221100      00111111      1234578889999999999999999999988766544

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.4e-38  Score=358.56  Aligned_cols=253  Identities=21%  Similarity=0.264  Sum_probs=191.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|+.. +++.||||++.....               ..+.+.+|+.++++++||||+++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~~~~   83 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---------------IDENVQREIINHRSLRHPNIVRFKE   83 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---------------SCHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---------------ccHHHHHHHHHHHhCCCCCCCcEEE
Confidence            367999999999999999999876 689999999854321               2356889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc--eE
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE--PY  841 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~--~k  841 (1035)
                      ++.+.+..|+||||+++|+|.+++...+.  +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.  +|
T Consensus        84 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~k  158 (361)
T 3uc3_A           84 VILTPTHLAIIMEYASGGELYERICNAGR--FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLK  158 (361)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEE
T ss_pred             EEeeCCEEEEEEEeCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEE
Confidence            99999999999999999999999977654  89999999999999999999999   9999999999999987765  99


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCcc-ccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEK-SDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |+|||+++......   ......||+.|+|||++.+..++.+ +||||+||++|||++|+.||....... .....+...
T Consensus       159 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~  234 (361)
T 3uc3_A          159 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQRI  234 (361)
T ss_dssp             ECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHHH
T ss_pred             EeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHHH
Confidence            99999997543322   2235679999999999887777655 899999999999999999997643321 111111111


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .      ...........  .......++.+||++||++|||+.|++++
T Consensus       235 ~------~~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          235 L------SVKYSIPDDIR--ISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             H------TTCCCCCTTSC--CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             h------cCCCCCCCcCC--CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0      00001000000  01223457888999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.6e-38  Score=348.88  Aligned_cols=260  Identities=21%  Similarity=0.272  Sum_probs=206.6

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.+.|.+.+.||+|+||.||+|.+. +|+.||||++.........        .....+.+.+|+.++++++||||+++
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~   80 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR--------RGVSREEIEREVSILRQVLHHNVITL   80 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCS--------SSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccc--------cchhHHHHHHHHHHHHhCCCCCcceE
Confidence            35678999999999999999999876 5899999999764332211        01236789999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC---
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF---  838 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~---  838 (1035)
                      ++++.+.+..|+||||+++++|.+++....  .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++   
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~  155 (321)
T 2a2a_A           81 HDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPI  155 (321)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSS
T ss_pred             EEEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCc
Confidence            999999999999999999999999997654  389999999999999999999999   999999999999999888   


Q ss_pred             -ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 -EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 -~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                       .+||+|||+++......   ......||+.|+|||+..+..++.++||||||+++|+|++|+.||.....  ......+
T Consensus       156 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i  230 (321)
T 2a2a_A          156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANI  230 (321)
T ss_dssp             CCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHH
T ss_pred             CCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH
Confidence             79999999998765432   22356799999999999988999999999999999999999999975321  1111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....   ...........+      ..+.+++.+||++||++|||+.|++++
T Consensus       231 ~~~~---~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          231 TSVS---YDFDEEFFSHTS------ELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HTTC---CCCCHHHHTTCC------HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             Hhcc---cccChhhhcccC------HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1100   000111111111      124567888999999999999999884

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-37  Score=351.61  Aligned_cols=265  Identities=26%  Similarity=0.353  Sum_probs=208.4

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhc--CCCCcee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS--IRHKNIV  759 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv  759 (1035)
                      ..+.++|...+.||+|+||.||+|++. ++.||||++...                 ..+.+.+|++++..  ++||||+
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----------------~~~~~~~e~~~~~~~~l~h~ni~   99 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR-----------------EERSWFREAEIYQTVMLRHENIL   99 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG-----------------GHHHHHHHHHHHHHSCCCCTTBC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch-----------------hHHHHHHHHHHHHHhhcCCCcEE
Confidence            445588999999999999999999885 899999998532                 13567889999887  7899999


Q ss_pred             eEEeEEEcCC----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhh--------ccCCCCeeccCC
Q 039419          760 RFLGCCWNRN----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLH--------HDCVPPIVHRDI  827 (1035)
Q Consensus       760 ~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~ivHrDi  827 (1035)
                      ++++++...+    ..|+||||+++|+|.+++...   .+++..++.++.|++.||+|||        +.   +|+||||
T Consensus       100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dl  173 (342)
T 1b6c_B          100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDL  173 (342)
T ss_dssp             CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCC
T ss_pred             EEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCC
Confidence            9999998876    789999999999999999764   3899999999999999999999        77   9999999


Q ss_pred             CcccEEEcCCCceEEeeccCccccccCCcc--ccccccCCcccccCCcccccC------CCCccccchhHHHHHHHHHhC
Q 039419          828 KANNILIGPEFEPYIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMM------KITEKSDVYSYGVVVLEVLTG  899 (1035)
Q Consensus       828 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvvl~elltg  899 (1035)
                      ||+||+++.++.+||+|||+++........  .......||+.|+|||++.+.      .++.++||||||+++|||++|
T Consensus       174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg  253 (342)
T 1b6c_B          174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR  253 (342)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence            999999999999999999999876544321  123456799999999997765      233689999999999999999


Q ss_pred             ----------CCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcc---cHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 039419          900 ----------KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEV---EIEEMLQTLGVALLCVNPTPDDRPTMKDV  966 (1035)
Q Consensus       900 ----------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~l~~~cl~~dP~~RPs~~el  966 (1035)
                                +.||....+.......+....      .....+...+.   .......+.+++.+||+.||++||++.++
T Consensus       254 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cCcCCcccccccCccccCcCcccHHHHHHHH------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence                      778876544333333322211      11111111111   11333345668899999999999999999


Q ss_pred             HHHHHHHHHh
Q 039419          967 AAMIKEIKQE  976 (1035)
Q Consensus       967 ~~~L~~~~~~  976 (1035)
                      +++|+.+.++
T Consensus       328 ~~~L~~i~~~  337 (342)
T 1b6c_B          328 KKTLSQLSQQ  337 (342)
T ss_dssp             HHHHHHHHHT
T ss_pred             HHHHHHHHHH
Confidence            9999998654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=362.02  Aligned_cols=271  Identities=19%  Similarity=0.261  Sum_probs=207.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||+||+|++.. ++.||||++......             ...+.+.+|++++++++||||++++++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~~~~   75 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-------------RPVDVQMREFEVLKKLNHKNIVKLFAI   75 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-------------SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-------------chHHHHHHHHHHHHhcCCCCCCeEEEe
Confidence            578899999999999999998764 899999999643221             125678899999999999999999999


Q ss_pred             EEcCC--cceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE----cCC
Q 039419          765 CWNRN--TRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI----GPE  837 (1035)
Q Consensus       765 ~~~~~--~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll----~~~  837 (1035)
                      +.+.+  ..|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.   +|+||||||+||++    +.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~  152 (396)
T 4eut_A           76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQ  152 (396)
T ss_dssp             EECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSC
T ss_pred             eccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCc
Confidence            98765  67999999999999999976543 3389999999999999999999999   99999999999999    778


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCccccc--------CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM--------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE  909 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~  909 (1035)
                      +.+||+|||+++......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||......
T Consensus       153 ~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~  229 (396)
T 4eut_A          153 SVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP  229 (396)
T ss_dssp             EEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT
T ss_pred             eeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc
Confidence            889999999998764432   2235679999999998754        56778999999999999999999999754322


Q ss_pred             ch--hHHHHHHHhccch--hhh----------cccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          910 GL--HIVDWVRQKRGAI--EVL----------DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       910 ~~--~~~~~~~~~~~~~--~~~----------~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ..  .....+.......  ..+          .................+..++.+||+.||++||++.|+++.++++..
T Consensus       230 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             TTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             cchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            21  1111111111100  000          000111111112233344568889999999999999999999888754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.8e-38  Score=352.76  Aligned_cols=254  Identities=20%  Similarity=0.272  Sum_probs=179.3

Q ss_pred             hcccc---CCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceee
Q 039419          686 KCLVE---DSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVR  760 (1035)
Q Consensus       686 ~~~~~---~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~  760 (1035)
                      ++|..   .+.||+|+||+||+|.+. +++.||||++...                 ....+.+|+.++++++ ||||++
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~e~~~l~~l~~h~niv~   70 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----------------MEANTQKEITALKLCEGHPNIVK   70 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----------------GHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----------------hhhhHHHHHHHHHHhcCCCCeeE
Confidence            44544   478999999999999876 5899999998531                 2456889999999997 999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC--
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF--  838 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~--  838 (1035)
                      +++++.+++..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++  
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~  145 (325)
T 3kn6_A           71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKH--FSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDN  145 (325)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHCSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----
T ss_pred             EEEEEEcCCEEEEEEEccCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCc
Confidence            99999999999999999999999999987644  89999999999999999999999   999999999999998766  


Q ss_pred             -ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC--chhHHH
Q 039419          839 -EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE--GLHIVD  915 (1035)
Q Consensus       839 -~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~--~~~~~~  915 (1035)
                       .+||+|||+++......  .......||+.|+|||+..+..++.++||||+||++|||++|+.||......  ......
T Consensus       146 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  223 (325)
T 3kn6_A          146 LEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE  223 (325)
T ss_dssp             CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH
T ss_pred             ccEEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH
Confidence             89999999998654432  2223567899999999999999999999999999999999999999754321  011111


Q ss_pred             HHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .......      .......+........+.+++.+||++||++||+++|++++
T Consensus       224 ~~~~i~~------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          224 IMKKIKK------GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHHHTT------TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             HHHHHHc------CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            1111100      00000100000111234567888999999999999998763

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.6e-38  Score=346.85  Aligned_cols=269  Identities=19%  Similarity=0.301  Sum_probs=200.5

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ..++|.+.+.||+|+||.||+|... +++.||||++........           ...+.+.+|+.++++++||||++++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~~   98 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA-----------KARADCIKEIDLLKQLNHPNVIKYY   98 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH-----------HHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH-----------HHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            3468999999999999999999764 689999999975332221           2356789999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++.+.+..++||||+++++|.+++...  ....+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~  175 (310)
T 2wqm_A           99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV  175 (310)
T ss_dssp             EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCE
Confidence            9999999999999999999999998752  234589999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      ||+|||+++.......  ......|++.|+|||+..+..++.++||||||+++|||++|+.||.............+...
T Consensus       176 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  253 (310)
T 2wqm_A          176 KLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC  253 (310)
T ss_dssp             EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT
T ss_pred             EEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc
Confidence            9999999986644321  22345789999999999888999999999999999999999999975432222222221111


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                      .     .........+      ..+..++.+||+.||++||++.++++.|+++.....+
T Consensus       254 ~-----~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          254 D-----YPPLPSDHYS------EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             C-----SCCCCTTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             c-----CCCCcccccC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            0     0000001111      1234578889999999999999999999999766654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.5e-39  Score=373.98  Aligned_cols=252  Identities=20%  Similarity=0.232  Sum_probs=194.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|... +++.||||++........           .....+.+|+.+++.++||||+++++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~l~~  215 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-----------DEVAHTLTENRVLQNSRHPFLTALKY  215 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------------CCCCCSCTTSCCEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhh-----------HHHHHHHHHHHHHHhCCCCeEeeEEE
Confidence            367999999999999999999775 589999999964322111           12356788999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceEE
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      ++.+.+..|+||||+++|+|.+++...+.  +++..+..++.||+.||+|||+ .   ||+||||||+|||++.++.+||
T Consensus       216 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl  290 (446)
T 4ejn_A          216 SFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKI  290 (446)
T ss_dssp             EEEETTEEEEEECCCSSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEE
T ss_pred             EEeeCCEEEEEEeeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999977654  8999999999999999999998 7   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+|+......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+.... 
T Consensus       291 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~~~~~~i~~~~-  365 (446)
T 4ejn_A          291 TDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILMEE-  365 (446)
T ss_dssp             CCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC-
T ss_pred             ccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--HHHHHHHHhCC-
Confidence            9999998643322  223457899999999999999999999999999999999999999975421  11111111100 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                            .......+      ..+.+++.+||++||++||     +++|++++
T Consensus       366 ------~~~p~~~~------~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          366 ------IRFPRTLG------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ------CCCCTTSC------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ------CCCCccCC------HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                  00111111      2234578889999999999     99999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-38  Score=344.49  Aligned_cols=262  Identities=22%  Similarity=0.319  Sum_probs=207.2

Q ss_pred             hccccCC-eeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDS-VVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~-~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||||++......             ...+.+.+|++++++++||||+++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~   75 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------------ADTEEMMREAQIMHQLDNPYIVRL   75 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch-------------hHHHHHHHHHHHHHhCCCCCEeEE
Confidence            4555555 9999999999999754   5788999999754221             125679999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++ ..+..++||||+++++|.+++.... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+|
T Consensus        76 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~k  150 (287)
T 1u59_A           76 IGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK  150 (287)
T ss_dssp             EEEE-ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred             EEEe-cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEE
Confidence            9999 4567899999999999999997543 3489999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      |+|||+++....... ........||+.|+|||+..+..++.++||||||+++|||++ |+.||.....  ......+..
T Consensus       151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~  228 (287)
T 1u59_A          151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ  228 (287)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT
T ss_pred             ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhc
Confidence            999999987654322 122234557899999999988889999999999999999998 9999975432  222222221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                      ..      ........+      ..+..++.+||+.||++||++.+++++|+.+......
T Consensus       229 ~~------~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          229 GK------RMECPPECP------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             TC------CCCCCTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             CC------cCCCCCCcC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            11      001111111      2344578889999999999999999999999766654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.9e-38  Score=361.57  Aligned_cols=254  Identities=21%  Similarity=0.271  Sum_probs=195.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC--CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR--HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~  763 (1035)
                      +.|.+.+.||+|+||.||+|...+++.||||++.......            ...+.+.+|+.++++++  ||||+++++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~Ei~~l~~l~~~~~~iv~~~~  123 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN------------QTLDSYRNEIAYLNKLQQHSDKIIRLYD  123 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCH------------HHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccH------------HHHHHHHHHHHHHHHcccCCCeEEEEEE
Confidence            4689999999999999999988889999999996543221            13567999999999996  599999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++..++..|+||| +.+++|.+++....  .+++..+..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+
T Consensus       124 ~~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~  196 (390)
T 2zmd_A          124 YEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLI  196 (390)
T ss_dssp             EEECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEEC
T ss_pred             EEecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEE
Confidence            9999999999999 56889999998765  488999999999999999999999   999999999999995 5889999


Q ss_pred             eccCccccccCCccccccccCCcccccCCccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      |||+++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......  
T Consensus       197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--  274 (390)
T 2zmd_A          197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--  274 (390)
T ss_dssp             CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--
T ss_pred             ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--
Confidence            9999987655433223345689999999998754           468899999999999999999999997532211  


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                        ..+..      .++.......+...  ...+.+++.+||+.||++||++.|++++-
T Consensus       275 --~~~~~------~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          275 --SKLHA------IIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             --HHHHH------HHCTTSCCCCCCCS--CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --HHHHH------HhCccccCCCCccc--hHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence              11111      11111111111111  11234578889999999999999999863

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.4e-38  Score=340.91  Aligned_cols=254  Identities=22%  Similarity=0.251  Sum_probs=202.3

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .++.++|...+.||+|+||+||+|.+.. +..||+|++.....              ...+.+.+|++++++++||||++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~~   70 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--------------EDVDRFKQEIEIMKSLDHPNIIR   70 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--------------SCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--------------chHHHHHHHHHHHHhCCCCCEee
Confidence            3456789999999999999999998764 77899999854321              12567999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE---cCC
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPE  837 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll---~~~  837 (1035)
                      +++++.+.+..|+||||+++++|.+++...+.  +++..+..++.|++.||+|||+.   +|+||||||+||++   +.+
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  145 (277)
T 3f3z_A           71 LYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPD  145 (277)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTT
T ss_pred             EEEEEecCCeEEEEEeccCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCC
Confidence            99999999999999999999999999877654  89999999999999999999999   99999999999999   788


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||.+.......   ......||+.|+|||+..+ .++.++||||||+++|||++|+.||.....  ......+
T Consensus       146 ~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~  219 (277)
T 3f3z_A          146 SPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD--SEVMLKI  219 (277)
T ss_dssp             CCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred             CcEEEEecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH--HHHHHHH
Confidence            999999999998765433   2235679999999998765 489999999999999999999999975422  1111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ......   .........      ......++.+||++||++||++.|++++
T Consensus       220 ~~~~~~---~~~~~~~~~------~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          220 REGTFT---FPEKDWLNV------SPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHCCCC---CCHHHHTTS------CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HhCCCC---CCchhhhcC------CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111000   000000011      1234557888999999999999999874

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.8e-38  Score=361.66  Aligned_cols=254  Identities=22%  Similarity=0.253  Sum_probs=191.7

Q ss_pred             HHHhccccC-CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhc-CCCCcee
Q 039419          683 QVLKCLVED-SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS-IRHKNIV  759 (1035)
Q Consensus       683 ~~~~~~~~~-~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv  759 (1035)
                      .+.+.|... +.||+|+||+||+|.+. +++.||||++..                   ...+.+|+.++.+ .+||||+
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------------------~~~~~~E~~~~~~~~~hp~iv  118 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIV  118 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBC
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------------------chhHHHHHHHHHHhcCCCCcc
Confidence            345667665 68999999999999776 589999999842                   2356788888754 4899999


Q ss_pred             eEEeEEEc----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          760 RFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       760 ~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++++..    .+..|+||||++||+|.+++.......+++..+..++.||+.||+|||+.   +|+||||||+|||++
T Consensus       119 ~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~  195 (400)
T 1nxk_A          119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYT  195 (400)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEES
T ss_pred             eEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEe
Confidence            99999875    56789999999999999999876655699999999999999999999999   999999999999999


Q ss_pred             C---CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch-
Q 039419          836 P---EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-  911 (1035)
Q Consensus       836 ~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~-  911 (1035)
                      .   ++.+||+|||+++......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ 
T Consensus       196 ~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  272 (400)
T 1nxk_A          196 SKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  272 (400)
T ss_dssp             SSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC
T ss_pred             cCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc
Confidence            7   7899999999998654322   22356799999999999999999999999999999999999999976543211 


Q ss_pred             -hHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          912 -HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       912 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                       .....+.....  ..... .....+      ..+.+++.+||+.||++|||+.|++++-
T Consensus       273 ~~~~~~i~~~~~--~~~~~-~~~~~s------~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          273 PGMKTRIRMGQY--EFPNP-EWSEVS------EEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             CSHHHHHHHTCC--CCCTT-TTTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHHHHcCcc--cCCCc-ccccCC------HHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence             11122211110  00000 001111      2245678889999999999999999863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.8e-38  Score=347.20  Aligned_cols=261  Identities=27%  Similarity=0.392  Sum_probs=192.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||+||+|++..  .||||++.......            ...+.|.+|+.++++++||||+++++++
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTP------------QQLQAFKNEVGVLRKTRHVNILLFMGYS   89 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCH------------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCH------------HHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence            568889999999999999998653  59999996543222            1356799999999999999999999965


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                       ..+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        90 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           90 -TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             -CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             -cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccc
Confidence             5567899999999999999996543 3489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |+++...............||+.|+|||++.   +..++.++||||||+++|||++|+.||...... ......+.....
T Consensus       165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~  243 (289)
T 3og7_A          165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSL  243 (289)
T ss_dssp             C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHHHHHTSC
T ss_pred             eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-HHHHHHhccccc
Confidence            9998665433223334567999999999876   667888999999999999999999999754322 122222221110


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      . ... .......+      ..+..++.+||+.||++||++.++++.|+++.
T Consensus       244 ~-~~~-~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          244 S-PDL-SKVRSNCP------KRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             C-CCT-TSSCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             C-cch-hhccccCC------HHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            0 000 00111111      22345788899999999999999999998864

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.1e-38  Score=343.16  Aligned_cols=262  Identities=22%  Similarity=0.351  Sum_probs=204.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .++|...+.||+|+||+||+|.+..    +..||+|++.......             ..+.+.+|+.++++++||||++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~~i~~   77 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD-------------NKEKFMSEAVIMKNLDHPHIVK   77 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH-------------HHHHHHHHHHHHHHHCCTTBCC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch-------------HHHHHHHHHHHHHhCCCCCcce
Confidence            3678899999999999999997643    3469999986543221             2568999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++.+ +..|+||||+++++|.+++...+ ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+
T Consensus        78 ~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  152 (281)
T 3cc6_A           78 LIGIIEE-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECV  152 (281)
T ss_dssp             EEEEECS-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEE
T ss_pred             EEEEEcC-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcE
Confidence            9999765 45689999999999999997654 3489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||.++....... .......+++.|+|||+..+..++.++||||||+++|||++ |+.||......  .....+..
T Consensus       153 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~  229 (281)
T 3cc6_A          153 KLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEK  229 (281)
T ss_dssp             EECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHH
T ss_pred             EeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhc
Confidence            9999999987654332 12234567889999999988899999999999999999998 99999754322  22222221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                      ...      .......+      ..+..++.+||+.||++||++.|++++|+++.....+
T Consensus       230 ~~~------~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  277 (281)
T 3cc6_A          230 GDR------LPKPDLCP------PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD  277 (281)
T ss_dssp             TCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCC------CCCCCCCC------HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence            110      00011111      1234578889999999999999999999998765543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.9e-38  Score=348.30  Aligned_cols=264  Identities=23%  Similarity=0.305  Sum_probs=187.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|.+. +++.||+|++......             ...+.+.+|+.++++++||||+++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~~   70 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-------------GTPSTAIREISLMKELKHENIVRLYD   70 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTT-------------CSCHHHHHHHHHHTTCCBTTBCCEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-------------ccHHHHHHHHHHHHhcCCCCcceEEE
Confidence            357888999999999999999775 5899999998654311             12457889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCC----CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRD----SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++.+++..|+||||++ |+|.+++.....    ..+++..+..++.||++||+|||+.   ||+||||||+||+++.++.
T Consensus        71 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~  146 (317)
T 2pmi_A           71 VIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQ  146 (317)
T ss_dssp             EECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred             EEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCC
Confidence            9999999999999997 699999876431    3489999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      +||+|||+++......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  .....+.
T Consensus       147 ~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~  222 (317)
T 2pmi_A          147 LKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE--EQLKLIF  222 (317)
T ss_dssp             EEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH
T ss_pred             EEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHH
Confidence            9999999998764322  12235578999999999876 46899999999999999999999999754321  1111111


Q ss_pred             H-hccchhh----------hcccccCCCcccHH----------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 Q-KRGAIEV----------LDKSLRARPEVEIE----------EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~-~~~~~~~----------~~~~~~~~~~~~~~----------~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      . .......          ........+.....          ....+.+++.+||++||++|||++|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          223 DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             HHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            1 1000000          00000000000000          01234568888999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-38  Score=355.56  Aligned_cols=270  Identities=26%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      |+..+.||+|+||+||+|.+.     +++.||||++......             ...+.+.+|++++++++||||++++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~   99 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP-------------QHRSGWKQEIDILRTLYHEHIIKYK   99 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH-------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh-------------HHHHHHHHHHHHHHhCCCcchhhEE
Confidence            488899999999999988653     5889999999754221             1256799999999999999999999


Q ss_pred             eEEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          763 GCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       763 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++.+.  ...++||||+++|+|.+++....   +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~  173 (318)
T 3lxp_A          100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLV  173 (318)
T ss_dssp             EEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCE
Confidence            999874  56799999999999999997654   89999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH--
Q 039419          841 YIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV--  917 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~--  917 (1035)
                      ||+|||.++........ .......||..|+|||+..+..++.++||||||+++|||++|+.||............+.  
T Consensus       174 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~  253 (318)
T 3lxp_A          174 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG  253 (318)
T ss_dssp             EECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCH
T ss_pred             EECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccccc
Confidence            99999999876543321 223355688999999999888899999999999999999999999864211000000000  


Q ss_pred             -HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          918 -RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       918 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                       .........+........+..  ....+.+++.+||+.||++||++.|+++.|+.+.....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          254 QMTVLRLTELLERGERLPRPDK--CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHhcccCCCCCcc--ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence             000000011111111111111  11234567888999999999999999999999876654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.9e-38  Score=346.26  Aligned_cols=265  Identities=22%  Similarity=0.265  Sum_probs=197.8

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ....++|...+.||+|+||.||+|.+. +++.||+|++........           ...+.+.+|+.++++++||||++
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~hp~iv~   98 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDP-----------VFRTRMQREARTAGRLQEPHVVP   98 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSH-----------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCH-----------HHHHHHHHHHHHHhhcCCCCeeE
Confidence            344678999999999999999999876 588999999865432211           23578999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++.+++..|+||||+++++|.+++.....  +++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~  173 (309)
T 2h34_A           99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFA  173 (309)
T ss_dssp             EEEEEEETTEEEEEEECCCCEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             EEEEEeeCCeEEEEEEecCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCE
Confidence            99999999999999999999999999987644  89999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      ||+|||++........ .......|++.|+|||+..+..++.++||||||+++|||++|+.||......  .....+...
T Consensus       174 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~  250 (309)
T 2h34_A          174 YLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQA  250 (309)
T ss_dssp             EECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSC
T ss_pred             EEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccC
Confidence            9999999986654322 2223557999999999999889999999999999999999999999753211  111111110


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-TMKDVAAMIKEIKQ  975 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-s~~el~~~L~~~~~  975 (1035)
                      ...    ........+.      .+..++.+||++||++|| +++++++.|+.+..
T Consensus       251 ~~~----~~~~~~~~~~------~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          251 IPR----PSTVRPGIPV------AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             CCC----GGGTSTTCCT------HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             CCC----ccccCCCCCH------HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence            000    0011111222      234477789999999999 99999999887643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=356.17  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=202.1

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      +..++|...+.||+|+||+||+|.+. +++.||||++............      ....+.+.+|+.++++++||||+++
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~Iv~~   94 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIE------DPKLGKVTLEIAILSRVEHANIIKV   94 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEE------ETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccc------hHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            45688999999999999999999765 5899999999765432211000      0123456789999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCC-ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          762 LGCCWNRNTRLLMYDYMPNG-SLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ++++.+.+..++||||+.+| +|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus        95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  169 (335)
T 3dls_A           95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTI  169 (335)
T ss_dssp             EEEEECSSEEEEEEECCTTSCBHHHHHHTCCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCccHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcE
Confidence            99999999999999999776 99999976544  89999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++.......   .....||+.|+|||+..+..+ +.++|||||||++|||++|+.||.....           
T Consensus       170 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------  235 (335)
T 3dls_A          170 KLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----------  235 (335)
T ss_dssp             EECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------
T ss_pred             EEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------
Confidence            9999999987654332   234679999999999887776 7899999999999999999999964210           


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                            ........ +.. ..  ..+..++.+||++||++||++++++++
T Consensus       236 ------~~~~~~~~-~~~-~~--~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ------TVEAAIHP-PYL-VS--KELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------GTTTCCCC-SSC-CC--HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------HHhhccCC-Ccc-cC--HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  01111111 110 11  123457888999999999999999885

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.7e-38  Score=347.98  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=203.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      +.|+..+.||+|+||.||+|++     .+++.||||++......             ...+.+.+|+.++++++||||++
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~   87 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------------NHIADLKKEIEILRNLYHENIVK   87 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------------CCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc-------------hhHHHHHHHHHHHHhCCCCCeee
Confidence            5588899999999999999984     35899999999754321             12567999999999999999999


Q ss_pred             EEeEEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          761 FLGCCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       761 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +++++.+.  ...++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        88 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~  163 (302)
T 4e5w_A           88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH  163 (302)
T ss_dssp             EEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             eeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCC
Confidence            99999876  56899999999999999996654 3389999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCC---------
Q 039419          839 EPYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIP---------  908 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~---------  908 (1035)
                      .+||+|||.++........ .......||..|+|||+..+..++.++||||+|+++|||++|+.|+.....         
T Consensus       164 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  243 (302)
T 4e5w_A          164 QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT  243 (302)
T ss_dssp             EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred             CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc
Confidence            9999999999876544321 223456788999999999888899999999999999999999998753210         


Q ss_pred             -CchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          909 -EGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       909 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                       ..........       .+........+...  ...+.+++.+||+.||++|||+.++++.|+++.
T Consensus       244 ~~~~~~~~~~~-------~~~~~~~~~~~~~~--~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          244 HGQMTVTRLVN-------TLKEGKRLPCPPNC--PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CGGGHHHHHHH-------HHHTTCCCCCCTTC--CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccCHHHHHH-------HHhccCCCCCCCCC--CHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence             0000000000       00000011111111  123456788899999999999999999998864

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.5e-38  Score=349.01  Aligned_cols=264  Identities=21%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|.+.. |+.||||++.......            ...+.+.+|+.++++++||||+++++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~   69 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP------------VIKKIALREIRMLKQLKHPNLVNLLE   69 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch------------HHHHHHHHHHHHHHhCCCCCccchhh
Confidence            4679999999999999999998764 8999999986543221            23567889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..++||||+++++|.+++...+.  +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        70 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~  144 (311)
T 4agu_A           70 VFRRKRRLHLVFEYCDHTVLHELDRYQRG--VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLC  144 (311)
T ss_dssp             EEEETTEEEEEEECCSEEHHHHHHHTSSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             eeecCCeEEEEEEeCCCchHHHHHhhhcC--CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEe
Confidence            99999999999999999999998876544  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||.++......  .......||+.|+|||+..+ ..++.++||||+|+++|+|++|+.||......  .....+.....
T Consensus       145 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~  220 (311)
T 4agu_A          145 DFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQLYLIRKTLG  220 (311)
T ss_dssp             CCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHC
T ss_pred             eCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhc
Confidence            999998764332  12235578999999998865 66899999999999999999999999754321  11111111100


Q ss_pred             c-h----------hhhcc-cccCCCc-ccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 A-I----------EVLDK-SLRARPE-VEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~-~----------~~~~~-~~~~~~~-~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      . .          ..... ....... ...     .......+++.+||++||++|||++|++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             SCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0 0          00000 0000000 000     011124568889999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-37  Score=347.42  Aligned_cols=271  Identities=27%  Similarity=0.355  Sum_probs=202.9

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC--CCCceee
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI--RHKNIVR  760 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~  760 (1035)
                      .+.++|.+.+.||+|+||.||+|++. ++.||||++...                 ....+.+|.+++...  +||||++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----------------~~~~~~~e~~~~~~~~~~h~~i~~   95 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT-----------------EEASWFRETEIYQTVLMRHENILG   95 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG-----------------GHHHHHHHHHHHTSTTCCCTTBCC
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc-----------------ccchhhhHHHHHHHHhhcCCCeee
Confidence            34588999999999999999999887 899999998432                 133456666776665  8999999


Q ss_pred             EEeEEEcC----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC-----CCCeeccCCCccc
Q 039419          761 FLGCCWNR----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC-----VPPIVHRDIKANN  831 (1035)
Q Consensus       761 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivHrDikp~N  831 (1035)
                      +++++.+.    ...|+||||+++|+|.++++...   +++..+..++.|++.||+|||+.+     .++|+||||||+|
T Consensus        96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N  172 (337)
T 3mdy_A           96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN  172 (337)
T ss_dssp             EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred             EEEEEccCCCCCCceEEEEeccCCCcHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence            99999887    67899999999999999997643   899999999999999999999751     2389999999999


Q ss_pred             EEEcCCCceEEeeccCccccccCCcc--ccccccCCcccccCCcccccCCCCcc------ccchhHHHHHHHHHhC----
Q 039419          832 ILIGPEFEPYIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMMKITEK------SDVYSYGVVVLEVLTG----  899 (1035)
Q Consensus       832 Ill~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlGvvl~elltg----  899 (1035)
                      |+++.++.+||+|||+++........  .......||+.|+|||++.+...+.+      +|||||||++|||++|    
T Consensus       173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            99999999999999999766443221  11234579999999999887766665      9999999999999999    


Q ss_pred             ------CCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          900 ------KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       900 ------~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                            +.||....+.......+......  ....+....... .......+.+++.+||+.||++||++.|++++|+.+
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSYEDMREIVCI--KKLRPSFPNRWS-SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTT--SCCCCCCCGGGG-GSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccccHhhhcCCCCchhhhHHHHhh--hccCccccccch-hhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence                  66665543333222222111100  000111110000 112333456788999999999999999999999998


Q ss_pred             HHhH
Q 039419          974 KQER  977 (1035)
Q Consensus       974 ~~~~  977 (1035)
                      .+..
T Consensus       330 ~~~~  333 (337)
T 3mdy_A          330 SESQ  333 (337)
T ss_dssp             HHTT
T ss_pred             Hhhc
Confidence            6543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.5e-39  Score=358.54  Aligned_cols=275  Identities=27%  Similarity=0.379  Sum_probs=204.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|+..+.||+|+||.||+|++     .+++.||||++.....              ...+.+.+|++++++++||||++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~~   88 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP--------------DQQRDFQREIQILKALHSDFIVK   88 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH--------------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH--------------HHHHHHHHHHHHHHhcCCCceeE
Confidence            5788999999999999999984     3588999999865321              12467899999999999999999


Q ss_pred             EEeEEEc--CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          761 FLGCCWN--RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       761 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +++++..  ....|+||||+++++|.+++..... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~  164 (327)
T 3lxl_A           89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEA  164 (327)
T ss_dssp             EEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             EEEEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCC
Confidence            9999874  4568999999999999999976432 389999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      .+||+|||.++....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||............+.
T Consensus       165 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  244 (327)
T 3lxl_A          165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE  244 (327)
T ss_dssp             EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred             CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence            999999999987654322 1223345688999999999888899999999999999999999999864211000000000


Q ss_pred             HHh---ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHHh
Q 039419          918 RQK---RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREEC  980 (1035)
Q Consensus       918 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~  980 (1035)
                      ...   ......+........+..  ....+.+++.+||++||++||++.|++++|+.+......+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  308 (327)
T 3lxl_A          245 RDVPALSRLLELLEEGQRLPAPPA--CPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC  308 (327)
T ss_dssp             --CCHHHHHHHHHHTTCCCCCCTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred             cccccHHHHHHHhhcccCCCCCCc--ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence            000   000001111111111111  1122355788899999999999999999999886655443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.2e-38  Score=348.90  Aligned_cols=262  Identities=23%  Similarity=0.381  Sum_probs=195.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+.||+|+||.||+|.+.    .++.||+|++.......            ...+.+.+|+.++++++||||+++
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~  101 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ------------REIEEFLSEAACMKDFSHPNVIRL  101 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH------------HHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch------------hHHHHHHHHHHHHhcCCCCCeeee
Confidence            67889999999999999999664    24589999986543221            124678999999999999999999


Q ss_pred             EeEEEcCCc-----ceEEEEeCCCCChhhhhhhc----CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccE
Q 039419          762 LGCCWNRNT-----RLLMYDYMPNGSLGSLLHER----RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNI  832 (1035)
Q Consensus       762 ~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NI  832 (1035)
                      ++++.+.+.     .++||||+++|+|.+++...    ....+++..++.++.||++||+|||+.   +|+||||||+||
T Consensus       102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NI  178 (313)
T 3brb_A          102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNC  178 (313)
T ss_dssp             CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGE
T ss_pred             eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceE
Confidence            999987553     49999999999999998532    234589999999999999999999999   999999999999


Q ss_pred             EEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCch
Q 039419          833 LIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGL  911 (1035)
Q Consensus       833 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~  911 (1035)
                      +++.++.+||+|||+++...............+++.|+|||...+..++.++||||||+++|||++ |..||......  
T Consensus       179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  256 (313)
T 3brb_A          179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--  256 (313)
T ss_dssp             EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred             EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--
Confidence            999999999999999987655443333445568889999999999899999999999999999999 88999754322  


Q ss_pred             hHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          912 HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       912 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      .....+....      ........+      ..+..++.+||+.||++||++.+++++|+.+...
T Consensus       257 ~~~~~~~~~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          257 EMYDYLLHGH------RLKQPEDCL------DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             GHHHHHHTTC------CCCCBTTCC------HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCC------CCCCCcccc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            2222221110      000111111      2345578889999999999999999999998654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.8e-38  Score=365.06  Aligned_cols=261  Identities=23%  Similarity=0.227  Sum_probs=193.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|.+. +++.||||++.......            ...+++.+|+.+++.++||||+++++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~l~~  128 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIISLLN  128 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH------------HHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh------------HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            478999999999999999999765 58999999996532111            23567889999999999999999999


Q ss_pred             EEEcCC------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          764 CCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       764 ~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++...+      ..|+||||+++ ++.+.+..    .+++..+..++.||+.||+|||+.   ||+||||||+|||++.+
T Consensus       129 ~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~  200 (464)
T 3ttj_A          129 VFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD  200 (464)
T ss_dssp             EECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             EEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCC
Confidence            997654      45999999965 56666643    288999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||+|+......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+...+
T Consensus       201 ~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~  276 (464)
T 3ttj_A          201 CTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVI  276 (464)
T ss_dssp             SCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH
T ss_pred             CCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Confidence            999999999998764432   234578999999999999999999999999999999999999999754211 1111111


Q ss_pred             HHhccc-hhhh-----------c---------------cc-ccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGA-IEVL-----------D---------------KS-LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~-~~~~-----------~---------------~~-~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...... .+..           .               .. ..............+.+++.+||+.||++|||++|++++
T Consensus       277 ~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          277 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            110000 0000           0               00 000000001113356778999999999999999999885

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.2e-38  Score=355.25  Aligned_cols=252  Identities=15%  Similarity=0.144  Sum_probs=202.2

Q ss_pred             hccccCCeeeeeCCcEEEEEE------ECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC---CC
Q 039419          686 KCLVEDSVVGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR---HK  756 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp  756 (1035)
                      ++|.+.+.||+|+||+||+|.      ..+++.||||++...                 ....+.+|++++++++   |+
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~e~~~~~~l~~~~~~  127 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----------------NPWEFYIGTQLMERLKPSMQH  127 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----------------CHHHHHHHHHHHHHSCGGGGG
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----------------ChhHHHHHHHHHHHhhhhhhh
Confidence            678899999999999999993      446899999998642                 2456888999988887   99


Q ss_pred             ceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhc---CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          757 NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER---RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      ||+++++++...+..|+||||+++|+|.+++...   ....+++..+..++.||++||+|||+.   +|+||||||+|||
T Consensus       128 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIl  204 (365)
T 3e7e_A          128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFI  204 (365)
T ss_dssp             GBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEE
T ss_pred             hhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEE
Confidence            9999999999999999999999999999999753   234599999999999999999999998   9999999999999


Q ss_pred             EcC-----------CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 039419          834 IGP-----------EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP  902 (1035)
Q Consensus       834 l~~-----------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P  902 (1035)
                      ++.           ++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  284 (365)
T 3e7e_A          205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM  284 (365)
T ss_dssp             ECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred             ecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence            998           899999999999765433323334567899999999999999999999999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHHHHHHHh
Q 039419          903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDR-PTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~R-Ps~~el~~~L~~~~~~  976 (1035)
                      |.......              ..........+.   .+  ..-.++..|++.+|.+| |+++++.+.|+++...
T Consensus       285 f~~~~~~~--------------~~~~~~~~~~~~---~~--~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          285 KVKNEGGE--------------CKPEGLFRRLPH---LD--MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             CEEEETTE--------------EEECSCCTTCSS---HH--HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cccCCCCc--------------eeechhccccCc---HH--HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            96432110              001111111111   11  12346777999999999 7888888888876544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-37  Score=340.82  Aligned_cols=254  Identities=21%  Similarity=0.269  Sum_probs=202.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||+|++.......            ...+.+.+|+.++++++||||+++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~   72 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA------------RDFQKLEREARICRKLQHPNIVRLHD   72 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH------------HHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence            467899999999999999999776 58999999986543221            12467889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc---e
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE---P  840 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---~  840 (1035)
                      ++.+.+..++||||+++++|.+++.....  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +
T Consensus        73 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~  147 (284)
T 3kk8_A           73 SIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAV  147 (284)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCE
T ss_pred             EEEcCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcE
Confidence            99999999999999999999999877654  89999999999999999999999   9999999999999986655   9


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      ||+|||.+.......   ......||+.|+|||+..+..++.++||||+|+++|+|++|+.||.....  ......+...
T Consensus       148 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~  222 (284)
T 3kk8_A          148 KLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKAG  222 (284)
T ss_dssp             EECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHT
T ss_pred             EEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--hHHHHHHHhc
Confidence            999999997664432   22356799999999999999999999999999999999999999965421  1111111111


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..  ....+. ....+      ....+++.+||++||++||+++|++++
T Consensus       223 ~~--~~~~~~-~~~~~------~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          223 AY--DYPSPE-WDTVT------PEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CC--CCCTTT-TTTSC------HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cc--cCCchh-hcccC------HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            10  000000 01111      123457888999999999999999885

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6e-38  Score=348.24  Aligned_cols=248  Identities=23%  Similarity=0.300  Sum_probs=192.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .++|+..+.||+|+||+||+|++. +++.||||++........            ....+.+|+..+.++ +||||++++
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~~~~~~~h~~iv~l~  123 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK------------DRARKLAEVGSHEKVGQHPCCVRLE  123 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH------------HHHHHHHHHHHHHHhcCCCcEEEEE
Confidence            478999999999999999999886 699999999865432221            134555666666665 899999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+.+..|+||||+ +++|.+++...+ ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||
T Consensus       124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl  198 (311)
T 3p1a_A          124 QAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKL  198 (311)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEE
T ss_pred             EEEEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999 779999887654 3489999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+++......   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...     ..  |......
T Consensus       199 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----~~--~~~~~~~  267 (311)
T 3p1a_A          199 GDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----EG--WQQLRQG  267 (311)
T ss_dssp             CCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----HH--HHHHTTT
T ss_pred             ccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----cH--HHHHhcc
Confidence            9999998664432   2335679999999998776 7899999999999999999997766421     11  1111100


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ..........+      ..+.+++.+||++||++|||++|++++
T Consensus       268 ---~~~~~~~~~~~------~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          268 ---YLPPEFTAGLS------SELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ---CCCHHHHTTSC------HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---CCCcccccCCC------HHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence               01111111111      234557888999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.4e-38  Score=371.39  Aligned_cols=254  Identities=19%  Similarity=0.265  Sum_probs=202.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||.||+|+++ +|+.||||++........           ...+.+.+|++++++++||||++++++
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~-----------~~~~~~~~E~~iL~~l~hp~Iv~l~~~  253 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-----------KGYQGAMVEKKILAKVHSRFIVSLAYA  253 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhh-----------HHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            56888899999999999999886 589999999965332211           234678999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +.+.+..|+||||++||+|.+++....  ...+++..+..++.||+.||+|||+.   ||+||||||+||+++.+|.+||
T Consensus       254 ~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL  330 (543)
T 3c4z_A          254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRI  330 (543)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred             EeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEE
Confidence            999999999999999999999987654  34589999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc--hhHHHHHHHh
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG--LHIVDWVRQK  920 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~  920 (1035)
                      +|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..+...+...
T Consensus       331 ~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~  408 (543)
T 3c4z_A          331 SDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ  408 (543)
T ss_dssp             CCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred             eecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence            99999987654332  2234689999999999999999999999999999999999999997643211  1111111110


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM-----KDVAA  968 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~-----~el~~  968 (1035)
                             ........+      .....++.+||++||++||++     +++++
T Consensus       409 -------~~~~p~~~s------~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 -------AVTYPDKFS------PASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -------CCCCCTTSC------HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -------ccCCCcccC------HHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                   000111111      123457788999999999975     56655

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.5e-38  Score=353.91  Aligned_cols=267  Identities=22%  Similarity=0.203  Sum_probs=201.5

Q ss_pred             cHHHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          680 TVEQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       680 ~~~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .+.++.++|...+.||+|+||+||+|.+. +++.||+|++........         .....+.+.+|+.++++++||||
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpni   90 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI---------NPKDVERIKTEVRLMKKLHHPNI   90 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC------------CHHHHHHHHHHHHHHCCCTTB
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc---------CHHHHHHHHHHHHHHHhCCCCCc
Confidence            57888999999999999999999999775 588999999865322110         01235789999999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcC--------------------------------------CCCCCHHHH
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------------------------------DSCLEWELR  800 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~  800 (1035)
                      +++++++.+.+..++||||++||+|.+++....                                      ...+++..+
T Consensus        91 v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (345)
T 3hko_A           91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI  170 (345)
T ss_dssp             CCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHH
T ss_pred             ceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHH
Confidence            999999999999999999999999999985211                                      112356778


Q ss_pred             HHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC--ceEEeeccCccccccCCc--cccccccCCcccccCCcccc
Q 039419          801 YRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF--EPYIADFGLAKLVVEGDF--ARSSNTVAGSYGYIAPEYGY  876 (1035)
Q Consensus       801 ~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~--~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~  876 (1035)
                      ..++.||++||+|||+.   +|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||++.
T Consensus       171 ~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  247 (345)
T 3hko_A          171 SNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN  247 (345)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence            88999999999999999   999999999999998776  899999999986644221  11234567999999999876


Q ss_pred             c--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccC
Q 039419          877 M--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVN  954 (1035)
Q Consensus       877 ~--~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~  954 (1035)
                      +  ..++.++||||||+++|||++|+.||......  .....+..         .......+........+.+++.+||+
T Consensus       248 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~  316 (345)
T 3hko_A          248 TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA--DTISQVLN---------KKLCFENPNYNVLSPLARDLLSNLLN  316 (345)
T ss_dssp             CSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH---------CCCCTTSGGGGGSCHHHHHHHHHHSC
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH--HHHHHHHh---------cccccCCcccccCCHHHHHHHHHHcC
Confidence            5  67889999999999999999999999754221  11111111         11100000000011233457888999


Q ss_pred             CCCCCCCCHHHHHHH
Q 039419          955 PTPDDRPTMKDVAAM  969 (1035)
Q Consensus       955 ~dP~~RPs~~el~~~  969 (1035)
                      +||++||++.|++++
T Consensus       317 ~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          317 RNVDERFDAMRALQH  331 (345)
T ss_dssp             SCTTTSCCHHHHHHS
T ss_pred             CChhHCCCHHHHhcC
Confidence            999999999999884

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.8e-38  Score=355.43  Aligned_cols=198  Identities=23%  Similarity=0.285  Sum_probs=175.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-----CCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-----HKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpni  758 (1035)
                      .++|.+.+.||+|+||+||+|++. +++.||||++....               ...+.+.+|+.+++.++     ||||
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK---------------KYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH---------------HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch---------------hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            378999999999999999999875 58999999985321               12456788999999986     9999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC--
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP--  836 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~--  836 (1035)
                      +++++++...+..++||||+ +++|.+++.......+++..+..++.||+.||+|||+.   ||+||||||+|||++.  
T Consensus        99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A           99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred             ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence            99999999999999999999 99999999887666699999999999999999999999   9999999999999975  


Q ss_pred             -----------------------CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHH
Q 039419          837 -----------------------EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVV  893 (1035)
Q Consensus       837 -----------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl  893 (1035)
                                             ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                   789999999999864332     2356799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 039419          894 LEVLTGKQPIDPT  906 (1035)
Q Consensus       894 ~elltg~~P~~~~  906 (1035)
                      |||++|+.||...
T Consensus       250 ~ell~g~~pf~~~  262 (360)
T 3llt_A          250 AELYTGSLLFRTH  262 (360)
T ss_dssp             HHHHHSSCSCCCS
T ss_pred             HHHHHCCCCCCCC
Confidence            9999999999754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.3e-38  Score=363.91  Aligned_cols=258  Identities=22%  Similarity=0.247  Sum_probs=200.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...++||+|+||+||+|+++. ++.||||++........           ...+.+.+|+.++..++||||++++++
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~-----------~~~~~~~~E~~il~~~~hp~Iv~l~~~  142 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR-----------AETACFREERDVLVNGDSKWITTLHYA  142 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT-----------TTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhH-----------HHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            689999999999999999998875 78999999864322111           113358899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||++||+|.+++.... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus       143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          143 FQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            999999999999999999999997642 3489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|+....... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||......  .....+..
T Consensus       219 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~  295 (437)
T 4aw2_A          219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMN  295 (437)
T ss_dssp             CTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT
T ss_pred             hhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--HHHHhhhh
Confidence            999987654332 2233568999999999976     556899999999999999999999999754221  11111110


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDD--RPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~--RPs~~el~~~  969 (1035)
                      ..   ..+  ....... .+.  ....+++.+|+..+|++  ||+++|++++
T Consensus       296 ~~---~~~--~~p~~~~-~~s--~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          296 HK---ERF--QFPTQVT-DVS--ENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HH---HHC--CCCSSCC-CSC--HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             cc---ccc--cCCcccc-cCC--HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            00   000  0111100 011  12345677788888888  9999999885

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.8e-38  Score=352.75  Aligned_cols=253  Identities=21%  Similarity=0.224  Sum_probs=198.4

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceee
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVR  760 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  760 (1035)
                      ...++|...+.||+|+||.||+|.++ +++.||||++.....                  .+.+|++++.++ +||||++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------------~~~~E~~~l~~~~~hp~iv~   80 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------------------DPTEEIEILLRYGQHPNIIT   80 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------------------CCHHHHHHHHHHTTSTTBCC
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------------------ChHHHHHHHHHhcCCCCcCe
Confidence            34678999999999999999999876 589999999964321                  234688888888 7999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC---
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE---  837 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~---  837 (1035)
                      +++++.+.+..|+||||++||+|.+++...+  .+++..+..++.||+.||+|||+.   ||+||||||+||++..+   
T Consensus        81 ~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~  155 (342)
T 2qr7_A           81 LKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGN  155 (342)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCS
T ss_pred             EEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCC
Confidence            9999999999999999999999999997654  389999999999999999999999   99999999999998543   


Q ss_pred             -CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-hhHHH
Q 039419          838 -FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG-LHIVD  915 (1035)
Q Consensus       838 -~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~-~~~~~  915 (1035)
                       +.+||+|||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..
T Consensus       156 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~  233 (342)
T 2qr7_A          156 PESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA  233 (342)
T ss_dssp             GGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH
T ss_pred             cCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH
Confidence             359999999998765432  12335679999999999888788999999999999999999999997542221 11222


Q ss_pred             HHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+.....   ..........+      ..+.+++.+||++||++||++.|++++
T Consensus       234 ~i~~~~~---~~~~~~~~~~s------~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          234 RIGSGKF---SLSGGYWNSVS------DTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             HHHHCCC---CCCSTTTTTSC------HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHccCCc---ccCccccccCC------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            2211100   00000011111      123457888999999999999999885

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-38  Score=344.67  Aligned_cols=254  Identities=25%  Similarity=0.324  Sum_probs=196.1

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.++|...+.||+|+||+||+|+.. +++.||+|++......             ...+.+.+|++++++++||||++++
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~   86 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-------------VPMEQIEAEIEVLKSLDHPNIIKIF   86 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-------------SCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-------------hhHHHHHHHHHHHHhCCCchHHhHH
Confidence            4578999999999999999999775 5899999998653221             1256899999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE---cCC
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPE  837 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll---~~~  837 (1035)
                      +++.+.+..|+||||+++|+|.+++...  ....+++..+..++.|+++||+|||+.   +|+||||||+||++   +.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~  163 (285)
T 3is5_A           87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPH  163 (285)
T ss_dssp             EEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTT
T ss_pred             HheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCC
Confidence            9999999999999999999999998653  234589999999999999999999999   99999999999999   456


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||+++......   ......||+.|+|||++. ..++.++||||||+++|||++|+.||......  ......
T Consensus       164 ~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~  237 (285)
T 3is5_A          164 SPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKA  237 (285)
T ss_dssp             CCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred             CCEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhh
Confidence            789999999998664432   223567999999999875 56889999999999999999999999754221  111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....       ..........   .....+++.+||++||++||++.|++++
T Consensus       238 ~~~~-------~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          238 TYKE-------PNYAVECRPL---TPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             HHCC-------CCCCC--CCC---CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ccCC-------cccccccCcC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1110       0000000000   1123457888999999999999999864

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=358.15  Aligned_cols=264  Identities=18%  Similarity=0.194  Sum_probs=205.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC---------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCC
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN---------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHK  756 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  756 (1035)
                      ++|...+.||+|+||.||+|++..         ++.||||++...                   +.+.+|+.++++++||
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------------~~~~~E~~~l~~l~h~  102 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------------GRLFNEQNFFQRAAKP  102 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------------STHHHHHHHHHHHCCH
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------------chHHHHHHHHHHhccc
Confidence            689999999999999999998764         789999998532                   2578999999999999


Q ss_pred             ceee---------------EEeEEEc-CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCC
Q 039419          757 NIVR---------------FLGCCWN-RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVP  820 (1035)
Q Consensus       757 niv~---------------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~  820 (1035)
                      ||++               +++++.. .+..|+||||+ +++|.+++.......+++..+..++.||+.||+|||+.   
T Consensus       103 niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---  178 (352)
T 2jii_A          103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---  178 (352)
T ss_dssp             HHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             chhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            9987               6777776 67889999999 99999999876445599999999999999999999999   


Q ss_pred             CeeccCCCcccEEEcCCC--ceEEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHH
Q 039419          821 PIVHRDIKANNILIGPEF--EPYIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVV  893 (1035)
Q Consensus       821 ~ivHrDikp~NIll~~~~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl  893 (1035)
                      +|+||||||+||+++.++  .+||+|||+++........     .......||+.|+|||+..+..++.++|||||||++
T Consensus       179 ~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il  258 (352)
T 2jii_A          179 EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM  258 (352)
T ss_dssp             TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence            999999999999999998  8999999999876543211     112345799999999999998999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCchhHHHHHHHhccch-hhhcccc-cCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          894 LEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI-EVLDKSL-RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       894 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      |||++|+.||....+....+........... ....... ....+      ..+..++.+||+.||++||+++++++.|+
T Consensus       259 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~  332 (352)
T 2jii_A          259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPS------ETLQKYLKVVMALTYEEKPPYAMLRNNLE  332 (352)
T ss_dssp             HHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCC------HHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             HHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCc------HHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence            9999999999865433322222222111000 0000000 00111      22345778899999999999999999999


Q ss_pred             HHHHhHH
Q 039419          972 EIKQERE  978 (1035)
Q Consensus       972 ~~~~~~~  978 (1035)
                      ++.....
T Consensus       333 ~~~~~~~  339 (352)
T 2jii_A          333 ALLQDLR  339 (352)
T ss_dssp             HHHHHTT
T ss_pred             HHHHhcC
Confidence            9876554

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.4e-37  Score=347.85  Aligned_cols=260  Identities=20%  Similarity=0.258  Sum_probs=201.9

Q ss_pred             HHHHHhccccC-CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCc
Q 039419          681 VEQVLKCLVED-SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKN  757 (1035)
Q Consensus       681 ~~~~~~~~~~~-~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn  757 (1035)
                      .+...+.|.+. +.||+|+||.||+|.+. +++.||+|++.......            .....+.+|+.++++++ |||
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~~   90 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ------------DCRAEILHEIAVLELAKSCPR   90 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE------------ECHHHHHHHHHHHHHTTTCTT
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch------------HHHHHHHHHHHHHHhccCCCC
Confidence            45566778777 89999999999999776 58999999986533221            23568999999999995 699


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-  836 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-  836 (1035)
                      |+++++++.+.+..|+||||+++|+|.+++.......+++..+..++.|++.||+|||+.   ||+||||||+||+++. 
T Consensus        91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~  167 (327)
T 3lm5_A           91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSI  167 (327)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCB
T ss_pred             EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecC
Confidence            999999999999999999999999999999766556699999999999999999999999   9999999999999987 


Q ss_pred             --CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          837 --EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       837 --~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                        ++.+||+|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......  ...
T Consensus       168 ~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~  242 (327)
T 3lm5_A          168 YPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--ETY  242 (327)
T ss_dssp             TTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH
T ss_pred             CCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHH
Confidence              7899999999998764432   223467999999999999999999999999999999999999999754221  111


Q ss_pred             HHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+.....  . .........+      ..+.+++.+||++||++||+++|++++
T Consensus       243 ~~i~~~~~--~-~~~~~~~~~~------~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          243 LNISQVNV--D-YSEETFSSVS------QLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHTCC--C-CCTTTTTTSC------HHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHhccc--c-cCchhhcccC------HHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11111100  0 0000001111      123457888999999999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-38  Score=357.60  Aligned_cols=261  Identities=26%  Similarity=0.384  Sum_probs=193.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC--CC--cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME--NG--EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ..|...+.||+|+||+||+|.+.  ++  ..||||.+......             ...++|.+|+.++++++||||+++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~il~~l~hpnIv~~  155 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-------------GEVSQFLTEGIIMKDFSHPNVLSL  155 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS-------------HHHHHHHHHHTTSTTCCCTTBCCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH-------------HHHHHHHHHHHHHHhCCCCCcceE
Confidence            34667789999999999999764  22  46899988542211             235689999999999999999999


Q ss_pred             EeEEEc-CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          762 LGCCWN-RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       762 ~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ++++.+ ++..|+||||+++|+|.++++... ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+
T Consensus       156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~  231 (373)
T 3c1x_A          156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTV  231 (373)
T ss_dssp             CEEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred             EEEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCE
Confidence            998764 457899999999999999997543 3478999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCcc--ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHH
Q 039419          841 YIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~  917 (1035)
                      ||+|||+++........  .......+|+.|+|||+..+..++.++|||||||++|||++ |..||.......  ....+
T Consensus       232 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~  309 (373)
T 3c1x_A          232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL  309 (373)
T ss_dssp             EECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHH
T ss_pred             EEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHH
Confidence            99999999866443221  12234567889999999999999999999999999999999 677776543322  22222


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ......      ......+      ..+..++.+||+.||++||++.|+++.|+++....
T Consensus       310 ~~~~~~------~~p~~~~------~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          310 LQGRRL------LQPEYCP------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             HTTCCC------CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HcCCCC------CCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            211100      0011111      12345788899999999999999999999986543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.4e-38  Score=359.56  Aligned_cols=206  Identities=30%  Similarity=0.407  Sum_probs=164.9

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCcee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIV  759 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv  759 (1035)
                      ..+.++|...+.||+|+||+||+|.+. +++.||||++.......            ...+++.+|+.+++++. ||||+
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~------------~~~~~~~~E~~~l~~l~~h~niv   72 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS------------TDAQRTFREIMILTELSGHENIV   72 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH------------HHHHHHHHHHHHHHHTTTCTTBC
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh------------HHHHHHHHHHHHHHhccCCCCCC
Confidence            356789999999999999999999765 58999999986432211            12467889999999997 99999


Q ss_pred             eEEeEEEcCC--cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          760 RFLGCCWNRN--TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       760 ~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++++++..++  ..|+||||++ |+|.++++..   .+++..+..++.||++||+|||+.   ||+||||||+|||++.+
T Consensus        73 ~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~  145 (388)
T 3oz6_A           73 NLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAE  145 (388)
T ss_dssp             CEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred             eeeeEEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCC
Confidence            9999998654  6799999996 6899998764   389999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCC-------------------ccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGD-------------------FARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVL  897 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~ell  897 (1035)
                      +.+||+|||+|+.+....                   ........+||+.|+|||++.+ ..++.++||||+||++|||+
T Consensus       146 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  225 (388)
T 3oz6_A          146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL  225 (388)
T ss_dssp             CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence            999999999998654311                   0112334689999999999876 67899999999999999999


Q ss_pred             hCCCCCCCC
Q 039419          898 TGKQPIDPT  906 (1035)
Q Consensus       898 tg~~P~~~~  906 (1035)
                      +|+.||...
T Consensus       226 ~g~~pf~~~  234 (388)
T 3oz6_A          226 CGKPIFPGS  234 (388)
T ss_dssp             HSSCSCCCS
T ss_pred             hCCCCCCCC
Confidence            999999754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-37  Score=343.10  Aligned_cols=260  Identities=26%  Similarity=0.387  Sum_probs=200.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ..|...+.||+|+||+||+|.+.+    ...||+|++......             ...+.+.+|+.++++++||||+++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~   91 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-------------GEVSQFLTEGIIMKDFSHPNVLSL   91 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSH-------------HHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCH-------------HHHHHHHHHHHHHHhCCCCCEeee
Confidence            468888999999999999997643    236899998653221             125679999999999999999999


Q ss_pred             EeEEE-cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          762 LGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       762 ~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ++++. .++..++||||+++|+|.++++... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~  167 (298)
T 3f66_A           92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTV  167 (298)
T ss_dssp             CEEECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred             eeEEEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCE
Confidence            99865 4567899999999999999997543 3488999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCcc--ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHH
Q 039419          841 YIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~  917 (1035)
                      ||+|||.++........  .......||+.|+|||...+..++.++||||+|+++|||++ |..||......  .....+
T Consensus       168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--~~~~~~  245 (298)
T 3f66_A          168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL  245 (298)
T ss_dssp             EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--THHHHH
T ss_pred             EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--HHHHHH
Confidence            99999999876543321  22334567889999999998899999999999999999999 55566543222  122221


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      .....      .......+   +   .+.+++.+||++||++||+++|+++.|+++...
T Consensus       246 ~~~~~------~~~~~~~~---~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          246 LQGRR------LLQPEYCP---D---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             HTTCC------CCCCTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hcCCC------CCCCccCC---H---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11110      00011111   1   244578889999999999999999999988653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.8e-38  Score=355.48  Aligned_cols=248  Identities=19%  Similarity=0.233  Sum_probs=192.3

Q ss_pred             cCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcC
Q 039419          690 EDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR  768 (1035)
Q Consensus       690 ~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  768 (1035)
                      ..+.||+|+||.||+|... +|+.||+|++......              ..+.+.+|+.++++++||||+++++++.+.
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  158 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--------------DKEEVKNEISVMNQLDHANLIQLYDAFESK  158 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHH--------------HHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc--------------cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            3568999999999999775 5899999998653221              246789999999999999999999999999


Q ss_pred             CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE--cCCCceEEeecc
Q 039419          769 NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI--GPEFEPYIADFG  846 (1035)
Q Consensus       769 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll--~~~~~~kl~DFG  846 (1035)
                      +..|+||||+++|+|.+++.... ..+++..+..++.||++||+|||+.   +|+||||||+||++  +.++.+||+|||
T Consensus       159 ~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG  234 (373)
T 2x4f_A          159 NDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFG  234 (373)
T ss_dssp             SEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCS
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCC
Confidence            99999999999999999886543 3489999999999999999999999   99999999999999  567889999999


Q ss_pred             CccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          847 LAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       847 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+.....  . 
T Consensus       235 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~--~-  306 (373)
T 2x4f_A          235 LARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNILACRW--D-  306 (373)
T ss_dssp             SCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCC--C-
T ss_pred             CceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccC--C-
Confidence            9987654332   23457999999999998888999999999999999999999999754221  11111111100  0 


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .........+      ..+.+++.+||++||++||++.|++++
T Consensus       307 ~~~~~~~~~~------~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          307 LEDEEFQDIS------EEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             SCSGGGTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CChhhhccCC------HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000001111      234567888999999999999999984

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-38  Score=359.91  Aligned_cols=257  Identities=20%  Similarity=0.197  Sum_probs=199.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+|+.+ +++.||||++........           ...+.+.+|+.++..++||||++++++
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~-----------~~~~~~~~E~~il~~~~hp~Iv~l~~~  129 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR-----------GEVSCFREERDVLVNGDRRWITQLHFA  129 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH-----------GGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhH-----------HHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            68999999999999999999876 589999999964322111           123458899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||++||+|.+++...+ ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||+|
T Consensus       130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          130 FQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            999999999999999999999998654 2489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc-------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      ||+++....... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||......  .....+
T Consensus       206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i  282 (412)
T 2vd5_A          206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--ETYGKI  282 (412)
T ss_dssp             CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH
T ss_pred             chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence            999987654332 1223568999999999876       356899999999999999999999999754221  111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDR---PTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~R---Ps~~el~~~  969 (1035)
                      ....  .....+......+      ....+++.+||. +|++|   |+++|++++
T Consensus       283 ~~~~--~~~~~p~~~~~~s------~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          283 VHYK--EHLSLPLVDEGVP------EEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HTHH--HHCCCC----CCC------HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             Hhcc--cCcCCCccccCCC------HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1000  0000000011111      233557788998 99998   689998775

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-37  Score=343.12  Aligned_cols=262  Identities=23%  Similarity=0.355  Sum_probs=203.7

Q ss_pred             hccccCC-eeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDS-VVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~-~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+ .||+|+||+||+|.+.   .++.||||++.......            ...+.+.+|+.++++++||||+++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~   83 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------------ALKDELLAEANVMQQLDNPYIVRM   83 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C------------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH------------HHHHHHHHHHHHHHhCCCCCEEEE
Confidence            5677777 9999999999999542   36889999996543211            235689999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++ ..+..|+||||+++++|.+++...+.  +++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+|
T Consensus        84 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~k  157 (291)
T 1xbb_A           84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAK  157 (291)
T ss_dssp             EEEE-ESSSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             EEEE-CCCCcEEEEEeCCCCCHHHHHHhCcC--CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEE
Confidence            9998 56778999999999999999987543  89999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      |+|||+++........ .......+++.|+|||+..+..++.++||||||+++|||++ |+.||.....  ......+..
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~  235 (291)
T 1xbb_A          158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEK  235 (291)
T ss_dssp             ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT
T ss_pred             EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHc
Confidence            9999999876543321 12223457789999999988889999999999999999999 9999975432  122222211


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE  979 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~~  979 (1035)
                      ..      ........+      ..+..++.+||+.||++||++.++++.|+++......
T Consensus       236 ~~------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          236 GE------RMGCPAGCP------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             TC------CCCCCTTCC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             CC------CCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            10      001111111      1234578889999999999999999999998665443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=357.85  Aligned_cols=273  Identities=16%  Similarity=0.197  Sum_probs=199.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+.||+|+||+||+|.+.    .+..||||++.........+.   ..........+.+|+..++.++||||+++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~---~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSEL---KFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHH---HHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHH---HHHHHHhhhHHHHHHHhhccccccCccee
Confidence            67999999999999999999876    578899999875432111000   00001123467889999999999999999


Q ss_pred             EeEEEc----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          762 LGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       762 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++++.+    ....|+||||+ +++|.+++...+  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            999987    67889999999 999999998765  489999999999999999999999   99999999999999988


Q ss_pred             C--ceEEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 039419          838 F--EPYIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG  910 (1035)
Q Consensus       838 ~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~  910 (1035)
                      +  .+||+|||+++.+......     .......||+.|+|||+..+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999876543211     11235679999999999998899999999999999999999999996432222


Q ss_pred             hhHHHHHHHhccc-hhhhccccc-CCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          911 LHIVDWVRQKRGA-IEVLDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       911 ~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ............. ......... ...+      ..+.+++.+||+.||++||+++++++.|+.+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          268 VAVQTAKTNLLDELPQSVLKWAPSGSSC------CEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHHTTTHHHHHHSCTTSCC------HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHHHhhcccccHHHHhhccccccH------HHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            2111111111000 000000000 0111      1344577789999999999999999998764

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.5e-38  Score=345.35  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=203.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+.+ ++.||+|++........           ...+.+.+|+.++++++||||+++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~~~~   82 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----------HQREKMSMEISIHRSLAHQHVVGFHG   82 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-----------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH-----------HHHHHHHHHHHHHHhCCCCCEeeeee
Confidence            4678999999999999999998764 78999999865332211           23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||+++++|.+++.....  +++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  157 (294)
T 2rku_A           83 FFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIG  157 (294)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred             eeccCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEE
Confidence            99999999999999999999999876543  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||.++......  .......||+.|+|||+..+..++.++||||||+++|||++|+.||......  .....+..  ..
T Consensus       158 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~--~~  231 (294)
T 2rku_A          158 DFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKK--NE  231 (294)
T ss_dssp             CCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT--TC
T ss_pred             eccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhh--cc
Confidence            999998764332  1223567999999999998888999999999999999999999999754211  11111110  00


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           .......+      .....++.+||+.||++||+++|++++
T Consensus       232 -----~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 -----YSIPKHIN------PVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -----CCCCTTSC------HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -----CCCccccC------HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 01111111      123457888999999999999999885

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.2e-37  Score=359.01  Aligned_cols=264  Identities=19%  Similarity=0.224  Sum_probs=205.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC-CceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH-KNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~  762 (1035)
                      .++|.+.+.||+|+||.||+|.+. +++.||||++.....                .+++.+|+++++.++| ++|+.+.
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------------~~~~~~E~~il~~L~~~~~i~~i~   69 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------HPQLLYESKIYRILQGGTGIPNVR   69 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----------------SCCHHHHHHHHHHTTTSTTCCCEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----------------cHHHHHHHHHHHHhcCCCCCCeEE
Confidence            367999999999999999999874 689999998754321                2347899999999986 6677777


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE---cCCCc
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFE  839 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~  839 (1035)
                      .++.+.+..++||||+ +++|.+++.... ..+++..++.++.||+.||+|||+.   +|+||||||+|||+   +.++.
T Consensus        70 ~~~~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~  144 (483)
T 3sv0_A           70 WFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQ  144 (483)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTC
T ss_pred             EEEeeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCe
Confidence            7777888899999999 999999997543 3489999999999999999999999   99999999999999   68899


Q ss_pred             eEEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch-hH
Q 039419          840 PYIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-HI  913 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~-~~  913 (1035)
                      +||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..
T Consensus       145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~  224 (483)
T 3sv0_A          145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK  224 (483)
T ss_dssp             EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH
T ss_pred             EEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH
Confidence            999999999877654321     122366899999999999999999999999999999999999999986543221 11


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ...+..... ...+ ..+....+      ..+..++..||+.||++||++.+|++.|+++....
T Consensus       225 ~~~i~~~~~-~~~~-~~l~~~~p------~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          225 YEKISEKKV-ATSI-EALCRGYP------TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHHHHH-HSCH-HHHHTTSC------HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHhhccc-cccH-HHHhcCCc------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            111111100 0000 01111111      13455788899999999999999999999986543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.5e-37  Score=338.68  Aligned_cols=258  Identities=21%  Similarity=0.296  Sum_probs=202.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||+|++..........        ....+.+.+|+.++++++||||+++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~~   75 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR--------GVSREEIEREVNILREIRHPNIITLHD   75 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--------SBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc--------chHHHHHHHHHHHHHhCCCCCeeehhh
Confidence            467999999999999999999876 58999999997654332210        123678999999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC----c
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF----E  839 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~----~  839 (1035)
                      ++.+.+..++||||+++++|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++    .
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           76 IFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred             eecCCCeEEEEEeecCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence            99999999999999999999999976544  89999999999999999999999   999999999999998877    8


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +||+|||.+.......   ......|++.|+|||+..+..++.++||||||+++|+|++|+.||.....  ......+..
T Consensus       151 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~  225 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--QETLTNISA  225 (283)
T ss_dssp             EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHT
T ss_pred             eEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--HHHHHHhHh
Confidence            9999999998764432   12345799999999999888999999999999999999999999975421  111111111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..   ...........+      ..+.+++.+||+.||++||++.|++++
T Consensus       226 ~~---~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          226 VN---YDFDEEYFSNTS------ELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             TC---CCCCHHHHTTCC------HHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             cc---cCCcchhcccCC------HHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            00   000000001111      124567888999999999999999984

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5e-38  Score=352.86  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=203.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+.+ ++.||+|++........           ...+.+.+|+.++++++||||+++++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~  108 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP-----------HQREKMSMEISIHRSLAHQHVVGFHG  108 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-----------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH-----------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4689999999999999999998764 78999999865332211           23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||+++++|.+++.....  +++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~  183 (335)
T 2owb_A          109 FFEDNDFVFVVLELCRRRSLLELHKRRKA--LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIG  183 (335)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEEC
T ss_pred             EEecCCeEEEEEecCCCCCHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEe
Confidence            99999999999999999999999877543  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+++......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......  .....+...   
T Consensus       184 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~---  256 (335)
T 2owb_A          184 DFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--ETYLRIKKN---  256 (335)
T ss_dssp             CCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT---
T ss_pred             eccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHhcC---
Confidence            999998764332  1223567999999999998888999999999999999999999999753211  111111110   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ........+      .....++.+||+.||++||+++|++++
T Consensus       257 ----~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 ----EYSIPKHIN------PVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ----CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----CCCCCccCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                001111111      123457888999999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.7e-38  Score=343.41  Aligned_cols=249  Identities=27%  Similarity=0.369  Sum_probs=202.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|.+. +++.||+|++........           ...+.+.+|+.++++++||||++++++
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~   82 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE-----------GVEHQLRREIEIQSHLRHPNILRMYNY   82 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchH-----------HHHHHHHHHHHHHhcCCCCCEeeEEEE
Confidence            67899999999999999999876 478899999864322111           235679999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++|+|.+++...+.  +++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~D  157 (284)
T 2vgo_A           83 FHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIAD  157 (284)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEcCCEEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEec
Confidence            9999999999999999999999987654  89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||.+.......    .....|++.|+|||+..+..++.++||||||+++|||++|+.||......  .....+..     
T Consensus       158 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~-----  226 (284)
T 2vgo_A          158 FGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--ETHRRIVN-----  226 (284)
T ss_dssp             CTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT-----
T ss_pred             ccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--HHHHHHhc-----
Confidence            99987653321    23567999999999999889999999999999999999999999754211  11111110     


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        .+.......+      ....+++.+||+.||++||++++++++
T Consensus       227 --~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          227 --VDLKFPPFLS------DGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             --TCCCCCTTSC------HHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             --cccCCCCcCC------HHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence              0111111111      123457888999999999999999885

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-37  Score=342.47  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=202.6

Q ss_pred             ccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      .|...+.||+|+||+||+|.+.+    +..||+|++......             ...+.+.+|+.++++++||||++++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~   88 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM-------------QQVEAFLREGLLMRGLNHPNVLALI   88 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH-------------HHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH-------------HHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            45667899999999999997542    237999998643221             1256789999999999999999999


Q ss_pred             eEEEcCCcc-eEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          763 GCCWNRNTR-LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       763 ~~~~~~~~~-~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      +++.+.+.. ++||||+.+|+|.+++.... ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+|
T Consensus        89 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~k  164 (298)
T 3pls_A           89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVK  164 (298)
T ss_dssp             EEECCSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred             EEEecCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence            999876655 99999999999999997643 3489999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCc--cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDF--ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      |+|||.++.......  ........+|+.|+|||...+..++.++||||||+++|||++|..|+..... .......+..
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~  243 (298)
T 3pls_A          165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQ  243 (298)
T ss_dssp             ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHT
T ss_pred             eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhc
Confidence            999999986644321  1223355789999999999999999999999999999999996665433221 1222222222


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ....      ......+      ..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       244 ~~~~------~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          244 GRRL------PQPEYCP------DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             TCCC------CCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCCC------CCCccch------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence            1100      0011111      12445788899999999999999999999986543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.6e-38  Score=342.54  Aligned_cols=253  Identities=21%  Similarity=0.375  Sum_probs=204.4

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ....+|...+.||+|+||.||+|.+. +++.||+|++....                  +.+.+|++++++++||||+++
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------~~~~~e~~~l~~l~h~~i~~~   69 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------------EKAEREVKALAKLDHVNIVHY   69 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------------GGGHHHHHHHHHCCCTTBCCE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------------HHHHHHHHHHHhCCCCCEEEE
Confidence            44578999999999999999999886 68999999985421                  246789999999999999999


Q ss_pred             EeEEEc----------------CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeecc
Q 039419          762 LGCCWN----------------RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHR  825 (1035)
Q Consensus       762 ~~~~~~----------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHr  825 (1035)
                      ++++..                ....|+||||+++|+|.+++.......+++..+..++.|++.||+|||+.   +|+||
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~  146 (284)
T 2a19_B           70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINR  146 (284)
T ss_dssp             EEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             eeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence            998864                34579999999999999999876555699999999999999999999999   99999


Q ss_pred             CCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCC
Q 039419          826 DIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP  905 (1035)
Q Consensus       826 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~  905 (1035)
                      ||||+||+++.++.+||+|||.++......   ......||+.|+|||+..+..++.++||||||+++|||++|..|+..
T Consensus       147 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             CCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             cCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence            999999999999999999999998765432   22345799999999999888999999999999999999999988742


Q ss_pred             CCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          906 TIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       906 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      .       ..+...      ..........+.      ....++.+||+.||++||++.|++++|+.+....+
T Consensus       224 ~-------~~~~~~------~~~~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          224 T-------SKFFTD------LRDGIISDIFDK------KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             H-------HHHHHH------HHTTCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             H-------HHHHHH------hhcccccccCCH------HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            1       111111      011111111221      23457788999999999999999999988864433

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.4e-38  Score=377.01  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=205.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||.||+|.+.++..||||++.....               ..+.|.+|+++|++++||||+++++++
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~~~~~~  331 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------------SPEAFLQEAQVMKKLRHEKLVQLYAVV  331 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---------------CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            56888899999999999999999888999999965321               246799999999999999999999998


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+ +..|+||||+++|+|.++++......+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+||
T Consensus       332 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             CS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCT
T ss_pred             ee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccc
Confidence            76 6789999999999999999865444589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.....  ......+...    
T Consensus       408 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~i~~~----  480 (535)
T 2h8h_A          408 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG----  480 (535)
T ss_dssp             TSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHHHHTT----
T ss_pred             ccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcC----
Confidence            99987643221 12234567889999999988899999999999999999999 9999975422  1122222111    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                            .+...+..+.  ..+.+++.+||+.||++||++++|++.|+++.
T Consensus       481 ------~~~~~~~~~~--~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          481 ------YRMPCPPECP--ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ------CCCCCCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ------CCCCCCCCCC--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                  1111111111  12345788899999999999999999987763

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-37  Score=339.95  Aligned_cols=266  Identities=18%  Similarity=0.234  Sum_probs=202.3

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.++|...+.||+|+||+||+|++ .+++.||||++.....                .+.+.+|+.++++++|++++..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~i~~~   70 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPTI   70 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------------------CCCHHHHHHHHHHHTTSTTCCCE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----------------chHHHHHHHHHHHhcCCCCCCee
Confidence            347899999999999999999986 4689999998654321                23478899999999988776666


Q ss_pred             eEE-EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE---cCCC
Q 039419          763 GCC-WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEF  838 (1035)
Q Consensus       763 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll---~~~~  838 (1035)
                      +.+ .+.+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.   +|+||||||+||++   +.++
T Consensus        71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~  145 (296)
T 4hgt_A           71 RWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGN  145 (296)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTT
T ss_pred             eeecCCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCC
Confidence            655 5667789999999 999999997543 2489999999999999999999999   99999999999999   7899


Q ss_pred             ceEEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc-hh
Q 039419          839 EPYIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG-LH  912 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~-~~  912 (1035)
                      .+||+|||+++........     .......||+.|+|||+..+..++.++|||||||++|||++|+.||....... ..
T Consensus       146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  225 (296)
T 4hgt_A          146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ  225 (296)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred             eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence            9999999999876554321     12335679999999999999999999999999999999999999998643321 11


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      ....+....  ............+      ..+..++.+||+.||++||+++++++.|+++.....
T Consensus       226 ~~~~~~~~~--~~~~~~~~~~~~~------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          226 KYERISEKK--MSTPIEVLCKGYP------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHHHHH--HHSCHHHHTTTSC------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhccc--ccchhhhhhccCC------HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            111111100  0000000111111      134457788999999999999999999999876554

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.7e-38  Score=342.78  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=198.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++|...+.||+|+||+||+|++. |+.||||++....                ..+.+.+|+.++++++||||++++++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----------------~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQLLGV   82 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh----------------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            468999999999999999999886 8899999986421                24678999999999999999999999


Q ss_pred             EEcC-CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          765 CWNR-NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       765 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      +.+. +..|+||||+++|+|.+++.......+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~  159 (278)
T 1byg_A           83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVS  159 (278)
T ss_dssp             ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred             EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEe
Confidence            7654 4789999999999999999876544478999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||.++......     ....+++.|+|||+..+..++.++||||||+++|||++ |+.||......  .....+...  
T Consensus       160 Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~--  230 (278)
T 1byg_A          160 DFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKG--  230 (278)
T ss_dssp             CCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTT--
T ss_pred             eccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcC--
Confidence            999987553321     23467889999999988899999999999999999998 99999754322  121111110  


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                          .........+      ..+..++.+||+.||++||++.|+++.|+++...
T Consensus       231 ----~~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 ----YKMDAPDGCP------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ----CCCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCcccCC------HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                0001111111      1234577889999999999999999999998643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.3e-38  Score=362.39  Aligned_cols=263  Identities=19%  Similarity=0.242  Sum_probs=193.5

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ..+.++|...+.||+|+||+||+|.+. +++.||||++...........      .......+.+|+.++++++||||++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~  204 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR------EADPALNVETEIEILKKLNHPCIIK  204 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------------CCHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccc------cchhHHHHHHHHHHHHhCCCCCEee
Confidence            556789999999999999999999765 589999999975432211100      0012335889999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC--
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF--  838 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~--  838 (1035)
                      +++++.. +..|+||||+++|+|.+++...+  .+++..+..++.|+++||+|||+.   +|+||||||+|||++.++  
T Consensus       205 l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~  278 (419)
T 3i6u_A          205 IKNFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED  278 (419)
T ss_dssp             CCEEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSS
T ss_pred             EEEEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCc
Confidence            9999754 45799999999999999987654  389999999999999999999999   999999999999997544  


Q ss_pred             -ceEEeeccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          839 -EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       839 -~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                       .+||+|||+++......   ......||+.|+|||++.   ...++.++|||||||++|||++|+.||....... ...
T Consensus       279 ~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~  354 (419)
T 3i6u_A          279 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLK  354 (419)
T ss_dssp             CCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC-CHH
T ss_pred             ceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH-HHH
Confidence             59999999998764432   233567999999999975   3567889999999999999999999997543221 222


Q ss_pred             HHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+......   ..+......      ...+.+++.+||+.||++||+++|++++
T Consensus       355 ~~i~~~~~~---~~~~~~~~~------~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          355 DQITSGKYN---FIPEVWAEV------SEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHHTTCCC---CCHHHHTTS------CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhcCCCC---CCchhhccc------CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            222111100   000000111      1234567888999999999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=345.92  Aligned_cols=268  Identities=21%  Similarity=0.244  Sum_probs=200.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC---CCceee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR---HKNIVR  760 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~  760 (1035)
                      .++|...+.||+|+||+||+|++. +++.||||++.........         ......+.+|+.++++++   ||||++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~h~niv~   78 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG---------GGLPISTVREVALLRRLEAFEHPNVVR   78 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTS---------SCCCHHHHHHHHHHHHHHHHCCTTBCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccc---------cccchhHHHHHHHHHHHhhcCCCCeEE
Confidence            478999999999999999999874 5899999998643221110         122356778888887775   999999


Q ss_pred             EEeEEEcCC-----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          761 FLGCCWNRN-----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       761 l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      +++++....     ..++||||+. |+|.+++.......+++..+..++.||+.||+|||+.   +|+||||||+||+++
T Consensus        79 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~  154 (308)
T 3g33_A           79 LMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVT  154 (308)
T ss_dssp             EEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEEC
T ss_pred             eeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc
Confidence            999998765     4789999996 6999999887666699999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                      .++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus       155 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~  230 (308)
T 3g33_A          155 SGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGK  230 (308)
T ss_dssp             TTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHH
T ss_pred             CCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence            99999999999998664332   234567999999999998899999999999999999999999999754321 11111


Q ss_pred             HHHHhccc-hhhhc-------ccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGA-IEVLD-------KSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~-~~~~~-------~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ........ .....       .......+....     ......+++.+||++||++|||+.|++++
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            11111000 00000       000000000000     01234567888999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=344.97  Aligned_cols=257  Identities=19%  Similarity=0.259  Sum_probs=198.8

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.++|.+.+.||+|+||.||+|.+. +++.||+|++........          ....+.+.+|+.++++++||||++++
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~   72 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI----------PNGEANVKKEIQLLRRLRHKNVIQLV   72 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS----------TTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc----------chhHHHHHHHHHHHHhcCCCCeeEEE
Confidence            4578999999999999999999875 588999999965322111          02356899999999999999999999


Q ss_pred             eEEEc--CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          763 GCCWN--RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       763 ~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++..  .+..|+||||++++ +.+++.......+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~  148 (305)
T 2wtk_C           73 DVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTL  148 (305)
T ss_dssp             EEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcE
Confidence            99853  45789999999876 87887766566699999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      ||+|||.+................||+.|+|||+..+..  ++.++||||||+++|||++|+.||.....  ......+.
T Consensus       149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~  226 (305)
T 2wtk_C          149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI--YKLFENIG  226 (305)
T ss_dssp             EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH
T ss_pred             EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH--HHHHHHHh
Confidence            999999998765433333334567999999999977544  47799999999999999999999975321  11111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..       ........+      ..+.+++.+||+.||++||+++|++++
T Consensus       227 ~~-------~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          227 KG-------SYAIPGDCG------PPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HC-------CCCCCSSSC------HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             cC-------CCCCCCccC------HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            10       001111111      123457788999999999999999885

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.8e-38  Score=351.37  Aligned_cols=250  Identities=28%  Similarity=0.380  Sum_probs=197.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .+.|...+.||+|+||+||+|+. .+++.||||++........           ...+.+.+|+.++++++||||+++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~~~  121 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-----------EKWQDIIKEVRFLQKLRHPNTIQYRG  121 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH-----------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch-----------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            35688899999999999999976 4689999999865432221           12467899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+||||+. |++.+++.... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+
T Consensus       122 ~~~~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~  196 (348)
T 1u5q_A          122 CYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLG  196 (348)
T ss_dssp             EEEETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EEEECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEe
Confidence            9999999999999996 68888886543 3489999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |||+++.....      ....||+.|+|||++.   ...++.++|||||||++|||++|+.||......  .....+...
T Consensus       197 DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~--~~~~~~~~~  268 (348)
T 1u5q_A          197 DFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN  268 (348)
T ss_dssp             CCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHS
T ss_pred             eccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHhc
Confidence            99999765332      3467999999999874   567899999999999999999999999653211  111111110


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .     .........+.      .+..++.+||+.||++|||+++++++
T Consensus       269 ~-----~~~~~~~~~~~------~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          269 E-----SPALQSGHWSE------YFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             C-----CCCCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C-----CCCCCCCCCCH------HHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0     00000111111      23457788999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-38  Score=355.94  Aligned_cols=259  Identities=21%  Similarity=0.257  Sum_probs=200.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCcee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIV  759 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  759 (1035)
                      .++|...+.||+|+||+||+|+.    .+++.||||++.........          ...+.+.+|+++++++ +||||+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~~h~~iv  122 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----------KTTEHTRTERQVLEHIRQSPFLV  122 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----------SSGGGCCCHHHHHHHHHTCTTBC
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh----------hHHHHHHHHHHHHHHccCCCcee
Confidence            36799999999999999999987    36899999999654321111          1234567899999999 699999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++++++.+.+..|+||||+++|+|.+++.....  +++..+..++.||++||+|||+.   +|+||||||+||+++.++.
T Consensus       123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  197 (355)
T 1vzo_A          123 TLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH  197 (355)
T ss_dssp             CEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             EEEEEEeeCceEEEEeecCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCc
Confidence            999999999999999999999999999987654  89999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +||+|||+++....... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ .....
T Consensus       198 ~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~  275 (355)
T 1vzo_A          198 VVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEIS  275 (355)
T ss_dssp             EEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHH
T ss_pred             EEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHH
Confidence            99999999986644322 22335679999999999875  3478899999999999999999999975432211 11111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAMI  970 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~L  970 (1035)
                      +....    .........+      ....+++.+||+.||++||     +++|++++.
T Consensus       276 ~~~~~----~~~~~~~~~~------~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          276 RRILK----SEPPYPQEMS------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHH----CCCCCCTTSC------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHhc----cCCCCCcccC------HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            11000    0011111111      1234578889999999999     999998864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1e-37  Score=340.40  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=193.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|.+. +++.||||++........           ...+.+.+|+.+++.++||||++++++
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL-----------DVVGKIKREIQNLKLFRHPHIIKLYQV   79 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccch-----------hHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            57889999999999999999876 689999999864322111           235688999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++++|.+++.....  +++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d  154 (276)
T 2h6d_A           80 ISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIAD  154 (276)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECC
T ss_pred             EecCCeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEee
Confidence            9999999999999999999999987654  89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.+........   .....||+.|+|||+..+..+ +.++||||||+++|+|++|+.||.....  ......+....  
T Consensus       155 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~--  227 (276)
T 2h6d_A          155 FGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--PTLFKKIRGGV--  227 (276)
T ss_dssp             CCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC--
T ss_pred             cccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcCc--
Confidence            999987644321   234578999999999887665 5899999999999999999999975321  11111111110  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           .......+      ..+..++.+||+.||++||++.|++++
T Consensus       228 -----~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 -----FYIPEYLN------RSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -----CCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -----ccCchhcC------HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 00111111      123457888999999999999999985

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.5e-37  Score=348.80  Aligned_cols=263  Identities=21%  Similarity=0.336  Sum_probs=204.4

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCcee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIV  759 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv  759 (1035)
                      ....++|...+.||+|+||.||+|.+. +|+.||||++..........      ......+.+.+|+++++++ +||||+
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~~hp~iv  163 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE------QLEEVREATRRETHILRQVAGHPHII  163 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHH------HHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHH------HHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            344578999999999999999999886 69999999986543211000      0012356788999999999 799999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++++++...+..|+||||++|++|.+++.....  +++..+..++.||+.||+|||+.   ||+||||||+||+++.++.
T Consensus       164 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             CEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred             EEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence            999999999999999999999999999986544  89999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCccccc------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI  913 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~  913 (1035)
                      +||+|||++.......   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....  ...
T Consensus       239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~  313 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILM  313 (365)
T ss_dssp             EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHH
T ss_pred             EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHH
Confidence            9999999998765432   2235689999999998753      3588899999999999999999999965321  111


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...+......  ...+. ....      ...+.+++.+||+.||++||++.|++++
T Consensus       314 ~~~i~~~~~~--~~~~~-~~~~------~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          314 LRMIMEGQYQ--FSSPE-WDDR------SSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHHHTCCC--CCHHH-HSSS------CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHhCCCC--CCCcc-cccC------CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111111000  00000 0011      1224557888999999999999999874

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-37  Score=347.53  Aligned_cols=255  Identities=21%  Similarity=0.258  Sum_probs=193.0

Q ss_pred             hcccc-CCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          686 KCLVE-DSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       686 ~~~~~-~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      +.|.+ .+.||+|+||+||+|.+. +++.||||++.....              ...+.+.+|++++.++ +||||++++
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~~~~h~~i~~~~   77 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--------------HIRSRVFREVEMLYQCQGHRNVLELI   77 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--------------CCHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--------------hhHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            45666 478999999999999765 689999999864321              2356789999999985 799999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc---
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE---  839 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~---  839 (1035)
                      +++.+++..|+||||+++|+|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++.   
T Consensus        78 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~  152 (316)
T 2ac3_A           78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRH--FNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSP  152 (316)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCS
T ss_pred             EEEeeCCEEEEEEEcCCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCc
Confidence            999999999999999999999999987654  89999999999999999999999   9999999999999998776   


Q ss_pred             eEEeeccCccccccCCc-----cccccccCCcccccCCccccc-----CCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 039419          840 PYIADFGLAKLVVEGDF-----ARSSNTVAGSYGYIAPEYGYM-----MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE  909 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~  909 (1035)
                      +||+|||+++.......     ........||+.|+|||+..+     ..++.++|||||||++|||++|+.||......
T Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  232 (316)
T 2ac3_A          153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS  232 (316)
T ss_dssp             EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence            99999999876543211     111224569999999998764     55889999999999999999999999765432


Q ss_pred             ch-------------hHHHHHHHhccchhhhcccccCCCccc-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          910 GL-------------HIVDWVRQKRGAIEVLDKSLRARPEVE-IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       910 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..             .....+...         . ...+... ......+.+++.+||+.||++||+++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~i~~~---------~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          233 DCGWDRGEACPACQNMLFESIQEG---------K-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             CSCC----CCHHHHHHHHHHHHHC---------C-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccccccchhHHHHHHHHHhcc---------C-cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            10             001111100         0 0000000 0011234568888999999999999999884

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.1e-37  Score=337.97  Aligned_cols=265  Identities=17%  Similarity=0.223  Sum_probs=204.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|++ .+++.||||++.....                .+.+.+|+.++++++|++++..+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~i~~~~   71 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPTIR   71 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----------------CCHHHHHHHHHHHHTTSTTCCCEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----------------hhHHHHHHHHHHHhhcCCCCCccc
Confidence            36789999999999999999987 5689999999854321                236889999999999887666555


Q ss_pred             EE-EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE---cCCCc
Q 039419          764 CC-WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFE  839 (1035)
Q Consensus       764 ~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~  839 (1035)
                      ++ .+.+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.   +|+||||||+||++   +.++.
T Consensus        72 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~  146 (296)
T 3uzp_A           72 WCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNL  146 (296)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTC
T ss_pred             cccCCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCe
Confidence            55 5667789999999 999999997543 3489999999999999999999999   99999999999999   48899


Q ss_pred             eEEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCC-chhH
Q 039419          840 PYIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE-GLHI  913 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~-~~~~  913 (1035)
                      +||+|||.++........     .......||+.|+|||+..+..++.++|||||||++|||++|+.||...... ....
T Consensus       147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  226 (296)
T 3uzp_A          147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK  226 (296)
T ss_dssp             EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred             EEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh
Confidence            999999999876554321     1224567999999999999989999999999999999999999999864322 1122


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      ...+.....  ...........+      ..+..++.+||+.||++||+++++++.|+++.....
T Consensus       227 ~~~~~~~~~--~~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          227 YERISEKKM--STPIEVLCKGYP------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHHHHH--HSCHHHHTTTSC------HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hhhhccccc--CCchHHHHhhCC------HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            221111100  000001111112      123457788999999999999999999999876554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.9e-38  Score=343.03  Aligned_cols=250  Identities=18%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-C-------cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-G-------EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN  757 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  757 (1035)
                      ++|...+.||+|+||+||+|.+.. +       ..||+|++.....              ...+.+.+|+.++++++|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~   73 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--------------NYSESFFEAASMMSKLSHKH   73 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--------------GGHHHHHHHHHHHHTSCCTT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--------------HHHHHHHHHHHHHHhCCCCC
Confidence            578889999999999999996653 3       5799999854221              23568999999999999999


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      |+++++++.+++..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++   +|+||||||+||+++.+
T Consensus        74 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  149 (289)
T 4fvq_A           74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIRE  149 (289)
T ss_dssp             BCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEEC
T ss_pred             EeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecC
Confidence            9999999999999999999999999999997654 3389999999999999999999999   99999999999999988


Q ss_pred             Cc--------eEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          838 FE--------PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       838 ~~--------~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      +.        +||+|||.+......      ....||+.|+|||+..+ ..++.++||||||+++|||++|..|+.....
T Consensus       150 ~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~  223 (289)
T 4fvq_A          150 EDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD  223 (289)
T ss_dssp             CBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             CcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence            87        999999998754322      23457889999999877 6789999999999999999996555433221


Q ss_pred             CchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          909 EGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      .. ........        ........+..      +.+++.+||+.||++|||+.+++++|+++.
T Consensus       224 ~~-~~~~~~~~--------~~~~~~~~~~~------l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          224 SQ-RKLQFYED--------RHQLPAPKAAE------LANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             HH-HHHHHHHT--------TCCCCCCSSCT------THHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             hH-HHHHHhhc--------cCCCCCCCCHH------HHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            11 11111110        01111111222      345677899999999999999999998764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.7e-38  Score=350.78  Aligned_cols=275  Identities=27%  Similarity=0.508  Sum_probs=169.2

Q ss_pred             CCCcccCCCCCCCCCCcc--ceeEEeCCC---CcEEEEEecCCcccc--cCCcCCCCCcccceEeecC-cccCCCCCCCC
Q 039419            3 SIPSALSNWNPSDSNPCK--WSHITCSPQ---NFVTEINIQSIELEL--PFPSNLSSLSFLQKLIISG-SNLTGPISPDL   74 (1035)
Q Consensus         3 ~~~~~l~~w~~~~~~~c~--w~gi~c~~~---~~v~~l~~~~~~~~~--~~~~~~~~l~~L~~L~L~~-~~l~~~~~~~~   74 (1035)
                      .+|..+++|..+ .+||.  |.||+|+..   +.|+.|+++++++.+  .+|..+..+++|++|+|++ |.+++.+|..+
T Consensus        19 ~~~~~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l   97 (313)
T 1ogq_A           19 GNPTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI   97 (313)
T ss_dssp             TCCGGGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGG
T ss_pred             CCcccccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhH
Confidence            467789999875 47998  999999864   567777777777766  6666666666666666664 66666666666


Q ss_pred             CCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhcccc-ccc
Q 039419           75 GDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLV-NLE  153 (1035)
Q Consensus        75 ~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~-~L~  153 (1035)
                      +.+++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..+..+++|++|+|++|.+++.+|..++.++ +|+
T Consensus        98 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~  177 (313)
T 1ogq_A           98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT  177 (313)
T ss_dssp             GGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCC
T ss_pred             hcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCc
Confidence            6666666666666666656666666666666666666666655666666666666666666655544444444443 333


Q ss_pred             eeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCC
Q 039419          154 VIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEN  233 (1035)
Q Consensus       154 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n  233 (1035)
                      +|++++|                         .+.+..|..++.++ |++|++++|.+++..|..+..+++|+.|+|++|
T Consensus       178 ~L~L~~N-------------------------~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  231 (313)
T 1ogq_A          178 SMTISRN-------------------------RLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN  231 (313)
T ss_dssp             EEECCSS-------------------------EEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSS
T ss_pred             EEECcCC-------------------------eeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCC
Confidence            3333333                         33344444444444 555555555554444444444444444444444


Q ss_pred             cCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCC
Q 039419          234 DLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPP  313 (1035)
Q Consensus       234 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  313 (1035)
                      .                        +++.+|. +..+++|++|+|++|+|++..|..|..+++|++|+|++|++++.+|.
T Consensus       232 ~------------------------l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~  286 (313)
T 1ogq_A          232 S------------------------LAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ  286 (313)
T ss_dssp             E------------------------ECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred             c------------------------eeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence            4                        4433333 45566666677777766666666666667777777777777666665


Q ss_pred             cccCCCccceeccccch
Q 039419          314 VLSNATSLLQLQLDTNQ  330 (1035)
Q Consensus       314 ~~~~l~~L~~L~L~~N~  330 (1035)
                      . ..+++|+.|++++|+
T Consensus       287 ~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          287 G-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             S-TTGGGSCGGGTCSSS
T ss_pred             C-ccccccChHHhcCCC
Confidence            4 666677777777665

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=373.94  Aligned_cols=253  Identities=23%  Similarity=0.327  Sum_probs=197.0

Q ss_pred             eeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCC
Q 039419          693 VVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      .||+|+||.||+|.+.   ++..||||+++.....             ...+.|.+|+.++++++|||||++++++.+ +
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------------~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~  408 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------------ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E  408 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-------------TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-------------HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence            7999999999999764   4677999999654211             135789999999999999999999999976 5


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             CeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            6899999999999999997543 3489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhhh
Q 039419          850 LVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVL  927 (1035)
Q Consensus       850 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~  927 (1035)
                      ....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.....  ......+....      
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~------  556 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGK------  556 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHTTC------
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC------
Confidence            7644322 112223446789999999998899999999999999999998 9999976432  22233322211      


Q ss_pred             cccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       928 ~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                          +...+..+  ...+..++.+||+.||++||++.++++.|+++....
T Consensus       557 ----~~~~p~~~--~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          557 ----RMECPPEC--PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             ----CCCCCTTC--CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCcC--CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                11111111  123345788899999999999999999999876543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.1e-37  Score=346.85  Aligned_cols=260  Identities=25%  Similarity=0.418  Sum_probs=202.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcE--EEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEV--IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  761 (1035)
                      ++|...+.||+|+||.||+|++. ++..  +|+|.+.......             ..+.+.+|+.+++++ +||||+++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~hp~iv~~   91 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-------------DHRDFAGELEVLCKLGHHPNIINL   91 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH-------------HHHHHHHHHHHHHhccCCCchhhh
Confidence            67889999999999999999765 4554  4999886432211             245789999999999 89999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCC
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI  827 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDi  827 (1035)
                      ++++.+.+..|+||||+++|+|.+++...+              ...+++..++.++.||++||+|||+.   ||+||||
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dl  168 (327)
T 1fvr_A           92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDL  168 (327)
T ss_dssp             EEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             ceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCC
Confidence            999999999999999999999999997653              23589999999999999999999999   9999999


Q ss_pred             CcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 039419          828 KANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPT  906 (1035)
Q Consensus       828 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~  906 (1035)
                      ||+||+++.++.+||+|||+++.....   .......+++.|+|||+..+..++.++||||||+++|||++ |+.||...
T Consensus       169 kp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  245 (327)
T 1fvr_A          169 AARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  245 (327)
T ss_dssp             SGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999999998743221   12234467889999999988889999999999999999998 99999754


Q ss_pred             CCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      ..     ........       .......+....  ..+.+++.+||+.||++||+++|+++.|+.+.....
T Consensus       246 ~~-----~~~~~~~~-------~~~~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          246 TC-----AELYEKLP-------QGYRLEKPLNCD--DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             CH-----HHHHHHGG-------GTCCCCCCTTBC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             cH-----HHHHHHhh-------cCCCCCCCCCCC--HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            21     11111111       000001111111  224457888999999999999999999999876544

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.8e-38  Score=352.36  Aligned_cols=273  Identities=23%  Similarity=0.333  Sum_probs=196.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHH--hcCCCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL--GSIRHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l--~~l~hpniv~l~  762 (1035)
                      .++|...+.||+|+||.||+|++ +++.||||++....                 .+.+..|.+++  ..++||||++++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----------------~~~~~~e~~~~~~~~~~h~~i~~~~   73 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----------------RQNFINEKNIYRVPLMEHDNIARFI   73 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----------------HHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----------------hhhHHHHHHHHHHHhccCcchhhhe
Confidence            36788999999999999999977 48999999985321                 23445555554  458999999999


Q ss_pred             eEEEc-----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC------CCCeeccCCCccc
Q 039419          763 GCCWN-----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC------VPPIVHRDIKANN  831 (1035)
Q Consensus       763 ~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~ivHrDikp~N  831 (1035)
                      +.+..     ....|+||||+++|+|.+++....   .++..+..++.||++||+|||+..      .++|+||||||+|
T Consensus        74 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~N  150 (336)
T 3g2f_A           74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRN  150 (336)
T ss_dssp             EEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGG
T ss_pred             ecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccce
Confidence            86643     225689999999999999997654   588999999999999999999862      2289999999999


Q ss_pred             EEEcCCCceEEeeccCccccccCCc------cccccccCCcccccCCccccc-------CCCCccccchhHHHHHHHHHh
Q 039419          832 ILIGPEFEPYIADFGLAKLVVEGDF------ARSSNTVAGSYGYIAPEYGYM-------MKITEKSDVYSYGVVVLEVLT  898 (1035)
Q Consensus       832 Ill~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvvl~ellt  898 (1035)
                      ||++.++.+||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++
T Consensus       151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~  230 (336)
T 3g2f_A          151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM  230 (336)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence            9999999999999999987654321      112234579999999999876       456678999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHH--hccc---------hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039419          899 GKQPIDPTIPEGLHIVDWVRQ--KRGA---------IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA  967 (1035)
Q Consensus       899 g~~P~~~~~~~~~~~~~~~~~--~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~  967 (1035)
                      |..||............+...  ....         .....+.+.............+.+++.+||+.||++|||++|++
T Consensus       231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l  310 (336)
T 3g2f_A          231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE  310 (336)
T ss_dssp             TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence            988765332111000000000  0000         00001111111111112333456788999999999999999999


Q ss_pred             HHHHHHHHhHH
Q 039419          968 AMIKEIKQERE  978 (1035)
Q Consensus       968 ~~L~~~~~~~~  978 (1035)
                      +.|+++....+
T Consensus       311 ~~L~~ll~~~~  321 (336)
T 3g2f_A          311 ERMAELMMIWE  321 (336)
T ss_dssp             HHHHHHHHCCC
T ss_pred             HHHHHHHHHHH
Confidence            99999875544

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.5e-38  Score=350.72  Aligned_cols=262  Identities=18%  Similarity=0.273  Sum_probs=191.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+|++. +++.||||++........             ...+.+|+.++++++||||++++++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------------~~~~~~E~~~l~~l~h~~iv~~~~~   68 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-------------PCTAIREVSLLKDLKHANIVTLHDI   68 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------------CCCCCCCHHHHSCCCCTTBCCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc-------------chhHHHHHHHHHhcCCCCCCeeeeE
Confidence            57889999999999999999876 689999999965432211             1234579999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..++||||++ |+|.+++...+ ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus        69 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  143 (324)
T 3mtl_A           69 IHTEKSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLAD  143 (324)
T ss_dssp             EECSSCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECS
T ss_pred             EeeCCEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEcc
Confidence            999999999999996 59999887654 3489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++......  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......  .....+....+.
T Consensus       144 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~  219 (324)
T 3mtl_A          144 FGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGT  219 (324)
T ss_dssp             SSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCC
T ss_pred             CcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCC
Confidence            99998654322  22234578999999998776 56899999999999999999999999754321  111111111000


Q ss_pred             --hhhhcccc----------cCCCcccH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 --IEVLDKSL----------RARPEVEI-----EEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 --~~~~~~~~----------~~~~~~~~-----~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        ........          ........     .......+++.+||+.||++|||++|++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence              00000000          00000000     001234568889999999999999999884

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5e-37  Score=362.75  Aligned_cols=255  Identities=22%  Similarity=0.260  Sum_probs=202.2

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.++|.+.+.||+|+||+||+|.+. +++.||||++.......            ...+.+.+|+.++++++||||+++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~   86 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN------------KDTSTILREVELLKKLDHPNIMKL   86 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC------------SCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc------------hHHHHHHHHHHHHHhCCCCCcCeE
Confidence            56788999999999999999999876 68999999985432111            125678999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc---CCC
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG---PEF  838 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~---~~~  838 (1035)
                      ++++.+.+..|+||||+.+|+|.+++...+.  +++..+..++.||+.||+|||+.   ||+||||||+||+++   .++
T Consensus        87 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  161 (486)
T 3mwu_A           87 FEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC  161 (486)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTC
T ss_pred             EEEEEcCCEEEEEEEcCCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence            9999999999999999999999999877654  89999999999999999999999   999999999999995   456


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .+||+|||+++......   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....  ......+.
T Consensus       162 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~  235 (486)
T 3mwu_A          162 DIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVE  235 (486)
T ss_dssp             CEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred             CEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Confidence            79999999998764432   2235679999999999875 589999999999999999999999975422  12222221


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....         ....+........+.+++.+||++||++|||+.|++++
T Consensus       236 ~~~~---------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          236 TGKY---------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HTCC---------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             hCCC---------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1110         00000000111234567888999999999999999985

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.4e-36  Score=357.23  Aligned_cols=346  Identities=27%  Similarity=0.419  Sum_probs=197.5

Q ss_pred             CCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccce
Q 039419           52 SLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNL  131 (1035)
Q Consensus        52 ~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  131 (1035)
                      .+++|+.|+++++.++ .+| .+..+++|++|+|++|.+++ +|. ++.+++|++|+|++|++++ ++. +..+++|++|
T Consensus        44 ~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L  117 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITP-LANLTNLTGL  117 (466)
T ss_dssp             HHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GTTCTTCCEE
T ss_pred             HhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCC-chh-hhccccCCEEECCCCcccc-Chh-hcCCCCCCEE
Confidence            4667778888887777 354 37777888888888888773 343 7778888888888888774 333 7777888888


Q ss_pred             eccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeeccccc
Q 039419          132 LLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTML  211 (1035)
Q Consensus       132 ~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l  211 (1035)
                      ++++|.+++ ++. +.++++|++|++++|. +. .++ .++.+++|+.|+++ +.+.+..  .++++++|++|++++|.+
T Consensus       118 ~L~~n~l~~-~~~-~~~l~~L~~L~l~~n~-l~-~~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l  189 (466)
T 1o6v_A          118 TLFNNQITD-IDP-LKNLTNLNRLELSSNT-IS-DIS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKV  189 (466)
T ss_dssp             ECCSSCCCC-CGG-GTTCTTCSEEEEEEEE-EC-CCG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             ECCCCCCCC-ChH-HcCCCCCCEEECCCCc-cC-CCh-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcC
Confidence            888887763 333 6777777777777765 11 222 35555566666554 2333221  255666666666666665


Q ss_pred             ccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccc
Q 039419          212 SGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSF  291 (1035)
Q Consensus       212 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~  291 (1035)
                      .+ + ..+..+++|+.|++++|.+++..|  ++.+++|++|++++|++.+.  ..+..+++|+.|++++|.+++..+  +
T Consensus       190 ~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~  261 (466)
T 1o6v_A          190 SD-I-SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--L  261 (466)
T ss_dssp             CC-C-GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred             CC-C-hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--h
Confidence            52 2 235556666666666666654333  45555556666665555532  235555566666666666554332  5


Q ss_pred             cCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCC
Q 039419          292 GNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHP  371 (1035)
Q Consensus       292 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~  371 (1035)
                      ..+++|++|++++|++.+..+  +..+++|+.|++++|+++.+           + .+..+++|+.|+|++|++++..+ 
T Consensus       262 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-----------~-~~~~l~~L~~L~L~~n~l~~~~~-  326 (466)
T 1o6v_A          262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI-----------S-PISNLKNLTYLTLYFNNISDISP-  326 (466)
T ss_dssp             TTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC-----------G-GGGGCTTCSEEECCSSCCSCCGG-
T ss_pred             hcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCc-----------h-hhcCCCCCCEEECcCCcCCCchh-
Confidence            555566666666665554332  55555555555555554421           1 14455555555555555554333 


Q ss_pred             CcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCcc
Q 039419          372 GLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQF  451 (1035)
Q Consensus       372 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  451 (1035)
                       +..+++|++|++++|++++.  .              .+.++++|++|++++|++++..|  +..+++|+.|++++|++
T Consensus       327 -~~~l~~L~~L~l~~n~l~~~--~--------------~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~  387 (466)
T 1o6v_A          327 -VSSLTKLQRLFFYNNKVSDV--S--------------SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW  387 (466)
T ss_dssp             -GGGCTTCCEEECCSSCCCCC--G--------------GGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEE
T ss_pred             -hccCccCCEeECCCCccCCc--h--------------hhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcc
Confidence             44555555555555555432  0              12334445555555555554443  45555555555555555


Q ss_pred             CC
Q 039419          452 VG  453 (1035)
Q Consensus       452 ~~  453 (1035)
                      ++
T Consensus       388 ~~  389 (466)
T 1o6v_A          388 TN  389 (466)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-37  Score=363.83  Aligned_cols=196  Identities=23%  Similarity=0.301  Sum_probs=154.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||+||+|.+. +++.||||++.......            ...+++.+|+.++++++|||||+++++
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~~  120 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDL------------IDCKRILREIAILNRLNHDHVVKVLDI  120 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCH------------HHHHHHHHHHHHHHhCCCCCCCceEEE
Confidence            67999999999999999999766 58999999986432211            125678999999999999999999999


Q ss_pred             EEcC-----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          765 CWNR-----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       765 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      +...     ...|+||||+ +|+|.++++...  .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.
T Consensus       121 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~  194 (458)
T 3rp9_A          121 VIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCS  194 (458)
T ss_dssp             CCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCC
T ss_pred             EecCCcccCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCC
Confidence            9543     4689999998 679999987654  489999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCcc-------------------------ccccccCCcccccCCccc-ccCCCCccccchhHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFA-------------------------RSSNTVAGSYGYIAPEYG-YMMKITEKSDVYSYGVVV  893 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvvl  893 (1035)
                      +||+|||+|+........                         ......+||+.|+|||++ .+..++.++|||||||++
T Consensus       195 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il  274 (458)
T 3rp9_A          195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF  274 (458)
T ss_dssp             EEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred             EeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHH
Confidence            999999999876432110                         123456789999999975 566799999999999999


Q ss_pred             HHHHhC
Q 039419          894 LEVLTG  899 (1035)
Q Consensus       894 ~elltg  899 (1035)
                      |||++|
T Consensus       275 ~elltg  280 (458)
T 3rp9_A          275 AELLNM  280 (458)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            999993

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7e-37  Score=362.04  Aligned_cols=256  Identities=22%  Similarity=0.278  Sum_probs=199.3

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ..+.+.|...+.||+|+||+||+|++. +++.||+|++........            ..+.+.+|+.++++++||||++
T Consensus        33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~hpniv~  100 (494)
T 3lij_A           33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS------------SNSKLLEEVAVLKLLDHPNIMK  100 (494)
T ss_dssp             CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C------------TTHHHHHHHHHHTTCCCTTBCC
T ss_pred             CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch------------HHHHHHHHHHHHHhCCCCCCCe
Confidence            345678999999999999999999876 588999999965432221            2467899999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC---C
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP---E  837 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~---~  837 (1035)
                      +++++.+.+..|+||||+++|+|.+++.....  +++..+..++.||+.||+|||+.   ||+||||||+||+++.   +
T Consensus       101 ~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  175 (494)
T 3lij_A          101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKD  175 (494)
T ss_dssp             EEEEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTT
T ss_pred             EEEEEEeCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCC
Confidence            99999999999999999999999999877654  89999999999999999999999   9999999999999976   4


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||+++......   ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.....  ......+
T Consensus       176 ~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i  249 (494)
T 3lij_A          176 ALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKV  249 (494)
T ss_dssp             CCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred             CcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence            559999999998765432   233567999999999876 5699999999999999999999999975422  1222222


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ......   .........+      ..+.+++.+||++||++|||+.|++++
T Consensus       250 ~~~~~~---~~~~~~~~~s------~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          250 EKGKYT---FDSPEWKNVS------EGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHTCCC---CCSGGGTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HhCCCC---CCchhcccCC------HHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            111100   0000011111      223457888999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.6e-37  Score=339.62  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.++|...+.||+|+||+||+|++. +|+.||+|++......              ..+.+.+|+.++++++||||+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~   71 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--------------RDSSLENEIAVLKKIKHENIVTL   71 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------------HHHHHHHHHHHCCCTTBCCE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--------------chHHHHHHHHHHHhCCCCCeeeh
Confidence            35678999999999999999999876 6899999999643211              13468899999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE---cCCC
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEF  838 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll---~~~~  838 (1035)
                      ++++.+.+..|+||||+++++|.+++...+.  +++..+..++.|++.||+|||+.   +|+||||||+||++   +.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~  146 (304)
T 2jam_A           72 EDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENS  146 (304)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTC
T ss_pred             hhhcccCCEEEEEEEcCCCccHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCC
Confidence            9999999999999999999999999977654  89999999999999999999999   99999999999999   7889


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .+||+|||.++.....    ......||+.|+|||+..+..++.++||||+|+++|||++|+.||.....  ......+.
T Consensus       147 ~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~  220 (304)
T 2jam_A          147 KIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIK  220 (304)
T ss_dssp             CEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHH
T ss_pred             CEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH
Confidence            9999999998754332    12245689999999999988999999999999999999999999975421  11111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....   ..........+      ....+++.+||++||++||+++|++++
T Consensus       221 ~~~~---~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          221 EGYY---EFESPFWDDIS------ESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             HCCC---CCCTTTTTTSC------HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCC---CCCccccccCC------HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1100   00000111111      234457888999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.8e-37  Score=336.49  Aligned_cols=250  Identities=26%  Similarity=0.379  Sum_probs=195.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||+||+|.+. ++..||+|++.......            ...+.+.+|+.++++++||||++++++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~   93 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK------------SERQRFKEEAEMLKGLQHPNIVRFYDS   93 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH------------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH------------HHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            45777889999999999999775 57899999986533221            135679999999999999999999999


Q ss_pred             EEc----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeccCCCcccEEEc-CC
Q 039419          765 CWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPP--IVHRDIKANNILIG-PE  837 (1035)
Q Consensus       765 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivHrDikp~NIll~-~~  837 (1035)
                      +..    ....++||||+++|+|.+++.....  +++..+..++.|++.||+|||+.   +  |+||||||+||+++ .+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~  168 (290)
T 1t4h_A           94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPT  168 (290)
T ss_dssp             EEEESSSCEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTT
T ss_pred             eccccCCCceEEEEEEecCCCCHHHHHHHccC--CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCC
Confidence            875    3457999999999999999987644  89999999999999999999998   7  99999999999997 78


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||++.......    .....||+.|+|||+.. ..++.++||||+|+++|+|++|+.||.......    ...
T Consensus       169 ~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~  239 (290)
T 1t4h_A          169 GSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIY  239 (290)
T ss_dssp             SCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHH
T ss_pred             CCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH----HHH
Confidence            999999999997543322    23457999999999876 468999999999999999999999997543211    111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ......  ..........+      ..+.+++.+||+.||++||+++|++++
T Consensus       240 ~~~~~~--~~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          240 RRVTSG--VKPASFDKVAI------PEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HHHTTT--CCCGGGGGCCC------HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhcc--CCccccCCCCC------HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            111100  00011111111      124567888999999999999999874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-37  Score=346.26  Aligned_cols=266  Identities=18%  Similarity=0.218  Sum_probs=192.6

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ...++|...+.||+|+||+||+|.+. +++.||||++.......            ...+.+.+|+.++++++||||+++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~   98 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE------------GVPGTAIREVSLLKELQHRNIIEL   98 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------------CHHHHHHGGGCCCTTBCCE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc------------ccchhHHHHHHHHHHcCCCCcceE
Confidence            34578999999999999999999765 68999999996543222            124567899999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc-----C
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG-----P  836 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~-----~  836 (1035)
                      ++++.+++..|+||||++ |+|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+||+++     .
T Consensus        99 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~  172 (329)
T 3gbz_A           99 KSVIHHNHRLHLIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASE  172 (329)
T ss_dssp             EEEEEETTEEEEEEECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----
T ss_pred             EEEEecCCEEEEEEecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCc
Confidence            999999999999999997 599999987654  89999999999999999999999   999999999999994     4


Q ss_pred             CCceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                      .+.+||+|||+++......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~  249 (329)
T 3gbz_A          173 TPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFK  249 (329)
T ss_dssp             CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred             cceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHH
Confidence            5569999999998764332  222345789999999998764 4899999999999999999999999754221 11111


Q ss_pred             HHHHhccch-hhh---------cccccCCCcccHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGAI-EVL---------DKSLRARPEVEIE------EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~~-~~~---------~~~~~~~~~~~~~------~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ......... ...         .............      ......+++.+||++||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            111110000 000         0000000000011      11234568889999999999999999874

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.2e-37  Score=340.44  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=203.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .+.|...+.||+|+||.||+|.+. +++.||||++......             ...+.+.+|+.++++++||||+++++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~   87 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-------------DEIEDIQQEITVLSQCDSPYVTKYYG   87 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-------------TTHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-------------HHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            356888999999999999999765 5899999998654322             12568999999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||+++++|.+++...   .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  161 (303)
T 3a7i_A           88 SYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLA  161 (303)
T ss_dssp             EEEETTEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEecCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEe
Confidence            999999999999999999999998653   389999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||.+........  ......||+.|+|||+..+..++.++||||||+++|||++|+.||......  .....+....  
T Consensus       162 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~--  235 (303)
T 3a7i_A          162 DFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKNN--  235 (303)
T ss_dssp             CCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSC--
T ss_pred             ecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcCC--
Confidence            9999987654332  223567999999999999889999999999999999999999999754221  1111111110  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                          ........+.      .+..++.+||++||++||++.+++++.
T Consensus       236 ----~~~~~~~~~~------~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          236 ----PPTLEGNYSK------PLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             ----CCCCCSSCCH------HHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ----CCCCccccCH------HHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence                0111111221      234577889999999999999998854

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-37  Score=364.51  Aligned_cols=255  Identities=24%  Similarity=0.293  Sum_probs=204.4

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ..++|...+.||+|+||+||+|.+. +++.||||++........           ...+.+.+|+.++++++||||++++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~~   92 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQK-----------TDKESLLREVQLLKQLDHPNIMKLY   92 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBS-----------SCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-----------hHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4578999999999999999999876 689999999965433221           2357899999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE---cCCCc
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI---GPEFE  839 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll---~~~~~  839 (1035)
                      +++.+.+..|+||||+.+|+|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+||++   +.++.
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  167 (484)
T 3nyv_A           93 EFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDAN  167 (484)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHTCSC--CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCC
T ss_pred             EEEEeCCEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCc
Confidence            999999999999999999999999976544  89999999999999999999999   99999999999999   56789


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +||+|||+++.+....   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....  ......+..
T Consensus       168 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~  241 (484)
T 3nyv_A          168 IRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEK  241 (484)
T ss_dssp             EEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred             EEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHc
Confidence            9999999998765432   2234579999999999765 689999999999999999999999975422  222222222


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....         ...+........+.+++.+||++||++|||+.|++++
T Consensus       242 ~~~~---------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          242 GKYT---------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CCCC---------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCC---------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            1100         0000000111233467888999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.7e-37  Score=373.88  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=195.9

Q ss_pred             CeeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcC
Q 039419          692 SVVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR  768 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  768 (1035)
                      +.||+|+||+||+|.+.   .++.||||+++......            ...+++.+|+.++++++|||||++++++.+ 
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~------------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  441 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------------ALKDELLAEANVMQQLDNPYIVRMIGICEA-  441 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG------------GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH------------HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            47999999999999553   46889999996532211            235789999999999999999999999864 


Q ss_pred             CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCc
Q 039419          769 NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA  848 (1035)
Q Consensus       769 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a  848 (1035)
                      +..++||||+++|+|.++++..+.  +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus       442 ~~~~lv~E~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla  516 (635)
T 4fl3_A          442 ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS  516 (635)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred             CCEEEEEEccCCCCHHHHHhhCCC--CCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence            567899999999999999976543  89999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          849 KLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       849 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      +....... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.....  ......+....     
T Consensus       517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~-----  589 (635)
T 4fl3_A          517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGE-----  589 (635)
T ss_dssp             HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC-----
T ss_pred             cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC-----
Confidence            87654332 122334557889999999999999999999999999999998 9999975422  12222222111     


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                       ........+      ..+.+++..||+.||++||+++++++.|+++..
T Consensus       590 -~~~~p~~~~------~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          590 -RMGCPAGCP------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             -CCCCCTTCC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             000111111      233457888999999999999999999988754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-37  Score=350.35  Aligned_cols=260  Identities=23%  Similarity=0.300  Sum_probs=192.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +|+.||||++.......            ...+++.+|+.++++++||||+++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~l~~   91 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE------------LFAKRAYRELRLLKHMRHENVIGLLD   91 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH------------HHHHHHHHHHHHHHHCCBTTBCCCSE
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCH------------HHHHHHHHHHHHHHhCCCcCCCCcee
Confidence            467999999999999999999775 58999999986532211            23567899999999999999999999


Q ss_pred             EEEcCC------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          764 CCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       764 ~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++...+      ..|+||||+ +++|.++++..   .+++..+..++.||++||+|||+.   ||+||||||+||+++.+
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~  164 (367)
T 1cm8_A           92 VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNED  164 (367)
T ss_dssp             EECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred             eEecCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCC
Confidence            997653      459999999 88999998763   389999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      +.+||+|||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+...
T Consensus       165 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i  238 (367)
T 1cm8_A          165 CELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEI  238 (367)
T ss_dssp             CCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred             CCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            99999999999865332     235678999999998776 67999999999999999999999999754221 011111


Q ss_pred             HHHhccc-hhhhc-----------ccccCCCccc-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRGA-IEVLD-----------KSLRARPEVE-----IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~~-~~~~~-----------~~~~~~~~~~-----~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +...... .+...           ..+.......     ........+++.+||+.||++|||++|++++
T Consensus       239 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            1100000 00000           0000000000     0011234567888999999999999999884

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-36  Score=341.49  Aligned_cols=254  Identities=21%  Similarity=0.222  Sum_probs=197.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      ++|...+.||+|+||+||+|.+. +++.||||++...                 ..+.+.+|+.++++++ ||||+++++
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------------~~~~~~~E~~~l~~l~~~~~i~~~~~   98 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----------------KKKKIKREIKILENLRGGPNIITLAD   98 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----------------CHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----------------chHHHHHHHHHHHHcCCCCCEEEeee
Confidence            67999999999999999999764 6899999998532                 2467899999999997 999999999


Q ss_pred             EEEc--CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC-ce
Q 039419          764 CCWN--RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF-EP  840 (1035)
Q Consensus       764 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~  840 (1035)
                      ++.+  ....++||||+++++|.++++.     +++..+..++.||+.||+|||+.   ||+||||||+||+++.++ .+
T Consensus        99 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~  170 (330)
T 3nsz_A           99 IVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKL  170 (330)
T ss_dssp             EEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred             eeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEE
Confidence            9987  5678999999999999998853     78899999999999999999999   999999999999999776 89


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++.......   .....||..|+|||+..+ ..++.++|||||||++|||++|+.||................
T Consensus       171 kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~  247 (330)
T 3nsz_A          171 RLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  247 (330)
T ss_dssp             EECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             EEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence            9999999987654332   235679999999999876 678999999999999999999999996543322222221111


Q ss_pred             hccc--hhhhcc-----------------------cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGA--IEVLDK-----------------------SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~--~~~~~~-----------------------~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....  .+.+..                       .........  ....+.+++.+||++||++|||++|++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL--VSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGG--CCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCCchhhhHHHHhccccccchhhhhhhccccchhhhcccccccc--CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000  000000                       000000000  11234568889999999999999999874

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-36  Score=340.30  Aligned_cols=263  Identities=20%  Similarity=0.253  Sum_probs=197.5

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ..+.++|.+.+.||+|+||.||+|.+. +++.||||++...........      .......+.+|+.++++++||||++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~   79 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAR------EADPALNVETEIEILKKLNHPCIIK   79 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------------CHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccc------cchhhhhHHHHHHHHHhCCCCCCce
Confidence            456688999999999999999999776 488999999976432211000      0012346889999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc-
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE-  839 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~-  839 (1035)
                      +++++..++ .|+||||+++++|.+++....  .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++. 
T Consensus        80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           80 IKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             EEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSS
T ss_pred             EeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCC
Confidence            999987655 899999999999999987654  489999999999999999999999   9999999999999987664 


Q ss_pred             --eEEeeccCccccccCCccccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          840 --PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       840 --~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                        +||+|||+++......   ......||+.|+|||++.   ...++.++|||||||++|+|++|+.||....... ...
T Consensus       154 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~  229 (322)
T 2ycf_A          154 CLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-SLK  229 (322)
T ss_dssp             CCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-CHH
T ss_pred             CeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-HHH
Confidence              9999999998764432   122456899999999863   5678899999999999999999999997543321 222


Q ss_pred             HHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+......   ..+......      ...+.+++.+||+.||++||++.+++++
T Consensus       230 ~~~~~~~~~---~~~~~~~~~------~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          230 DQITSGKYN---FIPEVWAEV------SEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHHHHTCCC---CCHHHHTTS------CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhCccc---cCchhhhhc------CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            222211100   000011111      1234567888999999999999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.4e-37  Score=361.88  Aligned_cols=266  Identities=23%  Similarity=0.290  Sum_probs=201.3

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .+.+.|.+.+.||+|+||+||+|.+. +++.||||++........... ..........+.+.+|+.++++++||||+++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS-DDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC-----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhccccccc-ccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            35678999999999999999999876 478999999976443221000 0001111346789999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC---
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF---  838 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~---  838 (1035)
                      ++++.+.+..|+||||++||+|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++   
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999999999977654  89999999999999999999999   999999999999998776   


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .+||+|||+++......   ......||+.|+|||++. ..++.++||||+||++|+|++|..||.....  ......+.
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~  260 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDIIKKVE  260 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Confidence            69999999998765432   223567999999999876 4689999999999999999999999975422  12222221


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....   .........+      ..+.+++.+||++||++|||++|++++
T Consensus       261 ~~~~~---~~~~~~~~~s------~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          261 KGKYY---FDFNDWKNIS------DEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HCCCC---CCHHHHTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCCC---CCccccCCCC------HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11100   0000001111      234567888999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-37  Score=347.62  Aligned_cols=272  Identities=23%  Similarity=0.275  Sum_probs=195.4

Q ss_pred             HHHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          681 VEQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       681 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      +....++|...+.||+|+||.||+|.+. +|+.||||++..........         ...+.+.+|+.++++++||||+
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv   75 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD---------GINRTALREIKLLQELSHPNII   75 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBC
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhh---------hhhHHHHHHHHHHhhCCCCCCC
Confidence            4455678999999999999999999876 58999999996543221110         1235788999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++++++.+.+..++||||+++ +|.+++.... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.
T Consensus        76 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~  150 (346)
T 1ua2_A           76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGV  150 (346)
T ss_dssp             CEEEEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             eEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCC
Confidence            999999999999999999975 8988887643 3478889999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      +||+|||+++......  .......||+.|+|||+..+. .++.++|||||||++|||++|..||...... ..+.....
T Consensus       151 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~  227 (346)
T 1ua2_A          151 LKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFE  227 (346)
T ss_dssp             EEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred             EEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence            9999999998764432  223356799999999988654 5889999999999999999999998754221 11111111


Q ss_pred             Hhccc-hhhhccc--------ccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGA-IEVLDKS--------LRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~-~~~~~~~--------~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..... .+.....        ....+.....     ....+.+++.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            11100 0000000        0000000011     01234568888999999999999999885

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.1e-37  Score=350.38  Aligned_cols=200  Identities=26%  Similarity=0.463  Sum_probs=175.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+|.+. +++.||+|++......             ...+.+.+|+.++++++||||++++++
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~~   99 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGFYGA   99 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH-------------HHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH-------------HHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence            57889999999999999999876 5899999998654221             235689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||+++++|.+++...+.  +++..+..++.|++.||+|||+..  +|+||||||+||+++.++.+||+|
T Consensus       100 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~D  175 (360)
T 3eqc_A          100 FYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCD  175 (360)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEECCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEE
Confidence            9999999999999999999999987654  899999999999999999999841  799999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      ||+++.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       176 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          176 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             CCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             CCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999765432    223467999999999999999999999999999999999999999754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.4e-37  Score=378.91  Aligned_cols=252  Identities=21%  Similarity=0.279  Sum_probs=202.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFL  762 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~  762 (1035)
                      .++|...+.||+|+||.||+|+++ +++.||||++........           ...+.+..|..++..+ +||+|++++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~-----------~~~~~~~~E~~~l~~~~~~~~i~~l~  408 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-----------DDVECTMVEKRVLALPGKPPFLTQLH  408 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHT-----------TTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccH-----------HHHHHHHHHHHHHHhccCCCeEEEEE
Confidence            467999999999999999999876 488999999965322111           1246788999999988 799999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+.+..|+||||++||+|.++++..+.  +++..+..++.||+.||+|||+.   +|+||||||+|||++.++++||
T Consensus       409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~--~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL  483 (674)
T 3pfq_A          409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI  483 (674)
T ss_dssp             EECBCSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEE
T ss_pred             EEEEeCCEEEEEEeCcCCCcHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEE
Confidence            999999999999999999999999987654  89999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      +|||+|+......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....  ......+.... 
T Consensus       484 ~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~~-  558 (674)
T 3pfq_A          484 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--DELFQSIMEHN-  558 (674)
T ss_dssp             CCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHSSC-
T ss_pred             eecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--HHHHHHHHhCC-
Confidence            9999998643332  223467899999999999999999999999999999999999999975421  11111111100 


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM-----KDVAAM  969 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~-----~el~~~  969 (1035)
                            .......+      ..+.+++.+||++||++||++     +||+++
T Consensus       559 ------~~~p~~~s------~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          559 ------VAYPKSMS------KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             ------CCCCTTSC------HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ------CCCCccCC------HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                  00111111      234557888999999999997     666653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=349.74  Aligned_cols=256  Identities=20%  Similarity=0.267  Sum_probs=183.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      .+|...+.||+|+||.||+|++. +++.||||++.....              ...+.+.+|+.+++++. ||||+++++
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~~h~~iv~~~~   93 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE--------------EKNRAIIQEVCFMKKLSGHPNIVQFCS   93 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH--------------HHHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch--------------HHHHHHHHHHHHHHHhccCCChhhccc
Confidence            47889999999999999999875 589999999854321              12467899999999996 999999999


Q ss_pred             EEEc--------CCcceEEEEeCCCCChhhhhhhc-CCCCCCHHHHHHHHHHHHHHHHHhhccCCCC--eeccCCCcccE
Q 039419          764 CCWN--------RNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQGLAYLHHDCVPP--IVHRDIKANNI  832 (1035)
Q Consensus       764 ~~~~--------~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--ivHrDikp~NI  832 (1035)
                      ++..        ....++||||+. |+|.+++... ....+++..+..++.||+.||+|||+.   +  |+||||||+||
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NI  169 (337)
T 3ll6_A           94 AASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENL  169 (337)
T ss_dssp             EEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGC
T ss_pred             cccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccE
Confidence            9942        334789999995 7999988652 234589999999999999999999998   7  99999999999


Q ss_pred             EEcCCCceEEeeccCccccccCCccc----------cccccCCcccccCCccc---ccCCCCccccchhHHHHHHHHHhC
Q 039419          833 LIGPEFEPYIADFGLAKLVVEGDFAR----------SSNTVAGSYGYIAPEYG---YMMKITEKSDVYSYGVVVLEVLTG  899 (1035)
Q Consensus       833 ll~~~~~~kl~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGvvl~elltg  899 (1035)
                      +++.++.+||+|||+++.........          ......||+.|+|||++   .+..++.++||||||+++|||++|
T Consensus       170 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g  249 (337)
T 3ll6_A          170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR  249 (337)
T ss_dssp             EECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred             EECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence            99999999999999998765432111          11245699999999987   566788999999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          900 KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       900 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      +.||......     ......      .........+..      +..++.+||+.||++||++.|++++|+.+...
T Consensus       250 ~~p~~~~~~~-----~~~~~~------~~~~~~~~~~~~------~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          250 QHPFEDGAKL-----RIVNGK------YSIPPHDTQYTV------FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             SCCC-----------------------CCCCTTCCSSGG------GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcchhHH-----HhhcCc------ccCCcccccchH------HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999743211     111110      000001111111      23577789999999999999999999988654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.3e-37  Score=337.74  Aligned_cols=248  Identities=19%  Similarity=0.270  Sum_probs=196.5

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRF  761 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  761 (1035)
                      ..++|...+.||+|+||+||+|.+. +++.||||++........            ....+.+|+..+.++ +||||+++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------------~~~~~~~e~~~~~~l~~h~~iv~~   76 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV------------DEQNALREVYAHAVLGQHSHVVRY   76 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH------------HHHHHHHHHHHHHHSCSCTTBCCE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH------------HHHHHHHHHHHHHHhCCCCCeeee
Confidence            4578999999999999999999876 689999999865432221            246788999999999 89999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCC--CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC--
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE--  837 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~--  837 (1035)
                      ++++.+.+..++||||+++|+|.+++.....  ..+++..+..++.||++||+|||+.   +|+||||||+||+++.+  
T Consensus        77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~  153 (289)
T 1x8b_A           77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSI  153 (289)
T ss_dssp             EEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----
T ss_pred             eeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCC
Confidence            9999999999999999999999999976532  4489999999999999999999999   99999999999999844  


Q ss_pred             -----------------CceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhC
Q 039419          838 -----------------FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTG  899 (1035)
Q Consensus       838 -----------------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg  899 (1035)
                                       ..+||+|||.+......      ....||+.|+|||+..+. .++.++||||||+++|||++|
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~  227 (289)
T 1x8b_A          154 PNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA  227 (289)
T ss_dssp             ----------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTC
T ss_pred             CcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcC
Confidence                             47999999999865432      234699999999998765 566899999999999999999


Q ss_pred             CCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          900 KQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       900 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..|+...     .....+..  ..    .+......+      ..+.+++.+||++||++||++.|++++
T Consensus       228 ~~~~~~~-----~~~~~~~~--~~----~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          228 EPLPRNG-----DQWHEIRQ--GR----LPRIPQVLS------QEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             CCCCSSS-----HHHHHHHT--TC----CCCCSSCCC------HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CCCCcch-----hHHHHHHc--CC----CCCCCcccC------HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            8776422     11111111  00    011111111      123457888999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.6e-37  Score=354.19  Aligned_cols=203  Identities=22%  Similarity=0.280  Sum_probs=167.9

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.++|...+.||+|+||+||+|.+. +++.||||++.......            ...+++.+|+.++++++||||++++
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~nIv~l~   91 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL------------IDCKRILREITILNRLKSDYIIRLY   91 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSH------------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcCh------------HHHHHHHHHHHHHHHcCCCCcceEE
Confidence            3468999999999999999999776 48899999996432211            1256889999999999999999999


Q ss_pred             eEEEcC-----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          763 GCCWNR-----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       763 ~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      +++...     +..|+||||+. |+|.++++...  .+++..+..++.||++||+|||+.   +|+||||||+|||++.+
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~  165 (432)
T 3n9x_A           92 DLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQD  165 (432)
T ss_dssp             EECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred             EEEecCCCCcCCeEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCC
Confidence            999776     56899999985 69999997654  389999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCcc--------------------ccccccCCcccccCCccc-ccCCCCccccchhHHHHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFA--------------------RSSNTVAGSYGYIAPEYG-YMMKITEKSDVYSYGVVVLEV  896 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGvvl~el  896 (1035)
                      +.+||+|||+|+........                    ......+||+.|+|||++ ....++.++||||+||++|||
T Consensus       166 ~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~el  245 (432)
T 3n9x_A          166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL  245 (432)
T ss_dssp             CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred             CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHH
Confidence            99999999999876543211                    123467899999999985 566799999999999999999


Q ss_pred             HhCCCCCC
Q 039419          897 LTGKQPID  904 (1035)
Q Consensus       897 ltg~~P~~  904 (1035)
                      ++|..||.
T Consensus       246 l~g~~p~~  253 (432)
T 3n9x_A          246 LNMLQSHI  253 (432)
T ss_dssp             HTTCTTTC
T ss_pred             Hhcccccc
Confidence            98665554

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.2e-36  Score=354.83  Aligned_cols=361  Identities=21%  Similarity=0.210  Sum_probs=180.3

Q ss_pred             CCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCC
Q 039419           93 GVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIG  172 (1035)
Q Consensus        93 ~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~  172 (1035)
                      ..+..++.+++|++|+|++|.+++ +| .+..+++|++|+|++|++++ +|  ++.+++|++|++++|            
T Consensus        33 ~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N------------   95 (457)
T 3bz5_A           33 TDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSN------------   95 (457)
T ss_dssp             TSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSS------------
T ss_pred             ccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCC------------
Confidence            344445555555555555555553 33 45555555555555555552 22  444444444444444            


Q ss_pred             CccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHh
Q 039419          173 DCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKM  252 (1035)
Q Consensus       173 ~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  252 (1035)
                                   .+++. +  ++.+++|++|++++|.+++ +|  ++.+++|+.|++++|.+++. +  ++.+++|++|
T Consensus        96 -------------~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L  153 (457)
T 3bz5_A           96 -------------KLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTEL  153 (457)
T ss_dssp             -------------CCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEE
T ss_pred             -------------CCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEE
Confidence                         34332 1  4445555555555555543 22  44555555555555555532 1  4444555555


Q ss_pred             hcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhh
Q 039419          253 LLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQIS  332 (1035)
Q Consensus       253 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  332 (1035)
                      ++++|+..+.+  .+..+++|+.|++++|++++ +|  +..+++|+.|++++|++++.   .+..+++|++|++++|+|+
T Consensus       154 ~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~  225 (457)
T 3bz5_A          154 DCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT  225 (457)
T ss_dssp             ECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCS
T ss_pred             ECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCccc
Confidence            55555333233  24455555555555555553 22  44555555555555555543   2444455555555554443


Q ss_pred             hhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccC
Q 039419          333 VFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFG  412 (1035)
Q Consensus       333 ~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~  412 (1035)
                      .           +|  +..+++|+.|++++|++++..   +..+++|+.|++++|+                        
T Consensus       226 ~-----------ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~------------------------  265 (457)
T 3bz5_A          226 E-----------ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTD------------------------  265 (457)
T ss_dssp             C-----------CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCC------------------------
T ss_pred             c-----------cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCC------------------------
Confidence            1           22  444455555555555555332   2233444444444432                        


Q ss_pred             CCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEE
Q 039419          413 NCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSL  492 (1035)
Q Consensus       413 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  492 (1035)
                          |+.|++++|.+.+.+|  +..+++|+.|++++|++.+.+|.   ...+|+.|++++|             ++|++|
T Consensus       266 ----L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L  323 (457)
T 3bz5_A          266 ----LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYL  323 (457)
T ss_dssp             ----CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEE
T ss_pred             ----CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEE
Confidence                4455555555544443  34455566666666655444432   1223333333322             345555


Q ss_pred             EcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCc
Q 039419          493 DLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT  572 (1035)
Q Consensus       493 ~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~  572 (1035)
                      +|++|+|++ ++  +..+..+ ..|++++|+|++        ++.|..|++++|++.+.    ..+..|..+++++|+|+
T Consensus       324 ~L~~N~l~~-l~--l~~l~~L-~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~----~~~~~l~~l~l~~N~l~  387 (457)
T 3bz5_A          324 YLNNTELTE-LD--VSHNTKL-KSLSCVNAHIQD--------FSSVGKIPALNNNFEAE----GQTITMPKETLTNNSLT  387 (457)
T ss_dssp             ECTTCCCSC-CC--CTTCTTC-SEEECCSSCCCB--------CTTGGGSSGGGTSEEEE----EEEEECCCBCCBTTBEE
T ss_pred             ECCCCcccc-cc--cccCCcC-cEEECCCCCCCC--------ccccccccccCCcEEec----ceeeecCccccccCcEE
Confidence            555555553 22  2232222 245555555543        24566667788877765    24556778899999999


Q ss_pred             ccCCCh
Q 039419          573 GYLPDS  578 (1035)
Q Consensus       573 ~~~p~~  578 (1035)
                      |.+|..
T Consensus       388 g~ip~~  393 (457)
T 3bz5_A          388 IAVSPD  393 (457)
T ss_dssp             EECCTT
T ss_pred             EEcChh
Confidence            988863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=345.92  Aligned_cols=259  Identities=22%  Similarity=0.316  Sum_probs=197.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|+. .+++.||||++.....              ...+.+.+|+.++++++||||++++++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--------------QDREEAQREADMHRLFNHPNILRLVAY   94 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH--------------HHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH--------------HHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            6799999999999999999987 4689999999854221              125678999999999999999999999


Q ss_pred             EEc----CCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          765 CWN----RNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       765 ~~~----~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +..    ....|+||||+++|+|.+++...  ....+++..+..++.|+++||+|||+.   +|+||||||+||+++.++
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~  171 (317)
T 2buj_A           95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEG  171 (317)
T ss_dssp             EEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTS
T ss_pred             EEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence            873    34679999999999999998763  234589999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCcc-------ccccccCCcccccCCcccccCC---CCccccchhHHHHHHHHHhCCCCCCCCCC
Q 039419          839 EPYIADFGLAKLVVEGDFA-------RSSNTVAGSYGYIAPEYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIP  908 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGvvl~elltg~~P~~~~~~  908 (1035)
                      .+||+|||.++........       .......||+.|+|||++.+..   ++.++||||||+++|||++|+.||.....
T Consensus       172 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  251 (317)
T 2buj_A          172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ  251 (317)
T ss_dssp             CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH
T ss_pred             CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc
Confidence            9999999998765321110       0012345799999999976544   68899999999999999999999953211


Q ss_pred             CchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          909 EGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       909 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ........+..          ..........  ...+..++.+||+.||++||++.+++++|+.+
T Consensus       252 ~~~~~~~~~~~----------~~~~~~~~~~--~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          252 KGDSVALAVQN----------QLSIPQSPRH--SSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             TTSCHHHHHHC----------C--CCCCTTS--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ccchhhHHhhc----------cCCCCccccC--CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence            11111111110          0000000011  12345578889999999999999999999876

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-37  Score=340.30  Aligned_cols=255  Identities=21%  Similarity=0.332  Sum_probs=199.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||+|++.......            ...+.+.+|+.++++++||||+++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~~~~   72 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE------------AEKQMLVSEVNLLRELKHPNIVRYYD   72 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH------------HHHHHHHHHHHHHHhcCCCCCCeEEE
Confidence            467899999999999999999876 58999999996543222            12567999999999999999999999


Q ss_pred             EEEc--CCcceEEEEeCCCCChhhhhhhcC--CCCCCHHHHHHHHHHHHHHHHHhhccCCCC-----eeccCCCcccEEE
Q 039419          764 CCWN--RNTRLLMYDYMPNGSLGSLLHERR--DSCLEWELRYRIILGAAQGLAYLHHDCVPP-----IVHRDIKANNILI  834 (1035)
Q Consensus       764 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----ivHrDikp~NIll  834 (1035)
                      ++.+  .+..|+||||+++++|.+++....  ...+++..+..++.|++.||+|||+.   +     |+||||||+||++
T Consensus        73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~  149 (279)
T 2w5a_A           73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFL  149 (279)
T ss_dssp             EEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEE
T ss_pred             EEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEE
Confidence            8854  567899999999999999997643  24489999999999999999999998   7     9999999999999


Q ss_pred             cCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          835 GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                      +.++.+||+|||.++.......  ......||+.|+|||+..+..++.++||||||+++|+|++|+.||.....  ....
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~  225 (279)
T 2w5a_A          150 DGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELA  225 (279)
T ss_dssp             CSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH
T ss_pred             cCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHH
Confidence            9999999999999987644321  12245689999999999888899999999999999999999999975421  1222


Q ss_pred             HHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Q 039419          915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI  970 (1035)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L  970 (1035)
                      ..+....      ........+      ..+.+++.+||+.||++||++.|+++++
T Consensus       226 ~~i~~~~------~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          226 GKIREGK------FRRIPYRYS------DELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHTC------CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHhhcc------cccCCcccC------HHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            2221110      001111111      1234578889999999999999998854

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.5e-37  Score=344.68  Aligned_cols=265  Identities=22%  Similarity=0.350  Sum_probs=197.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|++.. ++.||||++.......            ...+.+.+|+.++++++||||+++++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~   91 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK------------MVKKIAMREIKLLKQLRHENLVNLLE   91 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch------------HHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            4789999999999999999998764 8999999986543221            23567889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||+++++|.++......  +++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||+
T Consensus        92 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A           92 VCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             EEEETTEEEEEEECCSEEHHHHHHHSTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EeecCCEEEEEEecCCcchHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEE
Confidence            99999999999999999999888765443  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |||.++......  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ...........
T Consensus       167 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~  243 (331)
T 4aaa_A          167 DFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCLGN  243 (331)
T ss_dssp             CCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCS
T ss_pred             eCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCC
Confidence            999998654432  122345799999999998765 78999999999999999999999997543211 11111111000


Q ss_pred             c--------------hhhhcccccCCCcc---cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          923 A--------------IEVLDKSLRARPEV---EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       923 ~--------------~~~~~~~~~~~~~~---~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .              .....+......+.   .......+.+++.+||++||++|||++|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0              00000000000000   00011234568888999999999999999984

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=359.46  Aligned_cols=345  Identities=22%  Similarity=0.189  Sum_probs=221.6

Q ss_pred             ceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCcc
Q 039419          203 SLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNF  282 (1035)
Q Consensus       203 ~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~  282 (1035)
                      .++.+++.++ .+|..+.  ++++.|+|++|.+++..+..|.++++|++|+|++|.+.+..|..|.++++|++|+|++|+
T Consensus        15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            3444455554 4554442  456666666666666556666666666777777666666666667777777777777777


Q ss_pred             CCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccC
Q 039419          283 FSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH  362 (1035)
Q Consensus       283 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~  362 (1035)
                      +++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|++|+|+.+          .+..|.++++|+.|+|++
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~----------~~~~~~~l~~L~~L~l~~  161 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYI----------SHRAFSGLNSLEQLTLEK  161 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEE----------CTTSSTTCTTCCEEEEES
T ss_pred             CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCcccee----------ChhhccCCCCCCEEECCC
Confidence            7655555667777777777777777766666677777777777777666532          345666777777777777


Q ss_pred             cCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCcc
Q 039419          363 NALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQ  442 (1035)
Q Consensus       363 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~  442 (1035)
                      |.+++..+..|..+++|+.|+|++|.+.+..+..+.              .+++|++|++++|.+.+.+|.......+|+
T Consensus       162 n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~--------------~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~  227 (477)
T 2id5_A          162 CNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFK--------------RLYRLKVLEISHWPYLDTMTPNCLYGLNLT  227 (477)
T ss_dssp             CCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSC--------------SCTTCCEEEEECCTTCCEECTTTTTTCCCS
T ss_pred             CcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcc--------------cCcccceeeCCCCccccccCcccccCcccc
Confidence            777755555566777777777777777655544433              345577777777766655555555556777


Q ss_pred             EEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCc
Q 039419          443 VLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWN  522 (1035)
Q Consensus       443 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N  522 (1035)
                      .|+|++|+++++++..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++++.                    
T Consensus       228 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~--------------------  287 (477)
T 2id5_A          228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVV--------------------  287 (477)
T ss_dssp             EEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEE--------------------
T ss_pred             EEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceE--------------------
Confidence            777777777766666777777777777777777766666777777777777777777632                    


Q ss_pred             cCCCCCCccccCCccccEEeccCCcccCccc-cccccCCCcEEeccCCcCcccCCChhhhhccccccccccccCCCCC
Q 039419          523 ALSGAIPPQISALNKLSILDLSHNKLGGDLL-ALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSRG  599 (1035)
Q Consensus       523 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~~~  599 (1035)
                           .|..|..+++|++|+|++|+|++.+. .|..+++|+.|+|++|+|++.++....+.......+.++...|..|
T Consensus       288 -----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          288 -----EPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             -----CTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             -----CHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence                 23344555666666666666665443 4555666666666666666544433233334445556666666654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-37  Score=354.91  Aligned_cols=251  Identities=17%  Similarity=0.189  Sum_probs=189.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHH---HHHhcCCCCceee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI---KTLGSIRHKNIVR  760 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpniv~  760 (1035)
                      .++|...+.||+|+||+||+|.+. +|+.||||++........           ...+.+.+|+   .++++++|||||+
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~~l~hpniv~  140 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-----------NAIKQMKEEVLRLRLLRGIKNQKQAK  140 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT-----------THHHHHHHHHHGGGGSTTCCSHHHHH
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch-----------HHHHHHHHHHHHHHhccccCCHHHHH
Confidence            367888999999999999999864 589999999964322221           2357899999   5555668999999


Q ss_pred             EE-------eEEEcCCc-----------------ceEEEEeCCCCChhhhhhhcCCC-----CCCHHHHHHHHHHHHHHH
Q 039419          761 FL-------GCCWNRNT-----------------RLLMYDYMPNGSLGSLLHERRDS-----CLEWELRYRIILGAAQGL  811 (1035)
Q Consensus       761 l~-------~~~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~-----~l~~~~~~~i~~~ia~~L  811 (1035)
                      ++       +++.+++.                 .|+||||+ +|+|.+++...+..     .+++..+..++.||++||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL  219 (377)
T 3byv_A          141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL  219 (377)
T ss_dssp             HHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHH
Confidence            98       66665542                 78999999 68999999865321     123588888999999999


Q ss_pred             HHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccC-----------CC
Q 039419          812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-----------KI  880 (1035)
Q Consensus       812 ~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~  880 (1035)
                      +|||+.   +|+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .+
T Consensus       220 ~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~  290 (377)
T 3byv_A          220 ASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLM  290 (377)
T ss_dssp             HHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC
T ss_pred             HHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccC
Confidence            999999   999999999999999999999999999985322     2234567 999999998877           89


Q ss_pred             CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCC
Q 039419          881 TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDR  960 (1035)
Q Consensus       881 ~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~R  960 (1035)
                      +.++|||||||++|||++|+.||........            ...+.... ...+      ..+.+++.+||+.||++|
T Consensus       291 ~~~~DvwSlG~il~elltg~~Pf~~~~~~~~------------~~~~~~~~-~~~~------~~~~~li~~~L~~dp~~R  351 (377)
T 3byv_A          291 TFSFDAWALGLVIYWIWCADLPITKDAALGG------------SEWIFRSC-KNIP------QPVRALLEGFLRYPKEDR  351 (377)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCCC------CC------------SGGGGSSC-CCCC------HHHHHHHHHHTCSSGGGC
T ss_pred             ChhhhHHHHHHHHHHHHHCCCCCcccccccc------------hhhhhhhc-cCCC------HHHHHHHHHHcCCCchhC
Confidence            9999999999999999999999965322110            00111110 1111      123457888999999999


Q ss_pred             CCHHHHHH--HHHHHHH
Q 039419          961 PTMKDVAA--MIKEIKQ  975 (1035)
Q Consensus       961 Ps~~el~~--~L~~~~~  975 (1035)
                      |++.|+++  .++++..
T Consensus       352 pt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          352 LLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             CCHHHHHTSHHHHHHHH
T ss_pred             CCHHHHhhChHHHHHHH
Confidence            99999997  4454443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=340.53  Aligned_cols=269  Identities=27%  Similarity=0.401  Sum_probs=205.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-----CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ++|...+.||+|+||.||+|++     .+++.||||++.....              ...+.+.+|+.++++++||||++
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~  106 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--------------EHLRDFEREIEILKSLQHDNIVK  106 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS--------------HHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH--------------HHHHHHHHHHHHHHhCCCCCeee
Confidence            5688899999999999999984     3589999999865321              12467999999999999999999


Q ss_pred             EEeEEEcCC--cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          761 FLGCCWNRN--TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       761 l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +++++...+  ..++||||+++++|.+++...+ ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++
T Consensus       107 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~  182 (326)
T 2w1i_A          107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENEN  182 (326)
T ss_dssp             EEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred             EEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCC
Confidence            999987654  7899999999999999997654 3489999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      .+||+|||+++........ .......++..|+|||+..+..++.++||||||+++|||++|..||.....   .+....
T Consensus       183 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~---~~~~~~  259 (326)
T 2w1i_A          183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---EFMRMI  259 (326)
T ss_dssp             EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH---HHHHHH
T ss_pred             cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH---HHHHhh
Confidence            9999999999876543321 122345678889999998888899999999999999999999999863210   000000


Q ss_pred             HHhcc-------chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          918 RQKRG-------AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       918 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      .....       ..+.+........+..+  ...+..++.+||+.||++||++.|+++.|+.+..+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          260 GNDKQGQMIVFHLIELLKNNGRLPRPDGC--PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             CTTCCTHHHHHHHHHHHHTTCCCCCCTTC--CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccccchhhhHHHHHHHhhcCCCCCCCCcc--cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            00000       00011111011111111  123455788899999999999999999999987653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.3e-37  Score=355.54  Aligned_cols=198  Identities=23%  Similarity=0.253  Sum_probs=173.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC------CCCc
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI------RHKN  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~hpn  757 (1035)
                      ..+|.+.+.||+|+||+||+|.+. +++.||||++....               ...+.+.+|+.+++.+      +|+|
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---------------~~~~~~~~E~~~l~~l~~~~~~~~~~  160 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---------------RFHRQAAEEIRILEHLRKQDKDNTMN  160 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---------------HHHHHHHHHHHHHHHHHTTCTTSCSC
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---------------chHHHHHHHHHHHHHHhhccccCCcC
Confidence            457999999999999999999766 48999999996421               1235677888888877      5779


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      |+++++++...+..++||||+. ++|.+++.......+++..+..++.||+.||+|||+.   +|+||||||+|||++.+
T Consensus       161 iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~  236 (429)
T 3kvw_A          161 VIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQ  236 (429)
T ss_dssp             BCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESST
T ss_pred             EEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccC
Confidence            9999999999999999999995 6999999887666699999999999999999999999   99999999999999998


Q ss_pred             Cc--eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          838 FE--PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       838 ~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      +.  +||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       237 ~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          237 GRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            87  999999999754322     23567999999999999999999999999999999999999999754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=338.96  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ...+.|...+.||+|+||.||+|.+. +|+.||||++....                ..+.+.+|+.++++++||||+++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~e~~~l~~l~h~~i~~~   89 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----------------DLQEIIKEISIMQQCDSPHVVKY   89 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----------------CCHHHHHHHHHHHTCCCTTBCCE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----------------HHHHHHHHHHHHHhCCCCCCccE
Confidence            34578999999999999999999876 48999999986421                13578999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+.+..|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+|
T Consensus        90 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k  165 (314)
T 3com_A           90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAK  165 (314)
T ss_dssp             EEEEEETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             EEEEEeCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEE
Confidence            999999999999999999999999997433 3489999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |+|||.+.......  .......||+.|+|||+..+..++.++||||||+++|+|++|+.||......  .....+....
T Consensus       166 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~  241 (314)
T 3com_A          166 LADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM--RAIFMIPTNP  241 (314)
T ss_dssp             ECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSC
T ss_pred             Eeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHhcCC
Confidence            99999998764432  1233567999999999999889999999999999999999999999754221  1111111100


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                            .....  .+...  ...+.+++.+||+.||++||++.+++++
T Consensus       242 ------~~~~~--~~~~~--~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          242 ------PPTFR--KPELW--SDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ------CCCCS--SGGGS--CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ------CcccC--CcccC--CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                  00000  00001  1123457888999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-37  Score=340.94  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=193.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC--CCc--EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME--NGE--VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+.||+|+||+||+|++.  +++  .||||++........           ...+.+.+|+.++++++||||+++
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~   86 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-----------EAMDDFIREVNAMHSLDHRNLIRL   86 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C-----------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCH-----------HHHHHHHHHHHHHHhCCCCCcccE
Confidence            67899999999999999999753  233  689999865432221           235789999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.++. .++||||+++++|.+++.... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~k  161 (291)
T 1u46_A           87 YGVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVK  161 (291)
T ss_dssp             EEEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred             EEEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEE
Confidence            99998765 889999999999999997653 3388999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      |+|||+++........ .......+|..|+|||+..+..++.++||||||+++|||++ |+.||.....  ......+..
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~  239 (291)
T 1u46_A          162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKIDK  239 (291)
T ss_dssp             ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHT
T ss_pred             EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--HHHHHHHHc
Confidence            9999999876543321 12234567889999999888889999999999999999999 9999975422  111111111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ...     ........+      ..+.+++.+||+.||++||++.++++.|+++.+
T Consensus       240 ~~~-----~~~~~~~~~------~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          240 EGE-----RLPRPEDCP------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             SCC-----CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCC-----CCCCCcCcC------HHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            100     000011111      234557888999999999999999999988754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.9e-36  Score=342.58  Aligned_cols=266  Identities=23%  Similarity=0.312  Sum_probs=199.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|++. +|+.||||++.......            .....+.+|+.++++++||||+++++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~   83 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------------GFPITALREIKILQLLKHENVVNLIE   83 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS------------SSCHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc------------cchHHHHHHHHHHHhccCCCcccHhh
Confidence            478999999999999999999874 68999999986543222            12457889999999999999999999


Q ss_pred             EEEcC--------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          764 CCWNR--------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       764 ~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++.+.        +..|+||||+++ +|.+.+.... ..+++..+..++.||+.||+|||+.   ||+||||||+||+++
T Consensus        84 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~  158 (351)
T 3mi9_A           84 ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLIT  158 (351)
T ss_dssp             EEEEC--------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred             eeeccccccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEc
Confidence            99873        457999999964 7777776543 3389999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCc--cccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          836 PEFEPYIADFGLAKLVVEGDF--ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      .++.+||+|||+++.+.....  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  .
T Consensus       159 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~  236 (351)
T 3mi9_A          159 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--H  236 (351)
T ss_dssp             TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H
T ss_pred             CCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--H
Confidence            999999999999987653221  122345678999999998765 45799999999999999999999999754321  1


Q ss_pred             HHHHHHHhccc-h-hhhccc----------ccCCCcccHHH-------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          913 IVDWVRQKRGA-I-EVLDKS----------LRARPEVEIEE-------MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       913 ~~~~~~~~~~~-~-~~~~~~----------~~~~~~~~~~~-------~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....+...... . +.....          ..........+       .....+++.+||+.||++|||++|++++
T Consensus       237 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            11111111110 0 000000          00000001111       1235678899999999999999999885

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=5.5e-36  Score=352.20  Aligned_cols=348  Identities=25%  Similarity=0.375  Sum_probs=187.9

Q ss_pred             cccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCce
Q 039419          148 KLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVD  227 (1035)
Q Consensus       148 ~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~  227 (1035)
                      .+++|+.|++.+|.  ...+| .+..+++|++|++++|.+.+..+  ++++++|++|++++|.+.+..+  +.++++|++
T Consensus        44 ~l~~l~~L~l~~~~--i~~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  116 (466)
T 1o6v_A           44 DLDQVTTLQADRLG--IKSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG  116 (466)
T ss_dssp             HHHTCCEEECCSSC--CCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             HhccccEEecCCCC--CccCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence            45666666666664  22233 24445555555555555543322  4455555555555555442222  444555555


Q ss_pred             EEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCcc
Q 039419          228 LFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNI  307 (1035)
Q Consensus       228 L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l  307 (1035)
                      |++++|.++                        +..+  +.++++|++|++++|.+++ .+ .+.++++|++|+++ |.+
T Consensus       117 L~L~~n~l~------------------------~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~  167 (466)
T 1o6v_A          117 LTLFNNQIT------------------------DIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQV  167 (466)
T ss_dssp             EECCSSCCC------------------------CCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESC
T ss_pred             EECCCCCCC------------------------CChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-Ccc
Confidence            555555444                        3211  4444455555555554442 12 24444555555543 233


Q ss_pred             ccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEecccc
Q 039419          308 SGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISN  387 (1035)
Q Consensus       308 ~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  387 (1035)
                      .+..  .+.++++|++|++++|+++.+            ..+..+++|++|++++|.+++..+  +..+++|++|++++|
T Consensus       168 ~~~~--~~~~l~~L~~L~l~~n~l~~~------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n  231 (466)
T 1o6v_A          168 TDLK--PLANLTTLERLDISSNKVSDI------------SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN  231 (466)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCCCC------------GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred             cCch--hhccCCCCCEEECcCCcCCCC------------hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCC
Confidence            2221  144455555555555544321            124455555555555555554333  444555555555555


Q ss_pred             ccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccch
Q 039419          388 GISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNR  467 (1035)
Q Consensus       388 ~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  467 (1035)
                      ++++.                ..+..+++|++|++++|++++..+  +..+++|++|++++|++++..+  +..+++|+.
T Consensus       232 ~l~~~----------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  291 (466)
T 1o6v_A          232 QLKDI----------------GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN  291 (466)
T ss_dssp             CCCCC----------------GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred             Ccccc----------------hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCe
Confidence            55432                113334556666666666654433  5555666666666666665433  555666666


Q ss_pred             hhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCc
Q 039419          468 LILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNK  547 (1035)
Q Consensus       468 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  547 (1035)
                      |++++|++++..+  +..+++|++|+|++|++++..|  +..+..+ ..|++++|.+++.  +.+..+++|++|+|++|+
T Consensus       292 L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L-~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~  364 (466)
T 1o6v_A          292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKL-QRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ  364 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTC-CEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred             EEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccC-CEeECCCCccCCc--hhhccCCCCCEEeCCCCc
Confidence            6666666654333  5556666666666666654433  2222222 3566666666554  467788999999999999


Q ss_pred             ccCccccccccCCCcEEeccCCcCcccC
Q 039419          548 LGGDLLALSGLDNLVSLNVSYNNFTGYL  575 (1035)
Q Consensus       548 l~~~~~~~~~l~~L~~L~ls~N~l~~~~  575 (1035)
                      +.+.++ +..+++|+.|++++|++++.+
T Consensus       365 l~~~~~-~~~l~~L~~L~l~~n~~~~~p  391 (466)
T 1o6v_A          365 ISDLTP-LANLTRITQLGLNDQAWTNAP  391 (466)
T ss_dssp             CCBCGG-GTTCTTCCEEECCCEEEECCC
T ss_pred             cCccch-hhcCCCCCEEeccCCcccCCc
Confidence            988766 888999999999999998753

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.7e-36  Score=345.28  Aligned_cols=260  Identities=22%  Similarity=0.231  Sum_probs=190.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||||++.......            ...+.+.+|+.+++.++||||+++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~~~~   91 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIIGLLN   91 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCCh------------HHHHHHHHHHHHHHhcCCCCccceEE
Confidence            468999999999999999999765 58999999986532211            12467889999999999999999999


Q ss_pred             EEEcCC------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          764 CCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       764 ~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++...+      ..|+||||++ |+|.+++..    .+++..+..++.||+.||+|||+.   ||+||||||+||+++.+
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~  163 (371)
T 2xrw_A           92 VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD  163 (371)
T ss_dssp             EECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred             eeccccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCC
Confidence            997665      6799999996 578888753    288999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||+++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+
T Consensus       164 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i  238 (371)
T 2xrw_A          164 CTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI--DQWNKV  238 (371)
T ss_dssp             SCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred             CCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence            999999999998654322   223467999999999999889999999999999999999999999754221  111111


Q ss_pred             HHhccc--hhh--------------------------hccc-ccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          918 RQKRGA--IEV--------------------------LDKS-LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       918 ~~~~~~--~~~--------------------------~~~~-~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      ....+.  .+.                          .... ..............+.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          239 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            000000  000                          0000 00000001112345667899999999999999999998


Q ss_pred             H
Q 039419          969 M  969 (1035)
Q Consensus       969 ~  969 (1035)
                      +
T Consensus       319 h  319 (371)
T 2xrw_A          319 H  319 (371)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.1e-37  Score=347.79  Aligned_cols=276  Identities=21%  Similarity=0.307  Sum_probs=206.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCccccccc---ccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDC---QNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .++|...+.||+|+||.||+|.+ +++.||||++...........   ...........+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36799999999999999999988 899999999965432211100   00111111223789999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhh------hhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSL------LHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll  834 (1035)
                      ++++.+.+..|+||||+++|+|.++      +.......+++..+..++.|++.||+|||+ .   ||+||||||+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence            9999999999999999999999999      665435669999999999999999999999 8   99999999999999


Q ss_pred             cCCCceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCc-cccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          835 GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITE-KSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      +.++.+||+|||.+......    ......||+.|+|||+..+. .++. ++||||||+++|||++|+.||...... ..
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VE  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HH
Confidence            99999999999999876443    22356799999999998876 5666 999999999999999999999754332 22


Q ss_pred             HHHHHHHhccchhhhcc-cccCCCc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDK-SLRARPE-----VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....+............ .......     ........+.+++.+||+.||++||+++|++++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            22222111100000000 0000000     000011234567888999999999999999884

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=332.44  Aligned_cols=252  Identities=27%  Similarity=0.361  Sum_probs=194.1

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      +|.....||+|+||.||+|.+. +++.||||++.....              ...+.+.+|+.+++.++||||+++++++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~   88 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--------------RYSQPLHEEIALHKHLKHKNIVQYLGSF   88 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----------------HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--------------HHHHHHHHHHHHHHhCCCCCEeeEeeEE
Confidence            3445569999999999999875 588999999864321              1246789999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-CCceEEe
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-EFEPYIA  843 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~kl~  843 (1035)
                      .+.+..++||||+++++|.+++..... ..+++..+..++.|+++||+|||+.   +|+||||||+||+++. ++.+||+
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~  165 (295)
T 2clq_A           89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKIS  165 (295)
T ss_dssp             EETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEEC
T ss_pred             EeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEe
Confidence            999999999999999999999976532 3467888999999999999999999   9999999999999987 8999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCC--CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK--ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |||.++......  .......||+.|+|||+..+..  ++.++||||||+++|||++|+.||.............  .. 
T Consensus       166 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~-  240 (295)
T 2clq_A          166 DFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--GM-  240 (295)
T ss_dssp             CTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--HH-
T ss_pred             ecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--cc-
Confidence            999998764422  1223567999999999976543  7899999999999999999999996432211111100  00 


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ...........+      ..+..++.+||+.||++||++.+++++
T Consensus       241 ---~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          241 ---FKVHPEIPESMS------AEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ---HCCCCCCCTTSC------HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ---ccccccccccCC------HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               001111111111      123457888999999999999999873

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-36  Score=347.73  Aligned_cols=260  Identities=21%  Similarity=0.267  Sum_probs=191.9

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ..++|...+.||+|+||+||+|.+. +|+.||||++....                  ....+|+.+++.++||||++++
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------------------~~~~~E~~il~~l~hpnIv~l~   66 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------------------RYKNRELDIMKVLDHVNIIKLV   66 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------------------TSCCHHHHHHTTCCCTTBCCEE
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------------------chHHHHHHHHHHcCCCCccchh
Confidence            3468999999999999999999764 68999999985421                  1123799999999999999999


Q ss_pred             eEEEcC--------------------------------------CcceEEEEeCCCCChhhhhhh--cCCCCCCHHHHHH
Q 039419          763 GCCWNR--------------------------------------NTRLLMYDYMPNGSLGSLLHE--RRDSCLEWELRYR  802 (1035)
Q Consensus       763 ~~~~~~--------------------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~  802 (1035)
                      +++...                                      ...++||||++ |+|.+.+..  .....+++..+..
T Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~  145 (383)
T 3eb0_A           67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISI  145 (383)
T ss_dssp             EEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHH
T ss_pred             heeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHH
Confidence            998543                                      34789999997 588877764  2334589999999


Q ss_pred             HHHHHHHHHHHhhccCCCCeeccCCCcccEEEc-CCCceEEeeccCccccccCCccccccccCCcccccCCcccccC-CC
Q 039419          803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIG-PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KI  880 (1035)
Q Consensus       803 i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~  880 (1035)
                      ++.||++||+|||+.   ||+||||||+||+++ .++.+||+|||+|+......   ......||+.|+|||++.+. .+
T Consensus       146 i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~  219 (383)
T 3eb0_A          146 YIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEY  219 (383)
T ss_dssp             HHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCC
Confidence            999999999999999   999999999999998 68899999999998764433   22356789999999987764 48


Q ss_pred             CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc-hhhh---ccc-----ccCCCcccHH------HHHHH
Q 039419          881 TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA-IEVL---DKS-----LRARPEVEIE------EMLQT  945 (1035)
Q Consensus       881 ~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~-----~~~~~~~~~~------~~~~~  945 (1035)
                      +.++||||+||++|||++|+.||...... ......+...... .+.+   .+.     ..........      ....+
T Consensus       220 ~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (383)
T 3eb0_A          220 TPSIDLWSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA  298 (383)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred             CcchhhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence            99999999999999999999999754321 1112222111000 0000   000     0000000000      11234


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHHH
Q 039419          946 LGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       946 l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+++.+||+.||++|||+.|++++
T Consensus       299 ~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          299 IDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHccCChhhCCCHHHHhcC
Confidence            568888999999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.6e-37  Score=349.70  Aligned_cols=260  Identities=21%  Similarity=0.308  Sum_probs=191.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..+|...+.||+|+||+||+|++..+..||+|++.....                  ...+|+++++.++||||++++++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------------------~~~~E~~il~~l~h~niv~l~~~  100 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------------FKNRELQIMRIVKHPNVVDLKAF  100 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------------------SCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------------------hHHHHHHHHHhCCCCCcceEEEE
Confidence            357899999999999999999998877899999854221                  12369999999999999999999


Q ss_pred             EEcCCc------ceEEEEeCCCCChhhhhhh-cCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc-C
Q 039419          765 CWNRNT------RLLMYDYMPNGSLGSLLHE-RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG-P  836 (1035)
Q Consensus       765 ~~~~~~------~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~-~  836 (1035)
                      +...+.      .++||||++++.+...... .....+++..+..++.||++||+|||+.   ||+||||||+||+++ .
T Consensus       101 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~  177 (394)
T 4e7w_A          101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPP  177 (394)
T ss_dssp             EEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETT
T ss_pred             EEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCC
Confidence            965443      7899999976544333321 1234589999999999999999999999   999999999999999 7


Q ss_pred             CCceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                      ++.+||+|||+|+.......   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .....
T Consensus       178 ~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~  253 (394)
T 4e7w_A          178 SGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVE  253 (394)
T ss_dssp             TTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred             CCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence            99999999999987644332   2356789999999987654 5899999999999999999999999754321 11122


Q ss_pred             HHHHhccc-hh---hhc-----ccccCCCcccHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGA-IE---VLD-----KSLRARPEVEIE------EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~-~~---~~~-----~~~~~~~~~~~~------~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .++..... .+   ...     ............      ....+.+++.+||++||++|||+.|++++
T Consensus       254 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            21110000 00   000     000000000001      11245668889999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.6e-37  Score=354.43  Aligned_cols=201  Identities=25%  Similarity=0.351  Sum_probs=155.2

Q ss_pred             hcccc-CCeeeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVE-DSVVGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~-~~~iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      +.|.. .++||+|+||+||+|+++   +++.||||++....                ..+.+.+|+.++++++||||+++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~E~~~l~~l~hpniv~~   83 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----------------ISMSACREIALLRELKHPNVISL   83 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----------------CCHHHHHHHHHHHHCCCTTBCCC
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----------------CCHHHHHHHHHHHhcCCCCeeeE
Confidence            45665 568999999999999876   47899999985432                23468899999999999999999


Q ss_pred             EeEEEc--CCcceEEEEeCCCCChhhhhhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccE
Q 039419          762 LGCCWN--RNTRLLMYDYMPNGSLGSLLHERR-------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNI  832 (1035)
Q Consensus       762 ~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NI  832 (1035)
                      ++++..  ....|+||||+. |+|.+++...+       ...+++..+..++.||+.||+|||+.   +|+||||||+||
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NI  159 (405)
T 3rgf_A           84 QKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANI  159 (405)
T ss_dssp             CEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred             eeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHe
Confidence            999964  567899999995 58888876332       12489999999999999999999999   999999999999


Q ss_pred             EE----cCCCceEEeeccCccccccCCc-cccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          833 LI----GPEFEPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       833 ll----~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      |+    +.++.+||+|||+|+....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       160 ll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          160 LVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99    6788999999999987644321 1223456799999999998764 5899999999999999999999999754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.3e-37  Score=341.39  Aligned_cols=261  Identities=25%  Similarity=0.391  Sum_probs=183.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||||++......             ...+.+.+|+.++++++||||+++++
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~   80 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ-------------TSMDELLKEIQAMSQCHHPNIVSYYT   80 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------------CCCCCCCTTBCCEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc-------------hhHHHHHHHHHHHhhcCCCCEeeEEE
Confidence            367889999999999999999764 5899999998653221             12456889999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhc------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHER------RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++...+..++||||+++++|.+++...      ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.+
T Consensus        81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~  157 (303)
T 2vwi_A           81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGED  157 (303)
T ss_dssp             EEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTT
T ss_pred             EEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCC
Confidence            999999999999999999999998742      234589999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCc---cccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhH
Q 039419          838 FEPYIADFGLAKLVVEGDF---ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI  913 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~  913 (1035)
                      +.+||+|||.+........   ........||+.|+|||+..+ ..++.++||||||+++|||++|+.||........  
T Consensus       158 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--  235 (303)
T 2vwi_A          158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--  235 (303)
T ss_dssp             CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--
T ss_pred             CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--
Confidence            9999999999986643321   112234579999999998765 5689999999999999999999999976533221  


Q ss_pred             HHHHHHhcc-chh--hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          914 VDWVRQKRG-AIE--VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       914 ~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ......... ...  ..........+      ..+.+++.+||+.||++||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          236 LMLTLQNDPPSLETGVQDKEMLKKYG------KSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HHHHHTSSCCCTTC-----CCCCCCC------HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccCCCccccccccchhhhhhh------HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            111111000 000  00001111111      123457888999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.2e-37  Score=338.47  Aligned_cols=254  Identities=21%  Similarity=0.334  Sum_probs=195.1

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ..+.|.+.+.||+|+||.||+|.+. +++.||+|++.....              ...+.+.+|+.++++++||||++++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~   82 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--------------EELEDYIVEIEILATCDHPYIVKLL   82 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------------------CCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--------------HHHHHHHHHHHHHhcCCCCCEeeee
Confidence            3467899999999999999999886 489999999864321              1256789999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  158 (302)
T 2j7t_A           83 GAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRL  158 (302)
T ss_dssp             EEEECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             eeeeeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999987643 3389999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCccc-----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG-----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +|||++.......  .......||+.|+|||+.     .+..++.++||||||+++|+|++|+.||......  .....+
T Consensus       159 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~  234 (302)
T 2j7t_A          159 ADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKI  234 (302)
T ss_dssp             CCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH
T ss_pred             EECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHH
Confidence            9999876432211  112345799999999987     4667889999999999999999999999754221  111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....      +..  ..+...  ...+..++.+||+.||++||++.+++++
T Consensus       235 ~~~~~------~~~--~~~~~~--~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          235 AKSDP------PTL--LTPSKW--SVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             HHSCC------CCC--SSGGGS--CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             hccCC------ccc--CCcccc--CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            10000      000  001111  1123457888999999999999999873

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.6e-36  Score=341.81  Aligned_cols=264  Identities=23%  Similarity=0.259  Sum_probs=198.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||||++......             ...+.+.+|+.++++++||||+++++
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~   92 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ-------------TYCQRTLREIKILLRFRHENIIGIND   92 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH-------------HHHHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc-------------HHHHHHHHHHHHHHhcCCCCCcccee
Confidence            357999999999999999999765 5889999999643211             12467899999999999999999999


Q ss_pred             EEEcC-----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          764 CCWNR-----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       764 ~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      ++...     ...|+||||+. |+|.++++...   +++..+..++.||+.||+|||+.   ||+||||||+||+++.++
T Consensus        93 ~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~  165 (364)
T 3qyz_A           93 IIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTC  165 (364)
T ss_dssp             EECCSSTTTCCCEEEEEECCS-EEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred             EEecCCccccceEEEEEcccC-cCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCC
Confidence            99765     36799999996 59999987643   89999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCcc-ccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      .+||+|||.++........ .......||+.|+|||++. +..++.++||||+||++|||++|+.||....... .....
T Consensus       166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i  244 (364)
T 3qyz_A          166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHI  244 (364)
T ss_dssp             CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHH
T ss_pred             CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHH
Confidence            9999999999876543221 1234568999999999865 4458999999999999999999999997653221 11111


Q ss_pred             HHHhcc-chhhhc-----------ccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRG-AIEVLD-----------KSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~-~~~~~~-----------~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +..... ..+...           ............     ....+.+++.+||++||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          245 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            110000 000000           000000000000     01234568889999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-36  Score=337.59  Aligned_cols=253  Identities=22%  Similarity=0.272  Sum_probs=192.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC--CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR--HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~  763 (1035)
                      ++|.+.+.||+|+||.||+|.+.+++.||||++.......            ...+.+.+|+.++++++  ||||+++++
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN------------QTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH------------HHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc------------cchHHHHHHHHHHHhccccCCceEEEEE
Confidence            6799999999999999999998889999999996543221            13567899999999997  599999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||| +.+++|.+++....  .+++..+..++.|+++||+|||+.   +|+||||||+||++++ +.+||+
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence            9999999999999 55889999998754  389999999999999999999999   9999999999999964 899999


Q ss_pred             eccCccccccCCccccccccCCcccccCCccccc-----------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-----------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      |||+++...............||+.|+|||+..+           ..++.++||||||+++|||++|+.||.........
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  248 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK  248 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence            9999987654433223345679999999998765           46888999999999999999999999754321111


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....          .+.......+....  ..+.+++.+||+.||++||+++|++++
T Consensus       249 ~~~~----------~~~~~~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 LHAI----------IDPNHEIEFPDIPE--KDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHH----------HCTTSCCCCCCCSC--HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHH----------HhcccccCCcccch--HHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            1111          11111111111111  123457788999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.3e-36  Score=343.44  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=186.6

Q ss_pred             HHHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          681 VEQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       681 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      .....++|.+.+.||+|+||+||+|++. +++.||||++.....               ....+.+|+..++.++||||+
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~~l~~l~h~niv   82 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---------------FRNRELQIMQDLAVLHHPNIV   82 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---------------CCCHHHHHHHHHHHHCCTTBC
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---------------ccHHHHHHHHHHHhcCCCCcc
Confidence            4566789999999999999999999875 589999999854321               123567888889999999999


Q ss_pred             eEEeEEEcCCc-------ceEEEEeCCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHhh--ccCCCCeeccCCC
Q 039419          760 RFLGCCWNRNT-------RLLMYDYMPNGSLGSLLHE--RRDSCLEWELRYRIILGAAQGLAYLH--HDCVPPIVHRDIK  828 (1035)
Q Consensus       760 ~l~~~~~~~~~-------~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~ivHrDik  828 (1035)
                      ++++++...+.       .++||||+++ +|...+..  .....+++..+..++.|++.||+|||  +.   +|+|||||
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlk  158 (360)
T 3e3p_A           83 QLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIK  158 (360)
T ss_dssp             CEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCC
T ss_pred             cHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCC
Confidence            99999976443       7899999976 55544432  22345889999999999999999999  87   99999999


Q ss_pred             cccEEEcC-CCceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          829 ANNILIGP-EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       829 p~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      |+||+++. ++.+||+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       159 p~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          159 PHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             GGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            99999997 8999999999998765433   22356789999999987654 4899999999999999999999999764


Q ss_pred             CCCchhHHHHHHHhccc-hhhhccc--------cc---CCC------cccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          907 IPEGLHIVDWVRQKRGA-IEVLDKS--------LR---ARP------EVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~-~~~~~~~--------~~---~~~------~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      ... ......++..... .+.....        ..   ..+      .........+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          236 NSA-GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             SHH-HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ChH-HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            321 1111121111000 0000000        00   000      000012234567889999999999999999987


Q ss_pred             H
Q 039419          969 M  969 (1035)
Q Consensus       969 ~  969 (1035)
                      +
T Consensus       315 h  315 (360)
T 3e3p_A          315 H  315 (360)
T ss_dssp             S
T ss_pred             C
Confidence            4

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.7e-37  Score=347.54  Aligned_cols=259  Identities=24%  Similarity=0.303  Sum_probs=181.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +|+.||||++.......            ...+++.+|+.+++.++||||+++++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~~~~   95 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI------------IHAKRTYRELRLLKHMKHENVIGLLD   95 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCH------------HHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            478999999999999999999765 58999999986532211            12567889999999999999999999


Q ss_pred             EEEcC------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          764 CCWNR------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       764 ~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++...      ...|+||||+ +++|.++++..   .+++..+..++.||++||+|||+.   ||+||||||+||+++.+
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~  168 (367)
T 2fst_X           96 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED  168 (367)
T ss_dssp             EECSCSSGGGCCCCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             EEecCCccccCCeEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCC
Confidence            99754      5579999999 78999988753   389999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      +.+||+|||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....  ......
T Consensus       169 ~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~l~~  241 (367)
T 2fst_X          169 CELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKL  241 (367)
T ss_dssp             CCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH
T ss_pred             CCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Confidence            99999999999865332     234679999999999776 6789999999999999999999999975422  111111


Q ss_pred             HHHh-cc-chhhhc-----------ccccCCCcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQK-RG-AIEVLD-----------KSLRARPEVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~-~~-~~~~~~-----------~~~~~~~~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +... .. ..+...           ..+...+......     .....+++.+||..||++|||+.|++++
T Consensus       242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            1110 00 000000           0011111111111     1234668889999999999999999885

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-36  Score=350.70  Aligned_cols=258  Identities=25%  Similarity=0.339  Sum_probs=190.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ..|...+.||+|+||+||+|++. +++.||||++....                  ..+.+|++++++++|||||+++++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~il~~l~hpniv~l~~~  115 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------------RFKNRELQIMRKLDHCNIVRLRYF  115 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------------------TSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------------------hhHHHHHHHHHHcCCCCccceeeE
Confidence            35888899999999999999886 58999999985421                  112379999999999999999999


Q ss_pred             EEcCC------cceEEEEeCCCCChhhhhhh--cCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          765 CWNRN------TRLLMYDYMPNGSLGSLLHE--RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       765 ~~~~~------~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                      +...+      ..++||||+++ ++.+.+..  .....+++..+..++.||++||+|||+.   +|+||||||+|||++.
T Consensus       116 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~  191 (420)
T 1j1b_A          116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDP  191 (420)
T ss_dssp             EEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEET
T ss_pred             EeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeC
Confidence            85421      35789999975 67666543  2234589999999999999999999998   9999999999999996


Q ss_pred             C-CceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          837 E-FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       837 ~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                      + +.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.
T Consensus       192 ~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-~~~l~  267 (420)
T 1j1b_A          192 DTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLV  267 (420)
T ss_dssp             TTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHH
T ss_pred             CCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHH
Confidence            5 5789999999987644322   2346789999999998654 789999999999999999999999975422 11222


Q ss_pred             HHHHHhcc-chhhh---ccc-----ccCCCcccHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRG-AIEVL---DKS-----LRARPEVEIE------EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~-~~~~~---~~~-----~~~~~~~~~~------~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..++.... ..+.+   .+.     +.........      ....+.+++.+||+.||++||++.|++++
T Consensus       268 ~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            22221100 00000   000     0000000000      11245678889999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.7e-37  Score=352.08  Aligned_cols=257  Identities=12%  Similarity=0.023  Sum_probs=179.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC--CCCceeeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI--RHKNIVRFL  762 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~  762 (1035)
                      ..|...+.||+|+||+||+|.+. +++.||||++........           ...+.+.+|+.+++.+  +||||++++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~E~~~~~~l~~~hp~iv~~~  130 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR-----------SELERLHEATFAAARLLGESPEEARDR  130 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHH-----------HHHHHHHHHHHHHHHHHC---------
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccc-----------cHHHHHHHHHHHHHHhcccChhhhhhc
Confidence            45888999999999999999876 689999999976543222           1245777885544444  699988865


Q ss_pred             -------eEEEcCC-----------------cceEEEEeCCCCChhhhhhhcCCCCCCHHHH------HHHHHHHHHHHH
Q 039419          763 -------GCCWNRN-----------------TRLLMYDYMPNGSLGSLLHERRDSCLEWELR------YRIILGAAQGLA  812 (1035)
Q Consensus       763 -------~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~~L~  812 (1035)
                             +++..++                 ..|+||||++ |+|.+++...+.. +++..+      ..++.||++||+
T Consensus       131 ~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~vk~~i~~qi~~aL~  208 (371)
T 3q60_A          131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV-YVFRGDEGILALHILTAQLIRLAA  208 (371)
T ss_dssp             -CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc-cchhhhhhhhhHHHHHHHHHHHHH
Confidence                   5554332                 3799999998 8999999875332 455555      678899999999


Q ss_pred             HhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCccccc--CCCCccccchhHH
Q 039419          813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYG  890 (1035)
Q Consensus       813 ~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG  890 (1035)
                      |||++   +|+||||||+|||++.++.+||+|||+++......     ....||+.|+|||++.+  ..++.++||||||
T Consensus       209 ~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG  280 (371)
T 3q60_A          209 NLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLG  280 (371)
T ss_dssp             HHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH
T ss_pred             HHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHH
Confidence            99999   99999999999999999999999999998653321     13456799999999877  6799999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          891 VVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       891 vvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      |++|||++|+.||....+.....  |.  ...................+  ...+.+++.+||++||++||++.|++++
T Consensus       281 ~il~elltg~~Pf~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          281 LSIYRVWCLFLPFGLVTPGIKGS--WK--RPSLRVPGTDSLAFGSCTPL--PDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHHHHHHSSCSTTBCCTTCTTC--CC--BCCTTSCCCCSCCCTTSSCC--CHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHHHHHHhCCCCCCCcCcccccc--hh--hhhhhhccccccchhhccCC--CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99999999999998653321100  00  00000000000000000011  1233457888999999999999999873

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.1e-36  Score=332.68  Aligned_cols=255  Identities=20%  Similarity=0.314  Sum_probs=185.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|+..+.||+|+||+||+|++. +++.||||++........            ..+.+.++...++.++||||+++++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~~~~~~~~~~h~~iv~~~~   73 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE------------QKRLLMDLDISMRTVDCPFTVTFYG   73 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH------------HHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH------------HHHHHHHHHHHHHhCCCCeEEEEee
Confidence            367899999999999999999874 689999999965432221            1344555666688889999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++.+++..|+||||++ |+|.+++...  ....+++..+..++.|++.||+|||++.  ||+||||||+||+++.++.+|
T Consensus        74 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~k  150 (290)
T 3fme_A           74 ALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVK  150 (290)
T ss_dssp             EEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEE
T ss_pred             eeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEE
Confidence            9999999999999996 5888877542  3345899999999999999999999852  899999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      |+|||.++.......   .....||+.|+|||++    .+..++.++||||+|+++|||++|+.||.............+
T Consensus       151 l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  227 (290)
T 3fme_A          151 MCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV  227 (290)
T ss_dssp             BCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred             EeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence            999999987644322   2345799999999985    566789999999999999999999999975332222111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...          ....+....  ...+.+++.+||++||++|||+.|++++
T Consensus       228 ~~~----------~~~~~~~~~--~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          228 EEP----------SPQLPADKF--SAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HSC----------CCCCCTTTS--CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccC----------CCCcccccC--CHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            110          011111111  1123557888999999999999999984

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-36  Score=339.24  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=193.0

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRF  761 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  761 (1035)
                      ..++|...+.||+|+||.||+|++. +++.||||++.....               ..+.+.+|+.+++++ +||||+++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~e~~~l~~l~~h~~i~~~   86 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---------------EEEEIKQEINMLKKYSHHRNIATY   86 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------------TTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---------------cHHHHHHHHHHHHhccCCCCeeee
Confidence            3567899999999999999999875 689999999854321               235789999999999 79999999


Q ss_pred             EeEEEc------CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          762 LGCCWN------RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       762 ~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++..      .+..|+||||+++|+|.+++.......+++..+..++.||+.||+|||+.   ||+||||||+||+++
T Consensus        87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~  163 (326)
T 2x7f_A           87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT  163 (326)
T ss_dssp             EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred             eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc
Confidence            999987      45789999999999999999876545689999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG  910 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~  910 (1035)
                      .++.+||+|||++.......  .......||+.|+|||++.     +..++.++||||||+++|+|++|+.||...... 
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-  240 (326)
T 2x7f_A          164 ENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-  240 (326)
T ss_dssp             TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-
T ss_pred             CCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-
Confidence            99999999999998654322  1223457999999999876     567889999999999999999999999654221 


Q ss_pred             hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       .....+....     .........+      ..+..++.+||+.||++||++.+++++
T Consensus       241 -~~~~~~~~~~-----~~~~~~~~~~------~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          241 -RALFLIPRNP-----APRLKSKKWS------KKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             -HHHHHHHHSC-----CCCCSCSCSC------HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHhhcCc-----cccCCccccC------HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             1111111100     0000011111      123457788999999999999999884

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.6e-36  Score=328.58  Aligned_cols=256  Identities=23%  Similarity=0.283  Sum_probs=201.9

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      ....++|.+.+.||+|+||.||+|+.. +++.||||++.......            ...+.+.+|+.++++++||||++
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~i~~   85 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN------------KDTSTILREVELLKKLDHPNIMK   85 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS------------SCHHHHHHHHHHHHTCCCTTBCC
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch------------HHHHHHHHHHHHHHhccCCCccE
Confidence            455689999999999999999999876 68999999986432211            23568999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC---
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE---  837 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~---  837 (1035)
                      +++++.+.+..|+||||+++++|.+++.....  +++..+..++.||+.||+|||+.   +|+||||||+||+++.+   
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~  160 (287)
T 2wei_A           86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD  160 (287)
T ss_dssp             EEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTT
T ss_pred             EEEEEeCCCeEEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCc
Confidence            99999999999999999999999999876654  89999999999999999999999   99999999999999754   


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +.+||+|||.+.......   ......||+.|+|||+..+ .++.++||||||+++|+|++|+.||.....  ......+
T Consensus       161 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~  234 (287)
T 2wei_A          161 CDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRV  234 (287)
T ss_dssp             CCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred             ccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence            469999999998664432   1224468999999998765 488999999999999999999999975421  1122211


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ......   .........+      ....+++.+||++||++||++.|++++
T Consensus       235 ~~~~~~---~~~~~~~~~~------~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          235 ETGKYA---FDLPQWRTIS------DDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             HHCCCC---CCSGGGTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HcCCCC---CCchhhhhcC------HHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            111000   0000001111      234557888999999999999999984

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=356.36  Aligned_cols=347  Identities=19%  Similarity=0.181  Sum_probs=259.9

Q ss_pred             EEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhccccc
Q 039419          179 VVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNN  258 (1035)
Q Consensus       179 ~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~  258 (1035)
                      .++.++++++ .+|..+.  ++++.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus        15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            3444444444 3444432  466777777777776666677777777777777777776667777777777777777777


Q ss_pred             ccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhc
Q 039419          259 FDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQ  338 (1035)
Q Consensus       259 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~  338 (1035)
                      +.+..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|++|+++.+    
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----  167 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI----  167 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC----
T ss_pred             CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc----
Confidence            7755555677777777777777777777777777777778888877777777777777777788888877776532    


Q ss_pred             cccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccc
Q 039419          339 NKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQ  418 (1035)
Q Consensus       339 n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~  418 (1035)
                            .+..|..+++|+.|+|++|.+++..+..|..+++|++|++++|.+.+.+|..+..              ..+|+
T Consensus       168 ------~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~--------------~~~L~  227 (477)
T 2id5_A          168 ------PTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY--------------GLNLT  227 (477)
T ss_dssp             ------CHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTT--------------TCCCS
T ss_pred             ------ChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCccccc--------------Ccccc
Confidence                  2345777888888888888888777777888888888888888776555544322              23688


Q ss_pred             eeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCc
Q 039419          419 MLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK  498 (1035)
Q Consensus       419 ~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  498 (1035)
                      +|+|++|++++..+..|..+++|+.|+|++|+++++.+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+
T Consensus       228 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  307 (477)
T 2id5_A          228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ  307 (477)
T ss_dssp             EEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSC
T ss_pred             EEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCc
Confidence            99999999997666788999999999999999998888889999999999999999998889999999999999999998


Q ss_pred             CcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCC
Q 039419          499 LSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPD  577 (1035)
Q Consensus       499 l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~  577 (1035)
                      |++                         ..+..|..+++|++|+|++|++.++....+-...+..+++.++...+.-|.
T Consensus       308 l~~-------------------------~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          308 LTT-------------------------LEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             CSC-------------------------CCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             Cce-------------------------eCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCch
Confidence            872                         233456678899999999999988765444444455566777777665554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.3e-36  Score=331.51  Aligned_cols=263  Identities=21%  Similarity=0.272  Sum_probs=202.9

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceee
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVR  760 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~  760 (1035)
                      ...++|...+.||+|+||.||+|.+. +++.||||++..........     .......+.+.+|+.+++++. ||||++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA-----EEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCH-----HHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCH-----HHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            34578999999999999999999876 58999999996543211000     000123567899999999996 999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++.+.+..++||||+++++|.+++.....  +++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~  163 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNI  163 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcE
Confidence            99999999999999999999999999987643  89999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                      ||+|||.+.......   ......|++.|+|||+..      ...++.++||||||+++|||++|+.||.....  ....
T Consensus       164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~  238 (298)
T 1phk_A          164 KLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--MLML  238 (298)
T ss_dssp             EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHH
T ss_pred             EEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--HHHH
Confidence            999999998765432   223567999999999864      45688999999999999999999999965321  1111


Q ss_pred             HHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+....         .....+........+.+++.+||+.||++||++.|++++
T Consensus       239 ~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          239 RMIMSGN---------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHHHTC---------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhcCC---------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            1111110         000000000111234457888999999999999999873

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.9e-36  Score=338.42  Aligned_cols=258  Identities=18%  Similarity=0.229  Sum_probs=200.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-C-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc------
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-E-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN------  757 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------  757 (1035)
                      ++|.+.+.||+|+||+||+|.+ . +++.||||++....               ...+.+.+|+.+++.++|++      
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~~~~~~~   78 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD---------------RYCEAARSEIQVLEHLNTTDPNSTFR   78 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH---------------HHHHHHHHHHHHHHHHHHHCTTCTTC
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC---------------chhHHHHHHHHHHHHhhhcCCCCcee
Confidence            5799999999999999999976 3 58899999985421               12467889999999987654      


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-  836 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-  836 (1035)
                      ++++++++.+.+..++||||+ +++|.+++.......+++..+..++.||++||+|||+.   +|+||||||+||+++. 
T Consensus        79 i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~  154 (339)
T 1z57_A           79 CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQS  154 (339)
T ss_dssp             BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCC
T ss_pred             eEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecc
Confidence            999999999999999999999 89999999887666689999999999999999999999   9999999999999987 


Q ss_pred             ------------------CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh
Q 039419          837 ------------------EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT  898 (1035)
Q Consensus       837 ------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt  898 (1035)
                                        ++.+||+|||.++.....     .....||+.|+|||+..+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  229 (339)
T 1z57_A          155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence                              668999999999864332     235679999999999999899999999999999999999


Q ss_pred             CCCCCCCCCCCchhHHHHHHHhccc--hhhhc-----------------------------ccccCCCcccHHHHHHHHH
Q 039419          899 GKQPIDPTIPEGLHIVDWVRQKRGA--IEVLD-----------------------------KSLRARPEVEIEEMLQTLG  947 (1035)
Q Consensus       899 g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~~~~~~~~~~~~~l~  947 (1035)
                      |+.||......  .....+......  .....                             ................+.+
T Consensus       230 g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  307 (339)
T 1z57_A          230 GFTVFPTHDSK--EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD  307 (339)
T ss_dssp             SSCSCCCSCHH--HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred             CCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence            99999754321  111111110000  00000                             0000000001122344567


Q ss_pred             HHHhccCCCCCCCCCHHHHHHH
Q 039419          948 VALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       948 l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ++.+||+.||++|||++|++++
T Consensus       308 li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          308 LIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHhCcCcccccCHHHHhcC
Confidence            8999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3e-36  Score=366.14  Aligned_cols=260  Identities=23%  Similarity=0.345  Sum_probs=202.6

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .++|...+.||+|+||.||+|.+..    +..||||++......             ...+.|.+|+.++++++||||++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~  455 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-------------SVREKFLQEALTMRQFDHPHIVK  455 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH-------------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH-------------HHHHHHHHHHHHHHhCCCCCCCe
Confidence            3678899999999999999997743    567999998643221             23568999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +++++. ++..|+||||+++|+|.++++..+ ..+++..+..++.|+++||+|||+.   +|+||||||+|||++.++.+
T Consensus       456 l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~v  530 (656)
T 2j0j_A          456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV  530 (656)
T ss_dssp             EEEEEC-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred             EEEEEe-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCE
Confidence            999984 467899999999999999997653 3489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.....  ......+..
T Consensus       531 kL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~~~~i~~  607 (656)
T 2j0j_A          531 KLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIEN  607 (656)
T ss_dssp             EECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHH
T ss_pred             EEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHc
Confidence            9999999987644332 22234567889999999988899999999999999999997 9999975422  122222221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ...      .......+      ..+..++.+||+.||++||++.++++.|+.+..+.
T Consensus       608 ~~~------~~~~~~~~------~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          608 GER------LPMPPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             TCC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCC------CCCCcccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            110      00111111      23345788899999999999999999999986543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.9e-36  Score=347.55  Aligned_cols=261  Identities=22%  Similarity=0.232  Sum_probs=200.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC--------CC
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR--------HK  756 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp  756 (1035)
                      ++|.+.+.||+|+||+||+|.+. +++.||||++....               ...+.+.+|+.++++++        ||
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~~~~~~~~~~~  101 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE---------------HYTETALDEIRLLKSVRNSDPNDPNRE  101 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------------HHHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC---------------cchHHHHHHHHHHHHHhhcCCCCCCcc
Confidence            67999999999999999999765 58899999996421               12467889999999985        78


Q ss_pred             ceeeEEeEEE----cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccE
Q 039419          757 NIVRFLGCCW----NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNI  832 (1035)
Q Consensus       757 niv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NI  832 (1035)
                      ||+++++++.    +....|+||||+ ++++.+++.......+++..+..++.||+.||+|||+++  ||+||||||+||
T Consensus       102 ~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NI  178 (397)
T 1wak_A          102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENI  178 (397)
T ss_dssp             GBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGE
T ss_pred             eeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHe
Confidence            8999999997    556789999999 677777776655456999999999999999999999963  799999999999


Q ss_pred             EEcCCC-------------------------------------------------ceEEeeccCccccccCCcccccccc
Q 039419          833 LIGPEF-------------------------------------------------EPYIADFGLAKLVVEGDFARSSNTV  863 (1035)
Q Consensus       833 ll~~~~-------------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~  863 (1035)
                      |++.++                                                 .+||+|||.++.....     ....
T Consensus       179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~  253 (397)
T 1wak_A          179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTED  253 (397)
T ss_dssp             EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSC
T ss_pred             eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccC
Confidence            999775                                                 7999999999865432     2345


Q ss_pred             CCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch----hHHHHHHHhccc--h----------hhh
Q 039419          864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL----HIVDWVRQKRGA--I----------EVL  927 (1035)
Q Consensus       864 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~----~~~~~~~~~~~~--~----------~~~  927 (1035)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||........    .....+....+.  .          ...
T Consensus       254 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  333 (397)
T 1wak_A          254 IQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF  333 (397)
T ss_dssp             CSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred             CCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence            799999999999998999999999999999999999999986543221    111111110000  0          000


Q ss_pred             cc-----------------cccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          928 DK-----------------SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       928 ~~-----------------~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..                 .+.............+.+++.+||+.||++|||++|++++
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            00                 0000011122334456679999999999999999999874

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=9.1e-36  Score=342.17  Aligned_cols=337  Identities=22%  Similarity=0.233  Sum_probs=234.4

Q ss_pred             ccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEE
Q 039419          197 KLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTI  276 (1035)
Q Consensus       197 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  276 (1035)
                      .+++++.|++++|.++...+..+..+++|+.|+|++|.+++..+..|..+++|++|++++|.+.+..|..|.++++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            35667777777777663333345667777777777777776556667777777777777777776666667777777777


Q ss_pred             EccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCc
Q 039419          277 DLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLE  356 (1035)
Q Consensus       277 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~  356 (1035)
                      +|++|+++...+..|.++++|++|++++|++.+..+..|.++++|++|++++|+++.+             .+..+++|+
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-------------~~~~l~~L~  189 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-------------DLSLIPSLF  189 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-------------CGGGCTTCS
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-------------ccccccccc
Confidence            7777777755445567777777777777777766666677777777777777766532             245566777


Q ss_pred             EEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCccccc
Q 039419          357 AVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLA  436 (1035)
Q Consensus       357 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~  436 (1035)
                      .|++++|.+++.     ...++|++|++++|.++.....                 ..++|+.|+|++|++++.  ..+.
T Consensus       190 ~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~~~~-----------------~~~~L~~L~l~~n~l~~~--~~l~  245 (390)
T 3o6n_A          190 HANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGP-----------------VNVELTILKLQHNNLTDT--AWLL  245 (390)
T ss_dssp             EEECCSSCCSEE-----ECCSSCSEEECCSSCCCEEECC-----------------CCSSCCEEECCSSCCCCC--GGGG
T ss_pred             eeeccccccccc-----CCCCcceEEECCCCeeeecccc-----------------ccccccEEECCCCCCccc--HHHc
Confidence            777777777632     2335677777777777644221                 124577777777777743  4677


Q ss_pred             CCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcce
Q 039419          437 SLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDIS  516 (1035)
Q Consensus       437 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~  516 (1035)
                      .+++|++|+|++|++++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|++|+++ .+             
T Consensus       246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~-------------  310 (390)
T 3o6n_A          246 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HV-------------  310 (390)
T ss_dssp             GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CC-------------
T ss_pred             CCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ec-------------
Confidence            77777777777777777777777777777777777777763 4555666777777777777776 33             


Q ss_pred             eeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCChhhhhccccccccccccCC
Q 039419          517 LNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLC  596 (1035)
Q Consensus       517 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~N~~~c  596 (1035)
                                  |..+..+++|++|+|++|+++..+  +..+++|+.|++++|+|++... ...+..+....+.+++..|
T Consensus       311 ------------~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~c  375 (390)
T 3o6n_A          311 ------------ERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHC  375 (390)
T ss_dssp             ------------GGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCSCC
T ss_pred             ------------CccccccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccchhH-HHHHHHHHhhcccccCcee
Confidence                        334455678888888888887764  6778899999999999987532 2456777778888999999


Q ss_pred             CCCC
Q 039419          597 SRGH  600 (1035)
Q Consensus       597 ~~~~  600 (1035)
                      ..+.
T Consensus       376 ~~~~  379 (390)
T 3o6n_A          376 KIDY  379 (390)
T ss_dssp             CTTC
T ss_pred             cccc
Confidence            8654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.3e-36  Score=342.85  Aligned_cols=259  Identities=24%  Similarity=0.283  Sum_probs=194.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||+||+|.+. +|+.||||++.......            ...+.+.+|+.++++++||||+++++
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~~  108 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE------------IFAKRAYRELLLLKHMQHENVIGLLD  108 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccch------------hHHHHHHHHHHHHHhcCCCCchhhhh
Confidence            367889999999999999999775 58999999996543221            23567899999999999999999999


Q ss_pred             EEEcCCcc------eEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          764 CCWNRNTR------LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       764 ~~~~~~~~------~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      ++...+..      |+||||+. ++|.+++..    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.+
T Consensus       109 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~  180 (371)
T 4exu_A          109 VFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNED  180 (371)
T ss_dssp             EECSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred             heeccCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCC
Confidence            99877654      99999996 688887743    289999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      +.+||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ......
T Consensus       181 ~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i  254 (371)
T 4exu_A          181 CELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQI  254 (371)
T ss_dssp             CCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH
T ss_pred             CCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Confidence            99999999999865332     234678999999998876 77999999999999999999999999754211 111111


Q ss_pred             HHHhccc-hhhh-----------cccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRGA-IEVL-----------DKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~~-~~~~-----------~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +...... .+..           .......+.....     ....+.+++.+||+.||++|||++|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          255 LKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            1110000 0000           0000011111111     11244568888999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.5e-36  Score=334.70  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=198.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC--CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC---CCCcee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME--NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI---RHKNIV  759 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv  759 (1035)
                      .++|...+.||+|+||.||+|++.  +++.||+|++........            ....+.+|+.+++.+   +||||+
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~~~~h~~i~   77 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------------MPLSTIREVAVLRHLETFEHPNVV   77 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------------CBCTHHHHHHHHHHHHHTCCTTBC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc------------CCchhhHHHHHHHhhhccCCCCeE
Confidence            367999999999999999999873  588999999864332111            123466788877776   899999


Q ss_pred             eEEeEEE-----cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE
Q 039419          760 RFLGCCW-----NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       760 ~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll  834 (1035)
                      ++++++.     .....++||||+. |+|.+++.......+++..+..++.|++.||+|||+.   ||+||||||+||++
T Consensus        78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili  153 (326)
T 1blx_A           78 RLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILV  153 (326)
T ss_dssp             CEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred             eeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEE
Confidence            9999987     4567899999997 6999999877666689999999999999999999999   99999999999999


Q ss_pred             cCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          835 GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                      +.++.+||+|||.++......   ......||+.|+|||+..+..++.++||||||+++|||++|+.||......  ...
T Consensus       154 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~  228 (326)
T 1blx_A          154 TSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQL  228 (326)
T ss_dssp             CTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH
T ss_pred             cCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH--HHH
Confidence            999999999999998654322   233567999999999998889999999999999999999999999754321  111


Q ss_pred             HHHHHhccc--hhhhcc-------cccC-------CCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRGA--IEVLDK-------SLRA-------RPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~~--~~~~~~-------~~~~-------~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..+......  ......       ....       .......  ....+++.+||+.||++||++.|++++
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          229 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID--ELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC--HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCC--HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            111110000  000000       0000       0000011  123457888999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.2e-36  Score=343.66  Aligned_cols=276  Identities=19%  Similarity=0.219  Sum_probs=195.4

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ....++|...+.||+|+||.||+|.+.+|+.||||++..........   .........+.+.+|+.++++++||||+++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV---NILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCE---EGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchh---hhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            44558899999999999999999988889999999996543322110   001111234789999999999999999999


Q ss_pred             EeEEEcC-----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          762 LGCCWNR-----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       762 ~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                      ++++...     ...|+||||+. |+|.+++.... ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~  169 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLAD  169 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcC
Confidence            9998543     35799999997 68888887543 3489999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                      ++.+||+|||+++......   ......||+.|+|||+..+ ..++.++||||+||++|+|++|+.||....... ....
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~  245 (362)
T 3pg1_A          170 NNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLNK  245 (362)
T ss_dssp             TCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH
T ss_pred             CCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence            9999999999997543322   2235678999999998776 678999999999999999999999997542211 1111


Q ss_pred             HHHHhccc-------------hhhhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRGA-------------IEVLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+......             ...........+.....     ......+++.+||+.||++|||++|++++
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11100000             00011111111111000     01234568889999999999999999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-35  Score=340.17  Aligned_cols=200  Identities=24%  Similarity=0.274  Sum_probs=171.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CC-----c
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HK-----N  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----n  757 (1035)
                      .++|.+.+.||+|+||+||+|.+. +++.||||++....               ...+.+.+|+.+++.++ |+     +
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~~~~~~~  117 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK---------------AFLNQAQIEVRLLELMNKHDTEMKYY  117 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH---------------HHHHHHHHHHHHHHHHHHCSSGGGGG
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH---------------HHHHHHHHHHHHHHHHHhccccccee
Confidence            578999999999999999999776 58899999996421               12456778898888875 44     5


Q ss_pred             eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc--
Q 039419          758 IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG--  835 (1035)
Q Consensus       758 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~--  835 (1035)
                      |+++++++...+..|+||||+. |+|.+++.......+++..+..++.|++.||+|||.. ..||+||||||+|||++  
T Consensus       118 iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~  195 (382)
T 2vx3_A          118 IVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNP  195 (382)
T ss_dssp             BCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESST
T ss_pred             EEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecC
Confidence            9999999999999999999995 5999999877655689999999999999999999952 12899999999999995  


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      .++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       196 ~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          196 KRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            4788999999999876332     23567999999999999989999999999999999999999999754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=338.75  Aligned_cols=260  Identities=21%  Similarity=0.347  Sum_probs=195.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++|...+.||+|+||.||+|.+.+  .||+|++........            ..+.+.+|+.++++++||||++++++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~iv~~~~~   97 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNED------------QLKAFKREVMAYRQTRHENVVLFMGA   97 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCC------------CCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHH------------HHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            3678999999999999999998864  499999875432221            12356789999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..++||||+++++|.+++...+ ..+++..+..++.||++||+|||+.   +|+||||||+||+++ ++.+||+|
T Consensus        98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~D  172 (319)
T 2y4i_B           98 CMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITD  172 (319)
T ss_dssp             EECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECC
T ss_pred             EecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEee
Confidence            999999999999999999999997654 3488999999999999999999999   999999999999998 67999999


Q ss_pred             ccCccccccCC---ccccccccCCcccccCCccccc---------CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          845 FGLAKLVVEGD---FARSSNTVAGSYGYIAPEYGYM---------MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       845 FG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      ||+++......   .........||+.|+|||+..+         ..++.++||||||+++|||++|+.||......  .
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~  250 (319)
T 2y4i_B          173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE--A  250 (319)
T ss_dssp             CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH--H
T ss_pred             cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H
Confidence            99987653221   1122234569999999998764         45788999999999999999999999754221  1


Q ss_pred             HHHHHHHhccchhhhcccc-cCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          913 IVDWVRQKRGAIEVLDKSL-RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ....+...      ..+.. ....+..      +..++.+||+.||++||++.++++.|+.+....
T Consensus       251 ~~~~~~~~------~~~~~~~~~~~~~------l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          251 IIWQMGTG------MKPNLSQIGMGKE------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HHHHHHTT------CCCCCCCSSCCTT------HHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             HHHHhccC------CCCCCCcCCCCHH------HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            11111110      00111 1111222      345677899999999999999999998886554

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=8.8e-36  Score=337.60  Aligned_cols=263  Identities=23%  Similarity=0.291  Sum_probs=195.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +|+.||||++......             .....+.+|+.++++++||||+++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~iv~~~~   76 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP-------------LFALRTLREIKILKHFKHENIITIFN   76 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH-------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc-------------hHHHHHHHHHHHHHhCcCCCcCCeee
Confidence            467899999999999999999876 5899999999643211             12457889999999999999999999


Q ss_pred             EEEcC-----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          764 CCWNR-----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       764 ~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      ++...     ...|+||||+. |+|.+++...   .+++..+..++.|++.||+|||+.   ||+||||||+||+++.++
T Consensus        77 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~  149 (353)
T 2b9h_A           77 IQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNC  149 (353)
T ss_dssp             ECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTC
T ss_pred             eecccccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCC
Confidence            88754     56799999996 6999998763   389999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCccc--------cccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 039419          839 EPYIADFGLAKLVVEGDFAR--------SSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE  909 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~  909 (1035)
                      .+||+|||+++.........        ......||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus       150 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  229 (353)
T 2b9h_A          150 DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR  229 (353)
T ss_dssp             CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            99999999998765332111        122457899999999865 467899999999999999999999999754211


Q ss_pred             chhHHHHHHHhccch---h-----------hhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          910 GLHIVDWVRQKRGAI---E-----------VLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       910 ~~~~~~~~~~~~~~~---~-----------~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                        .....+....+..   .           .........+.....     ......+++.+||+.||++|||++|++++
T Consensus       230 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          230 --HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             --HHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --HHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              1111111000000   0           000000000000000     11234568888999999999999999874

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.9e-36  Score=336.50  Aligned_cols=254  Identities=22%  Similarity=0.264  Sum_probs=170.4

Q ss_pred             HHhccccC-CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          684 VLKCLVED-SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       684 ~~~~~~~~-~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      +.++|.+. +.||+|+||+||+|.+. +++.||||++....                  +........++.++||||+++
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------~~~~e~~~~~~~~~h~~i~~~   87 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------------------KARQEVDHHWQASGGPHIVCI   87 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------------------HHHHHHHHHHHHTTSTTBCCE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------------------HHHHHHHHHHHhcCCCChHHH
Confidence            45678875 46999999999999876 58999999985321                  112222333566799999999


Q ss_pred             EeEEEc----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-
Q 039419          762 LGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-  836 (1035)
Q Consensus       762 ~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-  836 (1035)
                      ++++..    ....++||||++||+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++. 
T Consensus        88 ~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~  164 (336)
T 3fhr_A           88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSK  164 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCS
T ss_pred             HHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEec
Confidence            999876    44579999999999999999887666799999999999999999999999   9999999999999976 


Q ss_pred             --CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHH
Q 039419          837 --EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       837 --~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~  914 (1035)
                        ++.+||+|||+++......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... 
T Consensus       165 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-  239 (336)
T 3fhr_A          165 EKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP-  239 (336)
T ss_dssp             STTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             CCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh-
Confidence              4559999999998654322    234578999999999988889999999999999999999999997543221100 


Q ss_pred             HHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....................+      ..+.+++.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          240 GMKRRIRLGQYGFPNPEWSEVS------EDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             -----------CCCTTTSTTCC------HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hHHHhhhccccccCchhhccCC------HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000000000000000001111      223457888999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.4e-36  Score=329.57  Aligned_cols=254  Identities=25%  Similarity=0.386  Sum_probs=188.8

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ..++|...+.||+|+||.||+|++. +++.||||++....               ...+.+.+|+.++++++||||++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~E~~~l~~l~h~~i~~~~   68 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE---------------EKLSTILSEVMLLASLNHQYVVRYY   68 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH---------------HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH---------------HHHHHHHHHHHHHHhcCchHHHHHH
Confidence            4578999999999999999999875 68999999984311               1246789999999999999999999


Q ss_pred             eEEEc-------------CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCc
Q 039419          763 GCCWN-------------RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKA  829 (1035)
Q Consensus       763 ~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp  829 (1035)
                      +++.+             .+..|+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.   +|+||||||
T Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp  144 (303)
T 1zy4_A           69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKP  144 (303)
T ss_dssp             EEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred             HHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCH
Confidence            99865             346799999999999999997643 3478899999999999999999999   999999999


Q ss_pred             ccEEEcCCCceEEeeccCccccccCCc------------cccccccCCcccccCCcccccC-CCCccccchhHHHHHHHH
Q 039419          830 NNILIGPEFEPYIADFGLAKLVVEGDF------------ARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEV  896 (1035)
Q Consensus       830 ~NIll~~~~~~kl~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~el  896 (1035)
                      +||+++.++.+||+|||.++.......            ........||+.|+|||+..+. .++.++||||||+++|||
T Consensus       145 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  224 (303)
T 1zy4_A          145 MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM  224 (303)
T ss_dssp             GGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHH
T ss_pred             HhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHH
Confidence            999999999999999999986543210            1122345689999999998754 689999999999999999


Q ss_pred             HhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          897 LTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       897 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ++   ||...    ..................+....      .....+..++.+||++||++||++.+++++
T Consensus       225 ~~---p~~~~----~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          225 IY---PFSTG----MERVNILKKLRSVSIEFPPDFDD------NKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HS---CCSSH----HHHHHHHHHHHSTTCCCCTTCCT------TTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             Hh---ccCCc----hhHHHHHHhccccccccCccccc------cchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            98   55421    11111111111110011111111      111223457888999999999999999884

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.7e-36  Score=332.68  Aligned_cols=261  Identities=21%  Similarity=0.272  Sum_probs=188.1

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+.. ++.||||++.....              ...+.+.+|+.++++++||||+++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~~   75 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP--------------QSVKHALREIKIIRRLDHDNIVKVFE   75 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH--------------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh--------------HHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence            3678899999999999999998775 89999999854321              12467899999999999999999999


Q ss_pred             EEE--------------cCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCc
Q 039419          764 CCW--------------NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKA  829 (1035)
Q Consensus       764 ~~~--------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp  829 (1035)
                      ++.              +....|+||||++ |+|.+++...   .+++..+..++.|++.||+|||+.   ||+||||||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  148 (320)
T 2i6l_A           76 ILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKP  148 (320)
T ss_dssp             EECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSG
T ss_pred             eccccccccccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCH
Confidence            874              3356799999997 6999998653   388999999999999999999999   999999999


Q ss_pred             ccEEEc-CCCceEEeeccCccccccCCc-cccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          830 NNILIG-PEFEPYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       830 ~NIll~-~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      +||+++ .++.+||+|||.++....... ........||..|+|||+..+ ..++.++||||||+++|||++|+.||...
T Consensus       149 ~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          149 ANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             GGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            999997 567999999999987643211 122234567999999998754 67899999999999999999999999754


Q ss_pred             CCCchhHHHHHHHhccc-hh------------hhcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          907 IPEGLHIVDWVRQKRGA-IE------------VLDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      ...  .....+...... ..            ........ +.....     ....+.+++.+||+.||++||+++|+++
T Consensus       229 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          229 HEL--EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTE-PHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SHH--HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTS-CCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CHH--HHHHHHHHhcCCCchhhhhhhhhcCcccccccccC-CCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            321  111111110000 00            00000000 000000     1123456888999999999999999988


Q ss_pred             H
Q 039419          969 M  969 (1035)
Q Consensus       969 ~  969 (1035)
                      +
T Consensus       306 h  306 (320)
T 2i6l_A          306 H  306 (320)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.8e-35  Score=335.28  Aligned_cols=259  Identities=19%  Similarity=0.219  Sum_probs=199.3

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CC-cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc-----
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NG-EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN-----  757 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-----  757 (1035)
                      .++|.+.+.||+|+||+||+|.+. ++ +.||+|++....               ...+.+.+|+.++++++|++     
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~~~~~~~~~   82 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---------------KYREAARLEINVLKKIKEKDKENKF   82 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---------------HHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---------------cchhHHHHHHHHHHHHhhcCCCCce
Confidence            368999999999999999999775 34 689999985421               12467889999999997765     


Q ss_pred             -eeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE--
Q 039419          758 -IVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI--  834 (1035)
Q Consensus       758 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll--  834 (1035)
                       ++.+++++...+..++||||+ ++++.+++.......+++..+..++.||+.||+|||+.   +|+||||||+||++  
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~  158 (355)
T 2eu9_A           83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVN  158 (355)
T ss_dssp             CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESC
T ss_pred             eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEec
Confidence             999999999999999999999 77888888776655699999999999999999999999   99999999999999  


Q ss_pred             -----------------cCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHH
Q 039419          835 -----------------GPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL  897 (1035)
Q Consensus       835 -----------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ell  897 (1035)
                                       +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  233 (355)
T 2eu9_A          159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY  233 (355)
T ss_dssp             CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence                             66789999999999864332     23567999999999999889999999999999999999


Q ss_pred             hCCCCCCCCCCCchhHHHHHHHhccc--hhhhc----------c-------------------cccCCCcccHHHHHHHH
Q 039419          898 TGKQPIDPTIPEGLHIVDWVRQKRGA--IEVLD----------K-------------------SLRARPEVEIEEMLQTL  946 (1035)
Q Consensus       898 tg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~----------~-------------------~~~~~~~~~~~~~~~~l  946 (1035)
                      +|+.||......  .....+......  .....          .                   ...............+.
T Consensus       234 ~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  311 (355)
T 2eu9_A          234 RGFTLFQTHENR--EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF  311 (355)
T ss_dssp             HSSCSCCCSSHH--HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred             hCCCCCCCCCHH--HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence            999999754321  111111111000  00000          0                   00000000112233556


Q ss_pred             HHHHhccCCCCCCCCCHHHHHHH
Q 039419          947 GVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       947 ~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +++.+||+.||++|||+.|++++
T Consensus       312 ~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          312 DLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHhcCChhhCcCHHHHhcC
Confidence            78999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.5e-36  Score=331.91  Aligned_cols=251  Identities=19%  Similarity=0.276  Sum_probs=189.5

Q ss_pred             HHHHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC----CC
Q 039419          681 VEQVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI----RH  755 (1035)
Q Consensus       681 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l----~h  755 (1035)
                      .+...++|...+.||+|+||.||+|.+. +++.||||++...........        .....+.+|+.+++++    +|
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~~h   97 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPL--------SDSVTCPLEVALLWKVGAGGGH   97 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------------CCCCHHHHHHHHHHSSCCC
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccc--------hhhHHHHHHHHHHHhhcccCCC
Confidence            4555688999999999999999999775 588999999976543221110        0123456789999888    89


Q ss_pred             CceeeEEeEEEcCCcceEEEEe-CCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE
Q 039419          756 KNIVRFLGCCWNRNTRLLMYDY-MPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       756 pniv~l~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll  834 (1035)
                      |||+++++++.+.+..++|||| +.+++|.+++.....  +++..+..++.||++||+|||+.   +|+||||||+||++
T Consensus        98 ~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~--~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~  172 (312)
T 2iwi_A           98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILI  172 (312)
T ss_dssp             SSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEE
T ss_pred             CCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEE
Confidence            9999999999999999999999 789999999987654  89999999999999999999999   99999999999999


Q ss_pred             c-CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCC-ccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          835 G-PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKIT-EKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       835 ~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      + .++.+||+|||+++......    .....||..|+|||+..+..+. .++||||||+++|||++|+.||...      
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------  242 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------  242 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------
T ss_pred             eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------
Confidence            9 88999999999998765432    2356799999999988766664 5899999999999999999999632      


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ......        ........+      .....++.+||+.||++||+++|++++
T Consensus       243 -~~~~~~--------~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          243 -QEILEA--------ELHFPAHVS------PDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -HHHHHT--------CCCCCTTSC------HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -HHHhhh--------ccCCcccCC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             011110        001111111      123457888999999999999999874

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=3.1e-35  Score=356.39  Aligned_cols=336  Identities=22%  Similarity=0.237  Sum_probs=227.5

Q ss_pred             cccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEE
Q 039419          198 LSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTID  277 (1035)
Q Consensus       198 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  277 (1035)
                      +++++.|++++|.+....+..+.++++|+.|+|++|.+++..|..|+.+++|+.|+|++|.+.+..|..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            45566666666666543334455666666666666666655555666666666666666666666666666666677777


Q ss_pred             ccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcE
Q 039419          278 LSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA  357 (1035)
Q Consensus       278 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~  357 (1035)
                      |++|.|++..+..|+++++|++|+|++|.+.+..|..|.++++|++|+|++|+|+.+             .+..+++|+.
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-------------~~~~l~~L~~  196 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-------------DLSLIPSLFH  196 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-------------CGGGCTTCSE
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-------------Chhhhhhhhh
Confidence            777766655555566666777777777766666666666666666666666666522             2445566777


Q ss_pred             EeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccC
Q 039419          358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLAS  437 (1035)
Q Consensus       358 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~  437 (1035)
                      |++++|.+++     +....+|+.|++++|.++...+..                 .++|+.|+|++|.+++  +..+..
T Consensus       197 L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~-----------------~~~L~~L~L~~n~l~~--~~~l~~  252 (597)
T 3oja_B          197 ANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV-----------------NVELTILKLQHNNLTD--TAWLLN  252 (597)
T ss_dssp             EECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC-----------------CSCCCEEECCSSCCCC--CGGGGG
T ss_pred             hhcccCcccc-----ccCCchhheeeccCCccccccccc-----------------CCCCCEEECCCCCCCC--Chhhcc
Confidence            7777776653     223456777777777766432211                 1457777777777775  356777


Q ss_pred             CCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCccee
Q 039419          438 LTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISL  517 (1035)
Q Consensus       438 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L  517 (1035)
                      +++|+.|+|++|.+.+.+|..|..+++|+.|+|++|.+++ +|..+..+++|++|+|++|.++ .+              
T Consensus       253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i--------------  316 (597)
T 3oja_B          253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HV--------------  316 (597)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CC--------------
T ss_pred             CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-cc--------------
Confidence            7777777777777777777777777777777777777774 4556666777777777777776 33              


Q ss_pred             eccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCChhhhhccccccccccccCCC
Q 039419          518 NLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCS  597 (1035)
Q Consensus       518 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~~~N~~~c~  597 (1035)
                                 |..+..+++|++|+|++|++.+.+  +..+++|+.|+|++|+|++... ...+..+....+.+|...|+
T Consensus       317 -----------~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~l~~N~~~~~~~-~~~~~~~~~~~~~~~~~~C~  382 (597)
T 3oja_B          317 -----------ERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSL-RALFRNVARPAVDDADQHCK  382 (597)
T ss_dssp             -----------GGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHH-HHHTTTCCTTTBCCCCCCCC
T ss_pred             -----------CcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEEeeCCCCCChhH-HHHHHHHhhhccccccccCC
Confidence                       444556678888889888887764  6678899999999999987643 34577778888899999998


Q ss_pred             CCC
Q 039419          598 RGH  600 (1035)
Q Consensus       598 ~~~  600 (1035)
                      .+.
T Consensus       383 ~~~  385 (597)
T 3oja_B          383 IDY  385 (597)
T ss_dssp             TTC
T ss_pred             cch
Confidence            753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.7e-36  Score=345.71  Aligned_cols=253  Identities=25%  Similarity=0.335  Sum_probs=184.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  764 (1035)
                      +.|...+.||+|+||+||.+...+|+.||||++...                 ..+.+.+|+.+++++ +|||||+++++
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----------------~~~~~~~E~~~l~~l~~HpnIv~~~~~   77 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----------------FCDIALMEIKLLTESDDHPNVIRYYCS   77 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----------------GHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----------------HHHHHHHHHHHHHhccCCCCcCeEEEE
Confidence            345567899999999998887778999999998532                 134678999999986 89999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCC-----CCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC--
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSC-----LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE--  837 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~--  837 (1035)
                      +.+++..|+||||+. |+|.+++.......     .++..++.++.||+.||+|||+.   +|+||||||+||+++.+  
T Consensus        78 ~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~  153 (434)
T 2rio_A           78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSR  153 (434)
T ss_dssp             EECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHH
T ss_pred             EecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcc
Confidence            999999999999995 69999997654311     12234567999999999999999   99999999999999754  


Q ss_pred             -----------CceEEeeccCccccccCCcc--ccccccCCcccccCCccccc-------CCCCccccchhHHHHHHHHH
Q 039419          838 -----------FEPYIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYM-------MKITEKSDVYSYGVVVLEVL  897 (1035)
Q Consensus       838 -----------~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGvvl~ell  897 (1035)
                                 +.+||+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ell  233 (434)
T 2rio_A          154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL  233 (434)
T ss_dssp             HHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHH
T ss_pred             cccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHH
Confidence                       48999999999876543221  11234679999999998765       67899999999999999999


Q ss_pred             h-CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          898 T-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       898 t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      + |+.||.......   ...+......     ......  ........+.+++.+||+.||++||++.+++++
T Consensus       234 t~g~~Pf~~~~~~~---~~i~~~~~~~-----~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          234 SKGKHPFGDKYSRE---SNIIRGIFSL-----DEMKCL--HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TTSCCTTCSTTTHH---HHHHHTCCCC-----CCCTTC--CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hCCCCCCCCchhhH---HHHhcCCCCc-----cccccc--ccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            9 999997543211   1111111000     000000  111223345678899999999999999999873

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.3e-36  Score=333.42  Aligned_cols=247  Identities=21%  Similarity=0.309  Sum_probs=197.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC--CCceeeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR--HKNIVRF  761 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l  761 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||||++...........        ...+.+.+|+.++++++  ||||+++
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--------~~~~~~~~E~~~l~~l~~~~~~i~~~  113 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPMEVVLLKKVSSGFSGVIRL  113 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC--------TTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh--------hhhhHHHHHHHHHHhhccCCCCceEE
Confidence            467999999999999999999765 589999999976433221110        01234668999999996  5999999


Q ss_pred             EeEEEcCCcceEEEEeCCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc-CCCc
Q 039419          762 LGCCWNRNTRLLMYDYMPN-GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG-PEFE  839 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~  839 (1035)
                      ++++.+++..++||||+.+ ++|.+++.....  +++..+..++.||++||+|||+.   +|+||||||+||+++ .++.
T Consensus       114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~--l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          114 LDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred             EEEEecCCcEEEEEEcCCCCccHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence            9999999999999999976 899999987644  89999999999999999999999   999999999999999 7899


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      +||+|||+++......    .....||+.|+|||+..+..+ +.++||||||+++|||++|+.||....       ....
T Consensus       189 ~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~  257 (320)
T 3a99_A          189 LKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR  257 (320)
T ss_dssp             EEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH
T ss_pred             EEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhc
Confidence            9999999998765432    234679999999999876665 678999999999999999999996320       1111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..        .......+.      .+..++.+||+.||++||+++|++++
T Consensus       258 ~~--------~~~~~~~~~------~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 GQ--------VFFRQRVSS------ECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CC--------CCCSSCCCH------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc--------ccccccCCH------HHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00        011111221      23457888999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-35  Score=332.62  Aligned_cols=258  Identities=24%  Similarity=0.289  Sum_probs=192.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||.||+|.+. +|+.||||++.......            ...+.+.+|+.++++++||||++++++
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~~~   91 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE------------IFAKRAYRELLLLKHMQHENVIGLLDV   91 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccch------------HHHHHHHHHHHHHHhcCCCCcccHhhe
Confidence            57888999999999999999775 58999999996533211            135678999999999999999999999


Q ss_pred             EEcCCc------ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          765 CWNRNT------RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       765 ~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      +...+.      .|+||||+. ++|.+++..    .+++..+..++.||+.||+|||+.   ||+||||||+||+++.++
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~  163 (353)
T 3coi_A           92 FTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDC  163 (353)
T ss_dssp             ECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTC
T ss_pred             EecccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCC
Confidence            987654      499999996 688888743    289999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      .+||+|||+++.....     .....||+.|+|||+..+ ..++.++||||||+++|||++|+.||....... ......
T Consensus       164 ~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~  237 (353)
T 3coi_A          164 ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQIL  237 (353)
T ss_dssp             CEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHH
T ss_pred             cEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH
Confidence            9999999999864332     234578999999998776 678999999999999999999999997543211 111111


Q ss_pred             HHhcc-chhhhc-----------ccccCCCc-----ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRG-AIEVLD-----------KSLRARPE-----VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~-~~~~~~-----------~~~~~~~~-----~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..... ..+...           ......+.     ........+.+++.+||+.||++||+++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            10000 000000           00000000     000112234567888999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=342.96  Aligned_cols=250  Identities=25%  Similarity=0.356  Sum_probs=184.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  764 (1035)
                      .+|...+.||+|+||+||.....+++.||||++.....                 +.+.+|+.+++++ +|||||+++++
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----------------~~~~~E~~~l~~l~~HpnIv~l~~~   86 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----------------SFADREVQLLRESDEHPNVIRYFCT   86 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----------------EECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----------------HHHHHHHHHHHhccCCCCcCeEEEE
Confidence            35888899999999997766667799999999965321                 1245899999999 79999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-----CCc
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-----EFE  839 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-----~~~  839 (1035)
                      +.+.+..|+||||+. |+|.+++...... .....+..++.||++||+|||+.   +|+||||||+||+++.     ...
T Consensus        87 ~~~~~~~~lv~E~~~-g~L~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~  161 (432)
T 3p23_A           87 EKDRQFQYIAIELCA-ATLQEYVEQKDFA-HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIK  161 (432)
T ss_dssp             EEETTEEEEEEECCS-EEHHHHHHSSSCC-CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCC
T ss_pred             EecCCEEEEEEECCC-CCHHHHHHhcCCC-ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCcee
Confidence            999999999999995 6999999765432 44455678999999999999999   9999999999999953     235


Q ss_pred             eEEeeccCccccccCCc-cccccccCCcccccCCcccc---cCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHH
Q 039419          840 PYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGY---MMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIV  914 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~  914 (1035)
                      +||+|||+|+....... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||.......   .
T Consensus       162 ~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~  238 (432)
T 3p23_A          162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---A  238 (432)
T ss_dssp             EEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---H
T ss_pred             EEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---H
Confidence            78999999987654321 12234567999999999987   4567889999999999999999 999996432211   1


Q ss_pred             HHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       915 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..... ..       ... .............+++.+||+.||++||+++|++++
T Consensus       239 ~~~~~-~~-------~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          239 NILLG-AC-------SLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             HHHTT-CC-------CCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhc-cC-------Ccc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            11000 00       000 001111222334568889999999999999999963

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.5e-35  Score=338.35  Aligned_cols=261  Identities=19%  Similarity=0.239  Sum_probs=196.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC----------
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR----------  754 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----------  754 (1035)
                      ++|...+.||+|+||+||+|++. +++.||||++....               ...+.+.+|+.++++++          
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~e~~~l~~l~~~~~~~~~~~   83 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------------VYTEAAEDEIKLLQRVNDADNTKEDSM   83 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------------HHHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---------------cchhhhhHHHHHHHHhhcccccchhcc
Confidence            57899999999999999999774 68999999986422               12457889999999886          


Q ss_pred             -CCceeeEEeEEEcCC----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCc
Q 039419          755 -HKNIVRFLGCCWNRN----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKA  829 (1035)
Q Consensus       755 -hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp  829 (1035)
                       ||||+++++++...+    ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+++  ||+||||||
T Consensus        84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp  160 (373)
T 1q8y_A           84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKP  160 (373)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSG
T ss_pred             ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCCh
Confidence             899999999998654    679999999 999999998766666999999999999999999999952  899999999


Q ss_pred             ccEEEc------CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 039419          830 NNILIG------PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI  903 (1035)
Q Consensus       830 ~NIll~------~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~  903 (1035)
                      +||+++      ..+.+||+|||+++.....     .....||+.|+|||+..+..++.++|||||||++|||++|+.||
T Consensus       161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  235 (373)
T 1q8y_A          161 ENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF  235 (373)
T ss_dssp             GGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             HHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            999995      3447999999999865432     23457999999999999989999999999999999999999999


Q ss_pred             CCCCCCc-----hhHHHHHHHhccch-----------hhhc-----------------ccccCCCcccHHHHHHHHHHHH
Q 039419          904 DPTIPEG-----LHIVDWVRQKRGAI-----------EVLD-----------------KSLRARPEVEIEEMLQTLGVAL  950 (1035)
Q Consensus       904 ~~~~~~~-----~~~~~~~~~~~~~~-----------~~~~-----------------~~~~~~~~~~~~~~~~~l~l~~  950 (1035)
                      .......     ......+.......           ..+.                 ................+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  315 (373)
T 1q8y_A          236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  315 (373)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence            7543211     11111111100000           0000                 0000011111233445567899


Q ss_pred             hccCCCCCCCCCHHHHHHH
Q 039419          951 LCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       951 ~cl~~dP~~RPs~~el~~~  969 (1035)
                      +||+.||++|||++|++++
T Consensus       316 ~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          316 PMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             GGGCSSTTTCBCHHHHHTC
T ss_pred             HHhccCccccCCHHHHhhC
Confidence            9999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.3e-35  Score=321.23  Aligned_cols=236  Identities=12%  Similarity=0.079  Sum_probs=181.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|.+.+.||+|+||.||+|.+.. ++.||||++........           ...+.+.+|+.++++++||||++++++
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~hp~iv~~~~~   99 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD-----------DVLQETLSRTLRLSRIDKPGVARVLDV   99 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCH-----------HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCH-----------HHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence            679999999999999999998764 89999999976543222           234689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..|+||||++|++|.++++..    .....+.+++.|++.||+|||+.   ||+||||||+||+++.++.+||++
T Consensus       100 ~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~  172 (286)
T 3uqc_A          100 VHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAY  172 (286)
T ss_dssp             EEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECS
T ss_pred             EEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEe
Confidence            99999999999999999999999542    35567889999999999999999   999999999999999999999985


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      +|                      |++       .++.++|||||||++|||++|+.||........... ........ 
T Consensus       173 ~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-~~~~~~~~-  221 (286)
T 3uqc_A          173 PA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-AERDTAGQ-  221 (286)
T ss_dssp             CC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-CCBCTTSC-
T ss_pred             cc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-HHHHhccC-
Confidence            43                      333       267899999999999999999999986533210000 00000000 


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ...........+      ..+..++.+||++||++| |+.|+++.|+++....
T Consensus       222 ~~~~~~~~~~~~------~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          222 PIEPADIDRDIP------FQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             BCCHHHHCTTSC------HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             CCChhhcccCCC------HHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            000000011111      123457888999999999 9999999999886543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-35  Score=329.06  Aligned_cols=256  Identities=24%  Similarity=0.344  Sum_probs=174.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHH-HHhcCCCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK-TLGSIRHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~  763 (1035)
                      ++|...+.||+|+||.||+|.+. +++.||||++.......             ...++.+|+. +++.++||||+++++
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~~~~h~niv~~~~   88 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-------------EQKQLLMDLDVVMRSSDCPYIVQFYG   88 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-------------HHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-------------HHHHHHHHHHHHHHcCCCCcEeeeee
Confidence            67889999999999999999875 68999999996543211             1345556666 677789999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhh---cCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHE---RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ++.+.+..|+||||+++ +|.+++..   .....+++..+..++.|+++||+|||+.  .+|+||||||+||+++.++.+
T Consensus        89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~  165 (327)
T 3aln_A           89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNI  165 (327)
T ss_dssp             EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEE
T ss_pred             EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCE
Confidence            99999999999999975 88877753   2234589999999999999999999995  279999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCccc----ccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG----YMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      ||+|||+++......   ......||+.|+|||+.    .+..++.++||||||+++|||++|+.||.......    ..
T Consensus       166 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~  238 (327)
T 3aln_A          166 KLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF----DQ  238 (327)
T ss_dssp             EECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------
T ss_pred             EEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH----HH
Confidence            999999998764432   12234799999999997    46678999999999999999999999997532110    00


Q ss_pred             HHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      +..   ........+........  ...+.+++.+||+.||++||++.+++++
T Consensus       239 ~~~---~~~~~~~~~~~~~~~~~--~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          239 LTQ---VVKGDPPQLSNSEEREF--SPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -CC---CCCSCCCCCCCCSSCCC--CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHH---HhcCCCCCCCCcccccC--CHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            000   00000001111000011  1234557888999999999999999884

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=329.31  Aligned_cols=254  Identities=21%  Similarity=0.301  Sum_probs=178.2

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|...+.||+|+||.||+|.+. +++.||||++........            ..+.+..+..+++.++||||+++++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------~~~~~~~~~~~~~~~~h~~i~~~~~   91 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE------------NKRILMDLDVVLKSHDCPYIVQCFG   91 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH------------HHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH------------HHHHHHHHHHHHHhcCCCceeeEEE
Confidence            467889999999999999999876 689999999965432221            1334555666788889999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceEE
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      ++.+.+..|+||||+ ++.+..+.... ...+++..+..++.|+++||+|||+ .   ||+||||||+||+++.++.+||
T Consensus        92 ~~~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl  166 (318)
T 2dyl_A           92 TFITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKL  166 (318)
T ss_dssp             EEECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEE
Confidence            999999999999999 55555555432 3448999999999999999999998 5   8999999999999999999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +|||.++......   ......||+.|+|||+..     ...++.++||||||+++|||++|+.||....... .....+
T Consensus       167 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~  242 (318)
T 2dyl_A          167 CDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-EVLTKV  242 (318)
T ss_dssp             CCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HHHHHH
T ss_pred             EECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-HHHHHH
Confidence            9999997664432   123457999999999974     5568899999999999999999999997532211 111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....      ........  ..  ...+..++.+||+.||++||++++++++
T Consensus       243 ~~~~------~~~~~~~~--~~--~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          243 LQEE------PPLLPGHM--GF--SGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHSC------CCCCCSSS--CC--CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             hccC------CCCCCccC--CC--CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1100      00011000  00  1123457788999999999999999884

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=4.9e-35  Score=336.05  Aligned_cols=351  Identities=18%  Similarity=0.164  Sum_probs=232.7

Q ss_pred             ccCCCCCCCCCCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCC-CCCCCCCceeeC
Q 039419            7 ALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPD-LGDCTQLTTIDV   85 (1035)
Q Consensus         7 ~l~~w~~~~~~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~-~~~l~~L~~L~l   85 (1035)
                      .+++|.....+||.|.+..|.-.+    +.+............-..+++++.|++++|.++ .+|+. +..+++|++|+|
T Consensus         2 ~~~~~~~~~~C~~~~~~~~c~~~~----~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L   76 (390)
T 3o6n_A            2 NVKPRQPEYKCIDSNLQYDCVFYD----VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNL   76 (390)
T ss_dssp             -----CCEECBCC------EEEES----CEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEEC
T ss_pred             CcCCCCCccceehhhhhhccceee----eeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEEC
Confidence            578999876444445555553111    112222222222222345688899999999988 45554 678899999999


Q ss_pred             CCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchh-hccccccceeecCCCcccC
Q 039419           86 SSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVE-LGKLVNLEVIRAGGNKDIA  164 (1035)
Q Consensus        86 s~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~-l~~l~~L~~L~l~~n~~~~  164 (1035)
                      ++|.+++..+..++.+++|++|+|++|.+++..|..++.+++|++|+|++|.++ .+|.. ++++++|++|++++|.   
T Consensus        77 ~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~---  152 (390)
T 3o6n_A           77 NDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN---  152 (390)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC---
T ss_pred             CCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCc---
Confidence            999988666778888999999999999988777777888888888888888887 45544 4677777777776664   


Q ss_pred             CCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhh
Q 039419          165 GKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELG  244 (1035)
Q Consensus       165 ~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~  244 (1035)
                                            +.+..|..++.+++|++|++++|.+++.   .+..+++|+.|++++|.+++     +.
T Consensus       153 ----------------------l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~  202 (390)
T 3o6n_A          153 ----------------------LERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LA  202 (390)
T ss_dssp             ----------------------CCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EE
T ss_pred             ----------------------cCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-----cC
Confidence                                  3333444555555555555555555532   24455566666666666552     22


Q ss_pred             cccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCcccee
Q 039419          245 KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQL  324 (1035)
Q Consensus       245 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  324 (1035)
                      ..++|++|++++|.+... |..  .+++|+.|++++|.+++.  ..+..+++|++|++++|.+.+..|..|..+++|++|
T Consensus       203 ~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  277 (390)
T 3o6n_A          203 IPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERL  277 (390)
T ss_dssp             CCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEE
T ss_pred             CCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEE
Confidence            334566666666666643 322  246788888888888753  467778888888888888887777788888888888


Q ss_pred             ccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcce
Q 039419          325 QLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI  404 (1035)
Q Consensus       325 ~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  404 (1035)
                      +|++|+|+.           +|..+..+++|++|+|++|+++ .+|..+..+++|++|++++|+|+...   +       
T Consensus       278 ~L~~n~l~~-----------~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~-------  335 (390)
T 3o6n_A          278 YISNNRLVA-----------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---L-------  335 (390)
T ss_dssp             ECCSSCCCE-----------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---C-------
T ss_pred             ECCCCcCcc-----------cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---c-------
Confidence            888887763           3455667788888888888887 45666777888888888888887542   2       


Q ss_pred             eEeeeccCCCCccceeecCCCccCCC
Q 039419          405 RLRLMSFGNCTQLQMLNLSNNTLGGT  430 (1035)
Q Consensus       405 ~L~~~~~~~l~~L~~L~L~~N~l~~~  430 (1035)
                             ..+++|++|++++|.++..
T Consensus       336 -------~~~~~L~~L~l~~N~~~~~  354 (390)
T 3o6n_A          336 -------STHHTLKNLTLSHNDWDCN  354 (390)
T ss_dssp             -------CTTCCCSEEECCSSCEEHH
T ss_pred             -------hhhccCCEEEcCCCCccch
Confidence                   2346688888888888753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.1e-35  Score=350.86  Aligned_cols=262  Identities=24%  Similarity=0.305  Sum_probs=193.6

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||||++......             ...+.+.+|+.++++++||||+++
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~-------------~~~~~~~~Ei~iL~~L~HpnIV~l   77 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP-------------KNRERWCLEIQIMKKLNHPNVVSA   77 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH-------------HHHHHHHHHHHHHHHCCBTTBCCE
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH-------------HHHHHHHHHHHHHHhCCCCCCCce
Confidence            34578999999999999999999775 5899999998653221             125679999999999999999999


Q ss_pred             EeEEEc------CCcceEEEEeCCCCChhhhhhhcCC-CCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEE
Q 039419          762 LGCCWN------RNTRLLMYDYMPNGSLGSLLHERRD-SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI  834 (1035)
Q Consensus       762 ~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll  834 (1035)
                      ++++..      .+..|+||||++||+|.+++..... ..+++..+..++.|++.||+|||+.   ||+||||||+||++
T Consensus        78 ~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl  154 (676)
T 3qa8_A           78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVL  154 (676)
T ss_dssp             EECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEE
T ss_pred             eeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEe
Confidence            998765      6678999999999999999986542 3488899999999999999999999   99999999999999


Q ss_pred             cCCCc---eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch
Q 039419          835 GPEFE---PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL  911 (1035)
Q Consensus       835 ~~~~~---~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~  911 (1035)
                      +.++.   +||+|||.++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||....    
T Consensus       155 ~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~----  227 (676)
T 3qa8_A          155 QPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW----  227 (676)
T ss_dssp             ECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSC----
T ss_pred             ecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCccc----
Confidence            97765   8999999998765433   2235689999999999999999999999999999999999999996531    


Q ss_pred             hHHHHHHHhcc-------chhhhc------ccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 039419          912 HIVDWVRQKRG-------AIEVLD------KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVA  967 (1035)
Q Consensus       912 ~~~~~~~~~~~-------~~~~~~------~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~  967 (1035)
                      ....|......       ..+...      ................+..++.+||++||++|||++|++
T Consensus       228 ~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          228 QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             HHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             chhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            11111110000       000000      000000000111122345688899999999999998854

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-34  Score=354.16  Aligned_cols=242  Identities=20%  Similarity=0.253  Sum_probs=191.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC--CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME--NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      ++|.+.+.||+|+||+||+|.+.  +++.||||++......             ...+.+.+|+.++++++||||+++++
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~~  146 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-------------EAQAMAMAERQFLAEVVHPSIVQIFN  146 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH-------------HHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH-------------HHHHHHHHHHHHHHhcCCCCcCeEee
Confidence            67999999999999999999875  5899999998643211             12467899999999999999999999


Q ss_pred             EEEcCCc-----ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          764 CCWNRNT-----RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       764 ~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      ++...+.     .|+||||++|++|.+++..    .+++..+..++.||++||+|||+.   ||+||||||+||+++.+ 
T Consensus       147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-  218 (681)
T 2pzi_A          147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-  218 (681)
T ss_dssp             EEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-
T ss_pred             eEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-
Confidence            9987665     6999999999999988754    389999999999999999999999   99999999999999985 


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .+||+|||+++.....      ....||+.|+|||++.+. ++.++|||||||++|+|++|..||........       
T Consensus       219 ~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------  284 (681)
T 2pzi_A          219 QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------  284 (681)
T ss_dssp             CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------
T ss_pred             cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-------
Confidence            8999999999865432      356799999999987664 48899999999999999999988864211100       


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHHHHh
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-TMKDVAAMIKEIKQE  976 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-s~~el~~~L~~~~~~  976 (1035)
                                   ... ............++.+||++||++|| +++++.+.+..+.+.
T Consensus       285 -------------~~~-~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          285 -------------PED-DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             -------------CTT-CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             -------------ccc-ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence                         000 00011112345688899999999999 466666667665443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-34  Score=334.44  Aligned_cols=251  Identities=17%  Similarity=0.208  Sum_probs=180.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC-Cce-----
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH-KNI-----  758 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pni-----  758 (1035)
                      +.|...+.||+|+||+||+|.+. +|+.||||++........           ...+.+.+|+.+++.++| +|.     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~-----------~~~~~~~~E~~~~~~l~~~~~~~~~~~  146 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-----------NAIKQMKEEVLRLRLLRGIKNQKQAKV  146 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------------CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccH-----------HHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence            45777889999999999999865 689999999874332221           124679999999999987 211     


Q ss_pred             ----------------eeEEeEEEc-----CCcceEEEEeCCCCChhhhhhh-----cCCCCCCHHHHHHHHHHHHHHHH
Q 039419          759 ----------------VRFLGCCWN-----RNTRLLMYDYMPNGSLGSLLHE-----RRDSCLEWELRYRIILGAAQGLA  812 (1035)
Q Consensus       759 ----------------v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~~L~  812 (1035)
                                      ..++.++..     ....+++|+++ +++|.++++.     .....+++..+..++.||++||+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  225 (413)
T 3dzo_A          147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA  225 (413)
T ss_dssp             HTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred             hcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHH
Confidence                            111111221     12346677765 7899998852     22334778889999999999999


Q ss_pred             HhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCccc----------ccCCCCc
Q 039419          813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYG----------YMMKITE  882 (1035)
Q Consensus       813 ~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~  882 (1035)
                      |||++   +|+||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.
T Consensus       226 ~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~  296 (413)
T 3dzo_A          226 SLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF  296 (413)
T ss_dssp             HHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred             HHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence            99999   9999999999999999999999999998865332     234567 999999998          5556888


Q ss_pred             cccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC
Q 039419          883 KSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT  962 (1035)
Q Consensus       883 ~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs  962 (1035)
                      ++|||||||++|||++|+.||.......               .....+......  .  ..+.+++.+||++||++||+
T Consensus       297 ~~DvwSlGvil~elltg~~Pf~~~~~~~---------------~~~~~~~~~~~~--~--~~~~~li~~~l~~dP~~Rpt  357 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCADLPNTDDAALG---------------GSEWIFRSCKNI--P--QPVRALLEGFLRYPKEDRLL  357 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCCTTGGGS---------------CSGGGGSSCCCC--C--HHHHHHHHHHTCSSGGGSCC
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCcchhh---------------hHHHHHhhcccC--C--HHHHHHHHHHccCChhhCcC
Confidence            9999999999999999999997542211               111111111111  1  22455788899999999999


Q ss_pred             HHHHHHH--HHHHHHh
Q 039419          963 MKDVAAM--IKEIKQE  976 (1035)
Q Consensus       963 ~~el~~~--L~~~~~~  976 (1035)
                      +.+++++  ++.+...
T Consensus       358 ~~~~l~~~~~~~~~~~  373 (413)
T 3dzo_A          358 PLQAMETPEYEQLRTE  373 (413)
T ss_dssp             HHHHTTSHHHHHHHHH
T ss_pred             HHHHHhCHHHHHHHHH
Confidence            9999874  4555443

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=3.7e-34  Score=346.94  Aligned_cols=351  Identities=17%  Similarity=0.134  Sum_probs=243.2

Q ss_pred             CcccCCCCCCCCCCcc----ceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCC
Q 039419            5 PSALSNWNPSDSNPCK----WSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQL   80 (1035)
Q Consensus         5 ~~~l~~w~~~~~~~c~----w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L   80 (1035)
                      .+.+++|.... +||.    |.++.|+..       +............--.+.+++.|++++|.+++..+..++.+++|
T Consensus         6 ~~~l~~~~~~~-~C~~~~~~~~c~~~~~~-------i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L   77 (597)
T 3oja_B            6 RYNVKPRQPEY-KCIDSNLQYDCVFYDVH-------IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV   77 (597)
T ss_dssp             -----CCCSEE-CCCCC--CCSEEECSCE-------ECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCC
T ss_pred             cccccCCCCCC-cCcccCcCceeEecCce-------ecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCC
Confidence            35678998875 5553    777777521       11111111111112346778888888888884333346778888


Q ss_pred             ceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCC
Q 039419           81 TTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGN  160 (1035)
Q Consensus        81 ~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n  160 (1035)
                      ++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..++.+++|++|+|++|.+++..+..|+++++|++|++++|
T Consensus        78 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N  157 (597)
T 3oja_B           78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN  157 (597)
T ss_dssp             SEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC
Confidence            88888888888777778888888888888888888766777788888888888888887333333566666666666666


Q ss_pred             cccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCC
Q 039419          161 KDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLP  240 (1035)
Q Consensus       161 ~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~  240 (1035)
                      .                         +.+..|..|+.+++|++|++++|.+++.   .+..+++|+.|++++|.+++   
T Consensus       158 ~-------------------------l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~---  206 (597)
T 3oja_B          158 N-------------------------LERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST---  206 (597)
T ss_dssp             C-------------------------CCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE---
T ss_pred             c-------------------------CCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc---
Confidence            4                         4444455556666666666666665532   24455666666666666653   


Q ss_pred             hhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCc
Q 039419          241 RELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATS  320 (1035)
Q Consensus       241 ~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  320 (1035)
                        +...++|+.|++++|.+....+. +  .++|+.|+|++|.+++  +..+..+++|+.|+|++|.+.+..|..|..+++
T Consensus       207 --l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  279 (597)
T 3oja_B          207 --LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR  279 (597)
T ss_dssp             --EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSS
T ss_pred             --ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccC
Confidence              23345666777777776643322 2  2578888888888885  366888888888888888888888888888888


Q ss_pred             cceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCC
Q 039419          321 LLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNC  400 (1035)
Q Consensus       321 L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  400 (1035)
                      |+.|+|++|+|+.           +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.|++..   +   
T Consensus       280 L~~L~Ls~N~l~~-----------l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~---  341 (597)
T 3oja_B          280 LERLYISNNRLVA-----------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---L---  341 (597)
T ss_dssp             CCEEECTTSCCCE-----------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---C---
T ss_pred             CCEEECCCCCCCC-----------CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---h---
Confidence            8888888888763           3556677889999999999998 56777888999999999999988653   2   


Q ss_pred             CcceeEeeeccCCCCccceeecCCCccCCC
Q 039419          401 SSLIRLRLMSFGNCTQLQMLNLSNNTLGGT  430 (1035)
Q Consensus       401 ~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~  430 (1035)
                                 ..+++|+.|+|++|.+++.
T Consensus       342 -----------~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          342 -----------STHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             -----------CTTCCCSEEECCSSCEEHH
T ss_pred             -----------hhcCCCCEEEeeCCCCCCh
Confidence                       2346789999999998854

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.2e-34  Score=313.67  Aligned_cols=233  Identities=22%  Similarity=0.279  Sum_probs=178.0

Q ss_pred             HHHhccccC-CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHH-hcCCCCcee
Q 039419          683 QVLKCLVED-SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL-GSIRHKNIV  759 (1035)
Q Consensus       683 ~~~~~~~~~-~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv  759 (1035)
                      .+.++|... +.||+|+||.||+|.+. +++.||+|++..                   ...+.+|+.++ +..+||||+
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------------------~~~~~~e~~~~~~~~~h~~i~   74 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIV   74 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBC
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------------------cHHHHHHHHHHHHhccCCCch
Confidence            345667776 78999999999999774 589999999842                   23577899988 556899999


Q ss_pred             eEEeEEEc----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          760 RFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       760 ~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++++++..    ....|+||||+++|+|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~  151 (299)
T 3m2w_A           75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYT  151 (299)
T ss_dssp             CEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEES
T ss_pred             hHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEe
Confidence            99999876    66789999999999999999887666699999999999999999999999   999999999999999


Q ss_pred             C---CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          836 P---EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       836 ~---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      .   ++.+||+|||++....                        +..++.++|||||||++|||++|+.||........ 
T Consensus       152 ~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-  206 (299)
T 3m2w_A          152 SKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-  206 (299)
T ss_dssp             SSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred             cCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-
Confidence            8   7889999999986432                        13456789999999999999999999975422100 


Q ss_pred             HHHHHHHhccchhhhcccccCCCccc-HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVE-IEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                             ...............+... ......+..++.+||+.||++||+++|++++
T Consensus       207 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          207 -------SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             --------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------hHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                   0000000000000000000 0011234557888999999999999999985

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.1e-32  Score=309.02  Aligned_cols=260  Identities=23%  Similarity=0.413  Sum_probs=161.4

Q ss_pred             CCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhcccc
Q 039419           50 LSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLK  129 (1035)
Q Consensus        50 ~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~  129 (1035)
                      +..+++|++|++++|.++ .++ .++.+++|++|++++|+++ .++. +..+++|++|+|++|.++ .+| .+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCS
T ss_pred             chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCccc-Cch-HHcCCCcCC
Confidence            457788899999999888 454 3888899999999999888 4554 888899999999999888 454 688889999


Q ss_pred             ceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeeccc
Q 039419          130 NLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTT  209 (1035)
Q Consensus       130 ~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n  209 (1035)
                      +|++++|.+. .++. +..+++|++|++++|....  .+..+..+++|+.|++++|.+.+..+  +..+++|++|++++|
T Consensus       114 ~L~l~~n~i~-~~~~-~~~l~~L~~L~l~~n~~~~--~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n  187 (347)
T 4fmz_A          114 ELYLNEDNIS-DISP-LANLTKMYSLNLGANHNLS--DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN  187 (347)
T ss_dssp             EEECTTSCCC-CCGG-GTTCTTCCEEECTTCTTCC--CCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred             EEECcCCccc-Cchh-hccCCceeEEECCCCCCcc--cccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence            9999999887 4444 7888888888888885222  22335566666666666666553322  555566666666666


Q ss_pred             ccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCc
Q 039419          210 MLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQ  289 (1035)
Q Consensus       210 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~  289 (1035)
                      .+.+ ++. +..+++|+.|++++|.+++..+  +..+++|++|++++|++.+..+  +..+++|++|++++|.+++.  .
T Consensus       188 ~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~  259 (347)
T 4fmz_A          188 QIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--N  259 (347)
T ss_dssp             CCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--G
T ss_pred             cccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--h
Confidence            5552 222 5555555555555555553322  4455555555555555553222  44555555555555555432  2


Q ss_pred             cccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchh
Q 039419          290 SFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI  331 (1035)
Q Consensus       290 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i  331 (1035)
                      .+..+++|++|++++|++++.  ..+..+++|++|++++|++
T Consensus       260 ~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l  299 (347)
T 4fmz_A          260 AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQL  299 (347)
T ss_dssp             GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred             hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcC
Confidence            344555555555555555432  2344444444444444444

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.7e-34  Score=319.05  Aligned_cols=251  Identities=12%  Similarity=0.077  Sum_probs=184.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC---------C
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR---------H  755 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------h  755 (1035)
                      .++|...+.||+|+||+||+|++ +|+.||||++.........      .......+.+.+|+.++++++         |
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h   91 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVN------GSHQKTFEEILPEIIISKELSLLSGEVCNRT   91 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBT------TBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccc------cccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence            47899999999999999999988 5899999999765322100      001123578899999999886         7


Q ss_pred             CceeeEEeEEE-----------------c-------------CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHH
Q 039419          756 KNIVRFLGCCW-----------------N-------------RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL  805 (1035)
Q Consensus       756 pniv~l~~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~  805 (1035)
                      ||||++.+.+.                 +             .+..|+||||+++|++.+.+..   ..+++..+..++.
T Consensus        92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~  168 (336)
T 2vuw_A           92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILH  168 (336)
T ss_dssp             CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHH
T ss_pred             CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHH
Confidence            77777777643                 2             6788999999999977766644   3389999999999


Q ss_pred             HHHHHHHHhh-ccCCCCeeccCCCcccEEEcCCC--------------------ceEEeeccCccccccCCccccccccC
Q 039419          806 GAAQGLAYLH-HDCVPPIVHRDIKANNILIGPEF--------------------EPYIADFGLAKLVVEGDFARSSNTVA  864 (1035)
Q Consensus       806 ~ia~~L~~LH-~~~~~~ivHrDikp~NIll~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~~  864 (1035)
                      ||+.||+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....       ...
T Consensus       169 qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~  238 (336)
T 2vuw_A          169 QLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVV  238 (336)
T ss_dssp             HHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEE
T ss_pred             HHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEE
Confidence            9999999999 88   999999999999999887                    8999999999876432       347


Q ss_pred             CcccccCCcccccCCCCccccchhHHHH-HHHHHhCCCCCCCCCCCchhHHHHHHHhccch-hhhcccccCCCcccHHHH
Q 039419          865 GSYGYIAPEYGYMMKITEKSDVYSYGVV-VLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI-EVLDKSLRARPEVEIEEM  942 (1035)
Q Consensus       865 gt~~y~aPE~~~~~~~~~~~Dv~SlGvv-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  942 (1035)
                      ||+.|+|||++.+.. +.++||||+|++ .+++++|..||..        ..|........ ..................
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  309 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIK  309 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHHHHhhhhhhccCcccchhhhhhcC
Confidence            999999999988766 899999998777 7888889998842        11211110000 000000011111111233


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHH-HH
Q 039419          943 LQTLGVALLCVNPTPDDRPTMKDVA-AM  969 (1035)
Q Consensus       943 ~~~l~l~~~cl~~dP~~RPs~~el~-~~  969 (1035)
                      ..+.+++.+||+.|     |++|++ ++
T Consensus       310 ~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          310 RKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHHHhccC-----CHHHHHhcC
Confidence            45667899999876     999888 53

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=3.7e-32  Score=307.01  Aligned_cols=308  Identities=26%  Similarity=0.315  Sum_probs=169.8

Q ss_pred             cccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCC
Q 039419          194 SLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSL  273 (1035)
Q Consensus       194 ~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L  273 (1035)
                      .+..+++|++|++++|.+. .++ .+..+++|++|++++|.+++. +. +..+++|++|++++|.+.. ++ .+..+++|
T Consensus        39 ~~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L  112 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNL  112 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTC
T ss_pred             cchhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcC
Confidence            3456667777777777666 333 366667777777777766633 32 6666666666666666653 22 46666666


Q ss_pred             cEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCC
Q 039419          274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCR  353 (1035)
Q Consensus       274 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~  353 (1035)
                      ++|++++|.+++..+  +..+++|++|++++|...... ..+..+++|++|++++|++..+           + .+..++
T Consensus       113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~-----------~-~~~~l~  177 (347)
T 4fmz_A          113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDV-----------T-PIANLT  177 (347)
T ss_dssp             SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCC-----------G-GGGGCT
T ss_pred             CEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCc-----------h-hhccCC
Confidence            666666666664322  566666666666666443222 2255555555555555554422           1 144555


Q ss_pred             CCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcc
Q 039419          354 SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS  433 (1035)
Q Consensus       354 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~  433 (1035)
                      +|++|++++|.+++..+  +..+++|+.|++++|.+++..+                +..+++|++|++++|++++..+ 
T Consensus       178 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~----------------~~~~~~L~~L~l~~n~l~~~~~-  238 (347)
T 4fmz_A          178 DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP----------------VANMTRLNSLKIGNNKITDLSP-  238 (347)
T ss_dssp             TCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG----------------GGGCTTCCEEECCSSCCCCCGG-
T ss_pred             CCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch----------------hhcCCcCCEEEccCCccCCCcc-
Confidence            55555555555553222  4445555555555555443211                2223444555555555543222 


Q ss_pred             cccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccC
Q 039419          434 SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGL  513 (1035)
Q Consensus       434 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l  513 (1035)
                       +..+++|++|++++|++++.  ..+..+++|+.|++++|++++.  ..+..+++|++|+|+                  
T Consensus       239 -~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~------------------  295 (347)
T 4fmz_A          239 -LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLN------------------  295 (347)
T ss_dssp             -GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECC------------------
T ss_pred             -hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECc------------------
Confidence             44444555555555554432  2344444444444444444432  224444444444444                  


Q ss_pred             cceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCc
Q 039419          514 DISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT  572 (1035)
Q Consensus       514 ~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~  572 (1035)
                             +|.+++..+..+..+++|++|+|++|++++.++ +..+++|+.|++++|+|+
T Consensus       296 -------~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          296 -------NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             -------SSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC---
T ss_pred             -------CCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhccc
Confidence                   444444555566677888888888888887666 778888888888888875

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.98  E-value=2e-32  Score=303.51  Aligned_cols=259  Identities=29%  Similarity=0.470  Sum_probs=174.9

Q ss_pred             CCCcEEEccCccCCC--CCCccccCCCCCcEEEccC-CccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCc
Q 039419          271 KSLKTIDLSLNFFSG--SLPQSFGNLSSLEELMLSN-NNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS  347 (1035)
Q Consensus       271 ~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~  347 (1035)
                      .+++.|+|++|.+++  .+|..|.++++|++|+|++ |.+.+.+|..|.++++|++|+|++|                  
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n------------------  111 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT------------------  111 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEE------------------
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCC------------------
Confidence            456677777777766  5666666777777777763 6666555555555555555555544                  


Q ss_pred             CCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCcc
Q 039419          348 TLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTL  427 (1035)
Q Consensus       348 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l  427 (1035)
                                      .+++.+|..|..+++|++|++++|.+++..|..+.              ++++|++|+|++|++
T Consensus       112 ----------------~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--------------~l~~L~~L~L~~N~l  161 (313)
T 1ogq_A          112 ----------------NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS--------------SLPNLVGITFDGNRI  161 (313)
T ss_dssp             ----------------CCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG--------------GCTTCCEEECCSSCC
T ss_pred             ----------------eeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHh--------------cCCCCCeEECcCCcc
Confidence                            44444444444444444444444444444443332              234455566666666


Q ss_pred             CCCCcccccCCC-CccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchh
Q 039419          428 GGTLPSSLASLT-RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVE  506 (1035)
Q Consensus       428 ~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  506 (1035)
                      ++.+|..+..++ +|++|++++|++++.+|..|..+. |+.|++++|++++..|..|..+++|++|+|++|++++.+|  
T Consensus       162 ~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--  238 (313)
T 1ogq_A          162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG--  238 (313)
T ss_dssp             EEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG--
T ss_pred             cCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecC--
Confidence            655666666666 677777777777766676776665 7777777777777777777777777777777777763322  


Q ss_pred             hhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccC-ccccccccCCCcEEeccCCcCcccCCChhhhhccc
Q 039419          507 LFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS  585 (1035)
Q Consensus       507 ~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~  585 (1035)
                                              .+..+++|++|+|++|++++ .+..+..+++|+.|+|++|+++|.+|....+++++
T Consensus       239 ------------------------~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~  294 (313)
T 1ogq_A          239 ------------------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFD  294 (313)
T ss_dssp             ------------------------GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSC
T ss_pred             ------------------------cccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccC
Confidence                                    13445778888888888874 45678888999999999999999999988899999


Q ss_pred             cccccccccCCCCCCCCCc
Q 039419          586 ATEMAGNQGLCSRGHESCF  604 (1035)
Q Consensus       586 ~~~~~~N~~~c~~~~~~c~  604 (1035)
                      .+++.+|+++|+.|...|.
T Consensus       295 ~l~l~~N~~lc~~p~~~C~  313 (313)
T 1ogq_A          295 VSAYANNKCLCGSPLPACT  313 (313)
T ss_dssp             GGGTCSSSEEESTTSSCCC
T ss_pred             hHHhcCCCCccCCCCCCCC
Confidence            9999999999999888773

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=2.7e-31  Score=297.73  Aligned_cols=288  Identities=22%  Similarity=0.298  Sum_probs=180.3

Q ss_pred             ceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcc
Q 039419          176 SLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLW  255 (1035)
Q Consensus       176 ~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~  255 (1035)
                      +++.++++++.+. .+|..+.  ++|++|++++|.+++..|..|.++++|++|+|++|.+++..|..|+++++|++|+++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            3444555555554 3444332  456666666666665445566666666666666666665556666666666666666


Q ss_pred             cccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccc--cCCCCcccCCCccceeccccchhhh
Q 039419          256 QNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS--GSIPPVLSNATSLLQLQLDTNQISV  333 (1035)
Q Consensus       256 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~i~~  333 (1035)
                      +|++. .+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.++  +..+..|..+ +|++|++++|+++.
T Consensus       111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~  186 (332)
T 2ft3_A          111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG  186 (332)
T ss_dssp             SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred             CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence            66666 3444333  66777777777777655556777777777777777774  2556666666 77777777776652


Q ss_pred             hhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCC
Q 039419          334 FFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGN  413 (1035)
Q Consensus       334 l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~  413 (1035)
                                 +|..+.  ++|++|++++|.+++..+..+..+++|++|++++|++++..+..+.              .
T Consensus       187 -----------l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~--------------~  239 (332)
T 2ft3_A          187 -----------IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS--------------F  239 (332)
T ss_dssp             -----------CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGG--------------G
T ss_pred             -----------cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhh--------------C
Confidence                       333332  5677777777777766666677777777777777777665554433              3


Q ss_pred             CCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCc------cccchhhccCCccc--ccCccccCC
Q 039419          414 CTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQL------ASLNRLILSKNSFS--GAIPSSLGR  485 (1035)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~Ls~N~l~--~~~~~~~~~  485 (1035)
                      +++|++|+|++|+++ .+|..+..+++|++|++++|+|+++.+..|...      ..|+.|++++|.+.  +..|..|..
T Consensus       240 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~  318 (332)
T 2ft3_A          240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC  318 (332)
T ss_dssp             CTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTT
T ss_pred             CCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccc
Confidence            455777777777777 556667777777777777777776666666543      45667777777665  456666777


Q ss_pred             CCCCcEEEcCCCc
Q 039419          486 CESLQSLDLSSNK  498 (1035)
Q Consensus       486 l~~L~~L~Ls~N~  498 (1035)
                      +++|+.|+|++|+
T Consensus       319 l~~L~~l~l~~n~  331 (332)
T 2ft3_A          319 VTDRLAIQFGNYK  331 (332)
T ss_dssp             BCCSTTEEC----
T ss_pred             cchhhhhhccccc
Confidence            7777777777664

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=2.6e-31  Score=297.60  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=176.3

Q ss_pred             CccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChh
Q 039419           18 PCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSS   97 (1035)
Q Consensus        18 ~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~   97 (1035)
                      .|.|+.+.|+..           ++. .+|..+.  +.|++|+|++|.+++..+..++.+++|++|+|++|++++..|..
T Consensus        30 ~c~l~~l~~~~~-----------~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~   95 (330)
T 1xku_A           30 QCHLRVVQCSDL-----------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA   95 (330)
T ss_dssp             EEETTEEECTTS-----------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred             cCCCeEEEecCC-----------Ccc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHH
Confidence            367777777643           222 3444443  56788888888888666667888888888888888888666888


Q ss_pred             hhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccce
Q 039419           98 IGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSL  177 (1035)
Q Consensus        98 i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L  177 (1035)
                      ++.+++|++|+|++|+++ .+|..+.  ++|++|++++|.+.+..+..++++++|++|++++|....             
T Consensus        96 ~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------  159 (330)
T 1xku_A           96 FAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS-------------  159 (330)
T ss_dssp             TTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG-------------
T ss_pred             hcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc-------------
Confidence            888888888888888887 5666554  678888888888775555667777777777777664110             


Q ss_pred             EEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccc
Q 039419          178 LVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQN  257 (1035)
Q Consensus       178 ~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n  257 (1035)
                                .+..+..+..+++|++|++++|.++ .+|..+.  ++|+.|++++|.+++..+..|..+++|++|++++|
T Consensus       160 ----------~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n  226 (330)
T 1xku_A          160 ----------SGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN  226 (330)
T ss_dssp             ----------GGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSS
T ss_pred             ----------cCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC
Confidence                      1234555666667777777777666 4555443  56777777777777666667777777777777777


Q ss_pred             cccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCccc
Q 039419          258 NFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLS  316 (1035)
Q Consensus       258 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  316 (1035)
                      .+.+..+..+..+++|+.|+|++|+++ .+|..+..+++|++|++++|+|++..+..|.
T Consensus       227 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~  284 (330)
T 1xku_A          227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC  284 (330)
T ss_dssp             CCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred             cCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcC
Confidence            777666666777777777777777777 5666677777777777777777766665554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.97  E-value=2.6e-31  Score=297.86  Aligned_cols=270  Identities=21%  Similarity=0.260  Sum_probs=191.0

Q ss_pred             cccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceec
Q 039419           54 SFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLL  133 (1035)
Q Consensus        54 ~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l  133 (1035)
                      ++|++|+|++|.+++..|..++.+++|++|+|++|++++..|..++.+++|++|+|++|+++ .+|..+.  ++|++|++
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l  130 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI  130 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred             CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence            45666666666666555556666666666666666666555666666666666666666666 4554444  56666666


Q ss_pred             cccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEecccccc--ccCcccccccccccceeeccccc
Q 039419          134 FDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVA--GSLPASLGKLSKLQSLSVYTTML  211 (1035)
Q Consensus       134 ~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~--~~~p~~l~~l~~L~~L~l~~n~l  211 (1035)
                      ++|.+.+..+..++.+++|++|++++|                         .+.  +..+..+..+ +|++|++++|.+
T Consensus       131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n-------------------------~l~~~~~~~~~~~~l-~L~~L~l~~n~l  184 (332)
T 2ft3_A          131 HDNRIRKVPKGVFSGLRNMNCIEMGGN-------------------------PLENSGFEPGAFDGL-KLNYLRISEAKL  184 (332)
T ss_dssp             CSSCCCCCCSGGGSSCSSCCEEECCSC-------------------------CCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred             CCCccCccCHhHhCCCccCCEEECCCC-------------------------ccccCCCCcccccCC-ccCEEECcCCCC
Confidence            666665333344555555555555555                         443  2456667777 788888888888


Q ss_pred             ccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccc
Q 039419          212 SGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSF  291 (1035)
Q Consensus       212 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~  291 (1035)
                      + .+|..+.  ++|+.|+|++|.+++..+..|..+++|+.|++++|++.+..+..+..+++|+.|+|++|+++ .+|..+
T Consensus       185 ~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  260 (332)
T 2ft3_A          185 T-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL  260 (332)
T ss_dssp             S-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred             C-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence            7 4666554  67888888888888777778888888888888888888777778888888999999999888 677778


Q ss_pred             cCCCCCcEEEccCCccccCCCCcccCC------CccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcC
Q 039419          292 GNLSSLEELMLSNNNISGSIPPVLSNA------TSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNA  364 (1035)
Q Consensus       292 ~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~  364 (1035)
                      ..+++|++|++++|+|+...+..|...      ..|+.|++++|.+...        +..|.+|..+++|+.+++++|+
T Consensus       261 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~--------~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW--------EVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             GGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG--------GSCGGGGTTBCCSTTEEC----
T ss_pred             hcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc--------ccCcccccccchhhhhhccccc
Confidence            888889999999998887777777653      6688899998887643        2345778889999999998885

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=7e-31  Score=294.13  Aligned_cols=279  Identities=18%  Similarity=0.173  Sum_probs=206.8

Q ss_pred             ccceeEEeCC---CCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCC
Q 039419           19 CKWSHITCSP---QNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP   95 (1035)
Q Consensus        19 c~w~gi~c~~---~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p   95 (1035)
                      |+..+++.-+   ...++.|+++++++.+..+..+..+++|++|+|++|.+++..|..++.+++|++|+|++|+++ .+|
T Consensus        38 ~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~  116 (330)
T 1xku_A           38 CSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELP  116 (330)
T ss_dssp             CTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCC
T ss_pred             ecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccC
Confidence            5555554432   246789999999999888888999999999999999999878999999999999999999999 778


Q ss_pred             hhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCC--CCchhhccccccceeecCCCcccCCCCCCcCCC
Q 039419           96 SSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSG--NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGD  173 (1035)
Q Consensus        96 ~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~--~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~  173 (1035)
                      ..+.  ++|++|++++|++++..+..+..+++|++|++++|.+..  ..+..+..+++|++|++++|.  ...+|..   
T Consensus       117 ~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~--l~~l~~~---  189 (330)
T 1xku_A          117 EKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN--ITTIPQG---  189 (330)
T ss_dssp             SSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC--CCSCCSS---
T ss_pred             hhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc--cccCCcc---
Confidence            7765  799999999999997777789999999999999999963  567788888888888888886  2223322   


Q ss_pred             ccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhh
Q 039419          174 CQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKML  253 (1035)
Q Consensus       174 l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~  253 (1035)
                                           +.  ++|++|++++|.+++..|..+..+++|+.|+|++|.+++..+..|..+++|++|+
T Consensus       190 ---------------------~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  246 (330)
T 1xku_A          190 ---------------------LP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH  246 (330)
T ss_dssp             ---------------------CC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred             ---------------------cc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEE
Confidence                                 21  4566666666666655566666666777777777776665555666777777777


Q ss_pred             cccccccccCCccccCCCCCcEEEccCccCCCCCCccccCC------CCCcEEEccCCcccc--CCCCcccCCCccceec
Q 039419          254 LWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNL------SSLEELMLSNNNISG--SIPPVLSNATSLLQLQ  325 (1035)
Q Consensus       254 l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l------~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~  325 (1035)
                      +++|++. .+|..+..+++|++|+|++|+|++..+..|...      +.|+.|++++|.+..  +.|..|..+.+++.++
T Consensus       247 L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~  325 (330)
T 1xku_A          247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ  325 (330)
T ss_dssp             CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEE
T ss_pred             CCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEE
Confidence            7777776 566677777888888888888876666666433      566667777776642  3344455555555555


Q ss_pred             cccc
Q 039419          326 LDTN  329 (1035)
Q Consensus       326 L~~N  329 (1035)
                      |++|
T Consensus       326 L~~N  329 (330)
T 1xku_A          326 LGNY  329 (330)
T ss_dssp             C---
T ss_pred             eccc
Confidence            5544

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.97  E-value=9.6e-32  Score=299.84  Aligned_cols=265  Identities=19%  Similarity=0.210  Sum_probs=185.1

Q ss_pred             ccCCCC---CCCCCCccceeEEeCCCCcEEEEEecCCcccccCCcCC--CCCcccceEeecCcccCCCCCCCCCCCCCCc
Q 039419            7 ALSNWN---PSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNL--SSLSFLQKLIISGSNLTGPISPDLGDCTQLT   81 (1035)
Q Consensus         7 ~l~~w~---~~~~~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~--~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~   81 (1035)
                      .+++|.   ....++|.|.|++|+..                 +..+  ...+.++.|+|++|.++ .+|+.++.+++|+
T Consensus        46 ~~~~w~~~~~~~~~~~~~~g~~~~~~-----------------~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~  107 (328)
T 4fcg_A           46 WHSAWRQANSNNPQIETRTGRALKAT-----------------ADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQ  107 (328)
T ss_dssp             HHHHHHHHTTTCTTSCCSHHHHHHHH-----------------HHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTCS
T ss_pred             hhhhhcccccccccccccCCcchhhh-----------------HHHHhcccccceeEEEccCCCch-hcChhhhhCCCCC
Confidence            356783   33457899999999521                 1111  12466888889999888 7888888899999


Q ss_pred             eeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCc
Q 039419           82 TIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK  161 (1035)
Q Consensus        82 ~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~  161 (1035)
                      +|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++.+++|++|+|++|++.+.+|..++..            
T Consensus       108 ~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------------  173 (328)
T 4fcg_A          108 HMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------------  173 (328)
T ss_dssp             EEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE------------
T ss_pred             EEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc------------
Confidence            9999999888 88888889999999999999888 788888888889999998888777777655431            


Q ss_pred             ccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCCh
Q 039419          162 DIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPR  241 (1035)
Q Consensus       162 ~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~  241 (1035)
                                                  ..+..+..+++|++|++++|.++ .+|..++++++|+.|+|++|.++ .+|.
T Consensus       174 ----------------------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~  223 (328)
T 4fcg_A          174 ----------------------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP  223 (328)
T ss_dssp             ----------------------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCG
T ss_pred             ----------------------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCch
Confidence                                        11223445556666666666665 55666666666666666666666 3444


Q ss_pred             hhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCcc
Q 039419          242 ELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSL  321 (1035)
Q Consensus       242 ~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  321 (1035)
                      .++.+++|++|++++|++.+.+|..+..+++|+.|+|++|.+.+.+|..|.++++|++|+|++|++.+.+|..+.++++|
T Consensus       224 ~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L  303 (328)
T 4fcg_A          224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN  303 (328)
T ss_dssp             GGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTT
T ss_pred             hhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCc
Confidence            56666666666666666666666666666666667776666666666666666677777777666666666666667777


Q ss_pred             ceeccccchhhh
Q 039419          322 LQLQLDTNQISV  333 (1035)
Q Consensus       322 ~~L~L~~N~i~~  333 (1035)
                      +.+++..|.+..
T Consensus       304 ~~l~l~~~~~~~  315 (328)
T 4fcg_A          304 CIILVPPHLQAQ  315 (328)
T ss_dssp             CEEECCGGGSCC
T ss_pred             eEEeCCHHHHHH
Confidence            776666665543

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=2.8e-33  Score=329.35  Aligned_cols=384  Identities=21%  Similarity=0.171  Sum_probs=276.6

Q ss_pred             cceEEEEeccccccccCccc-ccccccccceeeccccccc----CCccccccCcCCceEEecCCcCCCCCChhhh-ccc-
Q 039419          175 QSLLVVGLADTKVAGSLPAS-LGKLSKLQSLSVYTTMLSG----EIPPQIGNCSELVDLFLYENDLSGSLPRELG-KLQ-  247 (1035)
Q Consensus       175 ~~L~~L~l~~~~~~~~~p~~-l~~l~~L~~L~l~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~-~l~-  247 (1035)
                      ++|+.|+++++++++..... +..+++|++|++++|.+++    .++..+..+++|++|+|++|.+++..+..+. .++ 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            56777888877776554443 7788899999999998874    3466777889999999999988765454443 355 


Q ss_pred             ---chhHhhcccccccc----cCCccccCCCCCcEEEccCccCCCCCCcccc-----CCCCCcEEEccCCccccCC----
Q 039419          248 ---KLEKMLLWQNNFDG----AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFG-----NLSSLEELMLSNNNISGSI----  311 (1035)
Q Consensus       248 ---~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~----  311 (1035)
                         +|++|++++|++..    .++..+..+++|++|+|++|.+++..+..+.     ..++|++|++++|++++..    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               69999999999884    5588888999999999999998754444332     3568999999999988643    


Q ss_pred             CCcccCCCccceeccccchhhhhhhhccccCCCCCcCC-CCCCCCcEEeccCcCCCCC----CCCCcccCcccceEeccc
Q 039419          312 PPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTL-ANCRSLEAVDLSHNALTGS----LHPGLFQLQNLTKLLLIS  386 (1035)
Q Consensus       312 ~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~  386 (1035)
                      +..+..+++|++|++++|+|+.....      .+...+ ...++|++|+|++|.++..    ++..+..+++|++|++++
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~------~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~  236 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVR------VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS  236 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHH------HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCS
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHH------HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccC
Confidence            55667789999999999998754220      011111 1356899999999999854    355677789999999999


Q ss_pred             cccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCC----CcccccCCCCccEEEcCCCccCCCCchhccC-
Q 039419          387 NGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGT----LPSSLASLTRLQVLDISVNQFVGLIPESFGQ-  461 (1035)
Q Consensus       387 N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-  461 (1035)
                      |++++.....+.         ...+..+++|++|+|++|++++.    ++..+..+++|++|+|++|++.+..+..+.. 
T Consensus       237 n~l~~~~~~~l~---------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~  307 (461)
T 1z7x_W          237 NKLGDVGMAELC---------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET  307 (461)
T ss_dssp             SBCHHHHHHHHH---------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH
T ss_pred             CcCChHHHHHHH---------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH
Confidence            988753111100         01123467899999999999854    5677788999999999999987654444443 


Q ss_pred             ----ccccchhhccCCccccc----CccccCCCCCCcEEEcCCCcCcCccchhhhhh----ccCcceeeccCccCCC---
Q 039419          462 ----LASLNRLILSKNSFSGA----IPSSLGRCESLQSLDLSSNKLSGKIPVELFEI----EGLDISLNLSWNALSG---  526 (1035)
Q Consensus       462 ----l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~----~~l~~~L~Ls~N~l~~---  526 (1035)
                          .++|+.|++++|.+++.    ++..+..+++|++|+|++|.+++..+..+...    ...+..|++++|.+++   
T Consensus       308 l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~  387 (461)
T 1z7x_W          308 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSC  387 (461)
T ss_dssp             HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHH
T ss_pred             hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhH
Confidence                36899999999999865    46667788999999999999986555555432    1234467788887775   


Q ss_pred             -CCCccccCCccccEEeccCCcccCcc-cc----c-cccCCCcEEeccCCcCcc
Q 039419          527 -AIPPQISALNKLSILDLSHNKLGGDL-LA----L-SGLDNLVSLNVSYNNFTG  573 (1035)
Q Consensus       527 -~~~~~~~~l~~L~~L~L~~N~l~~~~-~~----~-~~l~~L~~L~ls~N~l~~  573 (1035)
                       .+|..+..+++|++|+|++|++++.. ..    + ....+|+.|++.+|.+..
T Consensus       388 ~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~  441 (461)
T 1z7x_W          388 SSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  441 (461)
T ss_dssp             HHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             HHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence             56667777777888888888776532 11    1 123457777777766654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.96  E-value=1.2e-33  Score=332.56  Aligned_cols=259  Identities=20%  Similarity=0.157  Sum_probs=138.4

Q ss_pred             CCCCceeeCCCCCCCCCCChh-hhccccccceEecccCCCCC----CchhhhhhccccceeccccccCCCCchhhcc-cc
Q 039419           77 CTQLTTIDVSSNSLVGGVPSS-IGKLINLQDLILNSNQLTGE----IPKELGACIKLKNLLLFDNYLSGNLPVELGK-LV  150 (1035)
Q Consensus        77 l~~L~~L~ls~n~l~~~~p~~-i~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~-l~  150 (1035)
                      +++|++|||++|++++..... +..+++|++|+|++|++++.    ++..+..+++|++|+|++|.+.+..+..+.. ++
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~   81 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ   81 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence            356788888888887443333 67788888888888887742    4556666788888888888876544444332 33


Q ss_pred             ----ccceeecCCCcccCCCCCCcCCCccceEEEEeccccccc----cCcccccccccccceeecccccccCCcccccc-
Q 039419          151 ----NLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG----SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGN-  221 (1035)
Q Consensus       151 ----~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~----~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~-  221 (1035)
                          +|++|++++|.                         +++    .++..+..+++|++|++++|.+.+..+..+.. 
T Consensus        82 ~~~~~L~~L~L~~n~-------------------------i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~  136 (461)
T 1z7x_W           82 TPSCKIQKLSLQNCC-------------------------LTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG  136 (461)
T ss_dssp             STTCCCCEEECTTSC-------------------------CBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH
T ss_pred             hCCCceeEEEccCCC-------------------------CCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHH
Confidence                35555555553                         332    33555555555666666555555433333222 


Q ss_pred             ----CcCCceEEecCCcCCCCC----ChhhhcccchhHhhcccccccccCCcccc-----CCCCCcEEEccCccCCCC--
Q 039419          222 ----CSELVDLFLYENDLSGSL----PRELGKLQKLEKMLLWQNNFDGAIPEEIG-----NCKSLKTIDLSLNFFSGS--  286 (1035)
Q Consensus       222 ----l~~L~~L~L~~n~l~~~~----~~~l~~l~~L~~L~l~~n~l~~~~p~~~~-----~l~~L~~L~L~~n~l~~~--  286 (1035)
                          .++|++|+|++|.+++..    +..+..+++|++|++++|.+.+..+..+.     ..++|++|+|++|.+++.  
T Consensus       137 l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~  216 (461)
T 1z7x_W          137 LLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC  216 (461)
T ss_dssp             HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH
T ss_pred             HhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHH
Confidence                334666666666555422    33334445555555555555433332222     244566666666666542  


Q ss_pred             --CCccccCCCCCcEEEccCCccccCC-----CCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEe
Q 039419          287 --LPQSFGNLSSLEELMLSNNNISGSI-----PPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVD  359 (1035)
Q Consensus       287 --~~~~~~~l~~L~~L~L~~N~l~~~~-----~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~  359 (1035)
                        ++..+..+++|++|++++|++.+..     +..+..+++|++|++++|+|+.....      .++..+..+++|++|+
T Consensus       217 ~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~------~l~~~l~~~~~L~~L~  290 (461)
T 1z7x_W          217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCG------DLCRVLRAKESLKELS  290 (461)
T ss_dssp             HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHH------HHHHHHHHCTTCCEEE
T ss_pred             HHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHH------HHHHHHhhCCCcceEE
Confidence              2444555566666666666554321     11222345555555555555432110      1223344455555555


Q ss_pred             ccCcCCC
Q 039419          360 LSHNALT  366 (1035)
Q Consensus       360 Ls~N~l~  366 (1035)
                      |++|.++
T Consensus       291 Ls~n~i~  297 (461)
T 1z7x_W          291 LAGNELG  297 (461)
T ss_dssp             CTTCCCH
T ss_pred             CCCCCCc
Confidence            5555554

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=6.6e-30  Score=289.02  Aligned_cols=284  Identities=20%  Similarity=0.218  Sum_probs=215.8

Q ss_pred             CCCCCCCCCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCC
Q 039419           10 NWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNS   89 (1035)
Q Consensus        10 ~w~~~~~~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~   89 (1035)
                      .|... ..+|.|.|+ |+-         ++++++ .+|..+.  ++|++|+|++|.+++..+..++.+++|++|+|++|+
T Consensus        22 ~~~~~-~~~C~~~~~-c~~---------~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~   87 (353)
T 2z80_A           22 SSNQA-SLSCDRNGI-CKG---------SSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNG   87 (353)
T ss_dssp             ------CCEECTTSE-EEC---------CSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             CCCcc-CCCCCCCeE-eeC---------CCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCc
Confidence            34443 357999998 753         344555 4666555  489999999999997666689999999999999999


Q ss_pred             CCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCch--hhccccccceeecCCCcccCCCC
Q 039419           90 LVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPV--ELGKLVNLEVIRAGGNKDIAGKI  167 (1035)
Q Consensus        90 l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~--~l~~l~~L~~L~l~~n~~~~~~~  167 (1035)
                      +++..|..++++++|++|+|++|++++..+..+..+++|++|++++|+++ .+|.  .++.+++|++|++++|..+....
T Consensus        88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~  166 (353)
T 2z80_A           88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQ  166 (353)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEEC
T ss_pred             cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccC
Confidence            99777888999999999999999999544445899999999999999998 5665  78999999999999986555556


Q ss_pred             CCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccc-cccCcCCceEEecCCcCCCCCChhhh--
Q 039419          168 PYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQ-IGNCSELVDLFLYENDLSGSLPRELG--  244 (1035)
Q Consensus       168 ~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~~~~l~--  244 (1035)
                      +..++.+++|+.|++++|.+.+..|..++.+++|++|++++|.+. .+|.. +..+++|+.|++++|.+++..+..+.  
T Consensus       167 ~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  245 (353)
T 2z80_A          167 RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG  245 (353)
T ss_dssp             TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC-----
T ss_pred             HHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCccccccccccccc
Confidence            678888999999999999998888889999999999999999887 44444 45688899999999988876554433  


Q ss_pred             -cccchhHhhcccccccc----cCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCcccc
Q 039419          245 -KLQKLEKMLLWQNNFDG----AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG  309 (1035)
Q Consensus       245 -~l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  309 (1035)
                       ....++.++++++.+.+    .+|..+..+++|+.|+|++|+|+...+..|.++++|++|+|++|.+.+
T Consensus       246 ~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~  315 (353)
T 2z80_A          246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  315 (353)
T ss_dssp             -CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence             23445555555555543    356667777777777777777774333345677777777777777664

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=4.2e-32  Score=330.07  Aligned_cols=141  Identities=17%  Similarity=0.174  Sum_probs=85.0

Q ss_pred             CCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCccc---CCCCCCCCC------------CCCCCc
Q 039419           17 NPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNL---TGPISPDLG------------DCTQLT   81 (1035)
Q Consensus        17 ~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l---~~~~~~~~~------------~l~~L~   81 (1035)
                      -|++|+++.+.....   +.+.. ......+..+..+++|++|+|+++..   .+.+|..++            .+++|+
T Consensus        40 vck~W~~~~~~~~~~---l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           40 VCRRWFKIDSETREH---VTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             SCHHHHHHHHHHCCE---EEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             HhHHHHHhhhccccE---EEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            356899997643322   22221 12223344456788899999988632   245555555            567777


Q ss_pred             eeeCCCCCCCCCCChhhhcc--ccccceEecccC-CCC-CCchhhhhhccccceeccccccCCC----Cchhhccccccc
Q 039419           82 TIDVSSNSLVGGVPSSIGKL--INLQDLILNSNQ-LTG-EIPKELGACIKLKNLLLFDNYLSGN----LPVELGKLVNLE  153 (1035)
Q Consensus        82 ~L~ls~n~l~~~~p~~i~~l--~~L~~L~L~~n~-l~~-~~p~~l~~l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~  153 (1035)
                      +|+|++|.+++..+..+..+  .+|++|+|++|. ++. .++..+..+++|++|+|++|.+.+.    ++..+..+++|+
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~  195 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE  195 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence            77777777776666666653  347777777765 221 1222334667777777777776654    333445566667


Q ss_pred             eeecCCCc
Q 039419          154 VIRAGGNK  161 (1035)
Q Consensus       154 ~L~l~~n~  161 (1035)
                      +|++++|.
T Consensus       196 ~L~L~~n~  203 (592)
T 3ogk_B          196 VLNFYMTE  203 (592)
T ss_dssp             EEECTTCC
T ss_pred             EEEeeccC
Confidence            77666664

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=3.2e-29  Score=277.40  Aligned_cols=253  Identities=22%  Similarity=0.234  Sum_probs=185.5

Q ss_pred             CCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCC-CCCCCCCCceeeCCCCCCC--CC
Q 039419           17 NPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISP-DLGDCTQLTTIDVSSNSLV--GG   93 (1035)
Q Consensus        17 ~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~-~~~~l~~L~~L~ls~n~l~--~~   93 (1035)
                      +.|.|.+|.|+..+           ++ .+|..+.  ++|++|+|++|.+++ +|. .++.+++|++|+|++|+++  +.
T Consensus         5 C~C~~~~l~c~~~~-----------l~-~ip~~~~--~~l~~L~L~~n~l~~-i~~~~~~~l~~L~~L~L~~n~l~~~~~   69 (306)
T 2z66_A            5 CSCSGTEIRCNSKG-----------LT-SVPTGIP--SSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGLSFKGC   69 (306)
T ss_dssp             CEEETTEEECCSSC-----------CS-SCCSCCC--TTCCEEECCSSCCCC-CCTTTTTTCTTCSEEECCSSCCCEEEE
T ss_pred             CeeCCCEEEcCCCC-----------cc-cCCCCCC--CCCCEEECCCCccCc-cCHhHhhccccCCEEECCCCccCcccC
Confidence            45999999998543           22 3444443  578899999999984 554 4788999999999999887  22


Q ss_pred             CChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCc-hhhccccccceeecCCCcccCCCCCCcCC
Q 039419           94 VPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLP-VELGKLVNLEVIRAGGNKDIAGKIPYEIG  172 (1035)
Q Consensus        94 ~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~l~~n~~~~~~~~~~~~  172 (1035)
                      .|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|.+++..+ ..+..+++|++|++++|            
T Consensus        70 ~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n------------  136 (306)
T 2z66_A           70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT------------  136 (306)
T ss_dssp             EEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTS------------
T ss_pred             cccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCC------------
Confidence            3677778888888888888887 677778888888888888888774332 34555555555555554            


Q ss_pred             CccceEEEEeccccccccCcccccccccccceeeccccccc-CCccccccCcCCceEEecCCcCCCCCChhhhcccchhH
Q 039419          173 DCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSG-EIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEK  251 (1035)
Q Consensus       173 ~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~  251 (1035)
                                   .+.+..+..+..+++|++|++++|.+.+ .+|..+..+++|+.|+|++|.+++..|..|..+++|++
T Consensus       137 -------------~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  203 (306)
T 2z66_A          137 -------------HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV  203 (306)
T ss_dssp             -------------CCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             -------------cCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCE
Confidence                         4555556666777777777777777765 46667777777777777777777666777777777777


Q ss_pred             hhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCC-CCcEEEccCCccccC
Q 039419          252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLS-SLEELMLSNNNISGS  310 (1035)
Q Consensus       252 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~  310 (1035)
                      |++++|++++..+..+..+++|+.|+|++|++++..+..+..++ +|++|+|++|.+...
T Consensus       204 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~  263 (306)
T 2z66_A          204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  263 (306)
T ss_dssp             EECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred             EECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence            77777777766666777788888888888888877777787774 788888888888753

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.95  E-value=2.6e-28  Score=270.07  Aligned_cols=85  Identities=27%  Similarity=0.412  Sum_probs=38.8

Q ss_pred             ccceeecCCCccCCCCcccccCCCCccEEEcCCCccCC-CCchhccCccccchhhccCCcccccCccccCCCCCCcEEEc
Q 039419          416 QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG-LIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL  494 (1035)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  494 (1035)
                      +|++|++++|++++..+..|..+++|++|++++|++.+ ..|..|..+++|+.|++++|++++..|..|..+++|++|+|
T Consensus       127 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  206 (306)
T 2z66_A          127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM  206 (306)
T ss_dssp             TCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEEC
Confidence            34444444444444444444444444444444444443 23444444444444444444444444444444444555544


Q ss_pred             CCCcCc
Q 039419          495 SSNKLS  500 (1035)
Q Consensus       495 s~N~l~  500 (1035)
                      ++|+++
T Consensus       207 ~~N~l~  212 (306)
T 2z66_A          207 SHNNFF  212 (306)
T ss_dssp             TTSCCS
T ss_pred             CCCccC
Confidence            444444

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=2.8e-29  Score=299.00  Aligned_cols=195  Identities=15%  Similarity=0.092  Sum_probs=133.1

Q ss_pred             eeeeeCCcEEEEEE-ECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeEEeEEEcCCc
Q 039419          693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRFLGCCWNRNT  770 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  770 (1035)
                      ..+.|++|.+..++ .--|+.||+|++............+    .....++|.+|+++|+++ .|+||+++++++++++.
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~----~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~  316 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEE----SQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS  316 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHH----HHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhh----hHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence            35677777777663 3348899999997543222111000    012356799999999999 69999999999999999


Q ss_pred             ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          771 RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       771 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      .||||||++|++|.+++...+.  ++..   +|+.||+.||+|+|++   |||||||||+|||++.+|.+||+|||+|+.
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCee
Confidence            9999999999999999987654  5554   5889999999999999   999999999999999999999999999987


Q ss_pred             cccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 039419          851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP  902 (1035)
Q Consensus       851 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P  902 (1035)
                      .....  ......+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus       389 ~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            64432  22345689999999999865 467789999999998887665444

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.95  E-value=6.1e-28  Score=272.83  Aligned_cols=271  Identities=19%  Similarity=0.176  Sum_probs=195.4

Q ss_pred             ccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceecc
Q 039419           55 FLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLF  134 (1035)
Q Consensus        55 ~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~  134 (1035)
                      .....++++++++ .+|..+.  ++|++|+|++|++++..+..+.++++|++|+|++|++++..|..+..+++|++|+|+
T Consensus        32 ~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (353)
T 2z80_A           32 RNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS  108 (353)
T ss_dssp             TTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence            3445788999999 7888766  589999999999996666689999999999999999997777889999999999999


Q ss_pred             ccccCCCCchhhccccccceeecCCCcccCCCCCC--cCCCccceEEEEeccc-cccccCcccccccccccceeeccccc
Q 039419          135 DNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPY--EIGDCQSLLVVGLADT-KVAGSLPASLGKLSKLQSLSVYTTML  211 (1035)
Q Consensus       135 ~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~--~~~~l~~L~~L~l~~~-~~~~~~p~~l~~l~~L~~L~l~~n~l  211 (1035)
                      +|++++..+..++++++|++|++++|.  ...+|.  .+..+++|+.|++++| .+.+..+..|+.+++|++|++++|.+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~--l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l  186 (353)
T 2z80_A          109 YNYLSNLSSSWFKPLSSLTFLNLLGNP--YKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL  186 (353)
T ss_dssp             SSCCSSCCHHHHTTCTTCSEEECTTCC--CSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCcCCcCCHhHhCCCccCCEEECCCCC--CcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence            999995444458999999999999997  334554  6778888888888887 46656667788888888888888888


Q ss_pred             ccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCcccc---CCCCCcEEEccCccCCC---
Q 039419          212 SGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIG---NCKSLKTIDLSLNFFSG---  285 (1035)
Q Consensus       212 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~---~l~~L~~L~L~~n~l~~---  285 (1035)
                      ++..|..+..+++|++|++++|.++...+..+..+++|++|++++|.+++..+..+.   ....++.++|+++.+++   
T Consensus       187 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l  266 (353)
T 2z80_A          187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL  266 (353)
T ss_dssp             CEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHH
T ss_pred             CccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcch
Confidence            877778888888888888888887633333344567777777777777755444332   34456666666665553   


Q ss_pred             -CCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccch
Q 039419          286 -SLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQ  330 (1035)
Q Consensus       286 -~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  330 (1035)
                       .+|..+.++++|++|++++|+++.+.+..|..+++|++|+|++|+
T Consensus       267 ~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~  312 (353)
T 2z80_A          267 FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNP  312 (353)
T ss_dssp             HHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             hhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCC
Confidence             234445556666666666666653333334444444444444443

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=2.6e-30  Score=314.26  Aligned_cols=347  Identities=15%  Similarity=0.126  Sum_probs=185.1

Q ss_pred             ccceEEEEecccccccc----Ccccccccccccceeecccccc----cCCccccccCcCCceEEecCCcCCCCCChhhhc
Q 039419          174 CQSLLVVGLADTKVAGS----LPASLGKLSKLQSLSVYTTMLS----GEIPPQIGNCSELVDLFLYENDLSGSLPRELGK  245 (1035)
Q Consensus       174 l~~L~~L~l~~~~~~~~----~p~~l~~l~~L~~L~l~~n~l~----~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~  245 (1035)
                      +++|++|++++|.+.+.    ++..+..+++|++|++++|.++    +.++..+.++++|+.|+|++|.+.+ ++..+..
T Consensus       163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~  241 (592)
T 3ogk_B          163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA  241 (592)
T ss_dssp             CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred             CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence            33444444444444333    2333445566666666666654    2233344556666666666666663 5556666


Q ss_pred             ccchhHhhccccccc---ccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCC-CcccCCCcc
Q 039419          246 LQKLEKMLLWQNNFD---GAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIP-PVLSNATSL  321 (1035)
Q Consensus       246 l~~L~~L~l~~n~l~---~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L  321 (1035)
                      +++|++|++++....   ...+..+..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|
T Consensus       242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L  320 (592)
T 3ogk_B          242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL  320 (592)
T ss_dssp             CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred             hhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence            666666666543222   233445666677777777765443 456666677777777777777653322 234666777


Q ss_pred             ceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccC-----------cCCCCCCC-CCcccCcccceEecccccc
Q 039419          322 LQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH-----------NALTGSLH-PGLFQLQNLTKLLLISNGI  389 (1035)
Q Consensus       322 ~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~-----------N~l~~~~~-~~~~~l~~L~~L~L~~N~i  389 (1035)
                      ++|+++ |.+...         .++..+..+++|++|++++           |.++.... ..+..+++|++|+++.|.+
T Consensus       321 ~~L~L~-~~~~~~---------~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l  390 (592)
T 3ogk_B          321 EVLETR-NVIGDR---------GLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI  390 (592)
T ss_dssp             CEEEEE-GGGHHH---------HHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCC
T ss_pred             CEEecc-CccCHH---------HHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCc
Confidence            777776 444321         1122334566777777773           44442211 1123466677777766666


Q ss_pred             ccCCCCCCCCCCcceeEeeeccCCCCccceeecC----CCccCCC-----CcccccCCCCccEEEcCCCc--cCCCCchh
Q 039419          390 SGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLS----NNTLGGT-----LPSSLASLTRLQVLDISVNQ--FVGLIPES  458 (1035)
Q Consensus       390 ~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~----~N~l~~~-----~~~~l~~l~~L~~L~Ls~N~--l~~~~~~~  458 (1035)
                      ++..+..++.             .+++|+.|+|+    .|.+++.     ++..+.++++|+.|++++|.  +++.....
T Consensus       391 ~~~~~~~l~~-------------~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~  457 (592)
T 3ogk_B          391 TNESLESIGT-------------YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY  457 (592)
T ss_dssp             CHHHHHHHHH-------------HCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred             cHHHHHHHHh-------------hCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence            5432222111             13456666664    5556543     22235556677777776432  44333333


Q ss_pred             cc-CccccchhhccCCcccc-cCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCc
Q 039419          459 FG-QLASLNRLILSKNSFSG-AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALN  536 (1035)
Q Consensus       459 ~~-~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~  536 (1035)
                      +. .+++|+.|++++|++++ .++..+..+++|++|+|++|.+++.....                        .+..++
T Consensus       458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~------------------------~~~~l~  513 (592)
T 3ogk_B          458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAA------------------------AVTKLP  513 (592)
T ss_dssp             HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHH------------------------HHHHCS
T ss_pred             HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHH------------------------HHHhcC
Confidence            32 35667777777776654 23344456667777777777665322221                        223456


Q ss_pred             cccEEeccCCcccCcc--ccccccCCCcEEeccCC
Q 039419          537 KLSILDLSHNKLGGDL--LALSGLDNLVSLNVSYN  569 (1035)
Q Consensus       537 ~L~~L~L~~N~l~~~~--~~~~~l~~L~~L~ls~N  569 (1035)
                      +|++|+|++|+++...  .....+|.|....+..+
T Consensus       514 ~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          514 SLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             SCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             ccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            6777777777765532  12234565555555444

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.94  E-value=4.3e-27  Score=275.19  Aligned_cols=227  Identities=23%  Similarity=0.218  Sum_probs=158.2

Q ss_pred             chhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccc
Q 039419          248 KLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLD  327 (1035)
Q Consensus       248 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  327 (1035)
                      +|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|.++++|++|+|++|+|+...+..|.++++|++|+|+
T Consensus        76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  155 (452)
T 3zyi_A           76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR  155 (452)
T ss_dssp             TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred             CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence            44555555555555555555555555555555555555555555555555556665555555555555555566666665


Q ss_pred             cchhhhhhhhccccCCCCCcCCCCCCCCcEEeccC-cCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeE
Q 039419          328 TNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH-NALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL  406 (1035)
Q Consensus       328 ~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  406 (1035)
                      +|+|+.+          .+..|.++++|+.|+|++ |.+....+..|..+++|++|+|++|++++. |            
T Consensus       156 ~N~l~~~----------~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~------------  212 (452)
T 3zyi_A          156 NNPIESI----------PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P------------  212 (452)
T ss_dssp             SCCCCEE----------CTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C------------
T ss_pred             CCCccee----------CHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c------------
Confidence            5555422          123556666666666666 344433344566677777777777777643 2            


Q ss_pred             eeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCC
Q 039419          407 RLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRC  486 (1035)
Q Consensus       407 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  486 (1035)
                         .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+++++.+..|..+++|+.|+|++|+|++..+..|..+
T Consensus       213 ---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          213 ---NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             ---CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             ---cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence               13455778899999999998888899999999999999999998888899999999999999999998888888999


Q ss_pred             CCCcEEEcCCCcCc
Q 039419          487 ESLQSLDLSSNKLS  500 (1035)
Q Consensus       487 ~~L~~L~Ls~N~l~  500 (1035)
                      ++|+.|+|++|.+.
T Consensus       290 ~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          290 RYLVELHLHHNPWN  303 (452)
T ss_dssp             TTCCEEECCSSCEE
T ss_pred             cCCCEEEccCCCcC
Confidence            99999999999886

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=5.5e-27  Score=273.29  Aligned_cols=227  Identities=22%  Similarity=0.236  Sum_probs=142.4

Q ss_pred             chhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccc
Q 039419          248 KLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLD  327 (1035)
Q Consensus       248 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  327 (1035)
                      +++.|+|++|++.+..+..|.++++|+.|+|++|.|++..+..|.++++|++|+|++|+|+.+.+..|..+++|++|+|+
T Consensus        65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  144 (440)
T 3zyj_A           65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR  144 (440)
T ss_dssp             TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred             CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence            33444444444444444444444555555555555544444445555555555555555544444445555555555555


Q ss_pred             cchhhhhhhhccccCCCCCcCCCCCCCCcEEeccC-cCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeE
Q 039419          328 TNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH-NALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRL  406 (1035)
Q Consensus       328 ~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  406 (1035)
                      +|+|+.+          .+..|..+++|++|+|++ |.+....+..|..+++|++|+|++|+++.+ |            
T Consensus       145 ~N~i~~~----------~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~------------  201 (440)
T 3zyj_A          145 NNPIESI----------PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-P------------  201 (440)
T ss_dssp             SCCCCEE----------CTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-C------------
T ss_pred             CCccccc----------CHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-c------------
Confidence            5544422          123455555666666665 333333333555666666666666666532 2            


Q ss_pred             eeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCC
Q 039419          407 RLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRC  486 (1035)
Q Consensus       407 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  486 (1035)
                         .+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|..+
T Consensus       202 ---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (440)
T 3zyj_A          202 ---NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPL  278 (440)
T ss_dssp             ---CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSC
T ss_pred             ---ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccc
Confidence               13445668888888888887778888888888888888888888888888888888888888888887777778888


Q ss_pred             CCCcEEEcCCCcCc
Q 039419          487 ESLQSLDLSSNKLS  500 (1035)
Q Consensus       487 ~~L~~L~Ls~N~l~  500 (1035)
                      ++|+.|+|++|.+.
T Consensus       279 ~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          279 HHLERIHLHHNPWN  292 (440)
T ss_dssp             TTCCEEECCSSCEE
T ss_pred             cCCCEEEcCCCCcc
Confidence            89999999999886

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=4.6e-28  Score=290.27  Aligned_cols=297  Identities=26%  Similarity=0.309  Sum_probs=156.5

Q ss_pred             ccCCCCCCCCCCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCC
Q 039419            7 ALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVS   86 (1035)
Q Consensus         7 ~l~~w~~~~~~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls   86 (1035)
                      ..+.|.... +||.|+|..|.-...                 ..+....++.|++++|+++ .+|..+.  ++|++|+|+
T Consensus        11 ~w~~W~~~~-~~~~~~~r~~~~~~~-----------------~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~   69 (622)
T 3g06_A           11 VWSAWRRAA-PAEESRGRAAVVQKM-----------------RACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIP   69 (622)
T ss_dssp             HHHHHHHTC-CGGGHHHHHHHHHHH-----------------HHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEEC
T ss_pred             HHHHHHhcC-CcchhccccccCccc-----------------ccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEec
Confidence            456787654 689998865421000                 0001122455555555555 4555444  455555555


Q ss_pred             CCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCC
Q 039419           87 SNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGK  166 (1035)
Q Consensus        87 ~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~  166 (1035)
                      +|+++ .+|.   .+++|++|+|++|+++ .+|.   .+++|++|+|++|.++ .+|.   .+++|+.|++++|+  ...
T Consensus        70 ~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~~N~--l~~  135 (622)
T 3g06_A           70 DNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIFGNQ--LTS  135 (622)
T ss_dssp             SCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECCSSC--CSC
T ss_pred             CCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECCCCC--CCc
Confidence            55555 4443   3455555555555555 3443   4455555555555554 2333   33444444444443  111


Q ss_pred             CCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcc
Q 039419          167 IPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKL  246 (1035)
Q Consensus       167 ~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l  246 (1035)
                      +|..                           +++|++|++++|.++ .+|.   .+.+|+.|++++|.+++ +|   ..+
T Consensus       136 lp~~---------------------------l~~L~~L~Ls~N~l~-~l~~---~~~~L~~L~L~~N~l~~-l~---~~~  180 (622)
T 3g06_A          136 LPVL---------------------------PPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLTS-LP---MLP  180 (622)
T ss_dssp             CCCC---------------------------CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSC-CC---CCC
T ss_pred             CCCC---------------------------CCCCCEEECcCCcCC-CcCC---ccCCCCEEECCCCCCCC-Cc---ccC
Confidence            2211                           133444444444443 2222   12344445555555542 33   223


Q ss_pred             cchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceecc
Q 039419          247 QKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQL  326 (1035)
Q Consensus       247 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  326 (1035)
                      ++|+.|++++|++++ +|..   +++|+.|++++|.|+. +|..   +++|+.|+|++|+|++ +|   ..+++|+.|+|
T Consensus       181 ~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~L  248 (622)
T 3g06_A          181 SGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMV  248 (622)
T ss_dssp             TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEEC
T ss_pred             CCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEEC
Confidence            445555555555553 3321   3566666666666663 3322   3566777777776664 33   34466777777


Q ss_pred             ccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCC
Q 039419          327 DTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNC  400 (1035)
Q Consensus       327 ~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  400 (1035)
                      ++|+|+.           +|.   .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+++..|..+..+
T Consensus       249 s~N~L~~-----------lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L  307 (622)
T 3g06_A          249 SGNRLTS-----------LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  307 (622)
T ss_dssp             CSSCCSC-----------CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred             CCCCCCc-----------CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence            7776652           233   4567778888888887 556777778888888888888877666554433

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.94  E-value=4.9e-27  Score=261.73  Aligned_cols=237  Identities=20%  Similarity=0.250  Sum_probs=200.6

Q ss_pred             CCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceee
Q 039419           77 CTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIR  156 (1035)
Q Consensus        77 l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~  156 (1035)
                      .+++++|+|++|+++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~  156 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS  156 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEE
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEE
Confidence            467888888888888 88888888888888888888888 78888888888888888888887 6676666666666666


Q ss_pred             cCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCC
Q 039419          157 AGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLS  236 (1035)
Q Consensus       157 l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~  236 (1035)
                      +++|+                         +.+.+|..++..               .++..+.++++|+.|+|++|.++
T Consensus       157 L~~n~-------------------------~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~  196 (328)
T 4fcg_A          157 IRACP-------------------------ELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR  196 (328)
T ss_dssp             EEEET-------------------------TCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC
T ss_pred             CCCCC-------------------------CccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC
Confidence            65543                         334555544431               23345677999999999999999


Q ss_pred             CCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCccc
Q 039419          237 GSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLS  316 (1035)
Q Consensus       237 ~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  316 (1035)
                       .+|..++.+++|++|++++|++.+ +|..+..+++|++|+|++|.+.+.+|..|+++++|++|+|++|++.+.+|..|.
T Consensus       197 -~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~  274 (328)
T 4fcg_A          197 -SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH  274 (328)
T ss_dssp             -CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGG
T ss_pred             -cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhh
Confidence             889999999999999999999995 677899999999999999999999999999999999999999999999999999


Q ss_pred             CCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCC
Q 039419          317 NATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS  368 (1035)
Q Consensus       317 ~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  368 (1035)
                      ++++|++|+|++|++.          +.+|..+.++++|+.+++..|.+...
T Consensus       275 ~l~~L~~L~L~~n~~~----------~~iP~~l~~L~~L~~l~l~~~~~~~l  316 (328)
T 4fcg_A          275 RLTQLEKLDLRGCVNL----------SRLPSLIAQLPANCIILVPPHLQAQL  316 (328)
T ss_dssp             GCTTCCEEECTTCTTC----------CCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred             cCCCCCEEeCCCCCch----------hhccHHHhhccCceEEeCCHHHHHHH
Confidence            9999999999998654          68999999999999999999988643

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.94  E-value=1.2e-26  Score=253.72  Aligned_cols=253  Identities=24%  Similarity=0.245  Sum_probs=148.5

Q ss_pred             cEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCC
Q 039419          274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCR  353 (1035)
Q Consensus       274 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~  353 (1035)
                      +.++++++.++ .+|..+  .++|++|++++|++++..+..|..+++|++|+|++|+|+.          ..|..|..++
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~----------~~~~~~~~l~   80 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR----------IDAAAFTGLA   80 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE----------ECTTTTTTCT
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccce----------eCHhhcCCcc
Confidence            45666666665 334322  2456666666666665555555555566666665555542          1234566666


Q ss_pred             CCcEEeccCcC-CCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc
Q 039419          354 SLEAVDLSHNA-LTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP  432 (1035)
Q Consensus       354 ~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~  432 (1035)
                      +|++|+|++|. ++...+..|..+++|++|++++|++++..|..+.              ++++|++|+|++|++++..+
T Consensus        81 ~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--------------~l~~L~~L~l~~n~l~~~~~  146 (285)
T 1ozn_A           81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR--------------GLAALQYLYLQDNALQALPD  146 (285)
T ss_dssp             TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--------------TCTTCCEEECCSSCCCCCCT
T ss_pred             CCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhh--------------CCcCCCEEECCCCcccccCH
Confidence            66666666665 5544455566666666666666666655444333              23446666666666665555


Q ss_pred             ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhcc
Q 039419          433 SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEG  512 (1035)
Q Consensus       433 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  512 (1035)
                      ..|..+++|++|+|++|+++++.+..|..+++|+.|++++|++++..|..|..+++|++|+|++|++++           
T Consensus       147 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------  215 (285)
T 1ozn_A          147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA-----------  215 (285)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC-----------
T ss_pred             hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc-----------
Confidence            556666666666666666666555556666666666666666666666666666666666666666652           


Q ss_pred             CcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCCh
Q 039419          513 LDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDS  578 (1035)
Q Consensus       513 l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~  578 (1035)
                                    ..+..+..+++|++|+|++|++.++....+-+..|+.+..+.|.+.+..|..
T Consensus       216 --------------~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          216 --------------LPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             --------------CCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGG
T ss_pred             --------------CCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchH
Confidence                          2223344556677777777777665443333334555556666666665543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.94  E-value=6.5e-27  Score=255.98  Aligned_cols=255  Identities=22%  Similarity=0.239  Sum_probs=145.3

Q ss_pred             cceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCc
Q 039419          202 QSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLN  281 (1035)
Q Consensus       202 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n  281 (1035)
                      ++++.+++.++ .+|..+  .++|+.|+|++|.+++..+..|..+++|++|++++|.+++..|..|.++++|++|+|++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            34455555554 344433  345666666666666555555666666666666666666555666666666666666666


Q ss_pred             c-CCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEec
Q 039419          282 F-FSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDL  360 (1035)
Q Consensus       282 ~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~L  360 (1035)
                      . ++...+..|..+++|++|++++|++.+..+..|.++++|++|++++|+|+.+          .+..|..+++|++|+|
T Consensus        91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----------~~~~~~~l~~L~~L~l  160 (285)
T 1ozn_A           91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQAL----------PDDTFRDLGNLTHLFL  160 (285)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC----------CTTTTTTCTTCCEEEC
T ss_pred             CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccccc----------CHhHhccCCCccEEEC
Confidence            5 5555556666666666666666666655555566666666666666555421          2234556666666666


Q ss_pred             cCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCC
Q 039419          361 SHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTR  440 (1035)
Q Consensus       361 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~  440 (1035)
                      ++|++++..+..|..+++|++|++++|++++..|..+..              +++|++|+|++|++++..+..+..+++
T Consensus       161 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--------------l~~L~~L~l~~n~l~~~~~~~~~~l~~  226 (285)
T 1ozn_A          161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD--------------LGRLMTLYLFANNLSALPTEALAPLRA  226 (285)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT--------------CTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred             CCCcccccCHHHhcCccccCEEECCCCcccccCHhHccC--------------cccccEeeCCCCcCCcCCHHHcccCcc
Confidence            666666444445556666666666666666555544433              344666666666666555555666666


Q ss_pred             ccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccC
Q 039419          441 LQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLG  484 (1035)
Q Consensus       441 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  484 (1035)
                      |++|+|++|++....+.. .-...++.+..+.|.+....|..+.
T Consensus       227 L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~  269 (285)
T 1ozn_A          227 LQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA  269 (285)
T ss_dssp             CCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGT
T ss_pred             cCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhC
Confidence            666666666665332211 1123344445555555555554443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=1.6e-26  Score=269.28  Aligned_cols=246  Identities=23%  Similarity=0.245  Sum_probs=181.9

Q ss_pred             cceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCc
Q 039419          202 QSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLN  281 (1035)
Q Consensus       202 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n  281 (1035)
                      ..++..++.++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|++|
T Consensus        46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n  122 (440)
T 3zyj_A           46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN  122 (440)
T ss_dssp             CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred             CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence            44555555555 5555543  46777777777777666667777777777777777777666677777777777777777


Q ss_pred             cCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccc-hhhhhhhhccccCCCCCcCCCCCCCCcEEec
Q 039419          282 FFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTN-QISVFFAWQNKLEGSIPSTLANCRSLEAVDL  360 (1035)
Q Consensus       282 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~L  360 (1035)
                      +|++..+..|..+++|++|+|++|+|....+..|.++++|++|+|++| .+..          ..+..|.++++|++|+|
T Consensus       123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~----------i~~~~~~~l~~L~~L~L  192 (440)
T 3zyj_A          123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSY----------ISEGAFEGLSNLRYLNL  192 (440)
T ss_dssp             CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCE----------ECTTTTTTCSSCCEEEC
T ss_pred             cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcce----------eCcchhhcccccCeecC
Confidence            777666667777777888888877777766777777778888887773 3332          22346777888888888


Q ss_pred             cCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCC
Q 039419          361 SHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTR  440 (1035)
Q Consensus       361 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~  440 (1035)
                      ++|.++. +| .+..+++|++|+|++|+|++..|..|.              ++++|+.|+|++|+|++..+..|..+++
T Consensus       193 ~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~--------------~l~~L~~L~L~~n~l~~~~~~~~~~l~~  256 (440)
T 3zyj_A          193 AMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQ--------------GLMHLQKLWMIQSQIQVIERNAFDNLQS  256 (440)
T ss_dssp             TTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTT--------------TCTTCCEEECTTCCCCEECTTSSTTCTT
T ss_pred             CCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhc--------------cCccCCEEECCCCceeEEChhhhcCCCC
Confidence            8888873 33 467788888888888888877666554              3456888888888888888888888888


Q ss_pred             ccEEEcCCCccCCCCchhccCccccchhhccCCccc
Q 039419          441 LQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS  476 (1035)
Q Consensus       441 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  476 (1035)
                      |+.|+|++|+|+++.+..|..+++|+.|+|++|.+.
T Consensus       257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             CCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            888888888888888888888888888888888875

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.94  E-value=1.6e-26  Score=270.36  Aligned_cols=246  Identities=23%  Similarity=0.274  Sum_probs=176.5

Q ss_pred             cceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCc
Q 039419          202 QSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLN  281 (1035)
Q Consensus       202 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n  281 (1035)
                      ..++.+++.++ .+|..+.  ++|+.|+|++|.+++..+..|.++++|++|+|++|++.+..+..|.++++|++|+|++|
T Consensus        57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n  133 (452)
T 3zyi_A           57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN  133 (452)
T ss_dssp             CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence            34455555555 4554443  46677777777777666666777777777777777777666677777777777777777


Q ss_pred             cCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceecccc-chhhhhhhhccccCCCCCcCCCCCCCCcEEec
Q 039419          282 FFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDT-NQISVFFAWQNKLEGSIPSTLANCRSLEAVDL  360 (1035)
Q Consensus       282 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~L  360 (1035)
                      +|++..+..|.++++|++|+|++|+|..+.+..|.++++|++|+|++ |.++.+          .+..|.++++|++|+|
T Consensus       134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i----------~~~~~~~l~~L~~L~L  203 (452)
T 3zyi_A          134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYI----------SEGAFEGLFNLKYLNL  203 (452)
T ss_dssp             CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEE----------CTTTTTTCTTCCEEEC
T ss_pred             cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCcccc----------ChhhccCCCCCCEEEC
Confidence            77766666677777777777777777766666777777777777776 333322          2245777788888888


Q ss_pred             cCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCC
Q 039419          361 SHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTR  440 (1035)
Q Consensus       361 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~  440 (1035)
                      ++|.+++.  +.+..+++|++|+|++|+|++..|..|              .++++|++|+|++|++++..+..|..+++
T Consensus       204 ~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~--------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  267 (452)
T 3zyi_A          204 GMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSF--------------HGLSSLKKLWVMNSQVSLIERNAFDGLAS  267 (452)
T ss_dssp             TTSCCSSC--CCCTTCTTCCEEECTTSCCSEECGGGG--------------TTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             CCCccccc--ccccccccccEEECcCCcCcccCcccc--------------cCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence            88888743  346777888888888888876655544              44566888888888888777888888888


Q ss_pred             ccEEEcCCCccCCCCchhccCccccchhhccCCccc
Q 039419          441 LQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS  476 (1035)
Q Consensus       441 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  476 (1035)
                      |+.|+|++|+|+++++..|..+++|+.|+|++|.+.
T Consensus       268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             CCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            888888888888877777888888888888888775

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=2.8e-27  Score=262.23  Aligned_cols=250  Identities=17%  Similarity=0.153  Sum_probs=166.6

Q ss_pred             hhhccccccceEecccCCCCCCchhhhhhccccceeccccccC-CCCchhhc-------cccccceeecCCCcccCCCCC
Q 039419           97 SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLS-GNLPVELG-------KLVNLEVIRAGGNKDIAGKIP  168 (1035)
Q Consensus        97 ~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~-~~~p~~l~-------~l~~L~~L~l~~n~~~~~~~~  168 (1035)
                      .++.+++|++|++++|.+  .+|..+...  |++|+|++|.+. ..+|..+.       ++++|++|++++|        
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n--------  105 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENL--------  105 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEE--------
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCC--------
Confidence            356677888888888888  577777665  888888888873 34555544       4555555555544        


Q ss_pred             CcCCCccceEEEEeccccccccCcccc--cccccccceeecccccccCCccccccC-----cCCceEEecCCcCCCCCCh
Q 039419          169 YEIGDCQSLLVVGLADTKVAGSLPASL--GKLSKLQSLSVYTTMLSGEIPPQIGNC-----SELVDLFLYENDLSGSLPR  241 (1035)
Q Consensus       169 ~~~~~l~~L~~L~l~~~~~~~~~p~~l--~~l~~L~~L~l~~n~l~~~~p~~l~~l-----~~L~~L~L~~n~l~~~~~~  241 (1035)
                                       ++++..|..+  +.+++|++|++++|.+++. |..+..+     ++|++|+|++|++++..|.
T Consensus       106 -----------------~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~  167 (312)
T 1wwl_A          106 -----------------EVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCE  167 (312)
T ss_dssp             -----------------BCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTT
T ss_pred             -----------------cccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHH
Confidence                             4444455544  5566666666666666544 5555555     6666666666666665556


Q ss_pred             hhhcccchhHhhccccccccc--CCccc--cCCCCCcEEEccCccCCCC---CCccccCCCCCcEEEccCCccccCCC-C
Q 039419          242 ELGKLQKLEKMLLWQNNFDGA--IPEEI--GNCKSLKTIDLSLNFFSGS---LPQSFGNLSSLEELMLSNNNISGSIP-P  313 (1035)
Q Consensus       242 ~l~~l~~L~~L~l~~n~l~~~--~p~~~--~~l~~L~~L~L~~n~l~~~---~~~~~~~l~~L~~L~L~~N~l~~~~~-~  313 (1035)
                      .|+.+++|++|++++|++.+.  .|..+  ..+++|++|+|++|+|++.   ....+.++++|++|+|++|++++..| .
T Consensus       168 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  247 (312)
T 1wwl_A          168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP  247 (312)
T ss_dssp             TCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCS
T ss_pred             HhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchh
Confidence            666666666666666665543  23333  6777788888888877731   12334567788888888888876654 4


Q ss_pred             cccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEecccccccc
Q 039419          314 VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISG  391 (1035)
Q Consensus       314 ~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~  391 (1035)
                      .+..+++|++|+|++|+|+           .+|..+.  ++|++|+|++|+|++. |. +..+++|++|++++|+|++
T Consensus       248 ~~~~l~~L~~L~Ls~N~l~-----------~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          248 SCDWPSQLNSLNLSFTGLK-----------QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CCCCCTTCCEEECTTSCCS-----------SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hhhhcCCCCEEECCCCccC-----------hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            5666778888888887776           3455555  7888888888888865 44 7788888888888888874

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.94  E-value=1.3e-27  Score=264.78  Aligned_cols=252  Identities=21%  Similarity=0.191  Sum_probs=208.5

Q ss_pred             hhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCccccc----
Q 039419          121 ELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLG----  196 (1035)
Q Consensus       121 ~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~----  196 (1035)
                      .++..++|++|++++|.+  .+|..+...  |++|++++|..               +         ...+|..+.    
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l---------------~---------~~~~~~~~~~~~~   89 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTV---------------R---------AARIPSRILFGAL   89 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEE---------------E---------EEECBHHHHHHHH
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--Hhhcccccccc---------------c---------CCCcCHHHHHHHH
Confidence            456778899999999998  778877765  88888877751               1         123444444    


Q ss_pred             ---ccccccceeecccccccCCcccc--ccCcCCceEEecCCcCCCCCChhhhcc-----cchhHhhcccccccccCCcc
Q 039419          197 ---KLSKLQSLSVYTTMLSGEIPPQI--GNCSELVDLFLYENDLSGSLPRELGKL-----QKLEKMLLWQNNFDGAIPEE  266 (1035)
Q Consensus       197 ---~l~~L~~L~l~~n~l~~~~p~~l--~~l~~L~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~l~~n~l~~~~p~~  266 (1035)
                         ++++|++|++++|.+++.+|..+  ..+++|++|+|++|.+++. |..++.+     ++|++|++++|++.+..|..
T Consensus        90 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~  168 (312)
T 1wwl_A           90 RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ  168 (312)
T ss_dssp             HHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTT
T ss_pred             HhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHH
Confidence               78999999999999999999987  8999999999999999977 8889888     99999999999999888899


Q ss_pred             ccCCCCCcEEEccCccCCCC--CCccc--cCCCCCcEEEccCCcccc---CCCCcccCCCccceeccccchhhhhhhhcc
Q 039419          267 IGNCKSLKTIDLSLNFFSGS--LPQSF--GNLSSLEELMLSNNNISG---SIPPVLSNATSLLQLQLDTNQISVFFAWQN  339 (1035)
Q Consensus       267 ~~~l~~L~~L~L~~n~l~~~--~~~~~--~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n  339 (1035)
                      |+.+++|++|+|++|++.+.  .+..+  .++++|++|+|++|+|++   .....+.++++|++|+|++|+|+.      
T Consensus       169 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~------  242 (312)
T 1wwl_A          169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD------  242 (312)
T ss_dssp             CCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCS------
T ss_pred             hccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCc------
Confidence            99999999999999998754  23334  899999999999999983   223455688999999999998873      


Q ss_pred             ccCCCCC-cCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccc
Q 039419          340 KLEGSIP-STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQ  418 (1035)
Q Consensus       340 ~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~  418 (1035)
                          ..| ..+..+++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|++. |. +.              .+++|+
T Consensus       243 ----~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~--------------~l~~L~  299 (312)
T 1wwl_A          243 ----AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PD--------------ELPQVG  299 (312)
T ss_dssp             ----SCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TT--------------TSCEEE
T ss_pred             ----ccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-Hh--------------hCCCCC
Confidence                232 45667899999999999999 6677766  8999999999999976 43 43              457799


Q ss_pred             eeecCCCccCCC
Q 039419          419 MLNLSNNTLGGT  430 (1035)
Q Consensus       419 ~L~L~~N~l~~~  430 (1035)
                      +|+|++|++++.
T Consensus       300 ~L~L~~N~l~~~  311 (312)
T 1wwl_A          300 NLSLKGNPFLDS  311 (312)
T ss_dssp             EEECTTCTTTCC
T ss_pred             EEeccCCCCCCC
Confidence            999999999853

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.93  E-value=2e-25  Score=267.35  Aligned_cols=267  Identities=26%  Similarity=0.326  Sum_probs=185.7

Q ss_pred             eEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhccc
Q 039419          177 LLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQ  256 (1035)
Q Consensus       177 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~  256 (1035)
                      ++.|++++|+++ .+|..+.  ++|++|++++|.++ .+|.   .+++|+.|+|++|+++ .+|.   .+++|++|++++
T Consensus        42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~  110 (622)
T 3g06_A           42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFS  110 (622)
T ss_dssp             CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECS
T ss_pred             CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcC
Confidence            344444444454 4444443  56666666666666 4554   4566777777777776 3443   556777777777


Q ss_pred             ccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhh
Q 039419          257 NNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFA  336 (1035)
Q Consensus       257 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~  336 (1035)
                      |++++ +|.   .+++|+.|+|++|+|++ +|..   +++|++|+|++|+++++ |.   .+.+|+.|++++|+|+.   
T Consensus       111 N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~---  175 (622)
T 3g06_A          111 NPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS---  175 (622)
T ss_dssp             CCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC---
T ss_pred             CcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC---
Confidence            77764 343   45778888888888874 4432   37788888888887753 33   24667788888887763   


Q ss_pred             hccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCc
Q 039419          337 WQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQ  416 (1035)
Q Consensus       337 ~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~  416 (1035)
                              +|   ..+++|+.|+|++|.|++ +|..   +++|+.|++++|.|+.+ |..                 +++
T Consensus       176 --------l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l-~~~-----------------~~~  222 (622)
T 3g06_A          176 --------LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-PAL-----------------PSG  222 (622)
T ss_dssp             --------CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSC-CCC-----------------CTT
T ss_pred             --------Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccccc-CCC-----------------CCC
Confidence                    33   345778888888888874 3332   47888888888888743 221                 256


Q ss_pred             cceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCC
Q 039419          417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSS  496 (1035)
Q Consensus       417 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  496 (1035)
                      |++|+|++|+|++ +|   ..+++|+.|+|++|+|+.+++    .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++
T Consensus       223 L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~  293 (622)
T 3g06_A          223 LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  293 (622)
T ss_dssp             CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred             CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence            8888999998885 44   455789999999999986543    5678889999999998 6678888999999999999


Q ss_pred             CcCcCccchhhhhhc
Q 039419          497 NKLSGKIPVELFEIE  511 (1035)
Q Consensus       497 N~l~~~~p~~~~~~~  511 (1035)
                      |++++.+|..+..+.
T Consensus       294 N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          294 NPLSERTLQALREIT  308 (622)
T ss_dssp             CCCCHHHHHHHHHHH
T ss_pred             CCCCCcCHHHHHhcc
Confidence            999887777666554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.93  E-value=1.5e-27  Score=265.05  Aligned_cols=253  Identities=21%  Similarity=0.187  Sum_probs=140.4

Q ss_pred             hhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchh
Q 039419          252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI  331 (1035)
Q Consensus       252 L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i  331 (1035)
                      ++++.+.+...+...+..+++|++|+|++|+|++..|..|.++++|++|+|++|++.+..+  |..+++|++|+|++|+|
T Consensus        15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l   92 (317)
T 3o53_A           15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV   92 (317)
T ss_dssp             ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred             eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence            3555555554444555566778888888888877666777788888888888887775443  66666666666666665


Q ss_pred             hhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeecc
Q 039419          332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSF  411 (1035)
Q Consensus       332 ~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~  411 (1035)
                      +.+               ...++|++|++++|++++..+..   +                                   
T Consensus        93 ~~l---------------~~~~~L~~L~l~~n~l~~~~~~~---~-----------------------------------  119 (317)
T 3o53_A           93 QEL---------------LVGPSIETLHAANNNISRVSCSR---G-----------------------------------  119 (317)
T ss_dssp             EEE---------------EECTTCCEEECCSSCCSEEEECC---C-----------------------------------
T ss_pred             ccc---------------cCCCCcCEEECCCCccCCcCccc---c-----------------------------------
Confidence            422               12255566666666555322211   2                                   


Q ss_pred             CCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhcc-CccccchhhccCCcccccCccccCCCCCCc
Q 039419          412 GNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFG-QLASLNRLILSKNSFSGAIPSSLGRCESLQ  490 (1035)
Q Consensus       412 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  490 (1035)
                         ++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+. .+++|++|+|++|+|++. +. ...+++|+
T Consensus       120 ---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~  194 (317)
T 3o53_A          120 ---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLK  194 (317)
T ss_dssp             ---SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCC
T ss_pred             ---CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCC
Confidence               3355555555555555555555556666666666666655444442 455666666666666533 22 22356666


Q ss_pred             EEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccC--ccccccccCCCcEEecc
Q 039419          491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG--DLLALSGLDNLVSLNVS  567 (1035)
Q Consensus       491 ~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~l~~L~~L~ls  567 (1035)
                      +|+|++|+|+ .+|..+..+..+. .|+|++|+++ .+|..+..+++|+.|+|++|++.+  .+..+..+++|+.|+++
T Consensus       195 ~L~Ls~N~l~-~l~~~~~~l~~L~-~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          195 TLDLSSNKLA-FMGPEFQSAAGVT-WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             EEECCSSCCC-EECGGGGGGTTCS-EEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             EEECCCCcCC-cchhhhcccCccc-EEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            6666666665 2333322222211 2333333333 223344555666666666666652  23445555555555555

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.93  E-value=2e-27  Score=264.07  Aligned_cols=268  Identities=20%  Similarity=0.204  Sum_probs=184.4

Q ss_pred             eEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhccc
Q 039419          177 LLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQ  256 (1035)
Q Consensus       177 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~  256 (1035)
                      ++..+++.+.+...+...+..+++|++|++++|.+++..|..|.++++|+.|+|++|.+++..+  |..+++|++|++++
T Consensus        12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~   89 (317)
T 3o53_A           12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN   89 (317)
T ss_dssp             EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred             eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence            5556666666665555556667778888888888876666777788888888888888775443  77777788888888


Q ss_pred             ccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhh
Q 039419          257 NNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFA  336 (1035)
Q Consensus       257 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~  336 (1035)
                      |++++..     ..++|++|++++|+|++..+.   .+++|++|++++|++++..+..|..+++|++|+|++|+|+.+  
T Consensus        90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--  159 (317)
T 3o53_A           90 NYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV--  159 (317)
T ss_dssp             SEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE--
T ss_pred             Ccccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc--
Confidence            7777432     237788888888888754433   356788888888888777677777777788888877777643  


Q ss_pred             hccccCCCCCcCC-CCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCC
Q 039419          337 WQNKLEGSIPSTL-ANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCT  415 (1035)
Q Consensus       337 ~~n~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~  415 (1035)
                              .+..+ ..+++|++|+|++|.+++. + ....+++|++|+|++|+|++..+.               |..++
T Consensus       160 --------~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~---------------~~~l~  214 (317)
T 3o53_A          160 --------NFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPE---------------FQSAA  214 (317)
T ss_dssp             --------EGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGG---------------GGGGT
T ss_pred             --------cHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchhh---------------hcccC
Confidence                    22333 3567788888888877744 2 223477777777777777754332               33446


Q ss_pred             ccceeecCCCccCCCCcccccCCCCccEEEcCCCccC-CCCchhccCccccchhhccC-CcccccCccc
Q 039419          416 QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFV-GLIPESFGQLASLNRLILSK-NSFSGAIPSS  482 (1035)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~  482 (1035)
                      +|++|+|++|+|+ .+|..+..+++|+.|++++|++. +.++..+..+++|+.|++++ +.+++..|..
T Consensus       215 ~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             TCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             cccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence            6777777777777 45666777777888888888777 56667777777777777774 3455554443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=2.1e-26  Score=270.77  Aligned_cols=218  Identities=24%  Similarity=0.224  Sum_probs=137.8

Q ss_pred             CCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcC
Q 039419          269 NCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPST  348 (1035)
Q Consensus       269 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~  348 (1035)
                      .+++|+.|+|++|.|++..|..|+++++|++|+|++|.+++..|  |..+++|++|+|++|+|+.+              
T Consensus        32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--------------   95 (487)
T 3oja_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL--------------   95 (487)
T ss_dssp             TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE--------------
T ss_pred             cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC--------------
Confidence            34578888888888887777788888888888888888875544  66666666666666665422              


Q ss_pred             CCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccC
Q 039419          349 LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG  428 (1035)
Q Consensus       349 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~  428 (1035)
                       ...++|+.|++++|.|++..+                        .                 .+++|+.|+|++|+|+
T Consensus        96 -~~~~~L~~L~L~~N~l~~~~~------------------------~-----------------~l~~L~~L~L~~N~l~  133 (487)
T 3oja_A           96 -LVGPSIETLHAANNNISRVSC------------------------S-----------------RGQGKKNIYLANNKIT  133 (487)
T ss_dssp             -EECTTCCEEECCSSCCCCEEE------------------------C-----------------CCSSCEEEECCSSCCC
T ss_pred             -CCCCCcCEEECcCCcCCCCCc------------------------c-----------------ccCCCCEEECCCCCCC
Confidence             112455555555555543222                        1                 1244666666777766


Q ss_pred             CCCcccccCCCCccEEEcCCCccCCCCchhcc-CccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhh
Q 039419          429 GTLPSSLASLTRLQVLDISVNQFVGLIPESFG-QLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVEL  507 (1035)
Q Consensus       429 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  507 (1035)
                      +..|..|..+++|+.|+|++|+|++.+|..|. .+++|+.|+|++|.|++..+  +..+++|++|+|++|.|++ +|.. 
T Consensus       134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~-  209 (487)
T 3oja_A          134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPE-  209 (487)
T ss_dssp             SGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGG-
T ss_pred             CCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHh-
Confidence            66666677777777777777777766666665 56777777777777765422  3346777777777777763 2222 


Q ss_pred             hhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCc
Q 039419          508 FEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT  572 (1035)
Q Consensus       508 ~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~  572 (1035)
                                              +..+++|+.|+|++|+|++.+..+..+++|+.|++++|++.
T Consensus       210 ------------------------~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~  250 (487)
T 3oja_A          210 ------------------------FQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFH  250 (487)
T ss_dssp             ------------------------GGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBC
T ss_pred             ------------------------HcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCc
Confidence                                    33445555666666666555555555566666666666665

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=8.9e-30  Score=309.72  Aligned_cols=439  Identities=16%  Similarity=0.171  Sum_probs=233.8

Q ss_pred             CCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCC---CCCCCC------------CCCCCCc
Q 039419           17 NPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTG---PISPDL------------GDCTQLT   81 (1035)
Q Consensus        17 ~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~---~~~~~~------------~~l~~L~   81 (1035)
                      -|++|+++...   ....+++...... .....+..+++|++|+|+++....   ..|..+            ..+++|+
T Consensus        33 vck~W~~~~~~---~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~  108 (594)
T 2p1m_B           33 VCKSWYEIERW---CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE  108 (594)
T ss_dssp             SCHHHHHHHHH---HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             HHHHHHHhhhh---hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence            46789998322   2234555433211 112235677889999999975321   122221            2466788


Q ss_pred             eeeCCCCCCCCCCChhhh-ccccccceEeccc-CCCCC-CchhhhhhccccceeccccccCCCCchhhc----cccccce
Q 039419           82 TIDVSSNSLVGGVPSSIG-KLINLQDLILNSN-QLTGE-IPKELGACIKLKNLLLFDNYLSGNLPVELG----KLVNLEV  154 (1035)
Q Consensus        82 ~L~ls~n~l~~~~p~~i~-~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~----~l~~L~~  154 (1035)
                      +|+|++|.+++..+..+. .+++|++|+|++| .+++. ++..+..+++|++|+|++|.+++..+..+.    .+++|++
T Consensus       109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~  188 (594)
T 2p1m_B          109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS  188 (594)
T ss_dssp             EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred             eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence            888888877766666665 5778888888877 45432 334445677888888888777655444443    4446677


Q ss_pred             eecCCCc-ccCCC-CCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecC
Q 039419          155 IRAGGNK-DIAGK-IPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYE  232 (1035)
Q Consensus       155 L~l~~n~-~~~~~-~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~  232 (1035)
                      |++++|. .+... +..-+..+++|+.|++++|...+.++..+..+++|++|++..+...                 +..
T Consensus       189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~-----------------~~~  251 (594)
T 2p1m_B          189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAE-----------------VRP  251 (594)
T ss_dssp             EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCC-----------------CCH
T ss_pred             EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCc-----------------cch
Confidence            7666663 00000 0011122345555555544222224444444455555543222100                 111


Q ss_pred             CcCCCCCChhhhcccchhHh-hcccccccccCCccccCCCCCcEEEccCccCCCCCCc-cccCCCCCcEEEccCCccccC
Q 039419          233 NDLSGSLPRELGKLQKLEKM-LLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQ-SFGNLSSLEELMLSNNNISGS  310 (1035)
Q Consensus       233 n~l~~~~~~~l~~l~~L~~L-~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~  310 (1035)
                      |.+. .++..+.++++|+.| .+.+... +.++..+..+++|+.|+|++|.+++.... .+..+++|++|++++| +...
T Consensus       252 ~~~~-~l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~  328 (594)
T 2p1m_B          252 DVYS-GLSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDA  328 (594)
T ss_dssp             HHHH-HHHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHH
T ss_pred             hhHH-HHHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHH
Confidence            1111 122233444444444 2222211 12333344455666666666655432111 2345566666666655 3211


Q ss_pred             -CCCcccCCCccceeccc---------cchhhhhhhhccccCCCCCcCC-CCCCCCcEEeccCcCCCCCCCCCcc-cCcc
Q 039419          311 -IPPVLSNATSLLQLQLD---------TNQISVFFAWQNKLEGSIPSTL-ANCRSLEAVDLSHNALTGSLHPGLF-QLQN  378 (1035)
Q Consensus       311 -~~~~~~~l~~L~~L~L~---------~N~i~~l~~~~n~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~  378 (1035)
                       .+.....+++|++|++.         .|.++....          ..+ ..+++|+.|+++.|.+++.....+. .+++
T Consensus       329 ~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l----------~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~  398 (594)
T 2p1m_B          329 GLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGL----------VSVSMGCPKLESVLYFCRQMTNAALITIARNRPN  398 (594)
T ss_dssp             HHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHH----------HHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTT
T ss_pred             HHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHH----------HHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCC
Confidence             11122235556666552         233332111          112 2367777777777777644333343 4677


Q ss_pred             cceEecc--c----cccccCCCC-CCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccC-CCCccEEEcCCCc
Q 039419          379 LTKLLLI--S----NGISGLIPP-EIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLAS-LTRLQVLDISVNQ  450 (1035)
Q Consensus       379 L~~L~L~--~----N~i~~~~~~-~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~-l~~L~~L~Ls~N~  450 (1035)
                      |+.|+++  +    |.+++...+ .+.          ..+.++++|+.|+|++ .+++..+..+.. +++|+.|+|++|.
T Consensus       399 L~~L~L~~~~~~~~~~l~~~~~~~~~~----------~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~  467 (594)
T 2p1m_B          399 MTRFRLCIIEPKAPDYLTLEPLDIGFG----------AIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAG  467 (594)
T ss_dssp             CCEEEEEESSTTCCCTTTCCCTHHHHH----------HHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCC
T ss_pred             cceeEeecccCCCcccccCCchhhHHH----------HHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCC
Confidence            8888887  3    344321100 000          0134566788888876 666544445554 7788889998888


Q ss_pred             cCCCCchhc-cCccccchhhccCCcccccCcc-ccCCCCCCcEEEcCCCcCc
Q 039419          451 FVGLIPESF-GQLASLNRLILSKNSFSGAIPS-SLGRCESLQSLDLSSNKLS  500 (1035)
Q Consensus       451 l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~  500 (1035)
                      +++.....+ ..+++|+.|+|++|.+++.... .+..+++|++|+|++|+++
T Consensus       468 i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          468 DSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS  519 (594)
T ss_dssp             SSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred             CcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence            875544444 5678888899998888644333 3445788999999999885

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.1e-25  Score=266.60  Aligned_cols=194  Identities=14%  Similarity=0.150  Sum_probs=148.9

Q ss_pred             ccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcC
Q 039419          689 VEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR  768 (1035)
Q Consensus       689 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  768 (1035)
                      ...+.||+|+||+||+|+.. ++.+++|+...+.......      ......+++.+|++++++++||||+++..++...
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~------~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERL------DENIRKSRTAREARYLALVKDFGIPAPYIFDVDL  411 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHH------HHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhh------hhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC
Confidence            45678999999999999554 7889999876543221100      0011246789999999999999999666666677


Q ss_pred             CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCc
Q 039419          769 NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA  848 (1035)
Q Consensus       769 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a  848 (1035)
                      +..|+||||++|++|.++++.          +..++.|+++||+|||++   +|+||||||+|||++.  .+||+|||++
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccC
Confidence            888999999999999999875          458999999999999999   9999999999999998  9999999999


Q ss_pred             cccccCCccc-----cccccCCcccccCCccccc--CCCCccccchhHHHHHHHHHhCCCCCC
Q 039419          849 KLVVEGDFAR-----SSNTVAGSYGYIAPEYGYM--MKITEKSDVYSYGVVVLEVLTGKQPID  904 (1035)
Q Consensus       849 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGvvl~elltg~~P~~  904 (1035)
                      +.........     ......||+.|||||++..  ..|+...|+|+..+-..+-+.++.+|.
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9775432111     1235679999999999876  567788999999999999888887763

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.91  E-value=2.5e-24  Score=233.19  Aligned_cols=217  Identities=22%  Similarity=0.206  Sum_probs=167.0

Q ss_pred             CCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCCh
Q 039419           17 NPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPS   96 (1035)
Q Consensus        17 ~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~   96 (1035)
                      ++|.|.|+.|.-.+.++.+++++++++ .+|..+.  ++|++|+|++|++++..+..++.+++|++|+|++|+++...+.
T Consensus         3 ~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~   79 (270)
T 2o6q_A            3 ALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG   79 (270)
T ss_dssp             CCBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT
T ss_pred             ccCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh
Confidence            689999999965555667889998888 4776665  6789999999999966666899999999999999999855455


Q ss_pred             hhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccc
Q 039419           97 SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS  176 (1035)
Q Consensus        97 ~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  176 (1035)
                      .+..+++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..++.+++|++|++++|. +....+..+..+++
T Consensus        80 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~-l~~~~~~~~~~l~~  158 (270)
T 2o6q_A           80 IFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE-LQSLPKGVFDKLTS  158 (270)
T ss_dssp             TTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-CCCCCTTTTTTCTT
T ss_pred             hhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCc-CCccCHhHccCCcc
Confidence            56889999999999999986555667889999999999999986666778888888888888886 33333344667777


Q ss_pred             eEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCC
Q 039419          177 LLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSG  237 (1035)
Q Consensus       177 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  237 (1035)
                      |+.|++++|.+.+..+..|..+++|++|++++|.+++..+..+..+++|+.|+|++|.+..
T Consensus       159 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          159 LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            7777777777776666667777777777777777775444556667777777777776653

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.91  E-value=3.9e-28  Score=295.26  Aligned_cols=430  Identities=15%  Similarity=0.146  Sum_probs=210.4

Q ss_pred             CCCCCCCceeeCCCCCCC---CCCCh------------hhhccccccceEecccCCCCCCchhhh-hhccccceecccc-
Q 039419           74 LGDCTQLTTIDVSSNSLV---GGVPS------------SIGKLINLQDLILNSNQLTGEIPKELG-ACIKLKNLLLFDN-  136 (1035)
Q Consensus        74 ~~~l~~L~~L~ls~n~l~---~~~p~------------~i~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~l~~n-  136 (1035)
                      +..+++|++|+|++|...   +..|.            ....+++|++|+|++|.+++..+..+. .+++|++|+|++| 
T Consensus        62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~  141 (594)
T 2p1m_B           62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE  141 (594)
T ss_dssp             HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE
T ss_pred             HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC
Confidence            345677788888776421   11121            123556777777777777665555554 5677777777776 


Q ss_pred             ccCCC-CchhhccccccceeecCCCcccCCCCCCc----CCCccceEEEEecccc--cccc-Ccccccccccccceeecc
Q 039419          137 YLSGN-LPVELGKLVNLEVIRAGGNKDIAGKIPYE----IGDCQSLLVVGLADTK--VAGS-LPASLGKLSKLQSLSVYT  208 (1035)
Q Consensus       137 ~l~~~-~p~~l~~l~~L~~L~l~~n~~~~~~~~~~----~~~l~~L~~L~l~~~~--~~~~-~p~~l~~l~~L~~L~l~~  208 (1035)
                      .+... ++..+.++++|++|++++|. +.+..+..    ...+++|+.|++++|.  +... ++..+..+++|++|++++
T Consensus       142 ~~~~~~l~~~~~~~~~L~~L~L~~~~-i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~  220 (594)
T 2p1m_B          142 GFSTDGLAAIAATCRNLKELDLRESD-VDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR  220 (594)
T ss_dssp             EEEHHHHHHHHHHCTTCCEEECTTCE-EECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred             CCCHHHHHHHHHhCCCCCEEeCcCCc-cCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCC
Confidence            34322 33334466666777666664 22222111    1133344444444443  1100 111112234444444444


Q ss_pred             c-ccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEE-EccCccCCCC
Q 039419          209 T-MLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTI-DLSLNFFSGS  286 (1035)
Q Consensus       209 n-~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L-~L~~n~l~~~  286 (1035)
                      | .+. .++..+..+++|+.|+++.+...                 +..|.+.+ ++..+.++++|+.| .+.+.... .
T Consensus       221 ~~~~~-~l~~~~~~~~~L~~L~l~~~~~~-----------------~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~~-~  280 (594)
T 2p1m_B          221 AVPLE-KLATLLQRAPQLEELGTGGYTAE-----------------VRPDVYSG-LSVALSGCKELRCLSGFWDAVPA-Y  280 (594)
T ss_dssp             TSCHH-HHHHHHHHCTTCSEEECSBCCCC-----------------CCHHHHHH-HHHHHHTCTTCCEEECCBTCCGG-G
T ss_pred             CCcHH-HHHHHHhcCCcceEcccccccCc-----------------cchhhHHH-HHHHHhcCCCcccccCCcccchh-h
Confidence            3 222 23333333444444443332210                 22333443 34467788888888 44433322 3


Q ss_pred             CCccccCCCCCcEEEccCCccccCC-CCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccC---
Q 039419          287 LPQSFGNLSSLEELMLSNNNISGSI-PPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH---  362 (1035)
Q Consensus       287 ~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~---  362 (1035)
                      ++..+..+++|++|+|++|.+++.. ...+..+++|++|++++| +....         ++.....+++|++|++++   
T Consensus       281 l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~---------l~~l~~~~~~L~~L~L~~~~~  350 (594)
T 2p1m_B          281 LPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAG---------LEVLASTCKDLRELRVFPSEP  350 (594)
T ss_dssp             GGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHH---------HHHHHHHCTTCCEEEEECSCT
T ss_pred             HHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHH---------HHHHHHhCCCCCEEEEecCcc
Confidence            4444556788888888888865432 223456777888888777 43211         112223467777777743   


Q ss_pred             ------cCCCCCCCCCcc-cCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecC--C----CccCC
Q 039419          363 ------NALTGSLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLS--N----NTLGG  429 (1035)
Q Consensus       363 ------N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~--~----N~l~~  429 (1035)
                            +.+++.....+. .+++|++|.+..|.+++.....+.             ..+++|+.|+|+  +    |.+++
T Consensus       351 ~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~-------------~~~~~L~~L~L~~~~~~~~~~l~~  417 (594)
T 2p1m_B          351 FVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIA-------------RNRPNMTRFRLCIIEPKAPDYLTL  417 (594)
T ss_dssp             TCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHH-------------HHCTTCCEEEEEESSTTCCCTTTC
T ss_pred             cccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHH-------------hhCCCcceeEeecccCCCcccccC
Confidence                  233311111111 245566665555555432111110             123445555555  2    33332


Q ss_pred             CC-----cccccCCCCccEEEcCCCccCCCCchhccC-ccccchhhccCCcccccCcccc-CCCCCCcEEEcCCCcCcCc
Q 039419          430 TL-----PSSLASLTRLQVLDISVNQFVGLIPESFGQ-LASLNRLILSKNSFSGAIPSSL-GRCESLQSLDLSSNKLSGK  502 (1035)
Q Consensus       430 ~~-----~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~  502 (1035)
                      ..     +..+..+++|+.|+|++ .+++.....+.. +++|+.|+|++|.+++.....+ ..+++|++|+|++|.++  
T Consensus       418 ~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~--  494 (594)
T 2p1m_B          418 EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG--  494 (594)
T ss_dssp             CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC--
T ss_pred             CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc--
Confidence            11     11133445555555544 333322222322 4445555555555543322222 33455555555555543  


Q ss_pred             cchhhhhhccCcceeeccCccCCCCCCc-cccCCccccEEeccCCcccCcc-ccc-cccCCCcEEeccCCcCcc
Q 039419          503 IPVELFEIEGLDISLNLSWNALSGAIPP-QISALNKLSILDLSHNKLGGDL-LAL-SGLDNLVSLNVSYNNFTG  573 (1035)
Q Consensus       503 ~p~~~~~~~~l~~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~-~~~-~~l~~L~~L~ls~N~l~~  573 (1035)
                                             +.... .+..+++|++|+|++|+++... ..+ ..+++|+...+..+....
T Consensus       495 -----------------------~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~~  545 (594)
T 2p1m_B          495 -----------------------DKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPD  545 (594)
T ss_dssp             -----------------------HHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCGG
T ss_pred             -----------------------HHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCccc
Confidence                                   22221 2345789999999999984422 233 567888887777776544

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.91  E-value=4e-25  Score=259.87  Aligned_cols=223  Identities=21%  Similarity=0.186  Sum_probs=175.2

Q ss_pred             CCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCC
Q 039419          350 ANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGG  429 (1035)
Q Consensus       350 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~  429 (1035)
                      ..+++|++|+|++|.+++..|..|..+++|++|+|++|.|++..|                |.++++|++|+|++|.|++
T Consensus        31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----------------l~~l~~L~~L~Ls~N~l~~   94 (487)
T 3oja_A           31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD----------------LESLSTLRTLDLNNNYVQE   94 (487)
T ss_dssp             TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE----------------CTTCTTCCEEECCSSEEEE
T ss_pred             ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc----------------cccCCCCCEEEecCCcCCC
Confidence            345578888888888887777778888888888888888775433                4455678888888888874


Q ss_pred             CCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhh
Q 039419          430 TLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFE  509 (1035)
Q Consensus       430 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  509 (1035)
                      ..     ..++|+.|++++|+|++..+..   +++|+.|+|++|.|++..|..|..+++|++|+|++|.|++.+|..++.
T Consensus        95 l~-----~~~~L~~L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~  166 (487)
T 3oja_A           95 LL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA  166 (487)
T ss_dssp             EE-----ECTTCCEEECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGG
T ss_pred             CC-----CCCCcCEEECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhh
Confidence            33     2378888888888888765543   467888888888888777778888888888888888888777777763


Q ss_pred             hccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCChhhhhccccccc
Q 039419          510 IEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEM  589 (1035)
Q Consensus       510 ~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~  589 (1035)
                      ....+..|+|++|.|++..+  +..+++|++|+|++|+|++.++.+..+++|+.|+|++|+|++.++....+..+..+++
T Consensus       167 ~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l  244 (487)
T 3oja_A          167 SSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDL  244 (487)
T ss_dssp             GTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEEC
T ss_pred             hCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEc
Confidence            33444578888888886632  3468999999999999999988899999999999999999987666566788899999


Q ss_pred             cccccCCCC
Q 039419          590 AGNQGLCSR  598 (1035)
Q Consensus       590 ~~N~~~c~~  598 (1035)
                      .+|++.|++
T Consensus       245 ~~N~l~c~~  253 (487)
T 3oja_A          245 RGNGFHCGT  253 (487)
T ss_dssp             TTCCBCHHH
T ss_pred             CCCCCcCcc
Confidence            999999874

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.91  E-value=1.2e-23  Score=228.71  Aligned_cols=213  Identities=23%  Similarity=0.257  Sum_probs=156.5

Q ss_pred             CCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc
Q 039419          353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP  432 (1035)
Q Consensus       353 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~  432 (1035)
                      ++|++|++++|.+++..+..|..+++|++|++++|++++..+..+.              ++++|++|+|++|++++..+
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--------------~l~~L~~L~L~~n~l~~~~~   93 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ--------------SLSHLSTLILTGNPIQSLAL   93 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTT--------------TCTTCCEEECTTCCCCEECT
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHcc--------------CCcCCCEEECCCCccCccCh
Confidence            4567777777777655555666777777777777777655544433              34557777777777776666


Q ss_pred             ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCccccc-CccccCCCCCCcEEEcCCCcCcCccchhhhhhc
Q 039419          433 SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGA-IPSSLGRCESLQSLDLSSNKLSGKIPVELFEIE  511 (1035)
Q Consensus       433 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  511 (1035)
                      ..|.++++|++|++++|++.+..+..|..+++|++|++++|++++. +|..|..+++|++|+|++|++++..+..+..+.
T Consensus        94 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  173 (276)
T 2z62_A           94 GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH  173 (276)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHH
T ss_pred             hhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhh
Confidence            7777777888888888887777666777777888888888887753 477778888888888888888755455554444


Q ss_pred             cCc---ceeeccCccCCCCCCccccCCccccEEeccCCcccCccc-cccccCCCcEEeccCCcCcccCCChhh
Q 039419          512 GLD---ISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL-ALSGLDNLVSLNVSYNNFTGYLPDSKL  580 (1035)
Q Consensus       512 ~l~---~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~ls~N~l~~~~p~~~~  580 (1035)
                      .+.   ..|++++|.+++..+..+.. .+|++|+|++|++++.+. .|..+++|+.|++++|+|++.+|....
T Consensus       174 ~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~~  245 (276)
T 2z62_A          174 QMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDY  245 (276)
T ss_dssp             TCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTHH
T ss_pred             hccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchHH
Confidence            332   26888888888776666655 489999999999998775 478899999999999999998876543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.90  E-value=5.3e-24  Score=231.58  Aligned_cols=214  Identities=22%  Similarity=0.225  Sum_probs=131.0

Q ss_pred             CCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccC
Q 039419          214 EIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGN  293 (1035)
Q Consensus       214 ~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  293 (1035)
                      .+|..+.  ++|+.|++++|.+++..+..|.++++|++|++++|++.+..+..|.++++|++|+|++|++++..+..|.+
T Consensus        21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~   98 (276)
T 2z62_A           21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG   98 (276)
T ss_dssp             SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred             ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence            4454442  35667777777666555556666666666666666666555566667777777777777776666666777


Q ss_pred             CCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCc
Q 039419          294 LSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGL  373 (1035)
Q Consensus       294 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~  373 (1035)
                      +++|++|++++|++.+..+..|..+++|++|++++|+|+.+         .+|..+..+++|++|+|++|++++..+..+
T Consensus        99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---------~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  169 (276)
T 2z62_A           99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF---------KLPEYFSNLTNLEHLDLSSNKIQSIYCTDL  169 (276)
T ss_dssp             CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC---------CCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred             CccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee---------cCchhhccCCCCCEEECCCCCCCcCCHHHh
Confidence            77777777777777665555566666666666666665421         245566666667777777776665555555


Q ss_pred             ccCcccc----eEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCC
Q 039419          374 FQLQNLT----KLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVN  449 (1035)
Q Consensus       374 ~~l~~L~----~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N  449 (1035)
                      ..+++|+    +|++++|++++..+..+..               .+|++|+|++|++++..+..|..+++|+.|+|++|
T Consensus       170 ~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~---------------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N  234 (276)
T 2z62_A          170 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKE---------------IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN  234 (276)
T ss_dssp             HHHHTCTTCCEEEECCSSCCCEECTTSSCS---------------CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSS
T ss_pred             hhhhhccccceeeecCCCcccccCccccCC---------------CcccEEECCCCceeecCHhHhcccccccEEEccCC
Confidence            5555555    5666666665444333221               24566666666666554445555666666666666


Q ss_pred             ccCC
Q 039419          450 QFVG  453 (1035)
Q Consensus       450 ~l~~  453 (1035)
                      ++..
T Consensus       235 ~~~c  238 (276)
T 2z62_A          235 PWDC  238 (276)
T ss_dssp             CBCC
T ss_pred             cccc
Confidence            6553

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.89  E-value=1.2e-22  Score=220.04  Aligned_cols=203  Identities=24%  Similarity=0.289  Sum_probs=154.0

Q ss_pred             CCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCC
Q 039419          272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLAN  351 (1035)
Q Consensus       272 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~  351 (1035)
                      +++.++++++.++ .+|..+.  ++|++|+|++|+++...+..|.++++|++|+|++|+|+.+          .+..|..
T Consensus        17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i----------~~~~~~~   83 (270)
T 2o6q_A           17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL----------PAGIFKE   83 (270)
T ss_dssp             TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCC----------CTTTTSS
T ss_pred             CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCee----------ChhhhcC
Confidence            4566777777766 3444343  4667777777777666666677777777777777666532          2245677


Q ss_pred             CCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCC
Q 039419          352 CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTL  431 (1035)
Q Consensus       352 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~  431 (1035)
                      +++|++|+|++|.++...+..|..+++|++|++++|++++..+..|.              ++++|++|+|++|+|++..
T Consensus        84 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--------------~l~~L~~L~Ls~n~l~~~~  149 (270)
T 2o6q_A           84 LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFD--------------SLTKLTYLSLGYNELQSLP  149 (270)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTT--------------TCTTCCEEECCSSCCCCCC
T ss_pred             CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhC--------------cCcCCCEEECCCCcCCccC
Confidence            78888888888888766666777788888888888888776665543              4466888888999888777


Q ss_pred             cccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcC
Q 039419          432 PSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSG  501 (1035)
Q Consensus       432 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  501 (1035)
                      +..|..+++|++|+|++|+++++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus       150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            7778889999999999999998888888889999999999999987777778889999999999999873

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.89  E-value=5.1e-23  Score=223.08  Aligned_cols=202  Identities=24%  Similarity=0.238  Sum_probs=116.6

Q ss_pred             cccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCcccee
Q 039419          245 KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQL  324 (1035)
Q Consensus       245 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  324 (1035)
                      .+.++..+++..+.+....  .+..+++|+.|++++|.++. . ..+..+++|++|++++|++.+.  ..+..+++|++|
T Consensus        17 ~~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L   90 (272)
T 3rfs_A           17 AFAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYL   90 (272)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEE
T ss_pred             hHHHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEE
Confidence            3556777888888776543  35678889999999998873 3 3478888888888888888753  245555555555


Q ss_pred             ccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcce
Q 039419          325 QLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI  404 (1035)
Q Consensus       325 ~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  404 (1035)
                      +|++|+|+.          ..+..|..+++|++|+|++|++++..+..|..+++|++|++++|+++              
T Consensus        91 ~L~~n~l~~----------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~--------------  146 (272)
T 3rfs_A           91 ILTGNQLQS----------LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ--------------  146 (272)
T ss_dssp             ECTTSCCCC----------CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC--------------
T ss_pred             ECCCCccCc----------cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccC--------------
Confidence            555555442          22334455555555555555555444444445555555555555554              


Q ss_pred             eEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccC
Q 039419          405 RLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLG  484 (1035)
Q Consensus       405 ~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  484 (1035)
                                              +..+..|..+++|++|++++|++++..+..|..+++|+.|++++|++++..+..|.
T Consensus       147 ------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  202 (272)
T 3rfs_A          147 ------------------------SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFD  202 (272)
T ss_dssp             ------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred             ------------------------ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHh
Confidence                                    44444444444555555555555444444444445555555555555444444445


Q ss_pred             CCCCCcEEEcCCCcCc
Q 039419          485 RCESLQSLDLSSNKLS  500 (1035)
Q Consensus       485 ~l~~L~~L~Ls~N~l~  500 (1035)
                      .+++|++|+|++|.+.
T Consensus       203 ~l~~L~~L~l~~N~~~  218 (272)
T 3rfs_A          203 RLTSLQYIWLHDNPWD  218 (272)
T ss_dssp             TCTTCCEEECCSSCBC
T ss_pred             CCcCCCEEEccCCCcc
Confidence            5555555555555544

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.89  E-value=9.3e-23  Score=222.74  Aligned_cols=203  Identities=26%  Similarity=0.248  Sum_probs=158.6

Q ss_pred             ccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCC
Q 039419          267 IGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP  346 (1035)
Q Consensus       267 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p  346 (1035)
                      +.++++++.+++++|.++ .+|..+.  ++|+.|+|++|+|++..+..|.++++|++|+|++|+|+.+           +
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-----------~   71 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-----------Q   71 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-----------E
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-----------c
Confidence            566777777777777777 3444443  5777788888877777777777777777888777777643           1


Q ss_pred             cCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCc
Q 039419          347 STLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNT  426 (1035)
Q Consensus       347 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~  426 (1035)
                       ....+++|++|+|++|+|+ .+|..+..+++|++|++++|+|++..+..|.              ++++|++|+|++|+
T Consensus        72 -~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~--------------~l~~L~~L~L~~N~  135 (290)
T 1p9a_G           72 -VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALR--------------GLGELQELYLKGNE  135 (290)
T ss_dssp             -CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTT--------------TCTTCCEEECTTSC
T ss_pred             -CCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHc--------------CCCCCCEEECCCCC
Confidence             2267788888888888887 5667777888888888888888876665544              44668888888898


Q ss_pred             cCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCc
Q 039419          427 LGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS  500 (1035)
Q Consensus       427 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (1035)
                      |++..+..|..+++|+.|+|++|+|+.+++..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       136 l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            88777777888889999999999999887778888899999999999998 66777777888999999999886

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=3.6e-25  Score=248.41  Aligned_cols=268  Identities=17%  Similarity=0.201  Sum_probs=182.0

Q ss_pred             CCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCC--cccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCC-
Q 039419           17 NPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSL--SFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGG-   93 (1035)
Q Consensus        17 ~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l--~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~-   93 (1035)
                      .|++|+++.|++ ..++.++++++++.   +..+..+  ++++.|++++|.+++..+. +..+++|++|+|++|.+.+. 
T Consensus        35 vc~~W~~~~~~~-~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~  109 (336)
T 2ast_B           35 VCKRWYRLASDE-SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST  109 (336)
T ss_dssp             SCHHHHHHHTCS-TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH
T ss_pred             HHHHHHHHhcCc-hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH
Confidence            477899999984 45778899888776   4556666  8899999999999865554 67789999999999988755 


Q ss_pred             CChhhhccccccceEecccCCCCCCchhhhhhccccceecccc-ccCCC-CchhhccccccceeecCCCcccCCCCCCcC
Q 039419           94 VPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDN-YLSGN-LPVELGKLVNLEVIRAGGNKDIAGKIPYEI  171 (1035)
Q Consensus        94 ~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n-~l~~~-~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~  171 (1035)
                      +|..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. ++..+..+++|++|++++|.          
T Consensus       110 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~----------  179 (336)
T 2ast_B          110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF----------  179 (336)
T ss_dssp             HHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT----------
T ss_pred             HHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC----------
Confidence            7888888999999999999888778888888889999999988 56642 55667777777777777762          


Q ss_pred             CCccceEEEEecccccccc-Ccccccccc-cccceeeccc--ccc-cCCccccccCcCCceEEecCCc-CCCCCChhhhc
Q 039419          172 GDCQSLLVVGLADTKVAGS-LPASLGKLS-KLQSLSVYTT--MLS-GEIPPQIGNCSELVDLFLYEND-LSGSLPRELGK  245 (1035)
Q Consensus       172 ~~l~~L~~L~l~~~~~~~~-~p~~l~~l~-~L~~L~l~~n--~l~-~~~p~~l~~l~~L~~L~L~~n~-l~~~~~~~l~~  245 (1035)
                                    .+++. ++..+..++ +|++|++++|  .++ +.++..+..+++|+.|+|++|. +++..+..+..
T Consensus       180 --------------~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~  245 (336)
T 2ast_B          180 --------------DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ  245 (336)
T ss_dssp             --------------TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGG
T ss_pred             --------------CcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhC
Confidence                          22221 344555566 6666666666  333 2445555566666666666666 55455555666


Q ss_pred             ccchhHhhccccc-ccccCCccccCCCCCcEEEccCccCCCCCCccccCC-CCCcEEEccCCccccCCCCcccC
Q 039419          246 LQKLEKMLLWQNN-FDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNL-SSLEELMLSNNNISGSIPPVLSN  317 (1035)
Q Consensus       246 l~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~  317 (1035)
                      +++|++|++++|. +.......+.++++|+.|++++| ++..   .+..+ .+|..|++++|++++..|..+..
T Consensus       246 l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          246 LNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             CTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCcccc
Confidence            6666666666663 22222224566677777777777 4322   23333 23555667777777666665543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.88  E-value=3.9e-23  Score=223.98  Aligned_cols=166  Identities=22%  Similarity=0.248  Sum_probs=83.6

Q ss_pred             cccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCc
Q 039419          219 IGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLE  298 (1035)
Q Consensus       219 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  298 (1035)
                      +..+++|++|+|++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|+
T Consensus        81 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  160 (272)
T 3rfs_A           81 LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT  160 (272)
T ss_dssp             GTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCC
Confidence            34444444444444444433333344444444444444444444444444555555555555555544444445555555


Q ss_pred             EEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcc
Q 039419          299 ELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQN  378 (1035)
Q Consensus       299 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  378 (1035)
                      +|++++|++++..+..|..+++|++|+|++|+|+.          ..+..+..+++|+.|+|++|.+.+.       +++
T Consensus       161 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~----------~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~  223 (272)
T 3rfs_A          161 ELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS----------VPDGVFDRLTSLQYIWLHDNPWDCT-------CPG  223 (272)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC----------CCTTTTTTCTTCCEEECCSSCBCCC-------TTT
T ss_pred             EEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc----------cCHHHHhCCcCCCEEEccCCCcccc-------CcH
Confidence            55555555554444445555555555555554431          2233455566666666666665532       335


Q ss_pred             cceEeccccccccCCCCCCCCCC
Q 039419          379 LTKLLLISNGISGLIPPEIGNCS  401 (1035)
Q Consensus       379 L~~L~L~~N~i~~~~~~~~~~l~  401 (1035)
                      |+.|+++.|.++|.+|..++.+.
T Consensus       224 l~~l~~~~n~~~g~ip~~~~~~~  246 (272)
T 3rfs_A          224 IRYLSEWINKHSGVVRNSAGSVA  246 (272)
T ss_dssp             THHHHHHHHHTGGGBBCTTSCBC
T ss_pred             HHHHHHHHHhCCCcccCcccccC
Confidence            66666666666666666665543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.88  E-value=2.4e-22  Score=219.48  Aligned_cols=180  Identities=27%  Similarity=0.253  Sum_probs=92.4

Q ss_pred             CCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc
Q 039419          353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP  432 (1035)
Q Consensus       353 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~  432 (1035)
                      ++|+.|+|++|.+++..+..|..+++|++|+|++|.|++..+                ...+++|++|+|++|+|+ .+|
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----------------~~~l~~L~~L~Ls~N~l~-~l~   93 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV----------------DGTLPVLGTLDLSHNQLQ-SLP   93 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC----------------CSCCTTCCEEECCSSCCS-SCC
T ss_pred             CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC----------------CCCCCcCCEEECCCCcCC-cCc
Confidence            345555555555554444445555555555555555443211                122344555555555554 334


Q ss_pred             ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhcc
Q 039419          433 SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEG  512 (1035)
Q Consensus       433 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  512 (1035)
                      ..+..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+            
T Consensus        94 ~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~------------  161 (290)
T 1p9a_G           94 LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT------------  161 (290)
T ss_dssp             CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS------------
T ss_pred             hhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC------------
Confidence            44444455555555555555444444444445555555555544444444444444444444444443            


Q ss_pred             CcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCccc
Q 039419          513 LDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGY  574 (1035)
Q Consensus       513 l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~  574 (1035)
                                   +..+..|..+++|++|+|++|+|+..+..+..+++|+.|+|++|+|.+.
T Consensus       162 -------------~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          162 -------------ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             -------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             -------------ccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCc
Confidence                         3334445566666777777777666666665666666666666666543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.88  E-value=6.9e-24  Score=240.20  Aligned_cols=104  Identities=21%  Similarity=0.114  Sum_probs=48.4

Q ss_pred             ecCCcccccCCcCCCCCcccceEeecCcccCCCCC----CCCCCCC-CCceeeCCCCCCCCCCChhhhcc-----ccccc
Q 039419           37 IQSIELELPFPSNLSSLSFLQKLIISGSNLTGPIS----PDLGDCT-QLTTIDVSSNSLVGGVPSSIGKL-----INLQD  106 (1035)
Q Consensus        37 ~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~----~~~~~l~-~L~~L~ls~n~l~~~~p~~i~~l-----~~L~~  106 (1035)
                      ++.+++.+.+|..+...++|++|+|++|.+++..+    ..+..++ +|++|+|++|++++..+..+..+     ++|++
T Consensus         5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~   84 (362)
T 3goz_A            5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS   84 (362)
T ss_dssp             CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred             cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence            34444444444444444445555555555544333    3334444 45555555555544444444443     44555


Q ss_pred             eEecccCCCCCCchhhhhh-----ccccceeccccccCC
Q 039419          107 LILNSNQLTGEIPKELGAC-----IKLKNLLLFDNYLSG  140 (1035)
Q Consensus       107 L~L~~n~l~~~~p~~l~~l-----~~L~~L~l~~n~l~~  140 (1035)
                      |+|++|++++..+..++..     ++|++|+|++|.+++
T Consensus        85 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~  123 (362)
T 3goz_A           85 LNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSS  123 (362)
T ss_dssp             EECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGG
T ss_pred             EECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCc
Confidence            5555555544444433332     445555555554443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.87  E-value=1.2e-23  Score=238.21  Aligned_cols=263  Identities=19%  Similarity=0.184  Sum_probs=138.4

Q ss_pred             eEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCC----hhhhccc-cccceEecccCCCCCCchhhhhh-----cc
Q 039419           58 KLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVP----SSIGKLI-NLQDLILNSNQLTGEIPKELGAC-----IK  127 (1035)
Q Consensus        58 ~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p----~~i~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~  127 (1035)
                      .++|+.|++++.+|..+...++|++|||++|.+++..+    +.+..++ +|++|+|++|++++..+..+..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            35677777777666666666667777777777775555    5666676 77777777777776667677665     77


Q ss_pred             ccceeccccccCCCCchhhccc-----cccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCccccc----c-
Q 039419          128 LKNLLLFDNYLSGNLPVELGKL-----VNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLG----K-  197 (1035)
Q Consensus       128 L~~L~l~~n~l~~~~p~~l~~l-----~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~----~-  197 (1035)
                      |++|+|++|.+++..+..++..     ++|++|++++|.                         +++..+..+.    . 
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~-------------------------l~~~~~~~l~~~l~~~  136 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND-------------------------FSSKSSSEFKQAFSNL  136 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSC-------------------------GGGSCHHHHHHHHTTS
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCc-------------------------CCcHHHHHHHHHHHhC
Confidence            7777777777775555544433     455555554443                         3333332222    2 


Q ss_pred             cccccceeecccccccCCcc----ccccCc-CCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCC-C
Q 039419          198 LSKLQSLSVYTTMLSGEIPP----QIGNCS-ELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNC-K  271 (1035)
Q Consensus       198 l~~L~~L~l~~n~l~~~~p~----~l~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l-~  271 (1035)
                      .++|++|++++|.+++..+.    .+..++ +|+.|+|++|.+++..+..+...                    +..+ +
T Consensus       137 ~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~  196 (362)
T 3goz_A          137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKF--------------------LASIPA  196 (362)
T ss_dssp             CTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH--------------------HHTSCT
T ss_pred             CCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHH--------------------HHhCCC
Confidence            13555555555555532222    223333 55566666555554444333322                    1122 2


Q ss_pred             CCcEEEccCccCCCC----CCccccC-CCCCcEEEccCCccccCCC----CcccCCCccceeccccchhhhhhhhccccC
Q 039419          272 SLKTIDLSLNFFSGS----LPQSFGN-LSSLEELMLSNNNISGSIP----PVLSNATSLLQLQLDTNQISVFFAWQNKLE  342 (1035)
Q Consensus       272 ~L~~L~L~~n~l~~~----~~~~~~~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~  342 (1035)
                      +|+.|+|++|.|++.    ++..+.. .++|++|+|++|+|++..+    ..+..+++|+.|+|++|++..+...   ..
T Consensus       197 ~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~---~~  273 (362)
T 3goz_A          197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKE---QC  273 (362)
T ss_dssp             TCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHH---HH
T ss_pred             CCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHH---HH
Confidence            444444444444421    1222222 1244444444444443222    2233444455555555542211000   00


Q ss_pred             CCCCcCCCCCCCCcEEeccCcCCCCC
Q 039419          343 GSIPSTLANCRSLEAVDLSHNALTGS  368 (1035)
Q Consensus       343 ~~~p~~l~~l~~L~~L~Ls~N~l~~~  368 (1035)
                      ..++..+..+++|+.||+++|.+...
T Consensus       274 ~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          274 KALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             HHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             HHHHHHhccCCceEEEecCCCcCCCc
Confidence            02234566777777788888877644

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=4.7e-22  Score=219.45  Aligned_cols=217  Identities=26%  Similarity=0.373  Sum_probs=165.6

Q ss_pred             ccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceec
Q 039419          246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQ  325 (1035)
Q Consensus       246 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  325 (1035)
                      +.++..+.+..+.+.+.+.  +..+++|+.|++++|.++. ++ .+..+++|++|+|++|++.+..+  +..+++|++|+
T Consensus        18 l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~   91 (308)
T 1h6u_A           18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (308)
T ss_dssp             HHHHHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEE
Confidence            4455566677766665332  4567788888888888874 34 57778888888888888875544  78888888888


Q ss_pred             cccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCccee
Q 039419          326 LDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR  405 (1035)
Q Consensus       326 L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  405 (1035)
                      |++|+|+.+            ..+..+++|++|+|++|++++..  .+..+++|++|++++|++++..+           
T Consensus        92 L~~n~l~~~------------~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~-----------  146 (308)
T 1h6u_A           92 LSGNPLKNV------------SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP-----------  146 (308)
T ss_dssp             CCSCCCSCC------------GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-----------
T ss_pred             ccCCcCCCc------------hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc-----------
Confidence            888877632            35777888888888888888543  37788888888888888875432           


Q ss_pred             EeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCC
Q 039419          406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGR  485 (1035)
Q Consensus       406 L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  485 (1035)
                           +.++++|++|+|++|++++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..+  +..
T Consensus       147 -----l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~  215 (308)
T 1h6u_A          147 -----LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LAN  215 (308)
T ss_dssp             -----GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTT
T ss_pred             -----ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccC
Confidence                 3456778899999999886443  8888999999999999987654  7888999999999999986553  788


Q ss_pred             CCCCcEEEcCCCcCcCccch
Q 039419          486 CESLQSLDLSSNKLSGKIPV  505 (1035)
Q Consensus       486 l~~L~~L~Ls~N~l~~~~p~  505 (1035)
                      +++|++|+|++|+++ ..|.
T Consensus       216 l~~L~~L~l~~N~i~-~~~~  234 (308)
T 1h6u_A          216 TSNLFIVTLTNQTIT-NQPV  234 (308)
T ss_dssp             CTTCCEEEEEEEEEE-CCCE
T ss_pred             CCCCCEEEccCCeee-cCCe
Confidence            999999999999987 4443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.86  E-value=3.5e-22  Score=221.00  Aligned_cols=206  Identities=22%  Similarity=0.260  Sum_probs=104.9

Q ss_pred             cCCceEEecCCcCCCCCChhh--hcccchhHhhcccccccccCC----ccccCCCCCcEEEccCccCCCCCCccccCCCC
Q 039419          223 SELVDLFLYENDLSGSLPREL--GKLQKLEKMLLWQNNFDGAIP----EEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSS  296 (1035)
Q Consensus       223 ~~L~~L~L~~n~l~~~~~~~l--~~l~~L~~L~l~~n~l~~~~p----~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  296 (1035)
                      ++|++|+|++|.+++..|..+  ..+++|++|++++|.+.+..+    ..+..+++|++|+|++|++++..+..|+++++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            345555555555555555544  455555555555555554333    22345666677777777666666666666666


Q ss_pred             CcEEEccCCccccC---C-CCcccCCCccceeccccchhhhhhhhccccCCCCCc-CCCCCCCCcEEeccCcCCCCCCCC
Q 039419          297 LEELMLSNNNISGS---I-PPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPS-TLANCRSLEAVDLSHNALTGSLHP  371 (1035)
Q Consensus       297 L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~~~  371 (1035)
                      |++|+|++|++.+.   . +..+..+++|++|+|++|+|+.+..        .+. .+..+++|++|+|++|+|++..|.
T Consensus       171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~--------~~~~l~~~l~~L~~L~Ls~N~l~~~~p~  242 (310)
T 4glp_A          171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTG--------VCAALAAAGVQPHSLDLSHNSLRATVNP  242 (310)
T ss_dssp             CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHH--------HHHHHHHHTCCCSSEECTTSCCCCCCCS
T ss_pred             CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHH--------HHHHHHhcCCCCCEEECCCCCCCccchh
Confidence            66777666665431   1 1223445555555555555542211        001 123445555555555555544444


Q ss_pred             CcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCcc
Q 039419          372 GLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQF  451 (1035)
Q Consensus       372 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  451 (1035)
                      .+..+                                   ..+++|++|+|++|+|+ .+|..+.  ++|++|+|++|+|
T Consensus       243 ~~~~~-----------------------------------~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l  284 (310)
T 4glp_A          243 SAPRC-----------------------------------MWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRL  284 (310)
T ss_dssp             CCSSC-----------------------------------CCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCC
T ss_pred             hHHhc-----------------------------------cCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcC
Confidence            33333                                   11234555555555555 3343332  4555566666655


Q ss_pred             CCCCchhccCccccchhhccCCccc
Q 039419          452 VGLIPESFGQLASLNRLILSKNSFS  476 (1035)
Q Consensus       452 ~~~~~~~~~~l~~L~~L~Ls~N~l~  476 (1035)
                      +++ |. +..+++|+.|+|++|+|+
T Consensus       285 ~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          285 NRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             CCC-ch-hhhCCCccEEECcCCCCC
Confidence            543 21 445555666666666554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.86  E-value=1.2e-21  Score=209.61  Aligned_cols=192  Identities=21%  Similarity=0.217  Sum_probs=123.9

Q ss_pred             CCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCCh
Q 039419           17 NPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPS   96 (1035)
Q Consensus        17 ~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~   96 (1035)
                      +||.|.|.+|...  .+.++++++++. .+|..+.  +.|+.|+|++|.+++..+..++.+++|++|+|++|.+++..|.
T Consensus         3 ~Cp~~~gC~C~~~--~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~   77 (251)
T 3m19_A            3 TCETVTGCTCNEG--KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG   77 (251)
T ss_dssp             -CHHHHSSEEEGG--GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred             cCCCCCceEcCCC--CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence            6899999999532  224566666665 4555444  4666677777776665555666666777777777766655555


Q ss_pred             hhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccc
Q 039419           97 SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS  176 (1035)
Q Consensus        97 ~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  176 (1035)
                      .+..+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+..                         +++
T Consensus        78 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-------------------------l~~  132 (251)
T 3m19_A           78 VFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDR-------------------------LTK  132 (251)
T ss_dssp             TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-------------------------CTT
T ss_pred             HhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhcc-------------------------CCc
Confidence            6666666666666666666444455566666666666666665332333344                         444


Q ss_pred             eEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCC
Q 039419          177 LLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGS  238 (1035)
Q Consensus       177 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~  238 (1035)
                      |+.|++++|++.+..+..|+.+++|++|+|++|++++..+..+..+++|+.|+|++|.+.+.
T Consensus       133 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          133 LKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             ccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            44444455555555555677778888888888888766666777788888888888887754

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.86  E-value=3.1e-22  Score=221.50  Aligned_cols=231  Identities=16%  Similarity=0.135  Sum_probs=144.3

Q ss_pred             CCceEEecCCcCCCCCCh---hhhcccchhHhhcccccccccCCccc--cCCCCCcEEEccCccCCCCCC----ccccCC
Q 039419          224 ELVDLFLYENDLSGSLPR---ELGKLQKLEKMLLWQNNFDGAIPEEI--GNCKSLKTIDLSLNFFSGSLP----QSFGNL  294 (1035)
Q Consensus       224 ~L~~L~L~~n~l~~~~~~---~l~~l~~L~~L~l~~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~~----~~~~~l  294 (1035)
                      .++.|.+.++.++.....   .+..+++|++|++++|.+.+..|..+  ..+++|++|+|++|.+++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            466677777665521111   11223456666777776666666665  666667777777776665433    233456


Q ss_pred             CCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcc
Q 039419          295 SSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLF  374 (1035)
Q Consensus       295 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  374 (1035)
                      ++|++|+|++|++.+..+..|.++++|++|+|++|++......      ..+..+..+++|++|+|++|+++. ++..  
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~------~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~--  215 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGL------MAALCPHKFPAIQNLALRNTGMET-PTGV--  215 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHH------HTTSCTTSSCCCCSCBCCSSCCCC-HHHH--
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhh------hHHHhhhcCCCCCEEECCCCCCCc-hHHH--
Confidence            6666666666666655556666666666666666654321000      001122344555555555555431 1110  


Q ss_pred             cCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCC---CCccEEEcCCCcc
Q 039419          375 QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL---TRLQVLDISVNQF  451 (1035)
Q Consensus       375 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l---~~L~~L~Ls~N~l  451 (1035)
                                         +.             ..+.++++|++|+|++|+|++..|..+..+   ++|++|+|++|+|
T Consensus       216 -------------------~~-------------~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l  263 (310)
T 4glp_A          216 -------------------CA-------------ALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGL  263 (310)
T ss_dssp             -------------------HH-------------HHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCC
T ss_pred             -------------------HH-------------HHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCC
Confidence                               00             012345668888888888887767777666   6999999999999


Q ss_pred             CCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCc
Q 039419          452 VGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS  500 (1035)
Q Consensus       452 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (1035)
                      +.+ |..+.  ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+
T Consensus       264 ~~l-p~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          264 EQV-PKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CSC-CSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             Cch-hhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence            954 55553  7999999999999965 43 788999999999999997

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.86  E-value=4.4e-22  Score=211.39  Aligned_cols=196  Identities=15%  Similarity=0.200  Sum_probs=100.8

Q ss_pred             CCcEEEccCccCCCCCCccccCCCCCcEEEccCCc-cccCCCCcccCCCccceecccc-chhhhhhhhccccCCCCCcCC
Q 039419          272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNN-ISGSIPPVLSNATSLLQLQLDT-NQISVFFAWQNKLEGSIPSTL  349 (1035)
Q Consensus       272 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~i~~l~~~~n~l~~~~p~~l  349 (1035)
                      +|++|+|++|+|++..+..|.++++|++|++++|+ ++.+.+..|.++++|++|++++ |+|+.+          .+..|
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i----------~~~~f  101 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI----------DPDAL  101 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEE----------CTTSE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEc----------CHHHh
Confidence            44444444444443333344444444444444443 4433334444444444444444 444321          12344


Q ss_pred             CCCCCCcEEeccCcCCCCCCCCCcccCcccc---eEecccc-ccccCCCCCCCCCCcceeEeeeccCCCCccc-eeecCC
Q 039419          350 ANCRSLEAVDLSHNALTGSLHPGLFQLQNLT---KLLLISN-GISGLIPPEIGNCSSLIRLRLMSFGNCTQLQ-MLNLSN  424 (1035)
Q Consensus       350 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~---~L~L~~N-~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~-~L~L~~  424 (1035)
                      .++++|++|++++|++++ +|. |..+++|+   +|++++| ++++..+..|              .++++|+ +|++++
T Consensus       102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~--------------~~l~~L~~~L~l~~  165 (239)
T 2xwt_C          102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAF--------------QGLCNETLTLKLYN  165 (239)
T ss_dssp             ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTT--------------TTTBSSEEEEECCS
T ss_pred             CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccc--------------cchhcceeEEEcCC
Confidence            445555555555555543 232 44444444   5555555 5554433333              2334466 666666


Q ss_pred             CccCCCCcccccCCCCccEEEcCCCc-cCCCCchhccCc-cccchhhccCCcccccCccccCCCCCCcEEEcCCC
Q 039419          425 NTLGGTLPSSLASLTRLQVLDISVNQ-FVGLIPESFGQL-ASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN  497 (1035)
Q Consensus       425 N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  497 (1035)
                      |+++.+.+..|.. ++|+.|+|++|+ ++++.+..|..+ ++|+.|++++|+|++..+.   .+++|+.|+++++
T Consensus       166 n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          166 NGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            6666333334444 667777777774 666666666666 6777777777777633322   4566777777665

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.86  E-value=8.2e-22  Score=209.27  Aligned_cols=196  Identities=17%  Similarity=0.178  Sum_probs=136.6

Q ss_pred             CCcEEeccCcCCCCCCCCCcccCcccceEeccccc-cccCCCCCCCCCCcceeEeeeccCCCCccceeecCC-CccCCCC
Q 039419          354 SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNG-ISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSN-NTLGGTL  431 (1035)
Q Consensus       354 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~-N~l~~~~  431 (1035)
                      +|++|++++|++++..+..|..+++|++|++++|+ ++++.+..|              .++++|++|+|++ |++++..
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f--------------~~l~~L~~L~l~~~n~l~~i~   97 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSF--------------YNLSKVTHIEIRNTRNLTYID   97 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTE--------------ESCTTCCEEEEEEETTCCEEC
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHc--------------CCCcCCcEEECCCCCCeeEcC
Confidence            67777777777775555566677777777777775 665544433              3445677777777 7777666


Q ss_pred             cccccCCCCccEEEcCCCccCCCCchhccCccccc---hhhccCC-cccccCccccCCCCCCc-EEEcCCCcCcCccchh
Q 039419          432 PSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN---RLILSKN-SFSGAIPSSLGRCESLQ-SLDLSSNKLSGKIPVE  506 (1035)
Q Consensus       432 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~  506 (1035)
                      +..|.++++|++|++++|+++++ |. |..+++|+   .|++++| ++++..+..|..+++|+ +|+|++|+++ .+|..
T Consensus        98 ~~~f~~l~~L~~L~l~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~  174 (239)
T 2xwt_C           98 PDALKELPLLKFLGIFNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY  174 (239)
T ss_dssp             TTSEECCTTCCEEEEEEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT
T ss_pred             HHHhCCCCCCCEEeCCCCCCccc-cc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh
Confidence            66777777888888888887764 43 77777776   8888888 77766666778888888 8888888887 66666


Q ss_pred             hhhhccCcceeeccCcc-CCCCCCccccCC-ccccEEeccCCcccCccccccccCCCcEEeccCC
Q 039419          507 LFEIEGLDISLNLSWNA-LSGAIPPQISAL-NKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYN  569 (1035)
Q Consensus       507 ~~~~~~l~~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N  569 (1035)
                      .+.. ..+..|++++|+ +++..+..|..+ ++|++|+|++|+++..+..  .+++|+.|+++++
T Consensus       175 ~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~  236 (239)
T 2xwt_C          175 AFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT  236 (239)
T ss_dssp             TTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred             hcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence            5555 233456666663 666666667777 7777777777777765544  5667777777665

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.85  E-value=9.4e-24  Score=241.61  Aligned_cols=242  Identities=18%  Similarity=0.235  Sum_probs=174.3

Q ss_pred             cCCcCCCCCcccceEeecCcccCCCCC----CCCCCCCCCceeeCCCC---CCCCCCChhh-------hccccccceEec
Q 039419           45 PFPSNLSSLSFLQKLIISGSNLTGPIS----PDLGDCTQLTTIDVSSN---SLVGGVPSSI-------GKLINLQDLILN  110 (1035)
Q Consensus        45 ~~~~~~~~l~~L~~L~L~~~~l~~~~~----~~~~~l~~L~~L~ls~n---~l~~~~p~~i-------~~l~~L~~L~L~  110 (1035)
                      .++..+..+++|++|+|++|.+++..+    ..+..+++|++|+|++|   ++.+.+|..+       ..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            456677888999999999999987633    45778999999999986   4555667666       678899999999


Q ss_pred             ccCCCC----CCchhhhhhccccceeccccccCCCCchhhcc----c---------cccceeecCCCcccCCCCCCcCCC
Q 039419          111 SNQLTG----EIPKELGACIKLKNLLLFDNYLSGNLPVELGK----L---------VNLEVIRAGGNKDIAGKIPYEIGD  173 (1035)
Q Consensus       111 ~n~l~~----~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~----l---------~~L~~L~l~~n~~~~~~~~~~~~~  173 (1035)
                      +|.+++    .+|..+..+++|++|+|++|.+.+..+..++.    +         ++|++|++++|.            
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~------------  170 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR------------  170 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC------------
T ss_pred             CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC------------
Confidence            999986    37778888999999999999886544444443    2         556666665554            


Q ss_pred             ccceEEEEecccccc-ccCc---ccccccccccceeeccccccc-----CCccccccCcCCceEEecCCcCC----CCCC
Q 039419          174 CQSLLVVGLADTKVA-GSLP---ASLGKLSKLQSLSVYTTMLSG-----EIPPQIGNCSELVDLFLYENDLS----GSLP  240 (1035)
Q Consensus       174 l~~L~~L~l~~~~~~-~~~p---~~l~~l~~L~~L~l~~n~l~~-----~~p~~l~~l~~L~~L~L~~n~l~----~~~~  240 (1035)
                                   ++ ..++   ..+..+++|++|++++|.++.     ..+..+..+++|+.|+|++|.++    ..+|
T Consensus       171 -------------l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~  237 (386)
T 2ca6_A          171 -------------LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA  237 (386)
T ss_dssp             -------------CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred             -------------CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHH
Confidence                         43 2222   355566677777777776652     23336667777777777777774    3556


Q ss_pred             hhhhcccchhHhhccccccccc----CCcccc--CCCCCcEEEccCccCCC----CCCccc-cCCCCCcEEEccCCcccc
Q 039419          241 RELGKLQKLEKMLLWQNNFDGA----IPEEIG--NCKSLKTIDLSLNFFSG----SLPQSF-GNLSSLEELMLSNNNISG  309 (1035)
Q Consensus       241 ~~l~~l~~L~~L~l~~n~l~~~----~p~~~~--~l~~L~~L~L~~n~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~  309 (1035)
                      ..+..+++|++|+|++|.+++.    ++..+.  .+++|+.|+|++|.|++    .+|..+ .++++|++|+|++|++++
T Consensus       238 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~  317 (386)
T 2ca6_A          238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  317 (386)
T ss_dssp             HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence            6677777777777777777654    455563  38888999999998886    366666 668889999999998886


Q ss_pred             CC
Q 039419          310 SI  311 (1035)
Q Consensus       310 ~~  311 (1035)
                      ..
T Consensus       318 ~~  319 (386)
T 2ca6_A          318 ED  319 (386)
T ss_dssp             TS
T ss_pred             ch
Confidence            55

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.85  E-value=1.7e-24  Score=247.71  Aligned_cols=248  Identities=22%  Similarity=0.244  Sum_probs=184.0

Q ss_pred             eecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCCh----hhhccccccceEeccc---CCCCCCchhh-------hhh
Q 039419           60 IISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPS----SIGKLINLQDLILNSN---QLTGEIPKEL-------GAC  125 (1035)
Q Consensus        60 ~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~----~i~~l~~L~~L~L~~n---~l~~~~p~~l-------~~l  125 (1035)
                      .++...+. .++..+..+++|++|+|++|++.+..+.    .+..+++|++|+|++|   ++++.+|..+       ..+
T Consensus        15 ~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~   93 (386)
T 2ca6_A           15 AITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKC   93 (386)
T ss_dssp             SCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTC
T ss_pred             CCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhC
Confidence            33444444 4555666777888888888887755333    3557788888888875   4444556555       466


Q ss_pred             ccccceeccccccCC----CCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCc----ccccc
Q 039419          126 IKLKNLLLFDNYLSG----NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLP----ASLGK  197 (1035)
Q Consensus       126 ~~L~~L~l~~n~l~~----~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p----~~l~~  197 (1035)
                      ++|++|+|++|.+.+    .+|..+..+++|++|++++|.                         +++..+    ..+..
T Consensus        94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~-------------------------l~~~~~~~l~~~l~~  148 (386)
T 2ca6_A           94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG-------------------------LGPQAGAKIARALQE  148 (386)
T ss_dssp             TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSC-------------------------CHHHHHHHHHHHHHH
T ss_pred             CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCC-------------------------CCHHHHHHHHHHHHH
Confidence            777777777777765    245556666666666666554                         433323    33444


Q ss_pred             c---------ccccceeecccccc-cCCc---cccccCcCCceEEecCCcCCC-----CCChhhhcccchhHhhcccccc
Q 039419          198 L---------SKLQSLSVYTTMLS-GEIP---PQIGNCSELVDLFLYENDLSG-----SLPRELGKLQKLEKMLLWQNNF  259 (1035)
Q Consensus       198 l---------~~L~~L~l~~n~l~-~~~p---~~l~~l~~L~~L~L~~n~l~~-----~~~~~l~~l~~L~~L~l~~n~l  259 (1035)
                      +         ++|++|++++|.++ +.++   ..+..+++|+.|+|++|.++.     ..+..+..+++|+.|+|++|.+
T Consensus       149 l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l  228 (386)
T 2ca6_A          149 LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF  228 (386)
T ss_dssp             HHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCC
T ss_pred             HhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCC
Confidence            4         89999999999997 3444   467789999999999999983     2344788999999999999999


Q ss_pred             c----ccCCccccCCCCCcEEEccCccCCCC----CCccc--cCCCCCcEEEccCCcccc----CCCCcc-cCCCcccee
Q 039419          260 D----GAIPEEIGNCKSLKTIDLSLNFFSGS----LPQSF--GNLSSLEELMLSNNNISG----SIPPVL-SNATSLLQL  324 (1035)
Q Consensus       260 ~----~~~p~~~~~l~~L~~L~L~~n~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L  324 (1035)
                      +    ..+|..+..+++|++|+|++|.|++.    ++..+  +.+++|++|+|++|.|+.    .+|..+ .++++|++|
T Consensus       229 ~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L  308 (386)
T 2ca6_A          229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL  308 (386)
T ss_dssp             HHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEE
T ss_pred             CcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEE
Confidence            6    57888899999999999999999865    45566  448999999999999997    366666 678999999


Q ss_pred             ccccchhhh
Q 039419          325 QLDTNQISV  333 (1035)
Q Consensus       325 ~L~~N~i~~  333 (1035)
                      +|++|+++.
T Consensus       309 ~l~~N~l~~  317 (386)
T 2ca6_A          309 ELNGNRFSE  317 (386)
T ss_dssp             ECTTSBSCT
T ss_pred             EccCCcCCc
Confidence            999999874

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=3.6e-22  Score=216.51  Aligned_cols=158  Identities=16%  Similarity=0.033  Sum_probs=116.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccc-cccc---cccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYD-CQND---KIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      .|...+.||+|+||.||+|.+.+|+.||||++.......... ...+   ..........+.+|++++++++  | ++++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            355668999999999999988779999999996533211100 0000   0000012567899999999999  4 5555


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEE
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI  842 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl  842 (1035)
                      +++. .+..|+||||++||+|.+ +..        .....++.|+++||+|||+.   ||+||||||+|||++ ++.+||
T Consensus       168 ~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          168 KVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             CEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEE
T ss_pred             eEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEE
Confidence            5443 356799999999999998 421        12346999999999999999   999999999999999 999999


Q ss_pred             eeccCccccccCCccccccccCCcccccCCcccc
Q 039419          843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY  876 (1035)
Q Consensus       843 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  876 (1035)
                      +|||+|+.               +..|+|||++.
T Consensus       234 ~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          234 IDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             CCCTTCEE---------------TTSTTHHHHHH
T ss_pred             EECCCCeE---------------CCCCCHHHHHH
Confidence            99999863               23468888754

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.85  E-value=3.6e-21  Score=216.64  Aligned_cols=240  Identities=20%  Similarity=0.211  Sum_probs=153.9

Q ss_pred             eEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCC-CccccCCCCCcE-EEccC
Q 039419          227 DLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSL-PQSFGNLSSLEE-LMLSN  304 (1035)
Q Consensus       227 ~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~-L~L~~  304 (1035)
                      .++.++++++ .+|..+  .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+ +..|.++++|.+ +.+++
T Consensus        13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            4445555555 344433  234555556666655444445666666666666666654333 345566666554 44455


Q ss_pred             CccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccC-cCCCCCCCCCcccCc-ccceE
Q 039419          305 NNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSH-NALTGSLHPGLFQLQ-NLTKL  382 (1035)
Q Consensus       305 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~-~L~~L  382 (1035)
                      |+|..+.|+.|.++++|++|++++|+|+.+          .+..+....++..|++.+ |.+....+..|..+. .++.|
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~----------~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L  159 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIKHL----------PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVIL  159 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCSSC----------CCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEE
T ss_pred             CcccccCchhhhhccccccccccccccccC----------Cchhhcccchhhhhhhccccccccccccchhhcchhhhhh
Confidence            666666666666666666666666665532          223444555666777754 556655555566554 57788


Q ss_pred             eccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecC-CCccCCCCcccccCCCCccEEEcCCCccCCCCchhccC
Q 039419          383 LLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLS-NNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQ  461 (1035)
Q Consensus       383 ~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~-~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  461 (1035)
                      +|++|+|+.+.+..+.               ..+|++|+++ +|.++.+.+..|.++++|++|||++|+|+.+++..|.+
T Consensus       160 ~L~~N~i~~i~~~~f~---------------~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~  224 (350)
T 4ay9_X          160 WLNKNGIQEIHNSAFN---------------GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN  224 (350)
T ss_dssp             ECCSSCCCEECTTSST---------------TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT
T ss_pred             ccccccccCCChhhcc---------------ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc
Confidence            8888888765444332               2458888886 47777666678899999999999999999888778888


Q ss_pred             ccccchhhccCCcccccCccccCCCCCCcEEEcCCCc
Q 039419          462 LASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK  498 (1035)
Q Consensus       462 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  498 (1035)
                      +++|+.+++.  .++ .+| .+..+++|+.++++++.
T Consensus       225 L~~L~~l~~~--~l~-~lP-~l~~l~~L~~l~l~~~~  257 (350)
T 4ay9_X          225 LKKLRARSTY--NLK-KLP-TLEKLVALMEASLTYPS  257 (350)
T ss_dssp             CCEEECTTCT--TCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred             chHhhhccCC--CcC-cCC-CchhCcChhhCcCCCCc
Confidence            8888777653  444 555 37889999999998764

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.85  E-value=3.5e-21  Score=212.46  Aligned_cols=208  Identities=24%  Similarity=0.368  Sum_probs=99.3

Q ss_pred             EEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCC
Q 039419          276 IDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSL  355 (1035)
Q Consensus       276 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L  355 (1035)
                      +.+..+.+++..  .+..+++|++|++++|.+... + .+..+++|++|+|++|+|+.+           +. +..+++|
T Consensus        24 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~-----------~~-~~~l~~L   87 (308)
T 1h6u_A           24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDL-----------AP-LKNLTKI   87 (308)
T ss_dssp             HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-----------GG-GTTCCSC
T ss_pred             HHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCC-----------hh-HccCCCC
Confidence            344445554321  244566666666666666532 2 344555555555555544421           12 4444455


Q ss_pred             cEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccc
Q 039419          356 EAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL  435 (1035)
Q Consensus       356 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  435 (1035)
                      ++|+|++|.+++.  +.+..++                                      +|++|+|++|++++. + .+
T Consensus        88 ~~L~L~~n~l~~~--~~~~~l~--------------------------------------~L~~L~l~~n~l~~~-~-~l  125 (308)
T 1h6u_A           88 TELELSGNPLKNV--SAIAGLQ--------------------------------------SIKTLDLTSTQITDV-T-PL  125 (308)
T ss_dssp             CEEECCSCCCSCC--GGGTTCT--------------------------------------TCCEEECTTSCCCCC-G-GG
T ss_pred             CEEEccCCcCCCc--hhhcCCC--------------------------------------CCCEEECCCCCCCCc-h-hh
Confidence            5555555544421  1233333                                      444444444444432 1 14


Q ss_pred             cCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcc
Q 039419          436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDI  515 (1035)
Q Consensus       436 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~  515 (1035)
                      ..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|++|+|++|++++ ++.          
T Consensus       126 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~----------  190 (308)
T 1h6u_A          126 AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD-ISP----------  190 (308)
T ss_dssp             TTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGG----------
T ss_pred             cCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc-Chh----------
Confidence            445555555555555554322  4445555555555555543222  4555555555555555541 111          


Q ss_pred             eeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcc
Q 039419          516 SLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTG  573 (1035)
Q Consensus       516 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~  573 (1035)
                                      +..+++|++|+|++|++.+.+ .+..+++|+.|++++|++++
T Consensus       191 ----------------l~~l~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          191 ----------------LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             ----------------GGGCTTCCEEECTTSCCCBCG-GGTTCTTCCEEEEEEEEEEC
T ss_pred             ----------------hcCCCCCCEEEccCCccCccc-cccCCCCCCEEEccCCeeec
Confidence                            334445555555555555444 24555555555555555554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.85  E-value=1.1e-20  Score=202.16  Aligned_cols=183  Identities=27%  Similarity=0.322  Sum_probs=116.3

Q ss_pred             CCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcc
Q 039419          354 SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS  433 (1035)
Q Consensus       354 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~  433 (1035)
                      +.+.++++++.++ .+|..+.  ++++.|+|++|++++..+..|.              ++++|++|+|++|+|++..+.
T Consensus        15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~--------------~l~~L~~L~L~~n~l~~~~~~   77 (251)
T 3m19_A           15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFR--------------GLTKLTWLNLDYNQLQTLSAG   77 (251)
T ss_dssp             GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTT--------------TCTTCCEEECTTSCCCCCCTT
T ss_pred             CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhc--------------CcccCCEEECCCCcCCccCHh
Confidence            4566777777776 3444433  4666666666666655554433              334566666666666666666


Q ss_pred             cccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccC
Q 039419          434 SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGL  513 (1035)
Q Consensus       434 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l  513 (1035)
                      .|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+             
T Consensus        78 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------------  144 (251)
T 3m19_A           78 VFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-------------  144 (251)
T ss_dssp             TTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-------------
T ss_pred             HhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC-------------
Confidence            6666666777777777766666666666666666666666666555555666666666666666665             


Q ss_pred             cceeeccCccCCCCCCccccCCccccEEeccCCcccCccc-cccccCCCcEEeccCCcCcccCCCh
Q 039419          514 DISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL-ALSGLDNLVSLNVSYNNFTGYLPDS  578 (1035)
Q Consensus       514 ~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~ls~N~l~~~~p~~  578 (1035)
                                  +..+..|..+++|++|+|++|+|++.+. .+..+++|+.|+|++|+|++.....
T Consensus       145 ------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~  198 (251)
T 3m19_A          145 ------------SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEI  198 (251)
T ss_dssp             ------------CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTH
T ss_pred             ------------ccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcccc
Confidence                        2334455666677777777777776553 5666777777777777777654443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.84  E-value=2e-22  Score=226.10  Aligned_cols=215  Identities=21%  Similarity=0.191  Sum_probs=134.5

Q ss_pred             CCCccceEEEEecccccccc-CcccccccccccceeecccccccCCccccccCcCCceEEecCC-cCCCC-CChhhhccc
Q 039419          171 IGDCQSLLVVGLADTKVAGS-LPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEN-DLSGS-LPRELGKLQ  247 (1035)
Q Consensus       171 ~~~l~~L~~L~l~~~~~~~~-~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~-~~~~l~~l~  247 (1035)
                      +..+++|+.|++++|.+.+. ++..+..+++|++|++++|.+++..+..++.+++|++|+|++| .+++. ++..+..++
T Consensus        89 ~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~  168 (336)
T 2ast_B           89 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS  168 (336)
T ss_dssp             CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred             hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCC
Confidence            33455555555555555544 5666667777777777777766666666777777777777777 45542 455566667


Q ss_pred             chhHhhcccc-ccccc-CCccccCCC-CCcEEEccCc--cCC-CCCCccccCCCCCcEEEccCCc-cccCCCCcccCCCc
Q 039419          248 KLEKMLLWQN-NFDGA-IPEEIGNCK-SLKTIDLSLN--FFS-GSLPQSFGNLSSLEELMLSNNN-ISGSIPPVLSNATS  320 (1035)
Q Consensus       248 ~L~~L~l~~n-~l~~~-~p~~~~~l~-~L~~L~L~~n--~l~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~  320 (1035)
                      +|++|++++| .+++. ++..+..++ +|++|+|++|  .++ +.++..+.++++|++|++++|. +++..+..+..+++
T Consensus       169 ~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~  248 (336)
T 2ast_B          169 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY  248 (336)
T ss_dssp             TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred             CCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCC
Confidence            7777777777 66643 455566677 7777777777  343 2345556667777777777777 55555566667777


Q ss_pred             cceeccccch-hhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccC-cccceEeccccccccCCCCCCC
Q 039419          321 LLQLQLDTNQ-ISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQL-QNLTKLLLISNGISGLIPPEIG  398 (1035)
Q Consensus       321 L~~L~L~~N~-i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~  398 (1035)
                      |++|++++|. +...          ....+..+++|+.|++++| ++   ...+..+ ..++.|++++|++++..|..++
T Consensus       249 L~~L~l~~~~~~~~~----------~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~  314 (336)
T 2ast_B          249 LQHLSLSRCYDIIPE----------TLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG  314 (336)
T ss_dssp             CCEEECTTCTTCCGG----------GGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred             CCEeeCCCCCCCCHH----------HHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence            7777777763 2210          0124666778888888877 33   2334444 3466666777777777766654


Q ss_pred             C
Q 039419          399 N  399 (1035)
Q Consensus       399 ~  399 (1035)
                      +
T Consensus       315 ~  315 (336)
T 2ast_B          315 N  315 (336)
T ss_dssp             S
T ss_pred             c
Confidence            3

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.83  E-value=1.1e-20  Score=212.74  Aligned_cols=225  Identities=20%  Similarity=0.144  Sum_probs=124.9

Q ss_pred             CCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccc-eeecCCCccCCCCc
Q 039419          354 SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQ-MLNLSNNTLGGTLP  432 (1035)
Q Consensus       354 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~-~L~L~~N~l~~~~~  432 (1035)
                      ++++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+|..             .|.+++++. .+.+++|+|+.+.|
T Consensus        31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~-------------~f~~L~~l~~~l~~~~N~l~~l~~   97 (350)
T 4ay9_X           31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD-------------VFSNLPKLHEIRIEKANNLLYINP   97 (350)
T ss_dssp             TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT-------------SBCSCTTCCEEEEEEETTCCEECT
T ss_pred             CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh-------------HhhcchhhhhhhcccCCcccccCc
Confidence            4455555555555333344555555555555555544322221             123333333 34455566665556


Q ss_pred             ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccC-CcccccCccccCCCC-CCcEEEcCCCcCcCccchhhhhh
Q 039419          433 SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSK-NSFSGAIPSSLGRCE-SLQSLDLSSNKLSGKIPVELFEI  510 (1035)
Q Consensus       433 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~~  510 (1035)
                      ..|..+++|++|++++|+|....+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+ .+|...|..
T Consensus        98 ~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~  176 (350)
T 4ay9_X           98 EAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNG  176 (350)
T ss_dssp             TSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTT
T ss_pred             hhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccc
Confidence            6666666666666666666666555555555666666644 455545455555543 4666777777776 566666655


Q ss_pred             ccCcceeecc-CccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCChhhhhccccccc
Q 039419          511 EGLDISLNLS-WNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEM  589 (1035)
Q Consensus       511 ~~l~~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~~~~  589 (1035)
                      ..+. .|+++ +|.++.+.+..|..+++|++|||++|+|+..+..  .+.+|+.|.+.+++--..+|....+.+|..+.+
T Consensus       177 ~~L~-~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~--~~~~L~~L~~l~~~~l~~lP~l~~l~~L~~l~l  253 (350)
T 4ay9_X          177 TQLD-ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY--GLENLKKLRARSTYNLKKLPTLEKLVALMEASL  253 (350)
T ss_dssp             EEEE-EEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSS--SCTTCCEEECTTCTTCCCCCCTTTCCSCCEEEC
T ss_pred             cchh-HHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChh--hhccchHhhhccCCCcCcCCCchhCcChhhCcC
Confidence            5433 45655 3556655566677777777888887777776642  234444554444433334455455566665554


Q ss_pred             cccccCC
Q 039419          590 AGNQGLC  596 (1035)
Q Consensus       590 ~~N~~~c  596 (1035)
                       .|+++|
T Consensus       254 -~~~~~c  259 (350)
T 4ay9_X          254 -TYPSHC  259 (350)
T ss_dssp             -SCHHHH
T ss_pred             -CCCccc
Confidence             355666

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.81  E-value=7.3e-20  Score=189.65  Aligned_cols=184  Identities=21%  Similarity=0.190  Sum_probs=129.6

Q ss_pred             CCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCCh
Q 039419           17 NPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPS   96 (1035)
Q Consensus        17 ~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~   96 (1035)
                      ..|.|.+|.|+..+.           . .+|..+  .++|++|+|++|++++..+..++.+++|++|+|++|++++..+.
T Consensus         5 C~C~~~~v~c~~~~l-----------~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~   70 (208)
T 2o6s_A            5 CSCSGTTVECYSQGR-----------T-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG   70 (208)
T ss_dssp             CEEETTEEECCSSCC-----------S-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred             CEECCCEEEecCCCc-----------c-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence            458999999986431           1 344444  35899999999999966666788999999999999999966666


Q ss_pred             hhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccc
Q 039419           97 SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS  176 (1035)
Q Consensus        97 ~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  176 (1035)
                      .+..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..+..+++|++|++++|. +.+..+..+..+++
T Consensus        71 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~  149 (208)
T 2o6s_A           71 VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQ-LKSVPDGVFDRLTS  149 (208)
T ss_dssp             TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC-CSCCCTTTTTTCTT
T ss_pred             hcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCc-cceeCHHHhccCCC
Confidence            67899999999999999996555567899999999999999985555557778888888887775 33222333455555


Q ss_pred             eEEEEeccccccccCcccccccccccceeecccccccCCccccccC
Q 039419          177 LLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNC  222 (1035)
Q Consensus       177 L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l  222 (1035)
                      |+.|++++|.+.+       .+++|++|++..|.++|.+|..++.+
T Consensus       150 L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l  188 (208)
T 2o6s_A          150 LQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSV  188 (208)
T ss_dssp             CCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred             ccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccc
Confidence            5555555554432       23345555555555555555544443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.81  E-value=8.1e-21  Score=224.58  Aligned_cols=208  Identities=24%  Similarity=0.355  Sum_probs=132.8

Q ss_pred             cCCCCCCCCCCc-----cceeE-EeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCc
Q 039419            8 LSNWNPSDSNPC-----KWSHI-TCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLT   81 (1035)
Q Consensus         8 l~~w~~~~~~~c-----~w~gi-~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~   81 (1035)
                      +.+|..+. ++|     .|.|+ .|.. +.++.|+++++++.+ +|..+.  ++|++|+|++|.|+ .+|   +.+++|+
T Consensus        33 l~~W~~~~-~~~~~~~~~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~  103 (571)
T 3cvr_A           33 WDKWEKQA-LPGENRNEAVSLLKECLI-NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLE  103 (571)
T ss_dssp             HHHHHTTC-CTTCCHHHHHHHHHHHHH-TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCC
T ss_pred             HHHHhccC-Cccccccchhhhcccccc-CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCC
Confidence            55786644 578     79999 7863 457778888888876 666663  67888888888887 566   4567888


Q ss_pred             eeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCc
Q 039419           82 TIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK  161 (1035)
Q Consensus        82 ~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~  161 (1035)
                      +|+|++|+|++ +|. +..  +|++|+|++|++++ +|.   .+++|++|+|++|.+++ +|.   .+++|++|++++|.
T Consensus       104 ~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~  171 (571)
T 3cvr_A          104 YLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQ  171 (571)
T ss_dssp             EEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC
T ss_pred             EEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCC
Confidence            88888888874 666 555  78888888888874 665   56778888888888773 554   45666666666665


Q ss_pred             ccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCC-------ceEEecCCc
Q 039419          162 DIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSEL-------VDLFLYEND  234 (1035)
Q Consensus       162 ~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L-------~~L~L~~n~  234 (1035)
                       +. .+|. +.  ++|+.                        |+|++|.++ .+|. +..  +|       +.|+|++|.
T Consensus       172 -L~-~lp~-l~--~~L~~------------------------L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~  218 (571)
T 3cvr_A          172 -LT-FLPE-LP--ESLEA------------------------LDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENR  218 (571)
T ss_dssp             -CS-CCCC-CC--TTCCE------------------------EECCSSCCS-SCCC-CC----------CCEEEECCSSC
T ss_pred             -CC-Ccch-hh--CCCCE------------------------EECcCCCCC-chhh-HHH--hhhcccccceEEecCCCc
Confidence             22 2443 33  44444                        445444444 3343 332  34       556666666


Q ss_pred             CCCCCChhhhcccchhHhhcccccccccCCccccCC
Q 039419          235 LSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNC  270 (1035)
Q Consensus       235 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l  270 (1035)
                      |+ .+|..+..+++|+.|+|++|.+++.+|..+..+
T Consensus       219 l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          219 IT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ  253 (571)
T ss_dssp             CC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred             ce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence            55 455555556666666666666655555555443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.81  E-value=6.2e-20  Score=216.99  Aligned_cols=189  Identities=27%  Similarity=0.335  Sum_probs=144.8

Q ss_pred             CCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCC
Q 039419          272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLAN  351 (1035)
Q Consensus       272 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~  351 (1035)
                      +|+.|+|++|.|++ +|..+.  ++|++|+|++|+|+ .+|   ..+++|++|+|++|+|+.           +|. +.+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-----------ip~-l~~  120 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-----------LPE-LPA  120 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-----------CCC-CCT
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-----------cch-hhc
Confidence            78888888888875 555442  67888888888887 444   346788888888887762           444 444


Q ss_pred             CCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCC
Q 039419          352 CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTL  431 (1035)
Q Consensus       352 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~  431 (1035)
                        +|+.|+|++|+|++ +|.   .+++|+.|+|++|+|+++ |.                 .+++|++|+|++|+|++ +
T Consensus       121 --~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-p~-----------------~l~~L~~L~Ls~N~L~~-l  175 (571)
T 3cvr_A          121 --SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTML-PE-----------------LPTSLEVLSVRNNQLTF-L  175 (571)
T ss_dssp             --TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CC-----------------CCTTCCEEECCSSCCSC-C
T ss_pred             --CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcC-CC-----------------cCCCcCEEECCCCCCCC-c
Confidence              88889999998886 444   578899999999988863 32                 13568999999999996 5


Q ss_pred             cccccCCCCccEEEcCCCccCCCCchhccCcccc-------chhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccc
Q 039419          432 PSSLASLTRLQVLDISVNQFVGLIPESFGQLASL-------NRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIP  504 (1035)
Q Consensus       432 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  504 (1035)
                      |. |.  ++|+.|+|++|+|+.+ |. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|
T Consensus       176 p~-l~--~~L~~L~Ls~N~L~~l-p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          176 PE-LP--ESLEALDVSTNLLESL-PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR  247 (571)
T ss_dssp             CC-CC--TTCCEEECCSSCCSSC-CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred             ch-hh--CCCCEEECcCCCCCch-hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence            55 65  8999999999999954 44 554  67       99999999998 577778889999999999999999999


Q ss_pred             hhhhhhcc
Q 039419          505 VELFEIEG  512 (1035)
Q Consensus       505 ~~~~~~~~  512 (1035)
                      ..+..+..
T Consensus       248 ~~l~~l~~  255 (571)
T 3cvr_A          248 ESLSQQTA  255 (571)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHhhc
Confidence            88877644

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.79  E-value=1.2e-18  Score=180.42  Aligned_cols=181  Identities=24%  Similarity=0.213  Sum_probs=112.8

Q ss_pred             cEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCC
Q 039419          274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCR  353 (1035)
Q Consensus       274 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~  353 (1035)
                      +.++++++.++. +|..+  .++|++|++++|++++..+..|..+++|++|+|++|+|+.          ..+..|..++
T Consensus        10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~----------~~~~~~~~l~   76 (208)
T 2o6s_A           10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS----------LPNGVFNKLT   76 (208)
T ss_dssp             TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC----------CCTTTTTTCT
T ss_pred             CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc----------cChhhcCCCC
Confidence            345555555552 33222  2355566666666555544455555555555555555442          1223456667


Q ss_pred             CCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcc
Q 039419          354 SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPS  433 (1035)
Q Consensus       354 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~  433 (1035)
                      +|++|+|++|++++..+..|..+++|++|++++|+|++..+..+.              ++++|++|+|++|++++..+.
T Consensus        77 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--------------~l~~L~~L~l~~N~l~~~~~~  142 (208)
T 2o6s_A           77 SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFD--------------KLTQLKDLRLYQNQLKSVPDG  142 (208)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT--------------TCTTCCEEECCSSCCSCCCTT
T ss_pred             CcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhc--------------cCCcCCEEECCCCccceeCHH
Confidence            777777777777655555566677777777777777655444333              345577777777777766666


Q ss_pred             cccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCC
Q 039419          434 SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCES  488 (1035)
Q Consensus       434 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  488 (1035)
                      .|..+++|++|++++|.+.+       .+++|+.|+++.|+++|.+|..++.++.
T Consensus       143 ~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          143 VFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             HhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            67777888888888887664       3456778888888888888877776554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.77  E-value=4.7e-19  Score=193.56  Aligned_cols=191  Identities=27%  Similarity=0.368  Sum_probs=113.3

Q ss_pred             ccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceec
Q 039419          246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQ  325 (1035)
Q Consensus       246 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  325 (1035)
                      +.++..+.+..+.+.+..+  +..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+  +..+++|++|+
T Consensus        23 l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~   96 (291)
T 1h6t_A           23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF   96 (291)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEE
Confidence            4455666676666664332  44677788888888888743 3 37777888888888888875544  66777777777


Q ss_pred             cccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCccee
Q 039419          326 LDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR  405 (1035)
Q Consensus       326 L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  405 (1035)
                      |++|+|+.+            ..+..+++|++|+|++|++++.  ..+..+++|+.|++++|++++.  .          
T Consensus        97 l~~n~l~~~------------~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~----------  150 (291)
T 1h6t_A           97 LDENKVKDL------------SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--T----------  150 (291)
T ss_dssp             CCSSCCCCG------------GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--G----------
T ss_pred             CCCCcCCCC------------hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--h----------
Confidence            777766532            2366677777777777777642  3455556666666666655532  1          


Q ss_pred             EeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCccc
Q 039419          406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS  476 (1035)
Q Consensus       406 L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  476 (1035)
                          .+..+++|++|+|++|++++..+  +..+++|+.|+|++|+|+++ + .+..+++|+.|++++|+++
T Consensus       151 ----~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          151 ----VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             ----GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred             ----hhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence                13334445555555555554332  55555555555555555543 1 2444555555555555544

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.77  E-value=1.2e-18  Score=181.96  Aligned_cols=136  Identities=26%  Similarity=0.281  Sum_probs=78.7

Q ss_pred             CccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeec
Q 039419          440 RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNL  519 (1035)
Q Consensus       440 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~L  519 (1035)
                      +|+.|+|++|+|+++.+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|+ .+|...|.....+..|+|
T Consensus        33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEEC
Confidence            4444555555544444444444445555555555554444444555555555555555554 333333322222334555


Q ss_pred             cCccCCCCCCccccCCccccEEeccCCcccCccc-cccccCCCcEEeccCCcCcccCC
Q 039419          520 SWNALSGAIPPQISALNKLSILDLSHNKLGGDLL-ALSGLDNLVSLNVSYNNFTGYLP  576 (1035)
Q Consensus       520 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~ls~N~l~~~~p  576 (1035)
                      ++|+|++..|..|..+++|++|+|++|+|++.+. .|..+++|+.|+|++|+|.+...
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            5555555666677778888888888888887664 57778888888888888876543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.77  E-value=7.8e-19  Score=210.13  Aligned_cols=191  Identities=27%  Similarity=0.377  Sum_probs=98.1

Q ss_pred             ccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceec
Q 039419          246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQ  325 (1035)
Q Consensus       246 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  325 (1035)
                      +.++..+.+..+.+....+  +..+++|+.|+|++|.|.. ++ .|..+++|+.|+|++|+|.+..+  |..+++|+.|+
T Consensus        20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~   93 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF   93 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred             HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence            3344455555555553322  3445556666666666553 22 35556666666666666554333  55555555555


Q ss_pred             cccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCccee
Q 039419          326 LDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR  405 (1035)
Q Consensus       326 L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  405 (1035)
                      |++|+|+.+            ..+..+++|+.|+|++|.|++.  +.+..+++|+.|+|++|+|++.  .          
T Consensus        94 Ls~N~l~~l------------~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~----------  147 (605)
T 1m9s_A           94 LDENKIKDL------------SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--T----------  147 (605)
T ss_dssp             CCSSCCCCC------------TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--G----------
T ss_pred             CcCCCCCCC------------hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--h----------
Confidence            555554421            2455555666666666666532  2345555555555555555432  1          


Q ss_pred             EeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCccc
Q 039419          406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFS  476 (1035)
Q Consensus       406 L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  476 (1035)
                          .|..+++|+.|+|++|+|++..|  +..+++|+.|+|++|+|+++  ..+..+++|+.|+|++|++.
T Consensus       148 ----~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          148 ----VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             ----GGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred             ----hhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence                13334445555555555554433  55555555555555555543  23555555555555555554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=1.9e-20  Score=222.92  Aligned_cols=199  Identities=18%  Similarity=0.088  Sum_probs=93.5

Q ss_pred             CCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccce
Q 039419           75 GDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEV  154 (1035)
Q Consensus        75 ~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~  154 (1035)
                      ..+++|+.|+|++|+++ .+|+.|+.|++|++|++++|.....+|..+           ..+.+.+..|..++.+++|+.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll-----------~~~~~~~~~~~~l~~l~~L~~  413 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM-----------RALDPLLYEKETLQYFSTLKA  413 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHH-----------HHHCTGGGHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHH-----------HhcccccCCHHHHHHHHhccc
Confidence            45666777777777766 667777777777777765553210111100           111233455666777777777


Q ss_pred             ee-cCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCC
Q 039419          155 IR-AGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEN  233 (1035)
Q Consensus       155 L~-l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n  233 (1035)
                      |+ ++.|.            +..|..+.+.+|.+....+      ..|+.|++++|.+++ +|. ++.+++|+.|+|++|
T Consensus       414 L~~l~~n~------------~~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N  473 (567)
T 1dce_A          414 VDPMRAAY------------LDDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN  473 (567)
T ss_dssp             HCGGGHHH------------HHHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred             Ccchhhcc------------cchhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence            66 44332            1223333333333332111      124444444444442 333 444444444444444


Q ss_pred             cCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCC-CccccCCCCCcEEEccCCccc
Q 039419          234 DLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSL-PQSFGNLSSLEELMLSNNNIS  308 (1035)
Q Consensus       234 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~  308 (1035)
                      .|+ .+|..|+.+++|+.|+|++|++++ +| .++.+++|+.|+|++|+|++.. |..|+.+++|+.|+|++|+++
T Consensus       474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~  546 (567)
T 1dce_A          474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  546 (567)
T ss_dssp             CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence            444 344444444444444444444443 33 3444444444444444444333 444444444444444444444

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.76  E-value=2.1e-18  Score=180.01  Aligned_cols=137  Identities=22%  Similarity=0.259  Sum_probs=89.5

Q ss_pred             cceeecCCCccCCCCc-ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcC
Q 039419          417 LQMLNLSNNTLGGTLP-SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLS  495 (1035)
Q Consensus       417 L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  495 (1035)
                      +++|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  113 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR  113 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence            4566666666664433 335556666666666666665555556666666666666666655555555566666666655


Q ss_pred             CCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCc-cccccccCCCcEEeccCCcCccc
Q 039419          496 SNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGD-LLALSGLDNLVSLNVSYNNFTGY  574 (1035)
Q Consensus       496 ~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~ls~N~l~~~  574 (1035)
                      +|+|+                         +..|..|..+++|++|+|++|+|++. +..|..+++|+.|+|++|+|++.
T Consensus       114 ~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A          114 SNRIT-------------------------CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             TSCCC-------------------------CBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CCcCC-------------------------eECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            55555                         45566677778888888888888876 45778888888888888888876


Q ss_pred             CCCh
Q 039419          575 LPDS  578 (1035)
Q Consensus       575 ~p~~  578 (1035)
                      .+-.
T Consensus       169 c~l~  172 (220)
T 2v70_A          169 CYLA  172 (220)
T ss_dssp             GGGH
T ss_pred             CchH
Confidence            6543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.76  E-value=2.6e-18  Score=179.34  Aligned_cols=156  Identities=23%  Similarity=0.280  Sum_probs=121.0

Q ss_pred             cEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccc
Q 039419          356 EAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL  435 (1035)
Q Consensus       356 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  435 (1035)
                      +.+++++|.++. +|..+.  ..+++|+|++|+|++..+..             .|.++++|++|+|++|+|++..+..|
T Consensus        14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~-------------~~~~l~~L~~L~L~~N~i~~i~~~~~   77 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATG-------------IFKKLPQLRKINFSNNKITDIEEGAF   77 (220)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCC-------------CGGGCTTCCEEECCSSCCCEECTTTT
T ss_pred             CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchh-------------hhccCCCCCEEECCCCcCCEECHHHh
Confidence            478888888874 454442  45678888888887664432             24456778888888888887777788


Q ss_pred             cCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcc
Q 039419          436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDI  515 (1035)
Q Consensus       436 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~  515 (1035)
                      .++++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++              
T Consensus        78 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--------------  143 (220)
T 2v70_A           78 EGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITT--------------  143 (220)
T ss_dssp             TTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCC--------------
T ss_pred             CCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCE--------------
Confidence            888888888888888888888888888888888888888888888888888888888888888873              


Q ss_pred             eeeccCccCCCCCCccccCCccccEEeccCCcccCcc
Q 039419          516 SLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL  552 (1035)
Q Consensus       516 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  552 (1035)
                                 ..|..|..+++|++|+|++|++.++.
T Consensus       144 -----------~~~~~~~~l~~L~~L~L~~N~l~c~c  169 (220)
T 2v70_A          144 -----------VAPGAFDTLHSLSTLNLLANPFNCNC  169 (220)
T ss_dssp             -----------BCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred             -----------ECHHHhcCCCCCCEEEecCcCCcCCC
Confidence                       33455667788888888888888755

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.75  E-value=2.7e-18  Score=193.92  Aligned_cols=180  Identities=29%  Similarity=0.272  Sum_probs=121.3

Q ss_pred             cEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccc
Q 039419          356 EAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL  435 (1035)
Q Consensus       356 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  435 (1035)
                      +.+++++|.|+ .+|..+.  ..++.|+|++|+|++..+..+.             .++++|++|+|++|+|+++.+..|
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~-------------~~l~~L~~L~L~~N~i~~i~~~~~   84 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTP-------------TRLTNLHSLLLSHNHLNFISSEAF   84 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSS-------------SCCTTCCEEECCSSCCCEECTTTT
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhh-------------hcccccCEEECCCCcCCccChhhc
Confidence            56778888777 3454443  3577788888887766555443             044668888888888887777778


Q ss_pred             cCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcc
Q 039419          436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDI  515 (1035)
Q Consensus       436 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~  515 (1035)
                      ..+++|++|+|++|+|+.+.+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|+ .+|..++..     
T Consensus        85 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~-----  158 (361)
T 2xot_A           85 VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD-----  158 (361)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC------
T ss_pred             cCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcC-----
Confidence            88888888888888888777777888888888888888888777778888888888888888887 455444310     


Q ss_pred             eeeccCccCCCCCCccccCCccccEEeccCCcccCcc-ccccccCC--CcEEeccCCcCcc
Q 039419          516 SLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LALSGLDN--LVSLNVSYNNFTG  573 (1035)
Q Consensus       516 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~--L~~L~ls~N~l~~  573 (1035)
                                      +..+++|+.|||++|+|+..+ ..+..++.  |+.|+|++|+|.+
T Consensus       159 ----------------~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          159 ----------------GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             -------------------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             ----------------cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence                            123455555555555555544 23444444  2555666666554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.75  E-value=2.7e-20  Score=221.55  Aligned_cols=218  Identities=18%  Similarity=0.191  Sum_probs=160.7

Q ss_pred             CCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhcccc
Q 039419           50 LSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLK  129 (1035)
Q Consensus        50 ~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~  129 (1035)
                      +..+++|+.|+|++|.++ .+|++++.|++|+.|++++|.....+|.          + +..+.+.+.+|..++.+++|+
T Consensus       345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~----------l-l~~~~~~~~~~~~l~~l~~L~  412 (567)
T 1dce_A          345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL----------L-MRALDPLLYEKETLQYFSTLK  412 (567)
T ss_dssp             CSTTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH----------H-HHHHCTGGGHHHHHHHHHHHH
T ss_pred             cccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH----------H-HHhcccccCCHHHHHHHHhcc
Confidence            477899999999999998 8999999999999999977642101111          1 112233345667777777777


Q ss_pred             cee-ccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecc
Q 039419          130 NLL-LFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYT  208 (1035)
Q Consensus       130 ~L~-l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~  208 (1035)
                      .|+ ++.|.+           .+|+.+.+++|. + ..++     ...|+.|++++|.+++ +|. |+.+++|+.|+|++
T Consensus       413 ~L~~l~~n~~-----------~~L~~l~l~~n~-i-~~l~-----~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~  472 (567)
T 1dce_A          413 AVDPMRAAYL-----------DDLRSKFLLENS-V-LKME-----YADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSH  472 (567)
T ss_dssp             HHCGGGHHHH-----------HHHHHHHHHHHH-H-HHHH-----HTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCS
T ss_pred             cCcchhhccc-----------chhhhhhhhccc-c-cccC-----ccCceEEEecCCCCCC-CcC-ccccccCcEeecCc
Confidence            777 555543           244444454443 1 1111     1136677777777775 565 88899999999999


Q ss_pred             cccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccC-CccccCCCCCcEEEccCccCCCCC
Q 039419          209 TMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAI-PEEIGNCKSLKTIDLSLNFFSGSL  287 (1035)
Q Consensus       209 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~  287 (1035)
                      |.++ .+|..++++++|+.|+|++|.|++ +| .|+.+++|+.|+|++|++++.. |..|..+++|+.|+|++|+|++..
T Consensus       473 N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~  549 (567)
T 1dce_A          473 NRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  549 (567)
T ss_dssp             SCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             cccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence            9988 788899999999999999999985 66 7889999999999999998776 889999999999999999998654


Q ss_pred             Ccc---ccCCCCCcEEEc
Q 039419          288 PQS---FGNLSSLEELML  302 (1035)
Q Consensus       288 ~~~---~~~l~~L~~L~L  302 (1035)
                      +..   +..+++|+.|++
T Consensus       550 ~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          550 GIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SCTTHHHHHCTTCSEEEC
T ss_pred             cHHHHHHHHCcccCccCC
Confidence            432   334788888864

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.75  E-value=5e-18  Score=177.12  Aligned_cols=155  Identities=25%  Similarity=0.308  Sum_probs=113.1

Q ss_pred             cEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccc
Q 039419          356 EAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL  435 (1035)
Q Consensus       356 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  435 (1035)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|+|+++.+..|              .++++|++|+|++|+|++..|..|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~--------------~~l~~L~~L~Ls~N~i~~~~~~~~   76 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAF--------------SPYKKLRRIDLSNNQISELAPDAF   76 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSS--------------TTCTTCCEEECCSSCCCEECTTTT
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHh--------------hCCCCCCEEECCCCcCCCcCHHHh
Confidence            56777777777 3444443  567777777777776555444              334567777788888777777778


Q ss_pred             cCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcc
Q 039419          436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDI  515 (1035)
Q Consensus       436 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~  515 (1035)
                      .++++|++|+|++|+|+.+++..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++              
T Consensus        77 ~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--------------  142 (220)
T 2v9t_B           77 QGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT--------------  142 (220)
T ss_dssp             TTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC--------------
T ss_pred             hCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCE--------------
Confidence            888888888888888887766777777788888888888877777777777788777777777762              


Q ss_pred             eeeccCccCCCCCCccccCCccccEEeccCCcccCcc
Q 039419          516 SLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL  552 (1035)
Q Consensus       516 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  552 (1035)
                                 ..+..|..+++|++|+|++|++.++.
T Consensus       143 -----------~~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B          143 -----------IAKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             -----------CCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             -----------ECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence                       33445667788999999999988754

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.75  E-value=1.3e-18  Score=208.24  Aligned_cols=182  Identities=26%  Similarity=0.351  Sum_probs=111.0

Q ss_pred             hcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccce
Q 039419          244 GKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQ  323 (1035)
Q Consensus       244 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  323 (1035)
                      ..+++|+.|++++|.+.. ++ .+..+++|+.|+|++|+|++..+  +..+++|+.|+|++|+|.+.  ..|..+++|+.
T Consensus        40 ~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~  113 (605)
T 1m9s_A           40 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKS  113 (605)
T ss_dssp             HHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCE
T ss_pred             hcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCE
Confidence            444555555555555542 22 35555666666666666654333  55666666666666666532  24556666666


Q ss_pred             eccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcc
Q 039419          324 LQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSL  403 (1035)
Q Consensus       324 L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  403 (1035)
                      |+|++|+|+.+            ..+..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|+|++..|  +      
T Consensus       114 L~Ls~N~l~~l------------~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l------  171 (605)
T 1m9s_A          114 LSLEHNGISDI------------NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L------  171 (605)
T ss_dssp             EECTTSCCCCC------------GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--G------
T ss_pred             EEecCCCCCCC------------ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--h------
Confidence            66666655422            2456667777777777777644  556677777777777777765443  2      


Q ss_pred             eeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCcc
Q 039419          404 IRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLA  463 (1035)
Q Consensus       404 ~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  463 (1035)
                              ..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|++.+.+...+..+.
T Consensus       172 --------~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~  221 (605)
T 1m9s_A          172 --------AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLV  221 (605)
T ss_dssp             --------TTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSSCE
T ss_pred             --------ccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcccccccEE
Confidence                    3446677888888888754  3577788888888888888765444444433

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.75  E-value=1.9e-18  Score=188.81  Aligned_cols=190  Identities=24%  Similarity=0.327  Sum_probs=102.5

Q ss_pred             CCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecC
Q 039419           79 QLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAG  158 (1035)
Q Consensus        79 ~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~  158 (1035)
                      ++..+.+..+.+.+..+  +..+++|++|++++|.++ .++ .+..+++|++|++++|++++ ++. ++.+++|++|+++
T Consensus        25 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~   98 (291)
T 1h6t_A           25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLD   98 (291)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECC
Confidence            34444454444442222  334555555555555555 233 35555555555555555542 222 4444444444444


Q ss_pred             CCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCC
Q 039419          159 GNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGS  238 (1035)
Q Consensus       159 ~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~  238 (1035)
                      +|                         .+.+  +..+..+++|++|++++|.+++ + ..+..+++|+.|++++|.+++.
T Consensus        99 ~n-------------------------~l~~--~~~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~  149 (291)
T 1h6t_A           99 EN-------------------------KVKD--LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI  149 (291)
T ss_dssp             SS-------------------------CCCC--GGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC
T ss_pred             CC-------------------------cCCC--ChhhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc
Confidence            44                         3332  1236666666666666666663 2 3566666666666666666643


Q ss_pred             CChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCcccc
Q 039419          239 LPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG  309 (1035)
Q Consensus       239 ~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  309 (1035)
                        ..+..+++|++|++++|++.+..+  +..+++|+.|+|++|.|++. + .+..+++|+.|++++|++..
T Consensus       150 --~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          150 --TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             --hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence              455666666666666666664333  56666666666666666642 2 35666666666666666654

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.75  E-value=9.1e-18  Score=176.39  Aligned_cols=139  Identities=22%  Similarity=0.267  Sum_probs=111.1

Q ss_pred             ccCCCCCCCCCCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCC
Q 039419            7 ALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVS   86 (1035)
Q Consensus         7 ~l~~w~~~~~~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls   86 (1035)
                      ....|.... +.|+|.+|.|+..+           + ..+|..+.  ++|++|+|++|.+++..|..+..+++|++|+|+
T Consensus         8 ~~~~~~~~~-~~Cs~~~v~c~~~~-----------l-~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~   72 (229)
T 3e6j_A            8 HHSAACPSQ-CSCSGTTVDCRSKR-----------H-ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLG   72 (229)
T ss_dssp             ---CCCCTT-CEEETTEEECTTSC-----------C-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             hhhccCCCC-CEEeCCEeEccCCC-----------c-CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECC
Confidence            344555543 67999999997542           2 14555554  889999999999998888889999999999999


Q ss_pred             CCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCc
Q 039419           87 SNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNK  161 (1035)
Q Consensus        87 ~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~  161 (1035)
                      +|++....+..+..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|.
T Consensus        73 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~  146 (229)
T 3e6j_A           73 SNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ  146 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSC
T ss_pred             CCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCc
Confidence            99998555566789999999999999999655666788999999999999998 788888888888888887775

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.74  E-value=9e-19  Score=215.15  Aligned_cols=245  Identities=18%  Similarity=0.149  Sum_probs=110.6

Q ss_pred             CCCCCCCCCccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEe-----ecCcccCCCCCCCCCCCCCCceee
Q 039419           10 NWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLI-----ISGSNLTGPISPDLGDCTQLTTID   84 (1035)
Q Consensus        10 ~w~~~~~~~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~-----L~~~~l~~~~~~~~~~l~~L~~L~   84 (1035)
                      .|......++.|.+++++. ..|+.+++..+++.. .+..+.....|+.+.     ++.|.+. ..++.+..++.|+.|+
T Consensus       154 ~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~  230 (727)
T 4b8c_D          154 QPTGDSTPSGTATNSAVST-PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALD  230 (727)
T ss_dssp             -----------------------------------------------------------------------CCCCCCEEE
T ss_pred             CCcCCCCccccCCCceecC-CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEE
Confidence            4544445578999999986 468899998888875 344443333344433     3334444 5577788899999999


Q ss_pred             CCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccC
Q 039419           85 VSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIA  164 (1035)
Q Consensus        85 ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~  164 (1035)
                      |++|.+. .+|..+..+++|++|+|++|.++ .+|..|+.|++|++|+|++|.|+ .+|..|++|++|++|+|++|.  .
T Consensus       231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~--l  305 (727)
T 4b8c_D          231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM--V  305 (727)
T ss_dssp             CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC--C
T ss_pred             CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC--C
Confidence            9999998 88888889999999999999998 88888999999999999999998 788888889899988888886  3


Q ss_pred             CCCCCcCCCccceEEEEeccccccccCccccccccc-ccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhh
Q 039419          165 GKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSK-LQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPREL  243 (1035)
Q Consensus       165 ~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~-L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l  243 (1035)
                      ..+|..++.+++|+.|+|++|.+.+.+|..+..+.. +..|+|++|.+++.+|..      |..|+++.|...   -..+
T Consensus       306 ~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~---~~~~  376 (727)
T 4b8c_D          306 TTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEP---QREY  376 (727)
T ss_dssp             CCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-------------------------
T ss_pred             CccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeeccccc---cccc
Confidence            466666777777777777777777666666655432 223566666666655543      344445544110   0111


Q ss_pred             hcccchhHhhcccccccccCCccccCCCCCcEEEccCccCC
Q 039419          244 GKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFS  284 (1035)
Q Consensus       244 ~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~  284 (1035)
                      +             .+.+..+..+.++..+....+++|.+.
T Consensus       377 ~-------------~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          377 D-------------SLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             --------------------------------------CCC
T ss_pred             C-------------Cccccccchhhcccccceeeeeccccc
Confidence            1             233334444556666777778888765

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.74  E-value=1.6e-17  Score=174.56  Aligned_cols=135  Identities=27%  Similarity=0.290  Sum_probs=77.7

Q ss_pred             ccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcC
Q 039419          416 QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLS  495 (1035)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  495 (1035)
                      +|++|+|++|+|++..|..|..+++|++|+|++|+|..+.+..|..+++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus        41 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls  120 (229)
T 3e6j_A           41 NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMC  120 (229)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEecc
Confidence            35555555555555555555556666666666666655555555666666666666666665555555666666666666


Q ss_pred             CCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcc-ccccccCCCcEEeccCCcCccc
Q 039419          496 SNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LALSGLDNLVSLNVSYNNFTGY  574 (1035)
Q Consensus       496 ~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~ls~N~l~~~  574 (1035)
                      +|+|+ .+|                         ..+..+++|++|+|++|+|++.+ ..|..+++|+.|+|++|+|++.
T Consensus       121 ~N~l~-~lp-------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          121 CNKLT-ELP-------------------------RGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             SSCCC-SCC-------------------------TTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             CCccc-ccC-------------------------cccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence            66665 333                         33344455555555555555544 2355566666666666666655


Q ss_pred             CC
Q 039419          575 LP  576 (1035)
Q Consensus       575 ~p  576 (1035)
                      ++
T Consensus       175 c~  176 (229)
T 3e6j_A          175 CR  176 (229)
T ss_dssp             BG
T ss_pred             cc
Confidence            54

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=3.8e-18  Score=182.67  Aligned_cols=150  Identities=19%  Similarity=0.178  Sum_probs=107.1

Q ss_pred             cccCCeeeeeCCcEEEEEEE-CCCcE--EEEEEecCCCcccccc---cccc-cc------cccccHHHHHHHHHHHhcCC
Q 039419          688 LVEDSVVGKGCSGIVYRAEM-ENGEV--IAVKKLWPTTMAAEYD---CQND-KI------GIGGVRDSFSAEIKTLGSIR  754 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~~~~---~~~~-~~------~~~~~~~~~~~E~~~l~~l~  754 (1035)
                      |...+.||+|+||.||+|.+ .+|+.  ||||++..........   ...+ ..      ........+.+|+.+++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            55678999999999999987 67888  9999976542111000   0000 00      00012346889999999998


Q ss_pred             CCce--eeEEeEEEcCCcceEEEEeCCC-C----ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhh-ccCCCCeeccC
Q 039419          755 HKNI--VRFLGCCWNRNTRLLMYDYMPN-G----SLGSLLHERRDSCLEWELRYRIILGAAQGLAYLH-HDCVPPIVHRD  826 (1035)
Q Consensus       755 hpni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~ivHrD  826 (1035)
                      |+++  +.++++    +..++||||+.+ |    +|.++...     .++..+..++.|++.|+.||| +.   ||+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence            8754  444443    367899999942 4    66665432     123456789999999999999 88   999999


Q ss_pred             CCcccEEEcCCCceEEeeccCcccc
Q 039419          827 IKANNILIGPEFEPYIADFGLAKLV  851 (1035)
Q Consensus       827 ikp~NIll~~~~~~kl~DFG~a~~~  851 (1035)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  8999999999754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.73  E-value=2.7e-18  Score=184.45  Aligned_cols=171  Identities=22%  Similarity=0.339  Sum_probs=112.1

Q ss_pred             cccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCcccee
Q 039419          245 KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQL  324 (1035)
Q Consensus       245 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  324 (1035)
                      .+.++..+++++|.+.+..  .+..+++|+.|++++|.|+. ++ .+..+++|++|+|++|+|++..+  |..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            5677788888888887433  57778888888888888874 44 57788888888888888876544  7777777777


Q ss_pred             ccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcce
Q 039419          325 QLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI  404 (1035)
Q Consensus       325 ~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  404 (1035)
                      +|++|+|+.+           |. +.. ++|+.|+|++|++++.  +.+..+++|++|++++|+|++..           
T Consensus        91 ~L~~N~l~~l-----------~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~-----------  144 (263)
T 1xeu_A           91 SVNRNRLKNL-----------NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV-----------  144 (263)
T ss_dssp             ECCSSCCSCC-----------TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG-----------
T ss_pred             ECCCCccCCc-----------Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh-----------
Confidence            7777776632           21 222 6677777777777642  24556666666666666665431           


Q ss_pred             eEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCC
Q 039419          405 RLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGL  454 (1035)
Q Consensus       405 ~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~  454 (1035)
                           .+..+++|++|+|++|+|++.  ..+..+++|+.|++++|++...
T Consensus       145 -----~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          145 -----MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             -----GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             -----HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence                 133345566666666666644  4555666666666666666544

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.73  E-value=1.1e-17  Score=188.95  Aligned_cols=163  Identities=28%  Similarity=0.265  Sum_probs=77.2

Q ss_pred             cEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCccc-CCCccceeccccchhhhhhhhccccCCCCCcCCCCC
Q 039419          274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLS-NATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC  352 (1035)
Q Consensus       274 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l  352 (1035)
                      +.+++++|.++ .+|..+.  +.++.|+|++|+|++..+..|. ++++|++|+|++|+|+.+          .+..|.++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i----------~~~~~~~l   87 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFI----------SSEAFVPV   87 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEE----------CTTTTTTC
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCcc----------ChhhccCC
Confidence            35566666665 3443332  3355666666666555444444 445555555554444321          12345555


Q ss_pred             CCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc
Q 039419          353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP  432 (1035)
Q Consensus       353 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~  432 (1035)
                      ++|++|+|++|+|+...+..|..+++|++|+|++|+|++..|..|.              ++++|++|+|++|+|++..+
T Consensus        88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--------------~l~~L~~L~L~~N~l~~l~~  153 (361)
T 2xot_A           88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFE--------------DMAQLQKLYLSQNQISRFPV  153 (361)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT--------------TCTTCCEEECCSSCCCSCCG
T ss_pred             CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhC--------------CcccCCEEECCCCcCCeeCH
Confidence            5555555555555544444444455555555555554443333322              22334555555555553333


Q ss_pred             ccc---cCCCCccEEEcCCCccCCCCchhccCcc
Q 039419          433 SSL---ASLTRLQVLDISVNQFVGLIPESFGQLA  463 (1035)
Q Consensus       433 ~~l---~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  463 (1035)
                      ..|   ..+++|+.|+|++|+|+.+.+..|..++
T Consensus       154 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~  187 (361)
T 2xot_A          154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLP  187 (361)
T ss_dssp             GGTC----CTTCCEEECCSSCCCCCCHHHHHHSC
T ss_pred             HHhcCcccCCcCCEEECCCCCCCccCHHHhhhcc
Confidence            333   3345555555555555544444444433

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.71  E-value=4.3e-18  Score=209.11  Aligned_cols=151  Identities=23%  Similarity=0.310  Sum_probs=99.5

Q ss_pred             CCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEE
Q 039419          414 CTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLD  493 (1035)
Q Consensus       414 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  493 (1035)
                      +++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+ .+|..|..+++|++|+|++|.|+ .+|..|+.+++|++|+
T Consensus       246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~  322 (727)
T 4b8c_D          246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLG  322 (727)
T ss_dssp             CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEE
T ss_pred             CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEe
Confidence            455777888888888 67788889999999999999999 55888999999999999999997 6788899999999999


Q ss_pred             cCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCC--------cccCcc-ccccccCCCcEE
Q 039419          494 LSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHN--------KLGGDL-LALSGLDNLVSL  564 (1035)
Q Consensus       494 Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N--------~l~~~~-~~~~~l~~L~~L  564 (1035)
                      |++|+|++.+|..++........++|++|.+++.+|.      .|+.|++++|        .|.... ..+..+..+...
T Consensus       323 L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~  396 (727)
T 4b8c_D          323 VEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFT  396 (727)
T ss_dssp             CTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C------------------------------------
T ss_pred             CCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecccccccccCCccccccchhhccccccee
Confidence            9999999888888876655445688999999988875      4667778877        222211 234445555556


Q ss_pred             eccCCcCcc
Q 039419          565 NVSYNNFTG  573 (1035)
Q Consensus       565 ~ls~N~l~~  573 (1035)
                      .+++|-+.+
T Consensus       397 ~ls~Nil~~  405 (727)
T 4b8c_D          397 VLSYNTLCQ  405 (727)
T ss_dssp             -----CCCG
T ss_pred             eeecccccc
Confidence            666666543

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.70  E-value=6.5e-18  Score=181.44  Aligned_cols=170  Identities=18%  Similarity=0.250  Sum_probs=105.8

Q ss_pred             ccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEE
Q 039419          197 KLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTI  276 (1035)
Q Consensus       197 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  276 (1035)
                      .+.++..++++++.++ .++ .+..+++|+.|++++|.++ .++ .+..+++|++|++++|++++..+  +..+++|+.|
T Consensus        17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            4666777777777776 333 5667777777777777777 344 56667777777777777664333  6667777777


Q ss_pred             EccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCc
Q 039419          277 DLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLE  356 (1035)
Q Consensus       277 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~  356 (1035)
                      +|++|++++. +. +.. ++|++|+|++|++++.  ..+..+++|+.|+|++|+|+.+            ..+..+++|+
T Consensus        91 ~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~------------~~l~~l~~L~  153 (263)
T 1xeu_A           91 SVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI------------VMLGFLSKLE  153 (263)
T ss_dssp             ECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC------------GGGGGCTTCC
T ss_pred             ECCCCccCCc-Cc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC------------hHHccCCCCC
Confidence            7777777643 32 222 6677777777776643  2356666666666666665532            2455566666


Q ss_pred             EEeccCcCCCCCCCCCcccCcccceEecccccccc
Q 039419          357 AVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISG  391 (1035)
Q Consensus       357 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~  391 (1035)
                      .|+|++|++++.  ..+..+++|+.|++++|++++
T Consensus       154 ~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          154 VLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             EEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred             EEECCCCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence            666666666643  445556666666666666554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.69  E-value=2.5e-17  Score=168.75  Aligned_cols=107  Identities=15%  Similarity=0.253  Sum_probs=46.1

Q ss_pred             cccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcE
Q 039419          196 GKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKT  275 (1035)
Q Consensus       196 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~  275 (1035)
                      +.+++|++|++++|.++ .+| .+..+++|+.|++++|.++.  +..+..+++|++|++++|++++..+..+..+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            33444444444444444 333 34444455555555543331  123344444444444444444333444444444444


Q ss_pred             EEccCccCCCCCCccccCCCCCcEEEccCCc
Q 039419          276 IDLSLNFFSGSLPQSFGNLSSLEELMLSNNN  306 (1035)
Q Consensus       276 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  306 (1035)
                      |+|++|++++..+..|+.+++|++|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            4444444443333444444444444444443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.69  E-value=4.9e-17  Score=165.71  Aligned_cols=157  Identities=21%  Similarity=0.273  Sum_probs=81.9

Q ss_pred             ccceeecCCCccCCCCcc-cccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEc
Q 039419          416 QLQMLNLSNNTLGGTLPS-SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL  494 (1035)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  494 (1035)
                      +|++|+|++|+|++..+. .|..+++|++|+|++|+|+++.|..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            355555555555544433 3555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCccc
Q 039419          495 SSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGY  574 (1035)
Q Consensus       495 s~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~  574 (1035)
                      ++|+|+                         +..|..|..+++|++|+|++|+++++....+-...|+...+.++...+.
T Consensus       110 ~~N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~  164 (192)
T 1w8a_A          110 YDNQIS-------------------------CVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             CSSCCC-------------------------EECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred             CCCcCC-------------------------eeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence            555554                         2334455566677777777777766543211111223333444444443


Q ss_pred             CCChhhhhccccccccccccCCCCC
Q 039419          575 LPDSKLFRQLSATEMAGNQGLCSRG  599 (1035)
Q Consensus       575 ~p~~~~~~~l~~~~~~~N~~~c~~~  599 (1035)
                      .|.  .++.....++..+...|..+
T Consensus       165 ~P~--~l~~~~l~~l~~~~~~C~~~  187 (192)
T 1w8a_A          165 APS--KVRDVQIKDLPHSEFKCSSE  187 (192)
T ss_dssp             SST--TTTTSBGGGSCTTTCCCCCC
T ss_pred             CCh--HHcCCChhhCcHhhcCcCCC
Confidence            333  23444444455555555543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.69  E-value=3.5e-17  Score=167.72  Aligned_cols=155  Identities=15%  Similarity=0.201  Sum_probs=103.3

Q ss_pred             ccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCC
Q 039419          218 QIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSL  297 (1035)
Q Consensus       218 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  297 (1035)
                      ....+++|+.|++++|.++ .+| .+..+++|++|++++|.+..  +..+..+++|++|++++|++++..+..|+.+++|
T Consensus        39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L  114 (197)
T 4ezg_A           39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL  114 (197)
T ss_dssp             BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred             ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence            3466778888888888887 455 57777777777777776552  3357777777777777777776666777777777


Q ss_pred             cEEEccCCccccCCCCcccCCCccceeccccch-hhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccC
Q 039419          298 EELMLSNNNISGSIPPVLSNATSLLQLQLDTNQ-ISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQL  376 (1035)
Q Consensus       298 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l  376 (1035)
                      ++|++++|++++..+..|..+++|++|++++|+ ++.           +| .+..+++|+.|++++|.+++. + .+..+
T Consensus       115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-----------~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l  180 (197)
T 4ezg_A          115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-----------IM-PLKTLPELKSLNIQFDGVHDY-R-GIEDF  180 (197)
T ss_dssp             CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-----------CG-GGGGCSSCCEEECTTBCCCCC-T-TGGGC
T ss_pred             CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-----------cH-hhcCCCCCCEEECCCCCCcCh-H-HhccC
Confidence            777777777776566666667777777777665 542           22 456666666666666666642 2 55566


Q ss_pred             cccceEeccccccc
Q 039419          377 QNLTKLLLISNGIS  390 (1035)
Q Consensus       377 ~~L~~L~L~~N~i~  390 (1035)
                      ++|++|++++|+|.
T Consensus       181 ~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          181 PKLNQLYAFSQTIG  194 (197)
T ss_dssp             SSCCEEEECBC---
T ss_pred             CCCCEEEeeCcccC
Confidence            66666666666654

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.67  E-value=2.9e-17  Score=183.09  Aligned_cols=200  Identities=12%  Similarity=0.102  Sum_probs=107.3

Q ss_pred             CCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCC
Q 039419          270 CKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTL  349 (1035)
Q Consensus       270 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l  349 (1035)
                      +++|+.|+|.+ .++.+...+|.++++|+.|++++|.+..+.+.+|.++.++..+.+..+....      .....-..+|
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~------~~~~i~~~~f  172 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYR------FKNRWEHFAF  172 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHH------TSTTTTTSCE
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhh------cccccccccc
Confidence            66666666666 5555555556666666666666666655555666665555555554432210      0000111233


Q ss_pred             CCCCCCc--------------------------EEeccCcCCCCCCCCCcc-cCcccceEeccccccccCCCCCCCCCCc
Q 039419          350 ANCRSLE--------------------------AVDLSHNALTGSLHPGLF-QLQNLTKLLLISNGISGLIPPEIGNCSS  402 (1035)
Q Consensus       350 ~~l~~L~--------------------------~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~  402 (1035)
                      .++.+|+                          .+.+.++-.. .....+. .+++|+.|+|++|+++.+.+..      
T Consensus       173 ~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~a------  245 (329)
T 3sb4_A          173 IEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFT------  245 (329)
T ss_dssp             EESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTT------
T ss_pred             ccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhh------
Confidence            3444444                          3333322111 0000111 2566666666666665443333      


Q ss_pred             ceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCcc-EEEcCCCccCCCCchhccCccccchhhccCCcccccCcc
Q 039419          403 LIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQ-VLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPS  481 (1035)
Q Consensus       403 L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  481 (1035)
                              |.++++|+.|+|.+| ++.+.+.+|.++++|+ .|++.+ .++.+.+.+|.++++|+.|++++|+++.+.+.
T Consensus       246 --------F~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~  315 (329)
T 3sb4_A          246 --------FAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDE  315 (329)
T ss_dssp             --------TTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTT
T ss_pred             --------hhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchh
Confidence                    344455666666666 5555566666666676 677666 56656666677777777777766666666666


Q ss_pred             ccCCCCCCcEEE
Q 039419          482 SLGRCESLQSLD  493 (1035)
Q Consensus       482 ~~~~l~~L~~L~  493 (1035)
                      +|.++++|+.|+
T Consensus       316 aF~~~~~L~~ly  327 (329)
T 3sb4_A          316 LFGNGVPSKLIY  327 (329)
T ss_dssp             TTCTTCCCCEEE
T ss_pred             hhcCCcchhhhc
Confidence            666666666665

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=1.7e-17  Score=183.48  Aligned_cols=147  Identities=14%  Similarity=0.080  Sum_probs=102.5

Q ss_pred             cccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccc-ccccccccc-------ccHHHHHHHHHHHhcCCCCcee
Q 039419          688 LVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYD-CQNDKIGIG-------GVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~~~-------~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      |.+.+.||+|+||.||+|...+|+.||||+++......... ...+.....       ..+-...+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            78889999999999999999999999999986542211100 000000000       0111224577777777555442


Q ss_pred             --eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          760 --RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       760 --~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                        +.++.    ...++||||++|++|.++...        .....++.|++.+|.|+|+.   |||||||||.|||++++
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREE  241 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEE
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCC
Confidence              22322    234799999999888765422        12356889999999999998   99999999999999887


Q ss_pred             C----------ceEEeeccCcc
Q 039419          838 F----------EPYIADFGLAK  849 (1035)
Q Consensus       838 ~----------~~kl~DFG~a~  849 (1035)
                      +          .+.|+||+-+-
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCE
T ss_pred             CCcccccccccceEEEEeCCcc
Confidence            6          38999999764

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.66  E-value=2.3e-16  Score=160.75  Aligned_cols=135  Identities=27%  Similarity=0.363  Sum_probs=114.7

Q ss_pred             cEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccc
Q 039419          356 EAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL  435 (1035)
Q Consensus       356 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  435 (1035)
                      +.+++++|.++ .+|..+..  +|++|++++|+|++..+..             .|.++++|++|+|++|+|++..|..|
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~-------------~~~~l~~L~~L~Ls~N~l~~~~~~~~   74 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDG-------------LFGRLPHLVKLELKRNQLTGIEPNAF   74 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSC-------------SGGGCTTCCEEECCSSCCCCBCTTTT
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCcc-------------ccccCCCCCEEECCCCCCCCcCHhHc
Confidence            67888888887 45555443  8888999999888765542             14456779999999999998889999


Q ss_pred             cCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchh
Q 039419          436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVE  506 (1035)
Q Consensus       436 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  506 (1035)
                      .++++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|.+++..+..
T Consensus        75 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~  145 (192)
T 1w8a_A           75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA  145 (192)
T ss_dssp             TTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH
T ss_pred             CCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcch
Confidence            99999999999999999998888999999999999999999999999999999999999999999776643

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.64  E-value=5.5e-17  Score=180.77  Aligned_cols=252  Identities=15%  Similarity=0.166  Sum_probs=168.7

Q ss_pred             cccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhc--------ccchhHhhcccccccccCCccccC
Q 039419          198 LSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGK--------LQKLEKMLLWQNNFDGAIPEEIGN  269 (1035)
Q Consensus       198 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~--------l~~L~~L~l~~n~l~~~~p~~~~~  269 (1035)
                      +++|+.|+|++|++. .....-+.++.+..+.+..|.|.   +..|.+        +++|++|+|.+ +++...+.+|.+
T Consensus        48 l~~L~~LdLs~n~i~-~~~~~~~~~~~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~  122 (329)
T 3sb4_A           48 FPSLKVLDISNAEIK-MYSGKAGTYPNGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKG  122 (329)
T ss_dssp             CTTCCEEEEEEEEEC-CEEESSSSSGGGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTT
T ss_pred             hccCeEEecCcceeE-EecCccccccccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHhhc
Confidence            667777777777776 11111112223455555555433   345666        78888888877 777666777888


Q ss_pred             CCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCcc----ccCCCCcccCCCccc-eeccccch-hhhhhhh----cc
Q 039419          270 CKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNI----SGSIPPVLSNATSLL-QLQLDTNQ-ISVFFAW----QN  339 (1035)
Q Consensus       270 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l----~~~~~~~~~~l~~L~-~L~L~~N~-i~~l~~~----~n  339 (1035)
                      +++|+.|++++|.+..+.+.+|.++.++..+.+..+..    .......|.++..|+ .+.+.... +......    .+
T Consensus       123 ~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~  202 (329)
T 3sb4_A          123 CDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPR  202 (329)
T ss_dssp             CTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGG
T ss_pred             CcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCcc
Confidence            88888888888888777777888777777777665322    223444555555555 22222110 0000000    00


Q ss_pred             -----ccCCCC----CcCC-CCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeee
Q 039419          340 -----KLEGSI----PSTL-ANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLM  409 (1035)
Q Consensus       340 -----~l~~~~----p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~  409 (1035)
                           .+.+.+    ...+ ..+++|+.|+|++|+++.+....|.++.+|++|+|.+| ++.+.+.              
T Consensus       203 ~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~--------------  267 (329)
T 3sb4_A          203 DINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQR--------------  267 (329)
T ss_dssp             GCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTT--------------
T ss_pred             ccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHH--------------
Confidence                 000000    0011 13789999999999999777888999999999999998 6654444              


Q ss_pred             ccCCCCccc-eeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhc
Q 039419          410 SFGNCTQLQ-MLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLIL  470 (1035)
Q Consensus       410 ~~~~l~~L~-~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  470 (1035)
                      +|.++++|+ .|++.+ +++.+.+.+|.++++|+.|+++.|+++.+.+.+|.++++|+.++.
T Consensus       268 aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          268 VFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             TTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             HhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            466667798 999988 788788899999999999999999999999999999999998864

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.60  E-value=8e-15  Score=166.71  Aligned_cols=271  Identities=11%  Similarity=0.168  Sum_probs=197.6

Q ss_pred             cccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEE
Q 039419          198 LSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTID  277 (1035)
Q Consensus       198 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~  277 (1035)
                      ...++.+.+.++ ++..-..+|.++ +|+.+.+..+ ++.+....|.+ .+|+.+.+.. .+....+.+|.++++|+.++
T Consensus       112 ~~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          112 LKGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             CSSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred             cCCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence            355666666543 443445566664 6888888766 66566666766 4688887765 66666677888888888888


Q ss_pred             ccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcE
Q 039419          278 LSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEA  357 (1035)
Q Consensus       278 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~  357 (1035)
                      |.+|+++.+....|. ..+|+.+.|.++ +..+...+|.++++|+.+++..| ++.+.          ..+|.+ .+|+.
T Consensus       187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~----------~~aF~~-~~L~~  252 (401)
T 4fdw_A          187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIG----------QEAFRE-SGITT  252 (401)
T ss_dssp             CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEEC----------TTTTTT-CCCSE
T ss_pred             cCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcc----------cccccc-CCccE
Confidence            888888866666776 578888888744 77677788888888888888764 44332          256666 67888


Q ss_pred             EeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccC
Q 039419          358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLAS  437 (1035)
Q Consensus       358 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~  437 (1035)
                      ++| .+.++.+....|.++++|+.+.+.+|.+...         .+..+....|.++++|+.++|. |.++.+...+|.+
T Consensus       253 i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~---------~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~  321 (401)
T 4fdw_A          253 VKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDD---------PEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGG  321 (401)
T ss_dssp             EEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCC---------TTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTT
T ss_pred             EEe-CCCccEEChhHhhCCCCCCEEEeCCccccCC---------cccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcC
Confidence            888 4556656677888888888888888776511         1123344467788888888888 4577677788888


Q ss_pred             CCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCC-CCcEEEcCCCcCc
Q 039419          438 LTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCE-SLQSLDLSSNKLS  500 (1035)
Q Consensus       438 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~  500 (1035)
                      +++|+.++|..| ++.+...+|.++ +|+.|++++|.+....+..|..++ +++.|++..|.+.
T Consensus       322 c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          322 NRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             CCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            899999999655 777778888888 899999999988877777788774 7888888877654

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.59  E-value=3.1e-15  Score=152.22  Aligned_cols=128  Identities=26%  Similarity=0.302  Sum_probs=69.6

Q ss_pred             eeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCc
Q 039419          419 MLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK  498 (1035)
Q Consensus       419 ~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  498 (1035)
                      .+++++|+++ .+|..+.  ++|++|+|++|+|+. +|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4555555555 2333322  355666666666653 33555556666666666666655555556666666666666655


Q ss_pred             CcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccc-cccccCCCcEEeccCCcCcccC
Q 039419          499 LSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL-ALSGLDNLVSLNVSYNNFTGYL  575 (1035)
Q Consensus       499 l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~ls~N~l~~~~  575 (1035)
                      |++                         +.+..|..+++|++|+|++|+|+..+. .|..+++|+.|+|++|+|.+..
T Consensus        90 l~~-------------------------i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A           90 LRC-------------------------IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             CCB-------------------------CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             cCE-------------------------eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence            552                         223334445555555555555555443 3555666666666666665533

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.59  E-value=1.5e-15  Score=151.22  Aligned_cols=134  Identities=22%  Similarity=0.217  Sum_probs=82.8

Q ss_pred             CccceeecCCCccC-CCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEE
Q 039419          415 TQLQMLNLSNNTLG-GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLD  493 (1035)
Q Consensus       415 ~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  493 (1035)
                      ++|++|+|++|+++ +.+|..+..+++|++|+|++|++++.  ..|..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            34555555555555 34455555555566666666655544  4455555555555555555544555455555555555


Q ss_pred             cCCCcCcCccchhhhhhccCcceeeccCccCCCCC-CccccCCccccEEeccCCcccCccc----cccccCCCcEEeccC
Q 039419          494 LSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAI-PPQISALNKLSILDLSHNKLGGDLL----ALSGLDNLVSLNVSY  568 (1035)
Q Consensus       494 Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~ls~  568 (1035)
                      |++|+|+                         +.. +..+..+++|++|+|++|++++.+.    .+..+++|+.|++++
T Consensus       102 Ls~N~l~-------------------------~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~  156 (168)
T 2ell_A          102 LSGNKLK-------------------------DISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYD  156 (168)
T ss_dssp             CBSSSCC-------------------------SSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEE
T ss_pred             ccCCccC-------------------------cchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCC
Confidence            5555554                         221 1456677888888888888887765    677888888888888


Q ss_pred             CcCcccC
Q 039419          569 NNFTGYL  575 (1035)
Q Consensus       569 N~l~~~~  575 (1035)
                      |.+...+
T Consensus       157 n~~~~~~  163 (168)
T 2ell_A          157 REDQEAP  163 (168)
T ss_dssp             TTSCBCC
T ss_pred             CChhhcc
Confidence            8877543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.56  E-value=5.4e-15  Score=147.11  Aligned_cols=131  Identities=21%  Similarity=0.175  Sum_probs=58.6

Q ss_pred             ceEEEEecccccc-ccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhc
Q 039419          176 SLLVVGLADTKVA-GSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLL  254 (1035)
Q Consensus       176 ~L~~L~l~~~~~~-~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l  254 (1035)
                      +|+.|++++|.+. +.+|..+..+++|++|++++|.+++.  ..+..+++|+.|+|++|.+++.+|..+..+++|+.|++
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            3444444444443 34444445555555555555555432  44445555555555555555434444444444444444


Q ss_pred             ccccccccC-CccccCCCCCcEEEccCccCCCCCC---ccccCCCCCcEEEccCCccc
Q 039419          255 WQNNFDGAI-PEEIGNCKSLKTIDLSLNFFSGSLP---QSFGNLSSLEELMLSNNNIS  308 (1035)
Q Consensus       255 ~~n~l~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~N~l~  308 (1035)
                      ++|++++.. +..+..+++|+.|++++|.+++..+   ..|..+++|++|++++|.+.
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            444444321 1334444444444444444443222   23444444444444444443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.55  E-value=3.7e-14  Score=161.26  Aligned_cols=128  Identities=11%  Similarity=0.114  Sum_probs=65.8

Q ss_pred             ccceeecCCCccCCCCcccccCCCCccEEEcCCCccC-----CCCchhccCccccchhhccCCcccccCccccCCCCCCc
Q 039419          416 QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFV-----GLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQ  490 (1035)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  490 (1035)
                      +|+.+.| .|.++.+...+|.++++|+.+++.+|.+.     .+.+.+|.++++|+.++|. |.++.+...+|.++++|+
T Consensus       249 ~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~  326 (401)
T 4fdw_A          249 GITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT  326 (401)
T ss_dssp             CCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred             CccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence            3444444 22333334444555555555555444433     2344455555555555555 234444445555555555


Q ss_pred             EEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcc-ccccccC-CCcEEeccC
Q 039419          491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LALSGLD-NLVSLNVSY  568 (1035)
Q Consensus       491 ~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~-~L~~L~ls~  568 (1035)
                      .|+|..| ++                         .+.+.+|.++ +|+.|++++|.+.... ..|.+++ +++.|++..
T Consensus       327 ~l~lp~~-l~-------------------------~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~  379 (401)
T 4fdw_A          327 QLTIPAN-VT-------------------------QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPA  379 (401)
T ss_dssp             EEEECTT-CC-------------------------EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECG
T ss_pred             EEEECcc-cc-------------------------EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCH
Confidence            5555333 22                         2344556666 6777777777665533 4566663 567777776


Q ss_pred             CcCc
Q 039419          569 NNFT  572 (1035)
Q Consensus       569 N~l~  572 (1035)
                      |.+.
T Consensus       380 ~~~~  383 (401)
T 4fdw_A          380 ESVE  383 (401)
T ss_dssp             GGHH
T ss_pred             HHHH
Confidence            6554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.55  E-value=5e-15  Score=144.08  Aligned_cols=128  Identities=23%  Similarity=0.303  Sum_probs=81.3

Q ss_pred             CccceeecCCCccC-CCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEE
Q 039419          415 TQLQMLNLSNNTLG-GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLD  493 (1035)
Q Consensus       415 ~~L~~L~L~~N~l~-~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  493 (1035)
                      ++|+.|++++|+++ +.+|..+..+++|++|++++|++++.  ..|..+++|++|++++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45666666666666 45566666666777777777766655  5566666666666666666655566555666666666


Q ss_pred             cCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccc----cccccCCCcEEeccC
Q 039419          494 LSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL----ALSGLDNLVSLNVSY  568 (1035)
Q Consensus       494 Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~ls~  568 (1035)
                      |++|++++ +|                       .+..+..+++|++|+|++|++++.+.    .+..+++|+.|++++
T Consensus        95 ls~N~i~~-~~-----------------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           95 LSGNKIKD-LS-----------------------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CTTSCCCS-HH-----------------------HHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCCcCCC-hH-----------------------HHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            66666652 11                       12345556677777777777766554    566777777777653

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.54  E-value=1.4e-14  Score=147.33  Aligned_cols=125  Identities=25%  Similarity=0.345  Sum_probs=63.5

Q ss_pred             ceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCcc
Q 039419          203 SLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNF  282 (1035)
Q Consensus       203 ~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~  282 (1035)
                      .+++++|.++ .+|..+.  ++|+.|+|++|.++ .+|..|..+++|+.|+|++|++++..+..|.++++|++|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            4445555554 4444332  35555555555555 344455555555555555555554444455555555555555555


Q ss_pred             CCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchh
Q 039419          283 FSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI  331 (1035)
Q Consensus       283 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i  331 (1035)
                      |++..+..|.++++|++|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~  138 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL  138 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCE
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCe
Confidence            5554444555555555555555555544444444444444444444443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.54  E-value=3.7e-14  Score=142.38  Aligned_cols=133  Identities=26%  Similarity=0.316  Sum_probs=107.9

Q ss_pred             CcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCccc
Q 039419          355 LEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSS  434 (1035)
Q Consensus       355 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~  434 (1035)
                      .+.+++++|.++. +|..+  .++|++|++++|++++..+..+.              ++++|++|+|++|+|++..+..
T Consensus         9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~--------------~l~~L~~L~l~~n~l~~~~~~~   71 (177)
T 2o6r_A            9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFD--------------KLTQLTKLSLSQNQIQSLPDGV   71 (177)
T ss_dssp             TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTT--------------TCTTCSEEECCSSCCCCCCTTT
T ss_pred             CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhc--------------CcccccEEECCCCcceEeChhH
Confidence            4678888888873 34333  26788888888888866555443              4466888999999998777777


Q ss_pred             ccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccc
Q 039419          435 LASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIP  504 (1035)
Q Consensus       435 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  504 (1035)
                      |..+++|++|+|++|+|++.++..|..+++|+.|++++|+|++..+..|..+++|++|+|++|.+.+..|
T Consensus        72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            8899999999999999998888888999999999999999997777778889999999999999986655

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.52  E-value=4.2e-15  Score=149.12  Aligned_cols=134  Identities=17%  Similarity=0.201  Sum_probs=80.5

Q ss_pred             CCCCccceeecCCCccCCCCcccccCCC-CccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCc
Q 039419          412 GNCTQLQMLNLSNNTLGGTLPSSLASLT-RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQ  490 (1035)
Q Consensus       412 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  490 (1035)
                      .++.+|++|+|++|+++.. +. +..+. +|++|+|++|+|+++  ..|..+++|++|+|++|+|++..+..|..+++|+
T Consensus        16 ~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   91 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   91 (176)
T ss_dssp             ECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             CCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence            3445566666666666632 32 33333 666666666666654  4555666666666666666644434445666666


Q ss_pred             EEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccc----cccccCCCcEEec
Q 039419          491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL----ALSGLDNLVSLNV  566 (1035)
Q Consensus       491 ~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~l  566 (1035)
                      +|+|++|+|+ .+|.                       ...+..+++|+.|+|++|++...+.    .+..+++|+.|++
T Consensus        92 ~L~L~~N~i~-~~~~-----------------------~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~  147 (176)
T 1a9n_A           92 ELILTNNSLV-ELGD-----------------------LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  147 (176)
T ss_dssp             EEECCSCCCC-CGGG-----------------------GGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             EEECCCCcCC-cchh-----------------------hHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCC
Confidence            6666666664 2221                       0145566777777777777776654    3777788888888


Q ss_pred             cCCcCcc
Q 039419          567 SYNNFTG  573 (1035)
Q Consensus       567 s~N~l~~  573 (1035)
                      ++|.+..
T Consensus       148 ~~n~~~~  154 (176)
T 1a9n_A          148 QKVKLKE  154 (176)
T ss_dssp             EECCHHH
T ss_pred             CcCCHHH
Confidence            8887654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.51  E-value=2e-14  Score=139.73  Aligned_cols=124  Identities=21%  Similarity=0.203  Sum_probs=62.4

Q ss_pred             EEEEEecCCccc-ccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEec
Q 039419           32 VTEINIQSIELE-LPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILN  110 (1035)
Q Consensus        32 v~~l~~~~~~~~-~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~  110 (1035)
                      ++.|+++++++. +.+|..+..+++|++|+|++|.+++.  +.++.+++|++|+|++|.+++.+|..++.+++|++|+|+
T Consensus        19 l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls   96 (149)
T 2je0_A           19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS   96 (149)
T ss_dssp             CSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred             CeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence            445555555554 44555555555555555555555532  445555555555555555554455544455555555555


Q ss_pred             ccCCCCC-CchhhhhhccccceeccccccCCCCc---hhhccccccceeec
Q 039419          111 SNQLTGE-IPKELGACIKLKNLLLFDNYLSGNLP---VELGKLVNLEVIRA  157 (1035)
Q Consensus       111 ~n~l~~~-~p~~l~~l~~L~~L~l~~n~l~~~~p---~~l~~l~~L~~L~l  157 (1035)
                      +|++++. .|..+..+++|++|++++|.+++..+   ..++.+++|++|++
T Consensus        97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l  147 (149)
T 2je0_A           97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG  147 (149)
T ss_dssp             TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred             CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence            5555521 12445555555555555555543322   24455555555544

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.50  E-value=6.1e-14  Score=140.78  Aligned_cols=134  Identities=21%  Similarity=0.256  Sum_probs=90.9

Q ss_pred             cceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCC
Q 039419          417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSS  496 (1035)
Q Consensus       417 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  496 (1035)
                      .+.+++++|+++. +|..+.  ++|+.|++++|+++++.+..|..+++|++|++++|+|++..+..|..+++|++|+|++
T Consensus         9 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A            9 GTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TTEEECCSSCCSS-CCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCcc-CCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            4566777777763 333322  4677777777777766666677777777777777777766666667777777777777


Q ss_pred             CcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcccc-ccccCCCcEEeccCCcCcccC
Q 039419          497 NKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLA-LSGLDNLVSLNVSYNNFTGYL  575 (1035)
Q Consensus       497 N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~ls~N~l~~~~  575 (1035)
                      |+|++                         ..+..|..+++|++|+|++|++++.+.. +..+++|+.|++++|++++.+
T Consensus        86 N~l~~-------------------------~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           86 NKLQS-------------------------LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             SCCCC-------------------------CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             CCccc-------------------------cCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence            77662                         2333455667777777777777766643 566788888888888888766


Q ss_pred             CCh
Q 039419          576 PDS  578 (1035)
Q Consensus       576 p~~  578 (1035)
                      |..
T Consensus       141 ~~l  143 (177)
T 2o6r_A          141 PRI  143 (177)
T ss_dssp             HHH
T ss_pred             ccH
Confidence            643

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.50  E-value=2.5e-13  Score=155.10  Aligned_cols=329  Identities=16%  Similarity=0.141  Sum_probs=148.3

Q ss_pred             ccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCC
Q 039419          193 ASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKS  272 (1035)
Q Consensus       193 ~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~  272 (1035)
                      .+|.++++|+++.+..+ ++.....+|.++++|+.++|..+ ++.+....|.++.+|+.+.+..+ +......+|.+...
T Consensus        65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~  141 (394)
T 4fs7_A           65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF  141 (394)
T ss_dssp             TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred             HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence            34444444444444322 33233344455555555555433 33233344445555554444322 22233344444433


Q ss_pred             CcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCC
Q 039419          273 LKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC  352 (1035)
Q Consensus       273 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l  352 (1035)
                      +........  ......+|.++++|+.+.+.++. ..+....|.++.+|+.+.+..| ++.+          -..+|.++
T Consensus       142 ~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I----------~~~~F~~~  207 (394)
T 4fs7_A          142 KEITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKII----------RDYCFAEC  207 (394)
T ss_dssp             SEEECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEE----------CTTTTTTC
T ss_pred             cccccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEe----------Cchhhccc
Confidence            322222221  11233456666666666665443 2245555666666666666544 2222          12455666


Q ss_pred             CCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc
Q 039419          353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP  432 (1035)
Q Consensus       353 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~  432 (1035)
                      ..|+.+.+..+...  +...+....+|+.+.+..+ ++              .+....|.++..|+.+.+..+... +..
T Consensus       208 ~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~--------------~i~~~~f~~~~~l~~~~~~~~~~~-i~~  269 (394)
T 4fs7_A          208 ILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FT--------------ELGKSVFYGCTDLESISIQNNKLR-IGG  269 (394)
T ss_dssp             TTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CC--------------EECSSTTTTCSSCCEEEECCTTCE-ECS
T ss_pred             cccceeecCCCceE--eehhhcccCCCceEEECCC-ce--------------ecccccccccccceeEEcCCCcce-eec
Confidence            66666665554432  2233334455555554322 11              122223444455555555554333 444


Q ss_pred             ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhcc
Q 039419          433 SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEG  512 (1035)
Q Consensus       433 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  512 (1035)
                      ..|.....++.+.+..+.+.   ...|..+.+|+.+.+.++ ++.+...+|.++.+|+.++|.++ ++ .|+...|..-.
T Consensus       270 ~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~  343 (394)
T 4fs7_A          270 SLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCT  343 (394)
T ss_dssp             CTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCT
T ss_pred             cccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCC
Confidence            45555555555555544322   234555555555555443 43344455555555665555433 33 23222222111


Q ss_pred             CcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEE
Q 039419          513 LDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSL  564 (1035)
Q Consensus       513 l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L  564 (1035)
                      .+..+++..| ++.+...+|.++.+|+.++|..| ++....+|.++++|+.+
T Consensus       344 ~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          344 SLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LEQYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GGGGGGGBCTTCEEEEE
T ss_pred             CCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CEEhhheecCCCCCcEE
Confidence            1112333222 33334455666666666666543 33223455555555543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.48  E-value=3.2e-13  Score=154.29  Aligned_cols=269  Identities=16%  Similarity=0.105  Sum_probs=122.9

Q ss_pred             cCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchh
Q 039419           66 LTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVE  145 (1035)
Q Consensus        66 l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~  145 (1035)
                      ++.....+|.++++|+.+.|.. .++.....+|.++.+|+.++|..+ ++......+..+.+|+.+.+..+ +.......
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~a  135 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEA  135 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeeccee
Confidence            4433344566666677776653 344333445666666666666543 33223334555666665554433 11112222


Q ss_pred             hccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCC
Q 039419          146 LGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSEL  225 (1035)
Q Consensus       146 l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L  225 (1035)
                      |.....++.......                           ......+|.++++|+.+.+.++... .....|.++.+|
T Consensus       136 F~~~~~~~~~~~~~~---------------------------~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L  187 (394)
T 4fs7_A          136 FKGCDFKEITIPEGV---------------------------TVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKL  187 (394)
T ss_dssp             TTTCCCSEEECCTTC---------------------------CEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTC
T ss_pred             eecccccccccCccc---------------------------cccchhhhcccCCCcEEecCCccce-eccccccCCCCc
Confidence            322222111111111                           1112234555555555555443222 334445555555


Q ss_pred             ceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCC
Q 039419          226 VDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN  305 (1035)
Q Consensus       226 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  305 (1035)
                      +.+.+..| ++.+....|.+...|+.+.+..+...  +.+.+....+|+.+.+..+. +......|.++..|+.+.+..+
T Consensus       188 ~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~  263 (394)
T 4fs7_A          188 KSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNN  263 (394)
T ss_dssp             CBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCT
T ss_pred             eEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCC
Confidence            55555544 33233444555555555544433322  12223334556666554432 2234455666666666666555


Q ss_pred             ccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEec
Q 039419          306 NISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLL  384 (1035)
Q Consensus       306 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  384 (1035)
                      ... +....|.....++.+.+..+.|.             ..+|..+.+|+.+.+.++ ++.+....|.++.+|+.+.|
T Consensus       264 ~~~-i~~~~F~~~~~l~~~~~~~~~i~-------------~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~l  327 (394)
T 4fs7_A          264 KLR-IGGSLFYNCSGLKKVIYGSVIVP-------------EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDL  327 (394)
T ss_dssp             TCE-ECSCTTTTCTTCCEEEECSSEEC-------------TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECC
T ss_pred             cce-eeccccccccccceeccCceeec-------------cccccccccccccccccc-cceechhhhcCCCCCCEEEe
Confidence            433 44455555555555554443322             124455555555555433 33233334444444444444

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.45  E-value=3.8e-14  Score=142.06  Aligned_cols=134  Identities=14%  Similarity=0.142  Sum_probs=86.7

Q ss_pred             ccccccccceeecccccccCCccccccCc-CCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCC
Q 039419          195 LGKLSKLQSLSVYTTMLSGEIPPQIGNCS-ELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSL  273 (1035)
Q Consensus       195 l~~l~~L~~L~l~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L  273 (1035)
                      +.++++|++|++++|.++ .+|. +..+. +|+.|+|++|.+++.  ..|..+++|++|++++|++++..+..+..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            445666666666666666 3443 33433 677777777777643  456666777777777777765544545677777


Q ss_pred             cEEEccCccCCCCCCc--cccCCCCCcEEEccCCccccCCCC----cccCCCccceeccccchhhhh
Q 039419          274 KTIDLSLNFFSGSLPQ--SFGNLSSLEELMLSNNNISGSIPP----VLSNATSLLQLQLDTNQISVF  334 (1035)
Q Consensus       274 ~~L~L~~n~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~i~~l  334 (1035)
                      ++|+|++|+|+ .+|.  .+..+++|+.|++++|.+.. .|.    .+..+++|+.|++++|.+...
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~~  155 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKER  155 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence            77777777776 3444  66777777777777777763 343    366777777777777766543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.43  E-value=2e-15  Score=154.61  Aligned_cols=155  Identities=22%  Similarity=0.247  Sum_probs=106.4

Q ss_pred             CCCCcccceEeecCcccCCCCCC------CCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhh
Q 039419           50 LSSLSFLQKLIISGSNLTGPISP------DLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELG  123 (1035)
Q Consensus        50 ~~~l~~L~~L~L~~~~l~~~~~~------~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~  123 (1035)
                      +.....++.++++++.++|.+|.      .++.+++|++|+|++|++++ +| .+..+++|++|+|++|+++ .+|..+.
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~   90 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA   90 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred             HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence            34455667777777777777666      67777788888888887773 66 7777888888888888877 6777777


Q ss_pred             hhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCc-cccccccccc
Q 039419          124 ACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLP-ASLGKLSKLQ  202 (1035)
Q Consensus       124 ~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p-~~l~~l~~L~  202 (1035)
                      .+++|++|++++|++++ +| .++.+++|++|++++|.                         +.+..+ ..+..+++|+
T Consensus        91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~-------------------------i~~~~~~~~l~~l~~L~  143 (198)
T 1ds9_A           91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNK-------------------------ITNWGEIDKLAALDKLE  143 (198)
T ss_dssp             HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEE-------------------------CCCHHHHHHHTTTTTCS
T ss_pred             cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCc-------------------------CCchhHHHHHhcCCCCC
Confidence            77788888888887763 44 56666777766666664                         322111 3566677777


Q ss_pred             ceeecccccccCCccc----------cccCcCCceEEecCCcCC
Q 039419          203 SLSVYTTMLSGEIPPQ----------IGNCSELVDLFLYENDLS  236 (1035)
Q Consensus       203 ~L~l~~n~l~~~~p~~----------l~~l~~L~~L~L~~n~l~  236 (1035)
                      +|++++|.+.+..|..          +..+++|+.|+  +|.++
T Consensus       144 ~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             EEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            7777777776554442          67778888776  56555

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.41  E-value=6.1e-15  Score=151.08  Aligned_cols=153  Identities=21%  Similarity=0.254  Sum_probs=112.8

Q ss_pred             CCCCCceeeCCCCCCCCCCCh------hhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccc
Q 039419           76 DCTQLTTIDVSSNSLVGGVPS------SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKL  149 (1035)
Q Consensus        76 ~l~~L~~L~ls~n~l~~~~p~------~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l  149 (1035)
                      ....++.++++.+.+.+.+|.      .++.+++|++|+|++|++++ +| .+..+++|++|++++|.++ .+|..+..+
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~   92 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA   92 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence            345666677777766666665      77777788888888877774 66 7777777888888777776 566666655


Q ss_pred             cccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCc-cccccCcCCceE
Q 039419          150 VNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIP-PQIGNCSELVDL  228 (1035)
Q Consensus       150 ~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L  228 (1035)
                      ++|++|++++|                         ++.+ +| .+..+++|++|++++|.+++..+ ..+..+++|+.|
T Consensus        93 ~~L~~L~L~~N-------------------------~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L  145 (198)
T 1ds9_A           93 DTLEELWISYN-------------------------QIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDL  145 (198)
T ss_dssp             HHCSEEEEEEE-------------------------ECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEE
T ss_pred             CcCCEEECcCC-------------------------cCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEE
Confidence            66666655555                         4543 34 68899999999999999984322 478999999999


Q ss_pred             EecCCcCCCCCCh----------hhhcccchhHhhccccccc
Q 039419          229 FLYENDLSGSLPR----------ELGKLQKLEKMLLWQNNFD  260 (1035)
Q Consensus       229 ~L~~n~l~~~~~~----------~l~~l~~L~~L~l~~n~l~  260 (1035)
                      ++++|.+++..|.          .+..+++|+.|+  +|.++
T Consensus       146 ~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          146 LLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             EecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            9999999866554          378899999886  56655

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.39  E-value=9.6e-13  Score=130.78  Aligned_cols=81  Identities=28%  Similarity=0.399  Sum_probs=48.7

Q ss_pred             cceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCC
Q 039419          417 LQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSS  496 (1035)
Q Consensus       417 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  496 (1035)
                      .+.|++++|+++. +|..+.  ++|++|+|++|+|+++.|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            4556666666663 444332  5666666666666666666666666666666666666655555556666666666666


Q ss_pred             CcCc
Q 039419          497 NKLS  500 (1035)
Q Consensus       497 N~l~  500 (1035)
                      |+|+
T Consensus        88 N~l~   91 (170)
T 3g39_A           88 NQLK   91 (170)
T ss_dssp             SCCC
T ss_pred             CccC
Confidence            6555

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.36  E-value=1.7e-12  Score=129.48  Aligned_cols=80  Identities=28%  Similarity=0.428  Sum_probs=47.5

Q ss_pred             ceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCC
Q 039419          418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN  497 (1035)
Q Consensus       418 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  497 (1035)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++++|..|..+++|+.|+|++|+|+++.+..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45666666665 3444332  56666666666666666666666666666666666666554445556666666666666


Q ss_pred             cCc
Q 039419          498 KLS  500 (1035)
Q Consensus       498 ~l~  500 (1035)
                      +|+
T Consensus        92 ~l~   94 (174)
T 2r9u_A           92 HLK   94 (174)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            555

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.35  E-value=2.2e-12  Score=128.20  Aligned_cols=88  Identities=27%  Similarity=0.327  Sum_probs=76.1

Q ss_pred             CccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEc
Q 039419          415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL  494 (1035)
Q Consensus       415 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  494 (1035)
                      ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            45788888888888777888888899999999999999888888889999999999999998777778999999999999


Q ss_pred             CCCcCcCc
Q 039419          495 SSNKLSGK  502 (1035)
Q Consensus       495 s~N~l~~~  502 (1035)
                      ++|+++..
T Consensus       110 ~~N~~~c~  117 (170)
T 3g39_A          110 LNNPWDCA  117 (170)
T ss_dssp             CSSCBCTT
T ss_pred             CCCCCCCC
Confidence            99999843

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.33  E-value=4.3e-12  Score=126.52  Aligned_cols=92  Identities=24%  Similarity=0.275  Sum_probs=75.5

Q ss_pred             CccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEc
Q 039419          415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL  494 (1035)
Q Consensus       415 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  494 (1035)
                      ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++++..|..+++|+.|+|++|+|++..+..|..+++|++|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            35778888888888777888888888888888888888877777888889999999999998766667888999999999


Q ss_pred             CCCcCcCccchhh
Q 039419          495 SSNKLSGKIPVEL  507 (1035)
Q Consensus       495 s~N~l~~~~p~~~  507 (1035)
                      ++|.+. ..+..+
T Consensus       113 ~~N~~~-c~~~~~  124 (174)
T 2r9u_A          113 YNNPWD-CECRDI  124 (174)
T ss_dssp             CSSCBC-TTBGGG
T ss_pred             CCCCcc-cccccH
Confidence            999987 444433

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.29  E-value=5.2e-11  Score=135.85  Aligned_cols=327  Identities=15%  Similarity=0.226  Sum_probs=193.0

Q ss_pred             Ccccccccc-cccceeecccccccCCccccccCcCCceEEecCCc---CCCCCChhhhcccchhHhhcccccccccCCcc
Q 039419          191 LPASLGKLS-KLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEND---LSGSLPRELGKLQKLEKMLLWQNNFDGAIPEE  266 (1035)
Q Consensus       191 ~p~~l~~l~-~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~---l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~  266 (1035)
                      ...+|.+.+ .|+.+.+..+ ++.....+|.++.+|+.+.+..|.   ++.+....|....+|+.+.+..+ ++.....+
T Consensus        55 g~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~a  132 (394)
T 4gt6_A           55 GDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEA  132 (394)
T ss_dssp             CTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTT
T ss_pred             CHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhh
Confidence            344565553 4777777654 554556677788888888887663   55455667777777777777544 44455667


Q ss_pred             ccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCC
Q 039419          267 IGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP  346 (1035)
Q Consensus       267 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p  346 (1035)
                      |.++.+|+.+.+..+.. .+....|..+.+|+.+.+.++ +..+...+|.+ ..|+.+.+..+-..           .-.
T Consensus       133 F~~c~~L~~i~lp~~~~-~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-----------i~~  198 (394)
T 4gt6_A          133 FHHCEELDTVTIPEGVT-SVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-----------IGT  198 (394)
T ss_dssp             TTTCTTCCEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-----------ECT
T ss_pred             hhhhcccccccccceee-eecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-----------ccc
Confidence            88888888888875533 366677888888888888765 44455666654 56777777654322           123


Q ss_pred             cCCCCCCCCcEEeccCcCCCCCCCCCcccC-cccceEeccc---ccccc-CCCCCCCCCCcceeEeeeccCCCCccceee
Q 039419          347 STLANCRSLEAVDLSHNALTGSLHPGLFQL-QNLTKLLLIS---NGISG-LIPPEIGNCSSLIRLRLMSFGNCTQLQMLN  421 (1035)
Q Consensus       347 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~---N~i~~-~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~  421 (1035)
                      .+|.++.+|.......+.... ....+... ..........   ..+.. .+|      .+++.+...+|.++..|+.+.
T Consensus       199 ~af~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip------~~v~~i~~~aF~~c~~L~~i~  271 (394)
T 4gt6_A          199 NAFSECFALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIP------NGVARIETHAFDSCAYLASVK  271 (394)
T ss_dssp             TTTTTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECC------TTEEEECTTTTTTCSSCCEEE
T ss_pred             chhhhccccceeccccccccc-ccceeecccccccccccccccccccceEEcC------CcceEcccceeeecccccEEe
Confidence            567777788877776665542 22222211 1111100000   00000 011      123344445677777777777


Q ss_pred             cCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcC
Q 039419          422 LSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSG  501 (1035)
Q Consensus       422 L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  501 (1035)
                      +.++..+ +...+|.+.+.|+.+.+. +.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.|..+ ++ 
T Consensus       272 lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-  346 (394)
T 4gt6_A          272 MPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-  346 (394)
T ss_dssp             CCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-
T ss_pred             cccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-
Confidence            7665443 555667777777777775 4455566667777777777777654 55455666777777777766543 33 


Q ss_pred             ccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcC
Q 039419          502 KIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNF  571 (1035)
Q Consensus       502 ~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l  571 (1035)
                                              .+...+|.++.+|+.+++.+|....  ..+.....|+.+.+..|.+
T Consensus       347 ------------------------~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          347 ------------------------KIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             ------------------------BCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC----------
T ss_pred             ------------------------EEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCCCE
Confidence                                    2445567778888888888775432  3556667777777766654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=1.8e-11  Score=131.40  Aligned_cols=146  Identities=12%  Similarity=0.006  Sum_probs=113.7

Q ss_pred             HHHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceee
Q 039419          682 EQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVR  760 (1035)
Q Consensus       682 ~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~  760 (1035)
                      ......|.....++.|+++.||++... ++.+++|+........              ...+.+|+.+++.+. +..+.+
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~--------------~~~~~~E~~~l~~l~~~~~vP~   74 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT--------------TYDVEREKDMMLWLEGKLPVPK   74 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS--------------TTCHHHHHHHHHHHTTTSCCCC
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC--------------HHHHHHHHHHHHHHhcCCCCCe
Confidence            455677877788888999999999765 6889999986421111              234889999999984 678889


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC----------------------
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC----------------------  818 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------  818 (1035)
                      +++++.+.+..|+||||++|.++.+.+..       ......++.+++++++.||+..                      
T Consensus        75 v~~~~~~~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~  147 (263)
T 3tm0_A           75 VLHFERHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLN  147 (263)
T ss_dssp             EEEEEEETTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHH
T ss_pred             EEEEEecCCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHh
Confidence            99999988899999999999999876321       1223467889999999999810                      


Q ss_pred             ----------------------------------CCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          819 ----------------------------------VPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       819 ----------------------------------~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                                                        .+.++|+|++|.||+++.++.+.|+||+.+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          148 NDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                              1369999999999999876666799998764

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.21  E-value=1.9e-11  Score=137.00  Aligned_cols=106  Identities=25%  Similarity=0.264  Sum_probs=78.3

Q ss_pred             eeecCCC-ccCCCCcccccCCCCccEEEcCC-CccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCC
Q 039419          419 MLNLSNN-TLGGTLPSSLASLTRLQVLDISV-NQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSS  496 (1035)
Q Consensus       419 ~L~L~~N-~l~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  496 (1035)
                      .++++++ +|++ +|. +..+++|+.|+|++ |+|.++++..|..+++|+.|+|++|+|++..|..|..+++|++|+|++
T Consensus        12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4577777 7774 566 88888888888885 888887778888888888888888888887777888888888888888


Q ss_pred             CcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCcc
Q 039419          497 NKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDL  552 (1035)
Q Consensus       497 N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  552 (1035)
                      |+|+ .+|..                        .|..++ |+.|+|++|+|.++.
T Consensus        90 N~l~-~~~~~------------------------~~~~~~-L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A           90 NALE-SLSWK------------------------TVQGLS-LQELVLSGNPLHCSC  119 (347)
T ss_dssp             SCCS-CCCST------------------------TTCSCC-CCEEECCSSCCCCCG
T ss_pred             Cccc-eeCHH------------------------HcccCC-ceEEEeeCCCccCCC
Confidence            8887 33322                        233333 777777777777654

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.18  E-value=1.6e-13  Score=154.45  Aligned_cols=42  Identities=24%  Similarity=0.259  Sum_probs=19.5

Q ss_pred             CCCCCCCcEEeccCcCCCCC----CCCCcccCcccceEeccccccc
Q 039419          349 LANCRSLEAVDLSHNALTGS----LHPGLFQLQNLTKLLLISNGIS  390 (1035)
Q Consensus       349 l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~  390 (1035)
                      +...++|++|+|++|.|+..    +...+...++|++|+|++|.|+
T Consensus       207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred             HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence            34444555555555555421    1122223455555555555554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.17  E-value=4.9e-13  Score=150.46  Aligned_cols=190  Identities=18%  Similarity=0.204  Sum_probs=84.9

Q ss_pred             CCCceeeCCCCCCCCCCChhhhcc-----ccccceEecccCCCCCCchhh-hhhccccceeccccccCCCCchhhccccc
Q 039419           78 TQLTTIDVSSNSLVGGVPSSIGKL-----INLQDLILNSNQLTGEIPKEL-GACIKLKNLLLFDNYLSGNLPVELGKLVN  151 (1035)
Q Consensus        78 ~~L~~L~ls~n~l~~~~p~~i~~l-----~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~l~~n~l~~~~p~~l~~l~~  151 (1035)
                      +.|++|+|++|.++......+..+     .+|++|+|++|.+++.....+ ..+++|++|+|++|.+.+.....++..  
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~--  149 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL--  149 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHH--
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHH--
Confidence            455666666666553333333333     456666666666553333333 234555666666665543222222210  


Q ss_pred             cceeecCCCcccCCCCCCcC-CCccceEEEEecccccccc----CcccccccccccceeecccccccC----CccccccC
Q 039419          152 LEVIRAGGNKDIAGKIPYEI-GDCQSLLVVGLADTKVAGS----LPASLGKLSKLQSLSVYTTMLSGE----IPPQIGNC  222 (1035)
Q Consensus       152 L~~L~l~~n~~~~~~~~~~~-~~l~~L~~L~l~~~~~~~~----~p~~l~~l~~L~~L~l~~n~l~~~----~p~~l~~l  222 (1035)
                                         + ...++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+.+.    ++..+...
T Consensus       150 -------------------L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~  210 (372)
T 3un9_A          150 -------------------LLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN  210 (372)
T ss_dssp             -------------------HHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGC
T ss_pred             -------------------HHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcC
Confidence                               0 0112333333333333321    223334445555555555554432    13333444


Q ss_pred             cCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCC-----C
Q 039419          223 SELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSS-----L  297 (1035)
Q Consensus       223 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-----L  297 (1035)
                      ++|+.|+|++|.|++....                    .++..+...++|++|+|++|.|++.....+..+..     |
T Consensus       211 ~~L~~L~Ls~N~i~~~g~~--------------------~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L  270 (372)
T 3un9_A          211 RQLQELNVAYNGAGDTAAL--------------------ALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGA  270 (372)
T ss_dssp             SCCCEEECCSSCCCHHHHH--------------------HHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------C
T ss_pred             CCcCeEECCCCCCCHHHHH--------------------HHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccc
Confidence            4555555555544421111                    12233445567777777777776544444433321     5


Q ss_pred             cEEE--ccCCccc
Q 039419          298 EELM--LSNNNIS  308 (1035)
Q Consensus       298 ~~L~--L~~N~l~  308 (1035)
                      +.+.  +..|.+.
T Consensus       271 ~~l~~ll~~~~~~  283 (372)
T 3un9_A          271 RVVVSLTEGTAVS  283 (372)
T ss_dssp             EEECCCC----CH
T ss_pred             hhhHhhhcCCccC
Confidence            5555  5555554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.17  E-value=2.4e-10  Score=130.35  Aligned_cols=317  Identities=13%  Similarity=0.174  Sum_probs=147.2

Q ss_pred             hhhcccc-ccceeecCCCcccCCCCCCcCCCccceEEEEecccc---ccccCcccccccccccceeecccccccCCcccc
Q 039419          144 VELGKLV-NLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTK---VAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQI  219 (1035)
Q Consensus       144 ~~l~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~---~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l  219 (1035)
                      ..|.+.+ .|+.+.+..+  +.......+.++++|+.+.+..+.   ++.....+|....+|+.+.+..+ ++.....+|
T Consensus        57 ~aF~~~~~~L~sI~iP~s--vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF  133 (394)
T 4gt6_A           57 RVFCNYKYVLTSVQIPDT--VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF  133 (394)
T ss_dssp             TTTTTCCSCCCEEEECTT--CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred             hhccCCCCcCEEEEECCC--eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence            3444443 4666666543  222334456666666666665542   44444455666666666655544 232344455


Q ss_pred             ccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcE
Q 039419          220 GNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEE  299 (1035)
Q Consensus       220 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  299 (1035)
                      ..+.+|+.+.+..+. ..+....|.....|+.+.+..+ +......+|.+ .+|+.+.+..+-.. ....+|.++.+|..
T Consensus       134 ~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~  209 (394)
T 4gt6_A          134 HHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALST  209 (394)
T ss_dssp             TTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCE
T ss_pred             hhhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccce
Confidence            666666666665432 2244445555555555555433 33233333432 45666665544333 44455555566665


Q ss_pred             EEccCCccccCCCCcccCC-------------CccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCC
Q 039419          300 LMLSNNNISGSIPPVLSNA-------------TSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALT  366 (1035)
Q Consensus       300 L~L~~N~l~~~~~~~~~~l-------------~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~  366 (1035)
                      .....+.........+...             ..+..+.+.           +.+...-..+|.++.+|+.+.+.++..+
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-----------~~v~~i~~~aF~~c~~L~~i~lp~~~~~  278 (394)
T 4gt6_A          210 ITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-----------NGVARIETHAFDSCAYLASVKMPDSVVS  278 (394)
T ss_dssp             EEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-----------TTEEEECTTTTTTCSSCCEEECCTTCCE
T ss_pred             ecccccccccccceeecccccccccccccccccccceEEcC-----------CcceEcccceeeecccccEEecccccce
Confidence            5554444331111111100             011111111           0111111234555555665555544332


Q ss_pred             CCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEc
Q 039419          367 GSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDI  446 (1035)
Q Consensus       367 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  446 (1035)
                       +....|.++.+|+.+.+. +.++              .+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+
T Consensus       279 -I~~~aF~~c~~L~~i~l~-~~i~--------------~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i  341 (394)
T 4gt6_A          279 -IGTGAFMNCPALQDIEFS-SRIT--------------ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI  341 (394)
T ss_dssp             -ECTTTTTTCTTCCEEECC-TTCC--------------EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred             -ecCcccccccccccccCC-Cccc--------------ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence             334445555555555553 2222              222234555555666666543 44444556666666666666


Q ss_pred             CCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcC
Q 039419          447 SVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKL  499 (1035)
Q Consensus       447 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  499 (1035)
                      ..+ ++.+...+|.++.+|+.+++.+|....   ..+....+|+.+.+..|.+
T Consensus       342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             Ccc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            543 554555666666666666666654431   2345555666666555543

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.14  E-value=2.8e-11  Score=135.63  Aligned_cols=108  Identities=22%  Similarity=0.206  Sum_probs=86.9

Q ss_pred             ccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecC-cccCCCCCCCCCCCCCCceeeCCCCCCCCCCChh
Q 039419           19 CKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISG-SNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSS   97 (1035)
Q Consensus        19 c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~-~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~   97 (1035)
                      |.|.+|.|+..+          ++. .+|. +..+++|++|+|++ |.|++..+..|+.|++|++|+|++|+|++..|..
T Consensus         8 C~~~~v~~~~~n----------~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~   75 (347)
T 2ifg_A            8 HGSSGLRCTRDG----------ALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA   75 (347)
T ss_dssp             SSSSCEECCSSC----------CCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred             ccCCEEEcCCCC----------CCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence            999999997532          344 3777 88999999999996 8998766678999999999999999999888888


Q ss_pred             hhccccccceEecccCCCCCCchhhhhhccccceeccccccC
Q 039419           98 IGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLS  139 (1035)
Q Consensus        98 i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~  139 (1035)
                      |++|++|++|+|++|+|++..+..+..+. |++|+|.+|.+.
T Consensus        76 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             GGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             hcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            89999999999999999844433444444 888888888876

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.06  E-value=2e-10  Score=122.97  Aligned_cols=129  Identities=16%  Similarity=0.101  Sum_probs=97.2

Q ss_pred             eeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc--eeeEEeEEEcCCcce
Q 039419          695 GKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN--IVRFLGCCWNRNTRL  772 (1035)
Q Consensus       695 G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~  772 (1035)
                      +.|..+.||++...+|+.+++|+.....                 ...+.+|+.+++.+.+.+  +.++++++...+..|
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----------------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSGA-----------------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSCT-----------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCccc-----------------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            4556699999987778889999975421                 124778999999985434  567899888888889


Q ss_pred             EEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC----------------------------------
Q 039419          773 LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC----------------------------------  818 (1035)
Q Consensus       773 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------------  818 (1035)
                      +||||++|.++.  ...     ..   ...++.++++.+..||+..                                  
T Consensus        92 ~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            999999998884  211     11   1256778888888888742                                  


Q ss_pred             ---------------------CCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          819 ---------------------VPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       819 ---------------------~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                                           ...++|+|++|.||+++.++.+.|+|||.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                 11399999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.99  E-value=1.1e-09  Score=123.09  Aligned_cols=142  Identities=13%  Similarity=0.193  Sum_probs=106.2

Q ss_pred             CCeeeeeCCcEEEEEEECCCcEEEEEEec--CCCcccccccccccccccccHHHHHHHHHHHhcCC--CCceeeEEeEEE
Q 039419          691 DSVVGKGCSGIVYRAEMENGEVIAVKKLW--PTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR--HKNIVRFLGCCW  766 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~  766 (1035)
                      .+.++.|.++.||+++..+ ..+++|+..  ......             ....+.+|+.+++.+.  +..+++++.++.
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~-------------~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~  108 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLP-------------SAHAIEREYRVMDALAGTDVPVAKMYALCE  108 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC-----------------------CHHHHHHHHHHHTTSSSCCCCEEEEEC
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCC-------------cHHHHHHHHHHHHHhhcCCCCCCcEEEECC
Confidence            4578999999999998764 678888775  321111             1235788999999997  456888999887


Q ss_pred             cC---CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC-------------------------
Q 039419          767 NR---NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC-------------------------  818 (1035)
Q Consensus       767 ~~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------  818 (1035)
                      +.   +..|+||||++|..+.+...    ..++...+..++.+++++|+.||+..                         
T Consensus       109 ~~~~~g~~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (359)
T 3dxp_A          109 DESVIGRAFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTK  184 (359)
T ss_dssp             CTTTTSSCEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHH
T ss_pred             CCCccCCeEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHH
Confidence            76   45899999999988754221    12677888899999999999999731                         


Q ss_pred             ------------------------------CCCeeccCCCcccEEEcCCCc--eEEeeccCccc
Q 039419          819 ------------------------------VPPIVHRDIKANNILIGPEFE--PYIADFGLAKL  850 (1035)
Q Consensus       819 ------------------------------~~~ivHrDikp~NIll~~~~~--~kl~DFG~a~~  850 (1035)
                                                    .+.++|||++|.||+++.++.  +.|+||+.+..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          185 QYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                          247999999999999997753  68999998864

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.91  E-value=1.2e-08  Score=115.73  Aligned_cols=303  Identities=10%  Similarity=0.043  Sum_probs=156.2

Q ss_pred             CCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccc
Q 039419           49 NLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKL  128 (1035)
Q Consensus        49 ~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L  128 (1035)
                      ++..-.+|+.+.+.. +++......|.++.+|+.++|..+ ++.....++.++ +|+.+.+..+ ++ .+....-...+|
T Consensus        41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~~~L  115 (379)
T 4h09_A           41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQGTDL  115 (379)
T ss_dssp             TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTTCCC
T ss_pred             ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-EeccceeccCCc
Confidence            355667788888864 566445567888888988888644 553445566665 5777766543 33 233222223467


Q ss_pred             cceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecc
Q 039419          129 KNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYT  208 (1035)
Q Consensus       129 ~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~  208 (1035)
                      +.+.+..+... .....+.+. +|+.+.+..+-  .......+..+..++.+.+..+.........+           ..
T Consensus       116 ~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~v--~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-----------~~  180 (379)
T 4h09_A          116 DDFEFPGATTE-IGNYIFYNS-SVKRIVIPKSV--TTIKDGIGYKAENLEKIEVSSNNKNYVAENYV-----------LY  180 (379)
T ss_dssp             SEEECCTTCCE-ECTTTTTTC-CCCEEEECTTC--CEECSCTTTTCTTCCEEEECTTCSSEEEETTE-----------EE
T ss_pred             ccccCCCcccc-ccccccccc-eeeeeecccee--eccccchhcccccccccccccccceeecccce-----------ec
Confidence            77777654321 222223222 34444333221  11112233344444444433322211000000           00


Q ss_pred             cccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCC
Q 039419          209 TMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLP  288 (1035)
Q Consensus       209 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~  288 (1035)
                      +... .....+.....+..+.+..+... .....+....+|+.+.+..+ +......+|.++..|+.+.+..+ ++.+..
T Consensus       181 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~  256 (379)
T 4h09_A          181 NKNK-TILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGS  256 (379)
T ss_dssp             ETTS-SEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECT
T ss_pred             cccc-ceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCc
Confidence            0000 12223333444444444433222 33344455555555555433 33344555666677777777655 444555


Q ss_pred             ccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCC
Q 039419          289 QSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGS  368 (1035)
Q Consensus       289 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  368 (1035)
                      .+|.++.+|+.+.+..+ +..+...+|.++.+|+.+.+..+.++.+.          ..+|.++.+|+.++|..+ ++.+
T Consensus       257 ~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~----------~~aF~~c~~L~~i~lp~~-l~~I  324 (379)
T 4h09_A          257 FLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLE----------PRVFMDCVKLSSVTLPTA-LKTI  324 (379)
T ss_dssp             TTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEEC----------TTTTTTCTTCCEEECCTT-CCEE
T ss_pred             cccceeehhcccccccc-ceeccccccccccccccccccccccceeh----------hhhhcCCCCCCEEEcCcc-ccEE
Confidence            66677777777777543 44455566777777777777666655432          246777777777777644 5545


Q ss_pred             CCCCcccCcccceEecccc
Q 039419          369 LHPGLFQLQNLTKLLLISN  387 (1035)
Q Consensus       369 ~~~~~~~l~~L~~L~L~~N  387 (1035)
                      ....|.++.+|+.+.+..+
T Consensus       325 ~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          325 QVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             CTTTTTTCTTCCCCCCCTT
T ss_pred             HHHHhhCCCCCCEEEECCc
Confidence            5566667777777766543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.89  E-value=4.8e-10  Score=124.82  Aligned_cols=91  Identities=15%  Similarity=0.182  Sum_probs=46.4

Q ss_pred             CchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCccccc--ccccccceeeccc--ccccC---
Q 039419          142 LPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLG--KLSKLQSLSVYTT--MLSGE---  214 (1035)
Q Consensus       142 ~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~--~l~~L~~L~l~~n--~l~~~---  214 (1035)
                      +...+..+++|+.|++.+|..+  .++. + .+++|+.|.+..+.+.......+.  .+++|++|+|+.+  ...+.   
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l--~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~  239 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNL--SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM  239 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTC--BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCG
T ss_pred             HHHHHhcCCCCcEEEEeCCCCc--eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhH
Confidence            3344555666666666655211  1222 2 256667777766666544444444  5677777776431  11111   


Q ss_pred             --Ccccc--ccCcCCceEEecCCcCC
Q 039419          215 --IPPQI--GNCSELVDLFLYENDLS  236 (1035)
Q Consensus       215 --~p~~l--~~l~~L~~L~L~~n~l~  236 (1035)
                        +...+  ..+++|+.|+|.+|.++
T Consensus       240 ~~l~~~l~~~~~p~Lr~L~L~~~~i~  265 (362)
T 2ra8_A          240 NVFRPLFSKDRFPNLKWLGIVDAEEQ  265 (362)
T ss_dssp             GGTGGGSCTTTCTTCCEEEEESCTTH
T ss_pred             HHHHHHHhcCCCCCcCEEeCCCCCCc
Confidence              11111  23566666666666655

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.86  E-value=3e-10  Score=126.50  Aligned_cols=62  Identities=19%  Similarity=0.183  Sum_probs=34.3

Q ss_pred             CChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhc--cccccceeecC
Q 039419           94 VPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELG--KLVNLEVIRAG  158 (1035)
Q Consensus        94 ~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~--~l~~L~~L~l~  158 (1035)
                      +...+..+++|+.|.|++|.-. .++. + .+++|++|+|..|.+.......++  .+++|++|+|+
T Consensus       164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~  227 (362)
T 2ra8_A          164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY  227 (362)
T ss_dssp             CHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred             HHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence            4444556667777777665211 1232 3 256677777766665533333443  56677777664

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.85  E-value=6.5e-08  Score=109.54  Aligned_cols=60  Identities=12%  Similarity=0.264  Sum_probs=27.3

Q ss_pred             cCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhcc
Q 039419          411 FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILS  471 (1035)
Q Consensus       411 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  471 (1035)
                      |.++.+|+.+.+.++.++.+...+|.+..+|+.++|..+ ++.+...+|.++.+|+.+.+.
T Consensus       282 F~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          282 CSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             TTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             cccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            344444444444444444344444444445555554432 333334444444444444443

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.84  E-value=1.1e-09  Score=120.04  Aligned_cols=187  Identities=19%  Similarity=0.158  Sum_probs=121.6

Q ss_pred             CCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCc--eeeEEeEEEc
Q 039419          691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKN--IVRFLGCCWN  767 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~  767 (1035)
                      .+.++.|....||++.    +.+++|+....                .....+.+|+++++.+. +..  +.+++.....
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----------------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~   84 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----------------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP   84 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH----------------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc----------------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC
Confidence            3568999999999874    56888986432                12457889999998883 332  4455555433


Q ss_pred             CC---cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhcc---------------------------
Q 039419          768 RN---TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHD---------------------------  817 (1035)
Q Consensus       768 ~~---~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------------  817 (1035)
                      .+   ..|+||||++|.++.+....    .++..++..++.++++.++.||+.                           
T Consensus        85 ~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (304)
T 3sg8_A           85 SETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKL  160 (304)
T ss_dssp             CSSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHH
Confidence            33   35899999999888754322    166777788888888888888861                           


Q ss_pred             ----------------------------CCCCeeccCCCcccEEEcC--CCceEEeeccCccccccCC-cccccccc--C
Q 039419          818 ----------------------------CVPPIVHRDIKANNILIGP--EFEPYIADFGLAKLVVEGD-FARSSNTV--A  864 (1035)
Q Consensus       818 ----------------------------~~~~ivHrDikp~NIll~~--~~~~kl~DFG~a~~~~~~~-~~~~~~~~--~  864 (1035)
                                                  ..+.++|+|++|.||+++.  ++.+.|+||+.+..-.+.. ........  .
T Consensus       161 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~  240 (304)
T 3sg8_A          161 LSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEY  240 (304)
T ss_dssp             HTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSC
T ss_pred             hcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhcccc
Confidence                                        1135899999999999998  4567899999987532210 00000000  0


Q ss_pred             Ccc-------cc--cC-CcccccCCCCccccchhHHHHHHHHHhCCCCC
Q 039419          865 GSY-------GY--IA-PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI  903 (1035)
Q Consensus       865 gt~-------~y--~a-PE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~  903 (1035)
                      +..       .|  .. |+...  +.....+.|++|.++|++.+|..+|
T Consensus       241 ~~~~~~~~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          241 GMEFVSKILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CHHHHHHHHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            000       11  11 11111  1112368999999999999998765

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.62  E-value=1.8e-09  Score=113.86  Aligned_cols=20  Identities=10%  Similarity=-0.187  Sum_probs=14.0

Q ss_pred             CccceeEEeCCCC-cEEEEEe
Q 039419           18 PCKWSHITCSPQN-FVTEINI   37 (1035)
Q Consensus        18 ~c~w~gi~c~~~~-~v~~l~~   37 (1035)
                      .|.|.|+.|+..+ +|+-+..
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~   97 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIIN   97 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEE
T ss_pred             HHhcCcEEECCCCCEEEEEEe
Confidence            5899999998764 4543333

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.33  E-value=1.9e-06  Score=92.39  Aligned_cols=134  Identities=18%  Similarity=0.129  Sum_probs=96.2

Q ss_pred             eeeeeCCc-EEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEeEEEcCC
Q 039419          693 VVGKGCSG-IVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLGCCWNRN  769 (1035)
Q Consensus       693 ~iG~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  769 (1035)
                      .+..|..| .||+.... ++..+++|+-...                 ....+.+|+.+|+.+. +--+.++++++.+.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----------------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~   93 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----------------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD   93 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----------------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----------------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECC
Confidence            45666666 69998765 4667899986431                 2346788999999884 334778899999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC-------------------------------
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC-------------------------------  818 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------  818 (1035)
                      ..|+|||+++|.++.+......      .....++.++++.+..||+..                               
T Consensus        94 ~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (272)
T 4gkh_A           94 DAWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF  167 (272)
T ss_dssp             EEEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred             eEEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence            9999999999988876543321      122345556666666666421                               


Q ss_pred             ------------------------CCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          819 ------------------------VPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       819 ------------------------~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                                              .+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                    1238999999999999987777799999875

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.33  E-value=4.9e-08  Score=102.81  Aligned_cols=98  Identities=22%  Similarity=0.245  Sum_probs=70.0

Q ss_pred             eEeeeccCCCCccce--eecCCCccC---CCCcccccCCCCccEEEcCCCccCCCC--chhccCccccchhhccCCcccc
Q 039419          405 RLRLMSFGNCTQLQM--LNLSNNTLG---GTLPSSLASLTRLQVLDISVNQFVGLI--PESFGQLASLNRLILSKNSFSG  477 (1035)
Q Consensus       405 ~L~~~~~~~l~~L~~--L~L~~N~l~---~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~  477 (1035)
                      .|++..|...+.|..  ++++.|+..   ..++....++++|+.|+|++|+|+++.  +..+..+++|+.|+|++|+|++
T Consensus       131 ~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~  210 (267)
T 3rw6_A          131 ALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS  210 (267)
T ss_dssp             EEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCS
T ss_pred             ccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCC
Confidence            455555666677776  778888544   122222356788999999999998743  4667788999999999999986


Q ss_pred             cCccccCCCC--CCcEEEcCCCcCcCccc
Q 039419          478 AIPSSLGRCE--SLQSLDLSSNKLSGKIP  504 (1035)
Q Consensus       478 ~~~~~~~~l~--~L~~L~Ls~N~l~~~~p  504 (1035)
                      .  ..+..+.  +|++|+|++|.+.+.+|
T Consensus       211 ~--~~l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          211 E--RELDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             G--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             c--hhhhhcccCCcceEEccCCcCccccC
Confidence            5  2344444  89999999999987665

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.32  E-value=2.1e-06  Score=93.62  Aligned_cols=135  Identities=19%  Similarity=0.179  Sum_probs=93.4

Q ss_pred             CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCC---ceeeEEeEEE-c
Q 039419          692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHK---NIVRFLGCCW-N  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~  767 (1035)
                      +.++.|....||+.    ++.+++|+....                .....+.+|+++++.+.+.   .+.+++.++. .
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~----------------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~   84 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKSQ----------------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS   84 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESSH----------------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCCc----------------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC
Confidence            46788999999998    567888885221                1245788999999999642   3667777774 4


Q ss_pred             CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhcc------------------------------
Q 039419          768 RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHD------------------------------  817 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------  817 (1035)
                      .+..|+||||++|..+.+....    .++......++.++++.|+.||+.                              
T Consensus        85 ~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~  160 (306)
T 3tdw_A           85 DGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV  160 (306)
T ss_dssp             TSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred             CCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence            5567899999999888763211    134444445555555555555532                              


Q ss_pred             ---------------------------CCCCeeccCCCcccEEEcC---CCc-eEEeeccCccc
Q 039419          818 ---------------------------CVPPIVHRDIKANNILIGP---EFE-PYIADFGLAKL  850 (1035)
Q Consensus       818 ---------------------------~~~~ivHrDikp~NIll~~---~~~-~kl~DFG~a~~  850 (1035)
                                                 ..+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                       2235799999999999987   455 47999998764

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.26  E-value=1.6e-07  Score=94.24  Aligned_cols=89  Identities=22%  Similarity=0.230  Sum_probs=53.4

Q ss_pred             CCCCccceeecCCC-ccCCC----CcccccCCCCccEEEcCCCccCCC----CchhccCccccchhhccCCccccc----
Q 039419          412 GNCTQLQMLNLSNN-TLGGT----LPSSLASLTRLQVLDISVNQFVGL----IPESFGQLASLNRLILSKNSFSGA----  478 (1035)
Q Consensus       412 ~~l~~L~~L~L~~N-~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----  478 (1035)
                      ...+.|++|+|++| .|...    +...+...+.|++|+|++|+|...    +...+...+.|++|+|++|.|...    
T Consensus        33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~  112 (185)
T 1io0_A           33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA  112 (185)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence            34455666666666 55521    233445556677777777776532    123344445677777777777532    


Q ss_pred             CccccCCCCCCcEEEc--CCCcCc
Q 039419          479 IPSSLGRCESLQSLDL--SSNKLS  500 (1035)
Q Consensus       479 ~~~~~~~l~~L~~L~L--s~N~l~  500 (1035)
                      +...+...+.|++|+|  ++|.|.
T Consensus       113 l~~~L~~n~~L~~L~L~~~~N~i~  136 (185)
T 1io0_A          113 LVEALQSNTSLIELRIDNQSQPLG  136 (185)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHhCCCceEEEecCCCCCCC
Confidence            3455666677888888  677776

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.26  E-value=3.8e-08  Score=98.74  Aligned_cols=117  Identities=16%  Similarity=0.133  Sum_probs=79.6

Q ss_pred             cCCcCCCCCcccceEeecCc-ccCCC----CCCCCCCCCCCceeeCCCCCCCCCC----ChhhhccccccceEecccCCC
Q 039419           45 PFPSNLSSLSFLQKLIISGS-NLTGP----ISPDLGDCTQLTTIDVSSNSLVGGV----PSSIGKLINLQDLILNSNQLT  115 (1035)
Q Consensus        45 ~~~~~~~~l~~L~~L~L~~~-~l~~~----~~~~~~~l~~L~~L~ls~n~l~~~~----p~~i~~l~~L~~L~L~~n~l~  115 (1035)
                      .+...+...+.|++|+|++| .++..    +...+...+.|++|+|++|.|.+..    .+.+...+.|++|+|++|.+.
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            34455777888999999998 88753    3334556788999999999887433    334455578899999998887


Q ss_pred             CC----Cchhhhhhccccceec--cccccCCCCch----hhccccccceeecCCCc
Q 039419          116 GE----IPKELGACIKLKNLLL--FDNYLSGNLPV----ELGKLVNLEVIRAGGNK  161 (1035)
Q Consensus       116 ~~----~p~~l~~l~~L~~L~l--~~n~l~~~~p~----~l~~l~~L~~L~l~~n~  161 (1035)
                      +.    +...+...++|++|+|  ++|.+......    .+...++|++|++++|.
T Consensus       107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~  162 (185)
T 1io0_A          107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  162 (185)
T ss_dssp             HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence            54    3445566678888888  77887754332    33334566666666554

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.21  E-value=2.5e-07  Score=90.20  Aligned_cols=84  Identities=15%  Similarity=0.090  Sum_probs=53.0

Q ss_pred             cccceEeecCcccCCCCCCCCCCCCCCceeeCCCCC-CCCCCChhhhcc----ccccceEeccc-CCCCCCchhhhhhcc
Q 039419           54 SFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNS-LVGGVPSSIGKL----INLQDLILNSN-QLTGEIPKELGACIK  127 (1035)
Q Consensus        54 ~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~-l~~~~p~~i~~l----~~L~~L~L~~n-~l~~~~p~~l~~l~~  127 (1035)
                      .+|++|||++|.|++.....+..+++|++|+|++|. |++..-..|+.+    ++|++|+|++| ++|+..-..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            357777777777776666666667777777777763 665444455543    35667777666 366555555666666


Q ss_pred             ccceeccccc
Q 039419          128 LKNLLLFDNY  137 (1035)
Q Consensus       128 L~~L~l~~n~  137 (1035)
                      |++|+|++|.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            6666666654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.16  E-value=5.4e-07  Score=87.83  Aligned_cols=86  Identities=9%  Similarity=0.094  Sum_probs=70.4

Q ss_pred             CCCceeeCCCCCCCCCCChhhhccccccceEeccc-CCCCCCchhhhhh----ccccceeccccc-cCCCCchhhccccc
Q 039419           78 TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSN-QLTGEIPKELGAC----IKLKNLLLFDNY-LSGNLPVELGKLVN  151 (1035)
Q Consensus        78 ~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n-~l~~~~p~~l~~l----~~L~~L~l~~n~-l~~~~p~~l~~l~~  151 (1035)
                      .+|++|||++|.|++..-..+.++++|++|+|++| ++++..-..++.+    ++|++|+|++|. +++..-..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            46999999999998777788889999999999999 5887666777764    479999999985 77666677888888


Q ss_pred             cceeecCCCccc
Q 039419          152 LEVIRAGGNKDI  163 (1035)
Q Consensus       152 L~~L~l~~n~~~  163 (1035)
                      |++|++++|..+
T Consensus       141 L~~L~L~~c~~I  152 (176)
T 3e4g_A          141 LKYLFLSDLPGV  152 (176)
T ss_dssp             CCEEEEESCTTC
T ss_pred             CCEEECCCCCCC
Confidence            888888888633

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.14  E-value=5.3e-06  Score=92.85  Aligned_cols=83  Identities=10%  Similarity=0.017  Sum_probs=56.0

Q ss_pred             Cee-eeeCCcEEEEEEEC-------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-C--Cceee
Q 039419          692 SVV-GKGCSGIVYRAEME-------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-H--KNIVR  760 (1035)
Q Consensus       692 ~~i-G~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pniv~  760 (1035)
                      +.| +.|....+|+.+..       +++.+++|+..........           ....+.+|+.+++.+. +  -.+.+
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~-----------~~~~~~~E~~~l~~L~~~~~vpvP~   94 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF-----------PTYRLDHQFEVIRLVGELTDVPVPR   94 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS-----------SCCCHHHHHHHHHHHHHHCCSCCCC
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC-----------chhHHHHHHHHHHHHhhcCCCCCCc
Confidence            466 78888999998654       2677888876432100000           0124678999998884 3  35778


Q ss_pred             EEeEEEcC---CcceEEEEeCCCCChhh
Q 039419          761 FLGCCWNR---NTRLLMYDYMPNGSLGS  785 (1035)
Q Consensus       761 l~~~~~~~---~~~~lv~e~~~~gsL~~  785 (1035)
                      ++.++.+.   +..|+||||++|..+.+
T Consensus        95 v~~~~~~~~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A           95 VRWIETTGDVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             EEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred             EEEEccCCCccCCceEEEEecCCCChhh
Confidence            88887665   35689999999877654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.84  E-value=4.4e-05  Score=84.73  Aligned_cols=138  Identities=14%  Similarity=0.237  Sum_probs=78.6

Q ss_pred             eeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC--CceeeEEe------E
Q 039419          693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH--KNIVRFLG------C  764 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~------~  764 (1035)
                      .|+.|..+.||++...+| .+++|+....                  .+.+..|+.+++.+..  -.+++++.      +
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~------------------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~   99 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP------------------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLY   99 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC------------------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC------------------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEE
Confidence            456678899999987655 5899988641                  1233445555555531  12333332      1


Q ss_pred             EEcCCcceEEEEeCCCCChh--------------hhhhhcCC-C-----------CCCHHHH------------------
Q 039419          765 CWNRNTRLLMYDYMPNGSLG--------------SLLHERRD-S-----------CLEWELR------------------  800 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~-~-----------~l~~~~~------------------  800 (1035)
                      ....+..++||||++|..+.              ..+|.... .           ...|...                  
T Consensus       100 ~~~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  179 (346)
T 2q83_A          100 SKHGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAE  179 (346)
T ss_dssp             EEETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             EEECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhc
Confidence            23456779999999987542              11221110 0           0122211                  


Q ss_pred             -------------HHHHHHHHHHHHHhhc----------cCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          801 -------------YRIILGAAQGLAYLHH----------DCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       801 -------------~~i~~~ia~~L~~LH~----------~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                                   ..+...+.+++++|++          ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          180 KEDPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCCcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                         0111223445666653          023489999999999999888889999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.84  E-value=8.8e-05  Score=80.39  Aligned_cols=137  Identities=17%  Similarity=0.168  Sum_probs=92.4

Q ss_pred             CCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC---CCceeeEEeEEEc
Q 039419          691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR---HKNIVRFLGCCWN  767 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~  767 (1035)
                      .+.|+.|....+|+.+.. ++.+++|+....                 ....+.+|+..|+.+.   ...++++++++..
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~-----------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~  102 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS-----------------YRSMFRAEADQLALLAKTNSINVPLVYGIGNS  102 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG-----------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc-----------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec
Confidence            357899999999999864 678889987431                 1356889999999884   3678899998888


Q ss_pred             CCcceEEEEeCCCCChhh-----------hhhhcCC-C-------------------CCCHHHHH---HHH---------
Q 039419          768 RNTRLLMYDYMPNGSLGS-----------LLHERRD-S-------------------CLEWELRY---RII---------  804 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~---------  804 (1035)
                      .+..|+||||++|..+..           .++.... .                   .-+|....   ++.         
T Consensus       103 ~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~  182 (312)
T 3jr1_A          103 QGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEK  182 (312)
T ss_dssp             SSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHH
T ss_pred             CCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHc
Confidence            888999999999986521           2232211 0                   11354322   111         


Q ss_pred             -------HHHHH-HHHHhhc-cCCCCeeccCCCcccEEEcCCCceEEeecc
Q 039419          805 -------LGAAQ-GLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIADFG  846 (1035)
Q Consensus       805 -------~~ia~-~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~DFG  846 (1035)
                             ..++. ....|.. ...+.++|+|+.+.|++++.++ +.|+||+
T Consensus       183 g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          183 GLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             TCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             CCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence                   11111 1223421 2245899999999999999887 8899973

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.82  E-value=6.6e-05  Score=85.16  Aligned_cols=81  Identities=12%  Similarity=0.090  Sum_probs=51.2

Q ss_pred             CCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCc-ccccccccccccccccHHHHHHHHHHHhcCCC--C-ceeeEEeEE
Q 039419          691 DSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTM-AAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH--K-NIVRFLGCC  765 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p-niv~l~~~~  765 (1035)
                      .+.||.|.++.||++... +++.++||...+... ....        .....+++..|+++++.+..  | .+.+++.+ 
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~--------~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-  105 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES--------WPLTIDRARIESSALIRQGEHVPHLVPRVFYS-  105 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC---------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCC--------CcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-
Confidence            357899999999999654 468899998764321 0000        00123567789999987732  3 44566654 


Q ss_pred             EcCCcceEEEEeCCCC
Q 039419          766 WNRNTRLLMYDYMPNG  781 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~g  781 (1035)
                       +.+..++||||++|.
T Consensus       106 -d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 -DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             -ETTTTEEEECCCTTS
T ss_pred             -cCCccEEEEEeCCCc
Confidence             455678999999774

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.60  E-value=0.00036  Score=75.13  Aligned_cols=79  Identities=20%  Similarity=0.246  Sum_probs=57.3

Q ss_pred             ccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-C--CceeeEEe
Q 039419          687 CLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-H--KNIVRFLG  763 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pniv~l~~  763 (1035)
                      +....+.+|.|..+.||+++..+|+.|++|+.......              ....|.+|+..|+.+. .  --++++++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~--------------~~~~~~~Ea~~L~~L~~~~~vpvP~v~~   81 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA--------------LDGLFRAEALGLDWLGRSFGSPVPQVAG   81 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC--------------CTTHHHHHHHHHHHHTCSTTCCSCCEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc--------------hhhHHHHHHHHHHHHHhhCCCCcceEEe
Confidence            34455788999999999999999999999987543211              1246889999999884 2  23455555


Q ss_pred             EEEcCCcceEEEEeCCCCCh
Q 039419          764 CCWNRNTRLLMYDYMPNGSL  783 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL  783 (1035)
                      +    +..++||||++++..
T Consensus        82 ~----~~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           82 W----DDRTLAMEWVDERPP   97 (288)
T ss_dssp             E----ETTEEEEECCCCCCC
T ss_pred             c----cCceEEEEeecccCC
Confidence            4    235899999987754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.46  E-value=0.00053  Score=78.23  Aligned_cols=77  Identities=8%  Similarity=0.055  Sum_probs=47.7

Q ss_pred             CCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccC--CcccccCCcccccC---CCCccccchhHHHHHH
Q 039419          820 PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVA--GSYGYIAPEYGYMM---KITEKSDVYSYGVVVL  894 (1035)
Q Consensus       820 ~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~Dv~SlGvvl~  894 (1035)
                      +.++|+|++|.|||++.++ ++++||+.+..-.+.-  .. ....  -...|++|+.....   ......++......+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            3899999999999998876 9999999987532210  00 0001  12346666654311   1112345567788888


Q ss_pred             HHHhCC
Q 039419          895 EVLTGK  900 (1035)
Q Consensus       895 elltg~  900 (1035)
                      +.+++.
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            877653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.21  E-value=0.0014  Score=72.01  Aligned_cols=31  Identities=45%  Similarity=0.504  Sum_probs=27.0

Q ss_pred             CCeeccCCCcccEEEcCC----CceEEeeccCccc
Q 039419          820 PPIVHRDIKANNILIGPE----FEPYIADFGLAKL  850 (1035)
Q Consensus       820 ~~ivHrDikp~NIll~~~----~~~kl~DFG~a~~  850 (1035)
                      +.++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999875    6789999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.06  E-value=0.0011  Score=71.84  Aligned_cols=72  Identities=13%  Similarity=0.105  Sum_probs=45.3

Q ss_pred             CCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce-eeEEeEEEcCC
Q 039419          691 DSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI-VRFLGCCWNRN  769 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~  769 (1035)
                      .+.|+.|....+|++     +.+++|+........               ....+|+.+++.+...++ .+++++  +.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~---------------~~r~~E~~~l~~l~~~g~~P~~~~~--~~~   80 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY---------------INRANEAVAAREAAKAGVSPEVLHV--DPA   80 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C---------------CCHHHHHHHHHHHHHTTSSCCEEEE--CTT
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce---------------eCHHHHHHHHHHHHHcCCCCceEEE--ECC
Confidence            567899999999999     568888875421100               012467877777642222 455553  444


Q ss_pred             cceEEEEeC-CCCChh
Q 039419          770 TRLLMYDYM-PNGSLG  784 (1035)
Q Consensus       770 ~~~lv~e~~-~~gsL~  784 (1035)
                      ..++|+||+ +|.++.
T Consensus        81 ~~~~v~e~i~~g~~l~   96 (301)
T 3dxq_A           81 TGVMVTRYIAGAQTMS   96 (301)
T ss_dssp             TCCEEEECCTTCEECC
T ss_pred             CCEEEEeecCCCccCC
Confidence            568999999 665553

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.03  E-value=0.0032  Score=69.04  Aligned_cols=140  Identities=14%  Similarity=0.142  Sum_probs=81.0

Q ss_pred             eeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCC--ceeeEEeE-----E
Q 039419          693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHK--NIVRFLGC-----C  765 (1035)
Q Consensus       693 ~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~-----~  765 (1035)
                      .++ |....||++...+|+.+++|...+...               ..+.+..|..+++.+...  .+++++..     .
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---------------~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~   96 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW---------------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL   96 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTTS---------------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCCC---------------CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEE
Confidence            466 888999999877787899999864321               134567788888877422  23444443     1


Q ss_pred             EcCCcceEEEEeCCCCChhh-----h---------hhhcC-------CCCCCHHHH----------------------HH
Q 039419          766 WNRNTRLLMYDYMPNGSLGS-----L---------LHERR-------DSCLEWELR----------------------YR  802 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~-----~---------l~~~~-------~~~l~~~~~----------------------~~  802 (1035)
                      ...+..+++|||++|..+..     +         ++...       ....++...                      ..
T Consensus        97 ~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  176 (328)
T 1zyl_A           97 NHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLK  176 (328)
T ss_dssp             EETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHH
T ss_pred             EECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHH
Confidence            22445678999998855421     0         11110       011222111                      01


Q ss_pred             HHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          803 IILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       803 i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      .+..++..++..-. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus       177 ~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          177 ATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            11122222222111 1223789999999999999 4 889999988753

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.01  E-value=0.00016  Score=71.84  Aligned_cols=84  Identities=14%  Similarity=0.149  Sum_probs=45.1

Q ss_pred             CCccceeecCCC-ccCC----CCcccccCCCCccEEEcCCCccCCC----CchhccCccccchhhccCCcccc----cCc
Q 039419          414 CTQLQMLNLSNN-TLGG----TLPSSLASLTRLQVLDISVNQFVGL----IPESFGQLASLNRLILSKNSFSG----AIP  480 (1035)
Q Consensus       414 l~~L~~L~L~~N-~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~~  480 (1035)
                      -+.|++|+|++| +|..    .+...+..-+.|+.|+|++|+|...    +...+..-+.|+.|+|++|.|..    .+.
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala  119 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL  119 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence            345666666654 5542    1233444555666666666666532    22233344556666666666653    233


Q ss_pred             cccCCCCCCcEEEcCCC
Q 039419          481 SSLGRCESLQSLDLSSN  497 (1035)
Q Consensus       481 ~~~~~l~~L~~L~Ls~N  497 (1035)
                      ..+...+.|++|+|++|
T Consensus       120 ~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          120 RSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHTTTTCCCSEEECCCC
T ss_pred             HHHhhCCceeEEECCCC
Confidence            34555566777777654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.98  E-value=8.1e-05  Score=73.90  Aligned_cols=117  Identities=15%  Similarity=0.137  Sum_probs=68.8

Q ss_pred             ccCCCCCcEEEccCc-cCCCC----CCccccCCCCCcEEEccCCccccCC----CCcccCCCccceeccccchhhhhhhh
Q 039419          267 IGNCKSLKTIDLSLN-FFSGS----LPQSFGNLSSLEELMLSNNNISGSI----PPVLSNATSLLQLQLDTNQISVFFAW  337 (1035)
Q Consensus       267 ~~~l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~i~~l~~~  337 (1035)
                      +.+-+.|+.|+|++| +|...    +...+..-+.|+.|+|++|+|....    ...+...+.|++|+|+.|+|+.-.+.
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            344567777777774 66532    2334555577778888888776432    33344566777777777777643321


Q ss_pred             ccccCCCCCcCCCCCCCCcEEeccCcCC---CCC----CCCCcccCcccceEecccccc
Q 039419          338 QNKLEGSIPSTLANCRSLEAVDLSHNAL---TGS----LHPGLFQLQNLTKLLLISNGI  389 (1035)
Q Consensus       338 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l---~~~----~~~~~~~l~~L~~L~L~~N~i  389 (1035)
                            .+..++...+.|++|+|++|..   ...    +...+...+.|++|+++.|.+
T Consensus       117 ------ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          117 ------RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             ------HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             ------HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence                  2234566666788888876533   211    223344556677777766654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.85  E-value=0.0032  Score=68.81  Aligned_cols=141  Identities=11%  Similarity=0.118  Sum_probs=78.8

Q ss_pred             CeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc--eeeEEeE-----
Q 039419          692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN--IVRFLGC-----  764 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~-----  764 (1035)
                      +.|+.|....+|++...+| .+++|+......                .+.+..|+.+++.+...+  +.+++..     
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~----------------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~   90 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRVE----------------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGEL   90 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-------------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCS
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCCCC----------------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCE
Confidence            3566788899999987755 688898854210                234667888877764212  2333321     


Q ss_pred             -EEcCCcceEEEEeCCCCChhh--------------hhhhcCC----CC---C---CHHHHHH------------HHHHH
Q 039419          765 -CWNRNTRLLMYDYMPNGSLGS--------------LLHERRD----SC---L---EWELRYR------------IILGA  807 (1035)
Q Consensus       765 -~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~~---l---~~~~~~~------------i~~~i  807 (1035)
                       ....+..+++|+|++|..+..              .++....    ..   .   .|.....            +...+
T Consensus        91 ~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l  170 (322)
T 2ppq_A           91 LGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI  170 (322)
T ss_dssp             CEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred             EEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHH
Confidence             122355689999999865421              1221110    00   0   1221100            00113


Q ss_pred             HHHHHHhhcc----CCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          808 AQGLAYLHHD----CVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       808 a~~L~~LH~~----~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      .+.++++++.    ...+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       171 ~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          171 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            3444455421    22379999999999999987666899999775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.85  E-value=0.0023  Score=71.20  Aligned_cols=140  Identities=16%  Similarity=0.186  Sum_probs=81.5

Q ss_pred             CeeeeeCCcEEEEEEEC--------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEE
Q 039419          692 SVVGKGCSGIVYRAEME--------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFL  762 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  762 (1035)
                      +.+..|-...+|++...        +++.|++|+.....               .....+.+|..+++.+. +.-..+++
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---------------~~~~~~~rE~~vl~~L~~~gv~P~ll  120 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---------------QGVDSLVLESVMFAILAERSLGPQLY  120 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------------------CCHHHHHHHHHHHHHHHHTTSSCCEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---------------chHHHHHHHHHHHHHHHhcCCCCeEE
Confidence            45677888899999765        24789999863311               01345668999998884 33336667


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhh-----------------hhhcC---CCCCC--HHHHHHHHHHHHH-----------
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSL-----------------LHERR---DSCLE--WELRYRIILGAAQ-----------  809 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~-----------------l~~~~---~~~l~--~~~~~~i~~~ia~-----------  809 (1035)
                      +.+.+    .+||||++|.++..-                 +|...   .....  +.++.++..++..           
T Consensus       121 ~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~  196 (379)
T 3feg_A          121 GVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNL  196 (379)
T ss_dssp             EEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCH
T ss_pred             EEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhh
Confidence            66543    289999998665421                 11111   11122  3444444433321           


Q ss_pred             --------HHHH----hhcc-CCCCeeccCCCcccEEEcCC----CceEEeeccCccc
Q 039419          810 --------GLAY----LHHD-CVPPIVHRDIKANNILIGPE----FEPYIADFGLAKL  850 (1035)
Q Consensus       810 --------~L~~----LH~~-~~~~ivHrDikp~NIll~~~----~~~kl~DFG~a~~  850 (1035)
                              .+..    |... ....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       197 ~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          197 LEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                    1222    2221 12379999999999999876    7899999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.81  E-value=0.0025  Score=72.59  Aligned_cols=72  Identities=13%  Similarity=0.253  Sum_probs=49.0

Q ss_pred             CeeeeeCCcEEEEEEECC--------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc-eeeEE
Q 039419          692 SVVGKGCSGIVYRAEMEN--------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN-IVRFL  762 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~  762 (1035)
                      +.|+.|....||++...+        ++.+++|+.....                ..+.+.+|..+++.+...+ .++++
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----------------~~~~li~E~~~l~~L~~~g~~P~l~  142 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----------------TESHLVAESVIFTLLSERHLGPKLY  142 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----------------CHHHHHHHHHHHHHHHHTTSSSCEE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----------------cHHHHHHHHHHHHHHHhCCCCCcEE
Confidence            467888899999998753        4789999873311                0134557999988884323 35677


Q ss_pred             eEEEcCCcceEEEEeCCCCCh
Q 039419          763 GCCWNRNTRLLMYDYMPNGSL  783 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL  783 (1035)
                      +.+.+    .+||||++|.++
T Consensus       143 ~~~~~----g~v~e~l~G~~l  159 (429)
T 1nw1_A          143 GIFSG----GRLEEYIPSRPL  159 (429)
T ss_dssp             EEETT----EEEECCCCEEEC
T ss_pred             EEeCC----CEEEEEeCCccc
Confidence            65532    389999987554

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.69  E-value=0.0075  Score=68.90  Aligned_cols=73  Identities=18%  Similarity=0.183  Sum_probs=47.3

Q ss_pred             CeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce-eeEEeEEEcCC
Q 039419          692 SVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI-VRFLGCCWNRN  769 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~  769 (1035)
                      +.|+.|-...+|++...+ ++.+++|+.....  ..            .. .-.+|..+++.+...++ .++++.+.  +
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~------------~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~  176 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE------------II-NREREKKISCILYNKNIAKKIYVFFT--N  176 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS------------CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh------------hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C
Confidence            467889899999998875 5788899874321  00            00 12478999988864333 56777662  2


Q ss_pred             cceEEEEeCCCCCh
Q 039419          770 TRLLMYDYMPNGSL  783 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL  783 (1035)
                        .+||||++|.++
T Consensus       177 --G~v~e~I~G~~l  188 (458)
T 2qg7_A          177 --GRIEEFMDGYAL  188 (458)
T ss_dssp             --EEEEECCCSEEC
T ss_pred             --eEEEEeeCCccC
Confidence              359999988555

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.58  E-value=0.0037  Score=69.79  Aligned_cols=73  Identities=7%  Similarity=0.084  Sum_probs=43.7

Q ss_pred             CeeeeeCCcEEEEEEECC---------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc-eeeE
Q 039419          692 SVVGKGCSGIVYRAEMEN---------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN-IVRF  761 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l  761 (1035)
                      +.++.|....+|++...+         ++.+++|+......  .             ......|..+++.+...+ +.++
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~-------------~~~~~~E~~~l~~L~~~g~~P~~  103 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--E-------------LYNTISEFEVYKTMSKYKIAPQL  103 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--G-------------TSCHHHHHHHHHHHHHTTSSCCE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--c-------------eecHHHHHHHHHHHHhcCCCCce
Confidence            467788889999998764         26888888754211  0             001357888888774223 4466


Q ss_pred             EeEEEcCCcceEEEEeCCCCCh
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSL  783 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL  783 (1035)
                      ++..  .  -++||||++|..+
T Consensus       104 ~~~~--~--~~~v~e~i~G~~l  121 (369)
T 3c5i_A          104 LNTF--N--GGRIEEWLYGDPL  121 (369)
T ss_dssp             EEEE--T--TEEEEECCCSEEC
T ss_pred             EEec--C--CcEEEEEecCCcC
Confidence            6544  2  3789999988644

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.36  E-value=0.01  Score=65.19  Aligned_cols=31  Identities=39%  Similarity=0.563  Sum_probs=27.6

Q ss_pred             CCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          820 PPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       820 ~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.19  E-value=0.0062  Score=56.34  Aligned_cols=24  Identities=25%  Similarity=0.203  Sum_probs=12.0

Q ss_pred             CCCccccCCccccEEeccCCcccC
Q 039419          527 AIPPQISALNKLSILDLSHNKLGG  550 (1035)
Q Consensus       527 ~~~~~~~~l~~L~~L~L~~N~l~~  550 (1035)
                      +.++.|..+++|++|+|++|.+.+
T Consensus        46 l~~~~f~~l~~L~~L~L~~NP~~C   69 (130)
T 3rfe_A           46 LPPGLLDALPALRTAHLGANPWRC   69 (130)
T ss_dssp             CCTTTGGGCTTCCEEECCSSCCBC
T ss_pred             cChhhhhhccccCEEEecCCCeec
Confidence            333444445555555555555544

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.11  E-value=0.0053  Score=56.79  Aligned_cols=36  Identities=22%  Similarity=0.358  Sum_probs=19.4

Q ss_pred             cchhhccCCcccccCccccCCCCCCcEEEcCCCcCc
Q 039419          465 LNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS  500 (1035)
Q Consensus       465 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (1035)
                      |+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            444555555555444444555555666666666554

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.84  E-value=0.17  Score=50.34  Aligned_cols=102  Identities=19%  Similarity=0.155  Sum_probs=66.2

Q ss_pred             ChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCcccccc
Q 039419          782 SLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN  861 (1035)
Q Consensus       782 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  861 (1035)
                      ||.+.+...+ .++++++++.++.|.+.+|.-.-.+-  .-..+=+.|..|++..+|.|...+ +.+.            
T Consensus        34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence            7888888765 46999999999999999988762110  111233457999999999887754 1110            


Q ss_pred             ccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 039419          862 TVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP  902 (1035)
Q Consensus       862 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P  902 (1035)
                        .....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              1123466888753 3456788899999999998875544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.56  E-value=0.13  Score=57.80  Aligned_cols=73  Identities=7%  Similarity=0.030  Sum_probs=47.6

Q ss_pred             CeeeeeCCcEEEEEEECC--------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEE
Q 039419          692 SVVGKGCSGIVYRAEMEN--------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFL  762 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~  762 (1035)
                      +.+..|-...+|+....+        ++.|++++..... ...              -.-.+|..+++.+. +.-..+++
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~--------------idR~~E~~~l~~L~~~gi~P~l~  140 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKF--------------YDSKVELDVFRYLSNINIAPNII  140 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CC--------------CCHHHHHHHHHHHHHTTSSCCEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chh--------------cCHHHHHHHHHHHHhcCCCCCEE
Confidence            467778889999998763        5789999864321 100              01347888888874 33345566


Q ss_pred             eEEEcCCcceEEEEeCCCCCh
Q 039419          763 GCCWNRNTRLLMYDYMPNGSL  783 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL  783 (1035)
                      +.+  .  -++||||++|..+
T Consensus       141 ~~~--~--~~~I~efI~G~~l  157 (424)
T 3mes_A          141 ADF--P--EGRIEEFIDGEPL  157 (424)
T ss_dssp             EEE--T--TEEEEECCCSEEC
T ss_pred             EEc--C--CCEEEEEeCCccC
Confidence            533  2  3789999998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.02  E-value=1.7  Score=48.53  Aligned_cols=30  Identities=23%  Similarity=0.411  Sum_probs=25.0

Q ss_pred             CeeccCCCcccEEE------cCCCceEEeeccCccc
Q 039419          821 PIVHRDIKANNILI------GPEFEPYIADFGLAKL  850 (1035)
Q Consensus       821 ~ivHrDikp~NIll------~~~~~~kl~DFG~a~~  850 (1035)
                      .++|+|+.+.||++      +++..++++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4466799999988753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.92  E-value=2.7  Score=41.85  Aligned_cols=83  Identities=8%  Similarity=0.030  Sum_probs=60.4

Q ss_pred             CCCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHH-HhhccCCCCeeccCCCcccE
Q 039419          754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA-YLHHDCVPPIVHRDIKANNI  832 (1035)
Q Consensus       754 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~ivHrDikp~NI  832 (1035)
                      .||++  -...-.+++...+.++.-+++.=...++.     .+...+++++..|+.... +++.+     +|--+.|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceE
Confidence            57887  33333566666666665434332333322     788999999999999888 77776     7888999999


Q ss_pred             EEcCCCceEEeeccCc
Q 039419          833 LIGPEFEPYIADFGLA  848 (1035)
Q Consensus       833 ll~~~~~~kl~DFG~a  848 (1035)
                      +++.++.+++.-.|+-
T Consensus       116 ~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          116 MFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EECTTCCEEESCCEET
T ss_pred             EEeCCCcEEEEEcCCc
Confidence            9999999999877763

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.67  E-value=1.9  Score=42.82  Aligned_cols=116  Identities=15%  Similarity=0.153  Sum_probs=76.2

Q ss_pred             CCCceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEE
Q 039419          754 RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNIL  833 (1035)
Q Consensus       754 ~hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIl  833 (1035)
                      .||+.+.. ..-.+++.+.+.++.  ..+..++-.-+.   .+...+++++..|+...++++.+     +|--+.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~--~~~~~~f~~ik~---~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDI--NDNHTPFDNIKS---FTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECC--CTTSEEGGGGGG---SCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEc--CcccCCHHHHHh---cCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEE
Confidence            58888866 445555554444443  333333332222   77899999999999988887766     78889999999


Q ss_pred             EcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 039419          834 IGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID  904 (1035)
Q Consensus       834 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~  904 (1035)
                      ++.++.+++.=.|+...+                   +|.-     .+...=.-.+=+++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~l-------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV-------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTB-------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999877753322                   2210     1111112235567788899988875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1035
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-63
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-56
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-51
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-48
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-39
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-37
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-27
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-10
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.004
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-25
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-24
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	9e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-13
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-12
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	7e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	8e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-09
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-08
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-08
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-07
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-06
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	1e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 1e-63
 Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 31/287 (10%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +G G  G VY+ +      +AVK L  T    +               +F  E+  L  
Sbjct: 15  RIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQ------------LQAFKNEVGVLRK 60

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
            RH NI+ F+G         ++  +    SL   LH   ++  E      I    AQG+ 
Sbjct: 61  TRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH-IIETKFEMIKLIDIARQTAQGMD 118

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YLH      I+HRD+K+NNI +  +    I DFGLA +      +     ++GS  ++AP
Sbjct: 119 YLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 873 EYGYMMK---ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK 929
           E   M      + +SDVY++G+V+ E++TG+ P        ++  D +    G    L  
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIFMVGR-GYLSP 229

Query: 930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
            L        + M +   +   C+    D+RP    + A I+ + + 
Sbjct: 230 DLSKVRSNCPKAMKR---LMAECLKKKRDERPLFPQILASIELLARS 273

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 1e-59
 Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 33/281 (11%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +G G  G V+         +AVK L   +M+                D+F AE   +  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------------PDAFLAEANLMKQ 64

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H+ +VR       +    ++ +YM NGSL   L       L       +    A+G+A
Sbjct: 65  LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           ++        +HRD++A NIL+       IADFGLA+L+ + ++  +         + AP
Sbjct: 124 FIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAP 179

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
           E       T KSDV+S+G+++ E++T  +   P +     I +  R  R           
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR----------M 229

Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            RP+   EE+ Q   +  LC    P+DRPT   + +++++ 
Sbjct: 230 VRPDNCPEELYQ---LMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 1e-56
 Identities = 60/283 (21%), Positives = 116/283 (40%), Gaps = 33/283 (11%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +G G  G+V+     N + +A+K +    M+                + F  E + +  
Sbjct: 12  EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------------EEDFIEEAEVMMK 56

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H  +V+  G C  +    L++++M +G L   L  +R      E    + L   +G+A
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMA 115

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YL       ++HRD+ A N L+G      ++DFG+ + V++  +  SS        + +P
Sbjct: 116 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 171

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLR 932
           E     + + KSDV+S+GV++ EV +  +           +V+ +               
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-EVVEDISTGFRLY-------- 222

Query: 933 ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
            +P +    + Q   +   C    P+DRP    +   + EI +
Sbjct: 223 -KPRLASTHVYQ---IMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (496), Expect = 2e-56
 Identities = 70/311 (22%), Positives = 120/311 (38%), Gaps = 57/311 (18%)

Query: 693 VVGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
            +G+G  G V++A        E   ++AVK L              +     ++  F  E
Sbjct: 20  DIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-------------KEEASADMQADFQRE 66

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC------------ 794
              +    + NIV+ LG C       L+++YM  G L   L                   
Sbjct: 67  AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 795 ----------LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                     L    +  I    A G+AYL        VHRD+   N L+G      IAD
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIAD 183

Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           FGL++ +   D+ ++    A    ++ PE  +  + T +SDV++YGVV+ E+ +      
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243

Query: 905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK 964
                G+   + +        V D ++ A PE    E+     +  LC +  P DRP+  
Sbjct: 244 Y----GMAHEEVIYY------VRDGNILACPENCPLELYN---LMRLCWSKLPADRPSFC 290

Query: 965 DVAAMIKEIKQ 975
            +  +++ + +
Sbjct: 291 SIHRILQRMCE 301

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 3e-56
 Identities = 66/326 (20%), Positives = 127/326 (38%), Gaps = 58/326 (17%)

Query: 692 SVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G G  G+V++     +G V+A K +                    +R+    E++ L
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLI-------------HLEIKPAIRNQIIRELQVL 58

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
                  IV F G  ++     +  ++M  GSL  +L +     +  ++  ++ +   +G
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKG 116

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           L YL       I+HRD+K +NIL+    E  + DFG++  +++      +N+  G+  Y+
Sbjct: 117 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYM 170

Query: 871 APEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV---------------- 914
           +PE       + +SD++S G+ ++E+  G+ PI P   + L ++                
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230

Query: 915 -----------DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRP 961
                         R      E+LD  +   P      +        +  C+   P +R 
Sbjct: 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290

Query: 962 TMKDVAAM--IKEIKQEREECMKVDM 985
            +K +     IK    E     +VD 
Sbjct: 291 DLKQLMVHAFIKRSDAE-----EVDF 311

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 4e-56
 Identities = 62/283 (21%), Positives = 122/283 (43%), Gaps = 37/283 (13%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +G G  G+V   +      +A+K +   +M+                D F  E K + +
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------------EDEFIEEAKVMMN 55

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           + H+ +V+  G C  +    ++ +YM NG L + L E R    + +    +     + + 
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAME 114

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           YL        +HRD+ A N L+  +    ++DFGL++ V++ ++  S  +      +  P
Sbjct: 115 YLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPP 170

Query: 873 EYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           E     K + KSD++++GV++ E+ + GK P +                    E + + L
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------------AEHIAQGL 218

Query: 932 R-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
           R  RP +  E++     +   C +   D+RPT K + + I ++
Sbjct: 219 RLYRPHLASEKVYT---IMYSCWHEKADERPTFKILLSNILDV 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 5e-56
 Identities = 76/324 (23%), Positives = 123/324 (37%), Gaps = 45/324 (13%)

Query: 684 VLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF 743
           + + +V    +GKG  G V+R +   GE +AVK        + +                
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF---------------R 44

Query: 744 SAEIKTLGSIRHKNIVRFLGCCWNRN----TRLLMYDYMPNGSLGSLLHERRDSCLEWEL 799
            AEI     +RH+NI+ F+      N       L+ DY  +GSL   L+      +  E 
Sbjct: 45  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEG 101

Query: 800 RYRIILGAAQGLAYLHHDCV-----PPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
             ++ L  A GLA+LH + V     P I HRD+K+ NIL+       IAD GLA      
Sbjct: 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161

Query: 855 D--FARSSNTVAGSYGYIAPEY------GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT 906
                 + N   G+  Y+APE           +  +++D+Y+ G+V  E+          
Sbjct: 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221

Query: 907 IPEGLHIVDWVRQKRGAIEVLDKSL--RARPEVE-----IEEMLQTLGVALLCVNPTPDD 959
               L   D V       E+       + RP +       E +     +   C       
Sbjct: 222 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281

Query: 960 RPTMKDVAAMIKEIKQEREECMKV 983
           R T   +   + ++ Q  +E +K+
Sbjct: 282 RLTALRIKKTLSQLSQ--QEGIKM 303

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-55
 Identities = 70/294 (23%), Positives = 124/294 (42%), Gaps = 33/294 (11%)

Query: 686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           + L  +  +G+GC G V+         +A+K L P TM+                ++F  
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------------PEAFLQ 61

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E + +  +RH+ +V+            ++ +YM  GSL   L       L       +  
Sbjct: 62  EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
             A G+AY+        VHRD++A NIL+G      +ADFGLA+L+ + ++  +      
Sbjct: 121 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKF 176

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE 925
              + APE     + T KSDV+S+G+++ E+ T  +   P +             R  ++
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----------REVLD 225

Query: 926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREE 979
            +++  R     E  E L  L     C    P++RPT + + A +++     E 
Sbjct: 226 QVERGYRMPCPPECPESLHDL--MCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 3e-55
 Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 39/284 (13%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +GKG  G V   +   G  +AVK +           +ND         +F AE   +  
Sbjct: 14  TIGKGEFGDVMLGD-YRGNKVAVKCI-----------KNDAT-----AQAFLAEASVMTQ 56

Query: 753 IRHKNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           +RH N+V+ LG        L ++ +YM  GSL   L  R  S L  +   +  L   + +
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL        VHRD+ A N+L+  +    ++DFGL K     + + + +T      + A
Sbjct: 117 EYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTA 168

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE     K + KSDV+S+G+++ E+ +  +   P IP            +  +  ++K  
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KDVVPRVEKGY 217

Query: 932 RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
           +          +  +     C +     RP+   +   ++ IK 
Sbjct: 218 KMDAPDGCPPAVYEV--MKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-54
 Identities = 74/307 (24%), Positives = 117/307 (38%), Gaps = 51/307 (16%)

Query: 693 VVGKGCSGIVYRAEM------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
            +G G  G V  A        +    +AVK L P+    E             R++  +E
Sbjct: 30  TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-------------REALMSE 76

Query: 747 IKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC----------- 794
           +K L  +  H NIV  LG C      L++ +Y   G L + L  +RDS            
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 795 -----LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
                L+ E         A+G+A+L        +HRD+ A NIL+       I DFGLA+
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE 909
            +                 ++APE  +    T +SDV+SYG+ + E+ +      P +P 
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253

Query: 910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
                  +++    +          PE    EM     +   C +  P  RPT K +  +
Sbjct: 254 DSKFYKMIKEGFRML---------SPEHAPAEMYD---IMKTCWDADPLKRPTFKQIVQL 301

Query: 970 IKEIKQE 976
           I++   E
Sbjct: 302 IEKQISE 308

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (483), Expect = 1e-54
 Identities = 68/306 (22%), Positives = 121/306 (39%), Gaps = 39/306 (12%)

Query: 678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDK 733
            F  E  + C+  + V+G G  G V    +    +    +A+K L       +       
Sbjct: 18  EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ------- 70

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDS 793
                 R  F +E   +G   H N++   G        +++ ++M NGSL S L +    
Sbjct: 71  ------RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ 124

Query: 794 CLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVE 853
                    ++ G A G+ YL        VHRD+ A NIL+       ++DFGL++ + +
Sbjct: 125 F-TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 854 GDFARSSNTVAGSYG---YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPE 909
                +  +  G      + APE     K T  SDV+SYG+V+ EV++ G++P      +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240

Query: 910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
            +            I  +++  R  P ++    L  L   L C     + RP    +   
Sbjct: 241 DV------------INAIEQDYRLPPPMDCPSALHQL--MLDCWQKDRNHRPKFGQIVNT 286

Query: 970 IKEIKQ 975
           + ++ +
Sbjct: 287 LDKMIR 292

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-54
 Identities = 62/293 (21%), Positives = 117/293 (39%), Gaps = 37/293 (12%)

Query: 689 VEDSVVGKGCSGIVYRAEMEN---GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSA 745
           +ED  +G G  G V +   +     + +AVK L             ++     ++D   A
Sbjct: 10  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL------------KNEANDPALKDELLA 57

Query: 746 EIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           E   +  + +  IVR +G C    + +L+ +    G L   L + R   ++ +    ++ 
Sbjct: 58  EANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVH 114

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG-DFARSSNTVA 864
             + G+ YL        VHRD+ A N+L+  +    I+DFGL+K +    ++ ++     
Sbjct: 115 QVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171

Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA 923
               + APE     K + KSDV+S+GV++ E  + G++P        +            
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------------ 219

Query: 924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
             +L+K  R          +  L    LC     ++RP    V   ++    +
Sbjct: 220 TAMLEKGERMGCPAGCPREMYDL--MNLCWTYDVENRPGFAAVELRLRNYYYD 270

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (478), Expect = 3e-54
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 35/286 (12%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G VY     +    +AVK L   TM                 + F  E   + 
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------------VEEFLKEAAVMK 68

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            I+H N+V+ LG C       ++ ++M  G+L   L E     +   +   +    +  +
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YL        +HRD+ A N L+G      +ADFGL++L + GD   +         + A
Sbjct: 129 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTA 184

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE     K + KSDV+++GV++ E+ T      P I                 E+L+K  
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------VYELLEKDY 233

Query: 932 R-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           R  RPE   E++ +   +   C    P DRP+  ++    + + QE
Sbjct: 234 RMERPEGCPEKVYE---LMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 9e-54
 Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 37/291 (12%)

Query: 688 LVEDSVVGKGCSGIVYRAEM---ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS 744
           L+ D  +G G  G V +      +    +A+K L   T  A+              +   
Sbjct: 11  LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD-------------TEEMM 57

Query: 745 AEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRII 804
            E + +  + +  IVR +G C      +L+ +    G L   L  +R+  +       ++
Sbjct: 58  REAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELL 115

Query: 805 LGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD-FARSSNTV 863
              + G+ YL        VHRD+ A N+L+       I+DFGL+K +   D +  + +  
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRG 922
                + APE     K + +SDV+SYGV + E L+ G++P        +           
Sbjct: 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV----------- 221

Query: 923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
            +  +++  R     E    L  L     C     +DRP    V   ++  
Sbjct: 222 -MAFIEQGKRMECPPECPPELYAL--MSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 4e-53
 Identities = 69/291 (23%), Positives = 119/291 (40%), Gaps = 37/291 (12%)

Query: 693 VVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           V+G+G  G VY   + +        AVK L             ++I   G    F  E  
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-------------NRITDIGEVSQFLTEGI 80

Query: 749 TLGSIRHKNIVRFLGCCW-NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
            +    H N++  LG C  +  + L++  YM +G L + +     +    +      L  
Sbjct: 81  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQV 139

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNT--VAG 865
           A+G+           VHRD+ A N ++  +F   +ADFGLA+ + + +F    N      
Sbjct: 140 AKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE 925
              ++A E     K T KSDV+S+GV++ E++T   P  P     ++  D          
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP----DVNTFDITVY------ 246

Query: 926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE 976
           +L      +PE   + + +   V L C +P  + RP+  ++ + I  I   
Sbjct: 247 LLQGRRLLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-52
 Identities = 64/295 (21%), Positives = 117/295 (39%), Gaps = 36/295 (12%)

Query: 687 CLVEDSVVGKGCSGIVYRAEMENGE-----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRD 741
           C+    V+G G  G VY+  ++         +A+K L       +             R 
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ-------------RV 54

Query: 742 SFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRY 801
            F  E   +G   H NI+R  G        +++ +YM NG+L       +D         
Sbjct: 55  DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF-LREKDGEFSVLQLV 113

Query: 802 RIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSN 861
            ++ G A G+ YL +      VHRD+ A NIL+       ++DFGL++++ +   A  + 
Sbjct: 114 GMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170

Query: 862 T-VAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK 920
           +       + APE     K T  SDV+S+G+V+ EV+T  +              W    
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-----------YWELSN 219

Query: 921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
              ++ ++   R    ++    +  L   + C       RP   D+ +++ ++ +
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQL--MMQCWQQERARRPKFADIVSILDKLIR 272

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 2e-52
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 38/282 (13%)

Query: 691 DSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           D  +G+G    VY+    E    +A  +L             D+      R  F  E + 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCEL------------QDRKLTKSERQRFKEEAEM 61

Query: 750 LGSIRHKNIVRFLGCC----WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           L  ++H NIVRF          +   +L+ + M +G+L + L   +   ++ ++      
Sbjct: 62  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCR 119

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILI-GPEFEPYIADFGLAKLVVEGDFARSSNTVA 864
              +GL +LH    PPI+HRD+K +NI I GP     I D GLA L      A  +  V 
Sbjct: 120 QILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVI 174

Query: 865 GSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           G+  ++APE  Y  K  E  DVY++G+ +LE+ T + P              + ++    
Sbjct: 175 GTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYS-----ECQNAAQIYRR---- 224

Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
            V      A  +      ++ +     C+    D+R ++KD+
Sbjct: 225 -VTSGVKPASFDKVAIPEVKEI--IEGCIRQNKDERYSIKDL 263

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-52
 Identities = 74/296 (25%), Positives = 112/296 (37%), Gaps = 42/296 (14%)

Query: 673 PFQKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQN 731
           PF + ++ + Q L         G+G  G V  A      E +AVK +             
Sbjct: 2   PFVE-DWDLVQTL---------GEGAYGEVQLAVNRVTEEAVAVKIV------------- 38

Query: 732 DKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR 791
           D        ++   EI     + H+N+V+F G     N + L  +Y   G L   +    
Sbjct: 39  DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI 98

Query: 792 DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
              +      R       G+ YLH      I HRDIK  N+L+       I+DFGLA + 
Sbjct: 99  --GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF 153

Query: 852 VEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEG 910
              +  R  N + G+  Y+APE     +   E  DV+S G+V+  +L G+ P D      
Sbjct: 154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213

Query: 911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
               DW  +K              P  +I+     L   +L  N  P  R T+ D+
Sbjct: 214 QEYSDWKEKK----------TYLNPWKKIDSAPLALLHKILVEN--PSARITIPDI 257

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (462), Expect = 9e-52
 Identities = 77/326 (23%), Positives = 134/326 (41%), Gaps = 42/326 (12%)

Query: 693  VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
             +G G  G VY A  + N EV+A+KK+  +   +    Q+              E++ L 
Sbjct: 22   EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-----------IIKEVRFLQ 70

Query: 752  SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
             +RH N +++ GC    +T  L+ +Y    +    L E     L+      +  GA QGL
Sbjct: 71   KLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS--DLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 812  AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            AYLH      ++HRD+KA NIL+       + DFG A ++        +N+  G+  ++A
Sbjct: 129  AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMA 179

Query: 872  PEY---GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLD 928
            PE        +   K DV+S G+  +E+   K P        ++ +  +        +  
Sbjct: 180  PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSALYH------IAQ 228

Query: 929  KSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDMLPS 988
                A       E  +       C+   P DRPT + +    + + +ER   + +D++  
Sbjct: 229  NESPALQSGHWSEYFRNF--VDSCLQKIPQDRPTSEVLLKH-RFVLRERPPTVIMDLIQR 285

Query: 989  EGSANGQRENNNSSSTAMMPNLYPQS 1014
               A   RE +N     M   L+ ++
Sbjct: 286  TKDAV--RELDNLQYRKMKKILFQEA 309

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 2e-51
 Identities = 55/281 (19%), Positives = 111/281 (39%), Gaps = 35/281 (12%)

Query: 693 VVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G   +     +G+++  K+L   +M                +    +E+  L 
Sbjct: 11  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------------TEAEKQMLVSEVNLLR 58

Query: 752 SIRHKNIVRFLGCCWNRNTRLLM--YDYMPNGSLGSLLHE--RRDSCLEWELRYRIILGA 807
            ++H NIVR+     +R    L    +Y   G L S++ +  +    L+ E   R++   
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 808 AQGLAYLH--HDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              L   H   D    ++HRD+K  N+ +  +    + DFGLA+++        +    G
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVG 176

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE 925
           +  Y++PE    M   EKSD++S G ++ E+     P            +   +      
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKELAGK------ 225

Query: 926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           + +   R  P    +E+ +   +    +N     RP+++++
Sbjct: 226 IREGKFRRIPYRYSDELNE---IITRMLNLKDYHRPSVEEI 263

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 4e-51
 Identities = 64/307 (20%), Positives = 113/307 (36%), Gaps = 56/307 (18%)

Query: 693 VVGKGCSGIVYRA------EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
           V+G G  G V  A      +      +AVK L     ++E             R++  +E
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-------------REALMSE 90

Query: 747 IKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD------------- 792
           +K +  +  H+NIV  LG C       L+++Y   G L + L  +R+             
Sbjct: 91  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150

Query: 793 --------SCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD 844
                   + L +E         A+G+ +L        VHRD+ A N+L+       I D
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICD 207

Query: 845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID 904
           FGLA+ ++                ++APE  +    T KSDV+SYG+++ E+ +      
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267

Query: 905 PTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK 964
           P IP   +    ++             +        E +  +     C       RP+  
Sbjct: 268 PGIPVDANFYKLIQNG----------FKMDQPFYATEEIYII--MQSCWAFDSRKRPSFP 315

Query: 965 DVAAMIK 971
           ++ + + 
Sbjct: 316 NLTSFLG 322

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 8e-51
 Identities = 66/319 (20%), Positives = 120/319 (37%), Gaps = 50/319 (15%)

Query: 693 VVGKGCSGIVYRAEMENG---EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           V+G+G  G V +A ++        A+K++              +         F+ E++ 
Sbjct: 17  VIGEGNFGQVLKARIKKDGLRMDAAIKRM-------------KEYASKDDHRDFAGELEV 63

Query: 750 LGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER--------------RDSC 794
           L  +  H NI+  LG C +R    L  +Y P+G+L   L +                 S 
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
           L  +         A+G+ YL        +HRD+ A NIL+G  +   IADFGL++     
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ--- 177

Query: 855 DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIV 914
           +             ++A E       T  SDV+SYGV++ E+++           G+   
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCA 233

Query: 915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK 974
           +   +       L +  R    +  ++ +  L     C    P +RP+   +   +  + 
Sbjct: 234 ELYEK-------LPQGYRLEKPLNCDDEVYDL--MRQCWREKPYERPSFAQILVSLNRML 284

Query: 975 QEREECMKVDMLPSEGSAN 993
           +ER+  +   +      A 
Sbjct: 285 EERKTYVNTTLYEKFTYAG 303

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-50
 Identities = 71/277 (25%), Positives = 111/277 (40%), Gaps = 40/277 (14%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +GKG  G VY A   ++  ++A+K L+   +              GV      E++   
Sbjct: 13  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-----------GVEHQLRREVEIQS 61

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            +RH NI+R  G   +     L+ +Y P G++   L   + S  + +     I   A  L
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANAL 119

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           +Y H      ++HRDIK  N+L+G   E  IADFG +             T+ G+  Y+ 
Sbjct: 120 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLP 172

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE        EK D++S GV+  E L GK P +    +               E   +  
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---------------ETYKRIS 217

Query: 932 RARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           R        + E  + L   LL  N  P  RP +++V
Sbjct: 218 RVEFTFPDFVTEGARDLISRLLKHN--PSQRPMLREV 252

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 7e-50
 Identities = 70/301 (23%), Positives = 117/301 (38%), Gaps = 39/301 (12%)

Query: 685 LKCLVEDS------VVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKI 734
           L CL+ +        +G G  G+V R E +        +AVK L P           D +
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-----------DVL 49

Query: 735 GIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC 794
                 D F  E+  + S+ H+N++R  G       +++  +  P GSL   L + +   
Sbjct: 50  SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH- 107

Query: 795 LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEG 854
                  R  +  A+G+ YL        +HRD+ A N+L+       I DFGL + + + 
Sbjct: 108 FLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164

Query: 855 -DFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI 913
            D           + + APE       +  SD + +GV + E+ T  Q        GL+ 
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI----GLNG 220

Query: 914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI 973
              + +     E L      RPE   +++     V + C    P+DRPT   +   + E 
Sbjct: 221 SQILHKIDKEGERLP-----RPEDCPQDIYN---VMVQCWAHKPEDRPTFVALRDFLLEA 272

Query: 974 K 974
           +
Sbjct: 273 Q 273

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 1e-48
 Identities = 67/297 (22%), Positives = 116/297 (39%), Gaps = 43/297 (14%)

Query: 693 VVGKGCSGIVYRAE------MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
            +G+G  G+VY          E    +A+K +       E             R  F  E
Sbjct: 27  ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE-------------RIEFLNE 73

Query: 747 IKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSC--------LEWE 798
              +      ++VR LG        L++ + M  G L S L   R +             
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133

Query: 799 LRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFAR 858
              ++    A G+AYL+       VHRD+ A N ++  +F   I DFG+ + + E D+ R
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 859 SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR 918
                     +++PE       T  SDV+S+GVV+ E+ T  +       +GL     +R
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY----QGLSNEQVLR 246

Query: 919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
                  V++  L  +P+   + + +   +  +C    P  RP+  ++ + IKE  +
Sbjct: 247 F------VMEGGLLDKPDNCPDMLFE---LMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-48
 Identities = 57/282 (20%), Positives = 108/282 (38%), Gaps = 42/282 (14%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G VY+A+  E   + A K +   +                  + +  EI  L 
Sbjct: 19  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--------------LEDYMVEIDILA 64

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           S  H NIV+ L   +  N   ++ ++   G++ +++ E     L       +       L
Sbjct: 65  SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDAL 123

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      I+HRD+KA NIL   + +  +ADFG++         +  ++  G+  ++A
Sbjct: 124 NYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMA 178

Query: 872 PEY-----GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
           PE              K+DV+S G+ ++E+   + P     P  + +    +  +     
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL----KIAKSEPPT 234

Query: 927 LDKSLRARPEVE--IEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           L +  R     +  +++ L+             D R T   +
Sbjct: 235 LAQPSRWSSNFKDFLKKCLE----------KNVDARWTTSQL 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 6e-48
 Identities = 68/319 (21%), Positives = 124/319 (38%), Gaps = 40/319 (12%)

Query: 693  VVGKGCSGIVYRAE-MENGEV----IAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
            V+G G  G VY+   +  GE     +A+K+L              +            E 
Sbjct: 16   VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-------------REATSPKANKEILDEA 62

Query: 748  KTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
              + S+ + ++ R LG C     +L+    MP G L   + E +D+    +      +  
Sbjct: 63   YVMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNI-GSQYLLNWCVQI 120

Query: 808  AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            A+G+ YL       +VHRD+ A N+L+       I DFGLAKL+   +    +       
Sbjct: 121  AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 868  GYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
             ++A E       T +SDV+SYGV V E++T G +P D      +              +
Sbjct: 178  KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------------SSI 225

Query: 927  LDKSLR-ARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQEREECMKVDM 985
            L+K  R  +P +   ++     + + C     D RP  +++     ++ ++ +  + +  
Sbjct: 226  LEKGERLPQPPICTIDVYM---IMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

Query: 986  LPSEGSANGQRENNNSSST 1004
                   +    N   +  
Sbjct: 283  DERMHLPSPTDSNFYRALM 301

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-47
 Identities = 64/291 (21%), Positives = 108/291 (37%), Gaps = 38/291 (13%)

Query: 693 VVGKGCSGIVYRAEM----ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
            +G+G  G V++            +A+K                      VR+ F  E  
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTC-------------KNCTSDSVREKFLQEAL 60

Query: 749 TLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA 808
           T+    H +IV+ +G        ++M +    G L S L  R+ S L+           +
Sbjct: 61  TMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYS-LDLASLILYAYQLS 118

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
             LAYL        VHRDI A N+L+       + DFGL++ + +  + ++S        
Sbjct: 119 TALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIK 174

Query: 869 YIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEVL 927
           ++APE     + T  SDV+ +GV + E+L  G +P        +            I  +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------------IGRI 222

Query: 928 DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE 978
           +   R          L +L     C    P  RP   ++ A +  I +E +
Sbjct: 223 ENGERLPMPPNCPPTLYSL--MTKCWAYDPSRRPRFTELKAQLSTILEEEK 271

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 3e-46
 Identities = 48/286 (16%), Positives = 98/286 (34%), Gaps = 37/286 (12%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G    V  A E+      A+K L    +  E                 + E   + 
Sbjct: 15  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-----------NKVPYVTRERDVMS 63

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            + H   V+      +         Y  NG L   + +      +           A+ +
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDET---CTRFYTAEIV 118

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           + L +     I+HRD+K  NIL+  +    I DFG AK++        +N+  G+  Y++
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE        + SD+++ G ++ +++ G  P                +      +  K +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPP---------------FRAGNEYLIFQKII 223

Query: 932 RARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
           +   +   +     + L   LL ++     R   ++       +K 
Sbjct: 224 KLEYDFPEKFFPKARDLVEKLLVLD--ATKRLGCEE-MEGYGPLKA 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 3e-45
 Identities = 60/278 (21%), Positives = 117/278 (42%), Gaps = 41/278 (14%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G SG VY A ++  G+ +A++++                     ++    EI  + 
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------------KELIINEILVMR 72

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
             ++ NIV +L      +   ++ +Y+  GSL  ++ E             +     Q L
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQAL 129

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            +LH +    ++HRDIK++NIL+G +    + DFG    +      RS  T+ G+  ++A
Sbjct: 130 EFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMA 184

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK-S 930
           PE         K D++S G++ +E++ G+ P     P               +  L   +
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---------------LRALYLIA 229

Query: 931 LRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTMKDV 966
               PE++  E L  +    L  C++   + R + K++
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 1e-44
 Identities = 69/304 (22%), Positives = 116/304 (38%), Gaps = 52/304 (17%)

Query: 693 VVGKGCSGIVYRAEM--------ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS 744
            +G+G  G V  AE              +AVK L                          
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-------------KSDATEKDLSDLI 66

Query: 745 AEIKTLGSI-RHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR------------ 791
           +E++ +  I +HKNI+  LG C       ++ +Y   G+L   L  RR            
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126

Query: 792 --DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK 849
             +  L  +         A+G+ YL        +HRD+ A N+L+  +    IADFGLA+
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183

Query: 850 LVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPE 909
            +   D+ + +        ++APE  +    T +SDV+S+GV++ E+ T      P +P 
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 242

Query: 910 GLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM 969
               V+ + +       +D     +P     E+     +   C +  P  RPT K +   
Sbjct: 243 ----VEELFKLLKEGHRMD-----KPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVED 290

Query: 970 IKEI 973
           +  I
Sbjct: 291 LDRI 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  162 bits (411), Expect = 2e-44
 Identities = 65/360 (18%), Positives = 133/360 (36%), Gaps = 52/360 (14%)

Query: 668  PWQLTPFQKLN-FTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAA 725
            P ++     L+ + + + L         G G  G+V+R  E   G   A K +     + 
Sbjct: 16   PVEIKHDHVLDHYDIHEEL---------GTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66

Query: 726  EYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGS 785
                          +++   EI+T+  +RH  +V       + N  +++Y++M  G L  
Sbjct: 67   --------------KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112

Query: 786  LLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYI--A 843
             + +   + +  +     +    +GL ++H +     VH D+K  NI+   +    +   
Sbjct: 113  KVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLI 168

Query: 844  DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPI 903
            DFGL   +       S     G+  + APE      +   +D++S GV+   +L+G  P 
Sbjct: 169  DFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 225

Query: 904  DPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTM 963
                  G +  + +R     ++  D ++       I E  +     LL  +  P+ R T+
Sbjct: 226  G-----GENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFIRKLLLAD--PNTRMTI 274

Query: 964  KDVAAM--IKEIKQEREECMKVDMLPSEGSANGQRENNNSSSTAMMPNLYPQSNNTSFSA 1021
                    +        +      +PS       R++  +   A    L P    +++S+
Sbjct: 275  HQALEHPWLTPGNAPGRD----SQIPSS-RYTKIRDSIKTKYDAWPEPLPPLGRISNYSS 329

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 7e-44
 Identities = 68/305 (22%), Positives = 118/305 (38%), Gaps = 50/305 (16%)

Query: 693 VVGKGCSGIVYRA------EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAE 746
            +G+G  G V  A      +      +AVK L      +E               +  +E
Sbjct: 20  PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE-------------HRALMSE 66

Query: 747 IKTLGSIRH-KNIVRFLGCCWNRNTRL-LMYDYMPNGSLGSLLHERRDSC---------- 794
           +K L  I H  N+V  LG C      L ++ ++   G+L + L  +R+            
Sbjct: 67  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 795 ----LEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL 850
               L  E         A+G+ +L        +HRD+ A NIL+  +    I DFGLA+ 
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 851 VVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEG 910
           + +               ++APE  +    T +SDV+S+GV++ E+ +      P    G
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----G 239

Query: 911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMI 970
           + I +   ++     + + +    P+    EM Q     L C +  P  RPT  ++   +
Sbjct: 240 VKIDEEFCRR-----LKEGTRMRAPDYTTPEMYQ---TMLDCWHGEPSQRPTFSELVEHL 291

Query: 971 KEIKQ 975
             + Q
Sbjct: 292 GNLLQ 296

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 6e-43
 Identities = 65/328 (19%), Positives = 116/328 (35%), Gaps = 46/328 (14%)

Query: 693  VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            V+G G    V  AE     +++A+K +              K  + G   S   EI  L 
Sbjct: 16   VLGTGAFSEVILAEDKRTQKLVAIKCI-------------AKKALEGKEGSMENEIAVLH 62

Query: 752  SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
             I+H NIV       +     L+   +  G L   + E+           R+I      +
Sbjct: 63   KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAV 120

Query: 812  AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
             YLH   +     +        +  + +  I+DFGL+K+   G      +T  G+ GY+A
Sbjct: 121  KYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVA 177

Query: 872  PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
            PE       ++  D +S GV+   +L G  P         +      Q    I   +   
Sbjct: 178  PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-----YDENDAKLFEQ----ILKAEYEF 228

Query: 932  RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV---------AAMIKEIKQEREECMK 982
             +    +I +  +     L+  +  P+ R T +            A+ K I Q   E +K
Sbjct: 229  DSPYWDDISDSAKDFIRHLMEKD--PEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIK 286

Query: 983  VDMLPSEGSANGQRENNNSSSTAMMPNL 1010
             +   S       +     ++TA++ ++
Sbjct: 287  KNFAKS-------KWKQAFNATAVVRHM 307

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (390), Expect = 2e-42
 Identities = 60/282 (21%), Positives = 110/282 (39%), Gaps = 32/282 (11%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G+G S +V R       +  AVK +  T   +    +  ++     R++   E+  L 
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL-----REATLKEVDILR 64

Query: 752 SIR-HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
            +  H NI++            L++D M  G L   L E+    L  +   +I+    + 
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEV 122

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYI 870
           +  LH      IVHRD+K  NIL+  +    + DFG +  +  G+       V G+  Y+
Sbjct: 123 ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 176

Query: 871 APEY------GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI 924
           APE              ++ D++S GV++  +L G  P           +  +R     I
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-----HRKQMLMLRM----I 227

Query: 925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
              +    +    +  + ++ L    L V   P  R T ++ 
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ--PQKRYTAEEA 267

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (381), Expect = 3e-41
 Identities = 59/288 (20%), Positives = 108/288 (37%), Gaps = 34/288 (11%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G G    V+ A  +     +AVK L                        F  E +   
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP-----------SFYLRFRREAQNAA 62

Query: 752 SIRHKNIVRFLGCCWNRNTRL----LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
           ++ H  IV                 ++ +Y+   +L  ++H      +  +    +I  A
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADA 120

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK-LVVEGDFARSSNTVAGS 866
            Q L + H      I+HRD+K  NI+I       + DFG+A+ +   G+    +  V G+
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 867 YGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEV 926
             Y++PE      +  +SDVYS G V+ EVLTG+ P       G   V    Q      +
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-----GDSPVSVAYQHVREDPI 232

Query: 927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-TMKDVAAMIKEI 973
              +       +++ ++         +   P++R  T  ++ A +  +
Sbjct: 233 PPSARHEGLSADLDAVVLK------ALAKNPENRYQTAAEMRADLVRV 274

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  153 bits (387), Expect = 3e-41
 Identities = 50/277 (18%), Positives = 97/277 (35%), Gaps = 35/277 (12%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G+V+R  E   G V   K +                     + +   EI  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD--------------KYTVKNEISIMN 81

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            + H  ++       ++   +L+ +++  G L   +    D  +        +  A +GL
Sbjct: 82  QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGL 140

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYI--ADFGLAKLVVEGDFARSSNTVAGSYGY 869
            ++H      IVH DIK  NI+   +    +   DFGLA  +   +          +  +
Sbjct: 141 KHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEF 194

Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK 929
            APE      +   +D+++ GV+   +L+G  P       G   ++ ++     ++  D 
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF-----AGEDDLETLQN----VKRCDW 245

Query: 930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
                    +    +     LL     P  R T+ D 
Sbjct: 246 EFDEDAFSSVSPEAKDFIKNLLQKE--PRKRLTVHDA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (375), Expect = 5e-40
 Identities = 62/286 (21%), Positives = 107/286 (37%), Gaps = 43/286 (15%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G V+      NG   A+K L           + + +      +  + E   L 
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVL-----------KKEIVVRLKQVEHTNDERLMLS 59

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            + H  I+R  G   +     ++ DY+  G L SLL + +         Y     AA+  
Sbjct: 60  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY-----AAEVC 114

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
             L +     I++RD+K  NIL+       I DFG AK V +      + T+ G+  YIA
Sbjct: 115 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIA 169

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE        +  D +S+G+++ E+L G  P                     ++  +K L
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY---------------DSNTMKTYEKIL 214

Query: 932 RARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
            A         E ++ L   L+  +     R    ++    +++K 
Sbjct: 215 NAELRFPPFFNEDVKDLLSRLITRD--LSQRLG--NLQNGTEDVKN 256

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 6e-40
 Identities = 65/308 (21%), Positives = 119/308 (38%), Gaps = 37/308 (12%)

Query: 692 SVVGKGCSGIVYRAE--MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKT 749
           + +G+G  G V++A      G  +A+K++   T          +           A ++ 
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---------EVAVLRH 63

Query: 750 LGSIRHKNIVRFLGCC----WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
           L +  H N+VR    C     +R T+L +     +  L + L +  +  +  E    ++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
              +GL +LH      +VHRD+K  NIL+    +  +ADFGLA++     F  +  +V  
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 177

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-----------HIV 914
           +  Y APE           D++S G +  E+   K     +                   
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 915 DWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTMKDVAAM--I 970
           DW R      +    S  A+P  +    +  LG  LL  C+   P  R +     +    
Sbjct: 238 DWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

Query: 971 KEIKQERE 978
           +++++ +E
Sbjct: 297 QDLERCKE 304

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 7e-40
 Identities = 59/289 (20%), Positives = 96/289 (33%), Gaps = 31/289 (10%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G    VY+A      +++A+KK+     +   D         G+  +   EIK L 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD---------GINRTALREIKLLQ 55

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            + H NI+  L    +++   L++D+M       +              Y         L
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY-----MLMTL 110

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
             L +     I+HRD+K NN+L+       +ADFGLAK    G   R+      +  Y A
Sbjct: 111 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRA 168

Query: 872 PE-YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-----------HIVDWVRQ 919
           PE            D+++ G ++ E+L     +                       W   
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228

Query: 920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTMKDV 966
                 V  KS    P   I        + L+       P  R T    
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 1e-39
 Identities = 65/292 (22%), Positives = 108/292 (36%), Gaps = 48/292 (16%)

Query: 678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           +F + ++L         GKG  G V+ AE  +  +  A+K L    +  + D        
Sbjct: 3   DFILHKML---------GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD-------- 45

Query: 737 GGVRDSFSAEIKTLG-SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCL 795
               +    E + L  +  H  +         +     + +Y+  G L   +        
Sbjct: 46  ---VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KF 100

Query: 796 EWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGD 855
           +             GL +LH      IV+RD+K +NIL+  +    IADFG+ K  + GD
Sbjct: 101 DLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157

Query: 856 FARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
               +NT  G+  YIAPE     K     D +S+GV++ E+L G+ P      E      
Sbjct: 158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ 209

Query: 916 WVRQKRGAIEVLDKSLRARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKD 965
                    E+        P     +E+  + L V L      P+ R  ++ 
Sbjct: 210 ---------ELFHSIRMDNPFYPRWLEKEAKDLLVKLFVRE--PEKRLGVRG 250

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-39
 Identities = 59/304 (19%), Positives = 109/304 (35%), Gaps = 45/304 (14%)

Query: 672 TPFQKLN----FTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAE 726
           T F++ N    +   + L         G G   +V +  E   G   A K +      + 
Sbjct: 1   TVFRQENVDDYYDTGEEL---------GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS 51

Query: 727 YDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSL 786
                     G  R+    E+  L  I+H N++       N+   +L+ + +  G L   
Sbjct: 52  RR--------GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF 103

Query: 787 LHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILI----GPEFEPYI 842
           L E+     E    +       Q L  +++     I H D+K  NI++     P+    I
Sbjct: 104 LAEKESLTEEEATEF-----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 158

Query: 843 ADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP 902
            DFGLA  +   DF      + G+  ++APE      +  ++D++S GV+   +L+G  P
Sbjct: 159 IDFGLAHKI---DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

Query: 903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT 962
                 +         +    +  ++             + +     LL  +  P  R T
Sbjct: 216 FLGDTKQ---------ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKD--PKKRMT 264

Query: 963 MKDV 966
           ++D 
Sbjct: 265 IQDS 268

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  148 bits (374), Expect = 2e-39
 Identities = 55/300 (18%), Positives = 105/300 (35%), Gaps = 42/300 (14%)

Query: 678 NFTVEQVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGI 736
           +F+V +++         G+G  G VY     + G++ A+K L    +  +          
Sbjct: 5   DFSVHRII---------GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET------ 49

Query: 737 GGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLE 796
             +  +    +  + +     IV         +    + D M  G L   L +       
Sbjct: 50  --LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-- 105

Query: 797 WELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDF 856
                        GL ++H+     +V+RD+K  NIL+       I+D GLA    +   
Sbjct: 106 EADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 160

Query: 857 ARSSNTVAGSYGYIAPEY-GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD 915
               +   G++GY+APE     +     +D +S G ++ ++L G  P      +  H +D
Sbjct: 161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218

Query: 916 WVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
            +                         L++L   LL  +   + R       A  +E+K+
Sbjct: 219 RMTLTM----------AVELPDSFSPELRSLLEGLLQRD--VNRRLGCLGRGA--QEVKE 264

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-39
 Identities = 47/277 (16%), Positives = 91/277 (32%), Gaps = 36/277 (12%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  GIV+R  E  + +    K +                           EI  L 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---------------VKKEISILN 56

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
             RH+NI+       +    +++++++    +   ++      L        +    + L
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEAL 115

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPY--IADFGLAKLVVEGDFARSSNTVAGSYGY 869
            +LH      I H DI+  NI+          I +FG A+ +       +   +  +  Y
Sbjct: 116 QFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEY 169

Query: 870 IAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDK 929
            APE      ++  +D++S G +V  +L+G  P      +   I++ +            
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEY------- 220

Query: 930 SLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
           +       EI          LL        R T  + 
Sbjct: 221 TFDEEAFKEISIEAMDFVDRLLVKE--RKSRMTASEA 255

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  142 bits (358), Expect = 3e-38
 Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 34/289 (11%)

Query: 693 VVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGS 752
            +G+G  G+VY+A+   GE  A+KK+                   G+  +   EI  L  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------------GIPSTTIREISILKE 56

Query: 753 IRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLA 812
           ++H NIV+       +   +L+++++       L        LE       +L    G+A
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIA 114

Query: 813 YLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAP 872
           Y H      ++HRD+K  N+LI  E E  IADFGLA+        R       +  Y AP
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAP 169

Query: 873 EYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-----------HIVDWVRQK 920
           +      K +   D++S G +  E++ G                       +  +W    
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 921 RGAIEVLDKSLRAR-PEVEIEEMLQTLGVALL--CVNPTPDDRPTMKDV 966
                  + ++    P     + L   G+ LL   +   P+ R T K  
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (357), Expect = 6e-38
 Identities = 48/294 (16%), Positives = 90/294 (30%), Gaps = 36/294 (12%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G +Y    +  GE +A+K     T                       E K   
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------------HPQLHIESKIYK 57

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            ++    +  +  C       +M   +   SL   L          +    +       +
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL-EDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 812 AYLHHDCVPPIVHRDIKANNILI---GPEFEPYIADFGLAKLVVEGD-----FARSSNTV 863
            Y+H       +HRD+K +N L+         YI DFGLAK   +         R +  +
Sbjct: 117 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 864 AGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA 923
            G+  Y +      ++ + + D+ S G V++    G       +        + R     
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYERISEKK 232

Query: 924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER 977
           +    + L      E    L        C +   DD+P    +  + + +   +
Sbjct: 233 MSTPIEVLCKGYPSEFATYLN------FCRSLRFDDKPDYSYLRQLFRNLFHRQ 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-37
 Identities = 55/295 (18%), Positives = 102/295 (34%), Gaps = 36/295 (12%)

Query: 692 SVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTL 750
           S +G+G  G+V  A +  N   +A+KK+                           EIK L
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKI-------------SPFEHQTYCQRTLREIKIL 60

Query: 751 GSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER-RDSCLEWELRYRIILGAAQ 809
              RH+NI+             +   Y+    +G+ L++  +   L  +     +    +
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSS-NTVAGSYG 868
           GL Y+H      ++HRD+K +N+L+    +  I DFGLA++                +  
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 869 YIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPID--------------PTIPEGLHI 913
           Y APE        T+  D++S G ++ E+L+ +                     P    +
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTMKDV 966
              +  K     +        P   +     +  + LL   +   P  R  ++  
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-37
 Identities = 57/290 (19%), Positives = 100/290 (34%), Gaps = 34/290 (11%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  G V++A+  E  E++A+K++                   GV  S   EI  L 
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------------GVPSSALREICLLK 56

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            ++HKNIVR      +     L++++              D   E    +       Q L
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLL 111

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
             L       ++HRD+K  N+LI    E  +A+FGLA+          S  V   +    
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVVTLWYRPP 170

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP--TIPEGLHIVDWVR----------- 918
                    +   D++S G +  E+    +P+ P   + + L  +  +            
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230

Query: 919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTMKDV 966
            K    +           V +   L   G  LL   +   P  R + ++ 
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 4e-37
 Identities = 62/287 (21%), Positives = 101/287 (35%), Gaps = 41/287 (14%)

Query: 689 VEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEI 747
           V   V+G G +G V +       E  A+K L                           E+
Sbjct: 15  VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------------CPKARREV 55

Query: 748 KTLGSI-RHKNIVRFLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYR 802
           +      +  +IVR +    N    R   L++ + +  G L S + +R D          
Sbjct: 56  ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115

Query: 803 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY---IADFGLAKLVVEGDFARS 859
           I+    + + YLH      I HRD+K  N+L   +       + DFG AK     +   S
Sbjct: 116 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---S 169

Query: 860 SNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ 919
             T   +  Y+APE     K  +  D++S GV++  +L G  P         H +     
Sbjct: 170 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY-----SNHGLAISPG 224

Query: 920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDV 966
            +  I +           E+ E ++ L   LL     P  R T+ + 
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTE--PTQRMTITEF 269

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-36
 Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 34/290 (11%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  G+VY+A     GEV+A+KK+   T               GV  +   EI  L 
Sbjct: 9   KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------------GVPSTAIREISLLK 56

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
            + H NIV+ L      N   L+++++ +  L   +     + +   L    +    QGL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           A+ H      ++HRD+K  N+LI  E    +ADFGLA+        R+      +  Y A
Sbjct: 116 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRA 170

Query: 872 PE-YGYMMKITEKSDVYSYGVVVLEVLTGKQP------------IDPTIPEGLHIVDWVR 918
           PE        +   D++S G +  E++T +              I  T+     +V    
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230

Query: 919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTMKDV 966
                 +        +   ++   L   G +LL   ++  P+ R + K  
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-36
 Identities = 53/295 (17%), Positives = 111/295 (37%), Gaps = 48/295 (16%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++G G  G VY    + +   +A+K +    ++   +  N              E+  L 
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPN--------GTRVPMEVVLLK 62

Query: 752 SIR--HKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQ 809
            +      ++R L      ++ +L+ +              R + L+ EL         +
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLE 121

Query: 810 GLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKLVVEGDFARSSNTVAGSYG 868
            + + H+     ++HRDIK  NILI     E  + DFG   L+ +  +        G+  
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRV 174

Query: 869 YIAPEY-GYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVL 927
           Y  PE+  Y       + V+S G+++ +++ G  P +                    E++
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----------------HDEEII 217

Query: 928 DKSLRARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM--IKEIKQERE 978
              +  R  V  E + +++       C+   P DRPT +++     ++++   +E
Sbjct: 218 RGQVFFRQRVSSECQHLIR------WCLALRPSDRPTFEEIQNHPWMQDVLLPQE 266

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-35
 Identities = 54/303 (17%), Positives = 104/303 (34%), Gaps = 46/303 (15%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  G V++A   + G+ +A+KK+        +              +   EIK L 
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF------------PITALREIKILQ 64

Query: 752 SIRHKNIVRFLGCCW--------NRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRI 803
            ++H+N+V  +  C          + +  L++D+  +   G L +      L    R   
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-- 122

Query: 804 ILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV--VEGDFARSSN 861
                  L  L++     I+HRD+KA N+LI  +    +ADFGLA+     +        
Sbjct: 123 ---MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 862 TVAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGKQP---------------IDP 905
               +  Y  PE            D++  G ++ E+ T                   +  
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239

Query: 906 TIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTM 963
           +I   +       +    +E++    R   +     +     + L+   +   P  R   
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

Query: 964 KDV 966
            D 
Sbjct: 300 DDA 302

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 2e-35
 Identities = 70/360 (19%), Positives = 127/360 (35%), Gaps = 61/360 (16%)

Query: 675  QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDK 733
            Q++++T  +V+         G G  G+VY+A+  ++GE++A+KK+               
Sbjct: 18   QEVSYTDTKVI---------GNGSFGVVYQAKLCDSGELVAIKKVLQD------------ 56

Query: 734  IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTR------LLMYDYMPNGSLGSLL 787
                  +   + E++ +  + H NIVR     ++   +       L+ DY+P        
Sbjct: 57   ------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110

Query: 788  H-ERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY-IADF 845
            H  R    L        +    + LAY+H      I HRDIK  N+L+ P+     + DF
Sbjct: 111  HYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDF 167

Query: 846  GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP--- 902
            G AK +V G+   S   +   Y             T   DV+S G V+ E+L G+     
Sbjct: 168  GSAKQLVRGEPNVS--YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225

Query: 903  -------------IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVA 949
                         +     E +  ++    +    ++                   L   
Sbjct: 226  DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR 285

Query: 950  LLCVNPTPDDRPTMKDVAAM--IKEIKQEREECMKVDMLPSEGSANGQRENNNSSSTAMM 1007
            LL     P  R T  +  A     E++    +       P+  +   Q  ++N     ++
Sbjct: 286  LLEYT--PTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATIL 343

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  134 bits (338), Expect = 2e-35
 Identities = 45/298 (15%), Positives = 96/298 (32%), Gaps = 42/298 (14%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G  G+++    + N + +A+K     + A +                   E +T  
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----------------LRDEYRTYK 55

Query: 752 SIRH-KNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQG 810
            +     I             +L+ D +  G     L +        +            
Sbjct: 56  LLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 113

Query: 811 LAYLHHDCVPPIVHRDIKANNILIGPEFEP-----YIADFGLAKLVVEGD-----FARSS 860
           +  +H      +V+RDIK +N LIG          Y+ DFG+ K   +         R  
Sbjct: 114 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

Query: 861 NTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP-TIPEGLHIVDWVRQ 919
             ++G+  Y++       + + + D+ + G V +  L G  P             + + +
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230

Query: 920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER 977
           K+ +  +  + L A    E  + +          N   D  P    +  +  ++ +  
Sbjct: 231 KKQSTPL--RELCAGFPEEFYKYMH------YARNLAFDATPDYDYLQGLFSKVLERL 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-34
 Identities = 58/286 (20%), Positives = 98/286 (34%), Gaps = 40/286 (13%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
           ++GKG  G V        G   A+K L    + A+ +                 E + L 
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-----------VAHTVTESRVLQ 60

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           + RH  +          +    + +Y   G L   L       +  E R R     A+ +
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFY--GAEIV 115

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
           + L +     +V+RDIK  N+++  +    I DFGL K  +      +  T  G+  Y+A
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLA 173

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE           D +  GVV+ E++ G+ P      E                + +  L
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---------------RLFELIL 218

Query: 932 RARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
                    +    ++L   LL  +  P  R       A  KE+ +
Sbjct: 219 MEEIRFPRTLSPEAKSLLAGLLKKD--PKQRLGGGPSDA--KEVME 260

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 3e-33
 Identities = 64/292 (21%), Positives = 108/292 (36%), Gaps = 40/292 (13%)

Query: 693 VVGKGCSGIVYRAE----MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIK 748
           V+G G  G V+        + G++ A+K L   T+  +              +    E +
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK----------AKTTEHTRTERQ 80

Query: 749 TLGSIRHK-NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGA 807
            L  IR    +V             L+ DY+  G L + L +R            + +  
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYV 135

Query: 808 AQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            + +  L H     I++RDIK  NIL+       + DFGL+K  V  +    +    G+ 
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTI 194

Query: 868 GYIAPE--YGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE 925
            Y+AP+   G      +  D +S GV++ E+LTG  P      +               E
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-----------AE 243

Query: 926 VLDKSLRARPEV--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ 975
           +  + L++ P    E+  + + L   LL  +  P  R           EIK+
Sbjct: 244 ISRRILKSEPPYPQEMSALAKDLIQRLLMKD--PKKRLGCG--PRDADEIKE 291

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  129 bits (324), Expect = 6e-33
 Identities = 51/278 (18%), Positives = 95/278 (34%), Gaps = 38/278 (13%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  G V   +  E+G   A+K L    +                 +    E + L 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-----------IEHTLNEKRILQ 96

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
           ++    +V+      + +   ++ +Y+  G + S L                        
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIA 871
            YLH      +++RD+K  N+LI  +    + DFG AK          + T+ G+   +A
Sbjct: 155 EYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206

Query: 872 PEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSL 931
           PE        +  D ++ GV++ E+  G  P     P    I + +   +          
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEKIVSGKV--------- 255

Query: 932 RARPEVEIEEMLQTLGVALLCVNPT---PDDRPTMKDV 966
             R        L+ L   LL V+ T    + +  + D+
Sbjct: 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 6e-32
 Identities = 65/327 (19%), Positives = 118/327 (36%), Gaps = 42/327 (12%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q++  T  +V     +   VG G  G V  A +   G  +A+KKL+    +  +      
Sbjct: 7   QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF------ 60

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHER--R 791
                       E++ L  +RH+N++  L       T     D+            +  +
Sbjct: 61  ------AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK 114

Query: 792 DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV 851
              L  +    ++    +GL Y+H   +    HRD+K  N+ +  + E  I DFGLA+  
Sbjct: 115 HEKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA 171

Query: 852 VEGDFARSSNTVAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGKQP-------- 902
                         +  Y APE     M+ T+  D++S G ++ E++TGK          
Sbjct: 172 DS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226

Query: 903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTL------GVALL--CVN 954
               I +          +R   +     ++  PE+E ++    L       V LL   + 
Sbjct: 227 QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLV 286

Query: 955 PTPDDRPTMKDVAAM--IKEIKQEREE 979
              + R T  +  A    + +    +E
Sbjct: 287 LDAEQRVTAGEALAHPYFESLHDTEDE 313

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (290), Expect = 1e-28
 Identities = 52/302 (17%), Positives = 101/302 (33%), Gaps = 55/302 (18%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G+G    V+ A  + N E + VK L P                   +     EIK L 
Sbjct: 42  KLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------------KKKIKREIKILE 84

Query: 752 SIR-HKNIVRFLGCCWNRNTRL--LMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA 808
           ++R   NI+       +  +R   L+++++ N     L        L        +    
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEIL 139

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPEF-EPYIADFGLAKLVVEGDFARSSNTVAGSY 867
           + L Y H      I+HRD+K +N++I  E  +  + D+GLA+    G     +  VA  Y
Sbjct: 140 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRY 194

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPT------------IPEGLHIVD 915
                            D++S G ++  ++  K+P                +     + D
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254

Query: 916 WVRQKRGAIE---------VLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPDDRPTMK 964
           ++ +    ++            K        E + ++    +  L   +      R T +
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

Query: 965 DV 966
           + 
Sbjct: 315 EA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-27
 Identities = 66/316 (20%), Positives = 115/316 (36%), Gaps = 48/316 (15%)

Query: 675 QKLNFTVEQVLKCLVEDSVVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDK 733
           Q+LN T+ +V +     S VG G  G V  A   + G  +AVKKL     +  +      
Sbjct: 7   QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH------ 60

Query: 734 IGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC-----WNRNTRLLMYDYMPNGSLGSLLH 788
                       E++ L  ++H+N++  L              + +  ++    L +++ 
Sbjct: 61  ------AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 114

Query: 789 ERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA 848
            ++   L  +    +I    +GL Y+H   +    HRD+K +N+ +  + E  I DFGLA
Sbjct: 115 CQK---LTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLA 168

Query: 849 KLVVEGDFARSSNTVAGSYGYIAPE-YGYMMKITEKSDVYSYGVVVLEVLTGKQP----- 902
           +                +  Y APE     M   +  D++S G ++ E+LTG+       
Sbjct: 169 R-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

Query: 903 ----------IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL- 951
                     +  T    L         R  I+ L + +       +      L V LL 
Sbjct: 224 HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ-MPKMNFANVFIGANPLAVDLLE 282

Query: 952 -CVNPTPDDRPTMKDV 966
             +    D R T    
Sbjct: 283 KMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 5e-27
 Identities = 57/308 (18%), Positives = 102/308 (33%), Gaps = 57/308 (18%)

Query: 693 VVGKGCSGIVYRA-EMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G  GIV  A +      +A+KKL        +                  E+  + 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH------------AKRAYRELVLMK 71

Query: 752 SIRHKNIVRFLGCCWNRNTR------LLMYDYMPNGSLGSLLHERRDSCLEWELRYRIIL 805
            + HKNI+  L     + T        L+ + M       +  E      + E    ++ 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLY 126

Query: 806 GAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAG 865
               G+ +LH      I+HRD+K +NI++  +    I DFGLA+                
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVV 180

Query: 866 SYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP----------------IDPTIPE 909
           +  Y APE    M   E  D++S G ++ E++  K                  +    PE
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240

Query: 910 GL---------HIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALL--CVNPTPD 958
            +         ++ +  +        L        + E  ++  +    LL   +   P 
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300

Query: 959 DRPTMKDV 966
            R ++ D 
Sbjct: 301 KRISVDDA 308

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  111 bits (278), Expect = 9e-27
 Identities = 98/423 (23%), Positives = 156/423 (36%), Gaps = 58/423 (13%)

Query: 51  SSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILN 110
           ++L+   K ++  +N+T  +S    D  Q+TT+      +       +  L NL  +  +
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 74

Query: 111 SNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYE 170
           +NQLT   P  L    KL ++L+ +N ++   P+     +    +      DI       
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 171 IGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFL 230
             +   L    ++D          +  LS L SL   +          + N + L  L +
Sbjct: 133 NLNRLELSSNTISD----------ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182

Query: 231 YENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQS 290
             N    S    L KL  LE ++   N      P  I    +L  + L+ N        +
Sbjct: 183 SSNK--VSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGT 236

Query: 291 FGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLA 350
             +L++L +L L+NN IS   P  LS  T L +L+L  NQIS           +      
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294

Query: 351 NCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS 410
           N                     +  L+NLT L L  N IS + P                
Sbjct: 295 NQL--------------EDISPISNLKNLTYLTLYFNNISDISP---------------- 324

Query: 411 FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLIL 470
             + T+LQ L  +NN +     SSLA+LT +  L    NQ   L P     L  + +L L
Sbjct: 325 VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 380

Query: 471 SKN 473
           +  
Sbjct: 381 NDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  104 bits (260), Expect = 2e-24
 Identities = 70/367 (19%), Positives = 129/367 (35%), Gaps = 47/367 (12%)

Query: 246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN 305
           L +  K +L + N    + +   +   + T+         S+      L++L ++  SNN
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNN 76

Query: 306 NISGSIPPVLSNATSLLQLQLDT-------------NQISVFFAWQNKLEGSIPSTLANC 352
            ++   P  L N T L+ + ++              N   +        +      L N 
Sbjct: 77  QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134

Query: 353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFG 412
             LE    + + ++        Q  +    +     ++ L   E  + SS     +    
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194

Query: 413 NCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSK 472
             T L+ L  +NN +    P  +   T L  L ++ NQ       +   L +L  L L+ 
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250

Query: 473 NSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDI----------------- 515
           N  S   P  L     L  L L +N++S   P+                           
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308

Query: 516 --SLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTG 573
              L L +N +S   P  +S+L KL  L  ++NK+   + +L+ L N+  L+  +N  + 
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISD 365

Query: 574 YLPDSKL 580
             P + L
Sbjct: 366 LTPLANL 372

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.1 bits (222), Expect = 1e-19
 Identities = 63/361 (17%), Positives = 113/361 (31%), Gaps = 46/361 (12%)

Query: 194 SLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLP----RELGKLQKL 249
           S   L ++ +L      +   I   +   + L  +    N L+   P     +L  +   
Sbjct: 39  SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMN 96

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG 309
              +                  + +  D+       +L +   + +++ ++   +   S 
Sbjct: 97  NNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSL 156

Query: 310 SIPPVLSNATSLLQLQLDTNQIS---------------------VFFAWQNKLEGSIPST 348
                 +  T L  L   T                            A  N++    P  
Sbjct: 157 QQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLG 216

Query: 349 LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
                +L+ + L+ N L       L  L NLT L L +N IS L P  +   + L  L+L
Sbjct: 217 --ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270

Query: 409 MSFGNCTQLQMLNLSNNTLGGT------LPSSLASLTRLQVLDISVNQFVGLIPESFGQL 462
            +        +  L+  T            S +++L  L  L +  N    + P     L
Sbjct: 271 GANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSL 328

Query: 463 ASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWN 522
             L RL  + N  S    SSL    ++  L    N++S   P  L  +  +   L L+  
Sbjct: 329 TKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRI-TQLGLNDQ 383

Query: 523 A 523
           A
Sbjct: 384 A 384

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 61.2 bits (147), Expect = 3e-10
 Identities = 65/316 (20%), Positives = 125/316 (39%), Gaps = 27/316 (8%)

Query: 293 NLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC 352
            L+   + +L   N++ ++    ++   +  LQ D   I         ++G     +   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI-------KSIDG-----VEYL 65

Query: 353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKL-LLISNGISGLIPPEIGNCSSLIRLRLMSF 411
            +L  ++ S+N LT      +  L+NLTKL  ++ N         + N ++L  L L + 
Sbjct: 66  NNLTQINFSNNQLT-----DITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 120

Query: 412 GNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILS 471
                  + NL+N        ++++ ++ L  L        G        LA+L  L   
Sbjct: 121 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 180

Query: 472 KNSFS-GAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPP 530
             S +  +  S L +  +L+SL  ++N++S   P+ +         L+L+ N L      
Sbjct: 181 DISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNL---DELSLNGNQLKD--IG 235

Query: 531 QISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLSATEMA 590
            +++L  L+ LDL++N++   L  LSGL  L  L +  N  +   P + L    +     
Sbjct: 236 TLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294

Query: 591 GNQGLCSRGHESCFLS 606
                 S       L+
Sbjct: 295 NQLEDISPISNLKNLT 310

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 4e-07
 Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 6/111 (5%)

Query: 2   SSIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLII 61
           S +    +  N   +          S    +T + +    +    P  +SSL+ LQ+L  
Sbjct: 279 SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFF 336

Query: 62  SGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSN 112
           + + ++      L + T +  +    N +    P  +  L  +  L LN  
Sbjct: 337 ANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.4 bits (88), Expect = 0.004
 Identities = 8/71 (11%), Positives = 24/71 (33%), Gaps = 4/71 (5%)

Query: 436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLS 495
            +L       +        + ++   L  +  L   +          +    +L  ++ S
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 74

Query: 496 SNKLSGKIPVE 506
           +N+L+   P++
Sbjct: 75  NNQLTDITPLK 85

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (267), Expect = 1e-25
 Identities = 41/218 (18%), Positives = 82/218 (37%), Gaps = 11/218 (5%)

Query: 693 VVGKGCSGIVYRAE-MENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            +G G    V+ A+ M N   +A+K +    +  E      K+    ++    A+     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKL----LQRVNDADNTKED 75

Query: 752 SIRHKNIVRFLGCC---WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAA 808
           S+   +I++ L            ++M   +   +L +L+ +     +      +I     
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 809 QGLAYLHHDCVPPIVHRDIKANNILIGPE-FEPYIADFGLAKLVVEGDFARSSNTVAGSY 867
            GL Y+H  C   I+H DIK  N+L+        +    +A L     +         + 
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDP 905
            Y +PE          +D++S   ++ E++TG    +P
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  103 bits (256), Expect = 2e-24
 Identities = 65/316 (20%), Positives = 119/316 (37%), Gaps = 36/316 (11%)

Query: 5   PSALSNWNPSDSNPC--KWSHITCSPQNF---VTEINIQSIELE--LPFPSNLSSLSFLQ 57
           P+ LS+W P+ ++ C   W  + C        V  +++  + L    P PS+L++L +L 
Sbjct: 21  PTTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79

Query: 58  KLIISGS-NLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTG 116
            L I G  NL GPI P +   TQL  + ++  ++ G +P  + ++  L  L  + N L+G
Sbjct: 80  FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG 139

Query: 117 EIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS 176
            +P  + +   L  +    N +SG +P   G    L          + GKIP    +   
Sbjct: 140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN- 198

Query: 177 LLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLS 236
                                     +    +  +       +    +         +  
Sbjct: 199 -------------------------LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233

Query: 237 GSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSS 296
                ++G  + L  + L  N   G +P+ +   K L ++++S N   G +P   GNL  
Sbjct: 234 AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQR 292

Query: 297 LEELMLSNNNISGSIP 312
            +    +NN      P
Sbjct: 293 FDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 80.6 bits (197), Expect = 6e-17
 Identities = 61/270 (22%), Positives = 103/270 (38%), Gaps = 7/270 (2%)

Query: 220 GNCSELVDLFLYENDLSG--SLPRELGKLQKLEKMLLWQN-NFDGAIPEEIGNCKSLKTI 276
                + +L L   +L     +P  L  L  L  + +    N  G IP  I     L  +
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 277 DLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFA 336
            ++    SG++P     + +L  L  S N +SG++PP +S+  +L+ +  D N+IS    
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 337 WQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPE 396
                   + +++   R+     +       +L       +N+ +        S     +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLS-RNMLEGDASVLFGSDKNTQK 225

Query: 397 IGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIP 456
           I    + +   L   G    L  L+L NN + GTLP  L  L  L  L++S N   G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

Query: 457 ESFGQLASLNRLILSKNSFSGAIPSSLGRC 486
           +  G L   +    + N      P  L  C
Sbjct: 286 Q-GGNLQRFDVSAYANNKCLCGSP--LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 80.2 bits (196), Expect = 9e-17
 Identities = 52/275 (18%), Positives = 94/275 (34%), Gaps = 27/275 (9%)

Query: 256 QNNFDGAIPEEIGNCKSLKTIDLSLNFFSG--SLPQSFGNLSSLEELMLSNN-NISGSIP 312
              + G + +       +  +DLS         +P S  NL  L  L +    N+ G IP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 313 PVLSNATSLLQLQLDTNQISVFFAW--------------QNKLEGSIPSTLANCRSLEAV 358
           P ++  T L  L +    +S                    N L G++P ++++  +L  +
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 359 DLSHNALTGSLHPGLFQLQNLTK-LLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQL 417
               N ++G++         L   + +  N ++G IPP   N +        +       
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS 214

Query: 418 QM--------LNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLI 469
            +                       +     L  LD+  N+  G +P+   QL  L+ L 
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 470 LSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIP 504
           +S N+  G IP   G  +       ++NK     P
Sbjct: 275 VSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.8 bits (182), Expect = 5e-15
 Identities = 63/278 (22%), Positives = 112/278 (40%), Gaps = 16/278 (5%)

Query: 126 IKLKNLLLFDNYLSGN--LPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLA 183
            ++ NL L    L     +P  L  L  L  +  GG  ++ G IP  I     L  + + 
Sbjct: 50  YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYIT 109

Query: 184 DTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPREL 243
            T V+G++P  L ++  L +L      LSG +PP I +   LV +    N +SG++P   
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169

Query: 244 GKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLS 303
           G   KL   +    N             +L  +DLS N   G     FG+  + +++ L+
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229

Query: 304 NNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHN 363
            N+++  +                +  ++      N++ G++P  L   + L ++++S N
Sbjct: 230 KNSLAFDLGK-----------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 364 ALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCS 401
            L G + P    LQ        +N    L    +  C+
Sbjct: 279 NLCGEI-PQGGNLQRFDVSAYANN--KCLCGSPLPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.0 bits (180), Expect = 1e-14
 Identities = 66/265 (24%), Positives = 101/265 (38%), Gaps = 36/265 (13%)

Query: 375 QLQNLTKLLLISNGISGL--IPPEIGNCSSLIRLRLMSFGN-----------CTQLQMLN 421
           Q   +  L L    +     IP  + N   L  L +    N            TQL  L 
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107

Query: 422 LSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPS 481
           +++  + G +P  L+ +  L  LD S N   G +P S   L +L  +    N  SGAIP 
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 482 SLGRCESLQS-LDLSSNKLSGKIPVELFEIEGLDIS---------------------LNL 519
           S G    L + + +S N+L+GKIP     +    +                         
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227

Query: 520 SWNALSGAIPPQISALNKLSILDLSHNKLGGDL-LALSGLDNLVSLNVSYNNFTGYLPDS 578
                      ++     L+ LDL +N++ G L   L+ L  L SLNVS+NN  G +P  
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287

Query: 579 KLFRQLSATEMAGNQGLCSRGHESC 603
              ++   +  A N+ LC     +C
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.2 bits (170), Expect = 2e-13
 Identities = 63/261 (24%), Positives = 104/261 (39%), Gaps = 31/261 (11%)

Query: 189 GSLPASLGKLSKLQSLSVYTTM-LSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQ 247
             +P+SL  L  L  L +     L G IPP I   ++L  L++   ++SG++P  L +++
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 248 KLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEE-LMLSNNN 306
            L  +    N   G +P  I +  +L  I    N  SG++P S+G+ S L   + +S N 
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185

Query: 307 ISGSIPPVLSNATSLLQLQLDTNQISVF------------FAWQNKLEGSIPSTLANCRS 354
           ++G IPP  +N                                           +   ++
Sbjct: 186 LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKN 245

Query: 355 LEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNC 414
           L  +DL +N + G+L  GL QL+ L  L +  N + G IP                 GN 
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP---------------QGGNL 290

Query: 415 TQLQMLNLSNNTL--GGTLPS 433
            +  +   +NN    G  LP+
Sbjct: 291 QRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 64.0 bits (154), Expect = 2e-11
 Identities = 57/287 (19%), Positives = 99/287 (34%), Gaps = 27/287 (9%)

Query: 292 GNLSSLEELMLSNNNISG--SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTL 349
                +  L LS  N+     IP  L+N   L  L +            N L G IP  +
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYI---------GGINNLVGPIPPAI 97

Query: 350 ANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLM 409
           A    L  + ++H  ++G++   L Q++ L  L    N +SG +PP              
Sbjct: 98  AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS------------- 144

Query: 410 SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLI 469
              +   L  +    N + G +P S  S ++L            L  +     A+LN   
Sbjct: 145 -ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN--RLTGKIPPTFANLNLAF 201

Query: 470 LSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIP 529
           +  +       +S+       +  +   K S    +    +      L+L  N + G +P
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261

Query: 530 PQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLP 576
             ++ L  L  L++S N L G++     L        + N      P
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 50.5 bits (119), Expect = 5e-07
 Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 3/65 (4%)

Query: 61  ISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPK 120
           +  + + G +   L     L +++VS N+L G +P   G L         +N+     P 
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP- 308

Query: 121 ELGAC 125
            L AC
Sbjct: 309 -LPAC 312

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 96.0 bits (238), Expect = 3e-23
 Identities = 33/208 (15%), Positives = 63/208 (30%), Gaps = 26/208 (12%)

Query: 692 SVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG 751
            ++G+G    V+    E      VK             +  K         FS       
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHT----SFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 752 SIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGL 811
               + + +  G    +     +Y +  N  L  L+  +    +  E    ++    + +
Sbjct: 62  RNEFRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116

Query: 812 AYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLV----VEGDFARSSNTVAGSY 867
           A  +H     IVH D+   N+L+  E   +I DF  +  V          R    +   +
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172

Query: 868 GYIAPEYGYMMKITEKSDVYSYGVVVLE 895
                 Y        + D+ S    +L+
Sbjct: 173 S---RTYRT------EKDINSAIDRILQ 191

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 98.2 bits (243), Expect = 7e-23
 Identities = 51/265 (19%), Positives = 87/265 (32%), Gaps = 7/265 (2%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSL 321
            +P+++        +DL  N  +      F NL +L  L+L NN IS   P   +    L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 322 LQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTK 381
            +L L  NQ+        K    +         +     +       +  G   L++   
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 382 LLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRL 441
                 G+  L    I +      +  +  G    L  L+L  N +     +SL  L  L
Sbjct: 142 ENGAFQGMKKLSYIRIADT----NITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNL 197

Query: 442 QVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSG 501
             L +S N    +   S      L  L L+ N     +P  L   + +Q + L +N +S 
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 256

Query: 502 KIPVELFEIEGLDISLNLSWNALSG 526
               +           + S  +L  
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFS 281

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 95.5 bits (236), Expect = 6e-22
 Identities = 59/288 (20%), Positives = 100/288 (34%), Gaps = 37/288 (12%)

Query: 238 SLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSL 297
            +P++L        + L  N        +  N K+L T+ L  N  S   P +F  L  L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 298 EELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISV-------------FFAWQNKLEGS 344
           E L LS N +      +      L   + +  ++                     K  G 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 345 IPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLI 404
                   + L  + ++   +T ++  GL    +LT+L L  N I+ +    +   ++L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 405 RLR----------LMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGL 454
           +L             S  N   L+ L+L+NN L    P  LA    +QV+ +  N    +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAI 257

Query: 455 IPESF------GQLASLNRLILSKNSFS-GAIPSSLGRC-ESLQSLDL 494
               F       + AS + + L  N      I  S  RC     ++ L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 88.9 bits (219), Expect = 8e-20
 Identities = 54/316 (17%), Positives = 104/316 (32%), Gaps = 28/316 (8%)

Query: 19  CKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCT 78
           C    + CS                   P +L        L +  + +T     D  +  
Sbjct: 10  CHLRVVQCSDLGLEK------------VPKDLPPD--TALLDLQNNKITEIKDGDFKNLK 55

Query: 79  QLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYL 138
            L T+ + +N +    P +   L+ L+ L L+ NQL     K      +L+        +
Sbjct: 56  NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115

Query: 139 SGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKL 198
             ++   L +++ +E+         +G         + L  + +ADT +  ++P  L   
Sbjct: 116 RKSVFNGLNQMIVVELG--TNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--P 170

Query: 199 SKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNN 258
             L  L +    ++      +   + L  L L  N +S      L     L ++ L  N 
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230

Query: 259 FDGAIPEEIGNCKSLKTIDLSLNFFSG------SLPQSFGNLSSLEELMLSNNNIS-GSI 311
               +P  + + K ++ + L  N  S         P      +S   + L +N +    I
Sbjct: 231 LVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289

Query: 312 PP-VLSNATSLLQLQL 326
            P           +QL
Sbjct: 290 QPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.8 bits (203), Expect = 1e-17
 Identities = 36/180 (20%), Positives = 64/180 (35%), Gaps = 5/180 (2%)

Query: 399 NCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPES 458
            CS L  L  +         +L+L NN +         +L  L  L +  N+   + P +
Sbjct: 16  QCSDL-GLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74

Query: 459 FGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLN 518
           F  L  L RL LSKN             + L+  +    K+   +   L ++  ++  L 
Sbjct: 75  FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE--LG 132

Query: 519 LSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDS 578
            +    SG        + KLS + ++   +    +      +L  L++  N  T     S
Sbjct: 133 TNPLKSSGIENGAFQGMKKLSYIRIADTNITT--IPQGLPPSLTELHLDGNKITKVDAAS 190

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.2 bits (227), Expect = 5e-21
 Identities = 56/289 (19%), Positives = 88/289 (30%), Gaps = 30/289 (10%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSL 321
           A+P  I    + + I L  N  S     SF    +L  L L +N ++             
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA-------- 74

Query: 322 LQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTK 381
                      +  +   +L    P+T      L  + L    L          L  L  
Sbjct: 75  -AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQY 133

Query: 382 LLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRL 441
           L L  N +  L                 +F +   L  L L  N +      +   L  L
Sbjct: 134 LYLQDNALQALPDD--------------TFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179

Query: 442 QVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSG 501
             L +  N+   + P +F  L  L  L L  N+ S     +L    +LQ L L+ N    
Sbjct: 180 DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239

Query: 502 KIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG 550
                      L      S + +  ++P +   L    +  L+ N L G
Sbjct: 240 DCRARPL-WAWLQ-KFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.3 bits (204), Expect = 5e-18
 Identities = 57/262 (21%), Positives = 94/262 (35%), Gaps = 17/262 (6%)

Query: 344 SIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSS- 402
           ++P  +    + + + L  N ++          +NLT L L SN ++ +        +  
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 403 ----------LIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFV 452
                     L  +   +F    +L  L+L    L    P     L  LQ L +  N   
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 453 GLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEG 512
            L  ++F  L +L  L L  N  S     +     SL  L L  N+++   P   F   G
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP-HAFRDLG 201

Query: 513 LDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT 572
             ++L L  N LS      ++ L  L  L L+ N    D  A      L     S +   
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVP 261

Query: 573 GYLPDS---KLFRQLSATEMAG 591
             LP     +  ++L+A ++ G
Sbjct: 262 CSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (201), Expect = 2e-17
 Identities = 63/287 (21%), Positives = 98/287 (34%), Gaps = 17/287 (5%)

Query: 81  TTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSG 140
            T       L   VP  I      Q + L+ N+++        AC  L  L L  N L+ 
Sbjct: 14  VTTSCPQQGLQA-VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70

Query: 141 NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSK 200
                   L  LE +    N  +    P        L  + L    +    P     L+ 
Sbjct: 71  IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130

Query: 201 LQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFD 260
           LQ L +    L         +   L  LFL+ N +S    R    L  L+++LL QN   
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190

Query: 261 GAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATS 320
              P    +   L T+ L  N  S    ++   L +L+ L L++N               
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAW 249

Query: 321 LLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTG 367
           L + +  ++++            S+P  LA  R L+   L+ N L G
Sbjct: 250 LQKFRGSSSEVP----------CSLPQRLAG-RDLK--RLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (168), Expect = 2e-13
 Identities = 51/252 (20%), Positives = 79/252 (31%), Gaps = 16/252 (6%)

Query: 358 VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQL 417
                  L  ++  G+       ++ L  N IS +       C +L  L L S       
Sbjct: 16  TSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 418 QMLNLSNNT-----------LGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLN 466
                               L    P++   L RL  L +       L P  F  LA+L 
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132

Query: 467 RLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSG 526
            L L  N+       +     +L  L L  N++S         +  LD    L  N ++ 
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAH 191

Query: 527 AIPPQISALNKLSILDLSHN-KLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKLFRQLS 585
             P     L +L  L L  N        AL+ L  L  L ++ N +        L+  L 
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251

Query: 586 ATEMAGNQGLCS 597
               + ++  CS
Sbjct: 252 KFRGSSSEVPCS 263

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.1 bits (167), Expect = 3e-13
 Identities = 57/288 (19%), Positives = 97/288 (33%), Gaps = 31/288 (10%)

Query: 167 IPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELV 226
           +P  I    +   + L   +++    AS      L  L +++ +L+          + L 
Sbjct: 26  VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 227 DLFLYENDLSGSL-PRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSG 285
            L L +N    S+ P     L +L  + L +       P       +L+ + L  N    
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 286 SLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSI 345
               +F +L +L  L L  N IS           SL +L L           QN++    
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL----------HQNRVAHVH 193

Query: 346 PSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR 405
           P    +   L  + L  N L+      L  L+ L  L L  N       P + +C +   
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN-------PWVCDCRAR-- 244

Query: 406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG 453
                      LQ    S++ +  +LP  LA      +  ++ N   G
Sbjct: 245 ------PLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.8 bits (156), Expect = 9e-12
 Identities = 53/311 (17%), Positives = 107/311 (34%), Gaps = 33/311 (10%)

Query: 18  PCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDC 77
           PC      C  +  VT  +     L+   P  + +    Q++ + G+ ++   +     C
Sbjct: 1   PCP-GACVCYNEPKVT-TSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRAC 55

Query: 78  TQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEI-PKELGACIKLKNLLLFDN 136
             LT + + SN L     ++   L  L+ L L+ N     + P       +L  L L   
Sbjct: 56  RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL--- 112

Query: 137 YLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLG 196
                                     +    P       +L  + L D  +      +  
Sbjct: 113 ----------------------DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 197 KLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQ 256
            L  L  L ++   +S            L  L L++N ++   P     L +L  + L+ 
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 257 NNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLS 316
           NN      E +   ++L+ + L+ N +     ++    + L++   S++ +  S+P  L+
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQRLA 269

Query: 317 NATSLLQLQLD 327
               L +L  +
Sbjct: 270 G-RDLKRLAAN 279

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.0 bits (133), Expect = 7e-09
 Identities = 38/236 (16%), Positives = 70/236 (29%), Gaps = 5/236 (2%)

Query: 2   SSIPSALSNWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLII 61
            +  +    W  S+      +                + +L    P+    L  L  L +
Sbjct: 53  RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112

Query: 62  SGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKE 121
               L             L  + +  N+L      +   L NL  L L+ N+++    + 
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172

Query: 122 LGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVG 181
                 L  LLL  N ++   P     L  L  +    N          +   ++L  + 
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLR 231

Query: 182 LADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSG 237
           L D         +    + LQ     ++ +   +P ++     L    L  NDL G
Sbjct: 232 LNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRD-LKR--LAANDLQG 283

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.7 bits (148), Expect = 7e-11
 Identities = 30/190 (15%), Positives = 51/190 (26%), Gaps = 6/190 (3%)

Query: 262 AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSL 321
           A+P ++   K    + LS N        +    + L +L L    ++             
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81

Query: 322 LQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTK 381
           L L  +  Q              +  +     SL    L        L+    +L+ L  
Sbjct: 82  LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141

Query: 382 LLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRL 441
            LL        +     N + L             L  L L  N+   T+P        L
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELP---AGLLNGLENLDTLLLQENS-LYTIPKGFFGSHLL 197

Query: 442 QVLDISVNQF 451
               +  N +
Sbjct: 198 PFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.6 bits (135), Expect = 3e-09
 Identities = 41/229 (17%), Positives = 59/229 (25%), Gaps = 60/229 (26%)

Query: 351 NCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMS 410
              S   V+     LT +L P L +  + T L L  N +       +   + L +L L  
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 411 FGNCTQLQMLNLSN-------------------------------NTLGGTLPSSLASLT 439
                      L                                 N L      +L  L 
Sbjct: 65  AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 440 RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKL 499
            LQ L +  N+   L P        L +L L+ N+ +      L   E+L +L L  N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

Query: 500 SGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKL 548
                                       IP      + L    L  N  
Sbjct: 185 Y--------------------------TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 8e-08
 Identities = 37/233 (15%), Positives = 70/233 (30%), Gaps = 32/233 (13%)

Query: 97  SIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIR 156
            + K+ +  ++  +   LT  +P +L        L L +N L       L     L  + 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 157 AGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIP 216
               +    ++                              L  L +L +    L     
Sbjct: 62  LDRAELTKLQVDG---------------------------TLPVLGTLDLSHNQLQSLPL 94

Query: 217 PQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTI 276
                 +  V      N L+      L  L +L+++ L  N      P  +     L+ +
Sbjct: 95  LGQTLPALTVLDV-SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153

Query: 277 DLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTN 329
            L+ N  +         L +L+ L+L  N++  +IP     +  L    L  N
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 1e-07
 Identities = 36/212 (16%), Positives = 62/212 (29%), Gaps = 10/212 (4%)

Query: 73  DLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLL 132
           ++        ++    +L   +P  + K  +   L L+ N L       L    +L  L 
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL- 60

Query: 133 LFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLP 192
                L      +L     L V+          +    +G     L V         SLP
Sbjct: 61  ----NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116

Query: 193 ASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYE-NDLSGSLPRELGKLQKLEK 251
               +                 +PP +   +  ++      N+L+      L  L+ L+ 
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176

Query: 252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFF 283
            LL Q N    IP+       L    L  N +
Sbjct: 177 -LLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.4 bits (111), Expect = 3e-06
 Identities = 37/211 (17%), Positives = 63/211 (29%), Gaps = 10/211 (4%)

Query: 51  SSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILN 110
           S ++   ++     NLT  + PDL      T + +S N L     +++     L  L L+
Sbjct: 7   SKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 111 SNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYE 170
             +LT            L  L   D   +    + L       +     + +    +P  
Sbjct: 64  RAELTKLQV-----DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 171 IGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPP-QIGNCSELVDLF 229
                  L           +LP  L   +              E+P   +     L  L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 230 LYENDLSGSLPRELGKLQKLEKMLLWQNNFD 260
           L EN L  ++P+       L    L  N + 
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 4e-05
 Identities = 38/209 (18%), Positives = 60/209 (28%), Gaps = 24/209 (11%)

Query: 410 SFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLI 469
                     +N     L   LP  L       +L +S N        +      L +L 
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 470 LSKNS--------------------FSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFE 509
           L +                              LG+     ++   S      +P+    
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 510 IEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNK-LGGDLLALSGLDNLVSLNVSY 568
             G    L L  N L    P  ++   KL  L L++N         L+GL+NL +L +  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 569 NNFTGYLPDSKLFRQLSATEMAGNQGLCS 597
           N+             L    + GN  LC+
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGNPWLCN 210

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.7 bits (143), Expect = 5e-10
 Identities = 40/271 (14%), Positives = 85/271 (31%), Gaps = 16/271 (5%)

Query: 202 QSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNF-D 260
           Q+L +    L  ++  ++ +   ++      + +   L  E     +++ M L  +    
Sbjct: 3   QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60

Query: 261 GAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEEL--MLSNNNISGSIPPVLSNA 318
             +   +  C  L+ + L     S  +  +    S+L  L     +     ++  +LS+ 
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 319 TSLLQLQLDTNQISVFFAWQNKL----EGSIPSTLANCRSLEAVDLSHNALTGSLHPGLF 374
           + L +L L           Q  +    E      L+  R           +    +    
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 375 QLQNLTKLLLISNGISGLIPP----EIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGT 430
            L +   L          +       +  C  +I   L+  G    L+ L +      GT
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 431 LPSSLASLTRLQVLDISVNQFVGLIPESFGQ 461
           L     +L  LQ   I+ + F  +   + G 
Sbjct: 241 LQLLKEALPHLQ---INCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (141), Expect = 8e-10
 Identities = 44/289 (15%), Positives = 85/289 (29%), Gaps = 39/289 (13%)

Query: 274 KTIDLSLNFFSGSLPQSFGNLSS--LEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
           +T+DL+        P   G L S  +       + +   +    S    +  + L  + I
Sbjct: 3   QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVI 58

Query: 332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLIS--NGI 389
                       ++   L+ C  L+ + L    L+  +   L +  NL +L L       
Sbjct: 59  E---------VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109

Query: 390 SGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVN 449
              +   + +CS L  L L    + T+  +     +        +L+   +         
Sbjct: 110 EFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLST 169

Query: 450 QFV-----------------GLIPESFGQLASLNRLILSK-NSFSGAIPSSLGRCESLQS 491
                                   + F QL  L  L LS+           LG   +L++
Sbjct: 170 LVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 229

Query: 492 LDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSI 540
           L +      G + +    +  L I+ +      +    P I       I
Sbjct: 230 LQVFGIVPDGTLQLLKEALPHLQINCSH----FTTIARPTIGNKKNQEI 274

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 3e-07
 Identities = 37/252 (14%), Positives = 79/252 (31%), Gaps = 14/252 (5%)

Query: 32  VTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTG-PISPDLGDCTQLTTIDVSSNSL 90
           V         ++ P   + S    +Q + +S S +    +   L  C++L  + +    L
Sbjct: 25  VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRL 83

Query: 91  VGGVPSSIGKLINLQDLILNSNQLTGEIPKE--------LGACIKLKNLLLFDNYLSGNL 142
              + +++ K  NL  L L+      E   +        L            + ++   +
Sbjct: 84  SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 143

Query: 143 PVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQ 202
                 +  L +     N   +            + +       +         +L+ LQ
Sbjct: 144 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203

Query: 203 SLSV-YTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDG 261
            LS+     +  E   ++G    L  L ++     G+L      L  L+   +  ++F  
Sbjct: 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTT 260

Query: 262 AIPEEIGNCKSL 273
                IGN K+ 
Sbjct: 261 IARPTIGNKKNQ 272

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 6e-07
 Identities = 15/91 (16%), Positives = 36/91 (39%), Gaps = 5/91 (5%)

Query: 490 QSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLG 549
           Q+LDL+   L   +   L     +  +     + +   +    S   ++  +DLS++ + 
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVI--AFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIE 59

Query: 550 GDLLA--LSGLDNLVSLNVSYNNFTGYLPDS 578
              L   LS    L +L++     +  + ++
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 58.7 bits (140), Expect = 1e-09
 Identities = 49/325 (15%), Positives = 93/325 (28%), Gaps = 31/325 (9%)

Query: 271 KSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISG----SIPPVLSNATSLLQLQL 326
           KSLK   ++      S+        S++E++LS N I       +   +++   L   + 
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 327 DTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKL---L 383
                        +    +   L  C  L  V LS NA   +    L    +       L
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 384 LISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG----GTLPSSLASLT 439
            + N   G         +           N   L+ +    N L          +  S  
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 440 RLQVLDISVNQFVGLIPESFGQLASLNRLIL---------SKNSFSGAIPSSLGRCESLQ 490
            L  + +  N       E            L           +  S A+  +L    +L+
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 491 SLDLSSNKLSGKIPVELFEIEGLDI-----SLNLSWNALSGAIPPQISA-----LNKLSI 540
            L L+   LS +    + +           +L L +N +       +       +  L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 541 LDLSHNKLGGDLLALSGLDNLVSLN 565
           L+L+ N+   +   +  +  + S  
Sbjct: 307 LELNGNRFSEEDDVVDEIREVFSTR 331

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.9 bits (117), Expect = 1e-06
 Identities = 49/335 (14%), Positives = 106/335 (31%), Gaps = 30/335 (8%)

Query: 147 GKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKV----AGSLPASLGKLSKLQ 202
           GK + L+ I     K +       + +  S+  + L+   +    A  L  ++     L+
Sbjct: 7   GKSLKLDAITTEDEKSVFA----VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 203 SLSV---YTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNF 259
                  +T  +  EIP  +    + +      + +  S        Q+     L ++  
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122

Query: 260 DGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNAT 319
              +              ++      ++ +   N   L  ++   N +        +   
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182

Query: 320 SLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALT----GSLHPGLFQ 375
              +  L T ++         +E  +   LA C+ L+ +DL  N  T     +L   L  
Sbjct: 183 QSHR-LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241

Query: 376 LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL 435
             NL +L L    +S      + +          S      LQ L L  N +      +L
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDA--------FSKLENIGLQTLRLQYNEIELDAVRTL 293

Query: 436 AS-----LTRLQVLDISVNQFVGLIPESFGQLASL 465
            +     +  L  L+++ N+F     +   ++  +
Sbjct: 294 KTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.1 bits (102), Expect = 6e-05
 Identities = 47/312 (15%), Positives = 85/312 (27%), Gaps = 34/312 (10%)

Query: 232 ENDLSGSLPRELGKLQKLEKMLLWQNNFDG----AIPEEIGNCKSLKTIDLSLNF----- 282
             D   S+   L +   +++++L  N         + E I + K L+  + S  F     
Sbjct: 17  TEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK 75

Query: 283 -----FSGSLPQSFGNLSSLEELMLSNNNISGS-------IPPVLSNATSLLQLQLDTNQ 330
                    L Q+      L  + LS+N    +            +    L         
Sbjct: 76  DEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGP 135

Query: 331 ISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGIS 390
            +     +   E ++     N   L ++    N L         +     +LL     + 
Sbjct: 136 QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 195

Query: 391 GLIPPEIGNCSSLIRLR----LMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDI 446
             I PE      L  L     L              S+                L    +
Sbjct: 196 NGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 255

Query: 447 SVNQFVGLI-PESFGQLASLNRLILSKNSFSGAIPSSL-----GRCESLQSLDLSSNKLS 500
           S      ++   S  +   L  L L  N        +L      +   L  L+L+ N+ S
Sbjct: 256 SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315

Query: 501 --GKIPVELFEI 510
               +  E+ E+
Sbjct: 316 EEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 0.002
 Identities = 13/96 (13%), Positives = 30/96 (31%), Gaps = 5/96 (5%)

Query: 508 FEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL-----ALSGLDNLV 562
           F IEG  + L+        ++   +   + +  + LS N +G +        ++   +L 
Sbjct: 3   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 563 SLNVSYNNFTGYLPDSKLFRQLSATEMAGNQGLCSR 598
               S         +     +L    +     L + 
Sbjct: 63  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTV 98

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 57.0 bits (136), Expect = 2e-09
 Identities = 37/227 (16%), Positives = 78/227 (34%), Gaps = 18/227 (7%)

Query: 269 NCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDT 328
              +   I    +  + ++ Q+  +L  +  L      ++ +I   +    +L+ L+L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72

Query: 329 NQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNG 388
           NQI+     +N  + +      N     +      ++                  L +  
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 389 ISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISV 448
           +  L   +I N S L  L  + + +    Q+ +           + LA+L++L  L    
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD----------LTPLANLSKLTTLKADD 182

Query: 449 NQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLS 495
           N+   + P     L +L  + L  N  S   P  L    +L  + L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 4e-08
 Identities = 24/225 (10%), Positives = 65/225 (28%), Gaps = 17/225 (7%)

Query: 293 NLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC 352
            L++  ++    +N++ ++    ++   +  L      ++        +EG     +   
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-------TIEG-----VQYL 62

Query: 353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFG 412
            +L  ++L  N +T              +L          I       +  +    ++  
Sbjct: 63  NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122

Query: 413 NCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSK 472
                             + +         +  +S+             L+ L  L    
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 473 NSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVE-LFEIEGLDIS 516
           N  S   P  L    +L  + L +N++S   P+     +  + ++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 1e-06
 Identities = 42/230 (18%), Positives = 69/230 (30%), Gaps = 20/230 (8%)

Query: 101 LINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGN 160
           L N   +    + +T  + +       +  L  F   ++  +   +  L NL  +    N
Sbjct: 18  LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73

Query: 161 KDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIG 220
                            L            L             ++  T         + 
Sbjct: 74  -------QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 221 NCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSL 280
             S L  L+L  N ++   P             L   N   +    + N   L T+    
Sbjct: 127 GLSNLQVLYLDLNQITNISPLA----GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 281 NFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQ 330
           N  S   P    +L +L E+ L NN IS   P  L+N ++L  + L TNQ
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 1e-06
 Identities = 40/231 (17%), Positives = 78/231 (33%), Gaps = 7/231 (3%)

Query: 315 LSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLF 374
           ++  T++  +  D    +       K   +   T A+   +  +      +T     G+ 
Sbjct: 3   ITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI--EGVQ 60

Query: 375 QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSS 434
            L NL  L L  N I+ L P +     + + L      N + +  L         +   +
Sbjct: 61  YLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQIT 120

Query: 435 LASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL 494
             +          +   +  I          N   LS  +   +  + L     L +L  
Sbjct: 121 DVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA 180

Query: 495 SSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSH 545
             NK+S   P  L  +  L I ++L  N +S   P  ++  + L I+ L++
Sbjct: 181 DDNKISDISP--LASLPNL-IEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 6e-05
 Identities = 40/235 (17%), Positives = 74/235 (31%), Gaps = 20/235 (8%)

Query: 70  ISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLK 129
           I PD         I    +++   V  +   L  +  L      +T    + +     L 
Sbjct: 12  IFPDPA-LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLI 66

Query: 130 NLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAG 189
            L L DN ++   P++    +    +     K+++     +              T    
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLD-------LTSTQI 119

Query: 190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKL 249
           +    L  LS LQ L +    ++   P       + + +   +     S    L  L KL
Sbjct: 120 TDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQV----SDLTPLANLSKL 175

Query: 250 EKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSN 304
             +    N      P  + +  +L  + L  N  S   P    N S+L  + L+N
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 31/219 (14%), Positives = 64/219 (29%), Gaps = 32/219 (14%)

Query: 375 QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSS 434
            L N  K+    + ++  +                   +   +  L+     +  T    
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA----------------DLDGITTLSAFGTGV--TTIEG 58

Query: 435 LASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL 494
           +  L  L  L++  NQ   L P       +   L  +      AI           +   
Sbjct: 59  VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ 118

Query: 495 SSNKLSGKIPVELFEIEGLDISL-------------NLSWNALSGAIPPQISALNKLSIL 541
            ++         L  +      +              LS      +    ++ L+KL+ L
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTL 178

Query: 542 DLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPDSKL 580
               NK+  D+  L+ L NL+ +++  N  +   P +  
Sbjct: 179 KADDNKIS-DISPLASLPNLIEVHLKNNQISDVSPLANT 216

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 0.001
 Identities = 13/80 (16%), Positives = 30/80 (37%), Gaps = 5/80 (6%)

Query: 506 ELFEIEGLD--ISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVS 563
            +F    L   I +    + ++  +    + L+ ++ L      +   +  +  L+NL+ 
Sbjct: 11  VIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIG 67

Query: 564 LNVSYNNFTGYLPDSKLFRQ 583
           L +  N  T   P   L + 
Sbjct: 68  LELKDNQITDLAPLKNLTKI 87

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.9 bits (128), Expect = 2e-08
 Identities = 33/205 (16%), Positives = 64/205 (31%), Gaps = 17/205 (8%)

Query: 246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN 305
             +  K  L + +   A+ +      S+  I  + +       Q    L ++ +L L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGN 78

Query: 306 NISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNAL 365
            ++   P             L           + K   S+             +   +  
Sbjct: 79  KLTDIKPLA----------NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128

Query: 366 TGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNN 425
                P L  L      +     +S L   +  +        ++     T+LQ L LS N
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 188

Query: 426 TLGGTLPSSLASLTRLQVLDISVNQ 450
            +  +   +LA L  L VL++  +Q
Sbjct: 189 HI--SDLRALAGLKNLDVLELF-SQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 3e-07
 Identities = 38/208 (18%), Positives = 74/208 (35%), Gaps = 24/208 (11%)

Query: 293 NLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC 352
             +   +  L   +++ ++    +   S+ Q+  + + I                 +   
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG------------IQYL 67

Query: 353 RSLEAVDLSHNALTGSLHPGLFQLQNLTKL----LLISNGISGLIPPEIGNCSSLIRLRL 408
            ++  + L+ N LT        +      L    +   + +  L   +  +        +
Sbjct: 68  PNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDI 127

Query: 409 MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRL 468
               +  QL+ L L NN    T  + L+ LT+L  L +  NQ   ++P     L  L  L
Sbjct: 128 NGLVHLPQLESLYLGNNK--ITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183

Query: 469 ILSKNSFSGAIPSSLGRCESLQSLDLSS 496
            LSKN  S     +L   ++L  L+L S
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 6e-06
 Identities = 38/216 (17%), Positives = 75/216 (34%), Gaps = 22/216 (10%)

Query: 262 AIPEEIG------NCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVL 315
            +P  I               +L     + ++ Q+   L+S+++++ +N++I       +
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64

Query: 316 SNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ 375
               ++ +L L+ N+++      N           N     +       L          
Sbjct: 65  QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124

Query: 376 LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL 435
                      NG+  L   E     +     +      T+L  L+L +N +   +P  L
Sbjct: 125 SDI--------NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--L 174

Query: 436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILS 471
           A LT+LQ L +S N    L   +   L +L+ L L 
Sbjct: 175 AGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 40/220 (18%), Positives = 76/220 (34%), Gaps = 30/220 (13%)

Query: 348 TLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLR 407
           +          +L   ++T ++     +L ++ +++  ++ I  +               
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--------------- 61

Query: 408 LMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNR 467
                    +  L L+ N L       LA+L  L  L +  N+   L      +      
Sbjct: 62  -QGIQYLPNVTKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLK----KL 114

Query: 468 LILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGA 527
             LS      +  + L     L+SL L +NK++    +            +   + +   
Sbjct: 115 KSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI--- 171

Query: 528 IPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVS 567
               ++ L KL  L LS N +  DL AL+GL NL  L + 
Sbjct: 172 --VPLAGLTKLQNLYLSKNHI-SDLRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 5e-05
 Identities = 17/91 (18%), Positives = 40/91 (43%), Gaps = 6/91 (6%)

Query: 493 DLSSNKLSGKIPV-ELFEIEGL--DISLNLSWNALSGAIPPQISALNKLSILDLSHNKLG 549
            L S  ++   P+ ++F  +     I  NL   +++ A+    + LN +  +  +++ + 
Sbjct: 2   PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 59

Query: 550 GDLLALSGLDNLVSLNVSYNNFTGYLPDSKL 580
             +  +  L N+  L ++ N  T   P + L
Sbjct: 60  -SVQGIQYLPNVTKLFLNGNKLTDIKPLANL 89

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.3 bits (122), Expect = 2e-08
 Identities = 24/108 (22%), Positives = 41/108 (37%), Gaps = 8/108 (7%)

Query: 468 LILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGA 527
           L L+    +  +   L +   +  LDLS N+L    P     +  L     L  +  +  
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALE 56

Query: 528 IPPQISALNKLSILDLSHNKL--GGDLLALSGLDNLVSLNVSYNNFTG 573
               ++ L +L  L L +N+L     +  L     LV LN+  N+   
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.1 bits (119), Expect = 6e-08
 Identities = 26/119 (21%), Positives = 42/119 (35%), Gaps = 26/119 (21%)

Query: 418 QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNR---------- 467
           ++L+L++  L  T+   L  L  +  LD+S N+    +P +   L  L            
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN 57

Query: 468 ------------LILSKNSF-SGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGL 513
                       L+L  N     A    L  C  L  L+L  N L  +  ++    E L
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.6 bits (110), Expect = 9e-07
 Identities = 20/110 (18%), Positives = 36/110 (32%), Gaps = 5/110 (4%)

Query: 214 EIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSL 273
            +   +     +  L L  N L    P  L  L+ LE +    N  +    + + N   L
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE--NVDGVANLPRL 67

Query: 274 KTIDLSLN-FFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLL 322
           + + L  N     +  Q   +   L  L L  N++      +      +L
Sbjct: 68  QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 24/126 (19%), Positives = 47/126 (37%), Gaps = 19/126 (15%)

Query: 274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISV 333
           + + L+    +         L  +  L LS+N +   +PP L+    L  LQ   N +  
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALEN 57

Query: 334 FFAWQ------------NKLEG-SIPSTLANCRSLEAVDLSHNALTG--SLHPGLFQ-LQ 377
                            N+L+  +    L +C  L  ++L  N+L     +   L + L 
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 378 NLTKLL 383
           +++ +L
Sbjct: 118 SVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 2e-05
 Identities = 31/148 (20%), Positives = 55/148 (37%), Gaps = 34/148 (22%)

Query: 300 LMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVD 359
           L L++ +++  +   L     +  L L  N++            ++P  LA  R LE + 
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-----------ALPPALAALRCLEVLQ 49

Query: 360 LSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQM 419
            S N        G+  L  L +LLL +N +      +                +C +L +
Sbjct: 50  ASDN--ALENVDGVANLPRLQELLLCNNRLQQSAAIQ-------------PLVSCPRLVL 94

Query: 420 LNLSNNTLGG------TLPSSLASLTRL 441
           LNL  N+L         L   L S++ +
Sbjct: 95  LNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.5 bits (89), Expect = 7e-04
 Identities = 26/111 (23%), Positives = 42/111 (37%), Gaps = 5/111 (4%)

Query: 43  ELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLI 102
           +L    +L  L  +  L +S + L     P L     L  +  S N         +  L 
Sbjct: 9   DLTVLCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDN--ALENVDGVANLP 65

Query: 103 NLQDLILNSNQLTG-EIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNL 152
            LQ+L+L +N+L      + L +C +L  L L  N L         +L  +
Sbjct: 66  RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 51.7 bits (122), Expect = 6e-08
 Identities = 46/200 (23%), Positives = 73/200 (36%), Gaps = 22/200 (11%)

Query: 350 ANCR-SLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
           A C      VD +   L   +   +    + T+LLL  N +  +                
Sbjct: 4   AMCHCEGTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSD------------- 47

Query: 409 MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRL 468
             FG    L  L L  N L G  P++    + +Q L +  N+   +  + F  L  L  L
Sbjct: 48  GLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTL 107

Query: 469 ILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAI 528
            L  N  S  +P S     SL SL+L+SN  +    +  F         +L+  A     
Sbjct: 108 NLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF--AEWLRKKSLNGGAARCGA 165

Query: 529 PPQISALNKLSILDLSHNKL 548
           P +   +  + I DL H++ 
Sbjct: 166 PSK---VRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.3 bits (108), Expect = 5e-06
 Identities = 33/199 (16%), Positives = 57/199 (28%), Gaps = 26/199 (13%)

Query: 272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
              T+D +       +P+         EL+L++N +       L      L         
Sbjct: 9   EGTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLV-------- 57

Query: 332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQ-LQNLTKLLLISNGIS 390
                 +      I        S              +   +F  L  L  L L  N IS
Sbjct: 58  --KLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS 115

Query: 391 GLIPPEIGNCSSLIRLRLMSFGNCTQLQM---------LNLSNNTLGGTLPSSLASLTRL 441
            ++P    + +SL  L L S        +          +L+        PS +  +   
Sbjct: 116 CVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV--- 172

Query: 442 QVLDISVNQFVGLIPESFG 460
           Q+ D+  ++F      S G
Sbjct: 173 QIKDLPHSEFKCSSENSEG 191

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.6 bits (124), Expect = 7e-08
 Identities = 28/245 (11%), Positives = 59/245 (24%), Gaps = 11/245 (4%)

Query: 264 PEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNAT---- 319
              I +C S +      +  +  +P       +  EL      +        S       
Sbjct: 2   HHRICHC-SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57

Query: 320 SLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNL 379
             +        I             I    AN       +   N                
Sbjct: 58  IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117

Query: 380 TKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLT 439
              +   + +  ++     N +     R    G   +  +L L+ N +      +     
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177

Query: 440 RLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKL 499
             ++     N    L  + F   +    L +S+          L   + L++    + K 
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK- 236

Query: 500 SGKIP 504
             K+P
Sbjct: 237 --KLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (110), Expect = 4e-06
 Identities = 31/242 (12%), Positives = 61/242 (25%), Gaps = 10/242 (4%)

Query: 77  CT-QLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFD 135
           C           + +   +PS + +  N  +L     +L             L+ + +  
Sbjct: 6   CHCSNRVFLCQESKVTE-IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQ 62

Query: 136 NYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASL 195
           N +   +  ++   +           +    I  E       L   L        LP   
Sbjct: 63  NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH 122

Query: 196 GKLSKLQSLSVYTTMLSGEIPPQIGNCSELVD---LFLYENDLSGSLPRELGKLQKLEKM 252
              S  + L      ++     +        +   L+L +N +           Q  E  
Sbjct: 123 KIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182

Query: 253 LLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIP 312
           L   NN +    +          +D+S             NL  L      N      +P
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLP 239

Query: 313 PV 314
            +
Sbjct: 240 TL 241

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 43/244 (17%), Positives = 73/244 (29%), Gaps = 19/244 (7%)

Query: 346 PSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR 405
              + +C S        + +T  +   L +  N  +L  +   +  +          L +
Sbjct: 2   HHRICHC-SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEK 57

Query: 406 LRLMSFGNCTQL------------QMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG 453
           + +        +            ++     N L    P +  +L  LQ L IS      
Sbjct: 58  IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117

Query: 454 LIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGL 513
           L             L +  N     I  +     S +S+ L  NK   +           
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177

Query: 514 DISLNLSWNALSGAIPPQI-SALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFT 572
              LNLS N     +P  +    +   ILD+S  ++    L   GL+NL  L        
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS--LPSYGLENLKKLRARSTYNL 235

Query: 573 GYLP 576
             LP
Sbjct: 236 KKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.002
 Identities = 11/75 (14%), Positives = 16/75 (21%)

Query: 252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSI 311
           + L +N             +  +      N         F   S    L +S   I    
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217

Query: 312 PPVLSNATSLLQLQL 326
              L N   L     
Sbjct: 218 SYGLENLKKLRARST 232

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.8 bits (127), Expect = 7e-08
 Identities = 16/74 (21%), Positives = 26/74 (35%), Gaps = 5/74 (6%)

Query: 441 LQVLDISVNQFVGL-IPESFGQLASLNRLILSKNSFSG----AIPSSLGRCESLQSLDLS 495
           +Q LDI   +       E    L     + L     +      I S+L    +L  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 496 SNKLSGKIPVELFE 509
           SN+L       + +
Sbjct: 64  SNELGDVGVHCVLQ 77

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 3e-07
 Identities = 21/90 (23%), Positives = 35/90 (38%), Gaps = 12/90 (13%)

Query: 464 SLNRLILSKNSFSG----AIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDIS--- 516
            L  L L+    S     ++ ++L    SL+ LDLS+N L     ++L E          
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 517 -LNLSWNALSGAIPPQISAL----NKLSIL 541
            L L     S  +  ++ AL      L ++
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 3e-07
 Identities = 18/132 (13%), Positives = 43/132 (32%), Gaps = 9/132 (6%)

Query: 10  NWNPSDSNPCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTG- 68
                       +      +  ++   ++   +           S L+ L ++  +++  
Sbjct: 325 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 384

Query: 69  ---PISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLI-----NLQDLILNSNQLTGEIPK 120
               ++  L     L  +D+S+N L       + + +      L+ L+L     + E+  
Sbjct: 385 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444

Query: 121 ELGACIKLKNLL 132
            L A  K K  L
Sbjct: 445 RLQALEKDKPSL 456

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 1e-06
 Identities = 18/94 (19%), Positives = 33/94 (35%), Gaps = 10/94 (10%)

Query: 488 SLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSG----AIPPQISALNKLSILDL 543
            +QSLD+   +LS     EL  +      + L    L+      I   +     L+ L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 544 SHNKLGGDLLAL------SGLDNLVSLNVSYNNF 571
             N+LG   +        +    +  L++     
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 1e-06
 Identities = 8/96 (8%), Positives = 26/96 (27%), Gaps = 5/96 (5%)

Query: 249 LEKMLLWQNNF-DGAIPEEIGNCKSLKTIDLSLNFFSG----SLPQSFGNLSSLEELMLS 303
           ++ + +      D    E +   +  + + L     +      +  +     +L EL L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 304 NNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQN 339
           +N +       +         ++    +        
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 9/78 (11%)

Query: 247 QKLEKMLLWQNNFDG----AIPEEIGNCKSLKTIDLSLNFFSGSLPQSFG-----NLSSL 297
             L  + L   +       ++   +    SL+ +DLS N    +               L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 298 EELMLSNNNISGSIPPVL 315
           E+L+L +   S  +   L
Sbjct: 429 EQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 19/73 (26%), Positives = 26/73 (35%), Gaps = 9/73 (12%)

Query: 269 NCKSLKTIDLSLNFFSG----SLPQSFGNLSSLEELMLSNNNISGSIPPVLSNA-----T 319
               L+ + L+    S     SL  +     SL EL LSNN +  +    L  +      
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 320 SLLQLQLDTNQIS 332
            L QL L     S
Sbjct: 427 LLEQLVLYDIYWS 439

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 15/82 (18%), Positives = 32/82 (39%), Gaps = 9/82 (10%)

Query: 411 FGNCTQLQMLNLSNNTLGGT----LPSSLASLTRLQVLDISVNQFVGLIPESFGQ----- 461
               + L++L L++  +  +    L ++L +   L+ LD+S N           +     
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 462 LASLNRLILSKNSFSGAIPSSL 483
              L +L+L    +S  +   L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 14/64 (21%), Positives = 22/64 (34%), Gaps = 6/64 (9%)

Query: 516 SLNLSWNALSGAIPPQI-SALNKLSILDLSHNKLGGDLL-----ALSGLDNLVSLNVSYN 569
           SL++    LS A   ++   L +  ++ L    L          AL     L  LN+  N
Sbjct: 6   SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65

Query: 570 NFTG 573
               
Sbjct: 66  ELGD 69

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 4e-06
 Identities = 15/104 (14%), Positives = 30/104 (28%), Gaps = 17/104 (16%)

Query: 378 NLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGG----TLPS 433
           ++  L +    +S     E+                  Q Q++ L +  L       + S
Sbjct: 3   DIQSLDIQCEELSDARWAEL-------------LPLLQQCQVVRLDDCGLTEARCKDISS 49

Query: 434 SLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSG 477
           +L     L  L++  N+   +      Q        + K S   
Sbjct: 50  ALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 5e-06
 Identities = 16/95 (16%), Positives = 31/95 (32%), Gaps = 12/95 (12%)

Query: 296 SLEELMLSNNNISGS-IPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRS 354
            ++ L +    +S +    +L        ++LD   ++            I S L    +
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC------KDISSALRVNPA 56

Query: 355 LEAVDLSHNALTGSLHPGLFQL-----QNLTKLLL 384
           L  ++L  N L       + Q        + KL L
Sbjct: 57  LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSL 91

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 8e-06
 Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 5/91 (5%)

Query: 56  LQKLIISGSNLTGPISPDLGDC-TQLTTIDVSSNSL----VGGVPSSIGKLINLQDLILN 110
           +Q L I    L+     +L     Q   + +    L       + S++     L +L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 111 SNQLTGEIPKELGACIKLKNLLLFDNYLSGN 141
           SN+L       +   ++  +  +    L   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 9e-06
 Identities = 15/97 (15%), Positives = 31/97 (31%), Gaps = 13/97 (13%)

Query: 346 PSTLANCRSLEAVDLSHNALTG----SLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCS 401
                    L  + L+   ++     SL   L    +L +L L +N +      ++    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL--VE 419

Query: 402 SLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL 438
           S+ +           L+ L L +      +   L +L
Sbjct: 420 SVRQ-------PGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 1e-05
 Identities = 15/82 (18%), Positives = 36/82 (43%), Gaps = 9/82 (10%)

Query: 77  CTQLTTIDVSSNSL----VGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIK----- 127
            + L  + ++   +       + +++    +L++L L++N L      +L   ++     
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 128 LKNLLLFDNYLSGNLPVELGKL 149
           L+ L+L+D Y S  +   L  L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 17/102 (16%), Positives = 29/102 (28%), Gaps = 17/102 (16%)

Query: 377 QNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLA 436
             L  L L    +S      +            +      L+ L+LSNN LG      L 
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAA----------TLLANHSLRELDLSNNCLGDAGILQLV 418

Query: 437 S-----LTRLQVLDISVNQFVGLIPESFGQLASLNRL--ILS 471
                    L+ L +    +   + +    L        ++S
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 3e-05
 Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 15/97 (15%)

Query: 221 NCSELVDLFLYENDLSG----SLPRELGKLQKLEKMLLWQNNFDGAIPEEIG-----NCK 271
             S L  L+L + D+S     SL   L     L ++ L  N    A   ++         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 272 SLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNIS 308
            L+ + L   ++S  +         L+ L     ++ 
Sbjct: 427 LLEQLVLYDIYWSEEMED------RLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 18/94 (19%), Positives = 35/94 (37%), Gaps = 15/94 (15%)

Query: 35  INIQSIEL------ELPFPSNLSSLSFLQKLIISGSNLTG----PISPDLGDCTQLTTID 84
           ++IQS+++      +  +   L  L   Q + +    LT      IS  L     L  ++
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 85  VSSNSLVGGVPSSIGKLI-----NLQDLILNSNQ 113
           + SN L       + + +      +Q L L +  
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 8e-05
 Identities = 18/110 (16%), Positives = 33/110 (30%), Gaps = 22/110 (20%)

Query: 320 SLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTG----SLHPGLFQ 375
            +  L +   ++S         +      L   +  + V L    LT      +   L  
Sbjct: 3   DIQSLDIQCEELS---------DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRV 53

Query: 376 LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNN 425
              L +L L SN +  +    +     L            ++Q L+L N 
Sbjct: 54  NPALAELNLRSNELGDVGVHCV--LQGL-------QTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 1e-04
 Identities = 22/101 (21%), Positives = 37/101 (36%), Gaps = 10/101 (9%)

Query: 291 FGNLSSLEELMLSNNNISG----SIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIP 346
               S L  L L++ ++S     S+   L    SL +L L  N +        +L  S+ 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI--LQLVESVR 422

Query: 347 STLANCRSLEAVDLSHNALTGSLHPGLFQL-QNLTKLLLIS 386
                   LE + L     +  +   L  L ++   L +IS
Sbjct: 423 Q---PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 15/78 (19%), Positives = 23/78 (29%), Gaps = 8/78 (10%)

Query: 486 CESLQSLDLSSNKLSGKIPVELFE-IEGLD--ISLNLSWNALSGAIPPQISA-----LNK 537
              L+ L L+   +S      L   +        L+LS N L  A   Q+          
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 538 LSILDLSHNKLGGDLLAL 555
           L  L L       ++   
Sbjct: 428 LEQLVLYDIYWSEEMEDR 445

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 17/73 (23%), Positives = 29/73 (39%), Gaps = 10/73 (13%)

Query: 516 SLNLSWNALSG----AIPPQISALNKLSILDLSHNKLGGD-LLALSG-----LDNLVSLN 565
            L L+   +S     ++   + A + L  LDLS+N LG   +L L          L  L 
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432

Query: 566 VSYNNFTGYLPDS 578
           +    ++  + D 
Sbjct: 433 LYDIYWSEEMEDR 445

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.3 bits (126), Expect = 8e-08
 Identities = 23/108 (21%), Positives = 41/108 (37%), Gaps = 9/108 (8%)

Query: 409 MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRL 468
             F   ++L       N     + S       L+ L++S N+ +  +P        L RL
Sbjct: 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERL 309

Query: 469 ILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDIS 516
           I S N  +  +P       +L+ L +  N L  + P     +E L ++
Sbjct: 310 IASFNHLA-EVPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 3e-07
 Identities = 27/103 (26%), Positives = 40/103 (38%), Gaps = 12/103 (11%)

Query: 394 PPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG 453
           PP +   ++              L+ LN+SNN L   LP   A   RL+ L  S N    
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELP---ALPPRLERLIASFNHLAE 318

Query: 454 LIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSS 496
            +PE    L  L+   +  N      P      ES++ L ++S
Sbjct: 319 -VPELPQNLKQLH---VEYNPLRE-FPDIP---ESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.0 bits (120), Expect = 4e-07
 Identities = 21/102 (20%), Positives = 36/102 (35%), Gaps = 19/102 (18%)

Query: 278 LSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAW 337
             LN  S  +        SLEEL +SNN +   +P +      L +L    N ++     
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA----- 317

Query: 338 QNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNL 379
                  +P    N + L    + +N L          +++L
Sbjct: 318 ------EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 2e-06
 Identities = 24/102 (23%), Positives = 41/102 (40%), Gaps = 16/102 (15%)

Query: 252 MLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSI 311
            L + N     I        SL+ +++S N     LP        LE L+ S N+++  +
Sbjct: 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EV 319

Query: 312 PPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCR 353
           P +  N   L QL ++ N +  F          IP ++ + R
Sbjct: 320 PELPQN---LKQLHVEYNPLREF--------PDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 6e-06
 Identities = 20/78 (25%), Positives = 34/78 (43%), Gaps = 9/78 (11%)

Query: 77  CTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDN 136
              L  ++VS+N L+  +P+       L+ LI + N L  E+P+       LK L +  N
Sbjct: 283 PPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLA-EVPELPQ---NLKQLHVEYN 334

Query: 137 YLSGNLPVELGKLVNLEV 154
            L    P     + +L +
Sbjct: 335 PLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 9e-06
 Identities = 23/92 (25%), Positives = 39/92 (42%), Gaps = 9/92 (9%)

Query: 470 LSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIP 529
              N+ S  I S      SL+ L++S+NKL  ++P     +E     L  S+N L+  +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLA-EVP 320

Query: 530 PQISALNKLSILDLSHNKLGGDLLALSGLDNL 561
                   L  L + +N L         +++L
Sbjct: 321 ELPQ---NLKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 3e-05
 Identities = 21/91 (23%), Positives = 32/91 (35%), Gaps = 9/91 (9%)

Query: 207 YTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEE 266
           Y    S EI         L +L +  N L   LP    +L++L       N+    +PE 
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHL-AEVPEL 322

Query: 267 IGNCKSLKTIDLSLNFFSGSLPQSFGNLSSL 297
             N   LK + +  N      P    ++  L
Sbjct: 323 PQN---LKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.3 bits (95), Expect = 4e-04
 Identities = 16/72 (22%), Positives = 31/72 (43%), Gaps = 8/72 (11%)

Query: 270 CKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTN 329
            +    ++L+    S SLP+   +L   E L+ S N+++  +P +  +   L  L +D N
Sbjct: 37  DRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQS---LKSLLVDNN 88

Query: 330 QISVFFAWQNKL 341
            +         L
Sbjct: 89  NLKALSDLPPLL 100

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 40.6 bits (93), Expect = 7e-04
 Identities = 20/63 (31%), Positives = 26/63 (41%), Gaps = 8/63 (12%)

Query: 516 SLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYL 575
            LN+S N L   +P       +L  L  S N L  ++  L    NL  L+V YN      
Sbjct: 288 ELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL--PQNLKQLHVEYNPLRE-F 339

Query: 576 PDS 578
           PD 
Sbjct: 340 PDI 342

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 23/108 (21%), Positives = 37/108 (34%), Gaps = 22/108 (20%)

Query: 301 MLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDL 360
           +   N  S  I  +     SL +L +  N++             +P+       L     
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-----------ELPALPPRLERL---IA 311

Query: 361 SHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRL 408
           S N L   + P L   QNL +L +  N +    P       S+  LR+
Sbjct: 312 SFNHLA-EV-PEL--PQNLKQLHVEYNPLREF-PDIP---ESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 19/68 (27%), Positives = 24/68 (35%), Gaps = 5/68 (7%)

Query: 414 CTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKN 473
             Q   L L+N  L  +LP        L+ L  S N    L PE    L SL     +  
Sbjct: 37  DRQAHELELNNLGL-SSLPELPPH---LESLVASCNSLTEL-PELPQSLKSLLVDNNNLK 91

Query: 474 SFSGAIPS 481
           + S   P 
Sbjct: 92  ALSDLPPL 99

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.9 bits (118), Expect = 1e-07
 Identities = 26/147 (17%), Positives = 51/147 (34%), Gaps = 7/147 (4%)

Query: 401 SSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFG 460
           + LI  +   + N  + + L+L    +   + +  A+L +   +D S N+   L  + F 
Sbjct: 5   AELIE-QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFP 60

Query: 461 QLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNK---LSGKIPVELFEIEGLDISL 517
            L  L  L+++ N               L  L L++N    L    P+   +       L
Sbjct: 61  LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL 120

Query: 518 NLSWNALSGAIPPQISALNKLSILDLS 544
                         I  + ++ +LD  
Sbjct: 121 RNPVTNKKHYRLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (98), Expect = 7e-05
 Identities = 23/168 (13%), Positives = 51/168 (30%), Gaps = 25/168 (14%)

Query: 278 LSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAW 337
           L+      +    + N     EL L    I   I  + +       +    N+I     +
Sbjct: 3   LTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 59

Query: 338 QNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEI 397
                          R L+ + +++N +          L +LT+L+L +N +  L   + 
Sbjct: 60  P------------LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP 107

Query: 398 GNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLD 445
                 +    +     T  +                +  + +++VLD
Sbjct: 108 LASLKSLTYLCILRNPVTNKKHYR----------LYVIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.8 bits (97), Expect = 8e-05
 Identities = 21/158 (13%), Positives = 41/158 (25%), Gaps = 23/158 (14%)

Query: 269 NCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDT 328
           N    + +DL        +      L   + +  S+N I       L     L +L+   
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-----RKLDGFPLLRRLK--- 66

Query: 329 NQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNG 388
                     N++             L  + L++N+L                 L I   
Sbjct: 67  ----TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILR- 121

Query: 389 ISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNT 426
                       ++    RL       Q+++L+     
Sbjct: 122 ---------NPVTNKKHYRLYVIYKVPQVRVLDFQKVK 150

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 34/190 (17%), Positives = 63/190 (33%), Gaps = 20/190 (10%)

Query: 269 NCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDT 328
                    L     + ++ Q+  +L  +  L      I  SI   +    +L Q+    
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71

Query: 329 NQIS--------------VFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLF 374
           NQ++              +    Q      + +           +   +         L 
Sbjct: 72  NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 131

Query: 375 QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSS 434
           +L+  +  +   + +SGL   +  N SS     L    N T L+ L++S+N +     S 
Sbjct: 132 RLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISV 189

Query: 435 LASLTRLQVL 444
           LA LT L+ L
Sbjct: 190 LAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.3 bits (90), Expect = 0.001
 Identities = 29/202 (14%), Positives = 59/202 (29%), Gaps = 32/202 (15%)

Query: 376 LQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSL 435
           L    K +L    ++  +                S  +  Q+  L      +       +
Sbjct: 17  LAEKMKTVLGKTNVTDTV----------------SQTDLDQVTTLQADRLGI--KSIDGV 58

Query: 436 ASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLS 495
             L  L  ++ S NQ   + P           +  ++ +    + +           +  
Sbjct: 59  EYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI 118

Query: 496 SNKLSGKIPVELFEIEGLDISLNLSWNALSGAI-------------PPQISALNKLSILD 542
           ++    K    L  +E    +++                          ++ L  L  LD
Sbjct: 119 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLD 178

Query: 543 LSHNKLGGDLLALSGLDNLVSL 564
           +S NK+  D+  L+ L NL SL
Sbjct: 179 ISSNKV-SDISVLAKLTNLESL 199

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 3e-05
 Identities = 22/145 (15%), Positives = 40/145 (27%), Gaps = 9/145 (6%)

Query: 217 PQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEI-GNCKSLKT 275
           P          L    +         L   + L ++ +        +          L+ 
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 276 IDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQ----- 330
           + +  +      P +F     L  L LS N +  S+        SL +L L  N      
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119

Query: 331 -ISVFFAWQNKLEGSIPSTLANCRS 354
            +     W+ +  G +P     C  
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHG 144

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 3e-05
 Identities = 24/150 (16%), Positives = 47/150 (31%), Gaps = 5/150 (3%)

Query: 214 EIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSL 273
           ++   +    +     L    L      +L        +   +++    +     N   L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPEL 67

Query: 274 KTIDLSLNFFSG--SLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQI 331
            +++LS N       +        +L+ L LS N +             L +L LD N +
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLS 361
           S  F  Q+    +I         L+  +L 
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLDGHELP 157

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 0.001
 Identities = 21/134 (15%), Positives = 36/134 (26%), Gaps = 16/134 (11%)

Query: 339 NKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIG 398
            ++E  +   ++         L    L     P L        L   S+  +  +     
Sbjct: 7   EQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEE 62

Query: 399 NCSSLIRLRL------------MSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDI 446
           N   L+ L L                    L++LNLS N L            +L+ L +
Sbjct: 63  NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122

Query: 447 SVNQFVGLIPESFG 460
             N       +   
Sbjct: 123 DGNSLSDTFRDQST 136

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 42.0 bits (97), Expect = 1e-04
 Identities = 32/172 (18%), Positives = 59/172 (34%), Gaps = 21/172 (12%)

Query: 265 EEIGNCKSLKTIDLSLNFFSGS---LPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSL 321
           EE  +  + +   + L+        +  +   L + + L LS NNI   I   LS   +L
Sbjct: 15  EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGMENL 72

Query: 322 LQL-----------QLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLH 370
             L            LD    ++   W +  + +  S +    +L  + +S+N +T    
Sbjct: 73  RILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGE 132

Query: 371 PGLF-QLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLN 421
                 L  L  LLL  N +           ++    R+        L+ L+
Sbjct: 133 IDKLAALDKLEDLLLAGNPLYNDYK----ENNATSEYRIEVVKRLPNLKKLD 180

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1035
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.91
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.88
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.87
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.81
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.8
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.77
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.74
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.74
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.73
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.73
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.72
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.71
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.71
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.7
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.68
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.67
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.67
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.52
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.52
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.47
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.46
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.44
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.41
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.37
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.37
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.25
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.23
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.2
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.16
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.34
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.29
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.21
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.07
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.52
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.49
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.35
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.8
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.54
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.42
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.08
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.01

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-49  Score=423.67  Aligned_cols=254  Identities=26%  Similarity=0.342  Sum_probs=204.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.......             ..+.+.+|+.++++++|||||+++++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-------------~~~~~~~Ei~~l~~l~HpnIv~~~~~   71 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD-------------CPENIKKEICINKMLNHENVVKFYGH   71 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------------CHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-------------HHHHHHHHHHHHHhCCCCCEeeEeee
Confidence            57999999999999999999875 58999999996543221             23568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.+++....  .+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        72 ~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~D  146 (271)
T d1nvra_          72 RREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISD  146 (271)
T ss_dssp             EEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred             eccCceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEcc
Confidence            999999999999999999999997544  499999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+|+..............+||+.|||||++.+..+ +.++||||+||++|||++|+.||............+... .. 
T Consensus       147 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-~~-  224 (271)
T d1nvra_         147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KT-  224 (271)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-CT-
T ss_pred             chhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC-
Confidence            999998765544444556789999999999888776 578999999999999999999997654333222222111 00 


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                              ...+...+.  ....+++.+||+.||++|||++|++++
T Consensus       225 --------~~~~~~~~s--~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         225 --------YLNPWKKID--SAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             --------TSTTGGGSC--HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------CCCccccCC--HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                    001111111  123457888999999999999999763

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-49  Score=418.64  Aligned_cols=249  Identities=25%  Similarity=0.393  Sum_probs=205.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|+++ +++.||||++......+.           ...+.+.+|++++++++|||||+++++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~hpnIv~~~~~   74 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-----------GVEHQLRREVEIQSHLRHPNILRLYGY   74 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccCh-----------HHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence            57999999999999999999876 589999999865332221           235789999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.+++...+.  +++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~~~~ivmEy~~~g~L~~~l~~~~~--l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~D  149 (263)
T d2j4za1          75 FHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD  149 (263)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred             EEECCEEEEEEeecCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecc
Confidence            9999999999999999999999987654  89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|+......    .....||+.|||||++.+..++.++|||||||++|||++|+.||.....  ......+...    
T Consensus       150 FG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~~----  219 (263)
T d2j4za1         150 FGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--QETYKRISRV----  219 (263)
T ss_dssp             CCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--HHHHHHHHTT----
T ss_pred             cceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--HHHHHHHHcC----
Confidence            99998654332    2356899999999999999999999999999999999999999975422  1111111111    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ....+...+      ..+.+++.+||++||++|||++|++++
T Consensus       220 ---~~~~p~~~s------~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         220 ---EFTFPDFVT------EGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ---CCCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---CCCCCccCC------HHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence               011111111      123457888999999999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-48  Score=415.61  Aligned_cols=262  Identities=27%  Similarity=0.368  Sum_probs=200.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||+||+|+++  ..||||++.......            ...+.|.+|+.++++++|||||++++++
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~------------~~~~~~~~E~~~l~~l~HpnIv~~~~~~   73 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP------------QQLQAFKNEVGVLRKTRHVNILLFMGYS   73 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT------------THHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH------------HHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence            56888999999999999999875  359999986543222            2357899999999999999999999987


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      . ++..++||||++||+|.++++..+ ..+++..+..++.|||+||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        74 ~-~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DF  148 (276)
T d1uwha_          74 T-APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDF  148 (276)
T ss_dssp             C-SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCC
T ss_pred             e-ccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccc
Confidence            5 456899999999999999997654 3489999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG  922 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~  922 (1035)
                      |+|+...............||+.|||||++.+   ..++.++|||||||++|||+||+.||....+.. .....+.....
T Consensus       149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~~~~~~  227 (276)
T d1uwha_         149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMVGRGYL  227 (276)
T ss_dssp             CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHHTSC
T ss_pred             cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCCC
Confidence            99987655443334456789999999999754   358899999999999999999999997543221 11122211110


Q ss_pred             chhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          923 AIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       923 ~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ..  .........+   +   .+.+++.+||+.||++|||++|++++|+.+.+
T Consensus       228 ~p--~~~~~~~~~~---~---~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         228 SP--DLSKVRSNCP---K---AMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CC--CGGGSCTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC--cchhccccch---H---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            00  0001111111   1   23457888999999999999999999998864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=414.08  Aligned_cols=257  Identities=23%  Similarity=0.394  Sum_probs=197.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|+..+.||+|+||+||+|++.+++.||||++.....               ..++|.+|++++++++|||||+++|++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---------------~~~~~~~E~~~l~~l~HpnIv~~~g~~   69 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---------------SEEDFIEEAEVMMKLSHPKLVQLYGVC   69 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC---------------cHHHHHHHHHHHHhcCCCCccccccee
Confidence            35778899999999999999999899999999864321               246799999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..|+||||+++|+|.+++.... ..+++..+..++.|||+||+|+|+.   +|+||||||+||+++.++.+||+||
T Consensus        70 ~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DF  145 (263)
T d1sm2a_          70 LEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDF  145 (263)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSC
T ss_pred             ccCCceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEeccc
Confidence            99999999999999999999987653 3488999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |+++....... .......||+.|+|||++.+..++.++|||||||++|||+|+..|+..... ...+...+.....   
T Consensus       146 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~---  220 (263)
T d1sm2a_         146 GMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFR---  220 (263)
T ss_dssp             C-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHHHTCC---
T ss_pred             chheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHHhcCC---
Confidence            99987655432 223356799999999999999999999999999999999995444432221 1222222222110   


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                         .......+      ..+.+++.+||++||++|||++|++++|+++.+
T Consensus       221 ---~~~p~~~~------~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 ---LYKPRLAS------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ---CCCCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCccccC------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence               00011111      234568888999999999999999999998853

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=420.39  Aligned_cols=253  Identities=18%  Similarity=0.239  Sum_probs=203.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|+++ +++.||||++........           ...+.+.+|++++++++|||||+++++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~HpnIv~l~~~   76 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-----------NKVPYVTRERDVMSRLDHPFFVKLYFT   76 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCH-----------HHHHHHHHHHHHHHHcCCCCeeEEEEE
Confidence            56999999999999999999875 589999999865332221           235689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.+++...+.  +++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~ivmEy~~gg~L~~~~~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~D  151 (288)
T d1uu3a_          77 FQDDEKLYFGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITD  151 (288)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred             EEECCEEEEEEEccCCCCHHHhhhccCC--CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecc
Confidence            9999999999999999999999887654  89999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|+.+............+||+.|||||++.+..++.++||||+||++|||++|+.||....+  ......+...    
T Consensus       152 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~~~----  225 (288)
T d1uu3a_         152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--YLIFQKIIKL----  225 (288)
T ss_dssp             CTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHTT----
T ss_pred             cccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--HHHHHHHHcC----
Confidence            9999987654433344567899999999999999999999999999999999999999975421  1111111110    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                         ...+....+      ..+.+++.+||++||++|||++|++++
T Consensus       226 ---~~~~p~~~s------~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 ---EYDFPEKFF------PKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ---CCCCCTTCC------HHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ---CCCCCccCC------HHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence               001111111      123567889999999999999998664

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=415.18  Aligned_cols=250  Identities=22%  Similarity=0.372  Sum_probs=202.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|+..+.||+|+||+||+|.+. +|+.||||++.....              ...+.+.+|+.++++++|||||+++++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--------------~~~~~~~~E~~il~~l~HpnIv~~~~~   85 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------------PKKELIINEILVMRENKNPNIVNYLDS   85 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--------------SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--------------hHHHHHHHHHHHHHhCCCCCEeeEeEE
Confidence            46999999999999999999765 599999999864321              124679999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.+++...   .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~D  159 (293)
T d1yhwa1          86 YLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD  159 (293)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeecc
Confidence            99999999999999999999988654   389999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|+......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+.....  
T Consensus       160 FG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~--  233 (293)
T d1yhwa1         160 FGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGT--  233 (293)
T ss_dssp             CTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHHCS--
T ss_pred             chhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHHHHhCCC--
Confidence            99998765433  2234568999999999999999999999999999999999999999754221  11111111100  


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                          ...  ..+..+.  ..+.+++.+||++||++|||++|++++
T Consensus       234 ----~~~--~~~~~~s--~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         234 ----PEL--QNPEKLS--AIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             ----CCC--SSGGGSC--HHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             ----CCC--CCcccCC--HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                000  0011111  123457888999999999999999874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-47  Score=412.25  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=206.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|+..+.||+|+||+||+|.+++++.||||++.....               ..+.|.+|+.++++++|||||++++++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---------------~~~~~~~E~~~l~~l~HpnIv~~~g~~   77 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---------------SPDAFLAEANLMKQLQHQRLVRLYAVV   77 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC---------------CHHHHHHHHHHHHhCCCCCEeEEEeee
Confidence            57888999999999999999999889999999864321               246799999999999999999999987


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+ +..|+||||+++|+|.+++.......+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        78 ~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          78 TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             cc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccc
Confidence            54 5679999999999999988766555589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccchh
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAIE  925 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~  925 (1035)
                      |+|+....... .......||+.|||||++.+..++.++|||||||++|||+||..|+..... .......+....    
T Consensus       154 Gla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i~~~~----  227 (272)
T d1qpca_         154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGY----  227 (272)
T ss_dssp             TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTC----
T ss_pred             cceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcC----
Confidence            99997755432 233456799999999999888999999999999999999997666543322 112222222110    


Q ss_pred             hhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          926 VLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       926 ~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                        ........+   +   .+.+++.+||+.||++|||++||++.|+++..
T Consensus       228 --~~~~p~~~~---~---~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         228 --RMVRPDNCP---E---ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             --CCCCCTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCcccCh---H---HHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence              011111111   1   23457888999999999999999999988753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-47  Score=416.18  Aligned_cols=260  Identities=25%  Similarity=0.418  Sum_probs=197.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-C---cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-G---EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+.||+|+||+||+|+++. +   ..||||++.......             ..+.|.+|+++|++++|||||++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~HpnIv~l   92 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-------------QRRDFLSEASIMGQFDHPNVIHL   92 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH-------------HHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH-------------HHHHHHHHHHHHHhCCCCCCccE
Confidence            567778899999999999998753 2   358999886543322             25679999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      +|++.+++..|+||||+++|+|.+++.... ..+++..+..++.|||+||+|||++   +|+||||||+|||++.++.+|
T Consensus        93 ~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~K  168 (299)
T d1jpaa_          93 EGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCK  168 (299)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             EEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEE
Confidence            999999999999999999999999887643 3489999999999999999999998   999999999999999999999


Q ss_pred             EeeccCccccccCCccc---cccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHH
Q 039419          842 IADFGLAKLVVEGDFAR---SSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~  917 (1035)
                      |+|||+|+.........   ......||+.|||||+..+..++.++|||||||++|||+| |+.||.....  ......+
T Consensus       169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i  246 (299)
T d1jpaa_         169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAI  246 (299)
T ss_dssp             ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH
T ss_pred             ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHH
Confidence            99999998765443221   1223468999999999999999999999999999999998 8999975422  2222222


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      ...          .+...+....  ..+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus       247 ~~~----------~~~~~~~~~~--~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         247 EQD----------YRLPPPMDCP--SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HTT----------CCCCCCTTCC--HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HcC----------CCCCCCccch--HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            211          1111111111  2234578889999999999999999999887643

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.5e-48  Score=417.07  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=210.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|...+.||+|+||+||+|.+. +++.||||++.....               ..++|.+|++++++++|||||+++++
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------------~~~~~~~E~~il~~l~HpnIv~~~~~   81 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQLLGV   81 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---------------hHHHHHHHHHHHHhCCCCCEecCCcc
Confidence            57888899999999999999876 488999999864321               24679999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||+++|+|.+++.......+++..+..++.|||+||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~D  158 (287)
T d1opja_          82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD  158 (287)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcc
Confidence            99999999999999999999999877667799999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|..||...... ......+..     
T Consensus       159 FG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~-----  231 (287)
T d1opja_         159 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEK-----  231 (287)
T ss_dssp             CCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHT-----
T ss_pred             ccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHHHHhc-----
Confidence            999987654432 2233456899999999999999999999999999999999987776533221 122222211     


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                           ..+...+..+.  ..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus       232 -----~~~~~~~~~~~--~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         232 -----DYRMERPEGCP--EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -----TCCCCCCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -----CCCCCCCccch--HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 11111111111  124557888999999999999999999887643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=409.97  Aligned_cols=256  Identities=20%  Similarity=0.333  Sum_probs=192.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++......+.            ..+.+.+|++++++++|||||+++++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIv~~~~~   71 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA------------EKQMLVSEVNLLRELKHPNIVRYYDR   71 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH------------HHHHHHHHHHHTTSCCCTTBCCEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH------------HHHHHHHHHHHHHHCCCCCEeeEEEE
Confidence            57899999999999999999775 589999999976543221            25679999999999999999999999


Q ss_pred             EEc--CCcceEEEEeCCCCChhhhhhhc--CCCCCCHHHHHHHHHHHHHHHHHhhccCC--CCeeccCCCcccEEEcCCC
Q 039419          765 CWN--RNTRLLMYDYMPNGSLGSLLHER--RDSCLEWELRYRIILGAAQGLAYLHHDCV--PPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       765 ~~~--~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~--~~ivHrDikp~NIll~~~~  838 (1035)
                      +.+  .+..|+||||++||+|.+++...  ....+++..++.++.||+.||+|||+++.  .+|+||||||+|||++.++
T Consensus        72 ~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~  151 (269)
T d2java1          72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ  151 (269)
T ss_dssp             EEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred             EEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence            975  35679999999999999998653  23459999999999999999999999721  1399999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .+||+|||+|+......  .......||+.|||||++.+..++.++|||||||++|||++|+.||.....  ......+.
T Consensus       152 ~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~  227 (269)
T d2java1         152 NVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIR  227 (269)
T ss_dssp             CEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH
T ss_pred             cEEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHH
Confidence            99999999998765432  223457899999999999999999999999999999999999999975422  12222221


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...      ...+....+.      .+.+++.+||++||++|||++|++++
T Consensus       228 ~~~------~~~~~~~~s~------~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         228 EGK------FRRIPYRYSD------ELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             HTC------CCCCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cCC------CCCCCcccCH------HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            110      0011111121      23457788999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=420.58  Aligned_cols=200  Identities=26%  Similarity=0.456  Sum_probs=177.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|++. +|+.||+|++......             ...+++.+|+.++++++|||||+++++
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~l~~~   72 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-------------AIRNQIIRELQVLHECNSPYIVGFYGA   72 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT-------------THHHHHHHHGGGGGGCCCTTBCCEEEE
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH-------------HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            57899999999999999999875 5899999998653211             235689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      |.+++..|+||||++||+|.+++.+.+.  +++..+..++.|++.||+|||+ .   ||+||||||+|||++.++.+||+
T Consensus        73 ~~~~~~~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~  147 (322)
T d1s9ja_          73 FYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLC  147 (322)
T ss_dssp             EECSSEEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEe
Confidence            9999999999999999999999987654  8999999999999999999997 5   89999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTI  907 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~  907 (1035)
                      |||+|+...+..    ....+||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus       148 DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         148 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             CCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             eCCCccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            999998764422    235689999999999999999999999999999999999999997643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-47  Score=401.99  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=207.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|+..+.||+|+||+||+|++++++.||||+++....               ..++|.+|+.++++++|||||+++|++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---------------~~~~~~~Ev~~~~~l~HpnIv~~~g~~   68 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---------------SEDEFIEEAKVMMNLSHEKLVQLYGVC   68 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---------------CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---------------CHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence            46788899999999999999999888999999865322               246799999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..++||||+++|+|.+++..... .+++..+.+++.|||+||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus        69 ~~~~~~~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~Df  144 (258)
T d1k2pa_          69 TKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDF  144 (258)
T ss_dssp             CCSSSEEEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCC
T ss_pred             eeCCceEEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcc
Confidence            999999999999999999999765543 388999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccch
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      |+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......  .....+...    
T Consensus       145 G~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~~----  217 (258)
T d1k2pa_         145 GLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQG----  217 (258)
T ss_dssp             SSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHTT----
T ss_pred             hhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHhC----
Confidence            99987655433 23335679999999999999999999999999999999998 89999755321  222222111    


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKE  972 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~  972 (1035)
                            .+...+....  ..+.+++.+||++||++|||+++++++|.+
T Consensus       218 ------~~~~~p~~~~--~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         218 ------LRLYRPHLAS--EKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ------CCCCCCTTCC--HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ------CCCCCccccc--HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                  1111111111  234567888999999999999999999865

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=406.78  Aligned_cols=262  Identities=24%  Similarity=0.403  Sum_probs=200.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCC-----cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENG-----EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .+|...++||+|+||+||+|.++.+     ..||||++.......             ..++|.+|++++++++|||||+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~-------------~~~~~~~E~~il~~l~H~nIv~   73 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-------------QRVDFLGEAGIMGQFSHHNIIR   73 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH-------------HHHHHHHHHHHHHTCCCTTBCC
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH-------------HHHHHHHHHHHHHhcCCCCEee
Confidence            4678889999999999999977542     479999996543222             2457999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ++|++.+.+..++||||+.+|++.+++.... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+
T Consensus        74 ~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~  149 (283)
T d1mqba_          74 LEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVC  149 (283)
T ss_dssp             EEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred             eeEEEecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeE
Confidence            9999999999999999999999999876543 3489999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||++|..|+..... ...+...+..
T Consensus       150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~  228 (283)
T d1mqba_         150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-NHEVMKAIND  228 (283)
T ss_dssp             EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHHHHHHT
T ss_pred             EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-HHHHHHHHhc
Confidence            99999999876543321 223345789999999999999999999999999999999997666643322 1222222221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      .          .+...+....  ..+.+++.+||+.||++||++.||++.|+.+.+..
T Consensus       229 ~----------~~~~~~~~~~--~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         229 G----------FRLPTPMDCP--SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             T----------CCCCCCTTCB--HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             c----------CCCCCchhhH--HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            1          1111111111  22455888999999999999999999999887543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-47  Score=410.03  Aligned_cols=252  Identities=23%  Similarity=0.315  Sum_probs=200.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|++.+.||+|+||+||+|++. +++.||||++......              ..+.|.+|++++++++|||||+++++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~l~~~   77 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--------------ELEDYMVEIDILASCDHPNIVKLLDA   77 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--------------GGGGTHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--------------HHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            45788899999999999999876 5899999998653211              24568899999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||++||+|.+++.... ..+++..+..++.||++||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        78 ~~~~~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~D  153 (288)
T d2jfla1          78 FYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLAD  153 (288)
T ss_dssp             EEETTEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             EeeCCeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEe
Confidence            999999999999999999999986543 3489999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccc-----cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-----MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|+......  .......||+.|||||++.     ...++.++||||+||++|||++|+.||....+.  .....+..
T Consensus       154 FG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~~i~~  229 (288)
T d2jfla1         154 FGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKIAK  229 (288)
T ss_dssp             CTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHHH
T ss_pred             chhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHHHc
Confidence            99997654322  1233578999999999863     456889999999999999999999999765332  12211111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...      +.. ..+ ..+  ...+.+++.+||++||++|||++|++++
T Consensus       230 ~~~------~~~-~~~-~~~--s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         230 SEP------PTL-AQP-SRW--SSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             SCC------CCC-SSG-GGS--CHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCC------CCC-Ccc-ccC--CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            110      000 001 111  1223457888999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.5e-47  Score=413.08  Aligned_cols=255  Identities=23%  Similarity=0.285  Sum_probs=189.2

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++.+.|++.+.||+|+||+||+|+++ +++.||||++.......             ..+.+.+|+.++++++|||||++
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------------~~~~~~~Ei~il~~l~HpnIv~l   72 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-------------KEGSMENEIAVLHKIKHPNIVAL   72 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------------CHHHHHHHTCCCTTBCCE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-------------HHHHHHHHHHHHHhCCCCCCCcE
Confidence            34567999999999999999999876 58999999996543322             13468899999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc---CCC
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG---PEF  838 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~---~~~  838 (1035)
                      ++++.+++..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||++   +|+||||||+||++.   +++
T Consensus        73 ~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~  147 (307)
T d1a06a_          73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDS  147 (307)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHTCSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTC
T ss_pred             EEEEEECCEEEEEEeccCCCcHHHhhhcccC--CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCc
Confidence            9999999999999999999999999976543  99999999999999999999999   999999999999995   578


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .+||+|||+|+......   .....+||+.|||||++.+..++.++||||+||++|||++|+.||.....  ......+.
T Consensus       148 ~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~  222 (307)
T d1a06a_         148 KIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--AKLFEQIL  222 (307)
T ss_dssp             CEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHH
T ss_pred             eEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHh
Confidence            99999999998764432   22356899999999999999999999999999999999999999975422  11222221


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....   ..........+      ..+.+++.+||++||++|||++|++++
T Consensus       223 ~~~~---~~~~~~~~~~s------~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         223 KAEY---EFDSPYWDDIS------DSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTCC---CCCTTTTTTSC------HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ccCC---CCCCccccCCC------HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1110   00001111111      123457888999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=405.28  Aligned_cols=258  Identities=22%  Similarity=0.330  Sum_probs=204.7

Q ss_pred             hccccCCe-eeeeCCcEEEEEEEC---CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSV-VGKGCSGIVYRAEME---NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~-iG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|...+. ||+|+||+||+|.++   ++..||||++......             ...++|.+|+++|++++|||||++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~-------------~~~~~~~~E~~il~~l~HpnIv~l   74 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------------ADTEEMMREAQIMHQLDNPYIVRL   74 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH-------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH-------------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            34556664 999999999999764   3557999999654322             125689999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      +|++.+ +..|+||||+++|+|.+++...+ ..+++..+..++.|||+||+|||++   +|+||||||+||+++.++.+|
T Consensus        75 ~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~K  149 (285)
T d1u59a_          75 IGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK  149 (285)
T ss_dssp             EEEEES-SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred             eeeecc-CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCcee
Confidence            999865 46799999999999999986543 3489999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      |+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....  ..+...+..
T Consensus       150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~  227 (285)
T d1u59a_         150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ  227 (285)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT
T ss_pred             eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHc
Confidence            9999999877554322 22335678999999999998899999999999999999998 9999975432  223333222


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ...      .......+   +   .+.+++.+||+.||++|||+.+|.+.|++...
T Consensus       228 ~~~------~~~p~~~~---~---~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         228 GKR------MECPPECP---P---ELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             TCC------CCCCTTCC---H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC------CCCCCcCC---H---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            110      01111111   1   23457888999999999999999999987754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=405.07  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             CeeeeeCCcEEEEEEECC---CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcC
Q 039419          692 SVVGKGCSGIVYRAEMEN---GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNR  768 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  768 (1035)
                      +.||+|+||+||+|.+.+   ++.||||++.......            ...++|.+|++++++++|||||++++++.+ 
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~------------~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-   79 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP------------ALKDELLAEANVMQQLDNPYIVRMIGICEA-   79 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C------------HHHHHHHHHHHHHHTCCCTTBCCEEEEEES-
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCH------------HHHHHHHHHHHHHHhCCCCCCceEEEEecc-
Confidence            579999999999997643   5689999996543221            235789999999999999999999999865 


Q ss_pred             CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCc
Q 039419          769 NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLA  848 (1035)
Q Consensus       769 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a  848 (1035)
                      +..|+||||+++|+|.++++....  +++..+..++.|||+||+|||+.   +|+||||||+|||++.++.+||+|||+|
T Consensus        80 ~~~~lvmE~~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla  154 (277)
T d1xbba_          80 ESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS  154 (277)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCEEEEEEcCCCCcHHHHHhhccC--CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhh
Confidence            457899999999999999987554  89999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccchhh
Q 039419          849 KLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGAIEV  926 (1035)
Q Consensus       849 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~  926 (1035)
                      +....... ........||+.|||||++.+..++.++|||||||++|||++ |+.||.....  ..+...+....     
T Consensus       155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~~~-----  227 (277)
T d1xbba_         155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGE-----  227 (277)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC-----
T ss_pred             hhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHcCC-----
Confidence            87654432 222345679999999999999999999999999999999998 8999975422  22222222111     


Q ss_pred             hcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          927 LDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       927 ~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                       ....+...+      ..+.+++.+||+.||++|||+++|.+.|++...
T Consensus       228 -~~~~p~~~~------~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         228 -RMGCPAGCP------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             -CCCCCTTCC------HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCcccC------HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence             001111111      123457888999999999999999998887643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=416.57  Aligned_cols=257  Identities=24%  Similarity=0.375  Sum_probs=205.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCce
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNI  758 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  758 (1035)
                      ++|++.+.||+|+||+||+|++..      ...||||++.......             ..+.+.+|+.+++++ +||||
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~HpnI  103 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-------------EREALMSELKMMTQLGSHENI  103 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------CHHHHHHHHHHHHHCCCTTB
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH-------------HHHHHHHHHHHHHHhcCCCcE
Confidence            678899999999999999997653      2369999986543221             246799999999998 89999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcc
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD---------------------SCLEWELRYRIILGAAQGLAYLHHD  817 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~  817 (1035)
                      |++++++.+.+..|+||||+++|+|.++++..+.                     ..+++..++.++.||++||+|||++
T Consensus       104 v~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~  183 (325)
T d1rjba_         104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK  183 (325)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             eEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999976532                     3488999999999999999999999


Q ss_pred             CCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHH
Q 039419          818 CVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVL  897 (1035)
Q Consensus       818 ~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ell  897 (1035)
                         +|+||||||+||+++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+
T Consensus       184 ---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~eml  260 (325)
T d1rjba_         184 ---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  260 (325)
T ss_dssp             ---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             ---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHH
Confidence               99999999999999999999999999998765544333344567899999999999999999999999999999999


Q ss_pred             h-CCCCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Q 039419          898 T-GKQPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIK  971 (1035)
Q Consensus       898 t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~  971 (1035)
                      | |+.||...... ..+...+...          .+...+..+.  ..+.+++.+||+.||++|||++||+++|.
T Consensus       261 t~g~~Pf~~~~~~-~~~~~~~~~~----------~~~~~p~~~~--~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         261 SLGVNPYPGIPVD-ANFYKLIQNG----------FKMDQPFYAT--EEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TTSCCSSTTCCCS-HHHHHHHHTT----------CCCCCCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hCCCCCCCCCCHH-HHHHHHHhcC----------CCCCCCCcCC--HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            8 89999754332 2222222221          1111111111  13455788899999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-46  Score=400.17  Aligned_cols=250  Identities=27%  Similarity=0.393  Sum_probs=194.3

Q ss_pred             cccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          688 LVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       688 ~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      |+..+.||+|+||+||+|.+. +++.||+|++.......            ...+.|.+|++++++++|||||++++++.
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~------------~~~~~~~~E~~il~~l~HpnIv~~~~~~~   78 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK------------SERQRFKEEAEMLKGLQHPNIVRFYDSWE   78 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH------------HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH------------HHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence            355678999999999999876 58899999986543222            12567999999999999999999999987


Q ss_pred             c----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc-CCCceE
Q 039419          767 N----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG-PEFEPY  841 (1035)
Q Consensus       767 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~-~~~~~k  841 (1035)
                      +    +...|+||||+++|+|.+++.....  +++..+..++.||++||+|||+++ ++|+||||||+|||++ +++.+|
T Consensus        79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~--~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~K  155 (270)
T d1t4ha_          79 STVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVK  155 (270)
T ss_dssp             EESSSCEEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEE
T ss_pred             eccccCCEEEEEEeCCCCCcHHHHHhcccc--ccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEE
Confidence            5    3457999999999999999987654  899999999999999999999981 1399999999999996 578999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      |+|||+|+.....    .....+||+.|||||++.+ .++.++||||+||++|||++|+.||...... ......+....
T Consensus       156 l~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-~~~~~~i~~~~  229 (270)
T d1t4ha_         156 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSGV  229 (270)
T ss_dssp             ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-HHHHHHHTTTC
T ss_pred             EeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-HHHHHHHHcCC
Confidence            9999999864332    2235689999999998765 6999999999999999999999999754221 11111111100


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                           ..........   +   .+.+++.+||++||++|||++|++++
T Consensus       230 -----~~~~~~~~~~---~---~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         230 -----KPASFDKVAI---P---EVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -----CCGGGGGCCC---H---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -----CCcccCccCC---H---HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                 0011111111   1   23457888999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-46  Score=408.88  Aligned_cols=249  Identities=27%  Similarity=0.363  Sum_probs=199.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      +.|+..+.||+|+||+||+|++. +++.||||++........           ...+.+.+|+.++++++|||||+++++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~~~~~   83 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-----------EKWQDIIKEVRFLQKLRHPNTIQYRGC   83 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHH-----------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCH-----------HHHHHHHHHHHHHHHCCCCCEeeEEEE
Confidence            46888999999999999999775 588999999975443222           224679999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+|||||.+|++..++...+  .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~D  158 (309)
T d1u5ra_          84 YLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGD  158 (309)
T ss_dssp             EEETTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECC
T ss_pred             EEECCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEee
Confidence            999999999999999999987765544  389999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCccccc---CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM---MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKR  921 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~  921 (1035)
                      ||+|+....      .....||+.|||||++.+   ..++.++|||||||++|||++|+.||......  .....+... 
T Consensus       159 FG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~~i~~~-  229 (309)
T d1u5ra_         159 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN-  229 (309)
T ss_dssp             CTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHS-
T ss_pred             cccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhC-
Confidence            999986533      235679999999998753   45899999999999999999999999754221  111111110 


Q ss_pred             cchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          922 GAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       922 ~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                       ..   ........+      ..+.+++.+||++||++|||++|++++
T Consensus       230 -~~---~~~~~~~~s------~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         230 -ES---PALQSGHWS------EYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -CC---CCCSCTTSC------HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -CC---CCCCCCCCC------HHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence             00   000011111      123457888999999999999999873

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-46  Score=402.95  Aligned_cols=259  Identities=21%  Similarity=0.277  Sum_probs=207.2

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.+.|++.+.||+|+||+||+|+++ +|+.||||++..........        ....+.+.+|+.++++++|||||+++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~   79 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--------GVSREDIEREVSILKEIQHPNVITLH   79 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--------SBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--------hHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3467999999999999999999875 68999999997654332211        12467899999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC----
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF----  838 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~----  838 (1035)
                      +++.+++..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||+.   +|+||||||+||+++.++    
T Consensus        80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~--l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          80 EVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred             EEEEECCEEEEEEEcCCCccccchhccccc--cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCccc
Confidence            999999999999999999999999987654  99999999999999999999999   999999999999998776    


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      .+|++|||+|+......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ......+.
T Consensus       155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--~~~~~~i~  229 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVS  229 (293)
T ss_dssp             CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHH
T ss_pred             ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--HHHHHHHH
Confidence            49999999998765432   23456799999999999999999999999999999999999999975421  11111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....   ..........+      ..+.+++.+||++||++|||++|++++
T Consensus       230 ~~~~---~~~~~~~~~~s------~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         230 AVNY---EFEDEYFSNTS------ALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             TTCC---CCCHHHHTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hcCC---CCCchhcCCCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1100   00000111111      233567888999999999999999874

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-46  Score=408.87  Aligned_cols=252  Identities=21%  Similarity=0.238  Sum_probs=206.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +++|++.+.||+|+||+||+|+.+ +|+.||||++........           ...+++.+|+.+|++++|||||++++
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~-----------~~~~~~~~E~~il~~l~hp~Iv~l~~   72 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----------DEVAHTVTESRVLQNTRHPFLTALKY   72 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCH-----------HHHHHHHHHHHHHHhCCCCCEEEEEe
Confidence            467999999999999999999875 689999999965432221           23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+||||++||+|.+++...+.  +++..+..++.||+.||+|||++   ||+||||||+|||++.+|.+||+
T Consensus        73 ~~~~~~~~~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~  147 (337)
T d1o6la_          73 AFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             eeccccccccceeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEe
Confidence            99999999999999999999999987665  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+|+......  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ......+....  
T Consensus       148 DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--~~~~~~i~~~~--  221 (337)
T d1o6la_         148 DFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILMEE--  221 (337)
T ss_dssp             CCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC--
T ss_pred             ecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--HHHHHHHhcCC--
Confidence            999998654432  223467899999999999999999999999999999999999999975432  11111111110  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                           ...+...+      ..+.+++.+||++||++||+     ++|++++
T Consensus       222 -----~~~p~~~s------~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         222 -----IRFPRTLS------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCCCTTSC------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCccCC------HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                 01111111      12345788899999999995     8888774

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-46  Score=400.73  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=200.5

Q ss_pred             HhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .++|++.+.||+|+||+||+|++++++.||||++.....               ..+.|.+|+.++++++|||||+++++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---------------~~~~~~~E~~~l~~l~h~nIv~~~g~   80 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---------------SPEAFLQEAQVMKKLRHEKLVQLYAV   80 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---------------CHHHHHHHHHHHHhcccCCEeEEEEE
Confidence            367999999999999999999999888999999864321               24679999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+ +..|+||||+++|+|..++.......+++..+..++.|||+||+|||+.   +|+||||||+|||++.++.+||+|
T Consensus        81 ~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~D  156 (285)
T d1fmka3          81 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVAD  156 (285)
T ss_dssp             ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             Eec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcc
Confidence            854 5679999999999999998776555699999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccch
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGAI  924 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~  924 (1035)
                      ||+|+....... .......||+.|+|||++....++.++|||||||++|||++|..||..... ......++....   
T Consensus       157 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~~~i~~~~---  231 (285)
T d1fmka3         157 FGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVERGY---  231 (285)
T ss_dssp             CCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTC---
T ss_pred             cchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcC---
Confidence            999987654332 233456799999999999999999999999999999999997766654322 122233332211   


Q ss_pred             hhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          925 EVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       925 ~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                             +...+..+.+  .+.+++.+||+.||++||++++|++.|++.
T Consensus       232 -------~~~~~~~~~~--~l~~li~~cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         232 -------RMPCPPECPE--SLHDLMCQCWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             -------CCCCCTTSCH--HHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred             -------CCCCCcccCH--HHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence                   1111111111  234578899999999999999999887664

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-45  Score=408.88  Aligned_cols=255  Identities=21%  Similarity=0.291  Sum_probs=204.7

Q ss_pred             HHHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          683 QVLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       683 ~~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      .++++|++.+.||+|+||+||+|++. +|+.||||++......              ..+.+.+|+.++++++|||||++
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~--------------~~~~~~~E~~il~~l~HpnIv~~   88 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--------------DKETVRKEIQTMSVLRHPTLVNL   88 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--------------HHHHHHHHHHHHHHTCCTTBCCE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--------------hHHHHHHHHHHHHhCCCCCCCcE
Confidence            35678999999999999999999875 5899999999653221              24678999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC--CCc
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP--EFE  839 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~--~~~  839 (1035)
                      ++++.+++..|+||||++||+|.+++.... ..+++..+..++.||+.||+|||++   ||+||||||+|||++.  ++.
T Consensus        89 ~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~  164 (350)
T d1koaa2          89 HDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE  164 (350)
T ss_dssp             EEEEEETTEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCC
T ss_pred             EEEEEECCEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCe
Confidence            999999999999999999999999986543 2389999999999999999999999   9999999999999964  578


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      +||+|||+|+......   ......||+.|||||++.+..++.++||||+||++|||++|+.||.....  ......+..
T Consensus       165 vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~  239 (350)
T d1koaa2         165 LKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DETLRNVKS  239 (350)
T ss_dssp             EEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH
T ss_pred             EEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHHHh
Confidence            9999999998765432   22356899999999999999999999999999999999999999975422  111221111


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....   .........+      ..+.+++.+||++||++|||++|++++
T Consensus       240 ~~~~---~~~~~~~~~s------~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         240 CDWN---MDDSAFSGIS------EDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             TCCC---SCCGGGGGCC------HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCC---CCcccccCCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1100   0000000111      123457888999999999999999885

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-45  Score=404.41  Aligned_cols=249  Identities=23%  Similarity=0.290  Sum_probs=203.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +++|++.+.||+|+||+||+|+++ +|+.||||++........           ...+.+.+|+.++++++|||||++++
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~HpnIv~~~~   71 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-----------KQVEHTNDERLMLSIVTHPFIIRMWG   71 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCH-----------HHHHHHHHHHHHHHhccCcChhheee
Confidence            357999999999999999999875 589999999965332221           23578999999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+||||++||+|..++.....  +++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+
T Consensus        72 ~~~~~~~~~ivmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~  146 (316)
T d1fota_          72 TFQDAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT  146 (316)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred             eEeeCCeeeeEeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEe
Confidence            99999999999999999999999877654  78899999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+|+.....     ....+||+.|||||++.+..++.++||||+||++|||++|+.||......  .....+...   
T Consensus       147 DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~~---  216 (316)
T d1fota_         147 DFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTYEKILNA---  216 (316)
T ss_dssp             CCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHC---
T ss_pred             cCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH--HHHHHHHcC---
Confidence            99999876432     23578999999999999999999999999999999999999999754221  111111110   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                          ........+      ..+.+++.+||.+||++|+     ++++++++
T Consensus       217 ----~~~~p~~~s------~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         217 ----ELRFPPFFN------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ----CCCCCTTSC------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCCCCCCC------HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                001111111      1234577889999999996     89999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3e-45  Score=407.09  Aligned_cols=254  Identities=19%  Similarity=0.243  Sum_probs=204.4

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.+.|++.+.||+|+||+||+|.+. +|+.||||++......              ..+.+.+|+.++++++|||||+++
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIv~~~   92 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL--------------DKYTVKNEISIMNQLHHPKLINLH   92 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--------------HHHHHHHHHHHHTTCCSTTBCCEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--------------HHHHHHHHHHHHHhCCCCCCCcEE
Confidence            4567999999999999999999775 6999999998653221              245788999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc--CCCce
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG--PEFEP  840 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~--~~~~~  840 (1035)
                      +++.+++..|+|||||+||+|.+++.... ..+++..+..++.||+.||+|||+.   ||+||||||+|||++  .++.+
T Consensus        93 ~~~~~~~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~v  168 (352)
T d1koba_          93 DAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV  168 (352)
T ss_dssp             EEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCE
T ss_pred             EEEEECCEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeE
Confidence            99999999999999999999998876543 3489999999999999999999999   999999999999998  67899


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      ||+|||+|+......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ......+...
T Consensus       169 kL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--~~~~~~i~~~  243 (352)
T d1koba_         169 KIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRC  243 (352)
T ss_dssp             EECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHHHHHHHHC
T ss_pred             EEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhC
Confidence            999999998775543   23356799999999999999999999999999999999999999975421  1111111111


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..   ..........+      ..+.+++.+||++||++|||++|++++
T Consensus       244 ~~---~~~~~~~~~~s------~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         244 DW---EFDEDAFSSVS------PEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CC---CCCSSTTTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CC---CCCcccccCCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            10   00111111111      123457888999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=392.44  Aligned_cols=251  Identities=26%  Similarity=0.376  Sum_probs=198.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|+..+.||+|+||.||+|+++ |+.||||+++.+.                ..+.|.+|++++++++|||||+++|++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----------------~~~~~~~E~~~l~~l~HpnIv~~~g~~   69 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----------------TAQAFLAEASVMTQLRHSNLVQLLGVI   69 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------------------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH----------------HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            56888899999999999999986 7899999985421                246799999999999999999999998


Q ss_pred             Ec-CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          766 WN-RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       766 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      .+ .+..|+||||+++|+|.+++..+....+++..+++++.||+.||+|||+.   +|+||||||+||+++.++.+|++|
T Consensus        70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~d  146 (262)
T d1byga_          70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSD  146 (262)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred             EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecc
Confidence            65 45689999999999999999876555689999999999999999999998   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||+++.....     .....+|..|+|||+..+..+++++|||||||++|||+| |+.||.....  .++..++....  
T Consensus       147 fg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~~--  217 (262)
T d1byga_         147 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY--  217 (262)
T ss_dssp             CCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTC--
T ss_pred             cccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC--
Confidence            9999865332     234568899999999999999999999999999999998 6877765422  23334432211  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                          ........+      ..+.+++.+||+.||++|||+.+++++|++++.
T Consensus       218 ----~~~~~~~~~------~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         218 ----KMDAPDGCP------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ----CCCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCccCC------HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                111111111      123467888999999999999999999998854

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-45  Score=392.34  Aligned_cols=259  Identities=23%  Similarity=0.355  Sum_probs=196.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC----CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN----GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|+..+.||+|+||+||+|.+..    +..||||++......             ...+.|.+|+.++++++|||||++
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l   73 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-------------SVREKFLQEALTMRQFDHPHIVKL   73 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH-------------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH-------------HHHHHHHHHHHHHHhCCCCCEeeE
Confidence            578899999999999999997753    456889988543222             235689999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++. ++..|+||||+++|+|.+++.... ..+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+|
T Consensus        74 ~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~K  148 (273)
T d1mp8a_          74 IGVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK  148 (273)
T ss_dssp             EEEEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred             EEEEe-cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEE
Confidence            99985 567899999999999999876543 3489999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......  .....+...
T Consensus       149 l~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~  225 (273)
T d1mp8a_         149 LGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENG  225 (273)
T ss_dssp             ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTT
T ss_pred             EccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcC
Confidence            999999987654332 23345678999999999999999999999999999999998 89999765332  222222221


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ..      .......+      ..+.+++.+||+.||++|||++||++.|+.+.++.
T Consensus       226 ~~------~~~~~~~~------~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         226 ER------LPMPPNCP------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             CC------CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC------CCCCCCCC------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            10      01111111      12455788899999999999999999999886543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-45  Score=400.19  Aligned_cols=261  Identities=26%  Similarity=0.407  Sum_probs=202.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-Cc----EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GE----VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  760 (1035)
                      .+|+..+.||+|+||+||+|.+.. |+    +||+|++......             ...++|.+|+.++++++|||||+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~   75 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-------------KANKEILDEAYVMASVDNPHVCR   75 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------------CTHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH-------------HHHHHHHHHHHHHHhCCCCCEee
Confidence            358889999999999999997753 43    5888888543211             23578999999999999999999


Q ss_pred             EEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          761 FLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       761 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      ++|++.++ ..+++|||+.+|+|.+++.... ..+++..+..++.|||+||+|||++   +|+||||||+||+++.++.+
T Consensus        76 l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~  150 (317)
T d1xkka_          76 LLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV  150 (317)
T ss_dssp             EEEEEESS-SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred             EEEEEecC-CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCe
Confidence            99999865 5678899999999999887653 4589999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |..||+.....  .+...+..
T Consensus       151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~  228 (317)
T d1xkka_         151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK  228 (317)
T ss_dssp             EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHH
T ss_pred             EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHc
Confidence            9999999998765544444445679999999999999999999999999999999998 78888754322  22333322


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQERE  978 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~~  978 (1035)
                      ...        . ..++. +.  ..+.+++.+||+.||++|||+.|++++|+.+.+...
T Consensus       229 ~~~--------~-~~p~~-~~--~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~  275 (317)
T d1xkka_         229 GER--------L-PQPPI-CT--IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  275 (317)
T ss_dssp             TCC--------C-CCCTT-BC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred             CCC--------C-CCCcc-cC--HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhChH
Confidence            110        0 01111 11  223457888999999999999999999988765543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-44  Score=391.40  Aligned_cols=263  Identities=23%  Similarity=0.321  Sum_probs=199.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|++.+.||+|+||+||+|++. +|+.||||++......+.           ...++|.+|++++++++|||||++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~E~~~l~~~~hpniv~~~~   74 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP-----------SFYLRFRREAQNAAALNHPAIVAVYD   74 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH-----------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH-----------HHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            367999999999999999999775 689999999976543322           23568999999999999999999999


Q ss_pred             EEEcCCc----ceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          764 CCWNRNT----RLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       764 ~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++...+.    .|+||||++||+|.+++...+.  +++..+..++.||++||+|||++   ||+||||||+|||++.++.
T Consensus        75 ~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~--l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~  149 (277)
T d1o6ya_          75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA  149 (277)
T ss_dssp             EEEEECSSSEEEEEEEECCCEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSC
T ss_pred             eeeeccCCCceEEEEEECCCCCEehhhhcccCC--CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCcccc
Confidence            9986543    7899999999999999877654  89999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCc-cccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          840 PYIADFGLAKLVVEGDF-ARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      ++++|||.++....... .......+||+.|||||++.+..+++++||||+||++|||+||+.||....+.. .....+.
T Consensus       150 ~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~~~~  228 (277)
T d1o6ya_         150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-VAYQHVR  228 (277)
T ss_dssp             EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred             ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-HHHHHHh
Confidence            99999999876543321 223345689999999999999999999999999999999999999997542211 1111111


Q ss_pred             HhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHHHH
Q 039419          919 QKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-TMKDVAAMIKEIK  974 (1035)
Q Consensus       919 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-s~~el~~~L~~~~  974 (1035)
                      ...    ..........+      ..+.+++.+||++||++|| |++++++.|..+.
T Consensus       229 ~~~----~~~~~~~~~~s------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         229 EDP----IPPSARHEGLS------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCC----CCGGGTSSSCC------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cCC----CCCchhccCCC------HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            100    00001111111      1234577889999999999 8999988887653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-45  Score=399.01  Aligned_cols=260  Identities=27%  Similarity=0.432  Sum_probs=207.9

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI  758 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  758 (1035)
                      .++|+..+.||+|+||+||+|+++      +++.||||++......             ...++|.+|++++++++||||
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~-------------~~~~~~~~E~~il~~l~h~ni   78 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------------DMQADFQREAALMAEFDNPNI   78 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH-------------HHHHHHHHHHHHHHTCCCTTB
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh-------------HHHHHHHHHHHHHHhcCCCCc
Confidence            357899999999999999999864      3578999998653322             125689999999999999999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhc
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD----------------------SCLEWELRYRIILGAAQGLAYLHH  816 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~  816 (1035)
                      +++++++.+.+..++||||+++|+|.++++....                      ..+++..++.++.|++.||+|||+
T Consensus        79 v~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~  158 (301)
T d1lufa_          79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE  158 (301)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc
Confidence            9999999999999999999999999999865321                      247899999999999999999999


Q ss_pred             cCCCCeeccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHH
Q 039419          817 DCVPPIVHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEV  896 (1035)
Q Consensus       817 ~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~el  896 (1035)
                      +   +|+||||||+|||++.++.+||+|||+|+...+...........||+.|+|||+..+..++.++|||||||++|||
T Consensus       159 ~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~el  235 (301)
T d1lufa_         159 R---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI  235 (301)
T ss_dssp             T---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             C---CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHH
Confidence            9   9999999999999999999999999999877555444444567899999999999999999999999999999999


Q ss_pred             HhCC-CCCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          897 LTGK-QPIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       897 ltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      ++|. .||....+  ......+....         ....+.....   .+.+++.+||+.||++||||.||++.|+++.
T Consensus       236 l~~~~~p~~~~~~--~e~~~~v~~~~---------~~~~p~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         236 FSYGLQPYYGMAH--EEVIYYVRDGN---------ILACPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HTTTCCTTTTSCH--HHHHHHHHTTC---------CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HccCCCCCCCCCH--HHHHHHHHcCC---------CCCCCccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            9986 46654322  22222222111         1111111112   3456888999999999999999999998763

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=396.86  Aligned_cols=262  Identities=23%  Similarity=0.340  Sum_probs=198.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCce
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNI  758 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  758 (1035)
                      ++|+..+.||+|+||+||+|++.      +++.||||++.......             ..+.+.+|..++.++ +||||
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-------------~~~~~~~e~~~l~~~~~h~~i   79 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-------------EHRALMSELKILIHIGHHLNV   79 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH-------------HHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH-------------HHHHHHHHHHHHHhhcCCCeE
Confidence            67999999999999999999764      24689999986533222             245788888888887 68999


Q ss_pred             eeEEeEEEcCC-cceEEEEeCCCCChhhhhhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCee
Q 039419          759 VRFLGCCWNRN-TRLLMYDYMPNGSLGSLLHERR--------------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIV  823 (1035)
Q Consensus       759 v~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iv  823 (1035)
                      |++++++.+.+ ..++||||+++|+|.++++..+              ...+++..+..++.||++||+|||++   +|+
T Consensus        80 v~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iv  156 (299)
T d1ywna1          80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCI  156 (299)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred             EEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCc
Confidence            99999987654 6799999999999999997543              23488999999999999999999999   999


Q ss_pred             ccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCC-CC
Q 039419          824 HRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-QP  902 (1035)
Q Consensus       824 HrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~-~P  902 (1035)
                      ||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||++|. .|
T Consensus       157 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p  236 (299)
T d1ywna1         157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  236 (299)
T ss_dssp             CSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence            99999999999999999999999998765544434445678999999999999999999999999999999999975 56


Q ss_pred             CCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      |..... ...+...+.....      .......+   +   .+.+++.+||+.||++|||++|++++|+.+.+.
T Consensus       237 ~~~~~~-~~~~~~~~~~~~~------~~~~~~~~---~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         237 YPGVKI-DEEFCRRLKEGTR------MRAPDYTT---P---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             STTCCC-SHHHHHHHHHTCC------CCCCTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCH-HHHHHHHHhcCCC------CCCCccCC---H---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            754322 2222222222110      01111111   1   245678889999999999999999999988654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.6e-45  Score=404.47  Aligned_cols=249  Identities=18%  Similarity=0.206  Sum_probs=204.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      +++|++.+.||+|+||+||+|+++ +|+.||||++........           ...+.+.+|+.+|++++|||||++++
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~-----------~~~~~~~~E~~il~~l~hpnIv~~~~  108 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL-----------KQIEHTLNEKRILQAVNFPFLVKLEF  108 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCH-----------HHHHHHHHHHHHHHHcCCCcEeeccc
Confidence            367999999999999999999875 699999999864332221           23567899999999999999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+.+..|+||||+.||+|.+++...+.  +++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+
T Consensus       109 ~~~~~~~~~~v~e~~~~g~l~~~l~~~~~--l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~  183 (350)
T d1rdqe_         109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             ccccccccccccccccccchhhhHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEee
Confidence            99999999999999999999999987654  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+|+.....     .....||+.|||||++.+..++.++|||||||++|||++|+.||....+  ......+....  
T Consensus       184 DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~i~~~~--  254 (350)
T d1rdqe_         184 DFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--IQIYEKIVSGK--  254 (350)
T ss_dssp             CCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHCC--
T ss_pred             eceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--HHHHHHHhcCC--
Confidence            99999876432     2356899999999999999999999999999999999999999975421  11111111110  


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                           .......+      ..+.+++.+||++||++|+     ++++++++
T Consensus       255 -----~~~p~~~s------~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         255 -----VRFPSHFS------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -----CCCCTTCC------HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCccCC------HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                 01111111      1234577889999999994     89999874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=395.13  Aligned_cols=263  Identities=27%  Similarity=0.387  Sum_probs=211.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCce
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNI  758 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpni  758 (1035)
                      ++|+..+.||+|+||.||+|++.      +++.||||++.......             ....|.+|+.+++++ +||||
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~-------------~~~~~~~E~~~~~~l~~HpnI   89 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-------------EREALMSELKVLSYLGNHMNI   89 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH-------------HHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHH-------------HHHHHHHHHHHHHhccCCCCE
Confidence            57888999999999999999752      46789999997643222             256799999999999 69999


Q ss_pred             eeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 039419          759 VRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD----------------SCLEWELRYRIILGAAQGLAYLHHDCVPPI  822 (1035)
Q Consensus       759 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  822 (1035)
                      |++++++.+++..|+||||+++|+|.++++....                ..+++..+..++.||++||+|||++   +|
T Consensus        90 v~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~i  166 (311)
T d1t46a_          90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NC  166 (311)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             EEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            9999999999999999999999999999976532                2488999999999999999999999   99


Q ss_pred             eccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCC
Q 039419          823 VHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQP  902 (1035)
Q Consensus       823 vHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P  902 (1035)
                      +||||||+||+++.++.+|++|||.++...............||+.|+|||+..+..++.++|||||||++|||+|+..|
T Consensus       167 vHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p  246 (311)
T d1t46a_         167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS  246 (311)
T ss_dssp             CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             eecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCC
Confidence            99999999999999999999999999987655444445567899999999999999999999999999999999995555


Q ss_pred             CCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          903 IDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                      +.........+...+....          +...+....  ..+.+++.+||++||++|||++|++++|+++..+
T Consensus       247 ~~~~~~~~~~~~~~i~~~~----------~~~~~~~~~--~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         247 PYPGMPVDSKFYKMIKEGF----------RMLSPEHAP--AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             SSTTCCSSHHHHHHHHHTC----------CCCCCTTSC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHhcCC----------CCCCccccc--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            4433333333333333211          111111111  2245578889999999999999999999876543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-44  Score=403.25  Aligned_cols=252  Identities=19%  Similarity=0.200  Sum_probs=198.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHH---HHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSF---SAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|.+.+.||+|+||+||+|++. +|+.||||++........           .....+   .+|+.+++.++|||||++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~-----------~~~~~~~~e~~~~~~l~~~~hpnIv~l   72 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----------QGETLALNERIMLSLVSTGDCPFIVCM   72 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH-----------TCHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh-----------hHHHHHHHHHHHHHHHhcCCCCcEEEE
Confidence            57899999999999999999876 589999999864332221           112233   345777888899999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      ++++.+++..|+||||++||+|.+++.....  +++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+|
T Consensus        73 ~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iK  147 (364)
T d1omwa3          73 SYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVR  147 (364)
T ss_dssp             EEEEECSSEEEEEECCCCSCBHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEE
T ss_pred             EEEEEECCEEEEEEEecCCCcHHHHHHhccc--ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEE
Confidence            9999999999999999999999999987654  88999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccccCCccccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          842 IADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      |+|||+|+......    .....||+.|+|||++. +..++.++||||+||++|||++|+.||.........  ...+..
T Consensus       148 l~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~  221 (364)
T d1omwa3         148 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMT  221 (364)
T ss_dssp             ECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHS
T ss_pred             EeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhc
Confidence            99999998765432    23568999999999986 456899999999999999999999999765433221  111111


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPT-----MKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs-----~~el~~~  969 (1035)
                      ...    ........+      ..+.+++.+||++||++|||     ++|++++
T Consensus       222 ~~~----~~~~~~~~s------~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         222 LTM----AVELPDSFS------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SSC----CCCCCSSSC------HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ccC----CCCCCCCCC------HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            100    011111111      12355788899999999999     6888774

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.7e-44  Score=386.15  Aligned_cols=260  Identities=22%  Similarity=0.278  Sum_probs=204.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      ++|++.+.||+|+||+||+|++. +++.||||++...........     ......+.+.+|+.++++++ |||||++++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~   77 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE-----EVQELREATLKEVDILRKVSGHPNIIQLKD   77 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHH-----HHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHH-----HHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence            57899999999999999999875 689999999976543321100     01123567899999999997 999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+||||++||+|.++++..+.  +++..+..++.||++||+|||++   ||+||||||+||+++.++.+||+
T Consensus        78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~--l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~  152 (277)
T d1phka_          78 TYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT  152 (277)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             ecccCcceEEEEEcCCCchHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEc
Confidence            99999999999999999999999987654  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccc------cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGY------MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      |||+++......   ......||+.|+|||+..      ...++.++||||+||++|||++|+.||....+.  .....+
T Consensus       153 DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--~~~~~i  227 (277)
T d1phka_         153 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLRMI  227 (277)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred             cchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--HHHHHH
Confidence            999998765532   223568999999999864      345788999999999999999999999754321  111111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .....  .     ........+.  ..+.+++.+||++||++||+++|++++
T Consensus       228 ~~~~~--~-----~~~~~~~~~s--~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGNY--Q-----FGSPEWDDYS--DTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTCC--C-----CCTTTGGGSC--HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCCC--C-----CCCcccccCC--HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11110  0     0010000111  234557888999999999999999764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=397.76  Aligned_cols=254  Identities=22%  Similarity=0.235  Sum_probs=197.8

Q ss_pred             HHhccccC-CeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceee
Q 039419          684 VLKCLVED-SVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVR  760 (1035)
Q Consensus       684 ~~~~~~~~-~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~  760 (1035)
                      +.++|.+. ++||+|+||+||+|++. +++.||||++..                   .+.+.+|+.++.++ +|||||+
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------------------~~~~~~E~~~~~~~~~hpnIv~   69 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------------------CPKARREVELHWRASQCPHIVR   69 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------------------SHHHHHHHHHHHHHTTSTTBCC
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------------------cHHHHHHHHHHHHhcCCCCCCe
Confidence            45778776 46999999999999774 689999999842                   24577899997665 8999999


Q ss_pred             EEeEEEc----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          761 FLGCCWN----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       761 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                      +++++.+    ....|+|||||+||+|.+++..++...+++..+..++.||+.||+|||+.   ||+||||||+|||++.
T Consensus        70 l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~  146 (335)
T d2ozaa1          70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTS  146 (335)
T ss_dssp             EEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESC
T ss_pred             EEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccc
Confidence            9999875    35689999999999999999876666799999999999999999999999   9999999999999985


Q ss_pred             ---CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhH
Q 039419          837 ---EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHI  913 (1035)
Q Consensus       837 ---~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~  913 (1035)
                         .+.+||+|||+|+......   ......||+.|||||++.+..++.++||||+||++|||+||+.||.......  .
T Consensus       147 ~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~  221 (335)
T d2ozaa1         147 KRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--I  221 (335)
T ss_dssp             SSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----
T ss_pred             ccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--H
Confidence               5679999999998765543   2345689999999999999999999999999999999999999997543221  1


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ...+....     .........+........+.+++.+||++||++|||+.|++++
T Consensus       222 ~~~~~~~i-----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         222 SPGMKTRI-----RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ------CC-----CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHH-----hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11111100     0000000000001111234567889999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=397.90  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=201.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHh-cCCCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLG-SIRHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~  763 (1035)
                      ++|++.+.||+|+||+||+|+++ +++.||||++........           ...+.+.+|..++. .++|||||++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~-----------~~~~~~~~e~~~l~~~~~hp~Iv~~~~   70 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-----------DDVECTMVEKRVLSLAWEHPFLTHMFC   70 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-----------TCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh-----------HHHHHHHHHHHHHHHhCCCCcEEEEEE
Confidence            57899999999999999999876 589999999965322211           22456777777765 689999999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEe
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIA  843 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~  843 (1035)
                      ++.+++..|+||||++||+|.++++....  +++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+
T Consensus        71 ~~~~~~~~yivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~  145 (320)
T d1xjda_          71 TFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIA  145 (320)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEccCCceeEEEeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecc
Confidence            99999999999999999999999987655  89999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          844 DFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       844 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |||+|+......  .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+.  .....+...   
T Consensus       146 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~---  218 (320)
T d1xjda_         146 DFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMD---  218 (320)
T ss_dssp             CCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC---
T ss_pred             ccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHcC---
Confidence            999998654432  2234568999999999999999999999999999999999999999754221  222212111   


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMK-DVAA  968 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~-el~~  968 (1035)
                          ........+      ..+.+++.+||++||++||++. |+++
T Consensus       219 ----~~~~p~~~s------~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 ----NPFYPRWLE------KEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ----CCCCCTTSC------HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----CCCCCccCC------HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                011111111      1235678889999999999995 7765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=386.92  Aligned_cols=259  Identities=25%  Similarity=0.374  Sum_probs=194.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC--C--cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN--G--EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  761 (1035)
                      ++|++.+.||+|+||+||+|++..  +  ..||||++........           ...++|.+|+.++++++|||||++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~-----------~~~~~~~~Ei~~l~~l~H~nIv~~   76 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP-----------EAMDDFIREVNAMHSLDHRNLIRL   76 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------C-----------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCH-----------HHHHHHHHHHHHHHhCCCCCEEEE
Confidence            568889999999999999997542  2  4789999865443222           235689999999999999999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceE
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPY  841 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~k  841 (1035)
                      +|++.+ +..++||||+++|++.+++..+.. .+++..+..++.|||+||+|||++   +|+||||||+||+++.++.+|
T Consensus        77 ~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vk  151 (273)
T d1u46a_          77 YGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVK  151 (273)
T ss_dssp             EEEECS-SSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEE
T ss_pred             EEEEee-cchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhcccccccee
Confidence            999965 467899999999999998876543 489999999999999999999998   999999999999999999999


Q ss_pred             EeeccCccccccCCcc-ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCCCCCCCCCCchhHHHHHHH
Q 039419          842 IADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       842 l~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      |+|||+++........ .......|+..|+|||+..+..++.++|||||||++|||+| |+.||.....  .....++..
T Consensus       152 l~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--~~~~~~i~~  229 (273)
T d1u46a_         152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQILHKIDK  229 (273)
T ss_dssp             ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHT
T ss_pred             eccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--HHHHHHHHh
Confidence            9999999977554322 22334568889999999999999999999999999999998 8999975422  222223221


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ....     .......+      ..+.+++.+||++||++|||++||.+.|+++
T Consensus       230 ~~~~-----~~~~~~~~------~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 EGER-----LPRPEDCP------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             SCCC-----CCCCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC-----CCCccccc------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1100     00111111      1244688889999999999999999988765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=395.41  Aligned_cols=253  Identities=18%  Similarity=0.226  Sum_probs=203.1

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      ++++|.+.+.||+|+||+||+|.++ +++.||||++.....               ....+.+|+++|++++|||||+++
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---------------~~~~~~~Ei~il~~l~HpnIv~~~   67 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---------------DQVLVKKEISILNIARHRNILHLH   67 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---------------HHHHHHHHHHHHHHSCCTTBCCEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---------------cHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4678999999999999999999876 588999999965321               134688999999999999999999


Q ss_pred             eEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC--Cce
Q 039419          763 GCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE--FEP  840 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~--~~~  840 (1035)
                      +++.+++..|+|||||+||+|.+++...+ ..+++.++..++.||+.||+|||+.   ||+||||||+|||++.+  +.+
T Consensus        68 ~~~~~~~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~i  143 (321)
T d1tkia_          68 ESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTI  143 (321)
T ss_dssp             EEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCE
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEE
Confidence            99999999999999999999999997654 2489999999999999999999999   99999999999999854  479


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHh
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQK  920 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~  920 (1035)
                      ||+|||+++......   ......||+.|+|||...+..++.++||||+||++|+|++|+.||......  .....+...
T Consensus       144 kl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~i~~~  218 (321)
T d1tkia_         144 KIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNA  218 (321)
T ss_dssp             EECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHT
T ss_pred             EEcccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC
Confidence            999999998764432   223467899999999999999999999999999999999999999754221  111111111


Q ss_pred             ccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          921 RGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       921 ~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..   ..........+      ..+.+++.+||.+||++|||++|++++
T Consensus       219 ~~---~~~~~~~~~~s------~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         219 EY---TFDEEAFKEIS------IEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CC---CCCHHHHTTSC------HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CC---CCChhhccCCC------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00   00000001111      123567888999999999999999885

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-44  Score=391.15  Aligned_cols=259  Identities=26%  Similarity=0.381  Sum_probs=205.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC--------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCC
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN--------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHK  756 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  756 (1035)
                      ++|.+.+.||+|+||.||+|+...        +..||||++..+....             ....+.+|+..+.++ +||
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~-------------~~~~~~~e~~~l~~~~~Hp   79 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-------------DLSDLISEMEMMKMIGKHK   79 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH-------------HHHHHHHHHHHHHHHCCCT
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH-------------HHHHHHHHHHHHHHhcCCC
Confidence            578889999999999999997532        3479999997543322             246788999999998 799


Q ss_pred             ceeeEEeEEEcCCcceEEEEeCCCCChhhhhhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhccCCCCe
Q 039419          757 NIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRD--------------SCLEWELRYRIILGAAQGLAYLHHDCVPPI  822 (1035)
Q Consensus       757 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  822 (1035)
                      |||++++++.+++..|+||||+++|+|.+++..+..              ..+++..+..++.||++||+|||+.   +|
T Consensus        80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~i  156 (299)
T d1fgka_          80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KC  156 (299)
T ss_dssp             TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CE
Confidence            999999999999999999999999999999976542              3489999999999999999999999   99


Q ss_pred             eccCCCcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHh-CCC
Q 039419          823 VHRDIKANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLT-GKQ  901 (1035)
Q Consensus       823 vHrDikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~ellt-g~~  901 (1035)
                      +||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~  236 (299)
T d1fgka_         157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS  236 (299)
T ss_dssp             CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             EeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCC
Confidence            9999999999999999999999999998766555445556789999999999999999999999999999999998 688


Q ss_pred             CCCCCCCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          902 PIDPTIPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       902 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      ||.....  ......+....      ........+   +   .+.+++.+||++||++|||+.||++.|+.+.
T Consensus       237 p~~~~~~--~~~~~~i~~~~------~~~~p~~~~---~---~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         237 PYPGVPV--EELFKLLKEGH------RMDKPSNCT---N---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             SSTTCCH--HHHHHHHHTTC------CCCCCSSCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCH--HHHHHHHHcCC------CCCCCccch---H---HHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            8864322  12222222111      001111111   1   2456888999999999999999999998875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=393.18  Aligned_cols=266  Identities=28%  Similarity=0.336  Sum_probs=198.0

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHH--HHHHHHhcCCCCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFS--AEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~E~~~l~~l~hpniv~l~~  763 (1035)
                      +.|...+.||+|+||+||+|++. |+.||||++....                 .+.+.  +|+..+..++|||||++++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-----------------~~~~~~e~ei~~~~~~~HpnIv~~~~   64 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-----------------ERSWFREAEIYQTVMLRHENILGFIA   64 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-----------------HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-----------------hhHHHHHHHHHHHhhCCCCcCcceEE
Confidence            56788899999999999999875 8999999985321                 22333  4555556789999999999


Q ss_pred             EEEcCC----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC-----CCCeeccCCCcccEEE
Q 039419          764 CCWNRN----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC-----VPPIVHRDIKANNILI  834 (1035)
Q Consensus       764 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~ivHrDikp~NIll  834 (1035)
                      ++.+++    ..|+||||+++|+|.++++...   +++..+..++.|+|.||+|+|+..     .++|+||||||+|||+
T Consensus        65 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl  141 (303)
T d1vjya_          65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV  141 (303)
T ss_dssp             EEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE
T ss_pred             EEEeCCCcceEEEEEEecccCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE
Confidence            998654    4689999999999999998643   899999999999999999999731     2399999999999999


Q ss_pred             cCCCceEEeeccCccccccCCcc--ccccccCCcccccCCcccccC------CCCccccchhHHHHHHHHHhCCCCCCCC
Q 039419          835 GPEFEPYIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMM------KITEKSDVYSYGVVVLEVLTGKQPIDPT  906 (1035)
Q Consensus       835 ~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGvvl~elltg~~P~~~~  906 (1035)
                      +.++.+||+|||+++........  .......||+.|+|||++.+.      .++.++|||||||++|||+||..||...
T Consensus       142 ~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~  221 (303)
T d1vjya_         142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  221 (303)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred             cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence            99999999999999877554321  223457899999999987654      2667899999999999999999887532


Q ss_pred             CCCchh---------HHHHHHHhccchhhhcccccCCCc---ccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 039419          907 IPEGLH---------IVDWVRQKRGAIEVLDKSLRARPE---VEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIK  974 (1035)
Q Consensus       907 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~  974 (1035)
                      ......         .......     .......+...+   ........+.+++.+||+.||++|||+.||++.|+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         222 EDYQLPYYDLVPSDPSVEEMRK-----VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHH-----HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccchhhcccccchHHHHHH-----HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            211100         0011111     111111111111   11223334566899999999999999999999999887


Q ss_pred             HhH
Q 039419          975 QER  977 (1035)
Q Consensus       975 ~~~  977 (1035)
                      ++.
T Consensus       297 ~~~  299 (303)
T d1vjya_         297 QQE  299 (303)
T ss_dssp             HHH
T ss_pred             Hhc
Confidence            543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=384.97  Aligned_cols=256  Identities=27%  Similarity=0.434  Sum_probs=200.1

Q ss_pred             CCeeeeeCCcEEEEEEECCC----cEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEE
Q 039419          691 DSVVGKGCSGIVYRAEMENG----EVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCW  766 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  766 (1035)
                      .++||+|+||+||+|++.++    ..||||++......             ...++|.+|++++++++|||||+++|++.
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   98 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI-------------GEVSQFLTEGIIMKDFSHPNVLSLLGICL   98 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH-------------HHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH-------------HHHHHHHHHHHHHHhCCCCCEeEEeEEEE
Confidence            46899999999999987542    36899998643221             12578999999999999999999999987


Q ss_pred             c-CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          767 N-RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       767 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      + ++..++||||+++|+|.++++... ...++..+.+++.|+|+||.|+|+.   +|+||||||+|||++.++.+||+||
T Consensus        99 ~~~~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DF  174 (311)
T d1r0pa_          99 RSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF  174 (311)
T ss_dssp             ETTTEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSS
T ss_pred             ecCCceEEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecc
Confidence            5 457899999999999999987654 3478888999999999999999999   9999999999999999999999999


Q ss_pred             cCccccccCCcc--ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          846 GLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       846 G~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      |+++........  .......||+.|+|||+..+..++.++||||||+++|||++|+.||...... .+...++......
T Consensus       175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~~~  253 (311)
T d1r0pa_         175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRL  253 (311)
T ss_dssp             GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCCC
T ss_pred             cchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCC
Confidence            999876554322  2233467999999999999999999999999999999999988887643221 1222222221110


Q ss_pred             hhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHh
Q 039419          924 IEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQE  976 (1035)
Q Consensus       924 ~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~  976 (1035)
                               ..+....+   .+.+++.+||+.||++||++.||+++|+.+...
T Consensus       254 ---------~~p~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         254 ---------LQPEYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ---------CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ---------CCcccCcH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                     01111111   234578899999999999999999999988643

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=389.80  Aligned_cols=257  Identities=25%  Similarity=0.389  Sum_probs=199.8

Q ss_pred             hccccCCeeeeeCCcEEEEEEECC-Cc--EEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC-CCCceeeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMEN-GE--VIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI-RHKNIVRF  761 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l  761 (1035)
                      ++|+..+.||+|+||+||+|.+++ +.  .||||++.......             ..+.|.+|+++++++ +|||||++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~E~~~l~~l~~HpnIv~~   76 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD-------------DHRDFAGELEVLCKLGHHPNIINL   76 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH-------------HHHHHHHHHHHHHhccCCCCEeeE
Confidence            678888999999999999997764 44  47788875432221             245799999999999 79999999


Q ss_pred             EeEEEcCCcceEEEEeCCCCChhhhhhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCC
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLGSLLHER--------------RDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDI  827 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDi  827 (1035)
                      ++++.+++..|+||||+++|+|.++++..              ....+++..+.+++.|||+||+|+|+.   +|+||||
T Consensus        77 ~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDl  153 (309)
T d1fvra_          77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDL  153 (309)
T ss_dssp             EEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             EEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---Ccccccc
Confidence            99999999999999999999999999754              234589999999999999999999999   9999999


Q ss_pred             CcccEEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCC-CCCCC
Q 039419          828 KANNILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQ-PIDPT  906 (1035)
Q Consensus       828 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~-P~~~~  906 (1035)
                      ||+|||++.++.+||+|||+|+......   ......||..|+|||.+.+..++.++|||||||++|||++|.. ||...
T Consensus       154 kp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~  230 (309)
T d1fvra_         154 AARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  230 (309)
T ss_dssp             SGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999998653322   2234568999999999999999999999999999999999765 56533


Q ss_pred             CCCchhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          907 IPEGLHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       907 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      .  ...+...+..          ..+...+..+.  ..+.+++.+||+.||++|||++||+++|+.+.+
T Consensus       231 ~--~~~~~~~i~~----------~~~~~~~~~~~--~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         231 T--CAELYEKLPQ----------GYRLEKPLNCD--DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             C--HHHHHHHGGG----------TCCCCCCTTBC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C--HHHHHHHHHh----------cCCCCCCccCC--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1  1122222111          11111111111  123457888999999999999999999998864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=385.26  Aligned_cols=265  Identities=24%  Similarity=0.331  Sum_probs=199.2

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|.+. +|+.||||++.......            ...+++.+|++++++++|||||+++++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------------~~~~~~~~Ei~il~~l~Hp~Iv~~~~~   69 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------------GVPSTAIREISLLKELNHPNIVKLLDV   69 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------------CCHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh------------HHHHHHHHHHHHHHhCCCCcEEEeccc
Confidence            57999999999999999999874 68999999996543221            124689999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+++..|+||||+.+ ++.+++.......+++..+..++.||+.||+|||++   +||||||||+|||++.++.+||+|
T Consensus        70 ~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~D  145 (298)
T d1gz8a_          70 IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLAD  145 (298)
T ss_dssp             EEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECS
T ss_pred             cccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceecc
Confidence            9999999999999964 556666555556699999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.|+......  .......||+.|+|||+..... ++.++||||+||++|+|++|+.||....... ............
T Consensus       146 FG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~  222 (298)
T d1gz8a_         146 FGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTP  222 (298)
T ss_dssp             TTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             CCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCC
Confidence            99998765432  2334568999999999866555 5789999999999999999999997542211 111111111111


Q ss_pred             hhhhccc----------ccCCCcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IEVLDKS----------LRARPEVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~~~~~~----------~~~~~~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .+.....          ...........     ...+.+++.+||++||++|||++|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000000          00000000010     1234567888999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=388.26  Aligned_cols=258  Identities=25%  Similarity=0.378  Sum_probs=206.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC------CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCcee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME------NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIV  759 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv  759 (1035)
                      ++|...+.||+|+||+||+|.+.      +++.||||++.......             ....|.+|+.++++++|||||
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~-------------~~~~~~~E~~il~~l~h~nIv   86 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-------------ERIEFLNEASVMKEFNCHHVV   86 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH-------------HHHHHHHHHHHGGGCCCTTBC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH-------------HHHHHHHHHHHHHHcCCCCEe
Confidence            67888999999999999999763      25789999996433221             245799999999999999999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCccc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERR--------DSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANN  831 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~N  831 (1035)
                      ++++++..++..++||||+++|+|.+++...+        ...+++..+.+++.|+|+||.|||++   +|+||||||+|
T Consensus        87 ~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~N  163 (308)
T d1p4oa_          87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARN  163 (308)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGG
T ss_pred             eeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCc
Confidence            99999999999999999999999999986542        13478999999999999999999999   99999999999


Q ss_pred             EEEcCCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCC-CCCCCCCCCc
Q 039419          832 ILIGPEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGK-QPIDPTIPEG  910 (1035)
Q Consensus       832 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~-~P~~~~~~~~  910 (1035)
                      ||++.++++||+|||+|+...............||+.|+|||.+.+..++.++||||||+++|||+||. .||.....  
T Consensus       164 iLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~--  241 (308)
T d1p4oa_         164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--  241 (308)
T ss_dssp             EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--
T ss_pred             eeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH--
Confidence            999999999999999998776654444445567999999999999999999999999999999999985 66654311  


Q ss_pred             hhHHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHH
Q 039419          911 LHIVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEI  973 (1035)
Q Consensus       911 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~  973 (1035)
                      ......+..         ......+. .+.  ..+.+++.+||+.||++|||++||+++|++.
T Consensus       242 ~~~~~~i~~---------~~~~~~p~-~~~--~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         242 EQVLRFVME---------GGLLDKPD-NCP--DMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHHHHHT---------TCCCCCCT-TCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHHHHh---------CCCCCCcc-cch--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            112222211         11111111 111  1345578889999999999999999998765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=388.46  Aligned_cols=261  Identities=24%  Similarity=0.281  Sum_probs=193.1

Q ss_pred             CCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEEEcCC
Q 039419          691 DSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCCWNRN  769 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  769 (1035)
                      .++||+|+||+||+|+++ +|+.||||++..........         ...+.+.+|+.++++++|||||++++++.+++
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~---------~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~   73 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD---------GINRTALREIKLLQELSHPNIIGLLDAFGHKS   73 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC---------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhH---------HHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence            468999999999999875 58999999996543322110         12457899999999999999999999999999


Q ss_pred             cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          770 TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                      ..|+||||+.++++..+....  ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||.|+
T Consensus        74 ~~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~  148 (299)
T d1ua2a_          74 NISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  148 (299)
T ss_dssp             CCEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             ceeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCcccc
Confidence            999999999888777666543  3488899999999999999999999   99999999999999999999999999998


Q ss_pred             ccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhcc--chhh
Q 039419          850 LVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRG--AIEV  926 (1035)
Q Consensus       850 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~  926 (1035)
                      ......  ......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....  .+....+....+  ..+.
T Consensus       149 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~--~~~l~~i~~~~~~~~~~~  224 (299)
T d1ua2a_         149 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--LDQLTRIFETLGTPTEEQ  224 (299)
T ss_dssp             TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCCCCTTT
T ss_pred             ccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH--HHHHHHHHHhcCCCChhh
Confidence            765433  22335679999999998764 4579999999999999999999999975422  111111111100  0000


Q ss_pred             hc--------ccccCCCcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          927 LD--------KSLRARPEVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       927 ~~--------~~~~~~~~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..        ......+......     .....+++.+||+.||++|||++|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         225 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            00        0000111111111     1235668889999999999999999874

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=380.61  Aligned_cols=246  Identities=21%  Similarity=0.314  Sum_probs=195.7

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC--CCceeeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR--HKNIVRFL  762 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~  762 (1035)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...........        ....++.+|+.++++++  |||||+++
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~--------~~~~~~~~E~~il~~l~~~h~nIv~~~   75 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPMEVVLLKKVSSGFSGVIRLL   75 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEEC--------TTCCEEEHHHHHHHHHCSSSCSBCCEE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhh--------hHHHHHHHHHHHHHHhccCCCCccEEE
Confidence            57899999999999999999775 689999999976543322111        01234668999999996  89999999


Q ss_pred             eEEEcCCcceEEEEeCCC-CChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-CCce
Q 039419          763 GCCWNRNTRLLMYDYMPN-GSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-EFEP  840 (1035)
Q Consensus       763 ~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-~~~~  840 (1035)
                      +++.+++..|+||||+.+ +++.+++.....  +++..+..++.||++||+|||++   +|+||||||+|||++. ++.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~--l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~v  150 (273)
T d1xwsa_          76 DWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGEL  150 (273)
T ss_dssp             EEEECSSEEEEEEECCSSEEEHHHHHHHHCS--CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEE
T ss_pred             EEEeeCCeEEEEEEeccCcchHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeE
Confidence            999999999999999976 678888876654  89999999999999999999999   9999999999999985 4799


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccCCC-CccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKI-TEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQ  919 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~  919 (1035)
                      ||+|||+|+.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....       ...+.
T Consensus       151 kl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~  219 (273)
T d1xwsa_         151 KLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRG  219 (273)
T ss_dssp             EECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHC
T ss_pred             EECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhc
Confidence            99999999865432    2335689999999999877665 567999999999999999999996420       11110


Q ss_pred             hccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          920 KRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       920 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                              ....+...+.      .+.+++.+||++||++|||++|++++
T Consensus       220 --------~~~~~~~~s~------~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 --------QVFFRQRVSS------ECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             --------CCCCSSCCCH------HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------ccCCCCCCCH------HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                    0111122222      23457788999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.1e-43  Score=379.25  Aligned_cols=264  Identities=22%  Similarity=0.268  Sum_probs=198.1

Q ss_pred             hccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      ++|...+.||+|+||+||+|++++|+.||||++.......            ...+++.+|+.+|++++|||||++++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~------------~~~~~~~~E~~il~~l~hpnIv~~~~~~   69 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------------GIPSTTIREISILKELKHSNIVKLYDVI   69 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG------------CCCHHHHHHHHGGGGCCCTTBCCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh------------HHHHHHHHHHHHHHhCCCCcEEeeeeec
Confidence            5789999999999999999999999999999996654322            1246899999999999999999999999


Q ss_pred             EcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEeec
Q 039419          766 WNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIADF  845 (1035)
Q Consensus       766 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~DF  845 (1035)
                      .+++..|++|||+.++.+..+....  ..+++..+..++.||++||+|||+.   +|+||||||+|||++.++.+|++||
T Consensus        70 ~~~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~Df  144 (286)
T d1ob3a_          70 HTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADF  144 (286)
T ss_dssp             ECSSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCT
T ss_pred             ccCCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccc
Confidence            9999999999999877776666544  3499999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc-
Q 039419          846 GLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA-  923 (1035)
Q Consensus       846 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-  923 (1035)
                      |.|........  ......|++.|+|||...+ ..++.++||||+||++|||++|+.||....... ............ 
T Consensus       145 G~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~  221 (286)
T d1ob3a_         145 GLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPN  221 (286)
T ss_dssp             THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             ccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCC
Confidence            99987654332  2335578999999998765 456899999999999999999999997543211 111111100000 


Q ss_pred             hh---------hhcccccCCCc---c--cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IE---------VLDKSLRARPE---V--EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~---------~~~~~~~~~~~---~--~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..         ...........   .  .........+++.+||++||++|||++|++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00         00000000000   0  00001234567888999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-42  Score=375.78  Aligned_cols=262  Identities=21%  Similarity=0.251  Sum_probs=193.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-C-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcC---CCCceee
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-N-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSI---RHKNIVR  760 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~  760 (1035)
                      ++|++.+.||+|+||+||+|++. + ++.||||++........            ....+.+|+.+++.+   +||||++
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~------------~~~~~~~E~~~l~~l~~~~HpnIv~   74 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------------MPLSTIREVAVLRHLETFEHPNVVR   74 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS------------CBCTHHHHHHHHHHHHHTCCTTBCC
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch------------HHHHHHHHHHHHHHHhhcCCCCcce
Confidence            67999999999999999999874 4 56799999865432221            123466788877766   7999999


Q ss_pred             EEeEEEc-----CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          761 FLGCCWN-----RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       761 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      +++++..     ....|++|||++++++..... .....+++..+..++.|++.||+|||++   +|+||||||+|||++
T Consensus        75 ~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~  150 (305)
T d1blxa_          75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVT  150 (305)
T ss_dssp             EEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred             eeeeecccccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEc
Confidence            9999863     246799999998876654433 3345589999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHH
Q 039419          836 PEFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVD  915 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~  915 (1035)
                      .++.+||+|||.++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||....+. ..+..
T Consensus       151 ~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~  226 (305)
T d1blxa_         151 SSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGK  226 (305)
T ss_dssp             TTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHH
T ss_pred             CCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence            9999999999999865433   2334678999999999999999999999999999999999999999754321 11111


Q ss_pred             HHHHhcc-chhhhc-----------ccccCC---CcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          916 WVRQKRG-AIEVLD-----------KSLRAR---PEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       916 ~~~~~~~-~~~~~~-----------~~~~~~---~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....... ......           ......   ....+.  ....+++.+||++||++|||++|++++
T Consensus       227 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID--ELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC--HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhhCCCchhcccccccchhhhhccccccchhhccccCC--HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            1111000 000000           000000   000111  123457888999999999999999875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.2e-40  Score=360.07  Aligned_cols=263  Identities=17%  Similarity=0.188  Sum_probs=204.9

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC-CceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH-KNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~  763 (1035)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....                .+.+.+|+++++.++| +|++.+++
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------------~~~~~~e~~~~~~l~~~~~i~~~~~   68 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------------APQLRDEYRTYKLLAGCTGIPNVYY   68 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------------SCCHHHHHHHHHHTTTCTTCCCEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----------------cHHHHHHHHHHHHhcCCCCCCEEEE
Confidence            57899999999999999999876 589999998754321                1246789999999975 89999999


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC-----CC
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP-----EF  838 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~-----~~  838 (1035)
                      ++.+....|+||||+ +++|.++++..+ ..+++..+..++.|++.||+|||+.   ||+||||||+|||++.     ++
T Consensus        69 ~~~~~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~  143 (293)
T d1csna_          69 FGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNAN  143 (293)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTT
T ss_pred             EeecCCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCC
Confidence            999999999999999 789999887654 3489999999999999999999999   9999999999999974     57


Q ss_pred             ceEEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCch-h
Q 039419          839 EPYIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGL-H  912 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~-~  912 (1035)
                      .+||+|||+|+.+......     .......||+.|||||++.+..+++++|||||||++|||++|+.||........ .
T Consensus       144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~  223 (293)
T d1csna_         144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  223 (293)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence            8999999999987543221     223456799999999999999999999999999999999999999986543322 1


Q ss_pred             HHHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHHhH
Q 039419          913 IVDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQER  977 (1035)
Q Consensus       913 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~~~  977 (1035)
                      ....+.....  ....+.+....+.      .+..++..|+..+|++||+++.+.+.++++.+..
T Consensus       224 ~~~~i~~~~~--~~~~~~l~~~~p~------~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         224 KYERIGEKKQ--STPLRELCAGFPE------EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHHHHH--HSCHHHHTTTSCH------HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHhccC--CCChHHhcCCCCH------HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            1111111110  0001111112221      2334667799999999999999999988876543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-40  Score=362.67  Aligned_cols=260  Identities=18%  Similarity=0.230  Sum_probs=196.4

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCc-eeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKN-IVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~  763 (1035)
                      ++|++.+.||+|+||+||+|++. +|+.||||++.....                .+++.+|++++++++|++ |+.+.+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------------~~~~~~E~~i~~~l~~~~~i~~~~~   70 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------------HPQLHIESKIYKMMQGGVGIPTIRW   70 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----------------SCCHHHHHHHHHHSTTSTTCCCEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----------------CHHHHHHHHHHHHccCCCcccEEEE
Confidence            46999999999999999999775 589999998754321                124788999999998765 555566


Q ss_pred             EEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC---CCce
Q 039419          764 CCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP---EFEP  840 (1035)
Q Consensus       764 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~---~~~~  840 (1035)
                      ++.+.+..++||||+ ++++...+.... ..+++..+..++.|+++||+|||++   +|+||||||+|||++.   +..+
T Consensus        71 ~~~~~~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~v  145 (299)
T d1ckia_          71 CGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV  145 (299)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCE
T ss_pred             EEecCCEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCcee
Confidence            667788889999999 667777665433 3489999999999999999999999   9999999999999864   4579


Q ss_pred             EEeeccCccccccCCcc-----ccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchh--H
Q 039419          841 YIADFGLAKLVVEGDFA-----RSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH--I  913 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~--~  913 (1035)
                      |++|||+|+.+......     .......||+.|||||++.+..++.++|||||||++|||++|+.||.........  .
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~  225 (299)
T d1ckia_         146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  225 (299)
T ss_dssp             EECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred             eeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence            99999999987654321     2234568999999999999999999999999999999999999999765432211  1


Q ss_pred             HHHHHHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHHHHH
Q 039419          914 VDWVRQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAMIKEIKQ  975 (1035)
Q Consensus       914 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~L~~~~~  975 (1035)
                      ..+....   .....+......+.      .+.+++..||+.||++||+++++.+.|+++..
T Consensus       226 ~~~~~~~---~~~~~~~~~~~~p~------~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         226 ERISEKK---MSTPIEVLCKGYPS------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHHHHHH---HHSCHHHHTTTSCH------HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhhccc---CCCChhHhccCCCH------HHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            1111100   00001111112221      23456778999999999999999999988754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=368.50  Aligned_cols=266  Identities=21%  Similarity=0.286  Sum_probs=195.4

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.......            ...+++.+|+.+|++++||||+++++
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------------~~~~~~~~E~~il~~l~h~nii~~~~   76 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------------GFPITALREIKILQLLKHENVVNLIE   76 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT------------SSCHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch------------HHHHHHHHHHHHHHHhcCCCccceEe
Confidence            478999999999999999999875 69999999986543221            23567899999999999999999999


Q ss_pred             EEEc--------CCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEc
Q 039419          764 CCWN--------RNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIG  835 (1035)
Q Consensus       764 ~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~  835 (1035)
                      ++..        ++..|+||||+.++.+..+....  ..++...+..++.||+.||+|||+.   ||+||||||+|||++
T Consensus        77 ~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~  151 (318)
T d3blha1          77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLIT  151 (318)
T ss_dssp             EEEC----------CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC
T ss_pred             eeecccccccccCceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeec
Confidence            9865        34579999999877766554433  3488999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccccCCcc--ccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchh
Q 039419          836 PEFEPYIADFGLAKLVVEGDFA--RSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLH  912 (1035)
Q Consensus       836 ~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~  912 (1035)
                      .++.+||+|||+++........  ......+||+.|+|||++.+. .+++++||||+||++|||++|+.||....+.  .
T Consensus       152 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~  229 (318)
T d3blha1         152 RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--H  229 (318)
T ss_dssp             TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H
T ss_pred             CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--H
Confidence            9999999999999876543221  222346799999999987654 6889999999999999999999999754221  1


Q ss_pred             HHHHHHHhccc-hhhhcc---------c--ccCCCcccHHH-------HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          913 IVDWVRQKRGA-IEVLDK---------S--LRARPEVEIEE-------MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       913 ~~~~~~~~~~~-~~~~~~---------~--~~~~~~~~~~~-------~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....+...... ......         .  ..........+       .....+++.+||++||++|||++|++++
T Consensus       230 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            11111111100 000000         0  00001111111       1234568899999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-41  Score=374.01  Aligned_cols=264  Identities=22%  Similarity=0.240  Sum_probs=194.3

Q ss_pred             hccccCCeeeeeCCcEEEEEEE-CCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEM-ENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|.+ .+|+.||||++......             ...+++.+|+.+|++++||||++++++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------------~~~~~~~~Ei~il~~l~hp~iv~~~~~   74 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ-------------TYCQRTLREIKILLRFRHENIIGINDI   74 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH-------------HHHHHHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh-------------HHHHHHHHHHHHHHHcCCCCCCcEEEE
Confidence            5689999999999999999976 47999999999643221             225678999999999999999999999


Q ss_pred             EEcCC----cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCce
Q 039419          765 CWNRN----TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEP  840 (1035)
Q Consensus       765 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~  840 (1035)
                      +....    ..+++|+|+.+|+|.+++...   .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+
T Consensus        75 ~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~  148 (345)
T d1pmea_          75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDL  148 (345)
T ss_dssp             ECCSSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred             EeeccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCE
Confidence            97654    235666777899999999754   389999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccccCCcc-ccccccCCcccccCCcccc-cCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH
Q 039419          841 YIADFGLAKLVVEGDFA-RSSNTVAGSYGYIAPEYGY-MMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR  918 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~  918 (1035)
                      ||+|||+|+........ .......||+.|+|||++. +..++.++||||+||++|||++|+.||........ ......
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~  227 (345)
T d1pmea_         149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILG  227 (345)
T ss_dssp             EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred             EEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhh
Confidence            99999999876543221 2234567999999999874 45678899999999999999999999975432111 111110


Q ss_pred             Hhccc-hhhh-----------cccccCCCcccHHH-----HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 QKRGA-IEVL-----------DKSLRARPEVEIEE-----MLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 ~~~~~-~~~~-----------~~~~~~~~~~~~~~-----~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ..... ....           ..............     ...+.+++.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000 0000           00000000000010     1134578899999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-41  Score=370.67  Aligned_cols=258  Identities=21%  Similarity=0.253  Sum_probs=200.7

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC----CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC-Ccee
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME----NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH-KNIV  759 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv  759 (1035)
                      +++|++.+.||+|+||+||+|...    +|+.||||++.......+.          ...+.+.+|++++++++| |||+
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~----------~~~~~~~~E~~il~~l~h~pnIv   92 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----------KTTEHTRTERQVLEHIRQSPFLV   92 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----------SSGGGCCCHHHHHHHHHTCTTBC
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch----------HHHHHHHHHHHHHHhccCCCeEE
Confidence            377999999999999999999752    4789999999764432221          124567899999999976 8999


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCc
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFE  839 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~  839 (1035)
                      ++++++.+....++||||+.+|+|.+++...+.  ++...+..++.||+.||+|+|+.   +|+||||||+||+++.++.
T Consensus        93 ~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~  167 (322)
T d1vzoa_          93 TLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH  167 (322)
T ss_dssp             CEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             EeeeeeccCCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCC
Confidence            999999999999999999999999999987765  78889999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccccCCccccccccCCcccccCCcccccC--CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          840 PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM--KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       840 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      +||+|||+|+.+...... ......|++.|+|||...+.  .++.++||||+||++|||++|+.||......... ....
T Consensus       168 vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~  245 (322)
T d1vzoa_         168 VVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEIS  245 (322)
T ss_dssp             EEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHH
T ss_pred             EEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH
Confidence            999999999876544322 23456799999999987654  4778999999999999999999999765433221 1111


Q ss_pred             HHhccchhhhcccccCCCcccHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 039419          918 RQKRGAIEVLDKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRP-----TMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RP-----s~~el~~~  969 (1035)
                      ....    ..........+      ..+.+++.+||++||++||     +++|++++
T Consensus       246 ~~~~----~~~~~~~~~~s------~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         246 RRIL----KSEPPYPQEMS------ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HHHH----HCCCCCCTTSC------HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             Hhcc----cCCCCCcccCC------HHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            1100    00001111111      2344577889999999999     47888763

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-40  Score=362.33  Aligned_cols=265  Identities=21%  Similarity=0.250  Sum_probs=201.6

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      ++|++.+.||+|+||+||+|++. +++.||||+++......            ...+++.+|+.+++.++||||++++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~------------~~~~~~~~E~~il~~l~h~niv~~~~~   69 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLHDV   69 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST------------THHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh------------HHHHHHHHHHHHHHhcCcCCEEeeccc
Confidence            57999999999999999999875 68999999996543221            235789999999999999999999999


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      +.+.+..++|||++.++++..++...+.  +++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        70 ~~~~~~~~iv~~~~~~~~l~~~~~~~~~--~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~D  144 (292)
T d1unla_          70 LHSDKKLTLVFEFCDQDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLAN  144 (292)
T ss_dssp             EECSSEEEEEEECCSEEHHHHHHHTTTC--CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred             cccccceeEEeeeccccccccccccccc--cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeee
Confidence            9999999999999999999888765543  88999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccccCCccccccccCCcccccCCcccccCC-CCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHHHhccc
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMK-ITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVRQKRGA  923 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~  923 (1035)
                      ||.|+.......  ......+++.|+|||++.... ++.++||||+||++|||++|+.||....................
T Consensus       145 FG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (292)
T d1unla_         145 FGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             CTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             cchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCC
Confidence            999987654332  223456788999999877554 68999999999999999999999754332221111111111100


Q ss_pred             hh-h---hccc-----------ccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          924 IE-V---LDKS-----------LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       924 ~~-~---~~~~-----------~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      .. .   ....           ................+++.+||++||++|||++|++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00 0   0000           000000000111234567888999999999999999874

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=371.02  Aligned_cols=257  Identities=23%  Similarity=0.292  Sum_probs=190.8

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++.......            ...+.+.+|+++|++++|||||++++
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~hpniv~l~~   84 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE------------LFAKRAYRELRLLKHMRHENVIGLLD   84 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH------------HHHHHHHHHHHHHHHCCBTTBCCCSE
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh------------HHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence            467999999999999999999775 59999999996543221            23567899999999999999999999


Q ss_pred             EEEcCC------cceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCC
Q 039419          764 CCWNRN------TRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPE  837 (1035)
Q Consensus       764 ~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~  837 (1035)
                      +|...+      ..|+||||+ +++|..+.+..   .+++..+..++.||+.||+|||++   ||+||||||+|||++.+
T Consensus        85 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~  157 (346)
T d1cm8a_          85 VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNED  157 (346)
T ss_dssp             EECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred             EeccCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccc
Confidence            998655      469999999 67888877543   389999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          838 FEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       838 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      +.+|++|||.|+.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ......
T Consensus       158 ~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~  231 (346)
T d1cm8a_         158 CELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEI  231 (346)
T ss_dssp             CCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred             cccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHH
Confidence            99999999999865432     235689999999998765 45789999999999999999999999754221 111111


Q ss_pred             HHHhccc-hh---------------hh----cccccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRGA-IE---------------VL----DKSLRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~~-~~---------------~~----~~~~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ....... .+               ..    ..........   ......+++.+||..||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN---ASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTT---CCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccC---CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            1100000 00               00    0000000000   01233567888999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=371.75  Aligned_cols=258  Identities=26%  Similarity=0.352  Sum_probs=188.6

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEeEE
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLGCC  765 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  765 (1035)
                      .|...++||+|+||+||+|++. +|+.||||++.....                  .+.+|+++|++++|||||++++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------------~~~~Ei~il~~l~h~niv~~~~~~   82 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------------FKNRELQIMRKLDHCNIVRLRYFF   82 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------------SCCHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------------------HHHHHHHHHHhcCCCCCCcEEEEE
Confidence            5788899999999999999876 589999999854321                  123799999999999999999998


Q ss_pred             EcC------CcceEEEEeCCCCChhhhhhh-cCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          766 WNR------NTRLLMYDYMPNGSLGSLLHE-RRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       766 ~~~------~~~~lv~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      ...      .+.|+||||++++.+..+.+. .....+++..+..++.||+.||+|||++   ||+||||||+|||++.++
T Consensus        83 ~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~  159 (350)
T d1q5ka_          83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT  159 (350)
T ss_dssp             EEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTT
T ss_pred             EecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCC
Confidence            643      246899999976644443332 2334599999999999999999999998   999999999999999775


Q ss_pred             -ceEEeeccCccccccCCccccccccCCcccccCCccccc-CCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          839 -EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYM-MKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       839 -~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                       .+||+|||+++.......   .....||+.|+|||...+ ..++.++||||+||++|||++|+.||...... ..+...
T Consensus       160 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i  235 (350)
T d1q5ka_         160 AVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEI  235 (350)
T ss_dssp             CCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHH
T ss_pred             CceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHH
Confidence             899999999987655432   235689999999998654 57899999999999999999999999754221 111111


Q ss_pred             HHHhccc-hhhh--------c---ccccCCCcc---cHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          917 VRQKRGA-IEVL--------D---KSLRARPEV---EIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       917 ~~~~~~~-~~~~--------~---~~~~~~~~~---~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ++..... .+..        .   +.....+..   .........+++.+||++||++|||++|++++
T Consensus       236 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         236 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1110000 0000        0   000000000   00011234567888999999999999999874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.8e-40  Score=362.27  Aligned_cols=254  Identities=20%  Similarity=0.215  Sum_probs=194.5

Q ss_pred             hccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeEEe
Q 039419          686 KCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRFLG  763 (1035)
Q Consensus       686 ~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  763 (1035)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...                 ..+++.+|+++|++++ ||||+++++
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----------------~~~~~~~Ei~il~~l~~hpnIv~~~~   97 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----------------KKKKIKREIKILENLRGGPNIITLAD   97 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----------------CHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----------------HHHHHHHHHHHHHhccCCCCCcEEEE
Confidence            67999999999999999999875 6899999998542                 1457889999999995 999999999


Q ss_pred             EEEcC--CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC-ce
Q 039419          764 CCWNR--NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF-EP  840 (1035)
Q Consensus       764 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~-~~  840 (1035)
                      ++...  ...++||||+.+++|..+.+     .+++..+..++.||+.||+|||++   ||+||||||+|||++.++ .+
T Consensus        98 ~~~~~~~~~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~v  169 (328)
T d3bqca1          98 IVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKL  169 (328)
T ss_dssp             EEECTTTCSEEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred             EEEecCCCceeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCee
Confidence            99754  46899999999999987643     389999999999999999999999   999999999999998655 68


Q ss_pred             EEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHHH-
Q 039419          841 YIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWVR-  918 (1035)
Q Consensus       841 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~~-  918 (1035)
                      ||+|||+|+......   ......||+.|+|||...+. .++.++||||+||++|||++|+.||............... 
T Consensus       170 kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~  246 (328)
T d3bqca1         170 RLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  246 (328)
T ss_dssp             EECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             eecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHH
Confidence            999999998765443   23456799999999987655 4799999999999999999999999765432211111110 


Q ss_pred             -----------Hhccc-hhhhcccc------------cCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          919 -----------QKRGA-IEVLDKSL------------RARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       919 -----------~~~~~-~~~~~~~~------------~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                                 ..... ........            ......  .......+++.+||.+||++|||++|++++
T Consensus       247 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQH--LVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGG--GCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HCCchhhhhhhhcccccCcccchhcccccccchhhcccccccc--cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       00000 00000000            000000  011234568889999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-39  Score=361.98  Aligned_cols=262  Identities=22%  Similarity=0.216  Sum_probs=189.2

Q ss_pred             HHhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEE
Q 039419          684 VLKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFL  762 (1035)
Q Consensus       684 ~~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  762 (1035)
                      +.++|++.+.||+|+||+||+|.+. +|+.||||++.......            ...+++.+|+.++++++|||||+++
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~------------~~~~~~~~Ei~il~~l~hpnIv~~~   82 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ------------THAKRAYRELVLMKCVNHKNIISLL   82 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH------------HHHHHHHHHHHHHHhcCCCCeeEEE
Confidence            3467999999999999999999876 59999999996543322            1246789999999999999999999


Q ss_pred             eEEEcC------CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcC
Q 039419          763 GCCWNR------NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGP  836 (1035)
Q Consensus       763 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~  836 (1035)
                      +++...      ...|+||||+.++.+ +.+..    .+++..+..++.||+.||+|||++   ||+||||||+|||++.
T Consensus        83 ~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~  154 (355)
T d2b1pa1          83 NVFTPQKTLEEFQDVYLVMELMDANLC-QVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS  154 (355)
T ss_dssp             EEECSCCSTTTCCEEEEEEECCSEEHH-HHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred             EEEecccccccCceeEEEEeccchHHH-Hhhhc----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccccccc
Confidence            999643      567999999966544 44432    389999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHH
Q 039419          837 EFEPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDW  916 (1035)
Q Consensus       837 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~  916 (1035)
                      ++.+|++|||.++......   ......||+.|+|||++.+..+++++||||+||++|||++|+.||...... ......
T Consensus       155 ~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i  230 (355)
T d2b1pa1         155 DCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKV  230 (355)
T ss_dssp             TCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred             ccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHH
Confidence            9999999999988664432   234567999999999999999999999999999999999999999754211 011111


Q ss_pred             HHHhccc---------------------------hhhhccc-ccCCCcccHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 039419          917 VRQKRGA---------------------------IEVLDKS-LRARPEVEIEEMLQTLGVALLCVNPTPDDRPTMKDVAA  968 (1035)
Q Consensus       917 ~~~~~~~---------------------------~~~~~~~-~~~~~~~~~~~~~~~l~l~~~cl~~dP~~RPs~~el~~  968 (1035)
                      .......                           ....... ..............+.+++.+|++.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         231 IEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1100000                           0000000 01111111223345667899999999999999999998


Q ss_pred             H
Q 039419          969 M  969 (1035)
Q Consensus       969 ~  969 (1035)
                      +
T Consensus       311 H  311 (355)
T d2b1pa1         311 H  311 (355)
T ss_dssp             S
T ss_pred             C
Confidence            5

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-39  Score=358.95  Aligned_cols=260  Identities=23%  Similarity=0.268  Sum_probs=193.0

Q ss_pred             HhccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCceeeEEe
Q 039419          685 LKCLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNIVRFLG  763 (1035)
Q Consensus       685 ~~~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~  763 (1035)
                      .++|++.+.||+|+||+||+|++. +|+.||||++.......            ...+++.+|++++++++|||||++++
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~------------~~~~~~~~Ei~il~~l~h~~iv~~~~   84 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI------------IHAKRTYRELRLLKHMKHENVIGLLD   84 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH------------HHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh------------HHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            367999999999999999999765 69999999997543221            12467899999999999999999999


Q ss_pred             EEEcC-----CcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCC
Q 039419          764 CCWNR-----NTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEF  838 (1035)
Q Consensus       764 ~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~  838 (1035)
                      ++...     ...+++|+|+.||+|.+++..+   .+++..+..++.||+.||+|||++   ||+||||||+|||++.++
T Consensus        85 ~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~  158 (348)
T d2gfsa1          85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  158 (348)
T ss_dssp             EECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred             EEeeccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccc
Confidence            98643     3457778888899999998654   389999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccccCCccccccccCCcccccCCcccccC-CCCccccchhHHHHHHHHHhCCCCCCCCCCCchhHHHHH
Q 039419          839 EPYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMM-KITEKSDVYSYGVVVLEVLTGKQPIDPTIPEGLHIVDWV  917 (1035)
Q Consensus       839 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGvvl~elltg~~P~~~~~~~~~~~~~~~  917 (1035)
                      .+|++|||.+.....     ......||+.|+|||...+. .++.++||||+||++|+|++|+.||......  .....+
T Consensus       159 ~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~--~~~~~i  231 (348)
T d2gfsa1         159 ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQLKLI  231 (348)
T ss_dssp             CEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred             cccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH--HHHHHH
Confidence            999999999975432     23356799999999986654 4688999999999999999999999754211  111111


Q ss_pred             HHhccc--hhh-----------hcccccCCCcccHH-----HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 039419          918 RQKRGA--IEV-----------LDKSLRARPEVEIE-----EMLQTLGVALLCVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       918 ~~~~~~--~~~-----------~~~~~~~~~~~~~~-----~~~~~l~l~~~cl~~dP~~RPs~~el~~~  969 (1035)
                      ......  .+.           ........+.....     ....+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            110000  000           00000001111111     11234568889999999999999999875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=3.8e-36  Score=331.52  Aligned_cols=275  Identities=26%  Similarity=0.524  Sum_probs=162.6

Q ss_pred             CCCcccCCCCCCCCCCc--cceeEEeCCCC---cEEEEEecCCcccc--cCCcCCCCCcccceEeecC-cccCCCCCCCC
Q 039419            3 SIPSALSNWNPSDSNPC--KWSHITCSPQN---FVTEINIQSIELEL--PFPSNLSSLSFLQKLIISG-SNLTGPISPDL   74 (1035)
Q Consensus         3 ~~~~~l~~w~~~~~~~c--~w~gi~c~~~~---~v~~l~~~~~~~~~--~~~~~~~~l~~L~~L~L~~-~~l~~~~~~~~   74 (1035)
                      ++|..+++|..++ |||  .|+||+|+..+   +|++|+++++++.+  .+|+.+++|++|++|+|++ |+++|.+|++|
T Consensus        19 ~~~~~l~sW~~~~-d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i   97 (313)
T d1ogqa_          19 GNPTTLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI   97 (313)
T ss_dssp             TCCGGGTTCCTTS-CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGG
T ss_pred             CCCCcCCCCCCCC-CCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccccccccccccccccccc
Confidence            5788999998754 899  59999998754   68888888887776  4667777777777777776 56776777777


Q ss_pred             CCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccce
Q 039419           75 GDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEV  154 (1035)
Q Consensus        75 ~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~  154 (1035)
                      ++|++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|..++.+++|+++++++|.+.+.+|..++.+..+  
T Consensus        98 ~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l--  175 (313)
T d1ogqa_          98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--  175 (313)
T ss_dssp             GGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTT--
T ss_pred             ccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccccccccccccccccc--
Confidence            777777777777777766666666666677777777766666666666666666666666666665555555544443  


Q ss_pred             eecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCc
Q 039419          155 IRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYEND  234 (1035)
Q Consensus       155 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~  234 (1035)
                                            ++.+.+++|++++..|..+..+..+ .+++.++...+.+|..+..+++|+.|++++|.
T Consensus       176 ----------------------~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~  232 (313)
T d1ogqa_         176 ----------------------FTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS  232 (313)
T ss_dssp             ----------------------CCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSE
T ss_pred             ----------------------ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccc
Confidence                                  1223333334444445555444333 35555555555555555555555555555555


Q ss_pred             CCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCC
Q 039419          235 LSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNN  305 (1035)
Q Consensus       235 l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  305 (1035)
                      +.+.++ .++.+++|+.|+|++|++++.+|..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|
T Consensus       233 l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N  301 (313)
T d1ogqa_         233 LAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN  301 (313)
T ss_dssp             ECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSS
T ss_pred             cccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCC
Confidence            543222 344444444444444444444444444444444444444444433332 333444444444444

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-34  Score=323.05  Aligned_cols=260  Identities=19%  Similarity=0.211  Sum_probs=187.5

Q ss_pred             ccccCCeeeeeCCcEEEEEEEC-CCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-----------
Q 039419          687 CLVEDSVVGKGCSGIVYRAEME-NGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-----------  754 (1035)
Q Consensus       687 ~~~~~~~iG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------  754 (1035)
                      +|++.+.||+|+||+||+|++. +|+.||||++..+..               ..+.+.+|+.++++++           
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~---------------~~~~~~~Ei~~l~~l~~~~~~~~~~~~   78 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV---------------YTEAAEDEIKLLQRVNDADNTKEDSMG   78 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH---------------HHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc---------------chHHHHHHHHHHHHhcchhhhhhhhcC
Confidence            5899999999999999999875 699999999964321               2356788999888875           


Q ss_pred             CCceeeEEeEEEcC--CcceEEEEeCCCCC-hhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcc
Q 039419          755 HKNIVRFLGCCWNR--NTRLLMYDYMPNGS-LGSLLHERRDSCLEWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKAN  830 (1035)
Q Consensus       755 hpniv~l~~~~~~~--~~~~lv~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~  830 (1035)
                      |+||+++++++...  ...+++|+++..+. ............+++..+..++.||+.|++|||+ .   ||+||||||+
T Consensus        79 ~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~  155 (362)
T d1q8ya_          79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPE  155 (362)
T ss_dssp             HTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGG
T ss_pred             cCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChh
Confidence            57899999988653  45567777765543 3344444445568999999999999999999998 5   8999999999


Q ss_pred             cEEEcCCCc------eEEeeccCccccccCCccccccccCCcccccCCcccccCCCCccccchhHHHHHHHHHhCCCCCC
Q 039419          831 NILIGPEFE------PYIADFGLAKLVVEGDFARSSNTVAGSYGYIAPEYGYMMKITEKSDVYSYGVVVLEVLTGKQPID  904 (1035)
Q Consensus       831 NIll~~~~~------~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGvvl~elltg~~P~~  904 (1035)
                      |||++.++.      ++++|||.+.....     ......||+.|+|||+..+..++.++||||+||+++||++|+.||.
T Consensus       156 NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         156 NVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             GEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             HeeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence            999987653      89999999875433     2245679999999999999999999999999999999999999997


Q ss_pred             CCCCCc-----hhHHHHHHHhccc-----------hhhhc-----ccc------------cCCCcccHHHHHHHHHHHHh
Q 039419          905 PTIPEG-----LHIVDWVRQKRGA-----------IEVLD-----KSL------------RARPEVEIEEMLQTLGVALL  951 (1035)
Q Consensus       905 ~~~~~~-----~~~~~~~~~~~~~-----------~~~~~-----~~~------------~~~~~~~~~~~~~~l~l~~~  951 (1035)
                      ......     ......+......           ....+     ...            ...............+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  310 (362)
T d1q8ya_         231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP  310 (362)
T ss_dssp             --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence            543211     0111111110000           00000     000            00111122334456779999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 039419          952 CVNPTPDDRPTMKDVAAM  969 (1035)
Q Consensus       952 cl~~dP~~RPs~~el~~~  969 (1035)
                      |+++||++|||++|++++
T Consensus       311 mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         311 MLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             GGCSSTTTCBCHHHHHTC
T ss_pred             HCCCChhHCcCHHHHhcC
Confidence            999999999999999874

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=2.8e-28  Score=276.59  Aligned_cols=357  Identities=24%  Similarity=0.298  Sum_probs=202.7

Q ss_pred             EeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceecccccc
Q 039419           59 LIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYL  138 (1035)
Q Consensus        59 L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l  138 (1035)
                      ..+..+.+++.+.  ...+.+|++|++++|+|+ .+ +.|..|++|++|+|++|+++ .+| .++++++|++|++++|.+
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~-~l~-~l~~L~~L~~L~L~~n~i  100 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLT-DIT-PLKNLTKLVDILMNNNQI  100 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCC
T ss_pred             HHhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCC-CCc-cccCCccccccccccccc
Confidence            3455555554332  235667777777777776 33 45677777777777777777 344 377777777777777777


Q ss_pred             CCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccCCccc
Q 039419          139 SGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQ  218 (1035)
Q Consensus       139 ~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~  218 (1035)
                      .+ ++ .++.+++|+.|+++++.. . .+ ........+..+....+.+....+................     .....
T Consensus       101 ~~-i~-~l~~l~~L~~L~~~~~~~-~-~~-~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~  170 (384)
T d2omza2         101 AD-IT-PLANLTNLTGLTLFNNQI-T-DI-DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV-----TDLKP  170 (384)
T ss_dssp             CC-CG-GGTTCTTCCEEECCSSCC-C-CC-GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESC-----CCCGG
T ss_pred             cc-cc-cccccccccccccccccc-c-cc-cccccccccccccccccccccccccccccccccccccccc-----chhhh
Confidence            63 33 366667777776666541 1 11 1112222333333333333211111111111111000000     11111


Q ss_pred             cccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCc
Q 039419          219 IGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLE  298 (1035)
Q Consensus       219 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  298 (1035)
                      +............                        .|...  ....+..+++++.+++++|.+++..|  +..+++|+
T Consensus       171 ~~~~~~~~~~~~~------------------------~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~  222 (384)
T d2omza2         171 LANLTTLERLDIS------------------------SNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLD  222 (384)
T ss_dssp             GTTCTTCCEEECC------------------------SSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCC
T ss_pred             hcccccccccccc------------------------ccccc--cccccccccccceeeccCCccCCCCc--ccccCCCC
Confidence            2222222222222                        22222  23334555666666666666664433  34455666


Q ss_pred             EEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcc
Q 039419          299 ELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQN  378 (1035)
Q Consensus       299 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  378 (1035)
                      +|++++|+++..  +.+..+++|+.|++++|+++.+            ..+..+++|+.|++++|++++..  .+..++.
T Consensus       223 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~------------~~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~  286 (384)
T d2omza2         223 ELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL------------APLSGLTKLTELKLGANQISNIS--PLAGLTA  286 (384)
T ss_dssp             EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC------------GGGTTCTTCSEEECCSSCCCCCG--GGTTCTT
T ss_pred             EEECCCCCCCCc--chhhcccccchhccccCccCCC------------CcccccccCCEeeccCcccCCCC--ccccccc
Confidence            666666666532  2455566666666666655422            23556677777777777776432  3566777


Q ss_pred             cceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchh
Q 039419          379 LTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPES  458 (1035)
Q Consensus       379 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~  458 (1035)
                      ++.+.+..|++++..                .+..++++++|++++|++++..  .+..+++|++|++++|+|+++ + .
T Consensus       287 l~~l~~~~n~l~~~~----------------~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~  346 (384)
T d2omza2         287 LTNLELNENQLEDIS----------------PISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-S  346 (384)
T ss_dssp             CSEEECCSSCCSCCG----------------GGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-G
T ss_pred             ccccccccccccccc----------------ccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-h
Confidence            777777777766421                2344566778888888887653  377788888888888888754 3 5


Q ss_pred             ccCccccchhhccCCcccccCccccCCCCCCcEEEcCCC
Q 039419          459 FGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSN  497 (1035)
Q Consensus       459 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  497 (1035)
                      |.++++|++|++++|+|++..|  +.++++|+.|+|++|
T Consensus       347 l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             HcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            7788888888888888886554  788888888888887

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=4.3e-29  Score=274.58  Aligned_cols=220  Identities=29%  Similarity=0.472  Sum_probs=142.4

Q ss_pred             CCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecC
Q 039419          344 SIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLS  423 (1035)
Q Consensus       344 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~  423 (1035)
                      .+|..|.++++|++|+|++|++.+..+..+..+.+|+.+++++|.+.+.+|..+.+              ++.|++++++
T Consensus        92 ~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~--------------l~~L~~l~l~  157 (313)
T d1ogqa_          92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS--------------LPNLVGITFD  157 (313)
T ss_dssp             CCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG--------------CTTCCEEECC
T ss_pred             ccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhcc--------------Ccccceeecc
Confidence            33444444455555555555555444444455555555555555555444443322              2345555556


Q ss_pred             CCccCCCCcccccCCCCc-cEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCc
Q 039419          424 NNTLGGTLPSSLASLTRL-QVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGK  502 (1035)
Q Consensus       424 ~N~l~~~~~~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  502 (1035)
                      +|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+.+.+|..+..+++|+.|++++|.+++.
T Consensus       158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~  236 (313)
T d1ogqa_         158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD  236 (313)
T ss_dssp             SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence            666555556555555544 566666666666666666555433 466666666666666666666666666666666532


Q ss_pred             cchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccC-ccccccccCCCcEEeccCCcCcccCCChhhh
Q 039419          503 IPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGG-DLLALSGLDNLVSLNVSYNNFTGYLPDSKLF  581 (1035)
Q Consensus       503 ~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~  581 (1035)
                      +                          +.+..+++|++|+|++|+|++ .|..+..+++|++|+|++|+|+|.+|....+
T Consensus       237 ~--------------------------~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L  290 (313)
T d1ogqa_         237 L--------------------------GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL  290 (313)
T ss_dssp             G--------------------------GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTG
T ss_pred             c--------------------------cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccC
Confidence            2                          234455677788888888874 5567888899999999999999999988788


Q ss_pred             hccccccccccccCCCCCCCCCc
Q 039419          582 RQLSATEMAGNQGLCSRGHESCF  604 (1035)
Q Consensus       582 ~~l~~~~~~~N~~~c~~~~~~c~  604 (1035)
                      .+++.+++.+|+.+||.|+.+|.
T Consensus       291 ~~L~~l~l~~N~~l~g~plp~c~  313 (313)
T d1ogqa_         291 QRFDVSAYANNKCLCGSPLPACT  313 (313)
T ss_dssp             GGSCGGGTCSSSEEESTTSSCCC
T ss_pred             CCCCHHHhCCCccccCCCCCCCC
Confidence            99999999999999999988884

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.95  E-value=1.4e-27  Score=270.80  Aligned_cols=343  Identities=27%  Similarity=0.363  Sum_probs=212.1

Q ss_pred             CCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccc
Q 039419           51 SSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKN  130 (1035)
Q Consensus        51 ~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  130 (1035)
                      ..+.+|++|++++++|+. + +.++.|++|++|+|++|+|+ .+| .+++|++|++|++++|++++ ++ .++.+++|+.
T Consensus        41 ~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~-~l~-~l~~L~~L~~L~L~~n~i~~-i~-~l~~l~~L~~  114 (384)
T d2omza2          41 TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLT-DIT-PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTG  114 (384)
T ss_dssp             HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCE
T ss_pred             HHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCC-CCc-cccCCccccccccccccccc-cc-cccccccccc
Confidence            467789999999999984 4 56888999999999999998 455 39999999999999999984 44 4889999999


Q ss_pred             eeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccc
Q 039419          131 LLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTM  210 (1035)
Q Consensus       131 L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~  210 (1035)
                      |++++|.+++..  .......+..+....|. +....+..................     ...+.............|.
T Consensus       115 L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  186 (384)
T d2omza2         115 LTLFNNQITDID--PLKNLTNLNRLELSSNT-ISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNK  186 (384)
T ss_dssp             EECCSSCCCCCG--GGTTCTTCSEEEEEEEE-ECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSC
T ss_pred             cccccccccccc--ccccccccccccccccc-ccccccccccccccccccccccch-----hhhhccccccccccccccc
Confidence            999999987432  23445566666665554 111111222222223333222222     2334455555555555555


Q ss_pred             cccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCcc
Q 039419          211 LSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQS  290 (1035)
Q Consensus       211 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~  290 (1035)
                      ..  ....+..+++++.+++++|.+++..|  +...++|++|++++|.++. + ..+..+++|+.|++++|.+++..  .
T Consensus       187 ~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~  258 (384)
T d2omza2         187 VS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--P  258 (384)
T ss_dssp             CC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--G
T ss_pred             cc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--c
Confidence            43  45667788889999999998885443  4556677777777777764 2 34667777777777777777533  2


Q ss_pred             ccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCC
Q 039419          291 FGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLH  370 (1035)
Q Consensus       291 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~  370 (1035)
                      +..+++|++|++++|++.+..  .+..+..++.+++..|+++.+            ..+..+++++.|++++|++++.. 
T Consensus       259 ~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~------------~~~~~~~~l~~L~ls~n~l~~l~-  323 (384)
T d2omza2         259 LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI------------SPISNLKNLTYLTLYFNNISDIS-  323 (384)
T ss_dssp             GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC------------GGGGGCTTCSEEECCSSCCSCCG-
T ss_pred             ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc------------cccchhcccCeEECCCCCCCCCc-
Confidence            666777777777777766432  244455555555555544321            22344444555555555554321 


Q ss_pred             CCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCc
Q 039419          371 PGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQ  450 (1035)
Q Consensus       371 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~  450 (1035)
                       .+..+                                      ++|++|+|++|+|++ ++ .+.++++|++|++++|+
T Consensus       324 -~l~~l--------------------------------------~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~  362 (384)
T d2omza2         324 -PVSSL--------------------------------------TKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQ  362 (384)
T ss_dssp             -GGGGC--------------------------------------TTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSC
T ss_pred             -ccccC--------------------------------------CCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCc
Confidence             13334                                      445555555555553 22 35555566666666666


Q ss_pred             cCCCCchhccCccccchhhccCC
Q 039419          451 FVGLIPESFGQLASLNRLILSKN  473 (1035)
Q Consensus       451 l~~~~~~~~~~l~~L~~L~Ls~N  473 (1035)
                      |++++|  +.++++|+.|+|++|
T Consensus       363 l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         363 ISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCChh--hccCCCCCEeeCCCC
Confidence            555433  555556666666555

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=1.2e-25  Score=245.90  Aligned_cols=253  Identities=23%  Similarity=0.313  Sum_probs=174.2

Q ss_pred             CccceeEEeCCCCcEEEEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChh
Q 039419           18 PCKWSHITCSPQNFVTEINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSS   97 (1035)
Q Consensus        18 ~c~w~gi~c~~~~~v~~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~   97 (1035)
                      -|.|++|.|+..           +++ .+|..+.  +.+++|+|++|+|+...+..|..+++|++|++++|.+....|..
T Consensus         9 ~c~~~~~~C~~~-----------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~   74 (305)
T d1xkua_           9 QCHLRVVQCSDL-----------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA   74 (305)
T ss_dssp             EEETTEEECTTS-----------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTT
T ss_pred             EecCCEEEecCC-----------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhh
Confidence            389999999853           233 5666664  67999999999999444457999999999999999999777888


Q ss_pred             hhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccce
Q 039419           98 IGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSL  177 (1035)
Q Consensus        98 i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L  177 (1035)
                      |.++++|++|++++|+++ .+|..+  ...|+.|++.+|.+.+..+..+.....++.++...|..               
T Consensus        75 f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~---------------  136 (305)
T d1xkua_          75 FAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL---------------  136 (305)
T ss_dssp             TTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC---------------
T ss_pred             hhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccc---------------
Confidence            999999999999999998 677543  35788889999988854455566666666666666541               


Q ss_pred             EEEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccc
Q 039419          178 LVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQN  257 (1035)
Q Consensus       178 ~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n  257 (1035)
                              ......+..+..+++|+.+++.+|.+. .+|..+  +++|+.|++++|.++...+..|.+++.++.|++++|
T Consensus       137 --------~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n  205 (305)
T d1xkua_         137 --------KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN  205 (305)
T ss_dssp             --------CGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSS
T ss_pred             --------cccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccc
Confidence                    111233445556666666666666665 344432  456666666666666666666666666666666666


Q ss_pred             cccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCc
Q 039419          258 NFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPV  314 (1035)
Q Consensus       258 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  314 (1035)
                      .+.+..+..+.++++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+.+....
T Consensus       206 ~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~  261 (305)
T d1xkua_         206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND  261 (305)
T ss_dssp             CCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTS
T ss_pred             cccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhh
Confidence            666655666666666666666666666 34556666666666666666666443333

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=5.6e-25  Score=240.47  Aligned_cols=89  Identities=26%  Similarity=0.341  Sum_probs=56.9

Q ss_pred             CccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEc
Q 039419          415 TQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL  494 (1035)
Q Consensus       415 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  494 (1035)
                      ++|+.|++++|.+++..+..|.+++.+++|++++|++.++.+..|.++++|++|+|++|+|+ .+|.+|..+++|++|+|
T Consensus       171 ~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~L  249 (305)
T d1xkua_         171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL  249 (305)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred             CccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEEC
Confidence            34566666666666566666666666666666666666666666666666666666666666 44556666666666666


Q ss_pred             CCCcCcCccch
Q 039419          495 SSNKLSGKIPV  505 (1035)
Q Consensus       495 s~N~l~~~~p~  505 (1035)
                      ++|+|+ .++.
T Consensus       250 s~N~i~-~i~~  259 (305)
T d1xkua_         250 HNNNIS-AIGS  259 (305)
T ss_dssp             CSSCCC-CCCT
T ss_pred             CCCccC-ccCh
Confidence            666666 4443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.3e-24  Score=232.75  Aligned_cols=223  Identities=23%  Similarity=0.219  Sum_probs=172.6

Q ss_pred             hcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccc-cchh
Q 039419          253 LLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLD-TNQI  331 (1035)
Q Consensus       253 ~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N~i  331 (1035)
                      ++++++++ .+|..+.  +++++|+|++|+|++..+..|.++++|++|++++|++..+.+..+.++..++.+... .|.+
T Consensus        17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~   93 (284)
T d1ozna_          17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL   93 (284)
T ss_dssp             ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred             EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence            34444444 4454443  457777888887776666677777788888888887777777777777777777654 3333


Q ss_pred             hhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeecc
Q 039419          332 SVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSF  411 (1035)
Q Consensus       332 ~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~  411 (1035)
                      +          ...+..|.++++|++|++++|.+....+..+....+|+.+++++|+|+++.+..|.             
T Consensus        94 ~----------~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~-------------  150 (284)
T d1ozna_          94 R----------SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR-------------  150 (284)
T ss_dssp             C----------CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT-------------
T ss_pred             c----------cccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhc-------------
Confidence            3          23456788888888888888888766677777788888888888888876655543             


Q ss_pred             CCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcE
Q 039419          412 GNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQS  491 (1035)
Q Consensus       412 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  491 (1035)
                       ++++|++|+|++|+|++..+.+|.++++|++|++++|+++++.|..|..+++|++|++++|++.+..+..|..+++|++
T Consensus       151 -~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~  229 (284)
T d1ozna_         151 -DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY  229 (284)
T ss_dssp             -TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred             -cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence             4466888999999998888888899999999999999999888899999999999999999999888888999999999


Q ss_pred             EEcCCCcCcCc
Q 039419          492 LDLSSNKLSGK  502 (1035)
Q Consensus       492 L~Ls~N~l~~~  502 (1035)
                      |+|++|++...
T Consensus       230 L~l~~N~l~C~  240 (284)
T d1ozna_         230 LRLNDNPWVCD  240 (284)
T ss_dssp             EECCSSCEECS
T ss_pred             EEecCCCCCCC
Confidence            99999998854

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=8.2e-24  Score=228.35  Aligned_cols=252  Identities=23%  Similarity=0.243  Sum_probs=179.6

Q ss_pred             cEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCC
Q 039419          274 KTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCR  353 (1035)
Q Consensus       274 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~  353 (1035)
                      ..++.++++++ .+|..+.  +++++|+|++|+|+.+.+..|.++++|++|++++|+|..+          .+..+..+.
T Consensus        14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i----------~~~~~~~~~   80 (284)
T d1ozna_          14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI----------DAAAFTGLA   80 (284)
T ss_dssp             CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE----------CTTTTTTCT
T ss_pred             eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccc----------ccccccccc
Confidence            45678888888 5665553  5688999999999877777888888888888888877643          235666677


Q ss_pred             CCcEEecc-CcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCc
Q 039419          354 SLEAVDLS-HNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLP  432 (1035)
Q Consensus       354 ~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~  432 (1035)
                      .++.++.. .|.++...+..|.++++|++|++++|.+....+..+.              ...+|+.+++++|+|+++.+
T Consensus        81 ~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~--------------~~~~L~~l~l~~N~l~~i~~  146 (284)
T d1ozna_          81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR--------------GLAALQYLYLQDNALQALPD  146 (284)
T ss_dssp             TCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT--------------TCTTCCEEECCSSCCCCCCT
T ss_pred             cccccccccccccccccchhhcccccCCEEecCCcccccccccccc--------------hhcccchhhhccccccccCh
Confidence            77777654 5666666677777778888888888877655444433              33557777777777776666


Q ss_pred             ccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhcc
Q 039419          433 SSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEG  512 (1035)
Q Consensus       433 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~  512 (1035)
                      ..|..+++|+.|++++|+|+++.+..|.++++|+.+++++|++++..|..|..+++|++||+++|++.+           
T Consensus       147 ~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~-----------  215 (284)
T d1ozna_         147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA-----------  215 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC-----------
T ss_pred             hHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccc-----------
Confidence            677777777777777777777777777777777777777777777777777777777777777777762           


Q ss_pred             CcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCC
Q 039419          513 LDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPD  577 (1035)
Q Consensus       513 l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~  577 (1035)
                                    ..+..|..+++|++|+|++|++.++....+-...++.+....+++.+..|.
T Consensus       216 --------------~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~  266 (284)
T d1ozna_         216 --------------LPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ  266 (284)
T ss_dssp             --------------CCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred             --------------ccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCch
Confidence                          334455667788888888888887654333334456666677777766554

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=2.9e-22  Score=213.57  Aligned_cols=201  Identities=26%  Similarity=0.245  Sum_probs=155.0

Q ss_pred             CCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcC
Q 039419          269 NCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPST  348 (1035)
Q Consensus       269 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~  348 (1035)
                      +...+.+++.+++.|+ .+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+            ..
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l------------~~   72 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL------------QV   72 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE------------EC
T ss_pred             ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc------------cc
Confidence            4455566677777777 3454443  4677777777777766666777777777777777777643            23


Q ss_pred             CCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccC
Q 039419          349 LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG  428 (1035)
Q Consensus       349 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~  428 (1035)
                      ++.+++|+.|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+              ..+.++++|++++|.++
T Consensus        73 ~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~--------------~~l~~l~~L~l~~n~l~  137 (266)
T d1p9ag_          73 DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL--------------RGLGELQELYLKGNELK  137 (266)
T ss_dssp             CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTT--------------TTCTTCCEEECTTSCCC
T ss_pred             cccccccccccccccccc-ccccccccccccccccccccccceeecccc--------------ccccccccccccccccc
Confidence            566788888888888887 446677788888888888888876555443              44566888899999998


Q ss_pred             CCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCc
Q 039419          429 GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLS  500 (1035)
Q Consensus       429 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  500 (1035)
                      ...+..+..+++|+.|++++|+|+++++..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus       138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            877888888899999999999999888888999999999999999998 67777888899999999999886

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.1e-21  Score=208.96  Aligned_cols=201  Identities=26%  Similarity=0.197  Sum_probs=114.0

Q ss_pred             CCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCC
Q 039419          352 CRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTL  431 (1035)
Q Consensus       352 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~  431 (1035)
                      ...+.+++++++.|+ .+|..+.  +++++|+|++|+|+++.+.              .|.++++|++|+|++|+|+.. 
T Consensus         9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~--------------~f~~l~~L~~L~L~~N~l~~l-   70 (266)
T d1p9ag_           9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLA--------------TLMPYTRLTQLNLDRAELTKL-   70 (266)
T ss_dssp             STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGG--------------GGTTCTTCCEEECTTSCCCEE-
T ss_pred             cCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHH--------------Hhhcccccccccccccccccc-
Confidence            344555666666666 3444432  3566666666666533222              234445566666666666532 


Q ss_pred             cccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhc
Q 039419          432 PSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIE  511 (1035)
Q Consensus       432 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  511 (1035)
                      + .+..+++|++|+|++|+++.. +..+..+++|+.|++++|.+....+..+..+.++++|++++|.++ .+|...+...
T Consensus        71 ~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l  147 (266)
T d1p9ag_          71 Q-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT  147 (266)
T ss_dssp             E-CCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTC
T ss_pred             c-ccccccccccccccccccccc-ccccccccccccccccccccceeeccccccccccccccccccccc-eecccccccc
Confidence            2 245566666666666666633 445556666666666666666555555666666666666666665 3443333333


Q ss_pred             cCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcc
Q 039419          512 GLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTG  573 (1035)
Q Consensus       512 ~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~  573 (1035)
                      .....+++++|+|++..++.|..+++|++|||++|+|+..+..+..+++|+.|+|++|+|.+
T Consensus       148 ~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             TTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             ccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCC
Confidence            33334555555555555556666666666666666666665555566666666666666554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=8.4e-23  Score=205.87  Aligned_cols=178  Identities=15%  Similarity=0.097  Sum_probs=123.0

Q ss_pred             ccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccc----cccccHHHHHHHHHHHhcCCCCceeeEEeE
Q 039419          689 VEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKI----GIGGVRDSFSAEIKTLGSIRHKNIVRFLGC  764 (1035)
Q Consensus       689 ~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~l~~~  764 (1035)
                      .+.+.||+|+||+||+|.+.+|+.||||++................    ..........+|...+.++.|+++++.+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4568999999999999998889999999986543221100000000    001123456679999999999999998875


Q ss_pred             EEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCeeccCCCcccEEEcCCCceEEee
Q 039419          765 CWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPEFEPYIAD  844 (1035)
Q Consensus       765 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ivHrDikp~NIll~~~~~~kl~D  844 (1035)
                      .    ..+++|||++++.+.+         ++......++.|+++|++|||+.   ||+||||||+|||++++ .++|+|
T Consensus        83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred             c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence            3    2479999998765543         23344567899999999999999   99999999999999965 489999


Q ss_pred             ccCccccccCCccccccccCCcccccCCc-----ccccCCCCccccchhHHHHH
Q 039419          845 FGLAKLVVEGDFARSSNTVAGSYGYIAPE-----YGYMMKITEKSDVYSYGVVV  893 (1035)
Q Consensus       845 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~Dv~SlGvvl  893 (1035)
                      ||.|........          ..|....     .+....|+.++|+||+.--+
T Consensus       146 FG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            999875432211          1111110     01245678899999976443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.81  E-value=1.1e-18  Score=194.00  Aligned_cols=300  Identities=24%  Similarity=0.283  Sum_probs=161.4

Q ss_pred             ccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceecc
Q 039419           55 FLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLF  134 (1035)
Q Consensus        55 ~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~  134 (1035)
                      ++++|||++++++ ++|+.   +++|++|+|++|+|+ .+|+.+   .+|++|++++|+++ .++. +  .+.|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--cccccccccc
Confidence            5788999999988 67763   467889999999998 778654   56888888888887 4442 1  1358888888


Q ss_pred             ccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEeccccccccCcccccccccccceeecccccccC
Q 039419          135 DNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGE  214 (1035)
Q Consensus       135 ~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~  214 (1035)
                      +|.+. .+|. ++.+++|++|++++|.  ....+...   ..+..+.+..+...  .+..+..                 
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~--~~~~~~~~---~~l~~l~~~~~~~~--~~~~l~~-----------------  160 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNS--LKKLPDLP---PSLEFIAAGNNQLE--ELPELQN-----------------  160 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSC--CSCCCCCC---TTCCEEECCSSCCS--SCCCCTT-----------------
T ss_pred             ccccc-cccc-hhhhccceeecccccc--cccccccc---ccccchhhcccccc--ccccccc-----------------
Confidence            88887 5664 5778888888887775  12222222   22223333322221  1223344                 


Q ss_pred             CccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCC
Q 039419          215 IPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNL  294 (1035)
Q Consensus       215 ~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  294 (1035)
                             ++.++.|++++|.+.. .+....   ..+.+....+.+. .++ .+..++.|+.+++++|.... .+.   ..
T Consensus       161 -------l~~l~~L~l~~n~~~~-~~~~~~---~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~  223 (353)
T d1jl5a_         161 -------LPFLTAIYADNNSLKK-LPDLPL---SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LP  223 (353)
T ss_dssp             -------CTTCCEEECCSSCCSS-CCCCCT---TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CC
T ss_pred             -------cccceecccccccccc-cccccc---ccccccccccccc-ccc-cccccccccccccccccccc-ccc---cc
Confidence                   4444444444444442 111111   1112222222222 222 24455666666666666552 222   23


Q ss_pred             CCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCC-CCCcEEeccCcCCCCCCCCCc
Q 039419          295 SSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANC-RSLEAVDLSHNALTGSLHPGL  373 (1035)
Q Consensus       295 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~~~~~  373 (1035)
                      .++..+.+.+|.+... +..   ...+...++..|.+..+               ..+ ......++..|.+.+.    .
T Consensus       224 ~~l~~~~~~~~~~~~~-~~~---~~~l~~~~~~~~~~~~l---------------~~l~~~~~~~~~~~~~~~~~----~  280 (353)
T d1jl5a_         224 PSLEALNVRDNYLTDL-PEL---PQSLTFLDVSENIFSGL---------------SELPPNLYYLNASSNEIRSL----C  280 (353)
T ss_dssp             TTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSEE---------------SCCCTTCCEEECCSSCCSEE----C
T ss_pred             cccccccccccccccc-ccc---ccccccccccccccccc---------------ccccchhcccccccCccccc----c
Confidence            4566666666665522 222   22333344433332211               111 2234455555555422    1


Q ss_pred             ccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCC
Q 039419          374 FQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVG  453 (1035)
Q Consensus       374 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~  453 (1035)
                      ..+++|++|+|++|+|+.+ |..                 +++|+.|+|++|+|+ .+|..   +++|++|+|++|+|+.
T Consensus       281 ~~~~~L~~L~Ls~N~l~~l-p~~-----------------~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         281 DLPPSLEELNVSNNKLIEL-PAL-----------------PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             CCCTTCCEEECCSSCCSCC-CCC-----------------CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS
T ss_pred             ccCCCCCEEECCCCccCcc-ccc-----------------cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC
Confidence            2245667777777766632 322                 245677777777776 34432   3467777777777774


Q ss_pred             C
Q 039419          454 L  454 (1035)
Q Consensus       454 ~  454 (1035)
                      +
T Consensus       339 l  339 (353)
T d1jl5a_         339 F  339 (353)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.80  E-value=3.5e-18  Score=189.90  Aligned_cols=35  Identities=31%  Similarity=0.278  Sum_probs=19.8

Q ss_pred             ccccEEeccCCcccCccccccccCCCcEEeccCCcCcc
Q 039419          536 NKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTG  573 (1035)
Q Consensus       536 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~  573 (1035)
                      ++|+.|+|++|+|+..+..   +++|++|+|++|+|+.
T Consensus       304 ~~L~~L~L~~N~L~~l~~~---~~~L~~L~L~~N~L~~  338 (353)
T d1jl5a_         304 PRLERLIASFNHLAEVPEL---PQNLKQLHVEYNPLRE  338 (353)
T ss_dssp             TTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSS
T ss_pred             CCCCEEECCCCcCCccccc---cCCCCEEECcCCcCCC
Confidence            4566666666666554422   3456666666666654

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=5.4e-19  Score=183.20  Aligned_cols=209  Identities=24%  Similarity=0.335  Sum_probs=152.2

Q ss_pred             ccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceec
Q 039419          246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQ  325 (1035)
Q Consensus       246 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  325 (1035)
                      +.++..++++.+++.+..  .+..+.+|+.|++.+|.|+. ++ .+.++++|++|++++|++.+..+  +..+++|++++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~   91 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence            445556677777766543  34566778888888888874 33 47778888888888888775443  77778888888


Q ss_pred             cccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCccee
Q 039419          326 LDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR  405 (1035)
Q Consensus       326 L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  405 (1035)
                      +++|.++.+            ..+.++++|+.+++++|...+.  ..+...+.++.+.++++.+....            
T Consensus        92 ~~~n~~~~i------------~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~------------  145 (227)
T d1h6ua2          92 LSGNPLKNV------------SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS------------  145 (227)
T ss_dssp             CCSCCCSCC------------GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG------------
T ss_pred             ccccccccc------------cccccccccccccccccccccc--chhccccchhhhhchhhhhchhh------------
Confidence            887777643            3467788888888888877633  34566778888888887765322            


Q ss_pred             EeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCC
Q 039419          406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGR  485 (1035)
Q Consensus       406 L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  485 (1035)
                          .+.++++|++|++++|++++.  ..+.++++|++|+|++|+++++.  .|..+++|++|+|++|+|++..|  +.+
T Consensus       146 ----~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~~--l~~  215 (227)
T d1h6ua2         146 ----PLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVSP--LAN  215 (227)
T ss_dssp             ----GGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCGG--GTT
T ss_pred             ----hhccccccccccccccccccc--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCcc--ccc
Confidence                244567788888888888743  34788889999999999988653  37888899999999999885533  788


Q ss_pred             CCCCcEEEcCC
Q 039419          486 CESLQSLDLSS  496 (1035)
Q Consensus       486 l~~L~~L~Ls~  496 (1035)
                      +++|++|+|++
T Consensus       216 l~~L~~L~lsn  226 (227)
T d1h6ua2         216 TSNLFIVTLTN  226 (227)
T ss_dssp             CTTCCEEEEEE
T ss_pred             CCCCCEEEeeC
Confidence            89999998863

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=1.4e-18  Score=179.92  Aligned_cols=207  Identities=20%  Similarity=0.289  Sum_probs=112.8

Q ss_pred             ccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEc
Q 039419          199 SKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDL  278 (1035)
Q Consensus       199 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L  278 (1035)
                      .++..+++..+.+++.  ..+..+.+|+.|++.+|.|+. + ..+.++++|++|++++|++.+..|  +..+++|+.+++
T Consensus        19 ~~~~~~~l~~~~~~d~--~~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~   92 (227)
T d1h6ua2          19 ANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL   92 (227)
T ss_dssp             HHHHHHHTTCSSTTSE--ECHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred             HHHHHHHhCCCCcCCc--CCHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--cccccccccccc
Confidence            3444455555555432  234455566666666666653 2 235555555555555555553222  455555555555


Q ss_pred             cCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEE
Q 039419          279 SLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAV  358 (1035)
Q Consensus       279 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L  358 (1035)
                      ++|.++. + ..+.++++|+.+++++|.+.+.                                    ..+...+.+..+
T Consensus        93 ~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~------------------------------------~~~~~~~~~~~l  134 (227)
T d1h6ua2          93 SGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV------------------------------------TPLAGLSNLQVL  134 (227)
T ss_dssp             CSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC------------------------------------GGGTTCTTCCEE
T ss_pred             ccccccc-c-cccccccccccccccccccccc------------------------------------chhccccchhhh
Confidence            5555542 1 2344555555555555544321                                    123444555566


Q ss_pred             eccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCcccccCC
Q 039419          359 DLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASL  438 (1035)
Q Consensus       359 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l  438 (1035)
                      .++++.+...  ..+...++|++|++++|.+++..                .|.++++|++|+|++|++++. + .+.++
T Consensus       135 ~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~----------------~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l  194 (227)
T d1h6ua2         135 YLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT----------------PLANLSKLTTLKADDNKISDI-S-PLASL  194 (227)
T ss_dssp             ECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG----------------GGTTCTTCCEEECCSSCCCCC-G-GGGGC
T ss_pred             hchhhhhchh--hhhccccccccccccccccccch----------------hhcccccceecccCCCccCCC-h-hhcCC
Confidence            6666655422  23455566666666666654321                234456677777777777643 2 36677


Q ss_pred             CCccEEEcCCCccCCCCchhccCccccchhhcc
Q 039419          439 TRLQVLDISVNQFVGLIPESFGQLASLNRLILS  471 (1035)
Q Consensus       439 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  471 (1035)
                      ++|++|+|++|+|+++.|  +.++++|+.|+++
T Consensus       195 ~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             TTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             CCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence            777777777777776532  6677777777765

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=5.2e-18  Score=177.74  Aligned_cols=50  Identities=20%  Similarity=0.128  Sum_probs=25.2

Q ss_pred             ecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhc
Q 039419          421 NLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLIL  470 (1035)
Q Consensus       421 ~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  470 (1035)
                      ++++|+|+.+.+..|.++++|++|+|++|+|+.+++..|.++++|+.|++
T Consensus       183 ~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             CTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             cccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence            34445555443444555555555555555555444444555555555444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=3.1e-18  Score=172.05  Aligned_cols=176  Identities=25%  Similarity=0.327  Sum_probs=135.4

Q ss_pred             CcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCccc
Q 039419          355 LEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSS  434 (1035)
Q Consensus       355 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~  434 (1035)
                      .+.+++++++++ .+|..+.  +++++|+|++|+|++.++..             .|.++++|++|+|++|++....+..
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~-------------~f~~l~~L~~L~L~~N~i~~~~~~~   73 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDG-------------LFGRLPHLVKLELKRNQLTGIEPNA   73 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSC-------------SGGGCTTCCEEECCSSCCCCBCTTT
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCccccccc-------------ccCCCceEeeeeccccccccccccc
Confidence            457889999998 5565553  68999999999997644332             3566788999999999999999999


Q ss_pred             ccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCc
Q 039419          435 LASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLD  514 (1035)
Q Consensus       435 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~  514 (1035)
                      |..+++|++|+|++|+|+.+.+..|.++++|++|+|++|+|+++.+.+|..+++|++|+|++|.+....+...+.  ...
T Consensus        74 ~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~--~~l  151 (192)
T d1w8aa_          74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWL  151 (192)
T ss_dssp             TTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHH
T ss_pred             cccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHh--hhh
Confidence            999999999999999999999999999999999999999999888999999999999999999998544333221  222


Q ss_pred             ceeeccCccCCCCCCccccCCccccEEeccCCcccCc
Q 039419          515 ISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGD  551 (1035)
Q Consensus       515 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  551 (1035)
                      ..+.+..|.++...|..   +..++.++|+.|++.+.
T Consensus       152 ~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~C~  185 (192)
T d1w8aa_         152 RKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCS  185 (192)
T ss_dssp             HHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCCC
T ss_pred             hhhcccCCCeEeCCChh---hcCCEeeecCHhhCcCC
Confidence            34556666665544443   33445556666666553

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.73  E-value=4.1e-21  Score=222.17  Aligned_cols=61  Identities=23%  Similarity=0.229  Sum_probs=29.9

Q ss_pred             CCceeeCCCCCCCCCC-ChhhhccccccceEecccCCCCC----CchhhhhhccccceeccccccC
Q 039419           79 QLTTIDVSSNSLVGGV-PSSIGKLINLQDLILNSNQLTGE----IPKELGACIKLKNLLLFDNYLS  139 (1035)
Q Consensus        79 ~L~~L~ls~n~l~~~~-p~~i~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~l~~n~l~  139 (1035)
                      +|++||+++|++++.. .+-+..+++|++|+|++|+++..    +...+..+++|++|||++|.++
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~   68 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG   68 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCC
Confidence            3555555555555221 23344555555666666555522    2233344555555555555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.72  E-value=3.9e-18  Score=171.35  Aligned_cols=158  Identities=21%  Similarity=0.276  Sum_probs=108.8

Q ss_pred             ccceeecCCCccCC-CCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEc
Q 039419          416 QLQMLNLSNNTLGG-TLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL  494 (1035)
Q Consensus       416 ~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  494 (1035)
                      ++++|+|++|+|++ ..+..|.++++|+.|+|++|++..+++..|..+++|++|+|++|+|+.+.+.+|.++++|++|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            46666666666654 33445566666666666666666666666666666666666666666555666666666666666


Q ss_pred             CCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCccc
Q 039419          495 SSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGY  574 (1035)
Q Consensus       495 s~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~  574 (1035)
                      ++|+|+                         ++.+++|..+++|++|+|++|.+.++....+-...++.+.+..|.+++.
T Consensus       110 ~~N~l~-------------------------~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~  164 (192)
T d1w8aa_         110 YDNQIS-------------------------CVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             CSSCCC-------------------------EECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred             CCcccc-------------------------ccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeC
Confidence            666665                         4556678888999999999999998765433344577788899999877


Q ss_pred             CCChhhhhccccccccccccCCCCCC
Q 039419          575 LPDSKLFRQLSATEMAGNQGLCSRGH  600 (1035)
Q Consensus       575 ~p~~~~~~~l~~~~~~~N~~~c~~~~  600 (1035)
                      .|.  .++.++..++..|...|..+.
T Consensus       165 ~p~--~l~~~~l~~L~~n~l~C~~~~  188 (192)
T d1w8aa_         165 APS--KVRDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             SST--TTTTSBGGGSCTTTCCCCCC-
T ss_pred             CCh--hhcCCEeeecCHhhCcCCCCC
Confidence            664  367777778889998887653

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=1.6e-17  Score=173.90  Aligned_cols=208  Identities=18%  Similarity=0.107  Sum_probs=116.8

Q ss_pred             EEEeccccccccCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCC-ChhhhcccchhHhhccc-
Q 039419          179 VVGLADTKVAGSLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSL-PRELGKLQKLEKMLLWQ-  256 (1035)
Q Consensus       179 ~L~l~~~~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~l~~-  256 (1035)
                      +++.++.+++ .+|..+-  +++++|++++|.++...+..|.++++|++|++++|.+...+ +..|..+++++++.+.. 
T Consensus        12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            4555555555 4554432  45677777777776434445677777777777777666433 33456666666666543 


Q ss_pred             ccccccCCccccCCCCCcEEEccCccCCCCCCc-cccCCCCCcEEEccCCccccCCCCcccCCC-ccceeccccchhhhh
Q 039419          257 NNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQ-SFGNLSSLEELMLSNNNISGSIPPVLSNAT-SLLQLQLDTNQISVF  334 (1035)
Q Consensus       257 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~l  334 (1035)
                      |++....+..|.++++|+.|++++|++....+. .+..++.|..+..+++.+..+.+..|.+++ .++.|++++|+|+.+
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i  168 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI  168 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE
T ss_pred             ccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc
Confidence            456556666677777777777777776533222 233445555556666666655555555543 566666666665532


Q ss_pred             hhhccccCCCCCcCCCCCCCCcE-EeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCC
Q 039419          335 FAWQNKLEGSIPSTLANCRSLEA-VDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNC  400 (1035)
Q Consensus       335 ~~~~n~l~~~~p~~l~~l~~L~~-L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l  400 (1035)
                                 +.......++.. +++++|+|+...+..|.++++|++|+|++|+|+.+.+..|.++
T Consensus       169 -----------~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l  224 (242)
T d1xwdc1         169 -----------HNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL  224 (242)
T ss_dssp             -----------CTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTC
T ss_pred             -----------ccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCC
Confidence                       222223333333 3455566664444445556666666666666654444333333

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=1.3e-20  Score=217.78  Aligned_cols=364  Identities=20%  Similarity=0.190  Sum_probs=179.1

Q ss_pred             ccccceEecccCCCCCC-chhhhhhccccceeccccccCC----CCchhhccccccceeecCCCcccCCCCCCcCCCccc
Q 039419          102 INLQDLILNSNQLTGEI-PKELGACIKLKNLLLFDNYLSG----NLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQS  176 (1035)
Q Consensus       102 ~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~l~~n~l~~----~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~  176 (1035)
                      .+|++|||+.|++++.. .+-+..+++|++|+|++|.++.    .+...+..+++|++|++++|. +......       
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~-i~~~~~~-------   73 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE-LGDVGVH-------   73 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCC-CHHHHHH-------
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCc-CChHHHH-------
Confidence            36899999999998643 3446778999999999998873    233445677778888877775 1100000       


Q ss_pred             eEEEEeccccccccCcccccc-cccccceeecccccccC----CccccccCcCCceEEecCCcCCCCCChhhhc-cc---
Q 039419          177 LLVVGLADTKVAGSLPASLGK-LSKLQSLSVYTTMLSGE----IPPQIGNCSELVDLFLYENDLSGSLPRELGK-LQ---  247 (1035)
Q Consensus       177 L~~L~l~~~~~~~~~p~~l~~-l~~L~~L~l~~n~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~-l~---  247 (1035)
                                   .+.+.+.. ..+|++|++++|.+++.    ++..+..+++|++|+|++|.+++.....+.. +.   
T Consensus        74 -------------~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~  140 (460)
T d1z7xw1          74 -------------CVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ  140 (460)
T ss_dssp             -------------HHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTT
T ss_pred             -------------HHHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccc
Confidence                         01111111 23455555555555432    2334455556666666666554221111110 00   


Q ss_pred             -chhHhhcccccccc----cCCccccCCCCCcEEEccCccCCCCCCc----cc-cCCCCCcEEEccCCccccCC----CC
Q 039419          248 -KLEKMLLWQNNFDG----AIPEEIGNCKSLKTIDLSLNFFSGSLPQ----SF-GNLSSLEELMLSNNNISGSI----PP  313 (1035)
Q Consensus       248 -~L~~L~l~~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~~~----~~-~~l~~L~~L~L~~N~l~~~~----~~  313 (1035)
                       ....+......+..    ..-..+.....++.++++++.+......    .+ ..-.....+++.++.+....    ..
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~  220 (460)
T d1z7xw1         141 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG  220 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred             cccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccc
Confidence             00001111111100    0011233445677777777665421111    11 11234556677666654221    12


Q ss_pred             cccCCCccceeccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCC----CCCcccCcccceEecccccc
Q 039419          314 VLSNATSLLQLQLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSL----HPGLFQLQNLTKLLLISNGI  389 (1035)
Q Consensus       314 ~~~~l~~L~~L~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~i  389 (1035)
                      .+.....++.+++.+|++.....     ....+..+.....|+.+++++|.+....    ...+...+.++.+++++|.+
T Consensus       221 ~l~~~~~~~~l~~~~n~~~~~~~-----~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i  295 (460)
T d1z7xw1         221 IVASKASLRELALGSNKLGDVGM-----AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL  295 (460)
T ss_dssp             HHHHCTTCCEEECCSSBCHHHHH-----HHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCC
T ss_pred             cccccccccccchhhcccccccc-----chhhcccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            23455667777777776543211     0011233445567777888877775221    11233456677777777766


Q ss_pred             ccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccCCCCccc----ccCCCCccEEEcCCCccCCC----Cchhcc-
Q 039419          390 SGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLGGTLPSS----LASLTRLQVLDISVNQFVGL----IPESFG-  460 (1035)
Q Consensus       390 ~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~~~~~~~----l~~l~~L~~L~Ls~N~l~~~----~~~~~~-  460 (1035)
                      +......+..         ........|+.+++++|.++......    +...++|++|+|++|+|...    ++..+. 
T Consensus       296 ~~~~~~~l~~---------~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~  366 (460)
T d1z7xw1         296 GDEGARLLCE---------TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ  366 (460)
T ss_dssp             HHHHHHHHHH---------HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTS
T ss_pred             cccccchhhc---------cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhc
Confidence            5311110000         00112245666677776665432222    23344666677776666432    112221 


Q ss_pred             CccccchhhccCCccccc----CccccCCCCCCcEEEcCCCcCc
Q 039419          461 QLASLNRLILSKNSFSGA----IPSSLGRCESLQSLDLSSNKLS  500 (1035)
Q Consensus       461 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~  500 (1035)
                      ..+.|++|+|++|.|+..    ++..+..+++|++|||++|+|+
T Consensus       367 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~  410 (460)
T d1z7xw1         367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG  410 (460)
T ss_dssp             TTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             ccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCC
Confidence            234466666666666431    2333445566666666666665

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.70  E-value=2e-17  Score=168.61  Aligned_cols=186  Identities=26%  Similarity=0.371  Sum_probs=107.8

Q ss_pred             ccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceec
Q 039419          246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQ  325 (1035)
Q Consensus       246 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  325 (1035)
                      +.++....+..+.+.+.++.  ..+.+|+.|++++|.++.. + .+..+++|++|+|++|+|++..  .++.+++|++|+
T Consensus        23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~   96 (210)
T d1h6ta2          23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLF   96 (210)
T ss_dssp             HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred             HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccc
Confidence            34445556667776655543  3466788888888888743 2 3677888888888888887543  245666666666


Q ss_pred             cccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCccee
Q 039419          326 LDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR  405 (1035)
Q Consensus       326 L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  405 (1035)
                      +++|+|+.+            ..+.++++|+.|++++|.+..  ...+..+++++                         
T Consensus        97 l~~n~i~~l------------~~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~-------------------------  137 (210)
T d1h6ta2          97 LDENKVKDL------------SSLKDLKKLKSLSLEHNGISD--INGLVHLPQLE-------------------------  137 (210)
T ss_dssp             CCSSCCCCG------------GGGTTCTTCCEEECTTSCCCC--CGGGGGCTTCC-------------------------
T ss_pred             ccccccccc------------ccccccccccccccccccccc--ccccccccccc-------------------------
Confidence            666666532            235556666666666666542  12344444444                         


Q ss_pred             EeeeccCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCC
Q 039419          406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGR  485 (1035)
Q Consensus       406 L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  485 (1035)
                                   .+++++|.+++  +..+..+++|+++++++|+++++.  .|.++++|+.|+|++|+|+. ++ .|.+
T Consensus       138 -------------~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~  198 (210)
T d1h6ta2         138 -------------SLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAG  198 (210)
T ss_dssp             -------------EEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTT
T ss_pred             -------------ccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-Ch-hhcC
Confidence                         44444444442  123444555666666666665432  25556666666666666653 23 3566


Q ss_pred             CCCCcEEEcC
Q 039419          486 CESLQSLDLS  495 (1035)
Q Consensus       486 l~~L~~L~Ls  495 (1035)
                      +++|++|+|+
T Consensus       199 l~~L~~L~Ls  208 (210)
T d1h6ta2         199 LKNLDVLELF  208 (210)
T ss_dssp             CTTCSEEEEE
T ss_pred             CCCCCEEEcc
Confidence            6666666664

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=6.6e-17  Score=163.26  Aligned_cols=125  Identities=27%  Similarity=0.345  Sum_probs=76.0

Q ss_pred             cccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCcccee
Q 039419          245 KLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQL  324 (1035)
Q Consensus       245 ~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  324 (1035)
                      .+.++..+.++.+.+++.++  ...+.+++.|++++|.|+..  ..+..+++|++|++++|++++..+  +.++++|++|
T Consensus        16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            34455566777777775443  24567888888888888743  246777888888888888775432  6666666666


Q ss_pred             ccccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEecccccc
Q 039419          325 QLDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGI  389 (1035)
Q Consensus       325 ~L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i  389 (1035)
                      ++++|.+..+            ..+.++++|+.|++++|.+...  ..+..+++|+.|++++|++
T Consensus        90 ~l~~n~~~~~------------~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l  140 (199)
T d2omxa2          90 LMNNNQIADI------------TPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTI  140 (199)
T ss_dssp             ECCSSCCCCC------------GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCC
T ss_pred             cccccccccc------------cccccccccccccccccccccc--cccchhhhhHHhhhhhhhh
Confidence            6666655432            2355666666666666665522  2234444444444444444

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.67  E-value=5.5e-17  Score=165.32  Aligned_cols=146  Identities=28%  Similarity=0.365  Sum_probs=107.1

Q ss_pred             CCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCccC
Q 039419          349 LANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTLG  428 (1035)
Q Consensus       349 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l~  428 (1035)
                      +..+++|++|+|++|+|++..  .+..+++|++|++++|+|+++.                .+.++++|+.|++++|.+.
T Consensus        64 l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~----------------~l~~l~~L~~L~l~~~~~~  125 (210)
T d1h6ta2          64 IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS----------------SLKDLKKLKSLSLEHNGIS  125 (210)
T ss_dssp             GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG----------------GGTTCTTCCEEECTTSCCC
T ss_pred             HhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc----------------ccccccccccccccccccc
Confidence            444566666666666666432  2455666777777777665321                2445677888888888887


Q ss_pred             CCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEcCCCcCcCccchhhh
Q 039419          429 GTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELF  508 (1035)
Q Consensus       429 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  508 (1035)
                      ..  ..+..++.|+.+++++|.+++.  ..+..+++|+.+++++|++++..  .+.++++|+.|+|++|+|+ .+| .+.
T Consensus       126 ~~--~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~-~l~-~l~  197 (210)
T d1h6ta2         126 DI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS-DLR-ALA  197 (210)
T ss_dssp             CC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-BCG-GGT
T ss_pred             cc--cccccccccccccccccccccc--ccccccccccccccccccccccc--cccCCCCCCEEECCCCCCC-CCh-hhc
Confidence            32  4688899999999999999864  45778999999999999998643  3899999999999999998 666 455


Q ss_pred             hhccCcceeeccC
Q 039419          509 EIEGLDISLNLSW  521 (1035)
Q Consensus       509 ~~~~l~~~L~Ls~  521 (1035)
                      .+..+. .|+|++
T Consensus       198 ~l~~L~-~L~Ls~  209 (210)
T d1h6ta2         198 GLKNLD-VLELFS  209 (210)
T ss_dssp             TCTTCS-EEEEEE
T ss_pred             CCCCCC-EEEccC
Confidence            555544 688764

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.67  E-value=2e-17  Score=167.14  Aligned_cols=161  Identities=29%  Similarity=0.417  Sum_probs=88.6

Q ss_pred             ccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCccccCCCCcccCCCccceec
Q 039419          246 LQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNNISGSIPPVLSNATSLLQLQ  325 (1035)
Q Consensus       246 l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  325 (1035)
                      +.+|++|++++|.+.. + +.+..+++|++|+|++|+|++..+  ++++++|++|++++|.+....  .+.+++.|+.|+
T Consensus        39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~  112 (199)
T d2omxa2          39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT  112 (199)
T ss_dssp             HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred             hcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--cccccccccccc
Confidence            3444444444444442 1 124455666666666666654322  566666666666666655322  255666666666


Q ss_pred             cccchhhhhhhhccccCCCCCcCCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCccee
Q 039419          326 LDTNQISVFFAWQNKLEGSIPSTLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIR  405 (1035)
Q Consensus       326 L~~N~i~~l~~~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  405 (1035)
                      +++|++..+            ..+..+++|+.|++++|++.. + +.+..+++|++|++.+|++++..            
T Consensus       113 l~~~~~~~~------------~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~------------  166 (199)
T d2omxa2         113 LFNNQITDI------------DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK------------  166 (199)
T ss_dssp             CCSSCCCCC------------GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG------------
T ss_pred             ccccccccc------------cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc------------
Confidence            666655422            235667777777777777763 2 34566666666666666665321            


Q ss_pred             EeeeccCCCCccceeecCCCccCCCCcccccCCCCccEE
Q 039419          406 LRLMSFGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVL  444 (1035)
Q Consensus       406 L~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L  444 (1035)
                          .|.++++|++|++++|+|++. + .+.++++|+.|
T Consensus       167 ----~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         167 ----PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             ----GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred             ----cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence                133445566666666666532 2 35555555554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=3e-16  Score=167.85  Aligned_cols=256  Identities=17%  Similarity=0.158  Sum_probs=140.7

Q ss_pred             EEEecCCcccccCCcCCCCCcccceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCC-CChhhhccccccceEeccc
Q 039419           34 EINIQSIELELPFPSNLSSLSFLQKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGG-VPSSIGKLINLQDLILNSN  112 (1035)
Q Consensus        34 ~l~~~~~~~~~~~~~~~~~l~~L~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~-~p~~i~~l~~L~~L~L~~n  112 (1035)
                      .+++++..+.......+.. ..+..+.+++..+. ..........+|++|||++|.+.+. +...+.++++|++|+|++|
T Consensus         4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             EEECCCCCCCchHHHHHHh-ccceEeeccccccc-cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence            4556555543222221211 12345555555554 2333344556788888887776633 3444567778888888888


Q ss_pred             CCCCCCchhhhhhccccceecccc-ccCCCC-chhhccccccceeecCCCcccCCCCCCcCCCccceEEEEecccccccc
Q 039419          113 QLTGEIPKELGACIKLKNLLLFDN-YLSGNL-PVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGS  190 (1035)
Q Consensus       113 ~l~~~~p~~l~~l~~L~~L~l~~n-~l~~~~-p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~  190 (1035)
                      .+++..+..++.+++|++|++++| .+++.. ..-...+++|++|++++|..+...                       .
T Consensus        82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~-----------------------~  138 (284)
T d2astb2          82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK-----------------------H  138 (284)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH-----------------------H
T ss_pred             CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccc-----------------------c
Confidence            777667777777777888888775 344221 122345677777777766422211                       0


Q ss_pred             Ccccccc-cccccceeeccc--ccccC-CccccccCcCCceEEecCC-cCCCCCChhhhcccchhHhhcccc-cccccCC
Q 039419          191 LPASLGK-LSKLQSLSVYTT--MLSGE-IPPQIGNCSELVDLFLYEN-DLSGSLPRELGKLQKLEKMLLWQN-NFDGAIP  264 (1035)
Q Consensus       191 ~p~~l~~-l~~L~~L~l~~n--~l~~~-~p~~l~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~l~~n-~l~~~~p  264 (1035)
                      +...+.. .++|+.|+++++  .++.. +...+.++++|++|+|++| .+++.....+.++++|++|++++| .+++...
T Consensus       139 ~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l  218 (284)
T d2astb2         139 VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL  218 (284)
T ss_dssp             HHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGG
T ss_pred             chhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHH
Confidence            1111222 235555555543  22211 2222344666677777664 355555566666677777777764 4555555


Q ss_pred             ccccCCCCCcEEEccCccCCCCCCccc-cCCCCCcEEEccCCccccCCCCcccCC
Q 039419          265 EEIGNCKSLKTIDLSLNFFSGSLPQSF-GNLSSLEELMLSNNNISGSIPPVLSNA  318 (1035)
Q Consensus       265 ~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l  318 (1035)
                      ..++++++|+.|+++++ ++...-..+ ..+++|   .+..++++...++.+++.
T Consensus       219 ~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ls~~~~~~~~~~  269 (284)
T d2astb2         219 LELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHFTTIARPTIGNK  269 (284)
T ss_dssp             GGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCSCCTTCSSCSST
T ss_pred             HHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccCCCCCCCccCcc
Confidence            56777788888888877 332221222 334444   456677776666655543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=2e-16  Score=169.25  Aligned_cols=246  Identities=18%  Similarity=0.186  Sum_probs=160.6

Q ss_pred             ceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCC-Cchhhhhhccccceeccc
Q 039419           57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGE-IPKELGACIKLKNLLLFD  135 (1035)
Q Consensus        57 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~l~~  135 (1035)
                      +.|||+++.+.......+.. ..+..+.++.+.+. ..........+|++|+|++|.+++. ++..+..+++|++|+|++
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~   80 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG   80 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccc-cchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence            46778777664322222211 23456666665555 2223334556788888888877643 334456778888888888


Q ss_pred             cccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEecccccccc-Ccccccccccccceeecccc-ccc
Q 039419          136 NYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTKVAGS-LPASLGKLSKLQSLSVYTTM-LSG  213 (1035)
Q Consensus       136 n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~-~p~~l~~l~~L~~L~l~~n~-l~~  213 (1035)
                      |.+.+..+..++++++|++|++++|..                        +++. +...+..+++|++|++++|. +++
T Consensus        81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~------------------------itd~~l~~l~~~~~~L~~L~ls~c~~~~~  136 (284)
T d2astb2          81 LRLSDPIVNTLAKNSNLVRLNLSGCSG------------------------FSEFALQTLLSSCSRLDELNLSWCFDFTE  136 (284)
T ss_dssp             CBCCHHHHHHHTTCTTCSEEECTTCBS------------------------CCHHHHHHHHHHCTTCCEEECCCCTTCCH
T ss_pred             cCCCcHHHHHHhcCCCCcCcccccccc------------------------ccccccchhhHHHHhcccccccccccccc
Confidence            887766677777777777777777642                        2211 12224567889999998863 432


Q ss_pred             C-Ccccccc-CcCCceEEecCCc--CCCC-CChhhhcccchhHhhcccc-cccccCCccccCCCCCcEEEccCc-cCCCC
Q 039419          214 E-IPPQIGN-CSELVDLFLYEND--LSGS-LPRELGKLQKLEKMLLWQN-NFDGAIPEEIGNCKSLKTIDLSLN-FFSGS  286 (1035)
Q Consensus       214 ~-~p~~l~~-l~~L~~L~L~~n~--l~~~-~~~~l~~l~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~L~~n-~l~~~  286 (1035)
                      . +...+.. .++|+.|+++++.  +++. +...+.++++|++|++++| .+++.....+..+++|++|+|++| .|++.
T Consensus       137 ~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~  216 (284)
T d2astb2         137 KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPE  216 (284)
T ss_dssp             HHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGG
T ss_pred             ccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChH
Confidence            1 2233434 4789999999763  4432 2223456899999999986 477778888999999999999995 78877


Q ss_pred             CCccccCCCCCcEEEccCCccccCCCCcccCC-Cccceeccccchhh
Q 039419          287 LPQSFGNLSSLEELMLSNNNISGSIPPVLSNA-TSLLQLQLDTNQIS  332 (1035)
Q Consensus       287 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~i~  332 (1035)
                      ....++++++|+.|+++++ ++.   ..+..+ ..+..|.+..+.++
T Consensus       217 ~l~~L~~~~~L~~L~l~~~-~~d---~~l~~l~~~lp~L~i~~~~ls  259 (284)
T d2astb2         217 TLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFT  259 (284)
T ss_dssp             GGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSC
T ss_pred             HHHHHhcCCCCCEEeeeCC-CCH---HHHHHHHHhCccccccCccCC
Confidence            7778899999999999988 332   222211 23444555666555

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=1.8e-14  Score=139.11  Aligned_cols=128  Identities=19%  Similarity=0.234  Sum_probs=79.1

Q ss_pred             cCCCCccceeecCCCccCCCCcccccCCCCccEEEcCCCccCCCCchhccCccccchhhccCCcccccCccccCCCCCCc
Q 039419          411 FGNCTQLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVNQFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQ  490 (1035)
Q Consensus       411 ~~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  490 (1035)
                      |.++.+|++|+|++|+|+. ++..+..+++|+.|+|++|+|+.+  +.|..+++|++|++++|+|+...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence            3444556666666666663 344555666666666666666644  2356666666666666666654444455566666


Q ss_pred             EEEcCCCcCcCccchhhhhhccCcceeeccCccCCCCCCccccCCccccEEeccCCcccCccc----cccccCCCcEEe
Q 039419          491 SLDLSSNKLSGKIPVELFEIEGLDISLNLSWNALSGAIPPQISALNKLSILDLSHNKLGGDLL----ALSGLDNLVSLN  565 (1035)
Q Consensus       491 ~L~Ls~N~l~~~~p~~~~~~~~l~~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~l~~L~~L~  565 (1035)
                      +|+|++|+|+ .++.                       -..+..+++|++|++++|+++..+.    .+..+|+|++||
T Consensus        91 ~L~L~~N~i~-~~~~-----------------------l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLV-ELGD-----------------------LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCC-CGGG-----------------------GGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cceecccccc-cccc-----------------------ccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            6666666665 2211                       1235567788888888888766542    467778888776

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=2.6e-14  Score=137.96  Aligned_cols=129  Identities=19%  Similarity=0.171  Sum_probs=95.3

Q ss_pred             CCCCCCCCcEEeccCcCCCCCCCCCcccCcccceEeccccccccCCCCCCCCCCcceeEeeeccCCCCccceeecCCCcc
Q 039419          348 TLANCRSLEAVDLSHNALTGSLHPGLFQLQNLTKLLLISNGISGLIPPEIGNCSSLIRLRLMSFGNCTQLQMLNLSNNTL  427 (1035)
Q Consensus       348 ~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~~~~~~~l~~L~~L~L~~N~l  427 (1035)
                      .|.+..+|++|+|++|+|+. ++..+..+++|+.|+|++|+|+.+                ..|..+++|++|++++|+|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l----------------~~~~~l~~L~~L~ls~N~i   75 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL----------------DGFPLLRRLKTLLVNNNRI   75 (162)
T ss_dssp             EEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE----------------CCCCCCSSCCEEECCSSCC
T ss_pred             hccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc----------------CCcccCcchhhhhcccccc
Confidence            35667778888888888884 455566788888888888888743                1245567788888888888


Q ss_pred             CCCCcccccCCCCccEEEcCCCccCCCCc-hhccCccccchhhccCCcccccC---ccccCCCCCCcEEE
Q 039419          428 GGTLPSSLASLTRLQVLDISVNQFVGLIP-ESFGQLASLNRLILSKNSFSGAI---PSSLGRCESLQSLD  493 (1035)
Q Consensus       428 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~  493 (1035)
                      +...+..+..+++|+.|++++|+|..... ..+..+++|+.|++++|.++...   +..+..+++|++||
T Consensus        76 ~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          76 CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cCCCccccccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            86666667778888888888888876533 46777888888888888886332   12467788888887

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.44  E-value=2.5e-15  Score=165.88  Aligned_cols=180  Identities=15%  Similarity=0.209  Sum_probs=102.2

Q ss_pred             cCCcCCCCCcccceEeecCcccCCC----CCCCCCCCCCCceeeCCCCCCCC---CCC-------hhhhccccccceEec
Q 039419           45 PFPSNLSSLSFLQKLIISGSNLTGP----ISPDLGDCTQLTTIDVSSNSLVG---GVP-------SSIGKLINLQDLILN  110 (1035)
Q Consensus        45 ~~~~~~~~l~~L~~L~L~~~~l~~~----~~~~~~~l~~L~~L~ls~n~l~~---~~p-------~~i~~l~~L~~L~L~  110 (1035)
                      .+...+.+...|++|+|++|.+...    +...+...+.|+.|+++++....   ..|       +.+..+++|++|+|+
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            3445567788899999999988643    33456778899999998876541   112       234456789999999


Q ss_pred             ccCCCCC----CchhhhhhccccceeccccccCCCCchhhccccccceeecCCCcccCCCCCCcCCCccceEEEEecccc
Q 039419          111 SNQLTGE----IPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGNKDIAGKIPYEIGDCQSLLVVGLADTK  186 (1035)
Q Consensus       111 ~n~l~~~----~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~~~  186 (1035)
                      +|.++..    +...+..+++|++|++++|.+.......++.  .|..+.....          ....+.|+.+.+++|.
T Consensus       102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~~~----------~~~~~~L~~l~l~~n~  169 (344)
T d2ca6a1         102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVNKK----------AKNAPPLRSIICGRNR  169 (344)
T ss_dssp             SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHHHH----------HHTCCCCCEEECCSSC
T ss_pred             ccccccccccchhhhhcccccchheecccccccccccccccc--cccccccccc----------cccCcccceeeccccc
Confidence            9888765    3334456788888888888775322222211  1111111100          1122344455555554


Q ss_pred             cccc----CcccccccccccceeecccccccC-----CccccccCcCCceEEecCCcCC
Q 039419          187 VAGS----LPASLGKLSKLQSLSVYTTMLSGE-----IPPQIGNCSELVDLFLYENDLS  236 (1035)
Q Consensus       187 ~~~~----~p~~l~~l~~L~~L~l~~n~l~~~-----~p~~l~~l~~L~~L~L~~n~l~  236 (1035)
                      +...    +...+...+.|++|++++|.+...     +...+..+++|+.|+|++|.++
T Consensus       170 i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         170 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             ccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence            4322    222334455666666666665431     2233455566666666666554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.41  E-value=1.7e-13  Score=125.57  Aligned_cols=101  Identities=28%  Similarity=0.393  Sum_probs=51.3

Q ss_pred             eEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccCCCCCcEEEccCccCCCCCCccccCCCCCcEEEccCCc
Q 039419          227 DLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTIDLSLNFFSGSLPQSFGNLSSLEELMLSNNN  306 (1035)
Q Consensus       227 ~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  306 (1035)
                      .|+|++|+++ .++ .+.++++|++|++++|+++ .+|..++.+++|+.|++++|+|++ ++ .++++++|++|++++|+
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            4555555555 222 2455555555555555555 344455555555555555555553 22 25555555555555555


Q ss_pred             cccCCC-CcccCCCccceeccccchhh
Q 039419          307 ISGSIP-PVLSNATSLLQLQLDTNQIS  332 (1035)
Q Consensus       307 l~~~~~-~~~~~l~~L~~L~L~~N~i~  332 (1035)
                      |..... ..+..+++|+.|++++|+|+
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            553321 23444444555555554444

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.37  E-value=5.7e-15  Score=162.97  Aligned_cols=38  Identities=21%  Similarity=0.172  Sum_probs=18.3

Q ss_pred             CCCcEEeccCcCCCCCC----CCCcc-cCcccceEeccccccc
Q 039419          353 RSLEAVDLSHNALTGSL----HPGLF-QLQNLTKLLLISNGIS  390 (1035)
Q Consensus       353 ~~L~~L~Ls~N~l~~~~----~~~~~-~l~~L~~L~L~~N~i~  390 (1035)
                      .+|++|++++|.|+...    ...+. ++++|++|+|++|++.
T Consensus       273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             CCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            44556666666554211    11121 2455666666666654

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.37  E-value=5.1e-13  Score=122.28  Aligned_cols=100  Identities=25%  Similarity=0.328  Sum_probs=71.5

Q ss_pred             ceEeecCcccCCCCCCCCCCCCCCceeeCCCCCCCCCCChhhhccccccceEecccCCCCCCchhhhhhccccceecccc
Q 039419           57 QKLIISGSNLTGPISPDLGDCTQLTTIDVSSNSLVGGVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDN  136 (1035)
Q Consensus        57 ~~L~L~~~~l~~~~~~~~~~l~~L~~L~ls~n~l~~~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n  136 (1035)
                      |.|+|++|+++ .++ .++.+++|++|++++|+|+ .+|+.++.+++|++|++++|+++ .+| .++.+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            56788888887 444 4777888888888888887 67777888888888888888887 455 4777788888888888


Q ss_pred             ccCCCC-chhhccccccceeecCCCc
Q 039419          137 YLSGNL-PVELGKLVNLEVIRAGGNK  161 (1035)
Q Consensus       137 ~l~~~~-p~~l~~l~~L~~L~l~~n~  161 (1035)
                      ++.+.. ...++.+++|++|++++|+
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~  101 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNS  101 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCc
Confidence            776321 2345666666666666664

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.25  E-value=5.8e-12  Score=120.31  Aligned_cols=84  Identities=20%  Similarity=0.162  Sum_probs=66.1

Q ss_pred             ccceeecCCCccCCCCcccccCCCCccEEEcCCC-ccCCCCchhccCccccchhhccCCcccccCccccCCCCCCcEEEc
Q 039419          416 QLQMLNLSNNTLGGTLPSSLASLTRLQVLDISVN-QFVGLIPESFGQLASLNRLILSKNSFSGAIPSSLGRCESLQSLDL  494 (1035)
Q Consensus       416 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  494 (1035)
                      ..+.++.+++.+. ..|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            3556778888877 45667778888888888755 488777778888888888888888888777778888888888888


Q ss_pred             CCCcCc
Q 039419          495 SSNKLS  500 (1035)
Q Consensus       495 s~N~l~  500 (1035)
                      ++|+|+
T Consensus        88 s~N~l~   93 (156)
T d2ifga3          88 SFNALE   93 (156)
T ss_dssp             CSSCCS
T ss_pred             cCCCCc
Confidence            888887

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.23  E-value=1.5e-13  Score=137.52  Aligned_cols=115  Identities=20%  Similarity=0.240  Sum_probs=73.7

Q ss_pred             cCcccccccccccceeecccccccCCccccccCcCCceEEecCCcCCCCCChhhhcccchhHhhcccccccccCCccccC
Q 039419          190 SLPASLGKLSKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSLPRELGKLQKLEKMLLWQNNFDGAIPEEIGN  269 (1035)
Q Consensus       190 ~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~  269 (1035)
                      .++.++..+++|++|+|++|.++ .++ .+..+++|+.|+|++|.|+ .++..+..+++|++|++++|+++..  ..+..
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~  113 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK  113 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred             hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence            44566777777777777777776 343 4677777777777777776 4455455556677777777766632  23566


Q ss_pred             CCCCcEEEccCccCCCCCC-ccccCCCCCcEEEccCCcccc
Q 039419          270 CKSLKTIDLSLNFFSGSLP-QSFGNLSSLEELMLSNNNISG  309 (1035)
Q Consensus       270 l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~  309 (1035)
                      +++|+.|+|++|+|+.... ..|..+++|+.|+|++|.+..
T Consensus       114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~  154 (198)
T d1m9la_         114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred             cccccccccccchhccccccccccCCCccceeecCCCcccc
Confidence            6677777777777663221 346666667777776666653

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.20  E-value=4.2e-13  Score=134.11  Aligned_cols=65  Identities=20%  Similarity=0.202  Sum_probs=29.1

Q ss_pred             CCChhhhccccccceEecccCCCCCCchhhhhhccccceeccccccCCCCchhhccccccceeecCCC
Q 039419           93 GVPSSIGKLINLQDLILNSNQLTGEIPKELGACIKLKNLLLFDNYLSGNLPVELGKLVNLEVIRAGGN  160 (1035)
Q Consensus        93 ~~p~~i~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n  160 (1035)
                      .++..+..|++|++|+|++|+++ .++ .+..+++|++|+|++|.++ .+|..+..+.+|++|++++|
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N  103 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYN  103 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEE
T ss_pred             hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccc
Confidence            33444445555555555555544 332 3444555555555555444 33333333334444444433

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=5.8e-11  Score=113.21  Aligned_cols=134  Identities=15%  Similarity=0.061  Sum_probs=87.8

Q ss_pred             ccEEEcCCCccCCCCchhccCccccchhhccCC-cccccCccccCCCCCCcEEEcCCCcCcCccchhhhhhccCcceeec
Q 039419          441 LQVLDISVNQFVGLIPESFGQLASLNRLILSKN-SFSGAIPSSLGRCESLQSLDLSSNKLSGKIPVELFEIEGLDISLNL  519 (1035)
Q Consensus       441 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~l~~~L~L  519 (1035)
                      ...++.+++.+.. .|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+                   
T Consensus        10 ~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-------------------   69 (156)
T d2ifga3          10 SSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-------------------   69 (156)
T ss_dssp             SSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-------------------
T ss_pred             CCeEEecCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-------------------
Confidence            4456777777764 3555666777777777655 466666666777777777777777766                   


Q ss_pred             cCccCCCCCCccccCCccccEEeccCCcccCccccccccCCCcEEeccCCcCcccCCC--hhhhhccccccccccccCCC
Q 039419          520 SWNALSGAIPPQISALNKLSILDLSHNKLGGDLLALSGLDNLVSLNVSYNNFTGYLPD--SKLFRQLSATEMAGNQGLCS  597 (1035)
Q Consensus       520 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~~~l~~~~~~~N~~~c~  597 (1035)
                            ++.+.+|..+++|++|+|++|+|+..+.......+|+.|+|++|+|....--  ...|.......+..+...|.
T Consensus        70 ------~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~  143 (156)
T d2ifga3          70 ------FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCH  143 (156)
T ss_dssp             ------EECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCS
T ss_pred             ------CcccccccccccccceeccCCCCcccChhhhccccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEEC
Confidence                  3455667778888888888888888776544455788899999988643321  12233333344445666776


Q ss_pred             CCC
Q 039419          598 RGH  600 (1035)
Q Consensus       598 ~~~  600 (1035)
                      .|.
T Consensus       144 ~p~  146 (156)
T d2ifga3         144 GQG  146 (156)
T ss_dssp             SSS
T ss_pred             cCh
Confidence            554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.34  E-value=7.2e-07  Score=92.55  Aligned_cols=147  Identities=12%  Similarity=0.019  Sum_probs=97.5

Q ss_pred             HHHHHhccccCCeeeeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCcee
Q 039419          681 VEQVLKCLVEDSVVGKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIV  759 (1035)
Q Consensus       681 ~~~~~~~~~~~~~iG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv  759 (1035)
                      +....+.|...+..+-++.+.||+.... ++.+++|+........              ...+.+|...+..+. +--+.
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~--------------~~~~~~E~~~l~~l~~~vpvP   73 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT--------------TYDVEREKDMMLWLEGKLPVP   73 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS--------------TTCHHHHHHHHHHHTTTSCCC
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccc--------------hhhHHHHHHHHHHHhccCCCC
Confidence            4455566665554444445789998754 5667888875432211              224678888887774 43467


Q ss_pred             eEEeEEEcCCcceEEEEeCCCCChhhhhhhcCCCCCCHHHHHHHHHHHHHHHHHhhccC---------------------
Q 039419          760 RFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRDSCLEWELRYRIILGAAQGLAYLHHDC---------------------  818 (1035)
Q Consensus       760 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------  818 (1035)
                      +++.++.+++..|+||++++|.++.+.....    ..   ...++.++++.++.||+..                     
T Consensus        74 ~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~  146 (263)
T d1j7la_          74 KVLHFERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL  146 (263)
T ss_dssp             CEEEEEEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred             cEEEEEecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHH
Confidence            7888888888899999999998876543211    11   2234445555555555321                     


Q ss_pred             -----------------------------------CCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          819 -----------------------------------VPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       819 -----------------------------------~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                                                         .+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                               0248999999999999987767799998775

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.29  E-value=4.1e-08  Score=93.73  Aligned_cols=45  Identities=27%  Similarity=0.234  Sum_probs=24.7

Q ss_pred             chhccCccccchhhccCCcccccC--ccccCCCCCCcEEEcCCCcCc
Q 039419          456 PESFGQLASLNRLILSKNSFSGAI--PSSLGRCESLQSLDLSSNKLS  500 (1035)
Q Consensus       456 ~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~  500 (1035)
                      +..+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|.|+
T Consensus        58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~  104 (162)
T d1koha1          58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK  104 (162)
T ss_dssp             HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred             HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence            334445556666666666665332  233445566666666666665

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.21  E-value=6.2e-08  Score=92.39  Aligned_cols=85  Identities=20%  Similarity=0.065  Sum_probs=40.6

Q ss_pred             ccccceeecccccccCCccccccCcCCceEEecCCcCCCCC--ChhhhcccchhHhhcccccccccCCccccCCCCCcEE
Q 039419          199 SKLQSLSVYTTMLSGEIPPQIGNCSELVDLFLYENDLSGSL--PRELGKLQKLEKMLLWQNNFDGAIPEEIGNCKSLKTI  276 (1035)
Q Consensus       199 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~--~~~l~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L  276 (1035)
                      ..+..+...++... .++..+.++++|+.|+|++|+|+..-  +..+..+++|+.|+|++|.++...+-.+....+|+.|
T Consensus        42 ~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L  120 (162)
T d1koha1          42 NIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL  120 (162)
T ss_dssp             TCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSC
T ss_pred             cchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhcccccee
Confidence            33344444444333 33334445666666666666666432  2234445555555555555553222222233345555


Q ss_pred             EccCccCC
Q 039419          277 DLSLNFFS  284 (1035)
Q Consensus       277 ~L~~n~l~  284 (1035)
                      ++++|.+.
T Consensus       121 ~L~~Npl~  128 (162)
T d1koha1         121 WLDGNSLS  128 (162)
T ss_dssp             CCTTSTTS
T ss_pred             ecCCCCcC
Confidence            55555554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.07  E-value=3.9e-06  Score=86.33  Aligned_cols=76  Identities=20%  Similarity=0.217  Sum_probs=55.2

Q ss_pred             eeeeeCC-cEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC--CCceeeEEeEEEcCC
Q 039419          693 VVGKGCS-GIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR--HKNIVRFLGCCWNRN  769 (1035)
Q Consensus       693 ~iG~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~  769 (1035)
                      .+..|.. +.||+....++..+++|......                 ...+.+|+..++.+.  .-.+.+++.+..+++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----------------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~   79 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----------------LNELQDEAARLSWLATTGVPCAAVLDVVTEAG   79 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----------------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----------------HhHHHHHHHHHHHHHhcCCCCCceeeeccccc
Confidence            3445543 68999998888889999865432                 123667888887773  334677888888888


Q ss_pred             cceEEEEeCCCCChhh
Q 039419          770 TRLLMYDYMPNGSLGS  785 (1035)
Q Consensus       770 ~~~lv~e~~~~gsL~~  785 (1035)
                      ..++||+|++|.++.+
T Consensus        80 ~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          80 RDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             CEEEEEECCSSEETTT
T ss_pred             ceEEEEEeeecccccc
Confidence            8999999999877643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.52  E-value=0.00017  Score=78.63  Aligned_cols=83  Identities=12%  Similarity=0.117  Sum_probs=51.1

Q ss_pred             CeeeeeCCcEEEEEEECC-CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-C--CceeeEEeEEEc
Q 039419          692 SVVGKGCSGIVYRAEMEN-GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-H--KNIVRFLGCCWN  767 (1035)
Q Consensus       692 ~~iG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~  767 (1035)
                      +.||.|....||+++..+ ++.|+||.-.+.......     ..  ....++...|++.++.+. +  ..+++++.+  +
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~-----~~--~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d  102 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-----SW--PLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  102 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--C-----CC--CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCC-----CC--CCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c
Confidence            467999999999997664 678999976542211100     00  011345567888887662 2  356666654  5


Q ss_pred             CCcceEEEEeCCCCCh
Q 039419          768 RNTRLLMYDYMPNGSL  783 (1035)
Q Consensus       768 ~~~~~lv~e~~~~gsL  783 (1035)
                      ++..++|||++.+..+
T Consensus       103 ~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         103 TEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTTEEEECCCTTSEE
T ss_pred             CCCCEEEEeccCCccc
Confidence            5667899999977543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.49  E-value=1.5e-05  Score=75.77  Aligned_cols=87  Identities=15%  Similarity=0.153  Sum_probs=53.1

Q ss_pred             CCccceeecCCC-ccCCC----CcccccCCCCccEEEcCCCccCCC----CchhccCccccchhhccCCccccc----Cc
Q 039419          414 CTQLQMLNLSNN-TLGGT----LPSSLASLTRLQVLDISVNQFVGL----IPESFGQLASLNRLILSKNSFSGA----IP  480 (1035)
Q Consensus       414 l~~L~~L~L~~N-~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~  480 (1035)
                      .++|++|+|+++ .++..    +...+...+.|+.|+|++|.+...    +...+...+.|+.|+|++|.|+..    +-
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~   93 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL   93 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence            356777777653 34421    223455556777777777777532    223344556677777777777632    23


Q ss_pred             cccCCCCCCcEEEcCCCcCc
Q 039419          481 SSLGRCESLQSLDLSSNKLS  500 (1035)
Q Consensus       481 ~~~~~l~~L~~L~Ls~N~l~  500 (1035)
                      ..+...+.|++|+|++|++.
T Consensus        94 ~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHTTTTCCCSEEECCCCSSC
T ss_pred             HHHHhCCcCCEEECCCCcCC
Confidence            35666777888888888765

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.35  E-value=1.8e-05  Score=75.16  Aligned_cols=91  Identities=18%  Similarity=0.173  Sum_probs=45.2

Q ss_pred             CCCCcEEEccCc-cCCCC----CCccccCCCCCcEEEccCCccccCC----CCcccCCCccceeccccchhhhhhhhccc
Q 039419          270 CKSLKTIDLSLN-FFSGS----LPQSFGNLSSLEELMLSNNNISGSI----PPVLSNATSLLQLQLDTNQISVFFAWQNK  340 (1035)
Q Consensus       270 l~~L~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~i~~l~~~~n~  340 (1035)
                      .++|+.|+|+++ .++..    +...+...++|++|+|++|.+....    ...+...+.|++|+|++|.|+.-...   
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~---   90 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA---   90 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH---
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH---
Confidence            455666666553 34321    1223444555666666666654221    12233445566666666655432210   


Q ss_pred             cCCCCCcCCCCCCCCcEEeccCcCCC
Q 039419          341 LEGSIPSTLANCRSLEAVDLSHNALT  366 (1035)
Q Consensus       341 l~~~~p~~l~~l~~L~~L~Ls~N~l~  366 (1035)
                         .+-.++...++|++|+|++|.+.
T Consensus        91 ---~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          91 ---RLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             ---HHHHHTTTTCCCSEEECCCCSSC
T ss_pred             ---HHHHHHHhCCcCCEEECCCCcCC
Confidence               12234555666777777766554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.80  E-value=0.0015  Score=68.98  Aligned_cols=136  Identities=14%  Similarity=0.131  Sum_probs=78.0

Q ss_pred             CCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCCCce--eeEE-----eEEEcCCc
Q 039419          698 CSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRHKNI--VRFL-----GCCWNRNT  770 (1035)
Q Consensus       698 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~-----~~~~~~~~  770 (1035)
                      ..-.||+++.++|+.|++|+..+...               ..+++..|...+..|...++  +..+     ..+...+.
T Consensus        34 ~EN~vy~v~~~dg~~~VlK~~rp~~~---------------s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~   98 (325)
T d1zyla1          34 YENRVYQFQDEDRRRFVVKFYRPERW---------------TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGF   98 (325)
T ss_dssp             SSSEEEEECCTTCCCEEEEEECTTTS---------------CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTE
T ss_pred             ccceeEEEEcCCCCEEEEEEeCCCCC---------------CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeE
Confidence            34689999999999999999865421               24567788888887742222  1111     11233556


Q ss_pred             ceEEEEeCCCCChhh-----h---------hhhc----C---CCCCCH-------------------H---HHHHHHHHH
Q 039419          771 RLLMYDYMPNGSLGS-----L---------LHER----R---DSCLEW-------------------E---LRYRIILGA  807 (1035)
Q Consensus       771 ~~lv~e~~~~gsL~~-----~---------l~~~----~---~~~l~~-------------------~---~~~~i~~~i  807 (1035)
                      .+.+++|++|..+..     +         ++..    .   ....+.                   .   .....+..+
T Consensus        99 ~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  178 (325)
T d1zyla1          99 YFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDEL  178 (325)
T ss_dssp             EEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHH
T ss_pred             EEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHH
Confidence            788999997754321     0         1110    0   011111                   1   111222223


Q ss_pred             HHHHHHh-hccCCCCeeccCCCcccEEEcCCCceEEeeccCccc
Q 039419          808 AQGLAYL-HHDCVPPIVHRDIKANNILIGPEFEPYIADFGLAKL  850 (1035)
Q Consensus       808 a~~L~~L-H~~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~~  850 (1035)
                      ...+... .+....+++|+|+.|.|||++.+  ..++||+.+..
T Consensus       179 ~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         179 IAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             HHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            3322222 12233479999999999999743  45899998763

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.54  E-value=0.00011  Score=69.43  Aligned_cols=111  Identities=17%  Similarity=0.106  Sum_probs=66.6

Q ss_pred             CCCCcccceEeecC-cccCCCCC----CCCCCCCCCceeeCCCCCCCCCCC----hhhhccccccceEecccCCCCCC--
Q 039419           50 LSSLSFLQKLIISG-SNLTGPIS----PDLGDCTQLTTIDVSSNSLVGGVP----SSIGKLINLQDLILNSNQLTGEI--  118 (1035)
Q Consensus        50 ~~~l~~L~~L~L~~-~~l~~~~~----~~~~~l~~L~~L~ls~n~l~~~~p----~~i~~l~~L~~L~L~~n~l~~~~--  118 (1035)
                      ..+.+.|++|+|++ +.++...-    ..+...++|++|+|++|.+.....    +.+...+.|+.|++++|.+....  
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence            34557788888887 45654332    334467788888888888764322    23455677888888888776432  


Q ss_pred             --chhhhhhccccceec--cccccCCC----CchhhccccccceeecCCC
Q 039419          119 --PKELGACIKLKNLLL--FDNYLSGN----LPVELGKLVNLEVIRAGGN  160 (1035)
Q Consensus       119 --p~~l~~l~~L~~L~l--~~n~l~~~----~p~~l~~l~~L~~L~l~~n  160 (1035)
                        ...+...++|+.++|  ++|.+...    +...+...++|+.|+++.+
T Consensus        93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~  142 (166)
T d1io0a_          93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred             HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence              234455566776444  45555432    2333445566666666544

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.42  E-value=0.00043  Score=65.21  Aligned_cols=39  Identities=15%  Similarity=0.212  Sum_probs=21.2

Q ss_pred             cCCccccEEec--cCCcccCc-----cccccccCCCcEEeccCCcC
Q 039419          533 SALNKLSILDL--SHNKLGGD-----LLALSGLDNLVSLNVSYNNF  571 (1035)
Q Consensus       533 ~~l~~L~~L~L--~~N~l~~~-----~~~~~~l~~L~~L~ls~N~l  571 (1035)
                      ...++|+.++|  ++|++...     ...+...++|+.|++++|..
T Consensus        99 ~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          99 QSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             GGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            34455655433  45555431     13355567777777776654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.08  E-value=0.0092  Score=62.26  Aligned_cols=152  Identities=12%  Similarity=0.050  Sum_probs=79.9

Q ss_pred             HHHHHhccccCCee-----eeeCCcEEEEEEECCCcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCCC
Q 039419          681 VEQVLKCLVEDSVV-----GKGCSGIVYRAEMENGEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIRH  755 (1035)
Q Consensus       681 ~~~~~~~~~~~~~i-----G~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  755 (1035)
                      ++.+++.|..++..     ..|---+.|+.+..+|+ +++|++.....                .+.+..|+.++..+..
T Consensus         8 l~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~----------------~~~l~~~~~~l~~L~~   70 (316)
T d2ppqa1           8 LRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE----------------KNDLPFFLGLMQHLAA   70 (316)
T ss_dssp             HHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-------------------CCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC----------------HHHHHHHHHHHHhhhh
Confidence            45666777765543     45666889999887654 89998754211                1245567777777642


Q ss_pred             Cce--eeEEe------EEEcCCcceEEEEeCCCCChhhh--------------hhhcCC-------CCC-----------
Q 039419          756 KNI--VRFLG------CCWNRNTRLLMYDYMPNGSLGSL--------------LHERRD-------SCL-----------  795 (1035)
Q Consensus       756 pni--v~l~~------~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~-------~~l-----------  795 (1035)
                      .++  ...+.      +....+..+.++.++.|......              ++....       ...           
T Consensus        71 ~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (316)
T d2ppqa1          71 KGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDK  150 (316)
T ss_dssp             TTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHH
T ss_pred             ccccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhH
Confidence            222  11111      01123445667777766444211              000000       000           


Q ss_pred             -------CHHHHHHHHHHHHHHHHHhhc-cCCCCeeccCCCcccEEEcCCCceEEeeccCcc
Q 039419          796 -------EWELRYRIILGAAQGLAYLHH-DCVPPIVHRDIKANNILIGPEFEPYIADFGLAK  849 (1035)
Q Consensus       796 -------~~~~~~~i~~~ia~~L~~LH~-~~~~~ivHrDikp~NIll~~~~~~kl~DFG~a~  849 (1035)
                             ........+..+...+...+. ....|++|+|+.++||+++.+...-|+||+.|.
T Consensus       151 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         151 SEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                   000011122222223333322 123489999999999999988777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.01  E-value=0.0085  Score=64.74  Aligned_cols=74  Identities=12%  Similarity=0.204  Sum_probs=49.2

Q ss_pred             CCeeeeeCCcEEEEEEECC--------CcEEEEEEecCCCcccccccccccccccccHHHHHHHHHHHhcCC-CCceeeE
Q 039419          691 DSVVGKGCSGIVYRAEMEN--------GEVIAVKKLWPTTMAAEYDCQNDKIGIGGVRDSFSAEIKTLGSIR-HKNIVRF  761 (1035)
Q Consensus       691 ~~~iG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l  761 (1035)
                      .+.|+-|-.-.+|++...+        .+.|.+++.....                ......+|..+++.+. +.-..++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----------------~~idr~~E~~i~~~ls~~gl~Pkl  110 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----------------TESHLVAESVIFTLLSERHLGPKL  110 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----------------CHHHHHHHHHHHHHHHHTTSSSCE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----------------hhhHHHHHHHHHHHHHhCCCCCeE
Confidence            3578888999999998654        3557777664211                1123457888888884 4444577


Q ss_pred             EeEEEcCCcceEEEEeCCCCChh
Q 039419          762 LGCCWNRNTRLLMYDYMPNGSLG  784 (1035)
Q Consensus       762 ~~~~~~~~~~~lv~e~~~~gsL~  784 (1035)
                      ++++.+    .+||||++|..+.
T Consensus       111 l~~~~~----g~I~efi~g~~l~  129 (395)
T d1nw1a_         111 YGIFSG----GRLEEYIPSRPLS  129 (395)
T ss_dssp             EEEETT----EEEECCCCEEECC
T ss_pred             EEEcCC----ceEEEEeccccCC
Confidence            777643    6899999876553